>AAS90609.1|FEATURES|farme|aminoglycoside|AAC(6')-I30|antibiotic inactivation|1
MSENPAIHIQDLTADDETAIQQVAAMLTEGFREHWWDAWPTLEEAVEEVRESFTEERISR
IARDSSGAILGWIGGQPTYAEVWELHPLVVRVDQQRRGVGRLLVADLEQQVKERGGLTLM
LGSDDQDEMTSLSGVDLYPDPWPHIAKIQNFKDHPYSFYQKLGYAIIGVVPDANGFGKPD
ILMAKRLA
>AAS90611.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSPKFLRIAVVLGLLSAIGPFAIDMYLPALPSIGEDLHAGTAAVQMSLLIFFLSMGFGQI
VVGPISDMVGRKLPLYGGLALFMVGGIGSAMAPTIEWLIAFRFLQGLGASAGMAVPRAIV
RDLHTGTEAAKLMSLLMLVFSVSPILAPLTGSQIIENFGWRAVFWTVTGAALLATILLAT
SLKETRPAEERVGSSFGTALAGYRFLMGDLNFLGLVAIAGFGIASFFVYLSSSSFILIDH
YGLSPSVYSVFFSINAVAFIGMSQLTGMLSERFGLKRVVWVAVTGYATTMVVLFAIMATG
VDRLDVMAALLFVGYGFLGLVIPTTSVLAMEEHGEIAGTASALMGTLHFAIGALAMGVAG
IFFNGTPLPMVAGITLCAVISFTLAKLTLGRTREAAEAPAE
>AAS90614.1|FEATURES|farme|aminoglycoside|AAC(6')-Iih|antibiotic inactivation|1
MEITTLTSDNDRLIHQAAQLLVDAFREHWPDAWPTMEEGLKEVGEMLETGRICRVAVDEK
GSLLGIIGGIPGYDGNVWELHPLAVQPLLQGQGIGQRLVEDFEVQVRSKGGLTITLGTDD
EDGMTSLANTDLYENLWEKIRDIRNLKGHPFEFYQKIGYIISGIVPDANGPGKPDILMAK
RVR
>ACH59002.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MKTIFGKRRQSAVVLITLIAILLASGQPYQSSQVRGAACLPDIIFDEPSQGPEKNEAISM
LTERLSSIINAAGGDIGIAVIHVETGHTTAIQGTTQLPLYSVFKLPLAIAVLKEIEENRL
QLDRKVRVTPADVAPGWTANAAMWRRPIDRTVAQLIEVSIIRSDNTSSDKLLQLVGGPAA
VTHRMRALGFPNIEIVSTVREFSENRTRPNTGSAEDLARLLVQLQKGELLQPQHSALLLG
FMHRATTGTERLRGSLPVGTPVADKTGTGDAGVVTNDVGIITLPKGQGHLAIAVLISGSK
LSPAAQEKLIAEIARAAYDAHVSRAE
>ACH58998.1|FEATURES|farme|beta_lactam|LRA-7|antibiotic inactivation|1
MRSKFLLATALVLSTAFTADAADAPKRLPVNITNQDWLKPFPGFKIVGNMYYVGTYDLGC
YLIDTGAGLILVNTGIMGSYPLMKASIESLGFKTSDIKIITATHGHSDHVADMASFKKDA
PSAVVYMSERDVESLESGGNFDYRRPAPEGRGGLVYDPIHVDVKTKPGDHIKLGNVDMTV
LQAYGHTPGATSFQFQQTDAGKTYNVMIVNMNGINAGVKLLGSPKYPTIVEDFKNTIDMQ
ATYKPDIWVSSHAGQFNLHQVYKPGDAYNPARFGDQAAYQQKIATAKANYEKQLAEERAA
AK
>ACN58929.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MNWHAVWSIYYFEMARAWRTLSQTIVSPVISTSLYFVVFGAAIGSRITEIEGVSYGSFIV
PGLIMLSLLTQSIANASFGIYFPRFTGTIYEILSAPVSYVEVLLGYVGAAASKSIILGFI
ILATAALFVPVHIAHPFWMIAFLVLTAITFSLLGFILGMWADGFERLQIVPLLIITPLTF
LGGTFYSINMLPPFWQKVTLANPVVYLVSGFRWSFYEISDVSVSLSLAMVAAFLAVFLGI
IGWIFKTGYRLKT
>ACH58994.1|FEATURES|farme|beta_lactam|LRA-17|antibiotic inactivation|1
MSIFRTILFVSILLLTSLANSPHATAQVTNTDRPEWSKPYKPFRIAGNIYYVGTYDLACY
LITTPQGHILINAALAGTVDQVKANVEALGFKFSDIKILLISQAHFDHVGGLAAIQKMTG
AKVMIDDQDAPVVEDGGNSDYIYGGKGVGSLFAPVHVDRKLHDHDNITLGGTQLEMLHHP
GHTKGSCSYLLTVKDEHRSYRVLIANIPYMLSEVTLPGMPTYPNVGKDFMYTYGAMRKLQ
FDIWVAAHSSQFGLQDVRKETDGYNPGAFGDKKKYLTTIDKTEDIYKEHFKGGK
>ACN58789.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MNFRAVKTIYYFEMARAWRTLAQTIVSPVISTSLYFVVFGAAIGSRMQQIEGVPYGAFIV
PGLIMLSLLTQSIANASFGIYFPRFTGTIYELLSAPVSYVEVLLGYVGAAASKSIILGLI
ILATAALFVPVHIAHPFWMIAFLLLTAITFSLLGFILGVWADGFERLQIVPLLVITPLTF
LGGSFYSINMLPPFWQKVTLANPVVYLVSGFRWSFYEISDVSVGVSLAMVGVFLTLFLGI
IGWIFKTGYRLKS
>ACN58749.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MESFYATKIDEFAKGKISRRALLESLTVAVTTTAATASTAANAAASDPALKVALVNHISY
NCPDFKKGADWYSKVFSLDQIGTTKIDTALPFGKKGEKPFGVTAGDVPLTSIIVRTRDLN
APAQGGGAPRRKSQALIEHMGYTVADFDREKAKVQLKALGVENVRDGGLYSLHMTDAFGY
DVQISGIANNALSDGA
>ACH59005.1|FEATURES|farme|beta_lactam|LRA-19|antibiotic inactivation|1
MNSEMSQTSFKIRILVTCLLSIAQLTMAQQVQVTEPPITNQDWVKPYPPFRIVGNLYYVG
TYDLACYLIVTPQGNILINTGLASSAPMIEASIKALGFKFSDTKILLTTQAHYDHVGAMA
AIKKSTNAQLMIDEKDSPVMADGGSSDYELFGSTGSTYEPVKADRLLKNGDKITLGGTTL
VMLHHPGHTKGSCSFLFDVKDESKSYKVLIANMPSIITSKKFSDIPTYPGIAEDYTYTFD
AMKKVHFDIWLSSHASQFGMHSKHKPGEAYNPGVFIDRAGYDKAVGDLEDKFSKKKQADK
>ACN58844.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQNDKEIVIDIKGLYKSFGNNHVLRGVDLQVERGENVVVLGRSGTGKSVLIKMICGLLTQ
DKGDIIVLGEDVKNITHKKLEELRLRVGFSFQLSALYDSMTIKENIAFPLKRNFKHLSKK
EVNDRVDEMLNAVSLIKSKDQYPAELSGGQKKRIGIARTLVLRPEIMLYDEPTAGLDPIS
SIEINSLIHNIKEEFNVSSIIITHDLVCAKTTGDRLVMMFDGVVQKQGTFEEVFDSDDER
IKSFYEYNFI
>ACN58777.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MDMLAATAAPDTARDAPDGDDTPLIELQGVTKTYFNGDLSVEVLHGVDLKIYAGELVAIM
GASGSGKSTLMNLLGCLDRPTTGTYKFMGHDVSDFDRDELAELRREAFGFVFQSYNLIAT
GTAAENVEVPAVYAGLLPAERHTRAKELLERLGLSDRAHHRPNQLSGGQQQRVSIARALM
NGGRVILADEPTGALDSKSGADVMRLLDELSAQGHTVILITHALEVAQHARRIIEIKDGD
IVADPGPSKPAAGELARHWTPRKGKESHLAEGLEAAKTALRALKANVFRSILTLLGIVIG
VASVIAMLAIGDGAKQAVIDRISAMGSNLLLVRPGAPNQRGFNGTATLVLADVKAIDEEV
PNVLAAVPEQQSNATLRYEGRDYSTQVNGTSAKFPLARQWKVAKGSFFTEDDEEDYATVA
VLGRTVADALFPDGEDALGKFVVVNNVIFQVIGVMSVRGASPIGQDQDDVVFVPYATSQL
RLSGQRFLRNATVAVNDVTRIDATQSAMESLLAERHGTVDFQVRNMASIMETATETQNTM
TILLGSIAAISLLVGGIGVMNIMLVSVTERTREIGIRMATGARTRNILQQFLIESLVVSS
MGGAIGVVIGLSVAALIAAFGTPVEYSVGPVLLAFGCAFATGLVFGYLPARKAAYLDPVV
ALASE
>ACH58985.1|FEATURES|farme|beta_lactam|LRA-2|antibiotic inactivation|1
MMDGIKKKTAAGAAAGSLLMMLGVFATPAAGGEAAFKDCPQCAQWNQQRKPFRIYGNTYF
VGTAGLSSILVTSDYGHVLIDGGLAQSAPLIKANIEALGFKLTDVKAILVSHVHPDHAGG
VAELQRQSGAQVYALRTAEAVLRTGRLTQDDPQSASKTATITPVPQVWVVQDDQLLGVGA
LRMRAIATPGHTPGGTSWTWDACEDGNCLKMIYADSLSAVAAGKYRFKDHPEVLQAFASS
FSRAESAPCDVLLTPHPDASQLFQRLDPEGGTRAASIKDDTACRRYVQAARDTLARKLAS
EG
>ACS83741.1|FEATURES|farme|aminoglycoside|AAC(6')-IIc|antibiotic inactivation|0
MFALRVDDEIELRLLEEHHAEEIFAVVDTNRAHLREWLAWVDEEVSANEAKDYIKMMRER
FAAFTGVAMGIWHQDRLVGAMSFVNIDQQSRWAEIGYWLGAPSQGRGIITRSCRAIINYA
FDDLKLNRIVIRCADGNHRSRAIPERLGFLQEGRLRQTIWLYDRFWDALIYGMLAGEWKA
QKQKGQV
>ACS83738.1|FEATURES|farme|aminoglycoside|AAC(6')-I30|antibiotic inactivation|1
MESQVEVCQKARKLTRLYRHSQSEVSVRIIDFPQEESQLIRQSAELLVEAFKQHWPKAWP
TMQDALETVHESFAENRLCRVALDDGGGVLGWIGGIESYDGKVWELHPLAVSPRAQGRGI
GRMLVEDLEAQVAARGGLTLWLGSDDEDGMTSLGGIDMYPNPLEHLAKIKNLRGHPYGFY
QKLGFVITGVMPDANGFGKPDIYLAKRVAQSKESTKNHAAFKLRVNDEIEIRMYEESDAE
TVFALVDRNREHLREWLIWVDATNSQEVTLQHIRDFERHYENKVALSAGIWLKGELAGAI
GVVGYHWHNRVMEIGYWLSASQQGKGIMTKAVSAMIDNAFNNLGLNRVEIHCASGNTRSR
AIPERLNFKQDGVMREAGLVNGQFVDKVIYSMLASEWKTYNQS
>ACT97678.1|FEATURES|farme|aminoglycoside|LS81_08155|antibiotic inactivation|1
MLKIAEKEDVPVAAELAGMLWPHHSREELEGELLSFIESGGMVFLWMEEGNPVAFAQCGI
RTDYVEGTHGGAIGYLEGIFVLEKFRRRGIGKVLLTACEEWAKEQGCEEFASDTELDNAE
GLSFHSGAGFYEANRIVCFVKNL
>ACT97592.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKNPKRNIAIVCGGDSSEHDVSMRSAQGLYSFFDKERYNVYIVDVKGLDWNVHFEDGTTA
PIDKNDFSFLVNGKLVVFDYAYITIHGTPGENGIMQGYFELLHIPYSTSGVLVEAMTFDK
FVLNNYLRGFGVNVADSLLLRRGEEDKYSEAEIASRIGWPCFVKPAADGSSFGISKVKNA
DQLAPALRVAFMESDEVMIERYLKGTEISVGCYKTKNKSVVFPATEVVTSNEFFDYDAKY
NGQVEEITPARLNPETAERVAEETSKIYDILHCNGIIRIDYIISQDQNGRDVINMLEINS
TPGMTATSFIPQQVRAAGLDIKDVLTDIIENQMS
>ACT97567.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGNKVPVD
RNDFSFTNGTEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFTC
NQYLKAFGVRIAESLLLRQGQSVSDEEVVEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQP
AIVKAFGEAEEVIVEAFMDGTELTCGCYKTKEKSVIFPPTEVVTHNEFFDYDAKYNGQVD
EITPARISDELTKRVQMLTSAIYDILGCSGIIRVDYIITAGEKLNLLEVNTTPGMTTTSF
IPQQVRAAGLDIKDVMTDIIENKLEVLSIKYKVLTILIDAV
>ACT97564.1|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MLYSIRYAQENYTIRDCVWKRGLIMNIVVLAGGTSTERDISILTSTKVCESLRRNGYNAN
IVDVFFGIDSENVDNFFNNDNDLEKLCKYLKNQTPDVEKELEARKALGKGFFGDNVLELC
QKADIVFMGLHGSNGEDGKIQAAFELMGIKYTGTDYISSAISMSKELTKKVLVPEGIPMP
KGIALHKGHKVEYVPFPCVVKPCCGGSSVGVSIVNSEEEFKRALTDAFSYEDNILVEEFI
KGREFSVGVLNGKALPVIEIEPLDGFYDYKNKYKAGATKETCPANLPKEISEKMQRWAEK
ACETAGVTTYARVDELLNEDGDIYCLEINTLPGMTGTSLLPQEAAAVGMSYDELTKKIIE
ISLEKYN
>ACT97532.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MRDEYNMRRRLVVKGFNAMGLTCFEPRGAFYAFPCIKSTGMTSQEFCTRLLEQKHVALVP
GDAFGASGEGYCRVSYAYSVEHLTEAMKRIRAFLEENGIAMPQ
>ACT97526.1|FEATURES|farme|chloramphenicol|catD|antibiotic inactivation|1
MVFEKIDRSSWKRNEYFENYFTNIPCTYSMTVKLDITQIKKKRMKLYPAMLYYLATIVNR
HSEFRTAINQEGELGIYDEMIPSYTIFHEDTETFSNLWTPYIPDFEAFSMAYANDMQRYG
SNYGMIGKPDVPENVFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYRDDEKIILPL
AIQVHHAVCDGFHICRFVNELQELINS
>ACT97467.1|FEATURES|farme|beta_lactam|CcrA|antibiotic inactivation|1
MKIITTIYLSVVLTFLTGCTTMKKLSSGTTVYRYANGFVTDSDNKIVAHYANGFVTKYSD
VVNQKHIKINDDLELFRLTPVCYLYTAWANMGRWGRVGSNGLVVIGKGKALLIDSPTLES
QIVELAWWFDKNLNVTFESFIPGHWHGDGVGGLAWLNRNGIKSYANRLTNNILASKGLEQ
SNVSFSDSLLLKVGNIKIEAYYLGGGHTVDNIVVWIPSQKILFGGCMLKDMETLNIGNIS
DAAPLEEWLQTVDRVERQFPNVEYVIPGHGKYGGKELFKHTKTIIENERQSKMNK
>ACT97463.1|FEATURES|NCBI|multidrug|MexB|antibiotic efflux|1
MALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALS
AKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGS
RIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSKKQ
>ACT97458.1|FEATURES|farme|beta_lactam|BL2e_cepa|antibiotic inactivation|1
MKTNRLILLLFILFPAYVLAGNRFQELYTNIHQFISQQKAEVGVAIIADGKDTVTIENNR
RYPLMSVFKLHQALAVGDYCKRHQLSFDTLLTVDSTDLQPNTYSPLRDRYPHGGKFSLKQ
LMEYTLHLSDNNACDILFKFTGGPAVTDRYIRSLGINDFSIQYTEDDMHQDLNLGYENWS
TPLATAEVIEALLTRTLFDKPHQEFIKEALVTCQTGTSRIVHPLQDKQVTVGHKTGTGDR
NASGQLIAINDAGFVQFPNGHRYTLVVFVKDSQESMEDTEAIIAQISEMVYQAFSNP
>ACT97607.1|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM
>ACT97593.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MTEKKTVALLCGGRSSEHPISLITAAGVLGAIDRTAYDVITIGITRDGRWYLTDEQQLAE
LTAGTRGTAEFPEGTQQVFLPMGAGDSRLTLVDAEGNVTRTAPVDVVFPLLHGPFGEDGT
VQGLLEMADLHYVGCGVTASAVGMDKHFMKVAFESAGLEVGPYEVVTNRQWEHEDREQIL
ERVLKLGFPMFVKPTRAGSSFGITKVDSVEELVPAIEEARRHDPKIIIEAGIVGREIECA
VLDGHHGEMPRASYPGEIEVVDQDHGFYDFEAKYVSESSAVTVCPANLPQDVQDRLRELA
VKAFLALDGEGLSRADFFYTEDGRLVINEVNTMPGFTPISMYKTMWENTGISYTDLISEL
LTLAMERPLGLR
>ACT97559.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVCGGDTSEFEVSLRSAQGIYSFIDKERYTLYIVEMRGTDWHVQLPDGTKTPVD
RNDFSFRLDGAKVVFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAAALTYDKFAC
NQYLKAFGVRIADSLLLRQGQSVSDEDVIGKIGLPCFIKPSLGGSSFGVTKVNVKEQIHP
AIAKAFAEAKEVLVEAFMDGMEITCGCYKNKEKSVVFPITEVVSHNEYFDYKAKYNGESD
EITPARIPDELRDRVQKLTSAIYDILGASGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAANLESKDVMTDIIENQL
>ACT97555.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLSDSEHKMCVVVLFGGMSSEHEVSRVSAGTFVDQLDRQRYELLTIGITKDGRWLYTEAT
SAQMADGSWEELPGNMPCVVSPDRADHGLILFTPAGQVEKVRADVVIPVLHGLWGEDGTV
QGLLELAGIPYVGCGVLASAVCMDKAVANAMFDASGIPHTKWLSATRWEIECDPEGVCDG
VIAKLGWPIFVKPANAGSSVGITKAHDRTELKEAIRLALANDRKVVFEAFVDGHEVECAV
IGSDPAVSTRPGEILAGAEFYTYDDKYKNGVSQVVIPAKLPEEKLDEVKTYAAMAYTALG
CEGLARCDFFVEKNTGRVLINEINTLPGFTPISMYPKLMEHEGIPVPALIDRLIALALER
TEKQHG
>ACT97550.1|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKIAVLCGGRSSERDVSLSTGIQVARALRETGHDVVLVDACVDFPLDCRPEEVFEKALPI
ENHAIGAAAPCVERFFDRASGFFGKNVLEICKSADIVFNALHGDEGENGKLQAVFDLLNI
CYTGSGAQGCMLAMNKSLSKQLFRTHGIPTPEAVILSESDKCRAAELCEKLGLPCVVKPA
SLGSSVGVSIVRTIDEFFTALDSAFSLEHTVIVEKYIKGREFAVGIVGSRVLPAIEIIPK
HGFYDYKNKYQPGCTVEICPADIDSDTAERMAEATRKVFRVLGLGAYARADFMVDENGIY
CLEANTLPGMTPVSLLPQEAAADKLDFPALLEAIIKESLLLRATERRH
>ACT97548.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMKETIAVLFGGQSSEHVVSCMSAANVIDQIDKDKYDLLLIGITEEGEWILTPSVEEIRN
DTWRDGRTHAVLSPDATRKCVIISEGDATKEVRVDVVFPVLHGLRGEDGTVQGLLELARI
PYVGCGVLASAVSMDKLYTKLIVDSLGIRQADYVPVRRSQLQDMNSVIASVENKLSYPVF
VKPSNAGSSRGVNKADNREELVFALNEAAKHDRKILVEETIIGHEVECAVFGGGLQEVKA
SGVGEIMAAAEFYDFDAKYYNAESKTVVDPELPGHAAEEKKKAAVEIFKAVDGYGLSRVD
FFVTDAGEVVFNEINTLPGFTAISMYPMLWEARGISKSRLVDDLINHAKERYDV
>ACT97530.1|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKRIIAIVAGGDSSEHDVSMRSAEGIYSFIDKDKYTLYIVELTKEKWEALLPDGSRAQID
RNDFSFSHDGQKVKPDFAYITIHGTPGENGILQGYFELLGIPYSTCDVLVSAMTFSKFTL
NQYLKGFGVRVAESMLVNKHHGISNEDVIEKIGLPCFIKPNASGSSFGVTKVKTAEQIQP
ALEKAFAESDDVMIEAFMDGIELANGCYKTKDKSVVFPITEVVSKNEFFDYNAKYNGEVT
EITPARLSPELTDRVQKLTSAVYDILGCKGIVRVDYIITEGEKINMLEINTTPGMTATSF
IPQPGSCSRYRYQRGYDRYYRRFVSEITRNYVYLNCD
>ACT97465.1|FEATURES|farme|beta_lactam|BL2e_cepa|antibiotic inactivation|1
MRITKKRSPRLILQSLVKNGCPYIIICIWCVLSGGCVQNKSQDSLKTLKTEIRHIIKDKK
ATIGVALILDGEDTLAINNAEKYPMMSVYKFHQALAVCDYLQKRHIPLSTSLYLDKKYFK
PDTYSPLRDKYPQGNLELPISELLVYTMQSSDNVACDILFDYIGGVNVVDEYIHSLGIND
VSITATEDEMHQDMDDCYKNWTTPMEAANLLELFMTQDFMRNEYTDFLKHIMIECGTGKD
RLPAPLPESEVKIGHKTGTSDKNDRGEYIGINDIGFVILPDGSRYVVAVFVKDSKENMET
NAKIISDISAAVYRYAGNR
>ACT97450.1|FEATURES|farme|beta_lactam|CfxA6|antibiotic inactivation|1
MSNYSVAELRNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSIS
QIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVK
INREKLDPKTWSPMMKDYSAPVISLTVKRSVALYSFPERQ
>ACT97382.1|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKRFLMSAVCSFYSIMAFGQIQIGDIKEVIQEKKATVGVAILYQDKIFTLSDNQQYPLMS
LFKFHVTVAVLKKMDREHIPLDSTVYITREQMHENTYSPLRNKYPNQGIHISLRDIITYT
IIYSDNNTCDWLIDFAGGIKKVDTFIKSLGIKKLNLTETEHSMHENIMNSYNNWSSPLSV
VQLIKKIYTDEILSATSFAFLEETMLNCSSGENKLKAGLPPNVKIGHKTGHSDRTSDGLQ
ISETDAGVIYLPDGERCYIAVLIKNSLESDETNARIMADITRVIYHSLQK
>ADI87846.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MEKNQHISLHKVSTNNLKQIDVTIPLNQLTVVTGVSGSGKSSLVFDTLYAEAYRRFVDSL
SSYARQYLKTLPKPDLQSVSNLPPAVAVKQGRSPANQRSTVGTLTELTHLIQTLFMHLGK
IQCYKCGRPVQKDHARSIVDNLLQDISTDTQLAIMAPLKGWSGLKGSALKKQLQEQGFVR
VSLDSEIFSLEDIDLKKIHSSNVIIDRLKCKPDEKTRLTEAVELALKVGRGLCLVGLPKE
ELRFSNALECTHCRINYLPASMVLFSFNHPLGACDSCHGYGRIANLDWDKVIPDKNSSIA
QDGIAPLNFGSHAEYYSEIKKSAKKLRIDLKKAFHQYTEREWQWLREGSGADFGGMKAYF
EWLNSKKYKAHYRIHAAKYNKYEICPSCNGRRYCRDALVYKIEGKNISDVHEMAIKDFKT
WLSVFNNAQEASKSSPEPIAGLSEALEEIESRIRYLVKVGLSYLNLNRVSGTLSGGELQR
IHMASCIGSSLTDTMYCLDEPTAGLHARDSQNLLDVICELRDQGNTVVIVEHDKQIMNGS
DFLIEIGPGSGHLGGHISYEGKAKSRSSAMPYPERPARKFGSYLKLEGAKTHNLKNIGVE
FPMGGLSVVCGVSGSGKTSLIQHTLFPMLESALGNRPMETIPAKSIGPKSVLDKIAQVLF
IDQKTLARSSRSNIATYLGIFEAIRKLFSSQERAKELKLGPGSFSFNVPGGRCETCKGLG
TVIEDLSFLGEVQVTCPQCEGKRFSSQVLSVTVRGQNLLQILSLTVHQAFELFYDHGEIR
DVLKPIIDLGLGYLTLGQSTNSFSGGEAQRLKLLSLLKETHSKSKSMLLIFDEPTTGLSD
KDVYNLWKHLDFLTQKGHTVIVIEHHLDMIRHADWLIEIGPDAADLGGQVVYQGSPGGIF
SAPLSKTAPFLKS
>CBI71210.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MTNDLTIRSATADDAALIVQFVAALAAYEKLSHEAKATEADITRDLFGADPRVFCEIAEW
QGRPVGFTLWFYTYSTFQGRHGIWLEDLFVDPSLRGKGIGKALLVNLARRCVTEGLGRFE
WWVLDWNEPSIEFYKSPGVGVDARTKWTKVRVDGDALRRLGAS
>CBI71185.1|FEATURES|farme|beta_lactam|PMI41_04644|antibiotic inactivation|1
MIPKTAAVLTASLFATCASVTLSHAADDANRVKSFVDAAIQPVMEKNTIPGMAVGVIADG
KSYIFEYGVTSKDTGKAVTASTIFEIGSISKTFVVTLATYAQANGQLSLSDPASKYLPAL
KGTEFGKVPLYHLGTHTPGGFPLQVPDNIKNDDQMMSYLKNWKPAYKAGTTRTYANPSIG
MLGVIAAKSMNEDFTALMEGTLFPALGLASTYINVPKSKMKDYAQGYTSKDKPARVNKAV
LSSEAYGVKTTAPDMVRFMQANMNMVKLENKLQRAIADTHRGYFKVGAMTQDLLWEQYNY
PVSLNALRLGNSREISSKPVPVEQIDPPIAPRSDVWINKTGSTNGFGAYVAFVPEKKIGI
VILANKYYPNEERINAAYEV
>CBI71190.1|FEATURES|farme|aminoglycoside|AAC(3)-IIIb|antibiotic inactivation|1
GKWAGTRGADMIIAALRDAVVLGYGAAYADWQGMDDVLADDAVFNDPALRPEIPPFDPKT
SRATRDNGSFPELLRTTPGALRSGSPGASCVAIGGRAEWFVADHALDYGYGPDSPFGELV
AAEGKVLMLGAPLDTMTLLHHAEHLADIPSKRIRRYEAPILIEGETVWRQFEEFDTSDPV
VASLPDDYFALIVEEFLGTGRGVRGNVGAATSVLVPAAEIVPFGVQWLETRFRK
>CBI71176.1|FEATURES|farme|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
MASQYYVHHLGQDDSELMNALLSVFGAAFNEVETYVGKRPGPEYIRRLLGSDYFIALAAL
EDNEVVGGIAAYHLKKFEQERKEIYISDLAVAEEHRRKGIATGLIRKLRKIAAARGAYVI
FVQADTGVEDEPAIALYTKLGVREDVLHFDIAVEDGDDAAAHANE
>AEC04637.1|FEATURES|farme|beta_lactam|bcere0023_30080|antibiotic inactivation|1
MWREVKQHMSNKFIKRVVKMKYWKILSLVFCTFAFAVNCKAHAGVKQIETKYNVKIGVYA
IDTNNGNSFSYRQDERFPFQSTVKMVVAAAALKNIEADERIKISSDDIVFWSPIVRLNLD
RGYMTIKELAEAAMSYSDNAATNILITRLGGTKSINEFAKSIGNASFYLENLEPNLNSDP
NNIHDSSTPKDMAQSVQKLLIENNVLSQENQHILKTWMMNNTTGYKKIRYGLPLGWSAAE
KTGGGSGTSHDIGIVWSPACKPIVLAIYTFSNKKDNAQQADKAIAETTKFILDEFSKKNI
CFSATDFK
>AET35510.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MNRKTAVVLFGGQSSEHVVSCMSVVNVINHMNREKYDLLLIGITEEGHWIKVESVEAIES
GRWREGTVNAVISPDATKQCVILTEGDRVEFVKADVVFPVLHGLYGEDGTVQGLLELARI
PYVGCGVLASAVSMDKLYTKIVVDDLGVRQAAYVPVMRSDLNDMASVVGRVEAKFSYPVF
VKPSNAGSSKGVARADGREELEAALREAANHDRKILVEEMIRGREIECAVFGGGLIPVEA
SGVGEILAAAEFYDFDAKYYNSDSRTVVNPDLPGDAVNQVREAAKAIFQAVDGYGLARVD
FFVKDDGTVVFNEINTLPGFTAISMYPMLWEAAGVTKDQLVDRLMEHAFDRFRL
>AET35496.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLAGGLSTERDVSFKTGDMVSKALRENGHNVILLDVFMGYSDKEENLTGIFDRTEE
VSVQVKDIPETAPDLAKVKASRKDQSDCFFGPNVINMCRMADIVFMALHGENGENGKIQA
AFDLFGIKYTGTGYLSSALAMDKGMAKQLFIAGGIPTPQGISTKKENRKDSAKELGLKLP
CVVKPCCGGSSIGVTIVRTEDEFKSALDEAFKWEDNLIIEEYVEGREFSVGVIDYKALPI
IEIAPIQGFYDYKNKYKAGSAVETCPAELPEEITEQMQHYAERVAEVLGLNTYSRSDFLL
NKNNEIYCLEANTLPGMTPTSLLPQEAGVLGINFNQLCEKLIEISLKKYEK
>AFH53890.1|FEATURES|farme|beta_lactam|TEM-116|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AFH53881.1|FEATURES|farme|beta_lactam|MHK_007990|antibiotic inactivation|1
MXIQHFRVXLIPFFAAFCLPVFAHPETLVKVKDAEHXLGARXGYIELDLNXGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDVGQXQLGRRIHYSQNDLVEYSPFTDKHLTDGMTVREL
CIAAITMXDNTAAKLLLTTIGGPKELIAFLXNMGDHXTRXDRWZXZLNEXIPND
>AGC09640.1|FEATURES|farme|aminoglycoside|AAC(3)-IIIb|antibiotic inactivation|1
MHSRASLVRDARSLGISPGDTLMVHASVRSVGEIAGGPDQIHLALEEALTERGTLMMYAS
CPAHYDEVGRGNLTAEQEREVLEKLPAFDAQTARSQRENGALVELLRTYPGSVVNDHVAR
FVVRGRHARHLISKQPWDYAFGKDSALDRFVQLGGKILLLGCDHDNVTFLHYAEHIVDIP
GKRVSRFKVPVLVNGERVWRDMEEFDTSEAAHPSWPDRFFARIVDGYLEKTNNRGGVLGD
SQSYVIDARGLLEHALQEMKRQAT
>AHN92777.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MEIRRAAIDDVRAVAWLACLLWPHHTLAEMEEEMEIFLTDEDSAIFLAWEDNAAVGFAQA
SLRRDYVEGSTSSPTGYLEGIYVMEAYRSRGFAAELLSACEAWAREKNCLQFASDCEIVN
SGSLIFHLKNGFTEANRIICFIKDL
>AHN92775.1|FEATURES|farme|aminoglycoside|BN682_00261|antibiotic inactivation|1
MSKGAIAMIRQATVSDAAAVAALSLRLWPDHTMEEMTAEFAALLASPEAAVFLAEDGAPM
GFAQCQLRHDYVEGASTSPTGYLEGVYVAPSHQRLGIAGKLLSACEVWAKAHGCTEFASD
CEIDNAASLAFHLAKGFTEASRNIHFIKPL
>AHN92774.1|FEATURES|farme|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEF
MPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCN
CPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGD
FSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDM
NKLQFHLMLDEFF
>AHN92771.1|FEATURES|farme|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|1
MAEAKKVSFRLMNDKDDLRFMLKWLTDERVLEFYDGRGSKFTAETIREKYTEEEDDFYRM
IIEYDSVPIGYAQMYRVQGELFEEYDYPETEEKIFAMDQFIGEPEYWNKGIGTEYCKAAC
RYLAEELGADAVILDPHKSNPRAIRAYEKAGFKVLRDLPAHELHEGKWEDCVLMEWRV
>AHN92769.1|FEATURES|farme|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MEILKDNIRIRLMTDADFPLMLKWLTDVRVLEFYGGRDLAYTMDTLREHYADPTDEQTTR
VIIEYCGTAIGYGQFYPVDYMEFGLEESDDIVYGIDQFIGEPDLWNRGIGSAYVIMLCEW
LKAEMEADAVVLDPHKDNKRAIRAYEKAGFRIIAELKEHEFFEGRKEDCWLMEWR
>AHN92754.1|FEATURES|farme|aminoglycoside|Mmwyl1_0154|antibiotic inactivation|0
RFFPGISTLFVSEDYRGNRISGKLIDFANQYAKSIGFDKTYIPTEFIGLYEKYGYCYVKD
IVNYGNGIDRLYVREIK
>AHN92736.1|FEATURES|farme|beta_lactam|bla1|antibiotic inactivation|1
MKLKNKASIKFGICVGLLCLSITGFTPFYSSTHAEAKSIEDTNMASCITNKKLVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLV
TYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKAK
RFETDLNSAIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSNRFTKDANYDNALIAEAAKI
VLNDLK
>AHN92732.1|FEATURES|farme|beta_lactam|BL2e_cepa|antibiotic inactivation|1
MRKLLFIIIYLSFISPAFADGNKAIENALHEYIKGKDARIGVAVIINGKDTVSVNGNRDF
PMMSVFKFPLALTVAHWINTNGMSLNDTVT
>AHN92730.1|FEATURES|farme|beta_lactam|ABV89_11680|antibiotic inactivation|1
MKKFCFLFLIICGLMFFCLQDCQARQKLNLADLENKYNAVIGVYAVDMENGKKICYKPDT
RFSYCSTHKVFTVAELLRQKNTSDLNEIRKFSAEDILSYAPITKDHVADGMTLAEICSAS
LRWSDNTAANLILQEIGGVENFKVALKNIGDKTTKPARNEPELNLFNPKDNRDTSTPRQM
VKNLQVYIFGDILSDDKKKLLIDWMSDNSITDTLIKAGTPQGWKVIDKSGSGDYGARNDI
AVIYPPNRKPIVMAIMSRRTEKNAKSDDAMIAEAAKRIFDNLVF
>AHN92727.1|FEATURES|farme|chloramphenicol|cat13|antibiotic inactivation|1
MAFRLIDIENWERKEFYEHFINQVVCTYSVVVNLDITNLKNHKLYPAMIWLLTKAVNDMP
EFRTSLTSEGLGIYDDMHPMYTVFNKDKKNFSGIWSYFSEDYDTFLKNYEIDAEKYSSST
RYAPKDGTPSNSFNISMVPWLEFSGFNINVFDDGHFLLPIFTMGKYFDRDGKRMLPLAIQ
VHHAVCDGYHIGLFVEKLQKYIDHFS
>AHN92725.1|FEATURES|farme|chloramphenicol|cat3|antibiotic inactivation|1
MAFRLIDLENWERKEFYEHFINQVVCTYSVVVNLDITNLKNHRLYPAMIWLLTKTVNDIP
EFRTSLTSEGLGIYDEMHPMYTVFNKENKNFSGIWSYFSEDYDTFLKNYEVDAEKYSTST
CYTPKDGTPSNSFNISMVPWLEFTGFNINVFDDGHFLLPIFTMGKYFEREGKRMLPLAIQ
VHHAVCDGYHVGLFVEKLQKHIDHFG
>AHN92714.1|FEATURES|farme|chloramphenicol|cat25|antibiotic inactivation|1
MAFQLIDLENWERREFYEHFIKEVVCTYSVVVNIDITNLKGQKLYPAMIWLLTKTVNDMP
EFRTSLTPEGLGIYDDMHPMYTVFNKENKNFSGIWAYFSADYETFLKAYEDDVQRYSTST
RYTPKEGAPANSFNISMVPWVEFTGFNINVFDEGKFLLPIFTMGKFFERDGRRLRPLAIQ
VHHAVCDGYHIGVFVEKLQNYIDQF
>AHN92710.1|FEATURES|farme|chloramphenicol|cat19|antibiotic inactivation|1
MALKLIDMQTWKRREFYEHFIKDVVCTYSAVVNIDITPLKGNKLYPAMIWCLTKTVNDMP
EFRTVLTPDGPGIYDDMHPMYTVFNKENKNFSGIWSYFSENYEAFLKSYEVDAAKYSQST
YYAPKDGTPANSFNISMVPWLEFTGFNINVFDEGKFLLPVFTMGKFFERDGKRILPLAIQ
VHHAVCDGYHISAFVAKLQEYVNYLGNQNKR
>AFQ60592.1|FEATURES|farme|tetracycline|tetG|antibiotic efflux|1
MGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVFAPMLGQLSDSYGRRPVLLA
SLAGAAVDYTIMASAPVLWVLYIGRLVSGVTGATGAVAASTIADSTGEGSRARWFGYMGA
CYGAGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLKETHHSHGGTGKPVRIK
PFVLLRLDDALRGLGALFAVFFIIQLIGQVPAALWVIYGEDRFQWNTATVGLSLAAFGAT
HAIFQAFVTGPLSSRLGERRTLLFGMAADATGFVLLAFATQGWMVFPILLLLAAGGVGMP
ALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSATAGAWNGWVWIVGAILY
LICLPILRRPFATSL
>AFQ60601.1|FEATURES|farme|tetracycline|tetG|antibiotic efflux|1
RLGERRTLLFGMAADATGFVLLAFATQGWMVFPIL
>AIA17719.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MMISHIAACSQNRVIGKDNHLPWKIPEDWKFFKDKTSGHILIMGRKTFESLGKPLPNRLN
VVITRDPTYQAPGAVVLPSVEAALEFAQTKFKDYPDEVFIGGGGEIYKQTLAIADRVYLT
VIHKDFDGDAFYPTLPEGEFQEVEKRDRTDPIPFTFFTYDRVKFKA
>AIA16594.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMRRVLDQGVRKCDRTGTGTLSTFGHQMRFDLADGFPLVTTKKLHLKSIVHELI
WFLSGDTNIAYLKANGVSIWDAWADEAGDLGPVYGAQWRSWPTGDGGSVDQIRQVVDQIR
TNPDSRRLIVSAWNPAEVDRMALPPCHCLFQFYVAEGRLSCQLYQRSADVFLGLPFNIAS
YALLTMMMAQVTGLQPGEFVHSLGDTHLYLNHLDQARLQLERDPRRLPTMRLNPEVNAIV
DFVYEDFVLEGYDPHPHIKAAVAM
>AIA15511.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSLEPSAEPLIALVVAMGENRAIGRGGGLPWRLSSDLRYFRKITMGKPVLMGRRTFKSLP
RVLDGRLNVVLSRDRGFVAPDAVMAHSLGEGLAAARASAKRTGAPEIMVIGGEDVFRAVL
PQTGRIYLTEVHASPDADTWFPELDMRDWREVSREAHPPGPKDDHAFSFVVLDRKR
>AIA15512.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLGKVRNSGARKGDRTNTGTLSIFGHQMRFDLADGFPLVTTKKLHVKSIVHELL
WFLQGSTNVRYLNEHGVTIWDEWADANGELGPVYGRQWRSWPAPDGRHIDQISNVVEALK
RDPDSRRHIVSAWNVGELDQMALLPCHCLFQFYVVDGKLSCQLYQRSADIFLGVPFNIAS
YALLTLMMAQVTGLEPGEFVHTFGDAHLYLNHLDQADAQLTRKPRALPRLEINPDIRSLF
DFAYEDFKLVGYDPHPAISAKVAV
>AIA14205.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDGGTKKDDRTGTGTLSTFGYQMRFNLDEGFPLLTTKKLHIKSIIYELL
WFLRGDTSIKYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRASDGRTIDQISQVIEQIK
SNPDSRRLIVSAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLQPGEFVHTLGDAHLYSNHLEQARLQLARAPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA14206.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSTDLKRFRELTMGHHIIVGRKTFESIGRPLPGRVM
IIITRSESIAVEGCFIARSVEEAVGLARERGESELFICGGAEIYAQTLGAADRLHLTLV
>AIA13712.1|FEATURES|farme|elfamycin|facT|antibiotic efflux|1
METVTERGYRYRWYVMAVVIIADVMDLLDATVANLAGPSIRAELGGGESTLQWILASYTL
TFAIGLVISARLGDIVGRKQMFIIGMAGFTIASLLCGIAPTPGLLIAARVLQGLLGAVMI
PQGLAMVKQSFHPDDLQKAFIPFGPIMALSAVAGPILAGVLIDGDLFGTGWRMIFLINVP
IGLAGAYLSWRYLPDVERDPAARLDLPGSLILAVASGLLVYPLVQGRELDWPAWIFGMIA
ASVVLFVVFARHERRSSFPVLEPSLFKHRGFVAGLVFLGLFFVAMTGFSLASNLFIQIGL
GYSPFDTGLAQTPMAFGMALGAVVSGALLGPKLGRHVLHLGLAVAALGLAWLGVVIGGGA
GIDGWDLAPALFLSGFGVGLIFAPLFDIILADLGDREVGSGSGLLNAVQQFTGALGVAVL
GTLLFGWVPDAGWFVATQHLIWVCVGCYAAAFAAVFALPMRAREDVLV
>AIA13149.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESFAPEGCFIAHSISDAVSLARKRGESELFICGGAEIYAQTFGVADRMYLTVVH
ADSEADTFFPEWDRDEWVELESEHRTADEKNQYPFTFKVLEKKSKI
>AIA13140.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MQARFVRNAVVLGLLSAIGPFAIDMYLPALPTIGKSLNADIGAVQLSLMLFFVSFGAFQL
VFGPISDMYGRKLPLYAGLVLFAIGGVGCAFAPDIATLNTFRFIQGIGACAGMVIPRAVV
RDLHTGIDAARMMSLLMLVFSISPILAPLTGSLIITLADWRAVFWVVTIAAILGLAMVAT
LLPETRPKALRVASGVRSALEGYRLLLRDRNFLALSLIGGFGIASFFVYLANSPFVLIEH
FGVTPVLFSVFFSINAVSFFAAAQFTGTLASRFGLRRVVRIAVIGYFTALAVLFALTAAG
VERLDVLATCLFIGYGFLGLVIPTTAVLAMEDHGEIAGTASALMGTLHFVTGALAVAAVG
LVADGTVLPMVGGIAACALATFILAQITLRQGQAVEVPAE
>AIA12623.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTGTGTLSTFGYQMRFNFSEGFPLLTTKKLHVKSIIYELL
WFLRGDTNVNYLREHGVRIWDQWADERGQLGPVYGAQWRSWRSADGRAIDQISQVIEQIK
SNPDSRRLIVSAWNVGELDRMALMPCHLLFQFYVAGGRLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLRPGDLVHTLGDAHLYSNHLEQARLQLSREPRALPQMKINPQVTSIF
QFDYSDFELSGYEPHPHIKAEVAV
>AIA12302.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSPKFLRIAVVLGLLSAIGPFAIDMYLPALPSIGEDLHAGTAAVQMSLLIFFLSMGFGQI
VVGPISDMVGRKLPLYGGLALFMVGGIGSAMAPTIEWLIAFRFLQGLGASAGMAVPRAIV
RDLHTGTEAAKLMSLLMLVFSVSPILAPLTGSQIIENFGWRAVFWTVTGAALLATILLAT
SLKETRPVEERVGSSFSTALSGYRFLLGDRNFLGLVAIAGFGIASFFVYLSSSSFILIDH
YGLSPSVYSVFFSINAVAFIGMSQLTGLLAERFGLRRVVRVAVTGYATTMVVLFAVMATG
VDRLDVMAALLFVGYGFLGLVIPTTSVLAMEEHGEIAGTASALMGTLHFAIGAVAMGVAG
IFFDGTPLPMVAGITLCAVISFTLAKVTLGRSRDAVEAPAE
>AIA12128.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESFAPEGCFIAHSISDAISFARERGESELFICGGAEIYAQMLGVADRMYLTVVH
ADSEADTFFPEWDKDEWVELESEHRTADEKNQYSFTFKVLARRSQV
>AIA10816.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGAKKDDRTGTGTLSTFGYQMRFNLGEGFPLLTTKKLHTKSIIYELL
WFLRGDTNVKYLQEHGVNIWNQWADERGDLGPVYGAQWRAWRASDGRTIDQISRLIEQIK
SNPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVAGGHLSCQLYQRSADVFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYSNHLEQARLQLTREPRPLPRMNINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA10806.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESFAPEGCFIAHSISDAVSLARERGESELFICGGAEIYAQTFGVADRMYLTVVH
ADSEADTFFPEWDRDEWVELESEHRTADEKNQYPFTFKVLEKKSKI
>AIA19111.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MFDNRTPFEAEEEAMTTTNPATAPRTYPSLRAAWIPLAALCLAFFVEMVDNTLLTIALPT
IGRDLGGSTTALQWVTGAYSLTFGGLLLTAGSTADRLGRRRVLLVGLAAFGVISLGVVAV
TTSGELIALRALLGIAAAAMAPITNSLVFRLFDEQVLRMRAMTVMIVVGMSGFVLGPLLG
GTALAHVSWEWLLLVNAPIAVLACIGVRLGVPADRPEDLTQDRLDLPGAGLSIATIGLAC
FALTSGVQHGWLSATTIASALGSVLALIAFIRHERRTASPMLDLTLFSRGTVRGAAMAQV
GTSIAMAGVMFGLILHFQYAWGWSPMRAGLANLPLIITMIAATPLSEWLARRFGHRVACL
IGSACLVASLVGLAWGVEHGYLAIAVCMVVMTIGLRTVMTICAVALVEAMPANRTSIGTA
LNDTAQEVGTSVGTAVVGTMVAVLVTKVLPSGTWGADLLETFFRGERITYLVLALIVGVV
ATWGASTLTNSRAVDEHGTEPRSAEEATEELVTSADPAR
>AIA17081.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MPGIEGGKVRTIVNIDVPDLVPAIRFYRAALGLRLARLIEDDVAELSGASSTVYLLKHPA
GSDATHGASPPRSYARHWTPVHIDFVVDDIEAAARQAIAAGAIQESELVEWRGSKCVTFS
DPFGHGFCVIEFEGGTYR
>AIA17040.1|FEATURES|farme|aminoglycoside|APH(2'')-Ie|antibiotic inactivation|0
MPREETMRDVAALVREALAGRDVHTIVEIEGGSDHRTFDVNGALVARLRRRPDEGTASAI
MREVRLLEVVSRVSPVPVPDVAGANPDRGLIVVTRLPGVPLLDSPPRHPMALIDPLARFL
RAVHGLPIAELEDLVERDEYGFEDYLEDAAEDLRQVAAHLPSDQQRAVEAFLGAPPPAAS
DNRTFCHNDLGAEHMLASDDGSVLTGVIDWSDAAIADPARDVGRILRDLGPAVARAIVRQ
LECAEPHHLLARARFYARCALLEDVSYGLRTAHHRYAERALDHFRGVFEDD
>AIA15648.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MTSPINSIKSANRAWIMLIVLTMLTVIGMTVVLPVLPFVVLQYVSEEKDLAIWVGVLEAV
NGLCAFLVAPFLGRLSDRFGRRPVIIAAAFGAAFAMALFGIGGALWILVLARVIQGLTAG
DLPALFAYLADITPPEKRAQRFGLLGALSGIGMMIGPAIGGLLAAISIQLPVFLTAAVGL
TIAILSIFLLPESLKPENRITAIRLRDVQPFGVFKNAFGRKELRGLMIAFGLLALPFGFF
VNNFSVLALDSVQWGPTQIGLLTAAVGIIDILIQGVLLGILLPRIGERGVIVSGIIAQMI
GLLGLAVVASVFAQPWVFIVGALMLAAGQGASTAAMDGAMSNAVGDDEQGWLGGATQSLN
AAMGTVAPLIAGALYVTVSHAAPYWLGAALMVVAAIVVGRAHIANTAKKQPADADAPAEQ
VAVAG
>AIA15307.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSPKFLRIAVVLGLLSAIGPFAIDMYLPALPSIGEDLHAGTAAVQMSLLIFFLSMGFGQI
VVGPISDMVGRKLPLYGGLALFMVGGIGSAMSPTIEWLIAFRFLQGLGASAGMAVPRAIV
RDLHTGTEAAKLMSLLMLVFSVSPILAPLTGSQIIENFGWRAVFWTVTGAALLATILLAT
SLKETRPAEERVGSSFGTALAGYRFLMGDRNFLGLVAIAGFGIASFFVYLSSSSFILIDH
YGLSPSVYSVFFSINAVAFIGMSQLTGLLSERFGLKRVVWVAVTGYATTMVVLFAVMATG
VDRLDLMAALLFVGYGFLGLVIPTTSVLAMEEHGEIAGTASALMGTLHFAIGAVAMGIAG
IFFDGTPLPMVAGITLCAVISFTLAKLTLGRTREAVEAPAE
>AIA15297.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
MLAIWVKETLPPEKRIKPDIKAMGDAWRTLFADRAFIGMTFIGAFAITGVFIYLGNSAFV
LSQHYGLSPRQYSLAFSANALAFFAATQLNGYLGNKYGMARLPIPAAAGFALTMCILAGL
FVAGFDGFWVMACVLFVGFSFIGILLPTIMVLALENHGDIAGTAASLMNTVQMMIGATAI
GVSGMLIKGSPTMMIVCIAGLSLATLACTFGTFKKK
>AIA14990.1|FEATURES|farme|beta_lactam|BL2a_III2|antibiotic inactivation|0
MVASLDQYGHELYRPGDDLGELELRTLISEYLYQSRGVNCLPEQVIVGAGNPALLQMLCK
IFEVNLSIGYEDPGYPRAREIFKVNHMKIIPIPVDDEGVCIRKLNEERPRLVYVTPSHQF
TLGTIMPVNRRIQLLKWAEEHQSFIIEDDYDGEFRSNGQPIPSLQGLDQHHRVIYMGTFS
QSLLPSLRISYMILPLPLIEKGREIASLYKQTVSCHSQLTLAQFIKSGEWQKHINRMRKL
YRKKRAVLLEAVRRELGQYVRIRGEN
>AIA14435.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MNARHDSADWAIEAHGLVKTFGDNRAVDGVDLLVRPGTVYGVLGPNGAGKTTTISMLATL
LKPDAGTARIFGHDVMKEAQVVRQLIGVTGQYASVDETLSATENLVIFSRLLGLGRKESR
QKADELLEPSGP
>AIA13723.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MAHIQSDLAVYRTAFYYRTTFDHRTTYEKEAIMNTTTTATTTSRTYPSLRAAWIPMTALC
LAFFVEMVDNTLLTIALPTIGRDLGSGTTALQWVTGAYSLTFGGLLLTAGSMADRLGRRR
VLLVGLAVFGTLSLAVIAVSTAGELIALRAALGLAAAAMAPITNSLVFRLFDDKALR
>AIA13626.1|FEATURES|farme|multidrug|mexV|antibiotic efflux|0
MSRAPSFVVLAASLAAGACGANATGTRAAAEPAAVSVSAVTVAEQPITRFIRVSGTLTAQ
EDAQVAAEIAGRVVATPVERGTLVNEGDNLIRISAEEVEAQAHEAQANAAQIEARLGLTG
GIAFDAERVPEVANAKAASALARIDFGRAEKLHAGKLLSQSEFDQRAAQLDAAERQYDVA
KNGAAQQYQALLGARARVALAQKAVADTVVKAPFAGAVGERFVSVGDYVTRGMKVATVMR
INPLRVELTVPEQYVSAVAT
>AIA13628.1|FEATURES|farme|beta_lactam|THIN-B|antibiotic inactivation|1
MATPATLRPDPAIVCSACAEWNAPRQPFKVFGNTYFVGSLGLSSVLIAGDQGLILIDVAL
PQSAPLIDANITALGFRTTDIKMILTSHAHYDHVGGVRSMQRFTGATVGGSARTVEALAL
GHPTPDDPQFATDPSVRFPAVTTGARVVKDGETLRVGNIAITAHYTPGHTPGATSWTWQS
CEGTRCLAMAYVDSITPVSNDSFKYTAQPGLVDRFRKSIGVVSNLPCDVLLTTHPSVSGM
DEKVKQRAQASGADPFIEAGACKALAQQSLAAFEKRVTEERAR
>AIA19267.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MIIAGRQCRPINLKKERFMNAQLIRAAIVLGLLSVIGPLAIDMYLPALPAIGQDLNASVG
AVQQSLMAFMLAFAVGQLVYGPLSDMFGRKPPLYAGIGIFLAGTIGAAFAPSIEWLVFFR
FVQGLGACAPMSLPRAIVRDNYTGAPAAQLMSLIMLVFSVSPILAPLSGSFVIQFGDWRT
LFYVMTGTGILGLLLVAFVLKETRPKAARTGSTLSSALGAYWQLLRDWKFMGLTLIGTFG
MSSFMAFLGNSSFVYIQHYGLTPTQYSIAFSVNAVSFFAVSQATGFLVGRFGLNRVVRIA
VGGFVAAMVGLLAVYLAGIDSVWVLGGFMFVAFGFLGLVLPSTSVLAMEEQGEIAGSASA
LMGTVQMVVAAVIMGIVGAFADGTAKPMVIAFAACALAAFLITQLTLGRGRQRSMAEVPA
E
>AIA19238.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MSTVQSPVKLTHETRIGVLYGGFSSERKVSLISGQNCFDALRRLGYKNAELIDVDHQIAR
TLADKRIEVAYIALHGKFGEDGCIQGLLELMGLPYTGCRVAASALTMNKALTKSVLKDAG
LPVIDSVVIKAGTVNGKPIEIGLSYPVMVKPINEGSSIGMSKVNRAEDLKEALHTAFNYA
DEVMVEEYVPGKSLTVGVVEVDGKPQVTPILELRPTQSEWYDLEAKYTEGGTEFILPAEL
SQAVTEAIQAATLQAHIAAGCRGVSRVDFVVDGEGRFYILEINTIPGMTPLSDLPAQAKA
MGIDYDQLVECILKTAVTDL
>AIA19215.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQAFHQLLKTVLADGVRKEDRTGTGTLSIFGYQMRFNLNAGFPLLTTKKLHTRSIVHELL
WFLKGDTNIQYLKDNKVTIWDEWADENGELGPVYGKQWRSWQAPDGRQIDQISSVISEIK
SNPNSRRLLVVAFNPGEIEKMALPPCHAFFQFYVAQGRLSCQLYQRSADIFLGVPFNIAS
YALLTHMIAQVCDLQVGEFIHTLGDAHLYSNHLEQAQLLLTREPKPLPQLVLNPEIKNIF
DFKYDDIKIENYESHPAIKAEVAI
>AIA19157.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MKTQHDQAKGRSAISANRFIILMLGALVTITPFSIDMYLPAFSQMAKDFGTTPAKISLSV
TSYFIGMAIGQMIYGPLLDRYGRKKPLYYGLGIYLLTSVGCLLSGSVNMLIALRFLQALG
GCVAWVAAMAMVRDFFSNEDMPKVLSLLILLIGSSPLLAPTVGGFITDSLGWQWVFIVLI
CMVVVDMIVTALFLPQKYQPDPSVSLKMKPMLATFYSILKHPQFAVYTWSGAFGFASMFI
YVAGSPVIFMEIFHVSPKLYGGIFALLSVGFIGSGQVNILLLKKYTSAQIYRVAIYVQVL
TSAIFLYGTLQGWYGLVATIVLFFIILSCLGFMYPNSNALALAPFKKNAGSASALIGCLQ
IGLAGLASGSVGLFNAKNSTPIVVMLFVTAVIGLLILVAGKRKAELTTGMA
>AIA19136.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKSIVVAYDSRRGIGASNDLLWQRDLPADLAHFKKLTMGGSLIMGRNTFESIGRALPGRE
NIVVTHRPLDVVDVVAVDSLAKAYETAHGNQFIIGGGQIYNQSIADVDIVYATEVHETFS
QAEVFFPELGDGWREVAREVHVADDRNKYAYDFVTYARR
>AIA19102.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKNLSVIVAVAENGVIGREGHLPWRLSADLQRFKRLTMGHHLIMGRRTFESIGRPLPGRT
TIVVTRQTNASWPGVLTAHSLEEAYRMASSDNEMFVVGGGEIYRQALADAERLYLTLVHA
DVEGDTRFVDVDWSLWELVEEEHREADQRNTAATTFCVYKKKN
>AIA19075.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTPKISMIAAIQKKDRGIGNDNKLLFAIKEDLQRFKALTTGHPIVMGRKTFESIGRPLPN
RTNIVITRNTDFVAEGCVVVSSLDEAIGKAKEVEQIEIFIIGGGEIYKQALPFTDRLYIT
EVEGEEEATVFFPEYTEFSKIISEGKTT
>AIA18830.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPPPKIIAIAAMNENRVIGAQGKIPWHIPEDMKRFAQLTTGYTVLMGRKTYESLPDAYRP
LPDRHNIVVTRRADSLKGQEGIRVVDSARAFIMRCMTNVERLETTKLWIIGGGEIYGETM
PLWEEVYLTLVKGKQAG
>AIA18816.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRAYLNLIQHVLDHGIQKDDRTGTGTLSIFGYQMRFNLAEGFPLVTTKKCHLRSIIHELL
WFLQGNTNIKYLNDNKVTIWDEWADAQGNLGPVYGKQWRSWPDINGGSIDQISQVIHDIK
NNPNSRRLIVSAWNVAQIPQMALAPCHTIFQFYVIEGKLSCQLYQRSADVFLGVPFNIAS
YALLTMMIAQVTNLKLGDFVHTFGDAHLYSNHLNQARLQLTRTPYPLPKMQINPAITSIF
DFTFEDFVLQNYQSHEAIKAPIAV
>AIA18680.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLSTIVATAKNGVIGKEGGLPWYLPAELAHFKEITMGHPIIMGRKTHESIGRALPGRANI
VITREKSYKSKGVTIAHSLDEAITEAKKSAGSDEIFIIGGEAIYKQAMPQLNRIYLTEVD
AEVHGDKFFKYDADQWQEIRRDKHLPDDKNQYGYSFVLLEKA
>AIA18662.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MSGDRSKKIGVLMGGLSREREVSLRSGQAVLEALQRLGYAVVGIDVDATVAKALEREKIE
VAFLALHGRYGEDGCIQGLLEILSIPYTGSSVLASSVAMDKYLTKEIAARLGLATAPDHF
WDGHRDGFEALQGKIDESATWVVKPSREGSTIGMAKVQGREQLEAALRQASQFDSQVLIE
QFIAGREVTVAILGEELFPIVEIAPKHGFFDFAAKYQSNETEYHCPADLPEALAARLRQD
LRRLYQRLGCEGVARADFIIDAAGTPYFLEINTLPGMTATSLVPKAAKAAGVSFDQLVEK
ILLTARLKNRED
>AIA18628.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKPYLDLMRHVLEQGTPKTDRTGTGTLSVFGHQLRFDLRQGFPLLTTKKLHMRSIIYELL
WFLRGDTNIGYLQEHGVRIWNEWSDEQGELGPVYGRQWRSWQAADGRCIDQISQVVEQIK
TNPDSRRLIVSAWNVGELERMALMPCHLLFQFYVANGRLSCQMYQRSADIFLGVPFNIAS
YALLTMMMAQVCGLEPGEFIHTLADAHLYSNHLEQARLQLEREPRPLPRMRINPAVTSIF
DFDYSDFELTGYDPHPHIKAEVAV
>AIA18629.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MDERRGIGRRGGLPWRLSSDMKRFRELTLGHHIVVGRKTFESIGKPLAGRQMIIVTRDPD
YHIAGCFTVHSIAEALELARQHGETELFICGGAEIYARTLDRAERLYLTRVHADCDADTF
FPEFNPEDWLETASETHGADEKNQHPFTFLLLERKA
>AIA18584.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTSLHEKFRPLPNRTNIVVTRQKNFNAPGCLVVHDIHEALSISKKENEPEAFIIGGAEIY
KLSMPDADRLYLTEINADVDGDTFFPRFDKTEWKETTRTHHESDEKHKFSFDFVIYDRIK
K
>AIA18520.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKITVLMGGPSAERNVSLASGIRIVLALRSRGHDVIAFDPSRGLISAEEEQRLASSKVGT
EPPSLDSLAETTGGAFVTGLERLPEIKDADVVFLGLHGGMGEDGTIQALLDTAHVKYTGS
GHLSSALAMDKDLSKKLFRFGGVQTANWLMAPASIEEVEQTLGLPVVVKPSKQGSTVGLT
VVKRREDFDAAVTEAWRYDDEGMIEQFIPGRELTVGVLGGQALPVGEIKPKHEIYDYECK
YTAGMAEEEFPAKLTGEQTMRVQEQAVAAFKALKLSGCARIDFRLAVTDDGEGDFYCLEA
NTLPGMTELSLIPQGAQAAGISFPELCERIAEEAHRMQGRG
>AIA18505.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MFVSIVVAIAENHAIGKNNKLLWHLPKDLKHFKEITSGHTIIMGRKTYDSVGKPLPNRRN
IVVTRQDIAIDGCEVVNSLPDALKLAEGVDEVFIVGGAEIYKQAMPLTDRIYLTIVHEDF
DGDTYFPEIKEDIWKEIAREDHQPDEKHAFAYSFITLERR
>AIA18503.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LLRHTLEHGIKKDDRTGTGTLSTFGYQMRFNLAEGFPLLTTKKLHTRSIFHELLWFLKGD
TNIKYLHDNQVTIWDEWADKEGNLGPVYGKQWRRWEGPDGKVYDQIKQVIEQIKTNPNSR
RLIVNAWNVADVSKMALPPCHLLFQFYVADGKLSCQLYQRSCDIFLGVPFNIASYALLTH
MIAQVTGLAVGDFVHTLGDAHLYLNHLDQAKEQLTRQSRPLPQLKLNPAVKDIDWFKYED
IEILNYDPHPAIKAPIAV
>AIA18485.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MKTILLAAMTANGFIARSTNELADWTSKEDKKFFVEETKKAGVMIMGRTTFATIGRALPG
RLIVVLTGKPEEVEVTEGVETASGDLKTILEGLEKRGYSSVVIAGGANVYSQFLNAGLVD
ELALTVEAKLFTSGVPLAQNLSHELSLTLLETRMLGEKSVLLRHRVNLSTEAR
>AIA18465.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MKHFKAIAAMSLNRVIGAGNKIPWHLPEDFKWFKATTTGHVILMGRKTFESIGKPLPNRT
TIVLSRSVWSHPVVRTIHNLDELPALVGSQQVFICGGAQIYEQTLPLCSDLFLTLVKCEV
ADGDAFFPPFEDSFELTEEIRDTPEFKILHYRKRN
>AIA18419.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRISTIVAVAKNGVIGKEGGLPWYLPAELARFKEVTMGHPIIMGRKTYESIGRALPGRTN
IAITRNKDFKAEGCIVVDSLETAIAEAKKAEGADEIFIIGGEQIYKEAMPLLNRIYLTKV
DADVKGDKFFHYDPKKWKEISSEKHSADEINKYSFTFTTLQRI
>AIA18385.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKLRVGVIFGGRSGEHEIAIRSARTVIEQINKAKYEVVPIAISQAGRWMSPSESIALLPD
QTREALGSDTFQNEPIALVGDTTRRGLTIFKENGSDTVPLDVIFPVLHGTFGEDGTIQGL
LEMADIPYVGCGVLASSCGMDKAVMKILFRDAGLPICKHIWFLRNEFETNPAAVTAQVGS
QLGYPCFVKPANLGSSVGVSKATDVSSLKDAIALAAEYDRKIIVEEALEMREIECAVLGN
DDPQASQPGEYLIRDQAKAFLDYTEKYSGTGNNEFVVPAPISPELAAKIRKMAVTAFKAV
DGSGLARVDFFLRNDTGELLVNEINTMPGLTDASGYPKMWAGSGKDFPTVIDELINLAIE
RHEDKSRNKTSR
>AIA18347.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYHDLIQHILDRGEERTGRTGTGTISVFGLQAKYDLREGFPLLTTKKVLFSAVVRELL
WFLRGATNINDDLTQHTPIWDAWAGPNGELGPIYGYQWRSWPRYVRIEGTDHYAREHVDQ
IRNLIDEIKTNPDSRRLLVSAWNVADLPQMALPPCHLLFQFYVINGRLDCQLYQRS
>AIA18264.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIVSLIAAVAANGVIGKNNDPPWKLPDDMRFFMETTKGHYVIMGRKNYDSLQDKFKPLPN
RTNIVVTRQKNLNAPGCIVVNDVTKAIDTAKDGDEKEAFVIGGAEIYKLTLSSAHKLYLT
EIQAAVEGDTYFPSFDKNDWKETYRKHHPSDERHKFAFDFVIYDRIK
>AIA18199.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMRHVMENGTQKHDRTGTGTISVFGYQMRFNLQDGFPMVTTKKLHLKSIIHELI
WFLSGDTNIKYLKDNGVRIWDEWADENGNLGPVYGYQWRSWPTPNGGHIDQISQIIDQIK
NNPDSRRIIVSAWNVADVNQMALPPCHSLFQFYVADGKLSCQLYQRSADIFLGVPFNIAS
YALLTMMVAQVCGLQYGDFIHTFGDAHLYNNHLEQTRLQLSREPRPLPTMKINPDVKDIF
SFKFEDFTLDNYDPWPHIKGEVAV
>AIA18167.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKLPPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIASYALLTMMIAQVCDLGPGDFV
HTLGDAHIYSNHFEQVALQLSRAPKPLPTMKLNRDVKNIFDFRFEDFTLENYDPYPAIKA
PVAV
>AIA18164.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLELIKTILEQGERREDRTGTGTISMFGMQAKYDLRDGFPLLTTKKVLFGSVVRELL
WFLRGSTNINDDLTQHTPIWDAWADDNGELGPVYGYQWRSWPKYIKQENGLYARGHVYQI
SNIIETIKTNPDSRRLIVSAWNVADLDEMALPPCHMMFQFYVINGRLDCQLYQRSADMAL
GVPFNIASYALLMMMIAKECNLTPGIFTHTLGDAHIYLNHLDGVMKQLERTPKGLPTVEI
ADKPFFELRYEDFALHNYDPYPFIKFPVSV
>AIA18153.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MDRNRGIGKNQTLPWSLPGDMKYFKRLTCQTSDPQKQNAVIMGRKTWESIPPKFRPLSNR
LNVVLTRDAHYQAAADVVIANDLAAALEQCDRSDIEKIFVIGGASIYEQALQGRHVDRIF
LTQIDAQYDCDTFFPVFEDRFGEVGDSTGGSDAGVSYRFKEFASLVSAFCLLLFLSCMPA
HAADLRNGAAVFERATCAMCHPNGDNTLCPDKPLKGPAFMRRFSSDAAIEKVIRKGVPNS
AMAPFDRDRISDKEMKDVVAFIRTFSANQKQPATKQPLSKSIP
>AIA18151.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMKHIVDHGTRKDDRTGTGTLSIFGHQMRFDLSEGFPLLTTKKLHLKSIIYELL
WFLKGDSNVKYLRDHGVNIWNEWADEAGDLGPVYGAQWRSWRTADSGAIDQIALVIDQIR
TNPNSRRLIVSAWNVGEIEKMALPPCHVVFQFYVAGGRLSCQLYQRSADVFLGVPFNIAS
YSLLTLMVAAVCDLKPGEFIHTFGDVHLYLNHLEQARIQLRREPLVLPRMKLNPSVKSIF
DFDYPDFEITGYEAHPHIKAEVAV
>AIA18132.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLIVAMDEKRGIGKAGKLPWRLSSDLKNFRELTMGHHLIVGRKTFESIGKPLPGRQM
IVVSRDRGFKPEGCLVAGSVQDALNIAQEHGETELFVIGGAEIYSQTLQAADRLYLTQVH
AEVDADTFFPELNFGEWNPADSSFQLADDKNEYAFTFTVLIRKRH
>AIA18054.1|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MKLRVGVIFGGRSGEHEIAIRSARTVIEQIDKSKYEVVPIAISKDGRWLSPSEAVTLLPD
ERRMSLGSDTTHNEAEPIALVGDTTRRGLTVFKENGSDSLPLDVIFPVLHGTFGEDGTIQ
GLLDMADIPYVGCGVLASSCGMDKAVMKILFRDAGLPICKHIWFLRNEFETNPAAVTAAV
GDQLGYPCFVKPTNLGSSVGVSRATDMSSLKDAIAIAAQYDRKIIVEEALDMREIECAVL
GNDDPQASQPGEYLIRDQAKAFLDYTEKYSGTGNNEFVVPAPISPELTAKIQKMAVAAFK
AVDGSGLARVDFFLRNDTGELLVNEINTMPGLTDASGYPKMWAGTGKNFPAVIDELIRLA
IERHDDRSRNKTSR
>AIA18053.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MQRKVALLFGGESPEHEISILSASKVGAALDQLIGTQTIPIYVTKTGMWHWSRPSGDIPS
EELIQAVTNDEAFARNYSPSGISFAQALLHLSVDEFATVLIIMHGANGEDGRLQGAFELA
GICYTGSGSAASALAMDKSRCQAYLEARGLPIPKFMPLPRGAYSDADAVGIVANEIGLPC
VVKPSGCGSSVGVTIVRDREQLDAALKMAFEYGELVQVEEFIQGREFTCGVLDSGKTTAL
PVTEIIVPKATFFDYKAKYTPGVTREVTPAEIDAALARRIQELAVEAHRAVGCEGFSRVD
FMADADGPKILEINTIPGMTQTSLLPQAAVVAGIQMPELMNIIIEHSIRRAGGVEVSA
>AIA17990.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAISENFAIGRDGKLPWHYSADLKNFKESTMGGTLVMGSKTWRSIGKALPGRQSI
VLSRTEIEDLPDGVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRWLVTRIPE
TVEDADVYMPLQFLDDFELVDSREIDEGLIVETFDRRT
>AIA17955.1|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|1
MKIIMIVAHTIDGFIAKSADQFIDWSSKEDKKMFREETKKAGVMIMGMTTYKTIGKPLPE
RLNIVLTSKADQLESIPDTLEYMNATPEEVIADLSARNFETVCVIGGARTYTEFLKAKLI
DEIWLTIEPVIFGQGVTTFTDDIMGVKCYLTKFINLNENSLQLRFRLEYE
>AIA17846.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNLEGSISRPRILAKFAKQAGAWQGYGQTDRRFGMKEDDVLRLRDELDLSLMVAMTPYQV
IGRGNTIPWRIPSDMKRFQDVTLGIGTMLMGRLTWESLPRRPLRDRHHIVLTRTGGIEAT
EQVTPVDSFEAACEVVRRLGGKACVIGGTQVYELFFPIVSRLYVTCVHGKIEGDKLFPIA
IDDLHENGWNWVSYNPQPKLRDERDEYPTLWFEWVRD
>AIA17809.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSAIAAMARNRVIGVDGDLPWNIPEDFKFFKDKTSGHAMIMGRKTFESLPQALPGRLH
IIVTRQEGYAPSLPANAKPGTALKVVSTIEDAVAFARTKTSEYGDEVFILGGGEIYKQML
SITDRIYLTEIHQDFPGDTKFPEFSKTEFIETERKPRKAGEGPNPSSVSFDFVTYDRK
>AIA17739.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRITILFGGTNKERLVSVASAQALHRALPEADLWFWDVADTVHEVTSQKLLSHTRPFEDE
FKPGNRGLPLEAALDKARAEDRVLVLGLHGGRAENGELQAMCELRGIPFTGSGSASSNLA
FDKVAAKRFAAYAGVAAPAGVALENLDAAFAEYGRLIAKPARDGSSYGLFFVNAKQDLVA
VRDAARAEEYLIEPFVAGVEATCGVLERPDGEVLSLPPIEIVPGEGTFDYTAKYLLKST
>AIA17736.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMRHVMENGTQKHDRTGTGTISVFGYQMRFNLQDGFPMVTTKKLHLKSIIHELI
WFLSGVTNIKYLKDNGVRIWDEWADADGNLGPVYGYQWRSWPTPGGGHIDQIAQIINQIK
TNPDSRRIMVSAWNVADVNQMALPPCHSLFQFYVADGKLSCQLYQRSADIFLGVPFNIAS
YALLTMMVAQVCGLQYGDFIHTFGDAHLYNNHLEQTKLQLSREPRPLPTMKINPDVKDIF
SFKFEDFTLENYDPWPHIKGEVAV
>AIA17737.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTISIVVAIAANNAIGKDNQLLWRLPNDLKHFKQITSGHTIIMGRKTYDSVGKPLPNRRN
IVITRQNMNIEGCEVVNSLDAALALCANEPEVFIVGGAEIYKQAMPLTDTIYLTIVHQSF
EGDTYFPEIKANEWIEIEREDHNPDEKHKFAYSFITLKRP
>AIA17699.1|FEATURES|farme|aminoglycoside|ANT(6)-Ia|antibiotic inactivation|0
MYSSFQLAKKYLQYYLTASNSKGHGMHSPFVFQFILHVLNNKSGHRPPAEIERLRTLLLH
DKRMLDIEDFGAGSRMASHKKRSVVQLAKYALKPKKYAQLFFRLVKHYQPQTILELGTSL
GLTTAYLAAANPSARIITIEGSEAIAAVAKENFATLLLTGIHQQLGNFDVLLPAVLKEHS
SFDLVYVDGNHRTV
>AIA17701.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TLFQFYVAKNKLSCQLYQRSADVFLGVPFNIASYALLTMMMAQVCELEPGDFVHTFGDVH
IYNNHLEQVKLQLSRSPFPLPTMKLNPAVKNIFDFTFADFTLENYQSHPAIKAPVAV
>AIA17500.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MNGTKPFTVCVIVAMDQGRIIGFKNRLPWHIPEDMKRFAKLTTGHTVLMGRKTYESLPDK
FRPLPKRKNMVITRSPAQFRAAEGVLVFSSPGAAIEHLHHHSEDVSGGQLWIIGGGEIYR
ETMEYVDQIYLTVVDGTHEGDVYFPEFEQDFVLAECETHEGFEYRLYRRKTQASAPD
>AIA17401.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLEHVMEHGVEKSDRTGTGTRSVFGYQMRFDLQKGFPLLTTKKLHTKSIIHELL
WFLKGETNIKYLKENGVSIWDDWADANGELGPVYGSQWRSWQTTDGRTIDQIEQVIEQIK
RNPDSRRLIVSAWNVGEIKMKLPPCHAFFQFYVANRKLSCQLYQRSADIFLGVPFNIASY
ALLTMMIAQVCDLEPGEFVHTLGDAHIYSNHFEQVNLQLSRTPRGLPAMKLNPSVKNIFD
FRFEDFALENYDPHPHIKGTVAV
>AIA17402.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNLSIIVALSENNVVGINNQLPWRLSADLKRLKTLTMGHHLIMGRKTYESIGRPLPGRTN
LIITRNRNYKAEGCVVVSSLKEALEKAKDDAEPFIFGGGEIFREGLPMVNKIYMTRIHEN
IQGDTRFPELNASEWKEISRQDFSADEKNDHDYSFIDLVRVG
>AIA17378.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLVRDVLDNGKPDENEARSDRTGVGTYSVFGRQARFNLEEGFPLVTTKKVHLKSI
IYELLWFLNGDTNVKYLNDHKVTIWDEWANSEGDLGSIYGKQWRSWQGPDGVKVDQIANV
VEQIRTNPHSRRMLVIAYNPGDLPKIAPPGCHTLFQFYVAHGKLSLQLYQRSADLMLGVP
FNIASYALLPDDGGAGDRIKTLRVCAYFR
>AIA17374.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MKVFIIAALSADGYIGIDASHRATSWTTKADLQFFVRKTKEAGTIVMGRKTFETIERPLK
DRRLIVLTSKPEDITIEDVEATSESLAELVARLEREGVTTLAVCGGSSIYTQFMEAGLAE
ELFITVMPKIFGQGLPLFGRQLDINLRLQHTEQLGENTVLLHYKTV
>AIA17375.1|FEATURES|farme|peptide|vph|antibiotic inactivation|0
MEQGTITRILQLYGIEHDDILAPQKGYRNSSFAILRGGQPPLNLILYKNEPGMLARIIRT
NAIGNFLHARGMPARRTFSPRIMQLKSAHQTRHAALYYYVSGSTIPWEAYTMERIKTLGK
TMGNMHSILADYSGDLPDIADELIALNRRMVRYFVEPDVARAMSQKLNIKIKQPSFMRLL
ASCKNQPSQALHMDFVRGNILFEGDDITGILDFEKAGRGTPAFDIARTLAFLLIDCKYKS
EDKTYKYFIQSGYTKRSASTFRAWQSVDRLVQFFLLHDFYKFLRHNPYEHLEQNEHFVRT
KAMLLKHGIIERAHVK
>AIA17359.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRSRGHQVTALDPARGVISAAEERELSTGKVGT
EPPSLETLSKFAEGAFPPNLTSMKEVKDADVAFLALHGGQGEDGTIQALLDMANVKYTGS
GHLSSALAMDKDLSKKLFRSEDVKTADWLMAPVTVEQVEGMLGLPVIVKPSKQGSTVGLS
LVKKREDIAKAIEEASKYDDEVMIESFIPGRELTVGILGDVALPVGEILPKHEIYDYECK
YTAGMATEEFPAKLSPEATEKVQQQALAAFRALKLRGYARIDFRLTSEGEFYCLEANTLP
GMTELSLIPQGAAAMGISFPELCERIVRLALG
>AIA17281.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYLNLLKHVMDNGAEKSDRTGTGTKSAFGYQMHFDLAEGFPLLTTKKLHTKSIFHELL
WFIKGDTNIKYLKENGVTIWNEWADENGELGPVYGSQWRAWKTSDGRTIYQLSNVIEQIK
KNPDSRRLIVSAWNVGEIDKMKLPPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIAS
YAAFTMMVAQVCNLKPGTFVHTLGDAHIYSNHFEQVNLQLSRDPRPLPKLILNPEVKNIF
DFKFEDLQIVNYDPHPHIKGAVAV
>AIA17170.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSQVVAISQNHAIGKDNQLIWHLPADLKHFKNVTMGHHMIMGRKTFESIGKPLPGRTT
IIITRDKNYKADGCIVVNSLEEAIETARKADDTEACIVGGGEIFKQAMDLTDKIYLTIIE
ERFEADIFYPELDPKEWALASREDFKPDEKNKYYYSFCEYTRIK
>AIA17095.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKNLLVAYDQNHGIGATGDLLWRRDLPADLRHFRDLTTGNAVIMGRKTFDSIGQPLPHRQ
NIVISRQAPTIEGVTVVGSLDEAYAAVDPDKEPFVIGGGDIFWLALPDADRIFATEVQAV
FPQATVFFPAIDRAEWFEVSRAHHPADKRNLYDFDFVIYERL
>AIA17026.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSHIVAVAQNDVIGAKNALPWNIPEDMKFFREKTKGKALIMGRKTFESVGHPLPHRLN
VVVTRQKDFASDAPNVVVKPDLASAIEYCRGQTSKYGDEIFIIGGGEIFKESMSLVDVIY
LTRIHRDFDGDIFYPQLPSDQFELIEQRDRTEPVPFSFLTYMRRK
>AIA16999.1|FEATURES|farme|puromycin|pur8|antibiotic efflux|1
MVILDGTVVNIAMPHIQQALHFSPSSLSWVQNAYALAFGGLLLLGARAGDLLGRRRVFIT
GISVFTLASLLGGLAPNAELLLAARVLQGIGGAIAAPAALTLLMLTYREGPERMKALGYY
SLVSSGGGSVGLVLGGMLTEWASWRWGLFVNVPIGIALVFAARRVLTETEPETGRFDVAG
ALTSTLGITSLVYGFIRVAEAGWTSAEVLAAFAVGVVLLVSFVLIERRVSHPIVPLRLFK
SAARSTSYLTMLLVVGTMFGMFFFLTQYLQGVLALSPLSAGLAFLPMTGLLFTASRVVPR
LVARIDGAKLMLAGSTLVVLGTVWLTRLDAHSTYLHDVVGPLLLFGGGAGMIFIPLVGRA
ISGVAPQDSGAASGMLNVVQQVGGALGLGILVTIFGTASRNSTSVIPREVLVDGVHAAFI
GALVYAGLSLTMIVISVRPWNWFRTEPAPVESLTQMEAAPSTTST
>AIA16973.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MPQTDWAIEAKNLKKSYGKVEVLKGLNLQVKRGTMLALLGPNGAGKTTTVKILSTLLSFD
GGTARVEGFDIVSDADKVRSVIGLNGQSAAVDELLTGRENLIMMGRLYRLTKASATARAE
ELLEEFDLVKAANRPAKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRLAMWNI
IKKLMESGTTILLTTQYLEEADQLADKIVVIDDGRVIAEGTAAELKSKVGKDRLELIFAN
PKTFEKAQTVLGKSVADSNPKTNAVGVVIQDNN
>AIA16947.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRFDLREGFPLLTTKKLHTRSIIAELLWFIQGSTNVKWLHEQGVTIWDEWADADGELGPI
YGYQWRSWPTPAGDHVDQLAGVIKSIKASPDSRRHIVSAWNVADLADMALPPCHAMFQFY
VAQGRLSCQLYQRSADIFLGVPFNIASY
>AIA16911.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MMNRIALIWAMDKNGLIGANNKMPWRLPADMAYFRATTTGHPVIMGRLTYESIGKPLVDR
TNIVLTRNDDYKPDGCIVVHSVEQTLDLYPEEKVFVIGGAQVYRQFLPHADLLYVTRIDH
DFSGDEYFPDVDWSQWQLIQETPGQVDDRNPYPYTFQVYSKK
>AIA16873.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MTDLPKKIAVLMGGPGSEREVSLATGRGVAKALRSLGAAVVEIDVRDENFQLPNDVDLAF
ITIHGTFGEDGELQKILEDRGVRYTGDGVEGSRNAFDKILSKKKFLEHNVATPESEVIDA
GRRPKMPVPLVVKPARQGSTVGVVIVKNESERDAAMKEAAKYDRKLLVEKFVSGRELTIG
ILGDQALPIIEIIPKGGFYDFNTKYPFLNPTAGASAQHVCPANIEATLTKKIQELALQAF
RALGLGVYARVDVILSNTGEPFVLEANTIPGMTEASLLPEAAAAAGIGYPDLCARIIALS
QVRQRSGEQARVKTKGKR
>AIA16822.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
PKLVYDKRMKYIIVAYDRNRVIGGGNKLLWQGHMKADMRRVKQLTTGNAIIMGRKTYESI
GRALPNRQNIVVTHRPLEAEGITTVGTLDEAFAAVLPDRDAYIFGGGQIYKQALPVVDQI
FATEIDKAFNGDIYFPTLGDDWHEITREDHQPDAENKYPYSFVTYAKTNLFKAA
>AIA16815.1|FEATURES|farme|multidrug|efmA|antibiotic efflux|0
MEVSIAYQNEDENGYGNLFLQRLMLIDLSPLKASRDYRLLFTGQLVSFFGTMMTFIVVPW
QMYQLTHSSAMVGSIYLAEFVPMVILAFVGGAMADFLDKRRLLRLTEIGQTTATVVLLVN
SLLPDPQVWILFLAVAVHAGFAAVQRPAFESFIQKVIPAEMMSAVMALNSIRYSVGAIVS
PAVAGIIATQFSASIAYAFDLVTFTASLWAVFLIRAVPPPENAEKPSFQSIKRAWKYAFG
RQELVGTYFIDIAAMFFAMPQALYPALAVVYGPQYVGFFPASIAAGALVAGLTSGWTKKI
NRHGLMVTIAAVLWGVAIIFFGLADSIVPALLFLGAAGFFDMISGIFRGSIWNQTIPNYL
RGRLASIEMMSYLTGPMLGSAKMGIVAESFGVKTAIVSGGVMCIAAVLGSAMFLPKFIGY
DGREGRRQREAEEAERAEMA
>AIA16774.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKISLVAAVAQNGIIGKKNDLPWRLPDDMKFFMETTKGHVVILGRKNYESLPPKFQPLPG
RTNIIVTRQENYDAPGSFVVNDIKNALEIAKESGETEAMVIGGSEIYALSLEYADRLYIT
EVLADVDGDVSFPAYNKKEWKEISRVHHDADQRHIYAFDFVVYERIEENLKYGDIDK
>AIA16760.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRFDLREGFPLLTTKKLHTRSIIAELLWFIQGSTNVKWLHEQGVTIWDEWADADGELGPI
YGYQWRSWPTPAGDHVDQLAGVIKSIKASPDSRRHIVSAWNVADLADMALPPCHAMFQFY
VAQGRLSCQLYQRSADIFLGVPFNIASYALLTHLVAQVCDLEVGDFVHTLGDAHLYLNHL
DQARLQLKREPRALPKLVLNAGVSSIDEFTSDDIAIEGYDPHPGIRAPIAV
>AIA16739.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MPGSINITHHTRIAVLCGGLSSEREVSLRSGNNCFEALKRLGYQNVVLIDMDRQVAQRLT
EEKAEVVFLALHGQYGEDGCVQGMLEILGIPYTGNRLTASAMTMNKDLTKKILAAEGLPV
LPSVTVYRNGKASDSLDNVSRLNFPVMVKPLSEGSSVGMSKVNQPEDLETAVATAAECGP
WIMIEQFVKGRDLTVGVFNRNGKPVVTPILEIRPKPGKAEWYDYNAKYTEGMTEFILPAE
LPDDVTRLVQEKTLEAHQAMGCYGVSRVDWVMDANHQAYILEVNTIPGMTNLSDLPAQAK
AMGVSYDELVECLLHTAALGMTATRG
>AIA16704.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLVAYDKQRGIGADSDLPWQRDMPADLKRFKELTTGNAIIMGWNTYESIGRVLPHRQNIV
MSRSPRAEVEGMTLAGSLESAYAAVEPGRETFVIGGGQVYAQALPTVDRVFATEVDAVFE
SATVFFPPLDMAIWKETSREHHDSDERNKYPYDFVVYERQ
>AIA16682.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRISIIAAVATNGVIGREGRLPWHLSTDLKRFKQLTMGHAIIMGRRTWESIGRPLPGRRT
IVVTRQSEYSVPEGVQVAASLDDALDAAQAAGECDAFVVGGAELYHEALGLADRLYFTEV
AADVEGDTYFPVNFDTFEWESWVTTETEAHAADAENDYAFVFVTLERTDPTAMAE
>AIA16683.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMPSAALHRDSAPRYNPVMRPYLDLMQRILDEGVAKGDRTGTGTRSIFGHQMRFDLADGF
PLVTTKKMHLKSIIYELLWFLRGDTNVRYLNDHGVSIWDEWADAEGELGPVYGYQWRSWP
TSNGQTIDQISEVIEQIRTKPDSRRLIVSAWNVGDLPKMALPPCHLMFQFYVADGRLSCQ
MYQRSADVFLGVPFNIASYALLTMMVAQVTDLEPGEFIHTFGDAHLYQNHLEQAQLQITR
EPRPLPTMSIEPRVRSIFDFEYDHFRLENYQPHPHIPAPIAV
>AIA16657.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMQHVLSHGTPKSDRTGTGTLSVFGAQLRFDLNAGFPLLTTKKVHLKSIIHELL
WFLKGETNIKYLKDNGVGIWDEWADERGDLGPVYGYQWRSWPAADGRHIDQIRLVLDQIR
ENPDSRRMIVSAWNVADLDKMALMPCHAFFQFYVADGRLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCGLKLGDFVHTFGDTHLYTNHLEQARAQLSRGPRKMPTMRLNPNVKNLF
DFKYEDFTLENYDPHPAIKAPVAV
>AIA16652.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MRSVLDLACGLNPLALPWMPLAPDARYYACDIYADMIAFLNSFFAQSGIRGQARVCDLVA
GAPDEQVDLALVLKALPPLEQQAKHAGRDLLRALNARHILVSFPAHSLGGRGKGMAENYE
QRFRALADAEGWSIERFVFPTELAFLIRKE
>AIA16645.1|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MIFGGRSGEHEVSLRSAESVINAIDKTKYEVVPIAITTEGRWLTSGDAAALLPAAVMASN
SHRQVAIIGDPTRHGLTRLDEREHVLPSEPLDAIFPVLHGTYGEDGTIQGLFEMAGVPYV
GCGVLASATGMDKIAMKQLFERAGLELIDYDWFPRSEWEKNRDAVIKRVNRLLGFPVFVK
PANLGSSVGISKAANKLELCDAIDDAARYDRKVVVERAVNGREIEVSILGNENPIASLPG
EIITGHEFYDYEDKYIDTTSRTEVPAKLPKKIISRIQRDAIRAFQAIDGSGLARVDFFVE
RGTNRVIINEINTMPGFTSISMYPKLWEASGIPYSDLIDRLIQLAIERHADKSRNLTSYQ
PRQQKK
>AIA16467.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNYVLHNSNKGKYANAAFCAGSARITRDLYSEKFLGVPFNISSYALLTHLVAHVTNLEAG
DFVYTLGDYHIYKNHLEQVQQLLSREPLPLPKLTINDPDNKLRGLEGLLAAKYENLSLIG
YQSHGKIAAPVAV
>AIA16421.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTEIVGIAAVARNGVIGSGNDIPWRIAEDWQRFKRLTMGQVLIMGRKTYDSIGRPLPGRT
TFVITRDRMWRGDGVRVVPALDEAFQQAALLGPATIFVAGGGEIYRAAWDRLDRLEITEV
DQIPPGEVTF
>AIA16422.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLDHVLSNGVPKGDRTGTGTLSTFGYQMRFDLSAGFPLLTTKRVHTRSVIAELL
WFIQGSTNVKWLHEKDVTIWDEWADADGELGPIYGYQWRSWPAPDGRHIDQLAGVIDSIK
ENPDSRRHLVNAWNVGELSQMALPPCHTMFQFYVAPPVDGDPDGRGRLSCQLYQRSADVF
LGVPFNIASYALLTHLVAQVCGLDVGDFVHTLGDAHLYLNHLDQARLQLTREPRALPKLI
IDPTITAIDDFGLEHVSIEGYDPHPGIKAPIAV
>AIA16358.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAIHAENITKRFGDFVALDDVSLEIDDGSLTALLGPSGSGKSTLLRVIAGLEQPDSGVVL
LGGRNVTSLPAHRRGIGFVFQHYAAFKHMTVAKNVAFGLDIRKRPKAEIKQRVAELIELV
HLDGLGDRYPSQLSGGQRQRMALARALAVEPDVLLLDEPFGALDAQVRKDLREWLRRLHD
EIHVTTVIVTHDQEEAMEVADSVVVMQRGRIEQEGPPRELYENPVNRFVMSFVGPVNELG
EALVRPHDVEITLSPNGTTIAATVERVVHLGFEVRVHVVLEDGTPMTAQLTRDEANRLRV
ESGADVFVRPRAVREFGEDDGSMAAVEEDVPAPVPSVTDPERRAPEPL
>AIA16350.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MHIVLVAAVTANGFIARSTNELADWTSKEDKKFFVEETKKHGVMIMGRTTFATIGKPLPG
RRIVVLTEKPEEVQVVEGSVETASGDLKTIIDGLSKRGYASCVIAGGSNVYSQFLNAGLV
NELALTFEPVMFTSGVRLAEKLERELQLEVKSVEKLGENAILARYSVH
>AIA16326.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
QLDLTWVHSILKKTHILKQNKMQQYHNLLKDILDYGVVKSDRTGTGTISIFGYQMRFNLA
EGFPLVTTKKIHVKSIIHELLWFLKGQTNSAYLKKQGVSIWDEWADEYGELGPVYGKQWR
SWEGPDGVIIDQITDVIEQIKKNPDSRRLIVSAWNVSDLPKMALSPCHAIFQFYVAEEKL
SCQLYQRSADVFLGVPFNIASYALLTLMVAQVCNLEPGDFIHTFGDVHIYNNHMEQVKLQ
LSRTPYPLPTMRLNPDVKTIFDFKYEDFILENYQYHPAIKAPVAV
>AIA16175.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MVTLVAAVAKNGCIGKNGELPWSIPEDMKRFKKLTTGSIVVMGRKTWESIPKKFRPLPNR
HNVVVTRQADYPVPDGVDRYTSLDEALDAFATNTVMVIGGAEIYNQAIGRADTLQLTHVD
RDVDGDTFFPTIDPTIWKETWREDHEGFSFVTYERV
>AIA16167.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQGKKVPDSGSDEWQNGIKEFTERIKKDADFAKWHGELGPVYGYQWRKWPTPDGRHIDQ
IKSAIETIKSNPDSRRIIVSAWNAAEVEEMAISGLPPCHLLFQFYVSDGKLSCQMYQRSA
DTFLGVPFNIASYSLLTMMIAQITGLKPGEFVHTFGDTHLYINHMKQVNEQLKRRPKPLP
TMKINPAVKNIDDFKFEDFELLNYNPHPAIWAPIAV
>AIA16164.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKANRLPWRLSSDMKRFRQLTMGHHIVVGRKTFESIGKPLPGRQM
IIVTRNENFRPAECLIARSVEDALALARAAGESEVFICGGAEIYAESLSAADRMYLTLVH
ADCDADVFFPEFGDEWAEIESERRDADAKNQYPFTFKLLVKKQS
>AIA16147.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MMLSLIVAASENNVIGLDNDIPWRLPDDWKHFKDTTLGCPVIMGRKTHESIGRVLPGRRN
IVVSRQKELKIEGCDVVASIQDALALAKTDAPREIFVIGGEGIFREALPLADRIYLTRVH
ATVEGDVFFPELNLKEWKEISRERHLADDHHPYAFDILILDRQK
>AIA16108.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VGEIPQMALPPCHAFFQFYVADQKLSCQLYQRSADLFLGVPFNIASYALLTHMMAAQAGL
GVGEVVWTGGDCHIYDNHVDQVALQLGREPRPYPELVLAHRDSIFDYQYEDIAILNYDPH
PAIKAPVAV
>AIA16099.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mph|antibiotic inactivation|1
MSEKTRQEVLELAHKHSLDIQADSLQFNESGLDFQVVLATDTEGERWILRFPRREDVLRS
VAQEKRTLELIAPLLAVEVPVWIVSTNELIAYKALCGVPTATVDPEAKCYLWAIDENNVP
EQFHQTLAEGIASLHHISVEKAHSAGLLIATAKEVRATMKQRMDVVRSEFGVDQQLWDRW
QRWLENDVFWSHETVLTHGDLHAGHILINARTEVTGFIDWTEAAINDPAVDFVAHYRTFG
EDALD
>AIA16079.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLSTIVATAKNGVIGKEGGLPWYLPAELAHFKEITMGHPIIMGRTTHESIGRALPGRANI
VITREKSYKSKGVTIAHSLDEAITEAKKSAGSDEIFIIGGEAIYKQAMPQLNRIYLTEVD
AEVHGDKFFKYDADQWQEIRRDKHLPDDKNQYGYSFVLLEKA
>AIA16029.1|FEATURES|farme|aminoglycoside|AAC(6')-Ia|antibiotic inactivation|0
ETLTHTTSTAVIAAAEDVRSADAEQLMTELSAELAALYEVADGSAGFKASDVEVPRAAFV
IARIDGFPVGCGALRPLDASTGEVKRMYTRRGFRRKGVAQAILAELERLAIEFGYTTIKL
QTGPKQLDAAALYELVGYHRIPRFSGNWDLVLAYQKDL
>AIA16021.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVDRQGAIGKGGKLPWHYSADMKFFKETTIGNACVMGYKTWLTLKRPLPNRLNI
VLSRSAEIEPLESVVVLRDVESVLQKADALTRDLFVIGGAQVYHAFLPHIDKWIVTEVPL
TVEGADTFIPENYLEGFSLADTKDLGEGLRVSSYIRSPAA
>AIA15981.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MFNQLDLTWVHSILKKTHILKQNKMQQYHNLLKDILDYGVVKSDRTGTGTISIFGYQMRF
NLAEGFPLVTTKKIHVKSIIHELLWFLKGQTNIAYLKKQGVSIWDEWADEYGELGPVYGK
QWRSWEGPDGVIIDQITDVIEQIKKNPDSRRLIVSAWNVSDLPKMALSPCHAIFQFYVAE
EKLSCQLYQRSADVFLGVPFNIASYALLTLMVAQVCNLEPGDFIHTFGDVHIYNNHMEQV
KLQLSRTPYPLPTMRLNPDVKTIFDFKYEDFILENYQYHPAIKAPVAV
>AIA15840.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MIFGGRSGEHEVSLRSAESVINALNPEKYEVVPIAINKQGRWLKSGEATQLLPSVVIKTA
DRHIALLGDPTDRGLTSVSNSVPTEGREQIDVLFPVLHGTYGEDGTIQGLFEMADIPYVG
CGVLASSAGMDKVVMKRLFREAGLPIVEYTHFLRTQWENNPEQIAERIAEEIGYPCFVKP
ANLGSSVGISKATDRASLDKAIGLAAKFDRKIIVERGIDARELEVSVLGNDEPQASFPGE
IVPQTAEFYDYIAKYVDAGGARLVIPAEVSRETTLKLQ
>AIA15823.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YQMRFNLEEGFPMVTTKKLHLKSIIHELIWFLSGDTNIKYLKDNNVRIWDEWADENGDLG
PVYGSQWRSWPTVDGRHIDQISQIIKTIKENPDSRRIIVSAWNVGDIENMALPPCHAFFQ
FYVADGKLSCQLYQRSADIFLGVPFNIASYAMLTMMVAQVCGLQYGEFIHTLGDAHLYNN
HLEQARLQLSRDPKPLPVLKINPEVKDIFAFTYEDFTLENYDPHPHIKATVAV
>AIA15772.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLENGATKQDRTGTGTASVFGYQMRFNLAEGFPLLTTKKLHLKSIIYELL
WFLRGETNVKYLQEHGVNIWNEWARENGELGPVYGAQWRSWTGSDGRSIDQISQVIDQIK
TNPNSRRLIVSAWNVGEIPRMELPPCHLLFQFYVANGKLSCQLYQRSADIFLGLPFNIAS
YSLLTMMVAQACDLEPGEFVLTLGDAHLYSNHFEQARLQLSREPLKLPRMKINPAVHSIF
DFDYNDFELVGYEAHPHIKAEVAV
>AIA15769.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRDIKDNGVKKEDRTGTGTVSVFGRQVRYNLNDGFPAVTTKKLYFNSVVHELL
WFLQGTGNIEYLARNNVHIWDEWPYKAYLQKNNLPVPSSDSTEWKTGIKEFIARIASDHE
FAEQWGDLGPVYGVQWRKWPDGKGGYIDQIATAIDTIKHNPSSRRIIVSAWNVAEIDEIV
SIGGLPPCHSLFQFNVADGKLDLHLYQRSADTFLGVPFNIASYSLLLAMIAQVTGLKPGE
FVHTLADAHIYLNHFDQVDEQLSRTPKELPQLWLNPDVTSIDKFTFEDIRLEGYDPYPPI
KAPIAV
>AIA15748.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKASIVAYDHNRTIGDHGEIPWQGKMRGDAHYFRDMTSGHPVIMGRGTYEAMGRLLPNRQ
NIIVTSQDLDIDGAVTVHTLDEAYSIAQTLDEKVFVIGGGQIYDAAMNDVDIIYATEIDA
STDGDVHFPVIDPTIWRETAREHHEADEKNIYDYDFITYERI
>AIA15715.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|1
MHIRSVVAELLWFLQGATNVKWLHEQGVTIWDEWADDSGELGPIYGYQWRSWPTPDERHV
DQIAAVIGGLKADPDSRRHLVSAWNVSDLEQMALPPCHTMFQFYVAPAPAGSDDPRGRLS
CQLYQRSADIFLGVPFNIASYALLTHLVAQVCDLAVGDFVHTLGDAHLYTNHLEQARLQL
TREPRGLPDAPAGSQHHRHRRLRAGAHQHRGLRPLRGDQGPDRGLRRMGRVTIVVAIGQN
GVIGADGDMPWPRTGDQVQFKALTMGHPMIMGRTTYESIGRPLPGRTSIVLTRNPSWAAE
GVEVAGDLPAGLARAAELDDEVFLIGGAQVYAAAIEAGVVDRMVVTHVHLSPEGDAWFPD
VDWTAWHETSREKYDTYDIATYDRS
>AIA15606.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MTKRIKLRTLLMGGFITLLFVGLMFRIYWVQVVKADFWAKQAMNTWITNEKIPQERGMLL
DRDGKVLAADAMAYTVAVGPKTIALLEKKNPDWKLTDRIVSKLHLVLGTSESTLREMITS
KKASDGTYLDQREIHPDGWKIDKAVKDRLETFRSELQKLTNEKNVGLYFMEEQKRYYPNG
SLASHILGYENKEGMAVMGLEKTLNDQLSGQPGSITYLKDGARTQLPNGQVEYKQAVNGK
NVTLTIDRDIQFYIEEALRKAYAEYKPISITAIAADPQTMEILGMASLPDYNPNNYWDFM
KDPNSFRDNAIQSVYEPGSTFKIVTLAGAVQEGLFNPTATYKSGSIKYSAKDKPVYDHNR
VGWGEITYLDGLKHSSNVAFVKLGYEMLGKDRLVKYITDFGFGQKTGIELPNEVSKSISL
NYPSEVATAAFGQGKVLVTPIQQVAAVAAVANGGKLMQPHIVKSITDPTTGQKQVTEPKV
IRQVISAETSRKVGDYLETVVSDQAIGTGKSAYIPGYRIAGKTGTAQKVTKSVDTNISGY
SKDKYVVSFIGYAPVENPKVVLYIVVDEPQIPNAGGGAVAGPIFKDIMGKSLLHLGIAPN
LPKTPDASATASASSSASKGVVVTATVPDVTGMTVSQAQTQLKQRSFPVGVLGNGGKVLQ
QLPKEGSVLPATQQIYLLTDTKPGNVPDLKGLSLRDALEMCSLLKVVCTVDGQGYVTSQK
AVKVGGKWILQLKLASPGG
>AIA15565.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKSIVVAYDSHRGIGASNDLLWQRDLPADLAHFKQLTMGGSLIMGRNTFESIGRALPGRE
NIVVTHRSLDVVDVVAVDSLAKAYESAHGNQFIIGGGQIYTQSLPDVDVVYATEVHASFS
QAEVFFPELDKNWREVSREAHVADDRNKYAYDFVTYARR
>AIA15558.1|FEATURES|farme|aminoglycoside|AAC(3)-Ic|antibiotic inactivation|0
SRSTYDGVVAGTVALKKVSNDVYEFTKMAVDEAYRRRGIAEALTYASFEKARELGATKVI
LYSNRVLTPAITMYHKLGFTEVPMEKDVVYQRSDIKMEIDLASLRPQADSYTNANAPAQH
FTTI
>AIA15496.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLAHVMEKGTNRGDRTGTGTRSVFGYQMRFDLSEGFPVLTTKKLHLRSIIHELL
WFLKGETNIAYLKENGVSIWDEWADEDGNLGPVYGAQWRSWPAPDGSHIDQIALLIEGLK
TNPNSRRHIVSAWNPALVDDMALPPCHCLFQFYVADGKLSCRLYQRSADIFLGVPFNIAS
YALLTLMVAQVTGLKPGDFVHTLGDTHIYSNHFEQAELQMKRTPKALPTMRLNPDVTSIF
DFKFEDFTLENYEADASIKAPIAV
>AIA15390.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MPARLQGVGKVEFIAMMASLMALNALAIDIMLPGLQQIGESLGVENPNHRQYVVSAYLFG
FGVAQLFYGPISDRFGRRKPLLIGLGIYILSAVAVVFVPSFAGLLLLRFAQGIGSAATRV
ISISIVRDVFGGRAMAEVMSLIMMVFMVVPVVAPGTGQIILLFGNWHLIFVVIALAALIV
SLWVIKRLPETLDPADVRPFTVASVANGFLIVLTNRVALCYTLASTFIFGALFGFINSAQ
QVYVGIYQLGAWFPLAFAAVAVFMSISAFLNSRWVGKLGMRRLSQTALLGFVGITFLWLV
VQLLSSTPMPFLLFLAFFAVAMFLFGLIASNFNSLAMEPLGHVAGTASSVLGFMGTIGGA
IIGAAIGQAFNGTATPMVAGFFTVAVIGLMFVLLGERGKLFRTQNAPV
>AIA15371.1|FEATURES|farme|elfamycin|facT|antibiotic efflux|1
MTTAHPTHSAHHHASKFTSRQKTIALIIVALAFVMDLLDNTIVNIAIPSIQSNLGASYST
IQWLIAGYSLAFAILLITGGRMGDVFGYKKMFLLGVGGFTITSLLCGLAWNSEILIVARL
LQGSMAALMVPQVMSLMQVLYKAHERGQVMGLFGALAGVAATLGPVIGGVLIHLNIAGLD
WRPIFLINIPVGIFALAAGWKYLPTGKSPHPLRLDVIGTAIIVVALFLLIFPLIEGRELD
WPAWTFGMMVAAAPVLVLFAWWQFKKDKKDRSPLIVPALMKTSTFIKGIVINLTFESAML
GFFLPFTLVIQVGLGYDVIKAALTGIPTAIGISVVMAVFSQKLIPKLGRYSLTIGTVVMA
AGLVLLYFMTRSLGLDMTPWEFIPGLLIIGAGMAMIMTPIFAVVLTDVDPKHAGSASGVL
NAVQQLGGSIGIALIGLFFFSQLATNAPASFDKVEPQLRNDLSSLQVPATMQDQVLASVK
TCYTDRAEAKDMSQTPESCKKLESSKAGNGHMSQAQAAINQKMTESITKSVTQANANNFT
NAFGVAVI
>AIA15369.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAVELIFETRSKASLALSDSYIMIKRSGLHIIRNRDQLLGAFFQPIMFLVLFASVFGGAI
SKALPPGVSYLNFLMAGIIVQTTAFGSTTTAIAVCNDLQKGIVDRFRSLPMSNLAVLNGH
VVSDLFRNGISTIVMILAGLIIGFRPHASFTDWLVIAGILILFTLAFSWLSAIVGILAKS
VEGVQWLTFVLVFPLTFASTAFVPSEGMNPVLKAFAVNQPITQVVEAVRALILGTPIGSH
GWLAAGWSVGILIISMPLASWLFRRKTAS
>AIA15305.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLQHVIDHGLEKSDRTGTGTLSVFGYQLRFDLTQGFPLPTTKKVHVRSVVAELL
WFLQGATNVKWLHEQGVTIWDEWADDSGELGPIYGYQWRSWPTPDERHIDQIAAVISGLK
TNPDSRRHLVSAWNVGDLEQMALPPCHTVFQFYVAPAPADSADQRGRLSCQLYQRSADIF
LGVPFNIASYALLTHLVAQVCDLAVGDFVHTLGDAHLYLNHLDQARRQLAREPRPLPTLR
LDPAITDIDDFGLEHIVIDGYDPHPGIKAPIAV
>AIA15292.1|FEATURES|farme|tetracycline|tetB|antibiotic efflux|0
EVAINVEGAAVEREVNKTVLPMMHGFYSLGTLAGAGVGMALTAFGIAANLHILLAALVCI
IPILTGIRAIPDGTGKNSTGEQKSAAKGLPFYRDIQLMLIGVVVLAMAFAEGSANDWLPL
LMVDGHGFSPTSGSLIYAGFTLGMTVGRFTGGWFIDRYSRVAVVRASALGGLGIAMIIFV
DVDWIAGVSVILWGLGASLGFPLTISAASDTGPDAPTRVSVVATTGYLAFLVGPPLLGFL
GEHYGLRSAMLVVLGLVIIAALVARAVAKPEAEQTLENGYER
>AIA15165.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MASAATMTTLPENIAVLMGGPGSEREVSLATGRGVANALRSLGATVTEVDVRGPDFVLPD
GVELAFISLHGTFGEDGQVQKILEDRGVAYTGEGVEESRLAFDKIESKDRFRAAQVATPY
WQIILAKQRPTIPPPFVVKAPRQGSTVGIYIVHSDREIEAAITKASQYDEQLLIEKFVSG
RELTVGVLGDLALPVLEIIPKGGVYDFTNKYPFLNPGAGGGAQHVCPAAISEEQTGAIQR
LALQAHRALGLQVYSRVDILLPEEEEPTVLEVNTIPGMTEASLLPEAAAAAGIPYPQLCA
RIIELSAKARPSKG
>AIA15095.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVILVAALSSDGFIARAASHGADWTGTADKKIFVKLTKAMGIMVMGSTTFATIGRALPG
RRTIVYTSNPQSITAEGVETTTEPPLDLINRLEQRGATGVAICGGAQIYTQFMQAGLIQD
FYLTHVPVVFGEGITLFSSPLDVHLDLVTSEPIGEGAVLMHYRLKSLSS
>AIA15017.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTLGLIWAQSASGVIGMDGAIPWRVPEDSAHFRAVTGNADVVMGRRTWDSLPERFRPLPG
RRNIVVTRQAGWNADGAVVADSVDAALRATAGDTWIIGGSELYESTIAKADVLEVSEIDT
ESRGDTFAPRIDDAWAPVQRDPADGSWHTSRTGIRYRFVRYERLGS
>AIA14981.1|FEATURES|farme|bacitracin|uppP|antibiotic efflux|0
MKSPESSDNPQRAASDASAAHAMAPHDSRARSIALAASLALIAFSLRTPITSVGPILLEA
VQATNLSRTGASLLTTLPSLCFGFFGPLAPLLARRLGSERALLALLALLTAGTALRVVPV
WQVLYLGQIVACFAIGLMNVLLPGVVKRDFPHHVALMTGIYSAAMCAGAAAAAAATVPAA
HALGHLLGGASDHAWAWALALWALPVALATVVWGARLPARSTSTGRRVHVVRGLWRDPLA
WTVTVFMGSQSALAYIVFGWLPTVLRTRGMSAVDAGFMLSLSVVTQAVASLLLPFLLARR
RDQRAVNVGALLLTGVGLMGCFFAPLSILWIWALLLGAAQGASFTLALTVIGLRSYDSHV
AAQLSSMAQGIGYLIASCGPFIAGSLLHATGSLSSLAALCAGICIVSAWFGYAAGRPEHV
NAHVE
>AIA14916.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKSLEPYGQQTMNKEGFPSMSSVQTPVKLSSQTRIGVLYGGLSSERKVSLISGQNCFDAL
KRLGYENAELIDVNHHIAQTLAEKRIEVAYIALHGKFGEDGCIQGLLELMGIPYTGCRVA
ASALTMNKATTKSVLKDAGLPVIDSVVIKAGTVNGKPMDIGLSYPVMVKPINEGSSIGMS
KVNRAEDLKEALHTAFKYADEVMVEEYVPGKSLTVGVVEVDGAPKVTPILELRPTQSEWY
DLEAKYTEGGTEFILPAELSDEVTRAIQDATLKAHVAAGCRGMSRIDFVVDAQNRFYILE
INTIPGMTPLSDLPAQAKAMGIDYDQLVECILKTATADF
>AIA14897.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MLLEIKNLHAAIDGKEILKGVNLQINKGEVHAIMGPNGSGKSTLAKVLAGHPSYEVTQGE
VFYEGKNLLELEPDERAREGVFLAFQYPVEVPGVSNSQFLRLAYNEKMKHLEQEELDPLE
TVS
>AIA14815.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MFYCLTLSIIVAASENNVIGVNNHLPWHLPVDMKYFKDTTMGKPIVMGRKSFEELGKVLP
GRPNIMITRQPHYAAEGLHIVPSLEAGIEKAKTFGTEEIFITGGGEIFKMALSIVDRLYM
TRVHATVQGDTYFPEFDPTGWKLVKNDRHEKDERHAYAMTFQVWERER
>AIA14814.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQISIIVAVSENGVIGKDNQLLWRLPDDLKRFKQLTLNHPMIMGRKTFDSIGKPLPGRTS
IVITRDPNFAFEGVVVVHSLEKALATARDLNVDEAFVIGGGEIYKQVQTLADKLYVTEVK
TMIDGDTFFEIENPDAWTETERIVHEADERHKLKFEFVNYIKQKF
>AIA14782.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MNGWQWALSDSWIMSKRSVLHIIRSMDQVLSLVLFPIMFMLLNRYVLGGAINTGDVSYVN
YLFAGIFVQTLAFGANYTTINLAVDLKEGIVDRFKSLPMASGSLLFGHITADLVRNVISG
IVIIAVGFLVGFRPTASAQDWLTVVGLAVLFTLSISWLSAILGLWVKSVEAAQWIGFVVI
FPLTFISSAFVPTDTMPSALQAFAENQPVTQTIDAMRSLLVGTPMNNAALYSVLWSVGII
VVSAPIAIWMFKNRTTQNK
>AIA14725.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKSSKHPEYQYLNLAKEILESGIKQTDRGTGVSDYSLFGRQSRYDLSEGFPLLTTKKVYW
KGVVEELYWFFSGQTNIKYLVDNNVHIWDDYPFKIYKEKNPKSKMTKDEFIENIRTDAKF
AKEWGELPRIYGEMWRKWPTRKKGKTIDQLQWAVNELKADPNAHNAIVNSWNPEYLYTMA
DRQDASRFPICHNMYQISNRNGRLSLILYQRSCDLFLGVPFNIASYSLLALVLAKVLDLE
PGEFIHDYGDVHIYENHIDQFKEQLMRKPRPFPTVKLVGKIKELSDFTPDKVVLENYDPH
PTIKAELTVAGGYYESKKKKK
>AIA14601.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAVKLEFDKRPKAVLALNDSLIMIKRSGTHILRNTDQLLGAFFQPIMFLVLFASVFGGAI
SKALPPGVSYLNFLMAGIIVQTAAFGSTTTALAVCNDLQKGIVDRFRSLPMSTLAVLNGH
VISDLFRNGISTLVMILAGLVIGFRPKADPLEWLLLVGILLLFTLAFSWMSAILGILAKS
VEGVQWLGFVLVFPLTFASTAFVPSEGMNSVLKAFAVNQPITHIVEALRALILGKPLGDH
GWLAVVWSLAILAVSVPLATIMFKRKTSN
>AIA14586.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKKQRIGILFGGRSGEHEVSLLSAASILKAIDKKKYDVLPIGITKQGQWLGAGDAQALL
AGESKQPLQLSAGADLVQQSGNLTQTVDVIFPVLHGTFGEDGTIQGLFELADIAYVGSGV
LGSAAGMDKDVMKKLFAAAGLPQTPYLALTRSEWKADPKRCTRLIEKALQYPVFVKPANL
GSSVGISKVHGRSELAAAMDLAAGFDRKLVIEQGVGGPGAKPRELEVAVLGNDAPEASVV
GEIVPNKEFYDYESKYADSPDDPSVPIIPAKLTAAAVKEIRTMAVAAFRACDCAGLARVD
FLMEPARKGKKARIYLNEINTMPGFTSISMYPKLWEASGLPYKQLIDRLIALAVERHQEK
MQTSFSRN
>AIA14574.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MNNLPKKIAVLMGGPGSERDVSLATGRGVAKALRSLGTEVSEIDVRGPDFEMSDDVEMAF
VAVHGTFGEDGQLQRILEERGVPYTGEGMRESETAFDKISSKERFDAAGVATPEWEIIKA
GERPTLSLPFVIKAPKQGSTVGVYIVRTDAELEHALTEAAKLEHALTEAAKYDERLLVEK
FIPARELTIGVLGERALPIIEIIPKGGFYDFTNKYPFLNPSAGGGAEHVCPAHISEEQTR
AIQELALQAHRSLGLKVYSRVDIMLPENGAPTVLEINTIPGMTEASLLPEAAAAAGISYP
ALCARIIELSQAARKAA
>AIA14548.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYQDLMRHVMENGTQKHDRTGTGTISVFGYQMRFNLQEGFPMVTTKKLHLKSIIHELI
WFLTGDTNIKYLKDNGVRIWDEWADENGNLGPVYGYQWRSWPTPNGGHIDQISQVINQIK
NNPDSRRMMVSAWNVADVNQMALPPCHSLFQFYVADGKLSCQLYQRSADIFLGVPFNIAS
YALLTMMVAQVCGLQYGDFIHTFGDAHLYNNHLEQTKLQLSREPRPLPTMKINPDVKDIF
DFKFEDFELQNYDPWPHIKGEVAV
>AIA14509.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTLGHQLQKRSVVMNAQIVRAAIVLGLLSVIGPLAVDMYLPALPAIGIGLGANSAAVQAS
LMAYLAAIAVGQLLYGPLSDMLGRKLPLYFGIGIYVLGSIGAALSPNVEWLVTFRLVQGI
GACASFTLPRAIVRDEYTGAPAAQLMSLLMLVFSVSPILAPLAGSAVIAFGDWRLLFWVM
SLGGVLCLLLAIFALRETRPKQARLNSGVGSAVSAYWTLLRDGRFMGLSLIGTFGMSAFM
AFLGNSSFVYIQHYGLTPTEYSLAFSVNAVSFFAVSQATGYLVGRFGLNRVVRTAVGGFV
VSMVALLAVYLGGVDSVWVLGIFMFIAFGFLGLVLPSTTVLAMEEQGAIAGSASALMGTV
QMIVASVVMGVVGAFSDGTARPMVIAFALCSIAAFAITQMTLGKGDGSRMIEVPAE
>AIA14487.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MATKLVFQQKPKWILALNDSLIMITRSSRHIIRNTDQLLGTFFQPIMFLVLFSTVFGGAI
SMALPKGVSYLDFLMAGIIVQTVAFGSTTTAIAVCNDLQKGIVDRFRSLPMANLAVLNGH
VISDVFRNAISTLVMILTGLAIGFRTHASFVDWLLITGILLLFTLAFSWLSAIMGVVAKS
VEGVQWLGFVVVFPLTFASTAFVPAEGMNRVLRAFAENQPITQIVEAVRALMLGTPTGNH
VWLAIVWCLGLLVISVPIASWLFRRKTTS
>AIA14473.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLAHVMNAGSDRGDRTGTGTRSVFGYQMRFDLSEGFPVLTTKKLHLRSIIHELL
WFLKGDTNIAYLKENGVSIWDEWADENGNLGPVYGAQWRSWPAPDGRQMDQIALLIESLK
VNPNSRRHIVSAWNPALVDDMALPPCHCLFQFYVADGKLSCQLYQRSADIFLGVPFNIAS
YALLTMMVAQVTGLKPGDFVHTLGDAHIYANHFEQAKLQMTRTPKPLPTMRLNPDVTSLF
DFTFEDFTLENYEADASIKAPIAV
>AIA14414.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MANNRYVIEVKNLTKSYGSNNVLKGIDLKVERGTMLALLGPNGAGKTTTVRILSTLLSFD
DGEVLVDGHNVKTEADRVRESIGLTGQSAAIDELLTGRENLVMMGRLYRLTPESAKARAQ
ELLEEFNLLDAAERPAKTYSGGMRRRLDLAVSLISTPPIIFLDEPTTGLDPRSRLAMWDI
INRLKEQGTTILLTTQYLEEADQLADKIVVIDGGRVIANGTANELKSKIGNDRLELTFAD
QETFKKALQTLGKAVIDTNDKEHTVTVVIKDTNADVKAVLEKLSQANIVITSMDIHKPTL
DDVFLSLTGTQKAATSEETK
>AIA14383.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MAEKTVIEVRGLKKSYDKTEVLKGVNIQVQRGTMLALLGPNGAGKTTTVRILSTLLKFDG
GTVKVAGYDVKTESDRVRSVIGLTGQSAAVDELLTGRENLVMMGRLYRLTPKSAKERAQE
LLEQFDLVKAADRPAKTYSGGMRRRLDLAVSLIAAPPIIFLDEPTTGLDPRSRLAMWQII
RKLMDDGTTILLTTQYLEEADQLADQIVVIDGGKVIAEGTATELKRKVGNDRLELTFKDQ
KTLEKAVKALQKDVVDTNEKEYTATVVIKDTNTDVRKALDKLSNQKVKIESLEIHKPTLD
DVFLSLTGKQNKDKKGQSNGG
>AIA14363.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MEKKHPEYQYLDLLQDIIDNGSDKELFFTPEILKQYEEKGEKPPTIRSVFGRQMRFDLKD
GFPLLTTKKVFTRGIIVELLWFLRGDSNIKYLVDNNVHIWDEWAWKRYNKVGKTRGLPEM
SQENFIAKLKEEPAESEFVKEWGDLITVYGRMWRRWPASDGREIDQLAWVIDGLRDKPFR
KSYVISAWNPDFIYSMASGNNSNEVPPFCHTTFQFAVTEKRKLNLGLYQRSGDVFLGVPF
NITSYALLLQMVAQVTGLEAGEFVHMLGDVHLYSNHFDQAKEQLSRTPRPFPTLKLNPER
KDINDFVFEDIVIEKYDPHPPIKAEIANIGGFEKKDNTLFTLKDKK
>AIA14364.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPRISAIAAIVNNRGLGKDNELLVRIPEDLARFKKLTSGHTVIMGRKTYESIGKPLPNRT
NIVVTRDAKYEAEGCQVVFSVEEALDLGRQLEPEEIFIIGGGKIYDEMLPYTERLYLTQV
EKEVEADTFFPEYKEFTKELEREEKEHEGTKYTWVTLER
>AIA14315.1|FEATURES|farme|trimethoprim|TS_Pyrimidine_HMase|antibiotic target alteration|0
MKAYLDLLQHLLDNGTRKTDRTGTGTLSCFGYQMRFDLADGFPLLTTKKLHTKSIIHELL
WFLQGDTNIAYLKENGVRIWDEWADADGDLGPVYGKQWRSWAAPDGRVIDQISDVLAMIK
KNPDLEPRRRAHHGPAAMPLPVPILRCGRKAQLPALPAQCGYLPRRTLQHRQLCAAHIDD
RAGLRSAAR
>AIA14286.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKVSMIVAMSENRVIGKENQLPWRLPEDLKRFKEITIGHPVIMGRKTFESIGRLLPGREN
IVITRQTEFSFPGAVVKSSLEAALSYCERKAEESFIIGGAEIYRLGMPYATRIYLTLIRK
SIEGDAYFPTLPSGFEETQRDDRNGDLPFSFLVLERKL
>AIA14250.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYNDVLKRIMDQGVDRQGRNAVTRALFVEQMRFKMSDGFPAMTTKRLAFKAVKSELLW
FLEGSNDDNRLKELNGSEKTIWTANAQASYWKPKAKFDGDLGRIYGVQWRSWLAPDGRVI
DQIAQAIDKIKNDPSNRRIIVSAWNPGEIDQMALPPCHMLFQFFVANGKLSLHMVQRSCD
MFLGVPFNIASYSLLLHMVAQVTGTTADECILTLNDAHIYHPHFDAVNEQLSREPMKLCS
LWLNPEIKDINDFTMDDIRLENYESHPTIPAEMIE
>AIA14243.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGSLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTHSESFAPEGCFSVHSISDAISFARERGESELFVCGGAEIYAQMFGVADRMYLTLVH
ADSEADTFFPEWDSSEWIEVESEHRTADEKNQYPFTFKVLARKSQV
>AIA14187.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MDEKRGIGKDGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQMIIVTRNES
FAPEGCFSVHSISDAISFAKERGESELFICGGAEIYAETLGAADRLYLTLVHADCDADTF
FPDCNSGEWIETESEHHAADEKNQYSFTFKVLERKHEA
>AIA14185.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MSSQRRWAVTAGVITGMFLAALEATVVGTAMPTVIASLGGLNHYSWVFSAYLITATVTVP
VWGKLSDLYGRRLLYQIGIAIFLLGSALSGMSTSMMHLVIFRAIQGLGAGALVPLGMTII
GDIYTVTERAKMQALFSGVWGLSSVIGPVVGGFITDQLSWRWVFYINLPVGLLTALILGL
ALKEPKRTERPAIDYAGAALLIAAITLLMLALVEGGAKLSTLFAARNLMLFAGAVVLTAI
FIRVERRAADPVVPFKLFRNRVVLISVVAGFLAGVAMFGAISFVPLFAQGALEMTATQAG
SLLTPLMLSWVGMSIIGGRILIRVGYRPLCIAGFTLLTLGFVLLSMFQRATPRVWLYVDL
ILIGAGLGLTMLTLLIAVQQAVSRAQLGIATSLNQFSRSIGGAVGVAVMGAVLSAGLASQ
LSEVASRGNTALTPERAAELSENPNALIDPHARAVLPPNVLDALQGSMAGAIHNVFWVGT
AFAVLALLVSFYLPRKGESTFERPEEEACSSETGERMMMAELTTIDPEHEPVVTQGD
>AIA14127.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKKIRVGVIYGGRSGEHEISLRSARSVIESLDSEKYDVVPIAITKEGKWLGPAQAVGML
PEETKQLVPGKVIKHANRDVAIIGDPSRSGLVTLETENEGTSSQPLDVVFPVLHGTYGED
GTLQGLLDMAGIPYVGCGVLASSCGMDKVAMKALFREAGLPLCKYIWLLRSEWERDPASI
MRRIKREIGFPCFIKPANLGSSVGVSKAIDKGSLEKAIELAARYDRKIMVEEGLDAREIE
CAVLGNDEPVASLPGEYVVYDEAAKFLDYTEKYSSTGHVEFVVPAPLSKSLIKKIQQMAT
LAFKAIDGAGLARVDFFLRRDTNELLINELNTLPGLTDVSGYPKMWEASGKSFPQVIDSL
IELAFERHKDKSRNQTSR
>AIA14118.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTHTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLKERGVNIWNEWADESGDLGPVYGAQWRTWRACDGQTVDQISRVIEQIK
SDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGRLSCQLYQRSADIFLGVPFNIAS
YSLLLAMVAQVTGKQPGDFVHTLADTHLYLNHLEQVEEQLSRKPFPLPTLKLNPDIKSID
GFKFEDIELVGYQSHPPIKAPIAV
>AIA14063.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSEIIGIAAVAVNGVIGADNDIPWRIPADWQRFKALTMGNVLIMGRKTYDSIGRPLPGRT
TFVITRDRMWRGGGVHAMPSLDEAFEQALLLAPEIVFVAGGGEIYRAAWNRLTRLEITEV
DRAPVGEVRFPTIDPGEWIETGRESYDGYRFVSYRRRSQREPAF
>AIA13974.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MIVNAWNVGELSKMRLAPCHLLFQFYVADGRLSCQLYQRSADIFLGVPFNIASYALLTMM
IAQVSDLRPGEFVHTLGDAHLYSNHLEQARLQLAREPRALPQMKINPSVKSIFEFDYSDF
ELSGYDPHPHIKAEVAV
>AIA13970.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKSGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGRPLPGRVM
IIITRSESIAVEGCFIARSVEEAVGLARERGESELFICGGAEIYAETLGAADRMYLTLVH
ADSEADTFFPEWNSSEWIEVESEHRTADEKNQYPFTFKVLARKSQV
>AIA13966.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MAIIGIVAVDENGAIGKNGSIPWHYSADVKFFKQQTIGHACVMGYKTWLSLKKPLKERLN
IVLSRKSEVEPQPNVIVLRDTLSILTLKKFLACDLFIIGGEQIYRSFLPHMDRWIVTQIP
VAVEGADTFMPEGYLKNFSPYDSQQLEENLKVTFYE
>AIA13951.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSTDLKRFRNLTMGHHIIVGRKTFESIGRPLPGRQT
IILTRNENFRPEGCFIARSVEDSLRLAEDRGESEAFICGGAEIYAQSLDKADRIYLTLVH
ADSGADTFFPDYNGDQWVERESEHHAADEKNQHPFTFKLLVKKAS
>AIA13880.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSTDLKRFRNLTMGHHIIVGRKTFESIGKPLPGRQM
IIVTHSESFAPEGCFSVHSISDAISFARERGESELFVCGGAEIYAQMFGVADRMYLTLVH
ADSEADTFFPDCNSGEWIETESEHHAADEKNQYSFTFKVLERKHEA
>AIA13875.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGIKKDDRTHTGTLSTFGYQMRFNLGEGFPLLTTKKLHTKSIIYELL
WFLRGETNIKYLKERGVNIWNEWADERGDLGPVYGAQWRAWRAGDGQTVDQISRVIEQIK
SDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGRLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVSDLNPGEFVHTLGDAHLYSNHLEQARLQLAREPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA13830.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
GTGERPVIALVVAIGENGAIGRGGELPWRLSSDMRYFRKVTMGKPVIMGRRTFKSLPRVL
DGRLNIVLTRDQGFVAPDAVMAHSLDEGLAAARDSAARTDAGEIMVIGGEDVFREVLPQA
HRIYLTEVHASPEADTWFPDFDKREWREVFRERHEAGPRDEHAFSFVVLERTDGP
>AIA13683.1|FEATURES|farme|aminocoumarin|novA|antibiotic efflux|0
EILRGLNLQINKGEVHAIMGPNGSGKSTLAKVLAGHPSYEVTMGEVFYEGVNLLDLEPDE
RAREGVFLAFQYPVEVPGVSNAQFLRLAYNEKMKHLGQEELDPLEFNDYLKEKAKVVEMD
KSFFNRSVNEGFSGGEKKRNEILQMAVLAPKLAVLDETDSGLDIDALRIVAEGVNKLRSA
DNAIILVTHYQRLLNYIEPDFVHVLAGGKIVKEGGKELALELEEKGYDWVKAAGN
>AIA13600.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MRHELVSDTNNRKSEIGNRKLRIAVLYGGKSGEHEVSLMSSASVMEELDDGKYEVTPVFI
NRDGCWDLPLETLRQFDVVFPVLHGPMGEDGTVQGLLVLLGVPFVGADVVGSAVGMDKAI
FKDVMRAHGLPVARCVVVLRHEWSRGQQAIIAQVEQELGWPVFVKPANMGSSVGINKCKT
PEQLPDAMNEALKWDRKVLIEAAVPNARELEVSVLGNDEMQASVVGEVRPRREFYDYAAK
YLVKGEEESELIIPADISDSLSQRVREMAVQVARLADVRGMTRVDFLMNGVSGDIYINEI
NTIPGFTSISMYPKLWAASGLPYPDLLDRLIELALEK
>AIA13479.1|FEATURES|farme|beta_lactam|AS202_10895|antibiotic inactivation|1
MNTRIGFLLLSLFIVGLNSAPAEAQDLSPYFKNTNGAFVLYDLKENHYIRYNEQRCRERF
SPKSTFKIPNSLIGLDTGVIRDADFTIAWNRQKYPPQDNWNQEPFIHWAQDHTLRSAIKY
SVVWYYRELALRVGKQKMMKYITAFNYGNKTISKDIDNFWLDNSLKISADEQVEFLKEFY
AGRLPVSKLAIETVKDILVLENTPAYKLSAKTGGGSIAEGKYIGWFVGYLETKGNVYFFA
TNIEGASFAEIREKRVELSKEILAALGYLPK
>AIA13449.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MQQQRVSIIAAIDEKNGLGKNNDLLFKIPGDMQRVRSLTTGHPLVMGRKTFASLGRLLPQ
RSHVVITRDPSSLETLSFQPEAVVSSLEEALEEVQKYPGAEEIFIFGGGQIFTEAIEKDL
VDRLYLTLVKGEYDADTFFPDYSAFTKVITSEEHEEDGYSYMFLDLEK
>AIA13427.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLDHVLTHGVEKSDRTGTGTLSTFGYQMRFDLGEGFPLLTTKKLHTRSIIGELL
WFIQGSTNVKWLHEQGITIWDEWADPDGELGPIYGYQWRSWPTAAGGHIDQLAGVINTIK
TVPDSRRHIVSAWNVGDLADMALPPCHAMFQFYVAQGRLSCQLYQRSADIFLGVPFNIAS
YALLTEMVAQVCGLEVGDFVHTLGDAHLYLNHLDQARLQLSREPRPLPRLVLNPSISAID
DFTFDDIAIEGYDPYPGIRAPIAV
>AIA13418.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
HEVSLVTAREVATALRESGYEVIELELDEHLPEKLLQTQPATVFPAVHGAPGEDGSLQGM
LEIMGISYVGSDVLASALAMHKATAKQLFQMAGLPITGSHLMREGDDLEATVAAIKEKLG
EPPYMVKPNTEGSALGATRVFDAGELRPAIERAVSPGKEVLIEEFIEGREMTVGILEEDD
GYRTFPLIEILSKKDWYDYEARYTPGMSEHICPAEVPPEVAAELARISLEAHKVLGCRDL
SRADLILTSSNDAYLLEVNTLPGMTPTSLFPDAAKVAGISFNSLMDHLIKRALRRRQS
>AIA13390.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRHVMETGTDRGDRTGKGTRSVFGYQMRFDLAEGFPVLTTKKLHLRSIIHELL
WFLKGDTNIAYLKENGVSIWDEWADEKGELGPVYGYQWRSWPAPDGSHVDQISQLIEGLK
VNPNSRRHIVSAWNVGQLDDMALPACHCLFQFYIADGKLSCQLYQRSADVFLGVPFNIAS
YALLTMMVAQVTGLKPGDFVHTLGDTHIYSDHFEQARLQLTRTPKALPTMRINPAVKDIF
SFRYEDFALEGYEADPHIKAAVAV
>AIA13367.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MPWHLPDELKRFKNITMGKVLIMGRKTFESIGRPLPGRYTIVVSRSKEMLPRIVTPATSL
ESALKHAKEMAANWGNEICVVGGGEIYRQTLDVIQRIYLTRIHQNIDGDTTYPLEALKDF
ECKESEEVTSSAIPYAATIWDRK
>AIA13335.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTNDPMTNDPMSNDLMTNDPLTPMTISIIVAVSENNVIGKNNDLPWHLPADMKFFKDTTM
GHCVVMGRKNFQSIPDKYSPLAGRTNIVVTRQKDFKAEGVITAHSIQEAIQVAKEKNETE
CFIIGGGEIFAQSLHFCDKIYLTRIHHVIDGDVHFPILNIDEWKELSRKDVPADEKNKFS
FSFLTYGRLK
>AIA13327.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSSSQSRLRIAVLFGGRSSEHDVSIMSATNVMRALDPERYDALPVYVSKDGRWLQSRFAD
GELDKPSSGTELCLVPGGRGRLLAVTPDGKAAEAGRIDIVFPVLHGLHGEDGAVQGLCQV
ARVPLAGCGILGSATALDKDIAKQLLKAAGLPVARSVTLDQEAPPALEALEGALGLPLFI
KPARQGSSVGVRKVSGSQEFAPALAEAFSHDRKLIAEEFIAGREIECSVLEDTKGGLFVS
RPGEIAPAESHGFYSYTAKYLDENGAALKVPAELPADVEARIRDMAARAFRALGCDGMAR
VDFFVMEDMRFVVNEVNTIPGFTDISMYSKAMAASGVAYAEVIDRLVEHGLARGA
>AIA13263.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MSRNRIILVTAGIMLSLFLASMESTVVATAMPTIVGQLGGLEHFSWVFSAFLLASTTTVP
LYGKLSDIYGRRKLYVFAMALFLIGSVLCGLANSMTQLIFARALQGIGAGGIMPLAFILI
GEMFSLEQRTKMQGVFSGVWGVSSIAGPLLGGFLVAQLSWRWIFYINVIPGLLAAALVAF
AWRDQIHSQKRPAVDYMGAALLTVSVVLLLLGLMEFGTSRSWIYIGVAIILFIALWWVER
RAVDPILPIPLFRDTLFATATAHGLLTGWAVFGSISFIPLFVQSVLGTDALQAGITITPM
LLGWVGASIVGTRILLRVGYRNLSVIGTALFAVGAFLMTLVGANSNQIMVMVFVTMMGIG
MGLSIPAFVIAVQTSVERRHLGTATSMLQFSRSMGGTLGVSVMGAMLSARLASNLSASGL
DTEMVAQLLDPIPGSEVVIDAGVRLAMANAIHVVFLVAFVAAALGLVSAFFTPRKELTEN
LPEPTPMSAD
>AIA13198.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSSDMKRFRELTMGHHIIVGRKTFESIGKPLPGREM
IIVTRSQSTAREGCFITHSVEEAVSLARERGESELFICGGAEIYAQTLGVADRLYLTLVH
ADCDADVFFPEWNGDEWVEVESADHTADEKNQYPFTFKVLARKHEA
>AIA13199.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSQVIGQIKSDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLFVAEGHLS
CQLYQRSADIFLGVPFNIASYALLTMMIAQVCDLKPGEFVHTLGDAHLYSNHLEQARLQL
TREPRALPQMKINPSVNSIFEFDYSDFELSGYEPHPHIKAEVAV
>AIA13188.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKKLRVGVIFGGRSGEHEVSVRSARAVIDALDARRYEVVPIAITKEGKWLSPARATRLLP
EETKKRVADKVASEERQPSALIGDPSSNGLVARESSGEDDALAPLQPLDVVFPVLHGTFG
EDGTIQGWLEMVGMPYVGCGVLASSCGMDKVAMKALFKEAGLPICRYTWLLRKDWDEDRG
AILRRVVREIGFPSFVKPANLGSSVGISKASDKSSLERAIDLAARYDRKVIIEEGLDARE
IECAVIGNEKPEASLPGEYVVKDPAAAFLDYTEKYSGTGHVEFVVPAPLPKSLTERIRRL
AVRAYQSLDCAGLARVDFFLRRDTRELLVNELNTIPGLTDVSGFPKMWEASGLPFPRVLD
RLIELALDRHKEKARNETSI
>AIA13077.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRVGVIFGGRSGEHEVSLRSAESVINAMDKSRYQIVPIGITQEGKWLVSGDAKTMLPHTV
MASNNHQQVAIIGDPTRQGLTRLDAGTSEPLDVVIPVLHGTYGEDGTIQGLLEMAGVPYV
GCGVLASATGMDKVVMKQLFTQAGLTVIDYEWFLRSSWEENPQAIIKQISRKLGFPVFVK
PANLGSSVGISKAKDKAELRASINDAARYDRRIIVERAVVGREIEVSILGNDHPMASLPG
EIITGHEFYDYEDKYVDTTSRTEVPARLPKKILERIQRDAVKAFQAIDGSGLARVDFFVE
RETNRVIINEINTMPGFTSISMYAKM
>AIA13021.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSSDLKRFRDLTMGHHIIVGRKTFESIGRPLPGRQT
IILTRNEGFRPEGCLISRSIEDAVRLAEDRGESEAFICGGAEIYAQSLDKADRIYLTLVH
ADSDADTFFPEYNGDQWIERESEHHDADEKNQYPFTFKLLVKKASLDDRAKDQTA
>AIA12993.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TTKRLPLKAIVHELLWFLAGDTNIKYLKDNGVSIWDEWADANGDLGPVYGSQWRSWPAPD
GRSIDQISNVIDMIRRNPDSRRLIVSAWNPADVDKMALPPCHCLFQFYVANGKLSCQLYQ
RSADVFLGVPFNIASYALLTMMVAQVTGLKPGDFVHSLGDTHLYSNHLEQARLQLTRPTR
PLPVMKINPEVKDIFAFRYEDFALEGYDPHPHIKAEVAV
>AIA12969.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SEKGDRTGTGTLSVFGHQMRFDLSKGFPLITTKKLHVRSIVHELLWFLKGDTNIKYLTEN
KVSIWDEWADEQGNLGPVYGKQWRSWETTDGQTIDQIAQVVEQIKTNPNSRRLMVIAYNP
GEVHKMALPPCHAFFQFYVANGKLSLQMYQRSADVFLGVPFNIASYALLCMMVAQVCDLA
PGEFIHTLGDAHLYSNHLEQARLQLTRESKPLPMMSINPAVKNLFDFKFEDFQLIGYDPH
PAIKAEVAV
>AIA12895.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MHGPNGEDGTVQGLLKLMQLPFVGSGVLGSALGMDKIAMKMAFAHAGLPQVKYIAVNRSE
IWSNPCVFPKLCDKIEAALGYPCFVKPANLGSSVGISKARSRAELEAALDSAASYDRRII
VEAGVVARELECAVLGNDNPKASTVGEITFQSDFYDYETKYTEGQADWSIPAKVSGAIAS
QIQEMAVQAFLAVDAAGLARVDFFYIESTGEVLINEINTFPGFTATSMYPQMWAADGISF
PELVDRLIQLALERHGEKG
>AIA12853.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DRTGTGTKSCFGYQMRFNLQEGFPLVTTKKLHVKSIIYELLWFIKGETNIKYLTDNGVTI
WNEWADENGELGPVYGKQWRSWEGAEGKVHDQLSDVIRQIRTNPDSRRIIISAWNVADLP
KMALMPCHTMFQFYVAEGKLSCQLYQRSADVFLGVPFNIASYALFTMMIAQVCDLQPGEF
IHTFGDVHLYNNHFEQAKLQLTRKPFPLPTMRINPAVKNIFDFEYDDFTLENYQFHPPIK
APVAV
>AIA12782.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MMNSFLVDKKIAVLCGGPSSEREVSLRSGSAVTKALRSLGAEAFEIDVRDENIHLPAGTE
LAFNALHGAFGEDGTVQAILEKKGVPYTGEGEEGSRLAFDKIASKERFVECGVPTAPYIT
LRKGEVPALPLPYVVKVPCQGSSVGVYLVKAMSERCAALEEAFKLAETVLVEALVSGREL
TIGILGDTPLPIIEIRPQGGFYSYENKYTWTNRGGAAEHECPARLSRAEKKIVEAAALAA
HRSLELEIYSRVDIILDAHRGPQVLEVNTIPGMTETSLLPEAAAAAGISMSQLCESIVRL
SLERRLANNR
>AIA12768.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB_3|antibiotic efflux|0
EIKDLHAGIEGREILKGLNLTVNRGEVHAIMGPNGSGKSTLSKVLAGHPTYEVLSGEVLY
EGKNLLELEPDERAREGIFLAFQYPVEVPGVSNSQFLRLAYNQKMKHHDMEELDPLEFND
YLTEKAKVVEMDKSFFKRSVNEGFSGGEKKRNEILQMAVLDPKLAILDETDSGLDIDALR
IVAEGVNKLRSSENGIILVTHYQRLLNYIKPDFVHVL
>AIA12664.1|FEATURES|farme|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MKKSLFYLALFSLSASCVAADLSSQQVTSLVKAAIEPLMEQQEIPGMSVAVLYKGRAQFV
NFGVADLESRRRVTENTLFELGSVSKTFTGTLAGVMIRNGEIRLNDPVQKYWPQLTGEQW
RPVRMLHLATYTAGGLPLQLPDDVSDQASLLRFYQEWQPEAAPGTLRQYSNASIGLFGSL
MVKGDYEQAMARNVFQPLRLTRTYITVPPSMMLDYAWGYKNGQPVRVSPGMLDAEAYGVK
STARDMLTFMQANVDPNRLSSGNAVLRNAIRTAQARYFKVGTLFQGLGWEIYDWPVTADT
LMGDSDNGVALQPRPATLLNPVGPSQSASWVHKTGATNGFGAYIAFIPERNSGVVILANK
NYPNPLRIKAAWQILQALQQEKPE
>AIA12661.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MPKSAIVVKNLHKSYGKLKVLEGINLTVETGKVFALLGPNGAGKTTIVRILSTLLKADSG
TIKVNGLDVREAPEKVREVIGLTGQYAAVDEYISGRENLEMMGRLYRLSKEDAAQRAQQL
LEQFDLVKAADRIAKNYSGGMRRRLDLATSLIATPPIIFLDEPTTGLDPRSRIAMWDIIK
DLVAGGTTILLTTQYLEEADLLADKIVVIDGGKVIAEGTADQLKQKVGNERLELTISKKS
NFKKAKQIVDGETLQVDEDQRKLSIANNGGATQVKNLLIELEKAKVDVETLALHKPTLDD
VFLTLTGKQTQDAEAEPDDESETRRKK
>AIA12519.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHELMERVLKEGVKKEDRTGTGTLSIFGHQMRFNLNEGFPLITTKKCHMKSIIHELL
WFLQGDSNIKYLKDNGVSIWNEWADENGNLGPVYGVQWRSWKTHDGRTVDQIKNLIEMIK
KNPDSRRLIVSAWNVSDVDKMALPPCHTMFQFYVANNKLSCQLYQRSADIFLGVPFNIAS
YALLTHMVAQVCGLGVGDFVHTFGDAHLYVNHLEQTQEQLKRSFFALPTLKINPEVKDIF
GFKYEDFELLNYQAHPHIKAPVAV
>AIA12516.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HVLTRGAEKSDRTGTGTLSTFGYQMRFDLREGFPLLTTKKLHTKSIIHELLWFLQGDTNI
KYLQDNGVKIWDEWADAEGNLGPVYGYQWRNWPTPNGGSIDQITKLVEMIKRNPDSRRLI
VTAWNPADVDRMALPPCHCLFQFYVAEGKLSCQLYQRSADTFLGVPFNIASYALLTLMVA
QVCGLKPGEFIHTFGDVHLYADHLEQARLQLTRAPSPLPKMELDPTVTDLFAFRFEHFAL
KDYDPHPHIKAAVSV
>AIA12512.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLRHILDNGTRKSDRTGTGTLSTFGYQMRFDLAEGFPALTTKKLHLRSIIHELL
WFLQGDTNIKYLKDNGVGIWDEWADADGNLGPVYGHQWRSWPAADGRTIDQISDLITQIK
KNPDSRRLIVSAWNPADIPNMALPPCHCLFQFYVADGRLSCQLYQRSADTFLGVPFNIAS
YALLTLMVAQVCDLQPGEFVHTFGDVHLYLDHLEQAKLQLTRDLRPLPTMAIDPSVKNIF
GFRFEHFTLKDYDPHPHIKAAVSV
>AIA12513.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MIISAIVAVAENRVIGRKGDLPWHLPDDLKFFQRTTLGHHVIMGRKNWDSIPLKYRPLKD
RVNVVITRQERFDAFGAVVVGSLQEALALARHEGENEAFIIGGGQIFAEAFRMGTIDRIY
MTRIHAQVEGDVFFPPLVGDWKEVWHEDHAADARHTYAFTFLRLERSVGKT
>AIA12467.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MARFDEIYQQMLQRIMTEGYREVNQRTNHETAALPGLSFSLDIQKEGFPLLGLRKIPTKI
FIAEQIWFISGARKPDDFLRDFTKIWDDFTNPGDVVTVAYGYRWRKYFGRDQLGLLVNLL
TKDPSSRHGVVVTWDPAGAGLGGVARGNVPCPFSFTVNIIGGRLNLMNVVRSNDMILGFP
HDVAGFALLQCILAQKLGVEPGTYTHTIANAHVYDIHYEAAETMIKRPATHTKVTLKLPK
EAYERAQQKDATLVEEINNALTTQYEPGEAIKGLRIVL
>AIA12365.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYLSLLKWVLEKGAPKSDRTGTGTVSVFGHQMRFDLNAGFPLVTTKKCHLKSIIHELL
WFIKGDTNIGYLKENGVKIWDEWADENGNLGPVYGKQWRSWPTHKGETVDQLAKVIEDIR
TNPDSRRLIVSAWNVADIPDMALAPCHCLFQFYVVNGRLSCQLYQRSADVFLGVPFNIAS
YALLTMMIAQVTGLQLGEFVHTFGDVHLYSNHIEQAKTQLERTPFALPKMLLNP
>AIA12270.1|FEATURES|farme|beta_lactam|LRA-18|antibiotic inactivation|1
MIISSTLRAFLTGGALSALLAASACHAADANAALRAIVDRAVRPVIAEYDLPGVAVAVTV
DGKASFFNYGLASLEDKTPVSENTLFELGSISKTFTATLASYAQVTGKLSLDDHPGKYLP
ELKGSAIDNATVLHLGTYTPGGLPLQFPDEVPDDGMLAYFKQWKADAAPGTQRRYPTPSL
GLFGHVAALSMGSGFADAVGSRILPGLGLKHTYLRVPAGAMGDYAWGYDKANKPGRMGPG
PLAAETYGIRSSAADMIRYLQANIAPSRLDTPLRRAVEGTHVGYFKIDGMVQGLGWEQYP
YPVSLKDLEAGNSQKMIWEANPASALVPPQTPPPATLFNKTGSTSRFGAYAAFVPAKKIG
VVILANKNYPIPARVKAAHAILVNLEARRAD
>AIA12227.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YDQLSDVIRQIKTTPDSRRMIISAWNVADLPEMALMPCHTMFQFYVANGRLSCQLYQRSA
DVFLGVPFNIASYALFTLMIAQVCDLEPGEFIHTFGDVHLYNNHFEQAKLQLGRKPFALP
TMRINPAVKNIFDFKYEDFTLENYQFHPPIKAPVAV
>AIA12188.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLATIRERGTSKDDRTHTGTLSIFGHQMRFDLAEGFPLVTTKKLHVKSIVHELL
WFLQGSTNVRYLREHGVRIWDEWADPKGDLGPVYGRQWRSWPAPDGRHIDQITQVVEGLK
RDPNSRRHIVSAWNAGELDRMALSPCHCLFQFYVADGRLSCQLYQRSADVFLGVPFNIAS
YALLTLMMAQVTGYEPGEFIHTFGDAHLYLNHLDQADEQLMREPRKLPRMEINPEIRSLF
DFAYEDFKLVGYDPHPAIKAPVAV
>AIA12175.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MQALREKGHEVVPVDTARGVLSASDEKALLGKGVSQVPPDMAALDMLRTGDPTAITRAPE
LKGVEVMFLALHGGAGEDGTLQGLLDLVGLPYTGSGRLASAIAMDKDISKRLMLDAAVPT
PEWLMAPAPFDEVEKKLGLPVIVKPSKQGSTVGLTLVKTREQYEPAVREAFLHDDEVMIE
GYVPGREFTVPILGDEALPVGEIIIASEIFDYESKYQPGMAQEVFPADITPAQAAEMQEL
ALNTHRALKLSGYSRVDFRMSEDGTFYCLEVNTLPGMTANSLFPKSARAAGISLAELCER
ICHLALEEHGSSQRV
>AIA12076.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSGLSPESAQRLKGMGKLEFIALAAFMMAVNSLAIDIMLPALQQIGASLGVENENHRQYV
VSAYLFGFGLAQLFYGPLSDRFGRRIPLLIGLCIYVVAAFGIAVVPTFAGLLALRFIQGL
GSAATRVITISIVRDVYGGRQMAEVMSLIMMVFMVIPVMAPSIGQVVMLFGNWHLIFAFM
AVVAMIVWSWMYFRLPETLHEDDVRPFTVRSVLGGFRIVLTDRVALCYTLASTFIFGALF
GFINSAQQIYVGIYGLGVWFPVAFAAVAAFMALSSFVNAKLVGRFGMRKLSHGALMGFLT
VNTLWLVLTLVWPGHVPFPIFIVLFALAMFQFGWIGSNFNSLAMEPLGHVAGTASSVLGF
MGTAGGTVIGAIIGQSFNGTALPLVTGFFSLSIIGLIFVLLAERGKLFQAHNKPV
>AIA12016.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTLPLILVVAVAENGVIGRDNQLLWRLKTDLGRFRRLTMGKPMIMGRKTFQSIGKPLPGR
ETIVLTRDAGFAAEGVHVVHSWEEAVAKGAELATRMGADSVAVAGGAEIYALALPQVQSI
FLTKVQAEPEGDAVFPDFDRSQFRETRREDHPEGGRRRAFVYLY
>AIA11985.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIIGIVAVDQNGAIGKGGKLPWHYSSDMKFFKETTIGHACVMGYKTWLTLKRPLPNRLNI
VMSRQSEIEPQESVIVIRDVESVLSRAENLAGHLFVIGGEQVYRAFLPHIERWLVTEVPL
KVEGADTFVPAGYLDGFSETAVKKLEENLVVRTYDRDSLSRVNT
>AIA11981.1|FEATURES|farme|beta_lactam|OXA-54|antibiotic inactivation|1
MRLKATLLTALFLLAALGCAKTTGRGSVVVEGQAQTAAPAAAQPDLAKHFKPYPAGAFVL
YDLKRDSYLRYNEARCRERFSPYSTFKIPNSLIGLDTGVITDAEYVIKWDKQKYPAHDRD
TLPFSAWWQDQTLRTAIKRSVVWYYRELALKVGERRMKEYVNRLDYGNEDASGPLNNFWL
NSTLKISADEQVEFLKRLYKEELPVSKRSTSIVKEIITLEETPGYKLSGKTGGGSLEENS
YLGWFVGYLETKDGTYFFATEIEGSTYLSIRDERIAVTKRILADLGHLRN
>AIA11964.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MREYHELLRLVLEKGRRKNDRTGVGTISYFGAQTRFDLSKGFPLLTTKRVHLKSVLFELL
WFIRGGTNIRFLTNHGVTIWNEWADANGDLGRIYGAQWCDWRTADGRSINQLKDVLSAIR
KNPDSRRLLVTAWNPGEIDQMKLPPCHAM
>AIA11802.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIVAYSKNHVIGRGGKMPWQGEMPGDAQHFRELSTGKTIIMGRKTYESIGHALPNRQNIV
VSLEPFNAPDALVVHSLADAYGAAENEIAIIGGGQIYAAALEDADIVYATEINAEFEDGD
TFFPVLSAEWQETAREDHKADEKNRYDYSFITYKKVDR
>AIA11803.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLELLQDIKDNGKLRPTRQGQEVVGVFGRQMRFNLQEGFPLLTTKKVFLRGIIHELL
WFLQGDSNIEYLVRNNVHIWDEWPFRAYLQATAQAIPEVGSTEWQAKLAQFTNQIATDHK
FARKYGELGPVYGHQWRHWPAGDGGEIDQITEVIEEMKHNPASRRLIVSAWNVADIQEMA
KAGLPPCHTLFQFYVNDGQLDCQLYQRSADYFLGVPFNIASYALLTMMIAQVTGLKPGDF
VHTLGDAHLFTNHFEQADLQLSRQPRTLPKMALNPKVTSIFDFAIDDFTLEGYDPHPGIK
APIAV
>AIA11765.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HELVWFMTGQSNIKYLVDNNVHIWDDYPYKDYQKLVEAGKAPELSKEDFIERIGSDDKFA
KKYGELPHIYGQQWRSWPRTNGESIDQLAWILNNIKNFPERKHSVLTVWNPEHLYSMALP
GEALSFPLCHILIHFNVADGKLSCQLYQRSADMFLGVPFNIGSYAALTQIMAHLAGLKVG
EFVHTFGDAHVYSNHIDQVKEQLGRKPRAFPTLTIDPKLKELDAVKAEHISLEGYDPHPM
IKGELTVAGGFQEKDRREFAKQKA
>AIA11753.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSLTIRRAQKGEAGLVLSFIRELAEYEKLLHEMEATQVDIDAALFGANPRLFCEIAEWNG
VPVGFAVWFVNFSTFSGRTGIYLEDLFVRPALRGKGIGKALLVHLAKHCVANGWSRLQWS
VLDWNTPSIAFYKSLGAELMDEWTICRIGGPALTALAQGTR
>AIA11606.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLDHVLTTGVAKGDRTGTGTLSTFGYQMRFDLSQGFPLLTTKKLHTRSIIAELL
WFLRGETNVSWLRDQGVSIWDEWADDDGELGPIYGYQWRSWPTPDDGHVDQIADVIRAIK
SNPDSRRLIVNAWNVGDLDQMALPPCHAMFQFYVADGRLSCQLYQRSADIFLGVPFNIAS
YALLTQMVAQVCSLDVGDFVHTLGDAHLYTNHIEQARLQLTREPRPLPKLILNPTITDID
RFGMDDITIEAYDPHPGIKAPIAV
>AIA11607.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MGIAAVGRNRVIGDGQDIPWRISEDWKRFQTLTMGHVLIMGRKTYDSIGRPLPGRTTIVI
TRDGAWRGDGVQVAPSVEEAFTRAQTLGPATIFVAGGGEIYRAAWNRLDRLEVTEVDQAP
EGEITFRRSIRRTGTRRAGNLATGTAS
>AIA11497.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MENISNVGEQVLNNKNNKILVMTGLMIGIIFSELDETVVNTAMPTIIRDLGGLSMYGWVA
GIYMLALSAFMPILGKLADLFSRKKVYFASMGFFIGGSIICGLSHSMIMLLIGRGIQGLG
AGGLMPLAMTISSDLFPIEQRAKVQAFMGPVMFIPMLLGPLMGGFFVDQASWHWIFFVNI
PVGLIAVIFLASGLKETHERKKVTIDWAGAILLVAAIISLLITPVLVENEGYTWSSPFII
SLLCAGVLLNGLFIWVESKVVEPIVPLHLFRNRNILVLSLLVFTVGCGLMGSFSSFPYFA
QNVLGLTPTESGYLTLPMMVGAVATSIVSGFLLTKVRYRELFVISFIMPVIGFYLFSKLN
ISTTTLQVIIFFFITGLGLGVMFGGDNLIVQESVEKEHKGIALATVPLFQSIGATVGVSM
FGTLLSSTLTSKLSSLGDELPKSMADNMNSLAAGGIPNGLTPELFMKIKILFIESFQHIY
TYAFVLTIIAFVLCFFLKKEVLSSKSEE
>AIA11486.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
AGAACPWLADGRLRQNEANMQSQIFRVALVLGLLSVIGPVAIDMYLPSLPAIGDQMGATT
AEVQLSLMAFMAAVAICQLAYGPVSDMVGRKPPLYFGIVLFTVGSVGCALAPSIEWLIAF
RFVQGIGACASMALPRAIVRDNYTGAEAAQLMSLLMLVFSVSPLLAPLSGSLVIQFGDWR
LIFWVMAAIGVLVTLLAVFALEETRPAALRVESSVGSAIRAYGVLLKDWNFLGLSFIGAF
GIGSFMGFIGNSSFVFIEHYGLTPTLYSLAFSVNALSFFAVSQSTGPLVRRFGLNRVVRV
AVAGFAVSMLALFAIFAVGIDSMWVLSALMFVGFGFLGLVVPSTAVLAMEEHGEIAGTAS
ALMGTLQLVSGAVVMGLVGAFFDGTAMPMVAGFAGCALLAFVLTQFTIRGESRPVAAPAE
>AIA11471.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MSAKVIAIVAMDEARAIGKGGALPWHIPEDMARFKRLTAGHVVIMGRKTWDSLPQKFRPL
PGRTNVVVTRNPATLVVPDGVVVASDPEAAVTEALATAGGERLVWIIGGSELYKSTLPLC
HAIDVAHVPGRHDADAFLPPFEADFIPSYEESGEVCRWIRYVRRP
>AIA11273.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESFAPEGCFIAHSISDAISLARERGESELFICGGAEIYAQMLGVADRMYLTVVH
ADSEADTFFPEWDKDEWVELESEHRTADEKNQYSFTFKVLERKHEA
>AIA11274.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDHGTKKDDRTGTGTLSTFGYQMRFNLGEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIGYLKEHGVNIWNEWADERGDLGPVYGAQWRTWRACDGRTIDQISQVIEQIK
SNPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVAGGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYLNHLEQARLQLTREPRALPQMKINHRSNPYL
NSTTLISSFQATNRIRT
>AIA11220.1|FEATURES|farme|aminocoumarin|novA|antibiotic efflux|0
MLLEIKNLHAGIDGKEILKGLNLQVDMGEVHAIMGPNGSGKSTLAKVLAGHPSYEVLQGE
VVYEGKNLLELEPDERAKEGIFMAFQYPVEVPGVSNAQFLRLAYNEKMKHLGLEELDPLE
FNDYLKEKAKVVDMSPEFFKRSVNEGFSGGEKKRNEILQMAVLEPKLAVLDETDSGLDID
ALRIVAEGVNYLRSADKAIILVTRRY
>AIA11212.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLIAALSKNRVIGKNNDLPWKLPDDMKFFMEKTKGHHTIMGRKNYDSIPLKFKPLPQ
RTNIVVTRQKKFQAPGCIVVDSLENGLAIAQDNDEPETFIIGGAEIYKLGLPHANRLYLT
EIDAEIDGDTFFPAVDRNQWKEISRLHHATDSRHAFAFDFVIYEKK
>AIA11081.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVEQIKSNPDSRRLIVSAWNVGELDRMALMPCHLLFQFYVAGGKLSCQLYQRSADIFLGL
PFNIASYSLLTMMMAQICGLKPGDFIHTLGDAHLYSNHLEQACLQLAREPRRLPQMRINP
SVKSIF
>AIA11053.1|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MSKIRIGVVFGGRSGEHEVSVLSARSVINGLDPEKYEVVPLGITREGKWLPPAGARAALE
AGVVNGNGSTLAVLPGGEQALMSLKGGAAEAGLPRLDVIFPVLHGTYGEDGTIQGLFEMA
GLPYVGAGVSGSAVGMDKALMKAIWTAHGLPQLAWQQVTRIDLEVRREKTVEMLLQKPGL
PCFVKPANLGSSVGISRATTREELEKALDHAAEYDRKLVVEEAAKKPREIEISVLGNDRP
EASLPGEIVHGHEFYDYKAKYLNTKGQETIIPADITPEQTARIKELAIEAYLALDLNGLS
RVDFFLDETGAIYLNEVNTMPGFTPVSMYARMWEKSGLSYGQLLDRLIELGLERYSDRQR
NRVDRGV
>AIA11008.1|FEATURES|farme|beta_lactam|SD53_15990|antibiotic inactivation|1
MKIKPLLLACFLIILSSFKFTGGDLQNKIETIISSTKADIGVAVMVPSSHDTILVNGMKP
YTMMSVVKFPQAVYILSLVDRGKLRLSQKVNFDAAELQRKTHSPMRDKYGKDPFEVTLEE
TIMWAVSHSDNIACDRLFELGGGVAANEKYFQDLGYHDFAIGVDYKHLDEKTMRANNTSP
LTMTRILERFYNGKLLAGSSRNLLLKFMTQSQNPEDRIKGNLPKGTVVAHKTGTSAAAEN
GTIQVFNDVGIITLPSGKQIILSVFVSASKEKSDDNAKAIAAIAKAVFDHYSN
>AIA11009.1|FEATURES|farme|aminoglycoside|AAC(6')-34|antibiotic inactivation|0
MDPEAYRLAFEMSDPGEQQEFFGYATRDRLEEERLRWQQGMVTFNKSFCWFTIFLKAEQT
AVGWCGFHTWYIPHRRAEIGYEISGDDYKRSGLMTEALAAVIDYGFTELNLNRIEAFVEP
GNEASIKLLEKSDFLKEGLLREHYFKNNEFQDSVVYGLFEKKDVNGLNQPGYHLQIKVTP
Y
>AIA10930.1|FEATURES|farme|beta_lactam|mrdA|antibiotic target alteration|0
MTLADSLAVSNNVVAVEAATGKMASCDDRNRLTDIKDYAVSPETVAKLIHEAGADASMVP
GKTDEIKIGKEPRLAIGATLGLSPLKLAVMAATLANGGEYHKPHLVSRIDAPNGDNIFEH
EDESRRVIDEKYAKIVNQVLVGVGTNPNGTGHKLLVDNHPLMMKTGTTDEELGDSWYFAS
NAVNPDHKNESAYVCAGWAGKNANRQGADVGGVCQSFYQSQLKGRPRVDFPAADMDAGKL
VGIVQAAPPPPPPPPVQTQQPEPTKVETPTVVPPVPTRHTEPSATPPTPQGTPTASSPPT
AGESTPRETPPAEEPGGGVEDPNAGEAPVPGVQPTG
>AIA10922.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKSDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRASDGRTMDQISRLIEQIK
SNPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGHLSCQL
>AIA10893.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MASAHPEYEYLKLLAEILKNGRSKPSRGVHDLKSIFGYQAHFDMRHGFPLLTTKKMPFKI
LMHETLWFISGSSDVDYLHDHKIFYWDGFLHEGSNDLGRVYGVQWRHWKRPDGSEFDQLQ
WAIDQLKTNPDSKGIIVSAWNAGELGDKRWNPDDYGDMRLPPCHTMFQFDLTKGKLRLHL
YQRSWDVFLGAPFNIAQYALLLHMVAHLIGAEPRELIISAGNAHLYKNHLDMAKEQVKRK
PYPFPKLKIVGNPKTIDDFTEENFVLEGYQSHPHIKAPLVIL
>AIA10894.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MAAITADGFIGKDASHLADWSSPEDKKLFVSLTKQAGTMVMGSKTFDTIGRALPGRRTIV
YTTHPEKYQGLGVVATSEDPAKLVGRLAQEGCEDLAIVGGAQIYDQFLRAGLVDELYLTI
EPVLFGKGINLLANSIETGLELKDTQKLNDNTILLHYAVKN
>AIA10751.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|0
RQLSVVGVIMLLIGELAGTFVQQVLHRPAEDMWIILAPAGIGLVSASIFMPHITQRFGRI
RLTVIGFIVLAAGFLLLPASEWVALHLNPQHGAESPLLLWTTVILVFFLGVAMAVVNIPT
QTLMQERAPEAGRARVLSLQFMIYNTGSIPVLLFAGIISQVLGFGLLIVLLSSSLLLFCW
WGVSYTRDADKQPEGQKEDDIVSSSSR
>AIA10604.1|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
SYAAFDKILSKEKFREHNVATPKWEVIEVGERPTIPIPLVVKPARQGSTVGVVIVKKASQ
LDAALAEAGKYDRKLLIEEFVSGRELTIGVLGDQALPILEIIPKGGFYDFNNKYPFLNPQ
AGGAAEHVCPAEIDPKKTKQIQELALRAFRAVGLVVYARVDVLLSDSGDPFVLEANTIPG
MTEASLLPEAAAAAGINYVDLCAHIIALSRARTERSRR
>AIA10551.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKTRVGVIFGGRSGEHEISIRSAKTVIEQIDKDKYDVIPIAIGKNGNWLNPSDSVGLLPA
TSGEALGDAVDGYTQDSVVVAGDTSYKGLTRLGGSDDEERTLGLDVIFPVLHGTYGEDGT
LQGLLEMAGLPYVGGGVLASACGMDKVVMKTLFRDADLPICKYVWFLRSEWERDNDAVIR
QVEAKLGYPCFVKPANLGSSVGVSRADNADSLKAAIELAAEYDRKIIVEEALDMREIECA
VMGNDEPEASLPGEYIIRDDAKKFLDYTEKYAGTGNNEFTVPAPISGELTDKIRKMAVNA
FKAVDGSGLARVDFFLRNDNGMLLVNEINTMPGLTDASGFPKMWAGTGKKFSDVLENLIE
LAIERHKDRSRNKTSY
>AIA10518.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMQHVLADGTHKSDRTGTGTLSVFGAQLRFDLNAGFPLLTTKKVHLKSIIHELL
WFLKGDTNVKYLKENGVSIWNEWADAEGNLGPVYGYQWRSWPAPDGRHIDQISQVLEQLK
SNPDSRRIIVSAWNVADLDRMALMPCHAFFQFYVAGGRLSCQMYQRSADLFLGVPFNIAS
YALLTMMTAQACGLKPGDLVHTLGDTHLYMNHLDQAREQLSRSPRKLPTLRLNPAVQNLF
DFKYEDFTLENYDPHPAIKAPIAV
>AIA10512.1|FEATURES|farme|beta_lactam|CcrA|antibiotic inactivation|1
MVWMRLAFCFLLGLTLCPSAVAQERVKIQLADDVFIEKLEPGVWRHVSYKTLPNLGPVPS
NGGIITVGSDILLIDSAWNNEQTKLILDWSEKELRAAPSIAVITHAHEDRIGGIHELHRR
GIRTVSSKLTAELAKQQGLEVPQQTFEGRRNLSLGGRSIEVYYPGPGHTKDNVVVWIPDK
HILFGGCLIKAAQAQNLGNIKEADLEQWPKTVETLAHEFKEVRLVVPGHGDPSGSEAMTH
TLELLEKAVPLKPPVKGSTSH
>AIA19307.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MAYMAAIAVGQLLYGPLSDMLGRKLPLYFGIGIYVLGSVGAALSPTVEWLVVFRFVQGIG
ACASFTLPRAIVRDEYTGAPAAQLMSLLMLVFSISPILAPLAGSAVIAFGDWRLLFWAMA
MGGVLCLLLAAFALRETRPKAARLNSGLGNAVSAYWTLLRDGRFMGLSLIGTFGMSAFMA
FLGN
>AIA19306.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVSLIVAASQNNVIGKDGKIPWFVRGEQKRFKELTMGHPIIMGRKTHESTGRTLPGRLN
VVISSNPNFKPFEGSVLVSSLQAALDLSEVKSAEEVFIIGGQQVFTEAMPLADRLYLTKI
HTTVDGDKFFEYDPNDWRLVSSEFHKRDEVPDRPFDFEICLYERRR
>AIA19176.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MEEKLEIVVAADLDNGIGKDNGLPWRIPGDMKFFQSLTSNATEGGINAIIVGRKTWESIP
EKRRPLKNRINIILTKNTAITAPDGVLVCNSLESALEALQGIEHQRCFIIGGAQIYKEAL
QHPLMTTIHLTRIMQEFDCDAHFPPIDDRFALAAVSDTMEENEIEYRFQRYEKKSAL
>AIA19141.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DEKGDLETAYGRYWRRFPHPVQKSHAPVAETGETAAPVQEIDQIQYVINEIRRNPYSRRL
VVTAWEPGNAETSKLPPCHYTFAFNVSPDERGEPRRLNCHLTQRSGDIALGIPFNLACYA
TLTQMLAQEVGLEVGHFAHTIIDAHIYCADAGSPMAAYDHVSGLKEQLKREPRPLSKLVI
AKKPFAELKFEDFRLEGYDPHPGIQFKVAV
>AIA19126.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNTTKEVRSEGQTGQYDKEIILSLLVATDENNVIGKDNKLPWHLPNDLKYFKNLTWAMPI
LMGRKTFDSIGKPLPGRKSIVITRSSEWKHDGVEVVHSIEEAIASAKQAGVKEIFVIGGA
EIFKTSFNQAFRIYRTLIHHAFEGDVYFPEIREEEWQLVSKRYCNTDEKNLFAHTFQVWE
RK
>AIA19124.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MIIGIVAISENFAIGRDGKLPWHYSADLKNFKESTMGGTLVMGSKTWRSIGKSLPGRQSI
VLSRTELEDLPDGVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRWLVTRI
>AIA19084.1|FEATURES|NCBI|multidrug|salA|antibiotic efflux|1
MIADISISEKSFGPKSLMTNVRFTINDAEKIGVIGRNGVGKSTLFGVLAGTDKDFSGEVN
YKPGTVVVATQQEYHDVGDKTVLQYILQGLPEYTDLSHIIETYPETMGDNLKKINEYTEA
LQRFDDKGFYQIEEQIERELNNFQLDGIAHREFTTLSGGQKRLVEVVKIMHSDAHLALID
EPTNHMDYIAKQQFIDWIKQAREAVLVITHDRDVLREVDRIIELKDGGSASFKGNYDGRY
>AIA19044.1|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|1
MEILLYYQCMHTFLIAAISLDGFIAEKTDQISTSWTSKEDKKFFSERTKQAGVIVMGSST
YKTIGRPLPGRVNVVYSKSSQFEFKDENEGFVTDLAPADLLKKLERDGHDEVAICGGAMI
YSMFMKAGLIDTLYLTIEPVLFGEGIKLFKDDISARLQLVNSSKMGENAVLLEYKLNK
>AIA19037.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
VAKNGVIGSNNSLPWYIPEDLRRFKALTTGKTVLMGKNTFDSIVNRIGKPLPNRKNIVLS
RKTDLELPPDVQLVNNLESILKSDEPEIMVIGGGQLYNQIINDADKLHITHVHEDIDGDV
MFPEVDWSQWKKTFEEPHGKFTFADYERI
>AIA19015.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|0
MRITVEKIGKKFIKEWIVRNASFELAAGEKYVFVGPNGSGKSTLLQLLTGVIPVSEGKIA
YTDVTGKEIETDHWYKHLVIAAPYLELIEEFTLREQIEFHNKFKPFKNGISARDFEDFIQ
LPHASGKIIRHFSSGMKQRVKLGLAFLSDVPVVFLDEPTTNLDVQGINWYLDHVMDNTQN
QLVLLGSNVQQEYEFCKNIISVSAFK
>AIA19010.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGRKTFESMKSKPLPGRKNIVITRQPGWNAEGVSVVDSVDAAASLAEQLNYKEIFIIGGG
MIYLIAFDRANKIYMTRVHTDLEGDTYFPVIEKNDWSLVSKTENPADEKHAYAFSFQLWE
RKSM
>AIA18947.1|FEATURES|farme|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|0
MSAHFTNKGYRVSYLADCAAHIPALAKMWFQELGQQWIPNASCAKAEKNLAAHLNQNTLP
LTFVVFNENSPIAMASLRKEDGLQSDLTPWLGSLIVSPNFRLQKIGEGLVNLIEHEALKL
GHQKLYLFTLDLTIHQWYERLGFACIGTDKLYHHPIRVMEKLI
>AIA18904.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MILSAVVAASDNDVIGNKGDIPWSIKGEQARVKQISMGKPLIMGRKTHDSIGRSLPGRLN
IVISRNPNYQVHDGSVLVGSLDEALGLKAVASADEVIIFGGQKIFEAAMPLLGRIYLTRV
HANFEGYSWFKFNSGQWKVISEERHQKNLSLGHPYDFDYLLLERK
>AIA18896.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MLISIIAAMDNNRVIGKNNDLPWRLPKEWQYVKKTTMGHPIVLGRKNFESIGKALPGRRN
IIVSRDYDYTAVGCEIVHTVEDVFRLCEGEEEIFIFGGEQIYTLFLPYVDKMYLTKIHHD
FEGDTFFSRN
>AIA18789.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MNKALIVILAAVTLDAVGIGLIFPILPRLLEDVTHTGEVTTLIGIMLALYSAMQFLFSPV
LGVLSDRYGRRPVLLLSLAGAAIDYLVMAFAPELWMLVLGRAIAGITSANMAVATAYITD
ISAEEERAKRFGYFHAMFGIGFIIGPVIGGILGDIWVRAPFLVAAGLNAVNFALALFVLP
ESRKGDSSAKFDFKTLNPFRPLGWAFSFTALLPLMAIFVIMNFVGTMYGTIWALFGQDMF
QWNGLMIGLSLGAFGLFHAGAQALLTGPVAARLGERWAMILGMACELTALLILGFATQGW
IVFALAPLFALGGIGMPALQSLTTQQVDADNQGKLQGVLASLVSLSAVFGPLFFSMVYFA
LKPTWPGLIWIVGGGVYLLALPLLLGIRRTPLATVTPEG
>AIA18785.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLIAAVSKNLVIGKNNDLPWNLPDDMKFFMNTTKGHHCIMGRKNYESIPEKFRPLPN
RTNIVVTRQKDFHAPNCIVVNSIDEALAIPRKNKETEAFIIGGAEIYRYAMEQTDRMYLT
EIDAIIDGDTHFPSFDKGTWKEIKRQHHMADDRHKYPFDFVVYEKNSH
>AIA18768.1|FEATURES|farme|beta_lactam|blaOXY|antibiotic inactivation|1
ANAEMMNATLQQKLASFEKMSGTKIGAAAINTADNTYLQYRATQRFPLCSTFKVMVTAAI
LQKSMAESDLLQQKIYYKKQDFVYYSPVTEKHLADGMTVAELSAAAMMMSDNTATNLLLK
KLGGPQAVTAFARSIGDQIFRNDRFEPDMSSSIPGDIRDTSTPLAMASSLRRLVLGDNLG
LVQRQQLQTWLIGNTTGDKLIRASVPQGWTVGDKSGKGDYGTRNDIAIIWPLHGAPIVMA
IYTTQSIKDAESRDAVVAGVARILLDELTQVNSGIKANIK
>AIA18739.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
FNIYMILSQVVAAADNNAIGKNNQLLWSLPNDTKFFKNTTWGMPVIMGRKTFESLGRPLT
GRTNIVITRQKDWQPAGAFVVNDLKGAMTIAASTDAKEAFIIGGGEIYKQTLPLTQRVYL
TRVHTTIDADAYFPEMNFAEWDLLSQLDFSADEKHAYAYSFQVWERKDGK
>AIA18737.1|FEATURES|NCBI|tetracycline|tet(30)|antibiotic efflux|1
MNKALTIILAAVTLDAIGIGLIFPILPRLLEDVTHTGEVTVIIGVMLALYSAMQFLFSPV
LGVLSDRYGRRPVLLVSLAGAAIDYLVMAFAPELWMLVLGRAIAGITSANMAVATAYITD
ISAEEERA
>AIA18729.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLIAALTTNRVIGKNNDLPWRLPDDMNYFMRTTKGHTVIMGRKNYESLPEKFRPLPN
RINIVVTRQKDFHAPGCKVVHSLEEAVELVKNSTETEVFNIGGAEIFTQGLSMADRLYLT
EINAILEGDTYFPEIDKSMWKETSRVHHAADDRHAFPFDFVVYDRKA
>AIA18705.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MQIILVAAHAQNRVIGRNNDLVWHLPRDFKHFKEITLGHPIIMGRKTFESLGKPLPKRTS
IIITRDTHYQQEGCIVVHSLKEAIAEASKLDDQIYIIGGAEIYKQALPYAHKMYLTEVKA
FPEGDAYFPEFSMGEWQETSRHSYQKDEKNEYDFDFVTWERKDNIAHK
>AIA18685.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAISENFAIGRDGKLPWHYSADLKNFKESTMGGTLVMGSKTWGSIGKALPGRQSI
VLSRTEIEDLTDDVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRCLVTRIPE
TVDDADVYMPLQFLDDFERVDSKEIGEGLIVETFDRRT
>AIA18669.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVFLLIALTADGLIGRDAHHLADWSSREDKKLFVRLTKEAGVIVFGFNTFETIGRALPG
RRMIVYTSDPSKITAQGVETTREAPADLVKRLKAEGANGLAVCGGASIYTQFMKAGVVDE
LYITIEPVMFGRGLTLFNDELEAHVRLLEVSKLNDNAVLLHYTVQKS
>AIA18632.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRISFIVAKAENNAIGLNNKLPWHLKDDLQNFKKLTMGHHILMGRKTFESIGKPLPGRMS
LVISSEPRAATESVFWFPNIWRAIKQAERAGETELFIIGGEKIFKSALTIADRIYLTNVM
GEVKGDTFFPSLSLKNWKLVSESSFSRNSENDHDFNIQVLDRR
>AIA18613.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNISTHPILSAIVAMAENRIIGKNNQLPWHLPADLKHFKTITSGHPILMGRKTHESIGKP
LPNRLNIILTRDPNYQTTGCTVVTSVESALKEAARHDENELFIIGGAEIYKQLLARIQRL
YLTIVHHEVEGDAWFPELNLQEWKEISRVRHEADEANAFAYSFVLLERT
>AIA18599.1|FEATURES|farme|beta_lactam|PMI39_02504|antibiotic target alteration|0
MNQYSVAGLSLAVIRNGQLDEVTAFGTLEAGTTRAVTTNSLFNSCSISKFITTMLVLTLS
EQGIVYLDENVNDKLTSWNIPTNLFTSQKSITLRNLLSHQSGLIDPPNSFEHYTPAKGLP
NMSELLSGKTLYCPVPIEVTYKPESEFHYSDASFCITELLLEDITGRSFSQLLEEHIFQP
LQMKYSTLFSPKDIDKTDVFACGHNKDRTVTNEKYPFYPFAAASGIWTTPTDLSALVIEI
IHSLQGKGKLKLSQKLVIDMISPQGCSKWTGLGVFLDDSNEELQVYSLGWGVGFQCMMVC
YPYCGNGAVIMTNSDLGVHQMEGIIGEVVKTLSL
>AIA18578.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MITGIVAISENFAIGRDGKLPWHYSADLKNFKESTMGGTLVMGAKTWRSIGKALPGRQSI
VLSRSEIVDLPDGVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRWLVTRIPE
TVDDADVYMPLQFLDDFELVDSKEIDEGLIVETFDRRT
>AIA18573.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
QINPHFCEPISIMPTNKKAAITFIFFTLLIDVMGFGLIIPVMADLIAQLKHIPMNIASNY
GAILLSVFAITQFLFSPVIGNLSDRFGRRPVLLCSLLGFGVDYIVLAIAPAYGWLFIGRV
VAGITGASFTTATAYIADVSTNETDRAKNFGLIGAAFGIGFVLGPALGGFLAHWGIRAPF
YAAAALCLLNCLYGYFFLPESLDAQHRRPFEWKRANPFGSLRFLTRHPEIGGLAIGFFLI
YLGAQSIQGNWNFFTIYRFGWSEKMIGISLALVGVLVGGVQAGLTRVINPKIGNENSIYL
GLSLYTFGLLLFAFANQSWMMFAFLVPYCLGGICGPSLQSVISGHVPVNQQGELQGALTS
LMSLTTIIGPPLMSLTFSYFTTDKAPFYFPGMQFLIGAVCMLLSVIIIYKVLNKEKKEHP
ELRTVIDNENV
>AIA18563.1|FEATURES|farme|aminoglycoside|BN77_3951|antibiotic inactivation|0
MLKQLPDGLILRSLSENIASDVERLPDFYASINAADDTDDIKEGVRVWTRDLMHGHATVT
LDDIFVVVDPAKDDLLVSATLLIPQTWRYEDVVIPVGRPELVATHPDYRNRRLVRALFDA
LHERSAALGHNLQVITGIAHFYRQFGYTMSLDRHGVHFLTAYVAGV
>AIA18519.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|1
MKDNLGREIESLDQGRHDSLAISGDNLILTLDHILQEYGQQLLQNKRGSIVAIEPSTGEI
LAMVSSPGYDPNELSISRSRGIAFTRLQSDTLKPLFDRSVMAMYPPGSIFKPILALAAMQ
EGVLDADRTIYCNGAYYSGGLKRGCHNHPSAHNVSAAIQYSCNTYFFTVYKDMIDISGYT
MPEIGMRKLNGILTEFGLGHKISIDVPSEKTGNLPGPSYFDQVYGSGKWRSPYILSMGIG
QGELQLTTLQMAHAAAIIANEGTYTDPHILKARVPAGELPQQEFYPRRRVSIDYRHFEPV
IEGMSGAVRAGTATLAYIPDIEVCGKTGTSENPHGEDHSVFFGFAPRDQPKIAIAVYIEN
AGWGGSFATPVGGLMIEKYLRGEISEPRKYIETRMLEADLIHKPKS
>AIA18426.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNNTRISIIAAIDEKRGLGKDNDLLFKISGDMQRLRTLTTGHPLVMGRKTFASLGRLLPN
RTHIVITRDPSSLEKLSYQPEIITSSLEEALEQAKNVILSEAKDLNKEDSSATPQNNKSG
EIFIFGGGQIFTEAVEKGLVDRLYLTLVKGDYGADTFFPDYSMFTKVLRQEEHQEGDYSY
TFLDLEK
>AIA18403.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MKVSLVAAVASNGVIGKNNDLPWHLPDDMKFFMETTKGHHVILGRKNYQSLPKKYQPLPN
RVNIIVTRQKNFDAPGCLIVNNINGAVSLARTNGEHEVMVIGWIRDIRACPCQLPIDCI
>AIA18381.1|FEATURES|farme|aminoglycoside|ASE45_04665|antibiotic inactivation|0
MEAQEVIQFLNATQDDLSELISLLADDELGKVREQNAAEIDSAYQIAFQEITSDKNNELI
VGKRNGKVIAVLQVTYIPGLTLRGSKRALIEGVRVSSQLRGQGTGRKLFYFAFEQAKKRG
CKVVQLTTNKTRTDAHRFYESVGFKGTHEGFKFAL
>AIA18371.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MIGAGIAGTAVCYWLRRFGFYPVLIEKSACIRKGGQGLDIRGVAIDIVKKMVIYEQICKM
RTQVECGRYVDVVGKTLHEEKGEKFAFRQDEDVEILRGDLIEILMKTIDDVPCHFNQSID
SIEQNDDDVIVYFKDARVEHYDLIIGADGIHSSIRRMVFDKDEYRLVNLAEAYFSIFSIP
NYLNLSHTEVQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQMQFLRDIFH
DFGWEAQKILELMPNSHDFYFDSVTQVKMRSWTKGQVALVGDASYSASPLSGQGNNLALV
GAYILAGELKAAEGNYKLAFNRYNELLHPFVEANQQLGAWVSESFLVPDAVSKEVAEERS
NRILQKVQIISNAIKLPEYE
>AIA18368.1|FEATURES|farme|beta_lactam|NPS|antibiotic inactivation|1
MENIEERLDARVGLLIRDSGTGWSWGHRADERFLMNSTAKVPLCGAVLAQVDKGAMRLTD
GLDVRAEDMVEYAPVTELRIGDTMQVGELCFAALDMSDNAAANSLIDHLGGPQEVTAFMR
QIGDDVSRLDRREPDLNRFETGDPRDTTSPAAAVDTLERLLVGDALSPSSRAQLTEWMTP
GGVTGALLRAFTPDSWRVADKSGSGSVTRNIVGMIAPPQGGPYFVAIYLSEAEADFDTRN
AAVVAISAAVVELIASR
>AIA18342.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLKSILLHGKEHQDRTGVGTISHFGFQTRFDLRKGFPIVTTKKIPFRWVAEELF
WFLSGDTNEANLRARGVDIWAEWADEAHTKRFARKPGDLGPVYGYLWRSFGGHYPEHDGV
DQIARLVGEIKNNPHSRRLIVTGWDPREADNVDLPPCHTLFQFKVENGSVLHCQLYQRSA
DAFLGVPFNISSYALLLRMVAHVCELAVGEFVYTLGDYHIYKNHLDQVNELLSREPLPLP
SLEIVDPTKRLRGLQGLLDLRYEDLNLSGYQSHGKIAAAVAV
>AIA18338.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MRISMIAAIGKDRQIGLKGDIPWSEPADLKVFKKLTMGHHLIIGRKTFESLKAPLPGRKV
VVLSSKIPPSPEYKHFSTLTDALQSAKAGGEDECFIAGGANVYAEGLGFAERIYLTRVAY
DGPADAFFPPLPENWAISASEPLSPTARLEIWEKTH
>AIA18327.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKISIIVAASENNIIGRNNDLPWYLPTDLKYFKDTTMGHCVIMGRKNFESIPAKYSPLAG
RTNIVVTRQKDFHAVGVEVTHSIEDAIELARKKNETECFITGGGEIFAQSLKFCDRIYLT
RIHAVIEGDVYFPVVNENEWKEISRKDIQADEKNKYPFSFIIYERY
>AIA18321.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MGRKNYDSLPDAYKPLPNRTNIVVTRQRAFSAPGCIVVHNIDDALNLARTRGESEAFVIG
GAEIYTLALANANRLYLTEIEADVDGDTYFPSFDKAQWKEVSRKHHDADQRHAYAFDFVV
YERIA
>AIA18314.1|FEATURES|farme|beta_lactam|IIU_05946|antibiotic inactivation|1
TVILISLAGIILMNSCQQKESLQSRIEKEFSREQGEFALAFEDLATGEQLLINAGERFHA
ASTMKTPVMIEVYKQVAEGRMSLHDSVEVKNTFKSIVDGSAYSLDVADDSDTLIYKQLGH
KRTLYSLMYDMIILSSNLATNLVIERVGAIHVTATMRGLGAKDIEVLRGVEDNKAYEKGL
NNTITAYDQLLIMKKIALGKAVSKEASDAMMNILFDQRYRDIVPANLPPEVKVADKRGWL
TGLEHDCAIVVLPNGHRYVLIILSRKLVDRDKAVKAMANVSRIIFDHVTAH
>AIA18298.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MISIVAAMDTKRGIGKNNDLLFKIPEDFVRMKKLTEGHPIIMGRRTFESIGRILPNRYNI
VITRDPDFEFPGLSGDRGTIVGSLEEAVTAAKRAPGSEEIIIFGGGQIFTEAVEKGLVDI
LHLTIVDGDFGADTFFPDYSQFTKILDEESGQSGEYHYRFVDLAKD
>AIA18256.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLRSILQYGTTHDDRTGVGTISHFGFQTRFDLRRGFPIVTTKRVPFRWVAEELF
WFLSGDTNEENLRARGVDIWAEWADDAHTAKFGREAGDLGPVYGYLWRSFGGDYPQRNGV
DQIARLMDQISSNPDSRRLIVTGWDPLQADNVDLPPCHTLFQFKVESRRTLHCQLYQRSA
DAFLGIPFNISSYALLTHLVAHVSGLEVGEFVYTLGDYHIYRNHLEQVNELLSRAPLPLP
ELKIDDPEKKLRGLDGLLNVKYEDLNLIGYQSHGKIAAPVAV
>AIA18202.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|0
MTTKPAHSNYPLVDVLAIWAESTSTLGDPIMGNTASRTGLPWPSDPEDLRHFATVTDGRL
LVMGRGTFEALPARMKTATALAKRPMAVLTTRSEFRVVRKNLLEVNASRVEPGDITKLVG
MLAHWSKRVRVAVIGGPTVIERLEPAIDHATVTYISGAYPGDVRAPSTRFLDTFRSEQVL
GKTAQGNTIVHYTNAAH
>AIA18183.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVFIIAALTADGFIGRDSGHSADWTGGEAQKVFVRLTKEAGTIVMGSRTFAPIGRALPG
RRNIVYTSRPDQITAEGVETTSEPAKDLIARLRKEGSKAVAICGGATIYDLFMREGLIDE
LYLTYVPIVFGKGVTLFSDGLDAKLDLQEQTKLDDGSVLLHYIVKK
>AIA18171.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIITFVVAMSKNRVIGVKNRLPWVLPTDLQHFQEKTKGHPVIMGSKTYDSIPENRRPLPG
RTNIVLTRDRGKTYPGCLMAHTLGEAITLAAQQPGSEEVCIIGGAHVFTEALPLANRIYL
TEVDAIIEDGDAFFPELDPVRWQVKEEGSFTKDEKNEYGGKFLVYERTGKFPIVEPGNGR
NEEYKAQLERILASGQCPFCPNGETLKEQEIIYENDTWFVKHNAFPLENTVFHFVLTPKR
HIEFFDDISDAEWIGLKACRQWLKEKYNFTGDALYARSGELLVTGATVAHFHCHIIVPAG
LVQVSFGSYHLK
>AIA18172.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ENLNKYDVHYWDAWADEEHAGWYDLPAGQFGRTYGAQWRSFNAGGPEPIDQIKRLFTIIE
KNPSDRGLLVNPWNPYDVDHLVIKPCHGQFRLLLMDDRFDMVVTQRSSDVPLGLPSNVVM
YKFLQMLICMKTGYKEGDLIYDIQDAHYYSDQEEGIKILIEREPKPYPKVTIDPIMVKVL
DAMLDGNDDPLSDKQFNPEGKPYKELLREWIKLEGYDAHPTIPYEVLPVDI
>AIA18138.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MRNLFCSAASLTISFVFLAASEIYGQESLRKEIENLVRPVNGSIGVGVRHLESGDTLTIH
GKDHFPMQSVYKFHLALAVLSDVDQGKLSMDQKVLIRKEEFIPNTVSPIADKYPDGNVAL
TVSELLSYTVSNSDNNGCDILFKLVGGPKKVEAYIRGLGVRDVAIVNTEREMHQDWDAQF
NNWTTPQGMVQLLDLFYQKKILSPESRDFLVKIMEQAATGKKRIKGQLPAGTVVAHKTGM
GGNDEVISAMNDVGVVTLPSGGHFAIALFVTNPKDSIEVVEAVMAKISKLVLDHYATAK
>AIA18126.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
RDGKLPWHYPADLKHFKETTMGGTIVMGSSTWHSIGRALPGRQSIVLSRSEIPDLPDEVI
LCHSVKQVIERAERLDGDVFVIGGAGVFESFQDEIERWIVTRVPETIENADVFMPVQFLD
DFEFVESRDIGDGLTVETFDRLQQSA
>AIA18112.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSNKIRVGVLFGGKSAEHEVSLLSAKSVVEAIDKEKYEVVLIGINKSGEWYLHENMDECL
VNCEDPKLIQLKMAKENVTVVPREKGNPLVNLSGSALNKQLDVVFPVLHGTYGEDGTIQG
LLKLVNVAFVGSGVLASAVGMDKDVMKRLLRDAGVPIAKFMTLHSHSYQSNSFEEIVATL
GLPFFVKPANLGSSVGISKVKNKQEFAAKISFCISIRS
>AIA18092.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYLGLLEDILENGVDRGDRTGTGTRGVFARQLRFNLSEGFPLVTTKKIHFKAVVYELL
WMLGGHTNVKWLQERGITIWDEWADENGELGPVYGAQWRKWLAFRKVADGDQHGLNGSFL
WEPKAIDQIAKVVRDIRENPNSRRLMVTAWNPADVDKMALPPCHCLFQFFVADAKLSCQL
YQRSADVFLGVPFNIASYALLTMMMAQVCGLAPGEFIHTFGDVHLYLNHFDQAREQLTRE
PRPLPLLELNPERRELDDFVYDDFRLLGYDALPNIKAAVSK
>AIA18069.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FHELLWFLKGDTNIKYLVDNDVHIWDEWPFQDYLIANNFTEKFPMYSEAWKLEKATFIER
IKTDAEFAKKWGDLGPVYGKQWRRWEGPDGIVYDQLGKAIEMIKKNPDSRRILVSAWNVS
DVYTHTKTAPPLCHTLFQFYVNDGKLSCQLYQRSADTFLGVPFNIASYSLLTHMIAQVCD
LDVGDFIHTFGDVHIYSNHIDQVKEQLNREPKSLPTLKLNPDVKRLEDFT
>AIA18067.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVCQFRASVLFSLPMTQYLDLLRLVLKDGKFKADRTGTGTYSVFGAQTRFPLANGFPVLT
TKKLHLKSIIYELLWFLRGDTNVKYLNDHGVTIWDEWADQDGNLGRVYGAQWCDWRTADG
RSINQIDQVIEQIKKNPDSRRLIVSAWNAGEIEKMALPPCHTMFQFFVQEGELSCQLYQR
SADLFLGVPFNVASYALLTLMVAQVCDLKPGTFVHTFGDLHLYANHLEQAKLQLTREPRP
LPQMKVNPAVRNIHDFKFEDFELIGYDPHPGIKAPIAV
>AIA18040.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MISIIVAMDLNGVIGVRGGAMPWGRGLKDDLAHFKKLTEGEMVIMGRKTFTDAINRPLPN
RVNIIVTRDATFNHQATGGAIIVVNSFDAAMVFAEETPYRHSFVIGGAEIYAQAIPRVDS
MFITRVDGQFAGDVLFPHFDRQEWELFGQVVYHKDDRNTYGFTIEHWKRRAALTSTTRPT
LTRATRTRRSTDAPSRRS
>AIA18023.1|FEATURES|farme|aminoglycoside|YH67_08905|antibiotic inactivation|0
MAFIPNFSQPPADTLLQWVRAAVDPHSEIVEIRPLEGGSSSTLYSITLRTGEMLREVVLR
QYDNLEWLAEEPDLARHEAAGLLWTEKTGLPTPRLLAVDKTGRVSGIPALVMTKLPGAVV
LRPPDMAGWLEGLAETLARIHRFEVKYFPWNYLPLY
>AIA17953.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MSKHIKILVIGAGIAGPAICYWLKRFGFSPVLIEKSPSIRKGGQALDIRGIATHIAKEMG
IYDEICNIRTRIECGRFVDTAGNILHEEHGEKFGFRQDDEVEILRGDLVEILMKTIADVP
CYFNQSITSMQQNDDNVIVNFKDGKIENYDIVIAADGIHSATRRMIFDKNEYQIIHLGSY
LSTFTLPNYLGLHHMDLECEANHKLVSLNSDNDPEIARAGFMFRSQHVLKDIRDENEQKQ
FLRDTFHDFGWETQHILNRMSQSDDFYFDAITQVKMNSWTKGRIALVGDAGYCPSPLSGQ
GNNLALVGAYILAGELKTANGNYIQAFTRYNALLRSFVEANQQFGVWVSESFLVEDEVSK
EVAEERSNKILAMIKSVSNAITLPQYE
>AIA17951.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|0
MGSAALNQGARYSALRSRNFSLLWIGLIVSNAGTWMQNVASGWLVLQLTDSPLWLGLLGL
SFALPMIVLPVVGGAVVDRVHRIRLLYVTQTGSMLLAFTLALLTWLNLVNVWHLLAVSFL
GAALLAFDNPARQALLPELVPPADLMNAISLNSATYNGAALVGPAIAGALLGPLGAGTLF
FLNGVSYLAVIFALLAMRDVRSHGGGKTTSLRASMWAGLAHAANHRFILALLALSALAGI
FGRSYQNLLPVFARDIWNGGPAGYGILLSSAGGGALLGALGMASVKSPSKPERVMLASGL
LFGLALFAFALSPNLILGALLLFVSGTASTVFGTMIATFVQLSTPNELRGRVMSLYAITL
IGLPSLGALGSGAVAEWLGGIVGAPRAVLAGALVVCLILIGVTPYFARRPMARHTNPSFR
G
>AIA17914.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKVSLVAAITLDGYISRTTDKIADWTSKEDKKVFVEITKRAGVIIMGGTTFRTIGRALPG
RRNIVYTKGAIDVEGIETTSEEPRVLLERLEREGCTEVAICGGAAIYGMFLAADVVTDLY
LTIEPVLFGSGISLSSVSLETIATLKDIRQLNESTVLMHYEVQN
>AIA17861.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|0
MKVSIIVAMTADGYIGRTTDHLATTWTNIEDKYLFTHYVKEAGNMVMGLNTFKTTAEKFP
GVFNKSMPGRRLLVYTPDPEEVTKYANVEAVTESPEKLVKRLEKEGVKHLAVCGGTTIYT
MFMQSGLVQDIYVDMQATLFGAGMPFLNASVDAQIELKDIKRLGDNNVLLHYAVKK
>AIA17800.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
VKEDKKWFKDVTKHVGTVVMGRKTYETMNSKPLPDRVNYILTRNPEAMEKTEGVIPITLE
KFRELKLRDYCIVGGYQIYNELWKDATVLYISRHKNVEIDGSEFKLDLKSCVLFDRSESE
DLVKEIYIQHPYISHIITYEYGEHPYLDQAQKIWQEKSVQGVHITVSLFI
>AIA17792.1|FEATURES|farme|aminoglycoside|WH87_16890|antibiotic inactivation|0
MIRTLTDRDFDAIHTAFLGAFSDYVIPMKPSADQLRSMFVRRGWVPELSLASFEGDVVTG
FVINCVSGDQAYNTGTGTLPSHRRSGLARELMKRSMSLLSPRTYTLEVISTNEKAVALYR
ALGFEEVRKLDAWSLNGEWRTGDLACPDRQDCLSSTFHRETWFTSRPSWQ
>AIA17791.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKGLDVNNKKIRVKNFHNETVKSAVELMAAAGINDPRKLHRSFIYRRISASQIQTYAEMY
PNMLRGALLEAPFPKEWELDMMHSSEETFEPKYYLRVIISLIVAVAENNVIGKDNTLPWH
LPADIEYFRNTTMGHCVIMGRKNYDSIPPKYRPLRGRTNIVVTRQKDFKAANCIVVNSVE
EALTEAKIKEETEVFIIGGADIYKQTMDRADKIYYTKIHHAFKGDTFFPSLDANQWALIS
KKDMKADAKNKFPFSFCVYARSKRQSKF
>AIA17785.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKVILIAAVSADGYIAKSTDHFAGWTSKEDKKLFVELTKKAGVMIMGRNTYDTIGKALPG
RLNIVYTSKPLDNPDIQTTQEGPAELLKRLSEQGYQEVALCGGQAIYDLFLKQGLVDELS
ITIEPKLFGSGITLSNSLAEAELRLVGSRKLNDDTLNLHYEVKK
>AIA17770.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLVVAASDNNVIGKNNQLLWHLPKDMKFFKNVTWAMPVVMGRKTFESIGSKPLPGRK
NIVITRQPGWQAEGVSVPGWQAEGVSVVDSVDAAASLAEGLNYKEIFIIGGGVIYMIAFD
RANKIYMTRVHADLEGDTYFPVIEKDDWALVSKTDNPVDEKHAYAFSFQLWERKTN
>AIA17733.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MKIMLLAAVTLDGKIARNEHHFVDWSSREDKKMFFATSKQAGVIIVGHNTYKTLPAPLPG
RLHVVLTTNTADKVAVPGQVEFTSDPPEKIVADLEARGYTEAVLTGGAQINALFLKAGLV
DEGWLTVEPLIFGVGIDLFRGTPFDVRARLIYMEQLNDGGTLHLRYSLRSP
>AIA17723.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MTMGYERIAERVAKVPPSGIRRFFDIVAQMPDVISLGIGEPDFVTPEHIRLAATRGLEVG
STAYTAYTSNSGLLELRLALAAHLEQLYGIGYDPEQELLITVGVSEALQNAMLATINPGD
EVIIPEPSFVAYPASVVFAGGTPVTVPTSVADSFQVTAAAIEAAITPRTRAILIGYPNNP
TGAVMPRARLLEIAALAEKHDLLVFSDEIYDRLVYGVEHTCFASLPGMRTRTVLLGGFSK
AYAMTGWRLGWLAAPDDITAATRKIHQYAIMSAPTIAQYAGLEALRNGEAAVQGMLAEYD
RRRRVIVGGLNQIGLPTFEAQGAFYVFPQISHLGLTSEEFAERLLHEQQVAVIPGDAFGP
SGAGFVRACYATSMDKIEMALDRIDKFVHSIR
>AIA17716.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIIAIAALSENRVIGQNGQLPWRIPEDLKRFKDLTMGHPVIMGRKTWESIPEKFRPLPGR
TNIVVTRQPDYAVPADVIVSSSVEDALKIFPSEHIYIIGGAEIYAAAMPHVDKIEMTLVK
KTIEGDGLTYFPDMDMAHWKELRREDHDEFSFVTYERV
>AIA17676.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MTISIIVAIAQNYAIGKNNQLLWHMPNDLKHFKQITSGRTIIMGRKTYESVGKPLPNRRN
IVVTRQDIEIPGCEVVKSIDEGLSLCADEDEVFIGGGAEIYRLAMDKTDRIYLTIIHKDF
EADTFFPEIDYLKWDEASREYNEPDEKNPLPYSFITLNRR
>AIA17659.1|FEATURES|farme|aminoglycoside|SG34_20990|antibiotic inactivation|0
VLNHPSFEIPNFQPAGLPIVEIGWRLSSQHWGKGYATEAAKAVLHYAFTELNLNEIISFT
VVANTQSRRVMEKIGLHHSEADDFDHPKLEENSPLKRHVLYRLTRDDYLTHEATINKRKK
>AIA17654.1|FEATURES|farme|beta_lactam|OXA-20|antibiotic inactivation|1
MFGGNGVAMRFWILVIFLTLGFCATASAQVWQERLDWAHFFADAGVKGTIVVSDERTHTH
WVYGEERARTRFLPASTFKIPHALFALDGGIVRDEFQIFPWDGTRRDLESWNKDQNLRLS
MRNSVVWVYQLFARQLGERRERNYLRRIAYGNADASGGIDRFWLEGGLRISAHEQVEFLE
RLYRNKLPFRVEHQRLVKDMLIVEAGRDWILRAKTGWGVRMDPQVGWWVGWVERPEGAIF
FALNMEMPHQGDDLPKREAIARAVLRSIDALPSN
>AIA17629.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|0
MNRKEKILLGILACLNFTHILDFMIMMPLGNFLMPYFGISARFFSWIVAAYPVTAFFAGL
IAAFYVDRFDRKKVLLFGYSGFLIGTICCGIAPDEYWLMAARVLTGLFGGLIGAQVLSII
ADVFPYEMRGRAMGTVFMAFSIASVFGVPFSLYLAKLISWHAPFLFIGILGVVVIPLIIR
FMPPIRGHLVNVGERKSVVSVLKSILSNKSQVMALSLTAMLMFGHFLVIPFINPYLEFNV
GFTKEQTPLIYMVGGTGAMISSNIIGRMADRFGKLRIFMVCMLCSLIPIFLITNMPPINF
YLVLAVFGFWFIFSTGRNIPAQAMISTVVDPTQRGQFMSFNSSFQQLFTGMASIVAGLIV
KQDLQGRILHYNWVGYLSAAVVFSTLFLANKLAKRQQIR
>AIA17624.1|FEATURES|farme|beta_lactam|BL3_l|antibiotic inactivation|1
MKNNLFRASFTSAVLLATAASAAEPVLPQLKAYETEDSWRQPVPPFALAEHSWYIGTAGL
SVVLVKTPQGAVLIDGGLPQAAGMVLQRIKELGVQPGDLKLILNSHAHIDHAGPLAQLKR
ETGAKLVLSAESAVLLARGDSDDLHFGEGLTFPPASADRIVMDGEVLELGGVRFTAHFTP
GHTPGSTSWTWDDQRAGRTLHIAYVDSLSAPGYQLIANPRYPRIVEDYGRSFATVRALPC
DLLLTPHPGGSGWTPEATASPHPEPMTCHEYADNAERALDELLEKQRHGQKPSAP
>AIA17608.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVFIIAAQTIDGFIGRDSGHLADWTGKADKKVFVELTKQAGTIVMGSRTFDTIGRALPG
RRNIVYTSNPAKYAHIPDIECTNEPPAQLVARLQQEGAMALAICGGTSVYDLFLRAGLVD
ELYLTIIPIAFGHGIRLLGEGPIASLRLLACQPLDDGAVLLHYASNK
>AIA17598.1|FEATURES|farme|aminoglycoside|AAC(3)-IIIb|antibiotic inactivation|1
MVHASLRAVGEVAGGPDEVHLAIKDVITDRGTLFMYASCPAYVDEVGRGNLTPAEEAEVL
ETLPAFDPHTARSARDNGALVEMFRTYPGSRVNVHVARFVVWGKHTDRLLTPQPWDYPFG
HGSLLERFVELDGKVLLLGSDHDNVTFLHYAEHIADIPDKCIARFKVPVLENGVRVWREM
AEVDTSSQGAHASWPDRFFAILVDSYLAATNNRGGRVGRAESYLFSARGLLEHALPKMEA
IARPRR
>AIA17544.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRGKGHEVTPMDPARGVINSAEERELSTGKVGA
EPPSLESLSKFAEGTFLPNLTGMKEIRNADVVFLALHGGQGEDGTLQALLDMAHVKYTGS
GHLSSALAMDKDLSKKLFRMEDVKTADWLMAPATTEQVEGILGLPVI
>AIA17507.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DFPGVTTHLATSWMPAYALGNKSRRRKVVVAPCHGTAVRVIVNDGRLTLQHVQRSADMPV
GSVLNMVGYAGVALELARVLDVEPYRYVHCFMDAHTYENQIPWVKRLIRRRPRAFPTFKI
LDSAPRDLLAFRSEHFELSDYDPHPAMDDIPVTE
>AIA17436.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
DTVVFAATQTAKSKGFNSSHFSFNVPGGRCETCQGSGIVTVEMQFLADVELTCEDCRGTR
FRDEILGVKYKGRNIDEVLDMTVREALLFFKDVKKLVTRLKMLEDVGLGYLRLGQSATTL
SGGEAQRVKLAAHLAQKTRSNTLFIFDEPTTGLHFDDINKLLAAFRALIDNGGSLVVIEH
NLDVIKTADHVIDLGPEGGVGGGEIVAIGTPEEIAKSPKSHTGKYLKQLLS
>AIA17406.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIAAMADNRVIGNKNKLPWHMPADFSWFKEKTKGKILILGLNTFKSIGEKPLPNRKHIIL
NRDPDYRVPENCFLATSIDEALEIAKKNISNSSEEIMICGGMSIYQQFLSKAQRLYLTYI
HTNVEGDAFFPEVNMDEWKEVSREDHEADQKNNHAYSFVVLERK
>AIA17381.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
TLGHPVIMGRKTWESLGKPLPGRDNIVVTRNADYEAPGAAIATSLEAALALCAGEKIAFV
IGGEKLFEESLPVAAGLVLTEIHRDFDGDTRFPEFDRTKWKAAQREAHTAADGMRFDFVM
YERG
>AIA17356.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTPFDQIYQGIIKNIMDNGIREMSERTGLETSALPGVSFSIDPIKDGFPILTLRKIPIKV
FIAEQMWFLSGARKPEDFLRDHTKIWDIFTNPGDVVTVAYGYRWRKHFGRDQIALLIDLL
KNEPSSRHGVVIAWDPAQDGLSLQKKKNVPCPYTFTVNIIGGKLHFHNIVRSNDMVLGFP
HDVAGFCLLQYILAQKLGVEVGIYSHSISNAHIYSNHYEGAKEMIARTNDHPQISIILPE
NSFERAEEKDVTLLDDLLNQVTTQYKPMDA
>AIA17283.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSEIRKTIVVAVSENGIIGRDGDMPWRLSADLKRFKALTLGKSVIMGRKTYESIGKPLPG
RANVVISRQAAAIDHPDVRMARSLTEAIGLAEDIAKRSGEDEICIIGGGQIYTQALDLAD
RLCVTHVETSVDGDTSFPTIDPTLWRATETIEVPAGDKDSYPTKFVVYDRR
>AIA17252.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISAIAAMSSNRVIGRDGDLPWNLPRDMKFFMNTTKGHHVIMGRANFASMNYMPLRNRV
NIVLTRDPFFITSSALVMHSIEEALAYAHAAGEEEAFIIGGGQIYEQSLPLLEKIYLTEV
IKEVPGDTYFPELDMNEWVLASSEYHDADAKNEIPMRFDVFVR
>AIA17244.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNISIVVAADENGVIGKDNKLPWRLPADLKHFRELPLGKPVLMGRKTFESIGKPLSGRRN
IVLTRAAGVTIEGCTVVNSLDDAIDAAGEADELMIIGGAEIYRESLELANRIYLTRVHTA
VEGDTRFPDLDYDEWRETSIEEHAPDERNEHAYSFEVLERLE
>AIA17220.1|FEATURES|farme|beta_lactam|OXA-20|antibiotic inactivation|1
MFGGNGVAMRFWILVIFLTLGFCATASAQVWQERLDWAHFFADAGVKGTIVVSDERTHTH
WVYGEERARTRFLPASTFKIPHALFALDGGIVRDEFQIFPWDGTRRDLESWNKDQNLRSS
MRNSVVWVYQLFARQLGERRERNYLRRIAYGNADASGGIDRFWLEGGLRISAHEQVEFLE
RLYRNKLPFRVEHQRLVKDMLIVEAGRDWILRAKTGWGVRMDPQVGWWVGWVERPEGAIF
FALNMEMPHQGDDLPKREAIARAVLRSIDALPSN
>AIA17153.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MPSEFGVSDPNKRQYIIGAFFAGMTIGTLLSGPISDSTGRKPAIFAGLLIYVAGSLLCLF
STSFEMLLAGRALQGVGASSPRIVSLAMVRDGQSGAAMARIMSFVMSVFMLVPILAPSIG
QLVLFVASWRMIFVGFLAMALIGGSFASVSSGWKTLPKEKRVAFSAGNLFRSAVEFFRFP
SAWGYTVSVGFVFASFICYLGTSQQIFAEQYVQGEWFAVWFGGFAIAIAFAMIFNGRMVM
RRGMRMLAKWAVRGCIVFSAIFLVVALELRRPSAALDPRRLHVLHLLLLRHPSSAITTPW
PWSMWATSPAWRRPFLARFLPSWRSPSAPGSASSMTAR
>AIA17113.1|FEATURES|farme|tetracenomycin|tcmA|antibiotic target alteration|0
MKQYLDLIRYVMENGERRDDRTGTGTIACFGLHAKYDLREGFPLITTKKVLFGSVVRELL
WFLRGSTNINDDLTQHTPIWDAWADENGELGPIYGYQWRFWPKYTPEEGQPGLYRREHVD
QVKDVL
>AIA17100.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIIIIAALAANRVIGKDEGIPFYLPDDLTRFKEATMGHTVVQGPKTLNSIVKRLGKPLPG
RENIVLTHHPDRIRVDGVKTIGEWWRIVEMSRYRDVFVIGGAELYKTALPDAQEMRLTRV
HAEVEGDTLFPIWRKEDWMLVSSESPDQGKNGFPFTWETYWRRSR
>AIA17057.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKIRVAVLCGGKSAEHEVSINSARNIIAALDPKKYDVTLIGIDKQGRWHLGNSVKLLGS
HEVHHISGTEGLALMPGKSSELFLDAAQKQWLQPIDVVFPVLHGPHGEDGTVQGLLKLAN
IPFVGTGVLGSAVCMDKDVMKRLLREAGLPIPKFLVYNRRDVAKINFENVSAQLGLPCFI
KPANLGSSVGISKVRNQQEFAAAVDAAFLYDNKIIIEE
>AIA17048.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|0
MKVFIVAALTADGFIGRGSDHLATEWTNKDDQKVFTRLVKPANNMVMGRNTFLTIARKYK
SVFTKSMPGRRLFVYTPDPAELADYPEVEAVSEPPAELVKRLSGEGLEQLAICGGTQIYT
MFMAAGVVDDLYLDVQATVFGAGQGLFNAPLQAEIVLESTERLGDNNLLLHYRV
>AIA16964.1|FEATURES|NCBI|tetracycline|tetZ|antibiotic efflux|1
MIGTVQRKVRAHADARLKGKLTVLMITAFVDMLGLVMVLPLLPFYATKLGGSATMVGGLI
AAFSLAQLASAPFWGSFSDRYGRRPALLSGLILSAIAYVIFAFASTLWLLLLSRIVQGFG
GGTIGVVQAYVTDVSDPKERAKSLGWLSAVTSLGAVIGPAIGSALVQLWGRHAPGLAAAA
FSLLVSLFAWEFLRESKQAPTTDEMALPPAPASAVMWNVLVHPGEAAPRLIWIYTIAIGA
FYGMAPTLPLVLQRYLPITESNVGYFVMYLGGIGFLVRSLILGRMIEVLGEARLARLGLI
LLGLGLALVSAIR
>AIA16937.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAISENFAIGRDGKLPWHYSADLKNFKESTMGGTLVMGAKTWRSIGKALPGRQSI
VLSRSEIEELPDGVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRWLVTRIPE
TVDDADVYMPLQFLDDFELVD
>AIA16935.1|FEATURES|farme|bacitracin|uppP|antibiotic efflux|0
EIVFQRGASGIGLLWAAAGIGLVTGALFAHALARRIGYHAYKRTISIAYLIHGGSYVLFS
QAGTFERAMFWIGMSRAAMGVSSVLNTGQLLRHVSNEYRGRVFATVESWSWTTMIVSMAI
AGIASEHVSARVIGAWSGVLSSTTAVWWAWANWRGHLPEPPVEGVDPDTVEIEEASPNI
>AIA16918.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPFDVSRIVFDVHFRYIRSMIVSLIAAASDNNVIGKDNWMPWHLPAELAYFRDVTRGKPV
IMGRKTLDAMGRPMPKRHNIVVSRQQDLQVEGVDTAHSVEEAIELTTKDAMEEIFVIGGE
QIYSAFLPHADRIYLTRVHTNIEGGEAFFPEFDENEWSITKNERHEADMENPLAFTVLVY
ERKKRGGTEKS
>AIA16902.1|FEATURES|farme|aminoglycoside|AAC(3)-IIIa|antibiotic inactivation|1
MTDSNDHLVTHGQLVEELETLGVAAGQIVMVHASVKAIGRIMGGPNVVVQALLDTLTPAG
TLMMYVGWENIPDFVSNLSPAVRQEYYAEHPPFDPRIARAVRDHGILAEIVRGWPGARRS
LNPEASVAAIGARAEWITQDHPLNYGYGAGSPLEKLVAARGQVLMLGAPLDTLTLLHYAE
NRARMRNKRVIRYSCPILRMGERVWVEIEDYDTGEPHGDYTFDGIAREYLAQGKGRQGTI
GHAPSYLFDAADLSTFAIAWLEERFGETT
>AIA16860.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MNGGFGKVAVLLGGRSAEREVSLKSGAAVLAALQRSGVNAQAFDPAERPLHELQGFDRVF
IALHGRYGEDGTIQGALELMGIPYTGSGVMASSVGMDKWRTKLLWRAAGIVTPNFELVEA
DSDMAGIEARLGLPLFVKPANEGSSIGISKVKQKGGLKAAYEEAAKADPLVLAEKFIGGG
EYTVGILGGMALPIIRIVPANEFYDYEAKYLRNDTQYLCPCGLSQAQEDQIRAEALQAFR
IVGGRGWGRVDFLMDEAGRHYFLEVNTSPGMTDHSLVPMAAKAAGI
>AIA16841.1|FEATURES|farme|aminoglycoside|AAC(3)-Ic|antibiotic inactivation|0
MRDFVIRTALPSDAPSILALLGELAAYGKAPEFNLNEAHVLRDMFGAACHCELALRDEEP
VGIATWYWTYKSFRAVRGLFVEDLYVRAAFRGQGLGKALLAHLAGKAEDAGGFLEWQVLD
WNSRAISFYKMLGAQAVPHWLNYRLEGEPLERLAQSRTDKR
>AIA16838.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|0
YRRYDPNELSISRSRGIAFTRLQSDTLKPLFDRSVMAMYPPGSIFKPILALAAMQEGVLD
EDRTIYCNGAYYSGGLKRGCHNHPSAHNVSAAIQYSCNTYFFTVYKDMIDISGYTMPEIG
MRKLNGILTEFGLGHKISIDVPSEKTGNLPGPSYFDQVYGSGKWRSPYILSMGIGQGELQ
LTTLQMAHAAAIIANEGTYTDPHILKARVPAGELPQQEFYPRRRVSIDYRHFEPVIEGMS
GAVRAGTATLAYIPDIEVCGKTGTSENPHGEDHSVFFGFAPRDQPKIAIAVYIENAGWGG
SFATPVGGLMIEKYLRGEISEPRKYIETRMLEADLIHKPKS
>AIA16794.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MVVAYDRHRAIGKAGGRPWEGGKLRADMKRFRELTRGKTVIMGRRTFQTDVGGRALPKRQ
NIVLSREEFAAPEVETAHTLAEAYRLAKGDIVVIGGGQIYKEALPDIDTIYATEIDGDIE
GDAFFPELADDEWRETSREMFAPDEDNMYGYSFVTFKRIK
>AIA16783.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MINNKTMSDYLTPLVRSIPSSGIRKFFDLVEGSKDIISLGVGEPDFATPWHVREACVYSL
ERGQTKYTSNAGLLELREAICEYLHHHFHTKYEPGNEILVTVGGSEAIDLALRALITPGD
EILIPEPCYISYSPITSLSGGIPKGIETYARDQFKLTAEALKASITPRSKVLILCYPSNP
TGGIMSYEDWLPIAKLVEENDLIVISDEIYAELTYGQKHVSFASLPKMLDRTIMVSGFSK
AFAMTGWRMGYACGHREIISAMLKIHQYTVMCAPVMGQVAALEALKNGLDEKDRMIESYN
QRRRLVVKGFRDIGLECHEPQGAFYAFPSIRSTGLSSEQFAQDLLKDARVAAVPGNVFGL
GGEGYIRCSYATSVLQLNEALERMGRFIRTIG
>AIA16779.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MLHNQNRPLLSAIVAMDKNRAIGHQNHLPWHLPADLKHFKSLTTHRAILMGRKTFESIGK
PLPNRTNIILTRDANYQAAGCITVTSIDHAIQEALLLHDPNNEIFIIGGAEIYQQLLPHI
QLLYLTIVHHTFEADAFFPALDNREWNEISREEHKADEQNVYDYTFLTLERIST
>AIA16777.1|FEATURES|farme|beta_lactam|AS202_10895|antibiotic inactivation|1
MTQRTSLDFKILLQVLFISLIVLPATAQVGAQDLSRFFKETKGAFVLYDLKQNRYLRHNQ
TRCRQRFSPFSTFKIPNSLIGLETKVLTDADYLMHWEPQKYPEAKDWTDPPFVHWKQDQT
LRSALKYSVVWYYRELAKRVGASQMKKYVAAFGYGNQDTSGGLASAQLFQAFWLNSSLQI
SADEQIEFLKKFYTGKLPVTERSTAIVKDILVLEKTPNYTLSGKTGGGSLPGGNSLGWFV
GYLETKGNVYFFATNIEGANYAAIRDRRIELTKQILAELGYMPK
>AIA16766.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MSGKRNAALGFIFVTLLLDVIGFGIIIPVLPTLISHLIGGTLSEAAQYGGWLMFAFSVMQ
FLFSPVLGNLSDKFGRRPVLLFSLFGFGLDYLLLAFAPNIAWLFIGRILAGITGASMTTA
TAYIADISEPEKRAQNFGMVGAAFGLGFIIGPVIGGVLGQFGPRIPFYAAAALTLLNWLY
GYFILPESLSQENRREFSWKRANPVGSLKQLKRYPVIAGMVGSLITIYIASHATQSTWAY
YTMEKFKWNEDWVGYSLGFVGLMVAIVQGGLIRIINPKLGSKNSVYLGIALYMVGFLLFA
FATKGWMMFAFLVPYCLGGIAGPALQGIISNQVPGNEQGELQGALTSLVSATSIIGPPIM
TNLFAYYTDPKNEIYFPGAPFLAGAICSLVSLILAVRSLANYQTTKEPEVAPVEIQSH
>AIA16728.1|FEATURES|farme|beta_lactam|OXA-54|antibiotic inactivation|1
MKQLLIIILFVIIVSAVAATKHVDNLQKPAPDLSPFFKDTTGAFVLYDLKNDRYIRYNEQ
RCRERFSPKSTFKIPNSLIGLESGVIRDADFVIPWNRQKYPPQDNWNQEPFSHWGQDHTL
RSAIKYSVVWYYRELALRVGESRMKKFVSAFRYGNENVSGEIDDFWLNGTLKISADEQVE
FLKAFYAERLPVSKRSINIVKDILVLEKTPAYTLRAKTGGGSIAEGKYIGWFVGYLETNG
DVYFFATNIEGSNFNAIRDKRIELTKQILMQLGYLTN
>AIA16716.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIILGPVAIAKNGVIGDSNDLPWYLPEDLKHFKQITMGHTVLMGRKTYDSIIKRLGKPLP
GRVNVVITRQEDFQAQPSVLVFHSLEQALDALKKDDVYIIGGAQIFAAALPYAQKIYVTH
VKKDYKGDVIFPEIDWQQWDMLDQEPHDEFTFATYIKK
>AIA16696.1|FEATURES|farme|macrolide-lincosamide-streptogramin|srmB|antibiotic inactivation|0
MSLNYLGPSAHRRMQVSKKPLINKKPLEKSPIILLLNGPSSSGKSTLAELLQSKLKDPFL
HIGIDKMIAMMPDKINNWEGGQSEQGFWWEEDTDSEGHQIYKIKMGPYAQKVSQTYKEVV
VTLAKNGHNIIVDEVAFGNKEIEIWREKLSEFNAFYIGIHCPLPTLEEREIARGDRIIGS
ARHQFYTVHEDIKYDLEVDTETHPLQECAERIISLFQ
>AIA16685.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MILSQILAVSENGVIGKDNKLVWNFPEDLKYFKKRTTGKVMIMGRKTFESFGKPLPNRFH
IVISRQFREFDHPQVQFVTSLQDAYRAAERLTLSDQWPEEVMIVGGGEIYRESMPDVQFI
YLTRIPGNYDGDTRFDLNLPKDFGIAFSQFSDVHPGLRWEIWSRAQTIAD
>AIA16674.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|1
MRKILSSVIAALFVAGMATAAMAGQPAAWTRPAKPFKILDNIYYVGTEGLASYLIVSDQG
AILLDGTLAENAGHIEKNIRALGFKLSDVKIILNSHSHFDHAAGISQLKQDTDAKVMARE
ADRSALENGKQEGDTNYGGASFPAVKVDRALKDGDVVELGKVKMVAIATPGHTKGCTTWQ
TTATDNGISRRVVFPCSITVAGNILVGNKGYPGIVEDFRRTFEKMASLEADVVLPAHPEF
ADVFQREAKQEAGDKDAYVDTQLLPRLVKKSKIAFEKELKAAQK
>AIA16629.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAMNMSKENMTKEFGKVGVLFGGRSAEREVSLMSGAGVLQALQSKGIDAHGFGTGLRSLS
ELAAEKFDRVFIALHGRYGEDGSLQGALEQLGIPYTGSGVMASSIAMDKVMTKRIWLSHG
LPTPRFAAFDAQATSAAQLQQAAVELGMPLMLKAPHEGSTIGISKVSNATDMEAGFAHCA
KYDEVVLAEEFISGRELTVPVLGKGRSARALPIVEIRAPQGNYDYQNKYFSDDTQYLCPA
PLDAELTEKIQALAVQAFNAVGCAGWGRVDFMLRAADNAPYLLELNSSPGMTGHSLVPMS
AKASGVSYEDLCVEILRSAALELHATQDWKPE
>AIA16603.1|FEATURES|farme|beta_lactam|OXA-50|antibiotic inactivation|1
MNTRIGFLLLSLFIVGLNSAPAEAQDLSPYFKNTNGAFVLYDLKENHYIRYNEQRCRERF
SPKSTFKIPNSLIGLDTGVIRDADFTIAWNRQKYPPQDNWNQEPFIHWAQDHTLRSAIKY
SVVWYYRELALRVGKQKMMKYITAFNYGNKTISKDIDNFWLDNSLKISADEQVEFLKEFY
AGRLPVSKLATETVKDILVLENTPAYKLSAKTGGGSIAEGKYIGWFVGYLETKGNVYFFA
TNIEGASFAEIREKRVELSKEILAALGYLPK
>AIA16583.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RTVLADGEKREDRTGTGTISLFGTQAKYDLRQGFPLLTTKKVNFAAVVRELLWFLKGSTN
INDDLHEHTNIWDAWADENGELGPIYGYQWRSWPAYDLDEKTGLYKKRHIDQIQNALDLI
KNNPDSRRIIVTAWNVADVPKMALPPCHMMFQFYVINGRLDCQLYQRSADLAVGVPFNIA
SYSLLMIMMAQECGLTPGVFTHTIGDAHIYQNHLEGLQKQLERKPGRLPDVEIPNKSLFD
LKFEDFTLKNYDHQGFIKFPVAV
>AIA16544.1|FEATURES|farme|beta_lactam|blaA|antibiotic inactivation|1
MKFSPLKYSLLLTVIMGTFINICTTGFASTQQIKPTSIAKKLSKLETSFDGQIGILAINT
ANNQRIQYRADERFPIQSTFKVMAVSAILKQSMTDKHLLQQKVTYTKQDLVFWSPITEKH
LADGMTISELCAAAMMYSDNTATNLIVKKLGGPSAVTTFARSIGDNTFRIDSWEPELNSN
SSDPRDTSTPTAMEKSLQKLTLGNVLASPQREQLVTWMKGNTTGDARIRAGVPKGWIVAD
KTGAGDDYGISNDIGIIWPPSCAPIVVTIYSVHNNKDTARRDDVIASATRMLIHEFAQTD
KCIKRKYD
>AIA16534.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKTIIVLAGGISAERDVSLRSGQAVVEALESKGYRTILHDPIHGIDNLPEADAVFLALHG
EGGEDGSLQADLEAVGRVYVGADATASALCFDKQVYKKLLAERDFPLANGQIVTKETIWQ
SPLTSQPFVLKPVDGGSSIDTHIIRDPANMPKAVIEKTLETYGEMLLEELIEGVELTVGI
LGDTPLQVVEIIPPAGGEFDFENKYNGASAELCPPEHLDQETQRQAQELALQVHGLTGVR
DLSRTDMIATPDGRLVVLETNTLPGLTPQSLYPKAAAASGIGMPELVDRLVQMALNRA
>AIA16506.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVFIIAALSADGYIGIDASHRATSWTTKADLQFFVRKTKEAGTIVMGRKTFETIGRPLN
DRRLIVLTSKPEDITIEDVEATSESPAELVARLEREGVTTLAVCGGSSIYTQFMEAGLAE
ELFITVMPKIFGQGLPLFGRQLDINLRLQHTEQLGENTVLLHYKTV
>AIA16497.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MKHFKAIAAMSENRVIGLGNKIPWHLPEDFKWFKKMTEGNIAVMGRKTFEGLPNPLPNRR
KLILTRHPRRLIKSRPELFGEYKEWRGGRSLQRLYQFHFTRMDGDKNQDIWIFNSLDKIH
PEEFTDEIFICGGAEVYAQALPFCSDL
>AIA16495.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTYILQPYDDLLEYVLEHGKEKQDRTGIGTLSVFGTQTRYDISEYFPLLTRRKVWPKAIF
AELLWMISGSTNIKDLQNLGSHIWDQWQSEEFEQKNNFVPGSLGPVYGFQLRHFGGLYWQ
GEKEDFTYGYGGVDQLQQVVDLLRSDPDSRRNLFSLWNPKDLYRQKLPVCHYSFQVYVDD
GKLSGMLTQRSCDLAIGCPANIQCYSTLLYMLAQQTGYQPGEFIHSIGSAHCYLNQLEGV
QEYVCREVVSSPKLELKPAKTINDYAMDNFNVIGYNPLGKISIPVAV
>AIA16461.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIILGPVAVSENNVIGKNNDLPWHLPEDLKHFKELTLGKTVLMGRKTFESIVSRLGKPLP
GRKNVVITRQEEYKAPAEVLVFKSLDEAVQNLLADDVYIIGGAEIFKQALPVAQAMEFTH
VHGNFEGDAFFPSVNWDEWEKVKEEKHEKFSFAKYIKRT
>AIA16457.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MAMTPERLIGAVGRLPWYLPEDLRRFRKLTMGHAMVMGRKTFSSLGRALPGRRNLVVSRN
PDPPEVAGVEWFNSLDAALAFARQSGESECFIAGGTEIYAEALEKSNRMYVTYVQRDFPF
QGDTYFPMWDQKQWRGISHELGKDLEFVVYERAQGDVAGASEVEMEAGN
>AIA16438.1|FEATURES|farme|streptothricin|sat-1|antibiotic inactivation|0
MTTILNSTKEDIPEIFRLYGLATVFQATKGSFVWPAFERSLVEEEIAARHQWKMIDGDTV
ACVWATTFSDPQIWEEKNADPAVYIHRIATNPDHRGENLVLQIVGWAKQYAKANNKKYIR
LDTVGNNLGLIKHYRRCGFEFLGLFKLKRRY
>AIA16407.1|FEATURES|farme|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
MMERETISQKAVTRQLLDLGVRPGGVLLVHCAFSKVRPVEGGPLGLIAALREALGPAGTL
VMPSMADDDEHPFDARQTPCLHMGIVAQTFWQLPGVRRSDSPHAFAAAGSEAERITAPHP
VAVPHGLDSPPGRVSEADGQVLLLGVGHGEDTTIHVAENMSGVRYRRKTHVLLHTDGQVT
RFDYGEVDHCCENFSQVDGWLDAQSMQRRGKVGHADARLARSRDIIAVASAQLRENETVF
LHPPGIDAECDEARASIPQESA
>AIA16402.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRIYAVAALTVDGFIGRYSGHFADWTGEEDKKVFVRLTKEAGTMVMGSKTFATIGRALPE
RRNIVMTSKPDKIKVEGVEATNETPEALVKRLEKEGVETLAVLGGAGIYTAFMQAGLMDE
LYITYVPVVFGGGITMFKGELDAKLEMREQTTLPDGSILVRYIVKKS
>AIA16333.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MDNNRYQKIADELATAIRSGELAPGTKLPPLRSIMRKHGVALATAVRAYNMLEAAGMVVG
ELGRGTFVRDTTVPGNDVLIQRSWPSAMIDLGFSYPLLPGQDELLRDGLRALASTGDLGS
LLQAPPQGGRLHYRESAARHLRNRAIRVPASQVLIVNGAQHGLSVTLSALLKPGDVLAVD
ALTYPGLKALAKLHRLELSALPMIDGIPDLGALHVLCTQRRVKAIYCMPTIHNPLGSVMP
LAARKRMADLAEQHNLLIIEDGAYAFLAEAAPEPVQRHAPDRTVYVSGLSKSVAAGLRVG
FVVAPPSCIPALEQAIRVSIWNTPSLNVALSCRWIESGVIDSLESAKRRDAKQRQVLARK
VLRNGKIRSNPSSYFLWLELPDEARAEEIARQLQEERILVATSEPFATTSHAPQAIRLAL
GTLPLAELRDALMKVDEAVSR
>AIA16317.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIDLVVARAHNGVIGSKNALPWYLSADLKHFKELTTGGTVIMGRNTYQSIVDRLHGPLPG
RRNIIISSTLTEVDGFEVYPHVDMALAATKPDEAVHIIGGAVLYEACLEQRLVDRIYLTE
VDADIPGDTFFPELQRAEWQETAREAHQADAKNPYDYSFVTLERIRSA
>AIA16318.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MYKPYDQRVPDTQYRDALQSILDKGRWSETRQGPRAKTLIGVQMHFPFENGFPVITDRSI
KSFWQKPIGELCGFINGARTREQLAEFGCTWWDEWTSLEKTSKRGLQPGDIGPGSYGAAF
HDFPTADGGSFDQYKHIVEQIKELPELRTHFVTPWIPQYIVRGEGKKQQVTIAPCHGWVH
VRIIENKLSLHMFQRSGDMPIGVPSNMIQYSALAMMIGHLTGYEPYEYVHTVSDAHIYED
QIEKLLPMLEREPRAFPTVRLTEEGKKITDIHDFRMEHFELSDYDPHPSIPKIPVAT
>AIA16235.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MRFHWIYILLLFYVLASACTKTANTAEVKQSPAPVAAAQNVDHELEQRLKTISDGSQGTV
GLSVVHIESGKTVSINGSSQLPLYSVYKLPLAVTVLKDVEEKRLRLDQKIHITPQNVVQG
TTANSALWQKPVDYTVEQLLEFSISRSDNTSSDKLVELVGGPLQVTERMRSLGFQNLDIH
ISSGEFVKTRQNPNTGSSDDLVQLLVQLHRGKILQPAQVNLLRGFMQRATTGLHRLRGDL
PRGTVVADKTGSGEADAVTKVAKVTNDVGIITLPRGRGHLAMAVLVNGSKLPDAAQEKLI
ADLARAAYDAYSKDVAK
>AIA16183.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIIGIVAVDRNLAIGKDGKLPWHYSADMRFFKETTIGNAVVMGRHTWLTLKGPLKDRQNI
VLSRGDSVQPTDSLIVKRDVEDVLGFASKLDCHLFIIGGAKVYESFQPYIQRWIVTEIPL
SVEGADTFMPANFLAGFKMYEVRQLEEGLRVKFYERPGG
>AIA16180.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIAIVAVDRNGAIGRDGKLPWHYSSDMKFFKETTTGNSCVMGYKTWLTLKRPLPNRLNI
VLSRQSEIAPQDSVVLLRDVESVLSLAEELNGDLFVIGGEQVYRSFQPHIQKWIVTEVPL
SVEGADAFVPKDYLEGFELTGTRKLEDDLNVSFYER
>AIA16169.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MIKPFLKRSIAPETHTTEAKLAYNDKTESITLVAAIDQALAIGREGKLLWPRRLQADMDH
FVSLTMGHTVAMGRKTYESISRKYRPLEGRDNWILTRDSTYSQPGCRIFHDVDEVLRAYL
GRDLFIAGGGEVYRLFLPHATRLVITHVDTRVEDADTFFPELPTSNWSQRVLFRHNRDER
NDFPFSVVEYTQIDEF
>AIA16152.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
TLVHDVLYAGIKKKRSEWNAHVGLFKEITGAELIDDVMLIDQSPIGRTPRSNPVTYIKAY
DAIREVFAATQTAKSKGFNSSHFSFNVPGGRCETCQGSGVVTVEMQFLADVELTCEDCRG
TRFRDEILGVKYKGRNIDEVLDMTVREALLFFKDVKKLVTRLKMLEDVGLGYLRLGQSAT
TLSGGEAQRVKLAAHLAQKTRSNTLFIFDEPTTGLHFDDINKLLAAFRALIDNGGSLVVI
EHNLDVIKTADHVIDLGPEGGVGGGEIVAIGTPEEIAKSPKSHTGKYLKQLLS
>AIA16106.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIILGPVAIAKNGIIGGDNDLPWYLPEDLKHFKKITTGHTVLMGRKTYDSIVKRLGKPLP
DRVNVVITRQEDYTAMPGVLVFHSVEQALDALKHDDVYVIGGAQIFAAALPLAEKMYVTH
VHKEYKGDVYFPKVDWEQWNKTEEEPHEEYTFATYERSH
>AIA16071.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPKISMIAALSKNNVIGDSGHIPWYISEELKRFRKITTGHPIIMGRKTHQSIGKILPDRT
NIIITRDLDFAIPGGVVVHSLEEALTEAAGSPGAEEIMVIGGGEIYRQVLPQADRLYLTV
VDAEMEGDVYFPDYSEFKKVVSHEETQAGGYNLTYLTLERT
>AIA16049.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MIIGIVAISENFAIGRDGKLPWHYSADLKHFKETTMGGTLVMGSKTWRSIGKALPGRQSI
VLSRSEIIDLPDGVLLCHSAKQVLERSERFPGSPFIIGGAAVYETFQDDINRWIVTRIPQ
TIDDADVYMPLQFLDDFERVDSKEIGEGLIVETFDRRT
>AIA16045.1|FEATURES|farme|macrolide-lincosamide-streptogramin|RlmA(II)|antibiotic target alteration|0
MKNGDHPGHSTSHTAASAFSGDAVKSYLEGPPRQVPGFSSLHRMATLLMAERMPDNGRVL
VLGAGGGLELKALAEAQAGWTFDGVDPSADMLQLARQVAGEHGNRIGFHRGNIDVAPEGP
FDAAVCLLTFHHIPIEQRLETLLQIRRRLKSGAPFVIAHMSFLQSEPERSIWIDRHLAFG
AIDGTDPARVENARKAMRERLHILAPEEEETMLREAGFSGVTLFYTAFSFRGWVAYA
>AIA15995.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MPSRTALVFAAVVSLSACVNKGETSAQKPATAGTPAASSTSAPQVADAELSARLKDICER
AGGRCGVAVTHVETGRGAAFEGATPLPLYSVFKLPLAVAVLKEVEEGRLQLDQKVRVEPE
ETVPGTEENSALWRQPSERPLRELLEFSIARSDNTSTDKMLELVGGPEAVTRRMRALGLD
HIEVRSTVKEFLKSRDAHPNTGAPEDLARLLVLLRKGEVLAPPQSALLLGIMARTVTGDR
RLRAGVPAGTPVADKTGSGPSTTNDVGVVTLPGDRGHLALAVLLDGSKLPSKQQEDLIAE
VARAAYEAHVRGK
>AIA15942.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|0
MIKTFIIAAVSADGFIAKDENHPAYWTSKEDKEKFIEHTKRAGVVVMGSTTYATLKRPLA
DRLNVVYSRKQTFEGAETTQDAPKDLLKKLEARGYSEVAICGGSHIYTMFLKAHCVDKIY
LTIEPKLFGVGINIFNETVNFELKLISSETTASGSLLVEYDVHYHGGKLAE
>AIA15919.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MGFIFITLLIDITGLGIIIPVFPKLIGQLTGGNISQVSQWGGILTVVYALIQFFCAPLIG
NLSDKYGRRPVLLTSLVGFGIDYLFMAFAPTIWWLFISRVIAGVTGASFTTASAYIADIS
TAENRAKNFGLIGAAFGLGFIIGPSLGGLLAHFGLRVPFFVAAGCCLLNALYGYFVLPES
LSKENRRQFEWKRANPVGSLTHLKKYPSVVGLMGSLVLVYIAAHSLQSTWTYINIERFNW
SEEKLGYSLGVVGIMTFLVQGILIRYINPKIGNEKSVYIGLSIYALGMLAFAFANQSWMM
FVFMIPYCLGGIAGPALQAILAGHVPKNEQGELQGALTSMMSLTSIIGPLVMTTLFAWFT
RPGASVHFSGAPFLLGSVLLMGSALIAYSVLKTEKQHIQKESEQFSFEKTEV
>AIA15839.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MPLGLSNRAVNMPASPIRKLVPLADEAKRRGVHIYHLNIGQPDIETPSCMLARLGTIEDR
VLAYTPSVGTPEFLAAMQHYYAAQGIPLDTKQIIATTGGSEALLFSFMACANPGDEAIVP
EPFYANYLAFAQMSGVKLVPLATSVENGFHLPPIEAWKAAITERTRFIVLCNPNNPTGTV
YEEHELRMVLELCREHSLYLVADEVYREFVYDGRRAMSALAFPEFSQHVIVADSLSKRYS
ACGIRLGVFVTRNLELYDAAYRMAQGRLSAPGIAQMIAAAATQLGPEYTDNVITEYQKRR
DVLYEGLSTIPGVFLRRPEGAFYFVARLPVADADAFARWLLTDFSHDGATVMVAPASGFY
ATPGGGKDMVRIAYVLNEHDLRKSVEILRLALAAYPARVEAALQAT
>AIA15822.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FPLLTLRKIPTKIFIAEQIWFTSGARKPDDFLRDYTRIWDDFTNPGDVVTVAYGYRWRKH
FGRDQLGKLVALLEKDPSSRHGVVVTWDPSADGLGGVSKGNVPCPYTFTVNIIGGRLNMM
NVVRSNDMILGFPHDVPGFALLQLMLAQRLGVKPGIYSHIIANAHVYDIHYDAAQEMISR
PTDHPKVVLELPENSFLRAEKKDHDLVEEINDVLVSQYQPAERIKGLKIVL
>AIA15807.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
GKPIIMGRKTFESIGKPLPGRETVVLTRSKYFRPEGAHVAGGWDEAVATAEALGSTMGAD
AIAVVGGAEIYALSLPHVQRIYLTRVETAPEGETRFPELPERAFRETRRAAHPPGTDDEH
PFVFIDLERT
>AIA15788.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MKVVIMAAVTLDGKIARDEAHFVDWTSREDKKLYYNFSKRAGVMIMGHNTYKTLPAPLPG
RLHVVLTTELAGKENKEGVVEFTDGSPEEIVAGLEARGYTEAMLAGGAQVNALFLKSNMV
DELWLTVEPLIFGAGIDLFRGVQFDLRGTLTYMERLNDSGSVHLRYSLK
>AIA15776.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
HFGRDQLGMLVNLLQKDPSSRHGVVVTWDPASDGLGGASKGNVPCPYSFTVNIIGGRLNM
MNVVRSNDMILGFPHDVAGFALLQLILAQKLGVKPGVYTHTIANAHVYDIHYDAAQMMID
RPAKQKKINLSLPEDAYDRAEKKDVALVEELNEQVQAQYEPGEPIKGLRIVL
>AIA15709.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MARISAIAAIVNNRGLGKDNELLVRIPEDLARFKKLTSGHAVIMGRKTYESIGKPLPNRT
NIVVTRDAKYEAEGCQIVFSVEEALDLARQLEPEEIFILGGGKIYTEMLPYTERLYLTVV
EKDAEADTFFPDYQEFTKELEREGKEHEGMKYSWVILER
>AIA15683.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MVRVAMIAGVAENGLIGVEGTIPWRIPSDMAFFKRTTMGKPIVMGRKQYESVGRPLPGRT
NLVVSRQPGYQPEGVIVINDLDAAIDHAIAIAEADRADEAMIIGGGEIYAAAMPRADRLY
ISHVALAPAGDVRFPVIDPAVWQLVEEPAVEPSP
>AIA15681.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MYNLKFAGFKVKRIFVKQVFIAVFIFLTVSSTVGFAQKAEFAKNIEAIAKEARGVVGVGI
MDLKSRETVVLNPSHKFPMQSVFKFPLAMAVLDQVDKGKFTLAQKIHVTKQDVSPKTWSP
LSKKYPNGEVDLTLAELLGYTVSMSDNNACDILFKLLGGPKNVEDYIRTLGVKDIAIVAT
EEEMSKHWDVQFTNWCRPAAMLQLLDVIYKGKKLSQTSNDFLLKVMTETTTGPNRIRGLL
PKDAKVAHKTGTSNTNEKGITAASNDVGIMTLPNGKQVAVVVFVSNAAADEKTRDAVIAK
ITKAAWDYYLK
>AIA15667.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
HKVVVETGINGREIECAVLGNDYPQASTCGEIVLNSEFYAYDTKYIDDNGAKVVVPAVID
ATVNDKIRQTAVDAYQALGCSGMARVDVFLTADNEVIINEINTLPGFTNISMYPKLWQAS
GLDYTSLITRLIELALERHQANVALKTTMNT
>AIA15624.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLAHVMEKGTNRGDRTGTGTRSVFGYQMRFDLSEGFPVLTTKKLHLRSIIHELL
WFLKGETNIAYLKENGVSIWDEWADEDGNLGPVYGAQWRSWPAPDGSHIDQIALLIEGLK
TNPNSRRHIVSAWNPALVDDMALPPCHCLFQFYVADGKLSCQLYQRSADIFLGVPFNIAS
YALLTLMVAQVTGLKPGDFVHTLGDTHIYSNHFEQAELQMKRTPKALPTMRLNPDVTSIF
DFKFEDFTLENYEADASIKAPIAV
>AIA15625.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTQPRITLIAAVSENGVIGRDLDMPWKLSTDLKRFKALTMGKPMIMGRKTFLSVGERPLP
GRPHIIISRNPDYRPQGVDVVSSLEDALSLAKEKAQALGVDEIFVAGGGEIYRQAMPFAD
QLSVTHVEVLLEGDTFFPAIDPAIFEKIDETPAPAGEKDNYPVRFATYRRYHAVQ
>AIA15620.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MAKFVMIVAASENGVIGDNNDLPWKRSLPRDMARFKRITQKIGTVLMGRKTAESLPKALP
KRRNLVLSRSGYERDGFETFSSLEAVAQAVGNSVVAVIGGGEIYSLCAPYATQAYLTRVG
AVCLGDTYLDVDAFKDYTLKGGLEQHPRDDKNAFPMTFMTLQNNAVQPLGAS
>AIA15597.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MTDNNAYASEFLKKSTLMFFPVFLIMYELVVNLSNDMYIPASTYLVDYFHTNAYYIQLTF
TSWFAGSMIVNPILGVLSDNLCRKKILLFSGLCFMAASLYCAVSADIYLFLLARFIQGVT
VTTIVICGYALVHDIYDDKRAIILISWMSGVLITAPMLGPLMGGYVIYFLNWQAIFVILA
FVAAVSLVGIKFVMPERQVISQEPINWGQELLTYVKILCHTEFMLLTMISAMLFGGIIAW
ITASPFLLIGKYDFTPVQFGLAQMPIFGSYIVGTFVLKFFLKLDIKETRIITIGIVVAAL
TSALMFLTRQTGISNVTHLLALVSLYSFVFGLISSPLNRVAVKAVDYGLGKTMAMFDFMI
GLSATVATILINVSAGDVLSLFYVTIGSFALLSCVFFTFNEVRSNVRKCR
>AIA15571.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKISIVAAITADGFIGRHAEHLVDWSSPEDKKFFTKITKEAGTIVMGSRTFSTINRALPG
RRSIVLTSHPETINASGVEATDEPLKELVERLTSEGATGLAVCGGATVYSQFMESGLVTD
MYLTIEPLLFGSGVPLFAGRLEVDMQLAEILKLNDNTILLHYRIPS
>AIA15552.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MMRRTPSLLVPLSAKMDGQDSDGLIRFRETVMVQKAVRMNEGRTRVEMVVSTIRQRIAGR
SLTPGARLPSVRGLAATLKLSTSTVVDAYERLVAEGAILARPGSGFYVANQAAPFARAET
GPKLDRAVDPFWISRQSLEADETDLKPGCGWLPPSWLPAEGMRRGLRTLARADGPALAEY
GSPLGLPPLRQLISRRMGERGIEASPDQIMLADSGTQAIDLLCRFLLEPGDTVLVDDPCY
FNFHALLRAHRAKIVSVPYTPSGPDIDLFAHVVAEHRPRLYITNSAIHNPTGATLSPVTA
HRLLKLADQFDLTIIEDDILTDFEYTPAPRLAAFDGLDRVIHIGSFS
>AIA15456.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
AVARNGVIGRNGGLPWRLPDDLKHFKELTMGHPILMGRRTFEEIKKPLPGRRNIVVSTTI
KEIPDVEVVRSLDDAMKLLSGTSGPVCVVGGAVLYAAALPVAHALELTELDDAFEGDTSF
PKFDKSQWRLVSDVRHEKDDRHATGFRFRRYERN
>AIA15433.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAKFDQIYQTLLQDIMTKGVREVNQRTGHETAALPGLAFSIGIEQDGFPLLTLRKIPTKI
FIAEQIWFTSGARKPDDFLRDYTRIWDDFTNPGDVVTVAYGYRWRKHFGRDQLGKLVALL
EKDPSSRHGVVVTWDPSADGLGGVSKGNVPCPYTFTVNIIGGRLNMMNVVRSNDMILGFP
HDVPGFALLQLMLAQRLGVKPGIYSHIIANAHVYDIHYDAAQEMISRPTDHPKVVLELPE
NSFLRAEKKDHDLVEEINDVLVSQYQPAERIKGLKIVL
>AIA15394.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MTTSKKSAMGFIFVTLLIDVMGWGLIIPVMADLIAELKHIPVNEASTYGALLLSVFAIMQ
FLFAPVVGNLSDKYGRRPILLLALLGFGIDYIILALAPTYGWLFLGRIIAGMTGASFTTA
SAYIADVSTDETRAKNFGLIGAAFGLGFVLGPALGGLLATFGIRAPFYAAAILCLLNVLY
GYFFLPESLDKEHRRPFEWKRANPFGSLKFLTRHPEIGELALCFFLIYLGAQSVQGNWNF
FTIYRFHWSEKMVGISLAVVGVLVGAVQAGLTRVVNPRIGDEKSIYLGLSLYTVGLILFA
FATQSWMMFLFLIPYCLGGICGPSLQSVIARHVPSNQQGELQGALTSLMSVTTIIGPLIM
NSTFAYFTSGKAPFHLPGVHFLIGAICMTISIMVAYKVLSRERRAATA
>AIA15387.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLEDIKKNGVLKPNRTGTDQIGVFGRQLRFDLSQGFPAMTTKKLFMRGIIHELI
WFLQGSTNIKYLVDNDVHIWDEWPYRHYLMEQGKAVPDSASAEWQTGIQEFTQKIKEDSK
FAKKWGELGPVYGYQWRNWPAPDGRHIDQIARAIDLIKNNPASRRIIVSAWNTADIDEMS
KAGIPPCHLLFQFYVADGKLSCQMYQRSADTFLGVPFNIASYSLLTMMMAQVTGLQPGDF
VHTFGDTHLYVNHLEQVDKQLSRQPRKLPTMKINPKVKSIDDFKFEDFELVGYDPHPGIK
APIAV
>AIA15346.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
TCDATTSAISMNKAYTKSIVNGIKGLHCARSIQLHKKDFHDIAAIGAALKFPLFVKPNNG
GSSVGMSKVYKITGLSEAINKAFKEDDQVLVEQFIEGREFSIGVARINGHIQVLPATEIK
STKDFFDYEAKYTPGASEEITPADIPDEKMGEIVEIVTQVYMRLNCRGMVRIDFILLGAT
SYFYFIEVNTTPGQSAASLIPQQVRAAGMNVGEFYGALIEGA
>AIA15337.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MAIDEQAPTQNRATGENFVSDRVNNVPPSGIRKFFDIVATMKDVISLGIGEPDFVSPEPI
LNAGIDSLKAGHTAYTSNSGILELRELLSKHIERLYKVHYDAEREILVTVGVSEALLLAF
MATLEPGSEVIVPEPCFVAYQPTVIFAGGVPVPVPTYVDQDFQVTVADLEMARTPRTRAI
LLGYPNNPTGAVLERSRLEEIAAWAVKNDLLVISDEIYDRLVYGIDHTCVSSLDGMWERT
ILLGGFSKSHAMTGWRIGYAAAPPAILAAMRKIHQYIIMSAPTTGQEAAIEALKSGEPFV
ESMRQEYDRRRRLIVDGFNRLGLRCFEPRGAFYAFPSIESTGLSDEEFCDRLLMEEKVAV
VPGSAFGMSGTGHVRASYATAYERIEEALVRIERFLNKLK
>AIA15287.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MKLGAFSVSLSVKDLPVSREFYENLGFTVFAGSMEQKYLIMKNDNALVGLFQGMFQGNIL
TFNPGWDENAHNLESFEDIRTIQHHLKSKGVSLLSEADESTTGPASIMLTDPDGNMILLD
QHY
>AIA15274.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
RKNFFGLVLGTFSLFIIASAAYGAQQSLRSNESVKPNNGIATFDPLIQKTTEKILSKYIK
KFDAKGGFVIIVDSRNGKVLASVNQRNQKNRAEKNWALSYRLEPASVMKGIVVASALEEK
VTTPNEELNCESGKYSYGGHLYQDWKPFKNLTTSEAIQKSSNICGIKIGQKLGSKKISDS
LKDFGFGNSGSTSEFPEAMAGQIPQPSQLSEPDYIALITTGYTGAPGFYVTPLEVVMAYA
AIANEGRLMKPILSSEPDSSVKFMKQVISPETSKQMKVILSDTVKKGTGTNAQSRLYTTA
GKTSTAFRPEPSENILVGGERGIAGFAGLAPVENSRLAVYVGIIDPMNTTKGDPHGNTHA
APVFREVIEKVLQQMNVSPDKSLSPE
>AIA15257.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
SKLKSFLRRRIEVFEIHQTPKRKNFFGLVLGTFSLFIIASAAYGAQQSLRSNESVKPNNG
IATFDPLIQKTTEKILSKYIKKFDAKGGFVIIVDSRNGKVLASVNQRNQKNRAEKNWALS
YRLEPASVMKGIVVASALEEKVTTPNEELNCESGKYSYGGHLYQDWKPFKNLTTSEAIQK
SSNICGIKIGQKLGSKKISDSLKDFGFGNSGSTSEFPEAMAGQIPQPSQLSEPDYIALIT
TGYTGAPGFYVTPLEVVMAYAAIANEGRLMKPILSSEPDSSVKFMKQVISPETSKQMKVI
LSDTVKKGTGTNAQSRLYTTAGKTSTAFRPEPSENILVGGERGIAGFAGLAPVENSRLAV
YVGIIDPMNTTKGDPHGNTHAAPVFREVIEKVLQQMNVSPDKSLSPE
>AIA15248.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target alteration|1
MPKMNFSVVVAATSNTFGIGRKGTLPWKIAEDMEFFKTITSTASSGKINAVIMGRKTYES
IPAKFKPLSGRTNVILSRNPELRNVLNLPESVHVKSNLSDALNLLKEDQAIDRIFVIGGE
SVYREALESKFCSKIYLTEVNTDIPDIDTFFPVIRANVFRMTQRGEEKSNGELKYRFTEY
EQIQPSSTFTTPTEPVLSPNPEEQQYLSLIKDIIDNGVLRGDRTGTGTISKFGVQMRFNL
RDNTLPLLTTKRVFWRGVAEELIWFVQGRTNSNELHDKGINIWDGNGSREFLDSRGLSHR
VVGDLGPVYGFQWRHFGAEVSLP
>AIA15243.1|FEATURES|farme|aminoglycoside|PSEEN3982|antibiotic inactivation|0
MAIELVRAMPEHIPQMARITYEAFKGIADAHNFPTDIPDVNVASMFIEMLVTRPDFYGVA
AVEDGVVLGHNFVQISDPVAAVGPICVEPNRQAKGVGRHLMQHIVEWSLKNHGPMVRLLQ
EGYNMRSLSLYAALGFVVREPVVLMEVIPASKPDSTTRALTAADLDACDALCQKVQKASR
KNELAAAIQFGPAMGCVPFGRFVGGPLKAFIVPGFFGFSAAVSDDELLDVMQEAARLSPP
PLHRTLMPTRQGTLFPAAMRRGFRSIKPFNTMSIGPYETPRGAWTPSIGY
>AIA15239.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTAIVLVAAMDRMRAIGRDNGLPWHLPDDFRYFKAVTMGKPILMGRKTAESLGRALPGRR
NLVMTRRGRVPFEGMRAVASVDEALRAADDDGATELCVIGGAEIYALTLPRADVLHVTHV
DTVVQGADVFFPAFDADAWRVVSRERHEADAKHAYGFEFVEYRR
>AIA15223.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MGMLVKMLQKDPSSRHGVVITWDPSSDGLGGASKANVPCPYTFTVNIMGGRLNMMNVVRS
NDVILGLPHDVAGFCLLQLILAQKLGVRPGVYTHVIANAHVYDIHYDAAKEMISRPADHP
KVTLQLPDGTFGRAEAKDIGLVDDINGSLLAQYRPGEAIKGLRIVL
>AIA15224.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVILIAALSADGFIARNTDELADWTGSEDKKLFVELTKRAGVMVMGRTTFETIGRALPG
RQTIVYSHRPLEIPGVTVTDESPTDLVQRLAATGQQELAICGGAAVYTQFMQAGVVDELY
LTVVPCLFGGGVTLFSQPLESSLRLLETRSLSDDVITLHYEVQK
>AIA15205.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
HLEVAAMTKSLPLSLIAALGENRVIGVDNSMPWHLPGDFKYFKATTLGKPIIMGRKTWDS
LGRPLPGRLNIVVSRQPDLQLEGAEVYPSLEAAVARAEEWAKAQGVDELMLIGGAQLYAQ
GLAQADRLYLTRVALSPQGDAWFPEFDLNEWKLVSNVENPAVEDKPAYNFEVWEKKQL
>AIA15197.1|FEATURES|NCBI|tetracycline|tet41|antibiotic efflux|1
MNKALVVILAAVMLDAVGIGLIFPILPALLRDVGHTSDISVLLGIMLALYSACQFLFSPI
LGVLSDRFGRRPVLLVSLAGAAVDYLIMALAPHLWMLVIGRAIAGVTSANMAVATAYITD
ITTEEERAQRFGLFHAMFGVGFIIGPVIGGILGDWWLHAPFLAAAMLNGVNFALALFVLP
ESRKGQADTRFAWTVS
>AIA15155.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKASIVAYDHNRTIGDHGEIPWQGKMRGDAHYFRDMTSGHPVIMGRGTYEAMGRLLPNRQ
NIIVTRKEGYTAEGCDVVHSLDEALTVAESNPEVFIIGGGEIYQLAMPKADRIYLTRVHA
RPEGDVFFTYDVAEWIETSREDYPADETNQYPYSFINLTRRK
>AIA15140.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MKHFKAIAAMSLNRVIGQGNKIPWHLPEDFKWFKKMTTGQVVVMGRKTFESIGKPLPNRE
TVILSRSNFAHPGVRTISDLNDLDLRNETRDVFICGGAQIYAQTLPLCSDLYLTLVKRTV
EGGDAFFPPFEDRFELAAELADNSDFKILHYRSACQH
>AIA15117.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MAAVTADGYIGKSANHLADWTSPEDKKLFVRLTKQAGVMVMGAGTFETIGRALPGRRTIV
YTHHPERVTAAGVETTTEPPAELVKRLRAEGAPGLAICGGAGIYSQFLEAGAVDELHLTV
EPILFGEGIKLLNQSTETTMSLIHFEPLGEHTIYLHYVLN
>AIA15116.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKLSIIVAVAENNVIGKDNQLIWRLPADLKHLKALTMGHPMVMGRKTFDSIGKPLPGRTS
IIITRQPNYTVEGCLVVHSLEQAIIEAGNLRTEEAFIVGGAEVYRQSMSITDKIYLTEVH
HSFDGDTFFPKIDPTIWKEVKRESFPADEKNAYDFDFVELENTLARHTKM
>AIA15109.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVVLIAAITVDGFIGKTADHLADWTGGADKKLFVQVTKEAGAIVMGSTTFATIGRALPG
RRMIVYTTKPKKITAGGVETTNEPPAKLIARLTKEGAHGLAVCGGATIYTQFMAAGVVDE
LYITVAPTVFGTGIPLFTTNEDIAQNLELIEQSLLDENTILLHYKTI
>AIA15107.1|FEATURES|farme|tetracycline|otrA|antibiotic inactivation|0
MFTRVVPDIAKTYGLDVRAIGNVQKGYRNESYKLTLADDKLVNLICFKREHGIVDRIARA
DAVSSHAAAAGLPVRIRYDERILKLQENSYAGIYEYLPGVTVAWEAYTKKHLKLLGWAMS
DLHTALQTMGADSPHLLADELASLNARMRRYFSDDNVVRALREKLSITLSFDVFDTFEAL
IVHSGRLDGKQYVHMDMVRGNVLFGGADTSDRWQLDDIALTGIIDFEKTAYGLPVCDVAR
TLAFLLVDCPKTRSDILNYFLNSGYRKRGTAKLENRELIAPFVRFFLVHDFYKFLRHTPY
ESLENNHHYVRTRDILLEYGMISITDK
>AIA15038.1|FEATURES|farme|beta_lactam|LRA-3|antibiotic inactivation|1
MSDTDQKMRIFMRSKLLLAAALLALSASVPLQAATPQRIHPPITNKEWETPFPGFKIVGN
MYYVGTYDLGCYLIDTGQGLILINSGAPGSYPLIKANIEKLGFKTSDIKIITSTHGHWDH
VGDLASFEKDAPNAKMYMSERDAPVLESGGNLDYRRAEGRGIIYDPVRVDVKTKPGDHIK
LGNVDMTVHAAYGHTPGATSFTFTQQDGGKTYNVLIVNMDGINAGVKLLGSPGYPTIVED
FANTLKDQATYKPDIWVSSHSGQFNLHTVYHPGDAYNPSRFGDLAAYQKKIADYQKAYEK
QLTEERAAKKS
>AIA15030.1|FEATURES|farme|fosfomycin|fosB|antibiotic target alteration|0
SRLIENAAALVNDKRIEGISEIRDESDRDGMRIVFELKRGEQADVILNNLFKHTQLQISF
GIINLSIVNGQPRELGLISTIKYFIEHRIDVVRRRTDYELRKAREREHILLGFRVALDNI
DEVIRLIRAAKSPKEARDSLVAASTKFTFNEVYLKAAGAAEPMRQLSERQAQAIIELQLQ
RLTGMEQEKIANELADIQRRIAEYLEILGSEKVLRDLIVKELKEVQKDHADERRTKIIED
PGDIRLEDLVAVEDMAVTVTHGGYLKRTAVDTYRRQTRGGKGRIGMGTRNEDFVEYFLVA
STHNYLLIFTNKGRVYWLKIYEIPDASTSGKGKHISNLINLQPDETVKAFLPVREFVPDR
YIVMVTKLGVIKKSELSEFDNPLSRGIIGATN
>AIA15023.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
PADSIVRDYAGFRTLDSVVRAKIVFGLSGCTIVSEEFHCPRALWIAQRHGLKAVAFAAPD
LKSRRWTWRVKAREHLARVACALDLYVLGRNPKFSGPKEPIVLSSIAPWNFKALAAMSEN
RVIGNGNKIPWHLPEDFKWFKKMTTGQFVVMGRKTFESIGRPLPNRTTLILSRSSFQFPG
VQTIADLDEIERAVPDLADRQVFICGGAQIYEQTLPLCSDLYLTLVKRVVEGDAFFPPFE
DQFTLKEEILDCPDFKILHYQNKKIFSGKDAKLQSS
>AIA15014.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSEIVLVVAAAENGVIGKDGAIPWRIADDMKRFKELTMGHAVVMGRKTWDSLPKKPLPGR
VNIVVTRQKDWRAEGALTASSLEVALENASGEIMVIGGGEIYAAALPLATRIELTEVHRE
FDGDAKFLFDRKGWQESARETHFTSDGLRYSYVTLER
>AIA15002.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKAIVVAMDKNNGIGAENDLLWQRDLPADLAHFKKLTVGKSVVMGRKTFESIGRPLPDRQ
NIVVSRSGPTGIEKVQTAYSLEAAYALAQYDIMVIGGGQIYAEALDDVDVLYVTYVDAEF
PQATVFFPQINCEDWQEVERDHHEADEKNKYSFDFVKYERID
>AIA14946.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MTATQTKLTLNKQTRIAVLYGGLSSEREVSLTSGKGCHDALKRLGYENAVLVDVGHDIAR
KLVDEKIEVAYIALHGKYGEDGCIQGLLELMGVPYTGCRVAASALTMNKALTKSVLKDAG
LPVIDSVVLKAGTVNGKAVRYRAELPGDGQTHQRGLQHRHEQGGQGRGPERGPHHGL
>AIA14893.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MVAGKKAGDMAIFSIRRARCGDENLVLTLLRELAEYEKLLDRFHITEEIVRRDYLGERPL
LNCDLAFDGDAPAGIATCIWTYHSFAARRGIFLEDLFVRPQTRGKGYGKALLSQLARNAA
GGSWRTSGVGSAGLESAFHRFLRKHRRETARRLAHISPGERGAREDGVVSAVVSFVLARA
GNGVIGANNAIPWRIPEDMKRFKAITMGKPIIMGRKTWDSFPKKPLPGRTNIVITRDANW
RADGAVAVHSLDEALKRAESEKPDEIAVIGGAEIYKLAFPYPRRIHLTEVHADVAGDATM
PAFDPALWRETAREDHVTADGLRYSYVTLDRR
>AIA14892.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
GHTVILGRKTYESMDGYYNASGRQMPGAMYIVVSRNADFEPARDNATVVHSIDEALAKAK
ALGDEQIFVIGGGAIFEAMLPYTDRIYLTVVQTEAGGDAYFPKLVDSQWRELSVENHTKD
EKNDHDYDMVVLERV
>AIA14889.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSISIIVAVSDNGVIGNNNQLLWRLPDDLKRFKQLTLNHPIIMGRKTFESIGKPLPGRTS
IVVTRNPEFNFEGVITVHSLHEAINEAKKIDQEIFIIGGGELYKQAQELTDKLFVTEVKT
EIEGDTHFKITDPEGWVETERIVHEADERHVCKFEFVNYIKKGY
>AIA14877.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNQYHDLLERILSDGAEKHDRTGTGTLSIFGHQMRFNLAAGFPLLTTKKLSLKSIVHELL
WFLKGDTNIRYLQENGVSIWDEWADANGDLGPVYGSQWRSWPAPDGRSIDQISNVIDMIR
RNPDSRRLIVSAWNPADVDRMALPPCHCLFQFYVANGKLSCQLYQRSADVFLGVPFNIAS
YALLTMMVAQVTGLKPGDFVHSLGDAHLYTNHLDQARLQLTRPTRALPIMKITPAVKDIF
AFRYEDFVLEGYDPHPHIKAQVAV
>AIA14878.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSLTIRRARHDEAGLVFSLIRELAEYEKLLHEVEASETDIHDALFGDQPRLFCEIAEWEG
DPAGVAVWFNTFSTFTGRPGIYLEDLFVRPALRGKGIGKALLAHLAKQCVANGWRRLQWA
VLDWNTPSIEFYKSQGAELVDDWTMCLVHGPALTALAQGKQ
>AIA14873.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MINMVVAAAQNGTIGINNDLPWHISSDLKHFKQLTTGKPVIMGTNTYNSIYNRLKGPLPN
RRNIVVSRQSTSLPAGFELAHSINEALALLGGSDASLIGGAQLFKSFLDQDLIDRIYLTE
VKADVKGDVYLPPLKQSDWQEVDRQPQRDGQWQYDFVTLERKQ
>AIA14832.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MIVFAAGCLERIVWPTIKTIKKLSWIHLEMPRSRYKSLVDTFATDIRCGRLPPGTRLPTH
RQLAESEGLALVTASRVYAELEAMGLVSGETGRGTFVRETSLPPGHGVDQPEVAAGVMDL
NFNYPSLPGQADLLRNALRQLALSGDLESHLRYQPHGGRLHERASVASHLRTRGLSVEAG
QVLIVSGAQHGLAVTMMALLKPGDVIAADALTYSGFKVLAQALHLEIVPIPVTETGPDLD
ALDTLCRRRSVRAVYTMPTLHNPLGWVMDAAWRNQLVSIARAHDLLIIEDAAYAFLATDP
PPPV
>AIA14828.1|FEATURES|farme|beta_lactam|OXA-18|antibiotic inactivation|1
MTIKRRIGFVIYSVFTMSCFGSFGVHAAETVQCTVILDAKTGEALHRNGECDKAFAPQSS
FKLPLAIMGYDAGILTNETTPRWDYKAEWKRPKREQQPTDPTIWERDSIVWYSQEVTRRL
GKEKFADYVRRFDYGNADVRGVKGQTDGPTESWLMSSLKISGDQQVDFCAAS
>AIA14769.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MKLTITLSHVVACTENGVIGRDGGMPWHLPDELKRFKATTMGKVLIMGRKTFESIGRPLP
GRYTIVVSRSREMLPRIVTPATSLEEAMTHAREMAPGWLNEICVVGGGEIYRQTLAMVDK
IYLTRIHQEIDGDTTYPLEGLKDFECIQSEEVTASAIPYAATIWVRRKAE
>AIA14747.1|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|1
MANNRYVIEVKNLTKSYGSNNVLKGIDLKVERGTMLALLGPNGAGKTTTVRILSTLLSFD
DGEVLVDGHNVKTEADRVRESIGLTGQSAAIDELLTGRENLVMMGRLYRLTPESAKARAQ
ELLEEFNLLDAAERPAKTYSGGMRRHFNLAVDSLIPEYCHQRPVWIVAA
>AIA14740.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAVKLEFDQRPKAVLALNDSLIMIKRSGTHIIRNTDQLLGTFFQPIMFLVLFASVFGGAI
SKALPEGVSYLNFLMAGIIVQTAAFGSTTTALAVCNDLQKGIVDRFRSLPMSTLAVLNGH
VVSDLFRNSISTIVMILAGLVIGFRPHASVTEWLLLASILLLFTLAFSWLSAILGIVAKS
VEGVQWLGFVLVFPLTFASTAFVPAEGMNSVLKAFAVNQPITHIVEALRALILGKPLGDH
GWLAIVWSVAILVIAVPLATIMFKRKTAN
>AIA14741.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
NLVDAAERPAKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRIAMWEIIKRLMA
NGTTILLTTQYLEEADQLADRIVVIDGGKVIAEGTANELKSKVGNDRLELTFKTEKERTE
AGKVLGKTVVSTDEKENSVTVVIKDTNTDVKDALEALAKKRILVQSMAIHKPTLDDVFLS
LTGKQKQPSTEGEEA
>AIA14686.1|FEATURES|farme|tetracycline|tetJ|antibiotic efflux|0
MLQKEKTMPAGQNYRPGPWLLVLGIILIASNLRAPITSVGPVVKNIRQDTGLTNTLTGLL
TTLPLLAFAFISPFAPRLARRFGMEKTLLGGLVVLGSGILLRAIPSEAALFSGTILVGMG
IAIGNVLLPGFVKSEFPHQAGIMTGVFIVCMGVGAALGAGLSNPLAAGLGWRGMLAGWAV
LSVIAIVVWLPTLKFSKRAPGVRADSLIPVSPGGNLWRSGLAWQITLFMGLQSLIFYVIV
AWLPEMLTNWGMDTATAGWMLSLFQLVGLPASFIMPVLAGRSHSQRWLVIITALAMFTGY
TGLLLFNTTLLPLWILLGGFGSGATISLALTFFVMRAHNTHQTAELSGMAQSVGYLMAAV
GPTLFGFIHDQTGGWSITLFLLIVFTILFLLVGLRAGSPGFVSEAPAPPAD
>AIA14685.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MAIEEAAKTPTKSDGASYVSERVNNVPPSGIRKFFDIVATMKDVISLGIGEPDFVTPAPI
LEAGIESLRAGHTAYTSNSGILQLRQLISKQLDRLYAVQYDADTELLVTVGVSEALLLAL
MATCEPGSEVIVPEPCFVAYQPTVTFAGGVPVAVPTYASQDFQVTVEDLEKARTPRTRAI
LLGYPNNPTGAVLDRSRLAEIAEWAAANNLLVISDEIYDRLYGTEHTCFSSLPGMQDRTI
LLGGFSKSHAMTGWRIGYAAAPAAILAAMRKVHQYIIMSAPTTGQEAAIEALKSGEPYVE
AMREEYDKRRRTIVDGFNRLGLTCFEPRGAFYAFPNIESTGLTDEEFSERLLHEEKVAVV
PGSAFGKSGMGHVRASYATSLPNIEEALNRMESFLGKLKK
>AIA14681.1|FEATURES|farme|beta_lactam|XM57_27510|antibiotic inactivation|1
MISRRQLLQAASIGLAGFGVIGRAGFVRAAAMSQEQFATELQRLERDSGGRLGVVLLDTA
TGKRAGHRMDERFPMCSTFKVLAASAILHNVDAGKESLERRVYFNETDLVTYSPETKKHV
GPSGMTIAELCKAAITLSDNTAGNLLLASIGGPKGFTDFARSLGDKMTRLDRIETALNEA
LPDDPRDTTTPNAMASDLQSLVLGKTLSAKSRAQLVEWLAANTTGGKRLRAGLPTGWHVG
DKTGTGDRGTANDIAVIWPTGRAPVIVTVYLTGATASADQQSAVIAGVGRAVGAVLT
>AIA14680.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
LTRGHPVIMGRKTAKDHLVAHYTKGPLPGRVNIVITKDKNFKLEGFVVVHSVEEAIEEAK
KAPGFDEAFVIGGSEIFSLVMPYADRLYLTKINAEAKDADTFFPDYSIFKKIVHEEDGEE
NGIKYKFIDLEK
>AIA14678.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
RLQSDPLLKDDKMNAQIIKAAVVLGLLSVIGPLAIDMYLPALPAIGADLGADVAQVQLTL
MAYMAAIAVCQLLYGPLSDMYGRKPPIYFGIGLYVVASLGAAWAPSIEWLTVFRFLQGVG
ACASMSLPRAIVRDGYTGAQAAQLMSLLMLVFSISPILAPLSGSIVLQFGDWRVMFYVMA
VVGVLSLLLLVFGLKETRPKEARLESSLRGALSAYWKLLRDWRFIGLSLIGAFGMASFMA
FLGNSSFVYIEHYGLTPTLYSLAFSVNAVSFFAVSQATGFLVGRFGLPRVVRVAVTGYVT
AMLALLALFLAGFDSIWVLATLMFVAFGFLGLVLPSTGVLAMEEQGEIAGSASALMGTIQ
MVIASVVMGIVGAFTDGTARPMVVAFAACAVAALVITLVTLRGSSRRNIAGAMAAPAE
>AIA14655.1|FEATURES|farme|multidrug|sav1866|antibiotic inactivation|0
MATVPPSGIRRFFDIAATMKDVISLGVGEPDFTTPDNIRQAGIQSIKEGMTRYTSNAGIL
ELRELLAQHLQRLYGVTYDPLKEILVTVGVSEALQVACIATLNPGDEVIIPEPSFVAYAP
SVIFAGAIPVSVATHMEQEFAPAIADIEAAITPRTRALLLGYPNNPTGAVLTLEL
>AIA14627.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKVILIAALSADGFIAKSSDHFSDWTSTEDKKLFVELTKKAGVILLGRKTYDTIGRALPG
RLNIVYSSKPIDNAEIETTQEPPGQLIKRLEEQGYEQLAVCGGQSIYDLFLSNNLADELY
ITIEPKLFGKGITLAKSMADTDLRLIDYKKLNDDTLN
>AIA14570.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|1
MDHNWKKNIILFLSGQTISLFGTALVQYAIMWHITLTTQSGVMMTISIVCGFLPTFFLSP
FAGVWADRYNRKKLIILSDSFIALSTLILAILFMNGYNALWLLFLISAIRALGTAVQTPA
VGAILPLLVPEDKLTKVNGVNGSIQALVMLTAPMLSAALLTMASIDVIFLIDVVTAAIAV
AVLLLFVRVKTHAKAAEQQTTSYFADMRKGFDYVKEHSYVKKFFVFMTFFMLLVAPAAFL
TPLQVTRTFGEDVWRLTAIEIAFSIGMMLGGALIASWGGFSNKIHTMTLSCLIFGLCTVA
LGVVPNFWIYIAFMGLAGVSMPLFNTPATVLLQEKVEVDYMGRVFGVMGMISSVTMPMGM
LVFGPLADVVDIEWLLIVSGALLFIQAFFLLGNKSLVEAGKPVAKPETEGGV
>AIA14511.1|FEATURES|farme|chloramphenicol|cmx|antibiotic efflux|1
MPVALYMLAVAVFAQATSEFMLAGLVPEIAAELAISTAAAGSLTSAFAVGMIVGAPGMAV
VCRRFPPRAALLVFLTVFVAVHIVGALTPSFTVLFATRVISALANAGFLAVALAVAVRMV
PAERTGRATALLLAGTTLACIVGVPAGALLGQAWGWRSAFWAVALISLPAIIGVVLGVPA
TAGRHRVGGVAGELGVLRRPNLSLTLLVGALVNGATFCSFTYLAPVLTERSGLDPSWVPI
GLALFGIGSFVGVTAAGRLADHHPGSVIVVGGIMLVLGWTIFALTAVHPTAALIAIGVQG
ALSFAVGSTVIARALVMAADAPTLGGSYATASFNVGAAVGPALGGLALDVTESAQTPIWI
SAALGAAGLLTAACAASASRRDSAVGVRSL
>AIA14492.1|FEATURES|farme|tetracycline|tet(30)|antibiotic efflux|1
MNKALIVILATVTIDAIGGGLIFPILPGLLAEVAGSGDIAWLFGAMLAAYAIMQFVASPV
LGALSDRFGRRPVLLLSLAGTLVDYLVMAFAPYGWVLVVGRTLAGITSANMAVASAYITD
ITPEDQRAQRFGLVGAVMSTGFIIGPIIGGVMGAWWLRSPFLVAAVFNGLNLALALFVLP
ESRKAAAGKFALKELNPLAPLVWLWNFKPLLPLVVVSVVFGLIAAIPGTIWAFYGAEKFG
WDSLHLGLSLSVFGISGALAQGLLVGPLSRRFGDLGTLMIGIGFDTVAYTLMGFADQSWM
GYAVAPLFALGGVAMPALNSLLTRRVGEDQQGQLQGVMASLMSLAGIVGPVLTTALYFST
KNVWIGTVWLVGAGLYLLATPLFATVRSPKAVAA
>AIA14493.1|FEATURES|farme|tetracycline|tet(30)|antibiotic efflux|1
MNKALVVILTAVMLDSIGIGLIFPILPALLRDVGHLSEVATLLGIMLALYSACQFLFSPI
LGVLSDRFGRRPVLLLSLAGAAIDYLIMAFAPELWMLVLGRAVSGITSANMAVATAYITD
ISTEEERARRFGLFHAMFGIGFIIGPVLGGVLGDIWVRAPFIAAAVLNATNLALALFVLP
ESRPGVKGARFDLDTLNPFKPLKWALTFKALIPLMAIFVIMNFVGTMYGTMWALFGEDAF
AWNGMMIGLSLGAFGVFHAGAQAFLTGPAVARLGERWALVVGMACEITALICMGIATQGW
VLFALAPLFALGGIGMPALQSLVTTQVGPDKQGQLQGVLASLVSLAAVFGPLFFSFAYFS
LRGTWT
>AIA14478.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MADIAQQRRQDRKDQADPNRIEGHGGENDDIAWLFGAMLAAYAIMQFVASPILGVLSDRF
GRRPVLLLSLAGAAIDYLIMAFAPELWMLVLGRAVSGITSACSMPCSALASSLGLCSVAC
WAISGCERHLLPRPCSTPSISPWRFSCCQNRGPA
>AIA14457.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
ETRPVEDRVGSSFGTALSAYRFLMGDRNFLGLTAIAGFAISSFFVYLSSSSFILIDHYGL
SPSIYSLFFSINAVAFIGMSQLTGTLSERFGLRRVVRVAVAGYATTMVVLVAVMATGVDR
LDVLAALLFVGYGFVGLVIPTTSVLAMEEHGSIAGTASALMGTLQFAI
>AIA14456.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
DFVRALADYEKLSHEVLATEADITRDFFGPDPKVYAQIAEWEGKPVGFALWFYTYSTFQG
RYGIWLEDLYVDPALRGKGIGKALLQHLAQRCVSEGLGRFEWWVLDWNEPSIAFYKSQGG
VMQDEWTKVRVEGEGLLKLGRSG
>AIA14454.1|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|1
KNGSGGNVAKTEYAIVAKDLHKSYGKNEVLKGVNLQVERGTMLALLGPNGAGKTTTVRIL
STLLRADSGNVTVGGFDVHSAADDVRSVIGLTGQSAAVDELLTGYENLEMMGRLYHLPKS
VAVQRANDLLEQFDLVKASKRTVKTYSGGMRRRLDLAVSLIATPPIIFLMSQLPALTPDP
AWPCGKSLRN
>AIA14440.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTISTIAAVARNGVIGAHNSIPWRLPSDFAFFKRTTMGKPVVMGRKTFESIGKPLAGRIN
IVVTRQQGYQPEGVLVFSSLMAAIEHARTMAAADGHDEVFIGGGAEIYREAMPLADRLYI
THVDLAPEGETRFPEIDADIWKAVAEVDVPLTGKDSATFRTVIYERRQPRAH
>AIA14389.1|FEATURES|farme|beta_lactam|ATN06_17210|antibiotic inactivation|1
MKTLLILCISLLSWASALAQSPTIQVSKLEENFYVHTSYNTYQGQLVPSNGMIVNTPKGV
ILIDTAWGDEQTQQLLAWIKKELRRKVILVIVTHAHSDRMGGIRTITKEKIRIVSTPFIR
ERAGQINENYGEYRPEPALSSDTTLTFGSLKTRVFYPGKGHAPENVVVWFPAQKILFGGC
FIKSVASTNLGNLSDADIPEWKLSLHRTEEKFPKPNIVIPGHGDPGGPELLTRTRELLDI
GK
>AIA14370.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MPPKIALIAAVARNGVIGRDGDMPWRIPSDFAWFKRATMGKPMGMGRKQFETFPKPLPGR
PHIVVTRQPQYQVEDPEVLVRHNLQEALAAGRRLAEASHLDEVMVIGGGDIYAQAMPVAD
RLYITHVDLEPEGDVRFPPINPEEWRPSDIIDNPPAASDAASYIIRVYERVEPGAH
>AIA14361.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIVSLIAARSQNGVIGKNNDLPWRLPDDSKYFMVTTRGHHAIMGRKNYDSLPEVFKPLPN
RTNIVVTRQPEFHAPGCIVVHSLEHALRIARENGESEAFVIGGAEIYALAMSQANRLYLT
EIDAVVEGDTYFPSFDKTQWRELSRRHHEVDEKHEYAFDYVIYERLP
>AIA14350.1|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
TFPFFFMPEVPAFASARNGYQAAGDTVIGNDVWIGSEAIIMPGVHVGDGAVIGTRALVTR
DVEPYAVVGGNPAKIIRKRFDDADIAMLLETKWWEWDDSELREVMPILSSGNIKALHEHW
QKVK
>AIA14332.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
EVIARDYFGAQPLLNCDLAFEGDTPVGCATWYWTYHSFAAQRGVYLEDLFVRPQTRGKGY
GKALLSHLARTAADIGGAQVEWEVLPWNTPSIDFYESIGAKRLSDWYVYNLSGDALKKMG
S
>AIA14333.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSAIVSFVLARADNGVIGVGNAMPWRIPEDLKYFKATTMGKPIVMGRKTWDSFPKKPLPG
RTNIVITRDPDWRAEGAVVTHALDEALAKAQSENPEEIAIIGGAEIYKLALPLATRIYLT
EVHMDAVGDVSMPAFDSAHWRETAREDHVTADNLRYSYVTLERR
>AIA14329.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
FIARQPRYVAHLRYMIAMVVATDKNRVIGRENKIPWRLKDDLVLLRNLTQNHAVILGRKT
YDSMLWYYEKSGKPMPGKMYVIVTRDAAYMPVRENAVVAHSIEEALQVARTFDEQIFVNG
GASIYEALLPYAERIYLTEVQAQAAGDVYFPSLDAQAWQEVSREHHVKGDRNEYDFDVVV
LDKIAS
>AIA14294.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKSQAKHPEYQYLDLLQEILDNGIRKVDRGTDVVLYSLFGRQTRYDLSQGFPLLTTKKVY
WKGVLHELYWFMSGNSNIKYLVDNNVHIWDDYPYKIYNWKREKTKLPELTKDEFVEKIAT
NAPFAKKWGELPKIYGEQWRRWPTRTPKRTVDQLGWVLQELKDDPDAKNLIVNSWNPEYL
YTMATYEDASRFPICHNMYQISNRNGKLSLQLYQRSADMFLGVPFNIASYALLTIILAKL
TGLEPGEFVHTFGDVHIYENHIDQVKEQLKRKPKPFPTVSIDKSVKTLDQFRPEHVTLEN
YDPHPMLKGELTVAGGFYEDKKKKAKKK
>AIA14290.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSEIVLVVAIADNGVIGKDGAIPWHISEDLKRFKAMTLGHTIVMGRKTWDSLPKKPLPGR
VNVVVTRQKDWQADGAVTASSLGQATCGTSGTVMVIGGAEIYERALPLASRIELTEVHRA
FEGDARFDLDRSGWTETARERHVTPDGLRYSYVTLVRS
>AIA14241.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPWGMSLKSDLRRFKNLTTGHAVIMGRVTFETIGRPLPHRRNIVLTRGDFRADGCDVVHS
LEEALAVACGDCFVIGGAEIYRQALPLADTVFETVVEAEFVGDRYFGPLGSEWVLSESSH
LYPDEDSPYGLRFLTWRKEVAHD
>AIA14234.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MTKSRISQKVSSIPPSGIRRFFDIAATMKDVISLGIGEPDFTTPKHITQAGIDSLVQGDT
HYTSNSGTIELRTAVADKLFEMYGVRYDPETEVLITVGVSEAMQCAMLAVVDPGDEVLVV
EPCFVAYKPSVVLAGGTAVVVPTRVEDDFQVTAAEIEKYITPQTKMLFIGYPNNPTGAVM
TKQRLQEIAALAEKYDLLVMSDEIYDRLVYGIDHTNFASLPNMRDRTILMGGFSKSYAMT
GWRVGYVCANPEILGAIRKVHQYAIMSAPTTAQHAALQALKHGEQDVKDMVNEYDLRRQT
ILAGLNTIGLPTFEPRGAFYVFPDVRPSGMTSADFSERLLMEQHVAAVPGDAFGESGTGF
VRMSYCNSMENIEEALERIERLVKNK
>AIA14198.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVFIIAALTADGLIARDSHHLAVSWTSKADKKHFVRLSKEAGHMVMGANQYATINRGLP
GRQTYVYSTDPISAEGVEVVTEEPAQLGARLAGQGEEQLAICGGAMIYDMFIHAGVVDEL
YLTIEPVIFGQGVKFFNENLNLKLS
>AIA14193.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GFPLLTTKKVLWTGVVRELLWFLRGSTNIRDDLSQHTPIWDAWADEEGELGPIYGHQWRR
WGAPFKQHARDKHELVGVREGVGIDQLQQAIDLIRKDPNSRRNIVSAWNVADIPHMALPP
CHAFFQFYVSNGRLDLQLYQRSADIGLGVPFNIASYALLLMIVAQETGLTPGVFVHTLGD
AHIYLNHIEGLKLQLTREPKPLPSVRIANKPMAELQFEDIQLIDYQHHPFIKLEVSV
>AIA14141.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MSEPTMPPNLTLIVAATPKNGIGKNGALPWPMLKKEMAYFARVTKRVPKPASSPNSASPS
NDDEPPAKLQNAVLMGRKTWDSIPPRFRPLKDRTNIVISSQPRSALPGLTDEVIVSSSIL
SALQDLEAGVKEGKVPGVGRVFVIGGARVYEGALGLECARSVLLTRLGKEFECDTFFPDL
GESGE
>AIA14112.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSTDLKRFRELTMGHHIIVGRKTFESIIVGRKTFES
IGRPLPGRVMIIITRNESTAFEGCFIARSIEEAVSLARERGESELFICGGAEIYAQTLDR
>AIA14101.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MATNRKAAIGFIFITLLIDVMGWGLIIPVMPELIAKLKGISVNEASSYGAWLISVYALVQ
FVCAPLIGNLSDRYGRRPVILFSLFGFGIDYLFLALAPTYGLLFIGRIIAGMTGASFTTA
AAYIADISTAETRAKNFGMIGAAFGLGFIIGPALGGLLAGWGTRAPFYAAAILCLLNCLY
GYFVLPESLSKENRRKFEWKRANPFGSLQLFKRYPTIGGLAFSFFLIYLAAQAVQGNWNF
FTIYRFGWNEKMVGISLAVVGLLVGVVQGVLTGFTTKKLGNERSVYLGLLLYSLGLVLFA
FATEGWMMFVFLIPYCLGGVAGPALQSILAGHVPPTEQGELQGALTSLMSLTTIIGPLIM
NNLFYFFTKDNAPVHFPGVSFLLGGIFMLLSTLVAWRVLSREKKTHPELLNVIEGSTEST
PGMH
>AIA14019.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MNAQLIRAAIILGLLSVVGPLAIDMYLPALPAIAADLGAPDARIQQSLMAFLAAFAIGQL
VYGPLSDMFGRKPPLYFGLGLFVLASVGSALAPNAEVLIVFRFLQGLGACASMSLPRAIV
RDNYTGAPAAQLMSLIMLVFSVSPILAPLSGSLVIAFADWRAMFWVMTIVGVLALLLLAF
ALKETRPKHARLDSGLGSAVRAYGTLLRDWRFLGLTLIGTFGMSSFMAFLGNSSFVYIDH
FGLTPTQYSLAFSINAVSFFAASQATGTLVGRFGLNRVVRVAVTGYAAAMLALFATVLAG
ADSVWVMGGFMFVAFGFLGLVLPTTGVLAMEEQGAIAGSASALMGTVQMVIAAVVMGIVG
AFADGSARPMVVAFAVCAVLAFAITQVTLGGRGRNMSEVPAE
>AIA13995.1|FEATURES|farme|aminoglycoside|ERS370000_04144|antibiotic inactivation|0
MIRLARTDDLPRLQDIERAAGEAFRGLGMDQIADDEPFSLDEMNAYVTAGRAWVWVDGLD
YPLAYLLTDIVDGNAHVEQVTVHPDQAHQGLGRELLHAARVWARGHGMQRQTLSTFRDVP
WNAPYYRRLGFQTLDAGSWGPELAKLMEHEAELGLTRWPRVAMWRPVVPPT
>AIA13841.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MKAQSDETARSWNRPVEPFHIIANIYYVGATEVSSFLITTPKGHILLDSGFAETVPLIQT
NFKKLGFKIEDVKILINSHAHYDHAGGLALLKELTGAKLVSSEADAALLANGGKGDFQWG
DELSYKPVKADRLLRDNDKVELGGVAVTARLTPGHTKGSLTWTMKVEEAGKQFDVVFAGS
TSAPGYKLVDNQKYPGIIKDYAHTFQLLKSLPCDVFLAPHGSIFSMLEKAGQLKQDEKHN
PFIDPKGYRNFIERTEKAYLQQLEKERQATKTN
>AIA13819.1|FEATURES|farme|beta_lactam|OXA-62|antibiotic inactivation|1
DLSIYDLQTGKLVEMPSDFDEFTERASPDYMGGTEKERANRDLLRKSMEAEGFTVNANEW
WHFDYKDWQSYAIYDIPFSAIGDLKTRFSEAKIEEHSDWKRFFDAAKAKGGIVIYDLREN
KYMVYDRERMNRGFVPASTSKIIHSLIFLDSGAVKDENEVFKWDGVKRFSPDWNKDHNLR
SAFQVSAAWFYVEASKRAGRETMQKYYDSADYGNRNTDGFGDAYWVKGDLRVTPKEQVDF
LIRLYENTLPFSQRSIELVKDIMIVEKTDNYVLRGKTGWSDTYTPQVGWWIGYVERSQNA
YFFALEMDMKNFADAEKRKIITKNILKSLKIIE
>AIA13813.1|FEATURES|farme|beta_lactam|OCH-7|antibiotic inactivation|1
MSGAALAADRDTAKIRHTVDRTIRPLMALHGIAGMAVGVVVDGRPYVFDYGVASKATKQP
VTRDTLFELGSVSKTFTATLASYAQIEGDLSLNDAVSRHLPSLDGTAFGKVTLLNLGTHT
PGGLPLQVPDEVHNDAQLMQYFRTWRPAGPPGTIRTYANPGIGTLGLIAAKSMSENFDTL
MQTRLFPALGLKHSY
>AIA13755.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MSRERISRRVRSVPPSGIRRFFDIAASMPDVISLGVGEPDFVTPGDIREAAMASIQEGKT
AYTSNSGLLELRYALAAHLGRLYGVSYDPEEELLLTVGVSEGMQNTMVALIDDDDEVIVP
EPCFVAYPASVIFADGVPVSVPTRVENQFQVTGEEIEAAVTPKTKAILIGYPNNPTGAVL
SRERMLEIAEIAERHDLIVISDEIYDRLVYGVEHTCFASLPGMRERTVLLGGFSKAYAMT
GWRLGWLAAPREITQAVRKVHQYAIMSAPTASQYAGLEALRFGEDSVVAMVAEYDRRRRR
IVDGFNAMGLPTFEPQGAFYAFPYIGHLGLSSEAFAERLLVEEQVAVVPGDAFGPSGAGY
IRACYATSMEKIEIALERIERFVRHVEAER
>AIA13749.1|FEATURES|farme|beta_lactam|OXA-5|antibiotic inactivation|1
MRTLQVDRSCDITACDLANLLKFMNRISRAIALILIVLGCITAVLVQTQQSALTAPTPAL
ESPPRPGDVAQTVNFGRHFQELGVEGSIAIYDLNSDRLYQHNPQRNATAFLPASTFKILN
SLISLETGVISDEIAVLTWDGTQRQFPAWNRDLNMREAIKLSAVWFYQVLARRVGHEQMQ
KWVAKVGYGNQKIGNKDDIDKFWLEGELRITPKEQIQFLRRLYKNDLPFSERSLSLVKDI
IIVEQTPDYTIRAKTGWANLGEQTKPQIGWYVGYLEKDKNVYFFATNIDIRNKNDPSARI
ELTRRCFKDLGLL
>AIA13742.1|FEATURES|farme|beta_lactam|SPG-1|antibiotic inactivation|1
MGLLLFGHLVNRRDILTQKPFLLRHQLAKLLSVVLLVLPSIAKAQSDETSRAWNRPVEPF
RIIGNVYYVGATEVSSFLITTPEGHILLDSGFAETVPLIQANLKKLGFKIEDVKILINSH
AHYDHD
>AIA13737.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MQAKHSFVSSFEFKTKDQRPKFKNQIMKFLSFALCVAFSASGCSPSSSQTSDVGSQPAEA
STPQAEGTTKTSALQNQIKEIAAEAKGKVGVTAVVLESGETVASLNPQEHFPMQSVYKLP
ISMAVMKAVDAGKVKLTDKVTISKSEFVGRAAHSPIRDQHPNGASLTVEELLRYALSESD
GTASDVLMKLAGGPAAVQALTELSIKDLIVLDTEQTFTQDKTAQYRNWATPEAAVALLRA
LHESRGVSESSQSLLLKFMTESTPGAKRLKGMLPAGTPVAHKTGTSGTDKGVTAATNDIG
IITLKNGKHVAIALFVSDSPADQVTREGVIAKIAKAVYDTVSGGR
>AIA13730.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MERDVSIASASQVVGALRSRGHQVIAYDSGRGRLAAADEQRLFAGKIDREPPDKRAVASL
PTVVSAPDLADVDLVFLAMHGGTGEDGTVQALLDLAGIPYTGSGKLGSALGWDKDVAKRL
FLAAGVPTAEWLMAPASPDLVAQRIGFPLIVKPNGQGSTVGLTLVATPAELAAAIELAGG
FDSAVMIERYIAGREITVGILDDAPLAVGEIIPKTGPIFDYAAKYQSGGAQEIFPADLTP
EQTARAQDLALRVHRALKLDTYSRVDFRMDAAGEFWCLE
>AIA13693.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
LPAIAKAQADETSRAWNRPVEPFRIIGNIYYVGATEVSSFLITTPKGHILLDSGLAETVP
LIQANLKKLGFKIEDVKILINSHAHYDHAGGLADLKELTGAKLMASEADAALLANGGKGD
FRWGDDLSYKPVKVDRVLRDNDEVELGGVTMTARLTPGHTKGSTTWMMKVNEAGKQFDVI
FAGSTSAPGYKLVDNPKYPGIIKDYAHTFQLLKSLPCDVFLAPHGSIFSMLEKA
>AIA13661.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MINILLAASENHVIGKDNKIPWHLPADLRYFKKLTTDNVVIMGRKTFDSIGKPLPNRVNI
VITRQQSFTADGAIVAHSVAEALKAAKEYADKETFIIGGEEICKQALPFVDRIYLTRIHA
YLDGDAYFPAPDLHEWMLVSSEQHEPDEKNKFAYDFEIYRRINN
>AIA13594.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MASSNEKQWISIKKTGMTKQKRLISILLLGLLTAIVPFSIDMYLPGFPDIAKSMGTTVTK
ISLSLSSFFIGTGLGQLMYGPLLDRFGRKKPLYAGLLLYCIASLGCAFSTEIDTFILLRF
IQALGACSATIAATAMVRDLFPPEENAKIFSFLILVLSASPMLAPTMGSYLSTSLGWSSI
FIVLAILIITIFLGVFFFLPESKGADKGYSLRVSSILKSYGAVLRESYFTIYAFLGAIAF
ASLFTYIASSPGVFMEHFGLTQKQYGWLFAGMASGLILASQINTLLLKYYRSERIILGAL
ILQNCFGASLLLVSLLDLAGFWGYGWATLFILVHHRVDYAECFRPCHETL
>AIA13592.1|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MKFKLIDTSKWDRKEFFNHYLNHVPCTYSMTLNLDLTILLKEIKKRDIKLYPTMIYLLSM
IVNKHEEFRTAIDVNGNVGIFDFLHPCYTVLQKDSQKFTNIWTEFTSLFSEFYKQYLLDV
QNYGEIKSFIAKPDMPLNTFNISSIPWISFTGFNLNLPKDTDYLLPIFTTGKYFEQNGKI
WLPIAIQVHHAVCDGFHIARFVSELQEAMNTLKLDEIKG
>AIA13578.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MTQTPTAPAPAAGPARPAASYIADRIQAIPPSGIRRFFDIAATMADVISLGIGEPDFVTP
APIVEAGIASLRRGDTHYTSNSGILELRQLLSAHLERLYGVSYNPETELLITVGVSEALL
LALTAILNPGDEVIVPEPCFVAYQPTVVLGGGRAVPVPTYVEQDFQVTVDDLERARTPRT
KAVLLGYPNNPTGAVLERARLEEIARWAIGHDLLVISDEIYDRLVYGITHTCFSSLPGAW
ERTLLLGGFSKSHAMTGWRIGYVAAPPDLLAAMRKIHQYIIMSAPTTAQEAAIEAIRGGE
SYVESMREEYDTRRRTIVSGFRSLGLDCFEPRGAFYAFPSIRSTGLSDSEFSERLLTEEH
VAMVPGSAFGESGQGFVRASYATALPQIEQALERIGRFVARCRRG
>AIA13562.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIRLIAAIDNKLGIAKNGTLPWTLPVEQHYFKEMTMRHGGIVLMGRRTYETIGRPLPGRQ
NFVLSSTLQDTDGITVVRDLKTFLQEQPDVWVMGGASVYEQTFEQADELYITRIDADFGC
DQFFPAFATDAFYLQRRSPVQRENNLNYLYEIYSRPS
>AIA13529.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MVLVTFLFLLAALASGQSGAPAPSCANCAEWNKRQEPFKIYGNTYYVGPHGLSSILITSK
AGHVLIDGALPESVPQVVANIRSLGFRVEDVKLVVNSHVHFDHGGGIAELQRLSGAEVAA
SPWSVEVLTKSGVGKGDPQFGSIPPVALIPKATTLRDGQTLRVGNIKLTTHFTPGHTPGG
TSWTWKSCEGKRCLSLVYADSLTPVSAEGFRFSDSREYPNAVKDFEKSFAFLRAARCDIL
LTSHPDASGLWQRLEGRERGVRPDPLVSPQGCKELSERASEQLRRRLASEKSQ
>AIA13509.1|FEATURES|farme|aminoglycoside|PROVALCAL_00921|antibiotic inactivation|0
MTQEIRQTNSLTLAERAQLFEWGVNIFGVQNEALTWRHKDVHFILSVDGEDVSHVGVLKH
EVSVAGERIPVGGVGGVVTIPTAQRRGYARELMSHVAQFFAGWEVDAGLLFCLQKRVPYY
GSQGWELVHDEVVIQQPDGNINSPLEVMVLPLRRSWPQGTIELNSLPW
>AIA13504.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MQKSSLLRHQLIKLLPVVLLFLPAIAKAQSDETSRAWNRPVEPFRIIGNIYYVGATEVSS
FLITTPKGHILLDSGFAETVPLIQANLKKLGFKIEDVKILINSHAHYDHAGGLADLKELT
GAKLMTSEADATLLANGGKGDFQWGDDLSYKPVKADRVLRDNDKVELGGVTLTARLTPGH
TKGSTTWMMKVNEAGKQFDVIFVGSTSAPGYKLVDNPKYPGIVADYTYTFRLLKSFHCDV
FLGPHGSFFALLDKAGRLKQGEQNNPFIDPKGYREFLEESEKDFLEQLEKQRQAGKTK
>AIA13500.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MTRISVLFLFIALIAGKVHGQTLSKEIVTLAKKYSADVGVGIITPEGDTVSVNGNRRYPM
QSVYKFHLALYILDQVDQKKLSLRQEIILTKRDLLPATHSPLRDSSRIGMRVTLQKLLQY
TVSYSDNIGCDILFRLAGGPSKVHDFIQAHGVSDVAVIYTEEEMHADWEKQFANYSTPKS
MVLLLDKFRKGEILSPSSTKLLMELMQNTTTGTKRLKGNLPEGTIVGHKTGTSGYREGIS
PATNDAGIVTLPGGRTYSIAVFVSKSRETEETNERIIAEISRMVYDNLK
>AIA13473.1|FEATURES|farme|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
EQRMKQLVTAFDYGNRDISGGIDYFWLGGGLRISADEQVEFLKKFYAGRLSVSKRSTEIV
KDILVLEQTPDYKLSAKTGGGPIAEGKYIGWFVGYVETKGNVYFFAINLEGASYPEIRDK
RIDLTRRILAGMGVLPKEKE
>AIA13414.1|FEATURES|farme|multidrug|AdeC|antibiotic efflux|0
MAIDEQAPAQQHATGEQFVSDRVNNVPPSGIRKFFDIVATMKDVISLGIGEPDFVSPEPI
LNAGIDSLKAGHTAYTSNSGILELRELLSKHIERLYKVHYDAEREILVTVGVSEALLLAF
MATLEPGSEVIVPEPCFVAYQPTVVFAGGVPVPVPTYVSQDFQ
>AIA13371.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MRVSLIVATDRNEAIGRHNRLPWHLPADLQRFRALTTGHVVVVGALTQQSIVGRLGKALP
DRVSVVVSRRMPESVISGVIPAISIDHATEIAQTISRFKGIDEWFVIGGHQIYEQCLPQV
SRVYRTLVDTVVAGADTFMPPNWLADFALIETSSGQDGDLPITFETYDRS
>AIA13342.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKTVLVAAITADGFIGRSADHLADWTGKSDKKLFVEVTRQAGTMVMGSRTFATIGRALPG
RRTIVYTSRPGAITAEGVETTAEAPADLVKRLQHEGTEGLAVVGGASIYGQFMAAGVVDE
IYLTVAPLVFGSGVPLFGQTLDARLELLESTKLDDNTILLHYRVAR
>AIA13311.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
EKRGIGKAGGLPWRLSSDMKRFRELTMGHHIIVGRKTFESIGKPLPGREMIIVTRSQSTA
REGCFITHSVEEAVSLARERGESELFICGGAEIYAQTLGVADRLYLTLVHADCDADVFFP
EWNGDEWVEVESADHTADEKNQYPFTFKVLARKHEA
>AIA13304.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
MKIDSNSRSVDLDPREAQFYENPYPAYHELRRKVFMLVPILAPSIGQLVLFVASWRMIFV
GFLAMALIAAIFLQVRQEETLPHEKRVTFSAGNLFRSAVEFFRFPSAWGYTVSVGFVFAS
FICYLGTSQQIFAEQYAQGEWFAVWFGGFAIAIAFAMIFNGRMVMRHGMRMLAKWAVRGC
IVFSAIFLVVALSYAGHPPLWTLGVYMFCTFFCSGILFGNYNAMAMEHVGHIAGMAAAIS
GTLSTLVALSIGTWFGQQYDGTVMPLVYAFLSMSVAAMLVSEGVEWAKRRG
>AIA13173.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MGAFTLTLTTALGSGAQQYLDRQLGNVTAPGVFYVMPKAETGFGTDEVKEYDPKKVSAAN
QFVATLSTADVNKLKDVKGVEEVKPYYSISGSYMSRGGDAKKYVASGFTIYTDFSLDLAA
GRLLNDGDRDRIILPDNYLSPLGFSNANEAVNKKITIAYQDLAQKTIERQMTVVGVMKKS
FVTQADIYIDDNTAKTMAESQGQDKRFMAAAVKFTDGDPAKEADQKKLLTEAGNYDAISM
KEQIKTITTIISAITTALNVVGVIALFAASFGIINTLLMSVYERTQEVGLMKALGMRRAK
VFALFAIEAVLVGFWGSVVAVATGYGVSKVVTQWASTSFLKDFQGFELLVVTPMNALFVV
VLIMAIAFLAGTLPALKASRLNPIEALRSE
>AIA13130.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTQHPEYQYLKLMADILQNGKSKPTRGIHGIKSIFGYQLKFDLRHGFPLLTTKKMPFQIL
LHELLWFVSGDSNIKYLQDHKIHYWDEFADKDLNLGPVYGVQWRHWQDPHSKDKNGEIDQ
LQWAIDQIKNNPHSKAILVSAWNPADLEEMRLPPCHTMFQFDVTKGKLRMLLYQRSSDVF
LGLPFNIAQYTMLLCMVAKLTGLEARELVVSIGNAHLYNNHLEQGR
>AIA13037.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MRAATPADAPVIWQLLNDLAVYEKAPVFTLTEAEVARDMLGGACHCELAFRDGEPVGIAT
WFWIYMSFRARRGLYLEDLFVRPQARGHGLGKMLLAHLAAKARAANGFMEWRVLDWNEPA
LAFYQGLGAKPVAQWLNYRLEGAALDRLGT
>AIA13030.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MLLPVVLLFLPSIAKAQADETSRSWNRPVEPFRIIGNIYYVGATEVSSFLITTPEGHILL
DSGFAETVPLIQANLKKLGFKIEDVKILINSHAHYDHAGGLADLKELTGAKLMASEADAA
LLADGGKGDFRWGDSLSYKPVKADRLLRDNDTVQLGGITLTVRLTPGHTKGSSTWMMKVK
EAGRQLDVIFAGSTSAPGYKLIDEPKYPGIIGDYEYTFRLLKSLQCDVFLGPHGSFFSLL
DKAARLKQGEKNNPFIDPKGYRGFIERSEKDFHEQLEKQRQAKKTD
>AIA13028.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MNWRDILMQKSSLLRHQLIKLLPVVLLFLPAIAKAQSDETSRAWNRPVEPFRIVGNIYYV
GATEVSSFLITTPEGHILLDSGLAETVPLIRANLIKLGFKIEDVKILINSHAHYDHAGGL
ADLKELTGAKLMTSEADAALLANGGKGDFRWGDDLSYKPVKVDRVLRDNDKVELGGVTMI
ARLTPGHTKGSTTWAMKVQEAGKQLDVIFMGSTSAPGYKLVDDPKYPGIVADYTYTFRLL
KSLHCDVFLGPHGSFFSLLEKAARLKQGEKNNPFIDPKGYRAFLEDSEKGFLEQLEKQRQ
ASKTK
>AIA13007.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MAHHASTRERLVILDEFYCTLFADLPPITSILDLACGLNPLAIPWMPLPAGVTYAACDIY
QDQVDFLQQCFVVFGVEGAAKPCDLLQACPTQAADVVLLLKTIPCLEQVDKTIGRKLLDT
LNAPILCVSFPAQSLGGRHKGMTVNYEQHFRELVADKPWRIERFDFATELVFRVLK
>AIA13009.1|FEATURES|farme|multidrug|fexA|antibiotic efflux|0
TVEQEPLSHTGGQPKTVIHMTGNPFRVALMTLVRGVQSRDFLLLCGSFFICGATTTGLVG
THLIPMSHEHGIPEVTAANMLALIGIFDLFGTMASGWLSDRYNNRWLLFWYYGLRGLSLI
FLPYAYGTGLFGLGLFVVFYGLDWVATVPPTVRLAADLFGKRNVGTVYAWIFAAHQLGAA
TAAFGAGALRTWLGDYQVSFMLAGGLALLAAGMVLRIGHDPHGDFLAVQPADTAISAAD
>AIA12964.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YDLSQGFPLLTTKKVYWKGVIQELYWFMSGQTNIKYLVDNNVHIWDDYPYKIYKQKINVI
ASKAKQSHKIESSIKDRRVAHAPRDDKSREMTKEEFIEKIKNDAAFAKKWGELPKIYGEM
WRSWPTRKGGKIDQLGWVLKELKEDPDARNLLVTSWNPEYLYTMAAHEDASRFPICHNMY
QVSQKDGKLYLQLYQRSADLFLGVPFNIASYSLLLLILCKITGYKPGEFVHTFGDAHIYA
NHIEQVKEQLKRKPKPFPKVVIDKSVKKLADFRPDLVTLEDYDPYPTLKGELTIAGGLYE
KSVKSTRNG
>AIA12943.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVDRNGAIGKDGRLPWHYSADLKFFKATTTGNAIVMGHNTWKTLTNPLPNRLNI
VLSRKAEIPPQESVLVLRDVESVLKLEKDLKTDLFVIGGAQIYSAFLPHIEKWIVTEVPL
SVEGADTFMPQNYLEGFEIIETKQLDTE
>AIA12941.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
SSDFYFSAVTQVKMNDWTKGRIALVGDAAYCPSPLSGQGNNLAFVGAYILAGELKTANGN
YIHAFKRYNTLLRSFVDVNQRFGVWVSESFLVKDEISKEIAEARSDKILTMIKSISNAIT
LPQYE
>AIA12940.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTDQSLAARALSRPEFIALCAALMALNALAIDVMLPALPYMGEALGVANENERQFVVGAY
MLGFGSAQLAFGPLTDRFGRRGPLLVGLGIYIACAFAATFAPTFAILLALRFTQGLGAAA
TRVIATSVIRDRFSGREMAEVLSLVFMVFMAMPIVAPGIGQIILLTGPWHFIFLFMAGLS
LAIAIWAYFRLPETLRPEYRRALTVKSVTDGFRIVLSNRMALFYGLAGTFLFGAVFGFII
CTQQIFAELYGLGPWFPVAFACMAGVMAVSSFINSRVVRRFGMRRLSHGALMVYLGMAVL
WLVLSLNGPIPFWVFYAMLLVIQFVFGWAASNMNALSMEPLGKVAGTAASVFGFTQTVGG
AVLGSIIGQQFNGTLTPNAVGYVVMGTLVLGCVLIAENGKLFGVGKEYQKPSPASAAAE
>AIA12861.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MKLLPVVLLLLPSIAKAQADETSRLWNRPVEPFRIIGNIYYVGATEVSSFLITTPEGHIL
LDSGFAETVPLIQANLKKLGFKIEDVKILINSHAHYDHAGGLADLKELTGAKLMTSEADA
ALLANGGKGDFRWGDSLSYKPVKTDRLLRDNDKVELGGITMTFRLTPGHTKGSTTWMMKV
KEGGRQFDVIFAGSTSAPGYKLVDEPKYPGIIGDYEYTFRLLKSLNCDVFLGPHGSFFSL
LDKAARLKQGEKNNPFIDPKGYRDFIEKSEKNFREQLEKQRQAGKTG
>AIA12822.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|1
MPRYLINLSILRRNRNFRYLFIGQFISFFGTMITGVALPYQIYMETHSTLMVGLLSLVQL
LPLLFTALAGGVVADRYHRRMLLLISELFLSIGSVLLVINAMLPTPSIWMIFVIASLMSA
FTGLHRPALESIVQQVVPKEDYPSVGALSTLKYSVAMIVGPAIGGLLIAKFGLVLTYIVD
VATFVISLISLLMMSHIPKPQTNTDDSAVSALIKGFRYALSRQELIGTYVVDFLAMIFGM
PTALFPAIALSFGGPEQLGMLYAAPAVGALFISIFSGWARNIKRHGVAIALAASFWGVAI
IGFGLAPNFFSALVFLSIAGAFDAISGLFRAIMWNETIPNHLRGRMAGIEMISYLSGPKL
GDTEAGLVAAAFGVTASVVSGGALCVIGVAICCFALPKFWHYKAE
>AIA12779.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKEMNALPKKIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEIDVRDENFELPRDID
LAFLAIHGTFGEDGQLQQILENRGVPYTGDGVKESWTAFDKIESKKKFEAAGVATPRWQV
IGANEKPTLPVPLVIKAPRQGSTVGVYIIKEAGKLEAALAEARKFDQQLLVEEFVPGRE
>AIA12778.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSAHCFGKGVSEVPPDHRSARHAAYRGSNSDHAGAGAGRRRRDVPRAACGAGEDGTLQGL
LDLVGLPYTGSGRLASAIAMDKDISKRLMLDAAVPTPEWLMAPAPFEEVEKKLGLPVIVK
PSKQGSTVGLTLVKTREEYEPAVRMAFQHDDEVMIEGFIAGREFTVPILGDAARFPSVRS
SLRARFSTTRPSISPDRRARCFPRTSHPRRQRRCSSSRSRRTAR
>AIA12774.1|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
GKLKSKEKFHEHGVVTPEWEIVRSNERPKIPVPIAVKPPCQGSTVGIVIVKNEGELDSAM
AEAAKYDEKLLIEKFVQGRELTIGILGDLALPIIEIIPKGGFYDFATKYPFLNPQAGASA
QHICPANIDPAKTKEIQELALHAFRSLGLKVYARVDVMLSDTGEPFVLEANTIPGMTETS
LLPEAAAVAGLSYPELCRRIIELSYAARPKGAGR
>AIA12763.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
PMLDLGLFSNGTVRGATIAQAGTAIAMASVMFGLILHFQYAYGWSPVKAGLANLPIIITM
LAASPLSEWLAKQFGHRIACLVGAACLGGSLLGLSWAVGHGYAAIAVCMVVMTIGLRTVM
TICAVALVDAMPANRTSIGTALNDTAQEVGTSVGTAVVGTLIAALVTTQLPAGTWGSDLV
ASFFHGEQIIYG
>AIA12701.1|FEATURES|farme|beta_lactam|ThisiDRAFT_0902|antibiotic inactivation|1
MKKHFLTIGARLVWILVAAVCISAQSAPPKEENKREADLVELITLDKTIKLDVRYARTDN
FVGKAVYTEARAFMQRPAAEALLKVHRKLKKQNLGLVIFDGYRPWSVTKLFWEVTPEDKR
KFVANPKSGSRHNRGCAVDLSMFDLKTGKLVEMPTDFDDFTDKASPKYEGATETQKKNRD
LLRQMMEAEGFTVNDNEWWHFDYKDWKEYAIYDIAFSQIGKLDVKVAEAAVEEKADWKQF
FDAADVTGGIYIYDLQRNKFSIYDRERMNRGFVPASTSKIIHSLIFLDAGAVKDENEVFK
WDGVERRVAAWNQDHNLRSALKTSAVWFYIEASKRVGREKMQKYYEQASYGNRDTDGFGA
DYWNTGDLRVTPKEQIDFLVRLYENRLPFSARSTEIVKDVLTLEKTDKYTLRAKTGWSDS
FTPQVGWFVGYVEKGSEAYFFATEIDIKKDADAAKRAEITKNILKSLRIIE
>AIA12698.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MRKIAVIFAQSLNDVIGQNNELPWAGRLKSDMSFFKQATEGGAVIAGRKTYESLPELFRP
LPSRLNVVLTGDQSFDPMAGSKRTQVDPADYLRAPSIPEALQAIPEHRDVYFIGGQRVFE
EALMLPELNTIYQTIVEANFEGDTPAPPIDEKNWGVAGVIEARAADATRGDHYGYQILEY
RRHDQLAASYVNPNNARSPAYRSQLEAIKQIEAGRFCPFCKGNKTYQGQELLGQWSGWEL
VRTNTPYLGSRHHLMLIPDRHLTTLDELNSGDWLAITHLLNQFKKRYRIQANVSFVREGV
LNLDHVGATVGHFHLNILVPEIVEGKASLMTVHYGPFPTADAVTLPA
>AIA12683.1|FEATURES|farme|beta_lactam|Shewmr7_3328|antibiotic inactivation|1
MKFIRSSLILLILAAGYAVSPVSAQDLSPFFKDIKGAFVLYDQKNDRYTRYDEARCRERF
SPKSTFKIPSSLIGLETGVIRDAEFVIPWNRQKYPPQDNWDQYPFKHWGQDHTLRSAIKY
SVVWYYRELALRVGEQRMKRFVTAFDYGNEDISGGIDNFWLNGGLRISADEQVEFLKKFY
AGRLPVSKRSIKIVKDILVLEKTPEYTLSAKTGGGSIAEETYIGWFVGYLETKGNVYFFA
TNIEGKSYPEIREKRIDVTKLILTKLGLLPK
>AIA12458.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVISTIVAVSRNNVIGKDNETPWYLPAELARFKELTIGHHVIMGRKTHESIGRALPGRQN
IVVTRNQNYHAKGCEVVTSIQEALDLAKDADEVFIIGGAAIYDQIMALLNRIYLTKVDAS
VDGDRYFKFNKDEWKQVSSEKHPADEKNKYGFEFQKWIRKA
>AIA12368.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
PVAIAKNGVIGDSNALPWYIPEDLKHFKKITKGRTVVMGRKTYDSIIKHLGKPLPDRVNV
VITRQEHFIAQPSVLVFHSIDQAVDALKNEDIYIIGGAQIFGETLPLAQKMYVTHVHAEY
KGDVVFPTIDWNSWDKVEEEVHEEYTFATYNRKS
>AIA12322.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MSRRILSIVIALAVPVVAAPLAAQGAPKLERQIAAIAPLSGGTVGVAATHLESGRSVFVN
ADDQFPLASTYKVPIAIQAFKLVEEGKLSLDQMVPVLPTDIHIGSEWNKLFQAPGVSLSF
RNVIEPMLIFSENSATDLALRLVGGGEAVTARLRALGINDMRIDRSTADVIAGPNGVPDV
WANGVFSKEKWQAGTASVSRARRDSAAYYYANDPRDHGSPRAMLTILTRLWKGELLNKAN
TAYMLDIMYRCETGQGRIKGMLPPGTRVAHKTGTFPGTTNDVGVIDLPDGTHVAIAVYIK
KSSKVPGADLEATIAQVSRAAYDYFLFTGEQRTGDRE
>AIA12314.1|FEATURES|farme|beta_lactam|SPM-1|antibiotic inactivation|1
MKNTLFIAALILASCAHDHGIQPSLSQNDAKEISSSASAAIPIDENLSATQLKPDVWLVQ
DKSFYDTNVLLAKMPGRTVVIASSFIDTPKTAKLIAWINQTLKPKEIRAINTHFHFDGTG
GNEAYHQEGVQTWSTQQTLSLYKARADSMRSSLADSLNDKQHGKDLRATNNTLADHIFNA
ADGLEWDFQGEKLIVYYPGPAHSPDNLVVYLPSKRILFGGCMVRALDYDLGNTADADLKN
YYKSALSLKRFPAEIVIPGHGQKGGMDLIDHTITLASKASQKP
>AIA12294.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MRTRNHLTHPARTLALATFLLLLAALVSGQTGAPQSSSSSCADCPEWNKPQRPFRIYGNT
YYVGPHGLSSILITSSAGHVLIDSALPESVPQVVANIRALGFRVEDVKLIVNSHVHFDHA
GGISELQRLSGAEVAASPWSVEVLTKSGVGPGDPQFGSIPPVALIQRATTLRDGQTLSVG
DIKLTAHFTPGHTPGGTSWTWQSCEGKRCLNLVYSDSMTAVSAKDFRFSDSREYPTALRD
FEKSFAFLRAARCDILLTSHPDASGLWQRLEGRERGVQPDPLISPNACKALAERASEQLG
RRLAAEKGR
>AIA12274.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MSIALCAFALMMTTSGAVRAQTPPLERAIKRLAESSGGIVGVSAIHIESGRRVSVNGSLR
FPMASVYKLPIALRVLQRVDRGELRLNAPVTLSTHDFRPGHSPIVEFANNKPVTLPLERL
LELMLGESDNSASDALLRLAGGPAAVTNRMQALGIMGINVSRPEGQLILNHRGVRELPPE
SEWTMAILDSLSAKITQAEREAAAAAYADDPRDTSTPDAMADLLVRIQRRDVLEPASMER
LLQITTATQTGPARLKGLLPIGTVVAHKTGTMGGTTNDVGIVTLPDDAGHLAIAVFVKAS
TKDVPERERAIAEIARTVYDFFVLKGQ
>AIA12265.1|FEATURES|farme|beta_lactam|K678_12262|antibiotic target alteration|0
EAMGKLPSSGLGVDAGRLGAYGEGIEVTPIQLAAITSAIANGGTLLVPRTPRTEQEGAQF
EAQIRRHSVSRARSSLIRIKRIRKDLKGGQLLKAPLRIYSEQPAYFMCVYSSRTDICITV
>AIA12247.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKKRVAVLMGGFSVEREVSLSSAQGVLNALQELGHEAIPIDVTRDMRAFIQNLETHKPDI
VLNILHGRWGEDGCMQGLLEMMGIPYSHTGVLGSALSMNKVVARMICEAKGIRIPEGQLA
KLVDVCAGQVMKRPYVIKPVGEGSSLGVHIILDEKTPLPNPQEWPFEDEVLVERYIPGRE
IQVAVMGGKAIGAIEICPKGAFYDYEAKYTDGKATHLMPAPIHPQVYAQVLEWAEKAHDV
LECRGITRSDFRYDDTQGEPGMLYYLETNPQPGLTPLSLVPEIAAHQGMTYAQLVQWMVE
DASCRR
>AIA12219.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MEFAHAENFIDVLPALNYLVFRGERCRRQSGREQSEKSMAIIGIVAVSRNGAIGRHGSIP
WHYSADLKFFKQQTVGNACVMGSKTWRSLKKPLPNRLNLVMSREAQVEADPSVIVLRDKQ
AVLSLKPYLSCDLFIIGGQQIYRAFAGEIDRWIVTEIPLVVEDADTFMPEDFLQGFKPYD
SRQLEENLNVTFYERSEQSTK
>AIA12215.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MRDAAADKAVNGSRVTNHGSRISLIVAMAKNRVIGANNKIPWHLPNELKMFKNLTMGHHI
VMGRRTYESINRPLPGRTTVIVTRQHDYSVPGAIIAHSIDEALDTCRRDNECFVIGGADL
FRATLPIANRLYLTIVDAEPAGDTFMPSFDMSQWHETSSQCFVPDDKHAHAYRFTIYDRI
GSEHQKQ
>AIA12171.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
MKQPTLTSGQVLFMALCTGLIVANIYYCQPLVVLISHEFGVAESTGGTITFFTQLGYALG
LLFFVPLGDMVEKRKQIVVTTGMAVLFLAMAAMSTSLLMLSAASLLIGATSIVPQLILPL
AAQWAHPERRGKVIGIVMSGLLIGILLSRTISGLIGAWLGWRSMFWIAALISLILLLMMQ
RLFPRTPSQFKGHYGQLMQSLITLVRQHPVLREASAINALTFASFGLFWTTMVLHLSGAP
FYLHSGSIGLFGLAAVAGALIAPLVGGRADKGNPRVAIGYGLLAVLLSYVIFYFLGGNVV
GMVIGIILLDLGQQSVHVSNQTRVYALMPEARNRLNTVYMTLSFVGTAFGSAIGLWVWSR
AGWVGVCITGALLLGGAFAVYGFTHGRVVKKVAL
>AIA12163.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MNKSESIVREDIKNSHTILSNPYAKMEKKAQEHIDPKRFGKVALLLGGSSGERAVSLESG
KAILEALQRKGVDVEAIDAQGDFIKRLVQGNFDRAFNIVHGKQGEDGVMQGLLEMLQLPY
VGSDVAASALAMDKARSKLIWSTLGLPTNSFGLAYDFEQAKQIVQELKTFPLAVKPNAEG
SSLGVTKLEKIEDLSVAFEKARPLWSSCD
>AIA12134.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVDRNGAIGKGGKLPWHYSADMKFFKETTTGNAVVMGHNTWRSLKKPLPNRLNI
VLSRKSEIKPQPSVIVLKDMLSVLSLKKFLACDLFVIGGEQVYRSFLPHIDRWIVTQIPL
AVEGADTFMPEGYLKNFSPYDSQQLEENLKVTFYE
>AIA12122.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MLLTLLVISLVSACYGSANPQNTNSVNRPADSVGTKTNEKRDNELQKEIEQIAAAAKGRV
GVEAVVLETGETASMNADAHFPMQSVYKFPIAMTALAQVDAGRLKLEQKVRVEKSDFVRE
GQRSPVRDQNPQGVELSLMELLRYAVSESDGTASDVVLRVVGGADVVNKYLSDLQVSGLV
VLNTEKEIGRDWETQYRNWASPEGAVSLLRALYDRRGLSEQSRALLLKLMTETPTGLKRL
KGLLPKDAVVAHKTGTSGANKSGINAATNDIGIITLPNGRHLVIAVFVSDSPADEATREG
VIAKIARAAWDRLSR
>AIA12096.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGRATYESIGHPLPERPNIVVTHQPNYQAPGCQVAHSVDEAVEVALQIARKHNGDEICII
GGGVIFEQSMALATKLHLTRIHATIEGGDAFFYYDPLQWIEISNEHHSADDKNQYAYTFS
VLTKRK
>AIA12062.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MKRILPAYILILIAFISACSGSGAVTQNAKPATTTATPSAPKTVEREDAELQKQIEQIAA
AAKGRVGVRAVTLETGEAVSLNPQEHYPMQSVYKLPIGMAVLEQVDAGKIKLEERVRVEK
SDYLKKEQHSPIRDNNPDGTELSVRELLRLAVSESDGTASDVLLRLVGGAEAVTKYLNRL
KVTGIIVANSEKEIGQDWETQYRNWASPEGAVTLLRALHERRALSEQSTALLLKFMTESP
TGPKRLKGLLPQGAVVAHKTGTSGVNASGINAATNDIGIMTLPNGRHVAIAVFVSDSPAG
IATSEAVIAKVARAVWDKWGK
>AIA11952.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTVSIIAAVDRNLLIGSNGEIPWLGLVPEDLKRFRELTLGHSVIMGRKTYESLPDAVRPL
PDRHNIVLTLKLGYSASGCTVVNDFGSALDAAESDEVFVIGGGQVYEQALFLANRIYLTE
VEGEFRGETFFPNLEWDKWCITAREDVPAKPPSYGCRLLVLDLKREQPCPEIVIEPQVDP
RYAKSPGYAADLEDILAQGVCPFCPENFNWHPNPILRKLGRWIITQNRQPYENTKHHFLL
KGDEHKEVSCRTDAPGLGLDEGFNQLGNGRVQVRRGRFGNTFRTFQLHRSNRSSPPRSPD
RARAGPEDESGYRGLIPIRIAQQRLRPPSIKTGAVNVPGRFQRPET
>AIA11897.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
PWSVEVLTKTGVGKGDPQFGSIRPVALVPRATTLRDDQVLRVGDIRLTAHFTPGHTPGGT
SWTWKSCEGKRCLSLVYSDSMTAVSAEGFRFSDSREYPAAVQDFEKSFAFLRSTRCDILL
TSHPDASGLWQRLEGRERGVRPDPVVSPNACKALAERASEQLRRRLESEKGRQ
>AIA11895.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
RLSGAKVAASPWSVEVLTKSGVGKGDPQFGSIAPVALIPRASTLRDGQMLRVGDIKLTAH
FTPGHTPGGTSWTWKSCEGKRCLSLVYSDSMTPVSAEGFRFSDSREYPTAVQDFRKSHAF
LRSTPCDILLTSHPDASGLWQRLEGRQRGDLPDPIIAPNACRELAERAEEQLRRRLESEK
GR
>AIA11844.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MKKALTVIYATVILDAAGIGLTLPIFPRLLQDVGHTDNLGWRFGAFLALYALMQFIFSPV
LGSLSDRFGRKPVLMLSLAGAAVDYVFMALAPSLWLLFIGRAIAGITGASNAVAAACVTD
ITEDAERTRRFGQLSACFGIGFIAGPAIGGVLGEFSVRLPFIAAAVLNAANLLMALFLLP
ETRKIGAEAEKQEFSPLAHFRWLLGYRLLLPLAGAYFVLALVGEVGGTIWVLYGQDKFSW
SPMMVGISLAAFGFFHAVVQAFIAGPISERWGEHRTLLIGIIADSAAYIIIALLTEGWMA
FLLMPLFCLGGIGAPALQSLVTGRVDNDHQGRAQGMLASMTSLASIIGPLAISTIYFASR
DVFPGLVWVLGAAFYVLCLPVAFTRRPKDATA
>AIA11830.1|FEATURES|farme|beta_lactam|SPM-1|antibiotic inactivation|1
MKNTLFIAALILASCAHDHGIQPSLSQNDAKEISSSASAAIPIDENLSATQLKPDVWLVQ
DKSFYDTNVLLAEMPDRTVVIASSFIDTPKTAKLIAWINQTLKPKEIRAINTHFHFDGTG
GNEAYHQEGVQTWSTQQTLSLYKARADSMRSSLADSLNDKQHGKDLRATNNTLADHIFNA
ADGLEWDFQGEKLIVYYPGPAHSPDNLVVYLPSKRILFGGCMVRALDYDLGNTADADLKN
YYKSALSLKRFPAEIVIPGHGQKGGMDLIDHTITLASKASQKP
>AIA11823.1|FEATURES|farme|beta_lactam|PI87_26790|antibiotic inactivation|1
MKNKLYTFSFLLFHILFLIIVSCSAPVGDHRDDFKRYFDEFHVTGCFVMYDLENSKFTDY
NPDRCAQRFIPASTFKIFNSLVALETKAIPDENYVIKWDGVLRNVPAWNHDQTMTEAIKN
STVWYYQEVARKIGEERMQQWLNLVHYGNRQMGSTIDSFWLNGDLRISADEQIEFLKNLY
TYQLPFSKRSMEIVKKILVRQDSLGYKLSFKTGLAIQDTTAIGWNVGYIETKGNIYFFAM
NIEAPKPLPENFAIARRMITERCLKELGVL
>AIA11795.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MVGRKTFESIGKPLPGRQMIIVTRSESIAFEGCFIVRSVEAAIDLARERGESELFVCGGA
EIYAQTLGAADRIYLTLVHADCDADTFFPEWNSDDWIEMESEHRTADEKNQHPFTFKTFA
RKSQV
>AIA11775.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MKKALTVIYATVILDAAGIGLTLPIFPRLLQDVGHTDNLGWRFGAFLALYALMQFIFSPV
LGSLSDRFGRKPVLMLSLAGAAVDYVFMALAPSLWLLFIGRAIAGITGASNAVAAACVTD
ITEDAERTRRFGQLSACFGIGFIAGPAIGGVLGEFSVRLPFIAAAVLNAANQLMALFLLP
ETRKIGAEAEKQEFSPLAHFRWLLGYRLLLPLAGAYFVLALVGEVGGTIWVLYGQDKFSW
SPMMVGISLAAFGFFHAVVQAFIAGPISERWGEHRTLLIGIIADSAAYIIIALLTEGWMA
FLLMPPFCLGGIGAPALQSLVTGRVDNDHQGRAQGMLASMTSLASIIGPLAISTIYFASR
DVFPGLVWVLGAAFYVLCLPVAFTRRPKDATA
>AIA11743.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MAPITNSLVFRLFDDDVLRRKAFTVMITVGMTGFILGPVLGGSALAHLDWQWLLIANAPI
ALIAWIGVRIGVPADHPEDLTHEKLDLPGALLSIAAIGLGCFTFTSGVLYGWTSWQTLGS
AIGALLALAGFVIHERRTPQPMVDLSLFSRGTIRGASLAQLATAVAMAAVMFGLILHFQY
AYGWSPMKAGLANLPLIVTMLLASPLAENLVTRFGHRVACLIGSGFLAGSMAGMAWAVEH
GYLAIAVFMVTFTIGLRVVMTTCAVALVDAMPSNRTSLATSLNDTAQEVGTSIGTAFIGT
MIAVLVTKVLPDGVWSDDLASSYFHGEQVAFLALAVLVGTIAAWGSVTLTDSHATDEH
>AIA11716.1|FEATURES|farme|tetracycline|tetC|antibiotic efflux|0
KWENLKRVLVSLFGATAGQGVVWYTGQFYALFYLQSILKVDATASNYIVAIALLLGMPFF
IVFGALSDRIGRKRIMMLGCLFAVLTYLPVYRMMTAAAGSNVVTAISQKNPVTGAISLTP
QADVNGALQPARTVLPYTSFGALISNPTAWRLILLVFVQVIWVTMVYGPDSGLSGRSFSG
PDQVYGSLSPLPYRQRGLRRPAAADRAVRDRKDRQYLCWPVLPDDYRQHHLHRRFAHAAG
DETRQDLG
>AIA11706.1|FEATURES|farme|beta_lactam|LRA-18|antibiotic inactivation|1
MATIKLGLSTAILATLASSAFAEGGERAQIAAAVDKAIRPIMREHKVPGMAVAVTVEGRH
YFLNYGVASKETNEPVTENTLFELGSISKAFAATLASYAQVTGKLSFDDHPGKYIPAFAG
TSIDKATLLHLATYTAGGLPLQFPDAVKSDADMVGYFSTWKPEAKPGKTRRYSNPSIGLF
GHTAALAMGGSFSAVLESEIFPKLGLKHSYVRVPDSQMGSYAWGYGKADKPIRVTAGTFD
AEAYGVKSSAADMIRFVETNIQPERLDGAIRKAVEGTHVGYFDSGKMVQGLGWEQYPYPV
SLERLLDGNSRDMALKSNPVKALDPPKRPDGSTLYNKTGSTNGFGGYVAFVPEKKIGIVL
LANRNYPNPERIKAAHAILKSLEGGGEVKADRPRRFACRGKPATPGNDIHQQLCSESSIS
ACLHIDAEYCHLHFAKARSDAVEFRRMWGCRCSNGW
>AIA11657.1|FEATURES|farme|fosfomycin|FosK|antibiotic inactivation|0
MHVVGLDHVVVNTQDVERAMHFYHEVLGLELLRLEEFRAGKVGFVSARISPETIIDIRPI
AAGERVTPNMDHYCLVLGPTDMHRLHAELKAQGIQVEDTVRPAWGAQGYGQQFKLSDPDG
NKIELRCYTGSQTA
>AIA11653.1|FEATURES|farme|aminoglycoside|rmtD|antibiotic target alteration|0
MSVSKETLTTVNEDKLHQLLGKFVSDFGAAFHAGMVVIGMELGLYKDMANEGPTLPSELA
QRTGTNERYVREWLNSQAAGGYVEYDASTGRYSLSAEQAFTLADENSPAYMPGAFLLATS
ALKAVPELTKRFRTGEGFGWHEHDTGLFRGTELFFRPGYAANLVSSWIPSLEGVEAKLNN
GAKVADVGCGLGASTILMAQSFPNSTFTGFDYHDRSIELAKERATEAGICTTWATP
>AIA11610.1|FEATURES|farme|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
MSLDVHQLSPNEVALMETLLATFGEAFNDMETYTGNRPRGAYSRRLLESDYFIALAALEY
GEIVGGLAAYELKKFEQERSEIYIYDLAVAKAHRRRGIATALIEKLKELGAARGAYVIFV
QADTAIEDEPAIALYSKLGVREEVLHFDIPVSQNNVDA
>AIA11493.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
KQSGMGFIFITLLIDVMGWGLIIPVMADLISELKQIPVNQASTYGALLLSVFAIMQFLFA
PVVGNLSDKYGRRPILLIALLGFGIDYIIQAIAPTYAWLFVGRVIAGMTGASFTTASAYI
ADVSTDENRAKNFGLIGAAFGLGFVLGPALGGFLATWGIRAPFYGAAVLCLLNFVYGFFL
LPESLDKAHRRPFDWRRANPFGSLRFLTKHPEIGELALCFFLIYLGAQAVQANWNFFTIY
RFQWTETMVGISLAVVGVLVGAVQAGLTRVINPRIGDDKSIYLGLSLYTVGLVLFAMATE
TWMMYAFLVPYCLGGICGPSLQSVISAHVPSNQQGELQGALTSLMSVTTIIGPPIMNSTF
AYFTSDKAPFYLPGIHFLIGAVCMLISVIIAYKILSREKREKPQFAGAIEGSLKKGDPEQ
KE
>AIA11478.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQIILIAALTDNYVLGKDNQLIWRLPEDLKNFKRLTSGFPVIMGRKTFESLGRPLPNRTN
IIITRNTDYQADGCVVAGSLEKAIDYAKPLTGEQVFVIGGGEIYAQALPLADRMYLTHVH
TQLDGDAFFPEFSTQDWHAAETQHFTKDEKHAYDFDIVTWERLAT
>AIA11474.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MILTTVVELWVMARKPLVSQVVAMTREGVIGRDNAMPWKLPDDLKRFKALTMGKPLLMGR
KTFLSIGKPLPGRTTFVLTRDSAWQAQGVTAVHSVEEAFEKIGDAPELCVVGGAEIYALT
LPVTDIIYLTRIHASIPGDTRFPALDTSEWRETERVEHPADERHAYAMTFSTLERRRV
>AIA11423.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVSLLVAYAHNGVIGKDNDLPWYLPADLKRFKELTTGKTVVMGRKTFDSIITRNGKPLPN
RTNVVITRDPSYHAEGAEVVHTIQDALTGSDEVFVIGGAEIFKQALPLADQIYATEIDAD
IEGDVYFPEIDKSVWRQAARESHQADEKNRYNYSYVTYEKTHG
>AIA11312.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIRAIAAIDDKLGIAAEGHPPYDIPWDIPIEVQRFKELTMGGIVVMGRRTYGTLTNPLPG
RRNIVVSHNLSAVREGFELVTDIEDFLNTAAGDVWIIGGAEMYAAVLHRCDELYLTQVRG
NYRCDRFFPNFEGRFKLIDESPEQEQNGYRFTYATYTRI
>AIA11280.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELVRRVLDEGERREDRTGTGTLSIFGAQTRYDLRQGFPLLTTKKVLWTGVVRELL
WFLRGSTNIRDELTQHTPIWDAWADEHGELGPIYGHQWRNWGAAFVKHANDGHALLGVRQ
GPGIDQLQQAIELIRKDPTSRRIIVSAWNVADLPHMALPPCHALFQFYVGRDRLDMQLYQ
RSADVALGVPFNIASYALLLMLVAQECGLTPGVFIHTLGDAHIYLNHVDGLKLQLTREPL
PPPRVEIAKKPLSEIAFEDIQLLDYQHHPFLKFEVSV
>AIA11272.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MKFALKFSTATMAFFGLLTSIHVAYGQGQLKKDIVESINSIKADVGVAILHLENGDTLSF
NGLHHFPMQSVYKFHLALAVLHAVDQGKLSLDHETFIAKSDFIPKTWSPIADKYPEGDVK
LTVSQLLSYTISQSDNNGCDILFRLVGGPRKVDEYIKGLGIIDVAIANTEAEMHENPDLQ
FKNWTTPRAMVQLLSLFYQGKILASPTHNLLVEMMEQTITGNKRIKGQLPQGTVVAHRTG
MSGQNEDGVRAALNDVGIITLPNGKHIAVALFVSNTRESIPASEELIAKISRIVFDYYSI
DAGKKK
>AIA11249.1|FEATURES|farme|aminoglycoside|SG34_20990|antibiotic inactivation|0
MTAITIASTDQHLEEILALQRRYHTRTLSAEVQSVEGFVFAEHTLPLLRRMAAQSPQAIA
LSEGHVVGYCLSLPISLQAEVPALVPMFEQFRRCVYRGKPLSDYRLVVGGQVCVDREHRG
QGLLARLYEQLRVSLGQDCDLCVTEIATRNQVSVRAHERMGFEIISAYNDAVEEWVIVAW
DLSRPAVLERALII
>AIA11245.1|FEATURES|farme|beta_lactam|AS202_10895|antibiotic inactivation|1
MKFMRAVLLLLMMVAAASASAQDLSPFFKDTKGSFVLYDLKNDRYTRYNEARCRERFSPK
STFKIPNSLIGLETGVIRDADFVIPWNRQKYPPDGWDEYPFIHWKQDHTLRSAIKYSVVW
YYRELALRVGAKRMKKYVTAFNYGNQDISGRIDDFWLGGPLRISADEQVEFLKKFYAGRL
PVSKRSTEIVKDILVLEKTPEYTLSAKTGGGSIKEGTYIGWFVGYVETKGNVYFFACNIE
GTSYPEIRDKRIDLTKRILAELGLLPK
>AIA11214.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MDRRRGIGRDNGLPWRLPADLKRFRELTMGHHIVVGRKTFESIGRPLPGREMIVVTRDRA
YRAEGCAIVHSFEEALALARGRGEGEVFVCGGAEIYALALPLADRMYLTMVEAEVEADTF
FPEWEERAWAERNVVRHESDERHSHPFTFKLLVREGGAGAAG
>AIA11206.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
GGSVIISLLVAMDEKRGIGKAGGLPWRLSTDLKRFRNLTMGHHIIVGRKTFESIGRPLPG
RQTIILSRNESFRPEGCLIARSVEDALRLAEDRGESEAFICGGAEIYAQSLDKADRIYLT
LVHADSGADTFFPAYNGEQWVERESEHHAADEKNQYPFTFKLLVKKAS
>AIA11182.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MRNSKQAAMGFIFVTLLIDVMGWGLIIPVMADLIAELKHIPVNEASTYGALLLSVFAIMQ
FLFAPVVGNLSDRYGRRPILLIALLGFGIDYIVLALAPTYGWLFLGRIIAGLTGASFTTA
SAYIADISTNENRAKNYGLIGAAFGLGFVLGPALGGFLATWGIRAPFYAAAALCLLNFLY
GYFLLPESLDKDHRRQFDWKRANPFGSLKFLTRHPEIGELAICFFLIYLAAQSVQGNWNF
FTIYRFHWSEKMVGISLAVVGVLVGAVQGGLTRVINPKIGDEKSIYLGISLYTLGLVLFA
VATETWMMFAFLVPYCLGGICGPSLQSVIAAHVPSNQQGELQGALTSLMSLTTIIGPLIM
NSTFAYFTSDKAPFHLPGVHFLIGAVCMLTCLLLTYKVLSRERKVKAVPVSSKST
>AIA11180.1|FEATURES|farme|multidrug|efmA|antibiotic efflux|1
AQAADPEHWLRKVILFLSGQTISLFGSMLVQYAVLWYVTITYQSGVVMMLTALFGFLPQA
IVSIFGGVWADRHNRKLLIIGADAAIALSTLALAFIMMGGYDAVWLIFLTMAIRSAGAGI
QMPAVSALIPQLTPTRNLMRVNGINGSIQSAMALLAPAAAGAIYAFSSATTSGAASLIPI
FFIDVVTAAIGIGLLALIPVGAVRRASDVPTGYFADLVDGVRYVVHHAFVRWLLIVFAII
FILTVAPSNLTPLMLVRSFDAGEQQNVVYLAVLEIAFSIGMVLGGIVVAS
>AIA11169.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
METTTTSTPAPTYLSLRAAALPLLALCLAFFVEMVDNTLLTIALPTIGRDLGSGTTALQW
VTGAYSLTFGGCLLTAGATADKLGRRRVLLVGLAAFGVLSLGVILVSSSGELIALRAALG
FAAAAMAPVTMSLIFRLFDDEKLRMRAITVVMVVGMSGFVLGPILGGTVLAHLSWEWLLI
ANAPIALIAWIGVRLGVPADRPEDLTSDPVDIPGAVLSIAGIGLACYTLTSGVEHGWLSG
TTLASALGAVGAVIAFARHERSATFPMLDLRLFSSGPARGAAITQMGASITMASVMFGLI
LHFQYAYGWSPMKAGLANLPLIITMIAATPLAEWLAARFGHRIACLVGTAFLVVSLLGMA
WGVEHGYLAIAVSMVILTLGLRTIMTICAVALVAAMPENRTSIGAALNDTAQEIGASVGT
AVVGTMIAALVTTALPPGAWSSDLVHSLFHGERVTYLVLAAIVGLVAT
>AIA11149.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTDVVVLYGGNSPEREVSIRSGKSVMTALDQAGIAYTSFDTANGLEFLDTLPKDSVVLPI
LHGVGGEDGSIQKELERRGLAYLGATSRVSEVCFDKSKALEVFQKNNIPTAAGAVVSQAE
YASHPLAKKPHVLKVARGGSSIGTLLVPDPTAVDKQQVQALFELDDTAILVELVQGIEIT
VPVLDGKALPVIEIKPPEGGEFDYENKYNGKTAEICPPVSIDEATQKEAQHVAERVYEAV
GCRHLGRVDIIVRPDGSMAVLEINTIPGMTDQSLFPKAAEVAGMDFPALVTKFVELARED
GGKQHDV
>AIA11150.1|FEATURES|farme|aminoglycoside|BN487_00430|antibiotic inactivation|0
MEANSMTFDYQSGEVYFQDKFVPFDDANVSIASSSVLYGLSIYTVFSVNWNEQEQKLHAF
RFKDHYQRLINSARIMDFHSFCDEWTYKRFEQTMHELISRNTLREDALVRVTVFIDELIA
GTKIHGLKNSVTAYIYPMGEILPLSGVNLCVSSWVRNADNSIPAKAKINGSYVNASLMKN
EALINGLDDAIALDHNGHVAEGTVANLFIVRDGKLATPDTSTD
>AIA11097.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PVITERDLSGVFFKGALAEHIAFLHGARTQEQLEEFGCKWWSRWVTKERTAIFNLPEGDL
GDGSYGAAWAAFPTAEGKPFNQIEHLMKQIKERPYLRTHILSPWIPQYTLQHEGLTRRVL
QHEGLTRRVVVAPCHGYVHVLCFPETKELVIHHFQRSGDLPVGVPFNFMQYAAFGMMVSQ
LIGYTLKEVVYTFSDVHIYESQYEKVNQIIGREPRKLPTVQLSESAKDIADIMDFRPEHF
ELTD
>AIA11072.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRDIKENGTKKEDRTGTGTVSVFGRQVRYNLADGFPAVTTKKLYFNSVVHELL
WFLQCTGNIEYLAQNNVHIWDEWPYKAYLQKNNLPVPSSDSDEWKTGIKEFIARIASDHE
FAEQWGDLGPVYGAQWRKWPDGKGGYIDQIAQVIDTIKNNPSSRRIIVSAWNVAEIDEIV
SIGGLPPCHSLFQFNVANGKLDLHLYQRSADTFLGVPFNIASYSLLLAMIAQVTGLKQGE
FVHTLADAHIYLNHFDQVDEQLARQPKELPKLWLNPEVKSIDEFTFDDIRLEGYDPHPPI
KAPIAV
>AIA11071.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
PWRLSSDMRYFRKVTMGKPVIMGRRTFKSLPRVLDGRLNIVLTRDQGFDAVMAHSLDEGL
AAARDSAARTDAGEIMVIGGEDVFREVLPQAHRIYLTEVHASPEADTWFPDFDKREWREV
FRERHEAGPRDEHAFSFVVLERTDGP
>AIA11062.1|FEATURES|farme|beta_lactam|OXA-55|antibiotic inactivation|1
MKFIKLLFVQIMFLCSLPGAMPVQAQDLSPFFKDINGAFVLYDLKNDHYIRYNEARCRER
FSPFSTFKIPNSLIGLESGVIKDADFIIPWDRRKYPPDDWTIEPFIHWGRDHTLRSAIKY
SVVWYYRELAGRVGERAMKEYVSKLHYGNQDISGGVDRFWLNSTLKISADEQVAFLKALY
KEELPVSSRSMKILKDILVLEETPQYKLSGKTGGGPNNGKGLGWFVGYVETKGNVYFFAT
NIEGADYLAIRDKRIALTKRILAELGHLPKS
>AIA11032.1|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|0
ATEGHRLLLAKRVRADPPSRQTRFGGMDGSMRIMRTHRWTRALAVTTAVLVGALLAAAPQ
AGQAPATAGKIVLASPERVGFSSESLKELDAAMQGIVDKKHLAGMVTVLARHGQVVQHKA
YGLQDVDSQTPMQLDTIVRIYSMTKPIVGAAMMMLYEDGKWKPSDPIAKHIPEFANLKVF
AGTDAAGTMILEPPAHAPTMGELMSHNAGFTYGLFGNSPVDKMYQADSPLDAPSLQVFIN
KMATLPLLYQPGEKWVYSVSVDIQGYLVQKMSGKSFPDFLRDR
>AIA10931.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MRNSKQAAMGFIFVTLLIDVMGWGLIIPVMADLIAELKHIPVNEASTYGALLLSVFAIMQ
FLFAPVVGNLSDRYGRRPILLIALLGFGIDYIVLALAPTYGWLFLGRIIAGLTGASFTTA
SAYIADISTNENRAKNYGL
>AIA10923.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
YGLTSPIPTTAAGVNQRAWVILIVLTMLTVIGMTVVLPVLPFVVLQYVSNENDLAIWVGV
LEAINGLCAFLVAPFLGRLSDRFGRRPVIVAAAFGAAFAMTLFGIGGALWVLVLARAIQG
LTAGDLPALFAYLADITPPEQRARRFGILGALSGIGMMIGPAVGGLLAAVSINLPVFITA
GVSLTVAVLSVFLLPESLKPENRISTITLHDVQPFAVFKNAFARKELRGLLIGFGLLALP
FGFFVNNFSVLALDSIQWGPTAIGLLTACVGVVDILVQGVLLGILLPRIGERGVIVSGIV
AQFIGLVALALVASLFAQPWVFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGAT
QSLQAAMSTVAPLIAAALYATVSHAAPYWLGAAIMVVAAVVISRAHIVSTAKKSADEQPA
ELVGARS
>AIA10911.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MLISTTPAAFAELKQASGAQMVAGEADKPLLEGGYYPGAREVKELDFPPVKVDRTVREGD
TVTIGNVTLTARETPGHSPGCTSWMFNVKDGDATRSVIIFCSGTVALNRLVTNPTYSGIV
TDYRKTFARAKDMKVDVLLAPHPEMYRMQDKRAMLSDGAPNPFVNPGEFNAYAATLEKAF
EDALAKQTADAQEKKG
>AIA10887.1|FEATURES|farme|macrolide-lincosamide-streptogramin|lmrC|antibiotic efflux|0
MKHLGQEELDPLEFKDLLKERAKIVEMDASFMNRSVNEGFSGGEKKRNEILQMAVLEPKL
AVLDETDSGLDIDALRIVAGGVNQLRDSEKAIILVTHYQRLLNYIVPDFVHVLANGQIVK
QGGKELALELEEKGYDWIKKAVSGQ
>AIA10864.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
VAKALRSRGAEVFEIDVRDGNFELPRDIDLAFLTIHGTFGEDGQLQQILENRGVPYTGDG
VKESWTAFDKIESKKKFEAAGVTTPRWQVIGANEKPTLPVPLVIKAPRQGSTVGVYIIKE
ADKLETTLAEARKFDQQLLVEEFVPGRELTIGILGDQALPILEIIPKGGFYDFTNKYPFL
NPQAGGGAEHVCPAKIEAKLTRKIQDLALRAYRSIGLQVYSRVDVLLPENAEPSVLEVNT
IPGMTEASLLPEAAAAAGIKYDELCLRIIELSRARREGAK
>AIA10824.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MNFKAIAAMSENRVIGNGNKIPWHLPEDFKWFKKMTTGQIVVMGRKTFESIGKPLPNRTT
IVLSRTNFQYPGVRTISDLVEIKRDIPDLVDSQIFICGGAQIYEQALPICFDLYLTLVKR
VVEGDAFFPTFENQFELVEEILDTSDFKILHYRNKEFSSDANTNDG
>AIA10813.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MIISMIAAVSKNRVIGKNNDLPWKLPDDMKFFMEKTKGHHAIMGRKNYESIPHKFKPLPN
RTNIVVTRQNNFNAPGCIVVDSLEKGLAIAKDNQEAEAFIIGGAEIYKLGMSYANQLYLT
EINAEIKGDTFFPEYDRAQWRETSRLHHDKDDRHAYEFDFVIYNKK
>AIA10770.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNNWNIVVMLGGPSAEREVSLRSGSAVAKALRSRGHQVTEVDPKDGTFSLPPKTDVVFLA
LHGTFGEDGTVQKELEKLGVPYTGCDPEASRIAFDKVLTKKRCVEAGVPTARFEIFAKSS
APWPANWQPPVVLKPVRQGSSVGLQFVNNVQEWSEKLSESLNYDTEVLMEEKIVGRETTV
GILDGKALPIVEVRVKQGEFDYKNKYTPGASEHFCPADFDPATTRRIQEAALGAFKAIGG
RDYSRVDVMVKTNGDPIVLEVNTLPGMTETSLLPDAAKAAGISYEQLCQKMVELALRRKK
>AIA10769.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
LLGLIFAEMDETVVSTAMPTIIRELHGLSLYGWVAGVYMLAMTIAMPILGRLADVFGRKK
IYMSCMALFCLGSIVCGSADSMAQLLIGRGIQGIGAGGLMPIALVIIGESFPLEQRAKVQ
SLIGPLMILPQLIGPTIGGYFVGNLNWHWLFLINIPVAVIAVAFLFKGLHESKGEEKHTI
DWAGAGTLVAALLSFLIAPVLIDNQGLSWSSPIIIGLLVLSAALIALFIRIESRAKQPII
PLHLFRNRNVVVLSLLVFTLMLGLMGGIATFPFFAQNVMDLRLPKRVI
>AIA10686.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTVTLIAAVASNGIIGANNELIWRLPADMKYFKQHTLGKPILMGRKTYESLGRPLKDRTN
VILSRSLDEAPEGCILVKSIPEALSMFADEPLMVIGGADIYAQTLEVADRLQLTEIGQPF
EGDVYFPEFDRSEWTLVSRVEGVQDDKNLLPHAFCIYERAVAK
>AIA10658.1|FEATURES|farme|beta_lactam|oxaSH|antibiotic inactivation|1
YPNKIIFICIMNTSTIKFFTGTLLLTLALGLFSFMFKSNPEVRDDLKPFYDKYGVDGSFV
LYDQKKQKYIIYNKDQVSKPFTPASTFKIFNSLVALETKVVADEYAVFKWDGQQRQVAAW
NADTDMRNAFKNSTVWYYQEIARRVGGKRMNSWLNKAKYGNADTSGGIDAFWLTGGLRIT
PMEQIGLLRKLHDDKLPFSMRSMNIVKDIMIVKDTLGYVLRAKAGLGKQGNQYVGWYVGY
ITTRDNTYYFSNCVQTDRRNAEFANARLNIVYDVLDRLAIVKK
>AIA10546.1|FEATURES|farme|beta_lactam|OXA-198|antibiotic inactivation|1
MKNLLSVFFVILLAQAFAFSQVDLQKPFQDCNLQGSITIYDYKNKKWIFSDEKDSQRETL
PASTFKIINSLIALETGAVKDEKEVLKWDGLKRQVEAWNADTDMENAFKNSTVWFYVEMA
KRIGKDKYKHYLSESIYGNGNLDTGQDNDFWNYGNFGVSPKNQIKFLRRLYLETLPFSKR
SFEIVKRIMIEEKTDNYILRAKTGWTRFGGNDTGWWVGYVEQKDNVYFFATRVIKKLETQ
NPNFSPCRKEITRKILKELKII
>AIA10542.1|FEATURES|farme|beta_lactam|CTX-M-86|antibiotic inactivation|1
MLLAANRAKAGSADIPGSKGLSDAMAALERRSGGRLGVAVLDTGSGRRFDWRGNEMFPMC
STFKFLLAAAILKRVDEGRESLTRRIPVSPGDLIPYAPFAETRVNGTPPTVAELCEATMT
LSDNVAANLLLPAVGDPAGLTAFVRSLGDERTRLDRNEPTLNSSIPGDPRDTTTPNAMVH
SMDRLMVGDALRPSSREQLIGWMVGNKTGDKRLRAGLPRDWRVGDKTGTGNGSFNDIAIV
WPGASPPILIASYVTQTPEGFKQGDAIHAEVARAAAGAFTG
>AIA10523.1|FEATURES|farme|trimethoprim|dfrA7|antibiotic target replacement|1
MRLSLMVARSENGVIGSGPDIPWKAKGEQLLLKAMTFNQWILVGRKTFDSMGALPNRKYA
VVTRSGRVSDDENVLFFNSIESALSELQNLAEHVFVLGGGELFESLIERADVIHQSIIHT
TVKGDVYFPSIPRDFVKVFDQYFESNENYTYEIWKRD
>AIA10509.1|FEATURES|farme|beta_lactam|OXA-198|antibiotic inactivation|1
VWFYQVLARRVGHEQMQKWVAKVGYGNQKIGNKDDIDKFWLEGELRITPNEQIQFLRRLY
KNDLPFSERSLSLVKDIIIVEQTPDYTIRAKTGWANFGEQTKPQIGWYVGYLEKDKNVYF
FATNVDIRNNNDASARIELTRRCFKDLALL
>AIA10499.1|FEATURES|farme|beta_lactam|WS68_16125|antibiotic inactivation|1
MAAPPAAGPEGQSRGPAHPEGQSRGPAYPEEPKRSPADPEGQSRKLAELERHAGGRLGVA
AVDTATGQRLEHRGNERFAMCSTFKFLLAAALLQRVDKGVEHLNRRIEYGEADLLEYAPV
SKQNVKQGGMALAEMCSAAVEWSDNTAANLLLQALGGPDRLTAFIRTLGDEVTRLDNNEP
KLNVVLPGEVHDTTSPLSMVRLLSTLLFGQVLSPDSRTRLQGWMLDAKVGQHRLPAGLPP
FWRIAHKTGTGSDQTNDVGVLWPPDRAPIVVAALYARGDIPQDRREAVLADVGRIVSSVF
>AIA10477.1|FEATURES|farme|beta_lactam|PEDO-2|antibiotic inactivation|1
MKLRYVRNAVVALALLSVQASAQEQPLTTKCESAPLTAAFTVFSETGQMPPNLVKFLGDA
ALQKIEPYKAFDNIYYVGICWVSAWLITSPNGHVLVDTLYGPYTGLMLDNIRSLGFDPKD
IKLVVVTHGHFDHAGGIAQLKSELAPGTRFAMSKEGWREGAEVSAAKRPIPWTMIEPDIV
LTDGETVSGGDIAIQAFETPGHTLGTVSFAFDARDGARTHRAITVGGLGLNAIRGPEQVE
AFIASVKRIRTLTQDGARPVELHLTTHGFSTGLTEAKDQLKTRKPADPHPLVDLAGFRKQ
LDELQAGAEKRLVVERQKKAN
>AIA10467.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
GKPLLLVANHRSFFDMYTVSSVIFRRTPRPVTLFFPVRAKFFYDRPVGWLVNFVMGWWAM
YPPFFREQKEIVKREFDKFSLRRLIQLASVGPGNVIGFHPEGKRNFGSDPYEFLPAQPGV
GKVIYSAKPQVIPVFIAGLGNDLAKQVLGNWTGGEKVRIWFGEPIDFSEFYEKGDRLRTH
KEIADFTMVKIGELGEKDREIFGTASSAS
>AIA10457.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MPSKYAITVKNLKKSYGKTEVLKGVNLSVERGTMLALLGPNGAGKTTTVRIMSTLLKFDG
GSVMIEGHDVSKEQDAVRNVIGLTGQSAAVDEMLTGRENLIMMGQLYRLTSKSAKARAEE
LLERFDLVKAANRPLKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRIAMWDII
NELKKGRYDNSFDDSIPRRSRPACRSDRGD
>AIA10429.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MIETKKTNKRLVLIGLILGLIFSELDETVVSTAMPTIIRELHGLSLYGWVAGVYMLAVTM
FMPILGKLADLYGRRRVYLSCMALFITGSVVSGLADSMTMLLVGRGIQGIGAGGLMPLAL
VIIGDTYPLEQRAKIQSLFGPLMILPQLLGPTVGGYMVGHVNWHWVFLINIPVGLLSAAV
LGIGMRESRGSEKRSIDWAGRFDARRCAAVLPYCARIDR
>AMJ38502.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
MSWIVLVIAGLLEVVWAIGLKYTHGFTRLTPSIITIAAMIVSIAMLSWAMRTLPVGTAYA
VWTGIGAVGAAITGILLLGESASPARLLSLGLIVAGIIGLKLSTH
>AMJ38500.1|FEATURES|farme|beta_lactam|ACT-17|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>AMJ38435.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MINRSSSGNRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYNAGIEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQNIEQFTLLRFLQGVSLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVAPWEGMFVLFAAL
AAISFFGLHRAMPETATRLGEKLSLKELGRDYKAVLKNGRFVAGALATGFVSLPLLAWIA
QSPVIIISGEQLSSYEYGLLQVPIFGALIIGNLVLARLTSRRTVRSLIIMGGWPIAAGLI
IAAVATVVSSHAYLWMTAGLSIYAFGIGVANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIEVSKHAYAFGGNGLFSLFNLANGVLWIALMVVFLKDKRVGNALQP
>AMJ38413.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
WQFLTRKTENARPAQPLPLVKTDLASLSPEQDTLVWLGHSSWYMQLAGKRILIDPVLSSY
AAPFSFLNKAFAGEYPWRAESMPEIDLLIISHDHYDHLDYATIKALLPKVKRVVTPLGVG
SHLRYWGMNPEIIDERDWNQSVHISDALTVHVLPARHFSGRGIKRNQTLWGSFMFVTPER
KVYYSGDSGYGPHFKAIGEQFGGVDLAIMENGQYDQDWKYIHMHPAETAQASADLNAKAV
VPGHNGRFVLAKHTWNDPLIQLAKASKDKNYRLLTPELGEPVRVSDTTQQFREWWE
>AMJ38348.1|FEATURES|farme|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MMKKSLCCAWLLTASFSTFAAAKTEQQIADIVNHTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANDRPVTRQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWALGAKRLYANSSIGLFGA
LAVKPSAMRYEEAMTRRVLQPLKLTHTWITVPQSGTKGLCLGLSRREARARLSGPA
>AMJ38347.1|FEATURES|farme|beta_lactam|CFE-1|antibiotic inactivation|1
MHVSPGQLDAEAYGVKSSLVDMTRWVQTNMDASQVQEKTLRQGIEIAQARYWRIGDMYQG
LGWEMLNWPVNPNSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAF
VPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ
>AMJ38300.1|FEATURES|farme|multidrug|farB|antibiotic efflux|0
MANDLHGQNYYGVILGASSIATMTGLPIGAALMNRVRLVRLLVGATLVLVFGALVSAVAP
SVIVFVIGSILRGLAGSILAMTSLGAVALGLSARARQLTLAFASASWVVASVVGPAYAAW
VTHLLSWRWAILLYLPFLLAARFVIAFNLKTESQKKDAPMSYQALFLIIIGVGVTIVPIA
GIGKILLLLVGIGLLTRVAILLMPSGTFSQRTQRRAALAGMFFLTGSYFAANELVSLTAH
DLFDASAKSLGYILTGGGLAWALLGVFCGIKPASSMLAYRIRSSIGLTLLLLSTAAISVV
SLTDSSLSHPTVFFVILWTLAGTGMGLTYLDTLNIFFEDPAVPDGITIEEMASSSVIVES
LSSTMFIPLTSSIVAMAFTNQQVTSTLPYGISWLIVVGLAFVAFYYLMGVQSSKNS
>AMJ38272.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
SIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHSLPIWDGWIWIIGLAFYCIIILL
SMTFMLTPQAQGSKQETSA
>AMJ38256.1|FEATURES|farme|beta_lactam|blaR1|antibiotic inactivation|1
NDFGFTPENIQTTKESIQLFSDVNCTIYGKTGTGCIEEKNVNGWFIGFVESKNHTYFFAT
NIQAIDNATGSIASEITLSILSDMNIYKL
>AMJ38195.1|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKNNIGIDNLIEVIT
NKFYSSTHRGQSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMY
TSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKP
EQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKE
PTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNIRIDKVRYMFNKIT
>AMJ38153.1|FEATURES|farme|beta_lactam|BL1_ampc|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKARSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>AMJ38114.1|FEATURES|farme|beta_lactam|lactamase_B_2|antibiotic inactivation|0
GSHLRYWGMDGALITEADWQQAVPASDALTVHVLPARHFSGRGLKRNQTLWASFLFVTRQ
QKIYYSGDSGYGPHFKAIGNEFGPVDLAIMENGQYDQDWKYIHMMPDETAQAADDLRARA
VLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQSFNAWWR
>AMJ38095.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGA
>AMJ38045.1|FEATURES|farme|beta_lactam|ACT-18|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKNYPNPARVEAAYHILDALQ
>AMJ37958.1|FEATURES|farme|beta_lactam|ACT-15|antibiotic inactivation|1
INEKILQQGIQLAQSRYWQTGDMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVVEVN
PPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTSYPNPARVEAAYHILEALQ
>AMJ37953.1|FEATURES|farme|beta_lactam|OXY-6-2|antibiotic inactivation|1
QLITIKESEMLKSSWRKSALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVAL
INTADDSQTLYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPIT
EKHLQSGMTLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPAL
NSAIPGDKRDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASW
AVGDKTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AMJ37906.1|FEATURES|farme|multidrug|efmA|antibiotic efflux|1
MRETPEVSGDDNANARAAVHSANKPGAAYAAAVANGESERAWIRRVALLLVGQAFSLLGS
SIVQYAIWWWIVLQTRTGSAMLLATLFGVVPQAVVSIFGGSWADRHSRKLLIMLPDMVIA
VVTVVLSLSFAMGWASLTMIFVVLFIRSAGGGVQTPAVQSFIPDVVPSGKLLRVNSIYGV
INSANTIVAPAVAAVLINTVPLWSILLVDVTTAIIGVGFVALIKAPKKSTEHVARRMAEA
ENSGQPTLEPMSDANADRSLIASVRRVFADLKDGFSYTWRRANLRNVVLGGALVCFVSVA
PMNLTLLLMTREYEGIDLNLGFINLTTASDKLAANELGWSIGMLLGGALMSTIGAKLIRN
NMRVVAFGIALVGVSVVGLGVVHNLLAYLLIDVVNGLASAICTGPMRTIIQTEADEKMVG
RVFGLDTTLSALGMPLGMLIFAPLADVIPISLVFIIGGVLTLPIGIYLFGQARRNVSVQV
TRTAA
>AMJ37904.1|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLYPVYHGSAKSNIGIEQLIEVIT
NKFYSSTYRKKSELCGNVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMY
TSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKP
QQREMLLDALLEISDSDPLLQYYVDSTTHEIILSFLGKVQMEVTCALLQEKYHVEVKIKK
PTVIYMERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQN
AVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLA
>AMJ37898.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
SDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLCFIGAVGYAAIQESFE
EAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAALAAISFFGLQRAMPET
ATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIAQSPIIIITGEQLSSY
EYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLW
MTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLIFTVGIEISKHAWLNG
GNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>AMJ37862.1|FEATURES|farme|multidrug|efrA|antibiotic efflux|1
MQIIMSFLMISMMFILVPRAAVSGERIAEVLAVDPVIKSPKNPKPFPQNVPGRLVFDHVS
FHYEGADEDVLHDISFEADPGQTTAFIGSTGSGKSTLINLIPRFYDVTDGAITLDGVDLR
DASLHDLRDKVGYVPQKGVLFSGTIDSNLRYGRKEATEEEVRQGAEIAQAMEFINANSDG
FER
>AMJ37743.1|FEATURES|farme|beta_lactam|PC1|antibiotic inactivation|1
MALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAIN
SAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNKI
IKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGK
LSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEP
IVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>AMJ37732.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
SSMSNTFTFLNAGILISIFLNAWLMEIVPLKTQLRFGFLLMVLAVAGLMFSHSLALFSAA
MFILGVVSGITMSIGTFLVTQMYEGRQRGSRLLFTDSFFSMAGMIFPMIAAFLLARSIEW
YWVYACIGLVYVAIFILTFGCEFPALGKHAPKTDAPVEKEKWGIGVLFLSVAALCYILGQ
LGFISWVPEYAKGLGMSLNDAGTLVSNFWMSYMVGMWAFSFILRFFDLQRILTVLAGLAA
ILMYVFNTGTPAHMAWSILALGFFSSAIYTTIITLGSQQTKVPSPKLVNFVLTCGTIGTM
LTFVVTGPIVEHSGPQAALLTANGLYAVVFVMCFLLGFVSRHRQHNTLTSH
>AMJ37697.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
RAQTYLQGIYASALSEDMTDNATEEITELLRRNHKLKEADDDDFTIRSQQELSSMLNSTT
DLMTTLLACIAGISLVVGGIGIMNIMYVSVTERTREIGLRMSVGARGVDILSQFLIEAIL
ISITGGLIGVIIGCGASWVVKSV
>AMJ37685.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MKAAAKTQKPKRQEEHANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVKEGDMR
SLRVQQVSTSRGMITDRSGRPLAVSVPVKAIWADPKEVHDAGGISVGDRWKALANALNIP
LDQLSARINANPKGRFIYLARQVNPDMAEYIKKLKLPGIHLREESRRYYPSGEVTAHLIG
FTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLTLSIDERL
QALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNLSGTPKEAMRNRTIT
DVFEPGSTVKPMVVMTALQRGVVRENSVLNTVPYRINGHEIKDVARYSELTLTGVLQKSS
NVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYG
LMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESIVRTVVHMMESVALPGGG
GVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASQPRFALVVVINDPQAGKY
YGGAVSAPVFGAIMGGVLRTMNIEPDALTTGDKNEFVINQGEGTGGRS
>AMJ37542.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MALLGIEPLLDRLPGSLSGGEKQRVAIGRALLTAPELLLLDEPLASLDIPRKRELLPYLQ
RLTREINIPMLYVSHSLDEILHLAD
>AMJ37511.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTWATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>AMJ37383.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
MSWIVLVIAGLLEVVWAIGLKYTHGFTRLTPSVITIAAMIVSIVMLSWAMRTLPVGTAYA
VWTGIGAVGAAITGILLLGESASPARLLSLGLIVAGIIGLKLSTH
>AMJ37338.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
VSIAMLSWAMRTLPVGTAYAVWTGIGAVGAAITGILLLGESASLARIASLALIVAGIIGL
KLSTH
>AMJ37335.1|FEATURES|farme|beta_lactam|CMY-118|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AMJ37322.1|FEATURES|farme|beta_lactam|CFE-1|antibiotic inactivation|1
PAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ
>AMJ37321.1|FEATURES|farme|beta_lactam|CMY-98|antibiotic inactivation|1
ATYTAGGLPLQIPDDVTDKAALLRFYQNWQPAWAPGTQRLYANSSIG
>AMJ37087.1|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTAITSFQWKNTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVIT
NKFYSSTHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMY
TSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKP
EQREMLLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIELKE
PTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVAQLPLGSGVQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLTPIVLEQAFRKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVIL
>AMJ37078.1|FEATURES|farme|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAM
>AMJ37020.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MKKPLFICVVLIMIIASAASLPFVLNAGFGQPPQGERLTEVEASPQYREGKFHNTLPTPG
YNGDKNMLVAMWEFLTKKTENARPTQPLPLVKTDLASLPLEQDTLVWLGHSSWYLQLAGK
RILIDPVLGNYAAPFSFLNKAFAGEYPWRAEIMPAIDLLIISHDHYDHLDYATIRALLPK
VKRVVTPLGVGSHLRYWGMKPEIIDERDWNQSVRISDALTVHVLPARHFSGRGIKRDRTL
WGSFMFVTPEQKVYYSGDSGYGPHFRAIGEQFGEVDVAIMENGQYDQDWKYIHMLPEETA
QASADLNAKAVVPGHNGRFVLAKHAWNDPLIQLAKASQDKNYRLLTPELGEPVRVSDTAQ
TFRAWWE
>AMJ36999.1|FEATURES|farme|beta_lactam|BL2a_pc|antibiotic inactivation|1
AQELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLN
KKVHINKDDIVGYSPILEKYVGKDITLKELIEASMTYSDNTANNKIIKEIGGIKKVKQHL
KELGDKVTNPVRYETELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMF
NNKTGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNK
>AMJ36955.1|FEATURES|farme|beta_lactam|MIR-16|antibiotic inactivation|1
GKAVHVSPGMLDAEAYGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAM
YQGLGWEMLNWPVDVKTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSY
VAFIPEKQLGIVMLANKSYPNPARVEAAYRILDALQ
>AMJ36906.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
MSWIVLLIAGLLEVVWAIGLKYTHGFTRLTPSIITIAAMIVSIAMLSWAMRTLPVGTAYA
VWTGIGAVGAAITGILLLGESASPARLLSLGLIVAGIIGLKLSTH
>AMJ36846.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRYQLDVDVIGYALSLALV
VGVLFSMGFGILADKFDKKRYMVWSVLVFILGFSAIPLVNNAILVVIFFALINCAYSVFS
TVLKAWFADRLTPEKKARIFSLNYTILNIGWTVGPPIGTLLVMHSINLPFWLAAACAAFP
>AMJ36704.1|FEATURES|farme|beta_lactam|ACT-32|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILDALQ
>AMJ36677.1|FEATURES|farme|beta_lactam|IND-5|antibiotic inactivation|0
MQGIKIYTILASSLISGSIFAQTEISTANSSTVNASYVEPSAEKIISPSDKLNNLFERNM
SQPYILQKIGERTYYVQRYFYSTTFYVGDKGVLLFDAPEGRGKYLLQAIRDVTPLPVTAL
VYSHYH
>AMJ36528.1|FEATURES|farme|beta_lactam|mecR1|antibiotic target replacement|1
MSIVYYKYLKEGVKMAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTVLAG
LIPFIPIKFSFIKFNNVNNQAPTVESKSHDLNHNIITTKPVQEFATDIHKFNWDSIDNIC
TVIWIVLVIILSFKFLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAEA
IQSPITFWYGKYIILIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSY
NPLVHIVKRKIIHDNEVEADRFVLNNINKNEFKTYAESIMDSVLKTSFFNKNILSHSFNG
KKSLLKNRLINIKEADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSD
YQILDESKNFGSNSGSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIIS
DKNSRMSWNHKHYLFESWNKEQDLNTAMQNSVNWY
>AMJ36444.1|FEATURES|farme|tetracycline|tetA(P)|antibiotic efflux|1
MVNKLSAYKTYLLFSAIAAMCFSLVATVMVVYHIEIVHLNPLQLILVGTTLELACFIFEI
PTGIVADVYSRKLSIVIGGVLTGVGFILEGSISSFVFVLVAQIVWGLGSTFISGSLEAWI
AEEEKNKDLDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLWLY
MPENNFKPSAPGDLNTFKKMVYTFKSGLKIVKSKSIIMILLAVTLFYGLSSEGYDRLSNA
HFLQDTTLPKLGNLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCINIL
YISSMLIFALTKNFSLMLIAYLATNTFRIINEPIFSAWLNGHIDDNSRATVLSINGQMNS
LGQILGGPIIGIIATNISVSIGIACTSLLVTPVLVLYIVAMIIDKKVDDRVGGIDYEENN
>AMJ36429.1|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRYMFQKIM
>AMJ36372.1|FEATURES|farme|multidrug|sav1866|antibiotic efflux|1
MLTIHVKLAIATFILLPFITIALGYFNKKMTKANTDIYDNLGEFNAGIEASVSGIRVTQS
FANEPFERKQFNYLNQMYRKSKLYFYKVMGVSSAYNYLLIRLINLFSLIFGAYYTIKGEI
TEGQFVGFILLANIFIRPIEKVNNMIESYPKGFAGFKRFTEEMDKQPSIKDLPGAVAVSH
LEGTIAYKDVSFAYEDGTKVLDHINLKIQPGETVAFVGQSGSGKTTLCNLLPRFYEVSSG
EITIDGRNIQQMTLASLRKQIGIVQQDVFLFPGTLRENIAYGNLNATEIDIQQAVKLAHL
EHVIQLMPDGLDTIIGERGVKLSGGQKQRVAIARMFLKNPPILILDEATSALDTETEQVI
QESLNS
>AMJ36364.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTTSAAESARIEPMVRITGLHKEFGPLHILKGIDLDVAPGEVCVLLGPSGSGKSTLLRCI
NQLETFEAGEVWVGGERVGYEHDPLPDGRLKRLSDKEIAAQRARVGMVFQRFNLFPHMTA
LGNVMEAPIKVSGLSKEEVKPLAMSLLERVGMADRADHYPAELSGGQQQRVAIARAMAMK
PELMLFDEPTSALDPELVGEVLSVLKDLAREGMTMIVVTHEMGFAREVADHVVFMDGGVV
VEAGSPDDVINHPKSERLQGFISSVL
>AMJ36072.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
LIIFVDSAWVAGVSVVLWGLGASLGFPLTISAASDTGPDAPTRVSVVATTGYLAFLVGPP
LLGYLGEHYGLRSAMLVVLALVILAAIVAKAVAKPDTKTQTAMENS
>AMJ36057.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>AMJ36019.1|FEATURES|farme|beta_lactam|SD1617_4203|antibiotic inactivation|1
SWVHKTGSTGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>AMJ35859.1|FEATURES|farme|beta_lactam|OXY-1-2|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGG
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AMJ35756.1|FEATURES|NCBI|multidrug|mdtG|antibiotic efflux|0
MTTYTRPVLLLLCGLLLLTLAIAVLNTLVPLWLAHENLPTWQVGMVSSSFFTGNLLGTLL
TGSLIKRFGFNRSYYLASLIFAVGCAGLGLMVGFWSWMVWRFIAGVGCAMIWVVVESALM
CSGTSRNRGRLLAAYMMVYYVGTVLGQLMVSKFPTDLMSVLPWVTGMVLAAILPLLFTRI
VNQSSEHQEATHVWPMLRLRQARLGINGCIISGIVLGSLYGLMPLYLNHQGVSDSGIGFW
MAVMVSAGIVGQWPIGRLADRFGRLLVLRVQVFVVIMGCLAMLSNAAMAPALFILGAAGF
TLYPVAMAWACEKVEHHQLVAMNQALLLSYTIGSLLGPTFTAMLMQNYSDNLLFIMIASV
SFIYLLMLLRKAGEHPTPVAHA
>AMJ35727.1|FEATURES|farme|tetracycline|tet33|antibiotic efflux|0
MDKIGYALSSALIVGVLFSMGFGILADKFDKKRYMTLAVLAFIGGFIAITLVNSVALVVF
FFALINCAYSVFSTVLKAWFADVLSPEKKAQIFSLNYTFLNIGWTVGPPIGTLLVMHSIN
LPFWLAAGCAALPLVFIQLFVQRTSAAIAQDNAVQWSPSVLLRDRALLWFTLSGLLASFV
GGSFASCISQYVLVVADSDFAEKVVAVVLPVNAAVVVALQYAVGRRLTARNIRPLMTFGT
VCFVLGLGGFVISDNSLLLWGISAAIFTLGEVIYAPGEYM
>AMJ35721.1|FEATURES|farme|tetracycline|tet39|antibiotic efflux|0
MKPSIRRSTAALLASSLLLTIGRGATLPFMTIYLTRVYDMSVENIGYALTVALTIGVVFS
LGFGVLADKFDKKRYMLVAIVAFIAGFMAIPLVNNVTLVVLFFALINCAYSVFSTVLKAW
FADVLTSSEKARVFSLNYSFLNIGWTIGPPVGTLLVMYSLQLPFWLAAFCAALPLGFIHF
FVQKSVASDSVEEKAPWQPSVLLKDRALFWYTLSGLMASYVGGSFASCISQYVLAAYADS
DFAEKVVAVVLPVNAVVVVTLQYALGRKISASNIRPLMTAATLFFILGLGGFMLSG
>AMJ35648.1|FEATURES|farme|tetracycline|tet39|antibiotic efflux|0
MKPSIRRSTAALLASSLLLTIGRGATLPFMTIYLTRVYDMSVENIGYALTVALTIGVVFS
LGFGVLADKFDKKRYMLVAIVAFIAGFMAIPLVNNVTLVVLFFALINCAYSVFSTVLKAW
FADVLTSSEKARVFSLNYSFLNIGWTIGPPVGTLLVMYSLQLPFWLAAFCAALPLGFIHF
FVQKSIASDSPEEKMPWQPSVLLKDRALFWYTLSSGLMASYVGGSFASCISQYVLAAYAD
SDFAEKVVAVVLPVNAVVVVTLQYALGRKISASNIRPLMTAATLFFILGLGGFMLSG
>AMJ35595.1|FEATURES|farme|chloramphenicol|cmlv|antibiotic inactivation|1
MTTHTVSRRVAWLRVVTLAIAAFIFNTTEFVPVGLLSDIAASFHMETAQVGIMLTIYAWV
VALMSLPFMLLTSQMERRKLLIGLFVVFIASHVLSFMAWNFTVLVISRVGIAFAHAVFWS
ITASLAIRLAPAGKRAQALSLIATGTALAMVLGLPIGRIVGQYFGWRTTFFAIGMGALIT
LVCLIKLLPKLPSEHSGSLKSLPLLMRRPALMSIYLLTVIVVTAHYTAYSYIEPFVQVVA
GFSANFATVLLLILGGAGIIGSILFGKLGNKHASALVSSAIGLLLACLLLLMPAAGSESH
LAILSLFWGVAIMIIGLGMQVKVLALAPDATDVAMSLFSGIFNLGIGAGALVGNQISLHV
SMSAIGYLGAIPALIALIWSVLIFRKWPVAMEEQTSHG
>AMJ35548.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
MQDDLQTRLFTGDGPNFPEPDMSWIILVIAGLLEVVWAIGLKYTHGFTRLTPSVITIAAM
IVSIVMLSWAMRTLPVGTAYAVWTGIGAVGAAITGILLLGESASLARIASLALIVAGIIG
LKLSTH
>AMJ35531.1|FEATURES|farme|beta_lactam|ACT-18|antibiotic inactivation|1
MAKPISRPAKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQ
GIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGALA
VKPSGMGYERAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYG
VKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANT
VIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANK
SYPNPARVEAAYHILDALQ
>AMJ35515.1|FEATURES|farme|beta_lactam|ACT-18|antibiotic inactivation|1
MTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTR
LYANASIGLFGALAVKPSGMGYERAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKA
VRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQG
LGWEMLNWPVEANTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAF
IPEKQIGIVMLANKSYPNPARVEAAYHILDALQ
>AMJ35514.1|FEATURES|farme|beta_lactam|ACT-18|antibiotic inactivation|1
MLNLTVCQAQSNPTDYACLTGPDIPLTRYYGRLLMMKKSLCCALLLGISCSALAAPVSEK
QLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHYYTFGKADIAASQTRYASDSVRAGFYK
>AMJ35400.1|FEATURES|farme|beta_lactam|ACT-18|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYERAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGVGSYVALYS
>AMJ35368.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVFSDYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALITEADWQQAIPVNDELTVHVLPARHFSGRGLKRNQTLW
ASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQS
FNAWWR
>AMJ35356.1|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MYTSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPS
KPEQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIEL
KEPTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSF
QNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGT
ELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDL
TFFTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>AMJ35352.1|FEATURES|farme|multidrug|adeF|antibiotic efflux|1
ELAPHAEERAIPGRVEAIRAVDIRARTEGVIVQRHFQDGQYVTEGDLLFTLDDAQPRAAL
ALAQAELKSAEASLRQSQQLLTRYERLINNHSISRNDVDTARMQRDVAAAAVQQAKARVE
AQQIVLSYTRIAAPVTGRVGHSAFHVGTLINPSSGVLVDIVQLDPVRVSFALDEAAFFSK
TGQHADIHALKQAWLAQIDVDGKRRDGVLTSIDNRIDARTGSVAVRAEFANPQHRLLPGG
SVTILFRPQGLQSRVMI
>AMJ35274.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVFSDSAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIRALPPKI
KRVITPLGVGSHLRYWGMDGALITEADWQQAIPVNDELTVHVLPARHFSGRGLKRNQTLW
ASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQS
FNAWWR
>AMJ35258.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
MFFFIPGLLMASWATRTPAIRDLLALSTAEMGVVLFGLSVGSMSGILCSAWLVKRFGTRK
VIRTTMSFAVLGMLVLSLALWLASAPLFAFGLAIFGASFGSAEVAINVEGAAVEREMNKT
VLPMMHGFYSFGTLFGAGVGMAVTGFGLPAAPHILAAALVAILPIAIAIRAIPEGTGKNA
AEAAHGEAKGLPVWRDAQLLLIGVIVLAMAFAEGSANDWLPLLMVDGHGFSPTSGSLIYA
GFTLGMTLGRFTGGWFIDRYSRVTVVRGSAVMGAMGIGLIIFVDNPWVAGISVLLWGIGA
SLGFPLTISAASDTGPDAPKRVSVVAITGYLAFLVGPPLLGFLGEHFGLRSAMMVVLGLV
MVAALVARAVAKPQSEPVMENS
>AMJ35203.1|FEATURES|farme|beta_lactam|OKP-B-6|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>AMJ35140.1|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTHTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRYMFQKIM
>AMJ35110.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVIFSVVAIMLLASATTLPFVLNAGFGQAPQGAQLSLVEQSPHYHDGQFHNQLPTPGF
TGQKNMLAAWWEFLVARRENARPAQPLPLVNTDLAGLPSGQDAMVWLGHSSWYLQLAGKR
ILIDPVFSNYAAPFSFINKAFTGDYPWHAEGMPEIDLLIISHDHYDHLDYATIKALMPKV
KRVITPLGVGSHLRYWGMESAIISEADWNQALQVSDELTVHVLPARHFSGRGLKRNQTLW
ASFMFVTPQQKIYYSGDSGYGPHFKAIGEQFGEVDLAIMENGQYDQDWKYIHMMPEETAQ
AADDVHARAVLPGHAGRFVLAKHTWDDPYKRLAEASTGRPWRLLTPMLGEPVWVADKTQS
FNAWWR
>AMJ35083.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTAKQNSSLGIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAVAAILASAM
IFFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNILFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
LLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR
>AMJ35064.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
GRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQ
GKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPE
LTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSI
GLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGA
LDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLD
WPVNPDIIINGSDNKIALAARPVKPITPPTPAVRAS
>AMJ34988.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVTFSVVAIMLLASATTLPFVLNAGFGQALQGAQLSLVEQSPHYHDGQFHNQLLTPGF
TGQKNMLAAWWEFLVAKRENARPAQPLPLVNTDLAGLPSGQDVMVWLGHSSWYLQLAGKR
ILIDPVFSNYAAPFSFINKAFAGDYPWHAEGMPDIDLLIISHDHYDHLDYATIKALMPKV
KRVVTPLGVGSHLRYWGMESAIISEADWNQSLQVSDELTVHVLPARHFSGRGLKRNQTLW
ASFMFVTPQQKIYYSGDSGYGPHFKAIGEQFGEVDLAIMENGQYDQDWKYIHMMPEETAQ
AADDVHARAVLPGHAGRFVLAKHTWDDPYKRLAEASTGRPWRLLTPMLGEPVWVADKTQS
FNAWWR
>AMJ34982.1|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
GPNFPEPDMSWIILVIAGLLEVVWAVGLKYTHGFSRLTPSVITVTAMIVSLALLAWAMKS
LPVGTAYAVWTGIGAVGAAITGIVLLGESANPMRLASLALIVLGIIGLKLSTH
>AMJ34849.1|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKNNIGIDNLIEVIT
NKFYSSTHRGQSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMY
TSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKP
EQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKE
PTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>AMJ34791.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
VRGSAVMGALGIGLIIFVDNPWVAGISVLPWGIGASLGFPLTISAASDTGPDAPKRVSVV
AITGYLAFLVGPPLLGFLGEHFGLRSAMMVVLGLVMVAALVARAVAKPQSEPVMENS
>AMJ34789.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MCIKITALMANVALIAPLLGPLVGAAWVHVLPWEMMFVLFAVLAAISFFGLQRAMPETAT
RLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIAQSPVIIISGEQATSYEY
GMLQVPIFGALIAGNLVLARLTARRTVRSLIIMGGWPIMFGLILSAAATVVSSHAYLWMT
AGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLIFTVGIELSKHAYELGGN
GLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQG
>AMJ34766.1|FEATURES|farme|beta_lactam|SHV-33|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMATTLRKLLTSPLSERPFAAAAAAVDGGRSGRRTVDPLRAAGGLVYRR
>AMJ34749.1|FEATURES|farme|beta_lactam|BSONL12_02412|antibiotic inactivation|1
MKKFCFLFLIICGLMVFCLQDCQARQKLNLADLENKYNAVIGVYAVDMENGKKICYKPDT
RFSYCSTHKVFTAAELLRQKNTSDLNEIRKFSAEDILSYAPITKDHVADGMTLAEICSAS
LRWSDNTAANLILQEIGGVENFKVALKNIGDKTTKPA
>AMJ34691.1|FEATURES|farme|tetracycline|tetA(60)|antibiotic efflux|1
RMIKAFGLEDRQSAQFAADAADTGAKNMRVARIDARFDPTIYIAIGAANLLAIGGGSWMV
IHGSLTLGQLTSFVMYLGLMIWPMLALAWMFNIVERGSAAYGRIRTMLEEAPAVDDGTEA
VPAGRGLLQVAIRDFIYPQASKPSLEQVNFTLQPGQMLGICGPTGAGKSTILALLQRHFD
VTHGEIRFHDL
>AMJ34559.1|FEATURES|farme|tetracycline|tetC|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRFQLEVDVIGYALSLALV
VGVLFSMGFGILADRFDKKRYMVWSVLVFILGFSAIPLVNNAPLVVIFFALINCAYSVFS
TVLKAWFADRLTAEKKARIFSLNYTILNIGWTVGPPIGTLLVMHSINLPFWLAAACAAFP
LVFIQLFLQ
>AMJ34514.1|FEATURES|farme|beta_lactam|SHV-33|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAED
>AMJ34513.1|FEATURES|farme|beta_lactam|SHV-67|antibiotic inactivation|1
MTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQL
LQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTP
ASMAERNQQIAGIGAALIEHWQR
>AMJ34484.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
ILNCLDRVGIRQAAKRLTDYPHQLSGGERQRVMIAMALLTRPELLIADEPTTALDVSVQA
QILQLLRELQGELNMGMLFITHNLSIVRKLAHRVAVMQNGRCVEQNNAATLFASPTHPYT
QKLLNSEPSGDPVPLPEPASTLLDVEQLQVAFPIRKGILKRIVDHNVVVKNISFTLRAGE
TLGLVGESGSGKSTTGLALLRLINSQGSIIFDGQPLQNLNRRQLLPIRHRIQVVFQDPNS
SLNPRLNVLQIIEEGLRVHQPTLSAAQREQQVIAVMHEVGLDPETRHRYPAEFSGGQRQR
IAIARALILKPSLIILDEPTSSLDKTVQAQILTLLKSLQQKHQLAYLFISHDLHVVRALC
HQVIVLRQGEVVEQGPCARVFAAPQQEYTRQLLALS
>AMJ34440.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
LFNDFQEPVVTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTL
STYILGFALGQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALANTIDQLIVMRFFHGLA
AAAASVVINALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILA
VAAILASAMIFFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFS
FLSAGPFVYIEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWIQFI
MAAWMVISALLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRF
GIGAIVGALLSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR
>AMJ34436.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MKRLTVCVVVIMLIGAAASLPFLLNAGFGQAPKGAQLSQVEQSPHYRDGQFHNQVPTPGY
TGNKSMLAAWWEFLVAKRENARPAHPLPLVATDLAGLSPEQDTLVWLGHSSWYLQLAGQR
ILIDPVFSNYAAPLSFLNKAFVGDYPWSAQTMPEIDLLILSHDHYDHLDLATIEALMPKI
KRVITPLGVGSHLRYWGMRGEIIDEMDWNQSIRVTDSLIVHALPARHFSGRGIKRNQTLW
ASFMFETPEQNVYYSGDSGYGPHFKAIGEQFGSVDLAIMENGQYDHDWKFIHMMPEETAQ
AAVDLHAKAVLPGHAGRFVLAKHTWDDPYKRLALASRRYNYRLLTPMLGEPVILSEPDQL
FTAWWQQVTQ
>AMJ34402.1|FEATURES|farme|aminoglycoside|APH(3'')-Ib|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVWLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>AMJ34360.1|FEATURES|farme|tetracycline|tetL|antibiotic efflux|0
MSSLSQAATAAEKRTNARYWIVVMLFIVTSFNYGDRATLSIAGSEMARDIGLDPVGMGYV
FSAFSWAYVIGQIPGGWLLDRFGSKRVYFWSIFIWSMFTLLQGFVDIFSGFGIIVALFTL
RFLVGLAESPSFPGNSRIVAAWFPAQERGRFLTPPSTLPPLFSRRSWAG
>AMJ34287.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
DRYSRVAVVRGSAVMGALGIGLIIFVDNPWVAGISVLLWGIGASLGFPLTISAASDTGPD
APKRVSVVAITGYLAFLVGPPLLGFLGEHFGLRSAMMVVLGLVMVAALVARAVAKPQSEP
VMENS
>AMJ34282.1|FEATURES|farme|multidrug|mdtG|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRFQLEVDVIGYALSLALV
VGVLFSMGFGILADRFDKKRYMVWSVLVFILGFSAIPLVNNALLVVIFFALINCAYSVFS
TVLKAWFADRLTAEKKARIFSLNYTILNIGWTVGPPIGTLLIMHSINLPFWLAAACAAFP
LVFIQLFLQRDGAAAAQPGAAPWSPSVLLRDRALLWFT
>AMJ34217.1|FEATURES|farme|multidrug|acrB|antibiotic efflux|1
MGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCA
ALLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAY
LFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTNYYLTKEKNNVESVFAVNG
FGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVEL
GTATGFDFELIDQAGLGHEKLTQA
>AMJ34156.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKMTLCALLIPASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGLVAMLRLFQKKS
WVS
>AMJ34088.1|FEATURES|farme|beta_lactam|TEM-116|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AMJ33991.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MKKPLFICVVLIMILASAASLPCVLNAGFGQPPQGEQLTAVEASPQYREGKFHNTLPTPG
YNGDKNMLVAMWDFLTKKTENARPARPLPLVKTDLASLPLEQDTLVWLGHSSWYLQLAGK
RILIDPVLGNYAAPYSFLNKAFAGEYPWRAESMPEIDLLIISHDHYDHLDYATIRALLPK
VKRVVTPLGVGSHLRYWGMNPEIIDERDWNQSVRISDELTVHVLPARHFSGRGIKRDRTL
WGSFMFVTPEQKVYYSGDSGYGPHFKAIGEQFGEVDLAIMENGQYDQDWKYIHMLPEETA
QASADLGAKAVVPGHNGRFVLAKHAWNDPLIQLANASKDQNYRLLTPELGEPVRVSDTTQ
TFRTWWE
>AMJ33893.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
DEPTKGIDIGSKAAVHQFMSELVGQGLAVIMVSSELPEVMGMADRIIVMHEGLMVAEYRA
GEATAETIVSAASGLGREAA
>AMJ33719.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MYPHEFSGGMRQRVMIAMALLCRPKLLIADEQ
>AMJ33713.1|FEATURES|farme|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|0
MFSDYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIPALLLKIKRVIT
PLGVGSHLRYWGMDGALITEADWQQAIPVNDELTVHVLPARHFSGRGLKRNQTLWASFLF
VTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQAADDL
RARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQSFNAWW
R
>AMJ33689.1|FEATURES|farme|beta_lactam|ACT-27|antibiotic inactivation|1
GTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVL
>AMJ33681.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
GLKYTHGFTRLTPSIITIAAMIVSIAMLSWAMRTLPVGTAYAVWTGIGAVGAAITGILLL
GESASPARLLSLGLIVAGIIGLKLSTH
>AMJ33484.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MPEIDLLIISHDHYDHLDYATIRALLPKIKRVITPLGVGSHLRYWGMDGALITEADWQQA
VPASDELTVHVLPARHFSGRGLKRNQTLWASFLFVTRQQKIYYSGDSGYGPHFKAIGNEF
GPVDLAIMENGQYDQDWKYIHMMPDETAQAADDLRARAVLPGHAGRFVLAKHSWDEPYQR
LAAASEGRAWRLLTPVQGEPVWVADKTQSFNAWWR
>AMJ33481.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MINRSSSGNRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYNAGIEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQNIEQFTLLRFLQGVSLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVAPWEGMFVLFAAL
AAISFFGLHRAMPETATRLGEKLSLKELGRDYKAVLKNGRFVAGALATGFVSLPLLAWIA
QSPVIIISGEQLSSYEYGLLQVPIFGALIIGNLVLARLTSRRTVRSLIIMGGWPIAAGLI
IAAVATVASSHAYLWMTAGLSIYAFGIGVANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>AMJ33455.1|FEATURES|farme|beta_lactam|ACT-35|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYAGLYS
>AMJ33430.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MPEINLYGQTVGDVVPDWNGAAVLPRETLVGQYCRLVPLDADSHAADLFDAYAQAPDDRD
WTWLASSRPTSVEAAACWVEGKSTDASLVPYAVIEQRFGRAVGLVCFMAIEREHGSVEIG
HVTWSPRMKNTVLGTESIWLLLRQAFALGYRRVEWKCDSLNTASRRAAERLGFIFEGRFR
QKIVRKGRNRDSDWLSMIDGEWPQCDAVLQRWLAAENFDEHGRQRRSMADFVTKSLHTE
>AMJ33252.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
KKVEIHFLPGKNAISHISFVGRPANASFTGDGPIVLEPDMSWIVLLIAGLLEVVWAIGLK
YTHGFTRLTPSIITIAAMIVSIAMLSWAMRTLPVGTAYAVWTGIGAVGAAITGILLLGES
ASPARLLSLGLIVAGIIGLKLSTH
>AMJ33248.1|FEATURES|farme|beta_lactam|OXY-2-7|antibiotic inactivation|1
MAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAGDYGTTND
IAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>AMJ33175.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
AALLASVMIFVFIDETLPVERRQKFHVRTTLGNFASLFRHKRVLSYMLASGFSFAGMFSF
LSAGPFVYIELNHVSPQHFGYYFALNIVFLFVMTIINSRFVRRVGALNMFRAGLWIQFVM
AIWLVLSALLGVGFWALVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFG
IGAIVGALLSTATFNTAWPMLWAIALCATCSILFYLYASRPRKTAHK
>AMJ33064.1|FEATURES|farme|beta_lactam|TEM-17|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGGPKELTAFLHNMGDHVTRLDRWEPELNEAI
PNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIAD
KSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AMJ33011.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
IQEISGGQQQRVALARALIVEPKLCLLDEPFCNLDAALRTRM
>AMJ32968.1|FEATURES|farme|beta_lactam|BL1_cmy2|antibiotic inactivation|1
PSDGPGHPFAFNYGTDFMMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQ
AIPGMAVAIIYEGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEI
KLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWT
PGAKRLYANSSIGLFGALAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGY
REGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIG
DMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFG
SYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ
>AMJ32905.1|FEATURES|farme|multidrug|farB|antibiotic efflux|0
LHRIGPPTKIKSGLFIAIAVIILELIGGMQSYLNQLILPIMANDLHGQNYYGVILGASSI
ATMTGLPIGAALMNRVRLVRLLVGATLVLVFGALVSAVAPSVIVFVIGSILRGLAGSILA
MTSLGAVALGLSGRARQLTLAFASASWVVASVVGPAYAAWVTHLLSWRWAILLYLPFLLA
ARFVIAFNLKTESQKKDAPMSYQALFLIIIGVGVTIVPIAGIGKILLLLVGIGLLTRVAI
LLMPSGTFSQRTQRRAALAGMFFLTGSYFAANELVSLTAHDLFDASAKSLGYILTGGGLA
WALLGVFCGIKPASSMLAYRIRSSIGLTLLLLSTAAISVVSLTDSSLSHPTVFFVILWTL
AGTGMGLTYLDTLNIFFEDPAVPDGITIEEMASSSVIVESLSSTMFIPLTSSIVAMAFTN
QQVTSTLPYGISWLIVVGLAFVAFYYLMGVQSSKNS
>AMJ32895.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
EQDTLVWLGHSSWYMQLAGKRILIDPVLSSYAAPFSFLNKAFAGEYPWRAESMPEIDLLI
ISHDHYDHLDYATIKALLPKVKRVVTPLGVGSHLRYWGMNPEIIDERDWNQSVHISDTLT
VHVLPARHFSGRGIKRNQTLWGSFMFVTPERKVYYSGDSGYGSHFKAIGEQFGGVDLAIM
ENGQYDQDWKYIHMHPAETAQASADLNAKAVVPGHNGRFVLAKHTWNDPLIQLAKASKDK
NYRLLTPELGEPVRVSDTTQQFREWWE
>AMJ32862.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
VDGHGFSPTSGSLIYAGFTLGMTVGRFTGGWFIDRYSRVAVVRASALMGALGIGLIIFVD
SAWVAGVSVVLWGLGASLGFPLTISAASDTGPDAPTRVSVVATTGYLAFLVGPPLLGYLG
EHYGLRSAMLVVLALVILAAIVAKAVAKPDTKTQTAMENS
>AMJ32838.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
LIDPVFSDYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIRALLPKIK
RVITPLGVGSHLRYWGMDGALITEADWQQAVPASDELTVHVLPARHFSGRGLKRNQTLWA
SFLFVTRQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQA
ADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQSF
NAWWR
>AMJ32762.1|FEATURES|farme|beta_lactam|MIR-14|antibiotic inactivation|1
ANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHL
ATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQ
>AMJ32734.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
VWKPNPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAGIYQGKP
YYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTA
KQWNGITLLHLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLF
GALAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPQSGRGALRLGLS
>AMJ32696.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MKKPLFICVVLIMIIASAASLPFVLNAGFGQPPQGERLTEVEASPQYREGKFHNTLPTPG
YNGDKNMLVAMWEFLTKKTENARPAQPLPLGKTDLASLPLEQDTLVWLGHSSWYLQLAGK
RILIDPVLGNYAAPFSFLNKAFAGEYPWRAEIMPAIDLLIISHDHYDHLDYATIRALLPK
VKRVVTPLGVGSHLRYWGMKPEIIDERDWNQSVRISDALTVHVLPARHFSGRGIKRDRTL
WGSFMFVTPEQKVYYSGDSGYGPHFRAIGEQFGEVDVAIMENGQYDQDWKYIHMLPEETA
QASADLNAKAVVPGHNGRFVLAKHAWNDPLIQLAKASQDKNYRLLTPELGEPVRVSDTAQ
TFRAWWE
>AMJ32681.1|FEATURES|farme|beta_lactam|ACT-25|antibiotic inactivation|1
GIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALA
VKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYG
VKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANT
VVEGSDSKVALAPLPV
>AMJ32552.1|FEATURES|farme|tetracycline|tetD|antibiotic efflux|1
SLLREYLPEGDVANHYGILLALYAVMQVCFAPLLGRWSDKLGRRPVLLLSLAGAAFDYTL
LALSNVLWMLYLGRIISGITGATGAVAASVVADSTAVSERTAWFGRLGAAFGAGLIAGPA
IGGLAGDISPHLPFVIAAILNACTFLMVFFIFKPAVQTEEKPAEQKQESAGISFITLLKP
LALLLFVFFTAQLIGQIPATVWVLFTESRFAWDSAAVGFSLAGLGAMHALFQAVVAGALA
KRLSEKTIIFAGFIADATAFLLMSAITSGWMVYPVLILLAGGGIALPALQGIISAGASAA
NQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQQSADGTVWLIGTALYGLLLAICLLIRKP
APVAATC
>AMJ32429.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
FPHAGLNKPPILARLTRSLQRRNAKIENRLDDFHRFPNNECVLTHNQVYPAHAIGWGLLS
GQDMNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPT
PGFTGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLA
GKRILIDPVFSDYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIRALL
PKIKRVITPLGVGSHLRYWGMDGALITEADWQQAVPASDELTVHVLPARHFSGRGLKRNQ
TLWASFLFVTRQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDE
TAQAADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADK
TQSFNAWWR
>AMJ32412.1|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPVYHGSAKNNIGIDNLIEVIT
NKFYSSTHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMY
TSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKP
QQREMLLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKE
PTIIYMERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPA
>AMJ32322.1|FEATURES|farme|aminoglycoside|SG34_20990|antibiotic inactivation|0
MTVEYTVIEKVPSAEAFCHLRVAAGMSPRPLEGARAGLPHSCYGVHILWQETPIAMGRIV
GDGAINFDIVDVAVDPAHQGKGLGRLVMEKLIAWLDANAFDGAYVTLVADVPALYAKFGF
ESVRPESEGMARVWRTRSR
>AMJ32295.1|FEATURES|farme|beta_lactam|ACT-27|antibiotic inactivation|1
DPVAKYWPELTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGT
TRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDG
KAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMY
QGLGWEMLNWPVE
>AMJ32289.1|FEATURES|farme|beta_lactam|MIR-10|antibiotic inactivation|1
ASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYPNPARVEAAYRILDALQ
>JX009357.1_1030|FEATURES|farme|beta_lactam|Rahaq2_4834|antibiotic inactivation|1
DSGGRLGVMLINTEDNSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNR
>JX009353.1_1033|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
LGLSNTHVRVPTGKSEQYAQGYDKDQKPVRVTPGALDSEAYGIKTSTQDLARYVIANLHP
ETLEKLAEVR
>JX009341.1_1044|FEATURES|farme|sulfonamide|sul1|antibiotic target replacement|1
VEVAAEADAMVTVFGILNLTEDSFFDESRRLDPAGAVTTAIEMLRVGSDVVDVGPAASHP
DARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPAL
YPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLI
LDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASL
AAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDAPETEG
>JX009325.1_1055|FEATURES|farme|beta_lactam|Rahaq_4870|antibiotic inactivation|1
MMKNTLRKIVLMAAAVVPMLAFSAVSWAQTATKMTSVQQQLAALEKDSGGRLGVMLINTE
DNSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLKKSDLVNYNPITEKHL
DTGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAI
PGDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGD
KTGSGDYGTTNDIAVIWPDNKAPLILITYFTQPEKDAKSRRDVLASAAKIVTQGY
>JX009323.1_1058|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MKRIHKLAVALLTALAIPAGHAADKVDIDAIVQPLMQKYGVPGMAIAVSVEGKQQFYHYG
VASKQTGKPITNQTLFEIGSLSKTFTATLAAYANDEGKLSFAEPASRYLPELRGSAFDHV
SLLNLATHTSGLPLFVPDEVTNDAQLMAYYKQWQPSQPAGSTRVYSNLGIGMLGMITAKS
LNQPFAQAMEQRLFPALGLTHSYINVPTGQMANYAQGYNKKDQPVRVTPGPLDAESYGVK
SNAQDLIRYLEANMQVAKVGDKWRKALDETHTGYYRAGVFTQDLMWESYPYPVALARLTE
GNNAGMIMNGTPATAITPPQREQGAAWFNKTGSTGGFSTYAVFLPKQKIAVVMLANKWFP
NDDRVAATYRIVQALEKP
>JX009239.1_1127|FEATURES|farme|beta_lactam|UCMB321_2366|antibiotic inactivation|1
MFKKNLAKLEVLVTSLLLVGASNSFAADTPQDKVKSIIDAAIEPIMQEQNIPGMAVAVLV
NGKPYHFNYGLASKATRQAVTDDTLFEIGSVSKTFAATLAGYAQAQGKLVPSERVSHYLP
ELKGSAFDNITVLQLGTYSAGGLPLQFPDAFDAQDKMLDYFKQWKPIYPAGSHRQYSNPS
LGLFGYVAAKSLGAPFDELIEKTLLPALGMKHTYLHVPPAQMPHYAEGYT
>JX009235.1_1130|FEATURES|farme|beta_lactam|BL1_sm|antibiotic inactivation|1
MKRIHKLAVALLTALAIPAGHAADKVDIDAIVQPLMQKYGVPGMAIAVSVEGKQQFYHYG
VASKQTGKPITNQTLFEIGSLSKTFTATLAAYANDEGKLSFAEPASRYLPELRGSAFDHV
SLLNLATHTSGLPLFVPDEVTNDAQLMAYYRQWQPPHAVGSYRVYSNLGIGMLGMITAKS
LNQSFTQAMEKQLLPALGMNHTYIKVPAEEMANYAQGYNKKDQPVRVTPGPLDAEAYGIK
SNAQDLIRYLDANMQVVKVGDPWRKALAATHTGYYRTGVFTQDLMWESYAYPEKLATLTE
GNNAGMIMNGAPATAITPPKQDQGAAWYNKTGSTGGFSTYAVFIPSQKIAVVMLANKWFP
NDDRVAATYRIVQALDKR
>JX009352.1_1175|FEATURES|farme|beta_lactam|AK972_2544|antibiotic inactivation|1
MISYYQHWKPDFAPGTQRLYSNPSIGLFGHLAAQSLGQPFDRLMEQTLLPKLGLKHTFI
>JX009348.1_1178|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
QDTLFEIGSISKTFTATLGGYAQATGKLKLSDTASQHLPALAGVFDHISLLQLATYTAGG
LPLQFPQSADTAQAMLGYFQHWTPTYAPGEQRLYSNPSIGLFGYLAAQSLAGLEQYPCAC
AHG
>JX009348.1_1179|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
VPTGKSEQYAQGYDKDQKPVRVTPGALDSEAYGIKTSTQDLARYVIANLHPETLE
>JX009344.1_1184|FEATURES|farme|tetracycline|tetG|antibiotic efflux|1
VRSSAIIALLIVGLDAMGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVFAPM
LGQLSDSYGRRPVLLASLAGAAVDYTIMASAPVLWVLYIGRLVSGVTGATGAVAASTIAD
STGEGSRARWFGYMGACYGAGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLK
ETHHSHGGTGKPVRIKPFVLLRLDDALRGLGALFAVFFIIQLIGQVPAALWVIYGEDRFQ
WNTATVGLSLAAFGATHAIFQAFVTGPLSSRLGERRTLLFGMAADATGFVLLAFATQGWM
VFPILLLLAAGGVGMPALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSAT
AGAWNGWVWIVGAILYLICLPILRRPFATSL
>JX009286.1_1236|FEATURES|farme|sulfonamide|sul1|antibiotic target replacement|1
VEVAAEADAMVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHP
DARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPAL
YPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLI
LDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASL
AAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>JX009242.1_1273|FEATURES|farme|beta_lactam|OXA-62|antibiotic inactivation|1
SLQISAREQVVFLQRLARGQLPFSARTQDIVRQISIAEANMDYVLHGKTGWYVDGKHDIG
WWVGWIERDGNITTVALNMDMRSDADAPKRARIARAVLKDLKLI
>JX009232.1_1282|FEATURES|farme|beta_lactam|OA39_00246|antibiotic inactivation|1
LSLFILCLSIMPSAYAINLHEKVKQYERDGWKVGVSVLFSDKKSVSINGSQRFPLNSTVK
AISCANVLSKVDNGSLSLNREMKVTEKNIESYSPVAKDYIGRPFSLSQACKAATEYSDNT
GANFSISSGGGPKGLTNFMRSIGDDITRSDRYEPDLTVNPESDLRDTTTPDAMSASIKKL
LTGNVLSDKSKTQLKEWMIDNKVADNMLRASLPPGWKIADRSGASDYGIRGITSMVWSDN
HEPVFISIYVRKKDTSLDERSEVIRVLGAHIFSEYLTK
>KF630358.1_11323|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
VQKKEEMNMNAIVAADKNWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGRKTLESFPNG
LPLKNRINIVLTGNPNYHVKDAVIVHTTEELLEELKKYDEEEIFVIGGESVYRMMLPYCS
KVYVTKIDHAYQADTYFPNLDQLEDWEMTEVSEEHTCFDLEYVFSTYERRQ
>KF630357.1_11326|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
RSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGAKAPVDRNDFSFVLDGEKVTFDFAYI
TIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFACNQYLKGFGVRIAESLLLRDG
QSVTDEDVMEKIGLPCFIKPSLGGSSFGVTKVTAKEQIQPAIAKAFAEAQEVLVEAFMDG
TEITCGCYKTKDKSVVFPITEVVSHNEYFDYEAKYNGASDEITPARISDDLTRRVQTLTS
AIYDILGAYGIIRVDYIITEGEKINLLEVNTTPGMTATSFIPQQVRAAGMEMKDVMTDII
ENKFKD
>KF630348.1_11349|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MKQPELSPYMMARKPSGIRIGQIKFLERKNPPILVNGSIGNVMRPMHPAMQRRLFDLGGV
NSPFHNGIVPYVPTTGTDECREAFLHILRSQGFDTTGLDVLVTDGASMAMEIIMLGVCGG
AGEEERPLLMFNPSYTNYDAVGLRIGRKTVTVERELNENGEFELPSVETVEQRIIETKPG
ALLIIPYDNPTGQLFSKETLIEYTKLCVKHNLWIISDEAYRELAYEKGKETSSIWALTDK
DVPGIEGRRISLETASKVWNACGLRIGAIITDNKLCYEKSVAEYTANLSANTLGQYIFGA
LKHESYAQLHNWYEQQRDYYRQMIFELHKGFKEVEPDFIVSRPEASIYFVIDVRKVAKPG
FDGVEFASWCAEHGAVSLDDGKEYTLLMAPLNGFYSGKNGDNNPGKTQLRVSFCENPELL
RLAPELLSKLFRAYEAQRNV
>KF630342.1_11359|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLKNMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADDFMVTMAT
GGFDVAFIAVHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIA
PGLALEVGDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQACDSLIRMGLRRAGIAC
>KF630327.1_11399|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVVLDAAGIPTAP
GVTVDARNFTAADGLAEIEDAGLTYPLFVKPSRAGSSFGVTKVEKADDRETQQDRLAAAI
ATAGEHDWKVLVEQGIDGREIECAVLCPKAGDEPEAAGPAKSCSIIRTTTSSTISTPSTW
MPPPATWKCLPICRSACLRTCVTWPVARSRPWMVPA
>KF630320.1_11420|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
LNLIETVHIYENHVDALREQLARRDQALPAPKIIVNPEVKDFYDFTPEDITLDGYEHLGK
LSMTVAV
>KF630293.1_11486|FEATURES|farme|chloramphenicol|catA13|antibiotic inactivation|1
MMQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTILN
RHEEFRTALDKNGQVGVFSEMLPCYTIFHKKTETFSSIWTEFTADYTEFLQNYQKDIDAY
GERKGMFAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYHIP
LSIQVHHAVCDGFHICRFVNELQELINS
>KF630291.1_11493|FEATURES|farme|beta_lactam|ACT-2|antibiotic inactivation|1
MMMTKSLCCALLLSTSCSVLATPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYEGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGADAIARGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHGFARNAGR
>KF630285.1_11511|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RRIMLEGTLKSDRTGTGTISLFGQQMRFDLSEGFPLLTTKTVFFKGLAYELLWFLKGSSN
VRWLQEHNVHIWDDWADENGDLGPVYGVQWRSWPAPTSEDPNRTIDQIGNVLDLIRNHPD
SRRMVVSAWNPAEVENMALPPCHALFQFYVADGRLSCQLYQRSCDMFIGVPFNIASYSLL
TMMIAQQTGLEPGEFVWTGGDCHVYDNHVDQFLEQLGRKPYPYPTIEIRKADSLFDYQYE
DFKVVGYQHHPTIKAPVAV
>KF630284.1_11512|FEATURES|farme|beta_lactam|BAMA_03925|antibiotic inactivation|1
DSNENVNADYDSLFQELEEKYDATLGIYALDTETNKEISYNADERFAYCSTYKALAAGAI
LEKYSIEELDNVIYFEEEDVLSYAPVAKDKVDTGMTIREICDAAVRQSDNTAGNLQFTLL
DGPNGFKQSLSKIGDTVSEPSRIETELNDAVPGDIRDTSTPKQLAFNLKEYVTGDILSDD
KKEIFIDWMSNNATGDELIRAGVPSDWIVADKSGAGSYGTRNDIAIVTPPNKKPIFVAVL
SKKAEQDAEYDNKLIADATKIIFDLIS
>KF630280.1_11518|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCRDIIDNGTSTEGEKVRPVWEDGPSAYTIKKFGIVNRYDLSKEFPALTLRRTGIKSCVD
EMLWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDL
KNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAA
NNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLN
PEVKDFYEFTPDDVRLDGYETHPQIKNIPIAV
>KF630276.1_11529|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MGVKIMKKKVAVLMGGISTEREVSLNSGKSVVDALDRDKYEVYEIILNDKMDVINKMPKG
IEFAFLMLHGKYGEDGTVQAILESMDIPYSGCGPLTSAMCMDKNITKKMLRDSGIPTADW
TIARSIEDIDYDKIEEMGYPVFIKPNSGGSSVATFKVECREDVEDAVRAGLEVDDIVMIE
AYLPGDEYTSFVLDGEVYPTIKISSPTGFFDFESKYSTGANAAKEEVVYLEKDLQDQINK
ASKAVWDTFYCRAYVRADFILSNGTFYVLELNTLPGMTPTSLIPRSANAKGLSYSELVDK
IMETSLK
>KF630268.1_11548|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVIT
NKFYSSTHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMY
TSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKP
QQREMLLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKE
PTIIYMERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>KF630232.1_11620|FEATURES|farme|tetracycline|tet40|antibiotic efflux|1
MFAKNSKAYSVYLLFRFVFSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVLETSCFLFE
IPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAW
IASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPVILGGSLCLLLGLVLVR
IMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLST
AHFLDDTVIPVIGPLNSVTWFGVISLIGSGLGILASQLLIARMEKKGTVSRTSVVMSTSA
GYILCLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLD
SFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD
>KF630228.1_11623|FEATURES|farme|aminoglycoside|KONIH1_14625|antibiotic inactivation|0
VAKFKVQGTVEEIKPLGAGLINDTYKVNTKETDAPDYVLQRINHAIFQNVEMLQSNIAAV
TSHIRKKLTEAGESDIDRKVLSFLSTEEGKTYWFDGDSYWRVMVFIPRAKTYETVNPEYS
NYAGQAFGNFQAMLADIPETLGETIPDFHNMEFRLKQLRDAVATNAAGRVAEVQYYLDEI
EKRADEMCKAERLYREGKLPKRVCHCDTKVNNMMFDEDGKVLCVIDLDGS
>KF630222.1_11640|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNIKGEKRMHLIVAVDKNWAIGKNNKLMWSIPADMKYFRETTKGNIVIMGRKTLESFPQG
QPLKNRVNIVITNNKDYKVKDAVVVHSIEEAIEEAKKYEGTPYVIGGESIYRAMLPYCDT
ALITKIDHAFDADTYFPNLDEDEEWEMTKISEEQTCFDLEYYFTVYERVSKK
>KF630210.1_11667|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKETLVLLYGGRSAEREVSVLSAESVMRAINYDKFFVKTYFITQSGDFIKTQEFSSKPA
DDEKLMTNATVVESQKIKPSDIYEEGAVVFPVLHGPMGEDGSIQGFLEILKMPYVGTNIL
SSSVAMDKISTKHVLESAGVPLVAYVTYVEGADLEKAVAEVNEKLTYPVFIKPANMGSSV
GISKADDEEGLRSAIDLALKYDSRILVETGVNAREIEVGILGNADVQTTLPGEVVKDVAF
YDYDAKYIDNKITMDIPAHIDSNIMEEMRGYATTAFRAIGGCGLSRCDFFLTEDGHVYLN
ELNTMPGFTQWSMYPLLWENMGLAYSDLIEKLVELAKEMFEKRESHLI
>KF630210.1_11670|FEATURES|farme|beta_lactam|CCC_03326|antibiotic target alteration|1
NPRGEIYDAAGNLLVSNTVKQVVAFTRSNTITAEEMKELAAKLSTLVTFTETNVTTRQKK
DYYLADSDTYAAVVKSLPDDEKYDSYGNNLTESEIYANAINAVTDDEINYSEDELKLVYI
FSQMNAASTFSTVNLTTGDLTEEQIAYITANQSKLSGISIATDWDRETPTSSLASIIGTV
SSKHSGLPAEEADDYLAKGYSLNDRVGTSYLEKEYEEYLQGTHTVREITTDKNGNVVSDE
VTSEGKAGQNLKLTVNSDFQAGVESILNQYYSADIADGYATYSEGAYAVALNPQTGAILA
MAGLSHETGSSTTTLDALGTINDIFVPGSVVKAATLTAGWESDVISGNQVIADQSINIAG
SSAITSWFTGSGSTNITAVQALEYSSNTYMVQVALKMMGQEYYSGMSLATTGMKEAMEEL
RAAYAEYGMGTSTGIDLPENTTGYISDDYSAGNVLTEAFGQYDSYTPMQLAQYAATVANG
GKRIAPHLVDSIYDNDGTDGIGTLGKTIETNVLNQINIQTMIWTFCNKGSIKW
>KF630207.1_11676|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MIKEFKSMKKNVVVIFGGDSSEHDVSCLSATTVIKNMDTEKYNVILVGITKEGKWLLVDG
VKDIEDGSWREGEVKAFISPDTTTRSLVILAEGTYKLQKVDVIFPVLHGMNGEDGTVQGL
FELSKIPYVGCGVLASAVSMDKVYTKIIVDHIGIDQAKFVHVRESDFEHLEEAMDRVEKE
IPYPIFVKPSCAGSSKGVSKAENRKELEAALYEAVKHDRNILCEETIVGREVECAVLGDR
TQVKSTCVGEILAAEEAAFYDFDAKYNNAESKTVVDPEMPEESKRKIKEDAEAIFRAVDG
FGLSRVDFFLEESGRVVFNEINTLPGFTSISMYPMLWKACGLDIPELLDTLIDQAMTRYR
>KF630206.1_11681|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
LPLVVKPVASGSSIGVSIAYTAEELRRSLTEGLALGGRTVLEEYIRGREIQVGILEDKAL
PSIEIIPKQGFYDYANKYQPGAALEVCPAEITPEEEARVRAAALRVYETLGLSVYSRADF
ILTEDGEPWFLEINTLPGMTPTSLLPQEAAAAGIDYNELCQRIVHASLEARKQGR
>KF630204.1_11685|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MLSIVVAKAKNNIIGKDNKLLWHLSDDLKRFRALTEGHTIIMGRKTFESLGRVLPNRKHI
VFSNNPDFKVNDENVEVVHSLLQIQEYIESEEEAFVIGGAMMYNFLMPYVSKMYVTEIEK
EFEGDTFFPRIDDKKWKEISREKGPEDGENNFEYNYVIYEKI
>KF630196.1_11704|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDRENPFPSEYDV
DAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLM
GIKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKT
CCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVEEYIKGREFSVAVVDGKAYPIIEIAP
LQGFYDYKNKYQAGSTIETCPAEISPELTEKMQHYAEAGAKALFMEGYCRLDFMMKENGD
MYCLEANTLPGMTPTSLIPQEAKVLGIDYPTLCEKLIEVSMKKYPAQDFTL
>KF630186.1_11724|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MDVLEKCKDIDLAFLALHGEFGEDGSVQNLLETMGIPYTGAGMLCSAICMSKDASKRMLK
SEGILTPNWYTARRGQEIEYDVIEKIGYPMFAKPNCGGSSVATFKVTNREELVHSIEEGF
KWDEEVIIEEFIKGEEITSFIMNGEVYPTIRITANKGDFFDFASKYDDGGASEDIVYYPA
DVQEMINDITKKCYRLFNCQVYVRIDMILREGKAYVLELNTLPGMTKNSLIPKSANAKGL
SYSGLLDKIVEYSVRVRGCSRI
>KF630185.1_11727|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MNIINIGILAHVDAGKTTLTESLLYASGTISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQGVYQSVRDKLSVDIIIKQTVSLPPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREELAREEQRRVQDASLFPVYHGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRLIYLRLYSGTLHLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAHKGEIVILPSDSVGLNDVLGDDTRLPRERWRDAPLPMLRTAIAPKTAEQRDR
LLDALTQIADTDPLLRYEVDSITHEIILSFLGRVQLEVVSALLAEKYKIETAVKEPTVIY
LERPLKVASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPVRCIQAYRTDLAFYTNGR
SVCLTELKGYQAVVGEPVIQPRRPNSRLDKVRHM
>KF630182.1_11734|FEATURES|farme|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|0
KRGTAMGMAGIVMAAGPAIGPVVGGLVIDSFGWRPMFIGIAVVALVILVGGTMMLKNVGE
LKNPKLNILSVILSTIAFGGLLYGFSSASTMGWSSPVVIISIVVGLVAFVAFVYKQVKLD
EPLLRVDTLATRNFRNSVILVTLINAAVAATNVTLPIFIQNVLGQSATVTGMVMLPAAAV
GIILSPVAGAAFDKFGPRGVGI
>KF630174.1_11750|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MDIALQINNLSKAYGKHQVLENISFTVVKGEIFALLGTNGAGKTTTLECLEGIRRYDTGK
ILINGKLGVQLQSSSLPADITAKEAIMLFAKWQDLEVTDDYFIYLGIKAFLKKQCHQLST
GQKRRLHLAIALLGHPDIIVLDEPTAGLDVEGRNSIHQEIKRLKTQGKTILLASHDMTEV
EELCDRIGVLNHGKIVFIGAPDQLHQTMQSKFKLKVRFSKVPRLNEQFEIVSQEQEYYIF
ETTNLEITLKAIIQLTEEQSIKIMEINTVQPKLEERFLKEVQS
>KF630169.1_11767|FEATURES|farme|beta_lactam|romA|antibiotic inactivation|0
DWNQSVRISDELTVHVLPARHFSGRGIKRDRTLWGSFMFVTPEQKVYYSGDSGYGPHFKA
IGEQFDGVDVAIMENGQYDQDWKYIHMLPEETAQASVDLNAKAVVPGHNGRFVLAKHTWN
DPLIQLAKASKDKNYRLLTPALGEPVRVNDATQTFRAWWE
>KF630167.1_11773|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MTKKIVAIWAEDENRLIGVNDGLPWRLPKELKHFKETTMGQALLMGRVTFDGMNRRILPG
RETLILTRDKSFEADGVRIVHDMDEVFDWFKKQDKTLYIVGGASIYKAFLPHCDAIIKTT
VHGVFEGDTYFPDIDLTSFRKVSETFNEKDDKNAYDFTITVL
>KF630163.1_11786|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
MEKKNIDWSSLGFGYVQTDYRYVSKFKDGAWDAGELTTDPNVTLNECAGVFQYAQTVFEG
MKAYTTEDGHIVTFRPDLNAERMANSAKRLEMPVFPEDRFVDAIVQTVKANAAYVPPYGS
GATLYVRPYMMGTNPVIGVKPADEYMFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPHGT
GHIKAGLNYAMSLHAIVDAHKNGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKS
NSILPSITRRSLIYVAKEYLGLEAEEREIYFDEVKDFAECGLCGTAAVISPVGKIVDHGK
EICFPSGMEKMGPVIQKLYDTLIGIQMGRIQAPEGWLKVIE
>KF630150.1_11819|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSTERDVSLTSGAGICITLRENGHQAFLLDVFLGFPYDSDKLEEVFTLPNA
GLEIADGIKTTEPDLAAIKASREDQSDCFLGPNVIDICRLADIVFMGLHGDVGENGKLQA
TFDILGIKYTGPNYLGSALAMDKGVTKQIFTMAGVPTPLGTNLTKDRKDTALSDLGLTLP
VVVKPCSGGSSIGVYIVDTMDAYKEAVENSFRYEDEIVIEPYIKGREFAVGIIDGKALPV
IEIIPKTGFFDYANKYQDGCTEEICPANIDEEVTERMQRAAELAFKALKLDIYSRADFLL
DENNDIYCLEVNSLPGMTAASLLPKEARAAGITYGDLCELIIQKSLARYNA
>KF630149.1_11821|FEATURES|farme|quinolone|patB|antibiotic efflux|0
IVNPGDEGILMEPSYVAYTPSVELTGALPVHIKLEHEDQFKLTPEKLKAAITPKTKAILM
NFPSNPTGGVMTKEDYAKLVPILKEHEIIVISDEIYAELTYDGTFCSPANFDEIKDQVII
ISGFSKAYAMTGWRLGYVLANKAFTDAMNKIHQYIIMSAPTAAQYGAIDALRNGDIHVAE
MRESYMTRRNFITKGFNRIGLPTHLPHGAFYIFPDIRGTGLTSDEFCVQLLEDQRVACVP
GTAFGDAGEGFIRVSYAYSIDHIREAIERIDRFMEKFRQK
>KF630147.1_11829|FEATURES|farme|tetracycline|tet32|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLTEAYRALSVLDGAVLVISAKDGVQAQTRILFHALQKMN
IPTIIFINKIDQNGIDLQRVYQSIKDKLTSDMIVMQEVSLSPQISMTDISDLDKWDMIIS
GSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAVTETFIT
ETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKKKIKITEMCIPSNG
EIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTWIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF630133.1_11867|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGVHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLQGDTNVKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIAS
YALLLQMVAQITGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKNIF
SFKYEDFELVNYDPWPHIAGKVSV
>KF630127.1_11890|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YSMTFNVTKEKDSDKLTLNGILNQRSQDVLAANNWNVCQYAVLLHMLAQVCDMKVGEFVH
VIADAHIYDRHIPMIEELIKREPLPAPKFWLNPEVKDFYEFTPDDVRLDGYETHPQIKNI
PIAV
>KF630115.1_11918|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADTQYLGIIENILDHGIYGQNRTGIATYKLPQQIMQFNLQEEFPILTTKFVAFKTAV
KELLWIWQMQSNDVRKLQEMNVHVWDEWMREDGTIGKAYGYQIAKYKQLDKLIKTIKEGP
DSRRMIVTLWNIEDLDDMALQPCAYETLWDVGDGYLNCMLIQRSGDMGLGVPFNTAQYAA
LQCMIAQVTGLKPGKFTHVINNAHIYENHVDALREQLARRNQALPAPKIIVNPEVKDFYD
FTPEDVTLDGYEHLGKLSMTVAV
>KF630114.1_11922|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNIIVAADKNWGIGRNNELLVSIPADMKMFREETTGKVVVMGRKTLESFPNGLPLKNRTN
IVITGNRDYQVKGAVIVHSIEEALKEVEKYPAEDVYCIGGDSIYKQMLPYCDTAHVTKID
FSYEADAYFPNLDEDPDWEITAESEEQTYFDLEYAFVKYERKDR
>KF630103.1_11944|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VHQDLHEMNLYPCAYSMTFNVTKEKNSDKLTLNGILNQRSQDVLAANNWNVCQYAVLLHM
LAQVCDMKVGEFVHVIADAHIYDRHVPMIEELISREPLPAPKFWLNPEVKDFYDFTPDDV
KLEGYETHPQIKNIPIAV
>KF630096.1_11960|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MPASPIRKLAPLADAAKQRGIHVYHLNIGQPDLPTPRAALDAIRNIDRTVLEYSPSQGYR
SYREKLVGYYKKYDINLSADDIIITTGGSEAVLFAFLSCLNPGDEIIVPEPAYANYMAFA
ISAGAVIRTVTTTIEEGFSLPKVEKFEELINERTKAILICNPNNPTGYLYTRREMNQIRD
MVKKYDLYLFSDEVYREFIYTGSPYISACHLEGIEENVVLIDSVSKRYSECGIRIGALIT
KNKEVRNAVMKFCQARLSPPLIGQIAAEASLDAPEEYTRETYDEYVERRKCLIDGLNRIP
GVYSPIPMGAFYTVAKLPVDDSEKFCAWCLSEFNYEGETVMMAPAAGFYTTPGAGRNEVR
IAYVLKKEDLVRALFVLRKALEAYPGRVED
>KF630095.1_11961|FEATURES|farme|fosfomycin|FosA2|antibiotic inactivation|0
MSPIEKSSKLENVCYDIRGPVLKEAKRLEEEGNKVLKLNIGNPAPFGFDAPDEILVDVIR
NLPTAQGYCDSKGLYSARKAIMQHYQARGMRDVTVEDIYIGNGVSELIVQAMQALLNSGD
EM
>KF630085.1_11982|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MALPPCHALFQFYVADGRLSCQLYQRSCDMFLGVPFNIASYSLLTLMMAQQTGLEPGEFV
WTGGDCHVYDNHIDQVLEQLSRTPYSYPQIRIRKADSLFDYDYSDFEIVNYQHHPTIKAP
VAV
>KF630056.1_12051|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
DPLPAPQFWLNPEIRDFYQFTRDDVKLIDYQTHDQIKNIPVAV
>KF630046.1_12078|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIGLIVARSKNNVIGKNGNIPWKIKGEQKQFRELTTGNVVIMGRKSYEEIGHPLPNRMNI
VVSTTTEYQGDNLV
>KF630042.1_12086|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNIIVAADKNWGIGRNNELLVSIPADMKMFREETTGKVVVMGRKTLESFPNGLPLKNRTN
IVITGNRDYQVKGAVIVHSIEEALKEVEKYPAEDVYCIGGDSIYKQMLPYCDTAHVTKID
FAYEADAYFPNLDEDPDWEITAESEEQTYFDLEYAFVKYERKDR
>KF630042.1_12087|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
TPDGKVVTPKSDSILPSITRRSLIYVAKEYLGLEAEEREVYFDEVKDFAECGLCGTAAVI
SPVGKINDHGKEICFPSGMEKMGPVIQKLYDTLTGIQMGRIEAPKGWIHVIE
>KF630034.1_12108|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|0
YSRADFIVSDADGEFYCLEMNALPGMTAASLLPKAAKAAGYEYSEFCEAIIQESMKARY
>KF630032.1_12115|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIVAADANWGIGRENKLLVSIPADMKFFRTTTTGKVVIMGRKTLESFPGGLPLKNRVN
IVITRDKNYKVKDAVVVHSIEEALEEAKKYSQEDVYVIGGDSIYKQMLPYCTKAHVTKID
FAYEADTFFPNLDEDEQWEVT
>KF630024.1_12137|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MVCKALREKNHQAVLVDVFCGIDVKGNLEDVFAEEAYDIDKAAEYMHSFDAGLNEMIASR
RRFFGPNVLELCEAADVVFLALHGANGEDGKVQATFDLLGIPYTGTGYLSSALAMDKSIT
KQFFRAHHVPTPNGVTLKKGQESEPLSGFGLELPVVVKPCCGGSSVGVYIAHTNEEYWQA
MKDAFSYEPEVVVEEYIEGREFSVGVVDGKAYPIIEIAPIEGFYDYTNKYKAGSTVETCP
AVLTEEQTKEMQKHAEDGAAALGIGNYCRLDFMMRKDGRMYCLEANTLPGMTPTSLLPQE
AQVLGISYPELCELLIQLSLRKRGKNA
>KF630002.1_12193|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLSSAAGICRTLVEKGHDAFLLDVFMGLENAPENLEDVFTLPDH
GLEIVKNISTEEPDLEAVKASRPDQSDCFFGPNVIELCRLADITFLGLHGGEGENGKLQA
SFDLLGIKYTGPDSLGCAVAMHKGVAKQIFLESGVDTPGGGTIYKNSEDQSYQSLGLTLP
VVVKPCSGGSSIGVYIVNTDEEYAEALKKSFRYEDELVVEPYIKGREFACGIIDGTALPP
IEIIPKTGFFDYANKYQDGATSEVCPADIPEEVAERMKELTVKAFNALKLNVYSRADFLL
DAEGNLFCLEMNTLPGMTSASLLPKEAKVYGIEYGDLCELIIKKSMEARY
>KF629994.1_12216|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADTIFVDMCRDILDNGYFTEGQDVRARWEDGSSAYTIKRFGIVNRYDLSKEFPALTL
RPTGWKNAIDELLWIWQKKTNDITQLQSHIWDAWAGEDNTIGKAYGYQLGKQYNFRQGRM
DQVDNVIWQLKNTPASRRIMTNIYNFEDLSKMGLEPCAYSMTFNVTDNRLNAILNQRSQD
VLVANNWNVVQYAVLVHMLAQVCGYEAGELVHVIADAHIYDKHVPLVEELIGRTQYPAPK
FEMNPDVKDFYEFTLDDFKLENYQAGPQIKNIPVAE
>KF629993.1_12221|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVVLRRPGKVVSFAHVGRTAEKRCSFCGCSAGTEKSVTFGRKTMRQYLELLDKIMKEGAV
KGDRTGTGTKSIFGYQMRFDLAEGFPLLTTKKLHLRSIIHELLWFLAGDTNIKYLHENKV
TIWDEWASPEGDLGPIYGYQWRSWPAPDGRHIDQIAAVVESIRTNPDSRRHIVSAWNVAD
IDRMALPPCHALFQFYVAEGRLSCQLYQRSADVFLGVPFNIASYALLTMMMAQVTGLRPG
DFIHTLGDAHIYLNHTEQAAEQLRRTPRPLPVMKLNPAVDSIFGFRYEDFTLEGYDPYPS
IKAPIAV
>KF629989.1_12234|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKISIIAAVDRRMAIGFQNKLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNR
RNVVLSTRPDTVCPGAEVFPSLEVALQSCKEDEHVYIIGGASVYRQALPLADELCLTEIN
DVAPEADAFFPEVSPAQWHEKSREAHPVDEKHLCPYAFVDYVKQ
>KF629977.1_12265|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGTEKSDRTGTGTISIFGHQMRFNLDDGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQEHGVRIWNEWADENGDLGHVYGYQWRSWPDYNGGFIDQISEVVETLK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKNIF
DFKFEDFELVNYDPHPHIAGAVAV
>KF629977.1_12266|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKVSIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTILMGRKTFESLPKGALPNR
RNIVLSSNPDTVCSGAEVFPSLETALRSCREDEHIYIIGGASIYQQALSFADELCLTEID
STAPEADAYFPEVSSKVWQEKSREAHPADEKHLCSYAFVDYVRK
>KF629962.1_12308|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MFSKLFFCLIFLTALTPLYSQEPLAQQLKSIIENKKATVGIAVLYNGKILVTVNDKAGYP
MMSTFKFPLALAVLERLDKQGLPLETELFISKPDLHPDTYSPLREARPEGNFKITIGELL
KYSVALSDNNACDILIDYLGGTSALQKYVRRQGIKQMKITATEDRMHKSGDPYLNHTRPS
SAVRLLEKFIQQELLSPVYQKFLENTMIATSTGSDKLKGLLPAETIIGHKTGSSDRDSTG
MKAGDNDMGFVYLPHGGDHYTIAVFITDSMEDDKTNAAIIAQISKAVYDYINEISS
>KF629962.1_12309|FEATURES|farme|aminoglycoside|AAC(2')-Ia|antibiotic inactivation|0
KSSFTVRQEREAEFPAIYELIRTAFATAEVSDGDEQDFANRLRIHGNYIPELALVAECQG
KLIGHIMLTRTVVTQDDGTPYEALMIAPLSVVLDYRNQGVGSALLKEGLRLAQSMGYRAA
FLCGNPAYYGRFGFKAIGEYGIRLAGLPEELAPYFMVHELIPGSLKSVHGTIDLHA
>KF629958.1_12321|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSLSIIVARAANGVIGNDNKLIWHLPDDLKMFKSRTMGRPIIMGRKTFESLPKVLPGRVH
YVLTGNRAYSVPEGVYVFHTVKELLSALPEGESFIIGGEKMYEAMFPYADKMYITEIEKE
YDGDAVFPSFRKEEWKETESVMGKGDPVHRFVTYERVRG
>KF629948.1_12354|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQIFLANCQEILSRGTWDTHLPVRPRWEDGTPAHTVKCFGLVNRYDLREEFPIQTI
RRMYLKSAVEELLWIWQKKSNNVRALSTGIWDAWADETGSIGKAYGYQMGVKHRYPEGEM
DQVDRVLYDLKHNPSSRRILTNLYNHHDLSEMALYPCAYSMTFNVSGHTLNAILNQRSQD
MLAANNWNVVQYAVLVHMMAQVSGLEAGELVHVIADAHIYDRHVPIVERMLEKEPRPAPR
FVMDPSVTDFYRFTRDSFSLEGYEPHPFEDKIPVAI
>KF629937.1_12387|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKIRVAVIFGGKSNEHDVSVVSATHVIKSIPKDKYDVICIGITKKGHWMKYIGDVDDIA
SNKWEQHPDNVPCVLSPDPLHKGFIALGENGEYQNVKVDVIFPVLHGKNGEDGTIQGLFQ
LAEIPFVGCDCISSANCMDKGLTHTVLDANGIKTAKWVGIITSELSHLDEKCDEMESKLG
YPMFVKPANCGSSVGVSKAKNRDELKSAIKSSLHLLMTARSL
>KF629934.1_12393|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQFDLEKEFPILTTKFVAFKTSVKEILWIWQKQSNDVRLLQQWNCHVWDEWMREDGTIGK
AYGYQLGKYHQVDTLLETLKKDPQSRRMVVDLWNVKDLPDMALYPCAFLTMWDVSDDGRL
NCMLVQRSGDMGLGVPFNMAQYAALVHMIAQVSGLRVGLFTHVINNAHVYKNHVDAMKTQ
LARLPKAYDAPVLKLNPDVHNFYDFKPEDIVLENYKHHEKIAMEVSV
>KF629931.1_12406|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGVHKEDRTGTGTISIFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLQGDTNIKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIAS
YALLLQMVARVTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKDIF
SFKYEDFELVNYDPWPHIAGKVSV
>KF629918.1_12441|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
AVKELLWIFKEQSNGVKRLQEQNVHIWDEWEMEDGTIGTSYGWVVQKFHQMDTLLQQLKT
NPQDRRMMLNLWQIPYLDTGALYPCCFLTMWDVTDGRLNCMLVQRSADWGLGVPFNTSQY
AVLVHLLALVSNLRPGLLTHVINNAHIYENQVEGIRLQLTRRAEAYEAPTLWVNPEIQNF
YEFQIQDIKLMGYKSHDKISMEVAV
>KF629913.1_12455|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGLSTERQVALTSGTGVCRALRERGHQAILVDMFLGLESYEGRLEDIFDAPDG
LCGDNRVTEEAPDLEAVRRSRKDQGPSLLGKDVLAVCAMADIVFLALHGSCGEDGRIQAT
LDLLGVPYTGSGYLGSCMAMDKSVTKRFLESEGIRTAPWRDVHYTASDIPRLVEELEVPC
AVKIVNGGSSIGVELPDTKEQLREALTKLLTYGDHVVVEKKIKGREIQIAVLGDTYLPAV
EIIPRGEYFDYVSKYQKGGAQEICPAPITEEEWHQIGEMALKLHRGLGLSVYSRSDFLLD
EEGKAWCLEINTLPGMTPTSLVPQEAAQVGLSYADLCERIVEESLKARGVQRT
>KF629910.1_12466|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPAITL
RKTYIKSATDELLWIWQKKSNNIHDLHSHIWDSWADESGSIGKAYGYQLGVKHQYKEGMM
DQVDRVIYDLKHNPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQEKGDDRLTLNGIL
NQRSQDVLAANNWNVCQYAVLMHMLAQVCDMRVGELVHVIADAHIYDRHVPIVKELIERP
QYDAPKFWLNPDIKDFYQFTTDDIKITDYVTGEQIKDIPIAV
>KF629902.1_12493|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKLFGKKVIYLEKLNVCVIFGGVSSEHEISKISAATVIDSLDTAKYNIHKIFIDTEGNWI
YFDKPTSEISTLPAGEYDKAIISPSRGDKGLLRFKNNGDIENIKTDVIIPVLHGKNGEDG
TIQGLFEIAGIPYVGSGVLGSAVCMDKCVAKILFKEAGIPQADWITVRTSDISNDNWIKN
VEEKLGFPCFIKPSNAGSSVGISKAHNREEVIEGVNLAFEHDSKVLIEEFVAASEVESAV
IGNTDPMVAENIGEIAPANEFYDFDAKYNDSSSKITIPANVTKDVEAKLKDYAIRAYKIC
ECGGLSRVDFFVDKESGTVRLNEINTLPGFTSISMYPKMWEKSGVGNFKLLDNLINYALD
KNNK
>KF629895.1_12515|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EIDRMALPPCHALFQSYVADGRLSCQLYQRSADVFLGVPFNIASYALLTMMIAQVTGLVP
GEFVHTLGDAHIYLNHREQVALQLTRTPRPLPVMRINPDVRSIFGFRYEDFSLDGYDPYP
SIKAPVAV
>KF629893.1_12522|FEATURES|farme|beta_lactam|BL3_l|antibiotic inactivation|0
MKLQFIGANHEVTGSCHYLQAGDSYMLVDYGMEQGVNQFENCPLPVPESQINFVFLTHAH
IDHSGMLPLLYAHGFRGKIYTTEATADLCSIMLRDCAHIQQQEAEWKSRKAKRHAGIEVE
EPLYTMEDAIGTINCIVPCPYGKELEINDNVTIRFTDVGHLLGSASIEVWLKEEGCSRKL
VFSGDIGNKNQPLIKDPEYTKTADYVVMESTYGDRLHGSTRPDYVRELTQIIQETLDKGG
NVVIPSFAVGRTQEMLYFIRKIKADGLVSNHADFPVYVDSPLAVEATGIFKQNERTCFDE
EAMELVRQGINPITFPGLRLAITSDESKAINFDETPKVIISASGMCDAGRVRHHLKHNLW
RPECTILFVGYQSVGTPGRALIDGVKEMRLFGETVDVNAQIRVLTGISGHADKNGLIDWI
EGFESKPKKVFIVHGEDLVTMSFADCLKDEHGLDAFAPYSGTVFNLTTETFEKITEPVAV
KKKTAAASGGQSSAYNRLVAAGQRLMALIGHCKGMANKDLAKFADQINSLCDKWN
>KF629888.1_12541|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLTSGAGICKTLLENGHQAYLLDLYFGLENAPANLEDVFTLPGA
GLEIAKNISTKEPDLEVLKKSRPDQSDCMFGPNVIELCRMADITFVALHGSVGENGKLQA
AFDLLGIKYTGCNSFGCALSMNKLVTKQIYKMSGVPTPRGTHLTKETKDLPLSELGYYLP
LVVKPCENGSSIGVYICHTEEEYNNAVRESFEKNPDEELVIEPYIKGREFASAVIAGKAL
PLVEIIPKDGVFNYENKYQAGGAQEICPPVSIDEETQQRMMRAGEEAFAALRMDVYARAD
FIIDDEDGEFYSLEMNALPGMTAASLLPKAAKAAGIEYNELCERIIEESMNARYR
>KF629884.1_12554|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
VNSNDYNREKIMNLIAAVDNNWAIGKNNQLLVRIPMDQKFFREMTTGKVVVMGRKTLESF
PNSRPLKNRTNIVLTHNPSYEVEGAVVVHSLDELHKELEKYNSEDIYIIGGQKIYEQLVD
ECDVAHITKVDFEYDADAYFPNLDGKPEWQITGDSEEQTYFDLEFYFLRYEKVK
>KF629884.1_12555|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KEFPAITLRKTYIKSATDELLWIWQKKSNNIHDLKSHVWDEWADEDGSIGKAYGYQLGVK
HQYKEGMMDQVDRVIYDLKHTPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQKKGDD
RLTLNGILNQRSQDVLAANNWNVCQYAVLMHMLAQVCDMRVGELVHVIADAHIYDRHVPI
VKELIERPQYDAPKFWLNPDIKDFYQFTTDDIKITDYVTGEQIKDIPIAV
>KF629875.1_12583|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MGYDVKQKIDTNAKIAVLMGGPSNEAEISRRSGKNIFKALQNLGYKNAELIEVDENIAAT
LRTKNIEFVYNAMHGRFGEDGCIQGMLEVMGIPYTGCGVMASSVCMNKEYTKNILKEAGI
PLIKSVLIKKGEDYKEKIKELKYPFMLKPVSEGSSIGMYKVNNPEEMAECFEKSAKYGQD
VMVEEFIQGKGLTVGVLEDGDKMFATEIIEFRTKTEWYDYEAKYTAGMTEFIIPAELSEE
MTKKVKQIAVDAFKACDCRGVSRVDFMVADDKAYVLEINTSPGMTDLSDLPAQSNAMGID
YDTLVQII
>KF629874.1_12586|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
FIKPSLGGSSFGVTKVKTKEQIQPAIVKAFGEAQEVLVEAFMDGTELTCGCYKTKEKTVI
FPPTEVVTHNEFFDYDAKYNGQVDEITPARISDELTKRVQMLTSAIYDILGCSGIIRVDY
IVTAGEKLNLLEVNTTPGMTTTSFIPQQVRAAGLDIKDVMTDIIENKF
>KF629867.1_12601|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MYLKSAVEELLWIWQKKSNNVRALSTGIWDAWADETGSIGKAYGYQMGVKHRYPEGEMDQ
VDRVLYDLKHNPSSRRILTNLYNHHDLSEMALYPCAYSMTFNVSGHTLNAILNQRSQDML
AANNWNVVQYAVLVHMMAQVSGLEAGELVHVIADAHIYDRHVPLVEELLGRTPYPAPRLR
LDPAVTDFYAFTPDSVQLENYRYHPLKEKIPVAI
>KF629858.1_12621|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNISIIVAIARNHGIGFENKLLYWLPNDLKRSKALTTGHTIIMGRKTFESLPKGALPNRR
NIVLSRREGAAFAGAECFPSLEIALSHCKEEEEIFIIGGASLYKEAMHIARQLYITFIDD
TSKEADAYFPEIKKEEWKETGREDHPTDEKHLYPYSFINYSRIK
>KF629850.1_12649|FEATURES|farme|chloramphenicol|catA13|antibiotic inactivation|1
MMQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTIIN
RHEEFRTALDENGQVGVFSEMLPCYTIFHKETETFSSIWTEFTADYTKFLQNYQKDIDAY
GERKGMFAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGEKYYIP
LSIQVHHAVCDGFHVCRFLDELQDLLNK
>KF629845.1_12659|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MISIIAAVDRKRGIGYQNRLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRN
VVLSTQKDLICPDAEVFSSLEEALNSCQPDEHVYIIGGASVYRQALPFAGALCLTEVDAE
APQVDAYFPEVAPTVWQEKSRESHPADEKHPCPYAFVDYIRR
>KF629841.1_12668|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
EKYNLYIVEMEGRRWEVQLPDGSKTPVDRNDFSFMNGAEKVVFDFAYITIHGTPGEDGRL
QGYFDMMRIPYSCCGVLAAAITYDKFVCNQYLKAFGVRISESLLLRQGQAVSDEDVVEKI
GLPCFIKPNLGGSSFGVTKVKTREQIQPAIAKAFSEAEEVMIEAFMGGTELTCGCYKTKE
KSVVFPLTEVVTHNEFFDYDAKYNGQVDEIITPARISEELTRRVQTLTSAIYDILGCSGI
IRVDYIITEGEKINLLEVNTTPGMTATSFIPQQVRAAGLDIKDVMTDIIENKF
>KF629833.1_12688|FEATURES|farme|trimethoprim|dfrA|antibiotic target replacement|0
RPLQNRTNIVLTHNPSYEVEGAVVVHSLDELHKELEKYNSEDIYIIGGQKIYGQLVDECD
VAHITKVDFEYDADAYFPNLDEKPEWQITGDSEEQTYFDLEFYFLRYEKVK
>KF629820.1_12726|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKQTLILLYGGRSAEREVSVLSAESVMRAVDYSAFEVKTYFITQSGDFIKTQEFIETPG
DDEKLMTNDTVEASQAIKPSDIYEEDAVVFPVLHGPMGEDGSIQGFLETLKLPYVGTNVL
SSSVAMDKIMTKRILEVAGVPQVAYTGYIEGEDLEAAVAETLEKLTFPVFVKPANMGSSV
GISKAENESELR
>KF629811.1_12754|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
KDFYDFTPEDITLDGYEHLGKLSMTVAV
>KF629808.1_12762|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGISTERDVSLVTGASVCRALRENGHKAIFVDLFLGLEQVPDPLEALFDAPDG
LCPDVKISAVAPDLEAVRRSRADQSTRLFGPHVLEVCALADLVFLGLHGQDGEDGRIQAA
FDLLGIRYTGGGYLGSGMAMDKSITKMIMDQVGIPNAPWRNIPHYTEADIPRLTEELEVP
CAVKVVNGGSSLGLALPDTKEELAQALHDLLRYGSHILVEKKIHGRELTVAVLGDRWLPA
AETIPASGAFDYAAKYQPMAAGGAREICPAEITPEQMAAAGELALRLHRALG
>KF629797.1_12792|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNIIAAVDKHWAIGNRGKLLVTIPDDQKLFREETKGKVIVMGRKTLESLPAGQPLAGRKN
VVLTRDEAYKVKGCEIFHNLKDAMEFLKQFKSEDIYIIGGAEIYEAFLPYCDTAHITWID
YEYMADTWLPNLDKDPDWEVTADSDEQTYFDLCYEFRRYERTGKKALELGEV
>KF629793.1_12800|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILRIYQKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYAEGDF
DQMDRVLYDLKHTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMIL
NQRSQDILAANNWNVCQYAILLMMVAQSIDMIPGELLHVIADAHIYDRHVDIVRELIERP
QFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF629789.1_12813|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKKRIVVMYGGKADEHSISCISAASALRALDTDKFEAIPVGITKDGKWIVNGENPLGWS
PDEGLPTVEKTPGAKDVVLEVALGQDGFFAREDDGTLTPFGHVDAVFPVLHGPYGEDGTI
QGLFEMMGVPYVGCGVLASAACMDKHYTKVLLAAACIPVAPGITLDARSFDKASEFKANA
DAIMAQVSEAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVYEASHHDWRILVEQG
IDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYMDAAASHVEVPANL
PEETLNLVRETAKKAFVAVDGAGLSRVDTFVTKDGKVMVNEINTMPGFTSISMYPKAWEA
TGVRYTDLITMLIEGVLR
>KF629773.1_12859|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSNENKKLTLAVIFGGVSSEHDISCISAKGIISNIDYNKYNVILLGITKDGRWYIFNDDI
SLLPNDRWTESKSLIPAYISPDTSVGGIVTAKGEVIELDCVFPVLHGKNGEDGTIQGLLQ
LAQIPYVGCDATSSGVCMDKAVANAVADAFDIPQAKWCAFTQYTFNKDRQQCIEYAVNKL
GFPIFVKPANAGSSVGITKAHNVNELIEAMAVAFKEDKKAVLEEFIDGHEVECAVLGNDE
PIPAEVGEIKAAADFYDFDAKYNNPQSELCIPADIPEEKRNEVRVQAVKAYKALGCEGMS
RVDFFVRKSDGAVLLNEINTIPGQTPISMYPKLFEAAGVPYKELIDRLIGCALSRGGKF
>KF629766.1_12880|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIIKELIKRPTYPAPKVTLNP
EVKDFYKFTVDDFMIEDYQAGPQIKNIPIAI
>KF629765.1_12883|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
TSLGHVDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVVLDAAGI
PTAPGVTVDARNFTAADVLAEIEDAGLTYPLFVKPSRAGSSFGVTKVEKADDRETQQDRL
AAAIATAGEHDWKVLVEQGIDGREIECAVLCPKAGDEPEASWPGEI
>KF629759.1_12897|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGRKTFESLPKGALPNRRNIVLSRREGAVFAGAECFPALEIALSHCKEEEEIFIIGGASL
YKEAMHIAQQLYITFIDDTSKEADAYFPEIKKEEWKETGREDHPTDEKHLYPYSFINYSR
IK
>KF629753.1_12915|FEATURES|farme|macrolide-lincosamide-streptogramin|RlmA(II)|antibiotic target alteration|0
MEYSKEDLMEAKKQIWGVGENMGTEESKKIWEENAQFWDNAMGDESNEFHREVVRPKVTE
LLSPNPADYILDIACGNGNYSSYLAQRGASVVAFDYSKKMIELAKRRQSQYAKQIEFCVA
DATDRKSILELKRNRAFTKAVSNMAIMDITDIEPLLMAVYELLQESGIFVFATQHPCFVT
LTEKYMTPHSYYDIAIEGQPKEQIYYHRSIQDIFNLCFRAGFVIDGFYEECFKTNKEIPM
VMIVRLKKVKRDSLK
>KF629740.1_12957|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
EGERKVFDYALIIIHGTPGEDGRLQGYLDMMGVPYSSCSMTSSVITFDKVTTKRTVAGRG
INLAREIFLCKGETAGPDEVIAEFGLPLFIKPNASGSSFGVTKVHTRDEVLPAVEAAFAQ
SDEVLIEECIEGREMGCGMMVAGGREYLFPITEIVSKKDFFDYQAKYTEGYSDEITPAQI
APEIAEELHRMTRIAYKACRCSGVVRVDFIVTPEGKPYMIEINSIPGMSAGSIVPKQAKA
MGMTLGEMFDLVIADTCRK
>KF629737.1_12967|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSPERDVSLSSGSLIANALIENGHDVLLLDLYLGYDGDAAQAEFLNRSDSE
RYSYTIPEREPDLEALKASSGNGRRLVGNGVLELCQRADVVFIALHGDIGENGQLQSMFD
VLGVCYTGTDYTGCLLAMDKDISKKLMAANGISTAGWRSFPIRQQEECDFSQVRYPCVVK
PCNGGSSVGVTMVDDADGLEEAIRAARVYEDQVIVEDRIFGREFSVGILNGEALPVIEVI
PKEGFYDYKNKYQTGMTQEICPAQLPDRLTRRLQESALAVHQLLRLGCYSRIDFMLDRNN
>KF629725.1_12999|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MEFKLIDKDNWKRKEYFDHYFFNVPCTYSMTVKMDITKIIKKKQKLYPTML
>KF629722.1_13004|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MRIVVLAGGLSTEREVSISSGTLVAEALRSKGHEVVLLDVFMGYEENICDIDALFKQNYS
FTDGNSIGDDVENTITNIKEAKEKRLDKTSRYIGRNVIEICAEADITFLALHGGEGENGQ
LQATLDLFGIKYTGSGYLGSALAMNKGLTKSVFMQKNINTPSGELYKNEKDALAWNMFPC
IVKPCSGGSSVGVSKVENADQYKKAVKEALKYEDEIVVEQFVTGREFSVGLIGGKALPPI
EIAPKSGMYDYAAKYQAGATVETCPADIDEETDKKLRDAATEAYEALHLESYARIDFLLD
KGGFTYCLEANTLPGMTPTSLLPQEAAVEGISYPDLCEKIIEISLAKYPKEKSDF
>KF629717.1_13020|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic target protection|0
MAGNRNEEMVYCSFCGKNQEEVKKIIAGNGVFICNECVALSQEIIREEMAEEVLADLAET
PKPKELLDILNNYVVGQDRAKRALAVAVYNHYKRINFTESREDNDVDLQKSNILMIGPTG
SGKTFLAQTLARSLNVPFAIADATSLTEAGYVGEDVENI
>KF629716.1_13028|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ILDAGSLGDNRTGMPAYKLPHQIMQFDLEKEFPILTTKFVAFKTSVKEILWIWQKQSNDV
RLLQQWNCHVWDEWMREDGTIGKAYGYQLGKYHQVDTLLETLKKDPQSRRMVVDLWNVKD
LPDMALYPCAFLTMWDVSDDGRLNCMLVQRSGDMGLGVPFNMAQYAALVHMIAQVSGLRV
GLFTHVINNAHVYRNHVDAMKTQLARLPKAYDTPVLKLNPDVHDFYDFKPEDIVLENYKH
HEKIAMEVSV
>KF629715.1_13031|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MISIIAAVDRKRGIGYQNRLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRN
VVLSSNPAAECPGAEVFTSLEAALESCQAEEKVYIIGGASIYRQAISLADELCLTEVNDT
APEADAFFPAVDTTIWHEKSREVNPADEKHLCSYAFVDYVRGID
>KF629714.1_13038|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTFNVTQKQGDDKLTLNAILNQRSQDVLTANNWNVCQYAVLMHMLAQVCDMKVGELVHVI
ADAHIYDRHVELVKELITRQQHPAPKFWLNPEIKDFYQFTPDDIKVTDYVTGPQIKNIPV
AI
>KF629712.1_13043|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
VSRIAMIAAYDRRRAIGKNGRIPWRIPGEQQRFRSLTLGQTVIFGRRTYEEIGVPLPGRE
NFIVSRTRQFTGAHLRTFPTLADAVAAAETEQVFLGGGAGIYAEGMALAETLYLTEIAGD
FHGDTFFPPLPAGQFARTAEERHGGGIPYVYVTYRRKW
>KF629711.1_13047|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLLSGAGICKTLREMGHQAFLLDVFFGLPYDSDKLEEIFDRPDG
GLEISKGISTSVPDLGALRKSRPDQSPSEIGPNVIELCQMADITFMALHGSIGENGKLQA
TFDNLGIKYTGPNSLGCTLSMNKLVTKQIFKTSGVPTPRGTSLTVKTKDTRLDELGYYLP
LVVKPCSNGSSIGVYICHTEEDYYDAIHKSFDVDNTDEVVIEPFIKGREFACGILAGKAL
PLVEIVPKDGLFDYANKYQAGGASEICPPISLDAETQELIQRAGERAFEALRMDVYSRAD
FIVSDADGEFYCLEMNALPGMTAASLLPKAAKAAGYEYSELCEAIIQESMKARY
>KF629694.1_13093|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VITKNNTVAVLMGGVSREADISRKTGTAILQALLSLGYHAVKVEYNPSCVLKQLKAVGAE
VVFIALHGKYGEDGTIQSILELSKIPYTGSGVSSSAITMDKIISSRVFKDAGVRMAFSKP
YYLKNGIDTVAESIEKNFKFPVVLKPACEGSTIGLEIVYEKEKLKEALKRVFAIESRILA
EAYLDGKEFTIAVLNGKALPIIQICPHSGQYDFHSKYTSGATRLYSTCTIAGSRG
>KF629692.1_13099|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MVERIYHVGLTVSDLDRSIAFYRDILGLEVQGEIFMAGEETDRLFRMKDTKARVAYLNGS
KAMEAPPIELIQFV
>KF629665.1_13170|FEATURES|farme|quinolone|patB|antibiotic efflux|0
IREEGMFSLEKGRTFYTSNAGLKELRKEICNYLERKIHVKYDAVHETLVTVGGSEAIDVG
LRCMLDPGDEVLIPQPSYVSYLPCTVMADGVPVIIPLQEKNEFKLTAEELEKYTTPKTKV
LVLPFPNNPTGAIMTREDLEPIAKFVEEHDLYVMSDEIYSELTYKEEHVSIASLPGMRER
TLVINGFSKGFAMTGWRLGYCCGPEVIISQMTKLHQFAIMCAPTNSQ
>KF629663.1_13174|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MDTETVSPNFDDIRPLNNSEVKDAIEKLVANEDFERALRYIKPNLNWEEFSVAMRACKTK
EEFKSTLAYDAVMTVAKNTTFSLTISGRSRLPKDKAACTFISNHRDIVLDASFLNVMLYD
VGYGMTQVAIGDNLLIRPWIETLVRLNNSFIVKRGVSVRQMLEVSKTLSAYIHHAIKNVN
ESVWIAQREGRAKDSDDRTQGSVLKMLSIGGDKDNLLLNLMDLNIVPVAISYEFDPCDFL
KAKEFQMKRDDPDFVKCQRDDLLSMETGILNNKGRVHFTITSPINDSLAKLDKDMEKNEL
VSAIASVI
>KF629661.1_13179|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKRLNIALMAGGDSSERGIALQSAAQIASALDPAKYDITLIDLHGRDWHYTSPDGRQWQV
DKNDFSITIDGEHKAFDYALILIHGTPGENGRLQGYLDMMGIPYSSCSMTSSVVTFDKIT
TKRTVAEFGIPLARGFFFGRDSRIDPKEIVRTLGLPVFVKPNASGSSFGVTKVKSEADIL
PAVAEAFAQGDEILIEECITGREMGCGMLVAGGREYVFPITEIVSKKDFFDYEAKYTAGF
SDEITPADITPEVKAELNRMTREAYRTCRCSGVVRVDFIVTPAGVPYFIELNSIPGMSRG
SIVPKQAREMGMSLGELYDIIIADTCRK
>KF629656.1_13189|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKKRIVVMYGGKADEHSISCISAASALRALDTDKFEAIPVGITKDGKWIVNGENPLGWS
LDEGLPTVEKTPGAKDVVLEVALGQDGFFAREDDGTLTPFGHVDAVFPVLHGPYGEDGTI
QGLFEMMGVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDARSFDKASEFKANA
DAIMAQVSEAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVYEASHHDWRILVEQG
IDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYMDAAASHVEVPANL
PEETLNLVRETAKKAFVAVDGAGLSRVDTFVTKDGKVMVNEINTMP
>KF629648.1_13206|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
AGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIAPGLALEAGDEVD
IDRIVEICGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKVLVEKCIEGTEIT
VGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPENYARAQELACAA
HKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLY
>KF629643.1_13215|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIGGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAAS
EFATEADEMLAAVQQAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVFEASHHDWR
VLVEQGIDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYVNSDASHV
EVPASLPEETLNRVRETAKKAFIAVDGTGLSRVDTFVTADGEVMVNEINTMPGFTSISMY
PKAWEATGVRYTDLITMLIEGVLR
>KF629628.1_13250|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VSCLSATTVIKNMDTEKYNVILVGITKEGRWLLVDSVKDIEDGSWREGEVKAFISPDTTT
RSLVILAEGTYKLQKVDVIFPVLHGMNGEDGTVQGLFELSKIPYVGCGVLASAVSMDKVY
TKIIVDHIGIDQAKFVHVRESDFEHLEEAMDRVEKEIPYPIFVKPSCAGSSKGVSKAENR
KELEAALYEAVKHDRNILCEETIVGREVECAVLGDRTQVKSTCVGEILAAEEAAFYDFDA
KYNNAESKTVVDPEMPEESKRKIKEDAEAIFRAVDGFGLSRVDFFLEESGRVVFNEINTL
PGFTSISMYPMLWKACGLDIPELLDTLIDQAMTRYR
>KF629627.1_13252|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
NMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADDFMVTMATGGFDVAF
IAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLSAKAGIPIAPGLALEV
GDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEY
>KF629622.1_13262|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGNKVPVD
RNDFSFMNGTEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFAC
NQYLKAFGVRIAESLLLRQGQSVSDEDVLEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQP
AIVKAFGEAEEVLVEAFMEGTELTCGCYKTKEKSVVFPPTEVVTHNEFFDYDAKYNGQVD
EITPARISDELTDRVQMLTSAIYDILGCSGIIRVDYIVTAGEKINL
>KF629602.1_13315|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
RKEERMNIIVAADKNWAIGKDGELLVRISEDMKNFSAITTGNVIVMGRKTLESFPGGKPL
PNRVNIVLTHEKDYNGKGAIVVHSEEELWEELSKYDTDSIFVTGGESIYRMLLPYCDTAY
ITRLDYAYEADTWMPNLDKEEHWSMVEKGEERYCFDLIYHFTTYKNERPALH
>KF629593.1_13349|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
GMTEEICPARIPEETAKKIQAISEHAFQALKLDVYARADFLLTEDGNIYCLEYNSLPGMT
AASLLPKEAKAAGIEFGELCELLIEKSMDARYCG
>KF629590.1_13356|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SIGKAYGYQMSVKHQYKEGMMDQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAY
SMTFNVTKKNDSDKLVLNGILNQRSQDVLAANNWNVCQYAVLMHMLAQVCDMQVGEFVHV
IADAHIYDEDAPIYDRHIALVEELISREPLPAPTFWLNPKVKDFYEFTPDDVRLDNYETG
PQIKNIPIAV
>KF629575.1_13382|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
LGLEAEEREVYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGPVIQKLY
DTLTGIQMGRIQAPEGWLKVIE
>KF629574.1_13388|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADKNWGIGKNNQLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRTN
IVITKNKDYDAKGAIVVHSIEEALEEIKKYPTEDVYCIGGDSIYEQMLPYCDVAHVTKID
FAYEADSHFPNLDEDDEWEITAESDEQTYFDLEYQFVKYERKK
>KF629567.1_13413|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MINNDKKITLAVIFGGVSSEHDISCISAKGIVSNIDYSKYNLILLGITKDGRWFIFNDNI
ELLPEDKWLNSKSLVPAYISPDSSVHGIVTAKGEIIKLDCVFPVLHGKNGEDGTVQGLLQ
LAQIPYVGCDATSSGVCMDKAVANAVADAFGINQAKWCAFTQYDFNKNRQECIDTAVNKL
GFPIFVKPANAGSSVGITKAHDIPELIEAMNVAFNEDKKAVLEEFIDGHEVECAVLGNVE
PIAAEVGEIKAAAEFYDFDAKYNNPASELCIPADIDLEKRNEVKAQAVKAYKALGCEGMS
RVDFFVRNSDGAVLLNEINTIPGQTPISMYPKLFEAAGVPYKELIDRLIGCALSRGGKF
>KF629555.1_13450|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIVAVDKNWAIGNNNELLVSIPDDMKFFREHTTGNVIIMGKKTLESFPGKRPLKNRVN
IVITKNQNYKVDGAIVVHSIEEAVEKAKGYNEDVYVIGGGSIYKQMLPYCDTAYVTYIDH
QYAADTFIPNLDEMTDQWELAEESDENTYFDLEYYFRTYKRK
>KF629554.1_13455|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LHMLAQVCDMEVGEFVHVIADAHIYDRHVPMIEELISREPLPAPQFWLNPEIRDFYQFTR
DDVKLIDYQTHDQIKNIPVAV
>KF629533.1_13510|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGIHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLQGDTNVKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIAS
YALLLQMVARVTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKDIF
SFKYEDFELVNYDPWPHIAGKVSV
>KF629529.1_13523|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
YDVTLVGIDQDGSWYLLDQGQDDLAQDTWLENSQVIQDIFGVLKQQDVVLPILHGAFGED
GTIQGLFELAGVPYVGCRVLASAVSMDKIYTKKILETAGIPQVKSLYVKKRYDGKLVVVN
KQFDEIEDIEKTVEKELGFPCFIKASRSGSSVGCYRCDHKEDLMTKLIEASKYDRHIVVE
ECVDCIELETAVLGNDDPIVSRVGQIMPHGEFYTFESKYEDEESKTCIPALVDQEIQDKI
REYALRVFKAVDGHGLSRVDFFLDKKSNQIYLNEINTLPGFTKISMYPQLMN
>KF629525.1_13532|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
VPRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTAYLAGGMF
LQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLCFIGAVGY
AAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAALAAISFFG
LQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIAQSPIIII
TGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATV
ISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLIFTVGIEI
SKHAWLNGGNGQFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>KF629524.1_13536|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGAKAPVD
RNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFAC
NQYLKGFGVRIAESLLLRGGQSVTDEDVMEKIGLPCFIKPSLGGSSFGVTKVTAKEQIQP
AITKAFAEAQEVLVEAFMDGTEITCGCYKTKDKSVVFPITEVVSHNEYFDYEAKYNGASD
EITPARISDDLTRRVQTLTSAIYDILGAYGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAAGMEMKDVMTDIIENKFKD
>KF629519.1_13554|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
PPLEDIDWSSIGFAYMPTDYRYVSNFKDGKWDEGTLSTDPNIVLNECAGVLQYSQSVFEG
LKAYTTEDGHIVTFRPDLNAERMAASAARLEMPVFPKERFIDAVEQVVKANAAWVPPYGS
GATLYLRPYMFGSNAVIGVKPADEYQFRILTTPVGPYFKGGAKPITIRVSDYDRAAPCGT
GNIKAGLNYAMSLHAIVDAHKQGFDENMYLDPKTRTKVEETGGANFIFVTKDGKVVTPKS
DSILPSITRRSLIYVAKEYLGLEAEEREVYFDEVKDFAECGLCGTAAVISPVGKINDHGK
EICFPSGMEKMGPVIQKLYDTLTGIQMGRIEAPKGWIHVIE
>KF629516.1_13562|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DLHEMNLYPCAYSMTFNVTKERGSDRLTLNGILNQRSNDVLAANNWNVCQYAVLLHMLAQ
VCDMQVGEFVHVIADAHIYDRHVPMIEELIKREPLPAPKFWLNPEIKDFYQFTRNDVKLI
DYETHEQIKDIPVAV
>KF629511.1_13579|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGEPAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMM
DQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIIKELIKRPTYPAPK
VTLNPEVKDFYKFTVDDFMIEDYQAGPQIKNIPIAI
>KF629505.1_13594|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VITKNNTVAVLMGGVSREADISRKTGTAILQALLSLGYHAVKVEYNPSCVLKQLKAVGAE
VVFIALHGKYGEDGTIQSILELSKIPYTGSGVSSSAITMDKIISSRVFKDAGVRMAFSKP
YYLKNGIDTVAESIEKNFKFPVVLKPACEGSTIGLEIVYEKEKLKEALKRVFAIESRILA
EAYLDGKEFTIAVLNGKALPIIQICPHSGQYDFHSKYTSGATDYIVPAPLPGAAADEMTR
MAILGYEAAECSGVVRFDFRTDKRGTPFLLEANSIPGMTETSLVPKAAAAIGMDFPSLCE
NILLKAGVGKV
>KF629480.1_13662|FEATURES|farme|macrolide-lincosamide-streptogramin|clpX|antibiotic target alteration|0
MVGNRTNDVKVYCSFCGKSQDEVKKIIAGNNVFICNECVALSQEIIKEELAEEVLADLAE
VPKPKELLATLDEYVVGQERAKRALAVAVYNHYKRVSFAESRDEEDVELQKSNILLIGPT
GSGKTFLAQTLAKSLNVPFAIADATSLTEAGYVGEDVENILLKLIQAADFNIERAERGII
YVDEIDKIAKKGENVSITRDVSGEGVQQALLKIIEGTVASVPPQGGRKHPNQEMIQINTK
NILFIVGGAFDGIEDIVKQRLGEKVIGFGQNNRKIDEDASYMQEIISEDIQKFGLIPEFI
GRLPVVAALEQLTTDDLVRILTEPRNALVKQYQTLLSYDGVELEFDEDALQAIANKAIER
KTGARGLRSIIEETMMDIMFEIPSRVEVTKVRITKDAVEGKDKPILEIA
>KF629474.1_13684|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLDLRFCAVKLASMALTPEQLADIRTRIPARPETGIPMPYEDLVRRILTEGTLKSDRTGT
GTVSLFGQQMRFDLSEYFPLLTTKTVFFKGLAYELLWFLKGSTNVRWLQEHNVHIWDEWA
DENGDLGPVYGAQWRSWPAPTPDDPNRTIDQISNVLDLVKNHPDSRRMVVSAWNPAEVEN
MALPPCHALFQFYVADGKLSCQLYQRSCDMFLGVPFNIASYSLLTLMIAQQTGLQPGEFV
WTGGDCHVYDNHIDQV
>KF629465.1_13708|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADQNWGIGKDNKLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRTN
IVITKNKDYDAKGAIVVHSIEEALEEIKKYPTEDVYCIGGDSIYEQMLPYCDVA
>KF629463.1_13712|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MSRADEIFKANCRDILDSGVWDTDLTVRPHWEDGTPAHTVKKFGLVNRYNLQEEFPILTL
RRTYFKTCIDELLWIWQQKSNNIHDLRGHIWDSWADETGSIGKAYS
>KF629461.1_13717|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLSSAAGICRTLVEKGHDAFLLDVFMGLENAPENLEDVFTLPDH
GLEIVKNISTEEPDLEAVKASRPDQSDCFFGPNVIELCRLADITFLGLHGGEGENGKLQA
SFDLLGIKYTGPDSLGCAVAMHKGVAKQIFLESGVDTPGGGTIYKNSEDQSYQSLGLTLP
VVVKPCSGGSSIGVYIVNTDEEYAEALKKSFRYEDELVVEPYIKGREFACGIIDGTALPP
IEIIPKTGFFDYANKYQDGATSEVCPADIPEEVAERMKELTVKAFNALKLNVYSRADFLL
DAKGNLFCLEMNTLPGMTSASLLPKEAKVYGIEYGDLCELIIKKSMEARY
>KF629459.1_13721|FEATURES|farme|multidrug|efmA|antibiotic efflux|1
MKENKNWKKQIALFLISQNLSMFGSSVVGFSIVWYITVTTESGFWITLSTLATLIPQVLV
SLWAGVFADRYNKKTIIMLADGFTALATLLAFVAFHYGFANLSFLIFIACLRSVGGGFQA
PAVNALYPEIVPREHLLRINGINQMANNVLLLLSPAAGGAILGMVGMQWTFLVDLLTAVI
AIAIMFRLKIVTRAADRSDSSVLKELREGVRYTWSQPLLRVMLVCYAVTFILITPAAFLS
PLMVVRSFGSEVWKLTANEMLWSLGALLGGAFVAWKGEFKNKITMIAVSLAVFGCTFALM
GLSRVFWVYLIFDCICGMFVPVLIASETVLIQTNTEKGYMGRVFALLQFVSQGMMPIAIL
GFGPLSDLVRIESIMIGCGLLLICWSLYFKKAAGRALCSI
>KF629456.1_13727|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
DARNFTAADVLAEIEDAGLTYPLFVKPSRAGSSFGVTKVEKADDRETQQDRLAAAIATAG
EHDWKVLVEQGIDGREIECAVLCPKAGDEPEASWPGEIVLDHQNDDQFYDFDSKYMDASA
SHVEVPANLPVSVLEDVRDVARRAFKAVDGAGLSRVDTFVTPDGTVMVNEINTMPGFTPI
SMYPKAWDATGVSYTELITRLIEGVLR
>KF629447.1_13753|FEATURES|farme|glycopeptide|vanM|antibiotic target alteration|1
MSKQTLILLYGGRSAEREVSVLSAESVMRAVDYNAFEVKTYFITQSGDFIKTQEFIETPG
DDEKLMTNDTVEASQAIKPSDIYEEDAVVFPVLHGPMGEDGSIQGFLETLKLPYVGTNVL
SSSVAMDKIMTKRILEVAGVPQVAYTVYIEGEDLEAAVAETLEKLTFPVFVKPANMGSSV
GISKAENESELRSAIDLALKYDSRILIEQGVVAREIEVGILGNTTVKTTDPGEVVKDVAF
YD
>KF629444.1_13761|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIVNADKNWGIGKKNELLVHIPNDMKMFRQMTTGKVVVMGRKTLESFPNGMPLPKRTN
IVLTHDKDYDAKGAIVVGSKEELLDELEEYKDEDIFIIGGESIYRMMLPYCDKAYVTRTD
FAYDADTYFPNLDEMPEWKLVKESEEETYFDIEYQFLVYQK
>KF629442.1_13767|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADKIFVTMCQDILENGTSTEGEKVRPHWEDGTSAYTIKKFGVVNRYDLSKEFPAITL
RKTAIKTCTEEMLWIWQRKSNNIHDLNSTVWDEWADENGSIGKAYGYQLAQKHQYREGMM
DQVDRVIYDLKNNPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQKQGDDKLTLNAIL
NQRSQDVLTANNWNVCQYAVLMNMLAQVCDMKVGELVHVIADAHIYDRHVELVKELITRQ
QHPATKFWLNPEIKDFYQFTPDDIKVTDYVTGPQIKNIPVAI
>KF629440.1_13771|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
NKLLVSIPSDMKFFRETTTGNVVVMGRKTLESFPNGMPLKNRTNIVLTGNRDYQVKGATV
GHSMEELLEELKKYNSEQIYVIGGDSVYRQMLPYCDVAHITRIDHAYEADAYFPNLDEME
DWYIAADSDEQTYFDLEYQFLMYKRKKK
>KF629437.1_13777|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MELKSGGIKDKHMSMADEIFINMCRDILENGTSTEGEKVRPHWPDGTSAYTIKKFGVVNR
YDLSKEFPLLTLRRTALKSATDEILWIWQQKSNNIHDLHSHIWDEWADEDGSIGKAYGYQ
LGVKHLYKEGLFDQVDRVIYDLKNNPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQK
IGHDKLTLNAVLNQRSQDVLAANNWNVVQYSVLLHMLAQVCDMEVGELVHVIADAHIYDR
HVPIIKELISRTPYPAPKFWLNPEIKDFYQFTRNDVRADDYVTGEQINDIPIAI
>KF629413.1_13843|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MGALVAGAKYRGEFEELISREPLPAPQFWLNPEIRDFYQFTRDDVKLIDYQTHDQIKNIP
VAV
>KF629401.1_13878|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVCGGDTSEFQVSLRSAQGIYSFIVKEKYTLYIVEMHGLDWHVQLPDGGKAPID
RNDFSFQMNGRKVTFDFAYITIHGTPGEDGRLQGYFDLLHIPYSCCGVLAAALTYDKFAC
NQYLKVFGVRIAESLVLRQGQSISDEDVIEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQP
AIVKAFDEAQEVLIEAYMEGTEVTCGCYKTKEKSVVFPITEVVTENEFFDYDAKYNGQVS
EITPARLSDDLTHRIQTLTSAIYDILGASGIIRVDYIITAGDKVNLLEVNTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIENQL
>KF629393.1_13905|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
SPSMSKPLPAPKFWLNPEVKDFYQFTRDDVKLIDYQTHDQIKNIPVAA
>KF629391.1_13909|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIAAVDKNWAIGLKNKLLVSIPADMKFFRETTTGKVVVMGRKTLESFPNQRPLKNRVN
IVLTKDEAYQVKDAVVVHDMEQLREELAKYPSEDIYVIGGESIYRQLVDECDVAHITKID
YAYEADAYFPNLDEKEEWEITADSEEQTYFDLEYQFLKYEKRSC
>KF629390.1_13911|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
ECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYMDAAASHVEVPANLPEETLN
LVRETAKKAFVAVDGAGLSRVDTFVTKDGKVMVNEINTMPGFTSISMYPKAWEATGVRYT
DLITMLIEGVLR
>KF629385.1_13925|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MEFEEIRPYHDEELPQIFEELIADPAFQQVACAVMPGVPFEAIAQKMRASKTKQEFQENL
CYGILHKLAKDTTDGLILESMAVLNKQSAYTYVSNHRDIILDSGFLSVLLVEQGLDTVEI
AIGDNLLIYPWIKKLVRINKCFTVQRALTMRQMLESSIRMSRYMHYTIAEKKQSIWIAQ
>KF629382.1_13931|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMQSEDKLCVVVLFGGMSSEHEVSRVSAGTFVDNLDRARYEVLTVGITREGRWLCTEATS
AQMADGSWEELPGNMPCVISPDRADHGMILFTPSGQVEKLHVDVVIPALHGLWGEDGTVQ
GLLELAGIPYVGCGVLASAVCMDKAVANALFDAAGIPHTKWLSACRWEIESDLDGVCDGA
IAKLGWPIFVKPANAGSSVGITKAHDRDELKQAIALALENDHKVVFEAFVDGHEVECAVI
GSDPAVATRPGEILAGAEFYTYDDKYKNGVSQVVIPARLSEEKLDEVKTYAAMAYTALNC
EGLARCDFFVEHGTNRVMINEINTFPGFTPISMYPKLMEHEGTPVPALIDHLIELALERT
EKQHG
>KF629379.1_13941|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VPFNIASYALLLQMMAQVTGLKAGDFIHTLGDAHIYLNHLEQVKLQLSREPRDLPQMRIN
PDVKNIFDFKFEDFELVNYNPHPHIAGKVSV
>KF629368.1_13973|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MIAAVGKNLELGKDNNLIWHFKDDMAFFKETTTGSSIIMGRKTFESLPKVLPRRKNIIIT
KKEDYKAEGATVVHSIGEALNEVESDTAFIIGGGDIYRQFLPKAEKLYLTEIEAECPDAD
AYFPAFNKAEYKKELLASYHDKGIHFSHVCYTKK
>KF629368.1_13974|FEATURES|farme|trimethoprim|thymidylate_synthase|antibiotic target alteration|0
MSQWDKDYLCLCRRILEEGTEVVNRTGTNTIKVPSHNFHFDLSKEFPILTTKQLFLRQAV
LEMLWIYQAQSNDVRWLQERDVKIWNEWEIDSEGYWNASQMLPDENGKLVKTPVHKFFGK
EWAHTIGTAYGYIVNKFQMTQQLIDKIKNHPEDRRMVMTLWQNDYLDTAVLPSCVWSSEW
DVTDGKLNCWVHQRSCDVPLGLPFNVTQYATLLCMLAQVCGLKPGTMDWSIKDAHIYVNQ
IDGIKEQLKRI
>KF629363.1_13991|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MKAKFFLSCMALAILFSACNTTNRTPKQKIEQQIDSFLKDKKATVGVAVLANDEIVAVYN
NQIHFPLLSVFKFHVGLAVLDKMDKDHIGLDSLIEVKSSQLKPDTYSPLRDEFPDQDITI
SLGELLKYTISKSDNNTCDILIEYVGGIDQVNEYVKSLGIKDCNLAATETLMHTSGDAYL
NWSTPEEVVRLLNIADKQPLFGTQYKDFLQVIMQETSTGKDKLKGQLPADVIVGHKTGSS
DRTPEGIKIADNDAGFVILPNGQKYYIAVFVMESQETDTDNAAIIASISKIVYDTLNSDI
Q
>KF629356.1_14009|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDCIVNVTQNWGIGKDGGLLVSISADLRRFRALTTGKTVIYGRKTLLTFPHTRPLPNREN
WILSATPGFSVPGAAVFPSLAALQEAMRTRPADSLCLIGGASVYRALLPWCSRVLLTQTC
ADLPADRFFPDLDRLPNWRCTDTGPLQEDGGHSFRYLTYENDAPLPL
>KF629355.1_14013|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKTTVAVIFGGCSSEYEISLLSASSIIRNIPKDKYEIIMLGITKEGHWLLFNGDVDEIE
NGTWEQHSENRTAFLSPDRGIHGIVMETEYGFSAIRIDVIFPVLHGKNGEDGTIQGLFQL
SGIPFVGCDTLASAVCMDKAVTNILLEAAGIDQANFMWFYASDYENVKEQVKEDIMADLG
GYPVFVKPANAGSSVGVSKAKNAAELDKAVAVAAKEDKKIVIEECIVGKEVECAVMGNAI
PKVSVVGEIAPSAEFYDYEDKYKNGTSKVYIPAPLDDELSAEICNTAAKAYRALGCSGLS
RVDFFVRDSDNAILLNEINTLPGFTSISMYSMLWKACGIDYGHLLDHIIQFAFDK
>KF629352.1_14022|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
MIKEFRSMKKNVVVIFGGDSSEHDVSCLSATTVIKNMDTEKYNVILVGITKEGRWLLVDS
VKDIEDGSWREGEVKAFISPDTTTRSLVILAEGTYKLQKVDVIFPVLHGMNGEDGTVQGL
FELSKIP
>KF629348.1_14036|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMM
DQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKPGHDKLTLNAIL
NQRSQDILAANNWNVVQYAALVYMMAQVCDMEPGELVHVIADAHIYDRHIPIIKEMIKRE
TYPAPKVTLNPEVKNFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF629347.1_14038|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PSYSVTKEPGEERLILNGVLNQRSQDVLAANNWNVCQYAILLMMVAQVNDMIPGELVHVI
ADAHIYDRHVPVIEELIKREQYPAPKVSLNPEVKDFYKFTTDDLIVEDYQAGEQIKNIPI
AV
>KF629347.1_14039|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNIIVAVDKNWAIGKENKLLVSIPADMKFFRSTTTGKVVVMGRKTLESFPNGLPLKNRTN
IVLTKDKNYKVKDAIIVHSIEEALEELKNYASEDVYVIGGDSIYAQMLPYCDTAHVTKID
FGYEADAWFPNLDENEEWKIAEESEEQTYFNLEYSFVKYVRK
>KF629337.1_14070|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
LLEWIVNLKRKGNTVSKQLIAIWAEAHNHVIGKNHTMPWHLPAELAHFKKTTMGSAILMG
RVTFDGMNRRCLPGRETLILTRDKEFNCEGVTTVTSVEEALAWFEQQDKDLYIAGGAGVY
KAFDGHYDSLIKTTIEADLEGDTYFPQLDMTAFKEVSRDRAVKDDKNAYDFSISRYEKEG
D
>KF629333.1_14084|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKISIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTILMGRKTFESLPKGALPNR
RNIVLSSNPATECPGAEVFPSLEAALQSCKEEEHIYIIGGASIYQQALSFADELCLTEID
DMTPEADAYFPEVSPEMWQEKSREAHPADEKHLCSYAFVDYVRK
>KF629327.1_14106|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVPEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM
>KF629321.1_14124|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSEKYRKKVKVAVIFGGYSSEYSVSLESSSAVIKNLDPEKYEVLPVGITKEGQWFSYTGS
VENIENDTWQQSEYCTPAMISPDRNTHGLVLLGEDGAKTMPIDVAFPVMHGKNGEDGTIQ
GLITMAGIPLAGCGILASALCMDKDRAHLVAEAAGVRVPKAMVLTQGDDRKMAVDFALKT
GYPVYVKPVKAGSSYGVTKVEKPVELQSAIIKAFQYDDEVIIEENMDGFEVGCAVLGNRN
LITGEVDEIQLSGGFFDFTEKYTLKTSEIHVPARIELRKMQEIKQIAKTIYRALGCRGFA
RVDMFLTPDGEIVFNEVNTIPGFTEHSRYPGMMKAAGLEFPEILERIIRLAME
>KF629307.1_14160|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKIVVLAGGISTERDVSLSSGRGVYNALKERGHQVILLDVFLGYEGDPGNIFELDRDWVK
DVAPVSEVAPDIDKIKASRKKPSNILFGDHVIEICQMADIVFMALHGDCGENGKVQAVFD
LFGIKYTGTDSFSSALAMDKSITKQLFLQNGVPTPASHLLTGKDDPYKPEFPCVVKVSGG
GSSVGVYIVQNEKEYADAVQDAFRYDAKVLVEQYIKGREFTDCVIEGKPYPVVEIEPVSG
FYDYKNKYQAGSTIETCPAKISDELTKKIQDTALKAYQVLGIKTYARMDVLMDENGDVYC
LEANTLPGMTPTSLIPQEAAVLGISYGELCELIIEISLKRW
>KF629301.1_14177|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MFSIIACISKVHRAIGYKNRLLYAIPSDMTRFRMLTTGHTIIMGRKTFESLPNGALPNRR
NIVISKTREQITGCEVYTSLEEALAARKEEVGNKEASDECFIIGGASIYEQALPFADKLY
LTIVEKEPEHADTFFPEINPAEWEVTEKEMRNENGLPFTFLTLYRKQ
>KF629300.1_14180|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
DVIEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQPAIVKAFDEAQEVLIEAYMEGTEVTCG
CYKTKEKSVVFPITEVVTENEFFDYDAKYNGQVSEITPARLSDDLTHRIQTLTSAIYDIL
GASGIIRVDYIITAGDKVNLLEVNTTPGMTATSFIPQQVRAAGLDIKDVMTDI
>KF629291.1_14204|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MFAIAAVSQNWGIGKDNHLLFHISADMKRFRELTEGKTVLMGRKTLQSLPGGKGLPRRRN
IVLTANHGFTAPDAEIAHTPVQAVFTAGEEAAVIGGESVYRLFLPLCERVYLTRVFADAE
ADAFFPDLDADPRWQVERESGIFEENGLRYQFVDYVPAEEEDDLADLLPDRSEPTPFAPV
EDFTDLTGFM
>KF629288.1_14216|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MAMSTISIVAAISDNNAIGKNLGLLWHMPADMKRFKDLTTGHAVIMGRKTFESLPKGGLP
NRKNVVLTTMPEAGFINCFACESMHDALDICEQEDNIF
>KF629287.1_14219|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NNIKDLSSHIWDEWADENGSIGKAYGYQLGVKYKFPHGEMDQVDNVLWQLKHTPYSRRIM
TNIYKFDDLMEMGLEPCAYSMTFNVTGDRLNAILNQRSQDILTANNWNVVQYAVLVHMMA
QVSGLKPGQLVHVIADAHIYDRHVDIVREMIQRPQYPAPKFSLNPEITDFYDFTTDDILI
EDYEKNPQIRNIPVAI
>KF629279.1_14237|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MFSKLFFCLIFLTALTPLYSQEPLAQQLKSIIENKKATVGIAVLYNGKILVTVNDKAGYP
MMSTFKFPLALAVLERLDKQGLPLETELFISKPDLHPDTYSPLREARPEGNFKITIGELL
KYSVALSDNNACDILIDYLGGTSALQKYVRRQGIKQMKITATEDRMHKSGDPYLNHTRPS
SAVRLLEKFIQQELLSPVYQKFLENTMIVTSTGSDKLKGLLPAETIIGHKTGSSDRDSTG
MKAGDNDMGFVYLPHGGDHYTIAVFITDSMEDDKTNAAIIAQISKAVYDYINEISS
>KF629264.1_14273|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|1
MNETKKLRVALFFGGVSSEHEVSCVSASTWLRALAQAPCADRYEVFPVGITKQGRWLACS
PTPEAMADGSWEKGADCTPCVLSPDRTDHGIWLLKDGKAELVHIDICAPVMHGKNGEDGT
IQGLFELARIPYVGCGVL
>KF629257.1_14291|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVTALKEAGYTSVELLDTAADDFMVTMAT
GGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIA
PGLALEVGDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPKDCEFYDLDVKYVDPTDIHRIPAQISPE
NYTRAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQVCDSLIRMGLRRAGIAC
>KF629252.1_14306|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKRTIAIVCGGDTSEFQVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGNKAPID
RNDFSFQVDGKKVTFDFAYITIHGTPGEDGRLQGYFDLLHIPYSCCGVLAAALTYDKFAC
NQYLKVFGVRIAESLVLRQGQSISDEDVIEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQP
AIVKAFGEAQEVLVEAFMEGTEGNLRLL
>KF629245.1_14323|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDSSELVVSLRSAQGLYSFIDKERYNLYIVEMEGHRWEVVLPDGSKTPID
RNDFSSMENGEKKQFDFAYITIHGTPGENGILQGYFDLLGIPYSSCNVLVSAMTFNKFTC
NQYLKGFGIRVAESLILRKGFEITDEEVINKIGLPCFIKPNAGGSSFGVTKVKTKEDIQP
AIEKAFEESDEVMIEAFMKGTEITCGCYKTSDKEVVFPITEVVSANEFFDYGAKYNGESQ
EITPARLPEDTAERVRLLTSAIYDILGCSGLIRIDYIITEGEKVNLLEINTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIENKF
>KF629242.1_14331|FEATURES|farme|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFACGATEKRGSVDKGDTITDSMDIEKRRGITIRAST
TSIVWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKANLSQDVLFMQNVVDGSVYPVCSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAITSFI
LPPASVSNRLSSYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIN
QGREINVDEVGANDIAIVEDMDDFRIGNYLGAEPCLIQGLSHQHPALKSSVRPDRPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKNYASEVSSYTKG
LGIFMVKPCGYQITKGGYSDNIRMNEKDKLLFMFQKSMSSK
>KF629239.1_14335|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPLEARFGDLNHVYGYQWRSWPKPDGRFIDQIAQAVELIRHNPESRRIIVSAWNVAEIGD
MALPPCHVLFQFYVAGGRLSCQLYQRSADTFLGVPFNIASYALLTLMTAQVCGLEPGEFV
HTLGDAHLYLNHMEQADEQLSREPRPLPVMRLNPDVKSLFDFRYGDFTLEGYDPWPAIKA
PMSF
>KF629234.1_14349|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISLIAAAGENNEIGKDGRMPWNLPGDLQHFKALTLGRTMLMGRKTFQSLPGVLPKRQHI
IVTRDVDFCNPHPRVQVISDLAGALERYEAEEEEIFVIGGGQIYKEAMPYASVIYLTRIH
KTYDADAFFPEISPEHWIMADRGPSMEEHDTRYEFITYRRRELPVKGGEQSQ
>KF629230.1_14359|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADTQYLGIIENILDHGIYGQNRTGIATYKLPQQIMQFNLQEEFPILTTKFVAFKTAV
KELLWIWQMQSNDVRKLQEMNVHVWDEWMREDGTIGKAYGYQIAKYKQLDKLIKTIKEDP
DGRRMIVTLWNIEDLDDMALQPCAYETLWDVGDGYLNCMLIQRSGDMGLGVPFNTAQYAA
LQCMIAQVTGLKPGKFTHVINNAHIYENHVDALREQLARRNQALPAPKIIVNPEVKDFYD
FTPEDVTLDGYEHLGKLSMTVAV
>KF629229.1_14361|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VKKLLIICGGQSTEHIISRMSCTSVLKNINKEKYDITLAGIEKDGTWYILNQTQDDLVND
SWLEGAVKVEDVYGLLRQQEVVYPVLHGMYGEDGTIQGLLELAEVPYVGCKVLGSSVAMD
KIYTKKILETVGIPQVKSLYVKKRYDGTLVVVDNTFDESADIADSVEKELRYPCFIKASN
SGSSVGCYRVDEEKELMPRLEEAAQYDRKIVIEECVDCIELETAVLGNDDPIVSRVGQIM
PHGVFYTFESKYEDEESKTCIPALVDEKIQEEIRNYALKVFKAIDGHGLSRVDFFLDKKT
NKVYLNEINTMPGFTKISMYPQLMADFGITYSDLIDKLIE
>KF629219.1_14387|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MELIVAVYDDWGIGRDGTQPVALSADRKFFRTTTRGAMVIAGRRTIEDFPGKQPLPGRVN
VALSRSVTVLPGFTVCDSAEDAAALSRTAERCFVIGGGSVYRQMLPFCDAAYVTKVHVTP
ESDTFFPNLDEDKDWYLAETLQSGEENGIAYEMCLYRRK
>KF629218.1_14390|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MTCKLSAIVAVCDDWGIGCEGDMVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGRPLK
NRRNIVLTRDESFAAEGVDVVHGVDEALVAVADEPVAWVIGGGEVYRQFLPYCVEAEVTH
NHCVHDVDTYFPDLDADPAWEIARRGGVATIAAGEGDEGLDYEFVTYRRVEA
>KF629208.1_14415|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|0
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYT
>KF629195.1_14450|FEATURES|farme|tetracycline|tet32|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAV
TSFYWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMD
IPTIIFINKIDQNGIDLQCVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIIS
GSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAIIETFIT
ETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDELPLSKKKKIKITEMCIPLNG
EIVPADHADPGEIVVLADDTLKLNDILGNEKLLPQKTRIDDPMPLLRTTVEPQKPEQREA
LLNALVEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVVTKEPSVIY
LERPQKKASCTIHIEVPPNPFWASIGLTVTPLPIGSGTQYKSEVSLGYLNQSFQNAVMEG
VRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPIVLEQALKKAGTQLLEPYL
SFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPSRCLGEYRNDLNFYTNGR
SVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM
>KF629190.1_14464|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVSIIAAVDRNLGIGFQNKLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRN
VVLSSNPATLCPGAEVFPTLEAALQSCQPEEQVYIIGGASVYKQAMPLADMLCLTEIAAE
APQVDAYFPAMDFAIWHEKSRESHLVDEKHPCSYAFVDYIRK
>KF629187.1_14475|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPLEVQQAGLKPGEFVWTGGDCHVYDNHVDQFLEQLGRKPYPYPTIEIRKADSLFDYQYE
DFKVVGYQHHPTIKAPVAV
>KF629180.1_14498|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGNKVPVD
RNDFSFMNGTEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFAC
NQYLKAFGVRIAESLLLRQGQSVSDEDVLEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQP
AIVKAFGEAEEVLVEAFMEWTELTCGCYKTKEKSVVFPPTEVVTHNEFFDYDAKYNGQVD
EITPA
>KF629178.1_14503|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VISPVSAVILSVLRREFKGSIGKITGFRKKMLVFWGSFAYDMYADRFLICGGGKEEPVLK
KLSVCVLFGGVSSEHEVSLRSAESVLNRLDKDKYHIFPVGITKDGDWILFGGKDYGMLPA
GTWQNCEDNRRAALSPVRGQGLLSFENDCVVRERIDVVFPVMHGENCEDGAIQGLLQIAG
IPYVGPHVAASAACMDKTITKLIADAAGVLQAAWQLVTREGFARSRENALNTVEARFAYP
VFVKPAGTGSSVGVAKAKDRAALEAAIEAALKYDRKGLVEEFISGQEVEVAVLGNDNPFA
SICGEIDSGAEFYDYDAKYISDCAHLYIPARISEQTTEQVRELAVRVYKAMGCRGMSRVG
FFVKSDGEVVFNEINTIPGFTSISMYPKLFEASGIPYSDLLDNLIALALEA
>KF629174.1_14513|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGIHKEDRTGTGTISVFGHQMRFNMDEGFPCLTTKKLHLKSIIYELL
WFLNGDTNVKYLQDHGVRIWNEWADADGSLGHIYGYQWRSWPDYKGGSIDQITEAVETIK
HNPDSRRIIVSAWNVADLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQATGLKAGDFVHTLGDAHIYSNHLEQVKLQLTREPRALPRMEINPDVKSIF
DFKFEDFNLTGYDPHPHIKGEVAV
>KF629170.1_14524|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGIEKSDRTGTGTISVFGHQMRFNMDESFPCLTTKKLHLKSIIHELL
WFLKGDTNVKYLQENGVRIWNEWADENGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIAS
YALLLQMVAHVTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKNIF
SFKYEDFELVNYDPWPHIAGKVSV
>KF629169.1_14527|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNIIVAADKNWGIGRNNELLVSIPADMKMFREETTGKVVVMGRKTLESFPNGLPLKNRTN
IVITGNRDYQVKGAVIVHSIEEALKEVEKYPAEDVYCIGGDSIYKQMLPYCDTAHVTKID
F
>KF629159.1_14550|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKPTLAVLFGGCSPEYSVSLQSSYAVLSNLNPDRYTVLPVGITQSGQWFHYTGAYDRIA
TDSWAEDPGCLTPVVVSQDRSVHGLLAFSAPRHQVIQVDYALPILHGKNGEDGTVQGLLE
LAGIPVVGCGTLASALCMDKDRAHKLASLAGVAVPASLVLKLGEDPQAAVDFARQTGYPL
FVKPVKAGSSYGISQIHQEEELLPALDLAFQYDNQVILEETIPGFEVGCAVIGTRELLVG
EIDEIELSGGFFDFTEKYTLKTSAIHVPARVDPQTAQAVKQTAKVLYRALGCAGFARVDL
FLTPQGKIVFNEINTIPGFTEHSRFPGMMQAAGMTFPEILDTILGQVMAP
>KF629155.1_14561|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLSSAAGICRTLVEKGHDAFLLDVFMGLENAPENLEDVFTLPDH
GLEIVKNISTEEPDLEAVKASRPDQSDCFFGPNVIELCRLADITFLGLHGGEGENGKLQA
SFDLLGIKYTGPDSLGCAVAMHKGVAKQIFLESGVDTPGGGTIYKNSEDQSYQSLGLTLP
VVVKPCSGGSSIGVYIVNTDEEYAEALKKSFHYEDELVVEPYIKGREFACGIIDGTALPP
IEIIPKTGFFDYANKYQDGATSEVCPADIPEEVAERMKELTVKAFNALKLNVYSRADFLL
DAEGNLFCLEMNTLPGMTSASLLPKEAKVYGIEYGDLCELIIKKSMEARY
>KF629150.1_14574|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
AANRWQIESDLEGVCAGVEAKLGWPVFVKPANAGSSVGISKVSNREELKKAIALALENDR
KVVFEAFVDGQEVECAVIGSDPAVATRPGEILAGAEFYTYDDKYKNGVSQTVIPAHLPEE
KLDEVKTYAAMAYTALGCEGLARCDFFVEKGTGRVMINEINTFPGFTSISMYPKLMEHEG
LPVPALIDRLIELALERTEKQHG
>KF629147.1_14579|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTL
RRTALKSAMDEILWIWQKKSNNIHDLHSHIWDSWADESGSIGKAYGYQLGVKHQYKEGMM
DQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQTPGNDKLTLNAIL
NQRSQDILAANNWNVVQYAALVYMMAQVCDMEAGELLHVVADCPYL
>KF629144.1_14585|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
DKLYTKIIVDTLGIRQAKYVPVYKEELPKMDEVVARVESALEYPVFVKPSRAGSSKGVNK
AANREQLKNALIEAADNDRKILVEETIIGREVECAVLGNLDVKASGVGEILSADEFYDFD
AKYYNSESKTLVDPPMPENMREQIREDAVKIFMALDGRGLSRVDFFLTESGVVFNEINTL
PGFTAISMYPMLWEAQGIPKKELVQKLIDLAFER
>KF629142.1_14592|FEATURES|farme|bacitracin|BcrA|antibiotic efflux|1
MIEFRNVTKSYGDFTAVEDISFSACDSSVCGLIGYNGAGKTTLIKCAAGLYKPDSGKVLI
DGESTYNSDEVRSRLFFVPDDLFFPVGSTPNSAARFYKDYYPEFSFGNFERMLKLFELDG
DAKIRGFSKGMQRQTEIALALASSPKVLLLDECLDGLDIAKKDICKQLFMDYMAQSGCTM
LISSHAIADLQNLCDRIVL
>KF629141.1_14595|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
IGKAYGYQMGVKHQYKEGMMDQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYS
VTFNVTKKPGHDKLTLNAILNQRSQDILAANNWNVVQYAALVYMMAQVCDMEPGELVHVI
ADAHIYDRHIPIIKEMIKRETYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPI
AI
>KF629133.1_14616|FEATURES|farme|aminoglycoside|rmtD|antibiotic target alteration|1
VTGAFMTEREYKRAMELAAARDWEALLGMHASTRERLPVESMDRVFDQLFEAIGTPARIL
DLACGLNPVYLAHRLPNAAIAGVDISGQCVNVIRAFGGAEARLGDLLCEIPEDEADAALM
FKVLPLLERQRTGAAMDALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRA
IAARLTGENELFYVLKRK
>KF629122.1_14643|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSYIERKRPQNCGMRRNIMKIVVLAGGISTEREISIVSGTQVCKALRSRGHQAILVDVYF
GREDADPMQAFTDEYDVDAAAAYARSFDGQVEKSIQEGKAFFGTNVIALCQAADVVFLAL
HGENGENGKVQAAFDLLGIRYTGSGYLGSAIAMDKGLSKQLFWQNEVPTPAGFILRKGED
ISLEAHGMTLPCVVKPCCGGSSVGVTIPKTQEEYEAAVADAFSYEDVIVVEEYIKGREFS
VGVVDGIAYPIIEIAPIEGFYDYTNKYKAGSTVETCPAVLTKEQTEQMQAYAVKGFKALQ
LDNYGRLDFMMSKDGKMYCLEANTLPGMTPTSLLPQEAQALGMDFADLCEKLIAVSAK
>KF629111.1_14663|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
QKEYEEALTDACQYGADIVVEEYINGREFSVAVVDGKAYPIIEIAPKQGFYDYKNKYQAG
STVETCPAEISPELTEKMQHYAEAGAKALCIEGYARFDFMMKENGDMYCLEANTLPGMTP
TSLIPQEAKVLGIDYPDLCEELIRISFKKYSK
>KF629104.1_14680|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
PALGYYMGEAYVNDYVQFGHIYQVKLGAGDRAQRVIDDVLKLSVPNASGEMVPCSSFTRV
EEQLGMDQINRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQE
TQAGTTTTVVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIY
TQIGIILLVALSAKNGILIVEFARDFRVQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVM
PLLFATGAGAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSKKQ
>KF629103.1_14681|FEATURES|farme|macrolide-lincosamide-streptogramin|macA|antibiotic inactivation|0
MNIPAEFDEIRPYLPEELPQIFEELIADPTFQDIMTRIIPDVPVEILCAKLRQCKTNLEV
QKTFFHKLLHDIMDQHSDGFDMDTSSLNDKTRNYTFVSNHRDIVLDPGFLSVGLLDNGFP
NTVEIAIGDNLLIFPWIKKLVRVNKAFIVQRTINRKQILESSMRMSRYIHFALTQKKENI
WIAQREGRAKDSNDRTQESVMKMLAMGGEGDYVDRLKELNIVPTSLSYEYDPCDYLKAME
MQQKRDIEGFKKSQEDDLQNMQTGIFGYKGHVHFQTAPCINEELEAFRGLPKTEVFARTA
SLIDHYIDGSEKME
>KF629103.1_14682|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MIEAFMDGIELANGCYKTHNKSVVFPITEVVSKNEFFDFNAKYKGEVTEITPARLSPELT
QRVQQLTSAIYDILDCKGIVRVDYIITEGDKINMLEINTTPGMTATSFIPQQVRAAGLDI
KDVMTDIIEDHFCQ
>KF629080.1_14748|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
DCVVRERIDVVFPVLHGENGEDGSIQGLLQLAGLPYVGPGVAASATCMDKTLTKLVADRA
GIRQAAWRLVTARELANNPEAVLDGVEKAFSYPVFIKPAGTGSSVGVSKAKNREALLAAL
TNASKYDSKILVEEFINGREVEVAVLGNAGPAASVCGEIDSGTEFYDYDAKYISDCAQLY
IPARISEEVSERVRDNAIRIYEAMGCRGLSRVDFFVTYEGQEIVFNEINTLPGFTSISMY
PKLFEAS
>KF629078.1_14753|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MIKEFRSMKKNVVVIFGGDSSEHDVSCLSATTVIKNMDTEKYNVILVGITKEGKWLLVDS
VKDIEDGSWREGEVKAFISPDTTTRSLVILAEGTYKLQKVDVIFPVLHGMNGEDGTVQGL
FELSKIPYVGCGVLASAVSMDKVYTKIIVDHIGIDQAKFVHVRESDFEHLEEAMDRVEKE
IPYPIFVKPSCAGSSKGVSKAENRKELEAALYEAVKHDRNILCEETIVGREVECAVLGDR
TQVKSTCVGEILAAEEAAFYDFDAKYNNAESKTVVDPEMPEESKRKIKEDAEAIFRAVDG
FGLSRVDFFLEESGRVVFNEINTLPGFTSISMYPMLWKACGLDIPELLDTLIDQAMTRYR
>KF629071.1_14771|FEATURES|farme|chloramphenicol|BN488_01641|antibiotic inactivation|1
MTVKLDITQIKKKRMRLYPAMLYYLATIVNRHSEFRTAINQEGELGIYDEMIPSYTIFHE
DTETFSDLWTEYMPNIEEFSRAYENDIQRYGSNHGMTGKPNVPENVFTVSMLPWSTFESF
NLNLQKGYSYLIPIFTLGKYYEEDERIF
>KF629071.1_14772|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MVGRIYHVGLTVSDLDRSVAFYRDILGLEFQGEIFMEGEETDKMFRKENCKARVAYLNGS
KALEAPPVELIQFVDSKIHKEQSDLFTTSISEVCFYTDNIDSVYKTLIENHVECLSEPQY
FDFRADGFGESRAFYFRDPDGIILEMMQPL
>KF629061.1_14793|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
HMPADMKRFKDLTTGHAVIMGRKTFESLPKGGLPNRKNVVLTTMPEAGFINCFACESMHD
ALDICEKEENIFIIGGSLVYRQGLGIADKMYLTRIHGEFPDADAFFPVVNWDLWEEVERQ
EFPADEKNPYPYTFLTYVRKK
>KF629060.1_14795|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNLIVNVDQNWAIGHKGKLLVSIPEDMKFFRSETSGKVVVLGRKTLATFPGGMPLKNRTN
IILTRNPDYQVKDAIVCHSVEEVLEEVKKYNSEDVYIIGGDTIYKEFLPYCDVAHVTRTD
HAYEADAWFPNLEEHQEG
>KF629058.1_14803|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MENSKRTIAIVCGGDSSEHDVSLRSGQGLYSFFDKERYNIYLVDVKGTDWHVALDNGETI
EIDKNDFSFVMNGKHVYFDYAYITIHGQPGENGVMQGYFDLIHLPYSTSGVLVEAMTFDK
YVLNNYLRGFGINVADSILLRRGEAYDEEEIAKRIGMPCFVKPAADGSSFGVSKVKNADQ
LAPALRVAFMESNEVMIEGFLDGTEISQGIYKTAEKTVVLPATEVVTTNEIFDYDAKYNG
QVQEITPARLSPETAEEVAKTTSRIYDILHANGIIRIDYIISKDKDGKDKVNMLEINTTP
GMTVTSFIPQQVRAAGLDIKDVLSEIVENQF
>KF629052.1_14819|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
IPYVGCGVLGSAVCMDKAVANTIMDAAGVPHCKWASAIRAELEGDHKTLLDSIEQRLGYP
IFVKPANAGSSVGITKATDRAVLEQAVVTALKEDDKVVFEEFIDGQEVECAAIGNPDDPA
TVSTTRPGEILAGAEFYTYDDKYKNGVSQTVIPAHLSEEKLDEVRTEARRAYLALGCAGL
SRCDFFVERGTGRVLCNELNTLPGFTSISMYPKLMEHEGLSYAQLVDRLLQLALHRRKGA
Y
>KF629043.1_14843|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MAKKRIVVMYGGKADEHSISCISAASALRALDTDKFEAIPVGITKDGKWIVNGENPLGWS
LDEGLPTVEKTPGAKDVVLEVALGQDGFFAREDDGTLTPFGHVDAVFPVLHGPYGEDGTI
QGLFEMMGVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDARSFDKASEFKTDA
DAIMAQVSEAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVYEASHHDWRILVEQG
IDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYMDAAASHVEVPANL
PEETLNLVRETAKKAFVAVDGAGLSRVDTFVTKDGKVMVNEINTMPGFTSISMYPKAWEA
TGVRYTDLITMLIEGVLR
>KF629036.1_14860|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MKIVVLAGGLSTERQVALTSGTGVCRALRERGHQAILVDMFLGLESYEGRLEDIFDAPDG
LCGDNRVTEEAPDLEAVRRSRKDQGPSLLGKDVLAVCAMADIVF
>KF629031.1_14873|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKAIVCADINWGIGKGTGMLFHIPADLKFLKEKTMGSTVIMGRTTFLSLPGQKALPGRKN
IVLTRDENWSAENVTVCHGIDELADIIENGENVFLMGGESVYNELIDSCDEAYVTRVNAD
GKAEKFFPDLDRRAGWKLVERSAAQESNGYVFTFDRYVKK
>KF629031.1_14874|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADEVFIANCKDILENGTWDTDYNVRPHWEDGTSAHTIKKFGIVNRYDLSKEFPAMTL
RKTFIKSATDELLWIWQKKSNNVNDFKGHVWDAWANEDGSIGKAYGYQLGVKHHYPEGDF
DQVDRVLYDLKHNPLSRRILTNIYVHADLSEMNLYPCAYSMTFNVTGKKLNAILNQRSQD
MLTANSWNVCQYATLVHMIAQVSGLEPGEFVHVIADAHIYDKHVPIVEELIKREPYDAPK
FVLDKSITDFYKFTPDSVHFEDYNYHEFTEKIPVAI
>KF629024.1_14891|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
QDISIMENMGLENWDTVIADCDELLEKYIAGEPMDKEELLREENRRIQSVSLFPVYHGSA
KVNLGIRQLIEAVTDTFQSPTGQNSSELCGTVFKVEYANQSQRLAYLRLYSGTLHLRDSV
ALAGKEKLKITEMRIPSKGEIVRTEIAHAGEIVIVPCDSLRLNDVLGNKLLLPRETWSDN
PLPLLRTTIAPEKPEQRERLLNALTEIADTDPLLRYEVDAVTHEIILSFLGRVQLEIISD
LLVEKYQLNTTAKEPTVIYMERPLKAVSHTIHIEVPPNPFWASIGLSVTPLPLGTGVQYE
SKVSVGYLNQSFQNAVLDGIRYGLEQGVYGWKVTDCKICFEYGLYYSPVSTPADFRSLAP
IVLEQVLKKAGTQLLEPYLSFTLYAPQEYLSRAYHDAPKYCASIETTQVKNSEVIFTGEI
PARCVQEYRNGLTFYTNGRSVCLTELKGYQIASGEPVFQPRRPNTRIDKVRHMFNKILPS
MMDL
>KF629020.1_14899|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PTLEVQLGIKHQYKEGMFDQVDRVIYDLKHNPASRRILTNIYNFEDLHEMNLYPCAYSMT
FNVTGDTLNAILNQRSQDMLTANNWNVVQYAVLTHMMAQVAGLKVGELVHVIADCHIYDR
HIPAVKAMLELDGYPTPTFRMDESITDFYAFTKDSFSMENYQFHPFNFEIPMAI
>KF629020.1_14900|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MELIVAVYDDWGIGRDGTQPVALSADRKFFRTTTRGAMVIAGRRTIEDFPGKQPLPGRVN
VALSRSVTALPGFTVCDSAEKAAALSRTTERCFVIGGG
>KF629013.1_14925|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
ARDYSCLRIVQWGFKAILKVTGVHTTVIGFENIPDEPVLFIGNHRSFFDILLTYSRCPRL
TGYVAKKEMEKIPLLSTWMRFVYCLFLDRENPKEGLKTILQAIDYVKQGISICIFPEGTR
NKGEELSMLPFKEGAFKIAAKTGCAIVPISMNNTAAIFENQFPRIKKVNVVVEYGTPIYP
KDLAPEDKKHIGAYVQNIIQETINKNAELI
>KF629010.1_14938|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NNWNVCQYAVLMHMLAQVCDMQVGELVHVIADAHIYDRHIPIIKELIGREQHPAPKFTLN
PEIKDFYQFTTKDITIEDYVTGPQIKNIPIAV
>KF628993.1_14987|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
PRAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDMTF
PQVCDSLIRMGLRRAGVAC
>KF628979.1_15022|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|0
MNKRLKEILKQYEERKHKIIKGDESMNIVVLAGGTSTEREISIVTGTGVCKALRKKGHNA
ILVDNFLRTGAGGLG
>KF628963.1_15061|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VKQKLLVLCGGQSSEHIVSRMSCTSVLNNLNHDKYDITLVGIDLDGKWYRLNHDQDDLSL
DSWLDNSVEVENVFELLKEHDVAFPVLHGLYGEDGTIQGLFELTKIPYVGARVLCSSVSM
DKIYTKKILDTVKIPQVKSAYVKKRYDNRLVIITKDFEEIYDVEEYIVNEIGMPCFIKAS
RSGSSLGCYRCDNREDLIGKLEAAAKYDRHIVVEENIDCIELETAVLGNDDVIVSRVGQI
MPHGEFYTFESKYEDAESKTCIPALVDEKIQEKIREYAIKAFKAVDGHGLSRVDFFLDKK
TNNIYLNEINTMPVY
>KF628952.1_15094|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKKVLVLFGGVSSEHDVSCVPASYVVSNIPRDKYEVCPLGITKEGEWFLFEGDVSLLPED
KWIKSGKCTKALLSPDRKDHGITVFRESGPEKIHIDVCFPVMHGKNGEDGTIQGLLELAG
IPYVGCGVLASSVCMDKAVTNTLADQAGIAQAKWLATDVNEYAKTAPNS
>KF628916.1_15181|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNVCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVIT
NKFYSSTHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMY
TSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKP
EQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKE
PTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>KF628912.1_15188|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
QKKSNNVNELKSHIWDSWADETGSIGKAYGYQMGVKHQYKEGRMDQTDRVIFDLKNNPYS
RRIMTNIYVHNDLHEMHLYPCAYSMTFNVTKEKDSEKLTLNAILNQRSQDVLAANNWNVC
QYAVLVHMLAQVCGMKAGEFVHVIADAHIYDRHVPMIEELISREPLPAPTFWLNPEITDF
YQFTRDDVKLIDYQTHDQIKNIPVAV
>KF628905.1_15201|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMDQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNG
ILNQRSQDVLAANNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIK
REPLPAPKFWLNPEVKDFYEFTPDDVRLDGYETHPQIKNIPIAV
>KF628896.1_15222|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LPRGPEVENMALPPCHALFQFYVADGRLSCQLYQRSCDMFIGVPFNIASYSLLTMMIAQQ
AGLEPGEFVWTGGDCHVYDNHVDQVLEQLAREPYPYPKIEIRKADSLFDYQYEDFTIVDY
RHHPTIKAPVAV
>KF628894.1_15228|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|0
MDIIVLAGGLSTERDVSFKTGSMVASALKENGHRVILLDVFMGYSDKEENLDGIFDRADE
ISVKVDDIPEVAPDLAAVKASRKDQSPCFFGPNVIRMCQMADIVFMALHGENGENGKL
>KF628887.1_15249|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
QQKMKKTIAIVAGGDSSEHDVSLRSAEGIHSFLDKERYEVYIIEIKGMTWEAHLKDGSRS
NVDRNDFSFMEGGKRIRPDFAYITIHGTPGENGILQGYFDLIHLPYSTSDVLVEAMTFNK
FTLNQYLKGFGVSVSESLIVRKGFEHLVTDDEIIEKIGLPCFVKPNAGGSSFGVTKVKSA
DQIHEAILKAMRESDEVMVEAFMEGTEISQGCYKTQEKEVVLPATEVVSDNEFFDYNAKY
NGQVREITPARLKEETAERVSLITSMIYDILGCSGIIRVDYIITHTTDENGKERERINML
EVNTTPGMTATSFIPQQVRAAGMDMKDVLTDIIENKLS
>KF628881.1_15262|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
VELHPNMRVMNFTESEQWDMVIEGNDYLLEKYTSGKLLEALELEQEESIRFHNCSLFPVY
HGSAKNNIGIDNLIEVITNKFYSSTHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHL
RDSVRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRE
RIENPLPLLQTTVEPSKPQQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQME
VISALLQEKYHVEIELKEPTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSG
MQYESSVSLGYLNQSFQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFR
MLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVIL
SGEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNK
IT
>KF628877.1_15272|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
YLPLVIKPCSGGSSIGVFIVHTEEEYLDAIHQSFDVHQEEEVVIEPYIKGREFACGILAG
KALPIVEIIPKDGVFNYENKYQAGGAQEICPPVSLDEKTQKKMKRMAEKAFRTLRMDVYA
RADFIVDDTDGKFYCLEMNGLPGMTPASLIPKAAKAAGLEYGDLCEQIIDESIKARYQ
>KF628865.1_15300|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
KLYTKIIVDTLGIRQAKYVPVYKEELPKMDEVVARVESALEYPVFVKPSRAGSSKGVNKA
ANREQLKNALVEAADNDRKILVEETIIGREVECAVLGNLDVKASGVGEILSADEFYDFDA
KYYNSESKTLVDPPMPGNMREQIREDAVKIFMALDGRGLSRVDFFLTESGVVFNEINTLP
GFTAISMYPMLWEAQGIPKKELVQKLIDLAMNRYDV
>KF628862.1_15308|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MQAIVAADNNWGIGYQNRLLVSIPSDMKSFRQKTTGNVVVMGRKTLESFPNGLPLKNRVN
IVLTKNKNYQVKDAVIVHSEEELLEELKKYPSEKIYVIGGESIYKMMLPYCDIVYVTKID
RAFQADTYFPNLDQMEDWKMTEEGEEQTCFDLEFAFTKYERC
>KF628861.1_15310|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNLIVAVDEKWGIGCDNDLLASIPGDMQYFKEKTTDGVVVMGRRTLESLPKQRGLPKRIN
YVLTSNSGFEAERCIAVHSEEELFKELEQYDPEHVFIIGGESIYRKFCKYCDKCFVTKMH
ADLHADKFMVNLDEDDDFKETWKSEMHSEN
>KF628853.1_15331|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADDFMVTMATDG
FDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPVAPG
LALEVGDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKVLV
EKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPENY
ARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDMTF
PQVCDSLIRMGLRRAGVAC
>KF628851.1_15335|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSPERNVSLSSGTMITHALRSLGHQAALVDMYFGLEDYDGPLEAFFDRDVT
DRWKQVDPKAPDLEAVKRQRKWKSPNQFGQGVLALCQMADIVFLAFHGTCGEDGRVQAAF
DLMGIPYTGAGYLGSAIAMDKDFTKRLIAELDVATPKWRRAEYTMKDIDSLTSTTPVPCV
VKPVASGSSIGVSIAHTKKELYAALVKGLEFGGQCVLEQYVKGREIQVGILAGKALPSIE
IIPSDGFYDYENKYQPGAAKEVCPAEIPPEWEKAVGKAAETVYEALGLTVYSRADFIVTE
DGTPWFLEINTLPGMTPTSLVPQEAAAIGLDYAGLCQRIIDESLKARNG
>KF628847.1_15345|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MNKKAPHRISEQHLTVLSWSAPLLAQLIMLIVMCMQRHWLYAAMLAPSLLGSALMLITMI
MRVRHEETNSNTITGSDSPVPTHHNGNEIDHAQLFADMPSISFEHLHGLDNDPLIWRTIV
RNWLVRSPTNGIGMSEHGIFHIDLASSGPHAMVAGTTGSGKSELLISWCMALAIRHSPQT
LHFVFLDFKGGSTFNALERLPHTVGNVCDLDLAHAVRALNAIEQELARREALVSAERVSR
FDQLSHPPARLVVVIDEFHALRDRLPDYMQRLNRLASLGRSLGMHLIVCTQNPMGQVHAD
MKANISLSICLRVTDQMQSNELIGTKDAALIPPAFPGAAYCHDGQRTVPFRCSAVHDIDS
LVHAINTASAFSGTTNPSPLFSAPLAPHAGKDDLTAPQREAWHHVPFALSDDGVLISTAF
LDVGHGNIAVIGACGSGKTNLLLCCASRLYESGRCTIRFTRKTNSEWTTDDGRISPQHER
TIWFVDDADELLSPFAAMPEADKLKTALADPSVTVIAAVEKPQSTLLERCLTRVAFPCGE
RATDVMMGIPSAVLDGFGVDDYAIAGRGVFIQQAWACPVQCAEFQGF
>KF628844.1_15358|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|0
MKIIVLAGGLSTERDVSLSSAAGICRTLVEKGHDAFLLDVFMGLENAPENLEDVFTLPDH
GLEIVKNISTEEPDLEAVKASRPDQ
>KF628840.1_15366|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MMQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTIIN
RHEEFRTALDENGQVGVFSEMLPCYTVFHKETETFSSIWTEFTADYTEFLQNYQKDIDAY
GERKGMFAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYYIP
LSIQVHHAVCDGFHVCRFLDELQDLLNK
>KF628834.1_15380|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIAVLAGGISTEREVSIVSGTGVCKALREKGHRAILIDVFCGDERIDITDKEEVFPAQY
DVDASAAYMRSMNGSIEAAKASGREFFGPNVLAVCKMADVVFLALHGADGEGGTVQAAFD
LFRIPYTGSGPLGSAMAMDKGISRKLFRECGVPTAAGLSLKREEKRLSASENGVGLPCIV
KPCCGGSSVGVAIAHTQEEYEDALTLAFGYEEEVVVEQFIEGREFSAGVIDGKPYPVIEI
APVEGFYDYKNKYTAGSTIETCPAVLSEEKTREMQQYAVKAYEALHLEGYGRMDFMMDGD
ENLYCLEANTLPGMTPTSLLPQEAAAVGIDFGSLCELLIEVSKKRWQ
>KF628833.1_15383|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MDKTLTKLVADRAGIRQAAWRLVTARELANNPEAVLDGVEKAFSYPMFIKPAGTGSSVGV
SKAKNREALLAALTNASKYDSKILVEEFINGREVEVAVLGNAGPAASVCGEIDSGTEFYD
YDAKYISDCAQLYIPARIPEEVSERVRDNAIRIYEAMGCRGLSRVDFFVTYEGHEIVFNE
INTLPGFTSISMYPKLFEASGIP
>KF628832.1_15386|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILWIYRDQKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYAEG
DFDQMDRVLYDLKHTPYSRRIKTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNM
ILNQRSQDILAANNWNVCQYAVLLMMVAQSVDMIPGELLHVIADAHIYDRHVDIVRELIG
RPQFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF628824.1_15409|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIAIIVAVAENGVIGGENRLLWHISEDLKHFKAVTTGHPVVMGRKTYESLGRPLPGRRNV
VVTRQNISIEGCDVVHSLDEALALFRPEEKVFVIGGAQIYAQALPLCDEFYLTRVFHAYQ
GDTCFPRWDEREWEIIDSESFASGKEFPYPFAFEHYRRRK
>KF628822.1_15414|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKRLNIALMAGGDSSEGEIALQSAAQIASALDPAKYDITLIDLHGRDWHYTSPDGRQWQV
DKNDFSITIDGEHKAFDYALILIHGTPGENGRLQGYLDMMGIPYSSCSMTSSVVTFDKIT
TKRTVAEFGIPLARGFFFGRDSRIDPKEIVRTLGLPVFVKPNASGSSFGVTKVKSEADIL
PAVAEAFTESDEILIEECIQGREMGCGMLIAKGREYIFPITEIVSKKEFFDYEAKYTAGC
SDEITPADIAPEIKAELNRLTALAYKACRCRGVVRVDFIVTPEGKPYLIEINSIPGMSGG
SIVPKQVREAGMTLGELYDLIIEDTYDRDRR
>KF628820.1_15419|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEKIKLAIIFGGKSSEYPVSLHSAGSLIHKINKERYELMFIGISKDGKWYAYDGDVEGIE
HDTWLCEEHCTPCVLSSSEGCKGFLKLHGDGTFTRMEVDCIFPVLHGKNGEDGTIQGLFE
LSGIPYVGCGHMSSAICMDKEMAHIVMEHAGITCAPFVCVYEADDLDYRKVYEHAKEALG
LPIFIKPANAGSSFGIHKMESFDGFEEAMKDAFYHDGKGKVILETTIKGFEIGVAVMGNK
ELFAGSVDEIETAAPFFDYEGKYEMVDSHIYCPARISPKLFEEAREIAKKAYRAMNCKGM
TRVDMFVTPEDTIVLNEVNTIPGFTDTSRYPTMMKEAGIPFPELIDKLVALAME
>KF628815.1_15434|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DEILWIYQKKSNNIHDLNSHIWDAWADEDGSIGTCYGDVVGRKFIYKGQETDQMDYVLQQ
LKENPYSRRIMTNLYQFEYLHSGALDPCCYSMTYNVTKDTGEDRLILNGVLNQRSQDILA
ANNWNVCQYSILLMMVAQVNGMIPGELLHVIADAHIYDRHVPAVRELISRTPYAAPKVTL
NPEIKDFYDFTTKDLIVEDYQAGPQIRNIPIAV
>KF628809.1_15446|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADHIFIDMCRDILENGTDTMGEKVRPKWEDTGESAYTIKRFGVVNRYDLRKEFPALT
LRKTALKSCMDEILWIYQKKSNNIHDLNSHIWDAWADEDGSIGTCYGDVVGRKFIYKGEE
TDQMDYVLRQLKENPYSRRIMTNLYQFEYLHSGALDPCCYSMTYNVTKDAAEDRLVLNGV
LNQRSQDVLAANNWNVCQYSILLMMVAQVNDMIPGELVHVIADAHIYDRHVPAVRELISR
TPYAAPKVTLNPEIKDFYDFTTKDLIVEDYQAGPQIRNIPIAV
>KF628804.1_15458|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADHIFMDMCRDILENGTDTKGEKVRPKWEDTGESAYTIKRFGVVNRYDLRKEFPALT
LRKTALKSCMDEILWIYQKKSNNIHDLNSHIWDAWADADGSIGTCYGDVVGRKFIYKGEE
TDQMDYVLRQLKENPYSRRIMTNLYQFEYLHSGALDPCCYSMTYNVTKDAAEDRLVLNGV
LNQRSQDVLAANNWNVCQYSILLMMVAQVNDMIPGELVHVIADAHIYDRHVPAVRELISR
TPYAAPKVTLNPEIKDFYDFTTKDLIVKDYQAGPQIRNIPIAV
>KF628793.1_15484|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PSVVNRYDLSKEFPALTLRRTGIKSCVDELLWIWQRKSNNVHDLKPHIWDSWADEDGSIG
KAYGYQMSVKHQYKEGMMDQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMT
FNVTKKKDSDKLVLNGILNQRSQDVLAANNWNVCQYAVLMHMLAQVCDMQVGEFVHVIAD
AHIYDRHIPLVEELISREPLPAPTFWLNPEVKNFYEFTPDDVRLDNYETGSQIKNIPIAV
>KF628791.1_15492|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEKLRVGIVFGGKSAEHEVSLQSAKNIVDAIDKSRFDVVLLGIDKQGQWHVSDASNYLLN
ADDPAHIALRPSATSLAQVPGKHEHQLIDAQNGQPLPTVDVIFPIVHGTLGEDGSLQGML
RVANLPFVGSDVLASAACMDKDVTKRLLRDAGLNIAPFITLTRANRHNISFAEVESKLGL
PLFVKPANQGSSVGVSKVTSEEQYAIAVDLAFEFDHKVIVEQGIKGREIECAVLGNDNPQ
ASTCGEIVLTSDFYAYDTKYIDEDGAKVVVPAAIAPEINDKIRAIAVQAYQTLGCAGMAR
VDVFLTPENEVVINEINTLPGFTNISMYPKLWQASGLGYTDLITRLIELALERHAADNAL
KTTM
>KF628777.1_15529|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
MEKKNIDWSNLGFSYLKTDYRYVSNYKDGAWDEGAMITDDTVTISECAGVLQYAQTVFEG
LKAYTTEDGRIVTFRPDLNGERMENSARRLEMPVFSKERFIQAVKETVKANAAYVPPYGS
GATLYIRPYMFGSNPVIGVKPADEYQFRVFTTPVGPYFKGGVKPLTIRVSDFDRAAPNGT
GHIKAGLNYAMSLHAIVDAHSQGFDENMYLDPGTRTKVEETGGANFLFITKDNTVVTPKS
HSILPSITRRSLIYVAEHYLGLKVEEREVLLDEVKDFAECGLCGTAAVISPVGKIVDHGR
EILLPAGMEQMGPVTQKLYDTLTGIQMGRLEAPEGWIQVIE
>KF628765.1_15552|FEATURES|farme|tetracycline|tet32|antibiotic target protection|1
LDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAITETFITETDDIQSELCGYVF
KVEYTDRKKRLTYLRLYHGTLHLRDELPLSKKKKIKITEMCIPLNGEIVPADHADPGEIV
VLADDTLKLNDILGNEKLLPQKTRIDDPMPLLRTTVEPQKPEQREALLNALVEIADTDPL
LHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVVTKEPSVIYLERPQKKASCTIHI
EVPPNPFWASIGLTVTPLPIGSGTQYKSEVSLGYLNQSFQNAVMEGVRYGMEQGLYGWGV
TDCQICFDYGVYYSPVSTPADFRFLAPIVLEQALKKAGTQLLEPYLSFTLFAPQEYLSRA
YNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGRSVCITELKGYQETS
GEPVFQPRRPNSRLDKIRHMFQK
>KF628750.1_15596|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSPERNVSLSSGTMITHALRSLGHQAALVDMYFGLEDYDGPLEAFFDRDVT
DRWKQVDPKAPDLEAVKRQRKWKSPNQFGQGVLALCQMADIVFLAFHGTCGEDGRVQAAF
DLMGIPYTGAGYLGSAIAMDKDFTKRLIAELDVATPKWRRAEYTMKDIDSLTSTTPVPCV
VKPVASGSSIGVSIAHTKKELYAALVKGLEFGGQCVLEQYVKGREIQVGILAGKALPSIE
IIPSDGFYDYENKYQPGAAKEVCPAEIPPEWEKAVGKAAETVYEALGLTVYSRADFIVTE
DGTPWFLEINTLPGMTPTSLVPQEAAAIGLDYAGLC
>KF628739.1_15635|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MDEVIIEKGFFDFEEKYTLKTSKIIIPAQIDQKTKNKIVNAGKRIFEKMVCKGFARIDFF
VDKNNEIYFNEINTIPGFTSHSRFPNMLKAKGYTFEEIVNSIIDEELQNE
>KF628730.1_15657|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNKRLKEILKQYKERKHKIIKGDESMNIVVLAGGTSTEREISIVTGTGVCKALRKKGHNA
ILVDIFCGLEPVDWDEPFGDKDYEVDSAAEYMRSFDDDIEEIKRTRRSFFGPNVLELCQA
ADIVFMGLHGANGEDGKVQATFDLMGIKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRG
VSMVKEEMTTDLKALGMEFPVVVKTCCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVE
EYIKGREFSVAVVDGKAYPIIEIAPLQGFYDYKNKYQAGSTIETCPAEISPELTEKMQHY
AEAGAKALFMEGYCRLDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGIDYPTLCEK
LI
>KF628726.1_15663|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MEPGELVHVIADAHIYDRHIPVIKELIKRPVYDAPKFSMNPDVKDFYEFTVDDFKIEDYK
AGEQIKDIPIAI
>KF628694.1_15742|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCPTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>KF628694.1_15744|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
VPFVFSAIVTKVIVEIPLPPGKISVQPSALQDDLQTPLFTGDGPNSPEPDMSWIILVIAG
LLEVVWAVGLKYTHGFSRLTPSVITVTAMIVSMALLAWAMKSLPVGTAYAVWTGIGAVGA
AITGIVLLGESANPMRLASLALIVLGIIGLKLSTH
>KF628683.1_15780|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNIVVLAGGSSTEREVSIVSGQGICTALRRRNHKAVLVDAYFGKESWGEEMFPQTYDIDA
EIKYMQEKSGELEETMKNRKEFFGPNVLEICKAADMVFLALHGSNGEDGKVQSVFDLMGI
PYTGSGPLSSGMAMDKGITKMVFEAKGVPTPKGITLQKGKCSSELADYDMDFPVIVKPCC
GGSSVGVCIAKNQEEYEAALDESFSYENEAVVEQFVEGREFSVAVVDGKAYPVIEIAPLQ
GFYDYKNKYEAGSTIETCPAEISESLTKEMQKNTQSRAIKRWACRPTADWILSWTKTETC
TVWRQTPCRE
>KF628681.1_15788|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SRLWTHIYKDHFEVVKQQIAREPLPKCKLVLNPDVKSIFDYKIEDIKIEDYQSHGKLVGK
VSV
>KF628680.1_15789|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDRENPFPSEYDV
DAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLM
GIKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKT
CCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVEEYIKGREFSVAVVDGKAYPIIEIAP
LQGFYDYKNKYQAGSTIETCPAEISPELTEKMQHYAEAGAKALFMEGYCRLDFMMKENGD
MYCLEANTLPGMTPTSLIPQEAKVLGIDYPTLCEKLI
>KF628679.1_15791|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MTKERDKMNIIVAVDKNWGIGKDNRLLVSIPADMKFFRTTTTGKVVVMGRKTLESFPGGQ
PLKNRTNIVLTRDVNYKVKDAVIVHSVEELLEELKKYDSEEVYVIGGDSVYSAMLDHCDT
AYVTKIDFAYEADTWFPNLDEREDWSPAEASEEQTYFDLEYQFVKYKKNCV
>KF628676.1_15800|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
AVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTT
KYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLY
ANSSIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVH
VSPGALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRY
>KF628671.1_15814|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MTKKIVAIWAQDEEGVIGKDNRLPWHLPAELQHFKETTLNHAILMGRVTFDGMGRRLLPQ
RETLILTRNPEEKIDGVATFHDVQSVLDWYQAQDKNLYILGGKQIFQAFEPYLDEVIVTH
IHARVEGDTYFPEEFDLSLFETVSSKFYSKDEKNPYDFTIQYRKRKEV
>KF628670.1_15816|FEATURES|farme|multidrug|ABC_transporter|antibiotic efflux|1
MALIKCDGISIAYEGQTVVRDLSFWIEQGDYLCIVGENGSGKSTLVKSLLGLKPPFKGQI
LLGDGLKQDEIGYLPQQTVVQKDFPASVYEVVLSGRLNSRGWRPFYSAADKKAARENMEL
LGIREMEHQCFRDLSGGQKQR
>KF628670.1_15819|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VDEMLWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIY
DLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVL
AANNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFW
LNPEVKDFYEFTPDDVRLDGYETHPQIKNIPIAV
>KF628666.1_15830|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
PSGSITLDGKNIFKMPTYARAKTGIGYVPQGREIFPQLTVRENILLGMEANKKVREIPEH
IFEIFPILKEFLDRKGGDLSGGQQQQLAIARAIVSNPKVLILDEPTEGIQPSVIWEIGRT
ITKLKEYMAVLMVEQYLEFVLEVSDKCYVMEKGRIQMSGKTEDLDKKKLQEMLAM
>KF628664.1_15833|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
DAYFGREEWGGEMFPLTYDIDAEAAYMKAKSRELEETMKNRKEFFGPNVLDICKAADIVF
LALHGSNGEDGKVQSVFDLMGIPYTGSGPLSSGMAMDKGITKMVFEAKGVPTPKGVTLQK
GKCGSDLSDYDMDFPVIVKPCCGGSSVGVCIAKNQAEYEAALEESFSYENEAVVEQFIEG
REFSVAVVDSKAYPVIEIAPLQGFYDYKNKYEAGSTIETCPAELPETLTREMQKYAELGY
KALALQAYARLDFILDKEGNMYCLEANTLPGMTPTSLIPQEAKVLGMDYPELCEKLIEVS
LKKYK
>KF628660.1_15841|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
FDLYGIKYTGSGHLASAIGMDKGVTKQIFMSKGVPTAKSVWIKKGESTDLKDYGMKVPVV
VKACNGGSSVGVVLVHQESEYEDAVKTCFELDNQILVEDFIKGREFSIGVINKKALPVVE
IIPRDGWYDYKNKYNGATEEVCPANLNDELTKKIQKVAEDACNAIGCEPYARADVMMDAD
GNMFCLEVNTLPGMTATSLVPQEAKAVGMDFPTLCDYLVELSLKRNN
>KF628651.1_15871|FEATURES|farme|tetracycline|MFS|antibiotic efflux|0
MNLSLRRSTSALLASSLLLTIGRGATLPFMTIYLSRQYSLSVDLIGYAMTIALTIGVVFS
LGFGILADKFDKKRYMLLAITAFASGFIAIPLVNNVTLVVLFFALINCAYSVFATVLKAW
FADNLSSTSKTKIFSINYTMLNIGWTIGPPLGTLLVMQSINLPFWLAAICSAFPMLFIQI
WVKRSEKIIATETGSVWSPKVLLQDKALLWFTCSGFLASFVSGAFASCISQYVMVIADGD
FAEKVVA
>KF628650.1_15873|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNFIVAVDKNWGIGNENKLLVSIPADMKFFRETTSGKVVVMGRKTLESFPNGLPLKNRTN
IVLTGNKDYKVKDAVIVHSMEELQEELKKYDSDDIYVIGGDSIYHQMLPYCSLGHVTKID
HEYVADSRFPDLDKMEEWEVTGESEEQTYFDLEYTFIRYERKKN
>KF628644.1_15887|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADHIFIDMCRDILENGTDTMGEKVRPKWEDTGESAYTIKRFGVVNRYDLRKEFPALT
LRKTALKSCMDEILWIYQKKSNNIHDLNSHIWDAWADEDGSIGTCYGDVVGRKFIYKGQE
TDQMDYVLQQLKENPYSRRIMTNLYQFEYLHSGALDPCCYSMTYNVTKDTGEDRLILNGV
LNQRSQDILAANNWNVCQYSILLMMVAQVNGMIPGELLHVIADAHIYDRHVPAVRELISR
TPYAAPKVSLNPEIKDFYDFTTKDLIVKDYQAGPQIRNIPIAV
>KF628638.1_15906|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
SLHAIVDAHNQGFDENMYLDPGTRTKVEETGGANFLFVTKDNTVVTPKSSSILPSITRRS
LIYVAEHYLGLKVEEREVLFEEVKDFAECGLCGTAAVISPVGKIVDHGKEIILPAGMEQM
GPVTQKLYDTLTGIQMGRLEAPEGWIQVIE
>KF628612.1_15976|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNLIVNADKNWGIGRENQLLVHIPNDMKMFRQTTTGKVVVMGRKTLESFPNGMPLPKRTN
IVLTTDQDYDGRGAIVVHSEDELFEELKQYADEDIFIIGGESIYRMMLPYCDTAYVTRLD
YAYDADTYFPDLDARKEWEIVKESEEQTYFDLEYVFLKYQRRNDD
>KF628612.1_15977|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NWNVVQYSVLLHMLAQVCGMEPGEFVHVIADAHIYDRHIPIIEELIKRPVYDAPKFSMNP
DVKDFYEFTVDDFKIEDYKAGEQIKDIPIAI
>KF628608.1_15984|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNIIVNVSKNWAIGKNGGLLFHISADMRFFKKHTTGNVIVMGRKTLDSLPGGRALPDRTN
IVLTRSAGLTRENVAVCHSFDELNDMPAGFDSKSVYVTGGESLYRKLLPLCDTAYVTKVD
KEIHDADAFMVDLDEHPDWAAAEESELFSDNGLDYRFVTYRKKS
>KF628597.1_16012|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAKFFLSCMALAILFSACNTTNRTPKQKIEQQIDSLLKDKKATVGVAVLANGETVAVYN
NQIHFPLLSVFKFHVGLAVLDKMDKGHIALDSLIEVKSSQLKSNTYSPLRDKFPDQDITI
SLGELLKYSISQSDNNACDILIEYAGGIDQVNEYVKSLGIKDCNLAATEDLMHTSGDAYL
NWSTPEEVVRLLNIADKQPLFGTQYKDFLQAIMQETSTGKDKLKGQLPADVIVGHKTGSS
DRTPEGIKIADNDAGFVILPNGQKYYIAVFVMESQETDADNAAIIANISKIVYDTLNSDI
Q
>KF628587.1_16041|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MLIYIWAQDEQGLVGKDNTLPWRLPNDWKFFKEVTMGQTILMGRKTFEGMGSRLLPGRQT
VLLTRSNDYEVPGAEVVTDIDAIIEDSKHEDIYVCGGAEVYRLLKDHVELLYCTRIHHTF
EGDTYFPTDFPWGDFVKVKSLEGEVDEKNVYPHTFEIYERKEDTL
>KF628578.1_16062|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
AGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYARAGIPIAPGLALEAGDEVD
IDRIVEICGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKVLVEKCIEGTEIT
VGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPENYARAQELACAA
HKALGCLGISRS
>KF628572.1_16072|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
IQRETFEAPKVWLNPDVKDFYAFTVDDLHVEDYVTGPQIKNIPIAI
>KF628563.1_16091|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
LPSRSIDWSELGFSYLKTDYRYVSNYKDGAWDEGAMITDDTVTISECAGVLQYAQTVFEG
LKAYTTEDGRIVTFRPDLNGERMENSARRLEMPVFSKERFVQAVIETVKANAAYVPPYGS
GATLYIRPYMFGSNPVIGVKPADEYQFRVFTTPVGPYFKGGVKPLTIRVSDFDRAAPNGT
GHIKAGLNYAMSLHAIVDAHSQGFDENMYLDPGTRTKVEETGGANFLFITKDNTVVTPKS
HSILPSITRRSLIYVAEHYLGLKVEEREVLLDEVKDFAECGLCGTAAVISPVGKIVDHGR
EILLPAGMEQMGPVTQKLYDTLTGIQMGRLEAPEGWIQVIE
>KF628552.1_16118|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSTLKLAVIFGGKSSEYPVSLHSAASLIRSLHKDKYELIFIGISKDGEWFAYDGDVDAIE
HDTWMDGNITPCVLSCSTAQKGFLKLKEDGSYETLPVDCIFPVLHGKNGEDGTIQGLFEL
SGIPYVGCDHMSSAICMDKEMAHIVMENAGIPCAPYLCVYEDEHLDYRHIYEEAKAKLGL
PIFIKPANAGSSFGIHKIASFDDFEESMKDAFYHDGRGKVILETTIEGFEIGCAVMGNKE
LFAGSVDEIETAAPFFDYEGKYQMVDSHIYCPARISKELFEEARSLALKDYRAMNCKGMT
RVDMFVTPQQSIVMNEVNTIPGFTDTSRYPTMMKEAGIEFGDLLDKLIAFALTR
>KF628551.1_16120|FEATURES|farme|multidrug|cmeB|antibiotic efflux|0
HPLSVMTSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQK
LQEKFSKKQ
>KF628549.1_16127|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKN
>KF628521.1_16196|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
CDALRSIGHNAVLLDVFFGNENKNLLDVSDFDVQAEKEKLQKLSKDVDKVKKERKGFFGE
NVFEICQQADIVFMALHGANGEDGKCQAAFDLQGIKYTGDGSVASALAMDKSITKQIFMA
QNVSTPKGIWIKKGESTNLSDYGMKIPVVVKASNGGSSVGVVIVKDEKDYDAALKECFAL
EDTIVIEEFVEGREFSVGVVDGKALPIVEIIPKTGWYDYKNKYLPGATEDVCPAQINEEL
TKKMQKLAEEACKALGIVTYSRADVLMKKDGSMYCIEVNTLPGMTVTSLVPQEARAMGME
FPQLCEHLINVSMKKYK
>KF628520.1_16198|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNKRLKEILKEYETRKHKIIKGDESMNIVVLAGGTSTEREISIVTGTGVCKALRQKGHNA
ILVDIFCGLEPVDWDEPFGDKDYEVDSAAEYMRSFDDDIENIKRTRRSFFGPNVLELCQA
ADIVFMGLHGSNGEDGKVQATFDLLGIRYTGTGYLSSALAMDKGLTKKIFLMDEVPTPKG
VSMLKENCTRDIHDLGMEFPVVVKTCCGGSSVGVYIVNDQKEYEDAIDGAYSYEDEVVVE
EYIKGREFSVAVVDGKAYPIIEIAPKQGFYDYKNKYQAGSTVETCPAEISPELTEKMQHY
AEAGAKALCIEGYARFDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGIDYPDLCEE
LIRISLKKYNK
>KF628519.1_16205|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MRIVVLAGGLSTERDVSISSGIKVASALREKGNEVVLLDVFMGYEENFCDIDALFKHNYS
FTDSLGVGTEIPDIKTVKENRLDKSSRFIGMNVIEICAEADITYLALHGGEGENGQIQAT
LDLFGIKYTGSGYLGSALAMNKALTKSVLIQNRVTTPAGRVYKSAQDAEDWSYYPCVVKP
CSGGSSVGITKAENRAEYLESVKEAFKYEKEIVVEQFIEGREFSVGVIGGRALPPIEIIP
KTGFYDYVAKYQAGATDEICPADITASEDDVLRKAAEAAFKALNLQSYARIDFILDKVSG
EAYCLEANSLPGMTPTSLLPQEAAAEGIDYPSLCEKIIEVSLEKYN
>KF628518.1_16208|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
VDQNWAIGQDGDQLCYLPPDLKRFQRRTTGHPVLLGRKTLATFPGGRPLKNRRNLILSRN
PAFAPEGGEVFSALDDALAAAPADTFVIGGESLYRQTLDRCDTVYVTKLHRRFPGADRFF
PNLDQAPAWVLAEVEGPYVYGDLAYTYCTYRRREA
>KF628500.1_16260|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKKRIVVMYGGKADEHSISCISAASALRALDTDKFEAIPVGITKDGKWIVNGENPLGWS
PDEGLPTVGKTPGAKEVVLEVALGQDGFFAREDDGTLTPFGHVDAVFPVLHGPYGEDGTI
QGLFEMMGVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDARSFDKASEFKANA
DAIMAQVSEAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVYEASRHDWRILVEQG
IDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYMDAAASHVEVPANL
PEETLNLVRETAKKAFVAVDGAGLSRVDTFVTKDGKVMVNEINTMPGFTSISMYPKAWEA
TGVRYTDLITMLIEGVLR
>KF628498.1_16267|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
CAYSMTFNVTQKKGDDRLTLNGILNQRSQDVLAANNWNVCQYAVLMHMLAQVCDMRVGEL
MHVIADAHIYDRHVPIVKELIERPQYDAPKFWLNPDIKDFYQFTTDDIKITDYVTGEQIK
DIPIAV
>KF628489.1_16295|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNIIVAADKNWAIGKDNKLLVSIPADMKMFRQETTGKVVVMGRKTLESFPNGLPLKNRTN
IVLTGNKDYKVKDAVIVHTIEELLEEIKKYPAEEVYCIGGDSVYKQLLPYCDTAHVTKID
FDYEADSYFPNLDEMPDWKVTAESEEQTYFDLEYTF
>KF628485.1_16302|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGVHKEDRTGTGTISVFGHQMRFNMEDGFPCLTTKKLHLKSIIYELL
WFLNGDTNAKYLQDHGVRIWNEWADENGDLGHIYGYQWRSWPDYKGGSIDQISEAVETIL
HNPDSRRIIVSAWNVGDINNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFIHTLGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKSIF
DFQYEDFELVNYDPHPHIAGKVSV
>KF628475.1_16331|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
KELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSDRNADGMKTADNDAGL
VILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>KF628459.1_16371|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YPCAYSMTFNVSGHTLNAILNQRSQDMLAANNWNVVQYAVLVHMMAQVSGLEAGELVHVI
ADAHIYDRHVPIVERMLEKEPRPAPRFVMDPSVTDFYRFTRDSFSLEGYEPHSFEDKIPV
AI
>KF628458.1_16373|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLTSGAGICKTLLGNGHHAYLLDLYFGLENAPANLEDVFTLPGA
GLEIAKNISTKEPDLEALKKSRPDQSDCMFGPNVIELCRMADITFVALHGSVGENGKLQA
AFDLLGIKYTGCNSFGCALSMNKLVTKQIYKMSGVPTPRGTHLTKETKDLPLSELGYYLP
LVVKPCENGSSIGVYICHTEEEYNNAVRESFEKNPDEELVIEPYIKGREFASAVIAGKAL
PLVEIIPKNGVFNYENKYQAGGAQEICPPVSIDEETQQRMMRAGEEAFAALRMDVYARAD
FIIDDEDGEFYSLEMNALPGMTAASLLPKAAKAAGIEYNELCERIIEESMNARYR
>KF628452.1_16386|FEATURES|farme|aminoglycoside|AAC(6')-Ia|antibiotic inactivation|0
ELALVAECQGKLIGHIMLTRTVVTQDDGTPYEALMIAPLSVVLDYRNQGVGSALLKEGLR
LAQSRVTGQLFFAAIRPTTDVSVSKRSENTVSGKPVCRKN
>KF628450.1_16392|FEATURES|farme|multidrug|Bmr|antibiotic target alteration|0
MSKWDRDYLGLCRRILDEGVEVVNRTGTNSIKVPSHHFHFDLSEEFPILTTKQLFIRQAV
LEMLWIYQVQSNDVRWLRERDVNIWNEWETDDNGTWHATQLVPDENGNLVKKQITKEFGR
EFAHTIGTAYGYIVNKFQMTQNLIDKIKNHPEDRRMVMTLW
>KF628447.1_16402|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLLSGAGICKTLREMGHQAFLLDVFFGLPCDSDKLEEVFDRPDG
GLEISKGISTSVPDLDALRKSRPDQSPSEIGPNVIELCQMADITFMALHGSIGENGKLQA
TFDNLGIKYTGPNSLGCTLSMNKLVTKQIFKTSGVPTPRGTSLTVKTKDTRLDELGYYLP
LVVKPCSNGSSIGVYICHTEEDYYNAIHKSFDIDNTDEVVIEPFIKGREFACGILAGKAL
PLVEIVPKDGLFDYANKYQAGGASEICPPISLDAETQELIQRAGEEAFAALRMDVYARAD
FIIDDEDGEFYSLEMNALPGMTAASLLPKAAKAAGIEYNELCERIIEESMNARYR
>KF628446.1_16405|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MKKIIVLVVLLALKNLAFGQLSQVRNSIEKIVADKKLELGFALYDFSTGDTLSINGEKRF
PMQSVFKFPIALAMLHEVDNKKFDLEQKIYLGKEDLRPGLWSPIEKQYPGGEVYLPLSEI
LKQTVSLSDNVGCDLLLKLLGGPLVVNDYIHGKGIADIRIQNNEQEIQSSWNVQFDNWIT
PDAMIQLLMQFNAKKLLLPESHSFLWKVMAETSTGSIKNKLPESIVVVHKTGHSGYNEKK
VSAATNDVGIMVAPNGKQLAFAIFVADSKEPQEVNANVIADIAVVLLQALQ
>KF628445.1_16409|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
GSSVGVYIVNDQKEYEEALTDACQYGADIVVEEYIKGREFSVAVVDEKAYPIIEIAPIQG
FYDYKNKYQAGSTVETCPAEISPELTAKMQENAVKAAKALGLTGYSRLDFMMKENGDMYC
LEANTLPGMTPTSLIPQEAKVLGMDYPTLCEELIRISLKKYE
>KF628433.1_16435|FEATURES|farme|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
IGEVDYWSKGIGTKYTKMIFEFLKKERNADAVILDPHQDNPRAIRMYQKAGFRIIEDLPE
HELHEGKKEDCYLMEYRYDDNETNVKAIKYIIEHSFDIKITSIKLIGNGNDSFAYEVNDN
MIFKFPRHEKANENLLKEIEILQYLENKTTFNIPKVLYVNNDNSNYKYCIACFTKINGVS
LSKEIYERLTDEEKDKLAQDLARFLKELHSSNYNKYQVDTIENYKKDYARLVELIFDKLD
DNEKMVINNIYNSILSNDDMLTINKSLVHNDFSCGNILFDTTTNRISGIIDFGDSCVSDT
DNDFYC
>KF628429.1_16446|FEATURES|farme|trimethoprim|thymidylate_synthase|antibiotic target alteration|0
MSKWDRDYLGLCRRILDEGVEVVNRTGTNSIKVPSHHFHFDLSEEFPILTTKQLFIRQAV
LEMLWIYQVQSNDVRWLRERDVNIWNEWETDDNGTWHATQLVPDENGNLVKKQITKEFGR
EFAHTIGTAYGYIVNKFQMTQNLIDKIKNHPEDRRMVMTLWQNDYLDTAVLPSCVWSSEW
DVTNGYLNCWVHQRSCDVPLGLPFNVTQYAVLMFMLAKVTGLKPGTMDWSIKDAHIYVNQ
VDGIKEQLRRLDEEGDLPAPKLWLNPEVDDFFKFDNSRDCLDVKLVDYKHLGKIKFPISQ
>KF628420.1_16465|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MVCKALREKNHQAVLVDVFCGIDVKGNLEDVFAEEAYDIDKAAEYMHSFDAGLNEMIESR
RRFFGPNVLELCEAADVVFLALHGANGEDGKVQATFDLLGIPYTGTGYLSSALAMDKSIT
KQFFRAHHVPTPNGVTLKKGQESEPLSGFGLELPVVVKPCCGGSSVGVYIAHTNEEYWQA
MKDAFSYEPEVVVEEYIEGREFSVGVVDGKAYPIIEIAPIEGFYDYTNKYKAGATVDTCP
AVLTEEQTKEMQKHAEDGAAALGIENYCRLDFMMRKDGRMYCLEANTLPGMTPTSLLPQE
AQVLGISYPELCELLIQLSLRKRGNNA
>KF628413.1_16478|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
EFIQGKELTVAIMQDGGMAVALPVINIVPHSGVYDFHSKYTKGETEYLVPAPLDKETTRH
VQELAVATYKVLGCSGVARVDVMLDEAGKGYVLEANTVPGMTATSLVPKAAAAVGISFPD
LCEKILLSASLNDK
>KF628411.1_16482|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIAIIVAVAENGVIGGDNRLLWHISEDLKHFKAVTTGHPVVMGRKTYESLGRPLPGRRNV
VVTRQNISIEGCDVVHSLDEALALFRPEEKVFVIGGAQIYAQALPLCDEFYLTRVFHAYQ
GDTCFPRWDEREWEIIDSESFASGKEFPYPFAFEHYRRRK
>KF628394.1_16523|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
LARNGEGSEQLQADNEPGKQKNKNVSDRRIIMNLIVAADKNWGIGKDNKLLVSIPSDMKF
FRQETMGKVVVMGRKTLESFPNGLPLKNRTNVVLTSDKNYQVKDAVIVHSIDEVLEELKK
YDDDEIYVIGGGKVYEELLPYCDVAHVTKIDFAFEADTHFQNLDE
>KF628389.1_16534|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MELIVAVYDDWGIGRDGTQPVALSADRKFFRATTRGAMVIAGRRTIEDFPGKQPLPGRVN
VALSRSVTALPGFTVCDSAEKAAALSRTAERCFV
>KF628371.1_16578|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
QFALTIAASTVLSGFNSLTLTPALCALMLQPTRPSKNPLYRGFNHLYDKTQGVYDRIVEY
LLQRPVASIVSYAVFTLIAVLLFVKWPSTFVPEEDDGYFLAVVQLPPASSLERTQAVGKQ
INKILDSYPEIKDYIGISGFSVMGGGEQSNAATYFIVLKNWNERKGKEHTAEAVVQRFNM
EVYGIQEAEIFAMVPPAIPGLGATGGLQLQLEDRHNLGATEMQRAVETLMEHYRNYPALA
SVSSQYQANVPQYFLNIDRDKVQLMGIPLNSVFTALGYYMGEAYVNDYVQFGHIYQVKLG
AGDRAQRVIDDVLKLSVPNASGEMVPFSSFTRVEEQLGMDQINRYNMYSTAAVTCNVAPG
SSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQAGTTTTVVFVMALLVAFLVLAAQYE
SWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALSAKNGILIVEFARDFR
AQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALN
TLLATVYIPNFYELMQKLQEKFSKKQ
>KF628362.1_16606|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNKADQYMERDIKNILENGYIDENPRPKYADGVPAHTYSVNHVCRTYDLSKGEFPICSLR
RIAWKTGIKEIFTIYQRPTNSISEMEKMGVTWWKDWDIGDGTIGQRYGATVKRYDLINKL
IDDIKKDPYGSRKVVSLWQENDLRETAGLAPCAYNTIWNVRGKYLDMVLIQRSGDMLTAS
GAGGVNEVQYAALLMMIARYTGYKPGVFTHFVANEQIYDRHINQAKEMLKRVENLKNSDT
QSKPMLKLNPEKTNFYDMAIEDFSMENYDPIVPQLKLELGI
>KF628355.1_16627|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMMAQVCDMEAGMAQVCDMEAGELLHVVADCHIYDRHIPLIKELIQRKPYPAPVVKLNPE
VKDFYQFTTDDLIVENYETWPQIKNIPIAV
>KF628351.1_16636|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICKTLLEKGHDAFLLDVFLGLENAPENLEDVFTLPGH
GLEIAKNISETEPDLAAVKASRPDQSDCFFGPNVIELCRLADMTFLGLHGGEGENGKLQA
SFDLLGIRYTGPDSLGCAVAMDKGLTKQIYMEAGVDTPSGVCL
>KF628350.1_16639|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGNKVPED
RNDFSFTNGTEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFTC
NQYLKAFGVRIAESLLLRQGQSISDEEVVEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQP
AIVKAFGEAQEVLVEAFMDGTELTCGCYKTKEKTVIFPPTEVVTHNEFFDYDAKYNGQVD
EITPARISDELTKRVQMLTSAIYDILGCSGIIRVDYIVTAGEKLNLLEVNTTPGMTTTSF
IPQQVRAAGLDIKDVMTDIIENKF
>KF628347.1_16646|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRRIKAEGVVRGDRTGTGTKGVFGHQMRFDLSEGFPLLTTKKVFLKGVIHELL
WFLAGDTNIKYLVDNGVHIWDNDAFRYYNELCVRHGVLPVDRDTFLRAAQDGVESPVEGY
RFGDLNHVYGYQWRSWPKPDGRFIDQIAQAVELIRHNPESRRIIVSAWNVAEIGDMALPP
CHVLFQFYVAGGRLSCQLYQRSADTFLGVPFNIASYALLTLMTAQVCGLEPGEFVHTLGD
AHLYLNHMEQADEQLSREPRPLPVMRLNPDVKSLFDFRYGDFTLEGYDPWPAIKAPMSF
>KF628344.1_16656|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MQYTISKEAKIAVLCGGMSSEREVSLRSGKNILAALKRLGYANAEIVDVSENIMNDLKGF
EYAYNTLHGKYGEDGCVQGVLEIMKIPYTGCGVMASAICMNKEFTKRILKNTKCTSYKIC
FFAAW
>KF628340.1_16668|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TVEYTIKKFGVVNRYDLRKEFPAMTLRRTALKSAMDEILWIWQKKSNNIHDLNSHIWDSW
ADEDGSIGKAYGYQMSVKHQYKEGMFDQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNL
YPCAYSMTFNVTQTPGNDKLTLNAILNQRSQDILAANNWNVCQYALLLMMMAQVCDMEAG
ELLHVVADCHIYDRHIPLIKELIQRKPYPAPVVKLNPEVKDFYQFTTDDLIVENYETWPQ
IKNIPIAV
>KF628328.1_16696|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
VQKKEEMNMNAIVAADKNWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGRKTLESFPNG
LPLKNRTNIVLTGNPNYHVKDAVIVHTTEELLEELKKYDEEEIFVIGGESIYRMMLPYCS
KVYVTKIDHAYQADTYFPNLEKDPDWQKTAETDEQTYFDLEYVFAKYERIK
>KF628307.1_16751|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GIDVKGNLEDVFAEEAYDIDKAAEYMHSFDAGLNEMIASRRRFFGPNVLELCEAADVVFL
ALHGANGEDGKVQATFDLLGIPYTGTGYLSSALAMDKSITKQFFRAHHVPTPNGVTLKKG
QESEPLSGFGLELPVVVKPCCGGSSVGVYIAHTNEEYWQAMKDAFSYEPEVVVEEYIEGR
EFSVGVVDGKAYPIIEIAPIEGFYDYTNKYKAG
>KF628303.1_16762|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
VSKQIIAIWAEARNHVIGKNHTMPWHLPAELAHFKKTTMGSAILMGRVTFDGMNRRCLPG
RETLILTRDKDFDCEEVTTVTSVEEALAWFEQQDKDLYIAGGAGVYKAFDGHYDVLIKTT
IEADLEGDTYFPQLDTTAFKEVSRDRVPKNEKNAYDFSISRYEKERD
>KF628282.1_16822|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
DLEVRKSERNQKNIMEKKNIVVLFGGQSSEHVVSCMSVQNVAANINEEKYNVILVGITED
GHWVKVDSLSQVKDDTWRESKTGAVLSPDAKEKCLIVTENGSFEKIPVDVVFPVLHGLYG
EDGTVQGILELAKIPYVGCGVLASVVSMDKLSTKRMVSGLGICQAAYVSVMKAELKDMDA
VIAKIGKRDPISGICKAV
>KF628281.1_16826|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVDGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAAS
GFAAEADEMLAAVQQAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVFEASHHYWR
VLVEQGIDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYVNSDASHV
EVPASLPEETLNRVRETAKKAFIAVDGTGLSRVDTFVTADGEVMVNEINTMPGFTPISMY
PKAWEATGVSNTDLITTLIEGVLR
>KF628277.1_16840|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLLSGAGICKTLREMGHQAFLLDVFFGLPYDSDKLEEIFDRPDG
GLEISKGISTSVPDLGALRKSRPDQSPSEIGPNVIELCQMADITFMALHGSIGENGKLQA
TFDNLGIKYTGPNSLGCTLSMNKLVTKQIFKTSGVPTPRGTSLTVKTKDTRLDELGYYLP
LVVKPCSNGSSIGVYICHTEEDYYDAIHKSFDIDNTDEVVIEPFIKGREFACGILAGKAL
PLVEIVPKDGLFDYANKYQAGGASEICPPVSLDAETQELIQRAGERAFEALRMDVYSRAD
FIVSDADGEFYCLEMNALPGMTAASLLPKAAKAAGYEYSEFCEAIIQESMKARY
>KF628271.1_16855|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
YTNKYKAGATVDTCPAVLTEEQTKEMQKHAEDGAAALGIENYCRLDFMMRKDGRMYCLEA
NTLPGMTPTSLLPQEAQVLGISYPELCELLIQLSLRKRGNNA
>KF628269.1_16861|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LSEMHLYPCAYSVTYNVTQRPQDDKPTLNMILNQRSQDILAANNWNVCQYAILLMMVAQS
VDMIAGELLHVIADAHIYDRHVDIVRELIERPQFAAPKVTLNPDVHDFYAFTTDDLIVEG
YEHGPQVKNIPIAV
>KF628263.1_16871|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTDKIAVLLGGTSAEREVSLNSGAAVLAGLREGGIDAYPVDPKEVDVTQLKSMGFQKVFI
ALHGRGGEDGTLQGMLELMGLPYTGSGVMASALSMDKLRSKLLWQGAGLPVAPWVALTRA
EFEKGLNDKQLAEISSLGLPVIVKPSREGSSVGMSKVVAENALQDALRLAFQHDEEVLIE
KWLSGPEFTIAILGEEILPSIRIQPAGTFYDYEAKYLSDETQYFCPAGLEASQEANLQAL
VLKAWTTLGCKGWGRIDVMLDSDGQFYLLEANTSPGMTSHSLVPMAARQAGMSFSQLVVR
ILELAD
>KF628261.1_16876|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MIAGELLHVIVDAHIYDRHVDIVRELIERPQFPAPKVSLNPEVTNFYDFTTDDLIVEDYN
HGPQVKNIPIAV
>KF628256.1_16886|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADDFMVTMAT
GGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIA
PGLALEAGDEVDIDRIVEICGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGVSRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQVCDSLIRMGLRRAGVAC
>KF628255.1_16891|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MGGKSSEHDVSLVSAKTVIENIDKDLYNVIMVGITKDGQWKLVDRLDHLEDGSWVNSKTS
AYICPDTGRKELLLERDGKVDRISIDVVFPVLHGMNGEDGTVQGLLELAAIPYVGCGVLA
SACSMDKFYTKIVVDSIGVRQAKFGWRKKT
>KF628242.1_16919|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYQEMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIKISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQVKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF628232.1_16943|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MEMPASPIRKLAPLADAAKQRGIHVFHLNIGQPDLPTPEVAIEAIRNIDRKVLEYSPSAG
YRSYREKLVGYYAKYNINLTADDIIITSGGSEAVLFSFLACLNPGDEIIVPEPAYANYMA
FAISAGAKIRTIATTIEEGFSLPKVEKFEELINERTRAILICNPNNPTGYLYTRREMNQI
RDLVKKYDLFLFSDEVYREFIYTGSPYISACHLEGIENNVVLIDSVSKRYSECGIRIGAL
ITKNKEIRDAVMKFCQARLSPPLIGQIAAEASLDADEDYLRDTYDEYVERRKCLIDGLNR
IPGVYSPIPMGAFYTVAKLPVDDSDKFCAWCLSEFEYEGQTVFMAPASGFYTTPGSGRNE
VRIAYVLKKDDLNRALFILQKALEAYPGRTE
>KF628228.1_16951|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GSIGKAYGYQLGVKHQYKEGLFDQVDRVLYDLKNNPASRRILTNLYNFEDLHEMHLYPCA
YSMTFNVSNGTLNAILNQRSQDMLAANNWNVCQYAVLVHMLAQVSGLKAGELVHVIADAH
IYDRHIPIIEKMLSEPEHPAPEFSLDPAVTDFYAFTPDSVRLENYCFSPFEDKIPIAV
>KF628227.1_16955|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETIL
HNNEVHYPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLRQKHSSQDL
DMSLGELLQYSISLSDNNACDILIEYAGGIGHIHQYIRKLGINDFNLSETEDSMHRNPQK
AYSNWSTPSEMVRLLKMADEKNLFAPVYRDFLWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGVVIMPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDEMK
>KF628224.1_16966|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>KF628218.1_16990|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPPGSVAQFLEQLGRKPYPYPTIEIRKADSLFDYQYEDFKVVGYQHHPTIKAPVAV
>KF628214.1_17001|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TTIPGGQDMSYADQVFRRNCEDILKNGVWDTELAVRPRWEDGTPAHTVKKFGIVNRYDLQ
REFPILTLRRTYWKSAVDELLWIWQKKSNNVHELSSHIWDAWADESGSIGKAYGYQLGVK
HQYKEGMFDQVDRVLYDLKHDPASRRILTNLYNFADLHEMALYPCAYSMTFNVSGDTLNA
ILNQRSQDMLAANNWNVVQYAVLVHMMAQVSGLKAGELVHVIADAHIYDRHVPIIEQMLS
EPEMPAPAFCIDPSVTDFYAFTKDSFRLEGYEPCPFEAKIPIAV
>KF628201.1_17037|FEATURES|farme|multidrug|ABC_transporter|antibiotic target protection|1
MLARDNLLLLDEPTNHLDIGSREALEEALAGYDGTIFIVSHDRYFINRLATRVLRLTNEG
CQSFEGGYDQYLERFQEAERTKTEQAPPKENAYKKRKEQESVRRRLQGRIRRTEEAVAAA
EEAVASLHRQLEDEAVAADYTRVLELTAELEEQNRRLEEQMALWEELQLEAEAMEEETPL
>KF628191.1_17065|FEATURES|farme|beta_lactam|mecR1|antibiotic target replacement|1
MKKHIIGTLFALVLLASVARASETVERTDLADIFQGFDGTFIMYDEGADRYTVFNKALSE
TRLPPCSTFKVFHALIGLDSGVLDRDDARTLMKWNGKPSSIAAWNHDQTLASAMRHSVVW
YFQRVATGIGEDRMQRGLDRIGYGNRDISGGLTRFWLQSSLKISPREQVGLLRALFNGSL
PFAAEDIAVVKRDITLSSGKGLRFMGKTGSGSDDADRGIIGWFVGGVETPHNRWSFAVNI
QGPDASGVRARGIAEAALKRLSILP
>KF628187.1_17080|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target protection|0
APHGTGHIKAGLNYAMSLHAIVDAHKNGFDENMYLDAATRTKVEETGGANFIFVTKDGKV
VTPKSNSILPSITRRSLIYVAKEYLGLEAEEREIYFDEVKDFAECGLCGTAAVISPVGKI
VDHGKEICFPSGMEKMGPVIQKLYDTLTGIQMGRIQAPEGWLKVIE
>KF628181.1_17093|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
AIETIKHNPDSRRIIVSAWNVADLKRMNLPPCHAFFQFYVADGKLSLQLYQRSADIFLGV
PFNIASYALLLMMVAQVTGLEAGEFVHTLGDAHIYTNHFEQVEEQLKRDPRKLPTMRINP
DVKSIFDFKYEDFTLENYNPHPHIKGIVAV
>KF628179.1_17098|FEATURES|farme|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFSTLQKLQ
IPTIIFINKIDRAGVNLERLYMDIKTNLSQDVLFMQTVVDGSVYPVCSQTYIKEEYKEFV
CNHDDDILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDIEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPNKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQVASSKAITDLQKLMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKGGYSDNTRMEEKDKLLFMFEKSVSSK
>KF628177.1_17103|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
APSLSGLEAGELVHVIADAHIYDRHVPIIEKLLEKDERPAPKFIIDKSVTDFYQFTRDSF
SLEGYDPQPFEDKIPVAI
>KF628175.1_17106|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMVAQVTGLEAGEFVHTLGDAHIYTNHFEQVEEQLKRDPRKLPTMRINPDVKSIFDFKYE
DFTLENYNPHPHIKGIVAV
>KF628174.1_17110|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNMILSADNNWAIGLNNKLLVSIPADMKFFRQTTTGNVVVMGRKTLESFPGGQPLKNRTN
IVLSTNPDYQVKGAIVVHSKEELLKELEKYDSDSIYVIGGATIYKMMLPYCDT
>KF628172.1_17119|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MDRVLYDLKHTPYSRRIMTNTYVFSDLSKMHLYPCAYSVTYNVTQRPQDDKPTLNMILNQ
RSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRHVNIVRELTERPQF
AAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF628170.1_17126|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVHDLKSHVWDEWADEDGSIGKAYGYQMGVKHQYKEGMM
DQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKSGHDKLTLNAIL
NQRSQDILAANNWNVVQYAALVYMMAQVCDMEAGELVHVIADAHIYDRHIPIIKEMIKRE
TYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF628168.1_17132|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADKIFVAMCEDIINNGTTTEGQKVRPRWEDGTPAHTIKKFGIINRYQLQEEFPILTL
RRTYWKSAVDELLWIWQKKSNNIHDLSSHIWDQWADESGSIGKAYGYQLSVKHHYPEGDM
DQVDRVLYDLKHNPASRRILTSLYNFEDLHDMHLYPCAYSMTFNVSGKVLNAILNQRSQD
MLTANNWNVVQYAILVHMFAQVSGLVPGELVHVIADAHIYDRHIPIVERMLERAPAPVPR
LIIDSSVTDFYAFTPDSFRLDGYTPAAFEEKIPIAI
>KF628163.1_17144|FEATURES|farme|trimethoprim|dfrA|antibiotic target replacement|1
MNAIVVTDKQWAIGRNGDLLFSLPGDMKHFRTLTTGGTVIMGRKTLDSFPGGRPLPKRRN
IVITRSPDLHREGCETVSTPEDALALAGDEENVWLIGGGSIYAALLGRCRRASVTRVDST
VSDADTFFPDLDALPNWKIERTGEAVTENGLTYRFVDYVNTALL
>KF628162.1_17147|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDLIVAVDQNWAIGKDGEQLLYLSQDLKRFKALTLGHAVILGRRTLSTFPGGRPLKGRRN
LILSTTPGFAPEGGEVYPSLDALLAAAPADAFVIGGESVYRALLDRCGTAYVTKILAQYP
ADRYFPDLDADPRWESVEESELLEENGVRFRYVTYRRRQEA
>KF628160.1_17152|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISLIVAVAENGVIGDRNALLWHISEDLRHFKAVTTGHPVVMGRKTWESLGRPLPNRTNV
VITRQNIEIPGCTVAHSLEEAVALFPADEEVFVIG
>KF628159.1_17154|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKWIVAADERGGIGKNGGLLVRIPADMKYFREKTLGKTVIMGRATLESFPGGKPLPKRRN
IVLSRTLPEGDAYEVCRSIEELMELTASDNTDDLFVIGGGQIYDQLLPYCNEALVTEIRG
VFDADTRITLPRDLPDWDKAAESDTI
>KF628158.1_17155|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FVHTFGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKSIFDFKFEDFELVNYDPHPHI
AGVVAV
>KF628157.1_17159|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLSIIVAIARNGIIGSGNSLIWHISEDLRRFKAITSGHPVVMGRKTFESIGRALPGRTNV
VITRQSSFLAEGCTVVHSLEEALALFPESEEVFVIGGGEIYAQALPRAQRFYLTEVDADY
EGDTRFPDWDRSQWLLTEQEHHPHGEKFPSPFTFLTYARKPAR
>KF628155.1_17165|FEATURES|farme|multidrug|cdeA|antibiotic efflux|0
VAKKSTAIDVTQGVIWQQLLSLCIPIFFSSFFQQAYTLIGTYIVGQFGGKLALGGIQATM
VLTELCIGFCVGVGAGCAVITGQYFGQHDDERLSRSVHTAMTLALVGGIVFSILGIVFVE
PMLVLMNTPHELLAEGVAYARCYFAAMVAALLLNMGTALLRAVGDTRGPAVIIASGCLVN
VVLDIIFVAVLHMEALGCGIAVALTICSNATMIVLRMMRAPGAWRLSLASLG
>KF628155.1_17167|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MTCKLSAIVAVCDDWGIGCEGDMVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGRPLK
NRRNIVLTRDEDFAPEGVDIVHSVDEALAAVADEPMAWVIGGGEVYRQFLPYCTEAEVTH
NHCVHAVDTFFPDLDADPAWEIARRDGVATIASGEGDEGVDYEFVTYRRVEA
>KF628154.1_17170|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MLQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTILN
RHEEFRTALDKNGQVGVFSEMLPCYTIFHKETETFSSIWTEFTADYTEFLQNYQKDIDAY
GERKGMFAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYYIP
LSIQVHHAVCDGFHVCRFLDELQDLLNK
>KF628150.1_17181|FEATURES|farme|multidrug|MexB|antibiotic efflux|1
ALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAG
AGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQERFSKKQ
>KF628148.1_17189|FEATURES|farme|polymyxin|arnA|antibiotic target alteration|0
MSHADQLFLQNCREILSHGVWDTDLPVRPRWEDGTPAHTIKKFGIINRYQLQEEFPILTL
RRTYWKSAVDELLWIWQKKSNNIHDLSSHIWDQWADESGSIGKAYGY
>KF628143.1_17200|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
IYVAQHYLGLEAEEREIYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMG
PVTQKLYETLTGTQMGRIEAPEGWIQVIE
>KF628140.1_17205|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEAIVAVYSDWGIGSGGTQPVVLKADRAHFKELTDGAAVIVGRKTLGDFPGGRPLKGRHN
IVVTRQDIEVAGAQVAHSTGEALTLAAEYERCLVIGGASVYRQFMPYLDTVHVTKIDLAP
QSDSYFENLDSSPNWERIDEERWQSEGDIRYCFVTYKRRA
>KF628130.1_17227|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLAANNWNVCQYAVLVHMFAQVSGLKAGELVHVIADAHIYDRHIPIIEKMLAEPEHPAPQ
FTLDPAVTNFYAFTPDSVRLENYQFSPFEDKIPIAV
>KF628119.1_17263|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGLFDQVDRVIYDLKNNPYSRRIMTNLY
VHQDLHEMNLYPCAYSMTFNVSKKPASEKLVLNGILNQRSNDVLAANNWNVCQYSVLMHM
LAQVCDMQVGELVHVIADAHIYDRHVPMIRELISREPLPAPKFWLNPEIKDFYEFTPDDV
KLIDYQTHEQIRNIPVAI
>KF628116.1_17270|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ADKVFIDMCRDIIENGTSTEGEKVRPRWEDGTPAYTIKKFGVVNRYDLSKEFPALTLRRT
GIKSCVDEMLWIWQKKSNNINDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGVLDQV
DRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQR
SQDVLAANNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHVPMIEELISREPLP
APKFWLNPEVKDFYDFTPDDVKLEGYETHPQIKNIPIAV
>KF628114.1_17273|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MQSEKMCVVLLFGGMSSEHEVSRVSVGNFVNNIDREKYETLAVGITKEGRWLYTEATAAQ
MADGSWEELAGNMPCVIRPDRADHGMILFTPEGHVEKVHVDVVIPVLHGLWGEDGTVQGL
LELAGIPYVGCGVLASAVCMDKAVANALFEANGVPHTKWVAANRWEIESDLEGVCDGVEQ
KLGWPVFVKPANAGSSVGISKVSSREELKKAIDLALENDRKVVFEAFVDGQEVECAVIGS
DPAVATRPGEILAGAEFYTYDDKYKNGVSQTVIPAHLPEAKLDEVKTYAAMAYTALNCEG
LARCDFFVEHGTGRVLINEINTFPGFTSISMYPKLMEHEGLPVPALIDRLIALALERKEK
QHG
>KF628112.1_17279|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PSNNIHDLHSHIWDSWADENGSIGKAYGYQLGVKHQYKEGMMDQVDRVLFDLKNNPYSRR
IMTNIYVHQDLHEMNLYPCAYSMTFNVTKEPGKDKLVLNAVLNQRSQDILAANNWNVCQY
SLLLMMIAQACDMEAGELVHVIADCHIYDRHIPVIKELISRKPYPAPTVKLNPEIKDFYK
FTTNDLIVENYETWPQIKNIPIAV
>KF628111.1_17282|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|0
MAKRVTVKELNSYVYEQKRRYKIMKIVVLAGGTSTEREISIVSGTGICGALRQKGHEAIL
VDIFCGVENVDWDEPFPG
>KF628110.1_17286|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIAAADKNWAIGKDGELLVRISEDMKNFSAITTGNVIVMGRKTLESFPGGKPLPNRVN
IVLTHEKDYNGKGAIVVHSEEELWEELSKYDTDSIFVTGGESIYRMLLPYCDTAYITRLD
YAYEADTWMPNLDKEEHWSMVEKGEERYCFDLIYHFTTYKNETPALH
>KF628107.1_17294|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTNIYVHQDLHEMNLYPCAYSVTFNVTKKSGHDKLTLNAILNQRSQDILAANNWNVVQYA
ALVYMMAQVCDMEAGELVHVIADAHIYDRHIPIIKEMIKRETYPAPKVTLNPEVKDFYEF
TTDDFKIEDYQAGEQIKDIPIAI
>KF628079.1_17363|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MALTEEQLADIRSRIPARPETDIPMPYEDLVRKILTEGTLKSDRTGTGTISLFGQQMRFD
LSKYFPLLTTKTVFFKGLAYELLWFLKGSSNINWLLEHNVHIWDEWADENGDLGPVYGVQ
WRSWPAPTPEDPNRTIDQISNVLDLIKHHPDSRRMIVSAWNPAEVEKMALPPCHALFQFY
VADDKLSCQLYQRSCDMFLGVPFNIASYSLLTMMMAQQAGLKPGEFVWTGGDCHVYDNHV
DQFLEQLGRKPYPYPTIEIRKADSLFDYQYEDFKVVGYQHHPTIKAPVAV
>KF628072.1_17379|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIIKELIKRPTYPAPKVTLN
PEVKDFYKFTVDDFMIEDYQAGPQIKNIPIAI
>KF628071.1_17383|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVHDLKSHVWDEWADEDGSIGKADGYQMGIKHQYKEGMM
DQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKSGHDKLTLNAIL
NQRSQDILAANNWNVVQYAALVYMMAQVCDMEAGELVHVIADAHIYDRHIPIIKEMIKRE
TYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF628070.1_17387|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTL
RRTALRSAMDEILWIWQKKSNNIHELHSHIWDSWADENGSIGKAYGYQLGVKHQYKEGMI
DQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQTPGNEKLTLNAIL
NQRSQDILTANNWNVCQYAILLMMIAQVCDMEAGELLHVVADCHIYDRHIPVVKEMNKRK
PYPAPIVKLNPEVKDFYQFTTDDLIVENYETWPQIKNIPVAI
>KF628066.1_17397|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EGEKVRPKWPDGTYAYTIKKFGVVNRYDLSKEFPAITLRKTYIRSAIDEILWIWQKKSNN
VHDLSSHIWDEWADEDGSIGKAYGYQLGKKHKYKEGEMDQVDRVLFDLKENPFSRRIMTN
IYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQDILAANNWNVVQYAALLMMFAQV
SGFEPGELVHVIADAHIYDRHIPIVKELIQRPVYPAPK
>KF628034.1_17473|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIGLIVARSKNNVIGKNGNIPWKIKGEQKQFRELTTGNVVIMGRKSYEEIGHPLPNRMNI
VVSTTTEYQGDNLVSVKSLEDALLLAKGRDVYISGGYGLFKEALQ
>KF628031.1_17479|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
QFGVVNRYDLSKEFPALTLRKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSI
GKAYGYQMGVKHQYKEGMMDQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSV
TFNVTKKPGHDKLTLNAILNQRSQDILAANNWNVVQYAALVYMMAQVCDMEPGELVHVIA
DAHIYDRHIPIIKEMIKRETYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPIA
I
>KF628026.1_17491|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLISGAGICRTLRERGHQAFLLDVFFGLPYDPDRLEEVFTLPDS
GLSIAEGIKTTTPDLAALKASRPDQSDCYLGPNVIELCRMADITFMALHGSVGENGKLQA
TFDILGIKYTGPNSLGCSLSMNKLVAKQVFKMSRVPTPRGTSLTAATKDTPLSELGYYLP
LVIKPCSGGSSIGVYIVHTEEEYTEAIRRSFEEDQQDEVVIEPYLKGREYACGIIAGKAL
PLVEIIPKDGIFNYENKYQTGGATELCPPQSLDIKTQKKMQKAAEKAFAALRMDVYSRAD
FIVDENDGKFYCLEMNGLPGMTPASLLPKAAKAIGIEYGDLCEIIIDQSFKARYTHTPGP
TLEGGKL
>KF628025.1_17494|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCRDIIDNGTSTEGEKVRPHWPDGEPAYTIKQFGVVNRYDLSKEFPALTLRKTYIKSAID
ELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMMDQVDRVIYDL
KHNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKPGHDKLTLNAILNQRSQDILAA
NNWNVVQYAALVYMMAQVCDMEPGELVHVIADAHIYDRHIPIIEEMIKRETYPAPKVTLN
PEVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF628024.1_17499|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKLISAADKNWAIGKDGELLVRISEDMKNFSAITTGNVIVMGRKTLESFPGGKPLPNRVN
IVLTHEKDYNGKGAIVVHSEEELWEELSKYDTDSIFVTGGESIYRMLLPYCDTAYITRLD
YAYEADTWMPNLDKEEHWSMVEKGEERYCFDLIYHFTTYKNERPALH
>KF628013.1_17528|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKDVFEHGVEKSDRTGVGTRSMFGYQMRFNLQEGFPLVTTKKLHLRSIIHELLWFLHGDS
NVKYLHDNKVTIWDEWADANGDLGPIYGVQWRHWKTSDGGYIDQISNLIHQIKTNPDSRR
LVVSAWNVGEIDKMALPPCHMFFQFYVAQGKLSCQLYQRSCDIFLGVPFNIASYSLLTHM
IAQQCDLDVGDFIWTGGDCHIYNNHFEQVKLQLSREPRPYPKLIIKRRPDSIFDYKFEDF
EIVDYDPWPAIKAPIAV
>KF628010.1_17534|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPSRSDWEVEGVPANNGDKRSIGQRYGAVVKKHDIINRLLAQLEANPWNRRNVISLWDYE
AFEETAGLQPCAFQTMFDVRRVGEDVYLDATLTQRSNDMLVAHHINAMQYVALQMMIAKH
FGWKVGKFFYFINNLHIYDNQFEQAEELLKRQPSDCQPRLVLNVPDETNFFDIKPEDFEL
VDYDPVKPQLKFDLAI
>KF628008.1_17539|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLTSGAGICKTLREKGHQAFLLDVFFGLPYDTDKLDEVFDLPGG
GLEIAEGIKTTVPDLEALKKQRPDQSDCLIGPNVLELCKMADITFMGLHGSIGEDGKLQA
MFDVLDIHYTGPNALSCTLSMNKLVSKQIFKMSGVPTPRGTSLTPKTKDTPLSELGYYLP
LVLKPCSGGSSIGVFIVHTEEEYKEAVHQSFDINHEEEVVVEPYIKGQEFACGILAGKAL
PLVEIVPKDGLFDYANKYQAGGAQEICPPVSISEELQEKMKRAGEAAFEALRMDVYARAD
FIVDESDGEIYCFEVNALPGMTSASLYPKAAKAYGLDYGDLCERIIEESKKARYQ
>KF628005.1_17545|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MKILEVQHVVKTYGSHQNQVTALSDVSFAAEQGEFIAIVGTSGSGKSTLSP
>KF627999.1_17562|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
AVSMDKLYTKIIVDGLGIRQAAYVPVMREQLADMDRTVSRIESRFSYPVFIKPSNAGSSK
GVSKAENRAELEAGLKEAARHDRKLLVEEMITGREVECAVFGGGSEEIKASGVGEILAAA
DFYDFDAKYYNAESKTVTDPELPGDAAEQIPRAAAAIFKAVDGYGLSRVDFFVKADGEVV
FNEINTMPGFTAISMYPMLWEARGIGKEQLVDMLLEHGLKRFS
>KF627996.1_17573|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MNLIVAVDQNWAIGKDGDQLVYLKEDLKRFRTLTSGHTVILGRKTLATFPGGRPLKNRRN
LILSRDSAFAPEGAEVFRSLEALRAAAPADSFVIGGASVYAALLDWCDTAYITKIGRAWE
GADAFFPDLDAGPDWEMAEEGEPQEHAGIPFRYVTYRRRKPHVCG
>KF627988.1_17593|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGTSTERDVSIVSGTGVCKALRQKGHQAILVDVFAGLESVKLEAAFEGDYDVE
AAAEYIKSFNERIQELEKQRRDFFGPNVVALCKAADIVFLALHGENGENGKVQAAFDLMK
IKYTGTGHTGSAMAMDKGITKALFQMYQVPTPKGVTMTVKNRRNDLSVHGMDFPVVVKTC
CGGSSIGVYIVQDQEAYVKALDEAFSYEEEVVIEEYIQGKEYTVAVVDGEAYPIVLIEPV
SGFYDYKNKYQAGATIETCPAPLDEEKTRKMQEYAVRGYKALALQAYGRLDFMMDEAGNM
YCLEANTLPGMTPTSLIPQEAAALGMDYPTLCEHLIEVSLKKYE
>KF627975.1_17631|FEATURES|farme|tetracycline|tet32|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAV
TSFYWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMD
IPTIIFINKIDQNGIDLQCVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIIS
GSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAIIETFIT
ETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNG
EIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPQKKASCTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEG
VRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYL
SFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGR
SVCITELKGYQE
>KF627966.1_17660|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKKRIVVMYGGKADEHSISCISAASALRALDTDKFEAIPVGITKDGKWIVNGENPLGWS
LDEGLPTVEKTPGAKDVVLEVALGQDGFFAREDDGTLTPFGHVDAVFPVLHGPYGEDGTI
QGLFEMMGVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDARSFDKASEFKANA
DAIMAQVSEAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVYEASHHDWRILVEQG
IDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYMDAAASHVEVPAKP
AGRDAEPRTRNRQEGVRRRGRCRSEPRGHLRDQGRQGDGQRNQHHAGLHVHLHVPQGMGG
HRRALHRPDHHAHRRRAAL
>KF627964.1|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MNIPAEFNEIRPYTPEELPQIYEELIADPAFRTVVESVMPGVPFEGLAMKMRQCKTNLEF
QKAFFYGLLWDLVKKTANGLTFDCSALSDLTRNYTFISNHRDIILDSAFLSILLIDNGMT
TVEIAIGDNLLIYPWIHKLVRVNKSFIVKRGLNMRQKLEASALMSRYMHFAMKEKHENLW
IAQRQGRAKDSNDRTQDSVLKMMAMAGEGDVTERLKELNIVPLAISYEYDPCDFLKAKEL
QQKRDDEHFQKSPEDDLINMQTGLYTAPSRVTEQASS
>KF627963.1_17671|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVAALKEAGYTSVELLDTAADNFMVTMAT
SGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIA
PGLALETGDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDEVRALPIVEIRKPEDCEFYNLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQVCDSLIRMGLRRAGIAC
>KF627955.1_17687|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GESAYTIKRFGVVNRYDLRKEFPALTLRKTALKSCMDEILWIYQKKSNNIHDLNSHIWDA
WADADGSIGTCYGDVVGRKFIYKGEETDQMDYVLRQLKENPYSRRIMTNLYQFEYLHSGA
LDPCCYSMTYNVTKDAAEDRLVLNGVLNQRSQDVLAANNWNVCQYSILLMMVAQVNDMIP
GELVHVIADAHIYDRHVPMIEELIKREPLPAPKFWLNPEIKDFYQFTRNDVKLIGYETHE
QIKDIPVAV
>KF627955.1_17688|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MREETGGNSRMNLIVAVDKNWAIGNGNKLLVSIPQDMKFFRETTKGKVVAMGRKTLESFP
GGQPLKNRVNVVLTTDQNYKANGAVIVHTIEQMLAELKKYASEDIFVIGGESIYRQLLPY
CSKAYVTRIDHAYDADTHFPDLDVDPQWEMTKISDEQTYFDLEYVFTIYERIS
>KF627948.1_17705|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAMSNSSKLSLCVIFGGVSSEHEVSRMSATSILENLSSEKYDVHMVGITKEGKWLLYTGD
VKEIVSGAWEQGPVTPAFLAPDPSVHGLVVLRDGTAETIPVDVIFPALHGKNGEDGTIQG
LFQLSGIPYVGCDTHSSSVCMDKAVTHTLLSNADIEQAHYLWFYADRFDVAPDTIKNKIQ
ARLDFPVFVKPANAGSSVGVSKVERLEDLDEAIRKAAKEDKKVVVEEGIKGQEVECAVLG
NRDAEASIVGEIGASAQFYDYDDKYINGTSQLYIPARIDPEVSDKIRQAAVRAYRLLGCS
GLARVDFFVTEGDHRVILNEINTLPGFTSISMYPKLWMAMGLSYSQLLDRLVELAFQ
>KF627947.1_17707|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTFNVTKKKDSDKLVLNGILNQRSQDVLAANNWNVCQYAVLMHMLAQVCDMQVGEFVHVI
ADAHIYDRHIPLVEELISREPLPAPTFWLNPEVKNFYEFTPDDVRLDNYETGSQIKNIPI
AV
>KF627945.1_17711|FEATURES|farme|macrolide-lincosamide-streptogramin|ErmH|antibiotic target alteration|0
MEYSKEDLMEAKKQIWGVGENMGTEESKKIWEENAQFWDNAMGDESNEFHREVVRPKVTE
LLSPNPADYILDIACGNGNYSSYLAQRGASVVAFDYSKKMIDLEGG
>KF627943.1_17715|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTL
RRTALRSAMDEILWIWQKKSNNIHELHSHIWDSWADENGSIGKAYGYQLGVKHQYKEGML
DQVDRVIYDLKNNPFSRRIMTNIYVHQDLQEMNLYPCAYSMTFNVTQTPGNEKLTLNAIL
NQRSQDILTANNWNVCQYAILLMMIAQVCDMEAGELLHVVADCHIYDRHIPVVKEMIKRK
PYPPPIVKLNPEVKDFYQFTTDDLIVENYETWPQIKNIPVAI
>KF627939.1_17729|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLISGAGICRTLREKGHKAYLLDVFFGLPYDPDKLEEVFDLPGG
GLEIAEGIKTTTPDLEALRASRPDQSDCYLGPNVIDLCRIADITFMGLHGSVGENGKLQA
TFDILGIKYTGPNSFGCALSMDKLVAKQIFKRSGVPTPRGTSLNRNTKDTPLEKLGYYLP
LVIKPCSGGSSIGVYIVHTEEEYREAIRCSFDVNHEDEVVIEPYIKGRGVCLQHHRRKGP
SADRDHSKRRNLQLRE
>KF627936.1_17735|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|1
MDTEKYNVILVGITKEGRWLLVDSVKDIEDGSWREGEVKAFISPDTTTRSLVILAEGTYK
LQKVDVIFPVLHGMNGEDGTVQGLFELSKIPYVGCGVLASAVSMDKVYTKIIVDHIGIDQ
AKFVHVRESDFEHLEEAMDRVEKEIPYPIFVKPSCAGSSKGVSKAENRKELEAALYEAVK
HDRNILCEETIVGREVECAVLGDRTQVKSTCVGEILAAEEAAFYDFDAKYNNAESKTVVD
PEMPEESKRKIKEDAEAIFRAVDGFGLSRVDFFLEESGRVVFNEINTLPGFTSISMYPML
WKACGLDIPELLDTLIDQAMTRYR
>KF627931.1_17752|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGAKAPVD
RNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFAC
NQYLKGFGVRIAESLLLRGGQSVTDEDVMEKIGLPCFIKHSLGGSSFGVTKVTAKEQIQP
AIAKAFAEAQEVLVEAFMDGTEITCGCYKTKDKSVVFPITEVVSHNEYFDYEAKYNGASD
EITPARISDDLTRRVQTLTSAIYDILGAYGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAAGMEMKDVMTDIIENKFKD
>KF627920.1_17780|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MEWNNKISENVQAVPFSGIRKFFDLASTMKDVISLGVGEPDYAAPDRVIDACIESLKNKE
TSYTSNWGLLELREEISCLFKKRYGLEYDPMNEIMITVGVSEAITVVMQTILNPGDQVLM
PDPAYLAYPACVRLVGGTPVLVPTFSDDEFRLRVDELEEKLTTKTKALLIGYPNNPTGTV
MDQASLEEIAAFAQRHDLIVISDEIYCDLTYEGEHTCFASIPGMKERTLVMNGFSKSYAM
TGLRIGYICGPKEVMQSLYKVHQYEILCAASTSQYGAIAALRKCDEDVKVMFDEYKIRRK
IVYDALAKMGLKVFKPKGAFYIFPDISCTGMNDEEFCDRLL
>KF627905.1_17817|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILWIWQKKSNNVHELNSHIWDEWADETGSIGKAYGYQIGQKSHYAEGDF
DQMDRVLYDLKHTPYSRRIMTNTYVFSDLPEMHLYPCAYSVTYNVTQRPQDDKPTLNMIL
NQRSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRHVNIVRELIERP
QFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF627882.1_17870|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ELRKENSNMSYADKLFIDMCSDIIENGYSTEGEKVRPKWPDGTYAYTIKKFGVVNRYDLS
KEFPAITLRKTYIRSAIDEILWIWQKKSNNVHDLSSHIWDEWADEDGSIGKAYGYQLGKK
HKYKEGEMDQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNA
ILNQRSQDILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIVKELIQ
RPVYPAPKDTLNPEVKDFYKFTVDDFTIEDYEAGPQIKNIPIAI
>KF627881.1_17873|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNIVVLAGGSSTEREVSIVSGQGICTALRRRNHKAVLVDAYFGKENWGEELFPQTYDIDA
EVVYMQEKSRELEDTVKSRKEFFGPGVLDICKAADMVFLALHGSNGEDGKVQSVFDLMGI
PYTGSGPLSSGMAMDKGITKMVFEAKGVPTPKGVTLQKGKCSSELADYDMDFPVIVKPCC
GGSSVGVCIAKNQEEYETALEESFSYENEAVVEQFIEGREFSVAVVDGKAYPVIEIAPLQ
GFYDYKNKYEAGSTIETCPAEISESLTREMQRYAEQGYKALGLQAYGRLDFIMDKDGNMY
CLEANTLPGMTPTSLIPQEAKALGMDYPELCEKLIEVSLKKYK
>KF627880.1_17876|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRNGYHEPEPGFAGQEKADDWGDDFPKTFSVNLIWAEADDKDGRPGAIGFDGGMP
WHLPEDMKRFKELTVSHPVIMGRRTWESLNVKYRPLPNRDNIVVSHNPQYLALGATVVTD
LDAALDIARQEAIPDDGLDRSEIWVIGGAQVFQEALPFASKAFVTKIQTSVDADTYAPDM
DALVDAGLWEVADPGHWKRTQKDDSRIKRYRFVTYRKIG
>KF627876.1_17887|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SIGKAYGYQPGVKHEYKEGMMDQVDRVLYDLENNPYSRRIMTNIYVHQDLHEMALYPCAY
SMTFNVTKKPDSPRLTLNAVLNQRSQDVLAANNWNVCQYALLLMMFAQVSGMEAGELLHV
IADAHIYDRHIPLVKELISRETHDAPVVRLNPEIRSFYDFTVDDLSVENYVTGPQIKNIP
IAV
>KF627868.1_17904|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MAKEIRMIAAVASDLGIGKDGKLLFHIKEDMAWFRSHTLHNVVVMGRKTLESFPGGRPLP
ERTHIVLSHKKHENTENVIWVTSVEEALAKMEKLPGEVYVTGGEQVYREFLPLASKLYLT
EVAQKCDADAYFPNFLSDGEWKKMEENKRDGFSFVTYERNR
>KF627853.1_17941|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKEKIVLLYGGRSAEREVSVLSAESVMRAINYDKYSVETYFITQAGDFIKTQTFEEKPA
ETERLMTNETIDWDAKVTPSSIYQEGAVVFPVLHGPMGEDGSVQGFLEVLKLPYVGCDIL
SSSVAMDKITTKRVLESAGIPQVPYVAVLEGDDLEAKIALIEKELTYPVFTKPSNMGSSV
GISKAENQAELRKSLELAFKYDSRVLVEQGVVAREIEVGLLGNYDVKSTLPGEVVKDVAF
YDYEAKYIDNKITMA
>KF627850.1_17947|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
VQKKEEMNMNAIVAADKNWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGRKTLESFPNG
LPLKNRTNIVLTGNPNYHVKDAVIVHTTEELLEELKKYDEEEIFVIGGESVYRMMLPYCS
KVYVTKIDHAYQADTYFPNLDQLEDWEMTEVSEEHTCFDLEYVFSTYERRQ
>KF627849.1_17950|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLSSAAGICRTLLEKGHDAFLLDVFMGLEHTPENLEDVFTLPDH
GLDIVKNISTEEPDLAAVKASRPDQSDCFFGPNVIELCRLADITFLGLHGGEGENGKLQA
AFDLLGIKYTGPDSLGCAVAMHKGVAKQIFLESGVDTPGGGTLYKNGSDLSYQSLGLTLP
VVVKPCSGGSSIGVYIVNTDEEYQNALEHSFHYEDEIVVEPYIKGREFACGIIDGKALPP
IEIIPKTGFFDYANKYQDGATMEVCPADIPEEVAERMKALTVKAFNALKLNVYSRADFLL
DAEGSLYCLEMNTLPGMTSASLMPKEAKVAGIEYSDLCELIIKKSMEARYSS
>KF627846.1_17962|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDWENPFPSEYDV
DAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLM
GIKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKT
CCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVEEYIKGREFSVAVVDGKAYPIIEIAP
LQGFYDYKNKYQAGSTIETCPAEISPELTEKMQHYAEAGAKALFMEGYCRLDFMMKENGD
MYCLEANTLPGMTPTSLIPQEAKVLGIDYPTLCEKLIEVSMKKYPTQDFTL
>KF627842.1_17971|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNLIVAVDKNWAIGYQNKLLVSIPEDMKFFRTTTTGKVVVMGRKTLETFPNGLPLKNRTN
IVLTRNPEYQVKGAEVVHSVDEALELISEYPPEDVYVIGGDTIYKQFLPYCDVAHVTRID
HEYMADAWFPNLEQDPDWELTGESDEKTYFDLEFTFCKYERTVAGRL
>KF627841.1_17976|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
VEYLLQRPVASIVSYAVFTLIAVLLFVKWPSTFVPEEDDGYFLAVVQLPPASSLERTQAV
GKQINKILDSYPEIKDYIGISGFSVMGGGEQSNAATYFIVLKNWNERKGKEHTAEAVVQR
FNMEVYGIQEAEIFAMVPPAIPGLGATGGLQLQLEDRHNLGATEMQRAVETLMEHYRNYP
ALASVSSQYQANVPQYFLNIDRDKGQLMGIPLNSVFTALGYYMGEAYVNDYVQFGHIYQV
KLGAGDRAQRVIDDVLKLSVPNASGEMVHFSSFTRVEEQLGMDQINRYNMYSTAAVTCNV
APGSSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQAGTTTTVVFVMALLVAFLVLAA
QYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALSAKNGILIVEFAR
DFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGM
ALNTLLATVYIPNFYELMQKLQEKFSKKQ
>KF627838.1_17982|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LTLRKTALKTCMDEILWIYQRKSNNIHDLNAHIWDAWADENGSIGTCYGDVVGRKFLYKG
EKIDQMDYVLKQLKENPYSRRIMTNLYQFEYLHSGGLDPCCYSMTYNVTKEKNSEKLVLN
GVLNQRSQDVLAANNWNVCQYAILLMMVAQVNDMIPGELVHVIADAHIYDRHVDIVKELI
SRDTYPAPKVSLNPEIKDFYAFTTADLIVENYQAGPQIKNIPIAV
>KF627837.1_17983|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|0
MKIIVLAGGLSPERDVSLTSGAGICKTLLENGHQAYLLDAFMGLDWDSDKLEEVFNQEDG
GLGIAADIQIKE
>KF627831.1_17996|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
AGLKPGEFVWTGGDCHVYDNHVDQFLEQLGRKPYPYPTIEIRKADSLFDYQYEDFKVVGY
QHHPTIKAPVAV
>KF627825.1|FEATURES|farme|trimethoprim|thymidylate_synthase|antibiotic target alteration|0
MSKADQQFVSMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILWI
>KF627821.1_18023|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|0
VERVFTANFFRIAAKAYVTKIDHAYDADTYFPDLDADPEWEMTKISDEQTYFDLEYVFVI
YERR
>KF627813.1_18044|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MEEGVWSEQARPKYKDGTTANSKYITGSFAEYDLSKGEFPITTLRPIAIKSAIKEVLWIY
QDQSNSLDVLEDKYNVYYWNDWEVEGVPANNGDKRSIGQRYGAVVKKHDIINRLLAQLEA
NPWNRRNVISLWDYEAFEETAGLQPCAFQTMFDVRRVGEDIYLDATLTQRSNDMLVAHHI
NAMQYVALQMMIAKHFGWEVGKFFYFINNLHIYDNQFEQAEELLKRQPSDCQPRLVLNVP
DGTNFFDIKPEDFELVDYDPVKPQLKFDLAI
>KF627813.1_18045|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
LLEWIVNLKRKGNTVSKQLIAIWAEAHNHVIGKNHTMPWHLPAELAHFKKTTMGSAILMG
RVTFDGMNRRCLPGRETLILTRDKDFDCEGVTTVTSVEEALAWFEQQDKDLYIAGGAGVY
KAFDGHYDALIKTTIEADLEGDTYFPQLDMTAFKVVSHERVAKDDKNAYDFSISRYEKEG
D
>KF627812.1_18050|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ADGSIGKAYGYQLGVKHQYKEGMMDQVDRVLFDLKENPYSRRIMTNIYVHQDLHEMNLYP
CAYSMTFNVTDDKLNAVLNQRSQDILTANNWNVVQYAVLLHMIAQVSGLKAGELVHVIAD
AHIYDRHIPLVKELISRETYPAPDFWINPEIKNFYDFTTDDVRLDNYQTGPQIKNIPVAV
>KF627810.1_18054|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTMRRTYYKSCIDELLWIWQKKSNRIAELKSHVWDSWADENGTIGKAYGYQLGVKHQYPE
GMFDQVDRVLYDLKHHPNSRRILTNIYNFEDLHAMGLYPCAYSMTFNVSGHTLNAILNQR
SQDMLAANNWNVVQYAVLVHMMAQVSGLQAGELVHVIADCHIYDRHVPLVEKLLKNPTYD
APRFHMDPAIQDFYQFTADSFTLEGYQYTPFDEKIPIAI
>KF627809.1_18058|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LSNGVWDTDLPVRPRWEDGTSAHTVKKFGIVNRYDLSKEFPILTLRRTYLKSALDELLWI
WQKKSNNIRDLGSHVWDQWADEDGSIGKAYGYQLGVRHRYPEGEFDQVDRILYDLKHNPA
SRRILSNLYNHADLSEMRLYPCAYSMTFNVSGNRLNAILNQRSQDMLTANNWNVCQYAVL
VHMLAQVSGLVAGELMHVIADAHIYDRHVPIVESIIDKEPYDPPVFRLDPAVDDFYAFTK
DSVTLEGYRYHELDIAIPVAV
>KF627807.1|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
YTYISNHRDIILDSGFLSILLIDQGMDTVEIAIGDNLLIYPWIKKLVRVNKSFIVQRALT
MRQMLESSARMSRYMHYTISEKNQSIWIAQREGRAKDSNDRTQDSVLKMLAMGGEGDLID
RLMEMNIAPLAISYEYDPCDFLKAQEFQLKRDIEGYKKTTQDDLINMQTGLFGYKGRVH
>KF627801.1_18079|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKKIIGIWAQTENGIIGKDQVMPWHLPAELQHFKETTMGQAILMGRVTFDGMKKRVLPGR
TSIILTQDQAYDPENDAVLVMHSKEEVLDWYQKQEKNLYIIGGSQILKLFSDQLEELIQT
MIHATIDGDTLAPTFEESHYERVRQVHHPKDEKNPYDFTVNYYKRKDLD
>KF627796.1_18090|FEATURES|farme|multidrug|sav1866|antibiotic efflux|1
LFTLPVGGWLYLQGSLSVASFLLFILLTMCFFTSFLNLVTIAMQSMELGSGLDHVKQIMD
MEVMQSGNKELPKTGSYGIDFAHVTFRYTKEGEEVLSDIDLHLKAGSINAFVGPSGAGKT
TAAQLIGRYWDADSGTVKIGGVPVNELKAENLSDLTAFVFQDVFLMEDTLLENIRMGTKA
TEEQVRQAAKAAQIDDFIMSLPNGYMTKIGDA
>KF627790.1_18103|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LEKEFPILTTKFVAFKTAVKEMLWIYRDQSNDVTKLQEQNVHIWDEWVDENNTIGRGYGY
QIAKFNQIDKLIETLKTNPQDRRMLMTMWNIEDLPHMTLQPCCFMTLWDVTDGKLNCMLI
QRSGDIPLGVPFNTSQYAVLVNLIAQVTGLKPGLFTHVINNAHIYENQVEGMKLQLTRAN
DEYEAPKLWINPEITNFYDFTADDIKLIDYKYHPAIKMEVSV
>KF627780.1_18138|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
VIGTGINRYLEENGRYSHMNLIVAVDEKWGIGKDGGLLAHLPEDMKYFRETTSGRTVVMG
RRTLESFPGGKPLKNRVNMVLSRNEAYSPEGVQVYHRAEDVLEALKDCNEDDVFIIGGGM
IYREFLPYCNKAYVTYIHRTFDVDTDFENLDQDENWKLESVSDGREHEGISFEFRIYRRV
R
>KF627776.1_18152|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|0
VYLDLDALLAAAPEDSFVIGGASVYRALLDQCSTAYVTKIEAAFPAADCWFPDLDSRPEW
RISEESESQEEDGVKFRYVTYRKEE
>KF627773.1_18161|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
NQQQNQGNYNAYQQQNYNPNFNPSGKPLKSKMVAGLLGIFLGGFGVHSFYLGYTGKGVAQ
IIVSLVTCGVGSLWGFIEGILILTGNISQDANGNPLAD
>KF627768.1_18173|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQIFVQNCKDILAHGVWDTDCPVRPKWDDGSPAHTIKLFGVINRYDLRKEFPILTV
RRTYWKTAVDELLWIWQKKSNNIHDLNSKIWDQWADETGSIGKAYGYQLGVKHHYPQGDM
DQVDKVLWDLKHDPASRRIMTNLYNHHDLSEMALYPCAYSMTFNVSGNTLNAILNQRSQD
MLTANGWNVTQYAILLHMIAQVSGLEAGELVHVIADAHIYDRHVPVVEKLLEAKQSPAPK
FIIDQSVTNFYAFTRDSF
>KF627762.1_18185|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKIRVAVIFGGKSNEHDVSVVSATHVIKSIPKDKYDVICIGITKKGHWMKYIGDVDDIA
SNKWEQHPDNVPCVLSPDPLHKGFIALGENGEYQNVKVDVIFPVLHGKNGEDGTIQGLFQ
LAEIPFVGYDCISSANCMDKGLTHTVLDANGIKTAKWVGIITSELSHLDKKCDEMESKLG
YPMFVKPANCAIKLAFAHDSKVIVEETIVGMECECAVMGNDEPFASTVGEVCSANDEFYD
FDAKYNDSASKTLIPARMSEESIEEIRKTAVKAYRAMGCSGLSRVDFFLMKDGTVILNEI
NTLPGHTPISMYPQLMQYEGMTPAQQEDKLIKLALDKAEVDYE
>KF627757.1_18196|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LGKKTVAVLFGSISSEYEVSLRSAASVLRNIPRDRYDVVMLGITKDGRWFEYAGSIDDIE
SDRWLQNGPVTPAFISPDRGAGGILRLLPDGPQPVAVDAVFPVLHGEHSEDGAIQGLLEM
AGLAYVGCGVLASAACMDKAVTHTILEAAGIEMTPYTVLTRGALAHFDETERMLAAKHGY
PMFIKPANTGSSVGVGKAKDAGGLCAALSEAFRFDRKVIAETAVVGDELECAVLGNFDRA
EASCVGEIVPRHEFYDYSGKYLDDSTDLYIPARISGEASERIRQTAVRAFAAMGCTGLSR
VDFFLTREGRVVLNEINTLPGFTSISMYPKLFEAVGLPYPELISRLIELAFEKHTDI
>KF627756.1_18197|FEATURES|farme|multidrug|norA|antibiotic efflux|0
RPVFGALSDKVHTKLGRRMPFIVAGTILAVIFMMLLPMIDNAEKARWNTGESFSNQVIFL
AVLFFTLVSMGLYRSPAVALMPDVTPNHLRSRANAVINLMGAVGGVYALIMIKVLVGKGE
TPDYLPLFASIAAVMAIAVGILVITIRENKLREEVEKAEAANAGTIEEKAMAEGVEAAGE
IEAVGDTGEIKSFDGKKQTGKTEGTKGMPKEVKRSMYFMLASIFLWFTAYNAVTTAFSRY
TKVVWKMEGGSFANCLMVATVAAILSYIPIGNISAKIGRKKTIMGGVLLMAACYGGAIFA
REYHPIVNVAFALIG
>KF627753.1_18202|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKIIVATDKNWGIGKDNKLLVSIPADMKMFRQETTGKVCVMGRKTLESFPGGLPLKNRTN
IVLTRNENYKVKDAIIVHSIEELMEELKKYPAEDVYCIGGDTIYKQLLPYCDAAQVTKID
FAYIADSYFPNLDEDPQWHVAAESEEQTYFDLEYKFVRYERNK
>KF627738.1_18248|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMM
DQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKPGHDKLTLNAIL
NQRSQDILAANNWNVVQYAALVYMMAQVCDMEPGELVHVIADAHIYDRHIQIIKEMIKRE
TYPAPKVTLNPEVKDFYGFTTDDFKIEDYQAGEQIKDIPIAI
>KF627724.1_18289|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MYMNDKISLLVLFGGVSSEHEVSCISAASVLDHIDREKYHISTIGITKEGNWFLTGSPIV
NISDGSWEQDESNRRAFIAPDRSIGGILAENGDGTFETIKVDVVFPVLHGKNGEDGTMQG
LLQIAGLPFVGPDTTASSASMDKAITKSMVEQAKSAHQAKCHVVNEGTYRSDPEAAAASV
MSFFENKLPLFVKPANAGSSVGISKVKESAELITALETAFNEDSKVVVEEAIVGREIEVA
VLGNGEPKASCIGEIFAANEFYDYNSKYENQKSRTGVVTDLTPEKEREIRDTAVRVFETM
GCTGLSRVDFFLEEGGRVVFNEINTLPGFTHISMYPKLWEASGIPYGELIDELIRLALEK
YKR
>KF627693.1_18377|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MRRRMKIIVAADKNWAIGNGGKLLCHIPGDLKYFKEKTTGKTVVMGRKTLESLPGGRPLP
NRTNIVLTKDKDFEKGGCVIAGSIEEVLRILSDMEGEAMVMGGGLIYRQLLPYCDGCYVT
KIDAAFEADTYFPDLDADGDFRLIWESRPHEENGVTYRFTEYERM
>KF627678.1_18412|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKVSIIAAVDRHMAIGFENKLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNR
RNIVLSSNPDTVCPGAEVFPSLEAALKSCREDEKVYIIGGASVYRQALSLADELCLTEVN
STAPEADAYFPEVSQELWHEKSREAHLADEKHLCSYAFVDYVRK
>KF627661.1_18454|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVCGGDTSEFQVSLRSAQGIYSFSDKEKYTLYIVEMHGLDWHVQLPDGAKTPVD
RNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFAC
NQYLKGFGVRIAESLLLRGGQSVTDEDVMEKIGLPCFIKASLGGSSFGVTKVTAKEQIQP
AIVKAFDEAQEVLIEAYMEGTEVTCGCYKTKEKSVVFPITEVVTENEFFDYDAKYNGQVS
EITPARLSDDLTHRIQTLTSAIYDILGASGIIRVDYIITAGDKVNLLEVNTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIENQL
>KF627652.1_18479|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIAAVDKNWAIGCKNKLLVSIPADMKFFRETTTGKVVVMGRKTLESFPNGQPLKKRVN
IVLTHDKNFKAGDAIIVHSMEELREELKKYPSEDIYVIGGETIYKQLLDDCDVAHITKID
YAFEADAYFPNLDADAGVENHAGQ
>KF627651.1_18483|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIVATDDDLLIGKKDSSNGMPWHNKEDLQHFKKTTLHQTILMGKTTYMAIGRPLPHR
KTIVVTRGELDDERVEVRHDLVETIQEYKNKKEDLFICGGASIYKQALPYVDELIISRIP
GKHEGETYFPSFNEYNFQLEKETQMETFVLQIYKKG
>KF627643.1_18513|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLLSGAGICKTLREMGHQALLLDVFFGLPYDSDKLEEIFDRPDG
GLEISKGISTSVPDLDALRKSRPDQSPSEIGPNVIELCQMADITFMALHGSIGENGKLQA
TFDNLGIKYTGPNSLGCTLSMNKLVTKQIFKTSGVPTPRGTSLTVKTKDARLDELGYYLP
LVVKPCSNGSSIGVYICHTEEDYYDAIHKSFDVDNTDEVVIEPFIKGREFACGILAGKAL
PLVEIVPKDGLFDYANKYQAGGASEICPPISLDAETQELIQRAGERAFEALRMDVYSRAD
FIVSDADGEFYCLEMHALPGMAAASLLPKAAKAAGYEYSELCEAIIQESMKARY
>KF627641.1_18519|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELLNRVLTEGVRKEDRTGTGTISVFGHQMRFNLEEGFPLLTTKKLHLKSIIYELL
WFLNGDTNVKYLQDHGVRIWNEWADADGSLGHIYGYQWRSWPDYKGGSIDQITEAVETIK
HNPDSRRIIVSAWNVADLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFIHTLGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKSIF
DFQYEDFELVNYDPHPHIAGKVSV
>KF627636.1_18532|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MDKTHTHSILDYNNIRTARWRALGLRNLNHLDRECADIADDLGFPMFVKPANAGSSIGIN
KAVDLESLKEAVKIAFSHDNKVIIEEFIKGQELEVAVFGYDSPFASFVGEIGKNNDFYDY
DSKYINNSVNLYIPAKIPDESAREIRETALNAYKAMGCKGLARIDFFLSENGEVILNEMN
TMPGFTSISMYPKLMEDLGMSYGYLI
>KF627635.1_18536|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MKLIVAVDACWAIGKDGDQLCYIPPDLKRFQRLTTGHPVLLGRKTLATFPGGRPLKNRRN
LILSTDPAFAPAGGEVFVPP
>KF627629.1_18551|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSTERDVSLTSGAGICITLRENGHQAFLLDVFLGFPYDSDKLEEVFTLPNA
GLEIADGIKTTEPDLAAIKASREDQSDCFLGPNVIDICRLADIVFMGLHGDVGENGKLQA
TFDILGIKYTGPNYLGSALAMDKGVTKQIFTMAGVPTPLGTNLTKDRKDTALSDLGLTLP
VVVKPCSGGSSIGVYIVDTMDAYKEAVENSFRYEDEIVIEPYIKGREFAVGIIDGKALPV
IEIIPKTGFFDYANKYQDGCTEEICPANIDEEVTERMQRAAELAFKALKLDIYSRADFL
>KF627627.1_18558|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LKKLSVCILFGGVSSEHEVSLRSAESVLNNIDQSKYNVFPVGITKDGDWILFGGKDYSML
PAGTWQNCENNRRAALSPVRGQGLLSFENDCVVRERIDVVFPVMHGENCEDGAIQGLLQI
AGIPYVGPHVAASAACMDKTITKLIASQVGVHQADWQLVTRESFARSREAALDAVEAKFP
YPVFVKPAGTGSSVGVAKARDREALEAAIETALKYDRKVLVEEFIRGQEVEVAVLGNENP
CASVCGEIDSGAEFYDYTAKYISDSARLYIPARISEQTSEQVREFAIRVYTAMGCRGLSR
VDFFVTADGGVVFNEINTIPGFTSISMYPKLFEASGIPYSELIDDLLALALEA
>KF627624.1_18562|FEATURES|farme|aminoglycoside|rmtD|antibiotic target alteration|1
MEKHNYLCGALVECAYAEAAARYAKAKDADRAARRELHRVAGAFFSREEARRAEKLLSQW
PEGGDEALSRILSLHASTRERLPLAAMDALYAHLFEITGKPRRVLDLACGLNPIYLAARG
INVLGLDAHLGAVALVNRFAEENALDARAEGADLRTAELPEERFDLALVFKLLPLLGANG
YDLLGRVRAGFVAVSFPTRTLSGRSVGMERNYSSAFEENCPQRFAIADRFVAGNELIYVL
KER
>KF627622.1_18568|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
AGELVHVIADAHIYDRHVPIVEEIIAREPYPAPALVLDPAVTDFYAFTRDDLKLEGYRAH
TLEEKIPVAV
>KF627618.1_18580|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VSSEHDVSCVSASYVVSNIPRDKYEVCPLGITKEGEWFLFEGDVSLLPEDKWIKSGKCTK
ALLSPDRKDHGITVFRESGPEKIHIDVCFPVMHGKNGEDGTIQGLLELSGIPYVGCGVLA
SSVCMDKAVTNTLADRAGIAQAKWLATDVNEYRENRTEFIKKAEATLGYPIFVKPANAGS
SVGITKAHDESELREALEKAFSCDRKAVLEEFVDGFEVECAVIGNYKPMASCIGQIISCN
EFYDYTAKYVSDSRLLIPAELPEDKQNEVRKEAVRAFKTLGCTGLSRVDFFVRKSDGRVM
FNEINTIPGFTSISMYPKLMEQSGVPYPKLLDKLFKLAAEIKEDK
>KF627616.1_18584|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KKMKIVVLAAGTSTEREVSIVSGTNVCKALRSKGHQAILVDVFFGKEGADSATAFDGDYD
VDAEAAYISSFNDQVKDAVASGREFFGPGVIELCKAADVVFMALHGANGEDGRVQAYFDL
CGIPYTGTGYLSSAMAMDKGITKKIFLTSGVPTPRGVELKKGKDSTNLADHNMELPVVVK
TCCGGSSVGVYITKTPEEYEEALQGAFSYEDEVVVEEYIEGREFSVGVVDGKAYPIIEIT
PVEGFYDYKNKYSAGATIDTCPAVLTEGQTRQMQAYAEAGCKALAVEGYARLDFLMKEDG
SMYCLEANTLPGMTPTSLLPQEAAALGIDYAQLCENLIEISMRKYQK
>KF627615.1_18587|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
LSHRSPTVSFLLSHVVLLIYVAQHCLGLEAEEREVTLEEVKDFAECGLCGTAAVISPVGK
IVDHGKEICFPSGMTEMGPVTKKLYEALTGIQMGRLEAPEGWLQVIE
>KF627615.1_18589|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTL
RRTALRSAMDEILWIWQKKSNNIHELHSHIWDSWADENGSIGKAYGYQLGVKHQYKEGMG
DQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQTPGNEKLTLNAIL
NQRSQDILTANNWNVCQYAILLMMIAQVCDMEAGELLHVVADCHIYDRHIPVVKEMIKRK
PYPAPIVKLNPEVKDFYQFTTDDLIVENYETWPQIKNIPVAI
>KF627608.1_18609|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MSQPVTYTGVVAMASGRGIGYRGALPWHLPDDLKTFKRITTGHPVLMGRKTYESIGRPLP
GRQNIVLTRDPSWTAEGVDVIHSVEELKRLPLMDPEVMVLGGAEIFSLMMPLMSRMWVSH
ISGEYPADTWLPPFEDRFRSANLHEQFEGFDLFLYE
>KF627603.1_18624|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MERSGIMNIIVAVDENWAIGCRGDLLVRIPADHKMFRNETLGKVVVLGRKTMDTFPGGLP
LQGRTNIVLTRNPEYQVKDAVAVHSVEELLEEVKKYDSRDVYVIGGDSVYRLLLPYCDTA
HVTKIDRAYEADAYFPNLDEDGEWEITADSEEQTYFDTTYHFVKYERKR
>KF627587.1_18665|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EVLWIYQDQSNSLDVLEDKYNVHYWNDWEVEGVPANNGDKRSIGQRYGAVVKKHDIINRL
LAQLEANPWNRRNVISLWDYEAFEETAGLQPCAFQTMFDVRRVGEDVYLDATLTQRSNDM
LVAHHINAMQYVALQMMIAKHFGWKVGKFFYFINNLHIYDNQFEQAEELLKRQPSDCQPR
LVLNVPDETNFFDIKPEDFELVDYDPVKPQLKFDLAI
>KF627581.1_18677|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MRGVAMIIGIWAEDEQGLIGEADKMPWSLPAEQKHFKETTMNQVILMGRKTFEGMNKRVL
PGRICIILTRDET
>KF627580.1_18678|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KEKDSDKLTLNGVLNQRSNDVLAANNWNVCQYALLLMMIAQVCDMKAGELLHVIADAHIY
DRHIPLVKELISRETHPAPKVWLNPEVKDFYAFTVDDLHVEDYVTGPQIKNIPIAV
>KF627573.1_18701|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MLSIIVAIAENNVIGKDNKLLWHVPEDLKRFK
>KF627572.1_18707|FEATURES|farme|bacitracin|BcrA|antibiotic efflux|1
MALIKCENVSIGYEGQTVVRDLNFEIGQGDYLCIVGENGSGKSTLVKSLLGLKAVDSGKI
EFGDGLKQKEIGYLPQQNDFQKDFPASVYEVVLSGRLNSRGFRPFYTATDKAEAAEKMEM
LGITDLRGQCFRDLSGGQKQRVPLARALCATKKLLLLDEPVTGLDPIVTAEFYQLIQKIN
RESGIAVV
>KF627564.1_18732|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIGLIVARSKNNVIGKNGNIPWKIKGEQKQFRELTTGNVVIMGRKSYEEIGHPLPNRMNI
VVSTTTEYQGDNLVSVKSLEDALLLAKGRDVYISGGYGLFKEALQIVDKMYITEVDLNIE
DGDTFFP
>KF627563.1_18735|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DEMLWIWQKKSNNINDLNSHIWDEWADENGSIGKAYGYQLGVKYKFPHGEMDQVDNVLWQ
LKNTPYSRRIMTNIYKFDDLMEMGLEPCAYSVTFNVTGDKLNAILNQRSQDILAANNWNV
VQYSVLVYMMAQVSGLKPGELVHVIADAHIYDRHVDVIKELITRPQYPAPKFSLNPEIKN
FYDFTVNDMRIDDYQKNPQVKNIPIAI
>KF627556.1_18753|FEATURES|farme|trimethoprim|dfrA|antibiotic target replacement|0
MEQLREELAKYPSEDIYVIGGESIYRQLVDECDVAHITKIDYAYEADAYFPNLDEKEEWE
ITADSEEQTYFDLEYQFLKYEKRSC
>KF627556.1_18754|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIAAVDKNWAIGLKNKLLVSIPADMKFFRETTTGKVVVMGRKTLESFPNQRPLKNRVN
IVLTKGRGISG
>KF627554.1_18762|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MSKIALIAAVAEKGAIGQNQQLLCHLPNDLKHFKTLTSGHTVVMGRKTFESLPNGALPNR
KNIVLTHNTALSWPNVTVVHTLDEIPIQDTTEDEIFILGGATLYNETIKIADTLYITHIH
HTFDDADTFFPTINPSEWEIANSQEMPADEKHAYPYTFVTYTRRRIENREPSDK
>KF627548.1_18781|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGVKHQYKEGMMDQVDRVLYDLKNNPYSRRIMTNIYVHQDLHEMALYPCAYSMTFNVTKE
KDSEKLTLNAVLNQRSQDILTANNWNVCQYALLLMMFAQVTDMKAGELLHVIADAHIYDR
HIPVVKELIARPTYDAPVVKLNPEVKDFYAFTTEDLIVGNYVTGPQVKNIPVAV
>KF627540.1_18803|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
TEEVQDISLRVFRALGLEVYARMDFIYDGRDFYCLEANTLPGMTPTSHLPQEAKAMGISY
PELCMRIIELSLEKYNK
>KF627529.1_18830|FEATURES|farme|beta_lactam|OI25_4698|antibiotic target alteration|0
MDQVDRVIYDLKNNPFSRRIMTNIYVHQDLHE
>KF627524.1_18843|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGIEKGDRTGTGTISVFGHQMRFNLDEGFPCLTTKKLHLKSIIYELL
WFLKGDTNVKYLQDHGVRIWNEWADETGDLGHVYGYQWRSWPTYDGGFIDQISEAVDAIK
HNPDSRRIIVSAWNVGDLDHMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMVAQVTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKNIF
SFKYEDFELVNYDPWPHIAGKVSV
>KF627524.1_18849|FEATURES|farme|aminoglycoside|acetyltransferase|antibiotic inactivation|0
MIEIKQVKTQDEVNYTFVEKLMHTAFPQEERRDTVQQREYSDNNPRFCNNIILENGNSIG
MISYWTMGDFYYIEHFAIDPSLRNGGYGKRVLEMIKKQLKGPIVLEVEEPNDEMSTRRIH
FYKRLEFTLHKKPFIQPPY
>KF627523.1_18851|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDSSELVVSLRSAQGLYSFIDKERYNLYIVEMEGHRWEVVLPDGSKTPID
RNDFSFMEKGEKKQFDFAYITIHGTPGENGILQGYFDLLGIPYSSCNVLVSAMTFNKFTC
NQYLKGFGIRVAESLILRKGFEITDEEVINKIGLPCFIKPNAGGSSFGVTKVKTKEDIQP
AIEKAFEESDEVMIEAFMKGTEITCGCYKTSDKEVVFPITEVVSANEFFDYGAKYNGESQ
EITPARLPEDTAERVRLLTSAIYDILGCSGLIRIDYIITEGEKVNLLEINTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIENKF
>KF627521.1_18858|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|0
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYT
>KF627513.1_18883|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VETLKHNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVP
FNIASYALLLQMMAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPRPLPQMKINPD
VKNIFDFKFEDFELVNYDPHPHIAGAVAV
>KF627503.1_18906|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNMNIVVLAGGISTEREVSIVSGTGVCQALRKKGHRAILVDVFCGDARVASECIEDCFPK
EYDVASAADYMRSMSEEIEEIKKSGREFFGPNVLKLCKLADIVFLALHGADGEGGTVQAA
FDLLRIPYTGSGHLGSAMAMDKNISRRLFQAYGVPTASGIALKKENPRLAAAENGVGLPC
IVKPCCGGSSVGVTIAHTEEEYQEALSAAFSYENEVIVEAYIHGREFSAGVIDGKAYPII
EIAPVEGFYDYQNKYTAGGTIETCPAELSKEQTEQMQSYAVKAYEALQLSGYGRMDFMMD
EQGRMYCLEANTLPGMTPTSLLPQEAAAVGIAFPELCELLIEVSMKARGQKR
>KF627494.1_18930|FEATURES|farme|peptide|EdeQ|antibiotic inactivation|0
MEKLMTQSFPSEEYRELEELRKYTDTKTHFYNNIIFHNNTPVGLITYWDFGHFYYIEHFA
IDPAQRNGGYGKSVLNHLCQLLKHPIVLEVEIPEEEMAKRRINFYQRQGFSLWEKPYQQP
PYKTGDNYLPML
>KF627476.1_18985|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KWEDTGAYAYTIKRFGVVNRYDLRKEFPALTLRKTALKTCMDEILWIYQRKSNNIHDLNA
HIWDAWADENGSIGTCYGDVVGRKFLYKGEKIDQMDYVLKQLKENPYSRRIMTNLYQFEY
LHSGGLDPCCYSMTYNVTKEKNSEKLVLNGVLNQRSQDVLAANNWNVCQYAILLMMVAQV
NDMIPGELVHVIADAHIYDRHVDIVKELISRDTYPAPKVSLNPEIKDFYAFTTADLIVEN
YQAGPQIKNIPIAV
>KF627464.1_19015|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKERHMFQKVM
>KF627462.1_19023|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GNLEDVFAEEAYDIDKAAEYMHSFDAGLNEMIESRRRFFGPNVLELCEAADVVFLALHGA
NGEDGKVQATFDLLGIPYTGTGYLSSALAMDKSITKQFFRAHHVPTPNGVTLKKGQESEP
LSGFGLELPVVVKPCCGGSSVGVYIAHTNEEYWQAMKDAFSYEPEVVVEEYIEGREFSVG
VVDGKAYPIIEIAPIEGFYDYTNKYKAGATVDTCPAVLTEEQTKEMQKHAEDGAAALGIE
NYCRLDFMMRKDGRMYCLEANTLPGMTPTSLLPQEAQVLGISYPELCELLIQLSLRKRGK
NE
>KF627456.1_19042|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
KRGIGYQNRLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRNVVLSTQKDLI
CPGTEVFPSLEEALSSCQPDEHVYIIGGASVYRQALPFADTLCLTEVDAEAPQVDAYFPE
VAPTVWQEKSRESHPADEKHPCPYAFVDYIRR
>KF627455.1_19045|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNKLASGVRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLTVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>KF627451.1_19060|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MAKKRIVVLYGGRADEHSISCISTAGVLAAMDTERFEPIPVGITKDGKWIIDGEDPRGWN
LDGDELPTVKITPKSRPVILDPSRGKDGFFAGEPDHLSNADSGFGTSFVSLSDPEIHHVL
TSLGHVDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVVLNAAGI
PTAPGIMVDARAFTAADVVAQIEVAGLAYPLFVKPSRAGSSFGVTKVDKAEDLETQQDRV
AAAIATAGEHDWKVLIEQGIDGREIECAVLCPKAGDEPEASWPGEIVLDHQNDDQFYDFD
SKYMDASASHVEVPANLPVSVLEDVRDVARRAFKAVDGAGLSRVDTFVTPDGTVMVNEIN
TMPGFTPISMYPKAWDATGVGYTELITRLIEGVLK
>KF627450.1_19063|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLDLPFCTVKLATMALTPEQLADIRTRIPARPETDIPMPYEDLVRKILTEGTLKSDRTGT
GTVSLFGQQMRFDLSEYFPLLTTKTVFFKGLAYELLWFLKGSTNVRWLQERNVHIWDEWA
DENGDLGPVYGAQWRTWPAPTPDDPNRTIDQISNVLDLVENHPDSRRMVVSAWNPAEVEN
MALPPCHALFQFYVADGKLSCQLYQRSCDMFLGVPFNIASYSLLTLMIAQQAGLQPGEFV
WTGGDCHVYDNHIDQVLEQLSRDPYPYPQIRINKADSLFDYDYSDFEIVGYQHHPTIKAP
VAV
>KF627448.1_19071|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGSAGLSATEEDWGDDYPKTFSVNLIWSEARDKEGRAGAIGLNGGM
PWHCAEDMKHFKELTVSHPVIMGRKTWESLGGKYRPLPNRDNIVVSHDPMYRAPGATVVT
SLDDALDMARQEAIPDDGLDRSEIWIIGGAQLYAKALPFADKAYVTDLAATVDADSYAPD
MASLVEAGMWREAEVGEWHTPAKEESGIDSYRFRILAKTK
>KF627418.1_19145|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
NIVLHECAGVLQYSQSVFEGLKAYTTEDGHIVTFRPDLNAERMAASAARLEMPVFPKERF
IDAVEQVVKANAAWVPPYGSGATLYLRPYMFGSNAVIGVKPADEYQFRILTTPVGPYFKG
GAKPITIRVSDYDRAAPCGTGNIKAGLNYAMSLHAIVDAHKQGFDENMYLDPKTRTKVEE
TGGANFIFVTKDGKVVTPKSDSILPSITRRSLIYVAKEYLGLEAEEREVYFDEVKDFAEC
GLCGTAAVISPVGKINDHGKEICFPSGMEKMGPVIQKLYDTLTGIQMGRIEAPKGWIHVI
E
>KF627391.1_19209|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MRDPLTKKVVDIAPSGIRKFFDIVSEMDNVISLGVGEPDFDTPWHIRDEGIYSLEKGRTF
YTSNAGLKELREEICKYLKRRFALDYDPITETLITVGGSEAIDLAMRVMLDPGDEVLIPE
PCYVSYVPCCILAGGKPHVIELQAKNEFRLTKEELLEHITEKTKILVLPFPNNPTGAIMS
REDLKAIAEVVEEKDLFVLSDEIYAELTYGGNHVSFASLPGMKERTITINGFSKSHAMTG
WRLGYACGPAPIIKQMTKVHQFAIMCAPTNSQYAAVEALRNGDADVEEMRQAYNGRRRYL
LHAFEEMGLPCFEPKGAFYVFPSIQKFGLSSDEFAERLLREERLAVVPGTAFGECGEGFL
RISYAYSLEDL
>KF627386.1_19223|FEATURES|farme|aminoglycoside|APH(2'')-IIIa|antibiotic inactivation|1
MAVFPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL
DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI
SDPDYDYVYLLEDCGELFTRQVMAYRGEVDLDTHIRKVSLFVTFDQVSYLLEGLRARDQD
WISEGLELLEEDKANNFGANSA
>KF627353.1_19330|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic target protection|0
MAGNRNEEMVYCSFCGKNQEEVKKIIAGNGVFICNECVALSQEIIREETAEEVLADLAET
PKPKELLDILNNYVVGQDRVKRALAVAVYNHYKRINFTESREDNDVDLQKSNILMIGPTG
SGKTYLAQTLARSLNVPFAIADATSLTEAGYVGEDVE
>KF627323.1_19423|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MISIIAAVDRKRGIGYQNRLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRN
VVLSTQKDLLYPGAEVFPSLEEALNSCQPDEHVYIIGGASVYRQALPFADALCLTEVDAE
ATQVDAYFPEVSPTVWQEKSRESHPADEKHPCPYAFVDYIRRQN
>KF627315.1_19447|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
LARNGEGSEQLQADNESGKQKNKNVSDRRIIMNLIVAADKNWGIGKDNKLLVSIPSDMKF
FRQETMGKVVVMGRKNLESFPNGLPLKNRTNVVLTSDKNYQVKDAVR
>KF627311.1_19461|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
RATLESFPGGRPLPGRRNIVLSKTLNRDDVLIVRSVDELMNIAGIDDAFVIGGGQVYSQL
LPYCDTAYITQLEGDFGAEVFMPDISEAGFVKTGSSDLKEENGVRFTFDVYTIKNKSR
>KF627309.1_19465|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DLHEMNLYPCAYSMTFNVTKEPGKDKLVLNAVLNQRSQDILAANNWNVCQYSLLLMMIAQ
ACDMEAGELVHVIADCHIYDRHIPVIKELISRKPYPAPTVKLNPEIKDFYKFTTDDLIVE
NYETWPQIKNIPIAV
>KF627308.1_19468|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MRKFHPYAVAAAAAGKKIYHLNIGQPDIHTPDALYDAIHNFRTPVLAYAASPGIPELISA
IEGYYRNIGVQLSESDILVTTGGSEALQIAANCLLDDGDEVIVPEPFYPNYHTFITTAGG
VIHPLHTRPEEGYFYADRARIEACITPKTKAIMITNPGNPTGTCLTSEQMKMLLDVAVEH
DLYLVADEVYREFTYDGEPLHSFGKFDYGQENLILIDSVSKRFSACGARIGCLISRNKDF
MANALKYCQARLSVATLDQIAAAALYTVGPDYFEQVRQEYKRRRDTVVRKLHEIPGVICE
CPRGA
>KF627303.1_19486|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
IDLFLTSPLRAGQAAYFRLVADPGPPPLRPVTEVTDETGTHLVEECDVPLGLPFNVTQYA
TLLCMLAQVCGLKPGTIDWSIKDAHIYVNQIDGIKEQLKRFDEQGDLPAPKLWLNPEVDD
FFKFDSSRDCKDVKLIDYKHLGKISFPISQ
>KF627298.1_19498|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
IVAADKNWAIGNGGKLLCHIPGDLKYFKEKTTGKTVVMGRKTLESLPGGRPLPNRTNIVL
TKDKDFEKGGCVIAGSIEEVLRILSDMEGEAMVMGGGLIYRQLLPYCDGCYVTKIDAAFE
ADTYFPDLDADGDFRLIWESRPHEENGVTYRFTEYERM
>KF627295.1_19503|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLKAGDFVHTLGDAHIYLNHLDQVKLQL
TREPRPLPQMKINPDVKSIFDFKYEDFELVNYDPHPHIAGKVSV
>KF627283.1_19536|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MMRNPLSKKITGIEPSGIRKFFDLVSEMPDAISLGVGEPDFDTPWRIREEGIYTLEQGKT
FYTSNAGLKDLKIEISKYLERKIHVEYDPDHEIMVTVGGSEGIDVALRAMLDPGDEVLIP
QPSYVSYLPCTILADGNPVVIPLQEKNEFKLTAEELEAAITPKTKMLVMPFPNNPTGSIM
TKEDLEPIAEVVKRHDLYVLSDEIYSELTYKTEHVSIASLPGMQERTLVINGFSKGFAMT
GWRLGYICGPSVIIEQMLKIHQFAIMCAPTNSQYAAIEGLRHCEDEVQQMRNAYNQRRRY
LVNEFAKMKLECFEPFGAFYIFPSIKEFGMTSEEFAMRFLEEEKVAVVPGSAFGESGEGF
LRVSYAYSLEDLKEAIGRLSRFVERLRSQK
>KF627280.1_19542|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
VKEMNLIAAVDANWAIGYKNKLLVSIPDDMKFFRQTTTGKVVVMGRKTLESFPNGQPLKN
RVNIVLTSDKNYKVKDAIVVHDLDELHKELEQYNSEDVYVIGGESIYRQLLDECDVAHIT
K
>KF627270.1_19575|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKKLLVVCGGQSSEHSISRISCNSVMKHLDKDKYEITLVGIAKDGKWYILKQEDNDLSK
DTWLDGAEVVEGVFDLLRSQDVAFPVLHGLYGEDGTIQGLFELAQLPYVGCRVFASSACM
DKIFAKKVFESAGIPQVKSVYVKKRNDGRLVVVEKDMEETEEVEASIMKELGMPCFIKAS
RSGSSVGCYRCDKVEDLLPKLEEAAKYDTHVVVEECVDCIELETAVLGNDDIIVSRVGQI
MPHGEFYTFESKYEDAESKTCIPAKVDEEIQEQIRKYAVRAFKAIDGHGLSRVDFFLDKK
TNHVYLNEINTLPGFTSISMYPQLMEDYGYSYSELLDKLIEIADEN
>KF627258.1_19600|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|1
MTYLCGRKEDLSLKKLSVCVLFGGISPEHEVSLRSAESVLNNLDKQKYNIFPVGITKDGD
WILFGGDDYAMLPAGTWQDHPNNRRAAISPVHGQGLLSFENDCVVRERIDVVFPVLHGEN
GEDGSMQGLLQIAGIPYVGPHVAASAACMDKTITKLIADHAGVRQAAWRLVTAAEFMRNA
AAVMDGVEAQFAYPVFVKPAGTGSSVGV
>KF627256.1_19604|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DNGTSTEGGKVRPVWEDGTSAYTIKKFGIVNRYDLSKEFPALTLRRTGIKSCVDEMLWIW
QKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDLKNNPYS
RRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAANNWNVC
QYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLNPEVKDF
YEFTPDDVRLDGYETHPQIKNIPIAV
>KF627249.1_19625|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VPSNQYETLMRHVYEHGTHKSDRTGTGTRSVFGYQMRFNLAEGFPLVTTKKLHLRSIIHE
LLWFLQGSSNIKYLHDNGVTIWDEWADENGDLGPVYGVQWRSWPAPDGSHVDQIENLMQQ
LRTNPDSRRMIVCAWNPGLVDQMALPPCHCLFQFYVADGRLSCQLYQRSCDIFLGVPFNI
ASYALLTHMVAQQAGLEVGDFVWTGGDCHLYDNHMEQTELQLSREPRPYPQLVIRRKPDS
IFDYRFEDFEITGYDPWPHIKAPVAV
>KF627243.1_19641|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTDKIAVLLGGTSAEREVSLNSGAAVLAGLREGGIDAYPVDPKEVDVTQLKSMGFQKVFI
ALHGRGGEDGTLQGMLELMGLPYTGSGVMASALSMDKLRSKLLWQGAGLPVAPWVALTRA
EFEKGLNDKQLAEISSLGLPVIVKPSREGSSVGMSKVVAENALQDALRLAFQHDEEVLIE
KWLSGPEFTVAILGEEILPSIRIQPAGTFYDYEAKYLSDETQYFCPAGLEALQEANLQAL
VLKAWTTLGCKGWGRIDVMLDSDGQFYLLEANTSPGMTSHSLVPMAARQAGMSFSQLVVR
ILELAD
>KF627232.1_19671|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MEHDSSRSGYHEPEPGLAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFEGGMP
WHLPEDMRRFKELTVSHPVIMGRKTWESLSPKYRPLPNRDNIVVSRDPAYTAPGATVVDS
LDDALDLAR
>KF627222.1_19698|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
IYDYEHKYQAGWTEEICPAEITDEQREKLQKAALAAYNALGLSVYARADFILTADDEPYC
LEVNTLPGMTPTSLVPQAAAAIGLGYSELCDKMINLSLEKYR
>KF627221.1_19699|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PHIHEMNLYPCAYSMTFNVTKKPGHDRLTLNAILNQRSQDILTANNWNVVQYAVLLHMIA
QVCGMEVGELVHVIADAHIYDRHIPLVKELISRPCYDAPTFWLNPEVKDFYQFTRDDVRV
DNYVTGPQITNIPVAV
>KF627220.1_19701|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
KYVRRQGIKQMKITATEDRMHKSGDPYLNHTRPSSAVRLLEKFIQQELLSPVYQKFLENT
MIATSTGSDKLKGLLPAETIIGHKTGSSDRDSTGMKAGDNDMGFVYLPHGGDHYTIAVFI
TDSMEDDKTNAAIIAKISKAVYDYINEISS
>KF627216.1_19714|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
PLKNRINIVLTRDRNYEAKGAVIVHDEEELMNELGKYDTEQIYIIGGESVYKMMLSYCDK
IYVTKVDRAFQADTYFPNLDEMSEWKMTQESEEQTCFDLEFCFTTYERC
>KF627208.1_19732|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
MAKENLVVIFGGRSSEHEVSCISVQTVAKAVDTEKYNMTLVGITKEGKWLRADNIESIAD
GSWRDGKVTAVISPDTTKELLILNGDKVERQRVDVIFPVLHGMYGEDGTIQGLFEMADIP
YVGCGVLASAASMDKFYTKIIVDNVGVRQAKFVPVLAEDFGDLDAAMDRVETGLDYPVFV
KPSKAGSSKGVNKAVDRQSLKSALEEAVKFDNKILVEETIAGRELECGVLGYKDNTQASG
VGEILAAAEFYDFDAKYNNAESKTVIGADIPAEIEAEIREDAVKIFRALDGFGLSRVDFF
LEKDTNKVVFNEINTLPGFTGISMYPMLWNAKGYDIGKLVTTLIEMAKER
>KF627194.1_19767|FEATURES|farme|beta_lactam|blaR1|antibiotic inactivation|1
MNDFALSVNKDTPSVTGYILLSIWIVGMLVMMILVIKSSLRLRTIKRSALPLQNPKVRRL
YNRCLNEMKIIRNIPVYSTAFLKSPIIVGFLKPCIYLPIHLISDYHESDMRYMLLHELQH
YRHKDAIANYLMNFAGVLYWFNPFVWFALREMRNDREIACDTSVLKMLEEDDYEDYGNTL
INFIEKVSFSPFPFAANLSGNMKQMKRRIINIASYEKPTFYKKLKGMTAFILTTVLIMGL
TPFISTYAADESRYQWKSSSENISYVDFSKYFGKYEGSFVLYDLRNDVWSIHDIEHATLR
VAPDSTYKIYDALFGLEEGVITPQDSFIAWNGENYPFEAWNADQTLQSAMASSVNWYFQS
VDEQLGTTSVYDYIKEIGYGNKNMSGDFSTYWMESSLKISPIEQVELLTQLQNNNFGFAP
ENINAVKDSICLSSSDAGTFYGKTGTGRVDGQDVNGWFIGYIETADNTYFFATNIGADSD
ATGGNATEITMSILSDMNIWK
>KF627177.1_19814|FEATURES|farme|beta_lactam|BL2a_III2|antibiotic inactivation|0
VRNPLSKKVTSIQPSGIRKFFDIVSEMDDVISLGVGEPDFDTPWHIRDEGIYTLEKGRTF
YTSNSGLKELREEITHYLKRRFELEYDPMHEVLVTVGGSEGIDVALRAMLDPGDEVLIPQ
PAYVSYLPCVVLADGVPV
>KF627173.1_19830|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCMATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKLPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADSMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDNADIIARISRMVY
DAMR
>KF627166.1_19850|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|0
MNIIVAADKNWGIGRNNELLVSIPADMK
>KF627164.1_19857|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VKEVLSLWQKRETERQENRMSYADKVFINMCRDIIENGTSTEGEKVRPKWEDGTAAYTIK
KFGVVNRYDLSKEFPALTLRRTAIKSCVDELLWIWQKKSNNVHELKSHIWDSWADENGSI
GKAYGYQMQVKHQYKEGMMDQVDRVLYDLKENPYSRRIMTNIYVHEDLHEMNLYPCAYSM
TFNVTKEEGSEQLTLNGILNQRSQDVLTANNWNVCQYAVLLHMFAQVCGMKAGELVHVIA
DAHIYDRHIPLIEELISREPLPAPKFWLNPE
>KF627162.1_19860|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MDLTEFNEIRPYNDEELPQIFEELIADPAFRKAATGAIPNVPFELLAQKMRTCKTKLDFQ
KAFCYGILWKIAEEHTNGLTLDHNALPNKKKAYTYISNHRDIILDSGFLSILLVDQGMDT
VEIAIGDNLLIYPWIKKLVRVNKSFIVQRALTMRQMLEASTRMSRYMHYTIAEKNQSIWI
AQREGRAKDSNDRTQDSVLKMLAMGGEGDLIGRLKEMNIAPLAISYEYDPCDFLKAREFQ
LKRDIEGYKKTTQDDLINMQTGLFGYKGKVHFQVASCINDELEQIDRSLPKP
>KF627158.1_19872|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSRTTVAVIFGGCSSEYEISLLSASSVIRNIPKDKYEIIMLGITKEGHWLLFNGDVDEIE
NGTWEKHSENRTAFLSPDRGIHGIVMETEYGFSAIRIDVIFPVLHGKNGEDGTIQGLFQL
SGIPFVGCDTLASAVCMDKAVTNILLEAAGIDQANFMWFYSSDYENVKGQVKEDIMADLG
GYPVFVKPANAGSSVGVSKAKNAAELDKAVAIAAKEDKKIVIEECIVGKEVECAVMGNAI
PKVSVVGEIAPSAEFYDYEDKYKNGTSKVYIPAPLDDGLSAEICNTAAKAYRALGCSGLS
RVDFFVRDSDNAVLLNEINTLPGFTSISMYSMLWKACGIDYGHLLDHIIQFAFDK
>KF627131.1_19944|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MKFSSKVKKCGLSPMRKFHPYAVAAEAKGRKIYHLNIGQPDVETPPQFFEAVRNFSQSVL
EYAPSPGVPELIDAVQKYYDNLNMHFEKDEILITTGGSEALSIVFQCILDDGDEVLIPEP
FYPNYATMVNTTGASIHPIPTSPEEGYRYADRAKIEAQINEHTRAIVCTNPGNPTGVVLT
PEEQRLMCDIAKEHNLFIIGDEAYREFVYAGEPLQSFGEYADAAENVIVID
>KF627126.1_19956|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MQAIVAADRNWGIGYQNRLLVSIPSDMKFFRQTTTGHVVVMGRKTLESFPNGLPLKNRTN
IVLTANKDYAVKDAIIVHSEKELLEELKKYDTDEIYVIGGESVYRMMLPYLDTIYVTKID
HAFQADTFFPNLDELEDWEMTEEGDEQTCFDLEFAFTRYERR
>KF627126.1_19957|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
DRHVPMIEELISREPLPAPKFWLNPEVKDFYDFTPDDVKLEGYETHPQIKNIPIAV
>KF627120.1_19972|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|0
MIMDENGQLWCLEANSLPGMTPTSFVPKEAAAVGISYDDLCEEIVRQSLKIKRR
>KF627117.1_19982|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
KPSKAGSSKGVSKADDRAALVVALKEAAKHDYKILVEETIVGREIECAVLGYGKNTKASR
VGEILAAAEFYDFDAKYNNAESKTVIGADLPDGKEAEVQKDAVAIFNALDGFGLSRVDFF
LEKDTNEVVFNEINTLPGFTSISMYPMLWKDKGYSIESLVETLIEMAKERP
>KF627107.1_20008|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
HVSLRSAQGIYSFIDKEKYTLYIVEMQGTRWEVQLPDGAKAPVDRNDFSFMLGTEKIKFD
FAYITIHGTPGEDGRLQGYFDMMHIPYSCCGVLAAAITYDKFTCNQYLKAFGVRIAESLL
LRQGQSVSDEDVMEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQPAIVKAFEEAQEVLVEA
FMEGTELTCGCYKTKDKTVIFPPTEVVTHNEFFDYDAKYNGQVDEITPARISDELTNRVQ
MLTSAIYDILGCSGIIRVDYIVTAGEKLNLLEVNTLLRE
>KF627103.1_20016|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VETIKHNPDSRRIIVSAWNVADLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVP
FNIASYALLLQMMAQVTGLKAGDFIHTLGDAHIYLNHLEQVKLQLTREPRPLPQMNINLD
VKSIFDFKFEDFELVNYDPHPHIAGAVAV
>KF627102.1_20018|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGNKVPVD
RNDFSFMNGTEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFAC
NQYLKAFGVRIAESLLLR
>KF627088.1_20058|FEATURES|farme|chloramphenicol|catS|antibiotic inactivation|1
PAMLYYLATIVNRHSEFRTAINQEGELGIYDEMIPSYTIFHEDTETFSNLWTPYIPDFEA
FSMAYANDMQRYGSNYGMIGKPDVPENVFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMG
KYYRDDEKIILPLAIQVHHAVCDGFHICRFVNELQELINS
>KF627086.1_20062|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIAAVDQNWAIGNKNELLVRIPADQKFFRETTTGKVVVMGRKTLESFPNGLPLKNRTN
IVLTHDHTYKVPGAVVVHDMDELHEELKKYDSEDIYVIGGETIYRQLLDECDVAHITKID
YAYDADAYFPNLDERPEWKITADSEEQTYFDLEYYFYRYERVK
>KF627085.1_20064|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
NKKAPHRISEQHLTVLSWSAPLLAQLIMLIVMCMQRHWLYAAMLAPSLLGSALMLITMIM
RVRHEETNSNTITGSDSPVPTHHNGNEIDHAQLFADMPSISFEHLHGLDNDPLIWRTIVR
NWLVRSPTNGIGMSEHGIFHIDLASSGPHAMVAGTTGSGKSELLISWCMALAIRHSPQTL
HFVFLDFKGGSTFNALERLPHTVGNVCDLDLAHAVRALNAIEQELARREALVSAERVSRF
DQLSHPPARLVVVIDEFHALRDRLPDYMQRLNRLASLGRSLGMHLIVCTQNPMGQVHADM
KANISLSICLRVTDQMQSNELIGTKDAALIPPAFPGAAYCHDGQRTVPFRCSAVHDIDSL
VHAINTASAFSGTTNPSPLFSAPLAPHAGKDDLTAPQREAWHHVPFALSDDGVLISTAFL
DVGHGNIAVIGACGSGKTNLLLCCASRLYESGRCTIRFTRKTNSEWTTDDGRTSPQHERT
IWFVDDADELLSPFAAMPEADKLKTALADPSVTVIAAVEKPQSTLLERCLTRVAFPCGER
ATDVMMGIPSAVLDGFGVDDYAIAGRGVFIQQARACPVQCAEFQGF
>KF627080.1_20079|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGEPAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMM
DQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKPGHDKLTLNAIL
NQRSQDILAANNWNVVQYAALVYMMAQVCDMEPGELVHVIADAHIYDRHTPIIKEMIKRE
TYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF627079.1_20083|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLCGGTSTEREVSLNSGSMVCDALRSIGHNAVLLDVFFGNENKNLLDVSDFDVQAE
KEKLQKLSKDVDKVKKERKGFFGENVFEICQQADIVFMALHGSNGEDGKCQAAFDLHGIK
YTGDGSVASALAMDKSITKQIFMAQNVSTPKGIWIKKGESTNLSDYGMKIPVVVKASNGG
SSVGVVIVKDEKDYDAALKECFALEDTIVIEEFVEGREFSVGVVDGKALPIVEIIPKTGW
YDYKNKYLPGATEDVCPAQINEELTKKMQKLAEEACKALGIVTYSRADVLMKKDGSMYCI
EVNTLPGMTVTSLVPQEARAMGMEFPQLCEHLINVSMKKYK
>KF627078.1_20085|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MDYDKLIAPAAREMRPSGIRKFFDLAADMPECISLGVGEPDFKTPWAVREAGIESLEHGR
TRYTANAGLKELRAEICRYLERRMHLHYDPLREVLVTVGGSEAIDMCIRTIVQPGDEVII
PEPCFVCYEPITTLSGGVPVHVPCRQEDEFRLRPEALKSAITPKTKLLIMPFPNNPTGAV
MEREDLEAIAEVLRDTNVMVLSDEIYAELNYGLRPHVSIATLPGMAERTIVVNGFSKSYA
MTGWRLGYACGPAPIIKIMTKIHQSAIMSAPTTSQYAAITALRECDGEIDKMRDEYNMRR
RLVVHGFNSMGLTCFEPRGAFYAFPCIKSTGMTSQEFCTKLLEQKHVALVPGDAFGASGE
GYCRVSYAYSVEHLTEAMKRIREFLKENGINSGEQ
>KF627068.1_20110|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
VIDYSKYLNDRARVIKPSGIRRFFDIANEMEDVISLSIGEPDFFTPWHIREEGITTLEKG
RTRYTPNRGLMALREEICRFLKRKYDLEYTAATDILVTVGGSEAIDMALRCLVGEGDEVI
IPEPCFVCYDPLTRMAGGVPVSIATKAENEFRLTPEELENAITDKTKVLIFPYPNNPTGA
VMRREHLKALSEIIIRHDLIVLSDEIYSELTYGGEPHVSIASLPGMKERTIVINGFSKTY
AMTGWRMGYAAGPKEIISPMTKLHQYGIMSAPTMSQYAAIEALKNGDDDIAEMRDQYDMR
RRLIVDGLNRLGLTCFEPEGAFYVFPSIQSTGMTSDEFCERLIYDKHVAVVPGSAFGACG
EGFVRISYAYSIKHLAEALNRIGAFLKELK
>KF627051.1_20151|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MEHDSSRSGYHEPEPGSAGLSATEEDWGDDFPKTFSVNLIWAQARDKEGRAGAIGLNGGM
PWHCAEDMKHFKELTVSHPVIMGRKTWESLGVKYRPLPNRDNIVISHNPMYRAPGATVVT
GLDDALDLARQEA
>KF627042.1_20176|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKNLKGKKIAVIVGGPSTEAAVSRNSGKNVAAALRAKGYDPIITELVPEEWARTLKEGQF
DIVFNALHGRYGEDGILQGTCEMMNVPYTGPGVMASAVGMNKVVSKSAFVGAGISTAPFR
YYFEEQGVDSIAEEILQVFSLPVVIKSAAQGSSIGTFIVRKKDDLKSALSEAFAYGKSIV
AEAFLSGREFTVAVMDELAFPVIEIISKTGRYDYESKYTPGLSEHICPAQISPELTKELQ
DLSLAVFRLFHCKGVARVDLMTDENGKAYVLEINTVPGMTETSLVPDASRAMGMPFEDLC
ERILEEASTGKF
>KF627037.1_20188|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
GLSATEEDWGDDYPKTFSVNLIWAEARDKEGRAGAIGLNGGMTWHCAEDMKHFKELTVSH
PVIMGRKTWESLGGKYRPLPNRDNIVVSHDPMYRAPGATVVTSLDDALDMARQEAIPDDG
LDRSEMWIIGGAQLFAKALPFADKAYVTDLAATVDADSYAPDMASLVEAGMWREAEVGEW
HTPAKEESGIDSYRFRILAKTK
>KF627032.1_20203|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|0
MEHDSSRNGYHEPEPGFAGQEKADDWGDDFPKTFSVNLIWAEADDKDGRPGAIGFDGGMP
WHLPEDMKRFKEL
>KF627032.1_20204|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRFDLSEGFPLLTTKTVFFKGLAYELLWFLKGSSNVRWLQEHNVHIWDDWADENGDLGPV
YGVQWRSWPAPTPEDPNRTIDQIGNVLDLIRNHPDSRRMVVSAWNPAEVENMALPPCHAL
FQFYVADGRLSCQLYQRSCDMFIGVPFNIASYSLLTMMIAQQTGLEPGEFVWTGGDCHVY
DNHVDQVLEQLSREPYPYPKIEIRKADSLFDYQYEDFTIVDYRHHPTIKAPVAV
>KF627026.1_20222|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MLAAIWAQDENGLIGKEDRLPWRLPNDLKFFKQMTEANTLVMGRKTFEGMGSRPLPNRQT
IVLTRDSSYKAEGVHVMHSVEDVLALEKETDGIFFIAGGSAVYQEFLPFCTILYRTVIHH
VFDGDAYFPPVDWSDWSLINTSQGEIDEKNRYPHQFETYQRNENPVKSGTGELTI
>KF627024.1_20226|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
TVSHPVIMGRRTWESLNVKYRPLPNRDNIVVSHNPQYLALGATVVTDLDAALDIARQEAI
PDDGLDRSEIWVIGGAQVFQEALPFASKAFVTKIQTSVDADTYAPDMDALVDAGLWEVAD
PGHWKRTQKDDSRIKRYRFVTYRKIG
>KF627017.1_20241|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKLFIDMCSDIIENGYSTEGEKVRPKWPDGTYAYTIKKFGVVNRYDLSKEFPAITL
RKTYIRSAIDEILWIWQKKSNNVHDLSSHIWDEWADEDGSIGKAYGYQLGKKHKYKEGEM
DQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNW
>KF627008.1_20258|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
SDAQNGQPLPTVDVIFPIVHGTLGEDGSLQGMLRVANLPFVGSDVLASAACMDKDVTKRL
LRDAGLNIAPFITLTRANRHNISFAEVESKLGLPLFVKPANQGSSVGVSKVTSEEQYTIA
VDLAFEFDHKVIVEQGIKGREIECAVLGNDNPQASTCGEIVLTSDFYAYDTKYIDEDGAK
VVVPAAIAPEINDKIRAIAVQAYQTLGCAGMARVDVFLTPENEVVINEINTLPGFTNISM
YPKLWQASGLGYTDLITRLIE
>KF626989.1_20295|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MLAQVCGLKPGTIDWSIKDAHIYVNQIDGIKEQLKRFDEQGDLPAPKLWLNPEVDDFFKF
DSSRDCKDVKLIDYKHLGKISFPISQ
>KF626989.1_20296|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MAICMIAAVGKNLELGKGNDLIWHFKDDMAFFKETTMGSSVIMGRKTFESLPKALPRRKN
IVITTRKDYEAEGATVVNSIENALKEVDSDNAFIIGGGDIYKQFLPMADKLYLTEIEAEC
DDAQVFFPAFNKDEYEKELLASYYDKGVHFSHICYTKK
>KF626983.1_20312|FEATURES|farme|multidrug|mtrC|antibiotic efflux|0
RKGQRFRRMAVRAELLKNIRQAEPYVPGEQPQNKVIKLNTNENPYPPAPGVERVLREMDT
DRFRLYPDPAAEELTGCLAEYYGVDRDQVFVGVGSDDVLSMCFLTFFNSGKPVLFPDITY
SFYKVWAELYKIPVT
>KF626982.1_20317|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
LARNGEGSEQLQADNESGKQKNKNVSDRRIIMNLIVAADKNWGIGKDNKLLVSIPSDMKF
FRQETMGKVVVMGRKTLESFPNGLPLKNRTNVVLTSDKNYQVKDAVIVHSIDEVLEELKK
YDDNEIYVIGGGKVYEELLPYCDVAHVTKIDFAFEADTHFPNLDEDPEWEITASSDEQTY
FDLEYTFVKYERK
>KF626966.1_20359|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNIIVAADKNWAIGKDNKLLVSIPADMKMFRQETTGKVVVMGRKTLESFPNGLPLKNRIN
IVLTGNKNYKVKDAIIVHTIEELLEEIKKYPSEEVYCIGGDSVYKQLLPYCDTAHVTKID
FGYEADSYFPNLDEMPEWKITAESDEQTYFDLEYSFVKYERVK
>KF626962.1_20369|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKVIAAADKNWAIGKDGELLVRISEDMKNFSAITTGNVIVMGRKTLESFPGGKPLPNRVN
IVLTHEKDYNGKGAIVVHSEEELWEELSKYDTDSIFVTGGESIYRMLLPYCDTAHVTKID
HAYEADSWFPNLDKEEHWSMVEKGEERYCFDLIYHFTTYKNERPALH
>KF626960.1_20374|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YDMKQYLDLLQHVLDHGILKEDRTGTGTHSVFGYQMRFDLQDGFPLLTTKKLHLKSIIHE
LLWFLKGDTNVKYLQENGVRIWNEWADENGDLGHIYGYQWRSWPDYNGGHIDQIKEAIHT
IQNNPDSRRIIVSAWNVADLPQMNLPPCHAFFQFYVANGKLSLQLYQRSADIFLGVPFNI
ASYALLLMMVAQVTGLEAGDFVHTLGDAHIYNNHIEQVREQLSREPRDLPKMKLNPDVKS
IFDFKYEDFELTDYNPHPHIAGKVAV
>KF626959.1_20378|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|0
MKDAFSYESEVVVEEYIEGREFSVGVVDGKAYPIIEIAPIEGFYDYTNKYKAGATVDTCP
AVLTEEQTKEMQKHAEDGAAALGIENYCRLDFMMRKDGRMYCLEAN
>KF626956.1_20386|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDCIVNVTQNWGIGKDGDLLVSISADLRRFRALTTGKTVIYGRKTLLTFPHARPLPNREN
WILSATPGFSVPGAAVFPSLAALQEAMRTRPADSLCLIGGASVYRALLPWCSRVLLTQTC
ADLPADRFFPDLDRLPNWRCTDTGPLQEDGGHCFRYLTYENDAPLPL
>KF626951.1_20401|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MFDQVDRVLYDLRHNPASRRILTSLYNFEDLHDMNLYPCAYSMTFNVSNGTLNAILNQRS
QDMLAANNWNVCQYAVLVHMFAQVSGLKAGELVHVIADAHIYDRHIPIIEKMLSEPEHPA
PQFTLDPAVTDFYAFTPDSVRLENYQFSPFEDKIPIAV
>KF626940.1_20425|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLKAGEFI
HTLGDAHIYLNHLDQVKLQLSREPRALPQMKINPDVKSIYDFQFEDFELVNYDPHPHIAG
IVAV
>KF626940.1_20426|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKISIIAAVDRRMAIGFQNKLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNR
RNVVLSTRPDTVCPGAEVFPSLEVALQSCKEDEHVYIIGGASVYQQALPLADELCLTEIN
DVAPEADAFFPEVSPAQWHEKSREAHPVDEKHLCPYAFVDYVKQ
>KF626938.1_20431|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLSSAAGICRTLLEKGHDAFLLDVFMGLEHAPEHLEDVFTLPDH
GLDIVKNISTEEPDLAAVKASRPDQSDCFFGPNVIELCRLADITFLGLHGGEGENGKLQA
AFDLLGIKYTGPDSLGCAVAMHKGVAKQIFLESGVDTPGGGTLYKNGSDLSYQSLGLTLP
VVVKPCSGGSSIGVYIVNTDEEYQNALEHSFHYEDEVVVEPYIKGREFACGIIDGEALPP
IEIIPKTGFFDYANKYQDGATMEVCPADIPEEVAERMKALTVKAFDALKLNVYSRADFLL
DAEGNLYCLEMNTLPGMTSASLMPKEAKVAGIEYSDLCELIIKKSMEARYSS
>KF626933.1_20443|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
VILGRKTLATFPGGRPLKNRRNLILSRDPAFAPEGAEVFRSLEALRAAAPADSFVIGGES
VYAALLDWCDTAYITKIGQAWEGADAFFPDLGAGPDWEMAEEGEPQEHAGIPFRYVTYRR
RKPHVCG
>KF626931.1_20447|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNIIVAADKNWAIGKDNKLLVSIPADMKMFRQETTGKVVVMGRKTLESFPNGLPLKNRTN
IVLTGNKDYNVKDAIIVHTVEELLEEIKKYPSEEVYCIGGDSVYKQLLPYCDTAHVTKID
FAYEADSYFPNLDEMPEWKVTAESDEQTYFDLEYSFMKYERIK
>KF626915.1_20490|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNLYPCAYSVTFNVTKKPGHDKLTLNAILNQRSQDILAANNWNVVQYAALVYMMAQVCDM
EAGELVHVIADAHIYDRHIPIIKEMIKRETYPAPKVTLNPEVKDFYEFTTDDFKIEDYQA
GEQIKDIPIAI
>KF626913.1_20495|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKVFVAMCQDILENGTSTEGELVRPHWEDGTSAYTIKKFGVVNRYDLSKEFPAITL
RKTYIKSATDELLWIWQKKSNNIHDLKSHVWDEWADEDGSIGKAYGYQLGVKHQYKEGMM
DQVDRVIYDLKHTPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQKKGDDRLTLNGIL
NQRSQDVLAANNWNVCQYAVLMHMLAQVCDMRVGELMHVIADAHIYDRHVPIVKELIERP
QYDAPKFWLNPDIKDFYQFTTDDIKITDYVTGEQIKDIPIAV
>KF626910.1_20501|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
MEKKNIDWSSLGFGYVQTDYRYVSKFKDGAWDAGELTTDPNVTLNECAGVFQYAQTVFEG
MKAYTTEDGHIVTFRPDLNAERMANSAKRLEMPVFPEDRFVDAIVQTVKANVAYVPPYGS
GATLYVRPYMMGTNPVIGVKPADEYMFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPHGT
GHIKAGLNYAMSLHAIVDAHKNGFDENMYLDPKTRTKVEETGGANFIFVTKDGKVVTPKS
DSILPSITRRSLIYVAKEYLGLEAEEREIYFDEVKDFAECGLCGTAAVISPVGKINDHGK
EICFPSGMEKMGPVIQKLYDTLTGIQMGRIEAPEGWIHVIE
>KF626896.1_20536|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MPRLYVVATPIGNLDDLTPRMRWALESASLIAAEDTRVTQKLLTVMGISRPLISNHQHNE
EARAPRIIERMIAENIDVAVTCDAGTPGISDPGMELVSAAWQVGIEVIPVSGPSAVITTL
SAAGFDAREFAFYGFLPRENGDLRKKLHAIAHGPRVAVAYESPHRIVNLVEQIAREIPGA
RVCVCCDLTKKFEKIERGLAGTVLERLKANPNVEKGEYCVAIELPEIEEEAPAAQLSPRH
MVMDALLEGMSMRDAVKCATQQGASRQDAYAASLEIKRWLESQLEE
>KF626895.1_20541|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADDFMVTMAT
GGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIA
PGLALEVGDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPKDCEFYDLDVKYVDPTDIHRIPAQISPE
NYTRAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQVCDSLIRMGLRRAGIAC
>KF626891.1_20550|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
MEKKNIDWSSLGFGYVQTDYRYVSKFKDGAWDAGELTTDPNVTLNECAGVFQYAQTVFEG
MKAYTTEDGHIVTFRPDLNAERMADSAKRLEMPVFPEDRFVDAIVQTVKANVAYVPPYGS
GATLYVRPYMMGTNPVIGVKPADEYMFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPHGT
GHIKAGLNYAMSLHAIVDAHKNGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKS
NSILPSITRRSLIYVAKEYLGLEAEEREVYFDEVKDFAECGLCGTAAVISPVG
>KF626881.1_20575|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KLNAILNQRSQDTLAANNWNVVQYSALLMMFAQVSGLEPGELVHVISDMHIYDRHVPIIK
ELIERETFPAPKVRLNPEIKNFYDFTVDDFIVEDYEHGKPIGKVPIAI
>KF626876.1_20589|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
RLIQERMAEAGIRNMGAYMRKMAPPKFWLNPEVKDFYDFTPDDVKLEGYETHPQIKNIPI
AV
>KF626870.1_20601|FEATURES|farme|triclosan|TriC|antibiotic inactivation|0
MNIPAEFDKIRPYTPEELPKIYEELIADPSFRAVVESVMPGIPFEALAEKMRLCRTNLEF
QKAFFYGLLWDLVKKCANGLTFDCSALTDKTMNYTFISNHRDIILDSAFLCILLIDQKMN
TVEIAIGDNLLIYPWIKKLVRINKSFIVQRGLSMRQKLEASALMSRYMHFAITHKHENLW
IAQRQGRAKDSNDRTQDSVLKMMAMAGEGDAIARLKELNLVPLSISYEYDPCDFLKAKEL
QQKRDDANFRKSPEDDLINMQTGLYGYKGRIHFQTSACLNKELDEIKERNLSKTEVFTAI
SELIDKH
>KF626861.1_20629|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVDGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAAS
EFAAGADEMLAAVQQAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVFEASHHDWR
VLVEQGIDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYVNSDASHV
EVPASLPEETLNRVRETAKKAFIAVDGAGLSRVDTFVTADGEVMVNEINTMPGFTPISMY
PKAWEATGVSYTDLITTLIEGVLR
>KF626850.1_20661|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNAIVVVDQNWGIGREGNLLVHLPGDLKYYKEKTIGNHIIVGRKTLESFPGGKPLPGREN
IVLTRDPGYAKDGCVICHTVEDVQDAVKDYDPETVFVAGGAEIYQEFFSLCDVFYVTKIY
ETFEADRYFPDLDEMGLKAAWESELQEEKGITYRFLKYVRENNR
>KF626849.1_20662|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ALLLMMMAQVCDMEAGELLHVVADCHIYDRHIPLVKDMIQRKPYPAPIVKLNPEVKDFYQ
FTTDDLIVENYETWPQIKNIPVAI
>KF626845.1_20670|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILCIYQKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYAEGDF
DQMDRVLYDLKHTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMIL
NQRSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRHVDIVREPIERP
QFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF626839.1_20691|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKLIAAMDEKRGIGKNGGLLCHLPSDLRYFKQVTLGRDVIMGRATLESFPGGRPLPGRRN
IVLSKTLNRDDVLIVRSVDELMNIAGIDDAFVIGGGQIYSQLLPYCDTAYITQLEGDLWR
RGVYAGYFGGGLCKDKFK
>KF626822.1_20736|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNKRLKEILKQYEERKHKIIKGDESMNIVVLAGGTSTEREISIVTGTGVCKALRKKGHNA
ILVDIFCGLEPVDWDEPFGDKDYEVDSAAEYMRSFDDDIEEIKRTRRSFFGPNVLELCQA
ADIVFMGLHGSNGEDGKVQATFDLLGIRYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKG
VSMLKENCTRNIHDLGMEFPVVVKTCCGGSSVGVYIVNNQKEYEDAIDGAYSYEDEVVVE
EYIRGREFSVAVVDGKAYPIIEIAPKQGFYDYKNKYQAGSTVETCPAEISPEQTEKMQHY
AEAGAKALCIEGYARFDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGIDYPDLCEE
LIRISFKKYSK
>KF626801.1_20788|FEATURES|farme|aminoglycoside|APH(2'')-Ig|antibiotic inactivation|1
MTMCEFSSPQIPITDIENAMERIGSPVRELRRLDAGDDSEVLLCNGLFVIKIPKRPSVRV
TQQREFAVYSFLKQYDLPALIPEVIFQCSEFNVMSFIPGENFGFQEYALLSEKEKEALAS
DMAIFLRRLHGISVPLSEKPFCEIFEDKRKRYLEDQEQLLEVLENRKLLNAPLQKNIQTI
YEHIGQNQELFNYAACLVHNDFSSSNMVFRHNRLYGVIDFGDVIVGDPDNDFLCLLDCSM
DDFGKDFGRKVLRHYGHRNPQLAERKAEINDAYWPIQQVLLGVQREDRSLFCKGYRELLA
IDPDAFIL
>KF626788.1_20816|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MVGRIYHVGLTVSDLDRSIAFYRDILGLEFQGEIFMEGEETDKMFRRANCKARVAYLNGS
KAIEAPPVELIQFVDSKIHKEQSDLFTTSISEVCFYTDDIDSVYKTLIENHVECLSEPQH
FDFRADGFGESRAFYFRDPDGIILEMMQPL
>KF626780.1_20838|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
LCMLAQVCGLKPGTIDWSIKDAHIYVNQIDGIKEQIERYETKGSLPAPTLWLNPEIDDFY
AFDASKDIKDIRLENYEHMGKIRFPLAQ
>KF626778.1_20843|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>KF626775.1_20853|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSKIALIAAVAEKGAIGRDQQLLCHLPNDLKHFKTLTSGHTVVMGRKTFESLPNGALPNR
KNIVLTHNTSLSWPN
>KF626759.1_20889|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MEITKLRKENGIPMSKQTLILLYGGRSAEREVSVLSAESVMRAVDYSAFEVKTYFITQSG
DFIKTQEFTETPGDDEKLMTNDTVVASQAIKPSDIYEEGAVVFPVLHGPMGEDGSIQGFL
ETLKLPYVGTNVLSSSVAMDKITTKHILEVVGVPQVAYTVFIEGEDLEAAVVRTVQKLTF
PVFVKPANMGSSVGISKAENEAELREAIDLALKYDSRILIEQGVVAREIEVGILGNTTVK
TTEPGEVVKDVAFYDYQAKYIDNKITMDIPAHVTAEVMTQMRAYAAKAFRALGGCGLARC
DFFLAEDGTIYLNELNTMPGLTQWSMYPLLWENMGLSYTDLIKELVALGQEMFEKRESHL
I
>KF626746.1_20914|FEATURES|farme|beta_lactam|HMPREF1604_00910|antibiotic inactivation|1
MAGRFVWKPDLMLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVSASWVHETGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>KF626720.1_20964|FEATURES|farme|tetracycline|tetV|antibiotic efflux|1
IAPPEDIVRANGLIRTFRNAGSVVGPLLGAWLAQLISPSFLFLDGAVCLAVSMPLVLSLK
LMPSCDDEANNNDDDASMISALRSIPSLFHTYIWLAVGVPFWALFLAVQSGATDVTMPLW
VVQESGRGAWSLMASITSSGYICGSLIALKLERPRHMFSKSVLFGALAIMPIFVVGTLDI
QVLWYVASFVAGLGLELSGVFWGSTMQTCVDKRHMGRVSSIDYAISFGLIPLAYGLYGFT
GTIHAAVVLTVSSSIMIVLVIIVFPFCYLIDHRSNSSGIINSSDV
>KF626716.1_20971|FEATURES|farme|chloramphenicol|BN488_01641|antibiotic inactivation|1
TYSITVKLDITRIKEKKQKLYPTMLYYLATVINRHAEFRTAINENGELGIYSEMIPCYTV
FHKDTETFSNLWTEYKANLDDFCAAYEEDMLKYGKQPGITGKPNIPSNSFTVSMLPWATF
EGFNLNLQKGYNYLIPIFTIGKYYQENERIMIPISIQVHHAVCDGFHVCRFTNELQELIN
N
>KF626700.1_21000|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTVIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM
>KF626678.1_21036|FEATURES|farme|aminoglycoside|aspartate_aminotransferase|antibiotic efflux|0
HHIWVISDEIYEHLNYDDAHTTYIGAAVPECRGQLLVLNGVAKTYAMPGWRVGWMVAPLE
VAKAATKLQGHMTSNVANISQRAALAAVAGPLDEVHEMRKAFDARRRAIVTALNDIEGVN
CPTPTGAFYAFADITALLGKPLGPKGTVSDTSADFAAALLDEAHVAAVPGEAFGAPGYLR
FSYALADEDLAEGMRRFKEWAN
>CAH19071|FEATURES|argannot|aminoglycoside|AAC(6')-IIa|antibiotic inactivation|1
MPSHDHPVTLRLMTEQDLPMLHEWLNRPHIVEWWGGEEQRPTLADVLEHYRPRILAHESV
TPYIAMLGEEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANPTQLNMGLGTELVRA
LVDRLFSDPTVTKIQTDPAPNNRRAIRCYEKAGFVQERVITTPDGQAVYMTQSRQAYERA
RGAA
>AAA03550|FEATURES|argannot|aminoglycoside|AAC(2')-Ia|antibiotic inactivation|1
MGIEYRSLHTSQLTLSEKEALYDLLIEGFEGDFSHDDFAHTLGGMHVMAFDQQKLVGHVA
IIQRHMALDNTPISVGYVEAMVVEQSYRRQGIGRQLMLQTNKIIASCYQLGLLSASDDGQ
KLYHSVGWQIWKGKLFELKQGSYIRSIEEEGGVMGWKADGEVDFTASLYCDFRGGDQW
>AAB41701|FEATURES|argannot|aminoglycoside|AAC(2')-Id|antibiotic inactivation|1
VLTQHVSEARTRGAIHTARLIHTSDLDQETRDGARRMVIEAFRDPSGDSDFTDDFTDDDW
DHALGGMHALISHHGALIAHGAVVQRRLMYRGPDGRGHALRCGYVEAVAVREDRRGDGLG
TAVLDALEQVIRGAYQIGALSASDIARPMYIARGWLSWEGPTSVLTPTEGIVRTPEDDRS
LFVLPVDLPDGLELDTAREITCDWRSGDPW
>AAA26548.1|FEATURES|argannot|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MNTIESITADLHGLGVRPGDLIMVHASLKAVGPVEGGAASVVSALRAAVGSAGTLMGYAS
WDRSPYEETLNGARMDEELRRRWPPFDLATSGTYPGFGLLNRFLLEAPDARRSAHPDASM
VAVGPLAATLTEPHRLGQALGEGSPLERFVGHGGKVLLLGAPLDSVTVLHYAEAIAPIPN
KRRVTYEMPMLGPDGRVRWELAEDFDSNGILDCFAVDGKPDAVETIAKAYVELGRHREGI
VGRAPSYLFEAQDIVSFGVTYLEQHFGAP
>ABS70977.1|FEATURES|argannot|aminoglycoside|AAC(3)-IIa|antibiotic inactivation|1
MHTRKAITEALQKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDEARRTWLPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRWVTYEMPMLGRDGEVAWKTASDYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPPHEAVERSCEPSG
>AAX16011|FEATURES|argannot|aminoglycoside|AAC(3)-Ib|antibiotic inactivation|1
MSITATIRIGPDEIPAMRAVLDLFGREFEDMSAYSDRQPTNDYLAKLLRSETFIALAAFD
QGTAIGGLAAYVLPKFEQARSEIYIYDLAVASSYRRQGIATSLISHLKREAIKIGAYVIY
VQADYGDDPAVALYTKLGVREDVMHFDIDPGTAT
>ABF52347|FEATURES|argannot|aminoglycoside|AAC(3)-Ib|antibiotic inactivation|1
MIVRRLGPGDIAAVRALNAVYGAAFDDPETYRADRPDDAWLARQLGREGVIVLVAELDGN
IVGGLTAYELPKLEAARSEIYLYDLAVDAAHRRCGIATALIGELQHIAAETGAWAVFVQA
DHGDDPAVALYTGLGAREDVMHFDLPPRPRGA
>AAA88552|FEATURES|argannot|aminoglycoside|AAC(3)-VIIa|antibiotic inactivation|1
MDELALLKRSDGPVTRTRLARDLTALGLGDGDTVMFHTRMSAVGYVAGGPETVIGALRDV
VGERGTLMVTCGWNDAPPYDFTDWPQTWQDARRAEHPAYDPVLSEADHNNGRLPEALRRR
PGAVRSRHPDASFAALGAAATALTADHPWDDPHGPDSPLARLVAMGGRVLLLGAPLEALT
LLHHAEALADAPGKRFVDYEQPILVDGERVWRRFHDIDSEDGAFDYSALVPEGTEAFEII
GRDMRAAGIGRRGTVGAADSHLFEARDVVDFGVAWMEEKLGRERGPGG
>BAA78619|FEATURES|argannot|aminoglycoside|AAC(3)-Xa|antibiotic inactivation|1
MDETELLRRSDGPVTRDRIRHDLAALGLVPGDTVMFHTRLSAIGYVSGGPQTVIDALLDV
VGPTGTLLVTCGWNDAPPYDFTDWPPAWQEAVRAHHPAFDPRTSEAEHANGRLPEALRRR
PGAVRSRHPDVSLAALGASAPALMDAHPWDDPHGPGSPLARLVALGGRVLLLGAPRDTMT
LLHHAEALAQAPGKRFVTYEQPIEVAGERVWRTFRDIDSEHGAFDYSSAVPEGQDPFAVI
VGSMLAAGIGREGFVGAARSRLFDAAPAVEFGVRWIEEHLNRDR
>CAG26810|FEATURES|argannot|aminoglycoside|AAC(6')-31|antibiotic inactivation|1
MTEHDLPMLHDWLNRPHIVEWWGGEETRPTLAEVLEQYLPSALAKESVTPYIAMLDEEPI
GYAQSYIALGSGDGWWEDETDPGVRGIDQSLANPSQLGKGLGTKLVCALVEMLFKDAEVT
KIQTDPSPNNLRAIRCYEKAGFVAQRTINTPDGPAVYMVQTRQAFEQARSAV
>AAP43642.1|FEATURES|argannot|aminoglycoside|AAC(6')-I30|antibiotic inactivation|1
MAYAFCEIGESNEYIIQAARILTKSFLDIGNDSWPDMKSATKEVEECIEKPNICLGIHEN
EKLLGWIGLRPMYKLTWELHPLVISTQYQNKGIGRLLINELEKQAKQNGIIGIVLGTDDE
YFKTSLSDVDLSGKNILDEIRNIKNIRNHPYEFYQRCGYSIVGVIPDANGKRKPDIWMWK
KISD
>AAA25688.1|FEATURES|argannot|aminoglycoside|AAC(6')-IIa|antibiotic inactivation|1
MSASTPPITLRLMTERDLPMLHDWLNRPHIVEWWGGDEERPTLDEVLEHYLPRAMAEESV
TPYIAMLGEEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQSLADPTQLNKGLGTRLVRA
LVELLFSDPTVTKIQTDPTPNNHRAIRCYEKAGFVREKIITTPDGPAVYMVQTRQAFERK
RGVA
>CAA31139.1|FEATURES|argannot|aminoglycoside|VN23_18795|antibiotic inactivation|1
MIEACHSVECPGWLQLRFLLWPQDSADEHLAEMAIFVAEPNRFAQFIAYDEANKPLGFVE
AALRSDYVNGTNSSPVAFLEGVYVLPEARRRGIAHALVGAVEIWARNRACTEFASDASTD
NPESHRFHQSLGFKETERVVYFRKMLAPE
>CAA39038|FEATURES|argannot|aminoglycoside|AAC(6')-If|antibiotic inactivation|1
MDEASLSMWVGLRSQLWPDHSYEDHILDSQHILSCPDKYVSFLAINNQSQAIAFADAAVR
HDYVNGCESSPVVYLEGIFVIPEQRGHGVAKLLVAAVQDWGVAKGCTEMASDAALDNHIS
YQMHQALGFEETERVVFFRKRIAG
>AAC41392|FEATURES|argannot|aminoglycoside|AAC(6')-Ij|antibiotic inactivation|1
MNIMPVSESLMADWLGLRKLLWPDHDEAHLQEMQRLLQQTQSLQLLAYSDTQQAIAMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPDYRRSGIATHLVQQVEAWAKPFGCIEFASDAALDN
RISHAMHQALGFHETERVVYFKKHIG
>AAA87229|FEATURES|argannot|aminoglycoside|AAC(6')-Ik|antibiotic inactivation|1
MNIKPASEASLKDWLKLRIKLWNDLEESHLQEMHQLLAEKHALQLLVYSDDHAVGMLEAS
IRYEYVNGTETSPVAFLEGIYVLPEYRRLGVATLLVRQVEAWAKQFSCTEFASDAALDNV
ISHAMHRALGFQETERVVYFSKKID
>AAD03490|FEATURES|argannot|aminoglycoside|AAC(6')-Ir|antibiotic inactivation|1
MKIMPVSEPFLADWLQLRILLWPDHEDAHLLEMRQLLEQPHTLQLLSYNDQQQAVAMLEA
SIRYEYVNGQQSSPVAFLEGIYVLPEYRRLGVASTLVQQVEHWAKQFACTEFASDAALDN
TISHAMHRALGFQETECVVYFKKNIS
>AAD03492|FEATURES|argannot|aminoglycoside|AAC(6')-It|antibiotic inactivation|1
MHIMPITESQLSDWLVLRCLLWPDHEDADLQEMRQLITQAHCLQLLAYTNTQKAIGMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPEYRRSGIATGLVQHVEIWAKQFACTEFASDATLDN
QISHAMHRALGFHETERVVYFKKNIG
>AEA07977|FEATURES|argannot|aminoglycoside|AAC(6')-Iaf|antibiotic inactivation|1
MIYNIINIADSEKNKEDAARILYSAFRGKGKDAWPTLDSAREEIAECIASPNICLGITLD
DRLVGWGGLRPMYETTWELHPLVIDPDYQGNGLGRLLLSKIESTATTNRIIGIMLGTDDE
TLSTSLSMTDIDESNIFQEIKNIINIKNHPFEFYKKCGYIIVGIVPNANGYRKPDIWMWK
NLEKKSG
>AAB59083.4|FEATURES|argannot|aminoglycoside|Ant3Ia|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>AAV49760|FEATURES|argannot|aminoglycoside|aadA12|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>CAI57696|FEATURES|argannot|aminoglycoside|aadA14|antibiotic inactivation|1
MTNKPPESIAEQVSEARSILENHLETIQAIHLFGSAVDGGLKPFSDIDLLVTVGTPLNES
TRAALMSDLLAVSAFPGTDSKRRALEVTVLTQEDVVPWRYPAKRQMQFGEWLRDDINARI
FEPALMDHDLAILLTKVRRHSVALYGPAAHEFFDEIPVVDVQRSLLETLTLWTTEADWKG
DERNIVLALVRIWYTAMTGEITSKVAAADWALQRLPREIKSVVIAARDAYLGLEAADLAA
YPKERADLRNHIHSSVTAKLQ
>CBH51824.1|FEATURES|argannot|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
MKMRTEKQIYDTILNFAKADDRIRVVTLEGSRTNINIIPDDFQDYDITFFVTDMQSFINS
DEWLNVFGERLIMQKPEDMELFPKEEKGYSYLMLFWDGVKIDLTLLPLEVLDEYFTWDKL
VKLLLDKDNRVTNIPVPTDEDYYIEHPTARSFDDCCNEFWNTVTYVVKGLCRKEILFAID
HLNNIVRMELLRMISWKVGIEQGYSFSLGKNYKFLERYISPELWKKILATYNMGSYTEMW
KSLELCMGIFRMVSKEVAQCLNYLYPDYDKNISNYVIRQKEKYQR
>CAA27061|FEATURES|argannot|aminoglycoside|APH(3')-IVa|antibiotic inactivation|1
MNESTRNWPEELLELLGQTELTVNKIGYSGDHVYHVKEYRGTPAFLKIAPSVWWRTLRPE
IEALAWLDGKLPVPKILYTAEHGGMDYLLMEALGGKDGSHETIQAKRKLFVKLYAEGLRS
VHGLDIRECPLSNGLEKKLRDAKRIVDESLVDPADIKEEYDCTPEELYGLLLESKPVTED
LVFAHGDYCAPNLIIDGEKLSGFIDLGRAGVADRYQDISLAIRSLRHDYGDDRYKALFLE
LYGLDGLDEDKVRYYIRLDEFF
>AAX82592|FEATURES|argannot|aminoglycoside|APH(6)-Ia|antibiotic inactivation|1
MSSSDHIHVPDGLAESYSRSGGEEGRAWIAGLPALVARCVDRWELKRDGGVRSGEASLVV
PVLRADGTRAALKLQMPREETTAALIGLRAWGGDGMVRLLDHDEESSTMLLERLDGSRTL
ASVEDDDEAMGVLAGLLNRLHSVPAPPGLRGLGEIAGAMVEEVPSAVDSLADPEDRSRLR
GWASAVAELVGEPGDRVLHWDLHYENVLAAEREPWLAIDPEPLVGDPGFDLWPALDTGWE
RIEATGDARRVVRRRFDLLTEALELDRGRAAGWTLARLLQNTLWDIEDGLTAIAPSQIAV
AEALAKP
>CAA29136|FEATURES|argannot|aminoglycoside|APH(6)-Ib|antibiotic inactivation|1
MSTSKLVEIPEPLAASYARAFGEEGQAWIAALPALVEELLDRWELTADGASASGEASLVL
PVLRTDGTRAVLKLQLPREETSAAITGLRTWNGHGVVRLLDHDPRSSTMLLERLDASRTL
ASVEDDDAAMGVLAGLLARLVSVPAPRGLRGLGDIAGAMLEEVPRAVAALADPADRRLLN
DWASAVAELVGEPGDRMLHWDLHYGNVLAAEREPWLAIDPEPLAGDPGFDLWPALDSRWD
DIVAQRDVVRVVRRRFDLLTEVLGLDRARAAGWTYGRLLQNALWDIEDGSAALDPAAVTL
AQALRGH
>CBL58181.1|FEATURES|argannot|aminoglycoside|apmA|antibiotic inactivation|0
MKTRLEQVLERYLNGREVAVWGVPTRRLLRALKPFKFHTADRVDPQYHYVVAVTDDDLTD
FLSDEQSKSFQYANDYLTFDDEGGELPFERMCFNVPVGRQTYFGDGVVGACENGYIKSIG
QFTSINGTAEIHANHQLNMTFVSDDIQNFFNEESMAVFQEKLRKDPKHPYAYSKEPMTIG
SDVYIGAHAFINASTVTSIGDGAIIGSGAVVLENVPPFAVVVGVPARIKRYRFSKEMIET
LLRVKWWDWSIEEINENVDALISPELFMKKYGSL
>AGE00988|FEATURES|argannot|aminoglycoside|rmtG|antibiotic target alteration|1
MRDPLFEKLAASKKYRDVCPDTIARILTECRAKYRREKEIDKAAREKLHGITAAFMTDAE
YRRAMEIAVRGGELAELMECHASTRERLPLEETDAVYARLLGAPDESALDLACGLNPAYL
QNRYPEMRVTGIDISGQCVRVLRALGVDARLGDLLAENAIPRARYSVALLFKILPLLDRQ
SAGAARRILEAVNADALICSFPTRSLSGRNVGMAVHYAAWMRDQLPEKWRIERTVETDNE
LYYVLKEKQDGEAVRGGDSHRESE
>CAA88265.1|FEATURES|argannot|aminoglycoside|sat-3|antibiotic inactivation|0
MTPQSMRELVICRASDADVLQLARCDFSFEVTAELEEPFDDMRSVPVKPPYLKNYGFDAD
ELVEHMNNSAGALFVARADNCLVGYLAVSQSWNEYAVIDDIAVDVPYRGSGVSRLLMDAA
VDWARNVPSAGVRLETQSVNLAACRFYRRYGFRLGGYDRYLYRGLHPGSREVALFWYLSF
>AAK68631|FEATURES|argannot|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSVSSRFPPEVTAWMERWRLLRDGELLTTHSSWILPVRQGDMPAMLKVARIPDEEAGYRL
LTWWDGQGAARVFASAAGALLMERASGAGDLAQIAWSGQDDEACRILCDTAARLHAPRSG
PPPDLHPLQEWFQPLFRLAAEHAALAPAASVARQLLAAPREVCPLHGDLHHENVLDFGDR
GWLAIDPHGLLGERTFDYANIFTNPDLSDPGRPLAILPGRLEARLSIVVATTGFEPERLL
RWIIAWTGLSAAWFIGDGDGEGEGAAIDLAVNAMARRLLD
>CAA63519.1|FEATURES|argannot|aminoglycoside|str|antibiotic inactivation|1
MRTEKEILNLVSEFAYQRSNVKIIALEGSRTNENIKKDKFQDYDFAFFVSDIECFTHEES
WLSLFGELLFIQKPEDMELFPPDLDYGYSYIMYFKDGIKMDITLINLKDLNRYFSDSDGL
VKILVDKDNLVIQEIVPDDSNYWLKKPTEREFYDCCNEFWSVSTYVAKGVFRREILFALD
HFNNILRPELLRMISWYIGFNRGFDFSLGKNYKFINKYLTDKEFNMFLATFEMNGYRKTY
QSFKLCCELFKYYSNKVSCLGNYNYPNYEKNIENFIRNNYEN
>AKP24021.1|FEATURES|argannot|aminoglycoside|aph(3'')-Ib|antibiotic inactivation|1
MGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVE
RELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANA
EENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG
>BAJ42218.1|FEATURES|argannot|beta_lactam|CMY-34|antibiotic inactivation|1
LKRSLLFSAVLCAASLTSVHAAQPITEPEFASDIVDRYADHIFYGSGATGMALVVIDGNQ
RVFRSYGETRPGNNVRPQLDSVVRIASLTKLMTSEMLVKLLDQGTVKLNDPLSKYAPPGA
RVPTYNGTPITLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWKYLSTAKLKAAPGSQ
AAYSNLAFDLLADALANASGKPYTQLFEEQITRPLGMKDTTYTPSPDQCRRLMVAERGAS
PCNNTLAAIGSGGVYSTPGDMMRWMQQYLSSDFYQRSNQADRMQTLIYQRAQFTKVIGMD
VPGKADALGLGWVYMAPKEGRPGIIQKTGGGGGFITYMAMIPQKNIGAFVVVTRSPLTRF
KNMSDGINDLVTELSGNKPLVIPAS
>AAF04736|FEATURES|argannot|beta_lactam|pbp1b|antibiotic target alteration|0
MQNQLNELKRKMLEFFQQKQKNKKSARPGKKGSSTKKSKTLDKSAIFPAILLSIKALFNL
LFVLGFLGGMLGAGIALGYGVALFDKVRVPQTEELVNQVKDISSISEITYSDGTVIASIE
SDLLRTSISSEQISENLKKAIIATEDEHFKEHKGVVPKAVIRATLGKFVGLGSSSGGSTL
TQQLIKQQVVGDAPTLARKAAEIVDALALERAMNKDEILTTYLNVAPFGRNNKGQNIAGA
RQAAEGIFGVDASQLTVPQAAFLAGLPQSPITYSPYENTGELKSDEDLEIGLRRAKAVLY
SMYRTGALSKDEYSQYKDYDLKQDFLPSGTVTGISRDYLYFTTLAEAQERMYDYLAQRDN
VSAKELKNEATQKFYRDLAAKEIENGGYKITTTIDQKIHSAMQSAVADYGYLLDDGTGRV
EVGNVLMDNQTGAILGFVGGRNYQENQNNHAFDTKRSPASTTKPLLAYGIAIDQGLMGSE
TILSNYPTNFANGNPIMYANSKGTGMMTLGEALNYSWNIPAYWTYRMLRENGVDVKGYME
KMGYEIPEYGIESLPMGGGIEVTVAQHTNGYQTLANNGVYHQKHVISKIEAADGRVVYEY
QDKPVQVYSKATATIMQGLLREVLSSRVTTTFKSNLTSLNPTLANADWIGKTGTTNQDEN
MWLMLSTPRLTLGGWIGHDDNHSLSRRAGYSNNSNYMAHLVNAIQQASPSIWGNERFALD
PSVVKSEVLKSTGQKPGKVSVEGKEVEVTGSTVTSYWANKSGAPATSYRFAIGGSDADYQ
NAWSSIVGSLPTPSSSSSSSSSSSDSSNSSTTRPSSSRARR
>AFH19307|FEATURES|argannot|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVDAAWQILNALQ
>CAB46491.1|FEATURES|argannot|beta_lactam|ACC-1|antibiotic inactivation|1
MQNTLKLLSVITCLAATVQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVTVNGK
NYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYVPELR
GSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIGTGLL
GMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNMEILG
NEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWEQLPY
PVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVM
LANKNYSIDQRVTVAYKILSSLEGNK
>AAF86691.1|FEATURES|argannot|beta_lactam|ACC-2|antibiotic inactivation|1
MRKKMQNTLKLLSVITCLAATAQGAMAANIDESKIKDTVDGLIQPLMQKNNIPGMSVAVT
IRGRNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAAILASYAQASGKLSLEQSVSHYV
PELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMTYLKAWKPADAAGTHRVYSNIG
TGLLGMIAAKSLGVSYEDAIEQTILPLLGMNQTYLKVPADQMENYAWGYNKKDEPVHVNM
EILGNEAYGIKTTSSDLLRYVQANMGQLKLDGNAKIQHALTATHTGYFKSGEITQDLMWE
QLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVMLANKNYSIDQRVTVAYKILSSLEVNK
>CCK86740.1|FEATURES|argannot|beta_lactam|ACC-5|antibiotic inactivation|1
MQNTLKLLSVITCLAATAQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVTVNGK
NYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQLSGKLSLDQSVSHYVPELR
GSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIGTGLL
GMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNMEILG
NEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWEQLPY
PVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVM
LANKNYSIDQRVTVAYKILSSLEGNK
>CAC85157|FEATURES|argannot|beta_lactam|ACT-4|antibiotic inactivation|1
MMTKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVADNASLLRFYQNWQPQWKPGTTRLYANTSIGLFGA
LAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMVNMKPDSLQDNSLRQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILSALQ
>ACJ05689|FEATURES|argannot|beta_lactam|ACT-5|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPFEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGMKTNVQDMANWVMANMAPENVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYPILDALQ
>CAJ19604|FEATURES|argannot|beta_lactam|OKP-A-7|antibiotic inactivation|1
MRCVRLCLISLIAALPLAVFASPQPLEQITLSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDERLDRRIRYPQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPAAMAERNQQIAKIGAALIEHWQR
>CAP12353|FEATURES|argannot|beta_lactam|OKP-A-11|antibiotic inactivation|1
MRYVRLCLISLIAALPLAAFASPPPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>CAP12354.2|FEATURES|argannot|beta_lactam|OKP-A-12|antibiotic inactivation|1
MRYVRLCLISLIAALPLAAFASPQPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>ACL68096|FEATURES|argannot|beta_lactam|OKP-A-13|antibiotic inactivation|1
MRYIRLCLFSLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>CAJ19619|FEATURES|argannot|beta_lactam|OKP-B-10|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
NMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAVIGAALIEHWQR
>AAZ79403|FEATURES|argannot|beta_lactam|blaOKP-B-14|antibiotic inactivation|1
MRYVCLCLISLVAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNEQIAGIGAALIEHWQR
>AEX08599|FEATURES|argannot|beta_lactam|NDM-6|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASVRAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AAU10324|FEATURES|argannot|beta_lactam|CF70_016075|antibiotic inactivation|1
MNVILNRRTFLLASAVVSASYSLGTLAGANRDDASFQDRLAKLEQQLNGRLGVCAIDTAN
GAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLTYTRADLVTYSPVTEKHVS
TGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIP
GDPRDTSTPQAMAMSLQRLALGDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDK
TGTGDYGSANDVAILWPPRRAPVVLALYSALENQQAEARNDVLADAARIVAEWVTG
>AAD22636|FEATURES|argannot|beta_lactam|MIR-1|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHFAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>ABQ57390|FEATURES|argannot|beta_lactam|MIR-2|antibiotic inactivation|1
LSCALLLSVTSAAFAAPMSETQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHYFTFGK
ADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQWQSIR
MLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKP
SGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEAYGVKT
NVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVG
GSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYP
NPARVEA
>BAA02563|FEATURES|argannot|beta_lactam|MOX-1|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGASVSEQTLFEIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSVFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLAFVKANIGGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVILEANPTAAPRESGSQVLFNKTGSSNGFGAYVAFVPARGIGIVMLA
NRNYPIPARVKAAHAILAQLAG
>CAB82578|FEATURES|argannot|beta_lactam|MOX-2|antibiotic inactivation|1
MQQRQSILWGALATLMWAGLAHAGETSPVDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIG
LFGHLAASSMKQPFAQLMEQTLLPGLGLHHTYVNVPKQAMASYAYGYSKEDKPIRVSPGM
LADEAYGIKTSSADLLRFVKANISGVHDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VSEQTLLAGNSAKVILEANPTAAPRESGSQMLFNKTGSTSGFGAYVAFVPAKGIGIVMLA
NRNYPIPARVKAAHAILTQLAR
>AAT90846|FEATURES|argannot|beta_lactam|SLB-1|antibiotic inactivation|1
MLSLPSYSHEVEPTSTTIQSVTSSLEGQLSISKLADGVYLHHSYKNVSNFGLVEANGLVV
IKDKQAFIIDTPWTDNDTQKLVDWITQQGFIPVASISTHSHQDRAGGIGYLNRQGITTTV
SETTQQILTENDKTTAKSTFTGMQYIMKTDLVEVYDLGAGHTKDNLVVWLPTQQILFGGC
LIKSLNSSTLGYTGEADLQQWPLTIAKVQAQFPQVKIVVPGHGQVGDKALLEHTIELLIP
KNETVNSSS
>BAL14456|FEATURES|argannot|beta_lactam|SMB-1|antibiotic inactivation|1
MKIIASLILAAFASVAQAQDRDWSSPQQPFTIYGNTHYVGTGGISAVLLSSPQGHILVDG
TTEKGAQVVAANIRAMGFKLSDVKYILSTHSHEDHAGGISAMQKLTGATVLAGAANVDTL
RTGVSPKSDPQFGSLSNFPGSAKVRAVADGELVKLGPLAVKAHATPGHTEGGITWTWQSC
EQGKCKDVVFADSLTAVSADSYRFSDHPEVVASLRGSFEAVEKLSCDIAIAAHPEVNDMW
TRQQRAAKEGNSAYVDNGACRAIAAAGRKRLETRLASEKR
>AAK83220|FEATURES|argannot|beta_lactam|blaRAHN-1|antibiotic inactivation|1
MMKNTLRKTALMAAAVVPMLAFSAASWAQTATKMTSVQQQLTALEKESGGRLGVMLIDTA
DNSQIAYRADERFAMCSTSKFMAASAILKESEVKKNLLTQHVALKQSDLVNYNPITEKHL
NDGMTIGELAAAALQYSDNAAMNKLIEHLGGPHKVTDYARTLGDKTFRLDRTEPTLNTAI
PGDDRDTTSPRAMALSLQHATLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGD
KTGSGDYGTTNDIAVIWPENKAPLVLVTYFTQPEKDAKSRRDVLASAAKIVTQGY
>CAA63714|FEATURES|argannot|beta_lactam|PER-2|antibiotic inactivation|1
MNVITKCVFTASALLMLGLSSFVVSAQSPLLKEQIETIVTGKKATVGVAVWGPDDLEPLL
LNPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQSVTVNRAAVLQNTWSPMMKDHQGDEF
TVAVQQLLQYSVSHSDNVACDLLFELVGGPQALHAYIQSLGVKEAAVVANEAQMHADDQV
QYQNWTSMKAAAQVLQKFEQKKQLSETSQALLWKWMVETTTGPQRLKGLLPAGTIVAHKT
GTSGVRAGKTAATNDAGVIMLPDGRPLLVAVFVKDSAESERTNEAIIAQVAQAAYQFELK
KLSAVSPD
>ACE77058|FEATURES|argannot|beta_lactam|PER-4|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEF
SVPVQQLLQYSVSHTDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELK
KLSALSPN
>AEA73285|FEATURES|argannot|beta_lactam|KPC-13|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLGTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDCWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAAGLALEGLGVNGQ
>AGF70638|FEATURES|argannot|beta_lactam|KPC-15|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVRWSPISEKYLTTGMTVLE
LSAAAVQYSDNAAANLLLKELGGPAKLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGGY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>AGJ01153|FEATURES|argannot|beta_lactam|KPC-16|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAASQRQQLVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>CAB75346|FEATURES|argannot|beta_lactam|L1|antibiotic inactivation|1
MRSTLLAFALSSLALAATLFTFDGAAADASLPQLQAYTVDPSWLQTMAPLQIADHTWQIG
THDLTALLVQTADGLVLIDGGMPQMASYLLTNMKARGTNTGPLRMVLLSHAHTDHAGPVA
EIKRRTGAQVVVNAETAVLLARGGSDDLHFGDEITFPPVNADRIVMDREVVKLGGIAFTA
HFMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVR
GLPCDLLLTPHPGASNWNYAAGSNASEKVLSCKAYADAAEKKFDAQLAKETAGAR
>CAA55007|FEATURES|argannot|beta_lactam|LAT-1|antibiotic inactivation|1
MMKKSLCSALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDCIARGEIKLSDPVTKYWPELTGKK
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGRLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABO21411|FEATURES|argannot|beta_lactam|IND-7|antibiotic inactivation|1
MKKSIRFFIVSILLSPFASAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSMYLVTKK
GVVLFDVPWEKVQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNNKGIKTYATAK
TNEFLKKDGKATSTEIIKIGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSNSATDLGYIKEANVEQWPKTINKLKAKYSKATLIIPGHDEWKGGGHVEHTLELLNKK
>BAD26594|FEATURES|argannot|beta_lactam|IMP-2|antibiotic inactivation|1
MKKLFVLCVCFLCSITAAGARLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYVKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESKK
PSQPSN
>BAA77393|FEATURES|argannot|beta_lactam|IMP-3|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIGWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPGHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>AER27704|FEATURES|argannot|beta_lactam|IMP-13|antibiotic inactivation|1
MKKLFVLCVCFFCSITAAGAALPDLKIEKLEEGVFVHTSFEEVNGWGVVTKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYEIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKSGKVQAKYSFSEVSYWLVKNKIEVFYPGPGHTQDNLVVWLPESKILFGGCFIKP
HGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEKGDASLMKRTWEQALKGLKESKK
TSSPSN
>BAD89185|FEATURES|argannot|beta_lactam|IMP-19|antibiotic inactivation|1
MKKLFVLCVCFLCSITAAGAALPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYVKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESKK
PSQPSN
>ABM68358|FEATURES|argannot|beta_lactam|IMP-24|antibiotic inactivation|1
MKKLFVLCVCFLCSITAAGAALPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESRK
PSQPSN
>AEU17778|FEATURES|argannot|beta_lactam|IMP-33|antibiotic inactivation|1
MKKLFVLCVCFFCSITAAGSSLPDLKIEKLEEGVFVHTSFEEVNGWGVVTKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKSGKVQAKYSFSEVSYWLVKNKIEVFYPGPGHTQDNLVVWLPESKILFGGCFVKP
HGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEKGDASLLKRTWEQALKGLKESKK
TSSPSN
>BAA08930.1|FEATURES|argannot|beta_lactam|IMP-1|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>BAM62795|FEATURES|argannot|beta_lactam|IMP-41|antibiotic inactivation|1
MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVFSKHGLVVLVNT
DAYLIDTPFTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKP
YGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLNESKK
SNTVH
>BAM62793|FEATURES|argannot|beta_lactam|IMP-42|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNRWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>BAQ56016|FEATURES|argannot|beta_lactam|IMP-51|antibiotic inactivation|1
MKKLSVFFMFLFCSIAASGEALPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
DAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGASYWLVKKKIEIFYPGPGHTPDNVVVWLPEHRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLVSKYGKAKLVVPGHSEVGDASLLKRTLEQAVKGLNESKK
LSKPSN
>AIY69088|FEATURES|argannot|beta_lactam|bla(IMI-8)|antibiotic inactivation|1
MSINAKKSKAAVFLSYFLIPISFYSQADTNAMDEIKKLETGFGGRVGVYALDTGSGKSFS
YRANERFPLCSSFKGFLAAAVLKGSQDNQLNINEIVNYNKRSLEPHSPITQKYKENGMSL
GDMAAAALQYSDNGAANIILERYIGGPEGMTNFMRSIGDEDFRLDRWELDLNTAIPGDER
DTSTPAAVGKSLKNLALGNILNDHEKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGTC
GAYGTANDYAVVWPKNRAPLIISVYTTKSEKEAKHDEKVIEEASRIAITHLK
>AAF89147|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
KEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESLPIIKANI
QKLGFNYKDIKILLLTQAHYDHTGALQDLKTETGAKFYADKADADVLRTGGNSDYEMGKY
GVTFKPVTPDKTLKDQDKITLGNTILTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMP
SIIVDKKFSEVTAYLNIQSDYAYTFKAMKNLDFDLWVASHASQFDLHEKRKEGDPYNPQL
FMDKQSYFQNLN
>ACZ72746|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFAILFFLLITFSWKAQVVKEPENTNEEWSRSYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGLAGSLPMIKENIKKLGFNYKDIKILLLTQAHYDHTGALKDLQTETGAKFYA
DSADADVLKTGGKSDYEMGKYGATFKPIKPDILLKDQDKIKLGNTTLTLLHHPGHTKGSC
SFIFETKDENRNYKVLIANMPSVIVDRKFSEIKDYPNIQADYAYTFKAMKKLDFDLWVAS
HASQFDLHTKHKEGDPYNPQVFMDKANYFAFLNSLETDYLEKIKNDSQKK
>AAY53478|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFMFICLGLSAQVVKEPENMPKEWNQAYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESFPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETAAKFYV
DKADVDVLRTGGKSDYEMGKYGVTFKPVTPDKTLKDQDKIKLGNITLTLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFGVMKKLDFDIWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLNKIKKDSQDK
>AIY26289|FEATURES|argannot|beta_lactam|GIM-2|antibiotic inactivation|1
MKNVLVFLILLVALPALAQGHKPLEVIKIEDGVYLHTSFKNIEGYGLVDSNGLVVLDNNQ
AYIIDTPWSEEDTKLLLSWATDRGYQVMASISTHSHGDRTAGIKLLNSKSIPTYTSELTK
KLLAREGKPVPTHYFKDDEFTLGNGLIELYYPGAGHTEDNIVAWLPKSKILFGGCLVRSH
EWEGLGYVGDASISSWADSIKNIVSKKYPIQMVVPGHGKVGSSDILDHTIDLAESASNKL
MQPTAEASAD
>AAK58421|FEATURES|argannot|beta_lactam|GES-2|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMNDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AAR97271|FEATURES|argannot|beta_lactam|GES-6|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>CBG22732|FEATURES|argannot|beta_lactam|GES-12|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGACANGARND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AEZ05108.1|FEATURES|argannot|beta_lactam|GES-20|antibiotic inactivation|1
MRFIHALLLAAIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>CAB89086|FEATURES|argannot|beta_lactam|FOX-4|antibiotic inactivation|1
MQQRRALALLMLGSLLLAPCTYASGEAPLTATVDGIIQPMLKAYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRATPGVLAA
EAYGIKTGSADLLKFVEANMGYQGDAALKSAIALTHTGFHSVGEMTQGLGWESYDYPVTE
QVLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>ADK73994|FEATURES|argannot|beta_lactam|FOX-8|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYASGEAPLTATVDGIIQPMLKEYRIPGIAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFVLDDKVSQHAPWLKGS
ALDGVTMAELATYSAGGLPLQFPDKVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRVTPGVLAA
EAYGIKTGSADLLKFAEANMGYQGDALVKSAIALTHTGFYSVGEMTQGLGWESYDYPVTE
QVLLAGNSPAVSLQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>AAB81957|FEATURES|argannot|beta_lactam|BSONL12_02412|antibiotic inactivation|1
MAAAAAIALLGGCGADAGSEPATTAASTTAPSTATDAATAEFAALEQRSGARLGVYAVDT
TSGAEVAYRADERFGMASTFKGLACGALLREHPLSSGYFDQVVRYSREEVVSYSPVTETR
VDTGMTVAELCHATITVSDNTAGNQILKLLGGPAGFTAFLRSLGDEVSRLDRWETELNEV
PPGEERDTTTPAAVAANYRALVLGDVLAEPERAQLRDWLVANTTGDQRIRAGVPAGWTVG
DKTGGGSHGGNNDVAVAWTETGDPIVIALLSHRTDPAAKADNALLAEATRAVVTALR
>AAL86999|FEATURES|argannot|beta_lactam|CTX-M-105|antibiotic inactivation|1
MTILLQRRQLLVAGAALALTASLTPLNVFAAGDSLQRQLAALETEVNGRIGLSLIDSASQ
QAWSYRGDERFPLCSTFKLLLVAAVLKRSESQPALMQQTLHWTPADHLSYMPVTAKHPQG
MTVSDLCAAALQYSDNLAANVLLTLLGGPASVTRLARSLGDSVTQLDRNEPTLNTAIPGD
PRDTTTPLHMSHSVQQLLVKSGLQTAQQQQLIAWLKGNTTGKNAIAAALPAGWEIGDKTG
SGGYGTTNDVAILWPPGKAPLILAIYFTQHAPEAKSRQDVLAKAAAIALKSVI
>AAN32638|FEATURES|argannot|beta_lactam|EBR-1|antibiotic inactivation|1
MKKLFSLIALIGSFAFGQIKPIQIDPINNNLFVYQTFNSFNGVEYNANGMYLVTNKGIVL
FDVPWQKSQYQELNDMLQEKYNLPVIAVFATHSHDDRAGDLSFYNELNIPTYATSLTNSK
LKKEGKATSKFEIELGKTYKFGNEKFVFEYFGEGHTSDNVVVWFPKYKVLNGGCLIKGAD
AVNLGYTGEANVVEWPKTVHKLVAKHPTIKQVIPGHDNWKATGHIENTFKLLEKK
>AAG36927|FEATURES|argannot|beta_lactam|DHA-2|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMMLNDPAEKYQPELALPQW
KGITLLDLATYTTGGLPLQVPDAVKNRAELLHFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AQS23610|FEATURES|argannot|beta_lactam|bla(IMI-8)|antibiotic inactivation|1
MFFLKKAQVHLFFFLCLPLNSFASQESNSIEQMRELEAAFGGRIGVYILNTKNGKEFSYR
QDERFPLCSSFKAFLAASVLKKTQDKSVSLDDMMEYSGRVMEKHSPVSEKYRKTGASVRT
LAKAAIQYSDNGASNLLMERYIGGPEGLTAFMRSTGDTDFRLDRWELELNSAIPGDERDT
STPKAVAMSLKNIAFGSVLDAKNKSLLQEWLKGNTTGNARIRAAVPDKWDVGDKTGTCGF
YGTANDVAILWPDANSPAVMAVYTTRPNQNDKHDEAVIKNSAKIAINAVYGSYK
>CAA90891|FEATURES|argannot|beta_lactam|BL2c_pse3|antibiotic inactivation|1
MMQRRHFLQKTLLALPIIFSGNLLTGCKTNLSDDYLPDDKITNNPNLLQNKLKEILPIWE
NKFNAKIGMTIIADNGELSSHRGNEYFPVNSTIKAFIASHILLLVDKEKLDLNEKIIIKE
SDLIEYSPVCKKYFDENKPISISELCEATITLSDNGSANILLDKIGGLTAFNQFLKEIGA
DMVLANNEPLLNRSHYGETSDTAKPIPYTKSLKALIVGNILSNQSKEQLITWLINDKVAD
NLLRKYLPKNWRIGDKTGTGSESKNIIAVIWNENNKPYFISLFITQPHDGKSLGFKNQKD
EIMAQIGKEIYPFL
>AAL55262|FEATURES|argannot|beta_lactam|TLA-2|antibiotic inactivation|1
MKKTTLLFLLISAFSLAQTSLLEQKINSIIKNKKATVGVSVLGFENGFKYDKNGDKKLPM
QSVFKFHIAAAVLNAVDQGKLSLDQKIMLNQSNLLENTWSPLRDKYPAGNIEIPLSEVIE
YTVAKSDNNGCDILLRLLGGTQVVQKFMDSKGVKGFQIKYNEEDMHKDWNVQYENYSTTK
SAADVLKKLYDGKLLSKKSTDYLMKVMLSTSTGLNKMVEQLPKNTPVARKTGASGKNNAG
LTGAENEIGIVTLPNGKHYALAVFVSNSMETDAVNCRMISDISKEVWEYFNK
>BAL40895|FEATURES|argannot|beta_lactam|TLA-3|antibiotic inactivation|1
MKKITFLILMVSAFATAQKSVLDEKISAVIKDKKATVGVSVLGFENAFKYSKNGDEKLPL
LSVFKFHLACAVLDMADKGKFSTDQKFLIKKSDLLENTWSPLREKFPEGNIELSLGEIIT
YTVAQSDNNTCDFLLRLIGGPQVVQHFMDSKGAKDLQIKYNEDDMHRDWKNQYGNESSTN
ATVSLLKKFYDGKLLTKKSTDFLMQIMLGTTTGTNKIVEQLPKGTPVAHKTGSSGKPDNI
LTVAENDMGIITLPNGKHYAIAVFVSNSTETEKVNTRMVSDISKIVWDNFNK
>ABY56045|FEATURES|argannot|beta_lactam|BL3_l|antibiotic inactivation|1
VRTLTTLGLALLLAQPAVAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKAEAAFDAQLKKQRGG
>AAP79046|FEATURES|argannot|beta_lactam|blaPLA-6A|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHQATVTTVKQAESQLQGRVGYAELDLASGQLLAGYRSDE
RFPMMSTFKVLLCGAVLSRVDAGEEQLDRRIHYRQQDLVEYSPVTEKHLTDGLTVGELCA
AAITLSDNTAANLLLTTLGGPQGLTSFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPQ
AMARTLRNLLTGRVLSSASQQQLQRWMVEDKVAGPLLRSVLPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTGTPATMDERNKQIAAIGATLIRHWSADENRP
>CAC87665|FEATURES|argannot|beta_lactam|CAU-1|antibiotic inactivation|1
MKRLILAAAASLLALASAAHADDMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGH
VVLDGGPNAETGKLVERNITALGFQLADVKILINTHAHYDHAGGLAQLKADTGAKLWISR
DDAPAMAAGHHIGDNIYGPTPMPAAKPDRSFGDQTKLKLGEIAMVAHLTPGHTIGCTSWT
TAVVEKGRPLTVTFPCSLSVAGNVLVGNKTHRTIVADYRASFAKLRAIPTDVMLPAHEEQ
GNLLAKRQKQLRGDPNAFVDPGELARFVDASEAAFNKELARQQAAGPNR
>AAM63403|FEATURES|argannot|beta_lactam|CEPH-A3|antibiotic inactivation|1
MMKGWIKCTLAGAVVLMASFWGGSVRAAGIELKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAVPQS
>AAR20595|FEATURES|argannot|beta_lactam|BLA1|antibiotic inactivation|1
MIVLKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLE
KKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKE
DLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGDRVT
MSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTKWMKGNATGDKL
IRAGVPTNWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEA
AEVIVNAFR
>CAB96921|FEATURES|argannot|beta_lactam|FEZ-1|antibiotic inactivation|1
MKKVLSLTALMMVLNHSSFAYPMPNPFPPFRIAGNLYYVGTDDLASYLIVTPRGNILINS
DLEANVPMIKASIKKLGFKFSDTKILLISHAHFDHAAGSELIKQQTKAKYMVMDEDVSVI
LSGGKSDFHYANDSSTYFTQSTVDKVLHDGERVELGGTVLTAHLTPGHTRGCTTWTMKLK
DHGKQYQAVIIGSIGVNPGYKLVDNITYPKIAEDYKHSIKVLESMRCDIFLGSHAGMFDL
KNKYVLLQKGQNNPFVDPTGCKNYIEQKANDFYTELKKQETA
>BAE75889|FEATURES|argannot|beta_lactam|mecC|antibiotic target replacement|1
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEV
EMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKED
GMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSK
KDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETES
RNYPLGKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT
IVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFE
KGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENG
NKKYDIDE
>AAP69915|FEATURES|argannot|beta_lactam|cphA6|antibiotic inactivation|1
MMKGWMKCGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTAVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFKLQDGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKEYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEALIKAAAHS
>F7RN35|FEATURES|UNIPROT_deepARG|beta_lactam|SOHN41_01775|antibiotic inactivation|1
MQRHTLLASMPLLSTLLSASLFSNVSVAQDLNVKEMQSLVDSAIKPLMAEFRIPGAVIGI
SIEGKQYFYQYGVSSKTTGQSVTEHTLFEIGSISKTFTATLANYAQIEGKLSLTNMASDY
VPALKGSHFDEISLINLATHTAGDLPMQVPDKVTNNAELMDYLTHWQPSFAAGTHRNYAN
PSIGLLGMIAAQSLDQTFQQALEQTIFPQLGMTSSYIKVPSNKMADYAQGYNKQDMPVRV
NPGVLADEAYGVKTTATDLLQFVEANMKMHPLAKPLQTALDETHTGYFDVGMMTQDMIWE
HYSYPIELDKILAGHTQKVVFGSMPVKPIVPPLAPQQNVWINKTGSTGGFAAYVAFIPAQ
KLGIVLLSNKNYPVPPRVEVGYQILTGIAKLRQE
>ADF36549|FEATURES|argannot|beta_lactam|SPM-1|antibiotic inactivation|1
MNSPKSRALLGFMGAFCLLLVAGAPLSAKSSDHVDLPYNLTATKIDSDVFVVTDRDFYSS
NVLVAKMLDGTVVIVSSPFENLGTQTLMDWVAKTMKPKKVVAINTHFHLDGTGGNEIYKK
MGAETWSSDLTKQLRLEENKKDRIKAAEFYKNEDLKRRILSSHPVPADNVFDLKQGKVFS
FSNELVEVSFPGPAHSPDNVVVYFPKKKLLFGGCMIKPKELGYLGDANVKAWPDSARRLK
KFDAKIVIPGHGEWGGPEMVNKTIKVAEKAVGEMRL
>CAA45828|FEATURES|argannot|beta_lactam|TEM-3|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAW66604|FEATURES|argannot|beta_lactam|TEM-11|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA76795|FEATURES|argannot|beta_lactam|TEM-22|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGGSERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ADC80822|FEATURES|argannot|beta_lactam|TEM-24|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ADL13944|FEATURES|argannot|beta_lactam|TEM-33|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAC32889|FEATURES|argannot|beta_lactam|TEM-43|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAC05975|FEATURES|argannot|beta_lactam|TEM-60|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDPNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMRTTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRCALPAGWLIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAD33116|FEATURES|argannot|beta_lactam|TEM-67|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCIPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
CGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAF19151|FEATURES|argannot|beta_lactam|TEM-72|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAL29434|FEATURES|argannot|beta_lactam|TEM-82|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDEQNRQIAEIGASLIKHW
>CAC43229|FEATURES|argannot|beta_lactam|TEM-85|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>AAK30619|FEATURES|argannot|beta_lactam|TEM-90|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTGGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>BAB16308|FEATURES|argannot|beta_lactam|TEM-91|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDCWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAM52215|FEATURES|argannot|beta_lactam|TEM-107|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAT46413|FEATURES|argannot|beta_lactam|TEM-109|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAS89984|FEATURES|argannot|beta_lactam|TEM-114|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAN05029|FEATURES|argannot|beta_lactam|TEM-118|antibiotic inactivation|1
FFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKV
LLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTA
ANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTMPAAMATTLRKLL
TGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGK
PSRIVVIYMTGSQATMDERNR
>AAS19171|FEATURES|argannot|beta_lactam|TEM-133|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAL08007|FEATURES|argannot|beta_lactam|TEM-137|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGRRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAZ23494|FEATURES|argannot|beta_lactam|TEM-139|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIEMDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABB72432|FEATURES|argannot|beta_lactam|TEM-54|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALLAGWFIADKSGAGERGS
LGIIEALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAJ66089|FEATURES|argannot|beta_lactam|TEM-150|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPDTLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABI74447|FEATURES|argannot|beta_lactam|TEM-152|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>AGA83484|FEATURES|argannot|beta_lactam|TEM-153|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTVSQATMDERNRQIAEIGASLIKHW
>ABI81768|FEATURES|argannot|beta_lactam|TEM-157|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQSDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABM54869|FEATURES|argannot|beta_lactam|TEM-159|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMISTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ACF32746|FEATURES|argannot|beta_lactam|TEM-163|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDEQNRQIAEIGASLIKLW
>ADB90239|FEATURES|argannot|beta_lactam|TEM-176|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSVLPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AEG64812|FEATURES|argannot|beta_lactam|TEM-185|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRREPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AET99222|FEATURES|argannot|beta_lactam|TEM-186|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNNERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AEK48085|FEATURES|argannot|beta_lactam|TEM-197|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AHA80960|FEATURES|argannot|beta_lactam|TEM-211|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMTDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDELNRQIAEIGASLIKHW
>CAO91853|FEATURES|argannot|beta_lactam|blaCMY-2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGLGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AAL16928|FEATURES|argannot|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACC60954|FEATURES|argannot|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEINPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AAS13399|FEATURES|argannot|beta_lactam|CMY-17|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVAFAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABS12248|FEATURES|argannot|beta_lactam|CMY-29|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQFPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGE
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACA97846|FEATURES|argannot|beta_lactam|CMY-32|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPEQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACJ65711|FEATURES|argannot|beta_lactam|CMY-44|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVAPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSY
PNPVRVEAAWRILEKLQ
>CBH19182|FEATURES|argannot|beta_lactam|CMY-46|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPKNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ADP02979|FEATURES|argannot|beta_lactam|CMY-48|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>CBI75447|FEATURES|argannot|beta_lactam|CMY-50|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWCIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ADQ38362|FEATURES|argannot|beta_lactam|CMY-53|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGICLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>ADK55604|FEATURES|argannot|beta_lactam|CMY-54|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLELDA
EAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPL
KADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVM
LANKSYPNPVRVEAAWRILEKLQ
>ADY19254|FEATURES|argannot|beta_lactam|CMY-58|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YCVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AEM97672|FEATURES|argannot|beta_lactam|CMY-60|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFIGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFU25635|FEATURES|argannot|beta_lactam|CMY-70|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMSKRVLHPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMTRWVQANMDASQVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFU25641|FEATURES|argannot|beta_lactam|CMY-72|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AFU25644|FEATURES|argannot|beta_lactam|CMY-77|antibiotic inactivation|1
MMKKSLCCALLLTAPLSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AJH76980|FEATURES|argannot|beta_lactam|blaCMY-106|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVTPGQLDAEA
YGVKSNVTDMARWIQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPTPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AIT76099|FEATURES|argannot|beta_lactam|CMY-114|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDYVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AIT76092|FEATURES|argannot|beta_lactam|CMY-115|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYKGKPYY
FTWGKADIANNHPVTQHTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMAHWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AIT76093|FEATURES|argannot|beta_lactam|CMY-116|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPVPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AIT76097|FEATURES|argannot|beta_lactam|CMY-117|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHAQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPVPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AIT76091|FEATURES|argannot|beta_lactam|CMY-118|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AKG51729|FEATURES|argannot|beta_lactam|blaCMY-131|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGE
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPRQLGAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AAG29813|FEATURES|argannot|beta_lactam|SME-2|antibiotic inactivation|1
MSNKVNFKTASFLFSVCLALSAFNAHANKSDAAAKQIKKLEEDFDGRIGVFAIDTGSGNT
FGYRSDERFPLCSSFKGFLAAAVLERVQQKKLDINQKVKYESRDLEYHSPITTKYKGSGM
TLGDMASAALQYSDNGATNIIMERFLGGPEGMTKFMRSIGDNEFRLDRWELELNTAIPGD
KRDTSTPKAVANSLNKLALGNVLNAKEKAIYQNWLKGNTTGDARIRASVPADWVVGDKTG
SCGAYGTANDYAVIWPKNRAPLIVSIYTTRKSKDDKHSDKTIAEASRIAIQAID
>AAS92558|FEATURES|argannot|beta_lactam|SME-3|antibiotic inactivation|1
MSNKVNFKTASFLFSVCLALSAFNAHANKSDAAAKQIKKLEEDFDGRIGVFAIDTGSGNT
FGYRSDERFPLCSSFKGFLAAAVLERVQQKKLDINQKVKYESRDLEYYSPITTKYKGSGM
TLGDMASAALQYSDNGATNIIMERFLGGPEGMTKFMRSIGDNEFRLDRWELELNTAIPGD
KRDTSTPKAVANSLNKLALGNVLNAKVKAIYQNWLKGNTTGDARIRASVPADWVVGDKTG
SCGAYGTANDYAVIWPKNRAPLIVSIYTTRKSKDDKHSDKTIAEASRIAIQAID
>AHV85514|FEATURES|argannot|beta_lactam|SME-5|antibiotic inactivation|1
MSNKVNFKTASFLFSVCLALSAFNAHANKSDAAAKQIKKLEEDFDGRIGVFAIDTGSGNT
FGYRSDERFPLCSSFKGFLAAAVLERVQQKKLDINQKVKYESRDLEYHSPITPKYKGSGM
TLGDMASAALQYSDNGATNIIMERFLGGPEGMTKFMRSIGDNEFRLDRWELELNTAIPGD
KRDTSTPKAVANSLNKLALGNVLNAKVKAIYQNWLKGNTTGDARIRASVPADWVVGDKTG
SCGAYGTANDYAVIWPKNRAPLIVSIYTTRKSKDDKHSDKTIAEASRIAIQAID
>AAB51384|FEATURES|argannot|beta_lactam|SHV-8|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARNTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAG17550|FEATURES|argannot|beta_lactam|SHV-14|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACG63555|FEATURES|argannot|beta_lactam|SHV-18|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAAKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAT75225|FEATURES|argannot|beta_lactam|SHV-30|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AEK48091|FEATURES|argannot|beta_lactam|SHV-45|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGA
>AAO53445|FEATURES|argannot|beta_lactam|SHV-46|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLNSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAI30650|FEATURES|argannot|beta_lactam|SHV-61|antibiotic inactivation|1
MRYIRRCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47126|FEATURES|argannot|beta_lactam|SHV-71|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKYLADGMTVGELCA
AAITMSDNSAANLLLATVGGPVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACO07070|FEATURES|argannot|beta_lactam|SHV-78|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASSRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47135|FEATURES|argannot|beta_lactam|SHV-80|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPTGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABS72351|FEATURES|argannot|beta_lactam|UUU_18620|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNRAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AEK48093|FEATURES|argannot|beta_lactam|SHV-110|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AEG79634|FEATURES|argannot|beta_lactam|SHV-120|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ADU15837|FEATURES|argannot|beta_lactam|UUU_18620|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMLSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AEK80394|FEATURES|argannot|beta_lactam|SHV-140|antibiotic inactivation|1
KRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYSQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFK93491|FEATURES|argannot|beta_lactam|SHV-144|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23955|FEATURES|argannot|beta_lactam|SHV-149|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESRLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTASLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23956|FEATURES|argannot|beta_lactam|SHV-150|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVVLLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23958|FEATURES|argannot|beta_lactam|SHV-152|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTARRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>BAM28879|FEATURES|argannot|beta_lactam|SHV-167|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDADDEQLERKIHYRQQDLVDYSPVSEKYLADGMTVGELCA
AAITMSDNSAANLLLATVGGPVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIE
>CAI43414|FEATURES|argannot|beta_lactam|OXY-2-1|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFAHSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>AAL17873|FEATURES|argannot|beta_lactam|OXY-2-8|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>ACV44455|FEATURES|argannot|beta_lactam|OXY-2-9|antibiotic inactivation|1
MIKSSWRKIAMLAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQIL
YRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTL
AELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERD
TSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGTGD
YGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>ACV44456|FEATURES|argannot|beta_lactam|OXY-2-10|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKNRKEVLAAATKIVTEGL
>AAN28732|FEATURES|argannot|beta_lactam|OXY-3-1|antibiotic inactivation|1
MIKTSWRKSALIAAALPLLLCSSSLWANAIQQKLADLEKSTGGRLGVALIDTTDNSQILY
RGDERFAMCSTGKVMAAAAVLKQSESNKDVVNKRLEIKASDLVVWSPVTEKHLQSGMTLA
ELSAAALQYSDNTAMNKMIGYLGGPEKVTAFARSIGDVTFRLDRTEPALNTAIPGDERDT
TTPLAMAESLHKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGAGDY
GTTNDIAVIWPENHAPLVLVTYFTQPLQDAKSRKDVLAAAAKIVTEGL
>AAL78161|FEATURES|argannot|beta_lactam|OXY-4-1|antibiotic inactivation|1
MLKSSWRKSALMAAAVPLLLASGSLWASADTLQQKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKIIGYLGGPEKVTAFAQSIGDVTFRLDRMEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGGG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>ADI82851.1|FEATURES|argannot|beta_lactam|OXA-2|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>AAC41449|FEATURES|argannot|beta_lactam|OXA-3|antibiotic inactivation|1
MAIRIFAILFSTFVFGTFAHAQEGMRERSDWRKFFSEFQAKGTIVVADERQTDRVILVFD
QVRSEKRYSPASTFKIPHTLFALDAGAARDEFQVFRWDGIKRSFAAHNQDQDLRSAMRNS
TVWIYELFAKEIGEDKARRYLKQIDYGNADPSTSNGDYWIDGNLAIAAQEQIAFLRKLYH
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRIGWWVGWVEWPTGPVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>ABI63579|FEATURES|argannot|beta_lactam|OXA-256|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>ABF70511|FEATURES|argannot|beta_lactam|OXA-21|antibiotic inactivation|1
MAIRIFAILFSTFVFGTFAHAQEGMRERSDWRKFFSEFQAKGTIVVADERQTDRVILVFD
QVRSEKRYSPASTFKIPHTLFALDAGAARDEFQVFRWDGIKRSFAAHNQDQDLRSAMRNS
TVWIYELFAKEIGEDKARRYLKQIDYGNADPSTSNGDYWIDGNLAIAAQEQIAFLRKLYH
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGPVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>CAD32564|FEATURES|argannot|beta_lactam|OXA-42|antibiotic inactivation|1
MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLVQDGDCGRRASPASTFKIAIS
LMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQR
FAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQISPLEQLEFLGKMLNRKLPVSPTAV
DMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDWARGSGWFVGWIVRGNQTLVFARLT
QDERKQPVSAGIRTREAFLRDLPRLLAAR
>AAP40270|FEATURES|argannot|beta_lactam|OXA-49|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVERIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAAMDIKPQVGWLTGWVEQPDG
KIVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ABK40505|FEATURES|argannot|beta_lactam|OXA-66|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAW81339|FEATURES|argannot|beta_lactam|OXA-68|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQEVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAW81341|FEATURES|argannot|beta_lactam|OXA-70|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQHEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAW81342|FEATURES|argannot|beta_lactam|OXA-71|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABV71246|FEATURES|argannot|beta_lactam|OXA-79|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGGDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAP69916|FEATURES|argannot|beta_lactam|OXA-85|antibiotic inactivation|1
MLLFMFSIISFGNENQFMKEIFERKGLNGTFVVYDLKNDKIDYYNLDRANERFYPASSFK
IFNTLIGLENGIVKNVDEMFYYYDGSKVFLDSWAKDSNLRYAIKVSQVPAYKKLARELGK
ERMQEGLNKLNYGNKEIGSEIDKFWLEGPLKISAMEQVKLLNLLSQSKLPFKLENQEQVK
DITILEKKDDFILHGKTGWATDNIVVPIGWFVGWIETSDNIYSFAINLDISDSKFLPKRE
EIVREYFKNINVIK
>ABD48715|FEATURES|argannot|beta_lactam|OXA-88|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACD84986|FEATURES|argannot|beta_lactam|OXA-90|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABF47919|FEATURES|argannot|beta_lactam|OXA-96|antibiotic inactivation|1
MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTY
DGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKD
FTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQMGTEVDQFWLKGPLTITPIQ
EVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEK
ADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL
>ABV31688|FEATURES|argannot|beta_lactam|OXA-108|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTTNPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNTDIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACH99105|FEATURES|argannot|beta_lactam|OXA-109|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIQVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABV31691|FEATURES|argannot|beta_lactam|OXA-111|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEMNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABW95047|FEATURES|argannot|beta_lactam|OXA-116|antibiotic inactivation|1
LLITSAIFISACSPYIVSANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIQQGQTQQSYG
NDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTLGDAMKA
SAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLA
NKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFS
LNLEMKKGIPSSVRKEITYKSL
>ACD84988|FEATURES|argannot|beta_lactam|OXA-130|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTTNPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNTDIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABW76134|FEATURES|argannot|beta_lactam|OXA-136|antibiotic inactivation|1
MSKKNFILIFIFVILISCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQ
VPAYKELARRIGLKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQVKLLTKLAQN
ELPYPIEIQKAVSDITILEQTYNYTLHGKTGLADSKNMTTEPIGWFVGWLEENDNIYVFA
LNIDNINSDDLAKRINIVKESLKALNLLK
>ABW76139|FEATURES|argannot|beta_lactam|OXA-137|antibiotic inactivation|1
MSKKNFILIFIFVILTSCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQ
VPAYKELARRIGLKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQIKLLTKLAQN
ELPYPIEIQKAVSDITILEQTYNYTLHGKTGLADSKNMTTEPIGWFVGWLEENDNIYVFA
LNIDNINSDDLAKRINIVKESLKALNLLK
>ADK35869|FEATURES|argannot|beta_lactam|OXA-165|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDVKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ADK35870|FEATURES|argannot|beta_lactam|OXA-166|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGALVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ADK35871|FEATURES|argannot|beta_lactam|OXA-167|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELMMKSLKQLNII
>ADK35874|FEATURES|argannot|beta_lactam|OXA-170|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEKSNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ADI58618|FEATURES|argannot|beta_lactam|OXA-174|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEKLGIL
>ADI58620|FEATURES|argannot|beta_lactam|OXA-176|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDSKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADI58622|FEATURES|argannot|beta_lactam|OXA-178|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDSKKRLFPEWEKDMTL
GDAMKASAILVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEB98922|FEATURES|argannot|beta_lactam|OXA-196|antibiotic inactivation|1
MNIQALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDHARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AFK28473|FEATURES|argannot|beta_lactam|OXA-207|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWVMGVTPQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMSGSIRNEITYKSLENLGII
>AEM66528|FEATURES|argannot|beta_lactam|OXA-209|antibiotic inactivation|1
MKKTFILLNLILLVNLNGYCQTKSLKSNEIVKPEFRNILDSLKVKGAILIYDVKNKTYYS
NDFSWTKTGIIPASTFKIPNSIIALETGIIKNDSTIFKWNGEKRKFKNWEEDLTFKKAFQ
VSCVPCYQEIARKIGVKRMKRYLKKLNYRGMVFDTLTIDQFWLEGESKITQMQQIDFLER
LYFSKFPISDRTIKIVKNIMEIERTENYILSGKTGLSSIEEKYNGWFVGYVETKSNVYFF
ATNVIPTDGLNVDDFISSRINVTKNALKQMNIMK
>CCA94649|FEATURES|argannot|beta_lactam|OXA-216|antibiotic inactivation|1
MNIKALLLITSAISISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAIKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AFM55002|FEATURES|argannot|beta_lactam|OXA-230|antibiotic inactivation|1
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERETEIPLLFNQAQTQAVFVTYDGIHL
KSYGNDLSRAKTEYIPASTFKMLNALIGLQNGKATNTEVFQWNGEKRAFSAWEKDMTLAE
AMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFA
YQLAMKQLPFDRNVQQQVKDMLYIERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKV
TAFALNMNMQAGNDPAERKQLTLSILDKLGLFFYLR
>AFH36332|FEATURES|argannot|beta_lactam|OXA-236|antibiotic inactivation|1
MKTLILLPLLSCLSLTACSLPVSNSSSQITSTQSIQTIAKLFDQAQSSGVLVIQRGPHLQ
VYGNDLSRAHTEYIPASTFKILNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQA
MQASAVPVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPVQEVEFAS
ALAQEQLAFDPQVQQQVKAMLLLQERQDYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIV
AFSLNMQMQSNMDPAIRLKILQQALAELALYPKAEG
>AFN65709|FEATURES|argannot|beta_lactam|OXA-239|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRLFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMNIKSQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>CCW28916|FEATURES|argannot|beta_lactam|OXA-309|antibiotic inactivation|1
MKTLQLALIALITTFGSACTTISPSVETAKNHQQQSAQQQIQQAFDQLQTTGVIVIKDKH
GLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATRTEVFKWDGQKRSFPAWEKDMTL
GQAMQASAVPVYQELARRIGVDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVL
FVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWAGWVETSTG
EKAYFALNMQMKTGISASVREQLVKQSLTALGII
>AFI56570|FEATURES|argannot|beta_lactam|blaADC-61|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPLDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AGL39360|FEATURES|argannot|beta_lactam|blaADC-68|antibiotic inactivation|1
MRFKKISCLLLSPLFIFNTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGAYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKIIFPALGLKHSYVNVAKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ALA14808|FEATURES|argannot|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYSVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ALA14810|FEATURES|argannot|beta_lactam|adc75|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ALA14811|FEATURES|argannot|beta_lactam|adc76|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGESRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ADW23164.1|FEATURES|argannot|beta_lactam|CARB-3|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>AAG23870|FEATURES|argannot|beta_lactam|CARB-3|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNSNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>AAF89154|FEATURES|argannot|beta_lactam|BD94_2866|antibiotic inactivation|1
MLKKIKISLILALGLTSLQAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
DKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYST
KMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGC
IIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQHTLDLINE
YQQKQKASN
>ABQ84947|FEATURES|argannot|beta_lactam|blaB-15|antibiotic inactivation|1
MMKKMKWALVLALGLTGLNAFGQETPEVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
SKGVVVIDSPWGEEKFKNFTDEIYKRHGKKVIMNIATHSHDDRAGGLEYFKSLGVKTYST
KMTDSILAKDNKPRAQYTFDNNKSFKVGKDEFQVYYPGKGHTADNVVVWFPKDKVLVGGC
IIKSGDSKDLGFLGEAYVNDWTQSVHNIQKKFPNVQYVVAGHDDWKDQTAIQHTLDLISE
YQQKQKASN
>ACA34904|FEATURES|argannot|beta_lactam|VEB-6|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVVYSNAQADNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>AGH33739|FEATURES|argannot|beta_lactam|VEB-8|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVEYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTAGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>AAK14293|FEATURES|argannot|beta_lactam|VEB-1a|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>AKO63208|FEATURES|argannot|beta_lactam|blaVEB-11|antibiotic inactivation|1
MKIVKRILLVLLSLFFTIVYSNAQTDNLTLKIENVLKEKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>ACQ77171|FEATURES|argannot|beta_lactam|VIM-19|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSAKVLYGGCAVHELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>ADO50679|FEATURES|argannot|beta_lactam|VIM-25|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRKAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLALSRTSAGNVADADLAEWPTSVERIQKHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>CBY80143|FEATURES|argannot|beta_lactam|VIM-26|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>ADX78234|FEATURES|argannot|beta_lactam|VIM-27|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHISTQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AFP99885|FEATURES|argannot|beta_lactam|VIM-29|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSAKVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKRYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AGE83081|FEATURES|argannot|beta_lactam|VIM-38|antibiotic inactivation|1
MLKVISSLLVYLTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRKAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLALSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVTAHKNRSVVE
>AGS82586|FEATURES|argannot|beta_lactam|VIM-39|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPAVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AJP67511|FEATURES|argannot|beta_lactam|VIM-43|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLVHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>BAC06849|FEATURES|argannot|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTETLVNWVADSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVN
QYIESTLKP
>BAC06850|FEATURES|argannot|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNYQAALLDTPINDAQTETLVNWVADSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVN
QYIESTSKP
>AAB17891|FEATURES|argannot|beta_lactam|CfxA|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNKSQAS
QYVAHISAVVYSLLMQTSVKS
>CAA06312|FEATURES|argannot|beta_lactam|CTX-M-7|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYVADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIRASDLVNYNPIAEKHVNGTM
TLAQLGAGALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNSAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWGVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>AAF65843|FEATURES|argannot|beta_lactam|CTX-M-10|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTVDVQQKLAELEQQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AAF72530|FEATURES|argannot|beta_lactam|CTX-M-14|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AAK55534|FEATURES|argannot|beta_lactam|CTX-M-19|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTESTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>CAC95175|FEATURES|argannot|beta_lactam|CTX-M-20|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDFLAAAAKIVTHGF
>AAP22736|FEATURES|argannot|beta_lactam|CTX-M-29|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>CAD89606|FEATURES|argannot|beta_lactam|CTX-M-32|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>BAD16611|FEATURES|argannot|beta_lactam|CTX-M-36|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>BAA07082|FEATURES|argannot|beta_lactam|CTX-M-44|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAERRRDILAAAAKIVTHGF
>ADA62518|FEATURES|argannot|beta_lactam|CTX-M-52|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTESTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>YP_002332251|FEATURES|argannot|beta_lactam|CTX-M-53|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTVDVQQKLAELEQQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVIYFTQPQPKAESRRDVLASAAKIVTDGL
>BAD90119|FEATURES|argannot|beta_lactam|CTX-M-63|antibiotic inactivation|1
MRHRVKRMMLMTTACISLLLGSAPLYAQANDVQQKLAALEKSSGGRLGVALIDTADNAQT
LYRADERFAMCSTSKVMAAAAVLKQSETQKNVLSQKVEIKSSDLINYNPIAEKHVNGTMT
LAELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARAIGDDTFRLDRTEPTLNTAIPGDPR
DTTTPLAMAQTLRHLTLGSALGETQRAQLVTWLKGNTTGAASIQAGLPTSWVVGDKTGSG
DYGTTNDIAVIWPEGRAPLILVTYFTQPEQKAENRRDVLAAAAKIVTDGY
>ACU87985|FEATURES|argannot|beta_lactam|CTX-M-64|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ABS90365|FEATURES|argannot|beta_lactam|CTX-M-67|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYSPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>CAQ42481|FEATURES|argannot|beta_lactam|CTX-M-78|antibiotic inactivation|1
MMRKSVRRAILMTTACVSLLLASVPLYAQANDIQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKDLLSQRVEIKSSDLINYNPIAEKHVNGTM
TLGELSAAALQYSDNTAMNKLIAHLGGPGKVTAFARVIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLRNLTLGNALGDTQRAQLVTWLKGNTTGAASIQAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLVLVTYFTQPEPKAESRRDVLAAAARIVTDGY
>ADA62553|FEATURES|argannot|beta_lactam|CTX-M-79|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>CAG28417|FEATURES|argannot|beta_lactam|CTX-M-96|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPSLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDILASAAKIVTDGL
>ADY02555|FEATURES|argannot|beta_lactam|CTX-M-104|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAENRRDVLASAARIIAEGL
>ADZ31262|FEATURES|argannot|beta_lactam|CTX-M-106|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDRTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRHDVLASAARIIAEG
>AEM44650|FEATURES|argannot|beta_lactam|CTX-M-107|antibiotic inactivation|1
VKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQI
LYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMS
LAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPR
DTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDRTGSG
GYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVT
>AFQ94051|FEATURES|argannot|beta_lactam|CTX-M-132|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AFY98865|FEATURES|argannot|beta_lactam|CTX-M-139|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLFAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>CAA28198|FEATURES|argannot|beta_lactam|LEN-1|antibiotic inactivation|1
MRYVRLCVISLLATLPLVVYAGPQPLEQIKQSESQLSGRVGMVEMDLANGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGQR
>CAG25814|FEATURES|argannot|beta_lactam|LEN-13|antibiotic inactivation|1
ATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLL
CGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSDNSAGN
LLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTA
QHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGPDGKPE
RIVVLYLRDTPASMAERNQHIAG
>BAO01151|FEATURES|argannot|beta_lactam|BL3_l|antibiotic inactivation|1
MRFLASLALPLFAANLAVAAPKPLPQLEAYEGLQAWLVPVEPLRISDHVWQIGTASISAL
LVKTDAGAVLIDGGMPQVADHLLANMKKLGVQPQDLRLILHSHAHIDHVGPLAAIKRATG
AVLVSNAESAVLLQRGGADDIHFGSGMLFAPLTPERLVQDGEAVTLGDTTFTVHFTPGHT
PGSMSWTWTDTQDGKPLRIAYADSLSAPGYQLRDNARYPHLVDAFRASFAAVRALPCDLL
LTPHAEGSGWDYTNAEKPHPAPVSCKAYADKAEQKLDQMLAEQAKSR
>BAM73613|FEATURES|argannot|beta_lactam|DIM-1|antibiotic inactivation|1
MRPFLFLIIFISHFAFANEEIPGLEVEEIDNGVFLHKSYSRVEGWGLVSSNGLVVISGGK
AFIIDTPWSESDTEKLVDWIRSKKYELAGSISTHSHEDKTAGIKWLNGKSITTYASALTN
EILKREGKEQARSSFKGNEFSLMDGFLEVYYPGGGHTIDNLVVWIPSSKILYGGCFIRSL
EPSGLGYTGEAKIDQWPQSARNTISKYPEAKIVVPGHGKIGDFELLKHTKVLAEKASNKA
NHGDR
>AAL60061|FEATURES|argannot|quinolone|QnrA1|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYIS
GCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>ACV83303|FEATURES|argannot|quinolone|QnrA7|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYIS
GCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>CAQ79275|FEATURES|argannot|quinolone|QnrVC1|antibiotic target protection|1
MAKYNEIFDNVDFSKQDLRESYFEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFD
YSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYIT
GCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLC
HCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVVLPD
>ABC86904.2|FEATURES|argannot|quinolone|QnrB1|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ABX72043|FEATURES|argannot|quinolone|QnrB13|antibiotic target protection|1
MTPLLYKKTSTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG
>ABX72044.1|FEATURES|argannot|quinolone|QnrB14|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLTERLGIAIIG
>ACS71746.1|FEATURES|argannot|quinolone|QnrB22|antibiotic target protection|1
MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYDRESQKGCNFSRA
NLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNT
NLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNS
ELGDLDIRVVDLQGVKLDSYQASLLLERLGIAVMG
>ACS71747|FEATURES|argannot|quinolone|QnrB23|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>ADN94685|FEATURES|argannot|quinolone|QnrB25|antibiotic target protection|1
MALALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTN
LSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG
>ADQ43424|FEATURES|argannot|quinolone|QnrB31|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG
>AEL00459|FEATURES|argannot|quinolone|QnrB37|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSE
LGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG
>AEL00461|FEATURES|argannot|quinolone|QnrB38|antibiotic target protection|1
MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG
>AEQ94272|FEATURES|argannot|quinolone|QnrB42|antibiotic target protection|1
MALVLVGEKIDRNCFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>AFA52643|FEATURES|argannot|quinolone|QnrB43|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AFA52645|FEATURES|argannot|quinolone|QnrB44|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AFA52644|FEATURES|argannot|quinolone|QnrB45|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ABC17628.2|FEATURES|argannot|quinolone|QnrB5|antibiotic target protection|1
MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG
>ACJ24509|FEATURES|argannot|quinolone|QnrS4|antibiotic target protection|1
METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFD
AADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFIS
GCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLC
HAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD
>AJA36815|FEATURES|argannot|quinolone|QnrVC7|antibiotic target protection|1
MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFS
YSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYIT
GCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLS
HSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD
>ACC85616.1|FEATURES|argannot|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSDLQKSVTFWHELLGLTLHARWNTGAYLTCGDLWVCLSYDEARGYVPP
QESDYTHYAFTVAAEDFEPFSHKLEQAGVTVWKQNKSEGASFYFLDPDGHKLELHVGSLA
ARLAACREKPYAGMVFTSDEA
>ACL82957.1|FEATURES|argannot|glycopeptide|vanRM|antibiotic target alteration|0
MRRISILIAEDEEEIADLLAIHLEKEGYDVIKVHDGQEALHVIQAQSIDLIILDIMMPKM
DGYEVTRQVRAQYNMPIIFLSAKTSDFDKVHGLVIGGDDYITKPFTPIELVARVNAQLRR
SMKLNHPQADDKKSILEFGEIVISPDQRTVFLYGENIGLTPKEFDILYLLASHPKKVYSV
ENIFQQVWNDAYFGGGNTVMVHIRTLRKKLGEDKRKNKLIKTVWGVGYTFNG
>ACL82958.1|FEATURES|argannot|glycopeptide|vanSM|antibiotic target alteration|0
MAKMRSSFRTKIILLFAVSMLLAGMVTYLLFKGLQLYYHTMIHRGNPLAELRDFIESIGD
FNFFFLLFILLSLSVFYILTKPYSAYFDEISTGIQYLALGDFKRRVNIQSNDEFGDIAQA
INQASEKLEEAIQRGDFSENSKEQLVVNLAHDLRTPLTSVLGYLDLVLKDEKLTKEQVRH
FLTIAFTKSQRLEKLIDELFEITRMNYGMLSIEKKPINLTDLLLQLKEELYPIFEKNGLT
ARMNTLPHLPVSADGEMLARVFENLLTNANRYGHDGQFVDINGFVDEEEVVVQVVNYGDS
IPPNELPYLFDMFYTGDKARTHKEDSTGLGLFIAKNIVEQHNGTVTAESSLIRTVFEVRL
PLESAPIDQV
>AAR84672.1|FEATURES|argannot|glycopeptide|vanRF|antibiotic target alteration|0
MKNITILIADDDAEIADLVAIHLEKEGYRVIKVSDGQETIDVIQNQPIDLLILDIMMPKM
DGFEVTRRIREKHNMPIIFLSAKTSDFDKVQGLVIGADDYMTKPFIPIELVARVNAQLRR
FMKLNQPKTKQNSNLEFGGLTISPEQRTVTLYGKNIELTPKEFEILFLLASNPNKVYRAE
DIFQKVWGDAYYEGGNTVMVHIRTLRKKLEEDKRKNKLIQTVWGVGYKFNG
>BAE96118.1|FEATURES|argannot|glycopeptide|vanXD|antibiotic target alteration|1
MEKNFVFLDEMLPGIRWDAKYATWDNFTGKPVDGYEVNRIVGTKELGAALRKAQKAAEKL
GYGLLLWDGYRPQCAVDCFLTWASLPENNLTKKRYYPNIKRNEMITKGYVASQSSHSRGS
AIDLTIFRLDTGMLVPMGGDFDFMDVRSHHAASGLSEEEAGNRERLRDIMERSGFEAYRY
EWWHYVLADEPYPDTYFDFCIA
>ABX79416.1|FEATURES|argannot|glycopeptide|VanRC|antibiotic target alteration|0
MAEKIIVVDDEKEIAELVTTFLRNEGFQVEPFYDGTSALAYLEKETVDVAVLDVMLPDID
GFQLLQTIRKTHFFPVLMLTAKGEDLDKITGLSLGADDYVTKPFNPLEVVARVKTQLRRY
QRYNQSAVPQKIEEYEKEGLLLKINSHQCFLYGKEVFLTPIEFKILLYLFEHQGSVVASE
TLFEAVWKEKYLDNNNTVMAHIARLREKLNEQPRKPKLIKTVWGVGYIIEK
>ABX79417.1|FEATURES|argannot|glycopeptide|VanSC|antibiotic target alteration|0
MLLLILIPLTVRFVAGLRVWYGYEPIYQILRLFADYWLVCLAIGALLIWVSTTIYYMSKA
ISYLNETIQATNQLIAEPTKRIVLSSNLIDVQEEMNQLREKNLQDQRAAKEAEQRKNDLI
VYLAHDLRTPLTSVIGYLTLLEEEPQLSSELRARYTKIALQKAQRLELLISEFFEITRFN
LTTIALQTETTDLSLMLEQLTFEFLPLLEEKNLHWQLQLQKKVYATVDTEKMERVFDNLI
RNAINYSYADSPLHLAISTSDDILIRLTNHGKTIPAEKIGLIFEPFYRMDASRATATGGT
GLGLPIAKEIVEALGGKIWAESRDETIVFSIRLPKVAMEKNEQRSKPHPSEPTA
>AAA65956.1|FEATURES|argannot|glycopeptide|vanA|antibiotic target alteration|1
MNRIKVAILFGGCSEEHDVSVKSAIEIAANINKEKYEPLYIGITKSGVWKMCEKPCAEWE
NDNCYSAVLSPDKKMHGLLVKKNHEYEINHVDVAFSALHGKSGEDGSIQGLFELSGIPFV
GCDIQSSAICMDKSLTYIVAKNAGIATPAFWVINKDDRPVAATFTYPVFVKPARSGSSFG
VKKVNSADELDYAIESARQYDSKILIEQAVSGCEVGCAVLGNSAALVVGEVDQIRLQYGI
FRIHQEVEPEKGSENAVITVPADLSAEERGRIQETAKKIYKALGCRGLARVDMFLQDNGR
IVLNEVNTLPGFTSYSRYPRMMAAAGIALPELIDRLIVLALKG
>AAF72363.1|FEATURES|argannot|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANINTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFELSGIPYVG
CDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGV
TKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTLPGFTSYSRYPRMVAAAGITLPALIDSLITLALKR
>ACL82961.1|FEATURES|argannot|glycopeptide|vanM|antibiotic target alteration|1
MNRLKIAILFGGCSEEHNVSVKSAAEIANNIDIGKYEPIYIGITQSGVWKTCEKPCIDWD
NEHCRSAVLSPDKKMHGLLIMQDKGYQIQRIDVVFSVLHGKSGEDGAIQGLFELSGIPYV
GCDIQSSAVCMDKSLAYIIAKNAGIATPEFQVIYKDDKPAADSFTYPVFVKPARSGSSYG
VNKVNSADELDSAIDLARQYDSKILIEQGVLGYEVGCAVLGNSFDLIVGEVDQIRLQHGI
FRIHQEAEPEKGSENATITVPAELSAEERERIKEAAKNIYKALGCRGLSRVDMFLQDNGR
IVLNEVNTMPGFTSYSRYPRMMVSAGITIPELIDHLIVLAVKE
>AAT38880.1|FEATURES|argannot|glycopeptide|vanHO|antibiotic target alteration|1
HIDVEYAESIGITVGNVAYSPDSVADFTLMLMLMVIRDAKSIIRRTEVHDYRLNAVRGKE
LRDLTVGVVGTGRIGVAVMDRLKGFGCRVLAYDTIPNASADYVPLDDLLQQSDIVTLHVP
LNTDTYHLLDRRNIEEMKGGAYIINTGRGPLIETEALISALESGNLGGAALDVLEGEEGI
FYADCRDKAIDGNKPLLRLQELSNVIISPHTAYYTDHALSDTVENSIINCLEFESGK
>AAD19834.1|FEATURES|argannot|glycopeptide|vanH|antibiotic target alteration|1
MTYSEPARSAAPRTGSPASASSSAVLARGITIYGCGSDEAALFREMAPRFGVMPNIVDEP
VSEANIGLVSGNRCISIGHKTKVTNSILLALAEAGVEYISTRSIGFNHIDVEYAASVGIT
VGNVAYSPDSVADFTLMLMLMAVRDAKSIIRRTEVHDYRLNEVRGKELRDLTVGVVGTGR
IGVAVLDRLRGFGCRVLAYDTLLTASADYVPLDELLQQSDIVTLHVPLNNDTYHLLDRKN
IERMKDGAYIINTGRGPLIETEALISALEDGKLGGAALDVVEGEEGIFYADCRNKPLESE
TLLRLEKLPNVLISPHTAYYTDHALSDTVENSIINCLQFRKREVVWVG
>AAY67969.1|FEATURES|argannot|glycopeptide|vanXYC|antibiotic target alteration|1
MNTLQLINKNHPLKKNQEPPHLVLAPFSDHDVYLQPEVAKQWERLVRATGLEKDIRLVDG
YRTEKEQRRLWEYSLKENGLAYTKQFVALPGCSEHQIGLAIDVGLKKQEDDDLICPHFRD
SAAADLFMQQMMNYGFILRYPEDKQEITGISYEPWHFRYVGLPHSQVITAQKWTLEEYHD
YLAQTVRQFA
>AAT38882.1|FEATURES|argannot|glycopeptide|vanXO|antibiotic target alteration|1
MKDDFVFVDEVVPGIRWDAKYATWDNFTGKPVDGYLVNRVVGTRAFCAALEKAREKAESL
GFGLLLWDVYRPQRAVDCFMRWAEQPEDGRKKLRHYPNIDRPQMFEKGYVATKSGHSRGS
TVDLTLYHLDTGELADMGGDHDVMDVVSHHGAAGITPEQEKNREHLCSIMVDSGFGSYEF
EWWHYTL
>AEI58861.1|FEATURES|argannot|glycopeptide|vanXI|antibiotic target alteration|1
MRDDFVFVDEVVSGIRWDAKYATWDNFTGKPVDGYLVNRVVGTRAFCAALEKARDKAAEL
GFGLLLWDVYRPQRAVDRFMRWAEEPEDGRKKARHYPNIERPQMFEQGYVATKSGHSRGS
TVDLTLYRLDTGELADMGGDHDLMDVVSHHGADGVPEEAAKNRAHLCAIMEGSGFSSYEC
EWWHYNLKDEPYPDTYFDFPIE
>AAY52006.1|FEATURES|argannot|glycopeptide|vanXA|antibiotic target alteration|1
MKIGFTFLDEILHGVRWDAKYATWDNFTGKPVDGYEVNRIVGTYELADALLKVKELAATQ
GYGLLLWDGYRPQRAVNCFLQWAAQPEDDLTKERYYPNIDRTEMVSKGYVASKSSHSRGS
AIDLTLYRLDTGELVPMGSGFDFMDERSHHAAKGISGNEAQNRRRLRSIMEDSGFEAYSF
EWWHYVLRNEPYPNSYFDFPVK
>AAF36804.1|FEATURES|argannot|glycopeptide|vanXF|antibiotic target alteration|1
MEKDFVFLDEILHGVRWDSKYATWDNFTGKPVDGYEVNRIAGTYALAVALLEVKKQAAAL
GYGLLLWDGYRPQRAVNCFLHWSAQPEDGRTKERYYPNIDRIEMVTKGYVASKSSHSRGS
AIDLTLYRLDTGALVPMGSGFDFMDERSHHTSKGISSNEAQNRQLLCSIMEYSGFESYVY
EWWHYVLRNEPYPSSYFDFPIGGNHLDPFSNFCGTVPLDALSP
>AAY52013.1|FEATURES|argannot|glycopeptide|VanYA|antibiotic target alteration|1
MKKWGFLLLFLLCLGFAFINKALFFQDKVEIQKYDQNHKDNIDNIENIGTPLSIQKNEIV
KEQIYQGNLLLINSKYPIRQESVKSDIVNLSKHNELINGYGLLNTNIYLSKGIAQKFSEM
INDAVKEGVSQFFINSGYRDFDEQSVLYQEMGADYALPAGYSEHNSGLSLDVGSSLTKME
RAPEGKWLKENAWKYGFILRYPKDKTDVTGIQYEPWHIRYVGFPHSAIMKEKNFALEEYM
DFLKEQKSITTTIDHQVYKIFYYPISQNTTIPVPANGQYEISGNNMDGVIVTVYSGKRD
>AAF36805.1|FEATURES|argannot|glycopeptide|vanYF|antibiotic target alteration|1
MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQI
YQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAA
EEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPE
GKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLK
EEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS
>AAA60990|FEATURES|argannot|glycopeptide|vanC|antibiotic target alteration|1
MKKIAIIFGGNSPEYTVSLASATSAIEALQSSPYDYDLSLIGIAPDAMDWYLYTGELENI
RQDTWLLDTKHKQKIQPLFEGNGFWLSEEQQTLVPDVLFPIMHGKYGEDGSIQGLFELMK
LPYVGCGVAGSALCMNKWLLHQAAAAIGVQSAPTILLTNQANQQEQIEAFIQTHGFPVFF
KPNEAGSSKGITKVTCVEEIASALKEAFTYCSAVLLQKNIAGVEIGCGILGNDSLTVGAC
DAISLVDGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYRSLGLKGLARIDFFV
TERGELYLNEINTMPGFTSHSRYPAMMAAVGLSYQELLQKLLVLAKEEVK
>AAK58489.1|FEATURES|argannot|glycopeptide|vanC|antibiotic target alteration|1
MKKIAIIFGGNSPEYTVSLASATSAIEALQSSPYDYDLSLIGIAPDAMDWYLYTGELENI
RQDTWLLDTKQKQKIQPLFEGNGFWLSEEQQTLVPDVLFPIMHGKYGEDGSIQGMFELMK
LPYVGCGVAGSALCMNKWLLHQAAAAIGVQSAPTILLTNHANQQEQIEAFIQTHGFPVFF
KPNEAGSSKGITKVTCVEEIASALKEAFTYCSAVLLQKNIAGVEIGCGILGNDSLTVGAC
DAISLVDGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYRSLGLKGLARIDFFV
TDQGELYLNEINTMPGFTSHSRYPAMMAAVGLSYQELLQKLLVLAKEEVK
>CAL64019.1|FEATURES|argannot|multidrug|cfr|antibiotic target alteration|1
MNFNNKTKYGKIQEFLRSNNEPDYRIKQITNAIFKQRISRFEDMKVLPKLLREDLINNFG
ETVLNIKLLAEQNSEQVTKVLFEVSKNERVETVNMKYKAGWESFCISSQCGCNFGCKFCA
TGDIGLKKNLTVDEITDQVLYFHLLGHQIDSISFMGMGEALANRQVFDALDSFTDPNLFA
LSPRRLSISTIGIIPSIKKITQEYPQVNLTFSLHSPYSEERSKLMPINDRYPIDEVMNIL
DEHIRLTSRKVYIAYIMLPGVNDSLEHANEVVSLLKSRYKSGKLYHVNLIRYNPTISAPE
MYGEANEGQVEAFYKVLKSAGIHVTIRSQFGIDIDAACGQLYGNYQNSQ
>AAC69327.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|Erm(31)|antibiotic target alteration|1
MAFSPQGGRHELGQNFLVDRSVIDEIDGLVARTKGPILEIGPGDGALTLPLSRHGRPITA
VELDGRRAQRLGARTPGHVTVVHHDFLQYPLPRNPHVVVGNVPFHLTTAIMRRLLDAQHW
HTAVLLVQWEVARRRAGVGGSTLLTAGWAPWYEFDLHSRVPARAFRPMPGVDGGVLAIRR
RSAPLVGQVKTYQDFVRQVFTGKGNGLKEILRRTGRISQRDLATWLRRNEISPHALPKDL
KPGQWASLWELTGGTADGSFDGTAGGGAAGSHGAARVGAGHPGGRVSASRRGVPQARRGR
GHAVRSSTGTEPRWGRGRAESA
>AAL68827|FEATURES|argannot|macrolide-lincosamide-streptogramin|Erm(36)|antibiotic target alteration|1
MPTYRGGRHEHGQNFLTDHTTIDRLSRLVGDSTGPIVEIGPGQGRLTRELQKLGRSLTAV
EIDSRLADRLASASQFREQKHVTVVNADFLHWPLPTTPYVVVGNVPFHLTTAILRRLLHD
GAWTQVVLLVQWEVARRRAGIGGSSMMTAQWWPWIDFSLHGRVPRSAFKPAPSVDGGLLE
MTRRPDPLLSPDARESYRQFVHDVFTSRGRGIGEILANVSSSLGKRGALQLLKSEGIRSS
SLPKDLSAEQWARLFTSASPTKSAKTGRNAHPAHSARRQGR
>ACH43059|FEATURES|argannot|macrolide-lincosamide-streptogramin|Erm(41)|antibiotic target alteration|1
VSGQRSRRQWGWYPLTDDWAARIVAESGVRSGEFVVDLGAGHGALTAHLVAAGARVLAVE
LHPGRARHLRSRFAEEDVRIAEADLLAFRWPRRPFRVVASPPYQVTSALIRSLLTPESRL
LAADLVLQRGAVHKHAKRALVRHWTLRAGITLPRSAFHHPPQVDSSVLVIRRR
>CAA26967.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
MNQKNPKDTQNFITSKKHVKEILNHTNISKQDNVIEIGSGKGHFTKELVKMSRSVTAIEI
DGGLCQVTKEAVNPSENIKVIQTDILKFSFPKHINYKIYGNIPYNISTDIVKRITFESQA
KYSYLIVEKGFAKRLQNLQRALGLLLMVEMDIKMLKKVPPLYFHPKPSVDSVLIVLERHQ
PLISKKDYKKYRSFVYKWVNREYRVLFTKNQFRQALKHANVTNINKLSKEQFLSIFNSYK
LFH
>AAA98217|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|1
MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVA
IENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFES
LGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALL
NIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQI
VCLSPSQWLNCFLEMLEVVPEKFHPS
>AAA22075|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmR|antibiotic target alteration|1
MAGPQDRPRGRGPSSGRPQRPVGGRSQRDRDRRVLGQNFLRDPATIRRIADAADVDPDGL
VVEAGPGEGLLTRELARRAGRVRTYELDQRLARRLSTDLAQETSIEVVHADFLTAPHPEE
PFQFVGAIPYGITSAIVDWCLTAPTLTSATLVTQQEFARKRTGDYGRWTALTVTTWPTFE
WQYVAKVDRTLFTPVPRVHSAIMRLRRRPQPLLRDAAARSRFADMVEIGFVGKGGSLYRS
LTREWPRSKVDSAFARADVHHDEIVAFVHPDQWITLFQLLDGSRGGAARGPGDQRGRRGR
PGGGPRPDGRAGGGPRRDAGGRRTGDGRGGRPRPPRGGQA
>ABV04087|FEATURES|argannot|macrolide-lincosamide-streptogramin|linG|antibiotic inactivation|1
MLQLKMIELFKEGCHEDARIIAALMFGSFAIGEGDEFSDIEFAVFIQDDHFENFDQRSWL
NAVSPVAAYFPDDFGHHTALFENGIRGEFHFMRKSDIPVISTWQGYGWFPSLEAAVLLDR
SGELSRYASALVGGPPIREGAPLVEGLVLNLISLMLFGANLLNRGEYARAWALLSKAHEN
LLKLVRLHEGATDHWPTPSRALEKDISEDSYNRYLACTSSAEPRALCAAYHQTWTWSLEL
FKSVTEPLNIELPRTVIAQAKRLLNESATPHNK
>ABE02099.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|mphA|antibiotic inactivation|1
MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVS
AKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDS
EVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRW
QRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFG
EEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLAAA
E
>AAF91071|FEATURES|argannot|macrolide-lincosamide-streptogramin|msrC|antibiotic target protection|1
MENLAVNITNLQVSFGNQLELSIDSLRVYQQDRIGIIGENGVGKSTLLKLIAGELFPDHG
KIQTEITFNYLPQLTYLAEAKDLNLELASHFQLRLEETSERKWSGGEERKIELIRLLSSY
EQGMLLDEPTTHLDRKSIDRLIEELRYYYGTLVFVSHDRYFLDELASKIWEVKDGEIREF
SGNYSAYLTQKELEKKTQLREAESIMKEKKRLEKSIQEKKKQAEKLEKVSSKKKKQQIRP
DRLSSSKQKDSVQKAIQKNAKTLERRLQKIGETTKPQQMKQIRFPVPKSLELHSRYPIMG
QNVQLERSGRTLLVNGDFQFSLGKKIAIVGENGSGKTTLLEHIRKQGEGILLSPKVSFQV
YQQKDYQMTSEESVIRFVMRQTEFSESLVRSLLNHLGFAQETLAKPLCTLSGGEATRLMI
ALLFTKPSNVLLLDEPTNFIDMATIEALEKLMQVYPGTILFTSHDSYFVERTADEVYEIK
GQKIKKVLTRNF
>AAA86871|FEATURES|argannot|macrolide-lincosamide-streptogramin|vatB|antibiotic inactivation|1
MKYGPDPNSIYPHEEIKSVCFIKNTITNPNIIVGDYTYYSDVNGAEKFEEHVTHHYEFRG
DKLVIGKFCAIAEGIEFIMNGANHRMNSITTYPFNIMGNGWEKATPSLEDLPFKGDTVVG
NDVWIGQNVTVMPGIQIGDGAIVAANSVVTKDVPPYRIIGGNPSRIIKKRFEDELIDYLL
QIKWWDWSAQKIFSNLETLCSSDLEKIKSIRD
>AAC61670.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|VgbB|antibiotic inactivation|1
MNFYLEEFNLSIPDSGPYGITSSEDGKVWFTQHKANKISSLDQSGRIKEFEVPTPDAKVM
CLIVSSLGDIWFTENGANKIGKLSKKGGFTEYPLPQPDSGPYGITEGLNGDIWFTQLNGD
RIGKLTADGTIYEYDLPNKGSYPAFITLGSDNALWFTENQNNSIGRITNTGKLEEYPLPT
NAAAPVGITSGNDGALWFVEIMGNKIGRITTTGEISEYDIPTPNARPHAITAGKNSEIWF
TEWGANQIGRITNDKTIQEYQLQTENAEPHGITFGKDGSVWFALKCKIGKLNLNE
>AAQ63644|FEATURES|argannot|chloramphenicol|cat|antibiotic inactivation|1
MEILTLLIRDTMGSKRIFLNPYFQQQPTFSLTNEINITILMKNLKKKHYKLYPAFIFMVT
KIVNAHREFRINFNSEGNLGYWTEICPLYTIFDNKSHTFSGIWSPNLTIFSEFHSKYEND
AERYNGTRRLFPKKPIPDNPIPISMIPWSSFTAFNLNINNGGDFLLPIITGGKYSQVNDE
LFLPVSIQNASCLFVMATMQSVFINDLQNLVDESEDWIYLVVSDEWYY
>CAA37805|FEATURES|argannot|chloramphenicol|catII|antibiotic inactivation|1
MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITALRTALAETGYKFYPLMIYLISR
AVNQFPEFRMALKDNELIYWDQSDPVFTVFHKETETFSALSCRYFPDLSEFMAGYNAVTA
EYQHDTRLFPQGNLPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEGDRVL
LPVSVQVHHAVCDGFHAARFINTLQLMCDNILK
>AAA92251|FEATURES|argannot|chloramphenicol|JP30_06285|antibiotic inactivation|1
MNFNKIDLDNWKRKEIFNHYLNQQTTFSITTEIDISVLYRNIKQEGYKFYPAFIFLVTRV
INSNTAFRTGYNSDGELGYWDKLEPLYTIFDGVSKTFSGIWTPVKNDFKEFYDLYLSDVE
KYNGSGKLFPKTPIPENAFSLSIIPWTSFTGFNLNINNNSNYLLPIITAGKFINKGNSIY
LPLSLQVHHSVCDGYHAGLFMNSIQELSDRPNDWLL
>ACQ42045|FEATURES|argannot|chloramphenicol|catB3|antibiotic inactivation|1
MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIG
SEAMVMPGIKIGHGAVIGSRSLVTKDVGHCCKVSDEAAFCLIQRPYISKTLLTRRISPRG
SP
>EDL73619|FEATURES|argannot|chloramphenicol|catB9|antibiotic inactivation|1
MNFFTSPFSGIPLDQQVTNPNIIVGKHSYYSGYYHGHSFDDCVRYLHPERDDVDKLVIGS
FCSIGSGAVFMMAGNQGHRSDWISTFPFFYQDNDNFADARDGFTRSGDTIIGHDVWIGTE
AMIMPGVKIGHGAIIASRSVVTKDVAPYEVVGSNPAKHIKFRFSDVEIAMLLEMAWWNWP
ESWLKESMQSLCSSDIEGLYLYWQSKART
>AAD02068.1|FEATURES|argannot|chloramphenicol|catB7|antibiotic inactivation|1
MGNYFESPFRGKLLSEQVSNPNIRVGRYSYYSGYYHGHSFDDCARYLMPDRDDVDKLVIG
SFCSIGSGAAFIMAGNQGHRAEWASTFPFHFMHEEPVFAGAVNGYQPAGDTLIGHDVWIG
TEAMFMPGVRVGHGAIIGSRALVTGDVEPYAIVGGNPARTIRKRFSDGDIQNLLEMAWWD
WPLADIEAAMPLLCTGDIPALYRHWKQRQATA
>AAB46601|FEATURES|argannot|chloramphenicol|cmx|antibiotic efflux|1
MPFALYMLALAVFVMGTSEFMLAGLLPAIATELDVSVGTAGLLTSAFAVGMVVGAPVIAA
FARRWPPRLTLIVCLLVFAGSHVIGAMTPVFSLLLITRVLSALANAGFLAVALSTATTLV
PANQKGRALSILLSGTTIATVVGVPAGALLGTALGWRTTFWAIAILCIPAAVGVIRGVTN
NVGRSETSATSPRLRVELSQLATPRLILAMALGALINGGTFAAFTFLAPIVTETAGLAEA
WVSVALVMFGIGSFLGVTIAGRLSDQRPGLVLAVGGPLLLTGWIVLAVVASHPVALIVLV
LVQGFLSFGVGSTLITRVLYAASGAPTMGGSYATAALNIGAAAGPVLGALGLATGLGLLA
PVWVASVLTAIALVIMLLTRRALTKTAAEAN
>ABV26705|FEATURES|argannot|rifampin|arr-4|antibiotic inactivation|1
MTNDWIPTSHDNCSQVAGPFYHGTKAKLTVGDLLSPGHPSHFEQGRKLKHIYFAALMEPA
IWGAELAMSLSSLEGRGHIYIVEPLGPFEDDPNLTNKKFPGNPTKSYRTTEPLRIVGIVE
DWQGHSPEVLQGMLASLEDLQRRGLAIIED
>AAB41059|FEATURES|argannot|rifampin|iri|antibiotic inactivation|0
MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLD
KFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGK
RVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEM
DVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLL
AIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFN
LGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELM
EFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQ
LSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA
>CAA37477|FEATURES|argannot|tetracycline|otrA|antibiotic target protection|1
MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAV
ATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLG
IPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFA
VRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHL
VHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTG
RVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAP
PSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGST
LAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITF
RLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKAN
ARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEG
TMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVL
KRV
>AAR96051|FEATURES|argannot|tetracycline|otrC|antibiotic efflux|1
MTRKTISNGARNAVEVRGLVKHFGEVKAVDGVDLDVREGTVLGVLGPXGAAXXRGALPAH
VXGPDAGRRPWRFXTWCANRRALRRTIGXHRPVRXGRRESFSGRENLYMIGRXLDLSRKD
ARARADELLERFSLTEAAGRAAAKYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTR
NEVWDEVRSMVRDGATVLLTTQYMEEAEQLAHELTVIDRGRVIADGKVDELKTKVGGRTL
QIRPAHAAELDRMVGAIAQAGLDGIAGATADHEDGVVNVPIVSDEQLSAVVGMLGERGFT
ISGHQHPSAQLXEVFLAITGQKTSEAADGGPQDGPQDQQGVQDKQYEEVPA
>CAC80727|FEATURES|argannot|tetracycline|tet31|antibiotic efflux|1
MIGKLIMMNRYITIALLITFLDATGMGLIMPVLPTLLEEFSVKESIATHYGFILAIYALM
QVIFAPILGQLSDKFGRKPVLILSLIGAVCDYTLLSFSSALWMLYLGRMIAGISAATGAV
AASMVADHTKKAERTKWFGKLGAAFGAGLIAGPAIGGFIGQYSAHFPFIIAAILNAIALI
MVIILFPKEQSRPKEIEQDQSKIHEKTTINAPLIHILKPVLLLLMLFFTVQLIGQIPAST
WVLFTEYRFEWNTFNIGLSLAGLGLMHIIFQAFVAGYIASRWKNETVFILGFILDASAFL
LLAFISQVWLVIPTLILLAGGGIALPALQGLISIKTADEHQGKIQGIMVSLTNITGIIGP
PIFAFSFAKTVTNWDGTLWLIGAVLYSILLGLYFLYQKIRAYKQLKSQTA
>CAD55718|FEATURES|argannot|tetracycline|tet36|antibiotic target protection|1
MRTINIGILAHIDAGKTSITENLLFASGATIVRGSVDKGNTTTDSMDIEKRRGITVRAST
TSIQWNDTKINIIDTPGHMDFLAEVERTFRMLDGAILVVSAKEGIQAQTRLLFNVLQQLE
IPTILFVNKIDREGVNLNQLYLEIQNSLSKDIIFMQSVEGKELTSSCTIHYISEKNRETI
LEKDDLLLEKYLSDTQLSNLDYWNSMVRLVQAAKLHPIYHGSAMYGIGIEDLLNSITTFI
ETSLPQENALSAYVYKIEHNKKEQKRAYLKIIGGTLKSRKLYSLNGSDENLKIRGLKTFY
SGDEIDVDEVFTNDIAIADHADNLMVGDYLGIMPNLFDKLNIPSPALKSSIHPAKVENRS
KLISAMNVLSVEDPSLAFSINADNNELEVSLYGATQREVILTLLEERFSVDAYFEEVKTI
YKERLKTKSEYTIHIEVPPNPYWASIGLIIEPLPIGAGLVMESEISLGYLNRSFQNAVFD
GVKKACESGLYGWEVTDLKVTFSHGIYYSPVSTPADFRSLAPYVFRLALQQADVELLEPI
LDFKLQIPLAVNARAITDINKMQGEISTITSDGDWTTILGNIPLDTSKEYSAEVSSYTQG
LGVFVTRFSGYRPTNKKVSRSVELNEKDKLMYMFEKESIK
>CAM12479|FEATURES|argannot|tetracycline|tet40|antibiotic efflux|1
MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVQEASCFLFE
MPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAW
IASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPLILGGSLCLLLGLVMVR
IMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLST
AHFLDDTVIPVIGPLNSVTWFGVISLIGNGLGILASQLLIARMEKKGTVSRTSVVMSTSA
GYILFLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLD
SFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD
>CCN79972|FEATURES|argannot|multidrug|mtrR|antibiotic efflux|0
MTKLQPNTVIRAALDLLNEVGVDGLTTRKLAERLGVQQPALYWHFRNKRALLDALAEAML
AENHTHSVPRADDDWRSFLIGNARSFRQALLAYRDGARIHAGTRPGAPQMETADAQLRFL
CEAGFSAGDAVNALMTISYFTVGAVLEEQAGDSDAGERGGTVEQAPLSPLLRAAIDAFDE
AGPDAAFEQGLAVIVDGLAKRRLVVRNVEGPRKGDD
>ACE95681|FEATURES|argannot|tetracycline|tetC|antibiotic efflux|1
MKSNNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCA
PVLGALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYI
ADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFL
MQESHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDR
FRWSATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAADALGYVLLAFATRG
WMAFPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTSIIGPLIVTAIYA
ASASTWNGLAWIVGAALYLVCLPALRRGAWSRATST
>AAA19179|FEATURES|argannot|tetracycline|tetK|antibiotic efflux|1
MFSLYKKFKGLFYSVLFWLCILSFFSVLNEMVLNVSLPDIANHFNTTPGITNWVNTAYML
TFSIGTAVYGKLSDYINIKKLLIIGISLSCLGSLIAFIGHNHFFILIFGRLVQGVGSAAF
PSLIMVVVARNITRKKQGKAFGFIGSIVALGEGLGPSIGGIIAHYIHWSYLLILPMITIV
TIPFLIKVMVPGKSTKNTLDIVGIVLMSISIICFMLFTTNYNWTFLILFTIFFVIFIKHI
SRVSNPFINPKLGKNIPFMLGLFSGGLIFSIVAGFISMVPYMMKTIYHVNVATIGNSVIF
PGTMSVIVFGYFGGFLVDRKGSLFVFILGSLSISISFLTIAFFVEFSMWLTTFMFIFVMG
GLSFTKTVISKIVSSSLSEEEVASGMSLLNFTSFLSEGTGIAIVGGLLSLQLINRKLVLE
FINYSSGVYSNILVAMAILIILCCLLTIIVFKRSEKQFE
>AAC72341|FEATURES|argannot|tetracycline|tetY|antibiotic efflux|1
MSKSLITALIVVALDAIGLGLIMPVVPALLNEFVPAEQTAFHYGVFLSLYAFMQVFCAPV
LGRLSDRYGRRIILLVSFLGATIDYSIMAAAPVLWVLYIGRIISGVTGATGAIAASIIAD
TTKQEERARWFGFMGACFGAGMIAGPAIGGVLGDISVHAPFVAGALLNAIAFCLVAFLLP
KTPSQPPEGQPAKINLFEGFRFNFAVQGLASFFALFFLMQLIGQAPAALWVIYGEQRLNW
DIGTAGVSLAVFGAAHTFVQAVLTGTLSKRLGDRGVLLLGMGADMCGFLLLAFITQSWMV
LPAIFMLATGGIGMPALQAIISGLVCDEKQGALQGTLTGLTNITSIIGPVGFTTLYGLTA
GQWDGWVWLVAASLYLIAIPLLRQSASLLRS
>AAA20117.1|FEATURES|argannot|tetracycline|tetB(P)|antibiotic target protection|1
MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSS
TISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKEL
NIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIIND
DAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLD
GICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKV
KKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISA
IDKEKNPELFKALTLLAEEDPLLAFAMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVE
FSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKS
FQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQ
TVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMK
IASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD
>CAA90683.1|FEATURES|argannot|trimethoprim|dfrA13|antibiotic target replacement|1
MNPESVRIYLVAAMGANRVIGNGPDIPWKIPGEQKIFRRLTESKVVVMGRKTFESIGKPL
PNRHTVVLSRQAGYSAPGCAVVSTLSHVSPSTAEHGKELYVARGAEVYALALPHANGVFL
SEVHQTFEGDAFFPVLNAAEFEVVSSETIQGTITYTHSVYARRNG
>BAD02331.1|FEATURES|argannot|trimethoprim|dfrA17|antibiotic target replacement|1
LKISLISAVSENGVIGSGPDIPWSVKGEQLLFKALTYNQWLLVGRKTFDSMGVLPNRKYA
VVSKNGISSSNENVLVFPSIENALKELSKVTDHVYVSGGGQIYNSLIEKADIIHLSTVHV
EVEGDIKFPIMPENFNLVFEQFFMSNINYTYQIWKKG
>CAC81320|FEATURES|argannot|trimethoprim|dfrA19|antibiotic target replacement|1
MSHPQLELIVAVDSKLGFGKGGKIPWKCKEDMARFTRISKEIRVCVIGKHTYTDMRDMQL
EKDGAEERIKEKGILPERESFVISSTLKQEDVIGATVVPDLRAVINLYENTDQRIAVIGG
EKLYIQALSSATKLHMTIIPREFDCDRFIPVDPIQNNFHIDSSASETVEATVDETQERIH
FATYVRNNQ
>ABB71176|FEATURES|argannot|trimethoprim|dfrA25|antibiotic target replacement|1
MAARAKNGVIGCGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGPLPNRKYAVVTRS
NWTAANENVVVFPSIDEAMGRLGEITDHVIVAGGGEIYHETIPMASTLHVSTIDVEPEGD
VFFPNIPGKFDVVFEQQFTSNINYCYQIWQKG
>CAL48457|FEATURES|argannot|trimethoprim|dfrA26|antibiotic target replacement|1
MADEEYDPLLDDDMEDAKVAVIAARAQNGCIGRHGKLPWKLPGDLKYFRERTWGKPIIMG
RKTWESLNGALPGRTNIVVTRQQGYEAEGARVVDSIEEAISLAQSIALIEAVDEIMVLGG
GEIYTQALPQADILYLTEVHASVDGDAFFPDVDLSQYQETQRQDFEPSGGNPYPFSFVVY
QRT
>BAD88719.1|FEATURES|argannot|trimethoprim|dfrA17|antibiotic target replacement|1
MKISIMAAVSENGVIGSGLDIPWHVQGEQLLFKAMTYNHWLLVGRKTFDSMGKLPNRKYA
VVTRSEMVSNDPDVIYFTSIESALSYLDNTTTHVFVSGGGEIYKALIEQADVIHLSVIHK
HISGDVFFPSVPQSFKQTFEQSFSSNIDYTYQIWAKG
>CAX16467|FEATURES|argannot|trimethoprim|dfrA22|antibiotic target replacement|1
MNPESVRIYLVAAMGANRVIGNGPDIPWNIPGEQKIFRRLTEGKVVVMGRKTFESIGKPL
PNRRTVVLSRQASYSAAGCAVVSTLSQAIAIAAEHGKELYVAGGAEVYALALPRADGVFL
SEVHQTFEGDAFFPALDAAEFDVVSAETVQATITYTHSVYARRNG
>CAB06660|FEATURES|argannot|trimethoprim|dfrA17|antibiotic target replacement|1
MKISLMAAVSENGVIGSGLDIPWHVQGEQLLFKAMTYNQWLLVGRKTFDSMGKLPNRKYA
VVTRSKIISNDPDVVYFASVESALAYLNNATAHIFVSGGGEIYKALIDQADVIHLSVIHK
HISGDVFFPPVPQGFKQTFEQSFSSNIDYTYQIWAKG
>ADB54781|FEATURES|argannot|trimethoprim|dfrB6|antibiotic target replacement|1
MDQGSNEVGNPVAGQFSFPSNAAFSMGDRVRKKSGAAWQGQIVGWYCTKLTPEGYAVESE
AHPGSVQIYPVAALERINGVQG
>CAA90486.1|FEATURES|argannot|trimethoprim|dfrD|antibiotic target replacement|1
MWSFLKISLIVAMDKKRVIGKDNDIPWRISSDWEYVKNTTKGHAIILGRKNLQSIGRALP
DRRNIILTRDKNFNFKDCEIAHSIEAAFKLCENEEEVFIFGGEQIYVMFLPYVEKMYVTK
IHHEFEGDTFFPVVNFDDWKEVSVEKGIKDEKNPYDYYFHIYERIR
>CAR62505.1|FEATURES|argannot|trimethoprim|dfrK|antibiotic target replacement|1
MKVSLIAAMDKNRVIGKENDIPWRIPEDWEYVKNTTKGYPIILGRKNLESIGRALPGRRN
IILTRDKGFSFNGCEIVHSIEDVFELCNSEEEIFIFGGEQIYNLFLPYVEKMYITKIHYE
FEGDTFFPEVNYEEWNEVSVTQGITNEKNPYTYYFHIYERKAS
>AKF16168|FEATURES|argannot|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>SBV31106|FEATURES|argannot|polymyxin|MCR-1|antibiotic target alteration|1
MTSHHSWYRYSINPFVLMGLVALFLAATANLTFFEKAMAVYPVSDNLGFIISMAVAVMGA
MLLIVVLLSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNAMQTDQAESKDLMN
LAFFVRIIGLGVLPSVLVAVAKVNYPTWGKGLIQRAMTWGVSLVLLLVPIGLFSSQYASF
FRVHKPVRFYINPITPIYSVGKLASIEYKKATAPTDTIYHAKDAVQTTKPSERKPRLVVF
VVGETARADHVQFNGYGRETFPQLAKVDGLANFSQVTSCGTSTAYSVPCMFSYLGQDDYD
VDTAKYQENVLDTLDRLGVGILWRDNNSDSKGVMDKLPATQYFDYKSATNNTICNTNPYN
ECRDVGMLVGLDDYVSANNGKDMLIMLHQMGNHGPAYFKRYDEQFAKFTPVCEGNELAKC
EHQSLINAYDNALLATDDFIAKSIDWLKTHEANYDVAMLYVSDHGESLGENGVYLHGMPN
AFAPKEQRAVPAFFWSNNTTFKPTASDTVLTHDAITPTLLKLFDVTAGKVKDRAAFIQ
>AGW16411.1|FEATURES|CARD|beta_lactam|OXA-329|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNTVKQHQIHSISANKNSEAIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKAITTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQF
AYQLAHKMLPFSKDVQEQVQSMVFIEEKNGRKIYAKSGWGWDIEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>CAL44992.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|lnuA|antibiotic inactivation|1
MKNNNVTEKDLFYILDLFEHMKVTYWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVI
QKLEDIGYKIEVDWMPSRMELKHEEYGYLDIHPINLNDDGSITQANPEGGNYVFQNDWFS
ETNYKGRKIPCISKEAQLLFHSGYDLTEKDHFDIKNLKSIT
>AIT76106.1|FEATURES|CARD|beta_lactam|DHA-15|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGYMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AEG74318.1|FEATURES|CARD|quinolone|QnrS6|antibiotic target protection|1
METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFD
VADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFIT
GCNLSYANMERVCLEKCELYENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLC
HAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD
>AGW16412.1|FEATURES|CARD|beta_lactam|OXA-330|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNLVKQHQIHSISANKSSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQF
AYQLAHKTLPFSKNVQEQVQSMVFIEKKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTSSSIRKEIAYKGLEQLGIL
>AAC76539.1|FEATURES|CARD|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLAAGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVTGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>CWV56762.1|FEATURES|CARD|fosfomycin|FosX|antibiotic inactivation|1
MISGLSHITLIVKDLNKTTAFLQNIFNAEEIYSSGDKTFSLSKEKFFLIAGLWICIMEGD
SLQERTYNHIAFQIQSEEVDEYTERIKALGVEMKPERPRVQGEGRSIYFYDFDNHLFELH
AGTLEERLKRYHE
>YP_006965431.1|FEATURES|CARD|chloramphenicol|catB3|antibiotic inactivation|1
MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIG
SEAMVMPGIKIGHGAVIGSRSLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWN
WSLEKIKAAMPMLCSSNIVGLHKYWLEFAV
>ACB73258.1|FEATURES|CARD|beta_lactam|SHV-56|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADRTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAA99931.1|FEATURES|CARD|thiostrepton|tsnR|antibiotic target alteration|0
MANLDVIVDRSDPAVQRIVDVTKHSRSVVRTVLIEDIEPLTQSIRAGVEFTEVYGLDTVP
FPGDLLAACEKRGIRVRLLSAAVANQVFKTEKKPKVFGIAKVPPAGRFADLESLSGDVVL
LDGVKIVGNIGAIVRTRSALGAAGIVLVDSGLGTIADRRLIRASRGYVFSLPIVLATRDE
ALAFFRDGGMRPVVFEADGKLSIGELDGIDERLVLVFGSEKTGPSGEFAGVATESVSIPM
NPAAESLNVSVSAGIALHRRARRNLSRPRG
>YP_499945.1|FEATURES|CARD|multidrug|arlS|antibiotic efflux|0
MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKP
VKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGI
EYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQI
TKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDA
SHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVND
ISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAI
KYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLG
LSIAQKIIQLNGGSIKIKSEINKGTTFKIIF
>AAV70602.1|FEATURES|CARD|beta_lactam|CTX-M-38|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAARIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AIY30331.1|FEATURES|CARD|beta_lactam|OXA-422|antibiotic inactivation|1
MNKYFTCYVVASPFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>AAM77075.1|FEATURES|CARD|chloramphenicol|cmlA5|antibiotic efflux|1
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLM
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWASQSVLGFIAPMWLVGIGVATAVSVSPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAESTSNPNR
>CAA56561.1|FEATURES|CARD|beta_lactam|CepS|antibiotic inactivation|1
MKQTRALPLLALGTLLLAPLSLAAPVDPLKAVVDDAIRPVLKQHRIPGMAVAVLKGGQAH
YFNYGLADVATGAKVNEQTLFEIGSVSKTYTATLGAYAVVKGGFKLDDQVSGHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVDSSDTMRAYYRHWTPPYQAGTQRQYSNPSIGLFG
HLAASSLQQPFSTLMEQTLLPALGLEHTYLQVPEAAMARYAFGYSKEDKPIRVNPGMLAD
EAYGIKTGSADLLAFVKANISGVDDKALQQAIALTHTGFYRIGEMSQGLGWESYAYPVSE
QTLLAGNSPAVSLKANPVTKFETPAAPGAMRLYNKTGSTGGFGAYVAFVPAKGIGIVMLA
NRNYPIEARVSAAHAILSQLAP
>AAA99504.1|FEATURES|CARD|bacitracin|bcrA|antibiotic efflux|1
MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQ
IEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIV
GLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAK
ERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVV
LMEQHFDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKITMSEDSLEDYFVKLI
GGGTIG
>ABO93588.1|FEATURES|CARD|quinolone|QnrB2|antibiotic target protection|1
MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG
>ACC99191.1|FEATURES|CARD|beta_lactam|SHV-112|antibiotic inactivation|1
WETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSV
LPAGWFIADKTGAGERGARGIVALLGPDNKAERIVVIYLRDTP
>AAF34335.1|FEATURES|CARD|beta_lactam|SHV-21|antibiotic inactivation|1
MLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKV
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEFCAAAITMSDNSA
ANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEAFPGDARDTTTPASMAATLRKLL
TSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARGIVALLGPNNK
AERIVVIYLRDTPASMAERN
>AIT76114.1|FEATURES|CARD|beta_lactam|MIR-16|antibiotic inactivation|1
MMTKSLSCALLLSVASAAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>ACQ82807.1|FEATURES|CARD|beta_lactam|PDC-1|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALTQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>ABW95048.1|FEATURES|CARD|beta_lactam|OXA-117|antibiotic inactivation|1
LLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQTQQSYG
NDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTLGDAMKA
SAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLA
NKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTEWVVQPQGNIVAFS
LNLEMKKGIPSSVRKEITYKSL
>AGW16407.1|FEATURES|CARD|beta_lactam|OXA-325|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNTVKQHQIHTISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTDYIPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQF
AYQLAHKTLPFSKNVQEQVQSMVFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>YP_186749.1|FEATURES|CARD|multidrug|sav1866|antibiotic efflux|1
MIKRYLQFVKPYKYRIFATIIVGIIKFGIPMLIPLLIKYAIDGVINNHALTTDEKVHHLT
IAIGIALFIFVIVRPPIEFIRQYLAQWTSNKILYDIRKKLYNHLQALSARFYANNQVGQV
ISRVINDVEQTKDFILTGLMNIWLDCITIIIALSIMFFLDVKLTLAALFIFPFYILTVYV
FFGRLRKLTRERSQALAEVQGFLHERVQGISVVKSFAIEDNEAKNFDKKNTNFLTRALKH
TRWNAYSFAAINTVTDIGPIIVIGVGAYLAISGSITVGTLAAFVGYLELLFGPLRRLVAS
FTTLTQSFASMDRVFQLIDEDYDIKNGVGAQPIEIKQGRIDIDHVSFQYNDNEAPILKDI
NLSIEKGETVAFVGMSGGGKSTLINLIPRFYDVTSGQILIDGHNIKDFLTGSLRNQIGLV
QQDNILFSDTVKENILLGRPTATDEEVVEAAKMANAHDFIMNLPQGYDTEVGERGVKLSG
GQKQRLSIARIFLNNPPILILDEATSALDLESESIIQEALDVLSKDRTTLIVAHRLSTIT
HADKIVVIENGHIVETGTHRELIAKQGAYEHLYSIQNL
>AAU06362.1|FEATURES|CARD|beta_lactam|KPC-4|antibiotic inactivation|1
SLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRA
EERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVRWSPISEKYLTTGMTVAEL
SAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSS
PRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGGYG
TANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>AAA85213.1|FEATURES|CARD|trimethoprim|dfrD|antibiotic target replacement|1
MKISLIVAMDKKRVIGKDNDIPWRISSDWEYVKNTTKGHAIILGRKNLQSIGRALPDRRN
IILTRDKNFNFKDCEIAHSIEAAFKLCENEEEVFIFGGEQIYVMFLPYVEKMYVTKIHHE
FEGDTFFPVVNFDDWKEVSVEKGIKDEKNPYDYYFHIYERIR
>YP_108402.1|FEATURES|CARD|multidrug|amrB|antibiotic efflux|1
MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEES
VTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEP
VRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAE
YAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLT
TPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVA
TEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQN
FRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFS
AFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLV
VYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSP
SAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFA
INMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADV
TKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIER
IASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEA
ARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFV
CVGRVFDVVPRRRGGAQAALEAK
>AAP22974.1|FEATURES|CARD|beta_lactam|GES-7|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AAA26685.1|FEATURES|CARD|aminoglycoside|AAC(3)-VIIIa|antibiotic inactivation|1
MDEKELIERAGGPVTRGRLVRDLEALGVGAGDTVMVHTRMSAIGYVVGGPQTVIDAVRDA
VGADGTLMAYCGWNDAPPYDLAEWPPAWREAARAEWPAYDPLLSEADRGNGRVPEALRHQ
PGAVRSRHPDASFVAVGPAAHPLMDDHPWDDPHGPDSPLARLAGAGGRVLLLGAPLDTLT
LLHHAEARAEAPGKRFVAYEQPVTVGGRRVWRRFRDVDTSRGVPYGRVVPEGVVPFTVIA
QDMLAAGIGRTGRVAAAPVHLFEAADVVRFGVEWIESRMGGAAGGA
>BAE78116.1|FEATURES|CARD|polymyxin|PmrC|antibiotic target alteration|1
MLKRLLKRPSLNLLAWLLLAAFYISICLNIAFFKQVLQALPLDSLHNVLVFLSMPVVAFS
VINIVLTLSSFLWLNRPLACLFILVGAAAQYFIMTYGIVIDRSMIANIIDTTPAESYALM
TPQMLLTLGFSGVLAALIACWIKIKPATSRLRSVLFRGANILVSVLLILLVAALFYKDYA
SLFRNNKELVKSLSPSNSIVASWSWYSHQRLANLPLVRIGEDAHRNPLMQNEKRKNLTIL
IVGETSRAENFSLNGYPRETNPRLAKDNVVYFPNTASCGTATAVSVPCMFSDMPREHYKE
ELAQHQEGVLDIIQRAGINVLWNDNDGGCKGACDRVPHQNVTALNLPDQCINGECYDEVL
FHGLEEYINNLQGDGVIVLHTIGSHGPTYYNRYPPQFRKFTPTCDTNEIQTCTKEQLVNT
YDNTLVYVDYIVDKAINLLKEHQDKFTTSLVYLSDHGESLGENGIYLHGLPYAIAPDSQK
QVPMLLWLSEDYQKRYQVDQNCLQKQAQTQHYSQDNLFSTLLGLTGVETKYYQAADDILQ
TCRRVSE
>AHY03238.1|FEATURES|CARD|quinolone|QnrD2|antibiotic target protection|1
MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAK
LKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTN
LSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGA
LGELDARRTNLDGVKLDGEQAFQLVESLGVIVHR
>AHL30273.1|FEATURES|CARD|beta_lactam|OXA-386|antibiotic inactivation|1
MKIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAD37403.1|FEATURES|CARD|beta_lactam|TLA-1|antibiotic inactivation|1
MTVPISIIFWGNIMKKHLVVIAFCVLFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAV
LGIEDNFKLNVNEKHHYPMQSTYKFHLALAVLDKLDKENISIDKKLFVKKSELLPNTWSP
LRDKYPDGNVDLSISEILKATVSRSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKAT
EEEMHKAWNVQYTNWTTPDATVQLLKKFYKNEILSKNSYDYLLNTMIETTTGPKRLKGLL
PDGTVVAHKTGSSDTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAE
ICKSVWDYLVKDGK
>AGN33258.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|vgaA|antibiotic target protection|1
MKIMLEGLHIKHYVQDRLLLNINRLKIYQNDRIGLVGKNGNGKTTLLHILYKKIVPEEGI
VKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNDYIEKLEQ
DLKNWHGAFIIVSHDRAFLDNLCTTIWEIEEGRITEYKGNYSNYVEQKELERHREELEYE
KYEKEKKRLEKAINIKEQKAQRATKKPKNLSSSESRIKGTKPYFAGKQKKLRKTIKSLET
RLEKLESVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDK
MAIIGSNGTGKTTFIKKIVHGNHGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQN
ETLIRTILARMHFFRDDVYKPINVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAI
EAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIK
EDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK
>CAA62957.1|FEATURES|CARD|beta_lactam|CMY-2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>YP_489321.1|FEATURES|CARD|multidrug|mdtG|antibiotic efflux|0
MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN
>AHA11124.1|FEATURES|CARD|beta_lactam|OXA-361|antibiotic inactivation|1
MKILILLPLFSCLGLTACSLPVSSSPSQITSIQSTQAIAQLFDQAQSAGVLVIQRGQQIQ
VYGNDLSRANTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFSAWEKDMTLGQA
MQASAVPVYQELARRIGLELMQQEVQCIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVS
ALAREQLAFDPQVQQQVKVMLLLQEQQAYRLYAKSGWGMDVEPQVGWLTGWVKTPQAEIV
AFSLNMQMRNGMDPAIRLEILQQALAELGLYPKAEG
>ACQ82812.1|FEATURES|CARD|beta_lactam|PDC-7|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>AAX14802.1|FEATURES|CARD|multidrug|adeJ|antibiotic efflux|1
MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENT
VTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPE
DVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGG
SYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLL
QTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANAL
DTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQ
NWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVM
SEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVL
SLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGK
IFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFF
MNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIK
DASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPN
GQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGS
RMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGD
AMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESW
SIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEF
AKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLG
GVLSATFLGIFFIPVFYVWIRSMFKYKPKTINTQEHKS
>YP_001245420.1|FEATURES|CARD|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>AJG06170.1|FEATURES|CARD|beta_lactam|ACT-36|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LTVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>AAC72362.1|FEATURES|CARD|beta_lactam|TEM-10|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>BAO37256.1|FEATURES|CARD|beta_lactam|CTX-M-137|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>YP_001569085.1|FEATURES|CARD|beta_lactam|PC1|antibiotic inactivation|1
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>ABS43151.1|FEATURES|CARD|multidrug|cmeB|antibiotic efflux|1
MFSKFFIERPVFASVVAIIISLAGVIGLTNLPIEQYPSLTPPTVKVSATYTGADAQTIAS
TVASPIEDAINGADNMIYMDSTSSSSGTMSLTVYFDIGTDPDQATIDVNNRISAATAKMP
DAVKKLGVTVRKTSSATLAAISMYSSDGSMSAVDVYNYIALNVLDELKRVPGVGDANAIG
NRNYSLRIWLKPDLLNKFKITATDVISAVNDQNAQYATGKIGEEPVTQKSPYVYSITMQG
RLQNPSEFENIILRTNDDGSFLRLKDIADVEIGSQQYSSQGRLNGNDAVPIIINLQSGAN
ALHTAELVQAKMQELSKNFPKGLTYKIPYDTTKFVIESIKEVIKTFIEALILVIIVMYMF
LKNFRATLIPMIAVPVSLLGTFAGLYVLGFSINLLTLFALILAIGIVVDDAIIVVENIDR
ILHENEQISVKDAAIQAMQEVSSPVISIVLVLCAVFIPVSFISGFVGEIQRQFALTLAIS
VTISGFVALTLTPSLCALFLRRNEGEPFKFVRKFNDFFDWSTSVFSAGVAYILKRTIRFV
LIFCIMLGTIFYLNKAVPNSLVPEEDQGLMIGIINLPSASALHRTISEVDHISQEVLKTN
GIKDAMAMIGFDLFTSSLKENAAAMFIGLQDWKDRNVSADKIAMELNKKFAFDRNASSIF
IGLPPIPGLSITGGFEMYVQNKSGKSYDQIQKDVNKLVAAANQRKELSRVRTTLDTTFPQ
YKLIIDRDKLKHYNLNMQDVFNTMNATIGTYYVNDFSMLGKNFQVNIRAKGDFRNTQDAL
KNIFVRSNDGKMIPLDSFLTLQRSSGPDDVKRFNLFPAAQVQGQPAPGYTSGQAIEAIAQ
VAKETLGDDYSIAWSGSAYQEVSSKGTASYAFALGMIFVFLILAAQYERWLIPLAVVTAV
PFAVFGSFLLVYLRGFSNDIYFQTGLLLLIGLSAKNAILIVEFAMEERFKKGKGVFEAAV
AAAKLRFRPIIMTSLAFTFGVLPMIFATGAGSASRHSLGTGLIGGMIAASTLAIFFVPLF
FYLLENFNEWLDKKRGKIHE
>AGW83448.1|FEATURES|CARD|beta_lactam|OXA-350|antibiotic inactivation|1
MYKKALIVTTSILFLSACSSNSVKQNQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQF
AYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMNKGTPSSIRKEIAYKGLEQLGIL
>AGW16406.1|FEATURES|CARD|beta_lactam|OXA-324|antibiotic inactivation|1
MYKKTLIVTTSILFLSACSSNSVKQHQIHSMSANKNSEEIKSLFDQAQTTGVLVIKRGKT
EEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATATEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQF
AYQLAHKTLPFSKDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLAIL
>AIT97310.1|FEATURES|CARD|beta_lactam|CTX-M-158|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSVAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AAA25655.1|FEATURES|CARD|chloramphenicol|cat|antibiotic inactivation|1
MDTKRVGILVVDLSQWGRKEHFEAFQSFAQCTFSQTVQLDITSLLKTVKQNGYKFYPTFI
YIISLLVNKHAEFRMAMKDGELVIWDSVNPGYNIFHEQTETFSSLWSYYHKDINRFLKTY
SEDIAQYGDDLAYFPKEFIENMFFVSANPWVSFTSFNLNMANINNFFAPVFTIGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRLLNEIQQYCDEGCK
>AAA23018.1|FEATURES|CARD|chloramphenicol|cat|antibiotic inactivation|1
MQFTKIDINNWTRKEYFDHYFGNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTIINR
HEEFRTALDENGQVGVFSEMLPCYTVFHKETETFSSIWTEFTADYTEFLQNYQKDIDAFG
ERMGMSAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEEGGKYYIPL
SIQVHHAVCDGFHVCRFLDELQDLLNK
>AAB23649.1|FEATURES|CARD|chloramphenicol|cat|antibiotic inactivation|1
MEFRLVDLKTWKRKEYFTHYFESVPCTYSMTVKLDITTIKTGKAKLYPALLYAVSTVVNR
HEEFRMTVDDEGQIGIFSEMMPCYTIFQKDTEMFSNIWTEYIGDYTEFCKQYEKDMQQYG
ENKGMMAKPNPPVNTFPVSMIPWTTFEGFNLNLQKGYGYLLPIFTFGRYYEENGKYWIPL
SIQVHHAVCDGFHTCRFINELQDVIQSLQNHGGDEE
>CAA43218.1|FEATURES|CARD|chloramphenicol|cat|antibiotic inactivation|1
MTFNIIKLENWDRKEYFEHYFNQQTTYSITKEIDITLFKDMSKKKGYEIYPSLIYAIMEV
VNKNKVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLL
EYKDKEEMFPKKPIPENTLPISMIPWIDFSSFNLNIGNNSNFLLPIITIGKFYSENNKIY
IPVALQLHHAVCDGYHASLFINEFQDIIKKVDDWI
>AAF34334.1|FEATURES|CARD|beta_lactam|SHV-20|antibiotic inactivation|1
MLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKV
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
ANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEAFPGDARDTTTPASMAATLRKLL
TSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARGIVALLGPNNK
AERIVVIYLRDTPASMAERN
>ACX92987.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|vatH|antibiotic inactivation|1
MAEKLKGPNSNEMYPIAGNKSVQFVKPSLTRPNIIVGEFTYYDSKNGELFEDQVLYHYEI
IGDRLIIGKFCSIGPGVTFIMNGANHRMDGSTYPFNIFGHGWEKHTPTLDMLPLKGDTIV
GNDVWIGLDATIMPGVKIGDGAIIAAKSVVTKDVDPSTIVGGNPAKQIKKRFSESKIQEL
LKIKWWDFEDQVISDNIDAILSLDVEALNNISKEND
>AFY16910.1|FEATURES|CARD|quinolone|QnrB62|antibiotic target protection|1
MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>AGW25368.1|FEATURES|CARD|beta_lactam|CTX-M-142|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTANVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>CAA25854.1|FEATURES|CARD|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MERWRLLRDGELLTTHSSWILPVRQGDMPAMLKVARIPDEEAGYRLLTWWDGQGAARVFA
SAAGALLMERASGAGDLAQIAWSGQDDEACRILCDTAARLHAPRSGPPPDLHPLQEWFQP
LFRLAAEHAALAPAASVARQLLAAPREVCPLHGDLHHENVLDFGDRGWLAIDPHGLLGER
TFDYANIFTNPDLSDPGRPLAILPGRLEARLSIVVATTGFEPERLLRWIIAWTGLSAAWF
IGDGDGEGEGAAIDLAVNAMARRLLD
>CCK86743.1|FEATURES|CARD|beta_lactam|CMY-90|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPGDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AGU69252.1|FEATURES|CARD|beta_lactam|OXA-314|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAF86642.1|FEATURES|CARD|glycopeptide|vanSC|antibiotic target alteration|0
MKNRNPLIRKLLTQYFVTTGILLAFLVMIPLVIRFIAGTRTWYGTEPIYYILRFFADRWL
FCVAIGALLIWFGTTIYYMTKAIGYLNETIQATTQLIEEPSKRITLSSHLIDVQEEMNQL
REKSLQDQRAAKEAEQRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPQLSNAMRNRYTEI
ALQKAQRLELLISEFFEITRFNLTTIVLQTETTDLSLMLEQLTFEFLPLLEEKNLNWQLN
LQKNVLATVDTEKIARVFDNLIRNAINYSYPDSPLLLELVESDSIHIRLTNRGKTIPEEM
IGRLFEPFYRMDSSRATATSGTGLGLPIAKEILLASGGDISAESKDETIIFNVRLPKPAN
N
>BAD10948.2|FEATURES|CARD|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
MELRGDDVVLRPVADGEGEVLDRIVREPEVAAWWSPPEDFAGMLAIVFEGEVVGAIQFYE
ETDPEFHHAGIDVFLTARHQGKGLGTDAVRTLARWLVAERGHHRLTIDPAAANTAAIRSY
RKVGFRPVGIMRAYGRDHRTGRWQDALLMDLLADELT
>AAC75089.1|FEATURES|CARD|polymyxin|pmrE|antibiotic target alteration|0
MKITISGTGYVGLSNGLLIAQNHEVVALDILPSRVAMLNDRISPIVDKEIQQFLQSDKIH
FNATLDKNEAYRDADYVIIATPTDYDPKTNYFNTSSVESVIKDVVEINPYAVMVIKSTVP
VGFTAAMHKKYRTENIIFSPEFLREGKALYDNLHPSRIVIGERSERAERFAALLQEGAIK
QNIPMLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAESLGLNSRQIIEGVCLDPRIGN
HYNNPSFGYGGYCLPKDTKQLLANYQSVPNNLISAIVDANRTRKDFIADAILSRKPQVVG
IYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVIIYEPVMKEDSFFNSRLERDLATFKQQA
DVIISNRMAEELKDVADKVYTRDLFGSD
>ABA71726.1|FEATURES|CARD|glycopeptide|vanUG|antibiotic target alteration|0
MRVSYNKLWKLLIDRDMKKGELREAVGVSKSTFAKLGKNENVSLTVLLAICEYLNCDFGD
IIEALPETPDKERDS
>CAA33795.1|FEATURES|CARD|beta_lactam|class|antibiotic inactivation|1
MRFTATVLSRVATGLALGLSMATASLAETPVEALSETVARIEEQLGARVGLSLMETGTGW
SWSHREDELFLMNSTVKVPVCGAILARWDAGRLSLSDALPVRKADLVPYAPVTETRVGGN
MTLDELCLAAIDMSDNVAANILIGHLGGPEAVTQFFRSVGDPTSRLDRIEPKLNDFASGD
ERDTTSPAAMSETLRALLLGDVLSPEARGKLAEWMRHGGVTGALLRAEAEDAWLILDKSG
SGSHTRNLVAVIQPEGGAPWIATMFISDTDAEFEVRNEALKDLGRAVVAVVRE
>AHL30278.1|FEATURES|CARD|beta_lactam|OXA-378|antibiotic inactivation|1
MNIQALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
IQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRIGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABF66011.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|lmrC|antibiotic target protection|1
KHKWVALFSIVSTFIYAGVQLYQPQIMKRIMTVMSSTTYSRHQMADKVSGYGVELLVVAG
IGIIFAIFSTLSAARIAQEIGADVREATYKKINTFSYENVEKFNAGNLVVRMTNDVTQVQ
NLMMMVFQILMRIPVLLIGAVVLSITTLPRLWWITVLLIVLIVLVTAVLMGRMGPHFMAF
QKLMDRINAIAKQNLRGSRVVKSFVQEKNQIKDFDETSDELYDHNWAVGKLFSAMIPLFT
VIAQGAIWLAIYFVSTFVTESTTVAQDSIGGIATFMTYMGMIMFAIIMGGMISMFASRGM
VSIGRINEVLNTDPAMKFDENAKDEVLSGSVKFDHVSFSYPNDEEPTLKDISFEVEPGQM
VGIVGATGAGKSTLAQLIPRLFDPTEGTVSVGGKDLKTVSRGTLKKNISIVLQKAILFSG
TIAGNIKQGKADATDEEMTRAARIAQAAEFITTKDGQYDSEVEERGNNFSGGQKQRLSIT
RGVVKNPNVLILDDSTSALDAKSEKLVQEALNKDLKDTTTIIIAQKISSVVHADNILVLD
QGKLVGQGTHQELVAENKIYQEIYDTQKAQED
>AAB66655.1|FEATURES|CARD|aminoglycoside|APH(9)-Ib|antibiotic inactivation|1
MEDLPENLDQESLFQGLREFGISTTSASYAPLGFGDYHWHITGDDGQRWFATVSDLEHKE
HCGHGAPAALRGLRRAMDTAVHLREQGGLPFVVAPRTTSDGASLVPLDSRYALTVFPHVS
ARPGEFGQKLTERERDQVLVLLAELHGQAPPKCTPTTDMVPTGLDGVHTALAEPSGTWTG
GPFSEPARELLAEHEATLRGRMAEFGELVARVRGRGAPLVVTHGEPHPGNLILGEDGYVL
VDWDTVGLAIPERDLSLISDDPAALARYTELTGHTPDPAALALYRLRWSLLDVAEFVEWF
RGEHQRTSDTEAAWQSFAETLDHLNSEVPS
>ACQ82806.1|FEATURES|CARD|beta_lactam|PDC-2|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTVTLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>AAA22597.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|ErmD|antibiotic target alteration|1
MKKKNHKYRGKKLNRGESPNFSGQHLMHNKKLIEEIVDRANISIDDTVLELGAGKGALTT
VLSQKAGKVLAVENDSKFVDILTRKTAQHSNTKIIHQDIMKIHLPKEKFVVVSNIPYAIT
TPIMKMLLNNPASGFQKGIIVMEKGAAKRFTSKFIKNSYVLAWRMWFDIGIVREISKEHF
SPPPKVDSAMVRITRKKDAPLSHKHYIAFRGLAEYALKEPNIPLCVRLRGIFTPRQMKHL
RKSLKINNEKTVGTLTENQWAVIFNTMTQYVMHHKWPRANKRKPGEI
>ABG91835.1|FEATURES|CARD|trimethoprim|dfrA17|antibiotic target replacement|1
MKISLISAVSENGVIGSGPDIPWSVKGEQLLFKALTYNQWLLVGRKTFDSMGVLPNRKYA
VVSKNGISSSNENVLVFPSIENALKELSKVTDHVYVSGGGQIYNSLIEKADIIHLSTVHV
EVEGDIKFPIMPENFNLVFEQFFMSNINYTYQIWKKG
>ABA71731.1|FEATURES|CARD|glycopeptide|vanG|antibiotic target alteration|1
MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKIL
NNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFE
LAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPL
FIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVG
RVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDM
FYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE
>AGZ83156.1|FEATURES|CARD|beta_lactam|OXA-360|antibiotic inactivation|1
MKILILLPLLSCLSLTACSFAVSNSPSQITSTQSIQAIVKLFDQAQSSGVLVIQRGPHLQ
VYGNELSRAHTEYVPASTFKMLNALIGLQHGKATTNEIFKWDRKKRSFAAWEKDMTLGQA
MQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQHIDNFWLVGPLKVTPKQEVKFAS
ALAQEQLAFDPRFQQQVKTMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIV
AFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG
>AAK13078.1|FEATURES|CARD|beta_lactam|IMP-4|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAEPLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVDA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFGGVNYWLVKNKIEVFYPGPGHTPDNLVVWLPERKILFGGCFIKP
YGLGNLGDANLEAWPKSAKLLISKYGKAKLVVPSHSEAGDASLLKLTLEQAVKGLNESKK
PSKLSN
>BAC61820.1|FEATURES|CARD|beta_lactam|CARB-22|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDKRWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTQFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>AEZ36150.1|FEATURES|CARD|multidrug|qepA|antibiotic efflux|1
MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLW
ILDIYGFFVAGFLITMGTLGDRIGRRRLLLIGAAFFAFASVLAALADTAALLIAARALLG
LAGATIAPSTMALVRNMFHDPRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFW
LNVPVMLLTLALGPRFLPEYRDPDAGHLDLASVLLSLAAVLLTIYGLKQLAEHGEGLASM
AALLAGLAVGALFLRRQGHIAYPLLDLRLFAHALFRAALAAYALAALAMFGVYIFMTQYL
QLVLGLSPLQAGLATLPCSLCFVIGSLLSPQLAARWPAARILVVGLSAAAFGFAVLGLGQ
GLWWLVPATIVKGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFSGALGIALFGS
VGLVVYRQALTSAALPGLPADALQTAGASLGGAVHLADTLPAWQGAALLAAARAGFTDAL
QATAWAGAVLVLVAAGLVARLLRKRPALASG
>AAF67494.2|FEATURES|CARD|aminocoumarin|novA|antibiotic efflux|1
MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFM
LREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQ
LQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRL
TVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADS
LTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGT
LVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGE
VRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVL
LDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEH
IVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQA
IDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAP
APAPVPARDERVGAA
>AEP40503.1|FEATURES|CARD|glycopeptide|vanRN|antibiotic target alteration|0
MDTIVIVDDEKEIANLMTTFLENEGFKVMTFYSGKEALDYIDQNGASLAILDVMLPDLDG
FQILQHIRQTFFFPVLMLTAKGENLDKITGLTLGADDYITKPFNPLEVVARVKTQLRRTQ
RYDQPSHSQSDEEFTKEGLVLKKNSHQVFLFDQEVLITPLEFKILLYLFEHQGTVVSSET
LFEEVWQEKYLDNNNTVMAHIARLREKLGEKPRKPKYIKTVWGVGYIIEK
>CCP42991.1|FEATURES|CARD|aminoglycoside|AAC(2')-Ic|antibiotic inactivation|1
MHTQVHTARLVHTADLDSETRQDIRQMVTGAFAGDFTETDWEHTLGGMHALIWHHGAIIA
HAAVIQRRLIYRGNALRCGYVEGVAVRADWRGQRLVSALLDAVEQVMRGAYQLGALSSSA
RARRLYASRGWLPWHGPTSVLAPTGPVRTPDDDGTVFVLPIDISLDTSAELMCDWRAGDV
W
>NP_309766.1|FEATURES|CARD|multidrug|H-NS|antibiotic efflux|0
MSEALKILNNIRTLRAQARECTLETLEEMLEKLEVVVNERREEESAAAAEVEERTRKLQQ
YREMLIADGIDPNELLNSLAAVKSGTKAKRAQRPAKYSYVDENGETKTWTGQGRTPAVIK
KAMDEQGKSLDDFLIKQ
>AAC60781.1|FEATURES|CARD|polymyxin|rosA|antibiotic efflux|0
MTDRSETELPPSVNTQPFDNTKVKRTSFSILGAISVSHLLNDMIQSLILAIYPLLQAEFS
LSFAQIGLITLTYQLTASLLQPLIGLYTDKHPQPYSLPIGMGFTLSGILLLAVATTFPGG
FTWHAALVGTGSSVFHPESSRVAARLPVAATVWLSLFLGGRQFRQRLGPLLAAILIAPYG
KGNVGWFSLAALLAIVVLLQVSKWYQQQQRATYGKVVKVSSAKILPKKTVISALAILMVL
IFSKYFYLTSISSYYTFYLMHKFGVSVQNAQIHLFVFLFAVAAGTIIGGPLGDRIGRKYV
IWGSILGVAPFTLILPYVSLYWTGVLTVIIGLILASAFSAILVYAQELIPGKVGMVSGLF
FGFAFGMGGLGAAVLGYVADLTSIELVYQICAFLPLLGIITVFLPNIEDK
>CAE51745.1|FEATURES|CARD|tetracycline|tet(D)|antibiotic efflux|0
MYIEQHSRYQNKANNIQLRYDDKQFHTTVIKDVLLWIEHNLDQSLLLDDVANKAGYTKWY
FQRLFKKVTGVTLASYIRARRLTKAAVELRLTKKTILEIALKYQFDSQQSFTRRFKYIFK
VTPSYYRRNKLWELEAMH
>NP_249820.1|FEATURES|CARD|fosfomycin|fosA|antibiotic inactivation|1
MLTGLNHLTLAVADLPASIAFYRDLLGFRLEARWDQGAYLELGSLWLCLSREPQYGGPAA
DYTHYAFGIAAADFARFAAQLRAHGVREWKQNRSEGDSFYFLDPDGHRLEAHVGDLRSRL
AACRQAPYAGMRFAD
>AAL27444.1|FEATURES|CARD|glycopeptide|vanTE|antibiotic target alteration|0
MKHRANGIDLFRIFAATMVVAIHTFPFQSIAPFLDEVITLTVFRVAVPFFFMITGYFLLG
RLSLNFSYNNNQRVKKYLYKIGMIYLYSILLYFPLSLLNGTISLKMNILLLLKVFIFDGT
FYHLWYFPASIIGTILVTLLLRSIGFKLTVAFSTCLYLVGLGGDSWYGITNQVPLLNKLY
TFIFSWSDYTRSGVFFTPVFLCLGIFAYRVSKKLTASKILNLLFYVFIIGMTFESIFLHR
FTNVKHDSMYLLLPSCALILFLMLLNWQPKLKVKESADLTLLVYILHPLVIVIVHSISKY
IPILKNSLLNFLLVVVCSFILAQLLLNLKRKLRVSKQKIPFERASKEISASAIHHNINEI
RKIIPKNTNIMGVVKANAYGCGMVEVAYELEKIGISFFCVATIEEAIALRKSGNQGDILI
LGYTHPNRINDIKKYNLIQSIVSEEHGKVLNLKKIPIRCHLQVDTGMHRLGVTPNVTIIQ
QMYLFSNLKIEGIYSHLGSSDSLEQESIARTNTQIFLFNNILSDLEQMGISYGYTHIQSS
YGILNYPELSFDFVRIGILCYGFLSDYNSPTKIPIDLQPIVKVKASLITERIVEAGEYVG
YGLGAKVEKRTRIGVVSIGYADGIPRALSNAKLTLEFKGQSIKQIGNICMDMMLVDLSEV
EDISLNDELIVLPNISKIADEEQTITNELLSRLGSRLGTELN
>AAC75429.1|FEATURES|CARD|multidrug|evgS|antibiotic efflux|0
MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVI
AVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDI
VLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIH
QSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQY
NFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQ
HPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSP
GGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHS
QLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVP
NASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVT
TLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVIS
HNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIE
KRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMS
HEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQ
LQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNA
LKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGS
GLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLS
ILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFEL
TRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIA
PQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIH
GAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND
>NP_274719.1|FEATURES|CARD|multidrug|mtrC|antibiotic efflux|1
MAFYAFKAMRAAALAAAVALVLSSCGKGGDAAQGGQPAGREAPAPVVGVVTVHPQTVALT
VELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLA
TAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNR
SRITAPISGFIGQSKVSEGTLLNAGDATVLATIRQTNPMYVNVTQSASEVMKLRRQIAEG
KLLAADGVIAVGIKFDDGTVYPEKGRLLFADPAVNESTGQITLRAAVPNDQNILMPGLYV
RVLMDQVAVDNAFVVPQQAVTRGAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKD
GDKVVVEGISIAGITGAKKVTPKEWASSENQAAAPQSGVQTASEAKPASEAK
>AAC46343.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib10|antibiotic inactivation|1
MLRSSSRPKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARP
TLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQ
LLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVT
TPDGPAVYMVQTRQAFERTRSDA
>ABU39978.1|FEATURES|CARD|beta_lactam|blaI|antibiotic inactivation|0
MSNQTPSISEAEWEVMKVLWKKGPQTANQVISAIQEQTDWKPKTIRTLLDRLTKKKVVGV
DKEQKIYVFFPLYSEEACKHAEAQSFVKRVYGGTVKPLLVQFLEEESLTKEELDELYAIL
DQKRKE
>AGK07370.1|FEATURES|CARD|beta_lactam|OXA-257|antibiotic inactivation|1
MKFKMKGLFYVILSSLAFSGCVYDSKLQRPVISERETEIPLLFNQAQTQAVFVTYDGIHL
KSYGNDLSRAKTEYIPASTFKMLNALIGLQNAKATNTEVFHWNGEKRAFSAWEKDMTLAE
AMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFA
YQLAMKQLPFDRNVQQQVKDMLYIERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKV
TAFALNMKMQAGDDLAERKQLTLSILDKLGLFFYLR
>AGU69253.1|FEATURES|CARD|beta_lactam|OXA-315|antibiotic inactivation|1
MNIQALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPIYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPHG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAB41701.1|FEATURES|CARD|aminoglycoside|AAC(2')-Id|antibiotic inactivation|1
MLTQHVSEARTRGAIHTARLIHTSDLDQETRDGARRMVIEAFRDPSGDSDFTDDFTDDDW
DHALGGMHALISHHGALIAHGAVVQRRLMYRGPDGRGHALRCGYVEAVAVREDRRGDGLG
TAVLDALEQVIRGAYQIGALSASDIARPMYIARGWLSWEGPTSVLTPTEGIVRTPEDDRS
LFVLPVDLPDGLELDTAREITCDWRSGDPW
>ADV91011.1|FEATURES|CARD|rifampin|RbpA|antibiotic target protection|0
MADRVLRGSRLGAVSYETDRNHDLAPRQVARYRTDNGEEFDVPFADDAEIPGTWLCRNGL
EGTLIEGDVPEPKKVKPPRTHWDMLLERRSVEELEELLKERLDLIKAKRRGTGS
>ACV32635.1|FEATURES|CARD|beta_lactam|SHV-125|antibiotic inactivation|1
MRYIRLNIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQ
>CBX53726.1|FEATURES|CARD|beta_lactam|TEM-40|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMISTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>BAE78084.1|FEATURES|CARD|multidrug|mdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVN
ATVEKARAAAKQATDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ
>AAM09853.1|FEATURES|CARD|glycopeptide|vanYD|antibiotic target alteration|0
MERQNNNENQYGRNRRKDKRKKLFFYRAACAMLGLLIVCVIFGAVYFLRESKDPVLPSKE
NTKTGKDYSFLADGQSEDESPISEPAISNRANAIDLNIIAANAIVMNKDTDALLYQKKRH
GQNCAGQYSKDDYGVDRA
>ADX95999.1|FEATURES|CARD|fosfomycin|FosB3|antibiotic inactivation|1
MIKGINHITYSVSNIAKSIEFYRDILGADILVESETLAYFNLGGIWLALNEEKNIPRSEI
KYSYTHIAFTISDNDFEDWYNWLKENEVNILEGRDRDIRDKKSIYFTDLDGHKLELHTGS
LEDRLSYYKEAKPHMNFYI
>AIT76094.1|FEATURES|CARD|beta_lactam|DHA-18|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKETALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSWKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESVQSRYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AHL39340.1|FEATURES|CARD|beta_lactam|ACT-27|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>CAD91132.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|lnuF|antibiotic inactivation|1
MLQQKMIERFKEACHEDARIIAALMFGSFAIGEGDEFSDIEFAVFIQNNHFENFDQRSWL
NAVSPVAAYFPDDFGHHTALFENGIRGEFHFMRKSDIPVISTWQGYGWFPSLEEAVLLDR
SGELSRYASALVGSPPKREGAPLVEGLVLNLISLMLFGANLLNRGEYARAWALLSKAHEN
LLKLVRLHEGATDHWPTPSRALEKDVSEDSYNRYLACTGSAEPKALCVAYHETWKWSLEL
FRSVAGPLNIELPRIVIAQTKRLLNESATPHNK
>CAA68516.1|FEATURES|CARD|aminoglycoside|APH(6)-Ia|antibiotic inactivation|1
MSSSDHIHVPDGLAESYSRSGGEEGRAWIAGLPALVARCVDRWELKRDGGVRSGEASLVV
PVLRADGTRAALKLQMPREETTAALIGLRAWGGDGMVRLLDHDEESSTMLLERLDGSRTL
ASVEDDDEAMGVLAGLLNRLHSVPAPPGLRGLGEIAGAMVEEVPSAVDSLADPEDRSRLR
GWASAVAELVGEPGDRVLHWDLHYENVLAAEREPWLAIDPEPLVGDPGFDLWPALDTGWE
RIEATGDARRVVRRRFDLLTESLELDRGRAAGWTLARLLQNTLWDIEDGLTAIAPSQIAV
AEALAKP
>AAD51344.1|FEATURES|CARD|multidrug|smeA|antibiotic efflux|1
MSLLRPLSRSPRPLLLPLLLALAACSADRTDAPAMPEVGVIIASAQPLALQQTLPGRAVP
FEISEVRPQIGGLIRQRLFTEGQQVKAGQLLYQVDPAPYQAAFDTARGQLAQAEATVLSA
QPKAERTRALVSMDAASKQDADDATSALKQAQANVIAARAALQAARINLDYTRVTAPIDG
RIGTSSVTAGALVAAGQDTALTTIQRLDPVYLDVTQSSTQMLALRKRLDAGLVKAIDGKA
QVKVLLEDGSTYAHEGTLEFVGSAVDPGTGNVKLRAVIPNPDGLLLPGMYLKAVLPMATD
ARALLVPQKAVVRNERGEPLLRLLDAKDHVVERRVSTGQVVGNQWQITSGLKAGERVIVS
NGSAVSLGQQVKAVAPTTAQLAAMPAVDPNGNTDEKSH
>AAG23871.1|FEATURES|CARD|beta_lactam|OXA-33|antibiotic inactivation|1
ANIIYSSASASTDISTVASPLFEGTEGCFLLYDVSTNAEIAQFNKAKCATQMAPDSTFKI
ALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVVWVSQEITQKIGLNKI
KNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLRKIINHNLPVKNSAIE
NTIENMYLQDLENSTKLYGKTGAGFTANRTLQNGWFEGFIISKSGHKYVFVSALTGNLGS
NLTSSIKAKKNAITIL
>AAS68233.1|FEATURES|CARD|multidrug|norA|antibiotic efflux|1
MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGT
LADKLGKKLIICIGLVFFAVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTGMIADIS
PGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNP
QKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDI
SIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISF
VVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLY
MAIAVSLSGIIIIFIEKGLKSRRKEAN
>BAM10414.1|FEATURES|CARD|multidrug|oprA|antibiotic efflux|0
MPLSKLSASSLALCLGLLGACSLAPRYQRPEAPIPTTYPAVPASQQAGDRARLDDWQQQF
TDPVLRQMIGQALEHNRNLRVAALRIEEARALYGVQASERLPTLEASGRYERERMRGETR
EAGEVEQRYRVAAGISAFELDFFGRVKNLGDAALADYLASEEAQRSARIALIAEVAGGYV
QERALYAQQRLAERTLHARENGLALVRKRYAAGMSTRIDLRSEEMLVESARATHAALVRE
RSQAVSGLQLLLGDFTGDWQDSQLDLEHLQLQPLPAGLPSELLARRPDIRQAEQQLRAAN
ANIGAARAAFFPSLRLSTDLGSASSGLHGLFRGGSRVWTFSPQMTLPIFDGGRNRANLDL
AEVRKDIAVNRYEESIQVAFREVADALSAGDQLELQLRAQRAVRDADRERLQLVRKRYAK
GVANYLEMLDAQRSLFDSEQQLIHLRGLRLNNGVALYRALGGGWSQG
>AAL27446.1|FEATURES|CARD|glycopeptide|vanSE|antibiotic target alteration|0
MKNNLTVQITKKYFYTMIIITTILVILPLVAKMFLSLRVWQGTEFFYPILYILNRSLGVW
LIVTPLFIWLIVTYMFFRKMISYLEEMIVATKSLIETPNEKIVLRVELAEFENEINHIRI
DSLENKKMAEEAGKKRDDLLTYLAHDLRTPLTSIIGYISLLQNEQTYLELDSTKRKNYID
IISDKANRLEHLLNDFFEIAKTGKSREEVYKEEVDLSLMLSQISSEFLPLLDEKKLEWDF
KIEPNVFVQLNINKFERVLDNLIRNAISYSLNDTTIKLTLEKVDEKVVVSVGNITDKVSE
KDIDQLFEPFYRGDKSRNTKTGNAGLGLAIAKQIISEHGGTIEAELQNNDFKVSIIL
>AGU59995.1|FEATURES|CARD|beta_lactam|CMY-99|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYSNSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPATAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AHY20039.1|FEATURES|CARD|beta_lactam|CTX-M-152|antibiotic inactivation|1
MRKSVRRAILMTTACVSLLLASVPLYAHANDVQQKLAALEKSSGGRLGVALINTADNTQT
LYRADERFAMCSTSKVMAAAAVLKQSETQKDLLSQRVEIKSSDLINYNPIAEKHVNGTMT
LGELSAAALQYSDNTAMNKLIAHLGGPGKVTAFARAIGDDTFRLDRTEPTLNTAIPGDPR
DTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGSG
DYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>AAB53445.1|FEATURES|CARD|aminoglycoside|SAT-4|antibiotic inactivation|0
MITEMKAEHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDEEDEE
ADCLEYIDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINI
SIEWAKHKNLHGLMLETQDNNLIACKFYHNCGFKIGSVDTMLYANFENNFEKAVFWYLRF
>AAP93922.1|FEATURES|CARD|tetracycline|tet(41)|antibiotic efflux|1
MKKPMLVILLTVLLDAVGIGLIMPILPALLRSLGGLDAGSVHYGALLAAYALMQFLFSPI
LGALSDRFGRRPVLLISLAGAAADYLLMAFAPTLAWLYLGRLLAGITGANMAVATAYVTD
ITPVGQRARRFGLVGAVFGVGFIVGPLLGGSLGEWHLHAPFLAAAMMNALNLVMAFFLLP
ESRKSRPRAAEKIRLNPFSSLRRLHGKPGLLPLAGIYLVMALVSQAPATLWILYGQDRFG
WSMMVAGLSLAGYGACHALSQAFAIGPLVARLGERKALLIGLAADAVGLALLSVATRGWA
PFALLPFFAAGGMALPALQALMAHKVDDDHQGELQGTLASMGSLIGVAGPLVATALYAAT
RDVWPGLVWALAAALYLVVPPLLARSRARDAAP
>AAX14803.1|FEATURES|CARD|multidrug|adeK|antibiotic efflux|0
MQKVWSISGRSIAVSALALALAACQSMRGPEPVVKTDIPQSYAYNSASGTSIAEQGYKQF
FADPRLLEVIDLALANNRDLRTATLNIERAQQQYQITQNNQLPTIGASGSAIRQVSQSRD
PNNPYSTYQVGLGVTAYELDFWGRVRSLKDAALDSYLATQSARDSTQISLISQVAQAWLN
YSFATANLRLAEQTLKAQLDSYNLNKKRFDVGIDSEVPLRQAQISVETARNDVANYKTQI
AQAQNLLNLLVGQPVPQNLLPTQPVKRIAQQNVFTAGLPSDLLNNRPDVKAAEYNLSAAG
ANIGAAKARLFPTISLTGSAGYASTDLSDLFKSGGFVWSVGPSLDLPIFDWGTRRANVKI
SETDQKIALSDYEKSVQSAFREVNDALATRANIGERLTAQQRLVEATNRNYTLSNARFRA
GIDSYLTVLDAQRSSYAAEQGLLLLQQANLNNQIELYKTLGGGLKANTSDTVVHQPSSAE
LKKQ
>AAB05628.1|FEATURES|CARD|glycopeptide|vanXB|antibiotic target alteration|1
MENGFLFLDEMLHGVRWDAKYATWDNFTGKPVDGYEVNRIIGTKAVALALREAQIHAARL
GYGLLLWDGYRPKSAVDCFLRWAAQPEDNLTKEKYYPNIERAELITKGYVASQSSHSRGS
TIDLTLYHLDTGELVSMGSNFDFMDERSHHTAKGIGNAEAQNRRCLRKIMESSGFQSYRF
EWWHYKLIDEPYPDTYFNFAVS
>AHA41501.1|FEATURES|CARD|glycopeptide|vanXO|antibiotic target alteration|1
MNDDFVYVDDWVPGVRWDAKYATWDNFTGKPVDGYLANRIVGTRALCAALEQAREKAASL
GFGLLLWDGYRPRRAVDSFLRWSEQPEDGQTKQRHYPNIDRPEMLEKGYVATQSGHSRGG
AVDLTLYHLATGELAPMGGDHDLMDPISHHRARGIKPIESKNRELLRSIMEDCGFDRYDC
EWWHYTLKREPYPDVYFDFPIT
>AIT76095.1|FEATURES|CARD|beta_lactam|OXA-398|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKQQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>CAA03986.1|FEATURES|CARD|tetracycline|tap|antibiotic efflux|0
MTNTKRGPLLLILFAALTAGAGNGITIVAFPWLVLQHNGSALDASIVAMAGTLPLLVATL
IAGAAVDYLGRRRVSMISDLLSALSVAAVPVLALIFGVDAVNVAVLAVLAGLGAFFDPAG
MTARETMLPEAAGRAGWTLDHANSVYEAVFNLGYIVGPGIGGLMIATLGGINTMWVTAGA
FCCSILAISVLRLEGAGAPDRSVLTEAVLAGIVEGLRFVWYTPVLRTLAIVDLVATGLYM
PMESVLFPKYFTDRNEPTELGWVLMALSIGGLLGALGYAVMSRYMSRRATMLTAVITLGV
AMTVIAFLPPLPLILVLCAIVGFVYGPIAPIYNYVMQTTAPQHLRGRVVGVMGSLAYAAG
PLGLILAGPLADAAGLHATFLALSLPMLLLGVVAVFLPRLRELDLASKP
>CCA61905.1|FEATURES|CARD|beta_lactam|TEM-184|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAVTMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AHA80104.1|FEATURES|CARD|beta_lactam|CMY-103|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAATKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEEKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQGKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>BAN10684.1|FEATURES|CARD|beta_lactam|OXA-254|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAITVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAT48653.1|FEATURES|CARD|beta_lactam|VIM-14|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSSEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>ABA42118.2|FEATURES|CARD|macrolide-lincosamide-streptogramin|oleI|antibiotic inactivation|0
MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGA
TPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASW
PAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAE
DGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYG
DRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADL
GEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERI
VELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGIL
AEAG
>CAE50925.1|FEATURES|CARD|aminoglycoside|AAC(6')-Iid|antibiotic inactivation|1
MIISEFDRENIVLRDQLADLLRLTWPDEYGTEPMKEVEQLMAPERIAVSAIEGEELVGFV
GAIPQYGKTGWELHPLVVASTHRKQQIGTRLVSYLEKEVASYGGLVIYLGTDDVEGQTNL
VETDLFEDTFAKLQEIKNINHHPYTFYEKLGYQIIGVIPDANGWNQPDIWLAKRVAKREP
TE
>YP_001844885.1|FEATURES|CARD|beta_lactam|OXA-20|antibiotic inactivation|1
MIIRFLALLFSAVVLVSLGHAQEKTHESSNWGKYFSDFNAKGTIVVVDERTNGNSTSVYN
ESRAQQRYSPASTFKIPHTLFALDAGAVRDEFHVFRWDGAKRSFAGHNQDQNLRSAMRNS
TVWVYQLFAKEIGENKARSYLEKLNYGNADPSTKSGDYWIDGNLAISANEQISILKKLYR
NELPFRVEHQRLVKDLMIVEAKRDWILRAKTGWDGQMGWWVGWVEWPTGPVFFALNIDTP
NRMEDLHKREAIARAILQSVNALPPN
>AHK51384.1|FEATURES|CARD|beta_lactam|OXA-387|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIMTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAS07017.3|FEATURES|CARD|beta_lactam|SRT-2|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEETLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNDAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIVQALEKR
>AGV28567.1|FEATURES|CARD|multidrug|adeN|antibiotic efflux|0
MHDPVLESHHLVCEKPQTRRGIERRLALLLSATELFLEKGYDAVSLDDIVNHAGGSKTSI
YKYFGNKDGLFTAICDYRREMFFKDICIAFQPEQTSLKDYLIQTLIRFYKPFIQPEHIAF
LRLVIEQTQCNATLSQYLYEKCALDVQNTIAQALLISHQSGEITCTSPDHSSLMYFGILR
DIEWRMIMGMPLPPNETEVIDYINYCVDIFLKGHHKV
>ACV32637.1|FEATURES|CARD|beta_lactam|SHV-127|antibiotic inactivation|1
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNNAERMVVIYLRDTPASMAERNQ
>CAA37605.1|FEATURES|CARD|aminoglycoside|APH(3'')-Ia|antibiotic inactivation|1
MSDHPGPGAVTPELFGVGGDWLAVTAGESGASVFRAADATRYAKCVPAADAAGLEAERDR
IAWLSGQGVPGPRVLDWYAGDAGACLVTRAVPGVPADRVGADDLRTAWGAVADAVRRLHE
VPVASCPFRRGLDSVVDAARDVVARGAVHPEFLPVEQRLVPPAELLARLTGELARRRDQE
AADTVVCHGDLCLPNIVLHPETLEVSGFIDLGRLGAADRHADLALLLANARETWVDEERA
RFADAAFAERYGIAPDPERLRFYLHLDPLTWG
>AJU57235.1|FEATURES|CARD|beta_lactam|CTX-M-160|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPEGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>EFF04178.1|FEATURES|CARD|multidrug|emrD|antibiotic efflux|1
MIMKRHRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGV
SQLFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMAR
TLPRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFS
MARWMPETRPVDAPRTRLLTSYKTLFGNGGFNCYLLMLIGGLAGIAAFEACSGVLMGAVL
GLSSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMN
VWTLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLP
QTGQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>AHL39324.1|FEATURES|CARD|beta_lactam|CMY-82|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTHYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTKRVLRPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMTRWVQANMDASQVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AAA22289.1|FEATURES|CARD|chloramphenicol|cat86|antibiotic inactivation|1
MFKQIDENYLRKEHFHHYMTLTRCSYSLVINLDITKLHAILKEKKLKVYPVQIYLLARAV
QKIPEFRMDQVNDELGYWEILHPSYTILNKETKTFSSIWTPFDENFAQFYKSCVADIETF
SKSSNLFPKPHMPENMFNISSLPWIDFTSFNLNVSTDEAYLLPIFTIGKFKVEEGKIILP
VAIQVHHAVCDGYHAGQYVEYLRWLIEHCDEWLNDSLHIT
>ABW06859.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|Erm(41)|antibiotic target alteration|1
MDLGAGHGALTAHLVAAGARVLAVELHPGRARHLRSRFAEEDVRVAEADLLAFRWPRRPF
RVVASPPYQVTSALIRSLLTPESRLLAADLVLQRGAVHKHAKRAPVRHWTLRAGITLPRS
AFHHPPQVDSSVLVIRRR
>AHF71363.1|FEATURES|CARD|beta_lactam|OXA-370|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYETRIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>ABP04245.1|FEATURES|CARD|beta_lactam|CTX-M-62|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTESTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AIL92327.1|FEATURES|CARD|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>AAN41439.1|FEATURES|CARD|aminoglycoside|aadA8|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>AGW16413.1|FEATURES|CARD|beta_lactam|OXA-331|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNTVKQNQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATITEVFKWNGQKRLFPDWEKDMTLS
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQF
AYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>ABU39979.1|FEATURES|CARD|beta_lactam|blaR1|antibiotic inactivation|1
MTLPHILLSLVLITATILVIFFVRAVFYKQLSAKWRYHLWFLLITVLTLPFIPIHLLTGL
SFFDQGRQQITPSAQKRFGFADQNEQWMVDFGTSVSRFDDTFIHAVFVSIWIGGMIFFLL
LTLYHYAKLQRLVKAASRIQNQKVENAFSDCMAELQITNKLTNLESPAIQTPMTFGWLKT
YILLPKNIELYLSDDEIRHVLLHELHHYKSKHIKVNYIFVVYQIVYWFHPLVWKAFKEMR
LDRELACDTEVLLTLGQREYKAYGQTIMRFLERNSRFLYLTNPLHSSKKAFKNTKSYNIA
FFYWRVKSGAQLKKPWVVFAGLTRFCIAQFPFLTATAVSTERYQFDESQAVVEDYSTYFA
GNEGSFVLYSLTSDQFEIYNKEKSVRRVSPNSSYKIYTALMALELGVIGRDDSWLEWDGV
EYEDEAWNSGQDLKSAMSQSVTWYFQELDERIKQRNIQSFVNQLDYGNKDLSGGLNHYWL
ESSLKISPVEQVELLHSFYTNQLDFKEEHVQFVKEVMKLEENQKGTLYGKTGTGIVNGHA
INGWFIGFVETETDTYFFATNIQQKIMHMEARLLKSLYPFCQAKEFID
>AFE48832.1|FEATURES|CARD|beta_lactam|TEM-196|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKIFESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>NP_358969.1|FEATURES|CARD|quinolone|patB|antibiotic efflux|0
MGKYDFTSLPNRLGHHTYKWKETETDSEVLPAWIADMDFVVLPEIHQAVQTYADQLVYGY
TYASEDLIKEVQKWEATQYGYNFDKEALVFIEGVVPAISTAIQTFTKEGEAVLINTPVYP
PFARSVKLNNRRLITNSLVEKDSLFEIDFDQLEKDLVEEEVKLYVLCNPHNPGGRVWEKE
VLEKIGQLCQKHGVLLVSDEIHQDLTLFGHKHQSFNTINPAFKNFAIVLSSATKTFNIAG
TKNSYAVIENPKLRLAFQKRLLANNQHEISGLGYLATEAAYRYGKDWLEELKQVFEDHIN
YVVDLFGKETKIKVMKPQGTYLIWLDFSAYDLTDETLQELLRNEAKVILNRGLDFGEEGS
LHARINIAMPKSLLQEVCQRIVATFAKC
>AJP18054.1|FEATURES|CARD|beta_lactam|NDM-14|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMGALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>NP_248846.1|FEATURES|CARD|triclosan|TriA|antibiotic efflux|0
MSDARGAFHSKGRWSRMALPAILCAGLLVGCGAEPPAEEHVRVLAQTVKMAEFASATSIT
GDIQARVQADQSFRVGGKIVERLVDVGDHVAAGQVLARLDPQDQRSNVENAQAAVAAQQA
QSKLADLNYQRQKALLPKGYTSQSEYDQALASVRSAQSSLKAAQAQLANARDLLSYTELR
ASDAGVITARQAEVGQVVQATVPIFTLARDGERDAVFNVYESLFSHDVDGQRITVSLLGK
PEVTASGKVREITPTVDERSGTLKVKVGLDSVPAEMSLGSVVNASVAAPAEHSVVLPWSA
LSKVGEQPAVWLLDQQGKARLQPVRVARYASEKVVIDGGLEAGQTVVTVGGQLLHPGQVV
EVAQPPQPTQSTASRDAVGGGQP
>NP_252367.1|FEATURES|CARD|multidrug|mexJ|antibiotic efflux|0
MYRHIPLVALSLFSSLFLAACGNGTPPPAAARPAIVVQPQPAGEVSQAFPGEIRARHEPE
LAFRIGGKVIRRLVEVGERVKKDQPLAELDPQDVRLQLEAARAQVSAAEANLQTVRAEYR
RYRTLLDRNLVSHSQFENIQNSYRAGEARLKQIRAEFNVADNQAGYAVLRSPQDGVIASR
RVEVGQVVAAGQTVFSLAADGEREVLIGLPEHSFERFRIGQPVSVELWSQRDRRFAGHIR
ELSPAADPQSRTFAARVAFDDRATPAELGQSARVYVAAAEAVPLSVPLSALTAEAGQAFV
WVVEPGSSTLRRQAVRTGPYAEDRVPVLEGLKAGDWVVATGVQVLREGQQVRPIDRANRT
VKLAAKE
>AAG07763.1|FEATURES|CARD|multidrug|mexW|antibiotic efflux|1
MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLP
PDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQ
VFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAF
AAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVR
AKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLI
PVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPF
EAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTL
SPMMCSRLLRHEENPSGLAHRLDLIFEGLKQRYQRALHGTLDTRPVVLVFAVLVLALIPV
LLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYN
GVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFV
LNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDL
GVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIE
THERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYV
QEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYT
QVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVI
PLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH
>AJP77058|FEATURES|CARD|beta_lactam|MSI-OXA|antibiotic inactivation|1
MSHTFIIDRLGASMIKQILAALLLISPLLAQAAEWKESAQVARLFKQEGVSGTFVVYDVA
ADSYTVHDRQRANTRFIPASTFKIPNTLIALAHGAVANVDEVVPYGGKPVARPEWARDMG
LREAIRISNVPVYQEVARRVGLDRMRSELVRMKYGNMQTGTVVDRFWLDGPLKISAVEQT
EFLTKLAQGTLPFTNVAMAAVREISRQDGAPELYAKTGWGSRPGEADIGWWVGWLKKDGK
LYAFALNMDLPDGAQDKRVSLAKAALRELGLL
>WP_011461302.1|FEATURES|CARD|glycopeptide|vanSI|antibiotic target alteration|0
MAIKLKSEKSKRKNDYSKLKRKLFLQMLLLVSATAATVILMRSVIQKNFSVGDSIVEFLK
NTFYLRDSDAVIIYRYIFLHNIEVITFIVILIFLVILLGFSISWFTKYFDEISDGMDKLV
GESTAEIALSAELGFMENKLNQIKSNLEKQKKAALEAEQRKNDLVVYLAHDIKTPLTSVI
GYLSLLDEAPDMPPEQKAKYVGITLEKAYRLEQLINEFFEITRFNLQTIVLNKEKINLLF
MLQQLADEFYPMLTPAQGKQVSVNVPEGLTLWGDADKLARVFNNILKNALAYSYENSVID
ISAQKQDKNTVITFTNQGNPIPQEKLETIFEKFFRLDTSRSTNTGGSGLGLAIAKEIANA
HGGNIFVQSNSEKTVFTVVLPQKQEKATDRHC
>WP_080510927.1|FEATURES|megares|glycopeptide|vanSI|antibiotic target alteration|0
MKSEKSKRKNDYSKLKRKLFLQMLLLVSATAATVILMRSVIQKNFSVGDSIVEFLKNTFY
LRDSDAVIIYRYIFLHNIEVITFIVILIFLVILLGFSISWFTKYFDEISDGMDKLVGEST
AEIALSAELGFMENKLNQIKSNLEKQKKAALEAEQRKNDLVVYLAHDIKTPLTSVIGYLS
LLDEAPDMPPEQKAKYVGITLEKAYRLEQLINEFFEITRFNLQTIVLNKEKINLLFMLQQ
LADEFYPMLTPAQGKQVSVNVPEGLTLWGDADKLARVFNNILKNALAYSYENSVIDISAQ
KQDKNTVITFTNQGNPIPQEKLETIFEKFFRLDTSRSTNTGGSGLGLAIAKEIANAHGGN
IFVQSNSEKTVFTVVLPQKQEKATDRHC
>WP_011303797|FEATURES|CARD|fusidic_acid|fusD|antibiotic inactivation|1
MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDVTRDEILSTFNSRNTTIRSNVE
KLMNVQLTKEQAQKILTTIQMYVKPFEHPSNKQVTNLFKKVKKLKTPLISDEVLQTSTYI
GWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKSFCSICNKESRVALFMRKTRTGNDGQ
YTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ
>AAA26793.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|1
MTVRGLVKHYGETKALDGVDLDVREGTVMGVLGPNGAGKTTLVRILSTLITPDSGQATVA
GYDVVRQPRQLRRVIGLTGQYASVDEKLPGWENLYLIGRLLDLSRKEARARADELLERFS
LTEAARRPAGTYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVKAMVGD
GVTVLLTTQYMEEAEQLASELTVVDRGRVIAKGGIEELKARVGGRTLRVRPVDPLQLRPL
AGMLDELGITGLASTTVDTETGALLVPILSDEQLTAVVGAVTARGITLSSITTELPSLDE
VFLSLTGHRASAPQDAEPARQEVAV
>AGN74946|FEATURES|CARD|multidrug|salA|antibiotic target protection|1
MLFLFEEKALEVEHKVLIPELTFSIEDHEHLAIVGVNGVGKSTLLKVIHQDQSVDSAMME
QDLTPYYDWTVMDYIIESYPEIAKIRLQLNHTDMINKYIELDGYIIEGEIVTEAKKLGIK
EEQLEQKISTLSGGEQTKVSFLKVKMSKASLLLIDEPTNHMDLEMKEWLTKAFKQEQRAI
LFVSHDRTFLNETPDAILELSLDGAKKYIGKYDKYKQQKDIEHETLKLQYEKQQKEQAAI
EETIKKYKAWYQKAEQSASVRSPYQQKQLSKLAKRFKSKEQQLNRKLDQEHIPNPHKKEK
TFSIQHHNFKSHYLVQFNHVSFAYDNRKIFDDVSFYIKRNQNVIVEGRNGTGKSTLIKLI
LGELEPTKGDITVHPELEIGYFSQDFENLNMHHTVLDEILEIPEMKEADARTILASFYFD
KDRINDVVETLSMGEKCRLQFVKLYFSNPHIMILDEPTNYFDIGMQENIIQLIQSFQGSV
LIVSHDNYFKSQIKDQTWTIKNHQMTHENVQVKDPINTESMKHHLKELEQYTDERNRETE
F
>Q0SSM7|FEATURES|CARD|peptide|mprF|antibiotic target alteration|0
MWDSLKKSYRHLKNILGFVTDKRNYENIKKLLKNYKILSDISNIIVSVLVFLSGILLIIS
GIYPSIFYKIKFLDNIYSLSFLRFSHRASILIGLMLIMTSKEVFFKVKRAYYVTLTLLIV
GGAFAFIKDLDYKEGIFILGVIILLILSKKSFYRKSIPIKVTKLSGILIVLSIVMIIFAS
FIHKFNIHFSKNYKYYIDFFHSTKGYLRIALFTYISFIIFVIIWYLTMPKIEDDERYMDA
DLEKVSKFFKEIDYGTIFSHLVYLKDKKVFWANEGESLIMYSKYKDKIIVLGDPIATKEN
LYSCIEEFQAFTNLYGYDVVFYEIEEKNFSTYHDAGYYFFKLGEEARIDLEEFNLIGSKK
SAFRNTLRRVEREGYNFSIIEPPFNNEVVSQLKEISDKWLGDRKEKGFSLGWFSEDYIQR
SPIAILKNEEENKIMGFVTIMDANDGGETVAIDLMRIDKDAPNASMDYLMLNLFLTFKEK
GYKYFSLGEAPLSNVGFNTHSHLQEKLARLVYNSGNIFYSFDGLRRYKSKFSPIWQPRYL
AYPKFMSLPEVFINLCLLIANSKERVEKK
>AKA86814.1|FEATURES|CARD|multidrug|optrA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AEY83581|FEATURES|CARD|mupirocin|mupB|antibiotic target alteration|0
MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKD
LFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFM
YEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCE
TSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKV
NYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLP
ADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESD
INIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIE
WYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIED
IPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYP
ADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPIS
MIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDY
TRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSR
FWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEY
INLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDE
INVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKL
QKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVI
QQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQ
KEIGIQLMSSFTN
>AAO47226.2|FEATURES|CARD|beta_lactam|XD36_3096|antibiotic target alteration|0
MSTFPAPAAGSRPQDGSDYTARHLMVLDGLEAVRKRPGMYIGSSDSRGLMHCLWEIIDNS
VDEALAGACDHIEVILHDDGSVEVTDNGRGIPVDTEPRTGLSGVELAYTKLHAGGKFGGG
SYAASGGLHGVGASVVNALSARLDIEVDRHGRTHAISFRRGAPGTYSAPGPDAPFTRAQG
LHRTARIPKSRTGTRVRYWADRQIFLKDAKLSLENLHQRARQTAFLVPGLTIVVRDEYGL
GEGGSKGEESFRFDGGISEFCEYLAADKPVCDVLRLTGQGTFKETVPVLDEHGQMTPTEV
TRELGVDVALRWGTGYDTTLRSFVNIIATPKGGTHVAGFEQAVAKTMNEVLRAKKLLRVA
EDDIVKDDALEGLTAVVTVRLAEPQFEGQTKEVLGTSAARRIVNTVISRELKAFLTSTKR
DAAAQARVVMEKAVAAARTRIAARQHKDAQRRKTALESSSLPAKLADCRSDDVERSELFI
VEGDSALGTAKLARNSEFQALLPIRGKILNVQKSSVTDMLKNAECGAIIQVIGAGSGRTF
DIDAARYGKIIMMTDADVDGSHIRTLLLTLFHRYMRPMVESGRVFAAVPPLHRIELVQPK
KGQDRYVYTYSDRELRDRLMEFQSKGVRYKDSIQRYKGLGEMDADQLAETTMDPRHRTLR
RINLSDLEAAEQVFDLLMGNDVAPRKEFISSSAATLDRSRIDI
>CAE00499.1|FEATURES|CARD|multidrug|cdeA|antibiotic efflux|0
MENLFTRKFTTFEFLKFVSPAIISMIFISLYTIIDGIFVSTLVGSDALASINIVLPIINL
VCGFGIMMATGGGAIVSIRMGENRQDEANSTFSFIVLFSLIVGILFTVISYFFIKEISIL
LGATDKLLPYCITYGKVMILCTPFYILKFIFEYFARTDGNSKFSLFLSVIGGVTNIILDY
VFIKYFGMGLLGAAVATAIGIILTCVLGIIYFLSNKSTLKLRKPKTDFRLIRDTMINGSS
EMVTELSTGITTFLFNVVALKLAGENGLAALTIVLYAHFLMTSVYLGFAAGVSPLISYNF
GAENSDKLKETFKHSLKFIFISSLLVFIIALVFAPFIVRVFVNPDNTVFKLALQGLKIFA
FAFLFVGINIFASGFFTAFHNGKISAIISFSRAFVFIIIGIIILPPMLNMTGLWLTVPFA
EVITIFISILFIKKYKGRYKY
>WP_004746565.1|FEATURES|CARD|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AGU01679.2|FEATURES|CARD|beta_lactam|Rm3|antibiotic inactivation|1
MSLTPPRALVLALLLASPGTQAQTPAPATPPTPGCEVCATWNADQAPFRLFGNTYYVGMK
GLSSVLVTSPQGHVLIDGGLPESAPKIIANIGALGFRIEDVKLILNSHGHIDHAGGLAEL
QRRSNALVAASPSAALDLASGEVGPDDPQYHALPKYPPVKDMRLARDGGQFNVGPVYLTA
HATPGHTPGGLSWTWQSCDGPRCLNMVYADSINAVSRPGFKFSASSEYPNALADLRHSFE
TLEKLPCDVLISAHPEASQLWQRLEASATGGSDAFVDPQACRAYVAAARTLLDSRLDQEK
QQ
>WP_063857798.1|FEATURES|CARD|beta_lactam|ADC-3|antibiotic inactivation|1
MRFKKISCLLLSPLFFFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIYANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLSAIKK
>WP_017725267.1|FEATURES|CARD|beta_lactam|ADC-6|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTLFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PAMLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857816.1|FEATURES|CARD|beta_lactam|ADC-7|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTSGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>ABB43029.1|FEATURES|CARD|aminoglycoside|AAC(3)-IV|antibiotic inactivation|1
MQYEWRKAELIGQLLNLGVTPGGVLLVHSSFRSVRPLEDGPLGLIEALRAALGPGGTLVM
PSWSGLDDEPFDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPLP
LPPHSPASPVARVHELDGQVLLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLVR
VDYLENDHCCERFALADRWLKEKSLQKEGPVGHAFARLIRSRDIVATALGQLGRDPLIFL
HPPEAGCEECDAARQSIG
>AMB19637.1|FEATURES|CARD|beta_lactam|OXA-368|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPVSTFKIPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGDIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>BAG33043.1|FEATURES|CARD|polymyxin|pgpB|antibiotic target alteration|0
MEYILEVERNLFLTLNGVQHPLLDGFFYLISAKWTWVIMSIAFLFFLFYKKPTKEALFIV
GAVLLSVLICDQLSSSFFKPFFARFRPSHHPDFIDYVKTVYGYRGGKYGFISGHTTNYIS
LALFTSRIFRNKFYTWTIWSVVALVIYSRIYIGVHFITDIIPGIAVGLIVGHFVYKVYLY
ARSRWLGASCPAHPSAVYAGDSIRLWTLSLIGFVFAMLCMSRQLTEILQYYVFLLF
>NP_415434.1|FEATURES|CARD|multidrug|msbA|antibiotic efflux|1
MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTD
RSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQS
TGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSI
AIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQ
GMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKS
LTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALR
NINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVA
LVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVL
LSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLS
TIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ
>APB03219.1|FEATURES|CARD|pleuromutilin|TaeA|antibiotic efflux|1
MNILTVEQVTKSYGDKILFQDASFGMEDQDKIGIIGVNGTGKSTFLRVIAGLEPPDSGKI
SMGNRIRVRYLAQNPEFDPDKTVLQQVFEGDLPEMKAVREYTETMELLELHPSHEELQQK
LLKLNQTLETLQAWQLESDAKTILSKLGIRNYEAKMGTLSGGQRKRVALAAALIQPSDLL
ILDEPTNHIDNESVAWLEQYLQKRRGALLMITHDRYFLDRVANVMLELDHGRLFRYEANY
SRFLELKAEREEREAASEQKRQNLLRSELAWIRRGAKARTTKQKARIERFEKLKDQEMVH
SSGELDVSVASTRLGRKILEIEGLRMKIDDKTLIQDLSYIAVPEDRIGIVGPNGSGKSTL
LNLIAGRIQPGGGEVVLGPTVKLGYFTQEHQEMDGSQRVIEYIKDEAEVVRTADGSAITA
AQMLERFLFPPALQWTPIAKLSGGEKRRLYLLRVLMSAPNVLLLDEPTNDLDIQTLSVLE
QYLDEFPGVCIVVSHDRFFLDRTVDKIMAFEGDGQIRVHVGSYSEYAEWMQRHGGEASGS
KAEASIAKSASGSSDGTDSDSAKEAPRERLKFSYKEQREFDQIDGLIEDTESKLASIQSE
METAGSDAARLQELMKAQEETERELEHLMERWTYLNELAEKIEQSKKS
>NP_251218.1|FEATURES|CARD|multidrug|MuxA|antibiotic efflux|1
MTPTTGKSKFRTLRPWLITALAFAAVIGLVMWLAAPASAPSSDGRPGRGGKPGAALPKAN
ALTVGVARVEQGDLALHFNALGTVTAFNTVNVKPRVNGELVKVLFQEGQEVKAGDLLAVV
DPRTYKAALAQAEGTLMQNQAQLKNAEIDLQRYKGLYAEDSIAKQTLDTQEAQVRQLQGT
IRTNQGQVDDARLNLTFTEVRAPISGRLGLRQVDIGNLVTSGDTTPLVVITQVKPISVVF
SLPQQQIGTVVEQMNGPGKLTVTALDRNQDKVLAEGTLTTLDNQIDTTTGTVKLKARFEN
ADGKLFPNQFVNVRLLAQTLKGVLTIPANAVQRGTNGIYVYVVGADNKVSQRSVAIGTSE
NERVVVESGLKAGEQVVVEGTDRLRDGMEVRVAEASPQVLEGEPQKPQTGRPSGLQGDSV
GSGSAE
>ANZ79240.1|FEATURES|CARD|tetracycline|tetA(60)|antibiotic efflux|1
MNDLLKVIINFIKKHPMRYLVSFILMIGSSIAAVYPARIIGQVVDKIVASELNAEWLGTQ
LVILVGIILVAYITESIWTYFIFIGYYEIQKELRVKLLRNNLRKKIPFYAHFRTGEIITR
SSEDVTTIGDMMGFGMFALMNSTLLMSVSIYMMVTTISLPLTIAAILPLPILSYLVYKWG
FDLEEEYNKAQNAVSQLNNEVLEMIDGTYVIRAYGQEDAMMDEFRAKTKKAMKQNIIVTE
IESRFIPLAQLFMMISFTIALFYGGYLVSTGAILVGDVIAFQVYMGAIMWPMFMIGDIIT
NYKRGKVATERINEVLKHDDEIERGGTKTLETIESIEFKDFHFMYPGEEAPLLKEINLTL
RKGETLGIVGKTGSGKTTLLMQLLHQFPYRGEKLLINGEPLIDYDTQSVAGHLAYVPQEH
TLFSRTIRENMLFGKEDATDDEIWEALTLASFEGDVKRMPDELDTMVGEKGVSLSGGQKQ
RLSIARAFLRNRECLILDDALSAVDAKTEREIISHLQQERGGCMNIISAHRLSAIRHADE
IIVMNEGRISERGTHEELLEQRGWYYEQYLTQEMEEEIE
>AAG16656.1|FEATURES|CARD|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSVLAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>ABG77965.1|FEATURES|CARD|multidrug|acrA|antibiotic efflux|1
MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQQAPEVGVVTLKSEPLQITTELPGRT
NAYRIAEVRPQVSGIILKRNFTEGGDVQAGESLYQIDPATYQASYESAKGDLAKAQAAAK
IAQLTLNRYQKLLGTKYISQQDYDTALADAQQANAAVVAAKAAVETARINLAYTKVTSPI
SGRIGKSSVTEGALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENG
KAKVELITNDGIKFPQEGTLEFSDVTVDQTTGSITLRAIFPNPDKNLLPGMFVRARLEEG
TNPTALLVPQQGVTRTPRGDASALVVGADNKVEMRNITATQAIGDKWLVTEGLKDGDRVI
VTGLQKVRPGAQVKAQEVKSDDKQQASAAGQSEQTKS
>ALV80601.1|FEATURES|CARD|multidrug|bcr-1|antibiotic efflux|1
MPASASRIQVGSGERRLLLLLSALVAFGPLSIDMYLPSLPAIAADLGASDAQVQRSISGF
LVGFCVGMLFYGPLSDRFGRRPVLLAGIALYLFSSLACALADSAGQLVLLRVLQALGGGA
ASVLARAMVRDLYPLGEAARMLALMHMVTMLAPLAAPLLGGYLMLWAGWRALFVVLALFA
GLCLLAVWRVAESHPPERRGGSLAQAFLAYGRLLGDRRALGYVLCMGLAFAGMFAYISAA
PFVFIEHFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSLLACVSGLFL
LGYAALGERGGLWALVPGLLCFVSVTGLLGANCIASLLALYPGQAGAASAVAVSGQFGLG
CLASLAVGWLALPGVLPMALVMAVCGVGSLLALGLALHGGNR
>NP_252408.1|FEATURES|CARD|multidrug|ArmR|antibiotic efflux|0
MSLNTPRNKPSRTETEAVAASSGRSAVGRRDYTEQLRRAARRNAWDLYGEHFY
>AAA22851.1|FEATURES|CARD|tetracycline|tet(L)|antibiotic efflux|1
MNTSYSQSNLRHNQILIWLCILSFFSVLNEMVLNVSLPDIANDFNKPPASTNWVNTAFML
TFSIGTAVYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFSLLIMARFIQGAGAAAF
PALVMVVVARYIPKENRGKAFGLIGSIVAMGEGVGPAIGGMIAHYIHWSYLLLIPMITII
TVPFLMKLLKKEVRIKGHFDIKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHI
RKVTDPFVDPGLGKNIPFMIGVLCGGIIFGTVAGFVSMVPYMMKDVHQLSTAEIGSVIIF
PGTMSVIIFGYIGGILVDRRGPLYVLNIGVTFLSVSFLTASFLLETTSWFMTIIIVFVLG
GLLFTKTVISTIVSSSLKQQEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIPLLDQRLLPM
EVDQSTYLYSNLLLLFSGIIVISWLVTLNVYKHSQRDF
>WP_063857794.1|FEATURES|CARD|beta_lactam|ADC-20|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKTVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTSGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ENU37733|FEATURES|CARD|aminoglycoside|ANT(3'')-IIc|antibiotic inactivation|1
MSETLQLEQLTGYLQQLLGESLFAIYLYGSAVDGGLGPESDLDILVVVSQALTLPQRQQL
AETLLQISHPIGAAQRALEVTIVRKDHILSGSYPLSYELQFGEWLRDELSQGDMLSEHAD
PDLSILLKKAQLHHRSLFGPSLTQWSVEIPDQQLWQAMADTYPSIVAHWDEDADERNQIL
ALCRIYFSLVTNEIAPKDQAAQWVIAQLQPQHQPVLQRMVQEYKGEIEKQNWQQQHHALQ
PVVDFLSSKIDERFKQKKV
>ASF81896.1|FEATURES|CARD|polymyxin|MCR-3|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNRARN
SEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLD
SEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYQFAPDDQTRVPMQ
VWMSPGFTKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>AAR20596.1|FEATURES|CARD|beta_lactam|Bla2|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERKVEHKVIKNETGTISISQLNKNVWVHTEL
GCFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENINFVVPGHG
EVGDKGLLLHTLDLLK
>WP_063857791.1|FEATURES|CARD|beta_lactam|ADC-16|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSSSIYAGNTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGGYAKTKGTISFNDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKEWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPQKYPANIQRAINETHQGFYQVGTMYQALGWEEFSY
PALLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AKR18013.1|FEATURES|CARD|beta_lactam|PDC-73|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNLSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQGKVPLKR
>AKR18018.1|FEATURES|CARD|beta_lactam|PDC-78|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALTQDKMRLDDRASQHWPALQGSHFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPRPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQGKVPLKR
>AKR18020.1|FEATURES|CARD|beta_lactam|PDC-80|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALTQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAGGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQGKVPLKR
>AKR18025.1|FEATURES|CARD|beta_lactam|PDC-85|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGHGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQAKVPLKR
>AKR18026.1|FEATURES|CARD|beta_lactam|PDC-86|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAKGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQAKVPLKR
>AKR18028.1|FEATURES|CARD|beta_lactam|PDC-88|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSMALQPHRIARL
PAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSGLE
QQAKVPLKR
>NP_418486.1|FEATURES|CARD|multidrug|robA|antibiotic efflux|0
MSHQKIIQDLIAWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLL
LAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL
>NP_252410.1|FEATURES|CARD|multidrug|nalC|antibiotic efflux|0
MNDASPRLTERGRQRRRAMLDAATQAFLEHGFEGTTLDMVIERAGGSRGTLYSSFGGKEG
LFAAVIAHMIGEIFDDSADQPRPAATLSATLEHFGRRFLTSLLDPRCQSLYRLVVAESPR
FPAIGKSFYEQGPQQSYLLLSERLAAVAPHMDEETLYAVACQFLEMLKADLFLKALSVAD
FQPTMALLETRLKLSVDIIACYLEHLSQSPAQG
>CAB12062.1|FEATURES|CARD|multidrug|lmrA|antibiotic efflux|0
MSYGDSREKILSAATRLFQLQGYYGTGLNQIIKESGAPKGSLYYHFPGGKEQLAIEAVNE
MKEYIRQKIADCMEACTDPAEGIQAFLKELSCQFSCTEDIEGLPVGLLAAETSLKSEPLR
EACHEAYKEWASVYEEKLRQTGCSESRAKEASTVVNAMIEGGILLSLTAKNSTPLLHISS
CIPDLLKR
>NP_415449.1|FEATURES|CARD|multidrug|ompF|reduced permeability to antibiotic|0
MMKRNILAVIVPALLVAGTANAAEIYNKDGNKVDLYGKAVGLHYFSKGNGENSYGGNGDM
TYARLGFKGETQINSDLTGYGQWEYNFQGNNSEGADAQTGNKTRLAFAGLKYADVGSFDY
GRNYGVVYDALGYTDMLPEFGGDTAYSDDFFVGRVGGVATYRNSNFFGLVDGLNFAVQYL
GKNERDTARRSNGDGVGGSISYEYEGFGIVGAYGAADRTNLQEAQPLGNGKKAEQWATGL
KYDANNIYLAANYGETRNATPITNKFTNTSGFANKTQDVLLVAQYQFDFGLRPSIAYTKS
KAKDVEGIGDVDLVNYFEVGATYYFNKNMSTYVDYIINQIDSDNKLGVGSDDTVAVGIVY
QF
>YP_039996.1|FEATURES|CARD|multidrug|acrF|antibiotic target alteration|0
MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG
NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT
DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV
YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL
RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG
EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT
TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR
IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT
HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG
FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT
VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG
MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG
TCYNQRPIVAVGDVVEFNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL
VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI
LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT
LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL
GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG
RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL
DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD
>WP_001025093|FEATURES|CARD|peptide|pgsA|antibiotic target alteration|0
MNIPNQITVFRVVLIPVFILFALVDFGFGNVSFLGGYEIRIELLISGFIFILASLSDFVD
GYLARKWNLVTNMGKFLDPLADKLLVASALIVLVQLGLTNSVVAIIIIAREFAVTGLRLL
QIEQGFVSAAGQLGKIKTAVTMVAITWLLLGDPLATLIGLSLGQILLYIGVIFTILSGIE
YFYKGRDVFKQK
>CCP43073.1|FEATURES|CARD|ethambutol|iniC|antibiotic efflux|0
MSTSDRVRAILHATIQAYRGAPAYRQRGDVFCQLDRIGARLAEPLRIALAGTLKAGKSTL
VNALVGDDIAPTDATEATRIVTWFRHGPTPRVTANHRGGRRANVPITRRGGLSFDLRRIN
PAELIDLEVEWPAEELIDATIVDTPGTSSLACDASERTLRLLVPADGVPRVDAVVFLLRT
LNAADVALLKQIGGLVGGSVGALGIIGVASRADEIGAGRIDAMLSANDVAKRFTRELNQM
GICQAVVPVSGLLALTARTLRQTEFIALRKLAGAERTELNRALLSVDRFVRRDSPLPVDA
GIRAQLLERFGMFGIRMSIAVLAAGVTDSTGLAAELLERSGLVALRNVIDQQFAQRSDML
KAHTALVSLRRFVQTHPVPATPYVIADIDPLLADTHAFEELRMLSLLPSRATTLNDDEIA
SLRRIIGGSGTSAAARLGLDPANSREAPRAALAAAQHWRRRAAHPLNDPFTTRACRAAVR
SAEAMVAEFSARR
>NP_312937.1|FEATURES|CARD|rifampin|rpoB|antibiotic target alteration|0
MVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQYGLEAAFRSVFPIQ
SYSGNSELQYVSYRLGEPVFDVQECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ
EVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR
GSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVIFEIRDNKLQME
LVPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKDDVKLIEVPVEYIAGKVVAKD
YIDESTGELICAANMELSLDLLAKLSQSGHKRIETLFTNDLDHGPYISETLRVDPTNDRL
SALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSLLREEIEGSGIL
SKDDIIDVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS
LGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTR
ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRKVTDGVVT
DEIHYLSAIEEGNYVIAQANSNLDEEGHFVEDLVTCRSKGESSLFSRDQVDYMDVSTQQV
VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVTAVAKR
GGVVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCINQMPCVSLGEPVERG
DVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVS
RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEK
LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEEMQLKQAKKDL
SEELQILEAGLFSRIRAVLVAGGVEAEKLDKLPRDRWLELGLTDEEKQNQLEQLAEQYDE
LKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRRIQPGDKMAGRHGNKGVISKIN
PIEDMPYDENGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAK
LREFIQRAYDLGADVRQKVDLSTFSDEEVMRLAENLRKGMPIATPVFDGAKEAEIKELLK
LGDLPTSGQIRLYDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG
GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMP
ESFNVLLKEIRSLGINIELEDE
>AAL82403.1|FEATURES|CARD|quinolone|gyrA|antibiotic target alteration|0
MTDLTRLPEHDVSTGIEPVSIIEEMQCSYLDYAMSVIVSRALPDVRDGLKPVHRRILHAM
NEMGLLFNKPYRKSAGVVGEVMGKFHPHGDASIYDALVRMAQDFSLRNPLIDGQGNFGSV
DGDPPAAMRYTECRLEKVAEELLADIDKDTVDFQDNYDGREHEPIVLPARFPNLLVNGSG
GIAVGMATNIPPHNLGEVIDGCVALIDNPNITIDEMLAIIPGPDFPTGGIILGHSGVRSA
YETGRGSIIMRAKVEIEEIRNQRQAIIVSEIPYQVNKATMVEKMAELVRDKRIEGISDLR
DESDRDGYRVVIELKREAVADVVLNQLYRYTPLQASFGCNMVALNGGKPEQMTLLDMLRA
FVSFREEVVSRRTKYLLRKARERAHVLVGLAIAVANIDEIIELIRKAHDPQTARTQLMER
RWPASEVAALIKLIDDPRHIIHEDNTYNLSEEQARAILELRLQRLTALGRNEIADELNAI
GEDIADYLGILASRSRIMDIVKSELSALRETFATPRRTVFGFGSAEMDCEDLIVPEDMVV
TVSHSGYIKRVPLNTYRAQRRGGKGRSGMATKDQDFVTRLFVANTHTPVLFFSSRGIVYK
EKVWRLPVGTPQSRGRALINMLPLQQGERITTIMPLPEDEASWGKLDIMFATTRGTVRRN
KLSDFIQVNRNGKIAMKLDEEGDEILSVETCTEHDDVVLITANGQCIRFPVTDIRVFSGR
NSMGVRGINMVEGDKVISMTILEHVEATSVERSAYIKRAINERRVAGSDDEDILTVDEDG
EETEVELTDERYAELSAHEQMLLTVSEFGYGKRSSSYDFRISGRGGKGIRATDLSKAAEI
GKLVAAFPVGERDQIMLVSDGGQLIRVPVNCIRIAGRSTKGVTVFNTAKGEKVVSVERIS
ESENDTNQLDIESEEHSGTVSMSEEKKL
>AAB57788.1|FEATURES|CARD|rifampin|rphB|reduced permeability to antibiotic|0
MKKSLIALTLAALPVAATADVTLYGAIKAGVQTYRSVEHTKGKVSKVETGSEIADFGSKI
GFKGQEDLGNGLKAVWQLEQGASVAGTNTGWGNKQSFVGLKGGFGTIRAGSLNSPLKNTG
ANVNAWESGKFTGNVLEISGMAQREHRYLSVRYDSPEFAGFSGSVQYAPKDNSGSNGESY
HVGLNYRNNGFFAQYAGLFQRYGEGTKKIEYEHQVYSIPSLFVEKLQVHRLVGGYDNNAL
YVSVAAQQQDAKLYGARRANSHNSQTEVAATAAYRFGNVTPRVSYAHGFKGTVDSADHDN
TYDQVVVGAEYDFSKRTSALVSAGWLQEGKGADKIVSTASAVVLRHKF
>CCP44244.1|FEATURES|CARD|beta_lactam|ROB-1|antibiotic target alteration|0
MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPL
LELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGI
HISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAG
KYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAK
TVCALLSDWLPATTGDIIYADGGAHTQLL
>CDO45096.1|FEATURES|CARD|beta_lactam|Sbal223_2079|antibiotic target alteration|0
MTQCASRRKSTPSRAILGAFASARGTRWVATIAGLIGFVLSVATPLLPVVQTTAMLDWPQ
RGQLGSVTAPLISLTPVDFTATVPCDVVRAMPPAGGVVLGTAPKQGKDANLQALFVVVSA
QRVDVTDRNVVILSVPREQVTSPQCQRIEVTSTHAGTFANFVGLKDPSGAPLRSGFPDPN
LRPQIVGVFTDLTGPAPPGLAVSATIDTRFSTRPTTLKLLAIIGAIVATVVALIALWRLD
QLDGRGSIAQLLLRPFRPASSPGGMRRLIPASWRTFTLTDAVVIFGFLLWHVIGANSSDD
GYILGMARVADHAGYMSNYFRWFGSPEDPFGWYYNLLALMTHVSDASLWMRLPDLAAGLV
CWLLLSREVLPRLGPAVAASKPAYWAAAMVLLTAWMPFNNGLRPEGIIALGSLVTYVLIE
RSMRYSRLTPAALAVVTAAFTLGVQPTGLIAVAALVAGGRPMLRILVRRHRLVGTLPLVS
PMLAAGTVILTVVFADQTLSTVLEATRVRAKIGPSQAWYTENLRYYYLILPTVDGSLSRR
FGFLITALCLFTAVFIMLRRKRIPSVARGPAWRLMGVIFGTMFFLMFTPTKWVHHFGLFA
AVGAAMAALTTVLVSPSVLRWSRNRMAFLAALFFLLALCWATTNGWWYVSSYGVPFNSAM
PKIDGITVSTIFFALFAIAAGYAAWLHFAPRGAGEGRLIRALTTAPVPIVAGFMAAVFVA
SMVAGIVRQYPTYSNGWSNVRAFVGGCGLADDVLVEPDTNAGFMKPLDGDSGSWGPLGPL
GGVNPVGFTPNGVPEHTVAEAIVMKPNQPGTDYDWDAPTKLTSPGINGSTVPLPYGLDPA
RVPLAGTYTTGAQQQSTLVSAWYLLPKPDDGHPLVVVTAAGKIAGNSVLHGYTPGQTVVL
EYAMPGPGALVPAGRMVPDDLYGEQPKAWRNLRFARAKMPADAVAVRVVAEDLSLTPEDW
IAVTPPRVPDLRSLQEYVGSTQPVLLDWAVGLAFPCQQPMLHANGIAEIPKFRITPDYSA
KKLDTDTWEDGTNGGLLGITDLLLRAHVMATYLSRDWARDWGSLRKFDTLVDAPPAQLEL
GTATRSGLWSPGKIRIGP
>WP_004025678.1|FEATURES|CARD|quinolone|gyrB|antibiotic target alteration|0
MNDSNKENKYTAESIKVLEGLEAVRKRPGMYIGSTQSEGLHHMIWEIVDNSIDEAMGGFA
TVVKVIIKKDGVIRVEDDGRGIPVGIHEKTGLSGVETVLTVLHAGGKFDNDSYKVSGGLH
GVGASVVNALSKNFKVWVNKNYVQHYVEFINGGHAIEPLKIINDKDIKEKGTTIEFIPDF
EIMEENEWDELKIMARLKQLAYLNKGVNIEFESEMTNRKEKWHYEGGLKEYIADLNAEKE
PLFDAIVYGEEEKEVKVPGHNDQTYNIKCEVAFQYNNSYNNSTHSFCNNINTTEGGTHEE
GFKLAITRLLNKYAIDKKYLKDTDDKITKEDVSEGLTAIISIKHPNPQYEGQTKKKLGNS
EVRPYVNEITSIIFEKFLNENPEESKKIVAKVMQAAEARRRSHEAREATRRKSPFESNSL
PGKLADCSNRDSSVTEIYIVEGDSAGGSAKTGREREFQAILPLRGKIINVEKAKIDKIFA
NEEIQNMITAFGAGIGPEFNIEKLRYSKIIIMTDADVDGSHIRILLLTFFYRYMLPLIQN
GNVYIAQPPLYKVSYGKTIKYAYSDQELEKIKSTLLNTKYNIQRYKGLGEMNPDQLWETT
MDPKNRLLLKVNIEDAAIADKTFSLLMGDDVTPRKEFIEKNAKYVKNIDA
>YP_040772.1|FEATURES|CARD|beta_lactam|CTX-M-101|antibiotic target alteration|0
MSEIIQDLSLEDVLGDRFGRYSKYIIQERALPDVRDGLKPVQRRILYAMYSSGNTHDKNF
RKSAKTVGDVIGQYHPHGDFSVYEAMVRLSQDWKLRHVLIEMHGNNGSIDNDPPAAMRYT
EAKLSLLAEELLRDINKETVSFISNYDDTTLEPMVLPSRFPNLLVNGSTGISAGYATDIP
PHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKKAYESGKGRIIVR
SKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEVRDETDRTGLRIA
IELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIIDSYLNHQIEVVAN
RTKFELDNAEKRMHIVEGLIKALSILDKVIELIRSSKNKRDAKENLIEVYEFTEEQAEAI
VMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEELNEIKKKFKSERL
SLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSYNASGVEDIGLKDGDSLLKH
QEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDEVVINVFNEKDFN
TDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDDLISVMRFEKDQLITIITNK
GMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMATQRGSLKRISFKI
LQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHGLINDIHKSEQYT
NGSFIVDTDDFGEVIDMYIS
>CAG39573|FEATURES|CARD|tetracycline|tetT|antibiotic target alteration|1
MAREFSLEKTRNIGIMAHIDAGKTTTTERILYYTGRIHKIGETHEGASQMDWMEQEQDRG
ITITSAATTAAWEGHRVNIIDTPGHVDFTVEVERSLRVLDGAVTVLDAQSGVEPQTETVW
RQATTYGVPRIVFVNKMDKLGANFEYSVSTLHDRLQANAAPIQLPIGAEDEFEAIIDLVE
MKCFKYTNDLGTEIEEIEIPEDHLDRAEEARASLIEAVAETSDELMEKYLGDEEISVSEL
KEAIRQATTNVEFYPVLCGTAFKNKGVQLMLDAVIDYLPSPLDVKPIIGHRASNPEEEVI
AKADDSAEFAALAFKVMTDPYVGKLTFFRVYSGTMTSGSYVKNSTKGKRERVGRLLQMHA
NSRQEIDTVYSGDIAAAVGLKDTGTGDTLCGEKNDIILESMEFPEPVIHLSVEPKSKADQ
DKMTQALVKLQEEDPTFHAHTDEETGQVIIGGMGELHLDILVDRMKKEFNVECNVGAPMV
SYRETFKSSAQVQGKFSRQSGGRGQYGDVHIEFTPNETGAGFEFENAIVGGVVPREYIPS
VEAGLKDAMENGVLAGYPLIDVKAKLYDGSYHDVDSSEMAFKIAASLALKEAAKKCDPVI
LEPMMKVTIEMPEEYMGDIMGDVTSRRGRVDGMEPRGNAQVVNAYVPLSEMFGYATSLRS
NTQGRGTYTMYFDHYAEVPKSIAEDIIKKNKGE
>NP_212606|FEATURES|CARD|fosfomycin|Borrelia|antibiotic target alteration|0
MHSYIVEGGYKIGGQITASGNKNAALPCILAALLTDEEVILENIPNINDVKVVLDILNDI
GADIAREGNTLKIKVLNIVKTEIDSSFTDLIRASILLLGPFVSRFGKIDMALPGGDVIGK
RRLDTHFYGLCKLGAKLSTKDRRIVLKANKLVGAEMFLDEASVTATENIIMAAVLAEGNT
VIMNAACEPHVQDLCNMLNSMGANILGIGSNVLEIKGVKKLSGTVFRIGADFMQVGSLIS
LAALTGGELEIKKADPQHFRLIRHVYSRLGINFEYDRENVYVRNKQELKVKLDFGGHIPK
IDDGPWPAFPTDLMSIIVVTATQVEGTVLVFEKMFESRMFFVDKLIKMGARIVLCDPHRV
VVTGKSSLKGNVLSSPDVRAGMSLLIAAFVAEGRSEIQNVYQIERGYEDVVNKLINLGAK
IKKVKSQ
>CUX99269.1|FEATURES|CARD|glycopeptide|vanTN|antibiotic target alteration|0
MNSSWRFFVVVEALLLLFAVWQIVNNTGLLLLVIFGIFNIYLAMRKYPRTKFQNFQLILG
SLVIFFSLVNSPALWMMVVLAVLFIGLKGVEISGIDLTKNAFWRKKQIMMVQTEQLKTHN
NERKRQQLFGNQRIGNDVYEWDDINIAIISGDTIIDLGNTLLPKDDNIVIVRKGIGRTRI
LVPLGVAIRLEHATLVGNVLFEEEQFSLKNEQIKICSSDYDENPRRLKIITNTLVGDVEV
IRI
>AAO82600.1|FEATURES|CARD|polymyxin|PmrB|antibiotic target alteration|0
MTDRISRRMISLYASLSTFIVILITLFSYFHSIKQNRWLLELLQRKVFYLPLIVHIVLIS
LLIGLLTFLLISLVQKGQYGRIEEKLRLLANGNYESPVLNKPTTSENQDHYLTEVEQDIW
SIKNKLLEMSKELQLLNSRPQLMDGQTKEEILENERHRLARELHDSVSQQLFAAMMMLSA
LNEQAQRTETPEPYRKQLAMVAEIINASQSEMRALLLHLRPISLEGKSLRKGIEQLLKEL
QTKIKIELIWDVEDVHLNSSIEDHLFRIVQELLSNTLRHAKAKELEVYLHQVDKNVLLRI
VDDGVGFDMKEQSNKAGSYGLNNIRERVVGMGGTVKIISFKGQGTSVEIKVPVIKEETAS
DQSNVSG
>NP_249871.1|FEATURES|CARD|multidrug|smeS|antibiotic efflux|0
MIRSLRIRLMLGAAALAVLFMLALLPALQRAFGIALENTIEQRLAADVATLVSAARVEKG
RLVMPEHLPVEEFNLPEAKVLGYIYDQNGDLLWRSTSAADESINYTPRYDGRGNEFHTTR
DAKGEEFFVFDVEIDLLRGKQAAYSIVTMQSVSEFESLLKGFREQLYLWLGGALLVLLGL
LWLGLTWGFRAMRGLSSELDQIESGERESLSEEHPRELLRLTHSLNRLLRSEHKQRERYR
HSLGDLAHSLKTPLAVLQGVGDQLAEEPGNREQVRVLQGQIERMSQQIGYQLQRASLRKS
GLVRHREQLAPLVETLCDALDKVYRDKRVSLQRDFSPSFSVPVERGALLELLGNLLENAY
RLCLGRVRVGARLGPGYSELWVEDDGPGVPAEQRARIIRRGERADTQHPGQGIGLAVALD
IIESYDGELSLDDSELGGACFRIRFATV
>CDJ73205|FEATURES|CARD|multidrug|evgA|antibiotic target alteration|0
MITVALIDDHLIVRSGFAQLLGLEPDLQVVAEFGSGREALAGLPGRGVQVCICDISMPDI
SGLELLSQLPKGMATIMLSVHDSPALVEQALNAGARGFLSKRCSPDELIAAVHTVATGGC
YLTPDIAIKLASGRQDPLTKRERQVAEKLAQGMAVKEIAAELGLSPKTVHVHRANLMEKL
GVSNDVELARRMFDGW
>WP_041918279.1|FEATURES|CARD|aminoglycoside|AAC(2')-Ia|antibiotic target alteration|0
MSNINYEGIEQMPLRTFTEKAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNA
AAKFKKSARTVGDVLGKFHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFA
AMRYTESRLSKISEILLSELGQGTVDFQPNFDGTLEEPQYLPARLPHILLNGTTGIAVGM
ATDIPPHNINEVADAAVMLLDNPKAGLDDVLNIIQGPDFPTEAEIISPKDDIRKMYETGR
GSIKMRATWHKEDGEIIISALPHQSSPSKIIAQIAEQMTAKKLPMVEDIRDEADYENPVR
IVLVPRSNRVDTDALMAHLFATTDLEKSYRVNMNMIGLDHKPAVKGLLQVLIEWLTFRRT
TVTRRLQHRLDKVLARLHILDGLMIAFLNIDEVIEIIRTEDEPKQVLMARFNLSDEQAEA
ILNLRLRHLAKLEEHQLQAEKDKLEEERSNLELILGSERRLNTLIKKEIQEDAKKYASPR
MSQLVEREEAKAISESEMTPAEPVTVILSEMGWVRCAKGHDIDPEGLSYKAGDKYLAHAC
GKSNQPVIFIDSTGRSYALDPLSLPSARSQGEPLTGKLTLPAGATIEQVIMEPEKQELLM
ASDAGYGFICKFEDLIARNKAGKALISLPENAKVLKPETLSESTSLLVSLTSAGRMLIFP
VRDLPALSKGKGNKIISIPAANAKARSELLVKLFLISEQASLEFHSGKRKITLKPEDLQK
FRAERGRKGSQLPRGLHSNVDIVVVEPEHNS
>YP_208330.1|FEATURES|CARD|chloramphenicol|AB432_04625|antibiotic target alteration|0
MNTQPHASHTDSNTLMLGRYAERAYLEYAMSVVKGRALPEVSDGQKPVQRRILFAMRDMG
LTAGAKPVKSARVVGEILGKYHPHGDSSAYEAMVRMAQDFTLRYPLIDGIGNFGSRDGDG
AAAMRYTEARLTPIAELLLSEINQGTVDFMPNYDGAFDEPLHLPARLPMVLLNGASGIAV
GMATEIPSHNLNEVTQAAIALLKKPTLETADLMQYIPAPDFAGGGQIITPADELRRIYET
GKGSVRVRARYEIEKLARGQWRVIVTELPPNANSAKILAEIEEQTNPKPKAGKKQLNQDR
LNTKKLMLDLIDRVRDESDGEHPVRLVFEPKSSRIDTDTFINTLMAQTSLEGNVSMNLVM
MGLDNRPAQKNLKTILQEWLDFRVVTVTRRLKFRLNQVEKRLHILEGRLKVFLHIDEVIK
VIRESDDPKADLMAVFGLTEIQAEDILEIRLRQLARLEGFKLEKELNELREEQGRLNIFL
GDENEKRKLIIKEMQADMKQFGDARRTLVEEAGRAVLTQTAADEPITLILSEKGWIRSRA
GHNLDLSQTAFKEGDRLKQTLEGRTVLPVVILDSSGRTYSIDAAEIPGGRGDGVPVSSLI
ELQNGAKPVAMLTGLPEQHYLLSSSGGYGFIAKLGDMVGRVKAGKVVMTADSGETVLPPV
AVYASSFINPDCKIIAATSQNRALAFPIGELKIMAKGKGLQIIGLNAGESMTHTAVSSEP
EILIESEGRRGAAHKDRLPVALIEAKRGKKGRLLPISGSLKQLSSPK
>YP_001086469.1|FEATURES|CARD|aminoglycoside|AAC(1)|antibiotic target alteration|0
MEENNKILPIEIAEEMKKSYIDYSMSVIAGRALPDVRDGLKPVHRRILYSMSELNLTPDK
PYRKSARIVGDVLGKYHPHGDTAVYYAMVRMAQDFSTRALLVDGHGNFGSVDGDSPAAMR
YTEAKMSKLSLELLRDIEKETVDFKPNFDESLKEPSVLPARYPNLLVNGSNGIAVGMATS
IPPHNLAEVIDATVYLIDNPECSVDDLIKFVQGPDFPTAAIIMGKESIAEAYRTGRGKVK
VRSRAFIEELPKGKQQIIVTEIPYQVNKAKLVERIAELVKEKRIEGISDLRDESNRNGMR
IVIELKRDANANIVLNNLYKHSQMEDTFSIIMLALVDGQPRVLNLKQILYHYIKHQEDVV
TRRTKFELNKAEARAHILEGLKIALDNIDAVISLIRASKTGQEAKLGLIEKFKLTEIQAQ
AILDMRLQRLTGLERDKIEAEYEDLIKKINRLKEILADERLLLNVIKDEITIIKENYSDE
RRTEIRHAEGEIDMRDLISDEEIAITLTHFGYIKRLPSDTYKSQKRGGRGISALTTREED
FVRHLVTTTTHSRLLFFTNKGRVFKLNAYEIPEGKRQAKGTAIVNLLQLSADEKIATLIP
IDGNDENEYLLLATKKGIVKKTKREEFKNINKSGLIAIGLRDDDELIGVELTDGKQEVLL
VTKEGMSIRFDENDIRYMGRTAMGVKGITLSKEDFVVSMNLCSKGTDVLVVSKNGFGKRT
NIEEYRSQIRAGKGIKTYNISEKTGTIVGADMVNEDDEIMIINSDGVLIRIRVNEISLFG
RVTSGVKLMKTNDEVNVVSIAKINIEEE
>NP_217187.1|FEATURES|CARD|beta_lactam|BN1047_01714|antibiotic target replacement|0
MPDSGQLGAADTPLRLLSSVHYLTDGELPQLYDYPDDGTWLRANFISSLDGGATVDGTSG
AMAGPGDRFVFNLLRELADVIVVGVGTVRIEGYSGVRMGVVQRQHRQARGQSEVPQLAIV
TRSGRLDRDMAVFTRTEMAPLVLTTTAVADDTRQRLAGLAEVIACSGDDPGTVDEAVLVS
QLAARGLRRILTEGGPTLLGTFVERDVLDELCLTIAPYVVGGLARRIVTGPGQVLTRMRC
AHVLTDDSGYLYTRYVKT
>NP_214855.1|FEATURES|CARD|isoniazid|iniB|antibiotic efflux|0
MTSLIDYILSLFRSEDAARSFVAAPGRAMTSAGLIDIAPHQISSVAANVVPGLNLGAGDP
MSGLRQAVAARHGFAQDVANVGFAGDAGAGVASVITTDVGAGLASGLGAGFLGQGGLALA
ASSGGFGGQVGLAAQVGLGFTAVIEAEVGAQVGAGLGIGTGLGAQAGMGFGGGVGLGLGG
QAGGVIGGSAAGAIGAGVGGRLGGNGQIGVAGQGAVGAGVGAGVGGQAGIASQIGVSAGG
GLGGVGNVSGLTGVSSNAVLASNASGQAGLIASEGAALNGAAMPHLSGPLAGVGVGGQAG
AAGGAGLGFGAVGHPTPQPAALGAAGVVAKTEAAAGVVGGVGGATAAGVGGAHGDILGHE
GAALGSVDTVNAGVTPVEHGLVLPSGPLIHGGTGGYGGMNPPVTDAPAPQVPARAQPMTT
AAEHTPAVTQPQHTPVEPPVHDKPPSHSVFDVGHEPPVTHTPPAPIELPSYGLFGLPGF
>A0A0Q3WM94|FEATURES|UNIPROT_deepARG|chloramphenicol|AN962_02850|antibiotic inactivation|1
MFKQIDENYPRKEHFHHYMTVTRCTYSLVIDLDITKLYAILKEKRLKVYPVQIYLLARAV
QKIPEFRMDQVNDALGYWEILHPSYTILNKETKTFSSIWTSYDENFARFYKSCVADMDTY
SKSNNLFPKPHMPENMFNISSLPWIDFTSFNLNVSTDITYLLPIFTLGQFKMKEEKITLP
VAIQVHHAVCDGYHVGQYVEYLRWLIEHCEEWLDDSLDMS
>A0A127T6T2|FEATURES|UNIPROT_deepARG|beta_lactam|LEN-22|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDA
>B4S7Y5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIELKDIYRTYQIGESPVRALRGVSLSVCKGEFIAIMGASGSGKSSLLHILGLLDKPDRG
DYLLSGRNVKTMSEDELASLRNNVAGFVFQQFHLLKRMSITDNVRLPHIYSGRKGDFRKE
AIERLATVGLQDRLDHSPNQLSGGEQQRAAIARALVRDPLMIFADEPTGNLDSKNSAEIM
HILKRLHEEGKTIIMVTHENDIAAYADRIIIMRDGQILSDERKSGCEIPEQDADNGVDVR
ADLKISLWRNGRFSGFLLQALQSMLSNKVRSFLSVLGILVGVASVIAMMALGEGAKASMQ
EQLKSMGSNLLSVRGGSAKIRGATQGAGAVTRFTLRDVADIAALSSVVKRAAGTVSGSAQ
LVYANNNWSTSLDGVGIQYGDMRSSIPSVGRWFTTDEIGKREKVAIIGVTVVKELFGNTN
PVGKTIKINRINFKVIGVAPAKGFAGHRDADDVVMIPVSTAMYRVLGKDYLDRIYVEAAS
PSLIDAAKTVVGQVIRKRHRLKESDESFSIRDMTEIQQMMTSTTETMSLLLGSIAAISLV
VGGIGIMNIMLVSVTERTREIGLRKAIGARKSDIMLQFIVESVGMTLTGGLIGIAAGAGV
SWALSVFAGWSVKTSLFSVLLATTFSMLIGLFFGLWPARKAADLKPVEALRYE
>A0A0Q8NP15|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEYINSILLGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LVDLLLGWRDPKNRAYAGKLILAFLITAVLGLIVKKLGFELPETAAPIAWALIIGGFWMI
FAEWAAARRPPHKEITWLVAILVGIAQVVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASAYELLKTFKDGGAANEDWTGLGIAFVVSTIVAFVAVKWLLSYIRSNR
FTLFAIYRIILGVALLGMAAAGIIA
>1XAT|FEATURES|ARDB_deepARG|chloramphenicol|catB7|antibiotic inactivation|1
MGNYFESPFRGKLLSEQVSNPNIRVGRYSYYSGYYHGHSFDDCARYLMPDRDDVDKLVIG
SFCSIGSGAAFIMAGNQGHRAEWASTFPFHFMHEEPAFAGAVNGYQPAGDTLIGHEVWIG
TEAMFMPGVRVGHGAIIGSRALVTGDVEPYAIVGGNPARTIRKRFSDGDIQNLLEMAWWD
WPLADIEAAMPLLCTGDIPALYQHWKQRQATA
>D9XZX7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MKDPPMQSRPPAPIAEFPVSGRDAGPYGITCGPDSALWFTMVHQGRIGRMTTAGDVTSYQ
LEPASGGPSIITTGPDDALWFTEFRSHRIGRITTTGTITSFPLPTPDAGPFGITTGPDDA
LWFTEAGADRIGRITPAGHVTEFPLPLPGAFPSAIAAGPDGRLWFTMNQANAIGAIGLDG
HVTVHPLPAPDSAPVGITAGADGAMWFVEIGAGRIGRITPDGKIDEFALPDPASRPHAIA
AGADGNCWFTEWGANRIGRITPDGRIDEHDLPSPSSEPHGITRGPDGAIWTALEIGTVAR
LSPH
>A0A0B0KIE9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLVKGFFSGDAEARHFVFSVLLAFIPAVVIGVFAVDFIKSVLFSPLVVAVAL
IVGGLIIFWVESIKFDHKTTDATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQDNMLNIAVGFVAAFISALFVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>A0A0Q9JGD4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHDLLVAAVLGVVEGLTEFLPVSSTGHLLLLGHFLGFESKGKAFEILVQLGAILAILLVY
FRRLLDIALRLPTDPSARRFVLGVLVAFLPAAVIGALAHGFIKGVLFNPFLVCTTLIAGG
LVLLVVDELELEVKHHDATKFPLLMYLKIGFIQCLAMVPGVSRSGSTIVGAMLLGADKRA
AAEFSFFLAMPTMAGAFAYDLLKNYKELTANDLTLIGIGFVTAFISALIVVRSFLDFVSK
RGFTPFAWWRIIVGSAGLAGLWVFG
>A0A127SLS3|FEATURES|UNIPROT_deepARG|chloramphenicol|catA16|antibiotic inactivation|1
MKLTLIDFDNWERREHYLHFINDVRCSYSACVNLDISSLNGQRLYPAMLWLLTRTVNEMP
EFRTSLTEDGPGYYSEMHPAYTVFNKDAKTFSGIWTAYQPDYPSFLRGYEEDVGKYSSTT
QYEPKPGRPANSFDVSMIPWVSFSGFNLNIFGDGTYLLPIFTMGKTFKENGKTMLPLAIQ
VHHAVCDGYHLGKFIETLQANINKFDA
>P18539|FEATURES|ARDB_deepARG|beta_lactam|SRT-2|antibiotic inactivation|1
MTKMNRCAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGV
ASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQSKLSFKDPASHYLPDVRGSAFDGVS
LLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSL
DQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIKS
NARDLIRYLDANLQQVKVASVARRWPRRTSVITSAGAFTQDLMWENYPYPVKLSRLIEGN
NAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVEMLANKWFPND
DRVEAAYHIIQALEKR
>A0A0X1TKP7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIEILKVIFLGIVEGITEWLPVSSTGHMILVDEFIKLNMTPEFMEMFFVVIQLGAIMA
VVCLFWDKLFPFEFKGGFKVKNDTMNLWFKIVVACLPAAVIGLLFDDWLDEHFYNYQTVA
LMLIIYGVLFIIIENYNKGRRSVINDLSQITYKFALMVGVFQLLALIPGTSRSGATIIGA
ILIGASRYVASEFTFFLAIPVMLGASLLKILKFGFVFTSAEAIILGTGTLVAFFVSILAI
KFLMGYIKKHDFKVFGWYRIVLGIIVLAYFWFMAA
>A0A0K3NIB7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWALGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Q1LSL8|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MVDIYGLVVALILGIVEGLTEFLPVSSTGHMILVSYMLGFNNDKTKIFEVLIQLGSILAV
IIICKQRWFLLFGLNLKKWEIYQHNINHGSRLHLYHIILGLIPSSILGLMFYEQIKSFFE
PKYVMYSLILGSLLLLISQLIHDKKPRATCIDDISYLQAFLIGCFQCFALLPGFSRSGAT
ISGGMLVGVSSDAAFEFSFLLAVPMIFGATILDLYRHLPVLSLDDIPMFIIGFITAFLVA
LITIKLFWRIIKGMSFIPFVLYRFLLVIVFYLILI
>A0A0A0IPC8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLWFIIKAIIIGIVEGITEFLPVSSTGHMIIVEDLINFKEGVMPASLYTKQYIDAFTM
IIQLGAILAIVVLYWGKIKRSFENFAPSKPKSGFKFWLNIAVAAVPAGVLGLKFHSKINE
KLFNPGSVTAALIVGAIWMIFAEKRYRGKFTTKDIDNVTIKQAFIIGCFQCLALWPGMSR
SASTIIGAWIVGLSTVAAAEFSFFLALPVMAGVTYKSLKDINVFALGSMHIVGLTVGFIV
SFIVALIVVDKFITFLKKKPMRVFAVYRILLGIVLIILSLFNVISM
>W0IJQ7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTRDWIGILSAALVSTCISTSGFAADELKLKAISDAAIKPIMDKYGIPGMAVAITADGQN
HIFNYGVESKDTNRPVTPTTMFELGSISKTFTVTLTSYADVTGRLSLSDKASKYLPSMKG
RPFGDVVLMDLGTHTAGGFPLQVPDEVKTEKQLMEYFATWKPSYAAGTHRTYANPSIGAL
GYITAKSMGKDFAALMEEQLFPSLGLTSTYINVPKSKMADYAQGYKRNGEPARMTPATLS
SEAYGVKSTAGDMIRFIDANMGLVELDDKLQQAITNTHTAYFDVGAMTQDLIWEQYSYPA
TLTTLMDNNSSAMLKTIPVKQLMPAMKPRDDVWINKTGSTNGFGAYVAFVPKERLGIIIL
ANKNYPNEDRVSAAYQILTDIISAR
>A1A7A0|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTFNFGELAAKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPHPVKDVRVLSRITTEAFNQRRKTIRNSLGNLFSVEVLTG
MGIDPAMRAENISVAQYCQMANYLAENAPLQES
>A0A088X7M9|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MNHSPLRRSLLAAAVFAPLIGACAPLIGNSNGVAAAERQLSELESSFGGRLGFVALDTAT
GARIAHRADERFPFCSTFKTMLSAAILARSAGDATLLQRRIPYAKRDLVSYSPVTEKHVG
DGMTVAELCAAALQYSDNTAANLLIALLGGPQAVTAYARSIGDTTFRLDRRETELNTAIP
GDERDTTTPAAMAASLRRLLVGDALGAAQRAQLDTWMLGNTTGAARIRAGVPADWRVADK
TGTGDYGTGNDIGVAYPPNRAPIVIVIYTTMRDKNAQARNDVLASAARIAARTFG
>E1THC4|FEATURES|UNIPROT_deepARG|beta_lactam|BC1003_5870|antibiotic inactivation|1
MKPGVISVMASVVFALSTTTTTSRAANDATGEMKAVVDAAVAPLMQKHHVPGMAIGVIAN
GNTYVFDYGVASTETGEPVTQRTLFEVGSVSKTFTATLAAYAQLNGKMKLSDDTQRYLPS
LRGTAFGQVSLLNLGTHTPGGLPLQVPDGIHDNAQLLQYFSAWKPAYAPGTYRTYANPGI
GTLGLIAAKSMGGSYASLVEQRIFPALGMKDSYIDVPAARMSDYAQGYTNAGAPIRMKGG
VLADEAYGVRTTAADMVRFVQANMSLIKVDDTLERAITATHTGYFKAGPLTQDLIWEQYA
YPVTLDTLHEGNAPSMAITPTPATAIEPPLAPQQDVWINKTGSTNGFGAYVAFVPRKRIG
VVLLANKNFPIEDRVGAAYRIMSALAPSRQ
>A0A0S8CZ69|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGVGQAAVLGVVEGLTEYLPVSSTGHLLVTQKLLGMGNSNSNSPRERESVKAAADAYAIC
IQAGAILAVLGLYGRRFKQMLRGVAGRDPAGLKMAINMAAGFLPAAVIGLLLEAQIKEHL
FGVWPVVWAWFVGGIGILALDWWKGRHPERPRNIKPLEELTWKMALVIGLAQCVAMWPGV
SRSLVTIMGGIMVGLTLLAAVEFSFLLGVVTLTAAASYDAIRFGSIMLESFDAEPLVVGL
VFAFLSAVVAVKCMVNYLSRHGLGVFGYYRVAVAFLVAVCYAANLI
>NP_511233|FEATURES|ARDB_deepARG|tetracycline|tetC|antibiotic efflux|1
MKSNNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCA
PVLGALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYI
ADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFL
MQESHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDR
FRWSATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAADALGYVLLAFATRG
WMAFPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTSIIGPLIVTAIYA
ASASTWNGLAWIVGAALYLVCLPALRRATST
>K9BYY3|FEATURES|UNIPROT_deepARG|beta_lactam|ACINWC323_3783|antibiotic inactivation|1
MLNSKRLSRPVKQLLVFAGLLSGSAPLWAQQLSEQQVQAIVDQQFKPLLQQYKIPGMAVG
ITLNGQHYFVNYGVASKQSQQPIRNSTLFELGSVSKTFNATLAGYAQAQGKLSWSDHPAK
YFPELKNSAVNRATLLNLGTYTAGGFPLQFPDEVVQQQEMIKYFQAWQPKTTVGAARQYS
NPSIGLMGYVTASAMKKPYTELLEKTLFPQLGLKQSFIQVPEQQLPNYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAQINPQQLQQPLRKAIENTHVGYFKVGAMTQGLGWE
QYAYPAKLETLLQGNSSKMALESHAVTPIAQPKIAPAATFFNKTGATNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYHVIQQLLQHNSAQ
>F4BMD3|FEATURES|UNIPROT_deepARG|bacitracin|yubB|antibiotic target alteration|0
MIFIELLKAAFLGIVEGVTEWLPISSTGHMILVEQFINLDASAGFKEMFFVVIQLGAILA
VVLIFFHKLNPFSPKKTTEEKRDTLSIWYKVIVGVLPAAVLGFLFDDWLNEHLYNYWTVA
IMLIVYGILFIVIENRNKGKESSITSFKDLTYKTAFLIGMFQVLSLIPGTSRSGATILGA
ILIGTSRFVATEYSFFLSIPIMFGASFLKIFKFGFDFTGMEVATLLTGMIVAFVVSIISI
KFLMGYIKNNDFKAFGWYRIILGVLVIAYFLLFG
>A5G7K8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILESIILGVVEGLSEFLPISSTGHLILASALLKIKQTDAHKVFEVTIQSGAILAVVYI
YRKQLASRSDLLLKVCAAFIPTGVLGYLLYKTVKSFFQPSMVSYMLIAGGIAFLAIERHL
KNRSSAGEGLQDISYGKALLIGIIQSLSMIPGVSRSGATIMGGLLVGMDRKAAAEFSFLL
AIPTMLAATAFDIYKNFGIFSFGDWQNILAGFVTSFIFAVIGIKALLKFITGHTFVPFAI
YRIAAGVLFLLFLP
>G8MM25|FEATURES|UNIPROT_deepARG|beta_lactam|BYI23_D003950|antibiotic inactivation|1
MQTMKCRALSALAAAIFSFGAMSGAAFSHDAASIRSTVDETIRPLMALHGIAGMAVGVVV
DGQPYVFDYGVASKATHAPVTRDTLFEIGSVSKTFTATLASYAQTQGDLSLTDPVSKYLP
ALGGSAFGKVTLLNLGTHTPGGLPLQVPDDIHDNGQLMRYFSAWRPMQPPGTIRTYANPG
IGTLGLITAKSMRQDFDALMQTRLFPALGLKHSYMQVPASKQRDYAQGYAKNDAPIRMKG
GVLSSEAYGVRTTAADMTRFLQINMNMVHIDPAFQRAVDATHTGYFQAGPMTQDLIWEQY
PYPVALQALLDGNTQAMIMNATPVTRIDPPQPPRDDVWINKTGSTNGFGTYIAFVPKARV
GIVMLANRNIPNEERVKAAYAIITSLTGSR
>L9MDY8|FEATURES|UNIPROT_deepARG|beta_lactam|ACINWC743_0148|antibiotic inactivation|1
MAFLKKTKTIFYVLISSMGLTTYVNANQQITTAKVENAMTQAFQPLMQKYAVPGMAIGVL
YQGKSYEKYYGVQSLADKKSVNKSTLFELGSVSKLFTATAGSYAQSVSKLSLQDHPGKYL
PALKNSEINQVTLLQLATYTTGNLPLQFPDPIKTDAQTLKYFQDWKVNQPVGQFRQYSNP
SIGLFGEATAKAMNIPFSTLLEQVIFPQLQLQHSYVNVPKAQQAQYAFGYDQNNRPIRVN
PGPFDAQAYGVKSNLPDLLQFLKLNLNPDQAKASIRPAIEGTHIGYFKMGGMTQALGWET
FDYPASLETLLESNSDRVVMQSNPVEKTLVKSGARVFHKTGSTNGFGTYLIYIPAEKFGL
VMLMNKRIANAERIQAAYEVLNTLKHTSKP
>A0A0T7GFM3|FEATURES|UNIPROT_deepARG|beta_lactam|NGAL_HAMBI1189_11740|antibiotic inactivation|1
MRFSGSANRTVAAGHAIALALVAAFNPGGARADETERRIATAVDKAMKPLMSENDIPGMA
VGVTINGRSFVWNYGLADREKAVPVGDDTLFEIGSISKTFTATLGAYAQAEGKLSFFDKG
SDHMSALRGSALDRVNLLDLGTYTAGGLPLQFPDEVADNRDITRFYRGWRPSYEPGTHRV
YSNPSIGLFGYLAAESLGKPFLSLMEGKLLPALGLRKTYLNVPAAEIQSYAFGYNKAGKP
IRVTPGALDAQAYGIKTTAADLLRFLEVNIDPSRLEPSLQKAMESMQIGYFRVGDMYQSL
GWELYAWPTTLDTVLEGNSSDMALKPQPAVRLNPPEKPGDEILLNKTGSTGGFGAYAAFV
PERRIGVVLLANRNFPIPARIKAAFTILKAVETIQEH
>V1DQ12|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPESIQPAVKTASILRLSNPSPLLGLMLITAAPLVANAAPQFQTEAIQTLVDSAVNPLMK
EYGIPGAIVGISMNGQQYFFPYGVSSKTTGQDVSKNTLFEIGSISKTFTATLANYAQIEG
KLTFTDKVSQYLPELRGSAFDQINLINLATHTAGDLPMQVPDKVTNNAELMRYFKEWQPA
YAAGTHRNYANPSIGLLGLIAAKQLGQSFPNVMEQTLFPQLGMTHSYLQVPSNKMADYAQ
GYNKQDQPVRLNPGVLADEAYGIKTSAGDLLRFVETNMQQHPLSPALQQAIDATHVGYFD
VGMMTQEMIWEHYPYPIALDKLLAGHTQEVVFGSVPVKAIEPAQAPQPDLWINKTGSTGG
FAAYVAYIPAKKLGIVLLSNKNYPVPPRVTVGYQILTALDALPAK
>A0A127SZA5|FEATURES|UNIPROT_deepARG|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MVKKSLRQFALLAATVFPLLAGSVSLQAQTLSVEQKLAALEQRSGGRLGVALIDTADGSQ
ILYRGDERFAMCSTSKVMAAAAVLKQSESQHDLLNQRIEIKKGDLTNYNPIAEKHVGGSM
SLSELSAAALQYSDNVAMNKLITQSTGWPAGGYRVCP
>E0TVV2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKIKGINHLLFSVSHLYTSIDFYQKVFDAKLLVKGKTTAYFDLNGIWLALNEEPGIPRND
IMASYTHIAFTIEDHEFEEMSARLKRLHVNILPGRERDERDRKSIYFTDPDGHKFEFHTG
TLQDRLRYYKQDKTHMDFYD
>U6ZLA4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSNKAVVFAYHDIGCAGIEALLNAGYEIAAVFTHADDPKENTFYGSVAQLCARKGIAVHA
PEDANHPLWIERIAKLNPDYLFSFYYRNLLSEQLLATASKGAFNLHGSLLPRYRGRAPAN
WVLVKGETETGVTLHRMVKRADAGAIIAQERVAIERSDTALSLHHKLRDAAASLLRDTLP
ALAQGKISETAQDESKASYFGRRTAADGKLDWKRPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAKGNEGQAPGRVISVDPLRIACGEDSLVITSGQRNANGLYLSGPQLANELG
LVDGSLLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDKYEVYGLDIGCDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDNSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIVDNENDCCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESKAFYGAGYQDVEHRKPSIENAKRLLDWEPTVEMSQTIGNTLDFFLREAMLEIA
DRTKEEAR
>G4F7X6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKLLAITTSFLMTSSLLFGSAAWALERADSDAVEALVNETIAPLMDEHRIPGMAVALSI
NGQQHYFHYGLANQETEVSVTEETLFELGSISKIFTAALTGYAQASGALSLSDPASQHLT
ALEGSAFDEITLLELGTYTAGELPLQFPESVQSEEQMIDFYRQWQPESTPGSHRLYSNPS
IGLLGYLTAQSLGKSYETLMEEALFAPLGFEHSYFQVPEAQQAHYAYGYSKEDEPIRVNP
GMLDAQAYGLKSTAADVLTFVEANMSGAELNEPLRQALATTRTGYFEVGNMTQGLGWESY
AYPVTLDQLLAGNSLEMILEPNPANRLAPPLAPRQKALYNKTGSTNGFGSYVAFVPGEQI
GIVMLANRNYPNQARIETAHQIISALTEPPG
>K9D4I8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDQNIIAFILGIVEGATEFLPVSSTGHMILVGDFLGFTGERASVFEVFIQLGAILSVFFY
YREKFMSMLRRENWIRNDRLSLAHIFFGMLPAMAIGFLGHSFIKNYLFSAGTVIIGLIVG
GLFMLWAEKRHKPITVDNVDQLSMYQCLQIGLFQVLALWPGFSRSGSTIAGGLMLGVSRK
AAADFSFIMAVPIMLIACIYDLLKIIDQLQWSDFVMFAIGFVTAFIFAYLSIVWFLKFLN
KSSLAGFAYYRFVIAVIAFAYFFLF
>C9L1R6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTFETIIIAIVEGLTEFLPVSSTGHMIITQNILGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNNTPVPAGTFWLKRLLHRFDFYWKLLVAFIPAAILGFLFSDKIDELLES
VTVVAVMLVIGGVFMLFCDRIFTKGSEDTVLTEKKAFNIGLFQCIAMIPGVSRSMATIVG
GMAQKLTRKEAAEFSFFLAVPTMFAATGYKVLKLFLDGGTEILMNNMPALIIGNVVAFIV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGAILVMLLMGYNLQIG
>A0A124PER3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALALGIIEGLTEFLPVSSTGHLIVAGSFLRFHSEQAKTFDVVIQFGAILAVC
WEYRRRIVDVVTGLPAQREARRFVMNVVIATLPAISLALLFEKTIKSVLFAPVPVAVALV
VGGVVILWVEGRRRERGAPARVQSIDALTPLDALKVGLAQCFALIPGMSRSGSTIIGGIL
FGLDRRVATEFSFFLAIPVIFGATLYETAKDWRAFDADSIGLFSIGLAAAFVSAFACVRW
LLRYVASHDFTVFAWYRIAFGLFVLLVGYSGWIEWT
>F1YZ08|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFVELLKAIFYGIVEGITEWLPISSTGHLILVEEFVKLNQSAAFMEMFNVVIQLGAILA
VIVRYFNRLNPFQPGKSKQEVQLTWQLWAKVIVAILPVVIIGLPFDNWFNAHFYNFITVA
LMLIVYGVAFIWVEKQHKNVEPEVTSLAKMSYKTALFIGLFQVLSIIPGTSRSGATILGG
IIMGTSRTVATEFTFFLGIPVMFGASLLKVLKFFLKGNVLGFGSILILLVASLTAFLVSL
LAIKFLTDYVKKHDFTAFGKYRIGLGIILVIYFIFTLIF
>C3GJ41|FEATURES|UNIPROT_deepARG|beta_lactam|bthur0010_22750|antibiotic inactivation|1
MKGMIVLKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTKWMKGNATG
DKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKRATYDNQLI
AEAAEVIVNAFR
>BAC79064|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALVQFACA
PVLGALSDRFGRRPILLVSLAGATVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYI
ADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFL
LPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDR
FHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRG
WMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYA
ASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQRADR
>A0A0R2GN45|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAIILGIIEGITEFLPISSTGHLYLADYFIKLNQPKSFINMFMVVIQLGAILSVI
LIYFNKLNPFAPSKSHQEKEATWQLWLKVIIAVLPSVIIGLPLNDWLDKNMTTWQVIAAT
LIIYGILFIILENYYKKRTPSLTKLNKLSYRMAFFIGCFQVLSLIPGTSRSGATIMGAML
LGTSRFVSTEFSFFLAIPTMLGASVLKLGKYFMSGNAFVGNQLAVLLVGMIVSFLVAYIS
IKFLLRYVRSHDFKAFGWYRIILGILVIIIGSIFA
>I7ABU5|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-15like|antibiotic inactivation|1
LLLGSVPLYAQTADVQQKLAELERQSEGRLGVALINTADNSQILYRADERFAMCSTSKVM
AAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAM
NKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTL
GKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRA
PLILVTYFTQPQPKAES
>F0JWD6|FEATURES|UNIPROT_deepARG|polymyxin|yfbF|antibiotic target alteration|0
MFEIHPIKKVSVVVPVYNEQESLPELINRTTAACESLGKEYEILLIDDGSSDASAQMLVE
ASQAPDSHIVSILLNRNYGQHSAIMAGFSYVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARQAVEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIATSGFSLAILLVVLRLAFGSQWSGEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQKVIRPASSIDIEENH
>L0BBB2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-96|antibiotic inactivation|1
MMKKSLCCALLLTASLSTFAAAKTEPQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNLVRVEAAWRILEKLQ
>A0A0U1YUZ1|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVAPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>B6VMJ3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKRFSVLTGSLLLAASLGVQASNTPDQTRLTNTVDKTIHSLMQEYDIPGMAIAVTFRGQ
HFFYQYGDASKESNTPVTKETIFELGSVSKTFAGSLISWAQVTGAISFSDKASQHFQPLA
GSAFDNINLLNIATYTAGGLPLQFPDEIDNNSKMVDWFQHWQPKYPPGTYRQYSNPSIGL
AGYIVAQRLEKPYSILVKNQILSPLGLHHTWFNVPAQEMKNYALGYSKENKPIRINPGVL
DEEAYGLKTSAQDLIGFVDANIDPSRVGDSKLAQAIRATHTGYYRTGEMTQGLGWELYHW
PVTLEQVLSGNSAEIAYQANKTTELSPPEPPTDALFINKTGSTNGFGAYVAFVPQEQMGI
VLLANKNYPNEARIKAAWQILKALK
>M5R0S1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFGQFKRSELKGKKIMNLWDLFVALVLGIVEGLTEYAPVSSTGHMIIVDDLWLKSKDIIT
PEAANTFKVVIQLGSILAVMIVFKDRILNLLGLKKNITEEQKRSGHKLTIAQIAVGLVPA
VILGFLFEDYIDKYLFDVRTVAVGLILGAVLMLVADWINKRKTETSSVDNMTYRQALYIG
LFQCLALWPGFSRSGSTIAGGVILGLNHRAAADFTFIMAMPIMAGASLLTLVKNAEYLTT
DMLPFFIVGFVSAFIVALFVVRFFLKLINKIKLVPFAIYRIILGLILFIMFM
>A0A0A0FAL7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVASQDVVTLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVTGGTEPV
VNTASGLRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRIMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>A0A0F6XUV3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTQPPGRITEYPLTADGTGPYGICAGPDGALWFTEVHAGRVGRIDLDGAVTTFALPTPDS
GPSVITAGPDGALWFTQQKANRIGRVTTRGEVREFALPTEGSGPFGLCAGPDGALWFTQM
STHRLGRITLEGAVTEFALEAGSYPSFIASGPDGALWFTQNASNRIGRITVDGQVSGFAL
PTPKAGPVGITRGPDEALWFVEILADRIGRIGLDGGITEHPLPRAGAKPHAIVTGADGAL
WFTQWGSNHIGRMTTSGEVTEYAIPTAKAEPHGIATGPDGALWFAEEAGKIGRLAPR
>A0A0C1HZ18|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLSRLAALAAAITLTLGYSAAQAGDQLQAKVDQIIRPLMQEQGITGMAVAVYARNHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLDAPAKRYHPALAGAP
IGDASVLELGAYSADCLPLQFPDAVQTPQQVVDFFRHWQPRAKPSTQRCYSNPSLGLFGD
LAARAQHQPFSTLMSEGLLKQMGLRNTYLQVPASAQGLYAQGYDSVDKPVRVGPGPYADE
AYGIKTSASDLLRYVRLHMQPEGLPPALAQATAITQRGYFQVGAMTQGLGWERYPYPVTL
ATLVDGNGPQLIREPQATTRLQPALPPLPAAWYNKTGSTNGFGAYAAFVPAEQLAVVLLA
NRNYPNEARVRAAFDILSGL
>YP_001141049|FEATURES|ARDB_deepARG|beta_lactam|BL1_fox|antibiotic inactivation|1
MELIYADARIDCASHGVGVTYIHHETHQMEKATTRSLLVLSTLLLSPLSHAKEAEPLTAL
VDGAIQPLLKEHRVPGMAVAVLKEGKAHYFNYGVADRESGARVSEQTLFEIGSVSKTLTA
TLGAYAAVKGGFQLEDKASQHAPWLKGSAFDGITMAELATYSAGGLPLQFPDEVDSTDKM
RAYYRQWTPAYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQV
PESAMANYAYGYSKEDKPVRVNPGVLAAEAYGIKTGSADLLKFVEANMGYQGDAVVKSAI
ALTHTGFYYVGEMTQGLGWESYAYPVTEQTLLAGNSSAVIYNANPVKSVATSQEMGGARL
YNKTCSTGGFGAYVAFVPAKGIGIVMLANRNYPNEARVKAAHAILSQLAE
>F7Y8X4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTFVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWKMLLELPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
IGGIVLLAVDRMNLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAIGFVAAFVTALIVVRFLLDY
VSRNGYSLFGWWRLVVGGVGLVALMIWG
>CAL44999|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|linA|antibiotic inactivation|1
MKNNNVTEKELFYILDLFEHMKVTYWLDGGWGVDVLTGKPQREHRDIDIDFDAQHTQKVI
QKLEDIGYKIEVDWMPSRMELKHEEYGYLDIHPINLNDDGSITQANPEGGNYVFQNDWFS
ETNYKDRKIPCISKEAQLLFHSGYDLTETDHFDIKNLKSIT
>U2NTP1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGETAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGTGKGHLTLIHILLGMVPAVVVGLVLHDQIKTLFNPIN
VMYALVVGGVLLLAAELLKPKQPKAVGIDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATALDLYKSMSFLTMQDLPMFAVGFVTAFVVALIA
IKAFLELIKRISFVSFAIYRFIIAGVVYMLFM
>A0A060KTW6|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDILASAAKIVTDGL
>A0A085A2L0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGIQALLDAGYDIEAIFTHPDNANENHFFGSVARIAAEQGIQVYAPD
DVNHPLWIERVRAMNPDVIFSFYYRNLLCNEILSAARLGAFNLHGSLLPKYRGRAPLNWV
LVNGEKETGVTLHRMTARADAGDIIAQHRVAIDEADVALTLHHKLRDAAKALLYDTLPAL
REGHFNETAQDESLATYVGRRTPEDGRLEWDKPAAELHNLVRAVSDPWPGAFGYAGANKF
IVWKSRLHREMQGAKPGTVLSVAPLIVACRDGALEIVTGQAEHGVYVQGGQLAQAMGLVA
GALLSSKPVVAIKRRTRVLILGVNGFIGNHLTERLLADDNYEIYGLDIGSDAISRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKHFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
HGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGVEALFRIIENKEGRCDGQIINIGNPDNEASIKELAEMLLASFERHPLRDRFPPFAGF
REVESSNYYGKGYQDVEHRKPSIRNAKRCLNWEPVVGMEKTIDETLDFFLRTVELADEKA
S
>A0A0T9UJT5|FEATURES|UNIPROT_deepARG|beta_lactam|blaA_1|antibiotic inactivation|1
MKSGLKRTLFMSVAVLPLFLATSIAQANPPVEHAKIQQKLMALEKESGGRLGVTLINTAD
NSQIHYRADERFPMCSTSKVMAASALLKKSETQKGLMDERIHFKKSDLVTWSPITEKKLQ
EGMTWAELSAATLQYSDNTAMNLILTQLGGPAKLTEFARSIGDKSFRLDRPEPELNTAIP
GDERDTSTPQAMAESLQNLTLGDALAKSQRAQLVGWLKGNTTGAASIRAGLPATWQVGDK
TGAGEYGTTNDIAVIWPDNHAPLILATYFTQPVKDAQNRREILAEAAKIAVSPFVDGIQ
>CAL64024|FEATURES|ARDB_deepARG|multidrug|fexA|antibiotic efflux|1
MKKDSKSKEMIQSEKRGSTRLLMMVLSLSVLVGAITADLVNPVLPLISKDLEASKSQVSW
IVSGIALVLAIGVPIYGRISDFFELRKLYIFAIMILASGSLLCAIAPNLPLLVLGRMVQG
AGMSAIPVLSIIAISKVFPQGKRGGALGIIAGSIGVGTAAGPIFGGVVGQYLGWNALFWS
TFLLAIMIVIGAYYALPTIKPAESVGSNKNFDFIGGLFLGLTVGLLLFGITQGETSGFSS
FSSLTSLIGSVVALVGFIWRIVTAENPFVPPVLFNNKDYVNTVIIAFFSMFAYFAVLVFV
PLLVVEVNGLSSGQAGMILLPGGVAVAILSPFVGRLSDRFGDKRLIITGMTLMGLSTLFL
STYASGASPLLVSVGVLGVGIAFAFTNSPANNAAVSALDADKVGVGMGIFQGALYLGAGT
GAGMIGALLSARRDATEPINPLYILDAMSYSDAFLAATGAILIALIAGLGLKKRG
>L7QJP2|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-8|antibiotic inactivation|1
MAYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSSVSEKHLAGGMTVGELCA
AAMTMSDNRAANLLLATVGGPAGLIAFLSQIGDNVTRLDRWETEVNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQTQ
>I7KWH5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILKAIILGIIEGLTEFLPISSTGHLIIANKYINFTGEFANVFDVVIQVGAILAVIFYFW
NKIFPSFDDKKQAKRVYSLWFKVVVGFLPAAVLGFLFEEKIDQYLFNPTSVAIALIFGAI
LLIIAENRLKRVRINDTDKMGYTDAALVGLFQCLALWPGMSRSASTIIGGLLIGLSREVS
AEFSFFLAIPTLVGASVLKLLKSSLAFSSIEWITLFVGTLVSFIVALLVIKLFMGYIKKK
DLKPFAYYRIVLAIVVLIVELL
>A0A0T9T3X9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_1|antibiotic efflux|1
MTALLELKGIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAVLDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGVGKNE
RRERANMLLTRLGLGERVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERIIEIKDGRIMADSGSKTVATAAASAAIS
LTPPAPSWQQLVGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVYDDMVALKAQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVYGMKLEQGTPITSEQVERQSQVVVIDRNTQRRLFPHLKEV
VGQVILIGNMPATVVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLIVE
MFLPNWQIAFPPMALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>W0F3K7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIIQTIILAVIEGLTEFLPISSTGHMIIASAVMKIDQDPFVKLFEVAVQLGAIISVIVF
YYKKFFPLNKWSFYLKLLVAVIPALVLGALFSKKIDMLFENPLIVAIMLFAGGFVLLFID
SLFKRPLITAEGEITYKKAFVIGIWQCLAMLPGISRSAASIIGGMQQKLTRSLAAEFSFF
LAVPTMCAATGKKLLDAYNETPQILMDKHNLFLLGIGNLIAFVVALIAIKFFISYLQKHG
FKLFGWYRIIVGAVLLVLIYKGIIV
>S3J3P0|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF0201_00190|antibiotic inactivation|1
MKKSLCLTLLLAAPCSTFAAPKQLTAQQIEKIVNRTISPLLKEQAIPGMAVAVIYKGYPL
YFTWGKADVQHNEPVTRQTLFELGSVSKTFTGVLGGDTLARGEISLSDPAQKYWPELTGS
QWKGITLLQLATYTAGGLPLQVPDEVTDSASLLNFYQSWQPQWAPGSKRLYANASIGLFG
ALMVKPSGMGFEQAMTTRVLEPLKLTHTWITVPPTEESHYAWGYRNDKAVRVSPGMLDAE
AYGVKSSIEDMAHWVQANMAPERVEQKNLQQGIKLAQSRYWRIGSMYQGLGWEMLNWPLK
GKVVIDGSDNKVALAPQTAVAINPPAPVVKASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPERVKAAYAILEALQ
>J7TRR6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALLELRNIYRRYPSGDSSVTVLDDVSLTISAGEMVAIIGQSGSGKSTLMNILGCLDTP
SDGHYFVAGKNTAELSGDELAALRREHFGFIFQRYHLLSHLSAEQNVEMPAIYAGLSARE
RRERAAALLQRLGLCERLIYRPGQLSGGQQQRVSIARALMNGGEVILADEPTGALDSQSG
KEVMAILRQLCDAGHTVIIVTHDPSIAAQAARIIEIKDGHILSDSGSVINPQAKALAAKP
ALKSSAFSRFLGRFNEALLMAWRAMVVNKMRTLLTMLGIIIGIASVVTILVIGDAAKALV
LSDIKSIGTNTIFVYPGKDFGSDPGQDQQSLKPGDVDVIRQQPYVYAASAEIENSARLRR
GNLDSAARITGIGPDFFTVYDMRFGEGRAFSPEMYERRSQVVIIDMNTKRKLFPHQNNVI
GEMLLVGNMPATVVGVIADRKSMFGNSKTLQVWMPYTTLTGRLMQRNYLDMISVRIRDGY
NTKNAEEQLVRLMTLRHGKKDTFTYNLDSIVKTVDKTTTTMQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARAGDVMQQFLIEAVLVCLMGGAIGLGLSYSIAFAAKM
ALPDWEFVFRPAAIVSAVICSTAIGIIFGFLPARNAAKLDPIDALARE
>J8SU89|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEEEHIPRNEI
YQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDYESIYFVDPDGHKFEFHSGT
LQDRINYYRDEKPHMTFY
>N9RL47|FEATURES|UNIPROT_deepARG|beta_lactam|F888_00556|antibiotic inactivation|1
MLNSKCLSGRVKQLLVLAGLLSGSAPLWAQQLSEQQVQAIVDQQFKPLLQQYKIPGMAVG
ITLNGQHYFVNYGVASKQSQQPIRNSTLFELGSVSKTFNATLAGYAQAQGKLSWSDHPAK
YFPELKNSAVNRATLLNLGTYTAGGFPLQFPDEVVQQQEMIKYFQVWQPKTTVGAARQYS
NPSIGLMGYVTALAMKKPYTELLEKTLFPQLGLKQSFIQVPEQQMSNYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAQINPQQLQQPLRKAIENTHVGYFKVGAMTQGLGWE
QYAYPAKLETLLQGNSSKMALESHAVTPIAQPKIAPAATFFNKTGATNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYHVIQQLLQHNSAQ
>C9Y0D2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDMHSLLVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPHEGLGKGRLSLIHILLGMVPAVVLGLVFHDFIKSLFNPIN
VTYALVVGGVLLIIAEVFKPKEPKAPGLDDMTYRQAFFIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFLLAVPMMMGATALDLYKSMGFLTMADLPMFAVGFVTAFVVALVA
IKTFLHIIKRISFIPFAIYRFIVAAAVYAVFM
>D4G0J9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGRIKIMTLWELFVAAILGIVEGLTEYAPVSSTGHMIIVDDIWLKSSNLMSEEAANSFKV
VIQLGSILAVAIVFKDRILNLLGLKKNITSDQEQGHKLSIAQIAVGLVPAAVLGFLFEDY
IDEYLFSVKTVAIGLIAGAILMLFADWVNKRKTATDTLDRISYKQAIAVGLFQCLALWPG
FSRSGSTISGGVILGLNHRAAADFTFIMAMPIMMGASFLSLVKHWDSLSSDLMPFFIVGF
ICAFVVALFVVRFFLRLINKIKLVPFAIYRIILGVILLLIMM
>A0A059V130|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRGKIFDVVFGLTSQPTARRFTGNLLLAFLPAVVLGVLFADLIHEYLFNPITVAAALV
VGGVIMLWAERREHRVEVDHVDDMRWSHALKIGFIQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDLPVFAIGFVTSFIFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLLILATWQFGWVDWATAHG
>G7SQZ4|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MNYIQSILLGIIEGITEFFPISSTGHMILASSLMGILNKRITKLFLISVQLGAVFSVVLL
YRKKFFFQKLDFYLKIFIASFPIGLFGFFFNSRITFFLENPLIVAISLLIGGLVILKAEN
YYEKNFSKKKNHNLTYFKAFIIGLFQCLSLIPGVSRSAATITSCMLQNIERKKAIEFSFF
LSIPVIVIATCKKLMEHYFPSIYLSFSLFDFRIGFLFSKELILQEIGLLLIGNIIAFITG
IISIKCFMSYIERKNFKLFGYYRIILGFFFIVIHYLVKPIGND
>ABJ15828|FEATURES|ARDB_deepARG|trimethoprim|dfrA12|antibiotic target replacement|1
MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPL
PNRHTLVISRQANYRATGCVVVSTLSHAIALASELGNELYVAGGAEIYTLALPHAHGVFL
SEVHQTFEGDAFFPMLNETEFELASTETIQAVIPYTHSVYARRNG
>A0A0F1AVC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRLPQREGEGTGRLTLIHILLGMLPAVVLGLVFHDTIKSLFNPI
NVMYALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTTGDIPMFAVGFITAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A089LNB4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGFDEQEPIMKTYEIVIQLGAILAIAL
VYRRRVLDLLGIGRQSRGRGGVMPAPRLNLIHIILGIAPALAVAFFARDFIKGLFGATTV
LWALVAGGILMIVAEWWNKHKSRVTAHELDDLSYGQALAIGLYQIISVLWPGFSRSGSTI
SGGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYKYFTKDTIMDFAIGFVIAFVVAY
FVVVLFMKLIQKIRPTHFAIYRFILAAVFWLFIMR
>YP_002418004|FEATURES|ARDB_deepARG|tetracycline|tet34|antibiotic target alteration|1
MSNKFVITWDNMQTYCRQLAEKQMPAEQWKGIWAVSRGGLVPGAILARELGIRHVDTICI
SSYDHDHQRDMTVVKAPEGDGEGFLIVEDLVDSGDTARKLREMYPKAKLIAVCAKPSGAD
LLDEYIVDIAQDTWIEQPWDTSLSYVEPVNRKSK
>YP_001345922|FEATURES|ARDB_deepARG|multidrug|oprM|antibiotic efflux|0
MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREF
FRDPQLQQLIGVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDL
STTGNPAISSQYGVTLGTTAWELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVAT
AYLTLKADQAQLQLTRDTLGTYQKSFDLTQRSYDVGVASALDLRQAQTAVEGARATLAQY
TRLVAQDQNALVLLLGSGIPANLPQGLGLDQTLLTEVPAGLPSDLLQRRPDILEAEHQLM
AANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGSWLFQPSINLPIFTAGSLRAS
LDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKASDEYYQLADKR
YRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKK
EDPQA
>ZP_02086796|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>Q399M3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MRQPLLKLAAVTRRFPAGDKDVVVLNNVNLSIHAGEIVAIVGASGSGKSTLMNILGCLDH
PSEGTYTVGGRDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTPRA
ERHARARELLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKS
GQDVIRILHELNALGHTIVIVTHDKAVARHAKRIIEISDGEIVADRPNRHYAEALAEAGV
DAAEAAEASEAAVGESPTRNRHDTPAPPAAVDTDPHVDTGTRTRRFAAGSGRFAEACRMA
WIALVSHRLRTLLTMLGIIIGITSVVSIVAIGEGAKRYMLDEIGSIGTNTINIYPGTDWG
DSRADAIQTLVPADVAALTEQPYVDSATPETSRTLLLRYRNVDVNALVSGVGDRFFQARG
MRFALGVAFDEDAVRRQVQVAVIDQNTRRKLFGATRNPIGEVILVDNVPCVVIGVTADKK
SAFGSVKSLNVWVPYTTASGRLFGQRYLDSITVRVRDGQPSAAAEKSLEKLMTQRHGRKD
FFTYNMDSVVKTVEKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAV
GARQSDILQQFLVEAVLVCLLGGTIGIALSFGLGALFSMFVAQWKMVFSAGAIVTAFVCS
TLTGVIFGFMPARNASRLDPIDALARD
>A0A0W0XKV7|FEATURES|UNIPROT_deepARG|beta_lactam|Lqui_2697|antibiotic inactivation|1
MKQYALLLLLPVLAFGSSLPPQRSCFLIKENQRILKQEGEDCNQRYAPASTFKIALSLMG
FDSGILKDPLHPLWPYKKEYELYLNVWKYPHNPSTWIRDSCVWYSQELTRQLGMPRFKAY
VQAFDYGNQDVSGDKGQNNGLTHAWLSSSLAISPTEQVDFLQKLINHQLPLQDKAYAMTK
KILFIQELVGGWKLYGKTGSGQQLSADKSHKLNLQHGWFVGWIEKDGRVIRFASHMADSK
EESSFASFRVKNEMMIKLWYLINELEK
>A0A109GIG1|FEATURES|UNIPROT_deepARG|beta_lactam|AWW70_04275|antibiotic inactivation|1
MKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKMLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNLKFGNIKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSISIENVLNRYGNMNLVVPGH
GEVGDRGLLLHTLDLLK
>R8VJS1|FEATURES|UNIPROT_deepARG|chloramphenicol|KQ1_02303|antibiotic inactivation|1
MRFHIIDRENWNREQYFEHYLKLKCTFSMTVNVDITMLLEELHQKGIKFYPVFIYLISKV
VNNHKEFRTCFNDEGVLGYWEEMTPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMR
CYANVHGLFTKENIPPNAFPISSIPWTSFTGFNLNINNDADFLLPIITCGKYFNEENKVM
LPVSLQVHHSVCDGYHASRFIEDLQELSNSCNLK
>A0A140GPJ5|FEATURES|UNIPROT_deepARG|beta_lactam|BL2b_tem1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQWGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCAAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQA
>B5ZZG7|FEATURES|UNIPROT_deepARG|beta_lactam|Rleg2_2947|antibiotic inactivation|1
MKSIRIRILSAVLLSAGAATSAFAADETNLKAITDAAIKPIIEKYAIPGIAVAITANGQD
HIFNYGVESKDTGRPVAPTTLFELGSISKTFTVTLASYAEASGPLSLSDKAGKFLPGMKG
KPFGDIALMNLGTHTAGGFPLQLPDEIKTEKQLLGYFETWQPSYTAGAQRSYANPSIGML
GYIVAKAMHADFAALMQGKLFAGLGLKSTYINVPKARLADYAQGYKRSGEPARMTPAVLS
SEAYGVKSTAGDMIRFVAANMGLVKLDEKLQQAITSTHIGYFKAGAMTQDLIWEQYAYPA
ALNDLLAGNSPAMLKTMPVSELRPPMKPRDDVWINKTGSTNGFGAYVAFIPKQRLGIVIL
ANKNYPNEDRVAAAYQILTALAAD
>A0A108U7Z3|FEATURES|UNIPROT_deepARG|aminoglycoside|AZ78_1791|antibiotic inactivation|1
MKAGWRVRRAEAADLAAWSLLREALWPQEDASRHADDIGQMLSRPHNAAAFLAVDADGVA
RGFAEASLRGDYVNGTDGSPVGFLEGWYVQPEFQRQGVGRALIEAVERWTVQSGCSELAS
DALLDNLDSHRAHEACGLRETERVVYFRKRLRDDG
>A0A0M0F6V0|FEATURES|UNIPROT_deepARG|chloramphenicol|M768_10240|antibiotic inactivation|1
MDTPVPVDLETWPRREHFEHFLHASPCTYAMTVELDVTALAAALAGSSRKTYVAQVWALA
TVVNRHEEFRLVLDDAGAPAVWPVVHPSFTVLNPERETFSAVWAPYDADFDAFHAAASAL
LAEHRTATAFLPQGAPPPNMFDVSSLPWASFTGFTLAIRDGWRHLAPIVTLGRYVERGGR
TFLPVAVQVHHAAADGFHVARLVNELQELVDDPSWLG
>F5LKW8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYSLWIAVIIGIVEGLTEFLPVSSTGHMILTQSLLGISDDEPLMKTFTIVIQLGAILAVV
IVYWKRILRILGINREPVAVKAGASRLNVLHILLGIVPAMGIAFLFDDLIETYLFSPKTV
VVSLILGGILMIIAEKKMDRTRGPVVEDMDGISYRQAFTIGLYQCLSVLIPGFSRSGATM
AGGMLHGVTRKAGADFTFIMAVPIMFAASGYSLLKSYKSFTSDDILFFAVGFIVSFIVAL
LAIVTFIRFVQRMKLTYFSYYRFALAAIFIVYLWVV
>CAD57199|FEATURES|ARDB_deepARG|chloramphenicol|catII|antibiotic inactivation|1
MNFTRIDLNTWNRREHFAFYRQQIKCGFSLTTKLDITALRTALAETGYKFYPLMIYLISR
AVNQFPEFRMALKDNELIYWDQSDPVFTVFHKETETFSALSCRYFPDLSEFMAGYNAVTA
EYQHDTRLFPQGNLPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEGDRVL
LPVSVQVHHAVCDGFHAARFINTLQLMCDNILK
>A0A125RM82|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYY
FTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQ
WQGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRQYANTSIGLFGA
LAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPSAQSKDYAWGYRDGKAVHVSPGQLDAEA
YGVKSSIEDMAHWVLANMNRETVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLNWPVSA
EVLINGSDNKVALAATPVTAVNPPAPPVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKSYPNPERVKAAYHEALQ
>E9LZM5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-14|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLSHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>J7SJM4|FEATURES|UNIPROT_deepARG|chloramphenicol|MU9_2880|antibiotic inactivation|1
MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITASRTALTETGYKFYPLMIYLISR
AVNQFPEFRMAMKDNELIYWDQSDPVFTVFHKETETFSVLSCRYFPDLSEFMAGYNAVTA
EHQHDTGLFPQGNLPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEGDRVL
LPVSVQVHHAVCDGFHAARFINTLQMMCDNILK
>A0A127SBP4|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-14|antibiotic inactivation|1
MMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDIADNTQVLYRGDER
FPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAA
ALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRA
MAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTND
IAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>A0A0E8TJS7|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ_2|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSPHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMAY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>S5HH52|FEATURES|UNIPROT_deepARG|aminoglycoside|CFSAN002050_14495|antibiotic inactivation|1
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFVAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHQALGFEETERVIFYRKRC
>A7ZDI7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MISLKNITKSFKLGENEIEILHGINLEIKKGEFIAIIGQSGSGKSTLMNILGCLDSPSGG
QYLLDGKDISKFDSDALAKLRRDKFGFIFQRYNLLSTMNALENVALPSIYAGANKSEREK
RANELLGSLGLSEKAKNLPNKLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGLRV
MEILVDLYKKGHTIIIVTHDPKIAEYASRVIEIKDGNIVSDNVKNSEIFEASKQTQPEKS
KFTYYKDQLIESFKMSVNAMLAHKLRSLLTMLGIIIGITAVISVVALGKGSQEQILAGIR
KIGTNTIDIMPGKGFGDMLSGKVKTLSISDANMLAKQSFLDSVTPNTSTSGVLTYENISL
SASLKGGGVGSFDVNGLKLEEGRIYDDDEVLNSASVALIDQNTKNSIFKNDDPIGKIILF
NKKPLRIIGVLQKDDFKMGDSSTLKIYAPYTTVLNKVTGDKFISSVTAKVNEGVNAQIAE
KSLSELLEIKHGKKDFFTRNSDSIKQTIEETISTMRLLISSIAVVSLVVGGIGVMNIMLV
SVTERTKEIGIKMAIGARQSNILQQFLIEAVLLCLIGGAIGIILSYAIGYIFNNFLNGFS
MIFSNGSIVLALVTSMAIGIIFGYMPAKNASKLNPIDALSRE
>A0A0T9RGU3|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MKSGLKRTLFMSVAALPLFLSTSIAQANTPVEHAKIQQKLMALEKESGGRLGVTLINTAD
NSQIHYRADERFPMCSTSKVMAASALLKKSETQKGLMDERIHFKKSDLVTWSPITEKKLQ
EGMTWAELSAATLQYSDNTAMNLILTQLGGPAKLTEFARSIGDKSFRLDRPEPELNTAIP
GDERDTSTPQAMAESLQNLTLGDALAKSQRAQLVGWLKGNTTGAASIRAGLPATWQVGDK
TGAGEYGTTNDIAVIWPDNHAPLILVTYFTQPVKDAQSRREILAEAAKIAVSPFVDGIQ
>A0A127T6U9|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-98|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANDRPVTRQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMGYEEAMTKRVLQPLKLTHTWITVPQSEQKDYAWGYREGKARACISGAA
>NP_846348|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLQGINHICFSVSNLEKSIEFYQKILQAKLLVKGRKLAYFDLNGLWIALNVEEDIPRNEI
KQSYTHMAFTVTNEALDHLKEVLIQNDVNILPGRERDERDQRSLYFTDPDGHKFEFHTGT
LQNRLEYYKEDKKHMTFYI
>K8CC62|FEATURES|UNIPROT_deepARG|beta_lactam|BN130_665|antibiotic inactivation|1
MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
SKATRKPVDEKTLFEIGSLSKTFTATLASAAQQEGKLDFSAPASQYLPALKGSAFDNVTL
LNLATHTSGTPLFVPDAVKSTAQLMAWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALD
KPFSEAMEQGLLKDFGMTHTFINVPDAAMGDYAQGYNKDDKPVRVTPGPLDAESYGLKSG
SADLLRYLQIQLGEQEVAPRWRQAINATHSGYYRSGEFTQGMMWEYYPWPSPLSRLLEGN
SSQRIMKGLAATAIVPPQPAPEAAWYNKTGSTNGFSTYAVFIPEKRIALIMLANKWFPND
DRVKAAYAIIQELDK
>L7G799|FEATURES|UNIPROT_deepARG|aminoglycoside|A989_16023|antibiotic inactivation|1
MSDGYSIRAAVAADLRAWAALRVALWPDERDAFGGVVEALQREDAANFLAFASDGHAIGF
ADVTLRQDYVNGTDSSPVGFLEGWYVVPEWRGRGVGRALLRRVQEWTCAQGCSQLASDAL
LDDAAAQAAHRACGFEESERVVYFRMPVAD
>A0A0K3NPP2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKLASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVYSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAIIRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGVEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVELTDKPS
>A0A0L5XC50|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAELGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSVLPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QAVESRSYYGKGYQDVAHRKPSIDNARRCLDWEPSIAMRDTVEETLDFFLRSVDIAERAS
>J7QK52|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|ybjZ|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDYFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A0J6KPU7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIIDVVVGLPTKPEARRFTTNLIIAVMPAVVLGVIFADVIHEYLFNPITVATALV
VGGVIMLWAERRQHVIRVETVDDMNWKDAVKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVRALLKF
ISNHSYAVFAWYRIGFGLLILATWQFGWIDWSAASA
>YP_791221|FEATURES|ARDB_deepARG|multidrug|amrB|antibiotic efflux|1
MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSASYPGASAKVVEEA
VTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNADLAAVEVQNRLKIVESRLPES
VRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVQTWGAE
YAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLV
TPEQFGEIPLRIRADGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVA
TAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQN
FRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMA
QEGLSPHDTTVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFS
AFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPVRWML
VYALVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVADVERYLAEHEP
VAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYA
MNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQ
IRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADGAKRLGIDDI
GRLHVRNEQGEMVPLATFAKAAWTLGPPQLTRYNGYPSFNLEGQAAPGYSSGEAMQAMEE
LMQGLPEGIAHEWSGQSFEERLSGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVP
LGVLGALHGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEA
ARLRLRPIVMTSLAFGFGVVPLALSSGAGSGAQVAIGTGVLGGIVTATVLAVFLVPLFFL
VVGRLFRLRKAPRTGTSPRIPTEQA
>A0A085JHY8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MRTPTPVNKVSVVIPVYNEQESLPDLISRTTAACRQLNTGYEILLIDDGSSDNSAQQIID
AAEAVDSHIVAILLNRNYGQHSAIMAGFSYVTGDLIVTLDADLQNPPEEIPALVDAARQG
YDVVGTVRQNRQDSPFRKIASRMINRLIQSTTGKAMGDYGCMLRAYRRPIVEAMLHCQER
STFIPILANTFARHTTEIPVHHAEREHGTSKYSFMRLINLMYDLVTCLTTTPLRMLSVVG
ALIACSGFLFAFLLVVLRLIFGAHWAAEGVFTLFAVLFIFIGAQFIGMGLLGEYIGRIYS
DVRARPRYFVQRVVNHATSSTNEDQL
>YP_248152|FEATURES|ARDB_deepARG|beta_lactam|pbp1a|antibiotic target alteration|0
MRIAKLILNTLLTLCILGLVAGGMLYFHLKSELPSVETLRTVELQQPMQIYTADGKLIGE
VGEQRRIPVKLADVPQRLIDAFLATEDNRFYDHHGLDPIGIARALFVAVSNGGASQGAST
ITQQLARNFFLTPEKTIIRKAREAVLAVEIENTLNKQEILELYLNKIFLGYRSYGVAAAA
QTYFGKALNELTLSEMAIIAGLPKAPSTMNPLYSLKRSEERRNVVLSRMLDEKYISKEEY
DAALKEPIVASYHGAKFEFRADYVTEMVRQEMVRRFGEENAYTSGYKVFTTVLSKDQAEA
QKAVRNNLIDYDMRHGYRSGAPLWQKNEAAWDNDRIVGFLRKLPDSEPFIPAAVIEIAKG
GADILLASGEKMTLSTNAMRWTGRSNPVKVGEQIWIRQRANGEWQLGQIPAANSALVSLN
SDNGAIEAVVGGFSYEQSKFNRATQSLVQVGSSIKPFIYAAALEKGLTLSSVLQDSPISI
QKPGQKMWQPKNSPDRYDGPMRLRVGLGQSKNMIAIRAIQTAGIDFTAEFLQRFGFKRDQ
YFASEALALGAASFTPLEMARAYAVFDNGGFLIEPYIIEKIQDNTGKDLFIANPKIACIE
CNDIPVIYGETKDKINGFANIPLGESALKPTDDSTNGEELDQQPETVPELPELQSNFTAL
KEDAIDLMAAAKNASSKIEYAPRVISGELAFLIRSALNTAIYGEQGLDWKGTSWRIAQSI
KRSDIGGKTGTTNSSKVAWYAGFGANLVTTTYVGFDDNKRVLGRGEAGAKTAMPAWITYM
KMALSDKPERKLPLPPKIVEKNIDTLTGLLSPNGGRKEYFIVGTEPTRTYLSEMQERGYY
VPTELQQRLNNEGNTPATQPQELF
>ABS72058|FEATURES|ARDB_deepARG|glycopeptide|VanD|antibiotic target alteration|1
MFKIKVAVLFGGCSEEHNVSIKSAMEIAANIDTKKYQPYYIGITKSGVWKMCEKPCLEWE
QYAGDPVVFSPDRSTHGLLIQKDKGYEIQPVDVVLPMIHGKFGEDGSIQGLLELSGIPYV
GCDIQSSVTCMDKALAYTVVKNAGIAVPGFRILQEGDRLETEDFVYPVFVKPARSGSSFG
VNKVCKAEELQAAIEEARKYDSKILIEEAVTGSEVGCAILGNGNDLMAGEVDQIELRHGF
FKIHQEAQPEKGSENAVIRVPAALPDEVRERIQKTAMKIYRILGCRGLARIDLFLREDGC
IVLNEVNTMPGFTSYSRYPRMMTAAGFTLTEILDRLIELSLRR
>YP_001025937|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MRTSRSRIAAAAFAVVFIAGLGTFGAIRVNAGAPEKSAAPLPEVDVATVLSKTITDWQSY
SGRLEAVEKVDVRPLVSGTIVSVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLAGAQ
ARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREASANLKAAEAALETARINLGYTRI
TAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYIGGAKDGRK
VPVELGLANESGYSRQGVIDSVDNRLDTSSGTIRVRARFDNADGALVPGLYARVKVGGSA
PHPALLIDDAAINTDQDKKFVFVVDQQGRVSYREVQLGAQHGNQRVIVGGLAASERIVVN
GTQRVRPGEQVKPHLVPMTGGDDAAAATPVAGGVQRPRAAQGNARA
>A0A0T7DYV2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKLNNALVAILSLTSFVTFAKTELTVSSQLKSVVDECAKGLMNEYDIPGLAVAVTIDGKR
YFYNYGFADESTGSLVTNDTIFELGSISKTFAATLTGYAQAKGKLNMDDKVKDYIPELEN
SILGNTKLVHVATYTAGGLPLQFPSEVTNDAEMMQYYKTWKPEYEAGTKRKYSNPSIGLF
GYIGALSMKSDYTEMMETLILPKLGMANTFVDVPKDKLNNYAFGYSSEGKPVRVNPGILD
AQAYGIKSTSLDMLQYIEANMGQAQLNTDIENALERTHTKYFDTDTFTQAVGWEGYDYPV
SLSQLLKGNSSDVILNAKPVQASVSGTLGRDVWYNKTGSTGGFGAYVAYVPSEKIGIVIL
ANKNYPNAERVEAAYNIISSVVK
>A0A0V9EEY4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTMGKAYEILLVDDGSSDDSALMLTE
AAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLVTCLTTTPLRLLSVFG
SIIALAGFTLSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKASQEENHP
>B7AQ01|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEIIKAIIFGIVEGITEWLPISSTGHLILFEKIFAFKNVSEGFWSMFEVVIQLGAILAV
VVLFWNSIFPFTNKNGRGFKESGILSHLDKEITTLWFKIIVACIPAVIFVVLGLDDVCEA
MFYNYFCVAIALIVFGVAFIVVENWNKNRTSKINSLGEITYQTALMIGLFQLIAAVFPGT
SRSGATIVGALLIGVSRTVAAEYTFFLAIPVMFGASLLKIVKFGFNFTAMEAALLIIGMA
AAFVVSLFVIRFLMGYIKKHDFKVFGWYRIILGAIVLLLRP
>D2RNN5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSENLIAVLLGIVEGLTEFIPVSSTGHMIIVGHMIGFEGNLAKIFDVVIQLGAILAVLVI
YKERFARFLTKEGWQMGTGLTGWHIAAGCVPTMAFAYLVHSFIKKYLFSPATVAVGLVLG
ALLMIVAERKIRGHEAELVQDVDHISIRQALYIGFFQFLSLWPGFSRSGSTMGGALLVGV
NRKAGADFTFIMALPVMVVACLYELLKNISALTGGDLAVLTIGFVTAFVVGYFSIVWFMK
FLQRSTLTAFGIYRILLALVTVWYFYM
>W8L0K2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDNLHALILGIIEGLTEFLPISSTGHMILGTTILGIDINEFWKSFLIIIQLGSILAVLFV
FWRKLFKGLDIWFKLAVGFFPTGLIGFVLYKYLKELFNGYVVVVMLILGGIVFIVIELAH
KNKEYKTNSLEKVSFLQAFCIGIIQSLAMIPGTSRSGASIIGGLLLGLNRKTAAEFSFLL
AIPTMIVATAYSIYKEPEILSNANALIPLSIGFVTAFVVAVFVIKFFLKFISKFDFIPFG
IYRIVLGILFFYLYYSGILNSGSEFKL
>A0A0G0B1K6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNVLNAIILGLVEGITEFLPISSTAHLIISSKLLNIPATEFQKFFEVFIQSGAILAVVFI
YWKIILKNRNLMINIILSFFPTAVIGLLLHKVIKGVFFESFTLIAISLFVIGLFFIVFEF
LLKKKIIKTDKKIIQMTILQALLIGVGQSLAVVPGVSRAGAVILIMMIMSFNREESALYS
FVLAVPTLLAASAFDFMKTDPQLIFAGNNPLFLFIGLTTSFLSALLAIKWFIKFLQKNSL
SIFGVYRIALSIFTFLL
>X6Q3X8|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1505_1825|antibiotic inactivation|1
MLKKQFVSVAAVAVLTTGVAFAAVQQDKVMYKQADGTYVVNTTSLCSNVKGFKGATPVEV
YIKNNKVIKVEALPNREGPKFYDKVKQGLFPKFVFSLFHKSATKDSANPPLTNVLTDSIS
QIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVN
INRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFI
ATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTL
KECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFV
KDFKGNESQASQYVAHISAVVYSLLMQTSVKS
>A0A011P660|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIENLNKSFGSPDNQTHVLKNINLSIKQGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGSCKISGKDTQKMTSNELSDLRQRKFGFIFQRYNLLPALTANENVALPAIYAGIDNLSR
KMRAEFLLDKLGLSDKTQNRPNELSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLEILQTLHQEGHTIIMVTHDPKIAAKASRIIEIKDGKIIQDKRLKPYVEQISPFDSSH
KKPRFFDQLSESFKMALNAIMAHKMRAILTMLGIIIGIASVISVVALGQGSQQQILANIN
SLGTNTMDIMNGTGFGDRRANLTKNLTISDATMLEQQNYVESTTPSSNISATLIYGNTTV
TGSVRGVGEQFINVKGLKLVSGRFFTADEVKEIAQVIVIDPNTQKELGINSPVEGNIILV
DKKPLRIIGVAQQSNNMNQSSLTLWAPYTTTMQRISGAKQIDALTVKIKDNVESQTAEKS
ITELLTAKHGKKDFFIINSDTIKQTITSTTNTMTLLISSIALISLIVGGIGVMNIMLVSV
TERTKEIGVRMAIGAKQNNILQQFLIEAILICLIGGLIGILFAIAIITTFNTLDENFKMI
LSVQSVVVAVLCSTLIGIIFGYLPARNASRLNPINALAQE
>K6I8A7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNHYLNAFLRSIIEAVTEFLPVSSTGHLFLFSSFFPFSGESFGIQFDDLFDIFIQSGAIL
SVLFLYREKFGSQIRSSLRYVTKQNSDPQGFYFLVRIAIGALPILVAGFIAKNFLDTIKT
RSDLLSILAGAWIFGGVLILVAEWFFQKRRGVEEKKPVGFRDAILIGIFQCAALIPGVSR
SAATIVTARFLGKDTKSSAEFSFFLAVPVLFAAGIYKLIKYRSILNEVTIPVLTFGFLIS
FLFCTLVIRLFLRYLQKHSFGVFGIYRILLGVGVLVFTKFIR
>A0A0B0D2I6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIHFLKVIILGMFEGLTEFAPISSTGHMIIVDEMWLHSKAFLGISIANTFKVVVQLGS
ILAVVVIFKEKFLLLLGLKEYSEDVKNRRLKISQVFVGLLPAAILGLLLEDFIDQYLFTV
QTVMIGLVLGAVLMIVADFTASDTPKVQTVDQMSYQQAFLIGLVQCFSLWPGFSRSGSTI
SAGVMFGMSHRSAADFTFIMAVPIMLGASGLSLYKNLEFFSIDALPLFAVGFLSAFMFAY
LTIQFFLKLINKIKLLPFAIYRLILAGAIYLIYF
>A0A0G0TI13|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIQTVVLAIIEGLTEFLPISSTGHLILASDFLNIRQTDFLKSFEIYIQLGAILSVLFL
YLGRLKKKEVILPTLTAFLPTAAIGFLLYGTVKNFLLGNTLITLAALFWGGVFIILIEYF
YKEREHHVESIEKISLKNSFIIGLFQSVSLVPGVSRAAATIIGARLMGVRRKTAAEFSFI
LALPTMLSATTLDLIKSDFSFTTNETLLIILGFVSSFVVATLAIKFFVDYIQNHSFIIFG
IYRIILSILFYFFILK
>A0A0W0NSZ3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTNAACKQLAYEYEIILVDDGSRDNSAQMLEDA
ANEDGSNIVAVILNRNYGQHAAIMAGFEQCRGEVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGVLFALALVILRLAFGAQWAGDGMFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGLVSSHTSTSSDQGQS
>A0A0R2Z6S7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGIVEGLTEFLPISSTGHQIIVADLINFGGERFEAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPKARRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALV
VGGVIMLWAERRQHAVRAETVDDITWKDALKVGLAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKALLKF
IASHSYAAFAWYRIAFGLVILATWQFGLVDWTAVKP
>A0A0Q8J5Z9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLAALLLGIIEGITEFLPISSTGHLLIAQHWLGARSDLFNISIQAGAILAVVVIYWK
RLWGLATGFTQRDNLDYLLKLGLAFGLTAVLGIAVKKAGFTLPDHVTPIAWALVLGGVWM
VAAEHFAAKRAAALGERSQITWTVAALVGIAQVVAGVFPGTSRSAATIFIALLAGTTSRA
AATEFAFLVGIPTMFAASGYELMHVLGTPAAANEDWSALAVAFIASAVTAFIAVKWLLRY
IQSHRFTAFAVYRVAFGAALLLLMPSGS
>A0A0J6NL10|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MACAALSVSAVAVAAPTPQAAVDAEIPALMRKNGIPGMAVGLAVGGDVQVYNYGVASKTD
HRPVTRATLFEIGSLSKTFTAALASYAQAEGRLSLADPLSQHLPALAGGGLERVTLLNLG
TQTSGLPLFVPDNVVNAGQLRRFIRSWRPKQPAGSQRVYSNIGIGVLGQIAAASMRMPYA
AAVEGRIFAKLGMDSSFVNIPAQRMSDYAQGYDKNDRPARLTPAPLADEAYGVKSNAADL
ARFLNANMGLLPMAPKLQGALKDAHIGYYRAGELTQSLIWEQYPYPVALPQLLSGNSAAY
IYQGMPAQRLDPPLPPQTRAFINKTGSTNGFSAYAAYIPEKRLGIVLLANKSYPLAERVS
AAYRILERLDDGLAPAARP
>L9LYZ9|FEATURES|UNIPROT_deepARG|beta_lactam|ACIN5021_2924|antibiotic inactivation|1
MRFKKISYLLLPSLFIFNTSIYAGNTSKDQEIKQLVDQNFKPLLEKYNVPGMAVGIIQNN
KKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLTLQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYINVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQRAINETHQGRYQVNSMYQALGWEEFAY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>U5KKE2|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWGIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKH
>W4BBC9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNRHGQAGQPVLSPAFQGGRELDIISSIIMGIIEGLTEFLPVSSTGHMILTAHLLGLSED
NESVKTFEVVVQLGAVLAVVVLYWNKFIDMFRFTGGSRPYSRRLNLGHIFLAMVPAVVIG
LVFRDWIKAHLFGPETVLYSLVIGGILMIVAERWSRKSGRITTHDVDDISYKQAFAVGIF
QILALWPGFSRSGSTISGGLFAGVSRVAAAEFTFLVSVPIMIGATGYDLYKSIDHLNGSD
FPIFAIGFIAAFIVAMLAIKTFLSILKKLSLTVFAVYRFVLAAVFFIILM
>A0A103RU62|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILIFKTLILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRRRIVSVVAGLPSRPDARRFALNVVIATIPAVALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILLAEARQRERGEAPRVQSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSIGLFALGLAASFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWLNWA
>ZP_03347409|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQLFYGPLSDRVG
RRPVILVGMSIFMVATLIAMTTHSLTVLIAASAMQGMGTGVGGVMARTLPRDLYEGTQLR
HANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMARWMPETRPAGA
PRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGLSSMVVSILFIL
PIPAAFFGAWFAGRPNKRFSALMWQSVICCLLAGLMMWIPGWFGVMNVWTLLIPAALFFF
GAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQTGQGSLGLLMTL
MGLLILACWLPLASRISHQGQTV
>H1BJB0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEILKAALYGILEGITEWLPVSSTGHMILFEEILPMKVSENFWNVFLVVIQLGAILAV
VLLYWNKIFPFNFKNKNRPFIRYDIMNLWGKILVACIPAAIVGIAFDDILEKYLYTSVVV
ATMLVLVGIAFLIIENRNRHKRARVTSLQELSYVDALKIGVFQLIAAIFPGTSRSGATIL
GGLMIGVSRTIAAEFTFFLAIPVMFGASLLKLLKFGLSFTGAELAILCTGMIVAFLVSVI
VIRFLMSYIKKHDFKIFGYYRIVLGIVVLACFFMGIIKM
>NP_940746|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmX|antibiotic target alteration|1
MSAYGHGRHEHGQNFLTDHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAYLGRAITAV
EVDAKLAAKLTQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAW
TDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRR
VGDPKIPIEQRKAFQAMVHTVFTARGRGIREILRRAGLFSSRSETQSWLHSRGIDPATLP
PRLHTSDWIDLFQVTGSSSPHHRPISPSGSSQRPPQRKNRSRRR
>A0A105TGB5|FEATURES|UNIPROT_deepARG|glycopeptide|arnD|antibiotic efflux|0
MQAGLRIDVDTYRGTREGVPQLLELLDEAQIKATFFFSVGPDNMGRHLWRLIKPRFFWKM
MRSKAASLYGWDILLAGTAWPGKPIGKDLGHLMRQTLAAGHEVGLHAWDHHGWQANTGRW
SERQLIEHIRLGVDTLSDITGQAVECSAAAGWRADERVVEAKQRFGFRYNSDCRGHSLFR
PRLADGSLGAPQIPVDLPTFDEVVGPHVSAADFNSYILDRFSPQRLNAYTIHAEVEGILM
ANDFRQLLVQARARDIQFQPLRNLLPADLDSVPAGQLSRGVLQGREGWLGVQQP
>A0A0W0MXW1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPTARRFTANLLIAFFPAVVLGVIFADLIHAYLFNPITVATALV
VGGIIMLWAERREHQVHAQTVDEITWQDALKVGFIQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTAFIFAMIAVKGLLKF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWAAAKA
>H5WR65|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSVLLLKAAVMGVVEGLTEFLPISSTGHLILAGSLLGFADAKAKVFDIAIQTGAIVAVI
IVYWQRLVDVAQGLGSEPKARRFVANVAIGFAPAVVLGLLFGKLIKAHLFNAPVVASTFI
LGGLVILWAERRPASAVRIHSVDDMGPLDALKVGLVQCLAMIPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAIPTLIGAGAYSLYKERALLSAADLPLFGVGLVVSFIAAWLCVRWLLR
YIASHTFVPFAWYRIAFGVLVLGTAWTGMVHWAE
>A0A0T9SBH0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSIINTLIFTAIATFPLYTLAQTKLTQQQVATIVNNTLTPLLEKQDIPGMAVAVFYD
GKPQFFNYGMADIKAGRPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTEYAPE
LTGSQWIDVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPQWAPGVMRNYSNASI
GLFGALAVKRSQLTFENYMKEYVFQPLKLDHTFITIPESMQSNYAWGYKDGQPVRVTLGM
LGEEAYGVKSTSQDMVRFMQANMDPESLPAANDKLKEAIIASQSRYFQAGDMFQGLGWEM
YNWPINPQRVIADSGNDIALKPRKVEALVPAQPAVRASWVHKTGATNGFGAYIVFIPEEK
VGIVMLANKNYPNPVRVQAAYDILQALR
>A0A0E4C296|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MPVLEIEPIKKVSVVIPVYNEQASLPALIERTAAACKTLNQSYEIILVDDGSSDDSSALL
TAAAEKEDLYITAILLNRNYGQHSAIMAGFNHASGDLIITLDADLQNPPEEIPRLVQTAE
EGYDVVGTIRSNRQDSFFRKTASKLINLMIQRTTGKKMKDYGCMLRAYRRHIIDAILNCH
ERSTFIPVLANIFARRTHEIPVQHAERAFGESKYGLIQLINLMYDLITCLTTTPLRLLSL
IGSMIALSGFALAVLLVVLRLIFGSIWAGGGVFTLFALLFMFIGAQFVGMGLLGEYIGRI
YNDVRARPRYFIHKIITAQTIKNPQGKK
>R5EFK4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLKAVLFGIVEGVTEWLPISSTGHLILLNEFITLNVSDEFRSMFDVVIQLGAILAVIV
LFFHKLNPFSPRKTEGEKKQTWQLWFKVIAAIIPSGIVGVLFDDWMEAHFHNATVVSIAL
IVYGVAFILVERRNARRVGGKTVEDVYAIDYKTALLIGCFQCLSLIPGTSRSGSTILGAI
LIGVGRSAGAEFSFFMAIPTMLGASAIKGLKFLLSGVAATGTEIGVLIVGCVVSFVVSLL
VIRGLMEYVRRHSFSAFGVYRIILGVVVLVYFALAG
>A0A0T6ZIH3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLLSIALALPTSIKARRFVLSVLIAFLPAAVIGAIAHDFIKTVLFETPMLICVVLI
VGGFILYAIDHLPLKPRYTDVMDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDFTLIAVGFIAAFVAGIFVVRSLLDF
VSRRGFTPFAIWRIVVGTAGLIGLWLLG
>D8N712|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIDVIKGLPNDPRQQRFALNVIVATIPAITLALIFGKAIKAHLFNPIVVASAFI
VGGLVILWAEWRERHRGQTHDPRGNALLEAAKAGAPRVETLDDLRMSDAIKVGLAQCFAL
IPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKERALLSTDDLSIFG
IGFVAAFISAFFCVRWLLRFIASHDFRGFAWYRIVFGVIVLVTAYTHLIAWQA
>B8ZI14|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAVPLLLASGALWASTDAIHQKLTDXEKRSGGRLGVALINTADNSQIL
YRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTL
AELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERD
TSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAGD
YAPP
>R8WVA8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEAAPIKKVSVVIPVFNEQESLPELIRRTSAACEKLGKDYEILLIDDGSNDHSAQLMMD
ASQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDVIITLDADLQNPPEEIPRLVATADEG
FDVVGTVRQNRQDSVFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAATGFILSILLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTQPTEENRA
>A0A068RD48|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSCVEPIKKVSVVIPVYNEQESLPALLERTTAACKQLTQPYEIILVEDGSSDGSAEILTA
AAQQPESQVIAVLLNRNYGQHSAIMAGFNQVTGDLIITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKSASRVINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARRTTEIDVRHAEREFGDSKYSLMKLINLMYDLVTCLTTTPLRLLSVVG
SVVALSGFVLALVLIALRLLLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGEQQIHKIQEEE
>A0A0R2YL53|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLSAGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPEYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQNVSIDRTDTGLSLHAKLRDAAATLLRDALP
QLAQGKLTETAQDESQATYFGRRTAADGKLDWKQPAETLFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVAKGNEGLAPGRVISVNPLRIACGEDSLVIQFGQRNENGLYLAGPALADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEIYGLDIGSDAIERLR
SHPNFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKVFYGTGYQDVAHRKPSIENAKRLLNWEPTVQMSETIGNTLDFFLREAMLEIA
QSIDEAK
>W5S5F3|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-42|antibiotic inactivation|1
SPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRW
EPELNEALPNDER
>Q2QCJ9|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVNGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>W0RAX5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTKLIEISALNKYVGSAENPAHILKNINLTIEQGDFVAIIGASGSGKSTLMNILGCLDTA
SSGSYKIEGVETQRLSSNQLSDLRQRKFGFIFQRYNLLSSLNAVENVALPAIYAGLENNA
RLKRGKELLDKLGLGDKAQHRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSG
ETVMEILQALHQEGHTLILVTHDPQIATHAERIIEIKDGAIIRDERQKVLSGKREDHKRP
AKKPRFIDQLIESFNMAVSAILAHKMRALLTMLGIIIGITSVISVVALGKGSQEQILSNI
NNLGTNTMSVYNGTGFGDRRANLTRNLTISDVSALARQNYVESATPTSSHSGTIVSGNVA
VSGQISGVGEQYFDVQGITLKSGRFFSAEEVVQSAQVVVIDSNTKNSLPFENPLGEIVLV
DKKPLQIIGVADNEMRQSSNLSLWTPYTTLMQRISGAKQIDSITVKIKDNVESQTAEKSL
TELLTARHGKKDFFVMNTDTIKQTIEATTGTMTLLISSIALISLVVGGIGVMNIMLVSVT
ERTKEIGVRMAIGAKQGNILQQFLIEAILICLLGGIIGILLAAMIIVGFNYWGSDFKMIL
SPESVVVAVVCSTLIGVIFGYIPARNASRLNPITALAQE
>M4QA56|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
DARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQN
DLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVT
RLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEGIKLQDHF
CASALPAGWFIADKSGAGER
>NP_765163|FEATURES|ARDB_deepARG|beta_lactam|PC1|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQAPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
IYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>Q8FFV6|FEATURES|UNIPROT_deepARG|multidrug|mdtQ|antibiotic efflux|0
MNRDSFYPAIACFPLLLMLAGCAPMHETRQALSQQTPAAQVDTALPTALKNGWPDSQWWL
EYHDNQLTSLINNALQSAPDMQVAEQRIQLAEAQAKAVATQDGPQLDFSADMERQKMSAE
GLMGPFALNDPAAGTTGPWYTNGTFGLTAGWHLDIWGKNRAEITARLGTVKARAAEREQT
RQLLAGSVARLYWEWQTQAALNTVLQQIEKEQNTIIATDRQLYQNGITSSVEGVETDINA
SKTRQQLNDVAGKMKIIEARLNALTNHQTKSLKLKTVALPKVASQLPDELGYSLLARRAD
LQAAHWYVESSLSTIDAAKAAFYPDINLMAFLQQDALHLSDLFRHSAQQMGVTAGLTLPI
FDSGRLNANLDIAKAESNLSIASYNKAVVEAVNDVARAASQVQTLAEKNQHQAQIERDAL
RVVGLAQARFNAGLIAGSRVSEARIPALRERANGLLLQGQWLDASIQLTGALGGGYKR
>A0A090YWB0|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIKGINHLCFSVSNLEKSIQFYEKVLEGKLLVKGRKTAYFHICGVWIALNEETDIPRNEI
HQSYTHLAFTVETEDFTHLLTRLEENKVHLLQGRERDIRDCQSIYFADPDGHKFEFHSGT
LQARLNYYKEAKPHMTFY
>J5MMU0|FEATURES|UNIPROT_deepARG|aminoglycoside|RCCGE510_19333|antibiotic inactivation|1
MRQEWSRNMEAIIEIGTIKDIEPWAQLRIALWPHHSLEDHRAELGREFLSEGGEAVAFIA
RNAANEAVGFAEATLRHDYVNGCSSSPVFFLEGIYMRPVDRRKGIARLLCNAVADWGKSL
GCVEFGSDARLENSASHALHTALGFEETQRVVFFRKPL
>K8WPH0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALLELKDITRRYPAGESEITVLKGVSLKINAGEMVAIIGASGSGKSTLMNIIGCLDKP
TTGEYFVAKQKVSLLDENQLAELRREHFGFIFQRYHLLSHLTAEQNVEMPAIYAGTGKVQ
RRERAIELLKKLGLEERVAYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSYSG
EEVMKILKDLCAQGHTVIIVTHDPKIAQQAERIIEINDGEIINDSGSISQIRIPPAQENS
SRKLTLGQIYGRFSEALLMAWRAMVVNKMRTLLTMLGIIIGIASVVSIMVIGDAAQEMVL
NDIKSIGTNTISVYPGEDFGSDDAQNRQSLKTSDVDAIAQQPYVQAVSGKLAKSTRLRKG
NLDASAQLMGVGQNYFQVYATKFSEGMNFTPDMVERRAQVVVIDANTKRRFFPNQKQVIG
ETILIGNMPATIIGVTAEQKSIFGSDNSLSVWLPDTTVNSKILNRPYLDTIVVRIKEGSN
AKSAEQQITRLLTLRHGKKDIFTYNIDTLVKTAEKTTRTMQLFLTLVAVISLIVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAVLVCLFGGLMGIGLAYGISLIVQMA
LPGWTFIFEPMAIISAFACSTIIGVVFGYLPARNAARLNPIDALARE
>A0A073KSP0|FEATURES|UNIPROT_deepARG|beta_lactam|SXM_0727|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQITFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>W8YE59|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-58|antibiotic inactivation|1
TIPQVNNSIIDQNVQALFNEISADAVFVTYDGQNIKKYGTHLDRAKTAYIPASTFKIANA
LIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQASTVPVYQELARRIGPSLMQSE
LQRIGYGNMQIGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPFKPEVQQQVKEMLYDP
QKRGG
>YP_002225919|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNRLQSGGRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQACLDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLATLLAKNIEQFTFLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAAL
AAIAFFGLQRAMPETATRRGETLSFKALGRDYRLVIKNRRFVAGALALGFVSLPLLAWIA
QSPIIIISGEQLSSYEYGLLQVPVFGALIAGNLVLARLTSRRTVRSLIVMGGWPIVAGLI
IAAAATVVSSHAYLWMTAGLSVYAFGIGLANAGLVRLTLFSSDMSKGTVSAAMGMLQMLI
FTVGIEVSKHAWLSGGNGLFSLFNLANGILWLLLMLVFLKDKRTGNSQTV
>J0KX08|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAIILGIVEGITEFLPISSTGHLVLVDEFIKMEQSKAFVDMFNVVIQLGAIMAVV
VIYFTKLNPWASKKSPLEKKQTWTLWKKVIIAVIPSIIIGLPLNDWMDSHLMNWLVVSIA
LIFYGILFIIIENHNAHTQPKFSDLNTLSYKTAIIIGLFQVLSLIPGTSRSGSTILGGIM
VGTSRYVAAEFSFFLAIPTMFGASLLKLYKFFSHGGSLAGLQGVILAVGVIVSFVVAYIS
IRFLLNYIKNKDFKVFGWYRIVLGIIVIGYFLIFH
>A0A0T1SAW9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTPTTVREYVVSGRDSGPYAITTGPDGALWFTLVHSGGIGRLVPGEEPVVHRLAPDSGPT
VITQGPDGALWFTEYKAHRIGRITTAGRVTEFALPTAECGPFGIATGPDGALWFTETAAD
RVGRITTDGTVTEYPLPGTGAFPSAIAAAGDAMWFTMNQANAVGRIGMDGRITVHELPTG
AAAPVGIAVGPDGSVWFTEIAAGQIGRMAPDGRITEYPLPDRSARPHAVTTDAAGTAWFT
EWGGNRVGSLTPEGTFTRHDLPTPASEPHGITVGPDGALWTALETGALARVAPTAPTAPT
APTAPTAPSTEQRNTP
>A0A0R1H152|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFNIIKAVILGIVEGITEFLPISSTGHLYLADEFVKLSESTAFINMFMVVIQLGAIMSVV
VLYFHKLNPLSPRKSSVEKHQTWVLWLKVILAVLPSVIIGLPLNDWMDAHLTSWQVIATT
LIIYGILFIVIENHNRQQSQNRHSHQITDLNALPMNTALFIGVFQVLSLIPGTSRSGATI
LGAILIGCSRYVATEFSFFLAIPTMFGASLLKVLKYFAHGNTFTGSQTVVLLVGVIVSFV
VAYVSIKFLLNYIKRNDFKAFGWYRIIVGVIVVLYFGLLH
>AAT70093|FEATURES|ARDB_deepARG|glycopeptide|VanA|antibiotic target alteration|1
MYRVKIAILFGGCSEEHDVSVKSAKEIANNINTEKYEPIYIGITRSGVWKMCEKPCMDWD
NENCRSAVLSPDKRMHGLLVMRDKGYQIQRIDAAFSVLHGKSGEDGAIQGLFELSGIPYV
GCDIQSSAVCMDKSLAYIIAKNDGIATPEFWVINKDDRPAAAAFTYPVFVKPARSGSSYG
VKKVNGADELDAAIESARQYDSKILIEQAVLGCEVGCAVLGNSSELIVGEVDQIRLQHGI
FRIHQEAEPEKGSENAVITIPADLSAEERGRIRDTAKKIYKALGCRGLARVDMFLQDNGR
IVLNEVNTLPGFTSYSRYPRMMVAAGITLPELIDRLIVLALKG
>YP_002315561|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MHIIELIKALILGLVEGATEFAPVSSTGHMIIVDDMWLKSSEFLGKYGANTFKVVIQLGS
VLAAVVVFKDKFFELLYLRKGEVRKGPRLTLMHIFVGLLPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIAADRFGKRTVAQTVDDITYKQAFIVGLVQCLSLWPGFSRSGSTISG
GVLVGMSHRAAADFTFIMAVPIMAGASAISLLKNWQYITFDALPFFVVGFISAFVFALLA
IRFFLRLINRVRLVPFAIYRIVLAAVIYVVYFA
>N8QI95|FEATURES|UNIPROT_deepARG|beta_lactam|F993_03488|antibiotic inactivation|1
MNQPKAFSLTLKKLFVLTGLLSCSSALWAGNLTEQQVQTIVDQQFKPLLAQYKIPGMAVA
VTLNGQHYFVNYGLASKQNQQAVSNNTLFELGSVSKTFNATLAAYAQAQGQLSLSDHPAK
YFPELKNTAVNRATILNLGTYNAGGFPLQFPDEVVHQQDMVKYFQTWQAKTKVGAARQYS
NPSIGLMGYVTALAMKKPYSELIETTLLPQLGMTQSFIRVPEQHMSQYAWGYKADQAMRV
SAGMFDAEAYGLKSSSADMLKFLDAQINPQQFKQPLRQAIENTHVGYFKVGAMTQGLGWE
QYAYPVALETLLQGNSSKMALESHAITAIKQPKLATPATFFNKTGATNGFGAYVAFIPQQ
KIGIVMLANTNFPNEERIKASYRVMQQLVQNNSAQ
>B8ZHX6|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MLKSSWRKSALMAAAVPLLLASGSLWASADTLQKKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKIIGYLGGPEKVTAFAQSIGDVTFRLDRMEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGGG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKS
>A0A0U2YPK4|FEATURES|UNIPROT_deepARG|aminoglycoside|aac(6')-Ih|antibiotic inactivation|1
MNIMPISESQLSDWLALRCLLWPDHEDVHLQEMRQLITQAHCLQLLAYTDTQQAIAMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPEYRRSGIATGLVQQVEIWAKQFACTEFASDAALDN
QISHAMHQALGFHETERVVYFKKNIG
>CAG34265|FEATURES|ARDB_deepARG|multidrug|smeE|antibiotic efflux|1
MARFFIDRPIFAWVIAIIIMLAGGLALFKLPVSMYPNVAPPAVEISATYPGASAKVVEDS
VTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQ
EVQRQGINVAKSSSGFLNVIAFVSENGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGG
KYAMRIWLDPNKLHTYGLSVAEVTAAIKAQNAQVAIGQLGGAPSVKGQQLNATINAQSRL
QTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANAL
DTAAGVDAALDDMKSFFPAGLKAEIPYDTTPFVRVSIKGVVQTLLEAIVLVFVVMYLFLQ
NFRATLIPTIAVPVVLLGTFGVLAMLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIM
SEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMAL
SVLVAIVLTPALCATMLKPLKKGEHHVAHRGLAGRFFNGFNRGFDRTSESYQRGVRGIIH
RPWRFMGIVAALFVLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESIAALEN
HFLQNEKDAVDSVFSVQGFSFAGMGQNAGMAFVKLKDWSERDANNGVMPITGRAMAALGQ
IKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAGSKKLANVRP
NGQEDTPQFRIDIDAAKATSLGLSIDQINGTLAAAWGSSYIDDFVDRGRVKRVFVQADQP
FRMVPEDFDLWSVKNDKGEMVPFSAFATKHWDYGSPRLERYNGVSAMEIQGEPAPGVASG
DAMAEIEQLAKQLPAGFGIEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAAMYESWSVP
TAVLLAAPLGILGAVLANTFKGLERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGAG
LIEAIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGV
FFVPLFFVVVQRVFKRKTAE
>A0A0J8FXA4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MNSKAVVFAYHDIGCAGIEALLTAGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPAFIFSFYYRNLLSEALLATASQGAFNLHGSLLPKYRGRAPAN
WVLVKGETETGVTLHRMVKRADAGAILAQQKVAIERDDTGLTLHAKLRDAASSLLRDALP
QLAQGKLSETAQDESQATYFGRRTAADGKLDWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNDNGLYLAGPSLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKK
>A0A0N8RE33|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADMIHHYLFNAITVATALV
LGGVIMLWAERREHTVRTETVDDMTWSDSLKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>I6H0P5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYDIAAIFTHADNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERIGQLAPDMIFSFYYRHLLSDEILRLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQQRITISPDDVALTLHHKLCQSAREVLAQALPAI
KAGDFQEYLQQEADATCFGRRTPEDSFLDWNNPCAQLHNMVRAVSDPWPGAFSYAGTQKF
TIWSSRQSANTSAALPGTVISVSPLLIACADGALEIITGQAGDGITMQGSQLAQVLGLVA
GSRLNSQPVSASKRRTRVLILGVNGFIGNHLTERLLREDNYEIYGLDIGSDAIERFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKDFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALFRIIENEGGRCDGEIINIGNPDNEASIQELAEMLLSCFEKHPLRQHFPPFAGF
RDVESSSYYGKGYQDVEHRKPSIRNAKRCLNWEPTIEMQETVEETLDFFLRSVDITEHTS
>A0A0G3QBI3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCTGIQALLEAGFEIAAIFTHADNAGENHFFKSVARLAAEQEIPVYAPD
DVNHPLWVDRIRALAPEVIFSFYYRNLLCNDILSLPTKGAFNLHGSLLPKYRGRAPLNWV
LVNGEKETGVTLHRMTQRADAGDIVAQQSVAISDTDVALSLHQKLCAASQSLLSDVLPKI
RSGQTQERAQDEAQATYVGRRTPEDGRLTWEKPAQELHNLVRAVSDPWPGAFGYVGTNKF
IVWKSRVRTDLAAAKPGTVLSVAPLVVACGEGALEIVTGQSANGVYMQGTQLAPAMGLVP
GALLSSRPFAAIKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLDSP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDANFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
TGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLDCFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLDWQPTVEMHQTVEETLDFFLRTVEVTEQKP
>A0A0H3CTI4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
FWRRLFGLIGIHFGRLPQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPINVM
YALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATISGGM
LMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTTGDIPMFAVGFITAFIVALIAIK
TFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>YP_002415222|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTMQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATMLEIASLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RTITQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLATEINKLQHAIAEGQCWQSDWRIT
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPATKPPSMVADAFTNPDYMRYAVKTLLA
CLICYTFYSGADWEGIHTCMLTCVIVANPNVGSSYQKMALRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>A0A099XSA0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLLETIILAVIEGITEFLPVSSTGHMIIASSFMRIATDDFTKLFTIVIQLGAILSVVVL
YWKRFFQSFDFYFKLLVAFIPAVVLGLLLNDVIDSLLESPITVAISLIIGGFILLKVDEW
FKGNEEFDEKNPNEHTEISYANALKIGFFQCLAMIPGTSRSGASIVGGMTQKINRKTAAE
FSFFLAVPTMLGATAKKSYDYYKAGFELSSDQINYLIIGNIVAFIVALIAIKSFIDYLSR
KGFKIFGYYRIILGITLLIIHFFIYRLTI
>A0A017IDM0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTAACESLGKEYEILLVDDGSNDNSAQMLVD
ASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPHLVEKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQHTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWATEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>Q104Z3|FEATURES|UNIPROT_deepARG|beta_lactam|bla(ampc-EC7)|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>JE0138|FEATURES|ARDB_deepARG|aminoglycoside|AAC(3)-IIa|antibiotic inactivation|1
MHTRKAITEALQKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDEARRTWLPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKALLLGRPLNSVTALHYAEAVADIPN
KRWVTYEMPMLGRDGEVAWKTASDYDSNGILDCFAIEGKPDRVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFVDHSEASARRPSSRSCEPSG
>D4XUI1|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MKLSKLYTLTVLIGFGLSGVACQHIHTPVLFNQIENDQTKQIASLFENVQTTGVLITFDG
QAYKAYGNDLNRAKTAYIPASTFKILNALIGIEHDKTSPNEVFKWDGQKRAFESWEKDLT
LAEAMQASAVPVYQALAQRIGLDLMAKEVKRIGFGNTRIGTQVDNFWLIGPLKITPIEEA
QFAYRLAKQELPFTPKTQQQVIDMLLVDEIRGTKVYAKSGWGMDITPQVGWWTGWIEDPN
GKVIAFSLNMEMNQPAHAAARKEIVYQALTQLKLL
>YP_002383660|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGFTPLAAVLLLSGSLALTGCDDKQAQQGGQQMPEVGVVTLKTEPLQITTELPGRT
SAFRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQAAYDSAKGDLAKAQAAAN
IAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPI
NGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENG
KAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
LNPNAILVPQQGVTRIPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVV
ISGLQKVRPGVQVKAQEVTADNNQQAASGTQPEQSKS
>CAO82974.1|FEATURES|ARDB_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MKFNLIDIEDWNRKPYFEHYLNAVRCTYSMTANLEITSLLREIKLKGLKLYPTLIYIITT
VVNRHKEFRTSFDQNGKLGYWDSMNPSYTIFHKDNETFSSIWTEYDENFPRFYYNYLEDI
RNYSDVMNFMPKAGQPANTINVSSIPWVNFTGFNLNIYNDATYLIPIFTLGKYFQQDNKI
LLPMSVQVHHAVCDGYHTSRFFNEAQELASNFETWLGEK
>A0A0U3YMJ8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTALLELRDIRRSYPSGETDVEVLKGVTLTINAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGSYKVADVDVATLSDDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAIYAGTGRAA
RQARARELLARLGLEARVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVIATLKQLRDRGHTVIIVTHDPDVAAQAERIIEIRDGEIISNPPPVGKRDAGGLPAQP
QDAPAFGQFINSFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVL
EDIRSIGTNTIDVYPGKDFGDDDPQYQQALQYDDLQAIQRQPWVSSATPTVSQNLRLRYG
NVDVAASANGVSGQYFNVYGMTFSEGNTFNDEQLRGRAQVVVIDSNARRQLFPNKANVVG
EVVLVGNMPATVIGVAGEKQSMFGSSKILRVWMPYSTMSGRIMGQSWLNSITVRVKEGYD
SGEAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTRTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARKSDVLQQFLIEAVLVCLVGGALGIGLSLLIALALQLI
LPGWEIGFSPVALLTAFLCSSATGVLFGWLPARNAARLNPVDALARE
>A0A150P309|FEATURES|UNIPROT_deepARG|bacitracin|BE08_25670|antibiotic target alteration|0
MFWFDAVLLGVLEGLTEFLPVSSTGHLILLGAWLGHESEAAKTLDIVIQLGAVLAVVVYF
RERLAVTVRGVLRRDPDSLRLALALAVGFVPAALVGLLFHKAIKAYLFGPGPVAAALIVG
GVLMVAVEAMRRRQPDQGAPRLEDVTLPRAAAIGFAQCFALWPGASRSMTTIVGGQLSGL
STAAAAEFSFLLAIPTLGAATIFDLAKNGRALLEAPGGPAALGVGLAVSFVVALLVIAVF
LRYLKRYGLAPFGWY
>U2MSJ8|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9145_0517|antibiotic inactivation|1
MSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTV
KVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPV
ISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADH
NKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVI
AHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVY
SLLMKTSVKS
>YP_002452410|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKTHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENINFVVPGHG
EVGDKGLLLHTLDLLK
>B0ME82|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILILKTIILGIVEGITEWLPISSTGHLILVDEFINLNVSAAFKEMFDVVIQLGAIMA
VVVLYFHKLNPLSPKKNRKQKHETMVLWYKVIFAVLPAAVIGILFDDAIHDRFFNPVVVA
ATLIIYGVLFIVIENHNERSRRRGMDSLSGLTYRMAFIIGVFQVLSLIPGTSRSGATIVG
GILIGCSRTVAAEFSFFLGIPVMFGASLLKILKFGLSFTGTELVVLAIGMIVSFLVSIVS
IKFLMGYVKRHDFKAFGVYRIILGILVIGYFMFFK
>A0A0X8KCX3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLKVVILGIVEGLTEWLPVSSTGHMILVDEFIRLNVSTAFMDMFLVVIQLGAILAVVVLN
AKKLNPFLGSKSRAERRETLDLWGKVIVACLPATVVGLAFNKYMEEHFMNAPVVASMLIL
YGILFIVVERWNKRRTPRVESLAALDYRTAFIIGVFQVLSLVPGTSRSGATILGGIIFGA
SRYVATEFTFFLAIPVMFGASFLKLVKFGWHYTGAELFILAVGMVTAFVVSILSIQFLLR
YIKRNDFTAFGWYRIALGILVLAYLFMVGDPTKE
>I4YV55|FEATURES|UNIPROT_deepARG|beta_lactam|MicloDRAFT_00044210|antibiotic inactivation|1
MPLPPRHLACLATILMGSIVGAPSSACAAGPVQDAEVRKAVDEAMKPVIAQYGLPGMAVA
VSVDGRRHFMAYGLASKEPQVPVTRDTLFELGSISKTFTATLATYAEVEGRLKLTDSVSR
HMPELKGSAFDKVRLVDLATHTAGGFPLQLPASVKDRKQLIAYYRAWKPTSASGTWRSYA
NPSIGLLGLVTARAMDASFTSLAERLFGDLGLRRTYVEVPAAEMKSYAWGYGRDGKPVRV
SRALLADEAYGVKSNAVDMIRFLEVNMGIGSVPEPIARSLRATRTCYFRSGELTQGLIWE
QYPYPVALDTFIAGNTMNQRASPAFAIDPPLAPRDDVIVNKTGSTLGFGAYVAFVPGRKI
GIVMLANKAYPNEARVRAAHQVLSRLTE
>A0A0X8JJ41|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDNLLTALILSIVEGLTEFLPVSSSGHLILVGDLLNFVGERAATFEVVIQLGAIMAVVVL
YWKRFWGLVQPQPYVRFAGMRGIWLLVLTSLPACVMGLLFHSLIKEYLFRPSTVLIALVV
GAVCMILVERRKHKPTCISLDDMTPRLALGIGCFQCLALWPGFSRSAATIMGGMLLGAKR
PLAAEYSFIAAVPIMVAATGFDMLKNLSLFTSADIPFFAVGIVGSFISALLAVKVFVALV
GRMTLVPFAVYRLLLAPFVYYFMVN
>A0A0B6XC94|FEATURES|UNIPROT_deepARG|polymyxin|pbgP|antibiotic target alteration|0
MTFEKIKKVSVIIPVYNEEESLPQLLERTIAACQQLEQKYELILVDDGSRDSSADILTQA
AETPENHVIAILLNRNYGQHSAIMAGFHQADGDLVITLDADLQNPPEEIPRLVKTAEEGY
DVVGTRRANRQDSWFRKTASKIINAMITKATGRSMGDYGCMLRAYRRHIVHAMLQCHERS
TFIPILANTFARRTTEIDVTHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLSVVGS
IIAVTGFLLAVLLIALRLIFGSIWAAEGVFTLFAILFMFIGAQFVAMGLLGEYVGRIYND
VRARPRYFIQKVVGVRKINDNQEKS
>A0A0M4P8V5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKLKAVILMVTLLFALGAPAQASRAASEGQVKSVVDSAIEPLMAKHHVPGMAVGIVANGK
TYVFDYGVASAETGKPVTQRTLFEIGSVSKTFTATLAEYAQLSGHLRLSDPTQTYLPSLR
GSAFGKVSLLNLGTHTPGGLPLQVPDEVHDNAQLLQYFSTWKPASAPGMYRTYANPGIGT
LGLITAKSMNQDFASLMEQRLFPALGMTSSYIHVPPTKMSDYAQGYTKDGAPIRMKGGVL
ADEAYGVRTTAADMLRFVQANMNLIDVDNQLQRAITATHTGYFKAGVLTQDLIWEQYAYP
VTLTTLHEGNAPAMATTATPVIAIEPPLPPQQNVWINKTGSTNGFGTYVAFIPQKHVGVV
LLANRNFPIEDRVSAAYRIVSALVASKQ
>E1KQY7|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9296_1218|antibiotic inactivation|1
MAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>A1ADA7|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKSASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLNWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A086EFG9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFADEKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGDVPHEGKTAGRLKLTHILLAMIPAVVLGLIFHDVIKSLFYPQN
VMYALVIGGFLLLAAEWFKPKQPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSWHFLSLADVPMFAVGFVTAFIVALIA
IKTFLKIIKRISFVPFAIYRFIVAGVVYMVFM
>B2CD66|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
LLTLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSD
NTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLR
KLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWYFADN
>V1AZH7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIGTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMHETIDETLDFFLRTVDLTDKPS
>YP_002890644|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDLSLLLVALVLGIVEGLTEFLPVSSTGHLIILGDLLGYNDDTSKVFKIVIQLAAILAVC
WDYRERLIKVASGITTEPSAQRFVGLLFIGFLPAAVLGLMFHSTIKGLLFNPITVATALV
VGGLIILYVEKRAYHPRLNSVDELRWTDALKVGFAQALAMIPGTSRSGATIMGGVIFGLS
RKTAAEFSFFLAIPTMFAATAYDLYKNWALLRVEDLPVFAVGFIASFVAAMWAVKSFIKF
ISNHTFVAFAWYRIVFGIFVLATWYFGWVEWSEP
>N9C5P4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLFKAAIMGLVEGITEFLPISSTGHLILSGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGAMKGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRQHLVVSSEVDDLTFKQATLIGLIQCFALIPGTSRSGSTIIGSLFLG
ISRKAAAEFSFFLGIPVLMGAGFLDMYKMRNDLHSNDLAVLAVGIVVAFISALIVIRALI
RYVSKHDFTAFAYYRIGFGVFILATWWTGWVHW
>R5FMK2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTFLQTIIISIVEGLTEFLPVSSTGHMIITQNLLGVPQGDPFVHAFTFIIQFGAILSVVC
LYWKDFFRLDHSPAPAGSSALGRFLHTWRFYWLLFVGVLPAVVVGLVAKKSGLLDWLLDS
VTVVAVMLVVGGIFMLFCDRIFNRGSEANKVNEKRAVKIGLFQCLAVIPGVSRSMATIVG
GMQQGLTRKRAAEYSFFLAVPTMAGATLLDVIDLLKGDTTWANSHNVTMLIVGCVVAFIV
AFLAMKWFVNFVTRYGFKVFGWYRIIVGGIILALILSGQSLVMVD
>A0A145YT69|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MTKITPEYTAVDLSSWARKEHFEVFQSFAQCTINQTVQLDITALLKHIKQVGWKFYPSII
SLISTVVNRHSEFRMAMKDNELVIWNEVHPSYTLFHKETETFSSLWSHFDGNIHHFQNVY
AEDVSRYGDNLAYWPKEEYRENIFFISDIPWVSFTSFNINVANMQNFFAPMFTFGKYFNQ
DGKVLLPFAVQVHHSVCDGFHVARLINELQEWCDNLPHY
>A0A084DKN5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLLVAACAAATAGRAAAATQDDLHDTVTRHIAPLMKQFAIPGMAIGVVAD
GKPYVFDYGVMSTQTGKPVDGDTLFEIGSVSKTLTATLAADGQEGGELSLADPAAKYLPA
LQGKPFGVLTLLNLGTHTPGGMPLQVPDSIHDDASLIRYLDAWRPAYAPGTYRTYSNVAI
GMLGWLTAKAMHKDFATLMEQRLFPSLGMTHTYINVPAAAQADYAQGYTKDGKPIRMTAG
MLWQPAYGVRTTAADLLRFVQANMGLVGTAPRLQRALERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLDGNAPKMLYDAVPASAIKPPLAPRADTWINKTGSTSGFSTYVAFVPSKRIA
IVMLANRSFPIEDRVKAAYGILGSLDGQR
>A0A060LZ65|FEATURES|UNIPROT_deepARG|beta_lactam|BleG1_0471|antibiotic inactivation|1
MKRYGAIFTLTVLAACGTPETTEQQQPDDENSAAVFSVLEDHYDARLGVYALDTGNGQTI
AYNEDERFAYASTHKALAIGVLLQQLSLDELDTQILFSEADLVTYSPITEQHVETGMSLH
EISDASIRYSDNTAANLIFNEIGGPSGFKEALREIGDEVTEPERMETELNDVKPGETRDT
STAKALAESLYAFSLGDALDEEKQTLLNDWLIHNTTGDALIRSGVPEGWLVGDKTGSASY
GTRNDIGIIWPPDEDPIVIAVLSSKEQADAESDDALIADATEAALRMLMDDFEYGASQTP
>C8WP28|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIIEALKAFLIGIVEGITEWLPISSTGHMILVDEFVKLQVSDEFLALFLVVIQLGAIMAV
LILYFHKLNPFSPKKDAVEKKSTWRLWGMVAIGCIPAAVIGLLFDDLVNEYFYNKVTVAA
MLILYGVVFIVLERRNRRRLREAEAALEAPRGRHARVSYGDVSDEAEASLFKITDVDEID
WKTALKIGCFQVLAIIPGTSRSGATIIGGMLAGCSRTAAAEFTFFLAIPIMFGWGLVKCI
KFVAAGIAMTSTEILVLAVGIITAFAMSVVAIKFLMGYIKKNDFTAFGWYRIVVGVLVLG
YFVFESMGMLP
>YP_415591|FEATURES|ARDB_deepARG|tetracycline|tet38|antibiotic efflux|1
MIMNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVI
GIGAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFALLLVGRIIQTAGLAAAET
LYVIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTL
PFLFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIK
NAQRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPG
YIVAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSF
ALMYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALS
SHFGIILIILGLMSIVGLVLFVILNRWTQSEK
>A0A0B3WTI8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWIEIFKAIILGIIEGITEWLPVSSTGHMILVDEFLQLGMSPAFKEMFFVVIQLGAIMA
VVILYWKKIFPFNFNKKPFVETDIIIMWVKIVIACVPAAVVGLLWDDQINALFYNFQTVA
TMLIIFGILFIVVENHNKGKRPLVTNMNQLTYKMAVIIGLFQLIAAVFPGTSRSGATILG
ALLIGVSREVAAEFTFFLAIPVMFGASLLKLVKFGFAFTSFELIVLGVGTVVSFVVSVWA
IKFLMGYIKKHDFKVFGWYRIILGIILLAYFFFMM
>A3DHS8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLELIKAIFLGIVEGITEWLPISSTGHMILVEEFINMNLSDEFMEMFRVVIQLGAIMAVV
VLYWNKLFPFSFEDRIQIKKDTFSLWIKVLAATLPAALIGVPFDDKIDELFYNYITVAIT
LIVYGVLFIIMENRNKSKIPAISTFEELGYKAVLLIGAFQVLALIPGTSRSGATILGAIM
IGCSREIAAEFSFYLAIPVMFGASLLKLVKFGFAFSQTELIILLTGMIVAFAVSIFAIKF
LMGYIKRNDFKAFGYYRIILGLIVVLYFLAVR
>U3UH20|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSLDVIFILKSVIIAIVEGLTEFIPVSSTGHMILVGNLIDFKGQFAEMFEVVIQLGAIL
AVVVLYWKKIKDSVREFLKFIFTGGKEGKIGFRFGMNVIIGCIPFAIIGVLFYDNIKSLF
NLQSVIIGFIVGGILLLVVETLFRKKNHSTDNIDKITPIQALKVGTLQVLSAWPGMSRSA
STIMGGWIAGLNSPTAAEFSFFLAVPAMVASSGKDLFEFDYSVMTPTLWIALVVGFIVAF
IVSIIVMEKFVNFLKKKPMRVFAIYRIIMGAVLAVLALTNIISI
>A0A127SX86|FEATURES|UNIPROT_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MFTLIDFENWERKEHYLHFYNDVRCSYSTCVNIDISNLNGQRLYPAMLWLLTQTINEMPE
FRTALTEKGLGYYSEMHPAYTIFNQEQKTFSGIWTAYKSNYTAFLSSYEADVAKYSSSGK
YAPKPERPVNSFDTSMIPWFSFTAFNLQVFGDGSYLLPIFTMGKAFDAGTKKMLPLAIQV
HHAVCDGYHVGRFIELLQKKIIGFDSGFNSTPSDTSATVKGRMYEMTDKAPWVFSDMSGN
CSNTISLCEATKEDAPFIASVYNQAILAGNCTCDTKTVTSEMREKWICQHAADGYPVYLC
LENGMPVGYGYLTAYRQGREAVNHVAEVSYYLDFS
>G4L436|FEATURES|UNIPROT_deepARG|aminoglycoside|TEH_23880|antibiotic inactivation|1
MYYQSLIDKFSAKCKEVFNSHLTGVYLHGSMAMNCFNSEKSDIDLIIIVENNIANNQKIK
FMDYVMKLNEQGPVKGMEFSIVQRKYCHPFVYPTPFELHFSQMHVKQYKHNPIKYIENMK
GKDKDLAAHFTMINHCGIVLHGEPIKDVFGKVPIKDYVDSIWRDIENARKDIVIEPMYMV
LNLCRVLAFLEDGLYLSKQQGGKWGLTHISKKYHLLIAEALYCYKTKHAMQVDKAYAKDL
ADQMLHNIEYKRGAV
>A0A0R1ZM33|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIIKAIIIGIVEGLTEFLPVSSTGHIDLVQSVIHMGQSADFKYMFNYVIQLGAIMAVV
FLYFHKLNPLAPSKTHAEKNATWTLWFKVIVAVIPSVIIGLPLNDWMDEHLQTPPVIATT
LIIYGILFIIIERYNKNRRPVVTSLADISFQLAILIGLFQALSIVPGTSRSGATILGAIL
LGTSRYVATEFSFFLAIPTMFGVSILKMGSFFLKGNTFGGGEIAVLATGFIVSMIVAWVT
IKWLLKFVQGHDFTGFGWYRIALGIVVLLVMFL
>A0A0P9ICL2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPKEKTFFGSVAQMCARHGIAVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLP
LLAAQRQLPTTPQDESRATYFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCTVGD
NKLIIWAASVDTSSNGEAPGTVISHEPLRIACGEGSLVITAGQRGDNGLYLSGEQLAREF
GLVAGSQLLDKAKRRSVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVVDGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGKGYQDVSHRTPSIDNAKKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>A0A0N0X0K9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPKEKTFFGSVAQLCARHGIPVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDPLLACAKKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLP
LLALGQLSGTPQDETLASCFGRRTPADGLIDWSLPAIQLYNLIRAVTQPYPGAFCAVGEN
KLIVWAASAEAGNNGEAPGTVISHDPLRIACGEGSLVINAGQRGDNGLYLSGAQLAREFG
LVEGSQLLDTEKRRPARRTRVLILGVNGFIGNHLSERLLQDDRYDIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSIDNARQLIGWTPGIELSETIGKTLDFFLREAMAEKA
DMR
>I0FXW4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDAIRAVILGIIEGVTEFLPVSSTGHLLLAERFFHLGEGAFWDSFTVLIQLGAILAIVV
LYFKKLWDVAIGMFTGDADARRFVIGVLVAFLPAVIVGLVAGKYIKSLLFNPWVVCFSLI
VGGAILLWVDRLDLKAREHDATRFPLLMYLYIGIAQCIAMIPGVSRSGASIVAAMFLGAD
KRAAAEFSFFLAIPTMIGAFAYDFYKNRSEMTMDHMGVVAIGFVVSFITAIIVVKTFLSY
VTRHGFVVFAWWRVIVGTLGLIALALGH
>A0A0J8G163|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MYQKSNFNVRNIFISALLLGAGPCMAASDLRKIVDSSVEPLMQQQGIAGLSVAVVKNGQA
QYFNYGVASTDSQQPVTEDTLFEIGSLSKTFTATLGGYAQATGKLKLQDKASQHLSALKG
SAFDRISLLQLATYTPGGLPLQFPSAADSAETMLTYFQRWKPTYAAGEQRRYSNPSIGLF
GYLTAQSLGQPFNVAMEKTLLPKLGLKNTHISVPADKAGLYAQGYDKQQKPVRVGPGALD
SEAYGLKTSTQDLARYVMVNMHPETLEKPLQQAIATTHTGYYTVNGMTQGLGWEFYPYPI
KLQALIDGNSTPMAMEPHKVNWLKPAQTQPKNVLFNKTGSTGGFGAYVAYVPSKDIGVVI
LANKNYPNAERVKVAHAILSAIDH
>I6BI29|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERDIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQMLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0U1H7V7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_1|antibiotic efflux|1
MAALLELKGIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAALDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNE
RRERANMLLTRLGLGERVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERVIEIKDGRIMADSGSKITQDVVSSDAIS
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVYDDMAALKAQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSDQYFRVYGMKLEQGTAITGEQVERQSQVVVIDRNTQRRLFPHIKDV
VGQVILIGNMPATVVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLIVE
MFLPNWQIAFPPVALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A0S1Z1Z4|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVTKRVLRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>E9XRN3|FEATURES|UNIPROT_deepARG|beta_lactam|ERFG_03731|antibiotic inactivation|1
MFKTTLCALLIIASCSALSAPQQLNEIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPEWASGTQRLYANASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDTII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0Q8IBE9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADMLGFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPGARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVAAALV
VGGFIMLWAERRQHEVHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFVPSDFPVFAIGFVTAFVFAMIAVRGLLKF
IANHSYAAFAWYRIVFGLIILATWQFGWVDWSAVKP
>A0A0P6S3W4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLVIELIKAIFFGIIEGITEWLPVSSTGHLILVQEFVALNQNQSFMEMFNIVIQLGAIFA
VILVYFERLNPFQPGKDAREVRLTWQLWLKVVIACIPSILIAVPLDDWFEAHFNNMFSVA
LALIVYGIAFIVVEKRHESIAPQVTQLSRMSYKTAFGIGCFQVLSIVPGTSRSGATILGA
IILGTSRTVAADFTFFLAIPTMFGYSGLKALKFFIEGHRLGGGQVLILVVASLVAFVVSL
QAIAFLTDYVKKHDFTIFGKYRIVLGSLLIVYSVFKWVF
>A0A090USY2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKVQHEGTGKGRLTLGHILLGMIPAVVLGLVFHDTIKSLFNPIN
VMYALVVGGVLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLSASDIPMFAVGFVTAFIVALVA
IKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0A7PIF9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDAARWAIFNIAIQPGAILAIVVL
YRKLFWDMFTGFFRRDPVAIAFVRNLLLAFFPAVILGLAFGDYIEVMLENAVIVAWALII
GGFAILLVERFAKTTDVGGVANVSVRQSILVGLVQCLAMIPGVSRSGATILGAMSFGVDR
KTAAEFSFFLALPTLTGATVLQLFKHRDAITSNDLGLIAVGSLVSFVVAWAVIKAFLAIV
TRYGFAPFAWYRIIAGVAALIWLGMR
>A0A127SSN8|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRTQQMSELENRIDSLLNGKEATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSSFEAVYRNW
STPSAMAQLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAQTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDNADIIARISRMVYDAMR
>R2S3B0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANIIKAAILGIIEGITEWLPISSTGHLILADQFIKLDASSQFMSMFNVVIQLGAILA
VVVLYFHKLNPFSPSKTTIEKKDTWTLWFKVIVACIPAVIIGLPLDDWLEAHFYKFLPVA
IVLIIYGIAFILVEKRNKNKTPRWTTLNDFTYQAALLVGLFQVLALVPGTSRSGATILGA
ILIDASRFVATEFSFFLGIPVMFGASGLKIVKYLVQGNSFKMEETIVLLVGTLVSFIVSV
LAIKFLLNYLKKNDFTVFGWYRIILGIILIGYWFIAM
>U3HM20|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQALILGVVEGITEFLPISSTGHQIIVADLIGFGGERFQAFNIIIQLGAILAVV
WEYRRKIFDVVVGLPRERSAQRFTGNLLVAFFPAVVLGVAFADLIHHYLFNPITVATALV
IGGVIMLWAERREHAIQAETVDDMNWKQALKVGLAQCLALVPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRHLFQPADLPVFALGFVVSFIFAMIAVRALLKF
IGNHSYAVFAWYRIGFGLLILATWQFGLIDWATAQG
>A0A127SLI0|FEATURES|UNIPROT_deepARG|chloramphenicol|catA16|antibiotic inactivation|1
MRKMTLTLIDFDNWERREHYLHFINEVRCSYSVCINLDISNLNGQRLYPAMLWLLTRTVN
EMPEFRTSLTENGLGYYSEMHPAYTVFNPDAKTFSGIWTAYQPDYPSFLRGYEEDAGKYS
STTQYEPKPGRPANSFDVSMVPWFSFSAFNLNIFSDGTYLLPIFTMGKTFEENEKTMLPL
AIQVHHAVCDGYHLGKFIETLQANINKFDA
>B8D8M0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDLHQVIVSIIIGVIEGITEFLPISSTGHMIIASHWLKIDNENTKILEIFIEFGSALSI
LYFFHKKILRILKFNINVKKTNTKNLHILLAILPTIFFGLLFYKKIKLLFNTYNVMYALI
LGGIFLLISEIFKPKKYKTCSINDISLLQSAIIGFFQIFCLYPGFSRSGATIGTAILLGI
KRSVAIEFSFIISIPLIMGASFYDFINNMHNFKILDLPIFFIGFMISFIVSILCIKKLLK
IINRTSLIFFGIYRFIISGLIYFIN
>A0A0M3R8A6|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY|antibiotic inactivation|1
MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKADLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKIIGYLGGPEKVTAFAQSIGDVTFRLDRMEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRTQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>A0A0A7A3F2|FEATURES|UNIPROT_deepARG|beta_lactam|Asd1617_05767|antibiotic inactivation|1
MGFLRSGCYPDSCHADWCRYNLTHHQCKSGPPMAGRFVWKPDPMFKTTLCALLITASCST
FAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFE
LGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQV
PDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQP
LKLNHTWINVPPAEEKNYAWGYREGKAVHISPGALDAETYGVKSTIEDMACWVRSNMNPR
DINDKTLHQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIVNGSDNKIALAARSVKAI
TPPTPAVRASWVHKTGSTGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>A0A0A8GY65|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILDYYHALILGIIEGLTEFLPISSTGHMILGAEILGLNIDDFWRSFFIIIQLGSILAVI
FIFKDKLTQKFDIWLKLAVGFLPAGGVGFIAYKFLKEIFNGYTVATMLIIGGIIFIIIEL
KHRKKDYVIHSLDEVSYKQAFLIGLTQALAIIPGTSRSGASIIGGLLLGLDRKIASEFSF
LLAIPTMIIATAYSIYKEPQVLSNMSNFIPLVIGFVTAFVVAFVVIKIFLKLISKINFIP
FGIYRIILGFVFLYLFMSGMLDISKTSV
>A0A108E6H2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|WT83_28940|antibiotic efflux|1
MNYRYDSIPLLELTAVERCFRVNDHPMIVLKQINLRIMRGEFVAITGKSGSGKSTLLNIL
GCLDRPTSGQYIIDGLPVGELSSDQLAQLRRQRFGFIFQRYHLLAHLNASENIQLPAAYA
NVNKECRKKRAQHLLAELGLTDHSDYRPAMLSGGQQQRVSIARALINGGEVILADEPTGA
LDAESRDDVMSTLLGLHRRGHTVIIVTHDQNIAQKAHRIIRMQEGRIVDDQTCHVATKSP
YVKAAPLGALHSSDTAIPKLAHTQTGDVFDIEARGAHSRHTIERWSNSIATGYISEALRT
AWISMNTHRSRTLLTMLGISIGIAAVVIVVALGQGAQAAVIQDIESVGTDIVGLYPGRDG
ADDQANATHTLVEADLAILRKQFYVDSATPTVSSSRVLVSNQGRATGSVRGVDADYFRVY
GIDMASGARFDAAAVQRHAQVAVIDDNTRERLFGNRDEVVGQTILIGTLPCTVIGVMAKH
ESLFGTPPTLSVLVPYTTAADRITGQWWFNDITLRLRDGVPNDVAEQYITKLLTVRHRVK
DFFVSTSEGFVRTVERAASTLTLLVLVVAIVSLFVGGIGVMNVMLMSVLERTREIGIRLA
VGARRSDIMYQFLAEASLLCLSGGLLGILLAFLVSTVFSLFVSVITVRLSTQVFTLACAC
SVTTGITFGFWPALNAARLDPVEALARE
>AAA62061|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVXFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWAMAMMGIAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVXXTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A0F3KX90|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFAGLSYAAFVHWNPSHVNDLINAILLGIIEGITEFLPISSTGHLLIAERWLGERSDLFN
VAIQAGAILAVTFIYWRTLWSFVQNWRRPETRDYILKLGVAFLITAVLGLIATKMGFKLP
ETITPIAWALIIGGIWMIGAEQVAAKRPDQAKITWRVAILVGLAQMVAGIFPGTSRSAAT
IFVAMLAGTSNRAAATEFAFLVGIPTMYAATGYELLKTYQHGGAAGEDWTGLGVAFVVST
LVAFAAVKWLLGYIRSHRFTAFAVYRIALGIALLLFLPTGG
>E5VRD5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNVIEIVKSIVLGIIQGITEWLPISSTGHLILFDNIWPMALSPEFFEVFKVVIQFGSILA
VLVLFFHKLNPFSPRKSRREKRDTYNLWKKVIVGCIPIIIVGLPLDMVLEDYLSGVYVIA
ATLILYGIAFIVIESRNRRPSMRSLEDLTYKAAFFIGCFQVLAAIPGTSRSGATILGAVL
LGCSRYVASEFSFFLAVPVMAGASGLKLIKYFLKVGMFSGSEWILLTVGTVVSFLVSILA
IRLLLSYIRKHDFKVFGVYRILLGIVVIVYFGFLV
>G4D1F5|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MELIKIIILGIVEGITEFLPISSTGHLILVSEILKLHSQSFENAFSVIIQLGAILAVVLL
YWDKLNPISKKKLSSSIVENESHLSISDRWHLRDKKTMRLIAKVIIGFLPAAVLGFLFDD
IIDKYLFNPTVVAITLIIYGVIIIFMEDKKKSEFKYEDIDELSVVDAFKIGVFQCLAMIP
GTSRSAATIIGGMTLGCNRTTAAEFSFFLAIPTMLGATALKVLKMGTSFTVSEWFYILVG
FVISFVVAYAVITKFMSYIQKHDFKVFGMYRIGLGVLVILFLKIF
>BAA02119|FEATURES|ARDB_deepARG|tetracycline|tetL|antibiotic efflux|1
MNTSYSQSTLRHNQVLIWLCVLSFFSVLNEMVLNVSLPDIANEFNKLPASANWVNTAFML
TFSIGTALYGKLSDQLGIKNLLLFGIMVNGLGSIIGFVGHSFFPILILARFIQGIGAAAF
PALVMVVVARYIPKENRGKAFGLIGSLVAMGEGVGPAIGGMVAHYIHWSYLLLIPTATII
TVPFLIKLLKKEERIRGHIDMAGIILMSAGIVFFMLFTTSYRFSFLIISILAFFIFVQHI
RKAQDPFVDPELGKNVFFVIGTLCGGLIFGTVAGFVSMVPYMMKDVHHLSTAAIGSGIIF
PGTMSVIIFGYIGGLLVDRKGSLYVLTIGSALLSSGFLIAAFFIDAAPWIMTIIVIFVFG
GLSFTKTVISTVVSSSLKEKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIGFLDHRLLPI
DVDHSTYLYSNMLILFAGTIVICWLVILNVYKRSRRHR
>A0A0W1CS55|FEATURES|UNIPROT_deepARG|aminoglycoside|ATE71_14205|antibiotic inactivation|1
MQVRDAEIADTPVWAAMRARLWPEADAAELADELPAMLGDETLWNFILIDEMNRAVGFAE
VQLRTMFDGCPVAPYPHIEGIWIDAVHRRTGAGRRLLAAIEERARKRGHDHIGSDVELDN
IGSQAWHNACGFEEEARSILYSKPL
>A0A0S3N3F5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQQIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQQTLFELGSVSKTFTGVLSGDAIAREEITLSDPVTKYWPELTAKQW
NRITLLHLATYTAGGLPLQVPDDIKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPINPD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAAAWQILNALQ
>ZP_03002230|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLALAAVSLYLAG
GMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFVHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPV
ILIDAGGLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLALLII
GNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNNLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELAEER
>A0A071I116|FEATURES|UNIPROT_deepARG|aminoglycoside|CN09_03395|antibiotic inactivation|1
MQIKEASFEHLDAWLRLRAELWPGSSMEHHRAELTQILTKENAIAFIACDQTGHAVGFAE
ATLRHDYVNGCKTSPVLFLEGIYVRREYRRRGVAQSLCRTVADWGRAAECREFASDALLD
HVESHAFHDALGFEETQRVVYFRKLL
>I0V0Z8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTRTVITEHPVPADSGSGTGPYGITTGPDGALWFTMARAGCIGRLVPGQEPTIHRLDPEC
GPTVIVSGPDGALWFTEYQGHRIGRVTVDGEITEFATPTAQAGPYGLTAGPDGALWFTEI
NADRIGRITTSGEITEYPLPLRGAFPSMIVTGSDGALWFTLNQANAIGRMAIDGTVTVHE
LPTEAAGPVGLTAGTDDALWFVEIMAGQIGRITTEGRITEYPLPDRAAKPHAIAAGADGR
QWFTEWGTGRVGSITSDGVIEVHDLPGANTEPHGITVGPDGAVWAALESGALARVEVKR
>W1N274|FEATURES|UNIPROT_deepARG|aminoglycoside|BJB45_00760|antibiotic inactivation|1
MTSSAATDSLPPDIRALLASIQLVLQRYLSDSLIAVYLHGSAVTSGLRRDSDVDVLVVVE
QPLTPALRQQLVTELLAYSASPEETTGLRPLEVMIFRRTELVNLRYPACSEFVYGEWLRE
ELEMGSVPGVECEPELTLVLAQARQEALPLVGPALAELVPIITRAQVRRATGDLLPSLLA
GLQGDERNVLLTLARMWRTLEVGDFVSKDVAAQWALTRSPAEHGKLLEYARQAYLGIISD
HWQVRESESLSTARYLLSRVERGL
>D7NGB2|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF0665_02624|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGHVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>A0A076YIY5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MGFLRSGCYPDSCHADWYRYNLTYRQCKSGPPMAGRFVWKPDLMFKTTLCALLITASCST
FAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFE
LGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQV
PDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQP
LKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVRSNMNPR
DINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAI
TPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>A0A0G3KFB6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>J8PS90|FEATURES|UNIPROT_deepARG|beta_lactam|IKS_03141|antibiotic inactivation|1
MLVSKKFFHIAHYKKMLPVVLLSCATLIGCSNSNIQSEPPKQTKQENTGNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIADATKI
VLDNLKVTNK
>A0A0E1MF48|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MKFHVIDREDWNREQYFEHYLKLKCTFSMTVNVDITMLLEEVYQKGIKFYPVFIYLISRV
VNNHKKFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRTFYKNYEDDMR
CYANVHGLFTKENIPPNVFPISSIPWTSFTGFNLNINNDADYLLPIITCGKYFNEENKVI
LPVSLQVHHSVCDGYHASRFIEDLQELSNSCNEWLK
>A0A0R2FQ09|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDLIKSAIVGIVEGITEFLPISSTGHIIIADAFLNIPGGPVWTKAFSHMYEYAIQLGAI
MAVIQLYFHKLNPFSQRKTAVERQETWSLWFKVIVGVLPAVVVGLLFNDYMEDNIWLVAA
MLILYGIFFIVIENYLQDKRPRLTDMTNISYKFALYVGLFQVLAIIPGTSRSGATILGAL
LLGASRFVATEFSFFMSIPVMFGVTILKVGTYLWHGGTFTGMQTGVMAVGFIVSWIVAYV
AIKFLLDYLKKNNFKPFGYYRIVVGLLVIVLVCMGIIR
>A0A009KWD8|FEATURES|UNIPROT_deepARG|beta_lactam|J518_0781|antibiotic inactivation|1
MRFKKISCLLFSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVAKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PTPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0D0RG75|FEATURES|UNIPROT_deepARG|beta_lactam|RT27_12225|antibiotic inactivation|1
MKKNTLLKVGLCVSLLGTTQFVSTISSVQASQKVEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKCVTDVIITHAHAD
RIGGITALKERGIKAHSTALTAELAKKSGYEEPLGDLQTITSLKFGNTKVETFYPGKGHT
EDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNINSVVPGH
GEVGDKGLLLHTLDLLK
>E8WMG7|FEATURES|UNIPROT_deepARG|beta_lactam|GM18_2318|antibiotic target replacement|1
MKPMQNIIPDDDGGGRRIIGLSIGAFAMFFLLLSRLWYLQVISAEDLIGQSENNRLRFVP
VAAPRGAILDRNGKVLVSNTPSFSVAVIPQDVKNKEQLIDNLARYLNLDRKEIETKWTKG
QGRAKYYPLVVASGITRDQMEYLEENRLSLSGVNIEMKPIRAYTNGVLASHLLGYLGEVS
EEELNSDRYQEYNAGDYVGKSGIERSWESYLHGTDGGRQIEVDARGRFLRTVTETGTSVG
NTVMLTIDLEMQKAAEKALGDQAGAAVAMDVNTGEILAFASSPDYDPALFTGRMPPDIWK
KYLDDERHPLENKALKGMYPPGSTFKIVTAIAGLEEGLIDEHTTIQCSGSYKFGNSTFRC
WEHKGHGTVDLRKSLRESCDVYYYKLAERLGVNRIAKYARRLGLGAPLGIGLENEKGGVI
PTEEWKLKRFGKKWYSGETLSVGIGQGYVLTTPVQLASMIATVANEGSVYRPHLVKRVVD
LDGKVLQDFAPQVLSKADLKPLTYRLVKEGLFAVVNEPHGTGGMSRLYEVKVAGKTGSSQ
VVKLRDSKGDVPYRFRDHALFVAFAPYEKPEIAVAVIVEHGEHGGSAAAPVSAKILRAYF
EGKGVIKKPVPKALPKEEEGGESVAEPDPGAAQE
>A0A0C2B3I2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AAY97109|FEATURES|ARDB_deepARG|rifampin|rif|antibiotic inactivation|0
MNNTIINSLIGGDDFIKRSNVFAVDSQIPTLYMPQYISLSGVMTNDGPDNQAIASFEIRD
QYITALNHLVLSLELPEVKGMGRFGYVPYVGYKCINHVSVSSCNGVIWEIDGEELYNNCI
NNTIALKHSGYSSELNDISIGLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITV
TVTFNPVSDIVIRDSSFDFETFNKEFVYVPELSFIGYMVKNVQIKPSFIEKPRRVIGQIN
QPTATVTEVHAATSLSVYTKPYYGNTDNKFISYPGYSQDEKDYIDAYVSRLLDDLVIVSD
GPPTGYPESAEIVEVPEDGVVSIQDADVYVKIDNVPDNMSVYLHTNLLMFGTRKNSFIYN
ISKKFSAITGTYSDATKRTVFAHISHTINIIDTSIPVSLWTSQRNVYNGDNRSAESKAKD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
FTPKIFFRPTTITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQG
VSITKIMGDNN
>W9ADV7|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MKKLSMKKFILFTSLLALISLVACAEADSSTESSPKEENENGQSAKLDEQFAALEDDFDA
QLGVYALDTGSNQTIAYRAEERYAFSSTYKALAAAFVLKENTKEELNEIITYTVDDLVPY
SPVTEKHVDTGMTLIEIGEAAVRTSDNTAGNLLFEALGGPAKFEEALRQIGDEVTQADRY
ETELNEFNPEDTRDTSTPKALTTNLKKFAVGDLLTVEKRELFTDWLQGNATGDTLIRAGA
PEGWVVGDKSGAGTYGTRNDIAVVWPPDREPIVIAIMSRHDTEDADYDDALISEAAEVVF
DALK
>R6HN37|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNMDNNFIAVIIGIVEGVTEFLPVSSTGHMIIVGNMLGFDGPVADLFDVFIQLGAILSVV
FIYKERFARFFTKEGWQPDKGLSVWHVAAGIVPVMGVAYLGYSYIKTYLFSPFTVAVGLV
LGAFWMMFAEYKTKDRQHQLENDIDKLTLKQAAVVGAFQLLSLWPGFSRSGSTIAGALLV
GLSREAAASFAFLIAVPLMFAACLYDLMKNMHHLTGSEFQMLAIGFVTAFIVSYFSVLWF
LKFLNKYSLTSFAYYRIILAVVALWYFYF
>S9Y9T8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIENLNKYFGLGQTQAHILKNINLSIERGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGICRIDGKETQTMSADELSDLRQRKLGFIFQRYNLLSALNANENVALPAIYAGMDSSSR
KKRADTLLTKLGLSDKTQHKPNELSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLEILRDLHHEGHTIIMVTHDPNIAAQASRVVEIKDGQIIRDEHQRADVL
>N6YES8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLSLLLVALILGIVEGLTEFLPVSSTGHLIIVGDLLGYNDDTSKVFKIVIQLAAILAVC
WDYRERLIKVAVGLPTQPSAQRFVWMLFIGFLPAAILGLMFHSTIKGLLFNPITVATALV
VGGLIILYVEKRAYHPRINDVDEMRWPDALKVGFAQALAMIPGTSRSGATIMGGLIFGLS
RKTAAEFSFFLAIPTMFAATAYDLYKNWALLRIEDLPVFAVGFVASFIAAMWAVKSFIKF
ISNHTFIVFAWYRIAFGIFVLATWYFGWVEWSEP
>CAG34249|FEATURES|ARDB_deepARG|multidrug|smeD|antibiotic efflux|1
MLLSRIRPFALSLAIAATVAACGGQPQAPEQGPGDVTVVTLKSETVGLTRELPGRTNAFL
VAEVRPQVNGIVAKRLFTEGGMVKAGEPLYQIEDASYRAQANSARAQLARAEATANAARL
SAKRITELAKVDAVSQQDLENAVAAQKQAEADVGAAKASLDAANVTLGYARITAPISGRI
GKSSVTQGALVSAGQANALATVQQLDPIYVDLTQSSAELLQLRRELAAGRLQDNQTLPVS
ILMEDGSTFEHKGTLEFSEVSVDPATGSFGLRVKVDNPDGLLMPGTYVRAVIGGGVRSDA
VLVPMQGIARDPKGDTTAMVVGKDNKVEVRPVKVSRTVXDKWLVEDGLKAGDKVIVEGLQ
KIGPGMPVKATEKGAAPAKPAAAAQPAAPAGDAK
>A5JTM0|FEATURES|UNIPROT_deepARG|beta_lactam|blaADC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQALEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>G9Z0X9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFTYPPVKKVSVVIPVYNEQESLPELIRRTDTACATLGRDYEILLVDDGSSDDSAQMLVE
AAEVEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVEKADEG
YDVVGTVRQNRQDSVFRKSASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRAVEIPVLHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSVVG
SVIAVVGFAFSILLIVLRLALGPEWSGDGVFMLFAILFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQGETVSQEEDRS
>A0A013TT11|FEATURES|UNIPROT_deepARG|beta_lactam|J663_0615|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSTSIYAGNTPKEQEVKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEIYYGLQSVQDKKAVNSSTFFELGSVSKLFTATAGGYAKAKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKTKNAIGEYRQYSNPSIG
LFGKIVALSMNKPFDQVLEKTIFPPLHLKNSYVNVPKTQMQNYAYGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLTFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNTIKK
>AAA16158|FEATURES|ARDB_deepARG|multidrug|NorA|antibiotic efflux|1
MNKQILVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGT
LADKLGKKLIICIGLILFSVSEFMFAIGQNFLILMLSRVIGGMSAGMVMPGVTGLIADIS
PSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDP
KKVSTNGFQKLEPQLLTKINWKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDI
SIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLIYSVIVLVLLVIADGYWTIMVISF
VVFIGFDMIRPAITNYFSNIAGDRQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIY
MAIGVSLAGVVIVLIEKQHRAKLKQQDL
>J3GAG0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRCVSIVIPVYNEQDSLPELLRRTEAACQQLHHDYEIVLVDDGSRDNSAQILEDA
ANRECSPVVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVAQAELGY
DVVATVRNNRQDSALRRWPSKLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEILVTHAEREHGESKYSPMRLISLMFDLITCMTTTPLRLLSIVGF
GMAGIGLLFAVMLIVLRLVFGAEWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRSTPSAPAPVVTVDGLTSTSSDQVLS
>A0A088TZP9|FEATURES|UNIPROT_deepARG|beta_lactam|DM39_6529|antibiotic inactivation|1
MRFNVTRFVATLLVAGCAAATAGRAAAFTPDDVRQAVDRTVAPLMKQYEIPGMAIGVIAD
GRPHVFDYGVMSTQTGQPVAADTLFEIGSVSKTLTATLAADAQERGELSLTDPVSRYVPA
LQRRPFGRVTLVELGTHTAGGLPLQVPDTIRDEAGLMRYLDAWQPAYAPGTRRTYSNVSV
GMLGWITAKAAGGDFSTLMTQRLFAPLGMTHTYIDLPDARMADYAQGYAKDGKPVRMTGG
ALWREAYGVRTTAADLLRFVQANLGRADTPPQLRRAIERTHAGYVRAAPLTQDLIWEQYP
YPVALPTLLEGNGMKMIVDATPASELKPPQPPRQDVWINKTGSTNGFSTYVAFIPAKRVG
IVMLANRSFPNDARVEAAYRILASLVDGR
>A0A0K1ZMV0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIDVIKGLPNDPRQQRFALNVIVATIPAITLALIFGKAIKAHLFNPIVVASAFI
IGGLVILWAEWRERHRGQTHDPRGNALLEAAKAGAPRVETLDDLRISDAFKVGLAQCFAL
IPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKERALLSTDDLSIFG
IGFVAAFISAFFCVRWLLRFIASHDFRGFAWYRIVFGVIVLVTAYTHLIAWQA
>A0A0Q7XB95|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILALKAIIMGLVEGFTEFLPISSTGHLILAGSLINFTGEVAQVFEIAIQAGAILAVM
WEYRARIGAVLGGITSDPRQQKLVVNLIVAFLPAAVLGFLFSKAIKAHLFAPVPVALAFI
VGAFVILWAERRHKVLPGAHRVQTVDDMTVVDAFKVGCAQCFALIPGTSRSGATIIGGML
FGLSRTAATEFSFFLAIPTLLAATVYSVFKARHDLHASDLPLFLIGGVAAFISAFLCVRW
LLRFISTHDFTGFAWYRIVFGVVVLITAHFGWVVWAE
>ABC38821|FEATURES|ARDB_deepARG|multidrug|OprA|antibiotic efflux|0
MRRPRGRHRSASPRRRARGTGDQVKTMMKPLARQGGPHGSRRPGGLRAWPAALAAALVTG
CTLAPRYERPAAPVPANYLPAAAGAPRAASPAAAGSGARDAQPASDARGGGNVQEMHDVR
LDDWRAYFTDPALRALIDAALANNRDLRIATLRIEEARGLYGVARADRLPSIDGSLGYER
TRLYDPVLRESATSSLYRASVGLSAFEIDLFGRVKSLSDAALAEYFATAEAQRAARVSLI
AEVASAYVRERALVDQLKLAERTLAARDATYALTQRRYAAGTSTAIELRTAEMLVASARA
SKAALEREHTQAASALKLLAGDFTAALPADAPALDELAVARVSPGLSSDLLEQRPDIRQA
EQRLVAANANIGAARAAFFPRIALTTDIGSVSDAFSGLFSAGSSVWTFAPRLTLPIFAGG
RNRANLDVADARKHIAVAEYEKTIQTAFREVADALAARDQIDAQLAAQQAVYGADAERLR
LAERRYGSGVASYLELLDAQRSTFESGQELIRLKQLRLTNAITLYRALGGGWSRAACGGE
DACA
>F7K6N1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKSVLFGIVEGITEWLPISSTGHMILLNEFVTLDVSPEFWEMFLVVIQLGAIMAVV
VLFWNKIFPFDLGRKRKKSIIKTDIFVMWFKILIACIPAMIYGIFLDDIIEPYLYNATTV
AIMLILFGAAFIIIENWNKGKKPKVNSLAALTYKDALIIGLFQLIAAIFPGTSRSGATIV
GALLIGVSRVIAAEFTFFLAIPVMFGASLLKLVKFGFHFTMTEASLLIVGMVVAFAVSMG
VISFLMGYIKKHDFKVFGWYRIVLGIVVLVYFYLIAA
>C5QQ51|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLIELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSTKFLGEQSAFTFKVVIQLGS
VFAAAWVFRDRFLEILHIGHHKPDNQASVQRRSQPKRLNLMHVLVGMIPAGILGFLFDDL
IEKYLFSVPTVMIGLFLGAIYMILADKYSEKVQHPQTVDQINYFQAFVIGISQAIAMWPG
FSRSGSTISTGVFMKLNHKAASDFTFIMSVPIMLAASGLSLLKHYEYIHLAHIPFYLLGF
LAAFIVGLIAIKTFLHLISKVKLIPFAIYRIVLVVIIAILYFGFGIGKGI
>A0A0F0TGQ7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGLHALLEAGYDIAAIFTHPDAAGENNFFGSVARIAAERGIPVYAPD
DINHPLWVDRIRDTAPDVIFSFYYRNLICDDILRLATKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVHRADAGAIIAQQRVAIDADETALQLHQKLCSVAQSLLRDALPTI
LNGTFSETAQDESKASCFGRRTPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDVPAAKPGTIVSVSPLIVSCGEQALEIVTGQTDNGVYVQGAQLAQSLGLVP
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGSDAISRFLNCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRNQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQAS
>N8QF28|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILAGQLLDFWTIEKREMFAVAVQIGAIAAV
IYEYWGKLWGALIGGLKGQEQGRRLSLNLIIASIPIVIVGLTFGDIIKAYLFNAITVAIA
LIVGGFIILWAERRPHSIKTQEVDDLTYKQATLIGLIQCLALFPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRADLHSNDMAVLAVGIIVAFISALIVIRALI
RYVSKHDFTAFAYYRIGFGLFILVTWWTGWVSW
>A0A0F5L2G6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNADQGLFVPLILGILEGLTEFLPVSSTGHLLLAGHFFGFTQPATFIVLIQLGAILAVIT
VYFAKIGELIRDALAGKPYAWHFAAAVVIASFPGALAGVLFRDYIQTVIYESPLVICLSL
LIGGIVLLIVDRMPIKQKYDDIYHYPWYLALIVGLFQMIALIPGVSRSGATVVGAMLFGA
SKRSAAEFTFFIALPIMIGAFGYDLYKSRNLIDMDLGLHIAIGFAASFVVGALVVRYLLD
FVSRHGFAPFAYWRILVGLAGLIALWLTA
>A0A0M2URN3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTYPEALILAIIEGITEFLPISSTGHMVIASTFMGIGNNALTKNFVIVIQLGAILSVVVL
YWRRFLASFRFYVKLVFAFLPAAVAGFFLEDYIDLLLANIWVVVASLILGGIILIFTDRW
FRHAEGTKEQEVSWLQGFKIGCFQCIAMIPGVSRAAATIIGGMTVGLNRRTAAEFSFFLA
VPTMLGASAKKMMDSYQTIQDHDLAILAFGSLVAFLVAMVAIRAFIGFLKQHGFKWFGYY
RIVFGMAIALIALLMNL
>A0A0E3UUA1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFGQIMKVIVLSFIEGLTEFIPVSSTGHMILVEHFLQLSSNKNFVNSFEIIIQLGAILSV
IIYFRKKIFPISIPLWSKIIVAMIPAVVIGLALDDFIEQKLFNPYVVVAMLIIYGIILIF
LEQIGKKKDIRRLRDISYKKALYIGLFQCLAMIPGTSRSAATIMGGMLIGVSRIAATEFS
FFLAIPTMLGATVLKLLKIKALSYGEIGLIVLGFILSFVFAYIFIAIFMEYIKKHNFKIF
GYYRIILGIVVAIILIFR
>A0A0X4EKW4|FEATURES|UNIPROT_deepARG|beta_lactam|AWI28_19250|antibiotic inactivation|1
MMKKSLCCALLLSASCSVFAASMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAAGKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSFEEAMTKRVFKPLKLDHTWINVPKAEEVHYAWGYRDGNAVRVSPGMLDAEA
YGVKTSVKDMASWVMVNMVPSSLQDTSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPVPPVNASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYRILSAL
>CAL13137|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVIAIIIMLAGSLAIMKLPVAQYPTIAPPAISISANYPGADATTVQNT
VTQVIEQNMNGIDNLLYMSSSSDSSGNVQLTLTFNSGTDPDIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVAGFISEDGTMKQEDIADYVGSNVKDPISRTAGVGDVQLFGS
QYAMRIWMDPHKLNNYGLTPVDVINAIKVQNNQVAAGQLGGTPPVPGQELNSSIIAQTRL
TNAEEFSQIMLKVNTDGSQVRLKDVAIVQLGAENYNIIARYNGKPAAGIGIKLATGANAL
NTSAAVKAELAKLQPFFPAGLKVVYPYDTTPFVKISINEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILSAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
QEEGLPPKEATKKSMEQIQGALVGIAMVLSAVFIPMAFFGGATGAIYRQFSITIVSAMVL
SVLVALILTPALCATMLKPIAKGEHGPKTGFFGWFNRMFEKSTHHYTDSVGNILRSTGRY
LVIYLAIVIGMGVLFLRLPTSFLPEEDQGVFLTMVQMPAGATQERTQKVLDQVTDYYLDK
EKDVVNSVFTVNGFGFSGQGQNTGLAFVSLKNWDERPGEQNKVPAIVARASAAFSQIKDG
LVFAFNLPAIVELGTATGFDFQLIDQGDVGHQKLTEARNQLLGMAAQHPDMLVGMRPNGL
EDTPQFKVEVDQEKAQALGVAISDINTTLGSAMGGSYVNDFIDRGRVKKVYVQADAPFRM
LPSDIDKWYVRNNAGQMVSFATFSSAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAM
DLMQELASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAASLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLV
ESTLEAVRMRLRPILMTSLAFILGVLPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFF
VPVFFVVVRRRFSRKNEDVEHAHAVDHKVK
>A0A0M1VVF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKFIGGEYLSPTFINSFLIIIQLGAIFSV
VVYFWKDISPFVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLNNVLIVAIT
LIAYGVIFIGIEVVYKLKNIKPKVKRFAGLKYRTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEMEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIVVIVLLY
>K8W9Q1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSFVDEFEEIKKVSVVIPVYNEEQSLPQLLERTIKACKQLTQSYELILVDDGSSDRSAKM
LTEAAENPDNHVIAIILNRNYGQHSAIMAGFNQADGDLVITLDADLQNPPEEIPRLVQTA
AEGYDVVGTRRANRQDSWFRKTASKMINAMITKATGRSMGDYGCMLRAYRRHIIQAMLQC
HERSTFIPILANTFARRTIEIDVAHAEREYGDSKYSFMKLINLMYDLLTCLTTAPLRLLS
VVGSVIAAGGFLLAVLLIVLRLVFGATWAADGVFTLFAILFMFIGAQFVAMGLLGEYIGR
IYNDVRARPRYFIQKVVGADLKTDKNQEEN
>ZP_03030716|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MNNHFGKGLMAGLKATHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAP
AAVSLYLAGGMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQ
GTSICFIATVGYVTVQEAFGQTKGIRLMAIITSIVLIAPIIGPLSGAALMHFVHWKVLFA
IIAIMGFISFVGLLLAMPETVKRGAVSFSAKSVLRDFRNVFCNRQFLFGAATISLSYIPM
MSWVAVSPVILIDAGGLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQ
LVGLALLIIGNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNNLPKGTVSASLNM
VILMVMSVSVEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELAEEQ
>A0A127SDL7|FEATURES|UNIPROT_deepARG|beta_lactam|TLA-3|antibiotic inactivation|1
MKKHLVVIVFCALFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAILGIEDNFKLNVNE
KHHYPMQSTYKFHLALAVLDKLDKENISVDKKLFVKKSDLLPDTWSPLRDKYPNGNLELS
FSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYT
NWTTP
>A0A0J6DBI5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQSVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>I6ZR62|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-1like|antibiotic inactivation|1
LLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSXILYRADERFAMCSTSKEM
AVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAM
NKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTL
GKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRA
PLILVTYFTQPQPKAES
>ABO60998|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTPLALAATLVFDVAAADAPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTA
LLVRTTEGAVLLDGGMPQMAGHLLDNMKARGVAPQDLRLILLSHAHADHAGPVAELKRRT
GAQVVANAETAVLLPRGGSNDLHFGDDITYPPASADRIIMDGERVTVGGMAFTAHFMPGH
TPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQYNARYPRLVEDYRRSFTTVRGLPCDL
LLTPHPGASRWNYAAGAEAGANVLTCKAYADAAEKAFDAQLAKETTGAR
>ABG69871|FEATURES|ARDB_deepARG|multidrug|EmrE|antibiotic efflux|0
MNSFVSLGFLLIIIVPAFISCHARAPWIHIHQDENGELCSNCSTILSSMNRKEYAMNPYI
YLGGAILAEVIGTTLMKFSEGFTRLWPSVGTIICYCASFWLLAQTLAYIPTGIAYAIWSG
VGIVLISLLSWGFFGQRLDLPAIIGMMLICAGVLVINLLSRSAPH
>A0A0C9Q5C6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTYLEALILAIIEGITEFLPVSSTGHMVIASTFMGISNNTLTKNFEIVIQLGAILSVVVL
YWRKFFTAFRFYLKLAFAFLPAAVVGFVLEDYIDYLLANVWVVIASLFLGGIVLIFADRW
FKHAEGMEEQEISWFQAFKIGCFQCIAMIPGVSRAAATIIGGMVVGLNRRTAAEFSFFLA
VPTMLGASAKKMMGSYKTIQHPDIVILLLGSFIAFVVAMFAIKAFIGFLKQHGFKWFGYY
RIVVGVALAIVAFMMKMDM
>J8AYF6|FEATURES|UNIPROT_deepARG|beta_lactam|IEE_02720|antibiotic inactivation|1
MIVSKKFFHISHYRKMLPVVLLSCVTLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNKS
>A0A127SUT7|FEATURES|UNIPROT_deepARG|beta_lactam|BL2a_III|antibiotic inactivation|1
MLQSYRHYLFRELKDKLIYVGFLKLLTTYKKEVKKVKKLYTLKPKFLYINLFLLLFTVIF
LTAGDNINQSTATETKQKKSSNTERKLAELERKYDARIGVYAIDTGTNYTVKYRPNERFA
YASTYKAFAAAILLQKKSVEKMNEVIKYTEEDLVSYSPITEKYVNTGMTLFDLSEAAVRY
SDNTAGNLILEALGGPSGYERSLRKIGDTVTEVNRYEPDLNDFTPGDSRDTSTPKALATN
LKKLALNRFLSDDKQTIFFDWIKGNATGDALIRAGAPKDFVVGDKSGAASYGTRNDVAVV
WRPNKEPIVIAIMSRYNSEDAKYDDKLIEEAANITLKSFN
>D0EJY5|FEATURES|UNIPROT_deepARG|beta_lactam|pdc-14|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQSYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0B4S2W3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWLLDIIKVIILGIVEGITEWLPVSSTGHMILVDEFLQLNQSAEFKEMFLVVIQLGAILA
VVIMFFNKLNPFSKKKTKDQQKDTINMWLKVIVGVIPAGVLGVLFDKTLEKYFYNFPTVA
FTLVLYGILFIVVENNPKFKKQNIKRFEDLSYSLAFYVGCFQVLSLIPGTSRSGATIIGA
LILGLSRSLAAEFSFFMSIPVMFGASLLKLRKFGFAFSFFQFFILILGMFVAFVVSVMAI
KMLMRYIKKHDFKVFGYYRIVLGAILILYYILH
>NP_880590|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDSTLHLLKAFFLGIVEGLTEFIPVSSTGHLIVIGDWINFASSSGKVFEVVIQFGSILA
VMWIFRARLWQLIRGTLTGVRQEVNFTRNLLLAFLPAAVIGAIFIKSIKQVFYHPGVVAV
TLVVGGFIMLWVERRAPHTPGDAPGAADDTASDERASAHTLEQISAKQALGVGVAQCVAM
IPGVSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDLYRNIGLLSQHDMSAIA
VGFVAAFLSALVVVRAVLRFVANHTYRVFAWYRIALGLVVAAWIYAK
>A0A0G3BFY9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKAAVMGIVEGLTEFLPISSTGHLILASSLLNMTGDVVKVFEIAIQTGAMIAVMWEYRER
LRNTVAGITYDPIAQRFALNVLIAFVPAVLLALVFGSLIKEHLFHPVPVATAFVVGGFII
LWVERRHRRHYGDRDLEGGRVARVETVDDMTALDALKVGLVQCLALLPGTSRSGATIIGS
MVFGFSRKAATEFSFFLGIPTLVGAGVYLLYKQRELLSVADLPMFAVGLVFAFFSALLCI
RWLIRYVSTHDFTLFAWYRIVFGIVVLVTAKTGWVTWHA
>A0A009EM92|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKQKSDVFVVAIQMGAIAAV
IYEYWARLWGAATGIVSGEPQGRRLGIGLILASIPIVLIGLTLGQTVKELLFNNIAIAIG
LIVGGLIIIWIEKNPPKVRAQEVEDLTVKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYDVYSTTEDWTVLAVGIIVSFISALLLIRAL
VAYVAKRDFMVFAWYRIASGLLILLFAFTGWRLW
>N9EBG0|FEATURES|UNIPROT_deepARG|beta_lactam|F937_01700|antibiotic inactivation|1
MRFKKISYLILPSLFIFNTSIYAGNTSKEQDIKKVVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKSVNSNTIFELGSVSKLFTATAGGYAKTKGKISFEDTPGKYWKEL
KNTPIDRVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNQIGEYRQYSNPSIG
LFGKVVGLSMNQPFSQVLEKTIFPSLHLKHSYVNVPKTQMQNYAFGYNQENQPIRVTPGP
LDAPAYGVKSTLPDMLSFIDANLNPQKYPADIRRAIDETHKGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSIKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>B5FNT9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAELGIPVYAPD
NVNHPIWVDRIAEFAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNEGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>A0A0R3AGD3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLDAGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPEYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVSIDRTDTGLSLHAKLRDAAATLLRDALP
QLAQGKLTETAQDEGQATYFGRRTAADGKLDWKRPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVLKGNEGLAPGRVISVNPLRIACGEDSLVIKFGQRNENGLYLAGPALADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEIYGLDIGSDAIERLR
SHPNFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDVCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPSVQMSETIGNTLDFFLREAMLEIA
DKK
>A0A0K8IWJ0|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPRESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0G1D8J1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVGYGRVIAGIGLSGTNGCVDHNGGSGGDMATACPLFLFFSIRFKMLTDLYGRGVPRLLS
ASTIPIRKGGRVVYGARLESVCGETHRGFKSHPFRFGLKSMLFDIFKAVILGIVEGATEF
LPISSTGHLIIVNQWLSLSGDVTKIFDIVIQGGAIVAVFFYFHKQLIPIGKNKGAVLHIW
VKALIGTIPALILGVIAGESVQKALFHPFVVSVALIIGGIALIVIERTKRVHSIDSIRGL
TYPTVILIGIIQCLAFIPGISRSAATMLGAMMLGASRKVSAEFSFFLAIPTILAAGVYSL
IKSGMVFNGQEVAVLVIGSSVSFCVAWAVTALFMKYIKSHSFEWFGYYRIVLGMLVAGLL
LFRVF
>A0A0F7FYG8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTMHTAIDLFAPGLAGTAPYGITEGPDGALWVTLTGSGEIARFDPATGALDRHPLDSAEA
GPMIITPGPDGALWFSRGRDHRVGRITTGGSATSYTLPTPACGPYGITTGPDGALWYAAM
NADLVGRITPEGRITEFPLGTTGAAPSALAAGPDGALWCTLNQAGAIARITLDGAVTLHT
LPTGAAGPVGITAGPDGALWFAEIAAGRIGRITTGGEITEFPLPDPGAKPHAITADPAGD
GCWFTEWGAGRIGHITPGGEFRHHPLPDPASEPHGLAGTADGALWVALETGQLARLRSTH
RQNG
>A0A064D514|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDIGCLGVQAVLDAGYDIAAIFTHADNPGENTFFGSVSRLAAEAGIPVYAPD
DVNHPIWAERISQLAPDVIFSFYYRHLLSDAILEQAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNRADAGAIIGQQRVAISPDDTALTLHHKLCQTARQVLEQALPAI
KRRETRDVLQNESDATYFGRRTPEDSFLTWNRPATTLHNMVRAVAAPWPGAFSYSGTQKF
TIWSSRVHSQPQTAQPGTVISVAPLLIACSEGALEVMTGQAGNGITMQGAQLAQVLGLVA
GSRLNSQSLATSKRRTRVLILGVNGFIGNHLTERLLREDHYEIYGLDIGSDAIGRFLNHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
DGLRFTLFRPFNWMGPRLDSLNSARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENAGGRCDGEIINIGNPENEASIKELAEMLLESFDKHPLRHHFPPFAGL
RVVESSSYYGKGYQDVEHRKPNIRNAKRCLDWEPTIDMRETVDETLDFFLRSVDLTEHSS
>Q6ZXJ8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAKLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAEYYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVML
>A0MYG3|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-77|antibiotic inactivation|1
MMKKSLCCALLLTAPFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAITRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEA
>A0A0N0X6U1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVDTAGLHDTRLDSDRPLLHLQGVSRSFMAGEREFQILKNIDLAINAGELVAIIGAS
GSGKSTLMNILGCLDHASTGSYQVNAQETRDLDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNVEIPAVYAGTPQSQRHQRAQALLTRLGLGGHLEHRPSQMSGGQQQRVSIARALMNGG
QVILADEPTGALDTASGKEVMRILLELHAAGHTVILVTHDPKVAANAERIIEVSDGEIIS
DRRTALQTLNAAEPQEAARQSLAPRRLVAGFGLFREAFNMAWIALISHRMRTLLTMLGII
IGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGSNFGDSRAKSIETLLPADVAALN
QLYYIDSATPVVGRSMLVRHRNIDVDAQLNGVSNRYFQVRNIQLAAGITFSEQDARRQAQ
VVVLDHNTAQRLFGAGVNPLGQVILVGKLPCTVIGVTSDHKNLFIAGNTLNIWMPYETAA
GRLLGQRHLDSISVRVKDGMPSKAVEEQIKTLMLQRHGTKDFFTNNLDSVMQTVQKTSRS
LTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAMMVC
LIGGVIGIGLSYGIGYLFTLFVKQWEMVFSLASVVTAFACSTLIGVLFGFVPARNAARLD
PIEALARD
>A0A0J1YCI8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGTQALLDAGYDIAAIFTHPDTAGENTFFGSVARIAAERGIPVYAPD
DVNHPLWVERIRALAPDMIFSFYYRNLLCDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVRRADAGAIVAQQKVAIDADDTALQLHHKLNATAQTLLRDVLPTI
LNGTFSETAQDESKASCFGRRTPEDGRLDWSKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAARPGTVVSVSPLIVSCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVALKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGADAISRFLNNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQAS
>A0A0S9CA76|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDLLTIILLGIVEGVTEFLPVSSTGHLVLAGALLGMSEGDATFDIVIQLGAILAVIVLF
WRRFLNVGLGLLQRRPDAISFTRNVLLGFLPSAVVGAIAYSAIRALLEAPGTGPFVVAVA
LIVGGVAILFIERVAPVAERSSVETMSWKTALKIGVVQCLSMIPGVSRSGATIMGARAMG
VDQETAAEFSFFLAIPTMMGATTLALWKSRNDLGDAHLSAIAIGFFVSFVVAMVVIRWFM
AIVTKHGFAPFAWYRIIIGVVALAALALR
>ZP_04615639|FEATURES|ARDB_deepARG|polymyxin|RosB|antibiotic efflux|0
MGTLAHRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGIILLMFGVGLHFSLKD
LLAVKSIAIPGAIAQIAVATLLGIGLSSLLGWDWVTGLVFGLCLSTASTVVLLRALEERQ
LIDSQRGQIAIGWLIVEDLAMVLALVLLPAFAGVIGSENISLSQLFTELAITIGKVIAFI
TLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMV
LNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILIREPLAVIASLAIIIFGKSAAA
FLLVRMFGHSKRTALTISVSLAQIGEFAFILAGLGISLGLMSEHGRNLVLASAILSIMLN
PLLFSLLDRYLIKTETIEDQILEEAVEEEKQIPVNLCNHAVLVGYGRVGSLLGAKLHTAG
VPVVVIENARTRVTALREQGIHAVLGNAANVEIMSLARLDCARWLLLTIPNGYEAGEIVA
SAREKRPDIKIIARAHYDDEVIYISDRGADQVVMGEREIANSMLNILKVDTLTEEDKQVV
YPS
>A0A147INC9|FEATURES|UNIPROT_deepARG|aminoglycoside|SB4_14720|antibiotic inactivation|1
MIVTPAAPEHSQGWLALRAMLWGEDAGDPAEIAERLAQGGGFVALENAQVIGFAEAAIRH
DYVNGCNTSPVLFLEGLCVDPAHRRQGVAGALVAAVADWGRAQGCTEFASDAELDNIDSH
AMHRALGFVETERVVYFRRML
>D7YP51|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAHLAPEVIFSFYYRHLICDAILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPTI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0X1SHU5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLVLIAKALVLAVVEGATEFIPVSSTGHQLLIGHFIGFHSPNNTFEVLIQLGAILAILF
VYFGRLWNIATALPNDPRARRFVLAILIAFLPAAIVGGLFSKYIKLYLFNPWIVCATLVA
GGIVLLVIDDTVGEPKTAPGDGPTEHPRKTDVFEFSLPMALKIGLFQCIAMIPGVSRSGA
TIVGAMLMGASKRSATEFSFYLAMPTMAGAFAKDLLDNYKNLSSNDALLIVIGFVAAFIS
ALIVVRTVLDYVSRHGFWLFAWWRIIVGSLGFAGLILFG
>A0A0F2NQ99|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTPIVLGIIEGITEFLPISSTGHLIIANQFFQLESNFRDIFDVVIQFGAILSVIVYFRDR
IIPFYKGQTDEQRRGILKLWQKTVVGVIPALITGALLGHKIKELLFNPLTVAIALVLGGV
ILIWIEGRKKTSIINDISGLSYVNALMIGLFQCLAMIPGTSRSAATIIGAMLLGTSRKVA
AEFSFFLAIPTMLAASAYSLLDAGLKLTTTQWQVLAVGFAVSFLVAWAVIAIFIDYISKR
DFKAFGYYRIVLGFLMLTVYFKIY
>K0VU13|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNKCWYLVALFISALSSNASIARADEFGEKAQTSFEPLVKEYDIPGLVVGVTRNGKHEFY
ALGLASRADNRPVTPDTLFELGSISKIFNVTLAALAEERGNLSLGDTVARHICADACSIG
DKLTLLDLATHHSGGLPLQVPDGVSNINGLVNWLKDWHPPQPGTRSYSNVSIGMLGYISG
KATGSDYKQVAQDVLFPAFGLRHTWIDVPKSELNQYAFGYDRKTNAPIRVNPGVLDAEAY
GVKSSVRDMLKVLDVELGHGNASDELRKAVERTQEGHYKTAFFTQDMIWEQYPWPADLQT
MVSGNGYDFIMKPQPIEKISPSLPPQKDVILNKTGSTNGFGGYIAIVPSEDIGVVVLANK
NYPNEARVKATYSLIKALLSRE
>A0A140DR55|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
VGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDAR
DTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAS
KRGARGIVALLGPNNKAERIVVIYLRE
>N8QXR5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILAGQLLDFWTLEKREMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAVTVAIA
LIVGGFVILWAERRQHKIISPEVEDLTFKQATLIGLIQCFALIPGTSRSGSTIIGSLFLG
ISRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMAILAVGIIVAFVSALIVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>K7Q959|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
VKENSMVYFGAKGVTVVGATWTPDTARELYKLIKRVSSKPVLEVINTNYHTDRAGGNAYW
KSIGAKVVATRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRA
FYVGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMQLPIKTV
IGGHDSPLHGPE
>A0A127SH14|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNADIIARISRMVY
DAMRRQGGYW
>V6MKN9|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MNYKKINLEQWNRKEHFLHYRHNLQCGFSLTTKIDITALKVVLTKNNLKLYPAMIYLIAK
MVNSYPESKMAIKNDELVIWDKINPAYTIFHPETETFSELWSEYCEDWCSFLQGYNQDHQ
KYKDDLSLSAKPNFPENHFCISMIPWVSFDGFNLNVANVRDYFPPIFTMGKYTQQNDKFL
LPISIQVHHATCDGFHIARMINKLQELCNDFSG
>J3YT07|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKTPIKIEKVSVVIPIYNEQESLPELMRRTIAACTKLNARYEIVLVDDGSNDNCANILTT
AAEIPDSHIIAILLNRNYGQHPAILAGFSYVTGDLIITLDADLQNPPEEIPRLVKVAEEG
YDVVGTVRKNRQDNWFRKRTSRIINALIQRTTGKIMGDYGCMLRAYRRGIIDAILHCNER
SIFIPILANTFARKIIEIPVMHSERGFGKTKYNFIKLINLMYDLITCLTTTPLRILSIIG
AIIGLLGFIFFFILVMLRLFLITNWSIEGVFMLFSILFIFIGAQFVGLGLLGEYIGRIYT
DVRARPRYFIQRVVSEKPLSSQQEIR
>D9RU25|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLQTIIISIVEGLTEFLPVSSTGHMIITQNLLGVPSGDEFVHAFTFIIQFGAILSVVC
LYWKRFFQIDHTPVPADETCTFKKIIHPIRFYWLLFIGVLPAVIIGLAAKKSGLLDWLLD
SVWVVAIMLVVGGIFMLYCDKLFNKGKEENQVTEKRAFSIGLFQCLSVIPGTSRSMATIV
GGMANGLTRKRAAEFSFFLAVPTMAGATLLDLLDLLKGDSTWASAHNLIMLAVGCVISFI
VALLAMKWFVSFLAKYGFKWFGWYRIIVGVIIIIMLLCDIPLNMVD
>A0A062IQ58|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFNTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVL
KNTPIDQVNLLQLATYTSSNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGFYQLGTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKE
>A0A127T4A3|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-34|antibiotic target alteration|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWAQQNHTLSISGGSESIRGRLSVRHQSIEGVAPNFSDVKNEFRLNMDMNASSKLRFGA
DLNYRTGESLQPAGLTPGGGESVVFQYMLHASKFSWPKYSTGEYGLGPQVNNPLLFAELT
GTNRNINNYITGSIKFDYDILPDLTFSTQYAARHGNNQIKNFSNRYVNRDPITGRVAQRL
VNALTENRNNLTEYTLNSLLTYSRNFNRHGLTALIGYSTVDNTQSQIMGFRQEFYNNDVQ
SLSQGSNENRNATGTDAEWGLRSYFSRLNYKFSDKYFVELNARYDGSSRFSEDHRYSFFP
SFSLGWRLSEETFWDNLKPYVNEFKLRGSRGATGNQAVGLYAFYETLSTVNYSFNDQPIQ
GFAQTNLANRQLTWETTTQTNLGFDMGILEDRLLLTFDYYNKMTDGILLQLPIPALIGLG
RY
>A0A0U2UCA5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYDWWVAVVIGIVEGVTEFLPVSSTGHMILAGTLLGVSEADERMKSFEIVIQLGAILAVA
IVYWKRIAGLFRFGNKKQAARKGLNLLHILLAILPAMTVAYLLSDWIKERLFSPETVLIG
LVLGGILLIIGEKQQSAVTADDVDKLSYYQAFMIGLWQIVALWPGFSRSGSTIAGGMLAG
ASRSAAADFSFIIAIPVMVAATGYEMLKSAGSFSSADFGFFAIGFAVSFVVALLAVVTFI
KFVQRFSLTFFAYYRFVLAALFWFFLLL
>A4KCT8|FEATURES|UNIPROT_deepARG|beta_lactam|BlaGIL-1|antibiotic inactivation|1
MPHFRLALIPLLTAFCLPAFAHPTTLNKVKEAESQLTARVGYAELDLTSGEILESYRLQE
RFPMMSTFKVLLCGAVLARVDAGKERLDRRIPFSRRDLVEYSPVTEKHLTDGMTVGELCD
AAITMSDNTAANLLLTAIGGPQGLTAFLRTTGDRVTRLDRWEPELNEALPGDKRDTTTPE
NMAQTLRQLLTGKILTTTSQQQLTHWMVTDKVAGPLLRSVLPAGWFIADKTGAGARGSRG
IVAALGPDGKPSRIVVIYITESQATMAERNRQIAGIGATLIQHWDE
>M1ZK93|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILELIKVIIIGIVEGITEWLPISSTGHMLLLDEFLQLNMSEEFKEMFFVVIQLGAILA
VVIIFWDKMFPFSFREKPIIKKDIFFIWFKVLVACIPSGIIGFLFDDFLEAYLGTPIVIG
AMLILYGILFIVIEAWNKKRKPKTNTLTEISYKTAFIIGMFQVLSLIPGTSRSGATIIGG
LIISVSRVAAAEFSFFLAVPTMFGASAFKLLKFGFDFTSSELLTLGLGMVIAFMVSVLAI
KFLMGYIKKHDFRVFGWYRIILGIIVLLYFALVR
>J8FQT5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASALDLIKSWDILSVADIPLFATGFITAFVVAMLAIVSFLKLLG
RVKLTPFAYYRFILAAVFYFFIM
>I2B7C2|FEATURES|UNIPROT_deepARG|beta_lactam|EBL_c13230|antibiotic inactivation|1
MKTITSCFSLLLALGLAPAACAAAPALSAPQLTRLVNDTIEPLRQSQAIPGMAVAVIYQG
KTQLFTWGYATLATRQPVTPDTLFELGSVSKTFTGVLGGQSVARGDISLDDCAGKYWTAL
NGPRWRGITLLHLATYTAGGLPLQVPDAVTTRAQLAAFYRQWQPQWAPGTTRLYANSSIG
LFGMLLARPSGMSFAALLDQRVLRPLGLKHSRVSVPAQEAARYAWGYKDGRPLRVSPGML
DAESYGVKSSVADMARWVEANMAPEQVQDATLQQGIRLAQSRYWRAGEMYQGLGWEMLNW
PVAEDVLVKGSENRVALAPQPVQQITPPQPPVSASWVHKTGSTNGFGTYVAFIPREQVGV
VILANKNYPNPLRIQAAWQIIRGVLDGAPSPSR
>E4KWN9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILDLIKVIFLGIIEGLTEFLPVSSTGHLIIADSFIKLEPKAFSNAFSVIIQLGAILAVV
YLYFYDINPIAKGKLVAVLGEEKYNELSFKDKFKYRDLETMRLIAKIIVGFLPAAFFGFL
LDDFIDAHLFNPITVAIALIFYGIVIIFMEKNNKDKDFKYETLDDIGLKTALFIGFFQCL
AMVPGTSRSAATIIGAMLLGCSRTSSAKFSFYLAVPTMLGATALKILKIGFSFSLWQWFL
ILLGGIISYIVALVVIKKFLGYVREHDFIPFGYYRIVLGLVVLCLGFFNII
>EEB58471|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQEAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
VGGVIMLWAERRVHTVRTETVDDMTWRDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFVFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>AAG45714|FEATURES|ARDB_deepARG|aminoglycoside|AAC(6')-Ia|antibiotic inactivation|1
MNYQIVNIAECSNYQLEAANILTEAFNDLGNNSWPDMTSATKEVKRCIESPNLCFGLLIN
NSLVGWIGLRPMYKETWELHPLVVRPDYQNKGIGKILLKELENRAREQGIIGIALGTDDE
YYRTSLSLITITEDNIFDSIKNIKNINKHPYEFYQKNGYYILGIIPNANGKNKPDIWMWK
SLIKE
>A0A154B6A4|FEATURES|UNIPROT_deepARG|beta_lactam|A3782_02695|antibiotic inactivation|1
MIVLKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLE
KKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKE
DLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVT
MSDRFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTDWMKGNATGDKL
IRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEAIYDNQLIKEA
AEVVIDAIK
>A0A150MBN9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVEIIKAIILGMVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYAANTFKVVIQLGS
ILAVVVVFKDRFIDLLGLRGRHRDGKPRLKLMQVIVGLIPAGVLGVLFEDYIDEHLFSTA
TVLIGLVLGALLMIVADWFAQKTTPKAQTVDQITYKQALIVGLVQCLSLWPGFSRSGSTI
SGGVLVGMSHRAAADFTFIMAVPIMMGASVLSLLKNWQYFTIDALPFFTAGFISAFLFAL
ISIRFFLKLINQIRLVPFAVYRIVLALVIYIVYF
>A0A0Q7APR9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVVLLIKAAIMGIVEGLTEFLPISSTGHLILAGSLLNFVGEKAKVFEIAVQTGAMFAVV
WEYRERLARTVKGITHEPQAQRFALNVLIAFLPAVVLGLAFGKYIKAHLFHPVPVALAFI
VGGLIILWVEARHKRLYGDMDMQGARKARIETVDDMRPMDALKVGLLQCLAMIPGTSRSG
ATIIGGVVLGMSRKAAAEFSFYLGIPTLMGAGAYSVLKQRDALDWGDLPMFAVGLVFAFI
SALLCIRWLIRYVSNHDFKIFAWYRIAFGLVVLATAYMGMDIWKD
>A0A060L064|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTPLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>NP_709856|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQIVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPNRAI
TQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAWWQS
CVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRLSESE
AVAARECNLENICQTLLQLGQMNPNTPPTPAAKPPSMVADAFTNPDYIRYAVKTLLACLI
CYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWL
DNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRA
LGIIIGTVVSAMIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQIRI
GLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQALDN
ALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPTSQAILPTLLKQEQHVCQLFARL
PDWTAPALTPATEQAQGATQ
>A0A0S0ZQ59|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-14|antibiotic inactivation|1
MQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRG
DERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAEL
SAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTT
PRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGT
TNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>W6VT56|FEATURES|UNIPROT_deepARG|beta_lactam|PMI25_000918|antibiotic inactivation|1
MSFINLRKVISCSAFGVIFAANACMAATPSDEQLQALVNKAVTPVMQQQQVPGLAVAIII
NGQPHYFNYGVAAKDTGQKVSENTLFEIGSVSKTFAATLAGYAQATGKLDLSTKASQLWP
ELKGSAFDNISVLQLGTYSAGGLPLQFPDPWDSANKMLSYYQQWKPSFPAGSQRLYSNPS
LGLFGYLAAKTLGQPYDQAMSETLLPKLGLQHTYLQVPKAQMSLYAQGYDKNNQPVRVTP
GAMDSEAYGVKTSAADMLRYVQVNLKPASLEAPLQQAIANTHTGYYSVGDMTQGLGWEMY
RYPISLDRLLAGNSTEMAMQPHKVQWFNPPQPQADNVLLNKTGSTGGFGSYVAFVPSKDV
GVVILANKNFPIPERVKIAHTILSVLTD
>ZP_02659083|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIADFRRALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGTTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQSGQAP
>A0A0K0N425|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
CRLERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQR
VEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQ
LGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGN
TTGAASIQAGLPASWVVGDKTGSGGYGTTNDI
>R9C1H5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIIAIILGIVEGLTEFAPVSSTGHLILVAHLLEFTGEKAKTFEIIIQLGSILAVVFVF
WRRILSILGIKKWQKGEEVGTLSIFHIAIGIIPFGIGGVLFYDFIKEVLFRSGTVVITLI
IGGLLMLAAEKWKPHKPTAETLDQVTYRQAFAVGMFQCFALVPGFSRSGATLSGGLLAGM
SHKTASEFTFIMAIPIMAAATGKDLFESWNYLTPQDLPLFLTGFFTAFIVALLAIKFFLQ
LINKIKLAPFAYYRFGLAFLFWIFIL
>A0A0P9ZHG2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGDRAAAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVILGVIFADLIHHYLFNPITVATALV
IGGVIMLWAERREHVVRAETVDDMKWTDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAGYSGYKYRDMFRPDDVAVFAIGFVTSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWAAAKA
>A0A0F7FDX6|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKPVSKYERIRQVLSELKQPSYRYSQITEAIFKGKVGEFERMVILPKSLRVKLIQTLGPR
VCSIFPVKELTSSQVSKVLFAVAGDEHIEAVRLHYERGWESYCISTQCGCGFGCKFCATG
TIGLKRNLTADEITDQLLYFHLNGHSLDSVSFMGMGEALANPHIFDALNILTDPSLFRLG
HRRITISTTGLLPGIDKLTREYPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLHVLDR
HIRHTGRKVYIAYLLLRGVNDSTAHAKAVAELLRGRGTGEHLYHVNLIPYNSTEVTPESY
RTSDSNQIDSFVRVLKSKGIKVTIRTQFGSDINAACGQLYGKE
>A0A0Q6QXH7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAIAFNIIIQLGAILAVV
WEFRRKIIDVVTGLPTQPGARRFTANLLIAFMPAVVLGVIFSDLIHKYLFNPITVATALV
VGGIIMLWAEKRQHEVHADTVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVAAAVYSGYKYRHLFVPSDFPVFAIGFVTAFIFAMIAVKGLLKF
IASHSYAAFAWYRIAFGLVILATWQFGWVDWAAVKP
>A0A0A8F6X9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIGFHSNHKVFEIAIQLGAVLAVVF
EYRQRFSNVLHGLGKDRKANRFVLNLAIAFIPAAVMGLLFGKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIADVDALRPIDALMIGVAQVFALVPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFIAAFVSGLVAVKALLR
FVSKKNYIPFAYYRIVFGIAIIILWLSGWISWE
>R9MR23|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKSILFGIVEGITEWLPISSTGHMILLDEFVKMDVEQDFWGMFLVVIQLGAILAVV
VLFWDKIWPFGKKNNSCPVKKNGFLSYCKKDIWIMWFKIVSACIPAAVVGLLFDEFFESL
FYNGVCVSIALIVFGIGFIMIENHNKNTRSKINSLSEITYQTALIIGFFQLIAAIFPGTS
RSGATILGALLIGVSRTVAAEFTFFLAIPVMFGASLLKLVKFGFAFSGNELTILVTGMAS
AFIVSIIVIRFLMGYIKKHDFKVFGWYRIILGIVVLAYFGFKAI
>J2WZJ9|FEATURES|UNIPROT_deepARG|aminoglycoside|PMI03_00650|antibiotic inactivation|1
MQIKEASLEHLDAWLRLRAELWPSSSMEYHRAELTQILTKENAIAFIACDQTGHAVGFAE
ATLRHDYVNGCKTSPVLFLEGIYVRREYRRQGVAQSLCRTVADWGRAAGCQEFASDALLD
NVESHAFHDALGFEETQRVVYFRKLL
>R7KJL6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIYQIKAFILGIVEGLTEFLPISSTGHLIIAGDLLNFDGPEVNTFSIAIQAGAIFAVC
WFYRVKLWNILTHLFKPGKEQQLAINIVVAFLPAAVLGVIFADMIERLLFNAVTVATALV
VGGLIIFWIENLHAKRSYAPRVQTMDDMTIKDAFLVGCMQCIAMIPGTSRSGSTIIGGLV
LGLSRKAATEFSFFLAIPTIFGATVYSLGKTFLRVSNEHSFVWTSDMTWGFSIGFVVSFI
SALIVVKWLLRYVSSNDFKPFGWYRIIFGVVILGTHFSGLVQW
>A0A0U0X2N5|FEATURES|UNIPROT_deepARG|chloramphenicol|cmlA|antibiotic inactivation|1
MPAEHALLVVMATFEPLDLQQWPRREWFEHYLDRCPTYYSMTVDLDITNLRAAVDASGRK
TYPTQIWALATVVNRHPEFRMALDDQGNPGVWDVVDPAFTVFNPDRETFAGISARYTPDF
DAFHSEAAELLSEYLNASTLFPQGAPRPRNVFDISSIPWTRFTGFTLTIAPGWAHLAPIF
TIGKFYEQEGRTMMPLALQIHHAAADGYHSARLVEELRQIIADPDWVRD
>A0A127SHC4|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-2|antibiotic inactivation|1
MLWSSNDVTQQGSRPKTKLGIKEKLMAIRIFAILFYIFSLATFAHAQEGTLERSDWRKFF
SEFQAKGTIVVADERQADRAMLVFDPVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIF
RWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSN
GDYWIEGSLAISAQEQIAFLRKLYRNELPFRVEQQRLVKELMIVEAGRNWILRAKTGWEG
RMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>Q9KJC3|FEATURES|UNIPROT_deepARG|multidrug|arpA|antibiotic efflux|1
MQFKPAVTALVSAVALATLLSGCKKEEAAPAAQAPQVGVVTIQPQAFTLTSELPGRTSAY
RVAEVRPQVNGIILKRLFKEGSEVKEGQQLYQIDPAVYEATLANAKANLLATRSLAERYK
QLIDEQAVSKQEYDDANAKRLQAEASLKSAQIDLRYTKVLAPISGRIGRSSFTEGALVSN
GQTDAMATIQQLDPIYVDVTQSTAELLKLRRDLESGQLQKAGNNAASVQLVLEDGSLFKQ
EGRLEFSEVAVDETTGSVTLRALFPNPDHTLLPGMFVHARLKAGVNANAILAPQQGVTRD
LKGAPTALVVNQENKVELRQLKASRTLGSDWLIEEGLNPGDRLITEGLQYVSPRRRGEGQ
RCHQRQEAGRP
>A0A0N1HM22|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLDVIFILKSIIIAIVEGLTEFIPVSSTGHMILVGNLIDFKGQFAEMFEVVIQLGAILA
VVVLYWKKIKDSVIEFFKFIFTGGKEGKTGFRFGINVIIGCIPFAIVGVLFYDNIKSLFN
LQSVIIGFIVGGILLLVVETLFRKKNHSTDNIDKITPVQALKVGTLQVLSAWPGMSRSAS
TIMGGWIAGLNSPIAAEFSFFLAVPAMVASSGKDLFEFDYSIMTPTLWIALVVGFIVAFI
VSIIVMEKFVEFLKKKPMRVFAIYRIIMGIVLAVLAFTNIISI
>A0A0V9E6I5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRLPQREGEGKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPI
NVMYALVVGGFLLIAAEVLKPKVPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTTGDIPMFAVGFITAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>K2PKS2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDQTIVGALLLGILEGLTEFIPVSSTGHILLAGHFLGFKSTGKAFEVLIQLGAILAILS
VYAGRLWQMLIDLPRDRATQRFVLGILLAFLPAMVIGVFAYKIIKTVFFETPLLICVMLI
LGGFVLLWVDRWATKPRYTDITKFPMSMYFTIGLIQCLSMIPGTSRSGSTIVGGLLLGAD
KRSAAEFSFFLAMPTMTGAFAYDLYKNYDVLSAADVKIIAIGFIAAFIAALIVVRWLLGY
VSKHGYSLFGWWRLIVGGVGLAALLMWG
>CAS09947|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQTGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLIDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0A0I1B8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLWFIIKAIIIGIVEGITEFLPVSSTGHMIIVEDLINFKEGVMPASLYTKQYIDAFTM
IIQLGAILAIVVLYWGKIKRSFENFAPSKPKSGFKFWLNIAVAAVPAGILGLKFHSKINE
KLFNPGSVTAALIVGAIWMIFAEKRYRGKFTTRDIDNVTIKQAFIIGCFQCLALWPGMSR
SASTIIGAWIVGLSTVAAAEFSFFLALPVMFGLTLKSLIFDINIFTLGSMHIIGLTVGFI
VSFIVALIVVDKFITFLKKRPMRVFAIYRILLGIVLIILSLFNVISM
>B2HID0|FEATURES|UNIPROT_deepARG|beta_lactam|MMAR_1674|antibiotic inactivation|1
MPGKGIRAGEGTPLGIITRAATPLILAIASLCALVATPAVAAPDALSAAVDSAFRPLLVQ
YDIPGMAVAVTVNGQQRYFNYGVAAKQSGAPVTADTIFEIGSVSKTFTATLACYAQELGR
ISLAGHPSAYMPQLAGSAIDKATLLNLGTYTAGGLPLQFPPEITDDAQMQAYFQQWAPDD
APGQQRRYSNPSIGLLGHLTALAMNSDFADLVQTQVFPKLGLSHSFIRVPQAQMDDYAWG
YNASNEPVRVNPGVFAAEAYGVKSSAPDMLRFVEANISPEGLPASMRRAVQATHLGYFNV
ADMVQGLGWEQYSYPVTLDQLLAGNSNTIAMQPNPVTPVAGVPPSGPRLFNKTGSTDGFG
AYAAFVPDKRIGIVMLANKNFPNAARITAAHAVLEKLAAESR
>ZP_03835080|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MQRIIAFFSQRATTLFFPIALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLY
LAGGMALQWLLGPLSDRIGRRPVLIAGALIFTLACTATLFTTSMTQFLVARFIQGTSICF
IATVGYVTVQEAFGQTKAIKLMAIITSIVLVAPVIGPLSGAALMHFVHWKFLFAIIAVMG
LIALTGLALAMPETVQRGAVPFSALGVVRDFRDVFRNRVFLFGAATLSLSYIPMMSWVAV
SPVILIDAGGMTTSQFAWAQAPVFGAVIVANMVVVRFVKDPTRPRFIWRAAPIQLSGLAV
LMAGNILWPHVWLWSVLGTSLYAFGIGMIFPTLFRFTLFSNKLPKGTVSASLNMVILTVM
AVSVEIGRWLWFNGGRISFHLLAVVAGIAVVFTLAGLLKRVRQHEANALAAES
>A0A0T7HCG0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALILGLIEGLTEFLPVSSTAHVLLAGHFLGFQSPGNTFAVLIQLGAILAILL
VYARKLLQIAADLPTSPKARRFVATVLIAFLPAAVIGALAHGFIKAVLFETPMLICVMLI
LGGFVLLVVDRIKFQPKYHDAMDYPLSLAFKIGLFQCLAMIPGTSRSGATIVGALLLGAD
KRSAAEFSFFLAMPTMLGAFALDLYKNRNALSLDDSALIAVGFIAAFVTAILVVRSLLDF
VSSRGYAPFAYWRIVIGAAGLIALLLGA
>A0A066TJ49|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILFLKALILGIVEGLTEFLPVSSTGHLIVVGNLLKFQTTGEVFDITIQLGAILAIVF
EYKHRFAHIITHIGKEPATNRFVLNLAIAFIPAAIVGLLFNKQIKHFLFNPITVATALVI
GGLLILWIEKRQSHIEPKVKNVEQMRPRDALVVGLAQILALIPGTSRSGSTIMGGMLWGI
ERKAATEFSFFLAVPVMIAATGYDMLKHMSEFTRDDLLLIAIGFIAAFLSALVAVKALLR
FVVHKNYIPFAWYRIIFGGIILLTWATGWVKW
>L0KGQ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFQSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
IGGVVLLVVDRMNLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLTSADLPIIAIGFVAAFVTALVVVRYLLDY
VSRNGYSLFGWWRLVVGIVGLVALMIWG
>C2P0R0|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0005_28330|antibiotic inactivation|1
MVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQIKQEITGNDSFVKLEKEFDAKLGIYAL
DTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNPITEKY
VDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGDTVTNPERFEPELNEV
PPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTGDNLIRAGVPGGWEVA
DKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKIVLDALKVTN
K
>I6ZR30|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-5|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDXQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAG
>A0A0G4D8P2|FEATURES|UNIPROT_deepARG|beta_lactam|KNN_06295|antibiotic inactivation|1
MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESTKQTNQTNQVKQENIGNHAFA
KLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITY
TREDLSNYNPITEMHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSACPST
>YP_002236533|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDIHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTANTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPEHEGKGSGRLSLIHILLGMIPAVVLGLIFHDTIKSLFNPV
NVMYALIVGGVLLIAAEVLKPKQPRAVGIDDMTYRQAFVIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDVYKSIGFLNMGDVPMFAVGFVMAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>YP_001616633|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MFWFDAVLLGVLEGLTEFLPVSSTGHLILLGAWLGHQSEAAKTLDIVIQLGAVLAVVVYF
RERLSTTVRGMVRRDPDSLRLALALAFAFLPAAVVGLLFHKAIKAHLFGPGPVAAALIVG
GFLMIGVESLRRRRPDQGAPRVEDVTFQRALAIGFAQCFSLWPGASRSMTTIVGGQLSGL
STAAAAEFSFLLAIPTLGAATVFDLVKNGRALLDAPGGIVALVVGLAVSFAVALLVIAVF
LRYLKRYGLAPFGWYRIALGALVLWLWIASRSAPAEAGAASASPAPRGDVAAAVDGLART
GDHPSRP
>A0A085G6Q0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVVESHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGNLLGFTGDTAKSFEVIIQLGSIMA
VVVMFWRRLFGMIGIHFGKPPVHEGTGTGRLNLGHIILGMLPATVIGLIFHSQIKALFEP
KNVIYALVVGGVWLIAAELLKPKKPRAEGVDDMTYRQALMIGVCQCLALWPGFSRSGATI
GGGMLSGVSRYAASEFSFLLAVPMMLGATVLDLYKSYTFLSMADLPMFATGFVVAFLVAL
IAIKTFLSVIKRFSFIPFAIYRFVVAFVAYTIFIA
>Q6FEB4|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSAVFVVAIQMGAIAAV
IYEYWSRLWGAATGMVTGEEKGRHLAISLILASIPIVLVGLSFGQTVKDLLFNDVAVAIG
LIVGGVIIMWIEKNPPKVNAVEVENIGLKQAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSHEVLQTSFDWSVLGVGILVSFVSALLLIRAL
VAYVAKRDFMVFAWYRIVSGLLILLFAYTGWTIW
>A0A0Y0AM42|FEATURES|UNIPROT_deepARG|beta_lactam|blaADC|antibiotic inactivation|1
IFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDK
KAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLAT
YTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFD
QVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVPAYGVKS
TLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSYPATLQTLLDS
NSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVMLTNKRIPNEE
>A0A127SDC6|FEATURES|UNIPROT_deepARG|beta_lactam|OCH-8|antibiotic inactivation|1
MRKTTVSALSITAVASLLTSVSVQAANAPSEKEIRHLVDETIKPVMAEHKIPGMAVAVTA
GGKTYFFGYGVASKESGQKVTEDTIFEIGSVSKTFTATLGGSGLAEGAFKPGDTATKYAP
KLAGSSFDNVSMLDLGTYTAGGLPLQFPDSVTDHKTMIDYFKNWKPDYPAGTQRRYSNPS
IGLFGYLAAQSMGEPFDKVMETRLIPAFGLKHTFIQVPESQMKNYAYGYSKANKPIRVSP
GAFDAQAYGIKTTAPDLIRFVQLNMDSTSLGQPMQKAVAATHTGYYKVGDMTQSLGWERY
AYPLSLKTLLGGNTSDMAMKSHKIEKLAPPLQPSDDMLLNKTGSTGGFGAYVAFVPGKKI
GIVMLANRNYPNDARIKAGYRILKALDGNQ
>A0A104K0L9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKFSKMMPAMTQAVLFCAAGAMLGIADTAFAAADRVQAVVDETIRPLMTEKQIPGMAVGV
VVDGKAHVFNYGVASKESGRPVTNATLFELGSVSKTFTATLASLAEVDKQLSLSDKVETY
LPPLRGSDFGKVRLLDLGAHTVGGLPLQVPDDVRDEAELISYLKHWHAAHAPGTFRTYSN
ISIGTLGILTANRLQQDSTSLMEGRLFPGLGLKNTFIDVPAAREADYAQGYTAAGKPIRM
KMEVVGREAYGVKSTAGDLLHFMQGNMKLIPLEASLQRAVTQTHTGYFQAGPMTQDLIWE
QYPYPVALKTLLTGNGPAMLFKGMKVTEIRPPEAPRDDVWINKTGSTNGFSSYVAFVPAK
RMGIVILANRSYPIEDRVAAAYRILTALDGAGQ
>A0A0F4TJP2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLGFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPGARRFTANLLIAFLPAVVLGVIFADLIHKYLFNPITVATALV
VGGFIMLWAERRQHEVHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFVPADFPVFAIGFVTAFVFAMIAVRGLLKF
IANHSYAAFAWYRIVFGLIILATWQFGWVDWSAAKP
>S1CUS0|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWMLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFVLCAAF
NAWLLPAWKLSTVRTPVREGMARVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
APSAVKWMYAIEACLSLTLLYPIARWSERRFRLEHRLMAGLLVMSLSMIPVEMVSNLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYVGGGWLFDLG
KSAQQPELPWIMLGIIGIITFVAMGWQFSQKRATRRLLERDA
>A0A127PGU7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSILKVLSFSACFLAAGSCAGAGTGLDQSSIKTAVDSAIEPLMQSYAIPGMAVAVTIDGK
NHFFNYGVASKETRQPVTNRTLFEIGSLSKTFTATLASYAQLDGKLSLSDSASKYLPSLR
GSSFDNVSLLNLGTHTAGGLPLQVPDDIGNTEQLMDYFKHWQPAHAAGTYRKYSNPSIGL
LGMIAAKSMDMSFEDAVEKKLFPELGMTHSYINVPAGQMKDYAQGYTTKDVPVRVNPGVL
ASEAYGVKSGSADLIRFIGANLQVIKLEARLQRAITDTHTGYFGSGEFTQDLIWEQYPYP
LELKQLLAGNATTSLYDELPAARLSPALPPQADVLINKTGSTNGFSSYAAFVPAKKIGIV
ILANKSYPIDQRVTAAYRILTRLDSEAASKN
>N9BVJ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGNLEAFKALFLGFIEGLTEFLPISSTGHLILFGHLIDFHSDSGRAFEVVIQLGAILAVC
WLYRKKIIDLVKGFFSGDAEARHFTFSVLIAFFPAVIIGVLAVDFIKSVLFSPMVVAVAL
IVGGLIIFWVESRDFKPSTIEATRITFKQAIIVGFVQCIAMIPGTSRSGATIIGGMLSGL
SRKAATEFSFFLAMPTMLGAATYDLMRNASILTSDNMLNIGLGFVAAFISALFVVRALVR
FVEKHTLRVFAWYRIALGAIIMLVMF
>G1WIP9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIELLKAAFLGLVEGITEWLPISSTGHMILVDEFIKLNVTEEFWNMFLVVIQLGAILA
VCLLFFHELNPFSSKKGKDGRRATWSLWGKIVLGCIPAAVIGIPLDDFMEEHLYSSVVVA
AALIVYGIAFIVIESWRARRRSELSAAGALPGSRPAGAHFAASPVASSAAGGAAGSAYDG
DSDFGAIASLDELSWKIALGIGCFQVLSLIPGTSRSGSTIIGGLLLGCTRSVASKFTFFL
AIPVMFGASALKLVKFFIKGGTFGAPELAILGVGCAVAFVVSLLAIKWLMGFVRRHDFKA
FGVYRIVLGVLVLAYFFAIAPALGLAA
>A0A0D0SZD1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_3|antibiotic efflux|1
MTQPLLELKGITRSFMAGEREFIALKGIDLSIHAGEMLAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGTETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPES
QRHSRARELLARLGLSGHVSHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVCDGQIISDKTNDSVGLELPSEAP
MEPRRSGARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVDALNQLYYVDSATPVVGRNL
LLRFGNIDLDAQVNGVSDRYFKVKGLKLEAGIAFSESDARRQAQVVVIDHNTRHRLFGPN
IDPLGQVILVGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGIIGISLSYAIGY
LFSLFVKEWEMVFSLGSIITAFACSTLIGIVFGFVPARNAARLDPIEALARD
>ZP_03747831|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MEQTPPSRSSFLILIPLHPEIQTGKRRLKTKKESNMDILTLLKALIMGIVEGLTEFLPIS
STGHLIVLGDLLNFHSNGKVFEIAIQLGAVLAVIFEYRQRFTSVLSGLGKDRAANRFVLN
LAIAFVPAALMGFLFRKQIKLYLFNPKTVAIMLVLGGLFILWVERRQSKVKPKVKSVDEM
HPIDALVVGCAQVCALVPGTSRSGSTIMGGMLWGIERKAATEFSFFLAVPMMIAATGYDV
FKHYELFTLQDIGLIAVGFIAAFLAGLLAIKSLLKFVSSKNYVPFAYYRIVFGGLILLTW
AMGWVKWAA
>D1LFI7|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
QLLNQPVEIMPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGV
TAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLV
TWLKGNTTGAASIRAGLPTSWT
>A0A103EIF8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWVLIVKALALGIVEGLTEFLPVSSTGHLIVAGSFLHFHAGYAKTFDVVIQFGAILAVC
WEYRRRIASVVTGLPTQPLARRFALNVVIATVPAVALALLFEKTIKSVLFAPVPVAVALI
AGGAVILWVEGRRDRAAPARVQSIDALTPLDALKVGLAQCFALIPGMSRSGSTIIGGMLF
GLERRVATEFSFFLAIPVICGATLYETAKDWRAFDADLLGLFGVGLIAAFVSAFACVRWL
LRYVASHDFTPFAWYRIVFGLFVLLVGYSGWIDWA
>A6QA78|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIQAIIIGIIEGFTEFLPISSTGHMIVASKFLGVAETDLTKAYEVIIQFAAILAVMLI
YREKITFKKIDLWMKLLFAFLPLAIVGFIFKDQVKALFNVQVVAWMFIIGGIIFLIVEYY
YKEQAWHVKDVEKVSWTQAWWVGFAQIFSLIPGTSRAGATIIGGLLAGLDRKTSAEFSFL
LAIPVMAVVSGYDLLKHYQDFADANWGAFLIGFIVAFIVAYATIKLFLVFLQRFTFVAFG
IYRIIFGIFLLMIL
>ZP_04307065|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVDNMKKNTLLKVGLCVSLLGTTQFVSTISSVQASQKVAQIVIKNETGTISISQLNK
NVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKKSGYEEPFGDLQTVTNLKFGNMKVETF
YPGKGHTEDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNI
NSVVPGHGEVGDRGLLLHTLDLLK
>A0A0A0Q8R9|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-5|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPFEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGMKTNVQDMANWVMANMAPENVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>CAI29521.1|FEATURES|ARDB_deepARG|trimethoprim|dfrA15|antibiotic target replacement|1
MKLSLMAAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSSDENVLVFPSIDEALNHLKTITDHVIVSGGGEIYKSLIDKADTLHISTIDI
EPEGDVYFPEIPGSFRPVFSKDFVSNINYSYQIWQKG
>E7NXF8|FEATURES|UNIPROT_deepARG|chloramphenicol|HMPREF9554_02777|antibiotic inactivation|1
MKQSQETLFSKIDIESWERKEYFLHYYNDVRCTYSVTVNVDITEVYNRVKYQSLRLYPTL
IWWIANTVNHFEFLRFNHDEDGNIGYYDEINPSFTFMPPNSEKFYVLWCEYDRSFKAFYD
RCVEVMDIFNTSKMFPMSDMPRNCFDISSVPWIEFTSFNLNVFSTGTHLPPIFTTGELIK
ENGRVKLPFSLQVHHAVCDGYHAGQFFAYLQKFADKASDWMKH
>A0A0T9USW7|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MSQNEEIKKVSVVIPVYNEQESLPALIERTSAACKLLTQPYEIILVDDGSSDNSADILTA
AANAPDSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVTVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SIIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGGEQTENNQEIEK
>C3AWY0|FEATURES|UNIPROT_deepARG|chloramphenicol|bmyco0002_58280|antibiotic inactivation|1
MNLKFNIINRDNWYRKEYFEHYLQQQTTFSLTNEINITILMKNLKKKNYKLYPAFIFMVT
KIVNSHREFRTSCNSEGNLGYWTEIFPSYTIFDKKTHTFSSIWSPNFANFSDFHSQYEKD
VEKYNGTGSLFPKIPIPDNNIPISMIPWSSFTAFNLNINNGGDFFLPIITGGKYSQVNDE
LFLPISLQIHHAVCDGYHASVFMNDLQKLANESTDWI
>A0A084YS37|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MMALLELSGISRSYQSGDQTVAVLKNVSLRIDAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLNGDALARLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAVALLQRLGLSERVGYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILKQLREQGHTVIIVTHDPAVAQQAERVIEIRDGEIIADSCPEQRSNPNAKPLEM
AAPAPSWQQTAGRFREALVMAWRAMAASKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPTFRQALKYDDLAALREQPYVSALSPTIASSMRLRL
GNVDVAANVTGVSEQFFRVYGMTFTQGTGIDQLQVQSQSQTVVIDANTQRRLFPHQKDVV
GKVILVGNMPATVVGVAKEKQSMFGSSKTLNVWVPYSTMANRLMGNAYFDSITVRIREGY
NSQEAEQQLTRLLTLRHGKKDIFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLLVQV
VLPGWQISFPPAALLSAFVCSTAIGVVFGYLPARSAARLNPIDALARE
>A0A0T9SJ94|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_1|antibiotic efflux|1
MSALLELKGIRRSYQSGEETVDVLQDVSLTIHAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAALDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNE
RRERATMLLTRLGLGERVGYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPNVAAQAERIIEIKDGRIMADSGSKAAQTVTTSEAIS
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVHDDMTALKAQAYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVYGMKLEQGTAITREQVERQSQVVVIDRNTQRRLFPHLKEV
VGQVILIGNMPATVVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLVVE
MFLPNWQIAFPPMALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>YP_793057|FEATURES|ARDB_deepARG|multidrug|mexD|antibiotic efflux|1
MSEFFIKRPNFAWVVALFISLAGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDS
VTSVLEESLNGAKGLLYFESTNNSNGSAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQ
AVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTTLGDYAARNINNELRRLPGVGKLQFF
SSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKG
TLDDPQEFGQVVLRANQDGSLVRLADVARLELGKESYNISSRLNGTPTVGGAIQLSPGAN
AIQTATLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLF
LQNVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVER
IMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSI
LFSGFLALTFTPALCATLLKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGR
FMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKS
REAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSAAAEIAALNEHFALPDDGTI
MAVSPPPIDGLGNSGGFALRLMDRGGVGREALLQARDTLLGEVQTNPKFLYAMMEGLAEA
PQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPE
SVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEM
ERLAAQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLI
VPIGAIGAVLAVMVAGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAI
EAARLRFRPIIMTSMAFILGVVPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPIC
FVWLLSLLRSRPAPIEQAATAGE
>CAA70207.1|FEATURES|CARD_deepARG|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVKRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIA
DEIYLIVEYGFAKRLLNTKRSLALFLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISHKDKQKYNYFVMKWVNKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>A0A0W0LHM1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVEVADLHEASIAAQQPLLQLDNVSRSFMAGDREVTVLKQINLSIHAGELVAIIGAS
GSGKSTLMNILGCLDNASSGIYRVAGQQTRDLDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNTEIPAVYAGTSQAGRHQRAQELLTRLGLGGHLEHRPSQMSGGQQQRVSIARALMNGG
EVILADEPTGALDTTSGKEVMRILLELHAMGHTVILVTHDPKVAANAERVIEVSDGEIIS
DRRTSPRVQPVAEPKPELQPTATARRRMIASFGLFREAFNMAWIALISHRMRTLLTMLGI
IIGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGSNFGDSRAKSIETLLPSDVTAL
NQMYYIDSATPVVGRSMLVRYRNIDVDAQLNGVSSRYFQVRNIQLAAGITFDDQDARRQA
QVVVLDHNTAQRLFGPGVDPLGKVILIGKLPCTVIGVTSDHKNMFIAGNTLNIWMPYETA
AGRVLGQRHLDSISVRVKDGMPSKVVEEEIKALMLQRHGTKDFFTNNLDSVMQTVQKTSR
SLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMV
CLIGGVIGIGLSYGIGYLFTLFVKQWEMVFSMASVVTAFACSTLIGVLFGFVPARNAARL
DPIEALARD
>D0L1W3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMLPDWLTAAVLGLVEGATEFLPISSTGHLIIAADFLGYTGDGAKVFEIFIQLGAILAVM
WFYRQKLTSVLVGLPRERSAQKFTLNLIVAFIPAAIIGLATHSYIKAHLFNPLFVAVALI
IGGFIILLVERFAPAPRIHHVDDMSWKDALKVGVAQCFALIPGTSRSGSTIMGGMMFGLS
RTTATEFSFFLAIPTMLAATLFDLIKHMHLLHPEDIHMMIIGFIAAFISGLVFVSMLLHY
ISKHTFKGFAYYRIVFGALVLWYFWP
>A0A0E2LS78|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILQAIVLAIVEGLTEFLPVSSTGHMIIAEGIMGMESTSFVRAFTVMIQFGAILSVLVL
YRKRFFCFPVAPRALGQGKGKEFMSRFDLYWKLLIALVPAIILGFLFEDWVDRMLGSVWV
VAVVLFLGGIFMLFVDKLFASSDREEITYPKAFVIGLFQCLAIFLPGLSRSMATIVGGQQ
QKLSRKAAAEFSFFLAVPTMLGATLLKAYKLYKEGGIEIFREHMTVLLVGNIVAFIVALA
AIKFFIGFLTRYGFKAFGYYRILVGGLLIVLMLSGVSLAV
>ZP_04228022|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MKGMMILKNKRMLKIGMCVGILGLSVTSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRHNERFAFASTYKALAAGVLLQQNSIDTLNEVIKF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQIGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIASNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKSLK
>A0A0C5PJE3|FEATURES|UNIPROT_deepARG|beta_lactam|pSF07202_057|antibiotic inactivation|1
MSIQHFRVALIPFFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFP
MMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAI
TMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMA
TTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIA
ALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>E3EG56|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIQGWNHICFSVSNLEKSIQFYQNVLDGKLLVKGRKLAYLDCLGMWLALNVEEDIPRNE
IHHSYTHIAFSVAEADFESMLNKLRTLNVTILPRRERNEQDKRSVYFTDPDGHKFEFHTG
QLQDRLEYYKNAKKHMTFYE
>A0A0U1YUM0|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-199|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVGSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>YP_001896735|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDWLLACKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDEHAKTFDVVIQLGAILAVC
WEFRRRIGSVVSGLPTRPDARRFTLNVIIATIPAIVLGLLFEKSIKAALFSPVPVAFALV
AGGVVILWAEARQRAQGETQARVQSVDDLSALDALKVGLAQCFALIPGMSRSGSTIIGGM
LFGLDRRVATEFSFFLAIPIIFGATAYELYKDWHLLSVDALGTFAIGFAAAFVSAFACVR
WLLRYIAAHDFTAFAWYRIGFGLLILLVGYSGALSWTE
>A0A0S3BND6|FEATURES|UNIPROT_deepARG|beta_lactam|AS145_19545|antibiotic inactivation|1
MKGWMKCGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKGV
TVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTR
DLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFV
YFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPELI
DHYEELIKAVPQS
>A0A0R2L917|FEATURES|UNIPROT_deepARG|aminoglycoside|IV66_GL000803|antibiotic inactivation|1
MRNLSNDKLPKQAMQALKIVEELLESSIVGVYLFGSAVKGGLRINSDIDVLVVVNQRLSE
PTRKKLTENLMSVSGKIGDEKGMRYLELTVINEEDSVPWQYPPRSEFVYGEWLRSEFENG
QIPEPNFDPDLAIVLAQAREHSVSLFGTNLSTILDPIPITDIRKAIKQSLPELIEGIKGD
ERNVILTLARMWQTMDIGEISPKDVAADWALPKLPKQQAEVLDIARRAYLGKYNDDWDGM
EAEIMSLVNHMRGKIESYFNIY
>Q9K319|FEATURES|UNIPROT_deepARG|beta_lactam|ampH|antibiotic inactivation|1
MSRLLLSGLLGAGLLFSLPASAATGCFLYADGNGQALSSEGDCSSQLPPASTFKIPLALM
GYDSGFLVDEEHPALPFKPGYDDWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPQEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSESDGWQIHGKTGMGYPKKLDGSLNREQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAKLKTL
>A0A0H4WFI4|FEATURES|UNIPROT_deepARG|aminoglycoside|ACR54_00646|antibiotic inactivation|1
MDISLIRATPAFAADWLSLRSALWPDAAATHARDIEAMLRRPGELAVLAYRGGRAVGLAE
AALRRDYVNGCETSPVAFLEGLYVVPDSRRQGVGAALCAEIERWGREQGCREFASDTALD
NHASQALHRRLGFAETERVVFFRKLLA
>A0A0H4LE51|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFIKLNESTAFINMFMVVIQFGAILAV
ILIYFHKLNPFSPKKNHREKNQTWSIWFKVIVAILPSVIIGLPLNDWMDAHLTSWQVISA
TLLIYGILFIVVENWLKNKRPQVEDLDHLSYKTAFTIGLFQVLSLVPGTSRSGATILGGM
TVGTSRFVATEFSFFLAIPTMFGASLLKIGKYFMNGHSFTGDQTIILLVGTLVSFIVAYA
SIKFLLDYIKRNDFKAFGWYRIILAIIVIAYFGIKSFA
>F5S9X3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|ybjZ|antibiotic efflux|1
MSLIECKNINRYFGEGENRVHVLKNINLTIQKGDFVAIIGQSGSGKSTLMNILGLLDTPT
SGAYSIAGTETSKMSADELAAMRRKRFGFIFQRYNLLSSISARDNVALPSVYAGLDYAER
SERADSLLDKLGLKGKEKNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDSGSGE
NVMEIIHELYAEGHTIIMVTHDPKIAAQANRVIEIKDGEIISDSSKTTEIAPSNVKSIQE
KHGLAFYKDQFQEACTMSVQAIVAHKMRSLLTMLGIIIGIAAVVSVVALGKGSQEKILAD
INSMGTNTISIFPGKGFGDRNRSRIKTLTVADGQAIAKLSYVEATTPSTSTSGTLTYQNT
DLTASLYGSGEGYFDVRGLKLGTGRLFDASDVKDNAQVVVIDNNTAEKLFPAGTNPLGKT
ILFRKRPLTVIGVLQKEDNMMGGSDSLNLYSPYTTVMSQISGDKFISSLAVKVKDNVDSQ
VAEKGITELLLARHGTEDFFMLNSDSIKQTIESTTGTMTMLISCIALISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARQSNILQQFLIEAILLCLIGGVSGVLISFGLAAVFNHFVT
DFAMSFSTASIVGAVVCSTAIGVVFGYMPAKNASKLNPIDALAHD
>A0A0G4JW61|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADLHSLFIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFADDKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGQVPHEGHTAGRLKLSHILLAMIPAVVLGLIFHDVIKSLFEPRN
VMYALVVGGFLLLAAEWLKPRHPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFILAVPMMLGATVLDLYKSWHFLSLADVPMFAVGFITAFIVALIA
IKTFLQVIKRISFVPFAIYRFIVAAAVYMVFL
>YP_001187672|FEATURES|ARDB_deepARG|multidrug|mexf|antibiotic efflux|1
MNFSQFFIQRPIFAAVLSLLILIGGAISLFQLPISEYPEVVPPTVVVRADFPGANPKVIG
ETVASPLEQAIVGVEGMLYMSSQSTIDGRLTLTVTFALGTDLDNAQVQVQNRVTRTMPTL
PTEVQRLGVTVDKASPDLTMVVHLTSPDQRYDMLYLSNYAALNVKDELARLDGVGDVQLF
GMGNYSLRVWLDPNKVASRGLTATDVVTAIREQNRQVAAGALGAPPSDAGNSFQLSINAQ
GRLVSEEEFENIIIRVGDNGEITRLRDIARVELGSNQYALRSLLNNQPAVAIPVFQRPGS
NAIEISDSVRERMAELKKSFPQGMDYEVVYDPTIFVRGSIEAVVHTLLEAVVLVVLVVVL
FLQTWRASIIPLAAVPVSLIGTFAVMHMFGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIALGKSPVEATRQAMKEVTGPIVATALVLCAVFVPTAFISGLSGQFYQQFALTIAIST
VISAINSLTLSPALAAILLKDHHAPKDGFSRLLDRLFAGWLFTPFNRMFERASNRYVGTV
RRVLRGSSIAMLVYGGLLVLGYLGFSSTPTGFVPQQDKQYLVAFAQLPDAATLDRTEVVI
KRMSEIASKHPGVENTVAFPGLSINGFTNSPNSGIVFVTLKDFGLRKDESLSAGAIAAEL
NGQFGEIQEAYLAIFPPPPVQGLGTIGGFRLQIQDRGNLGYDELYVQTQNILNKARQLPE
LNPMSVFTSYQVNVPQVDAAIDREKAKTHGVAISDIFDTLQVYLGSLYANDFNRFGRTYQ
VNVQADQQFRLEPEQIGQLKVRNNRGEMVPLSTFVKVDDSAGPDRVMHYNGFLTAEINGA
AAPGYSSGQAEAAIAKLLNEELPIGMTFEWTDLTYQQILAGNTAIFIFPLCVLLAFLVLA
AQYESWSLPLAVILIVPIVLFTAITGVIIAGLDNNIFTQIGLIVLVGLACKNAILIVEFA
KEKQEEGLDRVAAVLEACRLRLRPILMTSIAFIMAVVPLVLSSGAGAEMRHAMGVAVFSG
MIGVTFFGLLLTPVFYVLIRGFVEKREARKVARLQESHA
>A0A0J1VXF1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDISTLDGDALAKLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVERKK
RLERAQMLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPGASRAAATKEALP
PSTGWGQFSSGFREALAMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQSLKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKANVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A089WRP8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDFGCVGLRALVAAGYTVEAVFTHADNPAENQFFGSVARTAAELGIPVFAPE
DVNHPLWVERIAAMSPDVIFSFYYRHLLSDAILQSAVHGAYNLHGSLLPRYRGRAPLNWA
LVNGETETGVTLHRMVARADAGNIVAQQRVAIDESDTALSLHRKLRDVADQLLKDNLPAI
AAGKANDIPQDESQATYVGRRTPEDGRIEWQKPARTLYNLVRAVTEPWPGAFSFVGTTKF
IIWQAKVRTDFAAAKPGTVLSTSPLVVACGSDALEIVTGQGDNGIYLQGAQLAQSLGLVT
GAILNNSPVVSVKRRTRVLILGVNGFIGNHLTERLLQEDNYEVFGLDISSDAIERFLGNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKTIRDC
VKYKKRIIFPSTSEVYGMCTDPVFDEDNSNLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDI
KDGIEALFRIIENKDGVCDGQIINIGNPDNEASIRQLAEQLLESFEKHPLRNQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLHWQPTIEMEKTVAETLDFFLQTVETGRFSQ
DSE
>A0A0A8P352|FEATURES|UNIPROT_deepARG|beta_lactam|blaMOX-10|antibiotic inactivation|1
MQQRQSFLWGAVATLMWAGLAHAGETSPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGLHHTYVNVPKQAMASYAYGYSKEDKPIRVSPGM
LADEAYGIKTSSADLLRFVKANISGVDDKALQQAISLTHKGHYSVGGMTQGLGWERYAYP
VSEQTLLAGNSAKVILEANPTAAPRESGSQMLFNKTGSTSGFGAYVAFVPAKGIGIVMLA
NRNYPIPARVKAAHAILTQLAR
>A0A0D0QU86|FEATURES|UNIPROT_deepARG|beta_lactam|RW25_25770|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDSNTQSESPKQTKQTNQIKQETTSNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKITLDALKTTNK
>I2B559|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MVEAHSLISALILGIVEGLTEFLPVSSTGHMIIVGNLLGFTGDTAETFEVVIQLGSILAV
VVMFWRRLFSLIGINFGKPVPYEGDKHNPERTGRLSLIHILLGMVPAVVLGLVFHDTIKS
LFNPVNVMYALVVGGLLLLAAEWLKPGQPRAVGIDDMTYRQAFVIGCFQCLALWPGFSRS
GATISGGMLIGVSRYAASEFSFLLAVPMMMGATVLDLYKSWHFLSLHDLPMFAVGFVAAF
VVAMIAIKTFLTVIKRISFVPFAIYRFIVAAVVYAIFM
>N9TB35|FEATURES|UNIPROT_deepARG|beta_lactam|F902_01178|antibiotic inactivation|1
MNQPKAFSMTLKKLFVLTGLLSCSSALWAGNLTEQQVQTIVDQQFKPLLAQYKIPGMAVA
VTLNGQHYFVNYGLASKQNQQAVSNSTLFELGSVSKTFNATLAGYAQAQGQLSLSDHPAK
YFPELKNTAVNRATLLNLGTYSAGGFPLQFPDEVVQQQDMVKYFQTWQAKTKIGAARQYS
NPSIGLMGYVTALAMKKPYNELIEKTLLPQLGMTQSFIRVPEQHMPQYAWGYKADQAMRV
SPGMFDAEAYGLKSSSADMLKFLDAQINPQQFKQPLRKAIENTHVGYFKVGAMTQGLGWE
QYAYPVSLETLLQGNSSKMALESHAITAIKQPKLATPATYFNKTGSSNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYRVMQQLVQSNSAQ
>A0A095ENE7|FEATURES|UNIPROT_deepARG|beta_lactam|DM43_4431|antibiotic inactivation|1
MRFNATRFAATLFVAACATAAAGRAAAVTQDDLHDTVTRHIAPLMKQYAIPGMAVGIVAD
GKPYVFDYGVMSKQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPAAKYLPE
LQGKPFGVVTLLQLGTHTPGGTPLQVPDGIRDDAGLIRYLGAWRPDYAPGTHRKYSNVAI
GMLGWLTAKAMHRDFATLMEQRLFPALGMTHTYIDVPDARMADYAQGYTKDGKPTRMTQG
MLWQQAYGVRTTAADLLRFVQANMGMIQTAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLAGNAPKMLFDAVPASAIQPPLAPNPATWINKTGSTGGFSTYVAFVPAKRIA
IVMLANGNVPIEDRVKVAYRILGSLGDGR
>AAD51060|FEATURES|ARDB_deepARG|glycopeptide|VanD|antibiotic target alteration|1
MFRIKVAVLFGGCSEEHNVSIKSAMEIAANIDTKKYQPYYIGITKSGVWKMCEKPCLEWE
QYAGDPVVFSPDRSTHGLLIQKDTGYEIQPVDVGLPMIHGKFGEDGSIQGLLELSGIPYV
GCDIQSSVTCMDKALAYTVVKNAGIAVPGFRILQEGDRLETEDFVYPVFVKPARSGSSFG
VNKVCKAEELQAAIEDARKYDSKILIEEAVTGSEVGCAILGNGNDLMAGEVDQIELRHGF
FKIHQEAQPEKGSENAVIRVPAALPDEVIERIQKTAMKIYRILGCRGLARIDLFLREDGC
IVLNEVNTMPGFTSYSRYPRMMTAAGFTLTEILDRLIELSLRR
>Q3S4T8|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQGLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0A8I6R5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLDYYYALILGIIEGLTEFLPVSSTGHMILGAEILGLNIDDFWRSFFIIIQLGSILAVI
FIFKEKLTQKLDIWLKLAVGFLPAGGIGFIAYKFLKEIFNGYTVATMLIIGGIIFIIIEL
KHRKKDYTIHSLDEVSYKQAFLIGLTQALAIIPGTSRSGASIIGGLLLGLDRKVASEFSF
LLAIPTMIIATAYSIYKEPQVLSNMNNFIPLAIGFITAFVVAFVVIKIFLKLISKINFIP
FGIYRIILGFVFLYLFMSGALDISRTGV
>N9EAI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLLKGFFSGDAEARHFAFSVLIAFFPAVVIGIFAVDFIKSVLFSPLVVAVAL
IIGGLIIFWVESIKFEHKTTEATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQDNMLNIAVGFVAAFIAALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFIFL
>R9MI27|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDVLKVFILGLVEGITEWLPVSSTGHLILVGDLLKPGLSDAFMEMFNVVIQLGAIMAVV
VLYFHKLNPFSPTKTNKQKMLTWQMWIKVVIASVPAALIGIPFNDILDKIFYKPLPVAIM
LIVYGVLFIIIETRNQGKKPSVRRISDLTVGMLVWIGVFQMLALIPGTSRSGATIVGALM
IGISREVAAEFTFFLAIPAMFGASLLKLLKFGFKFTGQELGLLLFGCLVSFVVSVFAIKF
LMSYIKKHDFKVFGYYRIILGGLIVLITLIQMVFV
>A0A0U5IAE3|FEATURES|UNIPROT_deepARG|aminoglycoside|neo|antibiotic inactivation|1
MEAPNPFTDGLPLPLPWAWQEALADARIERQSIGVSRAYVARVQRPGQPDAFVKSEVIDA
FSELGDEIARLRWLQEQGQPAPTVIATAEEAGRRWLLMSALPGRDLASSPELAPQQLVEL
LADALRGLHALPVAACPFDQRLASRLQAAQARVEASLVDAHDFDDERLGQSPQQVFAELC
STRPDHEDLVVCHGDACLPNLMVAEGCFSGFIDCGRLGVADRYQDLALAARSLVHNFGDT
RWVAPLFQRYGAVADERRLAFYRLLDEFF
>A0A086GHY7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSIAEFPVSDAKAGPYGIAAGPDGALWFTLVHAGRIGRLTPDGETTSYALESASGGPSVI
TAGPDGALWFTEFRGHRIGRITTAGEVTSFPLPTPGAGPFGIAVGPDDALWFTEAGADRI
GRITTEGEVDEFPLPLSGAFPSAITAGPDGRLWFTMNQANAIGAISLDGEVTVHPLPTPG
AGPVGITAGGDGAMWFVEIGAGQIGRITPDGKIEEFPLPDRESRPHAIVADADIDGGCWF
TEWGANRVGRITRAARHHETHEQREPHEPHEQREVDEKREPYEIHEHDLPTPSSEPHGIA
LGPDGSMWTALETGSVARIRTAEEADSD
>S0ACD6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB21|antibiotic efflux|1
MAALLQLSGIRRSYQSGDQTVDVLKGVSLSIDAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLDGDALARLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAVALLQRLGLSERVSYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILKQLCEQGHTVIIVTHDPVVARQAERIIEIRDGEIIADSRPAQQGNPNAKPLEL
AAPAPSWQQMAGRFREALVMAWRAMAANKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPTFRQSLKYDDLDALREQPYISALSPTIASSMRLRL
GNVDVAANVTGVSEQFFRVYGMTFTQGAGIDPFQVQSQAQTVVIDANTQRRLFPHQKNVV
GEVMLVGNMPATVVGVAKEKQSMFGSSKTLNVWVPYSTMANRLMGNAYFDSITVRIRDDY
NSQEAEQQLTRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLLVQL
VLPGWQINFPPAALLSAFLCSTGIGVVFGYLPARSAARLNPIDALARE
>A0A064BQM8|FEATURES|UNIPROT_deepARG|aminoglycoside|DF40_017605|antibiotic inactivation|1
MEAPDPFTDGMPLPWAWRETLADARIERQSIGVSRADVARVHRPGQADAFLKSEVIDAFS
ELGDEIARLRWLQAQGQPAPTVIATAEEAGRRWLLMSALPGRDLASSPELPPQRLVELLA
DALRGLHAIPVAACPFDQRLASRLQAAQARVEAGLVDADDFDDERLGQSAQQVFAELRAT
RPNHEDLVVSHGDACLPNLLAAEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VAPLFRRYGVVPDERRLAFYRLLDEFF
>R7GDX6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILSAFLNMLKAILYGIVEGITEWLPISSTGHMILLDEWLNVEALYGKSFWDLFLVVIQL
GAIIAVVICFFSKLWPFSKTKTQEEKKDTWKLWLNVLIACVPAAIIGLLFDDWLNEHFYN
FTTVAIMLIAYGILFIVIEIFNKKREFKISDCKQITWKVALIIGIVQLLALIPGTSRSGI
TILGAMLIGLNRETSAEFSFFLSIPVMFGASLLKIVKYFIDGNAISGSQLAFLGIGSIVA
FLVSIVVIKFLLKYIKGHDFKVFGFYRIVLGIILIVYMIASM
>ZP_03730065|FEATURES|ARDB_deepARG|tetracycline|tet40|antibiotic efflux|1
MFSKNSKAYSVYLLFRFVYSLAASMATVLSIVYHLEVVQLDAFQLVLVGTVLETSCFLFE
IPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFATVLLAQVVWGCGDTFITGALEAW
IASEEEDKPMDKVFLRGIQMGQIGGVLGVVLGTLLGNINLQMPIILGGSLCLLLGLVLVR
IMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLST
AHFLDDTVIPVIGPLNSVTWFGVISLIGNGLGILASQLLIARMEKKGTVSRTSVVMSTSA
GYILCLVLFAVGRSFWFMLLMFLLAGLMRTIKEPVLAAWMNDHVEEKMRATVFSTSGQLD
SFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD
>V9GAG7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFITSIILGIVEGLTEFIPVSSTGHMILTAKVLGYEDQSPIMKTFEIVIQLGAILAIAI
VYWNRILTLLGWSRSEPLSREPARRRLNLLHVFLGIAPALIVAFFARDFIKGLFNAHTVL
YALVAGGIFMIFAEWYNKHKVKVTSHDLDDLTYRQALLIGVYQIISVLWPGFSRSGSTIS
GGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYRNFTSDTIGVFLAGFIVSFVVAYF
VVLAFMKLIQKIRLTHFAIYRFVLAAIFWLFIMH
>A0A0V8HK57|FEATURES|UNIPROT_deepARG|chloramphenicol|AS034_02425|antibiotic inactivation|1
MTFNRIDQENWQRKEYFEYYLQQQTTFSMTNNISITRLLENLKEKKYKLYPGFIYMVTRV
VNEHREFRTGFNEEGELGYWPEICPAYTIFDGRSHTFSCIWTPVTDDFATFHAHYLKDVE
IYNGTGRLFPKKPMPVNHIPISMVPWSSFTAFNLNIGTGRDYLLPIITAGKYSYADGEVL
LPVSMQIHHAVCDGYHAGVFMNELQDLADNSGDWL
>A0A0R2GYB6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIELLKSFIIGIVEGITEFLPISSTGHIIIADSLMGIPGGAVWTKAFTHMYEYVIQLGAI
MAVLQLYFNKLNPFAPSKTQVEKNQTWRLWSKVIVGVLPSAIIGLALNDYMGDNVWVVAT
MLILYGFLFIIIENYLSDKQPWLTDLNAMSYKMALFIGFFQVLAIIPGTSRSGATILGAL
LLGASRFVATEFSFFMSIPMMFGIAILKLGSYFLKGGSFTMIQSGVLFVGFMVSWVVAYI
AIKFLLDYVKKNDFKAFGYYRIAVGILVIALILVGVIKA
>ZP_04433866|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MYFAFISERNGDMLFANLWKAIILGIIEGITEWLPISSTGHLILVDEFIKLDLSKDFMEM
FNVVIQLGAIMAVVILYFHKLNPFSPKKNGEEKKDTWILWSKVLVACLPAAVIGLKFDDY
LDAHFYNFLTVSIMLIVYGIAFIIIEKRNKNVAPKCTNLKDFTYKAALIVGAFQVLALIP
GTSRSGATILGAILIGASRFVATEFSFFLGIPVMFGASFLKIFKFLAKGNTFGSEEIIIL
LTGSIVAFVVSIIAIKFLLNYLKKNDFTVFGWYRVILGAILIGYWLFS
>Q8RL91|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>C3XCX5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIELRNINKIYGSGNNQVHVLKDINLDIESGDFVAIIGQSGSGKSTLMNILGCLDTAS
SGDYKIAGEDLAGMSPDDLATLRSKYLGFIFQRYNLLATLNAEENVELPAIYSGLKSQER
KERADQILSNLELGNRIDHFPSELSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGL
NVMAILQQLNDQGHTIILVTHDQNIANYANRIIEIKDGAIISDIRKAPNKNKKEEFPPKD
NSRNTFAYLKDQFFEAFRMSIQAIKTHKLRSGLTMLGIIIGIASVVSVVALGKGSQEKIL
EDINSLGTNTIVVMPGKGFGDRNSSKYKTLTVNDAELLARQSYVDSTTPAVRTSGTLTRE
NISVTGQLNGVGDQYFDVTGLKPEAGRFFNKEDVKSGSAVVVIDQNTKEKLFPNTTDILG
KTIIFNRQPLKIIGISQKQNASFGTTDTLTMWSPYTAVMNRITGDRNISSITVKVKDNVS
MTAAEKNVIRFLTAKHGKEDFFTVNTDSIRQTIESTTNTMRLLISCIALISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARRNSVLQQFLIEAVLICLIGGFIGVLFVFGIGFLFSMF
VQAFTMSYSATSVILAISCSTLIGVIFGYIPARNASLLNPVDALCD
>N9LNV3|FEATURES|UNIPROT_deepARG|beta_lactam|F903_00442|antibiotic inactivation|1
MMKSNPLAMPSKKLLLIAGLLSCNSMLWAQQLTEQQVKQVLDQQFKPLLEQYKIPGMAVA
VTLNGQHYFINYGLASKQSKQAVSSDTLFELGSVSKTFNATLAGYAQAQGRLSFSDHPAK
YFPELKNTAVNRATILNLGTYSAGDFPLQFPDSVVKQQDMLKYYQTWQPKSQVGTTRQYS
NPSIGLMGYVTALAMKKPYPELVEKTLFPQLGMTQSFINVPEQHMSKYAWGYKADQAMRV
SAGMLDAEAYGVKSSSSDMLKFLDTQINVQQLQQPIRKAIENTHVGYFKVGSMTQGLGWE
QYQYPVKLETLLDGNSSKMALESHAVTPIKQPKIASPATFFNKTGATNGFGAYAAFIPQQ
KIGIVMLANTNFPNAERIKASYRSIEQLIQLQQVR
>A0A0Q8RV85|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDAARWAIFNIAIQPGAILAIVVL
YRKLFWEMFTGFFRRDPVAIAFVRNLLLAFFPAVILGLAFGDYIELLLENAVVVAWALII
GGFAILLVERFAKTKDVGGVANVSARQSMLVGLVQCIAMIPGVSRSGATILGAMSFGVDR
KTAAEFSFFLALPTLTGATVLQLFKHRDAITTNDLSLIAVGSLVSFVVAWAVIKAFLAVV
TRYGFAPFAWYRIIAGVAALIWLGMR
>N4NWI9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWGRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0K1HH95|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTIFDTIILGIVEGLTEFLPVSSTGHLILTSHLLNLEQTDTLKCFEVVIQLGSILAVVFM
FFKRLKQDISLWIKLIIGFIPTALIGFLLYSSIKGLFSPKITAYMLIIWGIIFIIVELFR
KKNPPKNETQKLEDITYKQAFIIGLSQCFAMIPGTSRSGATIIIGLLSGLSRKTAASFSF
LLAIPTMFAATFYDTYKNLNIFKENLSQIWLFLIGGFVAFVVALLAINLFLKFVSKFDYI
PFGVYRIIIGIVFLFFVL
>A0A0G0IU40|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILHSIILGIVEGITEFLPISSTGHLILTAKLLHLPETNFNKSFEIIIQLGAILAVLVI
YWKKLFLNKETFKKVALAFIPTAIIGLTLYKIIKSYLLGSTTVVLWSLLIGGIIIIIFEK
FYLPCTALVQGHENSETNLALEKITYKQALLIGLFQSIAIIPGVSRSAATIIGGLSLGLN
RKTIVEFSFLLAIPTMAAATGLDLIKNASSFSSSEFGILSIGFVTAFLVAILAVNWFLKF
ITKHTFITFGIYRIAIAILFFILFIK
>AAX14397|FEATURES|ARDB_deepARG|beta_lactam|mecC|antibiotic target replacement|1
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEV
EMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKED
GMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSK
KDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETES
RNYPLGKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT
IVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFE
KGIKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENG
NKKYDIDE
>ZP_03041263|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTEVIKAIILGIIEGLTEFLPVSSTGHLILAGNLLNFEGDAAITFKIVIQLGAVMAVLIL
YWKRYLEIGANLIRLDFSQSKGLNVVHMILAMLPALIIYLLFKDTIKSQLFGPTPVLIGL
VAGGLLMIIAARSRRTETADTMDGINYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFLISVPVMFGASLLDLYDSRDLLNSEDFFLMIIGFTTSFLVAMIAVATFIK
LIKRLRLEWFALYRFVLAALFYLIVIQ
>A0A0N0VK30|FEATURES|UNIPROT_deepARG|beta_lactam|PF66_02059|antibiotic inactivation|1
MEKSQIMPIRLTIRDKLLTSLLCLLSTGNSFAGQTPVDPLKAVVDAAIEPIMQEQGVPGL
AVAVLVNGQAHYFNYGVASKTDKQPVTENTLFEIGSVSKTFNATLAAYAVAQGKLSLAEN
TSHYLPELRGSAFDRISVLDLGTYTPGGLPLQFPNEADSTDKMMGYFQHWKPIYPVGERR
QYSNPSIGLFGYVAARSLGQPYDDLMERTLLPKLGLKHTYLRVPKDQMSRYAQGYTKEDK
PSRVGPGALDSEAYGIKTTASDLLHYVQVNMRPRQLDAPLQQAISLTHSGYYRFGDTTQG
LGWEFYPSPVKLDTLLEGTSYKMLEPQDITRFKTPQSPQADSWVNKTGATNGFGAYVAYL
PAKNIGIVLLANKNYPNPVRVKAAYQVLSAVQDMQ
>NP_462101|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNETSASLQLTQTLFDMSKWRGLTLQEKAAGIQDVTY
QTDQQTLILNTANAYFKVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEELRQVTGNYYPELASLNVEHFKTDKPKAVNALLKEAEN
RNLSLLQARLSQDLAREQIRQAQDGHLPTLNLTASTGISDTSYSGSKTNSTQYDDSNMGQ
NKIGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASISSI
NAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARYTYLINQLNIK
YALGTLNEQDLLALNSTLGKPIPTSPESVAPETPDQDAAADGYNAHSAAPAVQPTAARAN
SNNGNPFRH
>A0A0F4TH68|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRCVSIVIPVYNEQDSLPELLRRTEAACQQLHHDYEIVLVDDGSRDNSAQILEEA
AHRECSSVVAVILNRNYGQHAAIMAGFEQCKGDVIITLDADLQNPPEEIPRLVAQAELGY
DVVATVRNNRQDSALRRWPSKLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEILVPHAEREHGESKYSPMRLINLMFDLITCMTTTPLRLLSIVGF
AMAALGVLFAITLIVLRLAFGAHWAGDGTFVLFAVLFIFTGGQFIGMGLLGEYLGRMYGD
VRARPRFFIEKVLRNQPAAPAPVVTVDGLTSISSDQVHS
>G8EXA2|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
KCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVKENSMVYFGAKGVTVVGA
TWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTRDLMKS
DWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDE
QVLYGNCILKEKLGNLSFANVKEYPQTIERLKAMKLPIKTVIGGHDSPLHGPELIDHYEA
>I3XZR7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIFQSIIMGVVEGFTEFLPISSTGHMIIVGDWLGLEQNHFVKAYEIIIQFAAILAVVLN
YKEKFSPKKINLWMKLAVAFVPLGAVGFLFAKQIKALFSVEIVALMFIIGGIVFLAVEKF
YKPKEHFVDDVEKVSYKQALWIGIAQIFALIPGTSRAGASIIGAMLVGLTRKASAEFSFL
LAFPVMCATTGYDLLKHKSELFSDANFSVLAVGFVVSFVIAYATIKLFLKFLEKFTFVAF
GIYRILFGIALLLYA
>ZP_02643483|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGIDFLFILKALIIAIVEGLTEFVPVSSTGHMILVGDLIHFNTQSGGFPEMYEVVIQLGA
ILAVVVLYWRKISSSVVEFLSYIFSFIGLKTSGDKRKYEKRLAESKTGFRFGINVIIGTI
PAAILGLLFHDEIKEYLFSTKTVAIGFIVGGILLIVIENNFRKRAKRSKIVKDIDKMTYG
QSLLVGCFQCLSLWPGMSRSASTIMGGWISGLSTTVATEFTFFLAIPAMVGASGLDLFKF
DYSQMNATNWISLILGFIVAFIVSLVVIDKFINYLKKKPMRIFAIYRVFAGIVLAILIFT
KVIS
>A0A101VJV4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNETLTAILLGIVEGLTEFIPVSSTGHLILAAELFGYDAAEWAMFNVVIQLGAILAVVYQ
YWGTFWNAAMSALRLEGEGLRFIRNLLLAFLPSAVLGLALKDQIDIMLGSPMIVAWALIV
GGIAIIGIEKIADPRGDAGVADLPLKQVIGVGLAQCLSMIPGVSRSGATIMGALAMGVNR
KTAAEFSFFLAVPTMLGATTLELATRREELSAVGGAAGWEEIAIGFAVSFVVALVVIRAF
VAYVSRRGFAPFAWYRIVLGAAALAWLSAR
>A0A118DUE5|FEATURES|UNIPROT_deepARG|aminoglycoside|WS68_05870|antibiotic inactivation|1
MQPDVAFAVRIASAADAPAWRRLRHALWPHASNAEHARDIAAQLDAPHRYACFVAVAPAE
QPLGFAEIAVRNDAVNGCHTSPVLFLEGVYVDPSLRRRGIARSLIAAAAAWGATRGCSEF
ASDAPIDNAASYALHRALGFDETERVVFFRRTLPR
>A0A0D0SLQ9|FEATURES|UNIPROT_deepARG|beta_lactam|SH09_09290|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>AAN28000|FEATURES|ARDB_deepARG|trimethoprim|dfrA1|antibiotic target replacement|1
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSDNENVLIFPSIKDALTNLKKITDHVIVSGGGEVYKSLIDQVDTLHISTIDI
EPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>A0A0K6LX21|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MKNKAGIQVGLCIGLLCLSFTGFNPLFGSAYAEAKSIENTKMTSCITNQKFVQLEKKFDA
RLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLVTY
SPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKADRF
ETDLNSAIPGDRRDTSTAKALATDLKAFTLGNTLTTDKRTILTDWMRGNATGDELIRAGA
PAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDADYHNALIAEAAKVAL
HDLK
>L1M3L1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFPTLLLLCTCPLLAVADPAFDSQVRSAAERVMRDNGVAGLAIAISDHGKQYFYEFGVA
DKATGQAVSRDTLFELGSISKTFTDTLAARAQIDKRLSLHANAAEYLPELAGTAFGRLSL
INLATHSNGGMPLQLPDGISNQAQLFDWLRHWQPEHAADGWRAYANPGIGMLGVITARQL
GTSFVSAMQEQLLPELGLEHTYLQVPASQQALYARGYDKNDAPVRVNPGVLADEAYGVKS
SSRDMLRYVEAHLGRVQLAAPLKQALDDTRRGYYKRGAMTQDLIWEHYDYPLALQTLLDG
NDNRYALAGSPVNAINPPLAPQSKAWVNKTGATNGFGAYVAFVPEQQRAVVLLANRNYPN
GERVKLAWRLFELLDEQR
>A0A0B5NJK6|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMR
CYASVHGLFTKENIPPNIFPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEENKIM
LPVSLQVHHSICDGYHASRFIGDLQELSNSCNEWLK
>A0A073CY25|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLILKAIIIGIVEGITEFLPVSSTGHMIIAGSLIGFDGTVYRKAYTDMFSVVIQLGAIL
AVVVLYWDKIMSTLKNFFPSDRVPVKKCGLKFWINIVIASIPAAIIGIPFNDKIEEKLFY
PLPVTIALIVGAIWMIYAENRYRNNSKVISIDDVNAKQAIIIGVFQCLALWPGMSRSAST
IIGAWIVGLSTVAAAEFSFFLAIPAMIGASGMSLIKHNVFSTCSSIELIALAAGFIVSFV
VALVVIDKFIAFLKKKPMKVFAIYRIVLGIVLIILIYTNIITWH
>A0A073CWV7|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKQTKTKYGKMKQIVSNLKLPDYRYEQLTKAIFHQRIDNFDDMHILPKALRMSLVNEFGK
NVSSVIPVFSQDSKQVQKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCGFGCRFCAT
GSAGFKRNLTADEITDQLLYFYFNAHKLNSISFMGMGEAFANPELFDAVKILTDQNLFGL
SQRRITISTIGIIPEIRRLTKEFPQVNLAFSLHSPFESQRSDLMPINKRFPLNDVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHAEAVIDLLKNRGSWEHLYHIDLIPYNSTDKTTFK
FQSSSAIKQFCSTLKKAGISATVRTQFGSEISAACGQLCYENEL
>C3KAD3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACKQLAYEYEIILVDDGSRDNSAQLLEDA
AAEDGSNVVAVILNRNYGQHAAIMAGFEQCRGDVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGMLFAFALIVMRLAFGADWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGLVSSHTSTSADQV
>CAA36304|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MsrA|antibiotic target protection|1
MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESG
TVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNY
SPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRV
FKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIA
PDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPII
AQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMA
YYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSL
AVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELT
GQSIHDIT
>A0A0Q4R368|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVDLLNAILMGIVEGLTEFLPVSSTGHLILLADLLNFTGDRAKTFEVVIQFGAVLAVLVL
YRKRFLKLLNFNFSKSSGMNALHIALAMLPAGLIGVVFHGFIKEYLFSTTTVLIGLVAGG
ILMIFADRIKRKVTAEELDDLSYKQALAIGCFQVLALWPGFSRSGSTISGGMFFGASQKA
AAEFTFIVSVPMMAGASGIDLIKSREFLTMADMPLFLIGFITAFIVALIAVVTFINLIKK
LRLSWFAYYRFALAIVFAFIIL
>A0A0A3IX24|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELFDLIKAVILGFVEGMTEFAPVSSTGHLIIVDDMWLKTMEFLGSGSANTFKIVIQLGS
ILAVVVVMWKRMLSLVGLYKIPGQTSSRKFNLGHVLIGIIPAGIFGVLFEDFIDENLFTT
ETVIIGLIIGAFWMIVADKFGPRRPKIKSLDDLSYGTAFKVGIIQCLSLWPGFSRSGATI
SGGVMLGLDHRTASDFTFIMAVPIMAGASGLSLFKNWDQINVEHFWFYVVGFVSAFIFAL
VAIKFFLKLISKVKLVPFAIYRLVLAAVLIVVLYL
>R5T181|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWIKTIIYGIVEGITEWLPISSTGHMILLEKIMPMKVSSDFWEMYLVVIQLGAILAVVL
MFWNQLWPFCSKEKGYIKKDTFSMWFKIIVACVPAAVVELVWGDQLEAAFYHYQVVALML
ILVGIVFLIVERWNKGRDAKVTTIAQITYRAAFMIGMFQLIAALFPGTSRSGATIIGGLV
IGLSRTVAAEFTFFLAIPVMFGASLMKVMHFGLHFSGYELGMLLLGMFTAFLVSVLVIRF
LMDYIRKHDFKPFGWYRIVLGILVLVYFGIGA
>B5Y9K7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFYLSLLKAAALGVVEGVTEFLPVSSTGHLIIVNQWIRFPEPFNASFDVIVQMGAILAVV
MLFWNEYNVFNSKEKQHVLINYRNIIVAIIPAIIVGATFGDVIQTYLFSVLTVSIALILG
ALFLWYAERNSSGTVHKVGSINALTALKIGLFQLLSYFPGFSRSAASIGGGMLSGLTRET
AAQFSFLLGAPTLLAAGGYELLKSGFSFTMQEWAVLLVGCLFSFLSAYLVVKPFLQFVSK
RSYKPFIIYRVVLGALLLVMYFL
>I0QNP0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVTEGHQLLIALILGIVEGLTEFLPVSSTGHLIIAGNLMGYTDDKSKVFEVIIQLGSILA
VVVMFWRRLFGLIGIHFGKKVEHEGIGKGHLTLLHIILGMLPAVVIGLLFSHDIKGLFEP
KYVMYALVIGGIYILIAEWIKPKFPKAVGVDDITYLQAFLIGCLQCLALWPGFSRSGATI
GGGLLVGVSRYAASEYSFLLAVPMMLGASALDLYKNHSILSWSDLPMFAVGFITAFIVAL
IAIKTFLAVIKRISFVPFAIYRFVVAGLVYWVFMT
>A0A147GD00|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFTGERAMAFNIIIQLAAILAVM
WEFRGKIFDVLRGLPNQPRAQRFTGNLLLAFLPALVLGVLFADLIHEYLFNAVTVAAALV
LGGVIMLWAERRQHRVQVTHVDEMHWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RTAATEFSFFLAMPTMVGAAVYSGYKYRHLFRPDDLPVFALGFVTSFIFAMIAVRGLLKF
IANHSYAAFAWYRIVFGMLILASWLFGWVDWTVAHG
>A0A140RDI1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQGLLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAETEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVIERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNASRLDPVDALARE
>C8CE55|FEATURES|UNIPROT_deepARG|beta_lactam|BL2b_tem1|antibiotic inactivation|1
ESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGM
TVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDE
RDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEVDKVAGPLLRSALPAGWFIADKSGA
GERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNR
>A0A0P7JEQ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLLKALILGIIEGLTEFLPISSTGHLIVVGDLINFHSNGKVFEIAIQLGAVLAVIF
EYRQRFSHVITHVGRDKTVNRFVINLGIAFIPAAVVGLIFSKHIKTFLFNPITVATALVV
GGFIILWIERRQTTVKPKVNNVDEMRIRDALVVGLAQICALVPGTSRSGSTIMGGMLWGL
ERKVATEFSFFLAVPVMIAATTYDVLKHYKLFSAQDIGLIAIGFISAFAAGLLAVKALLK
FVATKNYVPFAYYRIIFGGLILLTWKMGWVSWTEM
>A0A077L029|FEATURES|UNIPROT_deepARG|aminoglycoside|AS4_23160|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTATTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEVLNLLNSIA
IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDFDAELWGDHKTYLSLWNELNETRVEER
LVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLKH
LKNDRPDKRNYFLKLDELN
>A0A086PA23|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASVWAMFNVVIQLGAILAVVV
LYWRTFWAVGMGLLRRDATSWRFLRNLVIAFIPSAIIGLALHDYIEILLGAPHVVAWALI
AGGVAILLIERTIKAGRFHGIADIPMVRVVGIGLIQCISMIPGVSRSGATIMGALALGVE
RRTAAEFSFFLAIPTMLGATTLELLKKGDQITSSAVGWDSIFLGFAVSFVVAVLVIRWFV
GLVSRHGFAPFAWYRILAGVGALAWLWAR
>G2S781|FEATURES|UNIPROT_deepARG|chloramphenicol|Entas_2396|antibiotic inactivation|1
MKKIIPEYTPVDLSRWARKEHFEVFQGFAQSTINQTVLIDITSLLKNIKVAGWKFYPTMI
FLLSKIVNRHAEFRMAMKNNELVIWNEVHPNYTIFHNETETFSSLWSHYDGNIHHFQNAY
SEDMARYGDNLAYWPKEESRENIFFVSAIPWVTFTSFNITVADMKNFFAPMFTLGKYYEQ
NGKVLLPVALQIHHSVCDGFHMARLFNELQAMCDDLPGQLVGLDG
>I3WA59|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVRK
>A0A068DCZ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFNSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
IGGVVLLAVDRMNLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLTSADLPIIAIGFVAAFVAALVVVRYLLDY
VSRNGYSLFGWWRLVVGIVGLVALMIWG
>AAB00446|FEATURES|ARDB_deepARG|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MERWRLLRDGELLTTHSSWILPVRQGDMPAMLKVARIPDEEAGYRLLTWWDGQGAARVFA
SAAGALLMERASGAGDLAQIAWSGQDDEACRILCDTAARLHAPRSGPPPDLHPLQEWFQP
LFRLAAEHAALAPAASVARQLLAAPREVCPLHGDLHHENVLDFGDRGWLASDPHGLLGER
TFDYANIFTNPDLSDPGRPLAILPGRLEARLSIVVATTGFEPERLLRWIIAWTGLSAAWF
IGDGDGEGAAIDLAVNAMARRLLD
>A0A060KZZ1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRPFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0U0C113|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MKNKAGIQVGICIGLLCLSFTGFSPLFGSTHAEAKSIENTKMSSCITNQKFVQLEKKFDA
RLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLVTY
SPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKADRF
ETDLNSAIPGDRRDTSTAKALATDLKAFTLGNTLTTDKRTILTDWMRGNATGDELIRAGA
PAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDADYHNALIAEAAKVAL
HDLK
>A0A0N7AKM4|FEATURES|UNIPROT_deepARG|beta_lactam|blaCphA|antibiotic inactivation|1
SLTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLE
VINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLP
NVVHDGDFTLQGGKVRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAY
PQTLERLKAMKLPIKTVIGGHDSPLHGPEL
>A0A0W0TL65|FEATURES|UNIPROT_deepARG|aminoglycoside|ant1|antibiotic inactivation|1
MTPMYSPDMQQQLKDSLELLKMILGSDLLGVYLYGSSLVGGLQKYSDIDLFVVTRRATTS
EEKARLIADLLQISGIYMKSSKLPIEMTLVEKAAINPWRYPPHFDFQYGDWLRQSFEKGI
IEPWVTHEMPDLALIVTQVLLKSQTLSGLEPERLLAPVPYHDFIKAMLHDLNRLAMDLEH
DTRNVLLTYARIWSTLETNAIRSKPAAADWVMNHLPKGYQPVMQRAKSICIGVENEYWDD
VKVLIKSCADFMANKINERASLINFEDPKLIKLHEEPLPGDSSFCSR
>YP_001579800|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVIALFIMLGGAFAIRALPVAQYPDIAPPVVSIYATYPGASAQVVEES
VTALIEREMNGAPGLLYTSATSSAGMASLYLTFRQGVNADLAAVEVQNRLKTVEARLPEP
VRRDGIQVEKAADNIQLVVSLTSDDGRMTGVQLGEYASANVVQALRRVDGVGRVQFWGAE
YAMRIWPDPVKLAGHGLTASDIAAAVRAHNARVTVGDIGRSAVPDSAPIAATVFADAPLK
TPADFGAIALRSQADGAALYLRDVARIEFGGSDYNYPSYVNGKVAVGMGIKLAPGSNAVA
TEKRVRAAMDELSAYFPPGVKYQIPYETSSFVRMSMNKVVTTLIEAAVLVFLVMFLFMQN
LRATLIPTLVVPVALAGTFGVMYAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EERLAPYDATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFALSLAVSIAFS
AFLALSLTPALCATLLKPVDDGHHDKRGFFGWFNRFVARSTQRYATRVGAMLNKPLRWLV
VYGALTAVAALMLTRLPSAFLPDEDQGNFMVMVIRPQGTPLAETMQSVREVESYLRREEP
AAYTFALGGFNLYGEGPNGGMIFVTLKNWNARQAARDHVQAIVARVNERFAGTPNTTVFA
MNSPALPDLGSTGGFDFRMQNRGGLDYAAFSAAREQLLAAGAKDAALTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMDEINTTLAVMFGSDYIGDFMHGTQVRRVIVQADGQHRLDPDDV
KKLRVRNARGEMVPLAAFATLHWTLGPPQLTRYNGYPSFTINGSAAPGHSSGEAMAAMER
IAATLPAGIGHAWSGQSFEERLSGAQAPLLFALSVLVVFLALAALYESWSIPLAVMLVVP
LGVIGAVLGVTLRAMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLLAQRMSLAQAALEA
ARLRLRPIVMTSLAFGVGVLPLAFASGAASGAQTAIGTGVLGGVIAATVLAVFLVPLFFV
VVGRLFGFGTRRRGNAPAVNVEGSR
>G7Q5X4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTETLAATVLGLVEGVTEFLPVSSTGHLILAGHLIGFTGDKADSFEVIIQLGAILAVVVL
YWKRFWWLLSPKPLHAFSGLRGIWLLFLTSLPAGLVGLVARKTIKAYLFGPITVALALAV
GALMIFWVERRRMRDRYYTLDEITPALAFGIGCFQCLSLWPGFSRSAATIMGGMLLGAKR
SLAAEYSFIAAVPIMFAATAYDFYKSAPLYSADDLGILAIGFVVSFLAALAAVKGFIVLV
KQVSLRPFAWYRLALAAAVFFFWPK
>CAG30572|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDRVQSLDPNFIREMQEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LFPLISMDYFNGTPVHISITEISFASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSALFADRIGVNHWFLLSGILIICIAIVFPMINEIRKLDLK
>A0A0A2UNC1|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNLQGINHITFSVSNLETSIEFYEQVFGATLLVEGEKTAYFDLNGLWIALNKEENIPRFE
IEESYTHIAFSVTEEDFNEVVSHLKSLEVRILDGRQRGELDKNSVYFTDPDGHKFEFHTG
TLEDRLSYYRQEKENMRFYI
>I3CYN0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLLALKALIMGIVEGLTEFLPISSTGHLILTNSLLQFTGPEFSKDKADVFEIVIQAGA
ILAVCWEYRARIAAVLTGLFTDRKAQRLVINLIIAFLPAAILGLLFSRRIKEMLFNPVSV
AIAFIVGGLIILWVERRNKDRMSMASARVETVDDMTALDALKVGIAQAFALIPGTSRSGA
TIIGGMMFGLSRKAATEFSFFLAIPTLFAATLYSLYKERALLSAADVPLFTVGTVAAFVS
AFLCVRWLLRYISSHDFTIFAWYRIVFGIIVLVTAYTGVVAWVE
>F8UU02|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MEKYFMMKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYH
GKPYYFTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQ
LTGQQWQGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASI
GLFGALAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQ
LDAEAYGVKSSIEDMAHWVLANMNSEAVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLN
WPVPAEVVINGSDNKGALAATPVTAVNPPAPSVKASWVHKTGSTGGFGSYVAFIPQQDLG
IVMLANKSYPNPERVKAAYHILEALQ
>A0A090Y3M9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSFIVAIVLAIVEGLTEFIPVSSTGHMILTAKLFGYDDQSPEMKTFEIVIQLGAILAMAW
VYRERILDLLGLSQKVKTVDPDAPSRRLNLLHVFLGILPALLVGYVFRDFIKSLFSSSTV
LWALVAGGVFMLFAEWFSKRKAKITAPDIDRLTYKQALLIGVYQCISVLWPGFSRSGSTI
AGGMLSGLSYRAASDFSFLIAIPIMCAVSGYEMLDSYRYLTSDTLGYFLVGFIVAFIVAY
VVIVAFFKLIQKIRLRHFAYYRFILAALFWIFIMR
>B4W7R2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDWLAAIILGLVEGLTEFIPVSSTGHMLLLGHFMGFQSSGKTFEIVIQLGALLAIVSVY
FRRLWALATRWPFDPEARRFLIGLLVAFAPAVVIGFLAYGFIKDVLFETPQVICVALIVG
GVILLLLDRMDKRPQWLDANQYPMRIYFLIGLFQCLAMIPGVSRSGATIAGGLLLKTDKR
SAAEFSFFLALPTMGAAVAYDLLKNHKTLDFSDVGLIVVGFVTAFLTALVVVRFLLDFVS
KHGFGPFAWWRIVVGVVGLALLQAGF
>A0A0J9FPB8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTFETIIIAIVEGLTEFLPVSSTGHMIITQNILGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNHTPAPAGASALKCFLHKFDFYWKLLVAFIPAAILGFLFSDKIDEMLES
VAIVAVMLVIGGIFMLFCDKIFSKGSEDTVLTEKKAFNIGLFQCIAMIPGVSRSMATIVG
GMAQKLTRKDAAEFSFFLAVPTMFAATGYKVLKLFLDGGTEILVNNMPALIIGNVVAFVV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGTILVMLLLGYNLEIG
>A0A0M2YG80|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGTGTGRLTLIHILLGMIPAVVIGLVLHDQIKTLFNPIN
VMYALVVGGLLLLAAEFLKPKQPKSVGVDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATGLDLYKSLGFLSMADFPMFAVGFITAFVVAMIA
IKVFLELIKRISFVSFAVYRFIVAAAVYMLFT
>AAM77080|FEATURES|ARDB_deepARG|trimethoprim|dfrA1|antibiotic target replacement|1
MVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
SFTSDNENVVIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGD
VYFPEIPSNFRPVFTQDFASNLNYSYQIWQKG
>A0A127SC97|FEATURES|UNIPROT_deepARG|beta_lactam|OCH-8|antibiotic inactivation|1
MRKTTVSALSITAVASLLTSVSVQAANAPSEKEIRHLVDETIKPVMAEHKIPGMAVAVTA
GGKTYFFGYGVASKESGQKVTEDTIFEIGSVSKTFTATLGGLGLAEGAFKPGDTATKYAP
KLAGSSFDNVSMLDLGTYTAGGLPLQFPDSVTDHKTMIDYFKNWKPDYPAGTQRRYSNPS
IGLFGYLAAQSMGEPFDKVMETRLIPAFGLKHTFIQVPESQMKNYAYGYSKANKPIRVSP
GAFDAQAYGIKTTAPDLIRFVQLNMDSTSLGQPMQKAVAATHTGYYKVGDMTQSLGWERY
AYPLSLKTLLGGNTSDMAMKSHKIEKLAPPLQPSDDMLLNKTGSTGGFGAYVAFVPGKKI
GIVMLANR
>YP_001346278|FEATURES|ARDB_deepARG|multidrug|mexH|antibiotic efflux|1
MQKPVLIASAALLCAAVVGIAVYATGSAKKDTGGFAGYPPVKVALATVERRVVPRLFDGV
GELEAGRQVQVAAEAAGRITRIAFESGQQVERGQLLVQLNDAVEQADLIRLKAQLRNAEI
LHARARKLVERNVASQEQLDNAVAARDMALGAVRQTQALIEQKAIRAPFSGRLGIRRVHL
GQYLGIAEPVASLVDARTLKSNFSLDESTSPELKVGQTLEVLVDAYPGRSFPARISAIDP
LIGKSRTVQVQAVLENPEGLLAAGMFASVRVSRKADAPSLSVPETAVTYTAYGDTVFVAR
QEGDQPLSARRVSVRVGERWDGRVEILQGLAEGDRVVTSGQINLSDGMAVEPVKEDTLSS
AVPPVPVAGR
>A0A0N0K2G9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDWLAAIILGIVEGLTEFIPVSSTGHLLLLGHFMGFESEGKTFEIVIQLGAILAIVSVY
FRRLWALATRWPHDARARHFIIGVLIAFLPAAVAGVALYPLIKEVLFETPLIICIALIVG
GVLLLLLDRMKRAPKYLDVSTYPFRVYALIGLFQCLALVPGVSRSGATVAGGLLLGTDKR
SAAEFTFFLALPTMGGAVAYDLFKSRNDLDFTDVGLIAVGFVTAFVTALFVVRFLLDFVS
RHGFAPFAWWRIAVGTLGLVLLWAGVGA
>A0A0A3IEW6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKIKGLNHLLFSVSDLEQSIAFYTDVFDAKLLVKGRTTAYFDLNGLWLALNEEKDIPRNE
ISESYTHIAFTIEAADFDEVYNKLEQLDVNILAGRKRDERDKKSIYFTDPDGHKFEFHTG
TLQDRLDYYNKEKTHMEFFED
>A0A0B5P923|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MSDIITAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNLKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKQEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWTYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTVFVLL
>A0A0Q4L212|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNYFQAIILAIIEGLTEFLPVSSTGHMIIGSSFMGIASDPFVKLFTVAIQLGAILSVVVL
YFKRFFKSINFYIKLVVAFIPAAIFGLLLSKKIDELLESPMAVGISLLVGGIILLFVDKW
FDKPTINEEEDINYLTALKIGFFQCIAMIPGVSRSGATIVGGMTQKLSRKVAAEFSFFLA
VPTMFAATAKKLLDFYQDGHTITQEQTNLLIIGNVVAFIVALLAIKSFIGYLNKHGFKMF
GWYRIVAGLIIIILLMTGHNLEII
>CAW29378|FEATURES|ARDB_deepARG|chloramphenicol|catB7|antibiotic inactivation|1
MGNYFESPFRGKLLSEQVSNPNIRVGRYSYYSGYYHGHSFDDCARYLMPDRDDVDKLVIG
SGAAFIMAGNQGHRAEWASTFPFHFMHEEPAFAGAVNGYQPAGDTLIGHDVWIGTEAMFM
PGVRVGHGAIIGSRALVTGDVEPYAIVGGNPARTIRKRFSDGDIQNLLEMAWWDWPLADI
EAAMPMLCTGDIPALYRHWKQRQATA
>ACB17731|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MTNLKSDTRGLHMNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTE
PLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQAAYDSA
KGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETAR
INLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQ
ELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLL
PGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWL
VTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>N8X8Z1|FEATURES|UNIPROT_deepARG|beta_lactam|F968_01046|antibiotic inactivation|1
MRFNKISCLLLSPLFIFNTSIYAENTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGIIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGIISFKDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLGLQFPDEVQTNQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFVNANLNPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKSNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKQNIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ZP_01172195|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLFHNPKYIVSTNFFLFCRFYSDGKVKKAGKGMQLINHFCFSVSNLERSISFYQEAFNAK
LLISGRTTAYFDLDGLWIALNEEKDIPRGEIKDSYTHIAFHAEEGELAGLEKRLIKAGAV
ILSGRSRHEKDGRSIYFEDPDGHKFEYHTGTLQDRLDYYRKEKPYMTFY
>A0A0R2UWF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIVEAIVLAIVEGITEFLPVSSTGHMIIASSLMGIAEDPFTKSFTIAIQLGAILSVVVL
YWKRFFKSFNFYLKLLAGFIPAMILGLLLGDVIDALLENVLVVAISLVAGGIVLLFIDKI
FGADTGDDQKEPGFRQAFIIGVFQCLALVPGVSRSAATIIGGLTQKLTRKAAAEFSFFLA
VPTMFAATIYKLYQFYDDGNSFGSAEIPPLVIGNVLAFIIAIIAMRSFVAYLTKYGFKVF
GWYRIAIGTVIIVMLALGFDLQIV
>A0A127SP43|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
EYFEHYFTNIPCTYSMTVKLDITQIKKKRMKLYPAMLYYLATVVNRHSEFRMTINQAGEL
GIYDEMIPSYTIFHEDTETFSNLWTEYVPNIEEFSRAYENDMQLYGSNHGMIGKPDVPEN
VFTVSMVPWSTFESFNLNLQKGYSYLIPIFTLGKYYEEDGKILLPLAVQVHHAVCDGFHI
CRFVNELQELING
>AAK02049.1|FEATURES|CARD_deepARG|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCIQSLIVSIVGTL
AVTLLNGDTAWPVICYATAMAVLVSLGLALLRSRDAATEKSPVV
>A0A0S6U8L4|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MRQTKTKYGKIKQIVSDLKLPDYRYEQLTKAIFHQRINNFDDMHILPKALKIALVNEFGK
NVSSVIPVFSQDTKQAQKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCGFGCRFCAT
GSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGL
SQRRITISTIGIIPGIQRLTKEFPQVNLAFSLHSPFESQRSNLMPINKRFPLNEVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHAEAVISLLKNRGSWEHLYHIDLIPYNSTDKTTLK
FESSSAIKQFCSTLKKAGISATVRTQFGSEISAACGQLCYENEL
>J2EEM5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFSALILGVVEGLTEFLPISSTGHQIVVADLLEFGGERSMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPTQPSARRFTANLLIAFLPAVVLGVLLADWIHHYLFNPITVAAALV
IGGFVMLWAEKRQHQVHAETVDQITWKDALKVGLAQCIAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRELFVPADFPVFAIGFVTAFIFAMIAVKALLRF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWTAAKP
>A0A0Q3W173|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNFNLQEINLPFSDSGPYGIAVSHDGKIWFTQHKANKISCFDQEGHIQEYTVPTPNARVM
CLTVSSKGDVWFTENGANKIGKLSTSGVFTEFPLPHPNSGPYGITEGQNGDIWFTEMNGN
RIGKLTTKGKIHEYELPNKGSYPSFITLGSDSSLWFTENQNNAIGKITESGELMEFPIPT
PASGPVGITRGNDNALWFVEIIGNKIGRITYSGEIIEYDIPTPNARPHAIAVGEEFDLWF
TEWGANKIGRLTRDQAIVEYTIKTHNAEPHGIVCDKDGVVWFALECNKIGKLTLI
>A0A127SSV8|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGAQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>YP_001570858|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCAMGAILFIVCAIF
NAWLLPAWKLSTVRTPVREGMRRVISDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
SPAAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLIMSLSMIPIGLAGNLQQL
FTLICAFYIGSVIAEPARETLSASLTDARARGSYMGFSRLGLAIGGAIGYIGGGWLFDMG
KTLAQPELPWMMLGIIGFITFLALGWQFSHKRTPRQYTGARRLI
>YP_002217746|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRQRNVNLMLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQ
LFYGPLSDRVGRRPVILVGMSIFMVATLFAMTTHSLTVLIAASAMQGMGTGVGGVMARTL
PRDLYEGTQLRHANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMA
RWMPETRPAGAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLMMWIPGWFGVMNVW
TLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQYIGSGVLAWLSAMLPQT
GQGSLGLLMTLMGLLILACWLPLASRISHQGQTV
>C5BDQ5|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSDFKTIQFVSVVIPVYNEQDSLSELLKRTIAACDSMGKQYEIVLVDDGSSDRSAEILRE
AAQRPGSRVVAVLLNRNYGQHSAIMAGFNHIKGDLVITLDADLQNPPEEIPRLVEAADQG
YDVVGTIRQDRQDSWFRRRASRLINGLIQRTTGKSMSDYGCMLRAYRSSVIKAMLHCHER
STFIPILANSFARRTIEIPVKHAEREHGESKYGLMKLINLMYDLVTCLTTTPLRALSIFG
SVVALLGFAFAVLLILMRLTLGPQWAAEGVFTLFAVLFIFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQNVVRANQPDEEQEK
>C9A5P3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFTNFIKAILFGIIEGITEWLPISSTGHLILANEFIGLNVTPEFMTMFNVVIQLGAILA
VVYLYFHKLNPFSPQKNELEKKDTWTLWFKVVVAVLPSVIIGLPLDDWLDAHFYNFFSVS
IVLIVYGIGFIVVEKRNKNKAPKCTDLNKFTYKAALIVGMFQVLALIPGTSRSGATILGA
IMIGASRYVAAEFSFFLGIPTMFGASALKIFKFLKDGNAFDFQGTVILLTGTIVSFIVSI
IAIRFLMNYIKRNDFTVFGWYRIVLGIILIGYWLIQL
>A0A0D5WQD4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLPTLAIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGQTAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPEHEGVGTGRLSLIHILLGMIPAVVLGLVLHDAIKSLFNPI
NVMYALVVGGVLLIAAECLKPKVPRAVGVDDITYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTMGDLPMFAVGFVTAFIVALI
AIKTFLQLIKRISFIPFAIYRFVVAAVVFFIFT
>A0A0D1M5R2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLTVILLGIVEGVTEFLPVSSTGHLILAGTLLGVQDKATATFDIVIQLGAILAVVVLY
WRRFWDVAVGLFARKPGAFAFVRNIVLGFLPAMVIGLVVYKAVKALLESPTVVAVALIVG
GIAILVIERLVKQARIESVEAMPWSTALGVGVVQCLAMIPGVSRSGATIMGALSMGVDRR
AAAEFSFFLAIPTMLAASAYDLLKSGATLGQGEWLSIAIGFVVSFVVAIVVIRWFVGIVS
RHGFAPFAWYRIIVGAVALVALQLR
>L1QCG1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILLLKTILLGIVEGITEWLPISSTGHLILADEFIKLNMTADFKEMFDVVIQLGAIMA
VVVLYFHKLNPFSPKKNHEEKMDTIILWTKVILAVFPAAIIGILFDDWLNDHFYNPPVVA
AMLIIYGVLFIIIENRNKRSRRRPMNDLSRLSYGMALGIGVFQILALIPGTSRSGATILG
GILLGCSRTVAAEFSFFLGIPVMFGASLLKIVKFGLAFTSTQLIVLIVGMVVSFLVSIGA
IKFLLGYIKKNDFKAFGVYRIILGLLVIVYFAFIK
>A0A0G1D4E5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTFLQAIILSIIEGFTEFLPISSTGHLILAQKYLDISTTEFSKTFDIVIQLAAILSVVWS
FRTRLTSSPKIWKQSLIAFIPTGIVGFVLYRYIRDILLESPLITAYSLLIGGLVLLVVDR
IKYFHQGQKSSLGLPTTQLLTIGFFQSISIVPGVSRSAASIIGGLVSGLSRVQAVEFSFF
LAIPTMLTASGYDLLKSGLYFTQSEYLLLLVGCLFSFASALAAVKFFLGYVKVHNFTAFA
IYRILLAVIVLLTLNS
>ZP_03043238|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MKKLLPILIGLSLYGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTY
QTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNALLKEAEK
RNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDDSN
MGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQL
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSA
RTTTSNGHNPFRN
>A0A0T9SF13|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_3|antibiotic efflux|1
MAALLELKGIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAALDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNE
RRERANMLLTRLGLGERVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERVIEIKDGRIMADSGSKITQEVVSSDAIS
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVYDDMAALKAQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSDQYFRVYGMKLEQGTAITREQVERQSQVVVIDRNTQRRLFPHIKDV
VGQVILIGNMPATVVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLIVE
MFLPNWQIAFPPVALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A0D6S8B9|FEATURES|UNIPROT_deepARG|aminoglycoside|SZ54_3010|antibiotic inactivation|1
MSGTFDVRNAGDYPDDWCLLRHRLWPDTAPEDHRAELQDVCETGAGFIVHDLDGSAIGFA
EVSLRRDYVNGCDTSPVAFLEGIYVEEAFRRQGVAALLVEQVTRWAIDQGVSELASDADI
ANLSSHRMHAALGFEETERVVYFRRSLIPKR
>A0A086YAJ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHNTIAALILGVLEGLTEFIPVSSTGHLLLAGHFLNFHSTGRSFEVVIQLGAILALLSV
YAGRLWQLFSAAPHDAGARRTILSVLVAFLPAAVIGVLAHGFIKDVLFETPMLIAIMLIL
GGFVLLWVDRMKVPVRYDDAEHLPVYTSLAIGFFQCLAMIPGVSRSGATIVGAMLLGTSK
RAAAEFSFFLSMPTMIGAVAYDLFKNRDVLDSAAWSEIAIGFVAAFVSALIVVRWLLGYV
SRRGYSLFGWWRIIVGAVALIALLIWG
>A0A091ACJ3|FEATURES|UNIPROT_deepARG|beta_lactam|JM66_05320|antibiotic inactivation|1
MKGWIKCGLAGALVLMASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKGV
TVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGARVVSTRQTR
DLMKSDWAEIVAFTRKGLPEYPDLPLVLPNEVHDGDFTLQEGKVRAFYAGPAHTPDGIFV
YFPEEQVLYGNCILKEKLGNLSFADVKAYPQTLARLKAMKLPIKIVVGGHDSPLHGPELI
DHYETLIKAAPQV
>B0RLU8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPQCTILSPPPALLSRPMSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFN
IVIQAGAILAICLALRQKLWTLATGLGERANRDYVLKIGVAFLVTAVVGLIVRKAGWQLP
ETIQPVAWALLIGGVWMLVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASA
IFLAMLLGLSKRSAAADFVFMVGIPTMFAASGYALLEMYKEGGFGSENWTDVSVAFIAAT
LTGFVVVKWLLGYIKKHRFTVFAVYRILLGAALLLWLPAA
>YP_001290033|FEATURES|ARDB_deepARG|beta_lactam|pbp1a|antibiotic target alteration|0
MRIAKLILSTLLTLCILGLVAGGMLYFYLKSELPSVETLRTVELQQPMQIYTADGKLIGE
VGEQRRIPVKLADVPQRLIDAFLATEDSRFYEHHGLDPIGIARALFVAVSNGGASQGAST
ITQQLARNFFLTPEKTIIRKAREAVLAVEIENTLNKQEILELYLNKIFLGYRSYGVAAAA
QTYFGKSLNELTLSEMAIIAGLPKAPSTMNPLYSLKRSEERRNVVLSRMLDEKYISKEEY
DAALKEPIVASYHGAKFEFRADYVTEMVRQEMVRRFGEENAYTSGYKVFTTVLSKDQDEA
QKAVRNNLIDYDMRHGYRGGAPLWQKNEAAWDNDRIVGFLRKLPDSEPFIPAAVIGITKG
GADILLASGEKMTLSTNAMRWTGRSNPVKVGEQIWIRQRANGEWQLGQIPSANSALVSLN
SDNGAIEAVVGGFSYEQSKFNRATQSLVQVGSSIKPFIYAAALEKGLTLSSVLQDSPISI
QKLGQKLWQPKNSPDRYDGPMRLRVGLGQSKNMIAIRAIQTAGIDFTAEFLQRFGFKRDQ
YFASEALALGAASFTPLEMARAYAVFDNGGFLIEPYIIEKIQDNTGKELFVANPKIACIE
CNDIPVIYGETKDKINGFANIPLGESALKPTDDSTNGEELDQQPETVPELPELQSNMTAL
KEDAIDLMAAAKNASSKIEYAPRVISGELAFLIRSALNTAIYGEQGLDWKGTSWRIAQSI
KRSDIGGKTGTTNSSKVAWYAGFGANLVTTTYVGFDDNKRVLGRREAGAKTAMPAWITYM
KTALSDKPERKLTLPPKIVEKSIDTLTGLLSPNGGRKEYFIVGTEPTRTYLSEMQERGYY
VPTELQQRLNSEGNTPTSAAQPEELF
>A0A0R5RPL8|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGLGN
AGLAGKS
>ZP_02433069|FEATURES|ARDB_deepARG|chloramphenicol|catI|antibiotic inactivation|1
MFDSLSSISFNELSRFSGAKEAKMEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTV
QLDITAFLKTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHE
QTETFSSLWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFD
LNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQG
GA
>A0A0Q8THT6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLVLLAKAALMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQKIRSTLVALPRERSAQRLVLNVLIGFLPAVVLGLLLGKAIKAHLFIPVVVASTFI
LGGFVILWAEKRPPGATRIHEVDDMGPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAMPTLIGAGVYSLYKERALLSVADIPMFAVGLVFSFFSAWLCVRWLLR
YISSHSFVPFAYYRIVFGMVVLITAWGGWVRWAE
>A0A150CSG1|FEATURES|UNIPROT_deepARG|beta_lactam|AT268_05175|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITYTKED
LVDYSPVTEKYVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILKEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAVVWPPNREPIIIVILSSKDEKEATYDNQLIAEAT
KVIVKALR
>ZP_04207693|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSTIKKVLFGPGPVVISLIAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSTADIPLFATGFITAFVVAMLAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFFIM
>AAC45552.1|FEATURES|CARD_deepARG|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIRYNISTDIIRKIVFDSIA
DEIYLIVEYGFAKRLLNTKRSLALLLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISHKDKQKYNYFVMKWVNKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>A0A0G3WZP5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSQPLLKLSSVTRRFPAGEKDVVVLNNVNLSINAGEIVAIVGASGSGKSTLMNILGCLDH
PSEGTYTVGGRDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTTRA
ERHERARELLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKS
GQDVIRILHELNALGHTIVIVTHDKDVARHARRIIEISDGEIVADRRNRHYAEALAEAFA
DAAEATAGEPSTHDRHDTPPPADADTGTRARRFAAGSGRFAEACRMAWIALVSHRLRTLL
TMLGIIIGITSVVSIVAIGEGAKRYMLDEIGSIGTNTINVYPGTDWGDSRADTIQTLVPA
DVAALAEQPYVDSATPETSRTLLLRYRNIDVNALVSGVGDRFFQARGMRFALGVAFDEDA
VRRQAQVAVIDQNTRRKLIGATRNPVGDVILVDNVPCVVIGVTADKKSAFGSVKSLNVWV
PYTTASGRLFGQRHLDSITVRVRDGQPSAAAEKSLEKLMIQRHGRKDFFTYNMDSVVKTV
EKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDILQQFLV
EAVLVCLLGGTIGIALSFGLGAVFSMFVAQWKMVFSAGAIVTAFVCSTLTGVIFGFMPAR
NASRLDPIDALARD
>AAA72095|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAAFLRRLHSIPVCNCPFNSDRVFRLTQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRFFYKYGIDNPDMNKLQFHLMLDEFF
>YP_405598|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAISLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A154AT89|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIITAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLIA
GAILMIFAEVKKQEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWAYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTVFVLL
>ZP_02377226|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTPRSRIAAAVATLAVVGLGTFGAMRVGASAPEKPAAPLPEVDVATVVPQTVTDWQ
AYSGRLEAVEKVDVRPQVPGTIVSVNFKDGALVKKGDVLFVIDPRPYQAEVDRAGAQLAA
AQARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREASANLKAAEAALETARINLGYT
RITAPVAGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYIGGARDG
RKVPVELGLANEAGYSRSGVIDSVDNRLDTSSGTIRVRARFDNADGSLVPGLYARVKVGG
SAPHQALLVDDAAINTDQDKKFVFVVDQQGRVSYREVQPGMQHGNRRVIVSGIAAGDRVI
VNGTQRVRPGEQVKPHMVPMTGGDAPSAPSAPLADNAKPAAPAKANS
>W0Q9P6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MILIEIENLNKYFGLGENQAHILKNINLTIEQGDFIAIIGASGSGKSTLMNIIGCLDTAS
SGICRIDGKETQQMSADELSDLRQRKFGFIFQRYNLLPALTANENVALPAIYAGMDTSSR
KQRADNLLAKLGLDDKTRNRPNELSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLEILRDLHQEGHTIIMVTHDPNIAAQASRVVEIKDGEIIRDERQKPYSTELKLNKTPH
QQPRFFDQLIESFKMASSAILAHKMRALLTMLGIIIGIASVISVVALGQGSQQQILANIN
SLGTNTMDILNGTGFGDRRANLTKNLTISDALALSRQNYVESTTPSSNVNATLIYGNTAV
TGSVRGVGEEFMDVKGLKLISGRFFTAEEVKNVAQVIVIDPNTQKDLGLPTPVEGKIILV
DKKPLQIIGVAEQANAMNQTSLTLWSPYSTIMQRVSGAKQIDSLTVKIKDNVESQTAEKS
ITELLTARHGKKDFFIINSDSIKQTITDTTNTMTLLISSIALISLIVGGIGVMNIMLVSV
TERTREIGVRMAIGAKQRNILQQFLIEAVVICLIGGVIGILLASAIIWAFNSLGSNFKMI
LSPESVIIAVLCSTLIGIVFGYIPARNASRLNPITALAQE
>A0A0D0JZH3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MCSFKPSKVFSHSAFALFFGSVACHAATPSDAQLQALVSQAVPPVMQQNNIPGLTVAITL
NGQAHYFNYGIADKDGGQKVTENTLFEVGSVSKTFTATLAGYAQATGKLDLSSKASQLWP
ELKGSAFDNVSVLQLGTYSAGGLPLQFPAEADSSDKMLGYYQQWKPQFPAGSHRLYSNPS
LGLFGYLTAKSLGQPFDQAMTQTLLPKLGLQHTFLSVPSAQSKLYAQGYDSADQPVRVSP
GALDAEAYGIKTSAADLLRYVQAQLKPASLAPDLHKAIVNTHLGYYRVGDMTQGLGWERY
AYPITLEKLQNGNSIPMAMEPHTVEWLTPPQAEPANVLFNKTGSTRGFGAYVAFVPSRDM
GIVILANKNYPNAERVKIAHTVFAALAD
>A0A127T4G4|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MEEATGQRQGGASQMTFTPIDREHWARKEYFDHYFSQVPCTYSAVFQLDITRIRQQKQKL
YPAMLYHIAGEVNCRDAFRTAYNKAGQLGIYDRMHPCYTVFHPERETFSNLWTEYDPDYE
TFCAAYQRDMAEYGNNPGLEGKPGTPENTFPVSMIPWASFQGFNLNLQNGYDFLLPIFTM
GKFYESDGKTLLPLAVQVHHAVCDGFHLCSFVNSLQARLDGTAAF
>A0A154AYA6|FEATURES|UNIPROT_deepARG|beta_lactam|A3782_22205|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEIAEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKWKFGNMKVETFYPGKGHTE
DNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENINFVVPGHG
EVGDKGLLLHTLDLLK
>J3ETJ7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTTDDANPVVDAIEKRYGQSSVKPYPIRCVSIVIPVYNEQDSLPELLRRTEAACQQLHHE
YEIVLVDDGSRDNSAQILEDAANREGSPVVAVILNRNYGQHAAIMAGFEHCKGDVVITLD
ADLQNPPEEIPRLVAQAELGYDVVATVRNNRKDSALRRWPSKLINLAVQRSTGVAMSDYG
CMLRAYRRTIVDAMLACSERSTFIPILANSFARHTTEIPVLHAEREHGESKYSPMRLINL
MFDLITCMTTTPLRLLSIVGFAMAALGVVFAITLIFLRLVFGAEWAGDGSFVLFAVLFVF
TGGQFIGMGLLGEYLGRMYSDVRARPRFFVEKVLRSQPATPAPVVTVDGLTSTSSDQVLS
>A0A0F4TZP2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTLFKVFILGAVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKISEIVKGLPTQRNAQRFTLNLLIGFLPAVVLGVLFADQIHHYLFNPITVAVALV
VGGIVMLWAEQRDHVVHVDHVDDMRWSDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEYSFFLAMPTMVGAAVYSGYKYRELFQTSDLPVFALGFVTAFFFAMIAVRGLLKF
IANHSYAAFAWYRIVFGLLILATWAFGWVNWTAAAAS
>F5MZR7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLNIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDIATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>A0A023D008|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAIILGIVEGVTEFLPISSTGHLVLVDQFIKLGQTSQFIDMFNVVIQLGAIMAVV
VIYFHKLNPWSPRKSSVEKKNTWTLWKKVIIAVLPSAIIGLPLNDWMDEHLMNWLVVSMA
LIVYGILFIVIENRNRDIEPRYADLNTLSYKTAIAIGIFQILSLVPGTSRSGSTILGGIA
IGTSRYVATEFSFFLAIPTMFGASLLKLYKFFKHGGSLAGLPGVVLAVGVLVSFVVAYIS
IRFLLNYVKKNDFKAFGWYRIILGIIVIGYFMLIH
>A0A022NAN1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANIIKAAILGIIEGITEWLPISSTGHLILADEFIKLDASSQFMSMFNVVIQLGAILA
VVVLYFHKLNPFAPSKSSIEKKDTWVLWSKVLVACVPAAIIGLLLDDWLDAHFYKFLPVA
IALIVYGIGFIIVEKRNKNKTPRWSNLNDLTFQAAILIGAFQVLALIPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASGLKIVKYLADGNTFQMEETVILLVGTVVSFIVSI
FAIKFLINYLKRNDFTVFGWYRIILGIILIGYWFIAM
>ACI02939|FEATURES|ARDB_deepARG|aminoglycoside|APH(6)-Id|antibiotic inactivation|1
MPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWR
NGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSA
LLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSS
RGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQ
AYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY
>G9WN20|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIVEFLKLIVFSLVEGFTEWLPISSTGHLILLQDIIPLHGSKEFFSTFEVLIQLAAVMA
VVQQFALRLWPFGKRKRGGGFYLKEEKAILIGKILLACLPAAVFGLALDDILDKYLYNGF
VVSLMLILYGFLFIFVEKRNENKNFRITKVEDLSWTLAFQIGLFQCLALIPGTSRSGATI
IGAMLLSVGRVAATEFSFFLSVPVMAGASLLKLIKHGGNFSGSEWFTLILAMILTYFVSI
YCIRFLLRYIRNHDFKVFAYYRIIFGGIVLLWFVVSRFLL
>A0A0F5Q3R3|FEATURES|UNIPROT_deepARG|aminoglycoside|WH87_16890|antibiotic inactivation|1
MIIATASPADATDWAAMRQALWPSHDIAEHVADIADYLAAPGDTLTLIARDTAGAAIGFA
EASIRHDFVNGCDTSPVGFLEGIYVVPEHRRTGIAGKLVDAVADWVRQRGYTQLASDADI
NNTQSHQMHEALGFEETQRVVYFRKQL
>V7ECJ9|FEATURES|UNIPROT_deepARG|beta_lactam|MHB_001273|antibiotic inactivation|1
MYTSLFPTVRNTAIFALLLGAGNCMAATDMRQVVDSTVQPLMQQQDIAGLSVAIVQNGKA
QYFNYGVASKESKQPVTENTLFEIGSVSKTFTATLAGYALANGKLKLSDPASQYLPALRG
DTFDHISLLNLGTYTAGGLPLQFPDESDNAGKMISYYQHWKPDFAPGTQRLYSNPSIGLF
GHLAAQSLGQPFDRLMAQTLLPKLGLKHTFISVPKSQMNLYAQGYDKSGKPVRVGPGALD
AEAYGIKTSTSDLIQYVEVNMHPAKLEKPLQQAIAATHTGYYTVDGMTQGLGWEMYPYPI
TLDALTQGNSAQMAFQPHKVNWLTPPQAPHADTLVNKTGATSGFGAYVAYVPSRGLGVVI
LANKNYPNAERVKVAHAILSAMDK
>ZP_04301662|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVEKMKKNTLLKLGVCVSLLGTTQFVSTVSSVKAEQKLEQKVIKNETGTISISQLNK
NVWVHTELGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITKLKFENMKVETF
YPGKGHTEDNIVVWLPQYNILAGGCLVKSAEAKNLGNVADAYVNEWSTSIENVLKRYGNI
NAVVPGHGEVGDKGLLLHTLDLLK
>YP_040175|FEATURES|ARDB_deepARG|multidrug|NorA|antibiotic efflux|1
MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGT
LADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADVS
PSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSVVLIHDP
KKSTTSGFQKLEPQLLTKINWKVFITPAILTLVLAFGLSAFETLYSLYTSYKVNYSPKDI
SIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLIYSVIVLVLLVIADGYWTIMVISF
AVFIGFDMIRPAITNYFSNIAGDRQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIY
MAIGVSLAGVVIVLIEKQHRAKLKQQDL
>D8JDD6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIVNLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESRQFEHKTLDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLVKNADVLTADNMINIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSA
>A0A0R1HG89|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSIIEMFKVIVLGVVEGITEWLPISSTGHMILVDEFLQLKESPAFMEMFFVVIQLGAIL
AVCVLYFHKLNPFSPKKSQLEKRDTWLLWSKVIVAVLPAAVIGLVADDWLNAKLYNFPVV
ALMLIIYGVLFIIIENKKANTTPAITSFTQVSYKTAILIGVFQVLALIPGTSRSGATILG
GILLGTSRFIAAEFSFFLSIPVMFGASLLKLFKYFHNGNSFTGDQSAVLLLGCAVAFFVS
IVAIKFLMGYIKSKDFKPFGWYRIVLGSLLLIYYFFIK
>C8VW43|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDILKAIILGIVEGITEFLPVSSTGHLILVNEFVGFTGNFAHMFDIVIQLGAILSVVLY
FKQKLFPIGKANIIEKRKALEIWKKTIIGVLPALFIGAALGEYIEEELFNPITVSITLLI
GGFILVFIERRTKQSSINDIYALDYKTALLIGFIQCLAMIPGTSRSAVTIIGAMLLGSSR
LVAAEYSFFLAIPTMFAATSYSLLKIGFALTPSQFYVLIVGFIVSFAVALTVIAGFMNYI
SKKDFKPFGYYRIILGILVLIYFKGI
>J7K0Z2|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELADNLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP
>A0A0J5Y6I2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWLTLLKALILGMVEGLTEFAPVSSTGHLIVVDDLIIKSQEILGKYPANTFKVVVQLGS
ILAVVIVFRDRFIEMLGLRRNKERTHTLKLSHIIVGLLPAMVLGLLFDDFIDEHLFSLKT
VLIGLAAGSILMIAADLFRPKVPVIETVDQLTYKKAIMVGLMQCIALWPGFSRSGSTISA
GVLFGLSYRAASDFTFIMAVPIMAGASGISLLKNWMYMTPEFAPFLITGFISAFIFAYLS
IRFFLTVISRIKLIPFAIYRLVLVAVILIFFM
>E5X1E3|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1016_02750|antibiotic inactivation|1
MIKFSKTHIFVLSLSLVCLVAVSMHLWPKSAKNSNGVVLQSQFFTDTISKIVAYYPGEIG
VAVIINNTDTITVNNKSIYPMMSVFKVHQALAICDDFGHKGFSLDSLMTIHRDELDPQTW
SPMMKEHLEPVIPLRVKDLLCYTLILSDNNASNFMFKKLVNITQTDSFIATLIPRLSFQI
AYTEEEMSADHDKAYANYTSPLGAAILMNRLFTDSLIDYDKQQFIIKTLEQCSTGKDRIA
APLLDKDGITIAHKTGSGYTNENGVLAAHNDVAYIRLPNGICYTLAVFVKDFKGNETQAA
KAIAHISAIVYSLVTQTIEHS
>ZP_04144736|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKKVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSAADIPLFATGFITAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>A0A068RAR0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLQLNGIRRSYQSGDQTVDVLKDVSLSIESGEMVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAMLNDDALAQLRREHFGFIFQRYHLLPHMIAAHNVEVPAVYAGLGKAE
RRERAEALLRRLGLGERVSYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
DEVMNILKQLRAQGHTVVIVTHDPAVAQQAERIIEIRDGEIIADSRNNQKGNQKVKSFGL
DAIVPSWQQMVGSLREALVMAWRAMTANKMRTALTMLGIIIGIASVVSILVIGDAAKQRV
LADIKSIGTNTIDIYPGKDFGDDNPTFRQSLKYEDLDALREQPYVSVLSPTIGSSTRLRL
GNVDVAANVSGVNEQYFRVYGMTFTQGAGIDVMQVQSQSQTVVIDANTQRRLFPHQKQVV
GEVILVGNMPATVVGVAKQKQSMFGSSKTLNIWVPYSTMANRLMGNTYFDSITVRIRDGY
SSHEVEQQLTRLLTLRHGKKDFFTYNMDSFVQAAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAILVCLVGGALGITLSFAIGLLVQL
LLPGWQISFPPTALLSAFVCSTGIGVVFGYLPARNAARLNPIDALARE
>YP_152202|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNETSASLQLTQTLFDMSKWRGLTLQEKAAGIQDVTY
QTDQQTLILNTANAYFKVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEELRQVTGNYYPELASLNVEHFKTDKPKAVNALLKEAEN
RNLSLLQARLSQDLAREQIRQAQDGHLPTLNLTASTGISDTSYSGSKTNAAQYDDSNMGQ
NKIGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASISSI
NAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARYTYLINQLNIK
YALGTLNEQDLLALNSTLGKPIPTSPESVAPETPEQDAAADGYNVHSAAPAVQPTAARAN
SNNGNPFRH
>A0A091ACG2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MNNTDIKLVSVIIPVYNEEASLPVLLSRVTAACELLPQDYEVILIDDGSHDGSTEIISEA
AAKDGSKLVGVLLNRNYGQHAAIMAGFETAKGDLVITLDADLQNPPEEIPRLVEAAMQGY
DVVGTVRRNRQDSWFRKTASRLINKSVQRATGVHMSDYGCMLRAYRRHIIDAMLCCQERS
TFIPILANSFARRTIELEVGHAERAHGESKYGLMHLINLMYDLVTCMTTTPLRLLSIVGS
VVAGIGFTFSILLILMRFVMGADWAADGVFTLFAILFTFVGVQLLGMGLLGEYIGRMYTD
VRARPRYFIHQVVRTASTPSQQEAE
>A0A059I5K4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGEKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGVGTGRLSLIHILLGMVPAVVVGLVLHDQIKMLFNPIN
VMYALVVGGVLLLAAEYLKPKQPKAVGVDDITYRQALMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSIGFLTMADFPMFAVGFVTAFIVALIA
IKAFLQLIKRISFVSFAIYRFIVAAAVYMVFM
>R6CGS2|FEATURES|UNIPROT_deepARG|chloramphenicol|BN509_00397|antibiotic inactivation|1
MFKLIDKDTWKRKPYFDHYFSQIRCTYSITVNIDISGIIAFKNKSRSKLYPLLIYVLTKA
VNNHEEFRTAINDKGELGVWDTLLPCYTVFHEENETFSNLWTEWNDDLIAFLSNYEQDIE
MFGGNYGIDAKPDTPANTFPISSLPWATFTGFNLNIFADGTYLLPIFTYGKYFQQDDKYL
IPLSIQVHHAVCDGFHVSRLINEIQQICNDIR
>BAA78801|FEATURES|ARDB_deepARG|aminoglycoside|Ant3Ia|antibiotic inactivation|1
MRSRNWSRTLTERSGGNGAVAVFMACYDCFFGVQSMPRASKQQARYAVGRCLMLWSSNDV
TQQGSRPKTKLNIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSD
IDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKREL
QFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALN
ETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEA
RQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>A0A0S2KLS7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILQTIILAIVEGLTEFLPVSSTGHMIITQSLLGIPSDEFVKAFTVIIQFGAILSVVVL
YWRRFFRLDHSPASESASNVQRFLHKWNFYYKLLVAFLPAMVIGGLLNGVIDRLLGSVMV
VAVMLVLGGVFMLFCDRLFDKGRENTVLTTRRALYIGLFQCIAMIPGVSRSMATIVGGMA
QKLTRKDAAEFSFFLAVPTMFAATCLDVLKMVLRMHETGDTGVFVDHLGTLLLGSVVAFF
VALLAIKGFVAFLTKYGFQAFGVYRIIVGGFIIVWLLLGHSLVMVD
>A0A0B4ZUG5|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
LIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMST
FKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSD
NTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLR
KLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGP
DGKPSRIVVIYTTGSQATM
>R6SYY2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLVIELLKALLYGIVEGITEWLPISSTGHLILLQEWLPFAFSEDRAFVAAYWEMFGVVIQ
LGAILAVVVLFWQRLFPFAGHRTARERREVWSLWGKVLIGCIPAGIIGTLGDKILEKITG
KDIDGWLFNAWTVAIALIVYGIAFLVIERVNQNRTPVVTDLRELSLSQAFSVGLFQALSI
IPGTSRSGSTILGSMLIGLSRPVAAEYSFFLAIPVMAGASGIKALGFFRYISETGTQVPE
EAWLLLAVGCLVSFLVSLLVIRFLTDFVKRHTFVPFGIYRILLGAAVLLYFLLVR
>A0A0D7LL52|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSHIRRSYPSGEGQVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPPQKPSGGRDIAEPT
VKTASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTALQKQPWVSSVTPAVSKNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRRQLFPNKAKVV
GEVVLVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTATGVLFGWLPARNAARLDPVDALARE
>A0A0J6MGP4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTMGKAYEILLVDDGSSDNSALMLTE
AAQVEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFG
SIIALAGFAISVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKASQEEIHP
>A0A0B2XZ45|FEATURES|UNIPROT_deepARG|beta_lactam|NT90_03710|antibiotic inactivation|1
MRLKKISYLLLPSLVILNTSIYAGNTAKDQQIKQLVDQNFKPLLEKYNVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGAYAKNKGKISFEDKPSKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVSLSMNQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQQNQPIRVNPGP
LDGPAYGVKSTLPDMLGFVHANLNPRQYPADIQRAINETHQGFYQVGTMYQALGWEEFSY
PATLQTLLDSNSDQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0U3LEQ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSGKRTVAHLELMLDTVMLIKAAIMGIVEGLTEFLPISSTGHLILAGSLLGGFDDTRGKV
FEIAIQTGAILAVIIVYWQRLRETAAGLGNDERARRFVLNVAIGFLPAVILGLLFGKAIK
AHLFTPVVVATTFIVGGIIILWAERRPASAVRVHEVDQMTPWDALKVGLVQCLAMVPGTS
RSGSTIIGGMLLGLSRKAATDFSFFLAIPTLIGAGLYSLYKERDSLAVADVPLFAVGLLF
SFISAWICVRWLLRYIASHSFTPFAWYRIAFGIVVLVTAYTGVVVWQD
>A0A0S4IFQ0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MICSRSVYIAVALMLGAPWSSAYANDPLRIKVDTVIGPLMQAEGISGMAVALYAHGHAHY
FSYGVASRDSGVPVSRDTLFEIGSLSKTFTATLVAVANAEGQLALDAPAKRYHPALGGTP
MGDATVQDLGTYSADCLPLQFPDTVNSPQQIVTFLRQWQPKGTPGAQRCYSNPSLGLFGD
LAARAQHQPFATLLEQNVLKPMGLHSTYLDVPSDARSLYAQGYDASDKPVRVNPGPYAQQ
AYGIKTSASDLLRYVRLNTQPDDLPAPLARAVLITRNGYAQIGEMTQGLGWERYAYPVTL
RTLLTGNGPQMIRGPQPAQRLQPPAAPLAAAWYNKTGSTNGFGSYAAFVPSEGLAIVLLA
NRNYPNEARVRAAFEILSGL
>V7ED22|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTMAACKQLAYEYEIILVDDGSRDNSAQLLEDA
AALEGSNVVAVILNRNYGQHAAIMAGFEHCRGDVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEILVHHAEREHGESKYSPMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGMLFAFALIVLRIAFGSGWAGDGMFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAETFTVDGLTSSHTSTSPSDQVSS
>Q53685|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|oleD|antibiotic inactivation|0
MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGPRPVLY
HSTLPGPDADPEAWGSTLLDNRRTFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVL
ARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPD
TFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLG
SAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQA
DLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRET
ALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNVGDRPAG
VRSDRQRSAL
>W0ANI6|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFVLCAAF
NAWLLPAWKLSTVRTPVREGMACVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMMPVGMVSSLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAQQPELPWMMLGIIGIITFLALGWQFSPKRAARRLLERDA
>A0A0A2HVJ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSVGQAAILGVVEGLTEYLPVSSTGHLLLAQRIMGIDGDSVGNGDQRSQDAVEAYTICIQ
AGAIIAVLGLYFRRVRQIFAGLAGRDPVGLRLLVNIIVGFLPAAVIGLLFNGTIKTWLFG
PWPVVTAWLTGGLAILAVHWHRQSQPQTARNGVALDDLTWKMALVIGLAQCIAMWPGVSR
SLITIVGGVLVGMSLPAAVEYSFLLGVLTLGGATAYDAVKHGEEMLQIFDPLSLTVGLVF
AFLSAVAAIKWMVSYLNRHGMAIFGYYRVCLGLAVAVLLATGKI
>A0A029JXV2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLTTYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0P9PK09|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADMIHHYLFNAITVATALV
VGGVIMLWAERREHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWVSAKA
>G8M653|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRAKIGSVVTGLPVRADARRFTINVIIATIPAIVLGLLFEKHIKSVLFSPVPVSVALI
IGGIVILWAEARQRERGALTRVHSVDDLTYGDAFKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATIYEMAKYWRTLTVDDLGLFAIGLIAAFISAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>A5YVZ0|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MREAVTIEISNQLSEVLSAIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>A0A064TG61|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMHETIDETLDFFLRTVDLTDKPS
>A0A0D0FL86|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLMFLKTIILGMVEGLTEFAPVSSTGHMIIVDDLWLQSKEFLGGQYVANTFKVVIQLG
SILAVVVVMKDRFLDLLGLKKRSFKIGQKSTGHLRLTHIIVGILPAGILGVLFEDIIDEV
LFGYQYVVYALIAGAILMIFADKFRAKRPAAETVDQITYKQALLIGLFQCLSLWPGFSRS
GATISGGVLMGLSHRAAADFTFIMAVPIMAGASLISLVKNWQYFSIDALPFFIAGFISAF
IFALISIRFFLKLIDRIKLVPFAIYRIILAVLLLLLVK
>ZP_04431003|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MHLWNLFVAAILGLVEGLTEFAPVSSTGHMIIVDDLILKSNHLYGTEAANVFKVVIQLGS
IMAMVVVFWDRFLNLLGLKKNITREQMYGERLRLTHVITGLVPAAVLGFLFEDYIDAHLF
SVNTVLVALVAGAVLMIVADLTRPRRPKTETVDEITYRQAFVIGLFQCLALWPGFSRSGS
TISGGVLLGMSHRAAADFTFIMAVPIMFGASFLSLVKHWGAVTPETIPFFITGFISAFIF
ALIAIKFFLALINKVKLIPFAVYRILLAIVLLLLIWNR
>A0A0S1RSB1|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
ILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQP
TDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSL
RISPLEQLAFLRKVVNRQLPVKAAAYELADNLFEV
>R6GXH3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAILYGIVEGITEWLPISSTGHLILLKELLPLSVTDEFWTMFEVVIQLGAICAVI
FLFFHKLNPFSPQKTALEKRKTWDLWGHVVVAVIPAGVLGVLLDDWLDAHLYNYITVAIT
LILYGVAFLFLERNQRSQPSIRRTSEISWSVAVYIGLFQCLSMIPGTSRSGATILGAMLL
GLSRSAAAEFSFFLAIPTMVGASFLKILKFVKEGVGMTGQEAAILIVGCLVAFVVSLIAI
RSLMNYVKRHSFAAFGVYRIALGLVVLLYFLFARAGA
>W1SHE5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIKGINHLLFSVSNLDKSIEFYQQVFEAKLLVKGKSTAYFDLNGLWLALNLEKDIPRNEI
NQSYTHIAFSIEEADFSTVYEKLKRLNVNILPGRSRDERDKRSIYFTDPDGHKFEFHTGT
LKDRLDYYKQEKSHMDFYI
>A9KK15|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MNYSKYETMKQLIADMKLPDYRYEQIIKAIFSQHTSTFEKMSTLPLELKKSLINTFGPSV
CCTVPVACQTSGQADKILFSLPDGNRVETVNLHYKKGWESFCISSQCGCGFGCQFCATGT
LGHKRNMTADEITDQLLYFHLNGHKLNSISFMGMGEPLANPNLFDALNILNDSSLFGLSQ
RRITISTIGIIPGIKRLTHEFPQINLAYSLHSPFENQRSELMPVNRSFPLHEVMNALDNH
IRHTGRRLFLAYIMLNGVNDSVDHAKALVELLQDRGPWAHLYHVDLIPYNATDKTPRKFA
SSDKITMKRFRDILHANGISVATRTQFGSDISAACGQLLGEKDV
>A0A0A2SEM6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHVIELIKALILGLVEGATEFAPVSSTGHMIIVDDMWLKSSEFLGKYGANTFKVVIQLGS
VLAAVVVFKDKFFELLYLRKSEVRTGPRLTLMHIFIGLLPAGVLGVLFEDYIDEHLFSTE
TVLIGLVLGALLMIAADRFGKRTKVAQTVDDITYKQAFIVGLVQCLSLWPGFSRSGSTIS
GGVLVGMSHRAAADFTFIMAVPIMAGASFISLLKNWQYITVDALPFFIVGFISAFVFALL
AIRFFLRLINRVRLVPFAIYRIVLAAVIYMVYFA
>BAD77819|FEATURES|ARDB_deepARG|trimethoprim|dfrA12|antibiotic target replacement|1
MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPL
PNRHTLVISRQANYRATGCVVVSTLSHAIALASELGNKLYVAGGAEIYTLALPHAHGMFL
SEVHQTFEGDAFFPMLNETEFELVSTETIQAVIPYTHSVYARRNG
>N2H7H1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAHLAPEVIFSFYYRHLICDAILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPTI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLNFFLRTVDLTDKPS
>R8KL27|FEATURES|UNIPROT_deepARG|beta_lactam|ICS_03162|antibiotic inactivation|1
MEQTCFGDCLLCVSKKSVKNLKGMMILKNNRMLKIGICVGILGLSLTTLEAFTGGALQVE
AKEKKGQVKHKHQATHKEFSQLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKAL
AAGVLLQQNSIDTLNEVIKFTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNI
LFHKIGGPKGYEKALRQMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGN
ALPDHKRQVLTEWMKGNATGDKLIRAGMPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPI
IIAVLSSKEEKEATYDNQLIAEAAEMIVKALK
>A0A0D8ZHZ2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSGAGLELDGVWRRFPSGEDEVAVLKNVTLSIAPGEMVAIVGASGSGKSTLMNILGCLDQ
PSEGRYRVAGQDAGCLDGDQLAALRRGHFGFIFQRYHLLPHLSALDNVAMPAVYAGMALH
QRRERARALLARLGLAGKEHHRPGQLSGGQQQRVSIARALMNGGRIILADEPTGALDSHS
GEEVMRILKELNAAGHTVIIVTHDPAIAAQTERVIEIRDGEILRDSGAPAREAASQATEA
QPDGGPLLRERLAEAFKMAMLAMSANRLRTALTMLGIVIGIASVVSVIAIGEGSRDYVLK
GIREMGTQTITVFRGKDWGDDKADGVRTFLPGDVAALEGEGYVDSVTPETAQAQRIRYRN
VDVNASVIGVGRDFFRVQGMKLAEGQSFSRDDIHFQRQVVVLDKNSRRKLFGDGEAVGRV
ILVGMVPATVIGVVAQRDRGFGGNSLQMWMPYSTAASRLFGQQHFDRFVIRVKDGQPTKL
AEKAIGALLTQRHGGKDFFTYNMDEILKTVESSSRALSLLLALVAVISLVVGGIGVMNIM
LVSVTERTREIGIRMAVGARQGDVLQQFLTEAVLVCLVGGAIGVALSYGVSFVFSLFVTE
WKMSLSPPVIALAVACSSLIGVLFGFLPARNAAKLNPIDALARE
>R6PY99|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLIELFKAALFGVIEGITEWLPISSTGHMILFNEFMPLQVSDEFYRMFEVVIQLGAIMA
VVVIFWNAIFPFQKPPYDPRRIRTGLISYLRMDIVMLWLKILVACVPAAVIGLLFNEKFE
ALFYNYTTVAIALIVFGIAFLIIETRHKGKRARVNSLEEITFQLALLIGVFQLIAAIFPG
TSRSGATIVGALLLGVSRTVAAEFTFFLAIPVMFGASLLKIVQFGFHFTGMEAAILLTGM
IVAFVVSVLVIKFLMGYIKKHDFKVFGWYRIVLGIVVLLYFGLIAK
>A0A0G8EQ42|FEATURES|UNIPROT_deepARG|beta_lactam|B4077_2479|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTDVENLKGMMILKNKRMLKIGICVGILGLSVTSLETFTGGSLQV
EAKEKTGQMKHKNQATYKDFSQLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKA
LAAGVLLQQNSTEKLNEVITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGN
ILFNKIGGPKGYEKALRQMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVG
NALPVHKRNILTGWMKGNATGDKLIRAGVPTDWIVADKSGAGSYGTRNDIAIVCPPNRAP
IIIAILSSKDEKEATYDNQLIAEATEVIVKALR
>M6DCM3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSSTGHLFLFSNFYPFSEGADFDDLFDIFIQSGAILSVLVIYRVKFLEQGRLAVRYLLRK
EDNKEGFLFLTKVTIGFLPIMAAGFLFRGFLDKIKGREDILAILGWAWFIGGILILASEF
WFKKREKIKTSEPIGIQDAVVIGIFQCLALIPGVSRSGATIVTARFLGKDTRSSAEFSFF
VAVPVLFLAGAYKLFKHRAVLNWENLPILSLGFVLSFLLCFLVIKWFLRYLRTHSFNGFG
WYRILLGISVLTFYKIVMQG
>L9M4X6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFHVLILAIIQGLAELLPVSSSAHVILAEKLMGFDPSAPDMTFLLVMLHTGTMFAVIV
YFWASWRKTYFSSITNFKKQAGFIILATAITGILGLTLQALIKHVFFAGANHFEIEQLFS
NSKLMAAALVSAGILIILSARLDRGQTGEISLKSAAWIGAIQALCLPFRGFSRSGATIST
GLFLGVARQKAEEFSFALAVVLTPAVIVKEFYRLMHAENFQNMHLTQLLFPSVLGMVFSF
IAGLAALKWLSSWLEHGRWQLFGFYCIGFAGVVLALG
>I7BPI9|FEATURES|UNIPROT_deepARG|beta_lactam|T1E_0103|antibiotic inactivation|1
MLRPRLAALAAAITLALGHASVQADDQLQAKVDQIIRPLMQEQGITGMAVAIYARDHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLEAPAKRYHPALAGVP
IGDATVLELGAYSADCLPLQFPDTVQTPQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHEPFSTLMSEGLLTKMGLKNTYLQVPASAQGLYAQGYDADDKPVRVGPGPYADE
AYGIKTSASDLLRYVRLHMQPQGLPPALVKATAITQQGYFQVGGMTQGLGWERYPYPVTL
STLIDGNSPRLIREPQATTRLQPALPALPAAWYNKTGATNGFGAYAAFVPAEQLAVVLLA
NRNYPNQARVQAAFDILSGL
>J2NHG4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRCVSIVIPVYNEQDSLPELLRRTEAACQQLHHDYEIVLVDDGSRDNSAQILEEA
ASRDCSPVVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVAQAELGY
DVVATVRNNRQDSALRRWPSKLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEILVTHAEREHGESKYSPMRLINLMFDLVTCMTTTPLRLLSIVGF
GMAALGVLFAIALIVLRMVFGAGWAGGGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKILRSTPSAPAPVVTVDGLTSTSSDQVLS
>A0A0A3J2K1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELFDLIKAVILGFVEGMTEFAPVSSTGHMIIVDEMWLKTVEFLEQGSANTFKIVIQLGS
ILAVVVVMWKRMLSLVGLYKIPGQTSSRKFNLGHVLVGIIPAGVLGVLFEDFIDEKLFFT
STVIVGLIIGAILMIIADKFGPRRPRVTSLDDLSYGSAFKIGIIQCLSLWPGFSRSGATI
SGGVLLGLDHKTASDFTFIMAVPIMAGASGLSLVKNWDQINFDHLSFYIIGFVSAFVFAL
ISIKFFLKLISRVKLVPFAIYRIVLAAILIVVLYL
>I1V579|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VMAAAAVLKKSESGPSLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNV
AMNKLIAHVGGPASVAAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNL
TLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVV
>YP_002636110|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDPISRTSGVGDVQLFGS
QYAMRIWMNPTELTKYQLTPVDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTDEFGKILLKVNQDGSQVRLRDVAKIELGGENYDVIAKFNGQPASGLGIKLATGANAL
DTATAIRAELKKMEPFFPPGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
TEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPVAKGDHGEGKKGFFGWFNRLFDKSTHHYTDSVGNILRSTGR
YLLLYLIIVVGMAYLFVRLPSSFLPDEDQGIFLTMVQLPAGATQERTQKVLDEVTDYYLN
KEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEKNKVEAITQRATAAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLFGEVAKYPDLLVGVRPNG
LEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDINDWYVRGSDGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MAMMEELASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
VEATLEAVRMRLRPILMTSLAFMLGVMPLVISSGAGSGAQNAVGTGVLGGMVTATVLAIF
FVPVFFVVVRRRFSRKSEDIEHSHSTEHR
>A0A0L6I7Z8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDNALYLIKAFILGILEGLTEFIPVSSTGHLILVGDWINFQSGDGKVFEVVIQLGSILA
VMWVFRARLLQLIRGTLTGVPSEVAFARNLIIAFLPAAVIGAIFIKTIKSVFYHPGVVVV
TLVLGGLIMLYVERKTHHTPGDAPGAADDTASDERASAHTLEQITWKQALGVGVAQCFAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVFDMYKNFGALTQHDLSGIA
VGFIAAFLSAMVVVRAVLRFVANHTYRVFAWYRIVFGAVVAAWIFTR
>YP_001691306|FEATURES|ARDB_deepARG|tetracycline|tetL|antibiotic efflux|1
MNTSYSQSNLRHNQILIWLCVLSFFSVLNEMVLNVSLPDIANDFNKSPASTNWVNTAFML
TFSIGTALYGKLSDQLGIKRLLLFGIIINCFGSVIAFVGHSFFPILILARFIQGAGAAAF
PALVMVVVARYIPKENRGKAFGLIGSIVAMGEGIGPAIGGMIAHFIHWSYLLLIPMMTII
TVPFLIKLLKKEVRIKGHFDIVGIILMSVGIVFFMLFTTSYNISFLIISILSFLIFVKHI
RKVTEPFVEPALGKNISFIIGVLCGGLIFGTVAGFISMVPYMMKDVYQLSTAAIGSVIIF
PGAMSVIIFGYIGGLLVDRKGPLYVLTIGVTFLSVSFLIAAFFLEVTPWLLTIILVFVFG
GLSFTKTVISTIVSSSLKQKEAGAGMSLLNFTSFLSEGMGIAIVGGLLSVRLLNQKLLPM
DLDQSTYLYSNMLFLFTGVVVTSWLITLNVYKRRQIQFKS
>A0A064BSM3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGFNQRENREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLEMAKAGQLGSEDWADVGVAFLAAAITGFVVVKWLMGYIKSH
RFTAFAIYRIALGAALLLWLPSGS
>A0A0M3BMW2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFQSPGNTFAVLIQLGAILAILL
VYFQKLMSIALSLPTSTQSRRFVATVLAGFLPAAVIGALAHDFIKTVLFETPILICVVLI
LGGFVLLAVDRMKFQPKYHNVMDYPVSLALKIGLCQCVAMIPGTSRSGATIVGALLLGAD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRSALSFDDTAVIAIGFIAAFVTALLVVRSLLDF
VSSRGYAPFAWWRILIGMVGLAALLLYR
>ABN80187|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MNIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMLLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMD
IPTVIFINKIDQAGVDLQGVYQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREELAQEEQRRVQDASLFPVYHGSAKKGLGIQPLMDAVTGLFQP
IGEQGSDALCGSVFKVEYTDCGQRLIYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRHMFSKITG
>YP_002445900|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKCKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEASYDNQLI
AEATEVIVKALR
>D2ZZI7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGANRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDSAT
SGSYQIDGIETAKMQPDELAALRRERFGFIFQRYNLLGSLTARDNVALPAVYMGMGGKER
SNRAEKLLQDLGLEGKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVIEIIQKLHKEGHTVIMVTHDPGIAAIANRIIEIRDGEIISDSSKNPEIPESKIERIKE
KSSWLFYYDQFVEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSEKKILAD
INAMGTNTISIFPGRGFGDRRSGRIKTLTIDDAKVIAKQSYVASATPQTTSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLESGRLFDEADVKEDAQVVVIDQNTKEKLFGTDVDPLGKT
VLFKKRPLTVIGVMEKEENSFGNSDVLMLWSPYTTVMHQITGESYTNSITVKIKDDANTQ
VAEKGLTELLKTRHGTEDFFMNNSDSIKQMVETTTGTMKLLISSIALISLVVGGIGVMNI
MLVSVTERTKEIGVRIAIGARRNNILQQFLIEAVLICIIGGLVGVGLSTLISLVFNHFVT
EFPMEISIGSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALSKD
>E0NQI8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTTLETIILAIVEGLTEFLPVSSTGHMIITQNLLNMESTPFVKAFTVIIQFGAILSVVVL
YWKRFFRLNTTPPPAGSSRYEAFRHKWDFYYKLLIAFLPAAVIGFLANKLIDRLLGSVLV
VATMLVVGGIFMLFCDRLFNKGDEKTSLSEGKALKIGFFQCLAMIPGVSRSMATIVGGMA
QGLTRKRAAEFSFFLAVPTMFAATCWDLYKLVRDGGLETLSANMAPLLIGSVVAFLVAMA
AIKGFVNFLTKYGFKAFGIYRILVGGFIIIWLLAGHPLAMVD
>P05193|FEATURES|ARDB_deepARG|beta_lactam|CMY-78|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDRIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPGDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>B5ULZ6|FEATURES|UNIPROT_deepARG|beta_lactam|BCAH1134_3258|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQIKQEITGNDSFV
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVLPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDTLKVTNK
>A0A0M5JX58|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNYWHALLLAIVEGLTEFLPVSSTGHMVIVANLLGIGQLPYTETYITGIQLGAILSVVVL
YWRRFLQSTGFYMKLAVAFLPFGFLGFLLKDVIEQLLKSVAVVAWALVLGGIVLLFVEQI
FKNKKPHYVSMPKYKQAFRIGLYQCIALIPGVSRSAATILGGLAQGFDRRSAADFSFLLA
VPTMVVITGYQLLKGYKSNPLSIDQLKMLLFGNAVAFAVAMLAVRSFVNFLTRYGFRAFG
FYRILVGAIILIMLGLGINLKLI
>ZP_04466634|FEATURES|ARDB_deepARG|beta_lactam|pbp1a|antibiotic target alteration|0
MRIAKLILNTLLTLCILGLVAGGMLYFHLKSELPSVETLKTVELQQPMQIYTADGKLIGE
VGEQRRIPVKLADVPQRLIDAFLATEDSRFYDHHGLDPIGIARALFVAVSNGGASQGAST
ITQQLARNFFLTSEKTIIRKAREAVLAVEIENTLNKQEILELYLNKIFLGYRSYGVAAAA
QTYFGKSLNELTLSEMAIIAGLPKAPSTMNPLYSLKRSEERRNVVLSRMLDEKYISKEEY
DAALKEPIVASYHGAKFEFRADYVTEMVRQEMVRRFGEENAYTSGYKVFTTVLSKDQAEA
QKAVRNNLIDYDMRHGYRGGAPLWQKNEAAWDNDRIVGFLRKLPDSEPFIPAAVIGIVKG
GAEILLASGEKMTLSTNAMRWTGRSNPVKVGEQIWIRQRANGEWQLGQIPSANSALVSLN
SDNGAIEAVVGGFSYEQSKFNRATQSLVQVGSSIKPFIYAAALEKGLTLSSVLQDSPISI
QKPGQKMWQPKNSPDRYDGPMRLRVGLGQSKNMIAIRVIQTAGIDFTAEFLQRFGFKRDQ
YFASEALALGAASFTPLEMARAYAVFDNGGFLIEPYIIEKIQDNTGKDLFIANPKIACIE
CNDIPVIYGETKDKINGFANIPLGESALKPTDDSTNGEELDQQPETVPELPELQSNFTAL
KEDAIDLMAAAKNASSKIEYAPRVISGELAFLIRSALNTAIYGEQGLDWKGTSWRIAQSI
KRSDIGGKTGTTNSSKVAWYAGFGANLVTTTYVGFDDNKRVLGRGEAGAKTAMPAWITYM
KTALSDKPERKLPLPPKIVEKSIDTLTGLLSPNGGRKEYFIVGTEPTRTYLSEMQERGYY
VPTELQQRLNNEGNTPATQPQELF
>A0A0G3DJ16|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLDYYYALILGIIEGLTEFLPVSSTGHMILGAEILGLNIDDFWRSFFIIIQLGSILAVI
FIFKDKLTQKLDIWLKLAVGFLPAGGVGFIAYKFLKEIFNGYTVATMLIIGGIIFIIIEL
KHRKKDYTIHSLDEVSYKQAFLIGLTQALAIIPGTSRSGASIIGGLLLGLDRKVASEFSF
LLAIPTMIIATAYSIYKEPQVLSNMNNFIPLAIGFITAFVVAFVVIKIFLKLISKINFIP
FGIYRIILGFVFLYLFMSGALDISRTGV
>G5IC12|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MATFIEILKVLVFGIVEGFTEWLPISSTGHMILLDEIIPLSVSTEFKDMFMVVIQLGAIL
AVVVLYFHRLNPFSPSKTEKQKRATVRLWTKILVACIPAAVIGLLIDDWMEAHLMNGYVV
AATLIIYGVLFIVIERYNEGQKPIVEKAGNITYRLAFCIGLFQVLSLVPGTSRSGATILG
AILLGCSRGVAAEFSFFLGIPVMFGASLLKIVKFGLGNFKGIEVFYLLFGMVVAFLISVY
SIKFLLDYIRKNDFTVFGFYRIGLGIVVLIYFAVTRLMAG
>Q8KT57|FEATURES|UNIPROT_deepARG|beta_lactam|cfxa2|antibiotic inactivation|1
MEKNRKKQIVVLSIALVGIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIT
APLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>YP_001969930|FEATURES|ARDB_deepARG|sulfonamide|sul2|antibiotic target replacement|1
MKHKNRELVLFFAITFYYSLFFYFKCSTDPIIEAPMNKSLIIFGIVNITSDSFSDGGRYL
APDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLD
SYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGD
IMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLP
VLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALK
ETARIRYQKTEGTSIESN
>R8NA09|FEATURES|UNIPROT_deepARG|beta_lactam|IK1_00219|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKALAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DNLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>B2FQI3|FEATURES|UNIPROT_deepARG|aminoglycoside|aac(6')-Iam|antibiotic inactivation|1
MIDSAPMIRQATPADAAAWARLRLGLWTDADDPLEELTQSLADAEGAVFLACAADGETVG
FAEVRLRHDYVNGTESSPVGFLEGWYVQPQWQGSGVGRALLAAVQAWTRDAGCRELASDS
RVEDVQAHAAHRACGFEETERVVYFRMPLEPSA
>J2TTN2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYAEMGCTGITALLNAGYEISAIFTHADTSPESHAFPSVARLAAEHGIAVYAPE
DADHPLWVDRIKSMTPDFIFSFYYRKLLSDNILNCARVGAFNLHGSLLPKYRGRAPLNWV
LVNGEKETGVTLHRMVKRADAGDIVAQQHVAIDEQDNALTLHRKLVACATQLLESALPAL
QYGDIVTTPQDHSQATMVGRRTPDDGRIKWEQSAQSINNLVRAVTDPWPGAFAFAGTVKF
VVWKGRVHSTEQHAKPGTVLSVEPFIIACGEGALEVVTGQSDNGVYMNGSQLAQSLGMVK
GALLYSQPVAAVKRRTRVLILGVNGFIGNHLTERLLQDDNFDVYGLDIGSDAISRFLEQP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDQHFDEDHSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGAQKRCFTDI
SDGIEALFRIIENQHNNCDGQIVNIGNPENEASIKELAERLLASFERHPLRSNFPPFAGF
REVESSSYYGKGYQDVEHRKPSIKNARRLIDWTPTVEMDTTIDNTLDFFLRTVELQEKP
>A0A125JXK6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKTLILGVVEGLTEFLPVSSTGHLIVAGSFLSFDDAHAKTFDVVIQFGAILAVC
WEYRRRIVSVVAGLPSRPDARRFALNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERGEAPRVQSVDALTPLDAFKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSIGLFALGLAASFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWLNWA
>R9B7J6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFVEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLVKGFFSGDAEARHFAFSVLLAFIPAVVIGIFAVDFIKSVLFSPLVVAVAL
IVGGLIIFWVESKNFDHKTTDATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQDNMLNIAVGFVAAFISALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>D3L8Y8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFGILKAIILGIVEGITEFLPISSTGHLIIVDQFVKISSNKAFTTTFEYVIQLGAIIAV
VLLYWKRLWPFGGGKTEKQRFNIWATWVKVVVGVIPSVIIGFLLNDWMDKHLMNWLVVSI
ALIVYGIAFIFIENYQKNRRPRVRTINHLTLADVLKIGFFQVLSIVPGTSRSGATILGGI
SIGVSREAAAEFSFFLSIPTMLGVSVLKIGSYLHSHGMFSGEQIVILLVGMFVSFVVAYV
VIKWLLRFIQTHDFKAFGWYRIILGVLVIALGAIGIID
>J8PHM1|FEATURES|UNIPROT_deepARG|beta_lactam|IKO_00402|antibiotic inactivation|1
MFILNKFFNILHYKKIVPAVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFTSTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DNLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A0Q4ZV79|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAMGIAKAVVLAVVEGATEFIPVSSTGHQLLVGHFIGFESPNNTFEVLIQLGAILAILA
VYFRRLLGITLSLPNDPKARRFVLGILLAFLPAAIIGGLFSKYIKYYLFNPWIVCATLVA
GGIVLLVLDETELEVKKRDVFDFTLPMDFKIGLFQCIAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAIPTMAGAFAKDLLDNYKNLSRDDTGLIIIGFIVAFISAFIVVRTVLDYV
ASHGFRLFAWWRIIVGSLGFAGLILFG
>I6YPM8|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKSDTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>A0A0D1YKI3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDQYIIAIILGIVEGLTEFLPVSSTGHLILTGELLGATEEKWKTFEIVIQLGSICAVLLL
FWRRILGLLGIGRKRTIGPQLNLLHIFIGILPAGVLGVLLHGFIKEKLFSSFTVLLSLII
GGILIIVAEKMQPRTTAETIDDLSYKQAFGIGLFQCLALWPGFSRSGATIAGGLLLGTSR
KAAAEFTFIMAIPVMMGASGLDLIKSWDMLAASDLGFFAVGFITAFIVAALAIVSFLKLV
ERISLTPFAIYRFLLAIVFYFFILQ
>A0A100VXX9|FEATURES|UNIPROT_deepARG|beta_lactam|RMCB_2111|antibiotic inactivation|1
MTGLSRRNVLIGSLAAVAVAGIGAPTASAAPLDDQIAGLEKRNNASIGVFAANVDSNRTV
AHRADETFAMCSTFKGYAAGRVLQQVDRGQLALDTRIFIDPSAIVANSPVTEERTGADMS
IGELCQAALQHSDNTAGNLLLKLIDGPPGITAFARSIGDNRTRLDRWETALNSAIPGDLR
DTSTPAALGAGYRAMLTGDVLSPPQRQQLEEWMRGNETSSMRAGLPAGWTSADKTGSGDY
GSTNDVGIAYGPDGQRLLLAVMTRSRADDPKAANLRPLIGELTALVVPSLL
>A0A0P7N9H4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAVEKVNATGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLSGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A0Q7TRN9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLDAASGLLSGPFADLIKAAILGIVEGLTEFLPVSSTGHLLLMEQFLGWGDGAFGKSFA
ILIQLGAILALLTIYFGRIWSLATNMFSRWEATRFVIGILLAFLPAAVIGVIAGGYIKTY
LFDVRIVCITLIIGGFVLLLVDRMNLKPRYFESTGFSLPMYFLIGICQCFAMIPGVSRSG
ATIVGAMMFGADRRSAAEFSFWLAMPTMVGAFAYEAFKSRHELANGNMLAIAVGFIFSFI
FGWIVVKTFLSYVQRHSFALFAWWRIVLGTLGVVAIYLL
>A0A0W1ET76|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDAARWAIFNIAIQPGAILAIVVL
YRKLFWEMFTGFFRRDPVAIAFVRNLLLAFFPAVILGLAFGDYIELLLENAVVVAWALII
GGFAILLVERFAKTKDVGGVANVSARQSMLVGLVQCIAMIPGVSRSGATILGAMSFGVDR
KTAAEFSFFLALPTLTGATVLQLFKHRDAITTNDLSLIAVGSLVSFVVAWAVIKAFLAVV
TRYGFAPFAWYRIIAGVAALIWLGMR
>D0S6X2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IIGALIIFWVESKQFEHKTDDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTADNMINIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSA
>NP_458943|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MQRIIQFFSQRATTLFFPMALILYDFAAYLTTDLIQPGIINVVRDFNADVSLAPASVSLY
LAGGMALQWLLGPLSDRIGRRPVLIAGALIFTLACAATLLTTSMTQFLVARFVQGTSICF
IATVGYVTVQEAFGQTKAIKLMAIITSIVLVAPVIGPLSGAALMHFVHWKVLFGIIAVMG
LLALCGLLLAMPETVQRGAVPFSAVSVLRDFRNVFRNPIFLTGAATLSLSYIPMMSWVAV
SPVILIDAGGMSTSQFAWAQVPVFGAVIVANMIVVRLVKDPTRPRFIWRAVPIQLSGLAT
LLLGNLLLPHVWLWSVLGTSLYAFGIGMIFPTLFRFTLFSNNLPKGTVSASLNMVILTVM
AVSVEVGRWLWFHGGRLPFHLLAAVAGVIVVFTLATLLQRVRQHEAAELAAEK
>N9RV49|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILTGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIISSIPIVIIGLTFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRPHQIVTQEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMAVLAVGIIVAFVSALVVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>A0A0Q6SP99|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALILGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQRLLSIAMALPSSAKARRFVLSVLLAFLPAAVIGAIAHDFIKTVLFETPMLICVVLI
IGGIILYAIDRMPLKPIYRDVMDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRAALDFNDATLIAVGFIAAFVSALLVVRSLLNF
VSSRGFAPFAIWRILVGTAGLIGLWLFG
>ZP_04437889|FEATURES|ARDB_deepARG|multidrug|lsaA|antibiotic target protection|1
MSKIELKQLSFAYDNQEALLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGE
ILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWKLERELTLLNVDPEVLWRPFSSLSGG
EKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVV
DHILAIEKSQLTLYQGNFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNR
EGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDIEYIDSL
SMDYQPTHHKTLLTVEELRLGYEKNWLFAPISFSINAGEIVGITGKNGSGKSSLIQYLLG
DFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVF
TNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVRPAMLVIE
HDAHFMKKITDKKIALKS
>M4R8R8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MGSAENPAHILKNINLTIEQGDFVAIIGASGSGKSTLMNILGCLDTASSGSYKIEGVETQ
RLSSNQLSDLRQRKFGFIFQRYNLLSSLNAVENVALPAIYAGLENNARLKRGKELLEKLG
LGDKAQHRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGETVMEILQALHQE
GHTLILVTHDPQIATHAERIIEIKDGAIIRDERQKVLSGKREDHKRPAKKPRFIDQLIES
FNMAVSAILAHKMRALLTMLGIIIGITSVISVVALGKGSQEQILSNINNLGTNTMSVYNG
TGFGDRRANLTRNLTISDVSALARQNYVESATPTSSHSGTIVSGNVAVSGQISGVGEQYF
DVQGITLKSGRFFSAEEVVQSAQVVVIDSNTKNSLPFENPLGEIVLVDKKPLQIIGVADN
EMRQSSNLSLWTPYTTLMQRISGAKQIDSITVKIKDNVESQTAEKSLTELLTARHGKKDF
FVMNTDTIKQTIEATTGTMTLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGVRMAIG
AKQGNILQQFLIEAILICLLGGIIGILLAAMIIVGFNYWGSDFKMILSPESVVVAVVCST
LIGVIFGYIPARNASRLNPITALAQE
>F4V858|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAALAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHVVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>E3CSR0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQTAQFIIELLKAVFLGIVEGITEWLPISSTGHLILVNEFLNLRQSKDFIDMFNIVIQLG
AILAVMVIYFKRLNPFQPGKTAREVQLTWQLWLKVVIACIPSAFFGLLLDDWMEAHLSNF
FVVAIMLVVYGIAFIWIEDRNRRVEPKVTDLARMSYKTAFYIGLFQVLSIIPGTSRSGAT
ILGGIIVGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFIDGNTLTGGQAAILLVASVTAF
LVSLFVIRFLMNYIKKHDFTVFGKYRIVLGIIVLFYGAVKLIFG
>Z4WYQ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESAILWIEALKSALFGVVEGITEWLPISSTGHMLLLNQFLPLNVSEDFWNMFLVVIQLG
AILAVCVGFFHKLNPFSPKKSRDEKRSTWKLWAKVVVSCVPAAAIGLPLNDFIEEHLGSP
FVIAATLIFYGIIFIVLELHREKVAATVKVEAPRGKHMRPDAPASLKAPSADNLARVQDI
DNLDWKTALGIGVFQVLAIVPGTSRSGATILGGLALGCSRAVAAEFTFFLAIPTMAGASA
LRLVRYFMKGNTFTAPEAIILGVGCLVAFIVSLVMVRALMGYVRKHDFKPFGVYRIILGI
AVIAYFLLVK
>B2CD55|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
GLFSFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQ
LLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVII
>A0A0Q6HTD1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWEIFVAVILGLVEGLTEFAPVSSTGHMIIVDDIWLKSNELFGSEVANAFKVVIQLGSIL
AVVVLFWGRFMDLLGLRKMKNPSAPGGQKLNLLQILVGLLPAGVLGLLFEDYIDENLFKM
KTVIVGLILGALLMIAADKFRPKMTAETVDQITYKQALGVGLIQCLSLWPGFSRSGSTIS
GGVLLGMSYRAASDFTFIMAVPIMAGASLLKIIKYWDIFTPEVLPFFIAGFISAFIFALF
CIRFFLVLINKVKLTPFAIYRIVLAVVLMFIFW
>W1SGQ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSENIIAFILGIVEGLTEFLPISSTGHLILVGNLLGFEGEKANTFEVIIQLGSMLAILVL
YWKRYLSLLNFSTIGKPEKKLDAIHIILGVLPAALVGLLLHNFIKNQLFSPNVVVVSLIA
GAILMIFAEKKHGKFVSSTVDELSYKQALTIGLFQCLAVIPGFSRAGSTISGGLLAGANH
KTAAEFSFLVALPIMVGATGLDLIKSLHFLHTSDIPMFAIGFVTAFVVAMCVAIVFIKVL
AKIGLTVFAYYRIALAALFIIFVIL
>A0A150C8D9|FEATURES|UNIPROT_deepARG|beta_lactam|AT269_19070|antibiotic inactivation|1
MLVSKKFFHIAHYKKMLPVVLLSCATLIGCSNSNIQSEPPKQTKQENTGNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGSLLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKTLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSFGTRNDIAIIWPPNKKPIMLAILSNHAKEDAKYDDKLIADATKI
VLDNLKVTNK
>A0A0F5ERG2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIELTHINKFFGEGENRTQVLKNINLNIQKGDFIAIIGQSGSGKSTLMNIIGCLDTAT
SGSYQIAGQEVSQLDRDALSDLRQKKFGFIFQRYNLLSTLSAVENVALPAIYAGIDQPTR
LARAKSLLEKLGLSDRLENKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVMEILTQLHSEGHTIILVTHDKNVANFANRIIEIKDGEIIEDRRKAEQISEKQAVSVQS
RKNPLQFYRDQFVESFKMSINAIVAHKLRSLLTMLGIIIGITSVVCVVALGNGSQQKILS
NINAIGTNTMDIYNGTGFGDRRAAKNQNLTVSDANILAKQSYIDSVTPNSSVSGTLTYGS
QSFSAQVRGVGEQFFNVKGLALAQGRFFTADEVKTSEQVAVIDENTLKDVFNHQNPLGKI
LMMNKKPLRVIGVAKSNNFGMNSSSLNIYIPYTTAMNKISGNQKISSITVKIRDEINSKV
AEKDLTNLLTVRHGKKDFFVMNTDTIKQTIESTTNTMKLLISSIALISLIVGGIGVMNIM
LVSVTERTKEIGVRMAIGARQFNILQQFLIEAVLICLIGGSTGVLLSLLIGMVFNLFVQD
FTMIFSTFSIVAALLCSSLIGVIFGYMPAKNASQLNPIIALAQE
>A0A0G8EMV7|FEATURES|UNIPROT_deepARG|beta_lactam|B4080_2229|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFS
QLEKKFNARLGVYVIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALR
>A0A0J6HM06|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRCVSIVIPVYNEQDSLPELLRRTEAACRQLHQDYEIVLVDDGSRDNSAQILEDA
ASRECSPVVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVAQAELGY
DVVATVRNNRQDSALRRWPSKLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEILVTHAEREHGESKYSPMRLISLMFDLITCMTTTPLRLLSIVGF
GMAGLGLLFAVMLIVLRLVFGAEWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRSHPSTPAPVVTVDGLTSTSSDQVLS
>K9A8K0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIVNLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAVAL
IVGALIIFWVESRQFEHKTLDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLVKNADVLTADNMINIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIALGVIILIAAMFFNLSA
>ABC60093|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ATITVAIVRIPKLGDRVQSLDPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LFPLISMDYFNGTPVHISITEISFASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSALFADRIGVNHWFLLSGILIICIAIVCPMINEIRKLDLK
>B8ZI28|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKS
>A0A0W7YKS4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIASILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLQKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLVA
GAILMLFAEVKKKEAAAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMIGATGLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>ZP_03345948|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFILCALF
NAWLLPAWKLSTARTPVREGMRRVMSNKRFVTYVLTLAGYYMLAVQAMLMLPIMVNDIAG
SPAAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMLPIGMVGNLQQL
FTLICAFYIGSVIAEPARETLSASPADARARGSYMGFSRLGLAIGGAISYIGGGWLFDMG
KALAQPELPWMMLGIIGFITFLALGWQFSHKRTPRRMLEPGA
>BAD65785|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDVWEWVVAAILGLVEGLTEYAPVSSTGHMIIVDDLWLKSSELVGSQNAYVFKIVIQLGS
ILAVALLFKDRLLQLAGFKKQAATQSEGRGLTLGKVAVGLLPAAVLGLLFEDKMESIFHV
RTVAFALIAGAFLMIAADFINKRNNKKKQQVDDISYKQALAIGLFQCLALWPGFSRSGST
ISGGVMLGLTHRAAANFTFIMAIPIMVGASALSLIKNWDALDISLLPFYATGFISAFLVS
LVVVRFFLKLINKIKLVPFALYRIALGLLLLFLFS
>R0F3L9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELCNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVTGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLVAAQAERMIEIHDGKIVHNPPAQEKKREQDVAAAA
VSTASGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQVLKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNASGVSGDYFNVYGISFSEGNTFNAVQQRDRAQVVVLDANTRRQLFPNKANVI
GEVVLVGNMPVIVIGVAEEKQSMYGNSNLLQIWLPYSTMSDRIMGQSWLNSITVRVKDGV
NSNQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0N0Z6M2|FEATURES|UNIPROT_deepARG|beta_lactam|M992_2411|antibiotic inactivation|1
MQCFRLPLILLLTAFCLPAFSVPETTLDRIKTTEEQLNGKVGYTELDLVSGKILESYRSK
ERFPMMSTHKVLLCAAILSRVDTGQEQLDRRIMYSQHNLDEYSPVTEKHLVDGMTVGELC
DAAITMSDNTAANLLLESMGGPQKLTSFLRKTGDQITRLDRYEPELNEAFPSDERDTTTP
ESMAQTMRNLFTGKILTPTSQAKLIDWMEADRVAGQLFRSVLPAGWYIADKSGAGKHGSR
GIVALLGPYGKPSRIVIIYMTQNEATMNELNRHIADIGNTLIKNW
>X5KT70|FEATURES|UNIPROT_deepARG|beta_lactam|BN978_04976|antibiotic inactivation|1
MTELSRRGVLIGSLAAIVAAGMSNQTASAAPLDGQISALEQRDNALIGIFATNLDNGRTV
TNRADDLFAMCSTFKGYAAGRILQQVGRGQLSLDKRVFVDPGAVVANSPVTGPRAGSEMS
LGELCQAALQQSDNTAANLLLRTMDGPAGITAFARSIGDDRTRLDRWETELNSAIPGDPR
DTSTPAALAAGYRRLLVEDALSPAQRGQLEEWMRGNQTSSLRAGLPAGWTTADKTGSGDY
GSTNDVGVAYGPDGQRLVLAVMTRSQADDPKADNLRPLIGELAALLVPSLL
>YP_002635521|FEATURES|ARDB_deepARG|multidrug|mepa|antibiotic efflux|0
MKDEQLYYFEKSPIFKAMMHFSLTMMIGTLLSVIYGILNIYFIGFLGDSHMISAISLTLP
IFAILMGLGNLFGVGGGTYISRLLGAKDYSKSKFVSSFSVYGGIVLGLIVILLTLPFSDQ
IAAILGARGETLAFTSNYLKVMFLSAPFVILFFILEQFARAVGAPIISMVGMLISVGLNI
ILDPILIFGFHLDVVGAALGTAISNVAAALFFIIYFMRNNDVVSLNIKFAKPTKQILTET
FKIGIPAFLMSILMGFTGLVLNLFLSHYGNFAIASYGISFRLVQVPELIIMGLCEGVVPL
IAYNFMANKTRMKDVIKMVIASIGVIFVICMVAVFTVGHHLIGLFSTDHAIIEMATFILK
VTMTSLLLNGIGFLFTGMLQATGQGRGATIMAILQGVVIIPVLFIMNGLFGLTGVIWSLL
IAETICAIASMLIVYALRDRLTVDTSQLVEG
>A0A0F0TFI0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACETLGKAYEILLVDDGSSDNSALMLTE
AAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLVITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFG
SIIALAGFTLSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKVSQEEKHP
>ZP_02635322|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGIDFLFILKALIIAIVEGLTEFVPVSSTGHMILVGDLIHFNTQSGGFPEMYEVVIQLGA
ILAVVVLYWRKISSSVVEFLCYIFSFIGLKTSGDKRKYEKRLAESKTGFRFGINVIIATI
PAAILGFLFDDEINKYLFSTKTVAVGFIVGGILLIVIENNFRKRAKRSKIVKDIDKMTYG
QSLLVGCFQCLSLWPGMSRSASTIMGGWISGLSTTVATEFTFFLGIPVMVGASGLKLFKF
DYSQMDGTYLIALILGFIVAFIVSLVVIDKFINYLKKKPMRVFAIYRVFAGIVLAILIFT
KVIS
>A0A0U3TSF1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|ybjZ|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNAITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDYFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>R5YDZ1|FEATURES|UNIPROT_deepARG|beta_lactam|BN537_02049|antibiotic target replacement|1
MGYLVYFNLVRAQKIVNNPHNERQNNFAQQVVRGNITDKDGVVLAETQTDEAGNESRVYP
YGDVFAHVIGYDSSLGKTGLESVENFELLTSNAFFLEKIRNEFQDTKNIGDTVVTTLDAQ
LQQAAYDALADNKGAVVVLEPATGKILAMVSKPTFDPNQIETEWDYLNSDSDNSPLLNRV
TQGAYAPGSTFKIVTALEFMRENPDYANYTYDCQGAITWGDTTIHCFASTVHGLEDLRSS
FANSCNSSFANIGLSLNKTSYRQTAEELLFNKKLPSVLDYSKSSFAVDENTGEAEIMMTA
MGQGNTLVSPYHMALITSAVANGGTLMRPYLVDKVTNHTGNEISKNVPKSYKKLMTSDEA
AQLKEYMRAVVEEGTGMDLNYGSYTVAGKTGTAEYSMDDGEKTHSWFVGFTNVDNPELVI
SVIIEGYDGNSGAKAVPIAKQILDSYYNR
>AAB22638|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-1|antibiotic inactivation|1
QTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAVAAVLKKSE
SEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLAELSAAALQYSDNVAMNKLISHVGGP
ASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRA
QLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQ
PQPKAESRRDVLASAAKIVTNGL
>S1CFA5|FEATURES|UNIPROT_deepARG|beta_lactam|A1SC_03510|antibiotic inactivation|1
MLKMTLCALLITASCSALAAPQQLNDIVHRTMTPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPVTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPDWTPGTQRLYANSSIGLFGSLAVK
PSGLSFEQAMDTRVFQPLKLTHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWLQSNIDPRNINDKTLQQGIQLAQSRYWKIGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPAPAVRTSWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPVRVAAAWQILNALQ
>B3GPP4|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMVQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>A0A127T1C3|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MSELENRIDSLLNGNKATVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQ
SISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIEYAG
GIKHINDYIRRLGIDSFNLSETEDDMHSSFEAVYRNWSTPSAMAQLLRTADEKELFSNKE
LKDFLWQTMIDTETGANKLKGMLPAQTVVGHKTGSSDRNADGMKTADNDAGLVILPDGRK
YYIATFIMDSYETDEDNADIIARISRMVYDAMR
>C7H1Z2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLEILKAILMGIVEGITEWLPISSTGHMILVEQVVKFNASEEFMSMFRVVIQLGAILAV
VVLFWNKLWPFGLRHGRVCSKPAVWQLWFKVVAATIPVLIISPLDDWFETRFYNYITVAA
MLILYGVLFILVENRRTAPHVTRLEQITYREAFIVGVWQMLAIIPGTSRSGATIVGGLLL
GLSRACVAEFTFFLAIPVMAGASLLKVVKFVLSGAAMTGTEIAVLVVGCVVAFVVSLAAI
RFLMDYVKRHNFKFFGLYRIVLGLIVLAVAAITAIA
>R4WED6|FEATURES|UNIPROT_deepARG|beta_lactam|AQU-1|antibiotic inactivation|1
SPLSSLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVFKEGQPHYFNY
GVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGSAFDG
ITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLAA
SSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVNPGMLADEAYG
IKTSSADLLAFVKANISGVDDKGLQQAIALTHQGRYSVGEMTQGLGWESYPYPVSEQTLQ
VGNSREVSFKGNPVKGFKVPVTFGEARLYNKTGSTSGFGAYVAFVPAKGVGIVMLANRSY
PIQE
>J3EEJ2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSHKAVVFAYHDIGCAGIEALLNAGYEIGAVFTHADDPKENTFYGSVAQLCSLKGIPVHA
PDDANHPLWVERIAKLNPDYIFSFYYRNLLSEALLATVSKGAFNLHGSLLPSYRGRAPAN
WVLVNGESETGVTLHRMVKRPDAGAIVAQQRVAIERSDTTLSLHGKLRDAAASLLRDTLP
ALAQGKVSETAQDESKASYFGRRTAADGKLLWSQPAEQLFNLVRAVTKPYPGAFCAVGEH
KLIVWSAEVIKGNEGQAPGRVISVDPLRIACGQDSLLINAGQRNDNGLYLSGPQLANELG
LVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDKYEVYGLDIGCDAIERLR
NHPHFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDRNFDEDSSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GSKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIVDNENDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESKSFYGAGYQDVEHRKPSIANAKRLLNWEPTVEMKETIGNTLDFFLREAMLEIA
EHSKEEAC
>S7WUC3|FEATURES|UNIPROT_deepARG|beta_lactam|L292_2194|antibiotic inactivation|1
MQTKYELKVKRLMMQSKYQNLFSNKTLMLIGLLSCSSSLWAQPLTELQIKKIVDQQFKPL
LEEYKIPGLAVAVTLDGQHYFVNYGVASLQSKQAMTNSTLFELGSVSKTFNATLAGYAQA
QGGLSLSDHPAKYFPELKNTSVNQATLLNLGTYSAGGFPLQFPVEVVTQQDMVQYFQNWK
TKTKIGEARQYSNPSIGLMGYVTALAMKKPYAELIEKTLLPQLGMTQSYIHVPEQKMSQY
AWGYKNNQAIRVSAGMFDAEAYGVKSSSSDMLKFLDAQINSAQLDRPIRQGVENTHIGYY
KVGAMTQGLGWEQYAYPVKLETLLQGNSSKMALESHAVTLIKHPQIASQSTYFNKTGSTN
GFGAYAAFVPQHKIGMVMLANTNFPNEARIKATYQAMQQILKQKAAP
>A0A0J5PAH3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAIIIGIVEGLTEFLPVSSTGHIDLVSQFVQISQGKDFENMFEYVIQFGAIMAVV
ILYFSKLNPFSAKKTVRERQDTWVLWFKVIIACLPSIIIGLPLNDFMDEHLHKPAVVATA
LIVYGILFIVIENIYKNKAPKISSLANIGYSTAFFIGLYQALSIVPGTSRSGATILGAII
LGASRYVATEFSFFLAIPTMVGVTILKVGSYLLKGNTFTGEQWAVLATGTFVSFIVAVVA
IKWLLKFVQTHDFKAFGWYRIIIGLIVFAVMFM
>EDK62636|FEATURES|ARDB_deepARG|quinolone|PmrA|antibiotic efflux|1
MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISA
ALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNA
TALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAI
LTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVR
DLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANA
SSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRIFAFNQVFFYLGGVVGPMAGS
AVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI
>A0A157S4M9|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDGTLYLIKAFVLGILEGLTEFIPVSSTGHLILFGDLIHFESSSGKVFEVVIQLGSILA
VMWIFRARLWQLVAGTLRGERQEVAFTRNLIVAFLPAAVVGAIFISAIKRLFYAPEVVAV
TLVLGGLIMLWVERRTHHTPGDQPGAADDTASDERATAHTLEQITWKQALAVGVAQCLAM
IPGTSRSGATIIGGMMAGIQRKTATEFSFFLAMPTMLAAAVYDMYRNMSLLTSHDLSAIA
VGFVAAFFSALLIVRAVLRFVANHTYRIFAWYRIALGIVVAAVLMA
>W7YNR4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLTSIILGIVEGITEFIPVSSTGHMILTSKLLGYNDQDPTMKTFEIVIQLGAILAIAI
VYWRRILDLLGIKKSQRTHGGLFPAKKLNLLHIIIGIAPALIVAFFARDFIKSLFSASTV
IWALVVGGLFMIFAEWFNKSKARITAEEMDDLTYKQVFMIGIYQILSVLWPGFSRSGATI
SGGMLSGASYKASADFSFLIAIPIMCAAAGYELLDSYKYMTKDTLGMFVIGFIVAFVVAY
VVVKIFMKFIQKIRLTHFAIYRFILAAVFWLFIMR
>C0EQK6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILILFKALILGIIEGLTEFLPISSTGHLIVFGDLMNFQSNGKVFEIAIQLGAVLAVVF
EYRQRFTHIIKGLGKERTANRFVLNLFIAFIPAAAVGLLFSKKIKLHLFNPITVATMLVL
GGFFILWVEKRQATAKPKVNHVDDMRPIDAFVVGCSQICALIPGTSRSGSTIMGGMLWGL
ERKTATEFSFFLAVPMMIAATGYDILKNYKLFTLQDVGQIAIGFIAAFIAGLLAVKALLK
FVSSKNYVPFAYYRIVFGGLILLTWMLGWVSWSE
>A0A084TE22|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKHNQAINFVSIVIPVYNEENCLQELIDRTTKASDSLGKDYELILVDDGSRDRSAEIIEE
ASAKEGSHVVGVILNRNYGQHNAIMAGFEQVRGDLIITLDADLQNPPEEIPNLVAKAEEG
FDSVGTVRKNRQDSALRRYPSKLINKLVKRSTGVEMNDYGCMLRAYRRHVVDAMLECHER
STFIPVLANGFSRHTTEIDVHHDERADGESKYSFMKLISLMFDLITSMTTAPLRLLSIVG
GGIAAAGIAFGVILMLMRIMFGSEWAGDGLFTLFAILFVFVGAQFVGLGLLGEYIGRIYS
DVRARPRFYVQDVLVGEATKNARESDELKNKE
>C8CE53|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-30|antibiotic inactivation|1
ESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGM
TVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDE
RDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEVDKVAGPLLRSALPAGWFIADKSGA
GERGSSGIIAALGPDGKPSRIVIIYTTGSQATMDERNRQI
>A0A0G8ESS1|FEATURES|UNIPROT_deepARG|beta_lactam|B4080_3222|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSESSKQTKQTNQTKQETTGNDSFV
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>D4E8G0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MASLLELHGIRRSYQSGEQTVDVLKDVSLSIDAGEMVAIMGASGSGKSTLMNILGCLDQP
SAGTYRVAGQDVATLDGDALAALRREHFGFIFQRYHLLPHLSASHNVEVPAVYAGLGKAA
RRERAEALLRRLGLAERVNYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLREQGHTVIIVTHDPAVAQQAERIIEIRDGEIIADSRPVSAERPQAKALEL
ATPAPSWQQIGGRFREALVMAWRAMAANKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPTYRQSLKYDDLDALREQPYVSALSPSIGSSMRLRF
GNVDVAANVNGVSEQYFRVYGMGFSQGTGIDALQLQSQAQIAVIDENTRRRLFPHSRNVI
GEVILVGNMPATVIGVAQQKQSMFGSSKTLSIWIPYSTMANRLMGNAYFDSITVRIREGY
NSQEAEQQLTRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGIMLSLAIGLLVQL
VLPGWQISFPPAALVSAFACSTGIGVVFGYLPARNAARLNPIDALARE
>A0ESH2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAA
NKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGIRMLDLA
TYTAGGLPLQVPDEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLFGALAVKPSGMSF
EQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKAIHVSPGMLDAEAYGVKTNIQDM
ASWLKANMNPDALSDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEAKTVVEGSDNK
VALAPLPVAEVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLANKSYPNPARV
EAAYRILSALQ
>A0A0F4IJI2|FEATURES|UNIPROT_deepARG|beta_lactam|VR43_13910|antibiotic inactivation|1
MEQTRRAVLTLGAGVALGAALPAGAARAAAPGGGGEAARRLRALEREYGARVGAYARDTG
TGRTVLYRADELFPMCSVFKAPAAAAVMRDLDRDGEFLARRIHYTQGDVTAAGGGSVTER
PENIAGGLTVAELCSAAIAQSDNCAANLLLRELGGPTAITRFCRSVGDRTTRLDRWEPEL
NSAEPSRVTDTTSPRAIARTYGRLVLGDALVPRHRELLTRWLVSNTTSDDRFRAGLPRDW
VIGDKTGAGSYGTNNNVGIAWPPGRPPVELAVLTTKPDAAAPRENALVARAAEVLAAALT
>YP_002707503|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRSSLLALTLAAVLPVAHARAADAPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTENLT
ALLVQTSEGAVLLDGGMPQMAGHLLDNLKARGVAAQDLRLILLSHAHADHAGPVAELKRR
TGARVVANAESAVLLARGGSDDLHFGDDITFAPASTDRIVMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTREGKPVRIAYADSLSAPGYQLRGNARYPRLIEDYTRSFATVRGLPCD
LLLTPHPGASHWDYAAGSKAGAKALTCKAYADDAEAKFDAQLANETVRAR
>A0A0A7JJR1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLSLRPSLLALAMTAACAPVLADDLQRQVDAVIQPLMQAQHIPGMVVAVYANGQERYFSY
GLADQAHKRAVTPDTLFEVGSVSKTYTATLVALASAEGRLDLDAPASRYQPALAGTALGK
ASVRALGAYSADCLPLQFPDEVTTDEQALNFLQHWQQKTTPETRRCYSNPSLGLFGDLAA
RAQQRPFADLMTQTLLPALGLKHTYLQVPTSAREQYAQGYDAQMRPVRVGPGPFADQAYG
IKTSASDMLRYLRTELDPQGLPAALSQAIGITHGGYYQVGEMTQGLGWERYPYPVKLDTL
IQGNAAQMIREPQVTRRLQPAQPDGAAYWYNKTGATNGFGAYVAFVPSKNVAIALLANRN
YPNDDRVRAAHAILALVSH
>A0A0Q8R3I6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRALPLFWILCCFLSGSSPATADTDRSQVRSIIDNAVRPVIQQYDLPGMAIAITMDGERY
FYHAGVMSRETRQPVTSNTLFEIGSISKTFTATLATYAQQDGKLSLDDTLSKHLPALRGS
SFEHVSLLNLATHTAGKLPLQVPDDIHGNDQLMDYLRQWRPVFSAGTHRTYSNISIGLLG
VAAAASMRLPFEDAIEKKLFPGLGMTHSYIRVPAEQTPHYAQGYSRKDAPVRLNPGVLAS
EAYGVKSNVVDMIRFIEANMQMLALDPKLQRAVIDTHAGYFKAGDMTQDLIWEQYPYPVA
LKQVLSGNSDAMVYGSTPVTSLDGPLPPAENMMINKTGSTNGFAAYVAFIPARKLGIVML
ANKNYPVAARVTAAYRILTALDKQMTGTR
>K8DKP3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDMHSLLVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGHPPHEGLGKSRLSLIHILLGMVPAVVLGLVFHDFIKSLFNPIN
VMYALVVGGVLLIIAEVLKPKEPKAPGLDDMTYRQAFFIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFLLAVPMMMGATALDLYKSMGFLTMADLPMFAVGFVTAFVVALVA
IKTFLHIIKRISFIPFAIYRFIVAAAVFAVFM
>A0A0P8M1D3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSHIRRSYPSGEGLVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPSQKPSGGRDIAEPT
VKTASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTALQKQPWVSSVTPAVSKNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRRQLFPNKAKVV
GEVVLVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTATGVLFGWLPARNAARLDPVDALARE
>YP_791220|FEATURES|ARDB_deepARG|multidrug|amrA|antibiotic efflux|1
MHIQWTGSLRGLLAALVALFLLGCEEAADTGKTAEAPAEVGVIVARPAPIGITSELPGRL
EAYRQAEVRARVAGIVTRRLYEEGQDVRAGTVLFQIDPAPLKAALDISRGALARAEASHA
AAADKLKRYADLIKDRAISEREYTEAQTDARQALAQIASAKAELEQARLRLGYATVTAPI
DGRARRALVTEGALVGEDSPTPLTRVEQIDPIYVNFSQPAGEVAAMQRAIREGQVKGVAD
KDIAVRLVLADGSEYPLAGELLFSDLAVDPGTDTIAMRALFRNPHRELLPGGYVQVRLQR
AVNPQAITVPRDALIRTAQSAVVKVVNPQGVVEDVEVRADTLQGRDWIISRGLKGGERVI
VENAAQHAAGSSVQAVVRQPASADAPSPLAASPAGQ
>G8EX98|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
KCGLAGALVLMASFWGGSVRAAGISLTQVSGPVYVVEDNYYVKENSMVYFGAKGVTVVGA
TWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKS
DWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDE
QVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKAVVGGHDSPLHGPELIDHYEA
>A0A0P0CPI6|FEATURES|UNIPROT_deepARG|beta_lactam|TEM|antibiotic inactivation|1
SPEGRFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVR
ELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDT
TMPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWLFADK
>A8RSC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLVEVLKIIVLGIVEGFTEWLPISSTGHMILVDEIIHLNQPDAFKDVFLVVIQLGAILA
VVVMFFHKLNPFSPSKSSRQKDATWALWIKIIIACVPAAILGLLLDDWMEAHLFNAYVVA
AALIVYGVLFIVLENSSVCTNPRFNKVGQISAKTAFLIGMVQLLALIPGTSRSGSTILGA
MVLGCSRAAAAEFSFFLGIPVMFGASLLKIVKYFLAGNVFTGPQIFYTILGMLIAFVVSI
YSIQFLMSYVRKHDFKFFGYYRIILGVIVLAYFGITALAS
>A0A127SPT4|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MFKLIDKDNWKRKPYFDHYFSQIRCTYSITVNIDISGIIAFKNKSRSKLYPLLIYVLTKA
VNNHEEFRTAINDKGELGVWDTLLPCYTVFHEENETFSNLWTEWNDDLIAFLSNYERDIE
MFGGNYGIDAKPDTPANTFPISSLPWATFTGFNLNIFADGTYLLPIFTYGKYFQQDDKYL
IPLSIQVHHAVCDGFHVSRLINEIQQICNDMR
>A0A0K6JSJ1|FEATURES|UNIPROT_deepARG|chloramphenicol|BN2127_JRS3_01519|antibiotic inactivation|1
MFKKIDENYPRKEHFHHYTKVTRCSYSLVIDLDITKLHSILKEKKLKVYPVQIYLLARAV
QKIPEFRMDIVNDELGHWDLLHPSYTILNKETKTFSSIWTPYDENFARFYRSCVADIEAY
SESNKLFPKPHMPENMFNISSLPWIDFTSFNLNVSTDETYLLPIFTLGKFKVEEGKIILP
VAIQVHHAVCDGFHAGQYVEYLRWLIEHCEEWLNESLYT
>A0A101CZZ0|FEATURES|UNIPROT_deepARG|beta_lactam|XD36_3096|antibiotic inactivation|1
MLIRSFLFPLFIAVFPIYSIAQDHSDWGKVFDGFDATGTVVVVDERANDSSVLVYRPERA
SKRFPPASTFKIPHTLFALDAGAVRDEFQIFYWDGVERSFAGHNHDQDLRSAMRSSAVWV
FQQFAKDIGEERAEDYLKRIDYGSADPSSDEGAYWIYGNLGISAHEQIAFLKRLYKNDLP
FQTDHQRLVKDVMIVEAGRDWILRGKTGWDGKMGWWVGWVEWPTGPVFFALNIDTPNRTG
DLAKREQITLAILQSIGALPTLKQ
>J0CFQ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYINAVLLGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWREPANRDYAAKLIVAFLITAILGLVVKKLGFELPETATPIAWALIIGGIWMI
FAEWAAARKAPHKEITWLVAILVGIAQIVAGIFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASGYELLKTFKDGGAANEDWTALGIAFVVSTIVAFIAVKWLLAYIRSNR
FTLFAIYRIILGVLLLGMAATGLIG
>F8LZ53|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIGIQTAEIINSGGK
>CAJ43422|FEATURES|ARDB_deepARG|beta_lactam|y56|antibiotic inactivation|1
MKHSSLRRALLLAGITLPLVNFSLPTWAAAIPGSLDKQLAALEHSANGRLGIAMINTGNG
TKILYRGARRFPFCSTFKFMLAAAVLGQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH
GMTVSELCAATIQYSDNTAANLLLKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPN
DPRDTTTPAAMAASINKLVLGDALHPAQRSQLTAWLKGNTTGDATIRAGAPTDWIVGDKT
GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATKIILS
>T2LHV2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDNLHALILGIIEGLTEFLPVSSTGHMILGTTILGIDINEFWKSFLIIIQLGSILAVLFV
FWRKLFKGLDIWFKLAVGFFPTGLIGLVLYKYLKELFNGYVVVAMLILGGIVFIVIELAH
KNKEYKTDSLEKVSFLQAFCIGIIQSLAMIPGTSRSGASIIGGLLLGLNRKTAAEFSFLL
AIPTMIIATAYSIYKEPELLSNANALVPLSIGFVTAFIVAVFVIKFFLKFISKFDFIPFG
IYRIVLGILFFYLYYSGILNAGSEFKL
>R7BK07|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWIEYLKVIILGIVEGITEWLPISSTGHLILVDEFMKLNMSDAFKEMFDVVIQLGAIMA
VVVIYFKKLIPIDSVKKDDNKSKLAWNKDKLIMWGKILVACMPAAIIGVPFDDKLDELFY
NAPTVAVMLIVYGIAFIVVEKLHKGKAFKINDISEITFKTAALIGIFQVLALIPGTSRSG
ATIVGAMIIGVGRTAAAEFTFYLAVPVMFGASFLKILKFGFAFTAAEAAALILGMVVAFA
VSVVAIKFLMSYIKKHDFTVFGWYRIVLGVIVLAMMFVK
>A0A090EHF1|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFGKLWQMLIKLPSDPQTRHFVIGILIAFLPAAVIGAVGHDFIKNYLFESPKLICSMLI
IGGVVLLVVDRINFKPVHHDVERFPLSVYLKIGLFQCLSLIPGTSRSGSTIVGALLMGVD
KRAAAEFSFFLAMPTMVGAFAFDLFKNRNVLTSADLPIIAVGFIAAFVAALIVVRFLLDY
VSKNGYALFGWWRLVVGGLGLAALMIWG
>S0IS47|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAVVYGIVEGITEWLPVSSTGHMILLEEIMPMKVSQEFWNMFLVVVQLGAILAVV
LLFWNRIFPFQRNRRRQIRIDWKIMNLWVKILVACIPAGIVGILFDDWLEEHLYNFRVVA
VMLIAVGIVFIVVENRNRGVRPVICTTDELDYRVVLLIGMFQLVAAVFPGTSRSGATIIG
ALMIGVSRTVAAEFTFYLAIPVMFGASLLKLLKFGLTFTSMELGILFTGMIVSFIVSVVV
IRFLMGYIKKHDFKVFGWYRIVLGAVVLLYFGVIA
>A0A0K1NIN7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLQTIIISIVEGLTEFLPVSSTGHMIITQNLLGVPQGDEFVHAFTFIIQFGAILSVVC
LYWKRFFHIDHPPVPADEKSTFKRIIHPVRFYWLLFVGVLPAVVIGLAAKKSGLLDWLLD
SVWVVAIMLVVGGVFMLFCDKIFNKGKEENLVTEKRAFSIGLFQCLSVIPGTSRSMATIV
GGMANGLTRRRAAEFSFFLAVPTMAGATLLDLLDLLKADGSWASAHNLTMLAVGCVVSFI
VALLAMKWFVNFLAKYGFKWFGWYRIIIGIIIIVMLLFDVPLNMVD
>A0A077EG89|FEATURES|UNIPROT_deepARG|beta_lactam|BD94_2866|antibiotic inactivation|1
MLKKIKISLILALGLTSLKAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
DKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYST
KMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGC
IIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQHTLDLINE
YQQKQKASN
>YP_302230|FEATURES|ARDB_deepARG|multidrug|MepA|antibiotic efflux|0
MKDEQLYYFEKSSVFKGMMHFSVPMMIGSLLSVIYGILNIYFIGFLGDSHMISAISLTLP
IFAVLMGLGNLFGIGGGTYISRLLGAKDYVKTKFVSSFSIYGGLILGVIVILMTIFATEQ
IAHLLGARGETLGFTSAYLKVMFLSAPFVILFFILEQFARSIGAPIISMIGMLASVVLNI
ILDTILIFGFDLNVVGAALGTAISNVVASLFFIIYFLRKSDIITMSLSYVRPTKEILVEI
FKVGFPAFLMSILMGVTGLVLNLFLAGYGNFAIASYGISFRLVQFPELIIMGLCEGVVPL
IAYNFMSDKARMKNIIKVVIMTIVVIFAVCMVIVFTTGHQLIGIFSNDAAIVGMATFMLK
VTMTSLLLNGIGFLFTGMLQATGQGRGATIMAILQGVVIIPVLFVMNGLFGLTGIVWSLL
IAETICALAAMLIVYLLRDRLTVDKAELLEG
>B8ZI13|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKHSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKADLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKIIGYLGGPEKVTAFAQSIGDVTFRLDRMEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYLPSRS
>J9CI51|FEATURES|UNIPROT_deepARG|beta_lactam|IG3_01953|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGFQLGYSVLNLLLGFSIENLKGMMILKNKRMLKIGLCVGILGL
SLTSLEAFTGGALQVEAKEKTGPVNHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITYTKDDLVEYSPVTEKHVDTGMTLGQ
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFETELNEAIPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKVLTEWMKGNATGDKLIRAGVPTDWIVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEAAYDNQLIAEATEVIVKALK
>B0KUW7|FEATURES|UNIPROT_deepARG|beta_lactam|PputGB1_2905|antibiotic inactivation|1
MPRPRLAALAAAITLTLGHACAQADDQLQAKVDQIIRPLMQEQGISGMAVAIYARDHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLDAPAKRYHPALAGVP
IGDATVLELGAYSADCLPLQFPDTVQTPQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHQPFATLMREGLLAKMGLENTYLQVPASAHGLYAQGYDATDKPVRVGPGPYADE
AYGIKTSASDLLRYVRLQMQPQGLPAALVKATAITQQGYFQVGAMTQGLGWERYPYPVTL
STLVDGNSPRLIREPQATTRLQPALPALSAAWYNKTGSTNGFGAYAAFVPSEQLAVVLLA
NRNYPNEARVRAAFEILSGL
>YP_966872|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MSDMITAAILGLVEGLTEFLPVSSTGHLIITGELLGFTGPKAATFEVAIQLGAILAVVVL
YWDRFWGLLRPQPYVRFAGLRGIMLLLLTSLPASVLGLAAHSTIKAHLFTPSTVAIALAV
GAIFMLLVERRTERPRYMTLDEMSPALALGIGCFQCLALWPGFSRSAATIMGGMLLGARR
GLAAEYSFIAAVPIMFAATGYDLLKSWTLFTPADLPFFATGFVVSFLSAWAAVKLFIALV
GRMTFRPFAWYRLAIAPLVYYFMAY
>W8Y062|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDIHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTANTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPEHEGKGSGRLSLIHILLGMIPAVVMGLIFHDTIKSLFNPV
NVMYALIVGGVLLIAAEVLKPKQPRAVGIDDMTYRQAFVIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDVYKSIGFLNMGDVPMFAVGFVMAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>CAA69997|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMNA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>A0A0U0NMI8|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLI
RAGVPTEWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAT
KVIVKALK
>K8X1R6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSFVDEFEEIKKVSVVIPVYNEEQSLPQLLERTIKSCKQLTQAYELILVDDGSSDRSAKM
LTEAAENPDNHVIAIILNRNYGQHSAIMAGFNQADGDLVITLDADLQNPPEEIPRLVETA
SQGYDVVGTRRANRQDSWFRKTASKMINALITKATGRSMGDYGCMLRAYRRHIIEAMLQC
HERSTFIPILANTFARRTIEIDVAHAEREFGDSKYSFLKLINLMYDLLTCLTTAPLRLLS
VVGSIIAAGGFLLAVLLIVLRLVFGATWAAEGVFTLFAVLFMFIGAQFVGMGLLGEYIGR
IYNDVRARPRYFIQKVVGADAKTDKNQEEN
>A0A0Q8IGI6|FEATURES|UNIPROT_deepARG|aminoglycoside|ASD83_19545|antibiotic inactivation|1
MDRADHLGQPVRVALARAEDAADWTAMRTALWPSGGDGAHAADIAQLLDDAGETINLIAR
GDDGVALGFIEAALRRDYVNGCKTSPVAFLEGIFVKPEARGQGVARAMVAAVEAWAREQG
CSEFASDTAPENFVSQDMHRALGFEETQRVVFFRKVLG
>YP_001846483|FEATURES|ARDB_deepARG|multidrug|adeB|antibiotic efflux|1
MMSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTIND
SVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLP
QVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFG
AEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQ
LSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANA
VKTAEVVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFL
HNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERI
MATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSIL
FSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMM
VIFLVITGITFTGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNP
DVKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSDVNSSMANSTEGETMAVL
PPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNIS
LKIDREKLSAFGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILN
LKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLI
AKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLG
IFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAK
LRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFIFI
LGAVEKLFSSKKKISS
>YP_001811891|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIATAAIVTLAVVGLGTFGAMRVNANAPEKAAAPLPEVDVATVVPQTVTDW
QSYSGRLEAVEKVDVRPQVSGTIVAVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
GAQARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREASANLKAAEAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYINGARN
GRKVPVELGLANETGYSRSGEIDSVDNRLDTSSGTIRVRARFDNADGALVPGLYARVKVG
GSAPHQALLVDDAAINTDQDKKFVFVVDQQGRVSYREVQQGMQHGNRRVIVSGLSAGDRV
IVNGTQRVRPGEQVKPHMVPMTGGDAPSAPLASTAKPAAPAKADS
>A0A143HXB6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNNIRRSYPSGDGTVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVERKK
RLERAQMLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRESRAAAPKEALP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKASVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAIITAFLCSTFTGILFGWLPARNAARLDPVDALARE
>D8MX48|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDKADTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKVPHEGTGKGHLTLIHILLGMVPAVVIGLIFHDKIKELFNPIN
VMYALVVGGVLLLAAEYLKPKNPKAVGVDDMTYRQAFVIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSIGFLSMADLPMFAVGFLTAFVVALIA
IKVFLNLIKRISFVPFAIYRFIVAAAVYMIFV
>T8K214|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLISDDILQLATAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSRLEWHKPACVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSLTTAAQPGSVISVAPLLIACGYGTLEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQSTCAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWLEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVAHRKPSIRNARRCLGWEPKIDMQETIDETLDFFLRTVDLAEKSS
>BAA12916|FEATURES|ARDB_deepARG|beta_lactam|CFE-1|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTTRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVVDMTRWVQANMDASQVQEKTLQQGIKLAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>A0A0J1D7W2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTRLALACLGLLPLAGHAAADTAALRDAVDRAIKPLMAQHGVPGMAVAVTVDGQTTFFNY
GLASKEQRRAVSEHTLFELGSVSKTFTATLGCYARNLGKLSFDDHPGKAMPQLKGSAIDR
ASLLELGTYTAGGLPQQMPDEVTNEAQMVAYFRDWIPDAPPGTQRRYSNPSIGLFGHATA
LALQSGFADAVEGRLFPALGLRHSHIRIPAAAMADYAWGYDSANKPVRVSPGVFDAETYG
VKSSAADMIRFVQENIDPGQLPEAMRDAVACTHTGYFQTGDTVQGLGWEQYRLPVSLARL
QAGNGDRMSRGANPVTRLEPPQSSPRGTLFNKTGATRGFGAYVLFVPDRRVGIVMLANKN
YPNAARVEAAHAILGQLIK
>A0A0G0CCL4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELHILEIIKAIILGVVEGLTEFLPISSTGHLILINELIYFDEDFTVLFDIVIQFGAIIA
VLVYFIKKLWPFTKDEIKNKETLNIWYKTIVAILPAIFFGALFADFIKEKLFNPWVVIIL
FIENKKETIKVFSIEDLSFKTAFFIGLIQCLSMIPGVSRSASTIMGGIVLGASRVVSTEF
SFFLAIPTMFAASAYSLLKYEGALNLNQIFILLIGFIVSFFVALAIVKFLINFVQKHNFK
IFGYYRIILGIIILLYFLIK
>ZP_04004395|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPCENDTPINWKRNLIVVWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKIMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQISN
>R4TPV1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|xtlE|antibiotic efflux|0
MNMTVELSPYLARPADQQQPLLRLQRVSRSFMAGDREFLALKGIDLQIHAGELVAIIGAS
GSGKSTLMNILGCLDHASAGSYQVSGQETRDLDDDALAALRRDHFGFIFQRYHLLPHLDA
LRNVEIPAVYAGVSQAGRHARARELLGRLGLASHLAHRPSQLSGGQQQRVSICRALMNGG
EVILADEPTGALDTASGKEVMNILLELHAAGHTVILVTHDPKVAAHAERIIEVSDGQIVS
DRRTRPEAPAPTAAAAPAVEQARPRLVASLGLFREAFKMAWIALVSHRMRTLLTMLGIII
GITSVVSISAIGEGAKGYVLKDIQAIGSNTIDIYSGTSFGDSRAKAIETLMPADVTALNA
LYYVDSATPVIGQSSLVRYRNIDVDVQLNGVSEQYFQVRNIPLASGIVFSADDARRQAQV
VVIDHNTRKRLFGDGVNPLGQVILVGKLPCTVIGVTAENKNLFVAGNTLNVWMPYETAAG
RVLGQRHLDSISVRIKDGMPSKRVEEEVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSL
TLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCL
IGGVIGIGLSYGIGYLFALFVKQWEMVFSLGSIVTAFVCSTLIGIVFGFVPARNAARLDP
IEALARD
>A0A076HZ87|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNYWYALILAIVEGLTEFLPVSSTGHMIIVANLLGIGQLPFTETFITSIQLGAILSVVVL
YWRRFLQSFDFYVKLLVAFLPFGVLGFLLKDVIQELLKSVTVVAISLVVGGVILLFVDRW
FSGTRKAVTTPSLGQALRIGLFQCLALVPGVSRSAATIVGGLAQGFDRRSAADFSFLLAV
PTMVVITAYQLYKTYKVDAPGVEDLKLLLFGNVVAFIVGLLAVKSFVNFVSRFGFRAFGF
YRIIVGVIILVMIALGIPMQLI
>K1GX05|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKNIIEIQNINKFFGEGENRVHILKDISISIEKGDFVSIIGQSGSGKSTLMNIIGCLDKA
TSGKYYIGGEEISGFSPDELSELRKKKFGFIFQRYHLLTSLNAQENVALPAIYAGVEHDE
RMKRAEKLLDKLELSTKLKNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSG
IRVMEILNQLHEEGHTIILVTHDKGIANQANRVIEIKDGEIFNDTRLREIKKENQEDKKS
VNDLKKNKFQVAKDQFFESFKMSVSAIVAHKMRSLLTMLGIIIGIASIVCVVAIGNGSQQ
KVLANISSLGTNTMDIFNGEGMGNRFANRIKSLSTTDVDILEKQSYVDSVTPNSSSSGTI
VYQNKSFSGSLKGVGADYFDVRGVTISSGRAFSKEDETDLTSVALIDENTQKSLFGENEN
PIGKVILFNKKPLKIIGTVELNNVIGMNSSELNVFAPYTVVMNKVSGEKYIGSITVKVKD
DIDSQVAQKSITDLLKAKHGKKDFFIMNTDTLKKTIESTTGTMKILISSIAVISLVVGGI
GVMNIMLVSVTERTKEIGIRMAIGAKEKNILQQFLLEAVLICFIGGIVGIVLSLLIGWGF
NSISTSFSMIFSSFSIVMAVLFSTLVGVVFGYMPAKNAAKLDPIEALSRE
>J2YF63|FEATURES|UNIPROT_deepARG|beta_lactam|PMI26_04206|antibiotic inactivation|1
MDRLKTIAAGMAIFAAGQCVAQDQIETLVNAAVQPVMQAEGIHGMAVAVTVNGQAHYFNY
GVASTETGSPVTKDTLFEIGSVSKTFTATLAAYAQDTGKLSLSDKASQILPALRGSAFDN
ISVLQLGTYSAGGLPLQFPAESDSADKMLGYYKQWKPLYAPGSHRLYSNPSLGLFGYLAA
HSMGQPFDDLMEKTLLPKLGLKHTYVHVPQDQMALYAQGYNKDGKPVRVTPGALDSEAYG
VKTSASDLLAYVDANMKPAHLDKPLQQAIALTHSAYYSVGDMTQGLGWEMYRYPITLDRL
LDGNSTPMAMQAHEVQWLNPPQAQPQNVLINKTGSTGGFGAYVAYVPSKEIGIVMLANKN
FPNAQRVRIAHQILSALGQ
>A0A0A6FL34|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVATALV
VGGIIMLWAEKRQHEVHAETVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IASHSYAAFAWYRIVFGLLILATWQFGWVDWAAARP
>N9BLX4|FEATURES|UNIPROT_deepARG|beta_lactam|F944_03268|antibiotic inactivation|1
MLSLLQRSRYSHKPLWSKKSLCLMGLLACSAPLDAKDLSEQQVKAVIDQQFKPLLAQYNI
PGLAVGVSLNGQHYFVNYGVASKQTQQAVSSHTLFELGSVSKIFNATLAGYAQATGKLSL
DDHPAQYFPALKNTAVNNATLLNLGTYTAGGFPLQFPDQVTEQQDMLKYFQTWQPKNTIG
TQRQYSNPSIGLMGYVTALAMEKPYTELLEKMLFPALGLNESFIDVPEQQMTQYAWGYKG
QQAMRVSAGMFDAEAYGVKSSSADLLKFLDAQINPQQLKQPLRKAIENTHVGYFKVGAMT
QGLGWEQYSYPIKLDTLLEGNSKQMAFESHAVIPIKQPKLADPATFFNKTGATNGFGAYV
AFIPQQKIGMVMLANTNFPNEERIKVSYRVMQQLLQSNSAQ
>J8BF81|FEATURES|UNIPROT_deepARG|chloramphenicol|IEI_02717|antibiotic inactivation|1
MRFHIIDRENWNREQYFEHYLKLKCTFSMTVNVDITRLLKELNQKGIKFYPVFIYLISRV
LNNHKEFRTCFNDEGVLGYWEEMTPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMR
CYANVHGLFTKENIPPNAFPISSIPWASFTGFNLNINNDGDFLLPIITCGKYFTEENKVI
LPVSLQVHHSVCDGYHASRFIEDLQELSNSCNEWLK
>R1H807|FEATURES|UNIPROT_deepARG|beta_lactam|G113_02924|antibiotic inactivation|1
MSRILLPGLIAASLLFSVPASAAGCWLFADGTGQPLSQQGECSQRLPPASTFKIPLALMG
YDSGFLVDEQLPALPFKAGDADFLPAWRETTTPSRWMDHSVIWYSQRLTEWLGEARFQQY
VDHFDYGNRDLAGNPGKQDGLTQAWLSSSLGISPLEQASFLGKLVSGKLPVAADAVRHTS
AIMRQPDIDGWQVYGKTGMGYFKQADGSLDRQRPIGWFVGWASKGDQTRIFVHTVLDKPG
KQFASVRAKEELFAALPDKLKQ
>BAC57479|FEATURES|ARDB_deepARG|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWEKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>ZP_00990220|FEATURES|ARDB_deepARG|tetracycline|tet34|antibiotic target alteration|1
MSNKFVITWDNMQTYCRQLAEKQMPAEQWKGIWAVSRGGLVPGAILARELGIRHVDTICI
SSYDHDHQRDMTVVKAPEGDGEGFLIVEDLVDSGDTARKLREMYPKAKLIAVCAKPSGAH
LLDEYIVDIAQDTWIEQPWDTSLSFIEPVNRKSK
>P36556|FEATURES|UNIPROT_deepARG|polymyxin|basR|antibiotic target alteration|0
MKILIVEDDTLLLQGLILAAQTEGYACDGVSTARAAEHSLESGHYSLMVLDLGLPDEDGL
HFLTRIRQKKYTLPVLILTAHDTLNDRITGLDVGADDYLVKPFALEELHARIRALLRRHN
NQGESELTVGNLTLNIGRHQAWRDGQELTLTPKEYALLSRLMLKAGSPVHREILYNDIYN
WDNEPSTNTLEVHIHNLRDKVGKSRIRTVRGFGYMLVATEES
>A0A0W1B3T1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDVIKAIILGIIEGLTEFLPVSSTGHLILAGNLLSFEGDAAITFKIVIQLGAVMAVLIL
YWKRYLEIGANMIRMDFSKSKGLNVIHMILAMLPALILYLLFKDTIKSQLFGPTPVLIGL
VVGGVLMIIAARNRRTETADTIDGINYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFIISVPVMFGASLLDLYDSRDLLSSDDLILMLIGFATSFLVAMIAVVTFIK
LIKRLRLEWFALYRFVLAALFYLIVIQ
>A0A0R1J1E5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFVKLNESAAFIHMFMVVIQFGAILAV
ILIYFHKLNPFSPRKSSHEKKLTWNIWFKVLVAIIPSVVIGFPLNDWMDAHLTSWQVIAA
TLLIYGILFIIVENYFKNKRPQVTDLDNLSYKTALEIGLFQVLSLVPGTSRSGATILGGI
SIGTSRFVATEFSFFLAIPTMFGASLLKILKYFKNGNTFTSSQAIILLIGTFVSFVVAYV
SIKFLLNYIKHNDFKAFGWYRIILAVIVILYFGFFKAFV
>A0A0G0RZC9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLYLYSIIAGLIQAITEFLPVSSSGHLIILHDILNFQVGNTLAFDVALHLGTALALIIY
FRRDIWKYILAVIEIFIPKRPVNQRDLKDVMLIIYASIPAVILGFLLNKFAPTMFRQTEV
VVVTLVVVALLFFIVEKTAKHTGDYTGMSIGKAFYIGCAQALALIPGVSRSGITIIAGMS
ADLKRSEAAKFSFLLSIPVVLGAGVLEMFDIAWTKLSNQEIMSIIVGFVVSATVGFVVIK
FFLKYIEHHKLNVFGWYRIGLALVLIIGMWLNK
>J8EYN3|FEATURES|UNIPROT_deepARG|beta_lactam|III_04425|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFT
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DNLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A0X7JYS0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQALLELKGISRSFVAGEKAFMALKNVNLTINAGEMVAITGASGSGKSTLMNILGCLDY
ATEGSYTINGRETRDLEDHELAELRRDHFGFIFQRYHLLPHLSAMHNVEMPSIYAGVTEA
QRHSRAKELLARLGLANHLVNRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTAS
GKEVMNILLELHAAGHTVIIVTHDAKVAANAERIIEMRDGEVLSDRANERVGMEAAAPAA
TQLKASPGRRLVASLGLFKEAFVMAWIALISHRMRTLLTMLGIVIGITSVVSIVAIGEGA
KRYVLSDIQAIGSNTIDIYPGTDFGDSHASAIQTLVLSDVTALSQLHYIDSATPNAGRNL
LLRFGNIDVDATVNGVSASSFQVRGIKIAEGITFSQEDDTRQAQVVVIDHNTRNRLFGPN
VEALGQIILVGNLPCTVIGVAAENKNIFNTSKALNVWVPYETAAGRLLGQRYLDSITVRI
KDGQPSKVVEANVVKLLEQRHGTKDFFTYNLDSIMQTVQKTSQSLALLLSLIALISLVVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGISLSFGIGF
VFSLLIKEWQMVFSLESIVTAFVCSSLIGIIFGFVPARNAARLDPIEALARD
>A0A0H4P2E4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEVIKAIVLGCVEGLTEFLPISSTGHLILVGHFLSFTGDKAKTFEIVIQLGSILAVVVL
YFKRFLSLFNFKKRSGLNLLHIIIGMIPASVLGFLFHDVIKNVLFSPFTVGIGLFLGAFL
MIYAEKKSKTESTQDLDHLSYKQAFIIGLYQCLSLWPGFSRAGSTISGGLLAGANHKTAA
EYSFLLAVPMMVAASGLDLLKSYQYLSIHDLNYFAAGFITAFIVAMLAIVFFLKILSKVK
LIPFAIYRIIIGIIVIAYFI
>A2RNZ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMDIDRLPYRAALYIDLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLNFEQFGVLLVACLVAF
GVSMVAIKFLTDYVKKHDFTFFGKYRIVLGIVLLIYAAFKAFLG
>D5LY09|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEEQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ACM47288|FEATURES|ARDB_deepARG|glycopeptide|vanXD|antibiotic target alteration|1
MKKNFAFLDEMIPGIRWDAKYATWDNFTGKPVDGYMVNRVMGTKELGVALRKAQKMAEKL
GYGLLLWDGYRPQCAVNCFLNWASQPEDNLTKKRYYPNIKRNEMVTKGYVASQSSHSRGS
AVDLTIFRLDTGMLVPMGGDFDFMDVRSHHAASGLSEEESKNRQCLRYIMESSGFEAYRY
EWWHYVLADEPYPDTYFDFCIA
>A0A0D6T623|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKAYLFQPYTVVIGLVA
GAFLMIFAEAKKAEVTAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIALPVMAGATGLDLLKSWKYLSAADIPMFAIGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAIVFTLFVLL
>R4WCW7|FEATURES|UNIPROT_deepARG|beta_lactam|AQU-1|antibiotic inactivation|1
SPLSLLALSALLLSPLTQAAPADPLVGVVDEVIRPLVKEHRIPGMAVAVFKEGQPHYFNY
GVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGSAFDG
ITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLAA
SSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLADEAYG
IKTSSADLLAFVKANINGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYPVSEQALQ
VGNSREVSFKGNPVKGFKAPVTFGEARLYNKTGSTNGFGAYVAFVPAKGVGIVMLANRSY
PIQE
>A0A095Z6R6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSMNIIYLLKAAFIGMIEGLSEFLPISSTAHLIIWGDWINFDSGEVKVYEIVIQFGSILA
VIWIYRHYLLELLGGLLRREQKYVLVTRNLILAFLPAAVIGLLIIDQVAKLLDGKFFVYV
FTLIVGGLIMLWVESRPHMSKANQLIDENTPLGAGLEKITWKQALVVGFAQCLAMVPGTS
RSGATIISGMIAGIPRRTATEFSFFLAMPTMLAATVLSLYKYGDQLSDENISAIVVGFIF
AFLSALVLVRAILRFVSKFSYKPFAIYRIIFGAVVGLWALGYL
>A0A0T9STW4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLKKSIINTLVFTTIATSPLYATAQTILTEQQVAAIVNKTLKPLLEQQNIPGMAVAVFYD
GKPQFFNYGVADIKAGIPVTENTLFELGSVSKTFTGIAGEYAAQTGIMNLNDPVTEYAPE
LTGSQWQGVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPQWAPGVMRNYSNASI
GLFGALAVKKSQLTFENYMKEFVFQPLKLTHTFITVPESMQSNYAWGYKDGQPVRVTLGM
LGEEAYGVKSTTKDMVRFMQANMEPNNLPTENDKLKKAIVAAQSRYFQAGDLFQGLGWEM
YNWPINPQTVIADSGNDIALKPRKVEELLPPQPATPASWVHKTGATNGFGAYIVFIPQEK
IGIVMLANKNYPNPVRVQAAYNILQALR
>B0P3M2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILLLKTVLLGIVEGITEWLPISSTGHLILADEFIKLNMTADFKEMFDVVIQLGAIMA
VVVLYFHKLNPFSPKKNHDEKMDTIILWTKVILAVFPAAIIGILFDDWLNDHFYNPPVVA
AMLIIYGVLFIIIENRNKRSRRRPMNDLSRLSYGMALGIGVFQILALIPGTSRSGATILG
GILLGCSRTVAAEFSFFLGIPVMFGASLLKIVKFGLAFTSTQLIVLIVGMVVSFLVSIGA
IKFLLGYIKKNDFKAFGVYRIILGLLVIVYFAFIK
>A0A0U4H8U7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKSKVSALLMMIVLASHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
SKATRKPVDEKTLFEIGSLSKTFTATLASEAQHEGKLDFSAPASQYLPALKGSAFDHVTL
LNLATHTAGTPLFVPDAVKNTAQLMAWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALD
KPFSEAMEQGLLKDFGMTHTFINVPDAAMDDYAQGYNKDDKPVRVTPGPLDAESYGLKSG
SADLLRYLQIQLGEQEVAPRWRQAINATHNGYYRSGEFTQGMMWEYYPWPSPLSRLLEGN
SSQRIMKGLAATTIVPPQPAPEAAWYNKTGSTNGFSTYAVFIPEKRIALIMLANKWFPND
DRVKAAYAIIQELDK
>YP_002367214|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTEWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALK
>G5QZW7|FEATURES|UNIPROT_deepARG|aminoglycoside|LTSESEN_2493|antibiotic inactivation|1
MDIRQMNRTHLDHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHQALGFEETERVIFYRKRC
>A0A0V9E3Y0|FEATURES|UNIPROT_deepARG|chloramphenicol|APT89_17335|antibiotic inactivation|1
MEKITPEYTSVDLSRWARKEHFEIFQGFAQSTFNQTVLIDITALLKHIKAVGWKFYPTII
FLISKIVNSHPEFRMAMKDNELIIWNEIHPNYTIFHNETETFSSLWSHYDGNIQHFQNTY
AEDIARYGNNFSYWPKEESRENIFFISGIPWVSFTSFNVNVAHMKNFFAPMFTLGKYYEQ
DGKVLLPLAVQVHHSVCDGFHVARLYNELQEMIDALPRSGA
>B9VQ92|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0F4TGE0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAIAFNIIIQLGAILAVV
WEFRRKIIDVVTGLPTQPGARRFTANLLIAFMPAVVLGVIFSDLIHKYLFNPITVATALV
VGGIIMLWAEKRQHEVHADTVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVAAAVYSGYKYRHLFVPSDFPVFAIGFVTAFIFAMIAVRGLLKF
IASHSYAAFAWYRIVFGLVILATWQFGWVDWAAVKP
>W8DN87|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
ALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADV
AANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGIRMLD
LATYTAGGLPLQVPDEVTDNASLLRFYQHWQPQWKPGATRLYANASIGLFGALAVKPSGM
SFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQ
DISSWVKANMNPAALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEAKTVVEGSD
NKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLANKSYPNPA
RVEA
>A0A0D6S0P7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLVSIALALPTSAKARRFVLAVALAFLPAAIIGALAHDFIKTVLFETPMLICVVLI
IGGVILLAVDRMPLNPKYTDIMDYPPSLAFKIGLFQCLAMIPGTSRSGATIVGSLLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDGALIAVGFIAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIAIGSLGLIALLVLD
>A0A107APN2|FEATURES|UNIPROT_deepARG|beta_lactam|WT44_29000|antibiotic inactivation|1
MTYSSQRRTLLLAAATAPLVLTVNACASSQAGAPSVASATSFDALEHAAGGRLGVCAIDT
ATGRRVQHRADERFPFCSTFKAMLIAAVLAQSVARPALLAQRVTYRQADLVRYSPVTEQH
VGAGMTVGELCEATAQYSDNSAANLLMKVLGGPSAVTAFARTIGDDTFRLDRWETELNTA
LPGDTRDTTTPAAMAASLRVLALGDALPAPQRAQFAAWLRGNKTGDKRIRAGVPAGWQVG
DKTGTGDYGTTNDVGVLWPPARGPVALAVYYTQARADAQAKDDVIAAATRIAIAALG
>A0A069XPM1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERGIEIRDGEIVRNPPAIEKVNVTGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKKRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPTRNAARLDPVDALARE
>T0PHK9|FEATURES|UNIPROT_deepARG|chloramphenicol|M918_20150|antibiotic inactivation|1
MKFNLIDIDQWDRKPYFEHYFNSVKCTYSITANIEITNLLKDIKITKLKLYPTLIYIIAT
VINNHEEFRTCFDENNNLGYWDSMSPNYTIFHEETKTFSNIWTEYDKSFSGFYNKYVEDN
KNYGNIMNFDPKLNEPANTFPISCIPWVSFTGFNLNIQDHGTYLTPIFTLGKYFEENNKV
FIPMSIQVHHAVCDGYHTSRFINEVQELASNSQSWLKH
>F5CE85|FEATURES|UNIPROT_deepARG|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGS
VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLKEYPDSGENI
VDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>A0A0Q8BY11|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACEQLAYEYEIILVDDGSRDDSAQLLEDA
AAAEGSHVVAVILNRNYGQHAAIMAGFEQCRGDVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGVLFAFALIIMRLAFGADWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGLVSSHTSTSPSDQVQS
>A0A0G0KIL2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIFQSALLGIIQGLTEFLPVSSSGHLVLVQSLIPNFSQEGILFDTFLHFGTILAVLVFY
FNRIIKLKFNEIKILAIATIPAVVVGFILKDGIDAIFQNTTLVGFALIVTGLMNLRTDEH
KEITDTVDIKNGIIIGLFQAFAILPGISRSGSTIFGGTLLGVKKEKAAEYSFLLSIPAVL
GANLLEIIKSGEDFVLLPEYIVGIICSFVFGLICIKVLLNMLSTNKFKYFGYYCILVGVV
SLIAK
>F0EAB9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADVIGFGGERAMAFNIIIQLAAILAVM
WEFRSRICEVVFGLRSQPKARRFTGNLFLAFLPAVVLGVLFADLIHEYLFNPVTVAAALV
VGGVIMLWAERRTHRVEVDHVDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMIGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYAAFAWYRIVFGLFILATWQFGWVNWTSVHG
>I5CU61|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKFGTVSARVAAMLCAMWMTSGASHAADATQDNLKRAVDAAIQPLMTKDKIPGMAVGVIV
DGRAVVFNYGVASTETGKPVTDATLFELGSVSKTFTATLTSWAQVDKQLSLTDSVAKYLP
TLRGTQFGSVSLLNLGTHTPGGLPLQVPDDIQNDDQMIRWFKAWRPAHAPGTVRTYANPG
IGALGMITAKSMGQDFTALIERRLFPALGLKNSFIDVPVDRAPDYAQGYTKTGQPIRMAG
GEFAPQAYGVKSTATDMLRFVEANMKQVELDAQLQRAITDTHTGYFQAGPMTQDLIWEQY
PYPVALNSLMEGNAPAMALDATPVTKIEPPEAPNDNVWINKTGSTNGFGSYVAFVPQKHM
GIVILGNRNFPILDRVAAAHRILTSLEQP
>F3WK54|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIIILDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>ZP_04168559|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MSEYSLIFYLFREERGVLKGINHLCFSVSNLENAIMFYERVLEGELLVKGRKLAYFNICG
VWIALNEEAHIPRKEIHQSYTHLAFSVEQEDFERLLQRLEENKVHILQGRERDVRDCESI
YFVDPDGHKFEFHSGTLQDRLNYYREEKPHMTFY
>A0A0N0XCV2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLIGFGDERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADLIHHYLFNAITVATALV
IGGVIMLWAERREHAVRTETVDDMTWTDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>B9JZ55|FEATURES|UNIPROT_deepARG|aminoglycoside|Avi_3210|antibiotic inactivation|1
MKSIVEIGTINDVEPWVQLRAALWPHHMIEDHRAELVRTFLSESGKAIAFIARNSANEAV
GFAEASLRHDYVNGCSSSPVLFLEGIYVRPADRRQGIAGLLCNAVANWGKSLGCVEFGSD
APLDNSASHALHTALGFEETQRVVFFRKPL
>A0A0G4QCE2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MPALLELNEVSRAYSNGEEETVVLNKVSLTINAGEMVAIMGASGSGKSTLMNILGCLDKP
SSGKYKVAGQSVAQMEGDQLAALRREHFGFIFQRYHLMAHLSAEQNVEIPAIYADKNATQ
RKERARELLTRLGLGERVDYRPNQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
KEVMAILKQLNEQGHTVIIVTHDPLIAEQAERIIEIKDGKIISDNRHQTTIHKVKKETTT
VLTSSYFGQIVGRFTQALEMAWRAMVVNKVRTLLTMLGIIIGIASVVTIIVIGDAAKSMV
LSDIKAIGSNTIDIYPGKDFGSDSPEDRQSLTLQDVFALKQQSYVQAVTPQVQFSTRLRR
GNQDSPASVAGVSEDYFIVYAMKFSQGRSFTQDMIQRQAQVVVIDENTRHRFFPVKKDVI
GEQIIIRNIPSTIVGVIADKKSAFGNGQSLRVWVPYSTLNSRILNRSYLDSITVRAIEGY
DASVAEQQMIRLLTIRHGKKDIFTYNLDSFIKAAESTTQTMQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVMQQFLIESVLVCLVGGVLGIALSFSIAMIASV
MLPDWHFVFQPIALISAFICSTAIGVIFGFLPARSAAKMNPIDALARE
>EDK34324|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDIVFILKAIIIGIVEGITEFIPVSSTGHMILVGWAIGFNGEFAKMFEVVIQLGAIMAVV
VLYWGKIKDSIIEFFTFIGTKGEKGKTGFRFGINIITASIPMGIVGLIFYSEIKSKFTPE
AVIAGFIAGGLLLLAVEKIHANRKFRVKSIDSITSIQAFKVGLLQILAVWPGMSRSASTI
MGGWIAGLSTPIAAEFSFFIAIPAMIGTTGKDLFEFNYSIMSTTLWISLILGFVVSFIVA
LIVMKKFIDYLKRKPMKIFAIYRIIAGLLLGILVFTGVIKLTV
>K0YN27|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVLFEALKAFLFGVVEGITEWLPISSTGHMMLLDEFVKLEVSEAFYSTFLVVIQLGAILA
VILLFFHKLNPFSPRKNAEQKRTTWNIWAKVVVGSIPAAIVGLLLDDWIEEHIMTNEDIA
AIVVSVALIVYGVIFIAIELRNRRLIAEASQPRGKHARTDGENPAPARMVSVDPDAEAEY
DASSVIAKVNTFDELSYGKAFIIGIFQSLAIIPGTSRSGSIIIGSMLVGTSRTIATEFAF
FLAIPIMLGWSVLKFIKHGFAYTGMEWMIFGIGLVTAFVVSVLAIKFLVGYVKKHDFTAF
GVYRIILGVVVLGYFLLIAA
>A0A127SQD1|FEATURES|UNIPROT_deepARG|chloramphenicol|catA16|antibiotic inactivation|1
MPEFRTSLTEDGLGYYSEMHPAYTVFNKDAKTFSGIWTAYQPDYPSFLRGYEEDTKKYSS
TTQYEPKPGRPANSFDVSMVPWFSFSAFNLNILGDGTYLLPIFTMGKTFEENEKTMLPLA
IQVHHAVCDGYHLGKFIETLQANINEFDA
>A0A059XMS6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MPRVEPIKKVSVVIPVYNEQESLPALLERTTAACKQLSQPYEIILVDDGSSDNSADMLTA
AAEKPGSHVIAVLLNRNYGQHSAIMAGFNQVTGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKSASRVINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEIDVRHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SIVALSGFVLALVLIALRLLLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGAQQGHNTQEEE
>R7AD28|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKSILYGIVEGITEWLPISSTGHMILLEEYMPMNVSKDFWDMFLVVIQLGAIMAVV
LLYWNKIFPFRIRKNEKIKVKQDILILWLKIIVACVPAAIVGLLFDDWLNEHLYNGFVVA
VMLIVVGVAFIIIENKNVNKPSRVNVLSQITYRDAIIIGVFQLIAAIFPGTSRSGATIVG
GLMIGVSRTVAAEFTFFLAIPVMFGASLLKIVRFGLSFSLMEFLILIVGMLVAFVVSILV
IRFLMGYIKKHDFKIFGYYRIILGAIVLLTFIF
>A0A108CUG5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHGIKRIMAAALFSTCATATIGYAANDRQDTVKSISDSVVLPIKAKYGIPGMAVGIVAD
GQTYVFNYGVASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKTGKYLPN
LQGSPFGNVTLAELGTHTPGGMPLQVPGNIRNEDQLMRYLKDWRPTYSPGTYRTYSNVSI
GTLGLITATSMGQQDFAVPLSRHLLSPLGMKSSYVEVPRSRMADYAQGYTKDGAPTRMAT
DVLSSKTYGIKTTAADLLRFVQANMGEVKLDKPLQQAITDTHTGYFNAGPMTQDLIWEQY
PYPVALKTLTEGNSLSMALNAMPVNEIKPPRAPQQQVWINKTGSTDGFGAYVAFVPARHM
GIVILANRHYPNEERVTAAYRILTSLGLDGR
>S6VIT7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQWNGTLVCTGLLLVSSVAFAEDNAAALDTLVQTEARKVMQENNIAGLSIAITRRGKQQL
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGQLSLTQSIDTYLPQLRDTR
LGKIPVFHLGTHTAGGFPIQVPENVQNTRQLMDYFKAWQPDYLPGTYRTYANPSIGLLGV
IAARSMNMPFQEAMQQRLFPALGLNSTYISVPDEKQALYAQGYNKLDEPVRVSPGILAAE
AYGVKSSSRDLIRFVEANIGLDQHDAPLQRALSDTRIGYFKVGGMIQDLAWEQYSTPIRL
DVLLAGNASAMLNTQKAEAIEPPLAAQPTAWVNKTGSTNGFGGYVAFIAERQIGIVILAN
KNYPNEERVKLAYRILQHAAPFN
>C2V7Y8|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0020_8040|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNAQSESPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLIKNSLEALDQKIRY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKNQLFLLYFLIMIKRMLNTMINLL
QTQPKSC
>A0A097R8D4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKKMQSTLQSTLKLLSVITCLALTAQGAMASEMDQAKIKDTVDSLIQPLMQKNNIPGMS
VAVTLNGKDYIYNYGLASKQPQQPVTDNTLFEVGSLSKTFAATLASYAQVSGKLSLDKSI
SHYVPELRGSSFDHISVLNAGTHTTGLALFMPEEVKNTDQLMAYLKAWKPADPAGTHRVY
SNIGTGLLGMIAAQSMGMTYEDAIEKTLLPKLGMTHTYLNVPADQAENYAWGYNKKNEPI
HVNMEVLGNEAYGIRTNASDLIRYVQANMGQLKLDGNSTLQKALTDTHIGYFKSGKITQD
LMWEQLPYPVSLPDLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVP
AKKMGIVMLANKNYSIDQRVTVAYKILSELEGK
>A0A0Q4RWS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVLLLAKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQKIRDTLVALPTERQAQRFALNVFIGFLPAVVLGLLFGKMIKAHLFTPVVVASTFI
LGGFIILWAERRSPAATRIQTVDEMTPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAIPTLIGAGVYSLYKERALLSAADIPMFAVGLVFSFISAWLCVRWLLR
YISSHSFVPFAYYRIVFGIIVLVTAWTGWVQWAE
>I3V350|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVVWEFRSKIFEVVFG
LTHQPKARRFTGNLLLAFMPAVVLGVLFADLIHEYLFNPVTVAAALVVGGVIMLWAERRK
HRVEVDHVDDMRWSHALKIGFIQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAM
PTMVGAAVYSGYKYRDLFQPGDLPVFALGFVTSFIFAMIAVRALLKFIANHSYAAFAWYR
IVFGLFILATWQFGWVDWSTAHG
>R6KQ59|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYYIEILKAIFLGIIQGITEWLPISSTGHMILVDQFIKLNFSTEYINTFLVVVQLGSILA
VVILYFNKLNPFSHSKNMQEKQEAWNLWIKVLIAVIPSGVVGILFEDKIDELFFNPTTVS
ITLIIYGVIFIFLENRDKRPTISAFSDLSYKTAFGIGIFQILALIPGTSRSGATIIGATL
IGASRFIAAEFSFFLAIPTMFGASALKLIKTGFQFNTFQWLILLIGSFVSFIVSIFAIKF
LMDYIKKHNFKSFGYYRIVLGLLVLLYFYVIVI
>YP_689681|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVSAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIALLMAPIVGGWVLVWLSWHYIFWILALAAILASAM
IYFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
PLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR
>A0A0A8TG41|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDLFVVAIQMGAIAAV
IYEYWGKLWGAAIGLFSGEPKGRHLGVSIIAASIPIMIVGLTCGDIVKELLFNDISVAIG
LIVGGLIIWWVEKNPPKVNAVEVDNITIKEAIYIGLIQVLALIPGTSRSGATIIGGMMLG
VSRKAATEFSFFLGIPVIVGAGLLDLFKNYHIYETTQDWTVFFVGLIVSFVSALILIRVL
VAYVSKRDFMVFAWYRIASGLIILLFALTGWKLW
>A0A0G8CI45|FEATURES|UNIPROT_deepARG|beta_lactam|B4147_3683|antibiotic inactivation|1
MKKNTLLKLGVCVSLLGTTQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKQRVTDFIITHAHAD
RIGGIKTLKERGIKAHSTAMTAELAKKNGYEEPLGDLQTITNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNINAVVPGH
GEVGDKELLLHTLDLLK
>NP_387454|FEATURES|ARDB_deepARG|tetracycline|tetC|antibiotic efflux|1
MKSNNALFVILGTVTLDAVGIGLVMPILPGLLRDIVHSDSIASHYGVLLALYALMQFICA
PVLGALSDRFGRRPVLLASLLGATIDYAVMATTPVLWILYAGRIVAGITGATGAVAGAYI
ADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFL
LQESHKGERRPMPLKAFNPVSSFRWARGMTIVTALMTVFFIMQLVGQVPAALWVIFGEDR
FRWNATMIGLSLAAFGILHALAQAFVTGPATKRFGEKQAIIAGMAADALGYVLLAFATRG
WMAFPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTAIIGPLIVTAIYA
ASASTWNGLAWIVGAALYLVCLPALRRGAWSRATST
>A0A0M2VQ08|FEATURES|UNIPROT_deepARG|chloramphenicol|XI25_15495|antibiotic inactivation|1
MKFHFMDREKWARRPYFEHYLNQKCTFSITANIDVTTLMEQLRSKGIKLYPAFIYMVSRA
VNAHPEFRTCFNDEGRLGYWEQMTPSYTIFHRDDQSFSSIWTAYSDNFHVFHENYQKDLK
QYADVKGLFTKDDIPLNTFPISSIPWVGFTGFNLNINNGYDFLLPIITGGKFFNQDGKTL
LPVSLQVHHAVCDGYHAGRFMENLQELADHAHHWLP
>Q00937|FEATURES|ARDB_deepARG|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGCVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKANLSQDVLFMQNVVDGSVYPVCSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAITSFI
LPPASVSNRLSSYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIN
QGREINVDEVGANDIAIVEDMDDFRIGNYLGAEPCLIQGLSHQHPALKSSVRPDRPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKGGYSDNIRMNEKDKLLFMFQKSMSSK
>A0A017IE82|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTAVFAYHDMGCLGIEGLLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLISDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIIAQLRVTIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSRLEWHKPACELHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSLTTAAQSGSVISVSPLLIACGYGTLEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQSTCAARHRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVLWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLGWEPKIDMQETIDETLDFFLRTVDLTEK
>A0A0A0YWA8|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLEPTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>C2P9H7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLDFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHGVIKTYLFQPYTVVIGLVA
GAILMLFAEVKKKEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSVNDIPMFVVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A0J7FBC6|FEATURES|UNIPROT_deepARG|beta_lactam|TU68_23125|antibiotic inactivation|1
MIVLKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLE
KKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKE
DLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVT
MSDRFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTDWMKGNATGDKL
IRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNKAPIIIAILSSKDEKGATYDNQLIAEA
AEVIVNAFR
>A0A0M9GCD9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSRPLLELKGITRRFVAGEKDFVALKDINLTINAGELVAITGASGSGKSTLMNVLGCLDQ
ANTGSYKVDGRETGSLTDDELAQLRRDHFGFIFQRYHLLPHLAASQNVEMPAVYAGTGES
RRNSRAHELLERLGLAAHLEHRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSAS
GKEVMKILLELHAAGHTVILVTHDDKVAAHAERIIEIRDGEIVSDRPNPNRPVEGGKTAQ
RPPAKPRQGNRLMAALALFQEAFVMAWVALISHRMRTLLTMLGIIIGITSVVSIVAIGEG
AKEYVLKDIQAIGSNTIEIFPGNDFGDNKAGSIETLALSDVAALNSEYYIDSASPNIGRS
LLVRYRNIDVTATVSGVSPSYFQVRGIKMGLGVPFNQDDARRQAQVVVIDHNTRIRLFGA
SADPLGQVILVDNLPCTVIGVTEDRKSIFNTSKSLNIWMPFETASGRVLGQRFLDSITVR
ARDGQPSKVVEDNINKLMERRHGTKDFFTYNLDSVMQTVQKTSQSLALLLSLIAVISLAV
GGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLLGGIIGISLSFGIG
YVFSLLVKEWKMVFSLSSIVTAFICSTLIGIVFGFVPARNAARLNPIEALARD
>R8VUZ0|FEATURES|UNIPROT_deepARG|chloramphenicol|HMPREF1526_02323|antibiotic inactivation|1
MDFQLIEQEAWKRKEYFDHYFKHVPCTYSITVKLDITALKDKKLYPTLLYGLTTIVNRHE
EFRTAMNENGQVGVFSEMMPCYTIFHKDTQTFSNLWTAYTADYTEFCARYQEDMEHYGNT
EGMMAKPNPPENTFPVSMIPWTTFEGFNLNLKNGYDYLLPIFTFGKYQQDNGKYYIPLSV
QVHHAVCDGFHTSRFINELQELIDTLGA
>D3EAM1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MQITVQEYKIANRESGPYGIAAGRDGAIWFTEQKGNRIGRITKGGDMRTFDVPTPDAGVM
SILSAPNGDLWFTEYKANKIGRMTIEGTFTEFELPEAGSSPYGLTEGPDGAIWFTQLIGN
RIGRITPAGVITEYDLPRAGSYPSYITAGPDGALWFTENQNNCIGRITVDGEIAEYRIPT
EQSGPVGITAGADGALWFVQINGNQIGRITTAGEITEFKLPSGNARPHAIAAGAREDLWF
TEWGANRIGRITCTGDITEYPIPTPSAEPHGIAVDSGGEVWFAEECDQIGRFIVQYEYS
>A0A0B4R9P4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWFDLFKALILGFVEGMTEFAPVSSTGHLIIVDDMWLKSQEFLGKYPANTFKIVIQLGS
ILAVVVVFWKRLFSLVGLYKMEGQQESTRFNLLHVIIGMLPAVVLGFTFKDLIDNHLFGV
ETVIYALVAGAILMIVADKFGPKKPTVNSLDDITYFQALKIGFVQCLSLWPGFSRSGATI
SGGVLFGLNHRVAADFTFIMAVPIMFGASLVSVLKNWDTLSMDYLSFYIVGFLSAFVFAL
ISIRFFLKLIGRIKLMPFAIYRLVLAAILAIIVFR
>C2PWT7|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0007_25250|antibiotic inactivation|1
MIVSKKFFHIAHYKKMLPVVLLSCVTLIGCSNSNIQSESPKQTTQEHISNQSFVKLEKDY
DAKLGIYALDTGTNQIVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYGLGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDTKYDDKLIANATKI
VLDALKVTNKS
>R8H390|FEATURES|UNIPROT_deepARG|beta_lactam|IKE_02459|antibiotic inactivation|1
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEQIVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLNTSKGLVLVDSSWDNKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGITALKERGIKAHSTALTAQLAKNSGYEEPLGDLQTITSLKFGNTKVETFYPGKGHT
EDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNINSVVPGH
GKVGDKGLLLHTLDLLK
>U5VGK8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSRFLLATLATATSLAWVHASAHADDTLQARVTQTIRPLMQAYGIAGMAVGVYHKGQAHY
FSFGVADKAAGTPVSADTLFEVGSLSKTYTATLAALASAEGKLDLDAPARRYQPALAGTY
LGDVSVLELGAYSADCLPLQFPDDVQTPRQVLTFFRQWKPHSERGTQRCYSNPSIGLFGD
LAARAQHRPFDPLMTQGLLPRMGLEHTYLNVPPEARSLYAQGYDAQDQPVRVNPGPYADP
AYGIKTSATDLLRYVRLHMQPSALPQPLQEATAITQAGYFQVGTMTQGLGWERYPYPVDL
QTLVDGNSPRLIREPQSTQRLKPASPALRNAWYNKTGSTNGFGAYAVFIPSEGQAVVLLA
NRNYPNEARVRAAWQILSGLSH
>A0A140CUV3|FEATURES|UNIPROT_deepARG|beta_lactam|blaIMP|antibiotic inactivation|1
MKKLFVLCVFLFCSITAAGESLPDLKIEKLEEGVYVHTSFEEVNGWGVFSKHGLVILVNT
DAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NDLLKQNGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
YGLGNLDDANVVAWPHSAEILMSRYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLKESKK
PSEPSN
>J7YM73|FEATURES|UNIPROT_deepARG|beta_lactam|IE7_03202|antibiotic inactivation|1
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKSGYEEPFGDLQTVTNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNINSVVPGH
GEVGDRGLLLHTLDLLK
>A0A0D1LV96|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMTDMLRAVILGIVEGVTEFLPVSSTGHLLLAERFFNLGEGNFWKSFAILIQLGAILAIL
VLYFNRLWRVALGMFSNPDDRRFVIGVLVAFLPAVVIGLIAGKYIKEFLFNPWVVCFTLI
VGGAVLLWVDQLDLKVYEDDATRFPLLMYFWIGVAQCLAMVPGVSRSGASIVAAMMLGAD
KRSAAEFSFFLAIPTMVGAFVYDFYKNRADFTSDNLSVIAVGFVVSFITAMIVVRAFLNF
VTRRGFTFFAWWRVIVGTLGLIALALGR
>A0A0J6L883|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEKSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEEVDIPRNEI
YQSYTHISFTVEQEDFNCLLKRLEENEVHILKGRERDVRDYESIYFLDPDGHKFEFHSGT
LQDRLNYYREAKPHMMFY
>A0A127SDU9|FEATURES|UNIPROT_deepARG|beta_lactam|OCH-2|antibiotic inactivation|1
SVSVQAANAPSEKEIRHLVDETIKPVMAEHKIPGMAVAVTAGGKTYFFGYGVASKESGQK
VTEDTIFEIGSVSKTFTATLGGLGLAEGAFKPGDTATKYAPKLAGSSFDNVSMLDLGTYT
AGGLPLQFPDSVTDHKTMIDYFKNWKPDYPAGTQRRYSNPSIGLFGYLAAQSMGEPFDKV
METRLIPAFGLKHTFIQVPESQMKNYAYGYSKANKPIRVSPGAFDAQAYGIKTTAPDLIR
FVQLNMDSTSLGQPMQKAVAATHTGYYKVGDMTQSLGWERYAYPLSLKTLLGGNTSDMAM
KSHKIEKLAPPLQPSDDMLLNKTGSTGGFGAYVAFVPGKKIGIVMLANR
>A0A127SLI6|FEATURES|UNIPROT_deepARG|chloramphenicol|catA15|antibiotic inactivation|1
MEFNIIDLNTWERKPYFEHFLNHTRCTFSMTANIDITKLLERTRVEDIKFYPTFIYMVMK
VVNSHVEFRTCFDEEGRLGYWEQMNPSYTIFHNDDKTFSDLWTDFNLDFNSFHKSYQEDM
KQYGEVKELSPKKQAPQNLVPISCIPWTSFTGFNLNIFNDGTYLLPIITGGKYFNQEDKV
LLPISLQVHHSVCDGYHASHFFKEMQQLADNCNEWLNVHF
>E7H175|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLYLLQATVLGIVEGLTEFLPISSTGHLIIASDLVGFAETPGADEFVVAIQSGAILAV
CWYYRERIWAVLRGLTSSPKEQRLAVNTVVAFLPAAVIGVFAAGYIKHYLFNPTAVAVAL
IVGGFIILWVENRIVRLRITPRVAAMDDMSWKDALLVGCMQCLAMIPGTSRSGSTIIGGM
VLGLSRRAATEFSFFLAIPTIFGATVYDLWKARDDLALDNLPGLALGTAVSFVSALLVVH
WLLRFVAAHDFKGFGWYRIGFGILILAASGFGWIEWRSI
>V2USM9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILLLKAAIMGLVEGITEFLPISSTGHLILTGQLLDFWTLEKREMFAVSVQIGAIAAV
IYQYWGKLWGALIGALTGDPEGRRLSLNLIVATIPIMLIGLTIGETVKAYLFNAVTVALA
LIVGGLVILWAERRQHIIACQEVDDISFKQAVFIGLIQCLALIPGTSRSGSTIIGSLFMG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHTQDMEVLGVGIVVAFISALVVIRALI
RYVSKHDFSAFAYYRIIFGLFILLTWGTGWVHW
>A0A073KP24|FEATURES|UNIPROT_deepARG|beta_lactam|SXM_2059|antibiotic inactivation|1
MVNAASQRGVSFPPNAQAIEALIDSTVNPLMNEYGIPGIAIGVSINGQQYFYPYGVSSKK
TGEKVNENTLFEIGSISKTFTATLATYAQLEGKLTLTDKVSQYLPELTGSHFDQINLIHL
ATHTAGNLPMQVPDNITNNAELISHLRAWLPAYAAGTHRNYANPSIGLLGVIAAKQLGQG
FPEAVEQTLFRQLGMTNSYFMVPTNKMTDYAQGYNKQDQPVRLNPGVLADEAYGIKTTVV
DLLRFVETNMQQHAVPARLQRAIDATHTGYFDVGMMTQAMIWEQYPYPIALDKLLTGHTQ
DVVFGSMPVKAITPPQAPEQNVWINKTGSTGGFAAYVAYIPAKKLALVLLSNKNYPVPPR
VTAGYQILIGLETLQN
>A0A0K1JAN0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLAQLFVALLLGIIEGLTEFLPVSSTGHLIIFGDLLGYNDEASKVFKIVIQLAAILAVC
WDYRERLVHVATGVVSDPAAQRFVGLLIVGFLPAAVLGVMFHSKIKALLFNPLTVATALI
VGGFVILWLEKRSYHPRINAVDEMRWPDALKVGFAQALAMIPGTSRSGATIMGGLVFGLS
RKTAAEFSFFLAIPTMFAATAYDLYKARDMLHAGDLPVFAVGFVASFVAAMWAVKTFIRF
VSNHTFIVFAWYRIIFGLIVLATWKFGLVAWSEV
>D0SKZ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILSGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGAMKGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRQHLVVSSEVDDLTFKQATLIGLIQCFALIPGTSRSGSTIIGSLFLG
ISRKAAAEFSFFLGIPVLMGAGLLDMYKMRNDLHSNDLAVLAVGIVVAFISALIVIRALI
RYVSKHDFTAFAYYRIGFGVFILATWWTGWVHW
>ABY77969|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MNSSTKIALVITLFDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWL
VFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>G8GMC1|FEATURES|UNIPROT_deepARG|beta_lactam|IMP|antibiotic inactivation|1
TAAESLPDLKIERLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNTEAYLIDTPFTAKDTEK
LVTWFVGRGYKIKGSISSHLHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSF
GGVSYWLVKNKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKPYGLGNLGDANLEAWPK
SAKLLMSKYGKAKL
>A0A0L1MMF8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVATALV
VGGIVMLWAERRQHEVHAESVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRNLFVPADFPVFAIGFVTAFIFAMIAVRALLIF
IASHSYATFAWYRIAFGLVILATWQFGWVDWTAVKP
>A0A127SCR7|FEATURES|UNIPROT_deepARG|beta_lactam|TLA-3|antibiotic inactivation|1
MKKHLVVIVFCALFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAILGIEDNFKLNVNE
KHHYPMQSTYKFHLALAVLDKLDKENISVDKKLFVKKSDLLPDTWSPLRDKYPNGNLELS
FSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYT
NWSTPDATVQLLKKFYKNEILSKNSYDFLLNTMIETTTGPKRLKGLLPDGTVVAHKTGSS
DTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYLIKGG
K
>A0A0L8EM84|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDAALYLIKACILGIVEGLTEFIPVSSTGHLILVGDWLNFESSQGKVFEVVIQLGSILA
VMWVFRARLARLIGGTLRGDRTEVAFTRNLLIAFLPAAVVGAVFIKSIKQIFYHPAVVVV
TLVLGGLIMLYVERRTRHTPGDVPGAADDTASDEHATARSLEQISWKQALGVGVAQCLAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAAYDMYKNIDLLTRHDLAGIA
VGFAAAFLSAMVVVRAVLRFVANHTYRVFAWYRIVFGGVVAAWIFTR
>A0A0E1GHT5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIKLENIKKSFITGGVSSEVLKGINLEIKKGEFVAIIGQSGSGKSTLMNILGCLDTPTSG
KYLLDSLDISKFKKDELSNLRLKKFGFIFQRYNLLSSNDTKSNVALPGIYAGMSKADRIN
RAKDILVKLGLETKFDTMPNHLSGGQQQRVSIARALMNGGEILLCDEPTGALDSSSGVMV
MQILDSLHKDGHTIIVVTHDKDIAAWADRIIEIKDGNIISDTRKNSQIYELKQNLKEIKP
NLKAIRDQFFESFVMSLGAIKSHKLRSFLTMLGIIIGIASVICVVALAKGSQQKILSDIN
NMGTNTITIFPGKGFGDMHSGRVRSLSIDDSNLLGKLDFVDFSTPRMNTSGLLTYANQSF
SGSLRSGSEYSLAISGLKIEKGRDFTKDDIINSRSNIIIDQFTKDAFFKDVDPIGKVILF
NKQPFTIVGLVKRDETSFSGDNLTVYAPYTTTMNKLTGDRDIRSIMLKLKDGVNAQVAEQ
SIIEVLKIRRGSKDFFTRNSDTIRQTIESTMNTMSLLISGIALISLMVGGIGVMNIMLVS
VFERTKEIGIRMAIGAKSKDIMTQFLIEAILLCAIGGSIGIGLAYAIGYGFNVFGGDFKM
IFSTASIFIALGVSSLIGIVFGYIPARNASKLNPIDALLRE
>I4L9B6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLELKGITRSFMAGEREFIALKGIDLTIHAGEMLAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPES
QRHSRARELLQRLGLASHITHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVCDGEIVSDKVNDSVGLELPSEAP
IEPRRSGARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIQTLMPSDVDALNQLYYVDSATPVVGRNL
LLRFGNIDVDAQVNGVSDRYFKVKGLKLEAGIAFSESDARRQAQVVVIDHNTRQRLFGPN
IDPLGQVILVGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGIIGISLSYAIGY
LFSLFVKEWEMVFSVGSIITAFACSTLIGIVFGFVPARNAARLDPIEALARD
>R5HC84|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEHGIEVLKVIFLGIVEGITEWLPISSTGHMLLVDEFLQMNVSEAFKDMFFVVIQLGAI
LAVVILFWEKMWPFQRKTPTQPAVRWDTIQMWCKVVVACIPGAVVTILFDDYIEAHLHTP
TVIAAALILYGVGFILIENWNKTRTPKVQTLAEITYRTAFLIGLFQVLSIIPGTSRSGST
IIGALLIGVSRVAAAEFTFFLAVPVMFGLSLLKLLKFGLVFTTPELVTLVVGSLVAFLVS
LVVIKFLMGYIKKHDFKVFGWYRIVLGGVVLAYFALK
>CAJ77844|FEATURES|ARDB_deepARG|multidrug|adeB|antibiotic efflux|1
MMSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTIND
SVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLP
QVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFG
AEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQ
LSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANA
VKTAEGVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFL
HNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERI
MATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSIL
FSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMM
VIFLVITGITFAGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNP
DVKSNTAILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSDVNSSMANSTEGETMAVL
PPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNIS
LKIDREKLSALGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILN
LKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLI
AKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLG
IFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAK
LRLRPILMTSLAFTCGVIPLVIATGASSETQHALGTGVFGGMISATILAIFFVPVFFIFI
LGAVEKLFSSKKKISS
>A0A0I9QQ12|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-21|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQMDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATARIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSVGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILERYKES
>AAY93315|FEATURES|ARDB_deepARG|beta_lactam|BL1_pse|antibiotic inactivation|1
MRHTTLTGLSVISACALLLGASSAFAETTADSALKTTVDATIRPLMHQQGIPGMAVAIIA
NGKRHYFNYGVASKDNQQPVDNDTLFEVGSVSKTYTATLAGYAQASGKLALEDHASQYLP
ALRGSAFDGISLLQLGTYTAGGLPLQFPDEVQGEDKTLDYYNTWKPTFSPGTQRQYSNPS
IGLLGYLAARSLGQPFDRLMEQTLFPKFGLKHSYIHLPKDQLGHYAQGYDKQNRPIRLSP
GPLDAEAYGVKTSAPDLLQFIAGNLQPGQFDRPLQQAMVATQSGYYQVGDMTQGLGWERY
AYPVPLARLLAGNSSAMALEPHPVQWLTPAAAPKADALYNKTGSTSGFGAYVVFVPSQQI
GIVLLANKNYPNEERIKAAHAILTALETGK
>S3JEY9|FEATURES|UNIPROT_deepARG|beta_lactam|ICA_02389|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGDRVTM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAT
EVIVKALK
>D2R0W2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLVWWQIVLLAIVQGIAEFLPISSSGHLVVIAPLLFGSTDSPEGISDLSIVLHLGTLGS
ILVHYFKRVSALLGEDRQILALLAIGTLPAVVVGLPLKLLFPAALESPLLAGVLLIVNGG
VLYLVSRIPPKENTYQQLSIGKSLAIGVCQAFAILPGLSRSGSTIAGGLSVGLSRSSAAT
FSFLLAIPAIAGAGVLEALSMIRKSEPLSTSPGLLLLGAAISFVVGIVSLRLLEKLLASG
RLPWFAIYSVIAGIAIVVWQWQGAIE
>A0A126G805|FEATURES|UNIPROT_deepARG|beta_lactam|blaVEB|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTAGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>S2XWS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEMLKVILLGIVEGITEWLPISSTGHLILVDEFIKLQASAAFKEMFNVVIQLGAIMAVV
VLYFHKLNPFSPKKTQKQKAWTIQLWMKVIVACIPAGVIGILFDDWMEAHLHKPEIISAM
LILYGILFIVVENWNKGKMPKVTKLSQLSYQTALLIGGWQVLSLIPGTSRSGATIVGALL
LGTSRYVAAEFTFFLAIPVMFGASFVKILKFGLSFTAMEAAMLLVGCLVAFVVSVIAIKF
LMGYIKKNDFKVFGYYRIILGALVLLYFTVFA
>A0A0G3WIP5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKVIELKNLTKTYHLEKLDVPVLHGINLDIYRGEFVAIMGASGSGKSTLLNILGLLDKPS
SGSFKLAGIEVSQYTDDELAALRNHYLGFIFQQFNLLSKLTAKENVSLPIIYANSKDEKK
HEDAKKLLELVGLADRMDHRPNEMSGGQQQRVAIARSLINKPLIIFADEPTGNLDTKSTK
EIIQILKDLNASGITIVMVTHEPELTAYATRTIKVQDGLIIADETAKKVEQTSGGSRANV
YEQKTFSLSRIKDYFAQGFRSLVGNKMRSVLSILGVMIGVASLISMLAVGNGAQKAIAEQ
VEGLGSNLLMVMPGASQRGGISSESGARLRLIPEDIADLKKNVRGIEGISGYASARAQVV
ANGKNYNTRLDGVSVDYAKMRNSQVESGRFFTEAENLERQRVAVVGKTIIKQIWGAADVN
PIGEYVKINRIDFQIIGVLPEKGSNGYRDEDDKIIVPLNTAIYRVIGTQYLSNLDVQVQE
NADMNAVADNITKRLLLTHRMPANAEDSVRVRNMAEIQEALSSMASSFSLLLGAIAFISL
LVGGIGIMNIMFVSVSERTKEIGLRKAIGANNADILFQFIIESIFVCCAGGIIGIIFGSG
VSILINQLADWTTSITAFSVILAFCFSAVTGLLFGVWPARKASLLNPIDALRHD
>A0A150TF67|FEATURES|UNIPROT_deepARG|bacitracin|BE18_32075|antibiotic target alteration|0
MFWFDAVLLGVLEGLTEFLPVSSTGHLILLGAWLGHESEAAKTLDIVIQLGAVLAVVVYF
RERLAVTVRGIFRRDPDSLRLALALAFAFFPAALVGLLFHKAIKAHLFGPGPVAVALIAG
GFLMIGVESARRRRPDQGAPRVEDVTLQRALAIGVAQCFSLWPGASRSMTTIVGGQLSGL
STAAAAEFSFLLAIPTLGAATVFDLAKNGRALLDAPGGAAALAVGLAVSFAVALLVIAVF
LRYLKRYGLAP
>A0A0E3GM50|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV-1|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMVATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQ
>A0A104A606|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDTHAKTFDVVIQFGAILAVC
WEYRQRIASIVSGLPSRPDARRFTLNVVIATIPAIALGLLLEKKIKAVLFSPVPVAFALV
AGGAIILWAEARQRERSEPPRVVSVDALTPLDALKVGIAQCFALIPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>N2JQ13|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTFPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0J6KKK3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
ILAVIVVMWKRMLSLVGLYKIEGQAKSINGRFNLLHVIVGMLPAVVLGFAFKDFIDDHLF
KVEHVVYALVAGAILMIAADKLAPRKPKVDSLDKISYGLAFKVGLVQCLSLWPGFSRSGA
TISGGVLFGMSHRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYFGFYAVGFISSFVF
ALLSIKFFLALISKVKLMPFAIYRLVLAAVLCVIIFM
>V2J2Q4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPIAMKPSKLPFSRPFSRSSFLRACLFVCLSACLSVNANTYAADDGDALTSAAIAAIVDA
AVKPAIAQHRLPGMAVAVTVDGKRYFYNYGQTAMRGGRPVTKETLFEIGSVSKTFAATLA
AYAEASGKLSLQDPVSRHLPALRGGTFDKVTLLQLGTHTSGLPLAVPERIRSEPDMAEYL
SAWRPPYPVGTHRVYSNNGIGLLGAIAAARLGGAYSDLVHAIVFQPLGMKHSYFKVPAER
QADHAQGYTAADAPIRMKEGYLWEPAYGIRSSSGDLVAFVEANMSGARIDDTLRQAIART
HVPRFRAGPITQDLIWEQYRYPPTLQQLLAGNAAILRAEAATPIVAAPSEQPAYLHKTGS
TNGYSAYVAFVPDKRIGIVLLANKAYPVDQRVTIGYEILSRIAERAKR
>E3HH45|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTENTLYLIKAFILGIIEGLTEFIPVSSTGHLILVGDWINFESSQGKVFEVVIQLGSILA
VMWVFRARLLTLIRGTLTGVPSEVAFTRNLIIAFLPAAVIGAIFIKSIKSVFYHPAVVVV
TLVLGGLIMLYVERKTHHTPGDMPGAADDTASDERATARTLEQITWKQALGVGVAQCLAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDMYKNMELLTQHDLTGIA
VGFVAAFLSAMVVVRAVLRFVANHTYRVFAWYRIIFGGVVAAWIFTR
>A0A0P9LCB6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MATVFLHSGNHFLHNNVKRRACGVASWGKVMDLWTAAQALILGIVEGLTEFLPISSTGHQ
IIVADLIGFGDERAMAFNIIIQLGAILAVVWEFRRKILDVVVGLPKQQQAQRFTLNLLIA
FMPAVVLGVIFADLIHHYLFNAITVATALVIGGVIMLWAERREHAVRTETVDDMTWTDAL
KIGLVQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAAVYSGYKYRDM
FRPDDFAVFAIGFITSFIFAMIAVRGLLKFIATHSYAVFAWYRIAFGLLILATWQFGWID
WASAKA
>ZP_04212238|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGIRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALK
>AAT49071|FEATURES|ARDB_deepARG|trimethoprim|dfrB2|antibiotic target replacement|1
MGQSSHEANAPVAGQFALPLSATFGFGDRVRKKSGAAWQGQVVGWYCTKLTPEGYAVESE
SHPGSVQIYPVAALERVA
>Q8RTD8|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-12|antibiotic inactivation|1
ALXPTLAAXYMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDAR
DTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAS
KRGARGIVALLGPNNKAERIVVIYLXX
>U3N8W9|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-114s|antibiotic inactivation|1
MTVRRLSCALGAALSLCALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELADNLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRSNAGLRARDELVRDWPAMAGAWRP
>A0A127SNT6|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
EEDGRIVLPLAVQVHHAVCDGFHICRFVNELQELINS
>I1V556|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-32|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPTSVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>V5MDQ0|FEATURES|UNIPROT_deepARG|beta_lactam|YBT1518_18690|antibiotic inactivation|1
MKKNTLLKVGLCVSLLGTTQFVSTISSVQASQKVEQIVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLNTSKGLVLVDSSWDNKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGITALKERGIKAHSTALTAELAKNSGYEEPLGDLQTITSLKFGNTKVETFYPGKGHT
EDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIGNVLKRYGNINSVVPGH
GEVGDKGLLLHTLDLLK
>B7VEQ5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVVGK
>P51563|FEATURES|ARDB_deepARG|tetracycline|tetG|antibiotic efflux|1
MRSSAIIALLIVGLDAMGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVFAPM
LGQLSDSYGRRPVLLASLAGAAVDYTIMASAPVLWVLYIGRLVSGVTGATGAVAASTIAD
STGEGSRARWFGYMGACYGAGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLK
ETHHSHGGTGKPVRIKPFVLLRLDDALRGLGALFAVFFIIQLIGQVPAALWVIYGEDRFQ
WNTATVGLSLAAFGATHAIFQAFVTGPLSSRLGERRTLLFGMAADGTGFVLLAFATQGWM
VFPILLLLAAGGVGMPALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSAT
AGAWNGWVWIVGAILYLICLPILRRPFATSLVI
>A0A0D3VB76|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILGIVEGITEFIPVSSTGHMILTSKLLGHDDQSEIMKTFEIVIQLGAILAIAM
VYWRRILNLLGLNRKTSVNAARSGSKLNLIHVILGIAPALIVAFFARDFIKSLFNANTVV
WALVAGGIFMIFAEWYNKSKVTVTAEDMDEMTYKQALSIGMFQIISVLWPGFSRSGSTIS
GGMISGVSYKASADFSFLIAIPIMCAASGYELLDAYKYFNSTTIGYFAIGFLISFVVAYV
VVLAFMKLIQKIRLTHFAIYRFVLAAVFWIFILN
>V1I3D6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAGLGIPVYAPD
NVNHPVWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVATVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPSAASGKRRIRVLILGVNGFIGNHLTERLLNEENYDVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIEELATLLLDSFDKHPLRGHFPPFAGF
QIVESRSYYGKGYQDVAHRKPNIDNARRCLDWEPSIAMRDTVEETLDFFLRSVDITERAS
>V6M907|FEATURES|UNIPROT_deepARG|beta_lactam|T458_11180|antibiotic inactivation|1
MKIFTQKIKLAMPLLLLSLYPPAGCSGSPDTNAQSAATVVQEASEVDADQQLGQLEKEYD
ARLGIYAIDTETGRTVSYRPDERFAYTSTFKPLAAGALLLKKPLDELDKVITYKKEDLVT
YSPVTEKHVEKGMTLREISDAAIRYSDNTAGNLLLKELGGPAGLETVLQEVGDHITKPER
YETDLNEAVPGDIRDTSTPKALATTLKAFTVDGVLPAEKQDVLIDWLKRNTTGDELIRAA
VPEGWTVGDKTGAGSYGTRNDIAVIWPPNQAPIVMAVLSSRTEQDATYDNALIAKAAKVV
LDSLELQEEK
>D2JKK7|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKNLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
IYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>A0A026RWL7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTAACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>L2VSU7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDIHPVKKVSVVIPVYNEQESLPELIRRTTAACELLGKEYEILLVDDGSNDNSAQMLVD
ASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPHLVEKADEG
YDVVGTVRQNRQDTWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0H0SNJ8|FEATURES|UNIPROT_deepARG|chloramphenicol|AA984_15495|antibiotic inactivation|1
MKFQRIDLDNWSRRSYFEHYLNRVNCTFSMTANIDISELLPALRQKGMKLYPAFLFMVTN
VVNAHREFRTSFHTDGELGYWESMIPSYTFFHQDDQTFSTMWTEFADEFPVFYQNYVADM
KRYGDNKGFVAKEPEPPYTFPVSCIPWVSFSGFNLNISGDGRYLLPIITSGKYFEQEGKT
LLPVSLQVHHAVCDGYHASLFINDLQKWATNYKEWLGVE
>A0A149PRZ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLLACKALILGVVEGLTEFLPVSSTGHLIVVGSLLDFSDEHAKTFDVVIQLGAILAVC
WEFRRRIGEVIVGLPSRPEARRFTLNVIIATIPAIVLGLLFEKSIKEVLFSPVPVAFALV
AGGVVILWAEARQRARGDAAVRVRSIDDLSPLDALKVGLAQCFALIPGTSRSGSTIIGGM
LFGIERRTATEFSFFLAIPILFGATAYELYKSWHLLSTDALGSFALGFVAAFVSAFVCVR
WLLRYVASHDFTVFAWYRIGFGLLILLIGYSGGLSWAD
>ZP_03624201|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYQEMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPLKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIKISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>ZP_02892568|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVIALFIMLGGAFAIRALPVAQYPDIAPPVVSIYATYPGASAQVVEES
VTALIEREMNGAPGLLYTSATSSAGAASLYLTFKQGVNADLAAVEVQNRLKTVEARLPEP
VRRDGIQVEKAADNIQLVVSLTSDDGRMTDVQLGEYASANVVQALRRVDGVGKVQFWGAE
YAMRIWPDPVKLAGHGLTASDIASAVRAHNARVTVGDIGRSAVPDSAPIAATVFADAPLK
TPADFGAIALRTQPDGSALHLRDVARIEFGGNDYNYPSYVNGKVATGMGIKLAPGSNAVS
TEKRVRATMDELSAYFPPGVKYQIPYETSSFVRVSMNKVVTTLIEAGVLVFLVMFLFMQN
LRATLIPTLVVPVALAGTFGVMYAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEGLAPYDATVKAMRQISGAIIGITVVLTSVFVPMAFFGGAVGNIYRQFALSLAVSIGFS
AFLALSLTPALCATLLKPVSGDHHEKRGFFGWFNGFVARSTQRYATRVGAMLKKPLRWLV
VYGALTAATALMLTQLPSAFLPDEDQGNFMVMVIRPQGTPLAETMQSVREVESYIRRDEP
AAYTFALGGFNLYGEGPNGGMIFVTLKNWKERKAERDHVQAIVARINERFAVTANTTVFA
MNSPALPDLGSTSGFDFRLQNRSGLDYAAFSAARERLLAAGGKDPALTDVMFAGTQDAPQ
LKLDIDRAKASALGVSMDEINTTLAVMFGSDYIGDFMHGTQVRRVIVQADGLHRLDPADV
KKLRVRNAGGEMVPLAAFATLHWTLGPPQLTRYNGYPSFTINGSAAPGHSSGEAMAAIER
IAAKLPAGIGHAWSGQSFEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVLGVTLRAMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLVDAALEA
ARLRLRPIVMTSLAFGVGVLPLAFASGAASGAQMAIGTGVLGGMITATVLAVFLVPLFFV
IVGRLFEVGPRRRGGSQPATMEGSQ
>A0A0D6DV00|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFIKAIILGIIEGITEWLPISSTAHLILADEFIKLKQPTEFMNMFNVVIQLGAILAVVV
IYFKKLNPFDKTKTARETQLTWQLWLKVIIACIPAAVIGLPLDKWLDAHFHKFVPIAFML
IIYGVAFIYIEKWAKTRPDKLVNLEVMPYQFAFYIGLIQLLSLMPGTSRSGVTILGAIIL
GASRFVAAEFTFFLGIPVMFGASLMKIVKFMFSGSGFSFYQFSILLIASLTAFLVSIVVI
KFLMDYIKKHDFTFFGKYRIVLGVIILVYAGISAVFG
>G7W3D5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILSSIIMGIIEGLTEFLPVSSTGHMILTADLLGLNTENDTVKTFEVIVQLGAVLAVVV
LYWRRFLSLFDFRRRISTQPRLNLLHIILAMIPAGVIGVLFRDVIKQYLFGPQTVLYSLV
IGGLLMIAAEKFHPPIKSHTVDEITYKQAFTIGIFQVLALWPGFSRSGSTMSGGLFARVS
HTAAAEFTFLVSVPVMLGASGIDMVKSMDHLSMSDFPVFAAGFITAFIVGMLAIKTFLGL
LKRLSLTSFAIYRFVLAAVFFFIIL
>A0A0F5I5D0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIELLKAIILGLVEGLTEFAPVSSTGHMILVDDMWLKSTEFLGQYAANTFKIVIQLGS
ILAVVIVFKDRFIDLLGLNRIFNKNEYNQAAANHLKLTHVIVGLVPAGVLGLLFEDYIDE
NLFTTETVLIGLFIGAVFMIVADLFRSKNPKVVSVDQISYKQALGVGLIQCLSLWPGFSR
SGATISGGVLLGMNHRTASDFTFIMAVPIMAGASFLSLLKNWEYFTLDALPFFIVGFISA
FVFALISIRFFLKLINKFKLIPFAIYRIILVLVIYFLYF
>A0A0D5L390|FEATURES|UNIPROT_deepARG|beta_lactam|BW21_4525|antibiotic inactivation|1
MKIRHALSSALVLLGCVAAPAHAKTLCTAIADATTGKFLLKDGDCSRRATPASTFKIAMS
LMGYDAGFLRNEHEPVLPYRDGYVDWGGAAWKQPTDPTRWLKYSVVWYSQQITHHLGAQR
VAQYAKAFGYGNADLSGDPGKNNGLDRAWIGSSLQISPLEQIGFLRRMLNRDLPVSANAI
DMTERIVDTTTLADGTIVHGKTGMAYPLLADGTRDKAHGFGWFVGWIKRGKETLVFASLT
QDERKEPGSTGVRTRDAFLRELPQRLAAH
>A0A0E1VZB1|FEATURES|UNIPROT_deepARG|beta_lactam|oxa|antibiotic inactivation|1
MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLLQDGDCGRRASPASTFKIAIS
LMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQR
FAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQISPLEQLEFLGKMLDRKLPVSPTAV
DMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDWARGSGWFVGWIVRGKQTLVFARLT
QDERKQPVSAGIRTREAFLRDLPRLLAAR
>A0A088X720|FEATURES|UNIPROT_deepARG|beta_lactam|DM82_6292|antibiotic inactivation|1
MKIRHALSSALVLLGCIAASARAETICTAIADAGSGNFLLKDGDCSRRTTPASTFKIAIS
LMGYDAGFLRNEHEPVLPYRDGYVDWGGAVWKQPTDPTRWLKYSVVWYSQRVTHTLGAQR
FARYAKAFDYGNADVSGDPGKNNGLDRAWIGSSLQISPLEQIGFLSKMLNRKLPVSATAI
DMTERIVDTTTLADGAVVHGKTGMAYPLLADGTRDKAHGFGWFVGWIKRGKETLVFARLT
QDEGRQPGSAGVRTRDAFLRDLPQLLATR
>N9RYB2|FEATURES|UNIPROT_deepARG|beta_lactam|F886_03127|antibiotic inactivation|1
MQFNKISCLLLSPLFIFNTSIYAGNTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGIIQNN
KKYETYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFKDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFVNANLNPQKYPADIQHAINETHKGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISNEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>YP_002113999|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQGVDVAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKKMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A127SV74|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETIL
HNNEVHYPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLRQKHSGQDL
DISLGEILQYSISLSDNNACDILIEYAGGIGHIHQYIRKLGINDFNLSETEDSMHQNPQK
AYANWSTPSEMVRLLKMADEKDLFAPVYRDFLWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGVVIMPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDEMK
>A0A0P0Z0V6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNVEAEREKGTGVQFNDIFDATLLGLIEGLTEFIPVSSTAHLLLVGRAIGWSSTGHSFEV
LIQLGAVLAVLSVYFGKLWHLAVTLPSDPRSRRFVASILLAFLPAAIIGAMAHGFIKGVL
FETPALVCTALIVGGFILLAIDRMPRRVRYTDAMDFPPLVCLIIGFFQCLAMIPGTSRSG
ATIVGALLMGTDKRSAAEFSFFLAMPTMAGAFAYDLIKNRDILSTNDLALIVIGFVAAFI
SALFVVKFLLDFVSRHGFAPFAWWRIIVGTIGLVALYAFA
>CCP44409.1|FEATURES|CARD_deepARG|macrolide-lincosamide-streptogramin|tsnr|antibiotic target alteration|0
MLTERSARVATAVKLHRHVGRRRAGRFLAEGPNLVAAALARGLVREVFVTEVAARRHELL
LAAHEASVHLVTERAAKALSDTVTPAGLVAVCDLPATRLEDVLAGSPQLIAVTVEIREPG
NAGTVIRIADAMGAAAVILAGRSVDPYNGKCLRASTGSIFAIPVVVAPDVGAAIADLRAA
GLQVLATAVDGEMALDDADRLLAEPTAWLFGPEAHGLSAEIAALADHRVHILMSGGAESL
NVAAAAAICLYESARALGRR
>C6PS69|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIFILKAIIIAIVEGVTEFIPVSSTGHMILVGWAIGFKGEFTKMFEVVIQLGAIMAVV
VLYWKKIKESIVEFLKFIFTKGREGKTGFKFGINVIASSIPMGIAGVLFYSKIKSRFIPE
AVIIGFVVGGLLLLIVENKFRNRKHKIESIDNITPKQAFKVGLFQLLCMWPGMSRSASTI
MGGWIAGLSTPIAAEFSFFMAIPAMIGSTGKDLFEFDYSIMTPTFWISLILGFVVAFIVA
LIVMRKFIDFLKKKPMKVFAIYRIIAGSLLGILVLTKVITLAV
>F1DI13|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
PVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLDNMGDHVTRLDRWE
PELNEAIPNDERDTTMPAAKATTLRKVLTGELLTLASRQQLIDWMEADKVAGPLLRSALP
AGWFIADKSGAGERGSRGIIAAL
>A0A0Q6PWC5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNADQGLFVPLILGIIEGLTEFLPVSSTAHILLAGHFLGFNSPGRVFEVLIQLGAILAIL
VVYFQRLLSIARDAIARKPGALRFILGVILASFPAAIAGVLLHDFIKTVIYETPVVFCVS
LIVGGIILLYVDQLKLTPKYTDIYNYPPLLCLYIGLFQVLALIPGVSRSGSTIVGALLLG
TDKRSAAEFTFFIAMPIMGGAFAYDLYKSRDFITAELGAAVIIGFAAAFVTAFFVVRYLL
DFISKNGFAVFAYWRIFVGAIGLWGILLFG
>A0A0B2B595|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSQPLLKLAAVTRRFPAGDKDVVVLSNVNLSIHAGEIVAIVGASGSGKSTLMNILGCLDH
PSEGTYTVGGRDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTPRA
ERHARARELLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKS
GQDVIRILHELNALGHTIVIVTHDQAVARHAKRIIEISDGEIVADRPNRHYAEALAEVSV
GAAEAAESIEAEAGALPADDRHDTPSPPAPVDTDAHPDTDTGTRTRRFAAGSGRFAEACR
MAWIALVSHRLRTLLTMLGIIIGITSVVSIVAIGEGAKRYMLDEIGSIGTNTINLYPGTD
WGDSRADAIQTLVPADVAALAEQPYVDSATPETSRTLLLRYRNVDVNALVSGVGDRFFQA
RGMRFAQGVAFDEDAVRRQVQVAVIDQNTRRKLFGATRNPIGEVILVDNVPCVVIGVTAD
KKSAFGSVKSLNVWVPYTTASGRLFGQRHLDSITVRVRDGQPSAAAEKSLEKLMTQRHGR
KDFFTYNMDSVVKTVEKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRM
AVGARQSDILQQFLVEAVLVCLLGGTIGIALSFGLGALFSMFVAQWKMVFSAGAIVTAFV
CSTLTGVIFGFMPARNASRLDPIDALARD
>YP_932216|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDITLLLTALILGIVEGLTEFLPVSSTGHLIILGDLLGYNDEASKVFKIVIQLAAILAVC
WDYRERLIKVAVGVPSDRSAQRFVGLLLLGFLPAAVLGFLFHSTIKNVLFNPLVVATALV
VGGLIILYVEKRAYHPRVTSVDEMRWGDALKVGFAQALAMIPGTSRSGATIMGGLIFGLS
RKTAAEFSFFLAIPTMLAATVYDVYKNWTLLRVEDLPVFAVGFVASFFAAMWAVKSFIRF
ISNHTFVVFAWYRIVFGIVVLATWQFDLVSWSTP
>A0A098FZT5|FEATURES|UNIPROT_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MKNDSPLFNVINLDTWPRKPYFDHYSQQVKCTYSLTIHIDIGKLLSLCKKESIKLYPVMI
YLITTAINQQEELRIDYSEQGELGIWNFRSPCYTLFHDDDKTFSNLWTPYNKDFSAFYLN
YLTDMETYGATKAFTPKEGEPGNTFPISCVPWLDFTAFNLNIYDDARYLAPIITIGKYTQ
QADKVVLPIAAQLHHAVCDGYHAGMLFELIKKLSSTPEEWINL
>A0A068QV88|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MNYTKFDIENWNRKEHFAYYRHSVQCGFSLTTKIDITRLISSLTEKEYKFYPAIIYILSK
AVNLYSEFKLAIKDDDLIIWDKVDPAFTIFHQETETFSSLWAEYSPDFHCFLANYATNFE
RYKADVSFFPQPNQPANHFHISSLPWVSFDGFNLNVANFTDYFAPIFTMGKYYKDSDQII
LPLAIQVHHAACDGFHVARLMNTIQKMCNERLE
>YP_348488|FEATURES|ARDB_deepARG|multidrug|MexD|antibiotic efflux|1
MSQFFIKRPNFAWVVALFISLAGLLVIPMLPVAQYPNVAPPQIKVTATYPGASAKVLVDS
VTSVIEESLNGAKNLLYFESTNNSNGIAEIAVTFQPGTDPQLAQVDVQNRLKKAEARMPQ
AVLTQGLEVEQTSAGFLLIYALNYKEGTQHSDTTALGDYAARNINNELRRVPGVGKLQFF
SSEAAMRVWLDPQKLVGYGLSIDDVSAAIRGQNVQVPAGSFGSTPTSSQQELTATLAVKG
TLDNPEEFSRIVLRANEDGSTVKLGDVARVEIGQESYNFNSRLNGRPAVAAAIQLSPGAN
AIQTATAVKQRLAELSAYFPDDVEYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLF
LQNIRYTLIPSIVVPVCLLGTLMMMYLMGFSVNMMTMFGMVLAIGILVDDAIVVVENVER
IMAEEGLSPVDATVKAMGQVSGAIIGITLVLSAVFMPLAFMSGSVGVIYQQFSVSLAVSI
LFSGFLALTFTPALCATLLKPIPQGHHEKRGFFGAFNRGFAKLTDRYSVLNNGLVARAGR
MMLVYLGIIAMLGFFYLRLPESFVPVEDQGYMIVDVQLPPGATRTRTEATGEQLERYLAT
RDGVQSTFLVSGFSFSGMGDNAALAFPVFKDWSERGEDQSAMAEVNALNEQFAVTNDGAV
MAVPPPPIDGLGNSGGFALRLQDRAGLGREALLAARDQVLGQANGNPKILYAMMEGLAES
PQLRVVIDRDKARTLGVSFESISSALSAAFGSEVINDFTNAGRQQRVVVQAEQGDRMTPE
SVLKLYVHNTAGDLVPLSAFVTTHWEEGPVQVVRYNGYPSVRIVGDAGPGYSTGEAMAEM
ERIAAQLPAGFSYEWTGLSYQEKVSSGQATQLFALAILVVFLLLVALYESWAIPLTVMLI
VPIGAIGAVLAVMVAGMPNDVYFKVGLITIIGLAAKNAILIVEFAKELWEKGYSLRDAAI
EAARLRFRPIVMTSMAFILGVVPLALATGAGAASQRAIGTGVIGGMLSATLLGVLFVPIC
FVWVLSMLRSKPAPIEQPALTQE
>F3DZU0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLDAGYDIAAVFTHADDPAEKTFFGSVAQLCARHDIPVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGEPLLAYAKNGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLREAASSLLCETLP
LLAQGQLSGTPQDESKATYFGRRTPADGLIDWSLPAARLYDLIRAVTQPYPGAFCPVGDN
KLIVWSARVEPRNNHQAPGTVISHDPLRIACGEDSLVISAGQRGDNGLYLSGAQLAREFG
LVEGSQLLDTQKRRPARRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGCDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRGGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSIYNARQLIDWTPGIELSETIGKTLDFFLREAMAEKA
DQC
>I6ZM14|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGATSIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>NP_840140|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDWLILLKALLLGIVEGLTEFLPISSTGHLILAGDLLNFNDDKAKVFTVAIQLGAILAVC
WEYRERLVNIIRNLGTRQANRFVINLFIAFLPAAILGLLFIKTIKHYLFHPMPVAIALVT
GGILILWAERREHRIEAETVDDMSWKQALQVGCAQCLALIPGTSRSGATIIGGLLFGLSR
KAAAEFSFFLAIPVMFAATFYDVYKHREFLYIDDLGMFATGSVAAFISALIAIRGFIRYI
SHHDFTLFAWYRIGFGLIVLLTAYSGLVDWSVD
>A0A0S1RSJ9|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQ
PTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISS
LRISPLEQLAFLRKLVNRQLPVKAAAYELAEDLFEVGQADRWRPYGKTGA
>A0A059IG62|FEATURES|UNIPROT_deepARG|beta_lactam|T296_06680|antibiotic inactivation|1
MKKSLFYLALFSLSASCVAADLSSQQVTSLVKAAIEPLMEQQEIPGMSVAVLYKGRAQFV
NFGVADLESRRRVTENTLFELGSVSKTFTGTLAGVMIRNGEIRLNDPVQKYWPQLTGEQW
RPVRMLHLATYTAGGLPLQLPDDVTDQASLLRFYQEWQPEAAPGTLRQYSNASIGLFGSL
MVKGDYEQAMARNVFQPLRLTRTYITVPPSMMLDYAWGYKNGQPVRVSPGMLDAEAYGVK
STARDMLTFMQANVDPNRLSSGNAVLRNAIRTAQARYFKVGTLFQGLGWEIYDWPVTADT
LMSDSDNGVALQPRPATLLNPVGPSQSASWVHKTGATNGFGAYIAFIPERNSGVVILANK
NYPNPLRIKAAWQILQALQQEKPE
>A0A0G3SBL4|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY|antibiotic inactivation|1
MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>A0A0P0QK30|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMVNYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAGTHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEATYRIIQALEKR
>A0A0A0Q7Y0|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-5|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>S3V2K4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESFLNALIRSVIEAVTEFLPVSSTGHLFLFSSFFPFSEGGEFDDLFDIFIQSGAILSVI
VLYHDRFLRHGQLSVNYLLGKEKNPEGILFVSQILIGCVPILIAGFLFKGKLDVIKARSD
LLLILGSAWVSGGVLILLSEIWFRRSSQIRDAEPIRLKDAILIGIFQCVALIPGVSRSAA
TIVTARFLKKDARHSAEFSFFLAVPVLLSAGAYKLYKYRHILNGDTLPILAFGFLASFLL
CILVIRWFLKYLQSHSFDAFGIYRVILGLAVLIFYKLN
>A0A0M4NJD6|FEATURES|UNIPROT_deepARG|beta_lactam|blaGES|antibiotic inactivation|1
MRFIHALLLAGIAHSAHASEKLTFKTDLERLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>A0A0A3EUX4|FEATURES|UNIPROT_deepARG|beta_lactam|OA39_00246|antibiotic inactivation|1
MKKLFLLLGLLACSSATYAAKLNEDISAIEEHISGRIGVSVWDTQTDEHWDYRGDERFPM
MSTFKTLACATMLSDMDNEKLDKNATAKVEERNMVVWSPVMDRMAGQTTRIEHACEAAML
MSDNTAANIVLRSIGGPRGVTTFLRSIGDKATRLDRFEPRLNEANPGDKRDTTTPNAMVN
TLRTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAM
IWKENHKPVYISIYITETDLSLQARDQVIAQVSQLILDEYNTI
>ZP_04216757|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFEDDRAKVFEVVIQLGSILAVVVV
FWKRLWSLVGIGKVTEGPSLNLLHIIIGMIPAGVLGVLFHSTIKKVLFGPGPVVISLIVG
GILMIVAEKFSKPSTAKTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSSADITLFATGFITAFLVAMLAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFIMR
>ZP_04620400|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKYFIDRPIFAWVIAIIIMLAGALAIMKLPVAQYPTIAPPAISISANYPGADATTVQNT
VTQVIEQNMNGIDNLLYMSSSSDSSGSVQLTLTFNSGTDPDIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVAGFISEDGTMQQEDIADYVGSNIKDPISRTAGVGDVQLFGS
QYAMRIWMDPHKLNNFGLTPVDVINAIKVQNNQVAAGQLGGTPPVPGQELNSSIIAQTRL
TNAEEFSQILLKVNTDGSQVRLKDVAIVQLGAESYNVIARYNGKPAAGIGIKLATGANAL
NTSAAVKAELEKLQPFFPAGLKVVYPYDTTPFVKISIHEVVKTLIEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILSVFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
QEEGLPPKEATKKSMEQIQGALVGIAMVLSAVFIPMAFFGGATGAIYRQFSITIVSAMVL
SVLVALILTPALCATMLKPIAKGEHGPKTGFFGWFNRMFEKSTHHYTDSVANILRSTGRY
LLIYLAIVVGMGVLFLRLPSSFLPEEDQGVFLTMVQMPAGATQERTQKVLNQVTDYYLDK
EKDVVNSVFTVNGFGFSGQGQNTGLAFISLKDWSERPGAENKVPAIVDRASAAFSQIKDG
LVFAFNLPAIVELGTATGFDFQLIDQGNVGHQKLTEARNQLFGMAAQHPDMLIGMRPNGL
EDTPQFKVEVDQEKAQALGVSISDINTTLGSAMGGNYVNDFIDRGRVKKVYVQAAAPFRM
LPDDIDKWYVRNNVGQMVSFNTFSSAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAM
DLMQELASKLPSGVGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAASLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLV
ESTLEAVRMRLRPILMTSLAFILGVLPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFF
VPVFFVVVRRRFSRKNEDIEHTHAVDHTVK
>U5NJ86|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-119|antibiotic inactivation|1
MVIRFFTILLSTFFLTSFVYAQEHVVVRSDWKKFFSDLRAEGAIVIADERLPKHTLSVFG
QERAAKRYSPASTFKIPHTLFALDADAARDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNS
AVWVYELFAKEVGEDKARRYLKQIDYGNADPSTIKGDYWIDGNLEISAHEQISFLRKLYR
NQLPFKVEHQRLVKDLMITEAGRNWILRAKTGWEGRFGWWVGWVEWPTGPVFFALNIDTP
NRTDDLFKREAIARAILRSIDALPPN
>S9T062|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKPTSKYETIGQILSDFKQPAYRYGQIIDAIFKQKIAEYERITILPKFLRQELARTLGPY
VSSVIPVKELTSQQVSKVLFAIGGDERIEAVRLSYKRGWKSYCISTQCGCGFGCRFCATG
TIGLKRNLTADEITDQLLHFHLNGHTLDSMSFMGMGEALANPHLFDALAILTNPNLFGLG
HRRITISTIGLLPGIEMLTREFPQVNLTFSMHSPFDEQRNELMPINKRFPLRDVLNTLDR
HIRHTGRKVYIAYILLRGFNDSAEHAKAVAALLRGRGAWEHLYHVNLIPYNSTEVTPQSY
LPSDPERIETFVRTLKMYGVNVTVRTQFGSDIKAACGQLYRADSKMNG
>A0A013T930|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-10|antibiotic inactivation|1
MRFNKISCLLLSPLFIFNTSIYAGNPSKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>J2N115|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSHKAVVFAYHDIGCAGIEALLNAGYEIGAVFTHADDPKENTFYGSVAQLCSLKGIPVHA
PEDANHPLWVERIAKLNPDYIFSFYYRNLLSEALLATASKGAFNLHGSLLPSYRGRAPAN
WVLVNGESETGVTLHRMVKRPDAGAIVAQQRVAIERSDTALSLHGKLRDAAASLLRDTLP
ALAQGKVSETAQDESRASYFGRRTAADGKLLWSQPAEQLFNLVRAVTKPYPGAFCAVGEH
KLIVWSAEVVKGNEGQAPGRVISVDPLRIACGQDSLLINAGQRNDNGLYLSGPQLANELG
LVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDKYEVYGLDIGCDAIERLR
HHPHFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQNFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GSKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIVDNENDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESKSFYGAGYQDVEHRKPSIANAKRLLNWEPTVEMKETIGNTLDFFLREAMLEIA
EHSKEEAC
>V7IDW6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLLLAFKALFLGIIEGLTEFLPISSTGHLIVAGSLIGFDAESHAVFNIAIQLGAILAVV
YEYRARFTHVLTHIGKDRLSNRFVLNLAIAFIPAAAIGLLLNDFIEKMLFNPVSVAAALV
VGGFLILWIEKRQSRVPPKVRSVDDMRPRDALAVGLFQILALIPGTSRSGSTIMGGMVWG
LDRKTATEFSFFLAVPIMVAASGYSILKNLSAFSSQELGLIAIGFAAAFASGLIAVKALL
RFVSSKNFVPFAYYRIIFGGIILLTWLCGWVNW
>A0A0G3GNV0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHMARSTLAGAFLLLCGATTGFAQDRIEETVNAAIEPLMKQQDIAGMAVAITLDGQRHFF
NYGVASKDTRQAVTDQTLFEIGSVSKTFTATLGAYALAQGKLSLSDPASRFAPELRGSAF
DGISLLNLATYSAGGLPLQFPQEADHPERMFDYFKAWKPLYPAGTQRLYSNPSIGLFGYL
AARSLGQPFEQAMEQTLMPKLGLTHSYVRVPPDQLERYAQGYAKDGKPVRVGPGALDAQA
YGVKTNSADLIRFVEANLQPEKLDADLRQAIATTHSGFYTMGGMTQGLGWEFYPYPVTLD
ALLAGNSVEVAMQPNKVQPLEPPRPAPDDAWINKTGSTGGFGAYAAFVPGRHMGIVLLAN
KNYPIEERVKVAYRILTALDKQ
>AAP43530|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFTRHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQKAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFMHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPV
ILIDAGSLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLSLLIV
GNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNKLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELVEEQ
>ABO60985|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTTFALTATLAFDVTAADAPLPQLQAYTVDASWLQPMAPLQIADRTWQIGTEDLTA
LLVQTADGAVLLDGGMPQMAGHLLDNMKARGVAAQDLRLILLSHAHADHAGPVAELKRRT
GASVAANAESAVLLARGGSNDLHFGDSITFPPASADRIIMDGEEVTVGGIAFTAHFMPGH
TPGSTAWTWTDTRDGQPVRIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVRGLPCDL
LLTPHPGASNWNYAAGAEAGANALTCKAYADAAEKKFDAQLAKETATAR
>W3YHT3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MMTTLLELHNITRRYPAGEQEITVLKDVSLKINAGEMVAIIGASGSGKSTLMNILGCLDK
PTSGEYFVAGQNIATLDNDQLAQLRREHFGFIFQRYHLLSHLSAEQNVEIPAIYAGAGKS
QRQERAVQLLQRLGLGERVHYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHS
GEEVMKILKDLCAQGHTVIIVTHDPKVAQQAERIVEIKDGEIINDSGMLATKKAEFPAKI
AMKKNPLGQWVSRFSEALLMAWRAMVVNKMRTLLTMLGIVIGIASVVSIMVIGDAAKGMV
LNDIKSIGTNTISVYPGKDFGSDDPENRQALKASDISAIAQQPYVQSVTGSIDTSARLRK
GNLDAVARVAGVGVGYFQVYGNKFAEGMGFTQDMLDRRAPVVVIDGNTKRRFFPNKQNVV
GETLLIGNMPATVIGVLGEQKSIFGSSKSLEVFLPDTTINSKLINRSYYDSIVVRVKDGI
DAKVAEQQLTRLLTLRHGKKDIFTYNIDTLVKTAEKTTQTMQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARTMDVMQQFLIEAVLVCLIGGLMGIGLSYGVSLIAQM
ALPGWTFAFDPIALVSAFACSTAIGIIFGFLPARNAARLNPIDALARE
>A0A0G2NKP7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|ybjZ|antibiotic efflux|1
MTALLELCNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAEEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDSVDALARE
>Q8VUL3|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANGSVAKLNL
>U2KFU9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLQTIIISIVEGLTEFLPVSSTGHMIITQNLLGVPSGDEFVHAFIFIIQFGAILSVVC
LYWKRFFHIDHTPVPAEETSSFKRIIHPIKFYWLLFIGVLPAVVIGLATKKSGLLDWLLD
SVWVVAIMLVVGGIFMLFCDKIFNKGKEENKVTEKRAFSIGLFQCLSVIPGTSRSMATIV
GGMANELTRKRAAEFSFFLAVPTMAGATLLDLLDLLKGDSTWASAHNLIMLAVGCVVSFI
VALLAMKWFVSFLAKYGFKWFGWYRIIVGVIIIIMLLCDIPLNMVD
>AAS16362|FEATURES|ARDB_deepARG|multidrug|floR|antibiotic efflux|1
MTTTRPAWVYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSILAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWIVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>YP_550152|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDIALLIKAAIMGVVEGLTEFLPISSTGHLILAGALLGFDDDKAKVFDIAIQTGAIFAVI
LVYWQKIRDTLVALPTEKQAQQFALNVLVAFVPAVVLGLLFGKAIQAHLFTPVVVASTFV
IGGFIILWAEKRQERNPAVARIHEVEAMTVMDALKVGLVQCLAMIPGTSRSGATIIGGML
LGLSRKAATDFSFYLAIPTLIGAGVYSLYKERALLSVADVPLFMVGLVFSFVSAWLCIRW
LLRYISSHSFIPFAWYRIAFGVVVLATAWSGVVTWTP
>Q9WVU6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGNGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0D0Q3A9|FEATURES|UNIPROT_deepARG|beta_lactam|RW26_04865|antibiotic inactivation|1
MKGWIKCGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKGV
TVVGATWTPDIARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTR
DLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFKLQEGKVRAFYAGPAHTPDGIFV
YFPDEQVLYGNCILKEKLGNLSFANVKEYPQTIERLKAMKLPIKTVIGGHDSPLHGPELI
DHYEALIKAAPQS
>A0A0B2WHJ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFADEKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGEVPHEGHTPGRLKLTHILLAMIPAVVLGLVFHDVIKSLFYPQN
VMYALVVGGFLLLAAEWLKPKKPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFILAVPMMMGATVLDLYKSWHFLALSDVPMFAVGFVTAFLVALIA
IKTFLKVIKRISFVPFAIYRFIVAGVVYMVFM
>A0A0N1B3F5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLIKAAIMGVVEGLTEFLPISSTGHLILAGDLLNFQGEKAKVFEIAIQTGAIVAVI
LFYWQRVWSTAAGIQQDEKARRFVINVLIAFFPAVILGLAFGAAIKAHLFTATVVATTFI
IGGFIILWAERRQAANPAAVRVAEVDDMTHADALKVGLVQCFAMIPGTSRSGATIIGGML
LGLSRKAATEFSFFLAIPTLIGAGVYSVYKQRALLSLADVPMFAVGFVFAFLSALVVVKW
LVRYVSSHTFVPFAWYRIIFGVVVLATAHFGIVSWSD
>A0A0B5BMY0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIENLNKYFGLGQTRAHILKNINLSIERGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGICRIDGKETQTMSADELSDLRQRKLGFIFQRYNLLSALNANENVALPAIYAGMDSSSR
KKRADTLLTKLGLSDKTQHKPNELSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLEILRDLHYEGHTIIMVTHDPNIAAQASRIVEIKDGQIIRDERQRTDVQETALNKTTT
QKPRFWNQLFESFKMATSAIMAHKMRAILTMLGIIIGITSVISVVALGRGSQQQILSNIN
NLGTNTMDIMNGTGFGDRRANLTKNLTISDALMLSRQNYVESTTPSSNVSATLIYGNTAV
TGSVRGVGEQFIDVKGLKLISGRFFSAEEVKNVAQVIVIDPNTQKDLGLTEPVEGKTILV
DKKPLQIIGVAQQSNNMNQSSLTLWAPYTTIMQRISGAKQIDSLTVKIKDDIESQTAEKS
IAELLVAKHGKKDFFIMNSDTIKQTITSTTNTMTLLISSIALISLIVGGIGVMNIMLVSV
TERTREIGVRMAIGAKQRNILQQFLIEAVVICLIGGVIGILLVSAIIWAFNTLGTNFKMM
LSPESVIIAVLCSTLIGVVFGYIPARNASQLNPITALAQE
>A0A0A8GSR8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIHLENIQKSINATPILKNINLSIQKGEFVAIIGQSGSGKTSLLNIIGTLDEPSSGKYFL
DEFEVTNLSKDEKARLRREKIGFIFQRYNLLSLLNAKDNVALPAVYAGKSKQERSQKAKE
LLAFLELDHKEFSKPNELSGGQQQRVSIARALMNGGELILADEPTGALDSKSGKIVLEIL
TKLNEQGHTIVLVTHDKEIAAKAKRIIEIKDGIIISDSKASTLQTPNSKTMPKERKNFNL
LKNQIFESFTMSLSSIIAHKLRSLLTMLGIIIGIASVVCVVALGLGAQQSILASISSIGT
NTIEVVSGRGLGDIRSGRTRLNLSDLKTLSSLSYLEAVEADVGKIGVVTYKNNSLQARIY
GVGPNHLRLRGLVNTAGRFINNEDIKENTNICIIDENALRILFDNMSAANVLGKSIIFNK
QPLTIVGVLKKERDNKGFRADENTIKIYTPYTTLMNKITGDKQIRAIVTKVKDDVNPALA
EEAMVKILEIKRGQKDFFTINSDAIKNAIEENTATLTLLISSIAVVSLIVGGIGVMNIML
VSVSERTREIGVRMAIGARKEDILMQFLIEAVLICSFGALFGVMLSFVIIEVFNSLNIGF
TMILSLNSVFLGLLSSVLIGLIFGFFPAKNAANLNPINALSKE
>A0A0X8GSZ0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MRKPLLELANIVRSFPAGDSEAVVLDQVNLCIHAGEMVAIVGASGSGKSTLMNILGCLDK
PTSGTYQVNGRDVSGLDSDELAGLRRDRFGFIFQRYHLLPHLSAQGNVEMPAVYSGLAKD
ARQDRAKALLRRLGLSDKFGHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHS
GEEVMNILRELHAQGHTVIIVTHDHKVADCAERIVEISDGRIISDRSKPVEVLVEGKIAP
HGREVKSLRVVLDRFLAALNMAWRAMSANRMRTLLTMLGVVIGITSVVSIVAIGEGAKRK
ILQNIGEIGSNTMNIFPGKDWGDDRAGSLRSLLPGDITALQAMPFIDSVTPSTSASLRLR
HRALDIGASVSGVGEYYFRVSGLQPALGRFFNSEDVASQSQLVVIDHNTQRKLFPNGADP
LGQVILVGNLPATVIGVAAENKSGFGGGGQSLQVWLPFTTTANRLFGQQYFNNITVRVKD
GQSSAAAEQSIEKLLTLRHGSKDFFIYNMDSVVKKIEQTSQMLALLLSMIALISLVVGGI
GVMNIMLVSVTERTREIGIRMAVGARQSDVMQQFLTESVLVCLIGGVIGVLLSLGIGALV
QFFVPDWQMIFSLGSFIAAFICSTLIGVFFGFLPARNAARLDPIEALARE
>A0A0V7Y5N7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANIIKAAILGIIEGITEWLPISSTGHLILADQFIKLDASTQFMSMFNVVIQLGAILA
VVVLYFHKLNPFSPSKTTIEKKDTWTLWFKVVVACIPAIIIGLPLDDWLEEHFHKFLPVA
IVLIVYGIAFIIVEKRNKTKKPRWTTLNDFTYQAALLVGLFQVLALVPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASGLKIVKYLAEGNSFKTEETIVLLVGTLVSFIVSV
LAIKFLLNYLKKNDFTAFGWYRIILGVILIGYWFIAM
>A0A0Q4UAY2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAAGLPLLVGTRVNDLIAAIILGIVEGVTEFLPVSSTGHLILAGALLGYDDARWQMFNIV
IQLGAILAVVVLYWRTFWTVLVGLFKRDPGSVRFVRNLLIAFIPAAVIGVLAKKHIEALL
LQPKVVAVALIVGGIAILVIERVVKPGTTRGIAAVPARTALGVGFLQCLAMIPGVSRSGA
TILGALTLGVERRTAAEFSFFLAIPTMLGASVVETAGHMDAMRAGNSVGPIEIAVGFVVA
FIVALLVVRWFVGIVGRHGFGPFAWYRIVAGSIALALLTMH
>CAB75601.1|FEATURES|CARD_deepARG|chloramphenicol|catIII|antibiotic inactivation|1
MNYTKFDVKNWVRREHFEFYRHRLPCGFSLTSKIDITTLKKSLDDSAYKFYPVMIYLIAQ
AVNQFDELRMAIKDDELIVWDSVDPQFTVFHQETETFSALSCPYSSDIDQFMVNYLSVME
RYKSDTKLFPQGVTPENHLNISALPWVNFDSFNLNVANFTDYFAPIITMAKYQQEGDRLL
LPLSVQVHHAVCDGFHVARFISRLQELCNSKLK
>A0A090UYV5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHTLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGHPPHEGEGKGRLTLIHILLGMIPAVVLGLVFHDAIKSLFNPIN
VMYALVVGGFLLIAAECLKPKTPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSYHFLTTADIPMFAVGFITAFIVALVA
IKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A095ZB37|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLFQTIVIAIVEGLTEFLPVSSTGHMIITQNLLGMQPGDPFVHAFTFIIQFGAILSVVC
LYWKRFFQMRNADEVSAKLRFYGLLIVGVLPAVFIGLAAKKSGLLDWLLDSVQVVAVMLV
LGGVFMLFCDKIFDQGRDERKVTARRAFVIGLFQCISVIPGVSRSMATIVGGMQQKLTRK
NAAEFSFFLAVPTMAGATLLDLLEMFGEDTTWATSHNITMLVVGCVVAFLVAMVAMKWFV
NFLAKYGFKAFGWYRIVVGGAILALMFCGQSLAMVD
>K7Q9V7|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
VKENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYW
KSIGAKVVATRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFMLQEGKVRA
FYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTV
VGGHDSPLHGPE
>A0A0U1XXY9|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVALWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISAIEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGW
>A0A0F6G7L9|FEATURES|UNIPROT_deepARG|aminoglycoside|BG16_4198|antibiotic inactivation|1
MTHPAALFKIRAAQASDAAAWRQLRRALWPHADDIEHARDIARQLDAPARHACFIASPPG
ILAPVGFAEVAVRHDDVNGCGASPVLFLEGVFVEPAARRSGVARALCATAAAWGTARGCA
AFASDAPLENAASHALHRALGFDETERVVFFRKPLAR
>V3PWC5|FEATURES|UNIPROT_deepARG|chloramphenicol|L370_02247|antibiotic inactivation|1
MKKTAPDYTPVDLSSWPRKEHFEVFQSFAECTINQTVLIDITALRKHIKEVGWKFYPTII
FLLSKIMNRHPEFRMAMKDNELVVWNEIHPSYTIFHNETETFSSLWSHFDGNMQHFQNTY
AEDVARYGNNLSYWPKEESRENVFFVSSIPWVTFTNFTMNIAHMKNFFSPMFTFGKYYEQ
DGKVLLPMAVQVHHSVCDGFHVARMFNELQEMCDELPNQSGEVNG
>A0A0P7L3E1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRCFGSGANRVHVLKDINLKIDKGDFVAIIGQSGSGKSTLMNILGCLDTPS
SGSYMVDGVETAKMEANELAGLRRKRFGFIFQRYNLLNALSARDNVALPAVYAGLPHKER
YNRANALLHRLGLEGKEENKPSELSGGQQQRVSIARALMNGGEILLADEPTGALDSKSGE
NVMDTIRQLHNEGHTIIMVTHDPKIAALANRVIEIKDGYIISDVSKNSEVAPGSVETLPE
NRSWLFRKDQLLESFRMSVQAIMSHKMRSLLTMLGIIIGIASVVSVVALGKGTQTKILGD
IAAIGTNTISIYPGKGFGDRFSGKIKTLTVADAEVIGRQSYVSNVTPMTASSGTITYRNA
DLTGQLYGVGNQYFDVRGFKLDEGRLFDEQDVKDNAQVVVIDQNTLKKLFPDNENPLGKV
ILFKKRPLTIIGTVKEEKNAFGGDSDSLQLWSPYTTVMNQITGERHISSLIVKVGDNASS
QAAENGLTELLISRHGTEDFFMRNSDSIKQTVESATGTMTLLISSIALISLVVGGIGVMN
IMLVSVTERTKEIGVRMAIGARQGNILQQFLIEAVLICLIGGMTGIALSILIGMTFNHFV
TDFAMTFSAMSVVGAVACSTIIGVVFGYIPANRASKLNPIDALAHD
>A0A0A8JH86|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIELIKALILGFVEGMTEFAPVSSTGHLIIVDDMWLKTTEFLGDRSAFTFKIVIQLGS
ILAVIVVFWKRLFSLVGLYKIDGQKMNSRFNLAHVVVGMLPAVIVGFALKDYIDEQLSGV
ETVIFALVAGSFLMLAADKFGPKKPKVNTLDQITYKQAFTVGLVQCLSLWPGFSRSGATI
SGGVLFGMNHKTAADFTFIMAVPIMAGASLVSVMKNWEELSMDDLSFYIVGFVSAFIFAL
ISIRFFLKLISRVKLVPFAIYRLVLAAVLAVIVFM
>D0WA73|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKNISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKER
SARAEKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASKVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSMGTNTISIFPGRGFGDRRSGKIRTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDDANTQV
AEKGLTELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>A0A060KT87|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVSGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A076V860|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
RRINLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYSDNTAMNKILEHLGGP
AKVTEFARTIGDKTFRLDRTEPTLNTAIPGDERDTSSPLAMAKSLQNLTLGKALGEPQRA
QLVEWMKGNTTGGASIRAGLPTTWIVGDKTGSGDYGTTNDIAVIWPANHAPLIL
>G3ESI3|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
PAFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVL
SRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTT
IGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRELLTGELLTL
ASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGVIAALGPDGKPSRIVVI
YTTGSQATMDERNRQIAEIGASL
>A0A0D0Q6S2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHIIELIKALILGLVEGMTEFAPVSSTGHMIIVDDMWLKSSEFLGKYGANTFKVVIQLGS
VLAAVVVFKDKFFELLYLRKGEVRKGPRLTLMHIFIGLLPAGVLGVLFEDYIDEHLFSTE
TVLIGLVLGALLMIAADRFGKRTVAQTVDDMTYKQAFIVGLVQCLSLWPGFSRSGSTISG
GVLVGMSHRAAADFTFIMAVPIMAGASAISLLKNWEYITLDALPFFIVGFISAFIFALIA
IRFFLRLINRVRLVPFAIYRIVLAAVIYIVYFA
>Q02652|FEATURES|ARDB_deepARG|tetracycline|tet|antibiotic target protection|1
MRTLNIGILAHVDAGKTSLTERLLFDHGAVDRLGSVDAGDTRTVDGGIERRRGITIRSAV
AAFTVGDTRVNLIDTPGHSDFVAEVERALEVLDGAVLLLSAVEGVQARTRVLMRALRRLR
LPTIVFVNKIDRAGARTDGLLGDVRRLLTPHVAPLTEVADAGTPRARVTRRPPDGRTAEA
LAEVDTEVLAALVDGPEPTGEDVARALAARTADGSFHPLYHGSALGGQGVAELVEGLLGL
IPAATPGTSGGTSGGTEPRGTVFAVRPGPAGERTAYLRLYGGEVHPRRRLTFLRRESDGR
TTEVSGRVTRLDVVGGDATLTAGNIAALTVPGGLRVGDRLGGPTDRAPQFAPPTLQTLVR
ARHPEQAAPLRSALLALADQDPLLHARPAASGATALLLYGEVQMEVLAATLAEDFGIEAE
FTPGRVRFLERPAGTDEAAEEMPWLDRTRYFATIGLRVEPGPRGSGGAFGYETELGALPR
AFHQAVEETVHDTLRTGLTGAAVTDYRVTLIRSGFSSPLSTAADFRGLTPLVLRRALARA
GTVLHEPYQAFEAEVPADTLAAVTALLASLGADFTGTTGGDPAWIVTGELPARRVREAEL
RLPGLTHGEAVWSSRPCEDRPLKAGNSGPGTGVGGHSGE
>A0A0S4SXD1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLSAIILGIVEGLTEFLPVSSTGHMILSAKLLGLEQTSVLKCFEVVIQLGSILAVVFM
FFDRLKEDFNLWIKLAIGFVPTAIIGFLAYKHIKTFFEPSTVAYMLIIGGIVFIIVELWH
KKINYEGDTKTLHEVSFKQAFLIGLSQCFAMIPGTSRSGSTIIAGLLCGLSREVAARFSF
LLAIPTMFAATAYDSYKNADIFVQNKEALWMFLVGGFMAFIVALIVIKLFLKFVSKFSYI
SFGIYRIALGSLFLIYVL
>A0A142ISB3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQAVILGVVEGLTEFLPISSTGHQIVVADLLGFGGERAMAFNIIIQLGAILAVM
WEYRRKILITVFNVPRQREAQRFTANLLIAFLPAVVIGVAFADLIHEYLFNAITVAAALI
IGGLVMLWAERRQHEVTVEEVDDMTWKEALKIGFAQCLAMIPGTSRSASTIIGGLLFGLS
RRAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDLPVFALGFVVSFVFAMIAVRALLKF
IANHSYAVFAWYRIGFGLLILATWQFHLIDWSSAQG
>YP_001571083|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MHNRLQSGVRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGLDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLATLLAKNIEQFTFLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAAL
AAIAFFGLQRAMPETATRRGETLSFKALGRDYRLVIKNRRFVAGALALGFVSLPLLAWIA
QSPIIIISGEQLSSYEYGLLQVPVFGALIAGNLVLARLTSRRTVRSLIVMGGWPIVAGLI
IAAAATVVSSHAYLWMTAGLSVYAFGIGLANAGLVRLTLFSSDMSKGTVSAAMGMLQMLI
FTVGIEVSKHAWLSGGNGLFSLFNLANGILWLLLMLVFLKDKRTGNLQTV
>A0A068EQ40|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-115|antibiotic inactivation|1
MKKSLCLTLLLAASCSTFAAPKQLTAQQIEKIVNRTISPLLKEQAIPGMAVAVIYKGYPL
YFTWGKADVQHNEPVTRQTLFELGSVSKTFTGVLGGDTLARGEISLSDPAQKYWPELTGS
QWKGITLLQLATYTAGGLPLQVPDEVTDSASLLNFYQSWQPQWAPGSKRLYANASIGLFG
ALMVKPSGMGFEQAMTTRVLEPLKLAHTWITVPPAEESHYAWGYRNDKAVRVSPGMLDAE
AYGVKSSIEDMAHWVQANMVPERVEDQNLQQGIKLAQSRYWRIGSMYQGLGWEMLNWPLK
GKVIIDGSDNKVALAPQTAVAIDPPAPLVKASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPERVKAAYAILEALQ
>V8G943|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDFLFLLKAAFLGIVEGVTEFLPISSTAHLLIVGDWIGFDAGQDKVYEIVIQLGSILAV
MWIYRQKISDVCVGTIKRNRSDLFFVRNLLLAFLPAAIIGLLLIKYIKQLLDGQFMVYAI
TLVVGGLIMLWVESRPEMAKHTHLTDDDLSHKTQRIEDISVKQALVVGFAQCLAMIPGTS
RSGSTIIAGMLAGIHRKTATEFSFFLAMPTMIAATVLSLYKYGSYLSESNLLAVVIGFVM
AFLSALLVVKALLSFVAKYSYKPFGWYRIIFGLIVGIWAYNLV
>J8JCX5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVKGRKLAYFNICGVWIALNEEIHIPRNEI
HQSYTHIAFSVEQKDFKRLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYREDKPHMTFY
>A0A0R2X2G2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLIEAIILAIIEGITEYLPVSSTGHMIIASSFMRIATDDFTKLFTIVIQLGAILSVVVL
YWKRFFQSFDFYLKLVVAFIPALILGLLLSDVIDELLESPVTVAVSLIIGGFILLKVDDW
FKANEEFDSENPTVYTKISYVTAFKIGLFQCLAMIPGTSRSGASIVGGMTQKINRKTAAE
FSFFLAVPTMLGATLKKSYDYYKAGFELSTDQINYLIVGNILAFVLALIAIKSFIDYLSK
KGFKIFGYYRILFGITLLIIHFSFYKLTI
>YP_002850805|FEATURES|ARDB_deepARG|tetracycline|tetB(P)|antibiotic target protection|1
MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSS
TISFNWNNVKVNIVDTPGHVDFISEVERSLSVLDGAILVISGVEGIQSQTRILFETLKEL
NIPTIIFVNKLDRIGANFNKVFEDIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCMIND
DAIDVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYASEGSLYPVFCGAAAIGLGVEDLLD
GICSYFPFAGDDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKV
KKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISA
IDKEKNPELFKALTLLAEEDPLLELEMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVE
FSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKS
FQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQ
TVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMK
IASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD
>W4ER49|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIQGINHLLFSVLNLEKSIKFYQNVFDAKLLVKGRSTAYFDVGGIWLALNVEEDISRNE
IHQSYTHIAFTIKDSDFDEMYEKLRNLNVNILSGRQRDQRDKKSIYFTDLDGHKFEFHTG
TLQDRMDYYLQHKKHMEFINDGKQK
>A0A0M2PJ59|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIIGIILGIVEGLTEFAPVSSTGHMILVGHLLGFDGTVRATTFEVIVQLGSILAVVFV
FWKRILSILGLYKMEAKEQGAGKLRYTHILIGILPFFIFGAIFYDFIKGLFSPQIVVISL
IAGGVLMLAAEFLRTPKPNAMTLDQITYKQALGMGLFQCFALIPGFSRMGATLSGGLLIG
MNHKTASEFSFIMAVPIMVAASGKDLLENWSHLSVSDLPLFITGFLTAFIVALIAIKFFL
NLINKIKLVPFALYRFVLAILVWIFIL
>1411197A|FEATURES|ARDB_deepARG|beta_lactam|BL2d_moxa|antibiotic inactivation|1
VACGQASGSESGQQPGLGGCGTSAHGSADAHEKEFRALEKKFDAHPGVYAIDTRDGQEIT
HRADERFAYGSTFKALQAGAILAQVLRDGREVRRGAEADGMDKVVHYGQDAILPNSPVTE
KHVADGMSLRELCDAVVAYSDNTAANLLFDQLGGRRGSTRVLKQLGDHTTSMDRYEQELG
SAVPGDPRDTSTPRAFAEDLRAFAVEDGEKAALAPNDREQLNDWMSGSRTGDALIRAGVP
KDWKVEDKSGQVKYGTRNDIAVVRPPGRAPIVVSVMSHGDTQDAEPHDELVAEAGLVVAD
GLK
>A7ZMC9|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMENID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMVSYIKRARSMRDIRNEKGTAKPDPAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVEPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRLPSVIILQRASR
>ABW87257|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRFILLAFALAVALPAVHASAAEAPLPQLRAYTVDASWLQPIAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNVKLRGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAAGSKASTEALTCNAYADAAEKKFDAQLARETAGTR
>A5ZYV0|FEATURES|UNIPROT_deepARG|chloramphenicol|RUMOBE_04223|antibiotic inactivation|1
KFFMFDSLSSISFNELSRFSGAKEAKMEKKITGYTPVDISQWHRKEHFEAFQSVAQCTYN
QTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTV
FHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFT
SFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDE
WQGGA
>A0A0A7KS89|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-27|antibiotic inactivation|1
MKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYF
TWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQW
QGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGAL
AVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYASGYREGKPVHVSPGQLDAEAY
GVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKAD
SIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLAN
KSYPNPVRVEAAWRILEKLQ
>A0A088NLI4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKRPPHLLLATALTLAAPPLLADDLQHSVDGVIQPLMREHGIAGMAVAVYANGQAHYFNY
GLADKASGQAVTRDTLFEVGSVSKTYTATLAALASAEGKLDLAAPASRYQPALAKAPIGS
ATVLELGAYSGDCLPLQFPDEVQTKEQTLAWFQHWQRRAEPGTQRCYSNPSLGLFGDLAA
RAQKRPFAELMTQGLLPRLGLEHTYLEVPANARGLYAQGYDAKDQPVRVSPGPYAEQAYG
IKTSASDLLRYVQLQLQPDALDPALRKAIAITQSGYFQVGAMTQGLGWERYSYPVSLDTL
LEYNGAKIIRGENPIKALNPALPTEPAAWYNKTGATGGFGAYVAFVPSKQMGIVLLANRN
YPNEERVRAAQRILSSLER
>A0A069IVC0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDWLAAIILGLVEGLTEFIPVSSTGHMLLLGHFMGFQSSGKTFEIVIQLGALLAIVSVY
FRRLWTLATRWPFDAEARRFLIGLLVAFAPAVVIGFLAYDFIKTVLFETPQVVCVALIVG
GILLLLLDRMDKRPQWLDANAYPMRVYFLIGLFQCLAMIPGVSRSGATIAGGLLLKTDKR
SAAEFSFFLALPTMGAAVAYDLLKNHKTLDFSDVGLIAVGFVTAFLTALVVVRFLLDFVS
KHGFGPFAWWRIVVGVVGLALLQAGF
>A0A084Y1Y1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKALILGLVEGFTEFLPVSSTGHLILAGDLLDFNDERGKLFEIVIQSGAILAVC
WEYRAKLSQVLLGLTSERAAQRFALNLLVAFLPLAIIGLLFGKMIKAHLFNAPVVALAFI
AGGFLILWAERREHRIRVESVDDLSLTDAFKLGCAQALALIPGTSRSGATIIGGLFFGLS
RRAATEFSFFLAIPTLIIATLYQLYKERALLSFDDLGMWIVGFLAAFISAFWAVRGLLRY
ISTHDFSIFAWYRIVFGIVVLVTWHYHWVSWTS
>NP_839157|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGVSQLFYGPISDRVG
RRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMARTLPRDLYERTQLR
HANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFSMARWMPETRPVDA
PRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVLGLSSMTVSILFIL
PIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMNVWTLLVPAALFFF
GAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLPQTGQGSLGLLMTL
MGLLIVLCWLPLATRMSHQGQPV
>P07944|FEATURES|ARDB_deepARG|beta_lactam|mecC|antibiotic target replacement|1
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEV
EMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKED
GMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTHMRLGIVPKNVSK
KDYKAIAKELSISEDYINNKWIKIGYKMIPSFHFKTVKKMDEYLSDFAKKFHLTTNETES
RNYPLGKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT
IVRVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELL
ALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKT
LDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKK
FEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSAL
ENNGNINAPHLLKDTKNKVWKKNIISKENINLLNDGMQQVVNKTHKEDIYRSYANLIGKS
GTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYE
NGNKKYDIDE
>R5FY99|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNSFIEFLKIVVFGVVEGFTEWLPISSTGHLILVENIVHLNVSEEFMNVFRVVIQLGAIL
AVLVLYFRRLNPFDPGKKPAQKRATWHLWFKIIIACLPAAVIGILLDEVLDKYLYNPYVV
AAMLIIYGVIFIAFENRNQHAEFRIKKVSQISYQTAFYIGLFQLLALIPGTSRSGATILG
AMMLGCSRTAASEFTFFLGIPVMFGASLLKILHYGLAFSAMELFFMAAAMVIAFVVSMYS
IQFLLGYVKKHDFKFFGYYRIVLGVIVLIYFGLTAILTK
>A0A126S3E0|FEATURES|UNIPROT_deepARG|beta_lactam|AWT69_002012|antibiotic inactivation|1
MKRPPRLLLATALTLAAPPLLANNLQATVDDVIPALMREQGIAGMAVAVYANGQSHYFNY
GLADKASRQPVSRDTLFEVGSVSKTYTATLAALASAEGKLDLQAPASRYQPALAKASIGK
ASVLELGTYSGDCLPLQFPDEVQTPAQTLAWFQHWQPRFAPGTHRCYSNPSLGLFGDLAA
RAQQQPFAELMTQQVLPRLGLKHTYLEVPASARGLYAQGYDVKDQPVRVNPGPYAEQAYG
IKTSASDLLHYVQLQLQPDTLDPAMRKAIAITQSGYFQVGAMIQGLGWERYPYPVSLDTL
LEYNGAKIIRGENPIQALTPALPADPGAWYNKTGATGGFGAYVAFVPSRQMGIVLLANRN
YPNEERVRAAQRILSSLEP
>E1GW60|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFQTIIIAIVEGITEFLPVSSTGHMIITQSLLGVKQGDPFVHAFTFIIQFGAILSVVC
LYWKRFFSFKHVSCVDKERGSSLLRFFRFYWLLFIGCLPAGVVGLLAKKSGLLDWLLDSV
SVVAVTLVLGGVFMLFCDRLFNKGKQENRVNVRRAFCIGLFQCLSVLPGMSRSMSTIVGG
MASGLTRKHAAEFSFFVAVPLMAAATLLDLYDLLKHGTQWATFHNLTVLALGCVIAFLVA
LLAMKWFVSFLTKYGFRLFGWYRIIVGGIILILLAMGVNLNMIE
>ZP_03486480|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYQEMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIKISEKEKIKITEMCVPTNG
ELCSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRTFIENPLPMLQTTIAAKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGKVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>A0A009R9F6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKYSYVNVPKTQIQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A7KFY3|FEATURES|UNIPROT_deepARG|aminoglycoside|Ant2Ia|antibiotic inactivation|1
MLPKTKLDIMREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLL
VTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGE
WQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLK
LWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAY
LGQKEDHLASRADHLEEFIRFVKGEIIKSVGK
>A0A0T6ZL69|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLLSIALALPTSVKARRFVSSVLLAFLPAALIGAAAHDFIKSVLFETPMLICVVLI
VGGVILYAIDRLPLQPRYTDVFDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMVGAFTLDLYKNRDALSFDDVGVIAIGFIAAFVAGIFVVRSLLDF
VSHRGFTPFAIWRIIVGTAGLVGLWLLG
>A0A084CG68|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPRYRLAPFPLAAALAMGAITAQAADPLQAQVDEIIQPLMQEHQIAGMAVALYADGQAHY
FNYGVANKADNSPVSADTLFEVGSLSKTYTATLAALASAEGKLDLQAPAQRYQPALAGTP
LGEASVLEFGAYSADCLPLQFPDAVHTDQQVLAFFRHWQPVAKHGTQRCYSNPSLGLFGD
LAARAQQRPFAELMTEGLLPQMGLKHTYLHVPADAQRLYAQGYDAHDQPVRVSSGPFADA
AYGIKTNATDLLRYVRLHMQPAELAPTLQKAAAITQAGYFQVGSMTQGLGWERYPYPASL
DTLVNGNSSKFALAPQATRRLNPELPAVPDAWYNKTGATNGFGAYVAFIPAQGKAIVLLA
NRNYPNEARVRAAYRILSSLDH
>A0A0K1QFK9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MLNRNPSIEEIWIADPGAGPYGLTTGPDAALWVTAIHAGSIIRLGATSGEEREVVHHPLK
SRTCGPSIITSAPDSGPDSPLWFTCSREHHIGRITTDGAITSFPTPTPDSAPFGITAGPD
GALWFTEMKADRIGRITCDGAITEFPLPIKGAFPSMITPGPDGALWFTLNQANAIGRIGL
DGEVTLHELPTPNAGPVGITLGSDDTLWFVEIAAGQIGRLTPDGKIQEFPLPERTAKPHA
IVADPAGGCWFTEWAANRIGYIGVTGEFQHHDLPSPSSEPHGITIGPDGAVWAALETGAV
ARLPRG
>R5WVE4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIEFLKAVFLGIVEGITEWLPISSTGHMILVDEFIKLNVTPEFKEFFLVVIQLGAILA
VVVLYWGKLWPFYIRELPKKQRAIIAKQPVFARGIMTFVERFCDKEKWVLWFKILVACIP
TIVIALPFNDFIEEKFNNYVVVSIALIVYGVIFIFIENYNKRRKATCRSLESMSFKTAFL
IGLFQVLSVIPGTSRSGSTIIGGILVGTSRTVAAEFTFFLAIPVMFGASLLKLIKFGFAF
TAGEVLILITGVVVAFVVSILAIKFLVGYIKKHDFKVFGWYRIVLGVLVLGYFIGKNVIG
>A0A0S4P0N9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDITFALALKAIIMGLVEGFTEFLPISSTGHLILAGSLLDFTDEKAKVFEIVIQAGAIMA
VCWEYRARIASVMSGLTSDPKAQKFMLNLIVAFMPLAVLGLALGKMIKSALFKPVPVALA
FIIGGIIILWVERRNKLNPPVVRVETVDDMTVLDAFKVGCAQAMALIPGTSRSGATIIGA
MMFGLPRKAATEFSFFLAIPTLLLATAYSLVKERALLSAADLPLFGIGSIAAFISAFLCV
RWLLRYISSHDFTVFAWYRIVFGIVVLASSHYGWVVWAE
>NP_460388|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYTSEARQLLALRIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLVMIVLWNAGYIIRSMHNID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFLGLLVNIPVNYIFIY
GHFGMPELGGIGCGVATAAVYWVMFIAMLSYIKHARSMRDIRNEKGFGKPDSVVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLGVGICMAVVTAIFTVTLRKHIALLYNDNPEVVALAAQLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYILALTDLVVDRMGPAG
FWMGFIIGLTSAAVLMMLRMRYLQRQPSAIILQRAAR
>E4KP91|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLQAIDLIELLKLFIISVVQGITEWLPISSTGHMILIEDFMPLNLSAEFRETFLILVQLG
SIMAVVVLYFHKLNPLSPSKNYQERKETWTLWFKVIVASIPVLIFGLFLNDYMDTYFYNP
TVVAIALIVYGFAFIWIEKSNHAKHSAKTEHLEDLSYNKAFKIGLFQSLAIIPGTSRSGS
TIMGGLLTNNSRFVATEFSFFLGIPVMFGASFLKLLKLGFSLSQVEIFYLIFSMVVAFIV
SIVVIRFLLTYLKRNDFTGFGYYRIALGAIVILYNLLIK
>YP_001871501|FEATURES|ARDB_deepARG|fosmidomycin|RosA|antibiotic efflux|0
MTDRSDTGCQQPVNVSVKRTSFSILGAISVSHLLNDMIQSLILAIYPLLQAEFSLSFAQI
GLITLTYQLTASLLQPLIGLYTDKHPQPYSLPIGMGFTLSGILLLAVATTFPVVLLAAAL
VGTGSSVFHPESSRVARMASGGRHGLAQSVFQVGGNFGSALGPLLAAIIIAPYGKGNVGW
FSLAALLAIVVLLQVSKWYKLQQRASYGKVLKISSAKTLPKNKIISTLAILMVLIFSKYF
YLTSISSYYTFYLIHKFGVSVQSAQIHLFVFLFAVAAGTIIGGPLGDKIGRKYVIWGSIL
GVAPLTLALPYASLYWTGILTVFIGVILASAFSAILVYAQELIPGKVGMVSGLFFGFAFG
MGGIGAAVLGYVADLTSIELVYQICAFLPLLGIFTALLPNLDDK
>J8NLV2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEEVHIPRNEI
HQSYTHIAFSVEQEDFERLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRINYYRDEKPHMTFY
>A0A0B5WWT4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHLWNLFVAAILGLVEGLTEFAPVSSTGHMIIVDDLILKSNHLYGTEAANVFKVVIQLGS
IMAMVVVFWDRFLNLLGLKKNITREQMYGERLKLTHVITGLVPAAVLGFLFEDYIDAHLF
SVNTVLVALVAGAVLMIVADLTRPRRPKTETVDQITYRQAFVVGLFQCLALWPGFSRSGS
TISGGVLLGMSHRAAADFTFIMAVPIMFGASFLSLVKHWGAVTPETIPFFITGFISAFIF
ALIAIKFFLALINKVKLIPFAVYRILLAIILLLLIWNR
>ZP_04298283|FEATURES|ARDB_deepARG|beta_lactam|BL2a_III|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITYTKDDLVEYSPITEKHVDTGMKLGE
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKDATYDNKLIADAAEVIVKALK
>A0A0M1YRB1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNHYLNAFLRSIIEAVTEFLPVSSTGHLFLFSSFFPFSGESFGIQFDDLFDIFIQSGAIL
SVLFLYREKFGSQIRSSLRYVTKQNSDPQGFYFLVRIAIGALPILVAGFIAKNFLDTIKT
RSDLLSILAGAWIFGGVLILVAEWFFQKRRGVEEKTPVGFRDAILIGIFQCAALIPGVSR
SAATIVTARFLGKDTKSSAEFSFFLAVPVLFAAGIYKLIKYRSILNEATIPVLTFGFLIS
FLFCTLVIRLFLRYLQKHSFGVFGIYRILLGVGVLVFTKFIR
>A0A0A0Q8R7|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-12|antibiotic inactivation|1
MMKKSLCCALLLSTSCATLAAPLSETQLAKVVERTVTPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTAQTLFELGSISKTFTGVLGGDAIARGEMSLGDPVTKYWPELTGKQ
WQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTMRLYANASIGLFGA
LAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKAEEQHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVVANMAPDGVQDASLKQGMVLAQSRYWRTGSMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>A0A0F6NAK1|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDDMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A023WTD3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVWVAIQALILGVVEGVTEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVI
WEYRRKIIDVVVGLPKERQAQKFTINLLIAFMPAVVLGVAFADLIHEYLFNPITVATALV
LGGIVMLWAERRDHAIRAETVDDMNWSLALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDFAVFAIGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRIGFGLLILATWQLGLIDWTSVQA
>A0A101JZS8|FEATURES|UNIPROT_deepARG|aminoglycoside|DK26_15510|antibiotic inactivation|1
MRLEACTFDMLDDWVALRLALWPDGSAEGHRNDAAGILESADDTAFIARDSDGMAIGLAE
AALRHDYVNGCESSPVGFLEGIYVRPEARKRGVARALCQAVEAWAAGHGCAEFASDAGLL
NTGSQQMHHALGFEETERVVYYRKRLQTG
>A0A0E2VDI5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLYALILGIIEGLTEFLPISSTGHMILGTTILGIDIDEFWKSFLIIIQLGSILAVIFV
FWRKLFQGLDIWLKLAVGFFPTGVIGLFVAKYLNALFNGWVVVGMLIFGGVVFILIELAH
KNKQYRINSLEEISFKQAFCIGIFQSLAMIPGTSRSGASIIGGLLLGFNRKVAAEFSFLL
AIPTMIIATAYSIYKEPELLSNANSLIPLGIGFITAFIVAVLVIKFFLKFISKFDFIPFG
IYRIILGFVFFYLYYSGILNAGSEFKL
>A0A120DQ55|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MRQPLLKLAAVTRRFPAGDKDVVVLNNVNLSIDAGEIVAIVGASGSGKSTLMNILGCLDH
PSEGTYTVGGRDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTPRA
ERHARARALLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKS
GQDVIRILHELNALGHTIVIVTHDKAVARHARRIIEISDGEIVADRPNRHYAEALAESSV
GADATPATPETVTDTPPAPPSEDAPPPASADTDIAPRTRRFAAGTGRFAEACRMAWIALV
SHRLRTLLTMLGIIIGITSVVSIVAVGEGAKRYMLEEIGSIGTNTISLYPGTDWGDSRAD
TIQTLVPADVAALAEQPYVDSATPETSRTLLLRYRNVDVHALVSGVGDSYFQTRGMRFAL
GVPFDDDAVRRQAQVAVIDQNTRRKLFGVTRNPVGEAILVDNVPCVVIGVTADKKSAFGS
VKSLNVWVPYTTASGRLFGQRHLDSITVRVRDGQPSAAAEKSLEKLMIQRHGRKDFFTYN
MDSVVKTVEKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQS
DILQQFLVEAVLVCLLGGTIGIALSFGLGALFSMFVAQWKMVFSVGAIVTAFVCSTLTGV
IFGFMPARNASRLDPIDALARD
>U2D2A2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIFIELLKVILLGIVEGITEWLPISSTGHMILVDEFIKLNVSEAFMEFFLVVIQLGAILA
VVVLYWNKLWPFYIRKIPKKTQMALRKQPAVPRTVLTFVEKYCDKDKWILWFKILVACLP
TIIIALPFNDIIEKKFYNYVVVAIMLIVYGVLFIVIENYNKRRRPTCTRLDELSFKTALI
IGCFQVLSVIPGTSRSGSTIIGGILAGTSRTVAAEFTFFLAIPVMFGASLLKLVKFGFAF
SSTELIILIVGVVVSFVVSVLAIKFLMGYIKKHDFKVFGWYRIILGILVLGYFVGKTFLA
>A0A127T6D3|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
ASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKSYYFTWGYADIAKKQPVTQ
QTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGG
LPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQT
RVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQS
NLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAAR
PVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQI
LNALQ
>YP_002243220|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIADFRRALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQSGQAP
>A0A0G1P5W0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILHSLILGIIEGLTEFLPVSSTFHLITASRLLGLTQTEFISLFEVVIQSGAILSLLFI
YTKTLLHNSRLLSLTIISFVPTAILGGLLYPIIKGTFFLNSSLQLSVFIAIGLVFFLLEA
LLARKHLVLHYELADLTNQHAVLIGFAQALAIIPGVSRSGIVLIIMLLLGYRRDESARYT
FLLSIPTILAASALDLYQGRHLFIGSSPYFLPLLIGFVSAFITAYFVVHWLLLFLRTHTL
RLFAWYRLIVGTLLAL
>A0A085GGQ1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTALLELRDIRRSYPSGDEQVEVLKGINITIEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGSYKVAGQDVALLDSDALATLRREHFGFIFQRYHLLSHLNATQNVEVPAVYAGTARVY
RQQRARALLMRLGLAERVDYLPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMATLKQLREQGHTVIIVTHDPSIAAQAQRVIEIRDGEIISNPPSVAQESAAQKEVKT
QPINSAFQQTISSFREAFAMAWLALAANKMRTLLTMLGIIIGIASVVSIVIVGDAAKQLV
LQDIRSIGTNTIDIYPGKDFGDDDPQYQQALKYDDLAAISQQPWVSSATPALSSNLRVRY
GNVDAAASVNGVSSQYFNVYGMSFSEGNTFNEEQLTGRAQVVVLDSNTKRQLFPNKANVV
GEIILVGNMPATVIGVAQEKQSMFGSSKILRVWLPYNTMAGRVMGQSWLNSITVRVNEGY
NSHEAEQQLNRLLQLRHGKKDFFTYNMDGLLKTAEKTTRTLQMFLTLVAVISLLVGGIGV
MNIMLVSVTERTKEIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSLLIAFTLQL
VLPGWEIGFSPMALLTAFACSTATGIIFGWLPARNAARLNPIDALARE
>A0A0A0YWK2|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLEPTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRVTLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>A0A0F3LMZ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWTRLWGAATGMFTGEETGRRLGFGLILASLPIILIGLTFGQTVKAMLFNDIAVAIG
LIIGGLIIIWIEKHPPQVRAQEVEDLTYKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYDVFQTTQDWTVLSVGIIVSFISALILIRAL
VAYVAKRDFMIFAWYRIVSGLLILLFAYTGWTLW
>K0WFM5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYINAAILGVVEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWRQPENRDYAAKLIVAFLITAILGLIVKKLGFELPETATPIAWALIIGGIWMI
FAEWAAARKAPHKEITWLVAILVGIAQIVAGIFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASGYELLKTFKDGGAAGEDWTALGIAFVVSTVVAFIAVKWLLAYIRSNR
FTLFAIYRIILGVLLLGMAATGLIA
>A0A061MTY4|FEATURES|UNIPROT_deepARG|aminoglycoside|RRH01S_07_00240|antibiotic inactivation|1
MQIKEASFEHLDAWLRLRAELWPSSSMEHHRAELTQILTKENAIAFIACNQTGHAVGFAE
ATLRHDYVNGCKTSPVLFLEGIYVRREYRRQGAAQLLCRAVADWGRASGCQEFASDALLD
NVESHAFHDALGFEETQRVVYFRKLL
>ZP_04244950|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MSEFSLIFCLFKEERGVLKGINHLCFSVSNLENSILFYERVLEGELLVKGRKLAYFNICG
VWIALNEEAHIPRKEIHQSYTHLAFSVEQKDFERLLHRLEENNVHILQGRERNVRDCESI
YFVDPDGHKFEFHSGTLQDRLNYYREEKPHMTFY
>Q2QCK2|FEATURES|UNIPROT_deepARG|beta_lactam|pse1|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKAELVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNQKKLESWMVKNQVTGNLLRSVMPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>YP_001571461|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTNGTMTQEDISDYVAANMKDPISRTSGVGDVQLFGS
QYAMRIWMNPTELTKYQLTPIDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTDEFGKILLKVNQDGSQVRLRDVAKIELGGENYDVIAQFNGQPASGLGIKLATGANAL
DTAAAIRAELKKMEPFFPPGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
TEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPVAKGDHGEEKKGFFGWFNRMFDKSTHHYTDSVGNILRSTGR
YLLLYLIIVVGMAYLFVRLPSSFLPDEDQGVFLTMVQLPAGATQERTQKVLDEVTDYYLN
KEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGDENKVEAITQRATAAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLFGEVAKYPDLLVGVRPNG
LEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDINDWYVRGRDGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MAMMEELASKLPAGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
VEATLEAVRMRLRPILMTSLAFMLGVMPLVISSGAGSGAQNAVGTGVLGGMVTATVLAIF
FVPVFFVVVRRRFSRKSEDIEHSHSTQHH
>Q2G3F4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTIVTAILLGIVEGLTEFLPVSSTGHLILATELFGYDAHQWAMFNVVIQLGAILAVVVQ
YWRTFWAVGMGLLRLEPISLRFLRNLLAAFIPSAILGLALKKYIDVLLGSPSVVCWALIA
GGIAILVIEKHAKQGEPSGIGQLPLRQAIGVGLAQCLAMVPGVSRSGATIMGALAMGIER
RTAAEFSFFLAIPTMLGATTLELLDNRDALLGGTMGVGWSEIGVGFAVSFVVALAVIRLF
VAYVSRAGFKPFAWYRIAAGAVALGWLAMR
>A0A0F6U9F2|FEATURES|UNIPROT_deepARG|aminoglycoside|neo_2|antibiotic inactivation|1
MHDAATSMPPQAPATWADYLAGYRWRGQGEGCSAATVHRLEAARRPTLFVKKEVLSAHAE
LPAEIARLRWLHGAGIDCPQVLNETQSDGRQWLLMSAVPGDTLSALAQRGELEPERLVRL
VAAALRRLHDLDPAACPFDHRLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLL
DRRPAVEDLVVAHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIEAELGAA
WAEAFLVEYGGDIDGERLAYFRLLDEFF
>A0A0M9AWZ1|FEATURES|UNIPROT_deepARG|aminoglycoside|AM274_25265|antibiotic inactivation|1
MIKRCTLLEHNGWLPLRVALWPDSAPNNHHDKQTLLSTPERYLVLIFVNEEGNALGFAEA
SIRTDYVNGTNSSPGPFLEGLYVQPASRGEGIARQLVARIQQWAEEMGCAELASDALLDN
QGSHAMHKALGFAETERVVYFLKPLGAIKA
>A5E8M5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSDTLRAVLLGIIEGVTEFLPVSSTGHLLLAERFFGLGEDGFWKSFAILIQLGAILAIV
ALYFFKLSRVAIGALSNADDRRFIIGVLIAFLPAVIIGLIAGKYIKALLFDPWVVCFSLI
VGGAILLWVDQIDLKPREHDATRYPLLMYLWIGVAQCLAMIPGVSRSGATIVAAMLLGGD
KRSAAEFSFFLAIPTMVGAFVYDFYKSRAEMTSDHLGLVAIGFVVSFITAMIVVKAFLGY
VTRHGFVLFAWWRVIVGTLGLIALALGK
>A0A0U2BG27|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MATPILSLKNIKKSFAFGDDSLEVLKGIDLDIYRGEMVAIVGQSGSGKSTLMNIMACLDT
PTSGEYRIDGLCTQEMNGEQLASLRRDKFGFIFQRYQLLSSLNATANVAMPAIYAGVSQK
TREQKAQALLAKLGLEQRLDHYPNQLSGGQQQRVSIARALMNGGQIIFADEPTGALDSQS
SRDVMAILTELNREGHTIILVTHDPKIAQSASRIITIADGQIISDDNNSNDTVNTTQDFQ
QNTHRTLNFQAIGRIKEAFHMAVLTMLASKMRTLLTMLGIIIGIASVVLIVALGNGSKQQ
ILNQINSMGSSTISVFMGGDNEDDTTPPNDLTFDDMYALETLPSVASTSPDLSMSMTAQV
GNHSKGVQVDGVGLNHHRLQNVQFVTGSMFRQSDLDNFSQNVIISEKTKQNFFKQNNALG
QILILNGVPTKVVGVFKYNGIEGNFDRNLKVWLPYRTYQARFAGESPRLNSITVLLKPNE
SSALASESINQLLTQRHGKKDFTLFNSDSLAKTVEKTAQSLTLLIGAIAVISLLVGGIGV
MNIMLVSVTERTGEIGVRMAVGATYGDIVWQFLIEAMVVCALGGVLGVLLAFGLGGLLQL
FDIKVIFSATSIALAVGCASLIGLVFGLMPAHKGAKLNPIEALNKG
>A0A0P0C8E0|FEATURES|UNIPROT_deepARG|aminoglycoside|kanR|antibiotic inactivation|1
MTHIQRETSCSRPRLISNMDADLYGYKGAPDNVGQSGATIYRLYGNPDAPKLFLKHGKGS
VANDVTNEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLKEYPDSGENI
VDALAVFLRRLHSIPVCKCPFNSDRVFRFAQAQSRMNNGLVDASEFDDEPNGLPVEQVWK
EMHKLLPFSPESVVTHGDFSLDNLIFDEGKFIGCIDVGRVGIADRYQDFALLRKWLGEFF
PSLQIKGFLKKWE
>A4TXM7|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MAEIMETILHALLLGIVEGLTEFLPVSSTGHLILLGDLLGFQGPPGKTFEIVIQLGAILA
VCVVYWRRLSGAAIGMFTNDRDMFFVRNILIGFLPAMLVGVVAYKHIRALLDSPIIVAIA
LVVGGVVILVLERVNKHPRFHAVEDFPVSLSVKIGLFQCLAMVPGVSRSGATIMGALLVG
ADRKAAAEFSFFLAIPTMLGATAYSLYKNWSELSFDNMGLIALGFAAAFIAALVVVRAAI
GLILRYGFTPFAWYRIVFGGAMLVFLLGR
>Q45726|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKQKTGQVKHKNQATHKEFSQLE
KKFDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKE
DLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGDRVT
MSDRFETELNEAIPGDIRDTSTAKRIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKL
IRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEASYDNQLIAEA
TEVIVKALK
>J8M3S4|FEATURES|UNIPROT_deepARG|beta_lactam|IK7_02258|antibiotic inactivation|1
MVEKKFQKRVTDFIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQT
ITSLKFGNTKVETFHPGKGRTEDNVVVWLPQYKILAGGCLVKSAEAKDLGNVADAYVNEW
STSIENVLKRYGNINSVVPGHGEVGDKGLLLHTLDLLK
>R6RQN3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSNFIEFLKIVVFGLVEGFTEWLPISSTGHLILVENIVHLNASAEFMKVFRVVIQLGAIM
AVVVLYFNRLNPWAPGKKKNQQLATWHLWIKILIACLPAAVVGLLLDEVLDTYLYNPYVV
AAMLIIYGILFIVLEKHNEYVDFPIKKVSQISYRTALYIGLFQLLALIPGTSRSGATILG
AMLLGCSRTASAEFTFFLGIPVMFGASLLKILHYGLDFSGMEFFFLLAGMVIAFAVSMYS
IKFLMGYVKKHDFRFFGYYRIILGVIVLAYFGVMAVMGL
>E2XRX6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLGSGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWVERVAKLNPDFIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVAIELSDTGLTLHAKLREAAANLLRDALP
QLSQGKLTETAQDETQATYFGRRTAADGKLDWKQPAHTLFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVQGNEGLAPGRVVSVNPLRIACGEDSLVIKFGQRNDNGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWAPTVEMSETIGNTLDFFLREAMLEIA
DKR
>B0K0H2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLIKAFIMGIVEGLTEFLPISSTGHLIIVGKFIHFTGNFATMFEIVIQLGAILAVVFY
YRKKIFASLKNLKPGSWGFNLWFKIFIAFIPAAVIGLLTHKYIEEHLFSPFTVAIALIAG
AIMMIVIEDTFGKRYKIDNMDKVDTKKSLLIGIAQVMSLFPGMSRSASTIMGGMLAGLSV
KAAAEFSFFLAIPTMFAATTLSLLKGFSAMSLLEWQALAVGFITSFLTALFVVDKFLPYL
TRHSLKPFAYYRLAVGVLMILLVAEKIVK
>D7YDV3|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9548_00703|antibiotic inactivation|1
RFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQG
KPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPEL
TAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIG
LFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGAL
DAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDW
PVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGI
VMLANKNYPNPARVAAAWQILNALQ
>B5THS2|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDAMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>W6RTI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MDFLEIFKAIILGIVQGITEWLPVSSTGHMILVDEFIKLNFSSTFVSTFLVVIQFGSILA
VLVLYFNKLNPFSPSKSVTERNDTISLWLKVIVAVAPSGIIGVLFDDKIEEVFFNPTVVS
ITLIIYGILFIFIENRNKKPAINSFSELTYKTAIFIGMFQILALIPGTSRSGATIIGAVL
LGTSRFVAAEFSFFLAVPTMLGASALKLLKAGFAFSSFEWIVLLTGSVVAFLVSIFAIKF
LMDYIKKHDFKVFGYYRIILGILVLLYFFVIK
>YP_001882481|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGVSQ
LFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMARTL
PRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCVGVTFSMA
RWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVLGL
SSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMNVW
TLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLPQT
GQGSLGLLMTLMGWLIVLCWLPLATRMSHQGQPV
>A0A125R6L3|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMTDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A0Q4I5H0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDSSTWAMFNVIIQLGAILAVVV
LYWRTFWAVGMGLLRREPVSWRFLRNLIIAFIPAAIIGLAVHDYVEMLLGAPKVVAWALI
VGGVAILLIERAVKEQRFHGIADIPVVRVLGIGLIQCIAMIPGVSRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGATALELLKKGDKITSAAVGWDSIALGFIVSFIVALLVIKWFV
GLVSKHGFAPFAWYRIIAGAAALIWLAAR
>A0A0P7NMI5|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHSHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0M7KBK5|FEATURES|UNIPROT_deepARG|aminoglycoside|ERS370000_04144|antibiotic inactivation|1
MKTAPITSSRDAAWLQLRMALWPDASASEHQEDMEDQVCAPDRYVQFLARVDNGQAIGLA
EAAIRTDYVNGTDSSPVAFLEGLYVMPEARRQGAARALIDAVRAWARDRGCKELASDTAL
DNVVSQAAHTRLGFRETERVVYFNMPI
>A0A0A0TRZ4|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MRQKNKYIRIQEFLKQNEFPDFRMKQITNAIFHGRINHFNEITVLPKSLRKMLVKEFGES
VLNIAALKEQHSEQVTKVLFEISGDEKIETVNMKYKAGWESFCISSQCGCHFGCTFCATG
DIGLKHNLTSDEITDQILYFHLKGHSIDSISFMGMGEALANRQVFDALHVLTNPELFALS
PRRLSISTIGIIPGIKKMTQNYPQVNLTFSLHSPFNEQRSKLMPINERYPLMEVMDTLDE
HIRVTSRKVYIAYIMLPGVNDSIDHANEVVKLLRGRYKRGNLFHVNIIRYNPTVSSPMRF
KEVNENQVVNFYKTLKSAGINVTIRSQFGIDIDAACGQLYGNYQKNNS
>I7LR06|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFIKAIILGIIEGITEWLPISSTGHLILTDEFIKLKQSTEFMNMFNVVIQLGAILAVVV
IYFKKLNPFDSSKTPRETQLTWQLWLKVIIACIPAVIIGLPLDDWLDAHFHKFVPIAFML
IIYGFAFIYVEKWAKTRPDTLTNLDRMSYRFAFYIGLIQVLSLMPGTSRSGVTILGAIIL
GASRFVATEFTFFLGIPVMFGASLLKIVKFMFSGVGFSLSQFAILMVASVTAFLVSIVVI
KFLMDYIKKHDFTFFGKYRIVLGAILLVYAGISAVFGG
>W7UIQ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIWEIIKTVILGIVEGITEWLPISSTGHLILVGEFLNLDKSDEFKEMFDVVIQLGAIMAV
VVIFWKKLWPFGKKNNSHPINKSPFGQMIKKDIFMMWFKVLVACLPAAVIGLLLDDWIDE
HLYNPWTVAIALIVFGIAFIIIENWNKGKKPKINTIAELTFNTAFIIGVFQLIAAIFPGT
SRSGATIVGALLIGVSRTVAAEFTFYLAIPVMFGASLLKLVKFGFNFSGSELVVLLTGCV
VSFLVSIFVIKFLMDYIKKHDFKVFGWYRIILGLLVLAYFGCKAIF
>CAE53427.1|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MIQSINHICFSVANLEKAIEFYQNILQAKLLVKGRKLAYFDLNGLWIALNVEESIPRNEI
QYSYTHIAFTVTNNEFDSLKEILIQNQVNILPGRERDDRDKRSIYFTDPDGHKFEFHTGT
LQDRLQYYKEDKKYMTFY
>F4T099|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTAACESLGKEYEILLIDDGSSDNSAHVLVE
ASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENK
>A0A0J1LJ93|FEATURES|UNIPROT_deepARG|aminoglycoside|SK35_04809|antibiotic inactivation|1
MNHIHRESTCARLQLNSSLDHELDGYKWARDHVGQSGAAIYRLYDKVDAPELYLKQGNGS
VANDITDEMVRLIWLKDYIPLPNVKHFSRTPDVALLVTTAIPGKTAFQMLEEHPDMSNDI
VDALATFLRRLHAIPVNSCPFNSNHQFRLTLAQNRMKNNLVDAEDFDDERNGCSVEQVWE
KMHTLLPFSSVPVVTHGDFSLDNIIFCNDEIVGCLDVGRVGIADQYQDLAILWNCLGEFS
HSLQNRLFQQYGIPQPDEKKLQFHLMLDEFF
>A0A0F4VA42|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MESESIMHNKLLSYSAFALFLSAGHCVADDRIEAIVKAAIEPVMQQQQIPGVAVAITVNG
QPHYFNYGVASKENGKVVTENTLFEIGSVSKTFTATLAAYAQATGKLSLSDKASSVLPDL
RGSAFDNISVLQLGTYSAGGLPLQFPDDADAPDKMLGYFQQWKPTYAAGTHRQYSNPSLG
LFGYLAAQSMGAPFDDVMEKTLLPKLGLKHTYLKVPQAQMGLYAQGYDKEDKPVRVGPGA
LDSEAYGVKTSAADMIRYVEANMKPASLEAPMQRAIATTHTGYYKVGDMTQGLGWEFYHY
PVPLDKLLAGNSTQMAMEAHEVQWLTPPQPQPESVLINKTGSTSGFGAYVAYVPSKDIGI
VILANKNYPNPERIKIAHTILSALSK
>R4V074|FEATURES|UNIPROT_deepARG|beta_lactam|blaWIN-1|antibiotic inactivation|1
MFNNTFRHKALLTVALMPLLFSSAPLWAQTPEQAKAVQQKLADLEKSTGGRLGVAMINTA
DNSQTVYRGEERFAMCSTSKVMAASAYLKASEQDKNLLNKHVDIKKSDLVNYNPITEKHL
DTGMTLGELGAAAIEYSDNVAMNKLIAQLGGPAKVTQFARSIGDETFRLDRTEPTLNTAI
PGDKRDTTSPLAMAQSLRKLALGDALAEPQRAQLVAWLKGNTTGAASIRAGLPASWTVGD
KTGSGDYGTTNDIAVVWPDNHAPLILVTYFTQPQQDAKARKDVLAAAAKIVTENL
>ACB17400|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMTAGLSLYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLLLMVIFLKDKQMGNSHEG
>A0A098R9Q5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAVILGIVEGITEFLPISSTGHLVLVDEFIKMQQSTQFTDMFNVVIQLGAIMAVV
VLYFHKLNPLSPRKDTTEKRNTWVLWSKVLLAVIPSVIVGLPLNDWMDEHLMNWAVVSAT
LIIYGVLFIVIENHNKRLTPRFANLQTLPYTTALFIGCFQLLSLIPGTSRSGATILGAIL
IGTSRYVATEFSFFMAIPTMFGASLLKLVKFFAHGGSLAGLQGAVLAVGVIVSFVVAYLS
IRFLLDYIKKNDFKAFGWYRIVLGVLVIGYFTLIH
>A0A0P8WY66|FEATURES|UNIPROT_deepARG|beta_lactam|AN402_5201|antibiotic inactivation|1
MIVLNKFFNMLHYKKIVPVVFLSCATLIGCSDSNTQSESPKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDAHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKAKNK
>A0A0M2DUJ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHAELVLKTLMMGVVEGITEFLPVSSTGHLILAGNALSFLAKEKRDVFEVFIQFGAMRAV
IWEYRARLAGVVVSARADQGARRFLVNLAIAFMPAAVLGLLIGSHVQRLLFSPGPVAVAL
VVGGIAILWAERRPVNVKAERAEEISRIDALKIGFVQCLALWPGTSRSGSTIIGGLWFGA
SRQAATEFSFFLGIPILGAASGYNLFKHWDALSSDDIGVFVMGLLASFAFALLAIRLLMR
YLTGHGFGVFAWYRIALGTLILAAVVT
>ZP_03043001|FEATURES|ARDB_deepARG|multidrug|mdtE|antibiotic efflux|1
MNRRRKLLIPLFFCGAMLTACDDKSAENAAAMTPEVGVVTLSPGSVNVLSELPGRTVPYE
VAEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARI
TFNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVS
GKSSVTVGALVTANQADSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPV
QLNLENGKRYSQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQN
VLLVPQEGVTHNAQGKATALILDKDDVVQLREIEASKAIGDQWVVTSGLQAGDRVIVSGL
QRIRPGIKARAISSSQENASTESKQ
>A0A109EL26|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLFVAACATATAGRAAAVTQDALHDTVTRQVAPLMKQYAIPGMAIGIVAD
GKPYVFDYGVMSRQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPVAKYLPE
LQGRPFGVVTLLQLGTHTPGGTPLQVPDSIRDDAGLIRYLDAWRPEYAPGTHRTYSNVAI
GMLGWLTAKATHQDFATLMAQRLFAALGMTHTTIDVPAARMADYAQGYTKDGKPVRMTEG
MLWQPAYGVRTTAADLLRFVQANMEMIPTAPRLRRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLAGNAPKMLFDAVPASAIQPPLAPNPATWINKTGSTGGFSTYVAFIPAKRIG
IVMLANGNVPIEDRVKVAYRILGSLGDADAR
>ACB17556|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETA
AVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLDTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
AAPVVEKK
>BAC67147|FEATURES|ARDB_deepARG|tetracycline|tetD|antibiotic efflux|1
MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPL
LGRWSDKLGRRPVLLLSLAGAAFDYTLLALSNVLWMLYLGRIISGITGATGAVAASVVAD
STAVSERTAWFGRLGAAFGAGLIAGPAIGGLAGDISPHLPFVIAAILNACTFLMVFFIFK
PAVQTEEKPAEQKQESAGISFITLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWD
SAAVGFSLAGLGAIHALFQAVVAGALAKRLSEKTIIFAGFIADATAFLLMSAITSGWMVY
PVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQQ
SADGTVWLIGTALYGLLLAICLLIRKPAPVAATC
>YP_001882199|FEATURES|ARDB_deepARG|multidrug|mdtE|antibiotic efflux|1
MNRRRKLLIPLLFCGAMLTACDDKSAENAAAMTSEVGVVTLSPGSVNVLSELPGRTVPYE
VAEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARI
TFNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVS
GKSSVTVGALVTANQADSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPV
QLNLENGKRYSQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQN
VLLVPQEGVTHNAQGKATALILDKDDVVQLREIEASKAIGDEWVVTSGLQAGDRVIVSGL
QRIRPGIKARAISSSQENASTESKQ
>CAJ00299|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNVCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDPVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKEPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0C2W508|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSAWELFVAFLLGLVEGLTEFAPVSSTGHMIVVDDLWLRSSEFLGSPVANTFKIVIQLGS
ILAVVVVFRQRIADLLGLHTSTRGQQNKLRLSHVFIGLLPAGVLGLLFEDYIDEHLFSLE
TVLIGLVIGAFLMIAADLVSGKKVKIETVDQISYRQAFSIGLIQCLSLWPGFSRSGSTIS
GGVLLGLSHRAAADFTFIMAVPIMMGASAISLMSKWEYFTIDMLPFFTIGFISAFVFALI
SIKFFLKLINRIRLIPFAIYRIILAAVIYILYF
>E2YZT9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MCFAFISERNGDMLFANLWKAIILGIIEGITEWLPISSTGHLILVDEFIKLDLSKDFMEM
FNVVIQLGAIMAVVILYFHKLNPFSPKKNGEEKKDTWILWSKVLVACLPAAVIGLKFDDY
LDAHFYNFLTVSIMLIVYGIAFIIIEKRNKNVAPKCTNLKDFTYKAALIVGAFQVLALIP
GTSRSGATILGAILIGASRFVATEFSFFLGIPVMFGASFLKIFKFLAKGNTFGSEEIIIL
LTGSIVAFVVSIIAIKFLLNYLKKNDFTVFGWYRVILGAILIGYWLFS
>A0A0K6KL35|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MKLEQQEINILHSDSGPYGIAISPEGKVWFTQHKANKISCLDRTGQIQEYIVPTPDAGVM
CLTVSSEGDIWFTENRANKIGKLTAKRQFIEYPLPHQHSAPYGITEGPDGDIWFTEMNGN
RIGKLTLEGKIHEYELPNEGSYPSFITLGSDHSLWFTENQNNAIGKITESGELTEFPIPT
PAAGPVGITKGHDDALWFVEIVGNKIGKITVSGDITEYDIPTPNARPHAIAAGVKSDLWF
TEWGGNKIGRLTSDQTIEEYTINTPHAEPHGIGCDNDGTVWFALECNKIGKLKLTK
>Q8CXK5|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MNIKGLNHLLFSVSNLEQSIDFYQQVFDAKLLVKGRSTAYFDLNGIWLALNEEKHIPRNE
INESYTHTAFSIDESELESAIQHLKALNVNILEGRERAEQDKQSIYFTDPDGHKFEFHTG
TLQERLKYYRDQKKHMTFY
>A0A076VXH5|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MCVGILSLSLASVKIFTGEPLQVKAKEKAEKTKHANHATHREFAQLEKKFDARLGVYAID
TGTNQTVTYRPNERFAYASTYKALAAGAVLQQNSIDKLDEVITYTKDDLVEYSPITEKHM
DTGMTLGEIAEAAIRYSDNTAGNLLFKKLDGPKGFEKALRQIGDKVTMADRFETDLNEAI
PGDIRDTSTAKTLATDLKAFTVGNALPTDKRKILTDWMRGNATGDKLIRSGVPKDWEVDD
KSGAGSYGTRNDIAIVWPPNRAPIIIAILSSRDKEDATYDNELIAQAAKVTINALK
>O87584|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPK
>A0A0U1XYQ3|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
FLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVALWNENKQQGFTNNLKRANQAFLPA
STFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQ
IGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISAIEQISFLRKLYHNKLHVSERSQR
IVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMD
>A0A0L7P1D4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESLFFIIKAIIIGIVEGITEFLPVSSTGHMIIVEDLIKFKEGAEPISLYTKQYIDAFTM
IIQLGAILAIVVLYWGKIKKSLENFSPSHPKSGFRFWLNIAIAAVPAGVLGLKYHSKINE
KLFNPASVTVALIVGAIWMIFAEKKYRGKFKTKDIDGVTIKQAFIIGCFQCLALWPGMSR
SASTIIGAWIVGVSTVAAAEFSFFLALPVMFGITLKSLKDINVFTLSSMHIIGLTVGFLV
SFFVALIVVDKFINFLKKKPMRVFAIYRILLGIVLIVLFWFNVI
>K0AYN9|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKQTKTKYEKIKQIVSNLKLPDYRYEQVTKAIFHQRIDNFDDMRILPKALRIALVNEFGK
NVSSIIPVFSQDSKQVQKLLFELTDGERIEAVALKYKQGWESFCVSSQCGCGFGCSFCAT
GSAGFKRNLTADEITDQLLYFYFNNHRLNSISFMGMGEAFANPELFDAVKILTDRNLFGL
SQRRITISTIGIIPGIQRLTKEFPQVNLAFSLHSPFESQRSDLMPINKTFPLNDVMKALD
EHVIHTGRRVFIAYIMLKGINDSKEHAEAVIGLLKSRGSWKHLYHIDLIPYNSTDKTTFK
FQPSSDIKQFYSTLKKAGINATVRTQFGSEISAACGQLCYENEL
>Q1BPZ6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MRQPLLKLAAVTRRFPAGDKDVVVLNNVNLSIGAGEIVAIVGASGSGKSTLMNILGCLDH
PSEGTYTVGGRDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTPRA
DRHARARELLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKS
GQDVIRILHELNALGHTIVIVTHDKAVARHARRIIEISDGEIVADRPNRHYAEAFAEVGV
GAAATTETAADTRSAPASGDAPPPANNDTAADPAPAPDASPPAPAVSPKHAGWRGSRSCR
TGCARCLTMLGIIIGITSVVSIVAVGEGAKRYMLEEIGSIGTNTISLYPGSDWGDSRADT
IQTLVPADVAALAEQPYVDSATPETSRTLLLRYRNVDVHALVSGVGDSYFQTRGMRFALG
VPFDDDAVRRQAQVAVIDQNTRRKLFGATRNPVGEAILVDNVPCVVIGVTADKKSAFGSV
KSLNVWVPYTTASGRLFGQRYLDSITVRVRDGQPSAAAEKSLEKLMIQRHGRKDFFTYNM
DSVVKTVEKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSD
ILQQFLVEAVLVCLLGGTIGIALSFGLGALFSVFVAQWKMVFSAGAIVTAFVCSTLTGVI
FGFMPARNASRLDPIDALARD
>A0A127T508|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELKNRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>A0A096CCK3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFQTIIIAIVEGITEFLPVSSTGHMIITQSLLGVKQGDPFVHAFTFIIQFGAILSVVC
LYWKRFFSFKHVSCVDKERGSSLLRFFRFYWLLFIGCLPAGVVGLLAKKSGLLDWLLDSV
SVVAVTLVLGGVFMLFCDRLFNKGRQENRVNVRRAFCIGLFQCLSVLPGMSRSMSTIVGG
MASGLTRKHAAEFSFFVAVPLMAAATLLDLYDLLKHGTQWATFHNLTVLALGCVIAFLVA
LLAMKWFVSFLTKYGFRLFGWYRIIVGGIILILLAMGVNLNMIE
>ACG58975|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSALFADRIGVNHWFLLSGILIICIAIVCPMINEIRKLDLK
>A0A0C2RTI2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIKGINHLLFSVSDLNRSIEFYQNVFGAKLLVKGRSTAYFDLNGIWLALNEEADIPREEI
KKSYTHTAFSVDEKELDDLYHHLMSHSANILSGRERDERDKQSIYFTDPDGHKFEFHTGT
LEDRLRYYKEEKPHMTFYDE
>H2J0G5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|Rahaq2_0060|antibiotic efflux|1
MPASEPLILLHHVSRVFSSGDQQVSVLDDVSLSVQAGEMLAIVGPSGSGKSTLMNILGGL
DIPDSGEVRIAGIDTLNASHEQLAALRSSNIGFIFQRYHLMPYLTAAENVAVPAQYTAMP
ENVQEQRAAYLLEHLGLKERMQHKPSQLSGGQQQRVSIARALMNGAPIILADEPTGALDA
QSGQEMMAILHGLHQSGHTIILVTHDRNVASQAERIIEISDGKIIADTPNPSVHQASVPV
VLLPAVNTGRSSWRQSLHDAIKMAWRALNGHRVRALLSMLGIIIGVTSVITSMAVGEGAK
LKIIRDISALGTSTVAVRPGLGWDNPRPDLSDSLTLGDVSTLSELPFAVHVSPVFTRNLE
AQVGGRQMFFNLTGVSSDYFAVHDLALKEGRKLNEHDVDAREPVLLIDSASAETLFHEDK
NPLGETIYLNNVPLRVVGITAPKGLKNMGGGLNAWMAYTTLQERLTGRMPVGAIEIQVAK
GMTLKEAQRRIEYVLEKSHGRRDFFIETDDMMLETLQKTSDSLTLLIATIAGISLVVGGV
GVMNIMLVSVAERMHEIGIRLAVGARAVDIMRQFLIESVVVCLFGCVVGVIVTFVAGTLF
SVLTNRFEMVFTPLPIFYSCCFSALIGLGFGFFPARFAARMKPTEALARE
>D0J3P5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLVKAAIMGIVEGLTEFLPISSTGHLILAGSLMGFVGGKAKVFEIAIQTGAIFAVMLVYW
QKIRDTLVELPSSRQAQKFALNVIIGFLPAVVLALLFGKYVQEHLFTPVIVATTFILGGF
VILWAEKRPAAATRVQSVDDMTALDALKVGLVQCFALVPGTSRSGSTIIGGMLMGLSRKA
ATDFSFFLAMPTLIGAGVYSLYKERALLSMADVPLFAVGLIFSFISAWLCVRWLLRFIST
NSFVPFAWYRIVFGIIVLVTAYTGIVDWHH
>I4YTX0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSQIIEALFLGLIEGLTEFLPVSSTGHLLLVGHFLGFESTGKTFEVLIQLGAILAILSVY
FNKLWSIAKALPYDPMARHFVIGVLVAFLPAAVIGALLHGFIKDVLFDPWIVCMTLIVGG
FVLMAIDRMPLEATKTDATRFPLSMYFKIGLIQCAAMVPGVSRSGATIVGAMLMGASKRA
AAEFSFFLAMPTMAGAFAYDLLKNYKFLSANDAVLIGAGFVSAFVAALVVVKLFLDYVSR
HGFTPFAYWRIIVGAAGLAALIVYG
>A0A087M0A3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNADQGLFVPLILGILEGLTEFLPVSSTGHLLLAGHFFGLTQPATFVVLIQLGAILAIVT
VYFAKLGLLIRDALTGKRYAWQFALSVFLACFPAVIAGVLLRDFIQGDLWESAALICWTL
LIGGFVLLIVDRLKLEPKYDDIYTFPWHLALIIGLFQMLSLVPGVSRSGSTVVGGMLFGA
SKRAAAEFTFFVALPIMVGAFGYDLYKSRDLIDASIALNVAVGFAAAFVVGALVVRYLLN
FVSRYGFAPFAWWRIAVGIFGLIGIYFFGR
>M6YU51|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNHYLNAFLRSIIEAVTEFLPVSSTGHLFLFSSFFPFSGESFGIQFDDLFDIFIQSGAIL
SVLFLYREKFGSQIRSSLRYVTKQNPDPQGFYFLVRIAIGALPILVAGFIAKNFLDTIKT
RSDLLSILAGAWIFGGVLILVAEWFFQKRRGVEEKTPVGFRDAILIGIFQCAALIPGVSR
SAATIVTARFLGKDTKSSAEFSFFLAVPVLFAAGIYKLIKYRSILNEATIPVLTFGFLIS
FLFCTLVIRLFLRYLQKHSFGVFGIYRILLGVGVLVFTKFIR
>NP_415632.1|FEATURES|CARD_deepARG|quinolone|mfd|antibiotic target alteration|0
MPEQYRYTLPVKAGEQRLLGELTGAACATLVAEIAERHAGPVVLIAPDMQNALRLHDEIS
QFTDQMVMNLADWETLPYDSFSPHQDIISSRLSTLYQLPTMQRGVLIVPVNTLMQRVCPH
SFLHGHALVMKKGQRLSRDALRTQLDSAGYRHVDQVMEHGEYATRGALLDLFPMGSELPY
RLDFFDDEIDSLRVFDVDSQRTLEEVEAINLLPAHEFPTDKAAIELFRSQWRDTFEVKRD
PEHIYQQVSKGTLPAGIEYWQPLFFSEPLPPLFSYFPANTLLVNTGDLETSAERFQADTL
ARFENRGVDPMRPLLPPQSLWLRVDELFSELKNWPRVQLKTEHLPTKAANANLGFQKLPD
LAVQAQQKAPLDALRKFLETFDGPVVFSVESEGRREALGELLARIKIAPQRIMRLDEASD
RGRYLMIGAAEHGFVDTVRNLALICESDLLGERVARRRQDSRRTINPDTLIRNLAELHIG
QPVVHLEHGVGRYAGMTTLEAGGITGEYLMLTYANDAKLYVPVSSLHLISRYAGGAEENA
PLHKLGGDAWSRARQKAAEKVRDVAAELLDIYAQRAAKEGFAFKHDREQYQLFCDSFPFE
TTPDQAQAINAVLSDMCQPLAMDRLVCGDVGFGKTEVAMRAAFLAVDNHKQVAVLVPTTL
LAQQHYDNFRDRFANWPVRIEMISRFRSAKEQTQILAEVAEGKIDILIGTHKLLQSDVKF
KDLGLLIVDEEHRFGVRHKERIKAMRANVDILTLTATPIPRTLNMAMSGMRDLSIIATPP
ARRLAVKTFVREYDSMVVREAILREILRGGQVYYLYNDVENIQKAAERLAELVPEARIAI
GHGQMRERELERVMNDFHHQRFNVLVCTTIIETGIDIPTANTIIIERADHFGLAQLHQLR
GRVGRSHHQAYAWLLTPHPKAMTTDAQKRLEAIASLEDLGAGFALATHDLEIRGAGELLG
EEQSGSMETIGFSLYMELLENAVDALKAGREPSLEDLTSQQTEVELRMPSLLPDDFIPDV
NTRLSFYKRIASAKTENELEEIKVELIDRFGLLPDPARTLLDIARLRQQAQKLGIRKLEG
NEKGGVIEFAEKNHVNPAWLIGLLQKQPQHYRLDGPTRLKFIQDLSERKTRIEWVRQFMR
ELEENAIA
>J8UZF3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAIAFNIIIQLAAILAVV
WEFRGKILEVVFGLTSQPTARRFTGNLLLAFLPAVVLGVLFADLIHHYLFNPITVATALV
VGGVIMLWAERRTHRVAVDHVDDMRWSHALKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYATFAWYRIAFGLLILATWQFGWIDWSTAQG
>A0A0Q6BQQ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYLDALILGFVEGLTEFIPVSSTGHILLLGELLGFQSKAGTFEVLIQLGAVLAVLSVYAS
KIYELVTTLPRSAASRRFVAGVLIAFLPAAVIGAFAHDFIKTVLFESPMTICVALLVGGI
ALLVIDRMPIERKYQSLGEYTLPLCFKIGLFQCLAMIPGTSRSGATIAGALLLGTDKRSA
AEFSFFLAMPTMAGAFAYDLFKNRDVLSTDDLSLIAVGFVMSFVTALFVVRYLLDFVSKH
GFAPFAWWRIAVGSIGIAVLLLR
>A0A0K6I1Z6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAHSAFVVVILGLVEGITEFLPISSTGHLILAASLMGWVSDKAKVFEIAIQSGAILAVM
WHYRARIAEVLSGMAASEPARRGKAWRFAVNVLIGFIPAAILGLLFASAIKRWLFAPVPV
AMAFIVGAFVIFWAEAWQKRSAQHVRIHHVDDMRAVDALKVGVAQAFALIPGTSRSGASI
IGGMLFGLSRAAATEFSFFLAIPTLLAATVYDLYKHRDLLSLSDVPTFGLGMAVAFVSAL
VVVRWLLRYVGGHSFVPFAWYRLVFGILVLVTAWGGWVNWSG
>V8R863|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MCSLKPSKVFSYSAFALFVGSVACHAATPTDAQLQALVSQAVTPVMQQNNIPGLTVAITL
NGQAHYFNYGVAAKDTAQKVSENTLFEVGSVSKTFTATLAGYAQATGKLDLSSMASQLWP
ELKGSAFDNISVLQLGTYSAGGLPLQFPAEADSSDKMLGYYQQWKPQFPTGSHRLYSNPS
LGLFGYLTAKSLGQPFDQAMTQTLLPKLGLQHTFLSVPSAQSKLYAQGYDSADQPVRVSP
GALDAEAYGIKTSAADLLRYVQAQLQPASLAPDLHQAIANTHIGYYRVGDMTQGLGWERY
AYPISLEKLQNGNSTPMAMEPHKVEWLTPPQAEPANVLFNKTGSTRGFGAYVAFVPSRDI
GIVILANKNYPNAERVKIAHEIFSQLTE
>D6NSN3|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGESRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRANPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>T8JAD9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGVERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKENVAGGTEPV
VKTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTITGILFGWLPARNAARLDPVDALARE
>A0A0K0GD59|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFIELLKAIILGLVEGLTEFAPVSSTGHMILVDDMWLKSTDFLGKYAANTFKIVIQLGS
ILAVVVVFKDRFIDLLGLNRVFNKKEQAKSGPHLKLTHIIVGLLPAGIFGLLFEDYIDEY
LFTTKTVLVGLLIGAIFMIVADLFRSKNPKVVSVDQISYKQAFSVGLIQCLSLWPGFSRS
GATISGGVLLGMNHRTASDFTFIMAVPIMAGASFLSLLKNWEYFTLEALPFFIVGFISAF
VFALVSIRFFLKLINKVKLVPFAIYRIILVIVIYFLYF
>A0A154TZ05|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRFFGSGENRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAT
SGSYQIDGIETSQMQPDELATLRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMDSKER
AERAEKLLGDLGLQNKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEDGHTVIMVTHDPGIAANANRVIEIRDGQIISDTSKNPDIPPSKVERIKE
KASWSFYYDQFMEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSQQKILED
INSMGTNTISIFPGRGFGDRRSGRIKTLTINDAKAISQQSYVASATPQTNSSGTLTYRNT
DLTASLYGVGEQYFDVRGLKLEEGRLFDDDDVKTDAQVVVIDQNTKTKLFGEGVNPLGKT
ILFKKRPLTVIGIMKKDDNSFGNSDSLMLWSPYTTVMHQITGESYTNSIVVKIKDDANTQ
VAEKSLTELLKARHGTEDFFMNNSDSIKEMVESTTGTMTLLISSIAVISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLSGVLLSASISLVFNYFVT
DFPMSISMTSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALAQD
>U2TUJ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLIELLKAILYGIVEGITEWLPISSTGHMLLLQRVMPLAVTADFWDMFLVVIQLGAILA
VCVLFFGRLNPFSRHKDAAGRRGTWALWAKIVVATIPAAIIGLPLNDWIDEHLQSSPVIA
AALIVYGAAFIVIETVRSRPRHAVGAHAVQTVADDDRARVRDMTELGFPTAIGIGIFQVL
SLVPGTSRSGSTIIGGLILGCSRPVAAEFTFFLAIPTMFGASALKLVKFCAGGNGFSSYE
GSILTAGCIVAFLVSLLAIRFLMGFVKRHDFRPFGVYRIILGVAVIAAMQLT
>A0A127T4E9|FEATURES|UNIPROT_deepARG|beta_lactam|NPS|antibiotic inactivation|1
MRFTATVLSRVATGLALGLSMATASLAETPVEALSETVARIEEQLGARVGLSLMETGTGW
SWSHREDELFLMNSTVKVPVCGAILARWDAGRLSLSDALPVRKADLVPYAPVTETRVGGN
MTLDELCLAAIDMSDNVAANILIGHLGGPEAVTQLFRSVGDPTSRLDRIEPKLNDFASGD
ERDTTSPAAMSETLRALLLGDVLSPEARGKLAEWMRHGGVTGALLRAEAEDAWLILDKSG
SGSHTRNLVAVIQPEGGAPWIATMFISDTDAEFEVRNEALKDLGRAVVAVVRE
>R5NBT1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKTIIYGVLEGITEWLPISSTGHLILLKSLLPLNVTSEFWSLFEVVIQFGAIMAVVLLYF
NKLWPFNKNYKECIKLWLMIIISCIPSAIVGILFDEVFEKYFYNKTSIAFALIIVGILFI
VVEKYNKPGNKEITYKSAFIIGLAQVIAAIFPGTSRSGITIITALLLGISREKSTEFTFL
MSVPVMFGASFLKLFKFGFVFAESEALSLMFGTVSAFITSIFVIKFLLKYIKNNNFIPFG
IYRIILGVLILL
>ACO24447|FEATURES|ARDB_deepARG|trimethoprim|dfrA17|antibiotic target replacement|1
MKISLISAVPENGVIGSGPDIPWSVKGEQLLFKALTYNQWLLVGRKTFDSMGVLPNRKYA
VVSKNGISSSNENVLVFPSIENALKELSKVTDHVYVSGGGQIYNSLIEKADIIHLSTVHV
EVEGDIKFPIMPENFNLVFEQFFMSNINYTYQIWKKG
>ABC54722|FEATURES|ARDB_deepARG|aminoglycoside|AAC(6')-Ib10|antibiotic inactivation|1
MLRSSKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLA
DVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLA
NASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPD
GPAVYMVQTRQAFERTRSDA
>S9ZT11|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFPLLLVALVLGIIEGLTEFLPVSSTGHLIIFGDLLGYNDDTSKVFKIVIQLAAILAVC
WDYRERLIKVASGLRTEPSAQRFVGMLFVAFLPAAVLGLMFHSKIKALLFNPITVATALV
VGGLIILYVEKRAYKPRIMEVEQMRWSDAVKVGFAQALAMIPGTSRSGSTIMGGLIFGLS
RKAATEFSFFLAIPTMFAATAYDLYKNWALLRAEDLPVFAVGFVASFVAAIWAVKSFIRF
ISNHTFIIFAWYRIAFGLFVLATWYFGWVEWSEA
>Q4U1X3|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVVVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAVEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRVDQLEEFVHYVKGEITKVVGK
>A0A103LHX9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILIGKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIVSIVSGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVQSVDALTPLDALKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFACVRW
LLRFVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>R7X847|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLAFKAVILGVVEGLTEFLPISSTGHLILAGSLLDFNDDKGKVFEIVIQFGAILAVC
WEFRVKIAQVVAGLGSDVKARRFAVNVIVACLPAIVLGLLLGKHIKAALFNPTVVATAFI
VGGVIILLVERHNRRNADAGKLPRVNSIDDLSFADALKVGCAQCLALVPGTSRSGATIIG
GMVFGLERKVATEFSFFLAIPILFGATLYELYKARSTLSVDDVSLFGIGFIAAFISAFIC
VRWLLRYIASHDFTAFAWYRIVFGLVVLATGYSGLVVWAD
>ZP_02068298|FEATURES|ARDB_deepARG|beta_lactam|BL2e_cepa|antibiotic inactivation|1
MRSFIVFLCLVPTLLFAQQTQLETQLKEAIKGKKAEIGIAVIIDGKDTITVNNDIHYPLM
SVFKFHQALALADYMGKQGQSLETRLAIKKSDLKPDTYSPLRDKYPQGGIEMSIADLLKY
TLQQSDNNACDILFDYQGGPDAVNKYIHSLGIRECAIVGTETAMHEDLNLCYENWTTPLA
AAELVEIFRKKPLFPKVYKDFIFQTMVECQTGQDRLVAPLLDKKITVGHKTGTGDLNAKG
QQIGCNDIGFVLLPGGRTYSIAVFVKDSEENNQANSKIIADISRIVYEYVMQH
>A0A127SI38|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-34|antibiotic inactivation|1
MMKKSLCCALLPTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>Q2NRV6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTTPMKIDKVSIVIPVYNEQESLPELMRRTVAACEQLDAAYEILLVDDGSSDDSAAVLTA
AAEAPGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLVVTLDADLQNPPEEIPRLVEVAAQD
YDVVGTVRQNRQDSWFRKRASRMINALIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARKTIEIPVMHSEREFGDSKYSLMKLVNLMYDLVTCLTTTPLRMLSVIG
SMIALLGFAFSLLLITLRLFLGSHWAAEGVFMLFAVLFIFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQCVVSQNPLSSQQETQ
>A0A0A2XX94|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQHIIEIKNLNKFFGEGENRVHILKNINLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
SSGSYQIAGKETAKLSADQLSELRQQRFGFIFQRYNLLSTLSAQENVALPAVYTGMAKPQ
RLQRAAQLLEKLGLGNKIDNKPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSG
ETVMQILQQLHQEGHTIILVTHDKHIAQFANRIIEIKDGEIIQDQRQSLQITVRKMTQAA
TNRGWQFYRDQFFEALNMSINAIIAHKLRSLLTMLGIIIGITSVVCVVALGNGSQQKVLQ
NINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQPYIESVTPNSSVSGTLTYRN
NAFTAQVRGVSEQYFNVKGIQTVAGQLFSGEQVKQNQSVAVIDQNTQKRIFQDRNPLGQI
IMINKKPLKVIGIVDIQNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTA
AAEKNVTALLLSRHGKKDFFILNTDSIKQTIESTTNTMKLLISSIALISLIVGGIGVMNI
MLVSVTERTKEIGVRMAIGAKQQNILQQFLIEAVLICLVGGIIGIILSGLIGFLFNRFMS
EFTMLFSTFSIVVAVLCSTLIGIIFGYVPAKNAAKLNPITALSQD
>A0A0F5L8W7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNADQGLFVPLILGILEGLTEFLPVSSTGHLLLAGHFFGLTQPATFVVLIQLGAILAVVT
VYFAKLGVLIRDALTGKRYAWNFALSVILACFPAVIAGVLLRDFIQGDLWESAALICWTL
LIGGFILLIVDRLDLKPKYDDIYTFPWHLALIVGLFQMLSLVPGVSRSGSTVVGGMLFGA
SKRAAAEFTFFIALPIMVGAFGYDLYKSRDLIDTSIALNVAIGFAAAFIVGAIVVRYLLN
FVSRYGFAPFAWWRIAVGVFGLVGIYFFGR
>A0A0M9GU93|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFITILKAVILGIVEGLTEFAPVSSTGHMIIVDDMLLQSNEFLGKYVANTFKIVIQLGS
ILAVVVIFRNRFIELLGLKNFRGGASTSKGSKQLKLTHVLVGLLPAGVLGLLFEDFIDEH
LFSLETVLIGLVVGAVLMIAADLFGPKEPKMQSVDQMTYKQAFSIGLIQCLSLWPGFSRS
GSTISGGVLLGMSHRAAADFTFIMAVPIMVGASGLSLLKNWQYFTIEALPFFAAGFITSF
IFALLSIKFFLQLINKIKLVPFAVYRIVLALVIYLVYF
>S3XIU1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFDTIILGIVEGLTEFLPVSSTGHLILTSHLLNLEQTNTLKCFEVVIQLGSILAVVFM
FFKRLKQDINLWIKLIIGFIPTALIGFLLYSSIKGLFSPKITAYMLIIWGIIFIVVELFR
KKNPPKNETQKLEDITYKQAFIIGLSQCFAMIPGTSRSGATIIIGLLSGLSRKTAASFSF
LLAIPTMFAATFYDTYKNLNIFKENLSQIWLFLIGGFVAFVVALLAINLFLKFVSKFDYI
PFGVYRIIIGIVFLFFVL
>B9XCI2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWISILILGIIEGITEFLPVSSTGHLLIAEHWLPKQSDLFNIVIQSGAVIAVIPIFWG
RITQFFTRWTEPKTRDYLLKIIVAFVITGAGGFILEKKGFKLPEKAFPIGLALLIGGVLF
LLVEFLIRGKKLSNEVTWSVAFAVGIGQLIAAVFPGSSRSGTTIILALLLGLSRPAATEF
TFLVGIPTMLAAGGLKIFKACFHHGVNAPHENWSMVALGTIVSAIVSFIAVKWLLRYVQT
HTFNAFGWYRIAVGILVLLFLR
>A0A0B3XVU8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MIDDIKNVSVVIPVYNEEESLPVLIERTLAACQKIGKPWEIILVDDGSSDRSADLLTEAA
SDPEKHIIAVLLNRNYGQHSAIMAGFQQAVGDVVITLDADLQNPPEEIPRLVEYAAQGYD
VVGTVRANRKDSLFRKLASKTINMMIRRSTGKSMADYGCMLRAYRRHIVSAMLRCHERST
FIPILANTFARKTIEIDVMHAEREFGTSKYSFLKLINLMYDLLTCLTTTPLRILSLIGSV
VALSGFLLALLLIGLRLFFGAEWAAEGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYTDV
RARPRYFVQKTVSAATPLATTLRDEEE
>W0H5P1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVEVAALHETTIDTGSPILHLQGVSRSFMAGDREFLALKHIDLAIHAGELVAIIGAS
GSGKSTLMNILGCLDHASGGSYKVNGQETRDLDDEELAALRRDHFGFIFQRYHLLPHLDA
VRNVEIPAVYAGKSQAQRHQRASELLTRLGLSGHLSHRPSQMSGGQQQRVSIARALMNGG
QVILADEPTGALDTASGKEVMNILLELHGLGHTVILVTHDPKVAAHAERIIEVSDGEIIS
DQRTVQKAQAAPEPEPQLQHEGAARRLGVSLGLFREAFNMAWIALISHRMRTLLTMLGII
IGITSVVSISAIGEGAKRYVLKDIQAIGSNTIDIYAGSNFGDSRAKSIETLLPSDVAALN
RMYYIDSATPVVGRSMLVRYRNIDVDAQLNGVSNRYFQVRNIQLAAGITFNEQDARRQAQ
VVVLDHNTAQRLFGPGVNPLGKVILIGNLPCTVIGVTSDHKNLFIAGNTLNIWMPYETAA
GRVLGQRHLDSISVRVKDGMPSKQVEEEIKALMLQRHGTKDFFTNNLDSVMQTVQKTSRS
LTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVC
LIGGVIGIALSYGIGYLFTLFVKQWEMVFSPASIVTAFACSTLIGVLFGFVPARNAARLD
PIEALARD
>L0FK04|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLSRLAALAAAITLTLGYSAAQADDQLQAKVDQIIRPLMQEQGITGMAVAVYARNHAYY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLDAPAKRYHPALAGAP
IGDASVLELGAYSADCLPLQFPDAVQTAQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMSEGLLKQMGLENTYLQVPASAQGLYAQGYDSADKPVRVGPGPYADE
AYGIKTSASDLLRYVRLHMQPERLPPALAQATAITQRGYFQVGAMTQGLGWERYPYPVTL
ATLIDGNGPQLIREPQATTRLQPALPPLPAAWYNKTGSTNGFGAYAAFVPAEQLAVVLLA
NRNYPNEARVRAAFDILSGL
>E3DK49|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTERAIEKVSVVIPVYNEQQSLPELMRRTDAACAQLALDYEILLVDDGSSDDSAALLTAA
AEAPGSPVVAVLLNRNYGQHSAIMAGFSHASGDLVITLDADLQNPPEEIPRLVATAQQGY
DVVGTVRQNRQDSRFRKFASRIINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERS
TFIPILANTFARRTTEIPVLHAEREFGDSKYSLMRLINLMYDLMTSLTTSPLRLLSVFGS
IIALSGFAFSLLLIALRLFLGAQWAGDGVFVLFAVLFIFVGAQFIAMGLLGEYIGRIYND
VRARPRYFIQRVVSRNADSIKEQKS
>D6JCF4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTKACESLRKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>E1I4Y0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASKAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>C3FMA0|FEATURES|UNIPROT_deepARG|beta_lactam|bthur0008_29430|antibiotic inactivation|1
MVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQTKQETTGNDSFAKLEKEFDAKLGIYAL
DTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNPITEKY
VDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPERFEPELNEV
HPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTGDNLIRAGVPGGWEVA
DKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHDKEDAKYDDKLIAEATKIALGVLKAKN
K
>CAS11569|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSALFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPTTSDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A095VSF4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTENALYLIKAFVLGIIEGLTEFIPVSSTGHLILVGDWINFQSSQGKVFEVVIQLGSILA
VMWVFRSRLLRLVRGTLTGVPSEVAFTRNLIIAFLPAAVVGAIFIKSIKSIFYHPSVVVV
TLVLGGLIMLYVERKTHHTPGDQPGAADDTASDERATARTLEQISWKQALGVGVAQCLAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDMYKNIDLLTQHDLSGIA
VGFVAAFLSAMVVVRAVLRFVANHTYRVFAWYRIVFGAVVAAWIFTR
>A0A0A1I7H3|FEATURES|UNIPROT_deepARG|beta_lactam|blaACT-34|antibiotic inactivation|1
MMMTKSLCCALLLSTSCSVLAIPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYEGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIVRGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAE
AYGVKTNVQDMASWVMVNMKPDSLQDNSLRKGLTLAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVEGSDNKVALAPLPAREVKPPVPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYRILSAL
>A0A0T9LUB0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_1|antibiotic efflux|1
MAALLELEGIRRSYQSGEEIVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGIYRVAGQNVDELDDDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNE
RRERANMLLTRLGLGERVSYRPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERVIEIKDGRIMADSGSKSGQAVAAAELMS
LTPAAPSWQQLVGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIEIYPGKDFGDDDPSTRQALVHDDMAALKAQSYVSAVSPSIGGSMRLR
FGNIDVAASVLGVSDEYSRVFGMAMEQGAPITREQVERQAQTVVIDLNTQRRLFPHMNDV
VGQVILVGNMPATVVGVAKEKQSMFGSNKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTLRHGKKDIFTYNMDSLLQTAEKTTQTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAVLVCLIGGALGITLSFAIGLIVE
MFLPNWRIAFPPMALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>C3K9G5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLELKGITRSFMAGEREFIALKGIDLTIHAGEMVAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPET
ARHSRARELLTRLGLAGHTTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVSDGEIVSDKANDGVGLELPSDTP
IEPRRSGARRLVASLGLFKEAFNMAWVALVSHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVDALNQLYYVDSATPVVGRNL
LLRFGNIDLDAQVNGVSDRYFKVKGLKLEAGIAFSESDARRQAQVVVIDHNTRHRLFGPN
VDPLGQVILVGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGLIGISLSYALGF
LFSLFVKEWEMVFSLGSIITAFACSTLIGIVFGFVPARNAARLDPIEALARD
>A0A107JPI7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHGIKRIMAAALFSTCATATIGYAANDRQDTVKSVSDSVVLPIMAKYGIPGMAVGIVAD
GQTYVFNYGVASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKAGKYLPN
LQGSPFGNVTLVELGTHTPGGVPLQVPGNIRNEDQLMRYLKDWRPTYSPGTYRTYSNVSI
GTLGLITATSMGQQDFAVPLSRHLLSPLGMKSSYVDVPRSRMADYAQGYTKDGAPTRMTT
DVLSSKTYGIKTTAADLLRFVQANMGEVKLDKPLQQAIIDTHTGYFNAGPMTQDLIWEQY
PYPVALKTLTEGNSLSMALNAMPVEEIKPPQAPQQQVWINKTGSTDGFGAYVAFVPARHM
GIVILANRHYPNEERVTAAYRILTSLGLDGR
>A0A0D8AXH0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLYALILGIIEGLTEFLPVSSTGHMILGTTILGIDIDEFWKSFLIIIQLGSILAVIFV
FWRKLFQGLDIWLKLAVGFFPTGVIGLFVAKYLNALFNGWVVVGMLIFGGVVLILIELAH
KNKQYRINSLEEISFKQAFCIGIFQSLAMIPGTSRSGASIIGGLLLGFNRKVAAEFSFLL
AIPTMIIATAYSIYKEPELLSNANSLIPLSIGFITAFIVAVLVIKFFLKFISKFDFIPFG
IYRIILGFVFFYLYYSGILNAGSEFKL
>J4QPX8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTENALYLIKAFILGILEGLTEFIPVSSTGHLILVGDWINFQSGDGKVFEVVIQLGSILA
VMWVFRARLLQLIRGALTGEPSEVAFARNLIIAFLPAAVIGAIFIKTIKSVFYHPGVVVV
TLVVGGLIMLYVERRTHHTPGDQPGAADDTASDERASAYTLEQITWKQALGVGVAQCFAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVFDMYKNFGVLTQHDLSGIA
VGFIAAFLSAMVVVRAVLRFVANHTYRVFAWYRIVFGAVVAAWIFTR
>D7PII4|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-1|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKESEVKKNLLTQHVGLKKSDLVNYNPITEKHLN
EGMTIGELAAAALQYSDNTAMNKLIEHLGGPHKVTDYARTLGDNTFRLDRTEPTLNTAIP
GDERDTTSPRAMALSLQHATLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWIVGDK
TGSGDYGTTNDIAVIWPENKAPLVLVTYFTQPEKDAKS
>A0A0F2JEJ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDFISALILGIVEGITEFLPISSTGHLIIVNQFVGFTEQFAKMFDVVIQLGAILSVVVY
FRKRLIPFGNLKSSKNQKIFDLWKKTIVGVIPALGIGFFAAHYIEERLFNTTVVSIALIV
GGLILLYIENKRHSFSIKSMDQLTYRTAFTIGIIQCLAMIPGTSRSASTIIGAMLLGASR
VVAAEFSFFLAIPTMVAASGYTLLKNGLMLTPHEFLVVGFGFFVSFVVAWVVIAGFMNYV
SKKDFKPFGYYRIVLGIIVLSYFGFLRP
>A0A0F5AIJ1|FEATURES|UNIPROT_deepARG|chloramphenicol|VT50_06085|antibiotic inactivation|1
MDAPTPIDLDTWPRRQHFEHYRRRVPCTYSMTVELDVTAFVAALRRSQRKSYIAQVWALA
TVVNRHDEFKMCLAASGEPAVWPVVHPAFTVFNPERETFACVWAPYDSDFGAFHDVAAPL
LTEHSRATDFFPQDARPANTFDVSSLPWASFTGFNLNIGDGWDHLAPIFTLGRYTERDGR
FLLPLAVQVHHAAADGFHSTRLVNELQALVAGPTWLAESPNA
>A0A0A6Q284|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFLEIIKAIILGIVEGITEWLPISSTGHMILVDQFLKLNVSKDFMDMFLVVIQLGAILA
VIVLYWEKIFPFKFSNGIKIEKDTMIMWVKIVIACIPAAVIGLLFDDQLNELFYNPTTVA
VMLILFGILFIVIENYNKGKRSKINSLSEITYNVAIMIGLFQLIAAVFPGTSRSGATIVG
ALLIGVSRTVAAEFTFFLAIPVMFGASALKLLKFGLATGFTMTGNELSILLVGMIVAFIV
SILAIKFLMSYIKNNDFKAFGWYRIILGIIVIGYFYLIK
>Q6REX5|FEATURES|UNIPROT_deepARG|beta_lactam|shv5|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKNGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQ
>Q6MPX9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIDIKGIRKSYQMGDTKVDVLKGISLKIERGDFVAIMGPSGSGKSTLMHILGLLDVPSEG
SYNLNGREVADLSEDELAIVRREEIGFIFQQFNLLPRMEAWQNVSLPLIYSEDGFSYDKA
QALLDKVGLAERIHHKSNELSGGQQQRIAIARSLINNPRIIFADEPTGNLDSKSEKEIIQ
ILHKLNDQGITVIVVTHEEEIGQQAKRLIRLRDGVIQSDERLQALPAAPTTAQEKRQEKT
AKWPVREMIEHLHQGFQTLAANKVRSGLSMLGILIGVAAVVGMLALGTGARQSIEKQLSS
LGSNLLVLRAGNVRVGGVMQESGVRIRISLDDVSTIKNQISGIKDVSPSSSGRGQITYLN
KNWNTQVMGVAPAYEQMRASTPIFGRFFSEEENQRRTLVAVIGTTVARELFGEKSPIGEM
IKINKVNFRVIGVLPEKGAAGPQDQDDRILVPVVTAMYRLFGRNYVDSVDIEVRDAADIP
EVQDSLQELMNKRHRVPVSSQGDAFNVFNMADIQQALNSTSQTLSMLLASIAAISLVVGG
IGIMNIMLVSVTERTKEIGLRKAIGARRRDILLQFLAESIVVSVCGGLLGIALGVGFSLL
ISKVLGWSTVVSAGSVILSFGFSALIGIVFGSYPASKASKLHPIEALRYE
>Q8VQB6|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVRLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVQTTISWRYPAKRELQFGEWQRNDILAGI
FEPAMIDIDLAILLTKAREHSVALVGPPAEEFFDPVPEQDLFEALRETLKLWNSQPDWAG
DERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLAS
RADHLEEFIRFVKGEIIKSVGK
>A0A0K2W3X8|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFGKLWQMLIKLPSDPQTRHFVIGILIAFLPAAVIGALAHDFIKNYLFESPKLICSMLI
VGGVVLLVVDRINFKPVHHDVERFPLSVYLKIGLFQCLSLIPGTSRSGSTIVGALLMGVD
KRAAAEFSFFLAMPTMVGAFAFDLFKNRNVLTSADLPIISVGFIAAFVAALIVVRFLLDY
VSRKGYALFGWWRLVVGGVGLVALMVWG
>CAC47932|FEATURES|ARDB_deepARG|tetracycline|tetX|antibiotic inactivation|1
MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTL
DLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDL
RAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTD
TEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFK
TPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKS
KRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFIY
GKEAQEESTQNEIEMFKPDFTFQQLLNV
>A0A0P0IV60|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-19|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEHTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>A0A029KLZ7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
DVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKSCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLITCGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>YP_001436495|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDMHSLLVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGHPPHEGVGKGRLSLIHILLGMVPAVVLGLVFHDFIKSLFNPIN
VMYALVVGGVLLIIAEVLKPKEPKAPGLDDMTYRQAFFIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFLLAVPMMMGATALDLYKSMGFLTMADLPMFAVGFVTAFVVALVA
IKTFLHIIKRISFIPFAIYRFIVAAAVFAVFM
>ABK84591|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MKNYIFVIKEALLVADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDDRAKVFEV
VIQLGSILAVVVIFWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVL
FGPGPVVISLVAGGILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGS
TISGGLLARVSHTAAAEYTFILAVPMMVAASGLDLIKSWDILSTADIPLFATGFITAFVV
AMLAIVSFLKLLSRVKLTPFAYYRFILAAVFYFFIM
>A0A0H4JQR5|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MKKTFILLNLILLVNLNGYCQTKSLKSNEIVKPEFRNILDSLKVKGAILIYDVKNKTYYS
NDFSWTKTGIIPASTFKIPNSIIALETGIIKNDSTIFKWNGEKRKFKNWEEDLTFKKAFQ
VSCVPCYQEIARKIGVKRMKRYLKKLNYRGMVFDTLTIDQFWLEGESKITQMQQIDFLER
LYFSKLPISKRTERIMKDIMEIEKTESYTLNGKSGWGMRNKGNNGWLVGYLETNKSVYFF
ATNIEKPETNIDEFPIIRLNSTKEAFRKLKLIK
>ZP_03319325|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLTDQFIIDSIVDAMHPQPGQAIVEIGPGLGALTEPVGSRMD
KMTVVELDRDLAARLHVHPQLKDKLTIIQQDAMTVDFGELAKQAGQPIRVFGNLPYNIST
PLMFHLFTFTNQISDMNFMLQKEVVNRLVAGPGSKAYGRLSVMAQYYCNVVPVLEVPPTA
FAPPPKVDSAVVRLIPHKENPYPVKDIKVLSRITTQAFNQRRKTIRNSLGDLFSVEQLTE
LGIDPGTRAENISVEHYCKMANYLCNFSE
>BAA08793|FEATURES|ARDB_deepARG|multidrug|Mdr|antibiotic efflux|1
MDTTTAKQASTKFVVLGLLLGILMSAMDNTIVATAMGNIVADLGSFDKFAWVTASYMVAV
MAGMPIYGKLSDMYGRKRFFLFGLIFFLIGSALCGIAQTMNQLIIFRAIQGIGGGALLPI
AFTIIFDLFPPEKRGKMSGMFGAVFGLSSVLGPLLGAIITDSISWHWVFYINVPIGALSL
FFIIRYYKESLEHRKQKIDWGGAITLVVSIVCLMFALELGGKTYDWNSIQIIGLFIVFAV
FFIAFFIVERKAEEPIISFWMFKNRLFATAQILAFLYGGTFIILAVFIPIFVQAVYGSSA
TSAGFILTPMMIGSVIGSMIGGIFQTKASFRNLMLISVIAFFIGMLLLSNMTPDTARVWL
TVFMMISGFGVGFNFSLLPAASMNDLEPRFRGTANSTNSFLRSFGMTLGVTIFGTVQTNV
FTNKLNDAFSGMKGSAGSGAAQNIGDPQEIFQAGTRSQIPDAILNRIIDAMSSSITYVFL
LALIPIVLAAVTILFMGKARVKTTAEMTKKAN
>A0A084A2V9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDVHLLFVAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDTAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGGKPVAHEGKTAGHLTLGHILLAMFPAVVLGLLFHDFIKSLFEA
KNVMYALIAGGVLLLVAEWLKPKNPRAVGLDDITYRQAFAIGCFQCLALWPGFSRSGSTI
SGGMLVGVNRYAASEFSFILAVPMMMGASILDLYKSLHFLTLADLPMFAVGFITAFVVAL
IAIKTFLQLIKRISFVPFAIYRFIVAGVVYMVFM
>A0A0P9Q3B9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLDAGYDIAAVFTHADDPAEKTFFGSVAQLCARHDIPVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRLLLGEPLLACAKKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMIKRADAGPIVAQQRVSISATDTALTLHGKLREAASSLLCETLP
LLAQGQLAGTPQDESKATYFGRRTPADGLIDWSLPAARLYDLVRAVTQPYPGAFCPVGDN
KLIVWSARVELRNNHQAPGTVISHDPLRIACGEDSLVISAGQRGDNGLYLSGAQLAREFG
LVEGSQLLDTQKRRPVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
TKPNFNFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARVIENRGGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSIDNARQLIDWTPGIELSETIGKTLDFFLREAMAEKA
DQC
>A0A077LQG2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNRTITLTAVTLALLGSPAAWSQTTDSQARDLLIEQAARQVMQQNGIAGMAIAVTDHGVQ
RFYNFGVAAKDTGSPVTSDTLFELGSISKTFTATLATWAQAQGKLQLDAPIDSYLPALHD
SRLGKVAVLHLATHTAGGFPLQVPDRVQDEQQLMAYFKAWQPQYLPGTHRSYANPSIGLL
GMIAAKSLGLPFDQAMQQGLLPALGLSATWIKVPADKQSLYAQGYDRQDQPVRLNPGILA
DQAYGVKSSSADLIRFVEANIASHPPTSPLQEALRATHTGYFSFGPAIQALAWESYPPPA
DLSALLAGNSNDMALKTQPAQALRPPVQPVPGSWLNKTGSTNGFGGYVAFMADREWGVVI
LANRNYPNPERVRLAQSILNAADTPLVR
>ZP_04072103|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMVLKNKRMLKIGICVGILGLSLTSLEAFTGGALQVEAKEKTGHVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RITMSDRFETALNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALR
>A0A0G8B736|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFSDPASHYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDRPFIQAMEQGMLPALGMSHTYIQVPAAQMVNYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQAKVAQPWREALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYRIVQALDKR
>A0A100WBX8|FEATURES|UNIPROT_deepARG|beta_lactam|RMCC_2286|antibiotic inactivation|1
MRLSRRSALIGGLTFAAAVCTTAQVHADPGSPLDQRIGALERRHNAVVGLSAVNLDGPGA
VSHRADESFAMCSTFKAYAAGRILQGVSRGEFSLDATEFVDPAAVVANSPRTGPRAGTEM
TLADLCQAALQVSDNTAANLLLKRLGGPPAITAYARSIGDERTRLDRWETELNSAIPGDL
RDTSTPAALAGGYRALLAGDALAPPQRSLLEQWMRANETSSMRAGLPQGWTTADKTGGGD
YGSTNDVGIAYGPDGRRVLLAIMTRSAADDPKADALRPLIGELATLVLPYLLDPNHP
>A0A0T9S5T4|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MKHSSLRRSLLLAGITLPLVNFAPPTWAAAIPGSLDKQLAALEHSANGRLGIAMINSGAG
TKILYRGAQRFPFCSTFKFMLAAAVLDQSQSQPNLLNKHINYHESDLLSYAPITCKNLAR
GMTVSELCAATIQYSDNTAANLLIKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPN
DPRDTTTPAAMAASMNKLVLGDALRPAQRSQLAAWLKGNTTGDATIRAGAPTDWIVGDKT
GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATQIILSQIS
>W0DPJ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MALWIAVLLGIIQGVFMFLPVSSTAHMVLAEHWLIGRGESLPSPDSPEMILFALVVHVGT
LVSIIVVFWPSLWRFTLGAAGGAWQWAGQGGRGPVPLYWRLFWLGMFSVLCTGLLGLAFK
AAFEQVFAHPWMIAITLTLTGILLWWTDRLPPRRRGLKGINWRVAGVIGLAQGLALMPGL
SRSAMTIMFSLFAGLKRRWAAEYSFFLAIPTISAATLLQAIQVYRAEEPPVIGFAALAVG
FVVAAVVGIVSLKLVIYFLYRAQLKVFSFYVWLLALAVAMGWIGV
>W6RUX7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEILFILKAALLGIVEGLTEFLPVSSTGHLVIFGEIIKFNNGVRQEFIDMFNMVIQLGAI
LSVIVIYWDKIWNTIKTFIPNVNICGNSTYKESGLHFWSIIALACIPGAALVLPFDDWVE
KNLFNSRVVALTLVLGGIAMIVFEKKYRDLKNNRTNSIFEVTYKQALIIGIFQCLSIVPG
MSRSASTIIGAWVAGLSTVAAAEFSFFLAIPVMFGMTTIKLFGIGGLTALTTSELLALGT
AFLVAFIVAIIVIDKFIGYLKKNSMKPFAIYRFCFAIVVLISGFFNII
>A0A0D4ZXG6|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
MLAVKIKPFTKPILIMKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFL
LYDASTNAEIAQFNKAKCATHMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIW
NSNHTPKTWMQFSVVWVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLE
SSLKISPEEQIQFLRKIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRT
LQNGWFEGFIISKSGHKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>C5ZXI4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLESLYFLCKTRLFMDLIYAIILGIVEGLTEFLPVSSTGHLILTSKLLGIQQDTFHKTFE
VMIQLGSILAVIFVFWERLFKNSLELWVKLAIGFLPAGILGFLLYDLIKMLFAPITTSIM
LIVGGIAFIVIEIFYKEKEHHTKEIAEISYKQSFLIGIFQALAMIPGTSRSGATIIGGLL
LGCNRKVATEFSFLLALPTMIIASGYSAYKNYAVFNADNLLVLGVGFVVAFLSALIAIKL
FLGFVSRFNFIPFGIYRIILGIAFLFYLEVF
>A0A0K2P5V7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDMHSLLVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGHPPHEGVGKNRLSLVHILLGMVPAVVLGLLFHDFIKSLFNPIN
VMYALVVGGVLLIAAELFKPKEPKAPGLDDMTYRQAFFIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFLLAVPMMMGATALDLYKSLGFLTMADVPMFAVGFVTAFVVALVA
IKTFLHIIKRISFIPFAIYRFIVAAAVFAVFM
>N9NX01|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVVAIQMGAIAAV
IYEYWARLWGAATGIVSGEPQGRRLGIGLILASIPIVLIGLTLGQTVKELLFNNIAIAIG
LIVGGLIIIWIEKNPPKVRAQEVEDLTVKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYDVYSTTEDWTVLAVGIIVSFISALLLIRAL
VAYVAKRDFMVFAWYRIASGLLILLFAFTGWRLW
>A0A0B3TW70|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
RLWSLATGLGERANRDYVLKVGVAFLVTAVVGLIVRKAGWQLPETLQPVAWALLIGGVWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGTENWADVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAVYRMLLGAALLLWLPAAAG
>D3T8E5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLIKAFIMGIVEGLTEFLPISSTGHLIIVGKFIHFTGNFATMFEIVIQLGAILAVVFY
YRKKIFASLKNLKPGSWGFNLWFKIFIAFIPAAVIGLLTHKYIEEHLFSPFTVAIALIAG
AIMMIVIEDTFGKRYKIDNMDKVDTKKSLLIGIAQIMSLFPGMSRSASTIMGGMLAGLSV
KAAAEFSFFLAIPTMLAATTLSLLKGFSAMSLLEWQALAVGFITSFLTALFVVDKFLSYL
TRHSLKPFAYYRLAVGVLMILLVAEKIVK
>C0Z8X5|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MEFQRIDLDNWSRRSYFEHYLNRVNCTFSMTANIDITELLPALRQKGMKLYPAFLYMVTN
VVNAHREFRTSFHADGELGYWESMIPSYTFFHQDDQTFSTMWTEFDDEFPVFYQNYVADM
KQYGDNKGLVAKELEPPYTFPVSCIPWVSFSGFNLNITGDGRYLLPIITSGKYFEQEGKT
LLPVSLQVHHAVCDGYHASLFINDLQKWATNYKEWLGVE
>G6CDG9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLTLNMIKTIILGIVEGFTEWLPISSTGHLVLVGSVLKLDESKAFIDMFNYVIQFGAIMA
VVILYFHKLNPFSPRKNQLEQKQTWTLWFKVIVAVIPSVIIGFPLNDWMDEHLMKNWIVA
SMLILYGVLFIVIENRNKHTTPKFADLNTLPWLTAFWIGCFQALSIIPGTSRSGATILGA
IILGTSRFVGAEFSFFMAIPTMVGVAILKIGKFLYQGNTFTGDQSIILLVGMLVSFIVSI
ISIKFLMDYIKKHDFKVFGWYRIILGLLVLGAMLFA
>J7Y4W2|FEATURES|UNIPROT_deepARG|beta_lactam|IE7_05371|antibiotic inactivation|1
MFVLNKFFTNSHYKKIVPVVLLSCVTLIGCSNSNTQSESPKQTNQINQVKQVNTGNHAFA
KLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREIGD
TVTNSERFEPELNEVNPGETHDTSTPEAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADATKVVLDTLKVTNK
>A0A0W0YAP0|FEATURES|UNIPROT_deepARG|beta_lactam|Lqua_0403|antibiotic inactivation|1
MKKLSVFLVMALFYCGTTWAQSSCFLVQENQTVLKHEGKDCNKRFAPESTFKIALSLMGF
DSKLLKDDLHPEWPYKKEYELYLNVWKYPHNPHTWIRDSCVWYSQVLTQQLGMTRFKNYV
DAFHYGNQDVSGDKGKNNGLTHAWLSSSLAISPTEQIQFLQRIVNEKLPVSHKALMMTKN
IIYIQELAGGWKLYGKTGNGRLLAKDKRQKLTLQHGWFVGWIEKDGRVITFANHIADSKT
QATFASFRAKNEALNQLFYLINELEQ
>Q8Y9K8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|1
MQQEATGGQKIRPIPIIASFLMAGFIGLFSETALNMALSDLIQVFDISSATVQWLTTGYL
LTLGILVPISGLLLQWFTTRGLFFTAVSFSIAGTLIAALSPTFAMLMIGRVVQAVGTALL
LPLMFNTILLIFPEHKRGSAMGMIGLVIMFAPAVGPTISGLILENLTWNWIFWISLPFLI
IALLFGMKFMQNVSVVTKPKIDILSIILSTLGFGGVVFAFSSAGESGWGSATVLVSIIVG
GIALGLFVWRQLTMEKPLMDLKVFKYPMFTLGLILVFISFMMILSTMILLPLYLQNSLAL
AAFSAGLVLLPGGVLNGLMSPFTGRLFDAYGPRALVIPGFIVAVVALFFLTRIEVGTSAL
TIIVLHSVLMIGISMVMMPAQTNGLNQLPPKLYPDGTAIMNTLQQVSGAIGTAVAITIMS
AGQKAYMETAQGVGPEQMVASLTAGIQNAFVFGLIMACIGLLCSLFIRKAK
>A0A0X8GRE1|FEATURES|UNIPROT_deepARG|aminoglycoside|VN23_18795|antibiotic inactivation|1
MITPCKSLNQPGWLDLRVALWPDCSNAEHLAEMALFLASPQRFAQFVEYDQAGRVLGFIE
LAVRGDYVNGTESSPVAFLEGIYVEPSARRRGIAGKLVAAAEQWAKEHGCKELASDAAID
NTQSHAMHKSLGFNETERVVFFKKAL
>A6T273|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPILALKAIIMGIVEGFTEFLPISSTGHLILAGSLLDFTGPKVKVFEIAIQTGAMLAVV
WEYRAKIAAVLGGLLTERKAQKFALNIIIAFLPAALLGLVFASKIKEKLFAPVPVAIAFI
VGGFIILWIEKRNRNTDFVARVETVDDMTMLDALKVGCAQAFALIPGTSRSGASIIGGMF
FGLSRKAATEFSFFLAIPTLMGATVYSVYKDRALLSMADIPLFGLGGFAAFVSAFLCVRW
LLRYISTHDFTFFAYYRIVFGLFVLLSAYYGWVVWAD
>CAD36021|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-IIIa|antibiotic inactivation|1
MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVERE
KDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIR
LFHSIDISDCPYTNSLNSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP
EEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVEL
FFDLLGIKPDWEKIKYYILLDELF
>A0A127T741|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCAILITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>YP_302125|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MLILELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSSEFLGSQSAFTFKIVIQLGS
VFAGAWVFRERYFEMLHIGKYRHEPIDGIGQKPKRLNLLHIIVGMIPAGVLGLLFDDVIQ
EYLFSVPTVMIGLFIGAIYMIIADIYSKKVTNPRNVDQINYFQAFVIGLSQAIAMWPGFS
RSGSTISTGVLMKMNHKSASDFTFIMAVPVMLAASGLSLVKNMEYIHMSDIGFYVLGFLA
AFIVGLIAIKTFLYLISKIKLIPFAIYRIVLVIIIAILYFGFGIGQGITGE
>S5MY40|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENAFFGSVSRQAAGLGIPVYAPD
NVNHPVWVDRIAELAPDIIFSFYYRHLLSEEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVANQRVAIAQDDMAITLHHKLCQAARQMLDRILPAM
KCGDISSVPQCESDATYYGRRRPEDGLIDWNKPVSTAHNLVRAVAAPWPGAFSYSGSQKF
TIWSSRICPDAPGALPGSVISVSPLRIACADGALEIITGQAGEGITVQGSQLAQTLGLVV
GARLNRPSAAGTKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAIGRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYHKRVVFPSTSEVYGMCTDTSFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPENEASIQELATLLLDSFDKHPLRRHFPPFAGF
QIVESGSYYGKGYQDVAHRKPNINNARRCLDWEPSITMRGTVEETLDFFLRSVEIADRAS
>A0A064CVH7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSNIRRSYPSGEEQVEVLKGITLQINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDRDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSRSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIHDGEIVRNPPAKHAAQGQGIQEPT
VKTASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLAAIQKQPWVTSATPAVSQNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGTTFNREQLNGRAQVVVLDSNTRRQLFPHKANVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTFTGVLFGWLPARNAARLDPVDALARE
>B7NNT4|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLIHDKILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KDGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKQS
>A0A080F191|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
FWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVM
YALVVGGLLLIAAECLKPKEPRARGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGM
LMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALIAIK
TFLQLIKRISFIPFAIYRFIVAAAGYVVFF
>A0A0G3SQY5|FEATURES|UNIPROT_deepARG|aminoglycoside|ERS381490_00812|antibiotic inactivation|1
MIVICDHDNLDAWLALRTALWPSSSPEDHRAEMREILASPHHSAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVEGARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>D3MUA0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIFKAIFLGIVQGITEWLPVSSTGHMILVDQFLHLAGSKKFVDTFLVVIQFGSILAVLI
LYFEKLNPFSKNKGPKARKATWDLWIKVVIAVIPSGLIGVLFEKKIDEVFFNPTVVALAL
IVYGIIMIWLESRHKRPNITKFSQVSYKTALMIGMFQVLALVPGTSRSGSTIIGASLLGT
SRFIAAEFSFFLAIPTMLGASLLKLLKAGFAFTGFEWFIMLVGSVTAFVVSVIVIKMFMS
YIKKHSFKSFGIYRICLGILVFVYFAFAG
>J8NIX0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFEDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSAADIPLFATGFITAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>CAB63488|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRFTLLAFALAVALPAVHASAAEAPLPQLRAYTVDASWLQPMAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAVGSKASAEALTCNAYADAAEKKFDAQLAKETAGAR
>A0A0A1GDZ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWIAFQALLLGVVEGITEFLPISSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVV
WEYRRKIFDVVVGLPREKQAQKFTGNLLVAFFPAVVLGITFADLIHKYLFNPITVATALV
IGGVVMLWAEKRQHEVQAETVDDMHWSHALKVGFAQCLALIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDLPIFAIGFITSFIFAMLAVRALLKF
IGNHSYAAFAWYRIIFGIIILATWQFSLIDWSTAAG
>Q4L202|FEATURES|UNIPROT_deepARG|beta_lactam|blaPLA-3A|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHQATVTTVKQAESQLQGRVGYAELDLASGQLLAGYRSDE
RFPMMSTFKVLLCGAVLSRVDAGEEQLDRRIHYRQQDLVEYSPVTEKHLTDGLTVGELCA
AAITLSDNTAANLLLTTLGGPQGLTSFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPQ
AMARTLRNLLTGRVLSSASQQQLQRWMVEDKVAGPLLRSVLPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTGPPATMDERNKQIAAIGATLVTHWSADENRP
>A0A089JWW1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIIKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSTELFGQYTANTFKVVIQLGS
ILAVVVIFRNRFIELLGLKRFSRKQLDPVTEQQPQLEKGGHLKLTQVLVGLVPAGVLGVL
FNDYIDEHLFSTSTVLIGLVVGAVLMIIADLFGPKKIQTESVDQITYKQALGVGLVQCFS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLLSLMKNWQYFTIDALPFF
IAGFISAFVFALLSMRFFLKLINRIKLLPFAIYRIVLAAVVYFVFF
>A0A0A2YDK8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQHIIEIKNLNKFFGEGENRVHILKNIHLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
SSGSYQIAGKETAKLSADQLSELRQQRFGFIFQRYNLLSTLSAQENVALPAVYTGMAKPQ
RLQRAAQLLEKLGLGNKIDNKPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSG
ETVMQILQQLHQEGHTIILVTHDKHIAQFANRIIEIKDGEIIQDQRQSLQITARKMTQAA
TNRGWQFYRDQFFEALNMSINAIIAHKLRSLLTMLGIIIGITSVVCVVALGNGSQQKVLQ
NINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQPYIESVTPNSSVSGTLTYRN
SAFTAQVRGVSEQYFNVKGIQTVAGQLFSGEQVKQNQSVAVIDQNTQKRIFQDRNPLGQI
IMINKKPLKVIGIVDIQNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTA
AAEKNVTALLLSRHGKKDFFILNTDSIKQTIESTTNTMKLLISSIALISLIVGGIGVMNI
MLVSVTERTKEIGIRMAIGAKQQNILQQFLIEAVLVCLVGGIIGIILSGLIGFLFNRFMS
EFTMLFSTFSIVVAVLCSTLIGIIFGYVPAKNAAKLNPITALSQE
>CAO78565|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM
>A0A0F0FEC0|FEATURES|UNIPROT_deepARG|beta_lactam|UB46_32240|antibiotic inactivation|1
MRHSPVRRTLLLAAASVPFTSACTSWAGRAGGSAAAQDRLAALESAAGGRLGVAALNTAN
GARISHRASERFPLCSTFKVLAASAILQRSAAESGLLQRRIAYTKDELVAYSPVTGKHAG
EGMTVSDLCAAALQYSDNTAANLLMHILGGPAAVTAFARSIGDDAFRLDRWETELNTAIP
GDPRDTSTPASMSRSLRRLALGDALGAAERGRLVAWMRGNTTGATRIRAGVPADWQVADK
TGSGDYGAANDVAVAWPPGKPPVVMAIYFTQGDKDAAYRNDVLATAARIVAEAIGQAGMA
>A0A0A6DE85|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKTVVFAYHDIGCAGIQALLDSGYDIAAVFTHADDPKENAFYGSVAQLCANKGIPVHA
PEDVNHPLWIERIAKLNPDYVFSFYYRHLLSESLLATAKKGAFNLHGSLLPSYRGRAPAN
WVLVNGEIETGVTLHRMVKRADAGAIVVQQRVAIERSDTALSLHGKLRIAATDLLRDTLP
AMLQGKTSETPQDESKASAYGRRTAADGKLLWAKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVVQGNHGQAPGRVISVDPLRIACGEDSLVILSGQRNDNGLFLSGPQLASELG
LVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIDRLR
SHPHFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKHFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIANAKRLLDWTPTVEMRETIGNTLDFFLREAMLEIA
DKR
>Q54001|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MQMKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDANGINSNETSASLQLTQTLFDMSKWRGLTLQEKAAGIQDV
TYQTDQQTLILNTANAYFKVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQN
ARAQYDTVLANEVTVRNNLDNAVEELRQVTGNYYPELASLNVEHFKTDKPKAVNALLKEA
ENRNLSLLQARLSQDLAREQIRQAQDGHLPTLNLTPSTGISDTSYSGSKTNAAQYDDSNM
GQNKIGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASIS
SINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARYTYLINQLN
IKYALGTLNEQDLLALNSTLGKPIPTSPESVAPETPDQDCAADGYNAHSAAPAVQPTAAR
ANSNNGNPFRH
>H3N2Y8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTANTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKKPEHEGQGSGRLSLIHILLGMIPAVVLGLIFHDTIKSLFNPI
NVMYALIVGGVLLIAAEVLKPKQPRAVGIDDMTYRQAFVIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDMYKSIGFLNASDIPMFAVGFVTAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>W3RNC7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTFDLIKAFVLGVVEGLTEFIPVSSTGHLLLIERFFGFDDDAFGKTFVVLIQLGAILAIL
SVYFLRLWRIAVGMFSDPAARRFVIGVLIAFLPAAVIGAAAGSFIKGTLFNPWVVCFTLI
VGGAILLWVDQLELKPRFHDATAFPLSMYLGIGIAQCLAMIPGVSRSGATIVASMLFGSD
KRSAAEFSFFLAMPTMAGAFAYDLYKNYALMTSDNLIVVTVGFVTAFLAALIVVRSLLDY
VSSKGFTLFAWWRVIVGTLGLIGLALGY
>YP_002037607|FEATURES|ARDB_deepARG|quinolone|PmrA|antibiotic efflux|1
MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISA
ALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNA
TALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTIFLLVGSFLFLAAI
LTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVR
DLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANA
SSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGS
AVAGQFGYQAVFYATSLCVAFSCLFNLIQFRTLLKVKEI
>A0A0W0HJ52|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLSTGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDYIFSFYYRNLLSEPLLATAGKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVIIERSDTGLTLHAKLRDAAITLLRDALP
QLAQGKLAETAQDESQATYFGRRTAADGKLEWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNADGLFLAGPALADALG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNENGVCDGQIVNIGNPENEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKK
>ZP_03836245|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDAPINWKRNLTVAWLGCFLTGAAFSLVMPFLPLYVESLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGLAQNIWQFLVLRALLGLLGG
FIPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPLAGGLLADQYGLRPVFFITASVL
LVCFILTLFFIRENFQPVSKKEMLHIREVVASLKKPKLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALISAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLGVLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISANYGFRAVFCVTAGVVLFNAIYSWNSLRRRRSAELAG
>Y5PG31|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIIIEFIKALILGIVEGLTEFAPVSSTGHMILVDDMWLQSSQFLGSHSAFTFKIVIQLGS
VFAAAWVFRERYFEMLHIGKYKHVAHSEGMRSKPHRLNLLHVLVGMIPAGILGVLFDDFI
EAHLFSVPTVMIGLFIGAIYMIIADKYSTKVKHPQTVDQINYFQAFVIGISQAVAMWPGF
SRSGSTISTGVLMKLNHKSASDFTFIMAVPIMLAASALSLLKNYQYIDLAHVPFYIIGFL
AAFIVGLIAIKTFLHLINKVKLVPFAIYRIVLVIFIAILYFGFGIGKGI
>AAU18406|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVRGRKLAYFNICGVWIALNEEIHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYREDKPHMTFY
>A0A009JCT3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLNSKRLSRPVKQLLVLAGLLSGSAPLWAQQLSEQQVQVIVDQQFKPLLQQYKIPGMAVG
ITLNGQHYFVNYGVASKQSQQPIRNSTLFELGSVSKTFNATLAGYAQAQGKLSWSDHPAK
YFPELKNSAVNRATLLNLGTYTAGGFPLQFPDEVVQQQEMIKYFQAWQPKTTVGAARQYS
NPSIGLMGYVTALAMKKPYTELLQKTLFPQLGLKQSFIQVPEQQLPNYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAQINPQQLQQPLRKAIENTHVGYFKVGAMTQGLGWE
QYAYPAKLETLLQGNSSKMALESHAVTPIAQPKIAPAATFFNKTGATNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYHVIQQLLQHNSAQ
>W4F3K9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIELLKALILGLVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGMYSANTFKIVVQLGS
ILAVVVVMWKRLLSLVGLYKIKGQPANRKFNLIHVIVGMLPAVILGFAFKDYIDDYLFGV
KPVIFSLVAGAILMIVADKFGPKRPTVTTLDKISYGQALKIGLVQCLSLWPGFSRSGATI
SGGVLLGLDHKTAADFTFIMAVPIMAGASLVSVLKNWEYMSMDHIGFYAVGFVSAFVFAL
LSIKFFLKLIDKIKLTPFAIYRIILAIVLAIIVF
>A0A127SQ83|FEATURES|UNIPROT_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MVPWFSFSAFNLNIFGDGTYLLPIFTMGKTFEENEKTMLPLAIQVHHAVCDGYHLGKFIE
TLQANINEFDA
>A0A0T9UAV9|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGKVPHEGKTSGHLTLGHILLAMIPAVGLGLVFHDVIKSLFNPHS
VMYALVAGGLLLLAAEWFKPKNPKAIGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMLGASALDLYKSLHFLTLGDVPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFVVAAAVYWVFM
>D4F134|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELYTLFNAFILGIVEGLTEFLPVSSTGHMIIVGHWLGFEGDKAKTFEVIIQLGSILAVV
VMFWRRLFGLIGIHFGRPPLHEGRSQGRLKLGHILLAMIPAVLLGLLFHDFIKTLFTPLT
VAYALVVGGLLLLAAEWLKPAQPRAVGLDDITYRQAFIIGCFQCLALWPGFSRSGATISG
GMLLGVSRYAASEFSFILAVPMMLGASALELYKSLPYLSWGDLPMFSVGFITAFVVALIA
IKTFLNVIKRISFVPFAIYRFVVAAAVYLLFC
>A0A060KZ07|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLPQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A009GZT9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESRQFEHKTLDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTSDNMVNIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSA
>A0A068H9Y2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGNVEVLKGITLNIAAGEMVAIVGASGSGKSTLMNILGCLDKP
TGGTYRVAGTDVARLNGDELARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGAERKA
RLARAHELLVRLGLGDRAEYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSRSG
EEVMGILHQLKAQGHTVIIVTHDPQVAAQAERVIEIHDGEIVRNPPALSPAQGGVLRQRT
AAEPSAWRQFSSGFREALIMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAIGTNTIDVYPGKDFGDDDPRYQQSLKYDDLLAIQKQPWVSSATPAVSKSLRLRA
DNIDVAASAEGVGAQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNARRQLFPHKARVV
GEVILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVNEGY
DSAVAEQQLLRLLELRHGKKDVFTWNMDSILKTAERTTHTLQLFLTLVAVIALVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLLIAFVLQL
FLPGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>ZP_01723236|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MEIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
ILAVIVVMWKRMLSLVGLYKIDGQSQSINRRFNLLHVIVGMLPAVVLGFAFKDFIDDHLF
KVEHVVYALVAGAILMIAADKLAPKKPKVDSLDKISYGLAFKVGLVQCLSLWPGFSRSGA
TISGGVLFGMSHRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYFGFYAVGFISSFIF
ALLSIKFFLALISKVKLMPFAIYRLVLAAVLCVIIFM
>L0EDD5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEDLFKVIILGIVEGLTEFLPVSSTGHMILAGNLLGYEGGSADTFKIVVQLGAVLAVFVL
YFRRYMDILKDMVRLKLNVPNKLNVIHMILAMLPALIVYLLFKDLIKNVLFGPGPVLISL
VAGGILMIAAELAKRRVTSENTDDITYKQALGIGIFQCLALWPGFSRSGSTISGGMLLGT
SRKAAADFTFIISVPVMFGATVLDLYDSRDLLTKDDLVLFLIGGAASFIVAMLAVVTFLN
LIKRLRLTWFALYRFVVAGLFYWLVMS
>T2HJ32|FEATURES|UNIPROT_deepARG|chloramphenicol|catA1|antibiotic inactivation|1
LKEAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVA
CYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLM
PLAIQVHHAVCDGFHVGRMLNELQQYCEKWQ
>E1UP29|FEATURES|UNIPROT_deepARG|bacitracin|yubB|antibiotic target alteration|0
MTNEGKNRMTLWEMFTAAVLGIVEGLTEYAPVSSTGHMIIADDIWLKSGSLMNPEAANSF
KVVIQLGSILAVAIVFKDRILNLLGLKKNVTRDQQKGYRLTIAQIAVGLVPAAVLGFLFE
DFIDRYLFSVRTVAYGLIAGAVLMLIADWINKRKETIDTVDRITYKQAFCVGLFQCLALW
PGFSRSGSTIAGGVILGLNHRAAADFTFIMAIPIMAGASLLKLVKYWSSLSPDMIPFFLV
GFICAFVVALLVVKFFLRLINRIKLVPFAIYRVILGIILIMLVR
>NP_455432|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELCNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>C6LFH5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIEILKAVLFGIVEGITEWLPISSTGHMILLDEFIKLNVSEEFMEMFLVVIQLGAILA
VVVLYFKRLWPFSLKEKYFIKKDTFSMWFKILVACIPAAVVGILFDEKLNELFYNYETVS
VALIVFGILFIVIERQNRGMKIKINSVAEITYPVALWIGAFQLIAAVFPGTSRSGATILG
AIMIGVSRTVAAEFTFFLAVPVMLGASLLKIVKFGFSFTQMELVLLLVGMVVAFLVSIAV
IKLLLGYIRKHDFTVFGWYRIILGVVVLAYFWAQG
>G2SBR9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPEHEGVGKGRLTLIHILLGMVPAVILGLVFHDTIKSLFNPI
NVMYALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDVYKSYHFLTAGDIPMFAVGFITAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>N8WQ34|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVVAIQMGAIAAV
IYEYWARLWGAATGIVSGEPQGRRLGIGLILASIPIVLIGLTLGQTVKELLFNNIAIAIG
LIIGGLIIIWIEKNPPKVRAQEVEDLTVKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYDVYSTTEDWTVLAVGIIVSFISALLLIRAL
VAYVAKRDFMVFAWYRIASGLLILLFAFTGWRLW
>A0A089V8K4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSDMEAINKVSVVIPVFNEQESLPELIRRTTAACDQMNRDYEILLVDDGSSDNSAALLTE
AAQAPGSHVVAVILNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVDTADQG
YDVVGTIRENRQDSVFRKTASRMINHLIQRTTGKAMNDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRTTEIMVRHSEREFGDSKYSFMKLINLMYDLVTCLTTTPLRLLSVVG
SVIALSGFTLALLLILLRLFFGAAWAADGVFTLFAVLFSFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRIVGNDPRFSEQDNEE
>S2FRC2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGIVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WQFRRKIFDVVVGLPTQPNARRFTANLLIAFFPAVVLGVIFADLIHHYLFNPITVATALV
VGGIVMLWAEKRQHEVHAESVDDMTWKDALIVGLAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFITAFIFAMIAVRGLLMF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWTAAKP
>V6MJL4|FEATURES|UNIPROT_deepARG|beta_lactam|K151_1439|antibiotic inactivation|1
MFKKTFRHTAAIAVSLISLLASPILLANTNNTIEEQLSTLEKYGKGRLGVALINTEDNSQ
ITYRGEERFAMASTSKVMAVAAVLKESEKQAGLLDKNITIKKSDLVVYSPITEKHLVTGM
SLAQLSAATLQYSDNTAMNKILDYLGGPAKVTQFARSINDVTYRLDRKEPELNTALHGDP
RDTTSPIAMAKSLQALTLGDALGLSQRQQLVTWLQGNTTGDHSIKAGLPKHWIVGDKTGS
GDYGTTNDIAVIWPENHAPLILVVYFTQQEKDAKYRKDIIAKAAEIVTKPFITSPKKES
>A0A060V7R1|FEATURES|UNIPROT_deepARG|polymyxin|yfbG|antibiotic target alteration|0
MKAVVFAYHDMGCTGIQALLDAGYDIAAIFTHPDNPGENHFFGSVARLAAEQGIPVWAPE
DVNHPLWIERIREMKPDVLFSFYYRNLLGDEILRLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMMNRADAGDIVAQQAVAIGPDDAALTLHRKLCAAATGLLGQALPAI
FAGTTDERPQDHSQATYVGRRTPEDGRLDWEQSAQTLHNLVRAVSDPWPGAFGYAGANKF
IVWKSRVRHDLPAAKPGTVISVAPLIVACQEGALEIVTGQTERGVYMQGAQLAQGLGLVS
GAVISSKPVVAVKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
NGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLACFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLNWEPKVEMEETVEHTLDFFLRTVELVDAKN
P
>A0A060KZZ5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDCAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0Q6T0Q6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALILGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQRLLAIALALPTSAKARGFVLSVLIAFLPAAVIGAIAHDFIKTVLFETPMLICIVLI
VGGVILYAIDKLPLQPKYRDVMDYPPSLAFKIGLFQCLAMIPGTSRSGATIAGALLLGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRNALDFNDSALIAVGFIAAFVAALLVVRSLLNF
VSTRGFAPFAIWRIVVGVAGLIGLLIFG
>A0A0P7MRC1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLMIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>D5L0D2|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREVVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVPVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0F5FSI7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNGDQGLFVPLILGILEGLTEFLPVSSTGHLLLAGHFFGLHQPATFIVLIQLGAILAVIS
VYFVKLGQLIGAALRGDRQAWHFALAVVITCLPAVVAGVLFREYIQGVIYETPVVICISL
LVGGFVLLAVDRMKLAPRYTEIYSYPWHLALIIGLFQMLSLIPGVSRSGSTVIGAMLFGA
DKRSAAEYTFFVALPIMAGAFGYDLYKSRNLIDMSLGLNIAIGFAASFVVGALVVRYLLD
FVSRHGFAPFAWWRIIVGGGGLIALWLMR
>A0A132CG79|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALALGIIEGLTEFLPVSSTGHLIVAGSFLRFHPEQAKTFDVVIQFGAILAVC
WEYRRRIVDVVTGLPAQREARRFVMNVVIATLPAISLALLFEKTIKSVLFAPVPVAVALV
AGGVVILWVEGRQRERGAPARVQSIDALTPLDALKVGLAQCFALIPGMSRSGSTIIGGML
CGLDRRIATEFSFFLAIPVIFGATLYETAKDWRAFDADSIGLFSIGLVAAFVSAFACVRW
LLRYVASHDFTAFAWYRIAFGLFVLLVGYSGWIEWT
>W6VL11|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHQYLFNPITVATALV
VGGVIMLWAERRQHEVHAETVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRQLFVPADFPVFAIGFITAFIFAMIAVRGLLKF
IASHSYAAFACYRIVFGLVILATWQFGWVDWSAAKP
>YP_002636476|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNRLQSGGRLGRQALLPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGLDWVPTSMTAY
LAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLATLLAKNIEQFTFLRFLQGISLCF
IGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAALA
AIAFFGLQRAMPETATRRGETLSFKALGRDYRLVIKNRRFVAGALALGFVSLPLLAWIAQ
SPIIIISGEQLSSYEYGLLQVPVFGALIAGNLVLARLTSRRTVRSLIVMGGWPIVAGLII
AAAATVVSSHAYLWMTAGLSVYAFGIGLANAGLVRLTLFSSDMSKGTVSAAMGMLQMLIF
TVGIEVSKHAWLSGGNGLFSLFNLANGILWLLLMLVFLKDKRTGNLQTV
>A0A0H5SFE8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAILLGIVEGITEWLPISSTGHMILVEEFIHLNLSDEFMEMFRVVIQLGAILAVV
ILYFNKLNPLSPRKSINEKKEIMNIWFNVIIGVLPAGIAGVLFDDWFDEHFYNYLMVAVM
LIVYGVLFILVENNNKDKEPKIVSFNELSYKTAFLIGLFQVLSLIPGTSRSGVTILGAIL
LGTSRYIAAEYSFFLSIPVMFGASALKLLKFGFNFTGMEVAILFTGMAVAFIVSILAIRF
LLTYIKRNNFKAFGWYRIGLGLIVLGYFAVKSLL
>A0A0Q4GDD8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNSFEAIVLAIVEGLTEFLPVSSTGHMIIASSFMGIASEPFVKLFTIVIQLGAILSVVVL
YFKRFFKSINFYIKLLVAFIPAAVFGLLLSKKIDELLESPMAVGISLLVGGIILLFVDKW
FNKPTINEEENISYLTALKIGFFQCIAMLPGVSRSGATIVGGMSQKLSRKVAAEFSFFLA
VPTMFAATAKKLYDFYKEGHTITQDQTNLLIIGNVVAFVVALLAIKSFIGYLNKNGFKVF
GWYRIAAGLIIIILLLSGHNLQII
>A0A0A7T2W7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMNIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLSFEQFGVLLVACIVAF
GVSMVAIKFLTDYVKKHDFTFFGKYRIVLGIILLIYAMFKAFLG
>C1FRK2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDIMFILKAIIIAVVEGLTEFIPVSSTGHMILVGSAINFNGDFAKMFEVVIQLGAILA
VVVRYWEKIKESIVEFFKFIFTKGKEGKTGFKFGVNVIVGSIPIGITGLLFYHKIKSLFR
PEAVIIGFIVGGILLLIIENMFRKKEHAVQDIDSITFTQALKVGLLQILSVWPGMSRSAS
TIMGGWIAGISTPIAAEFSFFLAIPAMIGTSLKDLFEFDYSIMTPTLWSALILGFVVAFI
VSIIVMNKFVSYLKKKPMKVFAIYRVLAGLLLAALVFTKIIVLTV
>A0A0Q0ENR3|FEATURES|UNIPROT_deepARG|beta_lactam|ALO40_02551|antibiotic inactivation|1
MQRNGTLLCTGLLLVSSVAFAEDNAAALDTLVQTEARKVMQENNIAGLSIAITRHGKQRF
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGQLSLTQSIDTYMPQLRDTR
PGKIPVFHLGTHTAGGFPIQVPENVQNTRQLMDYFKAWQPDYLPGTHRTYANPSIGLLGV
IAARSMNMPFQEAMQQRLFPALGLNSTYVSVPNDKQVLYAQGYNKLDEPVRVSPGILAAE
AYGVKSSSRDLIRFVEANIGLGQHDAPLQRALSDTRIGYFKVGGMTQDLAWEQYPTPMRL
DVLLAGNASAMLNTQKAEAIEPPLAEQPTAWVNKTGSTNGFGGYVAFIAERQIGIVILAN
KNYPNEERVKLAYRILQHAAPFN
>C8CE54|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-30|antibiotic inactivation|1
ESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGM
TVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDE
RDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEVDKVAGPLLRSALPAGWFIADKSGA
GERGSSGIIAALGPDGKPSRIVVIYTTGSQATMDERKRQI
>A0A0A0QAU9|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-1|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALTQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPSYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0H4RE73|FEATURES|UNIPROT_deepARG|fosfomycin|fosB2|antibiotic inactivation|1
MIQGINHICFSVSNLERSIIFYQKVLGAELLVKGKSTAYFSLNGMWLALNEEKDIPRSEI
QYSYTHLAFSISIESFDQAKELLKQHNVNILPGRNRDERDKKSIYFTDPDGHKFEFHTGT
LQDRLAYYQEEKPHMTFYSPKE
>N8VXX9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESRQFEHKTMDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTSDNMINIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIALGVIILIAAMFFNLSA
>X8K489|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLELIKAVIYGIVEGITEWLPVSSTGHLILLKSIMPMKVSDNFWNFFLVVVQLGAILAVV
IYFWNKIWPFNTKVKGKSFIRYDVMQLWVKIIVACFPAAIVGILLDDWVDKHLYNPTTVA
IMLILVGIAFIFVEKKNVNKEPRITSLRDISYKDALIIGAFQLIAAVLPGTSRSGSTIIG
GLLIGIDRTIAAEFTFFLAIPVMFGASLLKLLKFGLHFTAMEFGILFVGIVVSFLVSLFC
IRFLMAYVKKHDFKVFGWYRIALGAIVLIYFKLILA
>E1JYV1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTESLAATVLGLVEGATEFLPVSSTGHLILVGHLIGFTGAKADSFDVIIQLGAILAVVVL
YWKRFWWLLSPKPLHAFSGPRGLWMLFLTSLPAGLLGLAARKAIKTYLFGPITVAMALAV
GALMIFWVESRKKRDRFYTLDEMTPGLALGIGCFQCLALWPGFSRSAATIMGGMLLGAKR
GLAAEYSFIAAVPLMFAATLYDFYKSAALFSADDLLILGIGFVVSFISALVAVKGFIVLV
KHMSLRPFAWYRLALAATVFFFWPK
>A0A0S2IHQ1|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-55|antibiotic inactivation|1
AELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQR
VEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQ
LGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGN
TTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYST
>A0A095BVN7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDAARWAIFNIAIQPGAILAIVVL
YRKLFWEMFAGFFRRDPQAIAFVRNLLLAFFPAVVLGLAFGDYIELLLENAVVVAWALVI
GGFAILLVERFAKTRDVGGVANVSARQSILVGLVQCIAMIPGVSRSGATILGAMSFGVDR
KTAAEFSFFLALPTLTGATVLQLFKHRDAITTNDLGLIAVGAFVSFVVAWAVIKAFLAVV
TRYGFAPFAWYRIIVGVAALIWLGMR
>ABZ80060|FEATURES|ARDB_deepARG|rifampin|rif|antibiotic inactivation|0
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMPQYISLSGVMTNDGPDNQAIASFEIRD
QYITALNHLVLSLELPEVKGMGRFSYVPYVGYKCINHVSISSCNGVIWEIEGEELYNNCI
NNTIALKHSGYSSELNDISIGLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITV
TVTFNPVSDIVIRDSSFDFETFNKEFVYVPELSFIGYMVKNVQIKPSFIEKPRRVIGQIN
QPTATVTEVHAATSLSVYTKPYYGNTDNKFISYPGYSQDEKDYIDAYVSRLLDDLVIVSD
GPPTGYPESAEIVEVPEDGIVSIQDADVYVKIDNVPDNMSVYLHTNLLMFGTRKNSFIYN
ISKKFSAITGTYSDATKRTIFAHISHSINIIDTSIPVSLWTSQRNVYNGDNRSAESKAKD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
FTPKIFFRPTTITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQG
VSITKIMGDNN
>A0A0L6FRY4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MNMTVELSPRLARPADQQQPLLRLQGVSRSFMAGDREFLALKGIDLQIHAGELVAIIGAS
GSGKSTLMNILGCLDHASAGSYQVSGQETRDLDDDALAALRRDHFGFIFQRYHLLPHLDA
LRNVEIPAVYAGVPQAGRHARARELLGRLGLGTHLAHRPSQLSGGQQQRVSICRALMNGG
EVILADEPTGALDTASGKEVMNILLELHAAGHTVILVTHDPKVAAHAERIIEVSDGQIVS
DRRTRPEAPAPAAEAAPAVEQAPRRLVASLGLFREAFKMAWIALVSHRMRTLLTMLGIII
GITSVVSISAIGEGAKGYVLKDIQAIGSNTIDIYSGTSFGDSRAKAIETLMPADVTALNE
LYYVDSATPVIGQSSLVRYRNIDADVQLNGVSEQYFQVRNIPLASGIVFSADDARRQAQV
VVIDHNTRKRLFGDGVNPLGQVILVGKLPCTVIGVTAENKNLFVAGNTLNVWMPYETAAG
RVLGQRHLDSISVRIKDGMPSKRVEEEVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSL
TLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCL
IGGVIGIGLSYGIGYLFALFVKQWEMVFSLGSVVTAFVCSTLIGIVFGFVPARNAARLDP
IEALARD
>B1LL36|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>ZP_04631862|FEATURES|ARDB_deepARG|fosmidomycin|RosA|antibiotic efflux|0
MTDRSETEFQPSVNTSVKRTSFSILGAISVSHLLNDMIQSLILAIYPLLQAEFSLSFAQI
GLITLTYQLTASLLQPLIGLYTDKHPQPYSLPIGMGFTLSGILLLAVATTFPVVLLAAAL
VGTGSSVFHPESSRVARMASGGRHGMAQSIFQVGGNFGSALGPLLAAILIAPYGKGNVGW
FSLAALLAIVVLLQVSKWYQQQQRASHGKVIKVSSAKVLPRKTVVSTLAILMVLIFSKYF
YLTSISSYYTFYLMHKFGVSVQNAQIHLFVFLFAVAAGTIIGGPLGDRIGRKYVIWGSIL
GVAPFTLILPYASLYWIGILTVIIGVILASAFSAILVYAQELIPGKVGMVSGLFFGFAFG
MGGLGAAVLGYVADLTSIELVYQICAFLPLLGIFTALLPNIEDK
>A0A0G6PJK6|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MLFIELLKAIFFGVIEGVTEWLPISSTGHLILVQEFIRLHQDKAFMEMFNIVIQLGAIIA
VIVIYFERLNPFQPGKSPQQIRLTWQLWLKVAIACIPSIIIAVPLDDWFDAHFNHMLPIA
IALIVYGIAFLWIEKRNQTLEPRVVKLSRMSYKTAFFIGCFQVLSIIPGTSRSGATILGA
IILGASRTVAADFTFFLAIPTMFGYSGLKALKFFIDGNHLTLSQLLVLLVASLTAFAVSL
YVIKLLTDYVKKHDFTVFGRYRIVLGSLLIVYSVFKSLF
>YP_001462039|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAVIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIITCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQQAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>A0A070FEP2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHETIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>D7PII0|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-2|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLKKSDLVNYNPITEKHLD
TGMTVGELAAAALQYSDNTAMNKLIEQLGGPRKVTEYARTLGDKTFRLDRTEPTLNTAIP
GDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDK
TGSGDYGTTNDIAVIWPDNKAPLILITYFTQPEKDAKS
>E6V718|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLVKAATMGIVEGLTEFLPISSTGHLILAGSLLGGFGDNRGKVFEIAIQTGAIFAV
ILVYWQKIKSTVVALPRQPKARRLALNIFIGFLPAVVLGLLFGKVIKANLFIPTVVASTF
IIGGFIILWAEKRPPGSVRVEHVDDLTAWDALKVGLVQCFAMIPGTSRSGSTIIGGMLLG
LSRQAATDFSFFLAIPTLIGAGVYSVYKERALLSMADVPLFAVGLVFSFISAWLCVRWLL
KFISTHNFIPFAWYRIAFGIVVLVTAWTGTVVWAE
>AAG34685|FEATURES|ARDB_deepARG|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVATIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVG
CDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGV
TKVNGPEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTMPGFTSYSRYPRMVAAAGITLPALIDSLITLALKR
>C6CR02|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDFGCVGLRALVAAGYTVEAVFTHADNPAENQFFGSVARTAAELGIPVFAPE
DVNHPLWVERIAAMSPDVIFSFYYRHLLSDAILQSATHGAYNLHGSLLPRYRGRAPLNWA
LVNGETETGVTLHRMVTRADAGNIVAQQRVAIDESDTALSLHRKLRDVAEQLLKDALPAI
AAGKANDIAQDESQATYVGRRTPEDGRIEWQRPARTLYNLVRAVTEPWPGAFSFVGTTKF
IIWQAKVRTDFAAAKPGTVLSTSPLVVACGSDALEIVTGQGDNGIYLQGAQLAQSLGLVT
GAILNNAPVVSVKRRTRVLILGVNGFIGNHLTERLLQEDNYEVFGLDISSDAIERFLGNP
HFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKTIRDC
VKYKKRIIFPSTSEVYGMCTDPVFDEDNSNLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDI
KDGIEALFRIIENKDGVCDGQIINIGNPDNEASIRQLAEMLLESFEKHPLRNQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLHWQPTIEMEKTVAETLDFFLQTVETGQSSQ
DSE
>A0A0N8SQI2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVEVADLHEASIAAQQPLLQLENVSRSFMAGDREVTVLKQINLSIHAGELVAIIGAS
GSGKSTLMNILGCLDNASSGTYRVAGQQTRDLDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNTEIPAVYAGTSQAGRHQRAQELLTRLGLGGHLEHRPSQMSGGQQQRVSIARALMNGG
EVILADEPTGALDTTSGKEVMRILLELHAMGHTVILVTHDPKVAANAERVIEVSDGEIIS
DKRTSPRVQPVVEPKPALQPAATARRRMIASFGLFREAFNMAWIALISHRMRTLLTMLGI
IIGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGSNFGDSRAKSIETLLPSDVTAL
NQMYYIDSATPVVGRSMLVRYRNIDVDAQLNGVSSRYFQVRNIQLAAGITFDDQDARRQA
QVVVLDHNTAQRLFGPGVDPLGKVILIGKLPCTVIGVTSDHKNLFIAGNTLNIWMPYETA
AGRVLGQRHLDSISVRVKDGMPSKVVEEEIKALMLQRHGTKDFFTNNLDSVMQTVQKTSR
SLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMV
CLIGGVIGIGLSYGIGYLFTLFVKQWEMVFSMASVVTAFACSTLIGVLFGFVPARNAARL
DPIEALARD
>ABG71588|FEATURES|ARDB_deepARG|multidrug|mdtE|antibiotic efflux|1
MNRRRKLLIPLLFCGAMLTACDDKSAENAAAMTPEVGVVTLSPGSVNVLSELPGRTVPYE
VAEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARI
TFNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVS
GKSSVTVGALVTANQADSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPV
QLNLENGKRYGQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQN
VLLVPQEGVTHNAQGKATALILDKDDVVQLREIEASKAIGDQWVVTSGLQAGDRVIVSGL
QRIRPGIKARAISSSQENASTESKQ
>A0SKJ3|FEATURES|UNIPROT_deepARG|aminoglycoside|Ant3Ia|antibiotic inactivation|1
MREAVIAEVSTQLSEVVSVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>YP_002848923|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSQVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEKRGRFFSILMMQDSAGAVVGALLGSWLLQYDFRLVCATGAILFVLCAAF
NAWLLPAWKLSTVKIPVREGMSHVMHDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
SPAAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMMPIGLVGNLQQL
FTLICTFYIGSIIAEPARETLSASLANARARGSYMGFSRLGLAIGGAIGYIGGGWLFDMG
KALAQPELPWMMLGIIGLITFLALGWQFSLKRPTRGMLEPDA
>R4WAW3|FEATURES|UNIPROT_deepARG|beta_lactam|AQU-1|antibiotic inactivation|1
MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVFKEGQPH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVASLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQFMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLAD
EAYGIKTSSADLLAFVKANINGVDDKGLQQAIALTHQGRYSVGEMTQGLGWESYPYPVSE
QTLLAGNSVQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAAHSILSKLAP
>U2RHM1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKQEVEIMILDIVKVVLLSLVEGLTEFIPVSSTGHMIIVEQFLRLSENKQFVNAFEIIIQ
LGAILSVVVYYWHKIWPFSPKLSPRKRKEIIIMWIKIIVAVLPAVVLGLLFDDVIDEHLF
NPMTVSVMLVVYGILLIWLESGKKRKEKYKTISELPILTAVEIGIFQCLAMVPGTSRSAA
TIIGGVLLGLNRVLATEFSFFLAIPTMLGATLLKVVKMGSGLSGYEWFLIALGFVLSFIF
AYGVIKVFMNYIKKHDFKIFGYYRIIVGILILILFLTGVVK
>J3DAN7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MRPYPIRCVSIVIPVYNEQDSLPELLRRTEAACQQLHQDYEIVLVDDGSRDNSAQILEDA
ANRECSPVVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVAQAELGY
DVVATVRSNRQDSALRRWPSKLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEILVTHAEREHGESKYSPMRLISLMFDLITCMTTTPLRLLSIVGF
GMAGLGLLFAVMLIVLRLVFGAEWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRSTPSAPAPVVTVDGLTSTSSDQVLS
>B0TE55|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLYIVAIILGIVEGLTEFIPVSSTGHMILVGSLLGFEGDKAATFEVFIQLGAILAVLV
LYRDRFLNLILNLFADGIRFDDRGFTVWHVAIAMAPACLFGYLFHKPIKAYLFSDKTVLI
GLVLGGLLMLAAAWWRGPLRPIDVLERINYRQALFVGLIQCLSLWPGFSRSGATIAGGML
AGMTPAVAAEFSFIVAVPMMAVATGYDMLKSYPLLDASDLPFFALGFVVSFVVAWAAIVW
FLKLLQQIGLAPFAYYRFLVALLYGVLVIL
>NP_388196|FEATURES|ARDB_deepARG|tunicamycin|tmrB|reduced permeability to antibiotic|0
MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPQKMGFALRSMVPQEIAKDDFQSYPLWRA
FNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLR
TRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSL
RRFADRLMVKLNHIRIK
>A0A0Q0RZC3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFYGIEHEEFTKLFTIVIQLGAILSVLVL
YFKRFFQSLDFYFKLLVAFMPAVVFGLLFSKKIDALLENPLTVAISLLIGGIILLKVDDW
FNNSEDTEITYSRALKIGFFQCFAMIPGVSRSGASIVGGMSQKLSRTAAAEFSFFLAVPT
MLGATVKKCYDFYKDGYVLTEDQINILFIGNIVAFIVAMLAIKSFIGFLSKKGFKVFGYY
RIAAGLILLIIHYFIHPLTVI
>V9X0X1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRGKIFDVVFGLTSQPTARRFTGNLLLAFLPAVVLGVLFADLIHEYLFNPITVAAALV
VGGVIMLWAERREHRVEVDHVDDMRWSHALKIGFIQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDLPVFAIGFVTSFIFAMIAVRGLLKF
IANHSYAVFAWYRIAFGLLILATWQFGWVDWATAHG
>A0A0C2VE07|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIYDALILGTLEGLTEFLPISSTGHLILASKLLGLEQTDAHKAFEVSIQLGSILAVLFL
FAQKLLVDKTLWIKVGLAFLPTAIFGFLFYKTIKALFGDETVVIMLIIGGIVFLVVEYFR
RDSDDSKAKGIEDLSYKESLFIGLFQSFSMVPGTSRSGMTMLGGIFAGLKRRSAAEFSFL
LAIPTMVIATTYDLYKNRATMVVDDYGLVAIGFVTAFIVALITVKWMMNFLTKHTFIGFG
IYRIVVGLAFWYYMI
>G5DDT2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTXM-15|antibiotic inactivation|1
TADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSES
EPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPA
SVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAHTLRNLTLGKALGDSQRAQ
LVTWMKGNTTGAASIQAGLPASWVVGDKTGSGG
>C7F8X1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTXM-15|antibiotic inactivation|1
PCGSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAA
LQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAM
AQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTG
>N9V965|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDTYTLLVAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQLGSILAV
VAVFWRRLFGLIGIHFGQKPPQDHATLSLVHIILGMLPAVVIGLMIHSWIKANLFGPVTV
MYALVAGGILLIIAEKARPAVRAETLDDISYKQAFGIGCFQCLALWPGFSRSGATISGGM
LMGISRQAAAEFSFILAVPMMVAASGLDLYKSRDFLSLADLPMFAVGFVTAFVVAMFAIK
TFLALIRRLDFIPFALYRFVVAFAVYLVFVA
>F3VEP5|FEATURES|UNIPROT_deepARG|beta_lactam|SD15574_5202|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPQLLQYAHHGYIKQGQPADLVAMSRLFQKKSWV
>A0A0A6W3I2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGTGTGRLTLIHILLGMIPAVVIGLVLHDQIKTLFNPIN
VMYALVVGGLLLLAAEFLKPKQPKSVGVDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATGLDLYKSLGFLSMADFPMFAVGFITAFIVAMIA
IKVFLELIKRISFVSFAVYRFIVAAAVYMLFT
>W9T9U0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWIAVQALILGVVEGLTEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVI
WEYRRKIIDVVVGLPRQRQAQKFTANLLVAFMPAVVLGVAFADTIHEYLFNPITVATALV
IGGVVMLWAEKRDHTIRAETVDDMNWTLALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDFAVFAIGFVTSFVFAMLAVRALLKF
IGNHSYAAFAWYRIAFGLLILGTWQLGMIDWSTAVG
>A0A0Q4LMG2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWITYVVLGIIEGLTEFLPVSSTGHLILAGELFGYTDESSIVFKIAIQLGAILAVLVAY
RARFTGVALGLTRMDRQAIAFTRNILIGFLPAMVAGALFYDAIRAVMQKPVIVAVALIVG
GVLILLIERMVKRVRIHAVEDMSVGNAVSVGAMQCIAMLPGVSRSGATIMGALLLGVERR
TAAEFSFFLAVPTMIGATVYSLYKDRALLTLDDLTGIAIGFGAAFVVALLVVKGFVRIVG
RFGFAPFAWYRIVAGSMALIWLLAR
>ZP_01811734|FEATURES|ARDB_deepARG|quinolone|QnrS|antibiotic target protection|1
MDTNHSTYHHHNFAQQDLSDMTFTACTFIRCDFRRCNLRDTTFINCKFIEQGDIEGCHFG
IADLRDASFQNCQLAMANFSNANCYGIELRECDLKGANFTRPNFANQVSNRMYFCSAYIT
GCNLSYANFEQACLEKCELFENRWIGTYLAGASLKESDLSRGVFSEDVWGQFSMQGANLC
HAELEGLDPRKVDTSGIKIVAWQQEQLLETMGIVVMPD
>N8P498|FEATURES|UNIPROT_deepARG|beta_lactam|F994_00202|antibiotic inactivation|1
MLCVTKKGFRLSLFTLAIGLSTYSNAYDVKKDKDNIETTINQSFKPLMEKYGVLGMAVGV
IYNGGNHEQYYGIQSYIDDKAVDSQTIFELGSVSKIFTATAGAYAKSQGKLSFQDHPSKY
WPALQKSEINKVNLLKLVTYTSGNLPLQFPDSVKTNEQVLEYFQNWHIKNPPGQYRQYSN
PSIGLFGEITARSMKVPFISLLEQVIFPKFNLKHTYVNVPEEQKEHYAFGYDQKNNPIRV
SPGALDAQAYGVKSTLPDMLKFVSANLNVEKSNSDLKKAILETHKGYFKLGNMTQALGWE
TFSYPTTLEILQESNSEKIVMQSNYVEKNTIQTKSKVFHKTGSTNGFGTYVVFIPEEKFG
LVMLMNKKIPNEERIKAAYEVFNRLKSK
>YP_002850162|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQNSSIAIVFILGLLAMLMPLSIDMYLPALPVISEQFGVPAGSAQMTLSTYILGFAV
GQLLYGPMADSIGRKPVILGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLLAPIVGGWVLVWLSWHYIFWILAMAAVLASVM
IFTLIKETLPVERRQPFRLRTTIGNFASLFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVSPQHFGYYFALNIVFLFVMTIINSRFVRRVGALNMFRTGLWIQFVMAGWMVFSA
LFGLGFWALVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATCSILFYLYASRAQKR
>ZP_02696486|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDISDFRRALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQPGQAP
>A0A0X6ZY42|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLVSIALALPTSAKARRFVLAVALAFLPAAIIGALAHDFIKTVLFETPMLICVVLI
IGGVILLAVDRMPLKPKYTDIMDYPPSLAFKIGLFQCLAMIPGTSRSGATIVGSLLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDGALIAVGFIAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIAIGSLGLIALLVLG
>J8FCR9|FEATURES|UNIPROT_deepARG|beta_lactam|III_02866|antibiotic inactivation|1
MIVSKKFFHIAHYKKMLPVVLLSCATLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIADATKI
VLDYFKSNE
>YP_002226896|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFILCALF
NAWLLPAWKLSTVRTPVREGMRRVMSDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
SPAAVKWMYAIEACLSLTLLYPIALWSEKRFRLEHRLMAGLLVMSLSMLPIGMVGNLQQL
FTLICAFYIGSVIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDMG
KALAQPELPWMMLGIIGFITFLALGWQFSHKRTPRRMLEPGA
>A0A147FV56|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLEEKPIRKVSVVIPVYNEEQSLPELVRRTDAACRTLGLDYEILLVDDGSADRSAQMIAD
AADMPGSHVVGVLLNRNYGQHSAIMAGFSHVSGDVIITLDADLQNPPEEIPNLVKAAQQG
YDVVGTVRQNRQDSWFRRRASRTINHLIQRVTGKAMGDYGCMLRAYRRHIVDAMLNCHER
STFIPILANTFARRTIELPVTHAEREFGDSKYSFMKLINLMYDLVTCLTTTPLRLLSIVG
SLIALAGFAFSLILIVLRLFLGASWAGDGVFMLFAVLFIFVGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVIHPQQDAPSVQEIKQ
>A0A031FNN6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKTVVFAYHDIGCAGIEALLNSGYDIAAVFTHADDPKENTFYASVAQLCANKGIPVHA
PEDANHPLWIERIAKLDPDYIFSFYYRNLLSEPLLALAKKGAYNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIVAQQRVAIERSDTGLSLHAKLRTAASDLLCDILP
SMLQGNITETPQDESKATVFGRRTPADGKLVWAKPAEELFNLVRAVTRPYPGAFCAVGEH
KLIVWSADVVKGNEGQAPGRVISVDPLRIACGQDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIDRLR
SHPHFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDSSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIANAKRLLNWEPTVEMRETIGNTLDFFLREAMLEIA
DKK
>A0A150VW20|FEATURES|UNIPROT_deepARG|chloramphenicol|AWI43_09975|antibiotic inactivation|1
MDAPAPTSSPTPIDLDTWPRRQHFEHYRRLVPCTYAMTVELDVTAFAAALRRSPRKSYIA
QVWALSTVVNRHDEFRMCLTASGEPAVWPVVHPAFTVFNPERETFACVWAAHDPDFGAFH
DAAAPLLAEHGRATDFFPQGAPPANAFDVSSLPWTSFTGFNLNIGGNGWDHLAPIFTLGR
YTERDGRTLLPLAVQVHHAAADGFHSARLVNELQALVADPSWL
>A0A0N9X3M9|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-484|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATQQIAFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTGIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>A7Y2S8|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA3C|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0E1KW04|FEATURES|UNIPROT_deepARG|multidrug|rlmN|antibiotic target alteration|1
MKQTKTKYGKMKQIVSNLKLPDYRYKQLIKAIFHQRIDNFDDMHILPKALRMSLVNEFGK
NVSSVIPVFSQDSKQAQKLLIELTDGERIEAVGLKYKQGWESFCISCQCGCSFGCRFCAT
GSVGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGL
SQRRITISTIGIIPGIQRLTQKFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHAEAVVGLLKNRGSWEHLYHIDLIPYNSTDKTTFK
FQSSSAIKQFCSTLKKAGISATVRTQFGSEISAACGQLCYENEL
>B2ZTR3|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
LFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQ
DKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQL
ATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKP
FDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDALAYGVKSTLP
DMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSE
QIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVMLTNKRIPNEERIK
>D0EJY3|FEATURES|UNIPROT_deepARG|beta_lactam|pdc-12|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>Q8RIA6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVVILAIVEGITEFLPISSTGHMILVNKLIGGEYLSPTFRNSFLIIIQLGAIFSVVVYFW
KDISPFVKTKKEFVLKFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLDNVLIVAITLIAYG
VIFIGIEVVYKLKNIKPKVKRFAGLKYRTAFLIGFFQCLAMIPGTSRSGATIIGALLLGL
SRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEMEWSYLALGSAIAFVVAYIVIKWFMD
FIKKRSFASFGLYRIILGIIVIVLLY
>AAF27725.1|FEATURES|ARDB_deepARG|trimethoprim|dfrA15|antibiotic target replacement|1
MKLSLMAAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSSDENVLVFPSIDEALNHLKTITDHVIVSGGGEIYKSLIDKADTLHISTIDI
EPEGDVYFPEIPGSFRPVFSQDFVSNINYSYQIWQKG
>T1DQQ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTVLQSIILAIVEGLTEFLPVSSTGHMVLAEGLMGMESDSYTKAFTVIIQFGAMLSVLVL
YWRRFFDFRPLPGMTQPVLRMLSRFRFYGLLLLGVLPAAILGLLFEKYIDHMLGSVLVVA
LILLLGGVFMLFVDKMFASSNSSKPTPRSALIIGLYQCLAMVPGVSRSMATIVGGMQQGL
SRKAAAEFSFFLALPTMLGATLLKIYKLYKEGGQEIFMQHMDTLLIGNILAFIVALLAIK
GFVSFLTKYGFRAFGYYRIAMGSLILLLMLCGIPLNLQ
>A0A023RN19|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTESYALFVAFVLGIVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGQKPAPGHATLSLVHIILGMLPAVLIGLAIHSWIKAHLFGPETV
MYALVAGGILLIIAEKFRPAVTAETLDDISYKQAFGVGLFQCLALWPGFSRSGATISGGM
LMGISRHAAAEFSFIMAVPMMIAASGLDLYKSRDFLSMADFPMFAVGFVTAFAVAMVAIK
TFLALIRRLDFIPFAIYRFVVAFAVYLVFVA
>A0A0X8P2M6|FEATURES|UNIPROT_deepARG|beta_lactam|AL504_23915|antibiotic inactivation|1
MTVRLSSTALGAALSLSALAGAPAQAAVLCTVLADAADGRIVYQQGTQQACAARYTPAST
FKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTTR
ALGQERFQRYASAFHYGNEDVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKVVNRQLP
IKAAAYDLAENLFEVGEAGGWRMHGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVF
ARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK
>N9N962|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAIIQGFAELLPVSSSAHVILAEKLMGYDPSAPDMTFLLVMLHTGTMFAVIV
YFWKSWKDTYFSSWESFKRQAFYVVLATLITGVLGLALQALIKHVFFGGASSFEIEHLFS
NSKLMAAALAAAGILIILSSRLDRGQQGNINLRSASIIGAVQALCLPFRGFSRSGATIST
GLFLGVSRQRAEEFSFALAVVLTPAVILKELYRLVHAQGGQVVAHGQLSHVITPSLLGMC
FSFGAGLLALKWLSSWLEHGRWHLFGLYCLGFAVVVLCIH
>A0A068QMR5|FEATURES|UNIPROT_deepARG|aminoglycoside|XDD1_0504|antibiotic inactivation|1
MKNNLDIIMLIEELNESNLPVWIALREQLWPHHATAAHQADGEEIISSSQLVSFIVRDEA
GNGLGFADASVRHDYVNGCNSSPVVFLEGIFVSSSHRKCGIAKLLVDEVQSWGRKKGCKE
LASDTELDNVLSQQVHIGLGFQVTEKVVFFKKELN
>A4GVD2|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-101|antibiotic inactivation|1
MKTFAAYVITACLSSTALVSSITENTFWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIG
>ZP_04065292|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALR
>Q1HPG6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHSVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSEPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>A0A0B4VT69|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MTIEISNQLLEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKGVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>A0A0D7XAW2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MANNNILGINHLLFSVSDLSVSISFYEKVFDAKWLVKAEKTAYFDLNGIWLALNEEKDIK
RQEIHDSYTHIAFSIQQEDLPFWEKKLRDLGVNVLKGRKRHEGDKDSIYFSDPDGHKFEL
HTGSVFDRLQYYQNEKQHLSFHEGHIKALYDRNK
>A0A060KQC7|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVALLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0D1PJ36|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAMQAVILGIVEGLTEFLPISSTGHQIVVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPRQARAQRFTLNLLIAFMPPVVLGVLFADLIHEYLFNPITVAVALV
VGGVIMLWAERRQHVVRAEEVDDMRWTDALKIGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVFSGYKYRDLFQPDDFPVFAIGFVVSFIFAMIAVRGLLKF
IASHSYAVFAWYRIAFGLVILATWQFGWVDWAVAHG
>BAB35037|FEATURES|ARDB_deepARG|multidrug|EmrE|antibiotic efflux|0
MNPYIYLGGAILAEVIGTTLMKFSEGFTRLWPSVGTIICYCASFWLLAQTLAYIPTGIAY
AIWSGVGIVLISLLSWGFFGQRLDLPAVIGMMLICAGVLVINLLSRSTPH
>P22390|FEATURES|ARDB_deepARG|beta_lactam|BL2b_ula|antibiotic inactivation|1
MFKKRGRQTVLIAAVLAFFTASSPLLARTQGEPTQVQQKLAALEKQSGGRLGVALINTAD
RSQILYRGDERFAMCSTSKTMVAAAVLKQSETQHDILQQKMVIKKADLTNWNPVTEKYVD
KEMTLAELSAATLQYSDNTAMNKLLEHLGGTSNVTAFARSIGDTTFRLDRKEPELNTAIP
GDERDTTCPLAMAKSLHKLTLGDALAGAQRAQLVEWLKGNTTGGQSIRAGLPEGWVVGDK
TGAGDYGTTNDIAVIWPEDRAPLILVTYFTQPQQDAKGRKDILAAAAKIVTEGL
>A0A060KTG1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVVMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRLDVLASAAKIVTDGL
>R7JW83|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIIEWLKVILLGIVEGITEWLPISSTGHMILVDEFIKLNVTADFKNVFEVVIQLGAILA
VVVIYFWDLWPFHGKSKAKSKSYFANPSDNKVFAGIQNFVDNYCYLDKIIMWFKIVVSCL
PAAVIGLAFNDWIEAHLMNYVIVALMLIIYGVLFIIIENYNKTRTLSATKIKEITWKNAL
YIGVFQLLSIVPGTSRSGATIIGGILLGCSRELASEYTFFLAVPVMFGASLLKLVKHGFA
FTGVEVAIMIVGMLVAFAVSILAIKFLMQYIKKHDFKAFGWYRIVLGVIVLLYFVIKTVI
LKA
>L9LYT7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAIIQGFAELLPVSSSAHVILAEKLMGYDPSAPDMTFLLVMLHTGTMFAVIV
YFWKSWKKTYFSSWESFKKQAFYIILATLITGVLGLALQSIIKHVFFGGASSFEIEHLFS
NSKLMAAALISAGVLIILSSRLDRGQSGEISLRSASIIGAVQALCLPFRGFSRSGATIST
GLFLGVSRQKTEEFSFALAVVLTPAVILKELYRLVHAQGLQTVAHGQVFHSIVPSLLGMC
FSFGAGLLALKWLSSWLEHGRWHLFGLYCIGFAIVVLCVN
>A0A0Q7VNE5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQSQTIIEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFKSTGKAFEVLIQLGAILAILS
VYAGRFWTFLKRPDRFRLIGETIIGVLASLVWMGGCAFELAASAVRRRKPNLFLPPELPN
DPAVKMMVGLAIGFLPAAIIGVLAHDFIKTVLFETPKLICIMLILGGIVLLWIDRLDLKP
KYASVAEFPLSLYLKIGLFQCLAMIPGTSRSGATIVGGLLMGADKRAAAEFSFFLAIPTM
LGAFTLDLLKNWSVLSSADFPIIATGFVAALVMAVIVVRSLLGYVSRHGYALFGWWRLIV
GGLGLTALLIWG
>A0A0S1RUI0|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQ
PTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISS
LRISPLEQLAFLRRLVNRQLPVKAAAYELADNLFEVG
>AAS92348|FEATURES|ARDB_deepARG|beta_lactam|OXA-256|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPIAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>A0A0J6CX53|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMEMIIAIILGIVEGLTEFLPVSSTGHLILTGYWLGFTGERAKTFEIVIQLGSILAVVVM
YRKRFVDLLSPNKQQGGLSLAHLILGMIPAVVAGFLLHGLIKTYLFSPYTVVIGLVIGGV
LMIVADLKQRPPTSSSLDDLTLRQAFSIGLFQCLALWPGFSRSGATISGGVLLGTNHKTA
AEFSFILAVPMMVAASGYDLLKSYQYLTVSDIPLFATGFLSAFFVALLAIVTFIKFIERV
RLIPFAIYRFVLALFVWMVLF
>ACI82977|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMENID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMVSYIKRARSMRDIRNEKGTAKPDPAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVEPMGPAG
FWIGFIIGLTSAAIMMMLRMRYLQRLPSAIILQRASR
>ABS72059|FEATURES|ARDB_deepARG|glycopeptide|VanXD|antibiotic target alteration|1
MKKNFAFLDEMIPGIRWDAKYATWDNFTGKPVDGYMVNRVMGTKELGVALRKAQKMAEKL
GYGLLLWDGYRPQCAVDCFLNWASQPEDNLTKKRYYPNIKRNEMVAKGYVASQSSHSRGS
TVDLTIFHLNSGMLVPMGGDFDFMDERSHHAASGLSEEESKNRQCLRYIMESSGFEAYRY
EWWHYVLADEPYPDTYFDFCIA
>S0FQA4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLLFVLKSIVLGIVEGITEFLPISSTGHLRIFESLMHFESTTPHYVDMYTYVIQLGAI
LAVVLLYWKKIKDTIINFFPSKVGYEKSGFKFWFMIVIACVPGAILGILFNDLADKYLSG
SIIVAVVLFLGAIWMIYAENKFRNNNLTKQKLSVTPKQALIIGLFQCLAIIPGMSRSAST
IIGGWVSGLSTVVAAEFSFFLAIPVMFGMSFLKIFKLGGFNLLSGTEITALIVGFIVSFI
VAVAVISKFISYLKRKPMKGFAYYRMIFAVIVIVAGLLKIF
>A0A073JWK9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRITIQEYVVNEIESGPYGITAGKDGALWFTEQKGNRIGRINANGEMNSFPVPTANAGVM
SIISDQTGDLWFTEYNTSKIGKMSMNGLFEEYALPSTNAAPFGITEGPDGAMWFTEMNNG
RIGRITKSGEITEFELPNSKSFPSFITLGSDGALWFTQNQNNTIGRITTKGEVTEYPIPT
PNSGPVGIASGPDGAIWFVQIMGNKIGRITFEGEVKEFVIPTPNARPHAIIPGKNGDLWF
TEWAGNQISRITVEGVITEYTIPTNNAEPHGITFCPNGDIWFAEECNQIGRLTIIT
>A0A0Q7XMG7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIVGALVLGLIEGLTEFIPVSSTAHVLLAGHFMGFRSPGNTFAVLIQLGAILAILL
VYFQKLLQIALDLPHSTQARRFVLTVLLAFLPAAIIGALAHDFIKSVLFETPMLICVMLI
VGGFILLAVDKMSLRPRYTDITQYPAGLAFKIGLFQCLAMIPGTSRSGATIVGALLMGTD
KRSAAEFSFFLAMPTMLGAFVLDLYKNRNALSFDDAGIIAIGFVAAFVTALLVVRSLLDF
VSSRGFAPFAYWRILVGTAGLIGLLVFG
>A0A150DD31|FEATURES|UNIPROT_deepARG|beta_lactam|AT261_04240|antibiotic inactivation|1
MYVLNKFFTYKKIIPVVLLSCVTLIGCSNSNTPSEPPKQTKQIKQIKQENTGHDSFVKLE
KEYNAKLGIYALDTGTNQTVAYHPNDRFAFASTSKSLAAGALLRQNSIEALDERITYTRE
DLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGDTVT
KSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTGKRELLVDWMKRNTTGDKL
IRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLIADA
TKVVLDTLKVTNKN
>ZP_04577926|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDFILALKALIMGIVEGCTEFLPISSTGHLILAGSLLDFTGDNVKVFSIAIQAGAMLSVV
WVYRQKIASVIRGMFTNAKDRKFVVNLIVAFLPAAILGVLFSRKIQDFLFYPVPVAAAFI
AGGLLIIFVERRNEKNPVARVESVDDMTLMDAFKVGCAQAFALIPGTSRSGATIIGGMLF
GLSRKAATEFSFFLAMPTLFGAAVYSVFKERALLSAADVPLFTIGTISAFVSAFLCVRWL
LRYISSHNFIPFAWYRIAFGIFVLVSAHYGWVVWAE
>G9JVK3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-131|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GGYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>A0A088TIW5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIVSIVSGLPSRPDARRFTLNVVIATIPAIALGLLLEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVVSVDALTPLDALKVGIAQCFALIPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>R5S4Y0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIIKSIIFGIVEGITEWLPISSTGHMILLDEFIKMDVSDKFREMYLVVIQLGAIMAVV
LLFWWRIWPFCKEENFKKHYVKHKVAGFLDNFKFIKQDIFIMWFKIVAACVPAVIVELAF
GDNLEKWFYNYKTVAIMLILVGVVFIIVEEKNKKNIPSVNKIGQITYTTAFWIGMFQLVA
AVFPGTSRSGATIIGGLILGLSRTVAAEFTFYLAIPVMFGASLIKIIKFGFGFSALEAGI
LLTGMITAFIVSLFVIKFLMGYIKKHDFKVFGWYRIILGVLVLGYFALAG
>A0A0Q9UKZ9|FEATURES|UNIPROT_deepARG|beta_lactam|ASG97_25155|antibiotic inactivation|1
MNKRWFYQILAPIGLVLMVAGCSDEEKQVVQQSETEQTGGTNQTSENNTAKEATIKKFEQ
LEKEYDAKLGVYAIDTGTKKTVEFHENERFAFTSTHKALAVGALLHQESIEDLNQRITYT
SEDLVNYNPITEKHVDTGMTLKELADASLRYSDNTAGNLILEQLGGPAGFKKELEGIGDN
VTNPERIEPDLNVVNPGETHDTSTPIALATSLQAFTLGDALPTEKRELLIDWMKRNTTGD
ALIRAGVPKGWVVADKTGAGSYGTRNDIAIIWPSKGDPIVLAVLSSRDEKEADYNDELIA
EATEEVIKALKVKGK
>YP_001176309|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLVDNMLVVLGFFVVFPLISIRFVDQMGWAALMVGIALGLRQFVQQ
GLGVFGGAIADRFGAKPMIVTGMLLRAAGFATMGIAHDPWLLWFSCFLSGLGGTLFDPPR
TALVVKLIRPRQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAALFILCAAF
NAWLLPAWKLSTVKAPVREGLGRVMADKRFVTYVLTLTGYYMLAVQVMLMLPIMVNDIAG
SPAAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMTLSMMPIGLVSSVQQL
FVLICTFYIGSIIAEPARETLGAGLADPRARGSYMGFSRLGLALGGALGYAGGGWLFDSG
KAMNQSELPWVMLGVVGFITLIALWWQFSPKRSASGMLEPGA
>B4EPS2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLLVAACATATAGRAAAVTQDDLRDTVTRQIAPLMKQYAIPGMAIGIVAD
GKPYVFDYGVMSKQTGKPVTGDTLFEIGSVSKTLTATLASDAQEGGELSLADPAGKYLPE
LQGKPFGVVTLLQLGTHTPGGTPLQVPDSIRDDAGLIRYLDAWRPAYAPGTHRKYSNVAI
GMLGWLTAKAMHQDFATLMEQRLFPAIGMTHTYINVPAARMADYAQGYTKDGKPVRMTEG
MLWQPAYGVRTTAADLLRFVQANMGMIHTAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLAGNAPKMLFDAVPASAIQPPLAPNPATWINKTGSTGGFSTYVAFVPAKRIG
IVMLANGNVPIEERVKAAYRILGSLGDAR
>A0A0W0URX5|FEATURES|UNIPROT_deepARG|aminoglycoside|ant1_2|antibiotic inactivation|1
MNYPKEKIEPNPDAQQINECINLVTKVLGDNLLGVYLYGSALVGGLQKYSDIDLFVVTHH
ATTLSEKNELTKHLLHISGLYMKSAKRPIEMTVVEKGAVNPWHYPPRFDFQYGEWLRASF
EMGEIEPPNLEMPDLALIITQVLLKSQTLFGEQPEKILAPVPYADFIKAMLQDLDRLAAD
IKDDTRNVLLTLARIWCTLETNTICSKPDAADWVIERLPQIHQGVMYRAKSICIGDENEY
WEDIKASLKPCADWMLQEISTIKLSINPNKIAYKVSE
>A0A126PTU0|FEATURES|UNIPROT_deepARG|beta_lactam|AW879_21740|antibiotic inactivation|1
MMKKFLCCALLLSTSCSVLAAPMSEKQLTDVVERHVTPLMKAQGIPGMAVAVIYQGQPHY
FTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYHNWQPQWKPGTTRLYANSSIGLFGA
LAVKPSGMSYEQAMTTRVFKPLRLDHTWINVPKAEETHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMANMAPDALQDTTLKQGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPAREVSPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>A0A127SJD2|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MMQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTIIN
RHEEFRTALDENGQVGVFSEMLPCYTIFHKETETFSSIWTEFTADYTEFLQNYQKDIDAF
GERTGMSAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYYIP
LSIQVHHAVCDGYHVCRFLDELQELLNK
>AB0890|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MQMKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDANGINSNETSASLQLTQTLFDMSKWRGLTLQEKAAGIQDV
TYQTDQQTLILNTANAYFKVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQN
ARAQYDTVLANEVTARNNLDNAVEELRQVTGNYYPELASLNVEHFKTDKPKAVNALLKEA
ENRNLSLLQARLSQDLAREQIRQAQDGHLPTLNLTASTGISDTSYSGSKTNSAQYDDSNM
GQNKIGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASIS
SINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARYTYLINQLN
IKYALGTLNEQDLLALNSTLGKPIPTSPESVAPETPEQDAAADGYNAHSAAPAVQPTAAR
ANSNNGNPFRH
>CAJ31068|FEATURES|ARDB_deepARG|multidrug|fexA|antibiotic efflux|1
MKKDSKSKEMIQSEKRGSTRLLMMVLSLSVLVGAITADLVNPVLPLISKDLEASKSQVSW
IVSGIALVLAIGVPIYGRISDFFELRKLYIFAIMILASGSLLCAIAPNLPLLVLGRMVQG
AGMSAIPVLSVIAISKVFPQGKRGGALGIIAGSIGVGTAAGPIFGGVVGQYLGWNALFWF
TFLLAIMIVIGAYYALPTIKPAESVGSNKNFDFIGGLFLGLTVGLLLFGITQGETSGFSS
FSSLTSLIGSVVALVGFIWRIVTAENPFVPPVLFNNKDYVNTVIIAFLSMFAYFAVLVFV
PLLVVEVNGLSSGQAGMILLPGGVAVAILSPFVGRLSDRFGDKRLIITGMTLMGLSTLFL
STYASGASPLLVSVGVLGVGIAFAFTNSPANNAAVSALDADKVGVGMGIFQGALYLGAGT
GAGMIGALLSARRDATEPINPLYILDAMSYSDAFLAATGAILIALIAGLGLKKRG
>C4NV37|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-1|antibiotic inactivation|1
MQQCLFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABG77519|FEATURES|ARDB_deepARG|aminoglycoside|AAC(6')-Ib9|antibiotic inactivation|1
MLWSSNDVTQQGSRPKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWW
GGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDP
GVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGF
ERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>A0A0U1YUG9|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATKQISFLRKLYHNKLHASERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>YP_002116141|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNETSASLQLTQTLFDMSKWRGLTLQEKAAGIQDVTY
QTDQQTLILNTANAYFKVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEELRQVTGNYYPELASLNVEHFKTDKPKAVNALLKEAEN
RNLSLLQARLSQDLAREQIRQAQDGHLPTLNLTASTGISDTSYSGSKTNSAQYDDSNMGQ
NKIGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASISSI
NAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARYTYLINQLNIK
YALGTLNEQDLLALNSTLGKPIPTSPESVAPETPDQDAAADGYNAHSAAPAVQPTAARAN
SNNGNPFRH
>A0A0G3GME7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFSALILGVVEGLTEFLPISSTGHQIVVADLLVFGGERSMAFNIIIQLGAILAVV
WEFRQKIFDVVLGLPTQPSARRFTANLLIAFLPAVVLGVLLADWIHHYLFNPITVAAALV
VGGLVMLWAEKRQHRVHAETVDDITWKDALKVGLAQCIAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRELFVPADFPVFAIGFVTAFIFAMIAVKALLCF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWSAAQP
>A0A0Q6ZUE0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEDQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILS
VYFTKLLQIALSLPTSAASRRFVGAVLVGFLPAAVIGALAHDFIKTVLFETPMLICVVLI
LGGFVLLWIDRKPLTPRYHDVTEYPLSLALKIGFFQCLAMIPGTSRSGATIVGALLLGAD
KRSAAEFSFFLAMPTMVGAFALDLYKNRDALSFNDGALIAVGFIAAFVSAIFVVRSLLDF
VSRRGYAPFAYWRIAVGAIGLVALILVG
>A0A127SMA0|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNCKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDPFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>A0A097SRR5|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
ALIPFFAAFCLPVFAPPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIV
>CAA90687|FEATURES|ARDB_deepARG|trimethoprim|dfrA14|antibiotic target replacement|1
MKVSLIAAKRKNGVIGCGPDIPWSAKGEQLLFKALTYNQCLLVGRKTFESMGALPNRKYA
VVTRSGWTSNDDNVVVFQSIEEAMDRLAEFTGHVIVSGGGEIYRETLPMASTLHLSTIDI
EPEGDVFFPSIPNTFEVVFEQHFTSNINYCYQIWKKG
>A0A0B7DCH5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC_2|antibiotic inactivation|1
MSSINLTKAFSCSAFGLLFGAATCLGAPQTDEQLQALVKAAVTPVMQQQNIAGLAVALTI
NGQPHYFNYGVAAKDTGQKVSENTLFEVGSVSKTFTATLAGYAQATGKLDLSTKASTLWP
ELKGSAFDNISVLQLGTYSAGGLPLQFPADADSTDKMLGYYQQWKPAYSPGSHRLYSNPS
LGLFGYLTAKSLDQPFAQAMTETLLPKLGLKHTFIEVPASEAKLYAQGYDKNDKPVRVSP
GALDAEAYGIKTSAADLLRYVEANLKPANLEQPLQKAIAATHTGHYTVGDMTQGLGWERY
HYPISLEKLQAGNSTPMAMEPHKVKWLTPPQPEPANVLYNKTGATGGFGAYVAFVPSKDI
GIVILANKNYPNAERVKIAHEIFSALTN
>A0A0Q8ARS2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MDRLKTLVVCLGLLTAGQCVAQDPIESVVNAAVNPLMQTQGIAGMAVAVTANGKQHFFNY
GVASKETAKPVTENTLFEIGSVSKTYTATLAGYAQALGKLSFSDKASQVLPALHGSALDN
ISMLQLGTYSAGGLPLQFPAQFDSADKMLGYYQQWTPAYAPGSHRLYSNPSIGLFGYLAA
HSMGQPFDQLMENTLLPKLGLKHTFLKVPQEQMGLYAQGYNKQGEPVRVTPGALDSEAYG
VKTSAADLLRFVEANMHPATLERPLQQAIALTHTGYYSVGDMTQGLGWELYHYPVTLDRL
LAGNSTPMAMQAHEAQWLSPPQSPTQDLLINKTGSTGGFGAYVAFVPAKDIGIVILANKN
YPIAERVKIAHQVLSALSR
>G4WFL9|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQEGTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>A0A0J6HW95|FEATURES|UNIPROT_deepARG|glycopeptide|arnD|antibiotic efflux|0
MQAGLRIDVDTYRGTREGVPQLLELLDEAQIKATFFFSVGPDNMGRHLWRLIKPQFFWKM
MRSKAASLYGWDILLAGTAWPGKPIGKDLGHLMRQTLAAGHEVGLHAWDHHGWQANTARW
SETQLIEQIRRGVETLSDITGQAVECSAAAGWRADERVVQAKETFGFRYNSDCRGHSLFR
PRLADGRLGAPQIPVDLPTFDEVVGPHLNAADFNSFILDRFSPQKLNAYTIHAEVEGILM
ANDFRQLLAQARARDIHFHPLRDLLPEDIDSLPAGQLSRGVLEGREGWLGVQKP
>A0A0I9QPS2|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPGLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>A0A0P9L684|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVDIEALHETSINSDQPLLRLQQVSRSFMAGDREFQVLKHIDLAIHTGELVAIIGAS
GSGKSTLMNILGCLDHASAGSYQVNGQETRELDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNMEIPAIYAGTAQTTRHERAQALLTRLGLGGHLQHRPSQMSGGQQQRVSIARALMNGG
QVILADEPTGALDTASGKEVMRTLLELHAAGHTVILVTHDPKVAANAERIIEVSDGEIIS
DRRTAQTTQPAPEAQPATPPGPAPRRLLASLGLFREAFNMAWIALISHRMRTLLTMLGII
IGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGANFGDSRAKSIETLLPSDVAALN
QLYYIDSATPVVGRSMLVRYRNVDVDAQLNGVSSRYFQVRNIQLAAGITFSDQDARRQAQ
VVVLDHNTAQRLFGPGVNPLGQVILVGKLPSTVIGVTSDHKNLFIAGNTLNLWMPYETAA
GRVLGQRHLDSISVRVKDGMPSKAVEEQIKALMLQRHGTKDFFTNNLDSVMQTVQKTSRS
LTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVC
LMGGVIGIGLSYAIGYLFTLFVQQWEMVFSLASVVTAFACSTLIGVLFGFVPARNAARLD
PIEALARD
>A0A0F0ZWR2|FEATURES|UNIPROT_deepARG|chloramphenicol|SS37_24770|antibiotic inactivation|1
MKNTVPEYTPVDLSRWARKEHFEVFQSFAECTINQTVLIDITVLRKHIKTVGWKFYPTII
FLLSKIMNRHPEFRMAMKDNELVVWNEIHPSYTIFHPETETFSSLWSHYDGNMHHFQDTY
AEDTARYGNNLSYWPKEESRENVFFVSSIPWVTFTNFNMNIAHMKNFFSPMFTFGKYYEQ
DGKVLLPMAVQVHHSVCDGFHVARMFNELQEMCDGLPELSEEHNA
>A0A0M1NE95|FEATURES|UNIPROT_deepARG|chloramphenicol|AM232_20000|antibiotic inactivation|1
MKFNIIDRENWVRKEYFEHYLQQQTTFSITNEMNITVLMENLKKKNYKLYPAFIFMVTKI
VNSHREFRTSFNQEGNLGYWSEILPSYTIFDKKTYTFSSIWSPNVSRFSEFHSQYEEDVE
EYNGTGSLFPKTPIPDNHIPISMIPWSSFTAFNLNINNGGDFLLPIITGGKYSQIKNEWF
LPVSLQIHHAVCDGYHASVFMNDLQRFADESADWL
>A0A0E0W066|FEATURES|UNIPROT_deepARG|chloramphenicol|H9401_2289|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMR
CYASVHGLLTKENIPPNIFPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEENKIM
LPVSLQVHHSVCDGYHVSRFIEDLQELSNSCNEWLK
>A0A0P9BCB2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MDRLKTIAACVALLASGQCVAQDQIETVVNDAVEPVMQAQGIQGMAVAVTVNGRAHYFNY
GVASKETGKPVTRDTLFEIGSVSKTFTATLAAYAQATGKLSLSDKASQILPALRGSAFDH
ISVLQLGTYSAGGLPLQFPAESDSADKMLGYYKQWKPLYAPGSHRLYSNPSLGLFGYLTA
QSMGQPFDDLMEKTLLPKLGLKHTYVKVPQDQMSLYAQGYNKDGKPVRVSPGALDSEAYG
VKTSAADLLAYVDANMNPAPLEKPLQQAIALTHSGYYTVGNMTQGLGWEMYHYPITLDYL
LDGNSTPMAMEAHTVQWLNPPQTEPENVLINKTGSTGGFGAYVAFVPSEDIGIVILANKN
YPNAERVKIAHRILSALAQ
>A0A127I1Y9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACKQLAYEYEIILVDDGSRDNSAQLLEDA
AAEDGSNVVAVILNRNYGQHAAIMAGFEQCRGEVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGMLFALALIVMRLAFGADWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGLVSSHTSTSADQV
>A0A0K4RJR8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQQIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQQTLFELGSVSKTFTGVLGGDAIAREEITLSDPVTKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAAAWQILNALQ
>A0A0M2TC24|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWLLVKAFVLGIVEGLTEFLPVSSTGHLIVVGDLIGFYNEGKVFEIAIQLGAILAVVF
EYRQRFIHVVTGVTHDKKAQNFVLNLFVAFLPAAIIGLLFIKYIKLYLFNPITVATMLVL
GGLVILYAERRVHQVKIHDVDDITWKDALKVGCAQIVSMIPGTSRSGATIIGGLFFGFDR
KVAAEFSFFLAVPTMFAATFYDLFKHRDVLAFDQAPMFIVGFVTAFFSALLAVRTFVRFV
SNHSYEIFAWYRIAFGLVILATWYFGWVSWS
>A0A0F3LWL8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLEEKIIRKVSVVIPVYNEEESLPELVRRTDAACAVLNLDYEILLVDDGSSDRSVEMIAD
AADMPGSHVVGVLLNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPNLVQAAQQG
YDVVGTVRQNRQDSWFRRRASRTINQLIQRVTGKAMGDYGCMLRAYRRHIVDAMLNCHER
STFIPILANTFARRTIELPVAHAEREFGDSKYSFMKLINLMYDLVTCLTTTPLRLLSIVG
SLIALAGFAFSLVLIVLRLFLGADWAGDGVFMLFAVLFIFVGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVINSQKDVSSVQEIEQ
>K8NID1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLADLLKALFLGIVEGVTEFLPVSSTGHLLLAERIFNLDQDNFWKTFAVLIQLGAILAIL
VIYFQRLWHVATHMFTDPAARRFVIGVLVAFLPAVILGLIFGHFIKSVLFNPWVVCFSLI
AGGAVLLWVDQQDLNPRHHNAMTFPLPMYLGIGIAQCAAMIPGVSRSGASIVAAMLFGAD
KRSAAEFSFFLAIPTMIGAFVYDFYKGRGDMTMDHSLIIVVGFVVSFITAIIVVRSFLDF
VTRNGFTFFAWWRVIVGTLGLIALALGA
>ZP_04589788|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
VGGVIMLWAERRVHTVRTETVDDMTWTDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFVFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>Q84EZ8|FEATURES|UNIPROT_deepARG|beta_lactam|AmpC|antibiotic inactivation|1
MMKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYY
FTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQ
WQEISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGA
LAVKPSGMGFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQLDAEA
YGVKSSIEDMAHWVLANMNRETVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLNWPVSP
EVLINGSDNKVAPAATPVTAVKPPAPPVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKSYPNTERVKAAYHILQALQ
>A0A0A7EAJ4|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA7e|antibiotic inactivation|1
MSEKVPAEISVQLSQALNVIGRHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAPLNE
AVRQALLVDLLEVSASPGQNKALRALEVTIVVRSDIVPWRYPARRELQFGEWQRKDILAG
IFEPATIDADLAILLTKAKQHSIVLAGSAAKDLFISVPESDLFKALADTLKLWNSPPDWA
GDERNVVLTLSRIWYTAATGKIAPKDVAATWAMARLPAQHQPILLNAKRAYLGQEEDYLP
TRADQVAALIKFVKYEAVKLLGADQ
>A0A0W0M2I5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQWNQKRSLQAVLLTGLTLTSSLALAQEQNPKLDDFVRETAGKVMHENDIAGLSIAITHN
GKQQFYTYGTASKDAPQAITPDTLFELGSISKTFTATLATWAQSNGQLSLTERIDTYVPQ
LRDTRLGKVPVFHLGTHTAGGFPLQFPDKVQTTGQMMAYFKAWQPDYLPGTYRSYANPSV
GLLGLVAARSMKVPFDAAMQQRLFPALGLKNTFLTVPEEQMSRYAQGYNKLDEPVRVNPG
VLASEAYGVKSSSRDVLAFIEANMGRGQYDAPLQQALKDTRTGYFKVGGMTQDLIWEQYP
MPVKLDTLLEGNASNMVLQTQKAEPITPPLAAQSNTWVNKTGSTNGFGGYVAFIPEQQLG
IVILANRNYPNEERVKLAYRILNQVQCFDCKP
>ABE02098|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPVWIVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGDQVQSLEPNFIREMKEGIVVMRQNKGLFALLLLGTLYTFVYMPINA
LYPLISMEYFNGTPMHISITEIAFASGMLAGGLILGRLGSYEKRVPLITGSFFMMGASLA
IAGLLPPSGFIIFVVCCAIMGLSVPFYSGVQTALFQQKIKPEYLGRVFSFTGSIMSLAMP
LGLILSGFFADRIGINHWFLISGILIIGIAIVCPMMTEVRKLDLKQNS
>A0A0H3FRQ3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKTSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYY
FSWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQ
WQGITLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGA
LAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQLDAEA
YGVKSSIEDMAHWVLANMNSEAVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLNWPVPA
EVLINGSDNKVALAATPVTAVNPPAPPVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKSYPNPERVKAAYHILEALQ
>A0A085I085|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEYPLVKKVSVVIPVYNEQDSLPELIRRTDAACATLNRDYEILLVDDGSSDDSARMLVE
AAEATESHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVEKADEG
YDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVVG
SVIAVLGFAFSILLVVLRLALGPEWAGDGVFMLFAILFMFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQENLESEEENR
>A5Z1N5|FEATURES|UNIPROT_deepARG|beta_lactam|adc|antibiotic inactivation|1
LKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKY
EMYYGLQSVQDKKAVNSITIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNT
PIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFG
KVVALSMNKPFXQXLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDA
PAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPAT
LQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNK
RIPNEERIKAAYVVLNAI
>A0A0F4TIH9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIESLLNSGFDIAAVFTHPDDPKENAFYGSVAQLCARKGIPVHA
PEDANHPLWIERISKLNPDYLFSFYYRNLLSEPLLATASKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQKKVAIERSDTALSLHGKLRLAATDLLRDTLP
ALLQGKVNETPQDESKATVFGRRTPADGKLVWSKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWNAEVAQGNEGQAPGRVISVDPLRIACGEDSLVITAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQNFDEDTSNLIVGPINKQRWIYSISKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKR
>K4ZDB2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLNWWDMFVGFILGVVEGLTEFAPVSSTGHMILVDDFMLHSKEIFSPQMANMFKVVIQLG
SILAVVVVFWDRFFQLLGLKRAPVDPELGRAGHSRLKLTQVLVGLIPAAVLGLLFEKYID
QYLFSIQTVLIGLVLGAVLMVAADWFRPAKPTAKTVDQVTYMQALGIGLFQCLGLWPGFS
RSGSTISGGVLLGMSHRAAADFTFIMAVPVMAGASGLSLLKHWKDFSMDALPFFIVGFIS
AFLFALLSIRFFLKLINRIKLVPFAIYRVVLAAVIYFVFL
>B2V5I7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTTLEAVILGIVEGLTEFLPISSTGHLILVSNLLGIQQTEQHKAFEVSIQLGSILAVVFL
YFKKFLDTNLMKRILIAFIPTGILGFVLYKIIKSLFNPYIVVFMLVFGGLLLILIELYHK
NKSYDINSIYEVPYQKAFLIGVFQSLAMVPGTSRSGATIVGGLLLGLDRKTAAEFSFMLA
VPTMFMATFYDVYKNRSNFNLSDWENLIVGFVVAFISALFAIKWLLKFISNHSFIPFGIY
RIILGILYYLWY
>A6TIY6|FEATURES|UNIPROT_deepARG|aminoglycoside|str|antibiotic inactivation|1
MKEPPLNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRL
IWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSL
SVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQER
TDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAE
RAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG
>A0A0E3XAI9|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-11|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTNQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>A0A0M1Y2K5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANIIKAVILGIIEGITEWLPISSTGHLILADEFIKLDASSQFMSMFNVVIQLGAILA
VVVLYFHKLNPFSPSKSTVEKKDTWTLWFKVIVACIPAIIIGLPLDDWLEANFHKFLPVA
IVLIVYGIAFIIVEKRNKNKTPRWTSLNDFTYQAALLVGLFQVLALVPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASGLKIVKYLAEGNSFKMEETVILLVGTFVSFVVSV
LAIKFLLSYLKKNDFTAFGWYRIILGIILIGYWFIAM
>N9X6R5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIIETLKVIVLGIVEGFTEWLPISSTGHMILVDEIIHLKQPEDFKNMFMVVIQLGAILA
VVVMYFHKLNPFSPTKKPAQKRATLELWSKIILACIPAAIIGLLIDDIMEKYLMNGYVVA
ATLIIYGVLFIVIENANKSRNFEMQRVGDISYQTALYIGLFQLLSLIPGTSRSGSTILGA
MILGCSRGAAAEFSFFLGIPVMFGASFLKIVKYGLHFTGPQVFYLILGMVVAFIVSVYAI
RFLMGYIRKHDFKFFGYYRIVLGAIVLVYFGITAFIG
>Q106P7|FEATURES|UNIPROT_deepARG|beta_lactam|bla(ampC-EC15)|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAPPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A127SJC4|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLRELMQYSISQSD
NNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSSFEAVYRNWSTPSAMARLLR
TADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSDRNADGMKTADN
DAGLVILPDGRKYYIAAFVMDSYETDEDNADIIARISRMVYDAMRRQGGYW
>I4JMS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWIAVQALILGVVEGLTEFLPVSSTGHQIIVADLIGFGGDRALAFNIIIQLGAILAVV
WEYRRKILGVVVGLPKEREAQKFTLNLLIAFMPAVVLGVLFADLIHHYLFNPITVATALV
IGGIVMLWAENRDHRIEAETVDDMRWTHALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDFPVFAIGFVTSFLFAMLAVRALLKF
IGNHSYAAFAWYRIVFGILILATWQFGLIDWSTAVG
>ZP_03049119|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLDHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0M6ZHA3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDGQTIVNALILGIVEGLTEFIPVSSTGHILLLGHFLGFESTGKTFEVLIQLGAILAILS
VYFGRLWKLAVTLPSDATSRRFVFGILIAFLPAAVIGVLLHSFIKEVLFESPALICTTLL
VGGIILLWIDRLPLRPRYTNVMDYPLSLCLKIGFCQCLAMVPGVSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMAGAFAYDLYKNRNVLSADDLTLIVIGFVASFISGVFVVKGLLDF
VSRHGFAPFAWWRIFVGIAGFAGLYFLG
>YP_002045152|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGG
FIPNANALIATQVPRHKSGWALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVL
FICFLLTFFFIRENFLPVSKKEMLHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYDFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>N0B322|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHSWEAIFLGLIEGLTEYLPVSSTAHLLLTEELLGVKSTGRTFEVLIQLGAILALLTVYS
GRLWHLACALPSDARSRRFVLAVLIAFLPAAVIGAAAHSIIKNYLFESPLIICIALVLGG
IVLLFIDRIPLKPRYHDVMDIPVLNALGIGFCQCLAMIPGVSRSGSSIVGAMFFGTDKRT
AAEFSFFLAMPTMAGAFAYDLYKNWSLLTPDDVGLIALGFVAAFIAGVVVVRYALDFIAR
RGLSFFGWWRLLVGGVGLGALAVLH
>A0A0B2TV63|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDFGCVGLRALVAAGYTVEAVFTHADNPAENQFFGSVARTAAELGIPVFAPE
DVNHPLWVERIAAMSPDVIFSFYYRHLLSDAILQSAAHGAYNLHGSLLPRYRGRAPLNWA
LVNGETETGVTLHRMVARADAGNIVAQQRVAIDESDTALSLHRKLRDVADQLLKDNLPAI
AAGKANDIPQDESQATYVGRRTPEDGRIEWQKPARTLYNLVRAVTEPWPGAFSFVGTTKF
IIWQAKVRTDFAAAKPGTVLSTSPLVVACGSDALEIVTGQGDNGIYLQGAQLAQSLGLVT
GAILNNSPVVSVKRRTRVLILGVNGFIGNHLTERLLQEDNYEVFGLDISSDAIERFLGNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKTIRDC
VKYKKRIIFPSTSEVYGMCTDPVFDEDNSNLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDI
KDGIEALFRIIENKDGVCDGQIINIGNPDNEASIRQLAEQLLESFEKHPLRNQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLHWQPTIEMEKTVAETLDFFLQTVETGRFSQ
DSE
>BAH62770|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSSAETPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMMLMGMAQNIWQFLLLRALLGLLGG
FIPNANALIATQIPRHKSGWALGTLSTGAVSGALLGPLAGGFLADHWGLRTVFFMTAAVL
FICFLFTLFLIRENFVPIARKEMLSAREVFSSLQNPKLVLSLFVTSLIIQVATGSIAPIL
TLYVRDLAGNVSYIAFISGMIASVPGIAALMSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSTSQISGRIFSYNQSFRDIGNVT
GPLIGASVSANYGFRAVFLVTAGVVLFNAIYSTLSLRRPAADTSHSVN
>B1YIX1|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTIIELLKALLLGFIEGMTEFAPVSSTGHMIIVDDMWLQTTDFLGKYSANTFKIVIQLGS
ILAVIVVFWKRLFSLIGLYKIEGEHDASGTHKLKLRHVLIGLLPAAVLGLLFEDFIDENL
FSIDTVIIGLAAGAILMIAADKLGPKEPKTTSLDQISYRQAALVGLFQCISLWPGFSRSG
STISGGVFLGMNHRTAADFTFIMAVPIMFGASALSLVKNWEYINVGDLGFYVVGFIASFG
FALLSIRFFLKLINKIKLVPFAIYRLVLAAVLAVIVYM
>R5ST50|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTWEAIIIAVVEGLTEFLPVSSTGHMIITQNMLGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNHTPAPQGASSLQRFLHKFDFYWKLLVAFIPAAVLGFLFSDKIDAMLES
VVVVAVMLVIGGIFMLFCDRIFSKGSEKTEVTEKRAFFIGLFQCIAMIPGVSRSMATIVG
GMSQKLTRKDAAEFSFFLAVPTMFAATAYKVLKLFLDGGTEILVNNLSALLIGNVVAFIV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGLIIIMLLCGHSLEVL
>A0A0L6Z8Z3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLIFILKAIIIGIVEGITEFLPVSSTGHMIIVGNLIDFKAGVAPAALYTKQYIDAFTF
IIQLGAILAIVVLYWNKIISTFKNFSPRKPKSGFKFWFNIFIACIPAGVLGLTFNDWIEA
NLLNPITVTAGLLVGAFWMLFAEKKYRGKFTTKTIDEVNIKQAFFIGCFQCLAIWPGMSR
SASTIIGAWIAGLSTVAAAEFSFFLALPVMVGVTLKSLVDINLAALATVQIIALVVGFIV
SFIVALIVVDKFISFLQKRPMRVFAMYRILIGIILLLLFIFNVL
>A0A0J0LD80|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDTTGENNFFGSVARIAAERGIPVYAPD
DVNHPLWVERIRALAPDVIFSFYYRSLLSDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVRRADAGAIVAQQKVAIDADETALQLHQKLNATAQTLLRDALPGI
LNGIFSETAQDESKASCFGRRAPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLIVSCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGADAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQAS
>V4YM57|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLVEGITEFLPISSTGHLIVTGSLIGFHDDKAKVFDIAIQTGAIGAVVLVYWQRIWSTV
CELPTQAKAQSFTRNVLIAFFPAVVLGLAFGKAIKENLFNANVVAVALIVGGVIIWWAEK
RQATTVRVDSVDEMSAMDALKVGLIQCLAMVPGTSRSGATIIGGMLIGLSRRAATDFSFY
LAIPTLIGAGVYSLYKERALLAWSDVPMFAVGTVVAFFSAWWCIHWLLRYIATHSFMPFA
WYRVAFGCVILLTSATGWVEWAA
>A0A109FTJ6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNRIGRINATGEINSFPIPTANAGAM
SIISDQTGDLWFTEYNSSKIGKMSMNGLFEEYVLPTTNAAPFGITEGPDGAIWFTEMNNG
RIGRITKSGEITEFELPNSKSFPSFITLGSDGALWFTQNQNNRIGRITTKGEVKEYPIPT
PNSGPVGIASGPDGAIWFVQIMGNKIGRITFEGEVKEFVIPTPNARPHAIIPGKNRDLWF
TEWGGNQISRITVEGVITEYTIPTNNAEPHGITFCPDGDLWFAEECNQIGRLTIIT
>A0A143GHP2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MNSKAVVFAYHDIGCAGIEALLNAGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDYIFSFYYRNLLSEALLATAKKGAFNLHGSLLPQYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVVIDRTDTGLTLHAKLRDAATSLLRDALP
QLAQGKLTETAQDESKATYFGRRTAADGKLDWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNENGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEIYGLDIGSDAIERLR
SHPNFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDNCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKR
>A0A125X5U5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVTGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLMSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWFPARNAARLDPVDALARE
>YP_002116741|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MLLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQLFYGPLSD
RVGRRPVILVGMSIFMVATLIAMTTHSLTVLIVASAMQGMGTGVGGVMARTLPRDLYEGT
QLRHANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMARWMPETRP
AGAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGLSSMVVSIL
FILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLMMWIPGWFGVMNVWTLLIPAAL
FFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQTGQGSLGLL
MTLMGLLILACWLPLASRISHQGQTV
>S3H8K4|FEATURES|UNIPROT_deepARG|beta_lactam|RGCCGE502_28523|antibiotic inactivation|1
MRNISQSTLGILATASVLIGAGAHAAERQSELAGVVNAIAVPLMAKNNIPGMAIAVTVGG
KHYTYNYGVASKASGQKVTDATLFEIGSVSKTFTATLAGYAQASGDLSFTDSPDKYLPEL
AASRLAGATMLDLGTYTAGGLPLQFPDDVTDHKAMVGYYKSWKPAYAPGTYRVYSNPSIG
LFGYAAAKAMGWPFDDLMQQKLFLALGLSHTFIAVPKADDENYAYGYSKAGKAIRVSPGV
LDSEAYGVKMSASDMLRFVEANMDGSDLDKTMQSALAATHTGYYRIGSMTQGLGWEMYKY
PTTLDQLLAGNSADMTLKANEIEKLSPPRPPAKDMLLNKTGSTNGFGAYVAFVPSKSIGI
VLFANKNYPNSERVKAAYKILATLDDDLPAANAD
>A0A126PF83|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTYWHALLLAIVEGITEFLPVSSTGHMIIASALLGIQMTPFAKLYLVVIQLGAILSVLVV
YWKRFFQSIDFYLKLLVAFLPIVVVGLLLKKHIDALLESVTTVGAMLLLGGVVLLFVDKW
FPQEDSQKGGHPVTNPSWKEAFVIGLFQCLAVVPGVSRSAATIIGGLTQKLTRRAAAEFA
FFLAMPTMAAAAAKDLYDFYKEAKTHGVSLNHLFSGQEIKLLVLGNVVAFVVALLAIRLF
VGFVAKYGFRAFGIYRIIVGGLLLLLIGLGVNLQLV
>A0A0F7JK76|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWFYAIVYGIVEGITEFLPISSTGHLILTGNLMGVPWTKEVKDAFEVVIQGGAILSVLV
YYWRDFLKIRHVNTDPQQRTLWLGVLVACVPAVILGLLFGDAIKATLFRPSVVAWALIVG
GILMWLIESRRVTPNVDAIEKIGVRRSLMIGALQCLALLWPGFSRSASSILGGMILGLDR
ATATKFSFYLGVPTLGGAALLNLIQERELIFGEIGLLNVLIGAGVSFVTAYLAIGWLLKF
VSTNNFKPFAIYRVIVGVLILVLLATGVMTNGNLA
>X2KIT0|FEATURES|UNIPROT_deepARG|aminoglycoside|SEET0819_14790|antibiotic inactivation|1
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQTDHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>A0A158SKW7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAVILGIVEGITEFLPISSTGHLVLVDEFIKLNEPKKFIDMFNVVIQLGAIMAVV
VLYFHKLNPWSPKKSRLERSQTWTLWKKVIIAVIPSVIIGLPLNDWMDAHLMNWLVVSIA
LIVYGVLFIVIENHNQNLRPRFDSLNTLPYKVAILIGCFQILSLIPGTSRSGATILGAIL
IGTSRYVAAEFSFFLAIPTMFGASLLKLYKFFAHGGTLAGNQGLILAVGVIVSFVVAYAS
IRFLLNYIKTKDFKAFGWYRIILGVIVIAYFALLAH
>A0A0P7D9B6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLSRLAALAAAITLTLGYSAAQADDQLQAKVDQIIRPLMQEQGITGMAVAVYARNHAYY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLDAPAKRYHPALAGAP
IGDASVLELGAYSADCLPLQFPDAVQTAQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMSEGLLKQMGLENTYLQVPASAQGLYAQGYDSADKPVRVGPGPYADE
AYGIKTSASDLLRYVRLHMQPERLPPALAQATAITQRGYFQVGAMTQSLGWERYPYPVTL
ATLIDGNGPQLIREPQATTRLQPALPPLPAAWYNKTGSTNGFGAYAAFVPAEQLAVVLLA
NRNYPNEARVRAAFDILSGL
>W0MQW2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADMIHHYLFNAITVATALV
IGGVIMLWAERREHTVRTETVDDMTWIDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPEDFAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A137Y246|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKPKHFSMNLKRLLIVAGVFSVSSTLWAKDLTEQQVKAVIDQQFKPLLAQYNIPGLAVA
VTLNGQHYFVNYGVASKQSQQPVRNDTLFELGSVSKTFNATLAGYAQAQGKLSFSDHPAK
YFPELNNTAVNRASILNLGTYTAGGFSLQFPDEVVTQQDMVKYFQKWQPKTKISVARQYS
NPSIGLMGYVTALAMKKPYSELIEKTLFPQLGLKQSFIHVPESQMENYAWGYKNDQAMRV
SAGMFDAEAYGVKSSSADMLKFIDAQLNPQQLKQPMRKTIENTHVGYFKVGAMTQGLGWE
QYTYPVSLATLLQGNSSKMALESHTVTPIKQPKLASAATLFNKTGATNGFGAYVAFIPQQ
KIGIVMLANTNFPNEARITASYQTIQQLLKQQ
>A0A0U0GM27|FEATURES|UNIPROT_deepARG|bacitracin|uppP_3|antibiotic target alteration|0
MSDIITAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKQGATSYSLDNLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWTYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTVFVLL
>B2CD56|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
HGRRTSGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLS
ARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVV
IYDGRMPP
>A0A0S2ZKM9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIMLVIILALVEGITEFLPVSSTGHMILVNQLIGGEYLSPTFINSFLIIIQLGAILSV
VVYFWKDISPFVGTKKEFGLRLQLWMKIIVGVLPAMVIGLLLDDIIDKYFMNNTLIIAIT
LIVYGVIFIGIEVVYKLKNIKPKVKKFSGLKYGTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLLKNGLAFTQMEWSYLALGSAIAFVVAYMVI
KWFMAFIKKRSFASFGLYRIILGIIVIVLLY
>N8WZK6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAIIQGFAELLPVSSSAHVILAEKLMGYDPSAPDMTFLLVMLHTGTMFAVIV
YFWKSWKKTYFSSWESFKKQAFYIILATLITGVLGLALQSIIKHVFFGGASSFEIEHLFS
NSKLMAAALISAGVLIILSSRLDRGQQGEISLRSACIIGAVQALCLPFRGFSRSGATIST
GLFLGVSRQKAEEFSFALAVVLTPAVIVKELYRLIHAQGLQTVAHGQVFHSMVPSLLGMC
FSFGAGLLALKWLSSWLEHGRWHLFGLYCIGFAIVVLCVN
>R6J4V9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDQNLIAVIVGFVEGVTEFLPVSSTGHMIIVGHMLGFDGPAADIFDVFVQLGAILSVIFI
YKERFARFFTKEGWQADKGLSVWHVAAGIVPVMGVAFFAYKYIKEYLFSPFTVAIGLVLG
ALLMMYAEYKTKDNQAELLDDLDKISLKQAALVGAFQLLSLWPGFSRSGSTLAGGLLVGL
KRETAANYTFLIAVPLMFVACLYDLLKNISILTVDDLQMLAIGFVVAFVVAYWSVLWFLK
FLHKYSLTSFAYYRIILAVAALTYFYF
>U6ZJX0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDFGCVGLRALVAAGYTVEAVFTHADNPAENQFFGSVARTAAELGIPVFAPE
DVNHPLWVERIAAMSPDVIFSFYYRHLLSDAILQSATHGAYNLHGSLLPRYRGRAPLNWA
LVNGETETGVTLHRMVARADAGNIVAQQRVAIDESDTALSLHRKLRDVADQLLKDTLPAL
AAGKANDIPQDESQATYVGRRTPEDGRIEWQKPARTLYNLVRAVTEPWPGAFSFVGTTKF
IIWQAKVRTDFAAARPGTVLSTSPLVVACGSDALEIVTGQGDTGIYLQGAQLAQSLGLVT
GAILNNSPVVSVKRRTRVLILGVNGFIGNHLTERLLQEDNYEVFGLDISSDAIERFLGNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKTIRDC
VKYKKRIIFPSTSEVYGMCTDPVFDEDNSNLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDI
KDGIEALFRIIENKDGVCDGQIINIGNPDNEASIRQLAEQLLESFEKHPLRNQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLQWQPTIEMEKTVAETLDFFLQTVETGRFSQ
DNE
>A0A095SRN6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYIQAIILAIIEGITEFLPVSSTGHMIIASSFFGIAQDDFTKLFTIVIQLGTILSVVVL
YFKRFFQSFDFYFKLLVAFIPAVVFGLLFSKKIDALLENPVTVAISLLIGGIILLKVDDW
FSKETEVTESQEISYATAFKIGVFQCLAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFFL
AVPTMLGATLKKCYDYYKDGLTLTDEQINLLIIGNVVGFIVALLAIKTFIGFLSKNGFKV
FGYYRIVVGIALLVIHFFIQKLDVI
>A0A0B5SI36|FEATURES|UNIPROT_deepARG|chloramphenicol|BG05_3643|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCSFSMTANVDITMMLEEIHQKEIKFYPTSIYVISRV
INKHTEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMR
CYANVHGFFPKENIPPNIFPISGIPWTSFTGFNLNINNDGDSLLPIITCGKYFNDGSRVM
LPVSLQVHHAVCDGYHASRFIEDLQELANTCNEWLK
>J2Y923|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHVAKSLLTGTFLLACGTTPGFAQDRLEETVNAVIQPLMKQQNIAGMAVAITHNGQHRFF
NYGMASKDTKKPVNDQTLFEIGSISKTFTATLGAYAQAQGKLSLSDPASRFAPELRGSAF
DGISLLNLATYTPGGLPLQFPDEADHPDRMLDYYKGWKPLYPAGTQRLYSNPSIGLFGFL
AARSLGQPFDEAMEHTLMPGLGLKHSYLRVPQDQLSRYAQGYAKDGKPVRVGPGALDSEA
YGVKTSSSDLVRFIEANLRPGKLDADLRKAIATTHTGFYTVGGMTQGLGWERYPYPVSLE
VLLAGNSTPMAMQANKVEPLDPPRPAPDDAWINKTGSTGGFGAYAAFVPGKDMGIVLLAN
KNYPNEERVKAAYQILTALQGL
>B0BL05|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLAVHLCGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGAER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVVGK
>YP_002807856|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLAAGANAQ
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVTGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>A0A0T6HBP7|FEATURES|UNIPROT_deepARG|chloramphenicol|AO896_03550|antibiotic inactivation|1
MSYTRVDISSWNRREHFEIFRGDGQCTFSQTVQLDITRLLDFTRSRGYRFYPVFIHSIAK
VVNRFPEYRMAMKGDELIVWDCVHPNYTTFHPDTETFSSFWSHYHDDLARFLAEYSMDRE
KYRNDHSYFPKGFIENVFYVSANPWVSFTSFDFNFASANNFFAPLFTVGKYYSQAGKTLV
PLAVQVHHAVCDGFHAARLVTELQKLCDEAGG
>A0A127SI91|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDLMLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIDQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>R5ACM2|FEATURES|UNIPROT_deepARG|chloramphenicol|BN452_01100|antibiotic inactivation|1
MEFHLIDLEQWPRKEHFHHYLNQVPCFYSMTVELDVTELKLHGGRFYPSMIHALAVVVNR
HPEFRMALNEKGELGWFDQLSPSYTVFHPETETFSCLWTEYTPDREEFIRRYEEDLRIYG
NVTAFDAKPECPPAFNVSAIPWESFSSFHLELPRGEKYLLPIFTVGRYHQVGDRWMLPLA
IQVHHAVCDGFHACRFAEELRQELGKKLV
>A0A069IFD5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRRRITTVVGGLATDEKARRFAINVIVATVPAIVLALVFGKWIKAHLFNPITVATAFI
VGGVVILWAEWRESHRGRVSHPQGNALLKAAQAGAPRIESVDDLNWRDAIKVGLAQCFAL
IPGTSRSGATIIGGMLFGLSRQVATEFSFFLAIPVIFGATVYELYKSRALLSADDLGIFG
IGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIVFGIVVLVTAYSGLIAWHA
>A0A098RUS3|FEATURES|UNIPROT_deepARG|aminoglycoside|LW14_04385|antibiotic inactivation|1
MSGTFDVRNAGDYPDDWCLLRHRLWPDTAPEDHRAELQDVCETGAGFIVHDLDGSAIGFA
EVSLRRDYVNGCDTSPVAFLEGIYVEEAFRRQGVAALLVEQVTRWAIDQGVSELASDADI
ANLSSHRMHAALGFEETERVVYFRRSLIPRR
>I2BY05|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLSAGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPEYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVTIERSDTGLSLHAKLRDAATALLRDALP
QLAQGKLSETAQDESKATYFGRRTAADGKLDWKKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWQADVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNENGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNGVCDGQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIDNAKRLLNWEPSVEMSETIGNTLDFFLREAMLEIA
DKK
>CAR59921|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELCNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAMLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0R3LX64|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSEVVKAVILGIIEGITEFLPVSSTGHMLLAQRYFGLGEGAFWQSFVILIQLGAILAIV
MLYFVKLSRVALGMFTNPDDRRFVIGVLVAFLPAVIIGLIAGKYIKELLFNPWVVCFTLI
VGGAILLWVDQLDLKPTEDDATRYPLMMYLWIGIAQCVAMIPGVSRSGASIVAAMLLGGD
KRSAAEFSFFLAIPTMIGAFAYDFYKNRAEMTVDHVGILAIGFVVSFITAAIVVKTFLTY
VTRHGFTFFAWWRVAAGTLGLLALALGK
>I4KGC7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLSAGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPEYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQTVAIERSDTGLSLHAKLRDAATALLRDALP
QLAQGKLSETAQDESKATYFGRRTAADGKLDWKQPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWQADVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNENGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNGVCDGQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPSVEMSETIGNTLDFFLREAMLEIA
DKK
>A0A0D0THL4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIDCVSIVIPVYNEQESLPELLRRTTAACKQLAYEYEIILVDDGSRDDSAQLLEDA
AAAEGSNVVAVILNRNYGQHAAIMAGFEQCRGDVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGVLFAFALIIMRLAFGADWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGLVSSHTSTSTSSSDQVQS
>A0A150EDU3|FEATURES|UNIPROT_deepARG|chloramphenicol|AT258_07095|antibiotic inactivation|1
MSFYIIDRDNWNREQYFTHYLKLKCTFSMTVNVDITRLLKELHQKRIKFYPVFIYLISRV
INNHKEFRTCFNDEGVLGYWEQMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMR
CYASAHGLFTKENIPSNVFPISSIPWASFTGFNLNITNDGDFLLPIITCGKYFNEENKVM
LPVSLQVHHSVCDGYHASRFIEDLQKLSNSCNEWLK
>Q76DI4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPRALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNP
ARVAAAWQILNALQ
>G7WA87|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDFVSALILGIVEGITEFLPISSTGHLIIVNQFVGFTEQFAKMFDVVIQLGAILSVVVY
FRHRLIPFGNMKSSNNQRIFELWKKTIVGVVPALGIGYLAADYIEERLFNTTVVALALII
GGIILLLIEGRRHAFKIKSIEQLSYRTAFSIGIIQCLAMIPGTSRSASTIIGAMLLGASR
VVAAEFSFFLAIPTMVAASGYTLLKNGLLLTPHEFLIVGFGFIVSFIVAWLVIAGFMSYV
SRKDFKPFGYYRILLGIVVLVYFSLFAA
>A0A0M3CJN3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVVGLPTQPSARRFTANLLIAFFPAVILGVIFADLIHHYLFNPITVATALV
VGGIIMLWAEKRQHEVHAESVDDMTWKDALKVGLAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADLPVFALGFVTAFIFAMIAVRGLLKF
IASHSYAAFAWYRIAFGLLILATWQFGWVDWTAVKP
>Q2VCD9|FEATURES|UNIPROT_deepARG|beta_lactam|blaPLA-6A|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHQATVTTVKQAESQLQGRVGYAELDLASGQLLAGYRSDE
RFPMMSTFKVLLCGAVLSRVDAGEEQLDRRIHYRQQDLVEYSPVTEKHLTDGLTVGELCA
AAITLSDNTAANLLLTTLGGPQGLTSFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPQ
AMARTLRNLLTGSVLSSASQQQLQRWMVEDKVAGPLLRSVLPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTGTPATMDERNKQIAAIGATLIRHWSADENRP
>C3KAD2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLNTGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDYLFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVIIERSDTGLTLHAKLRDAASNLLRDALP
QLAQGKLAETAQDESQATYFGRRTAADGKLEWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLVVWQADVVKGNEGLAPGRVISVNPLRIACGEDSLVIKFGQRNDNGLYLAGPSLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKK
>K7YS00|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIDIKGIRKSYQMGDTKVDVLKGISLKIERGDFVAIMGPSGSGKSTLMHILGLLDVPSEG
SYNLNGREVADLSEDELAIVRREEIGFIFQQFNLLPRMEAWQNVSLPLIYSEDGFSYDKA
HTLLDKVGLAERIHHKSNELSGGQQQRIAIARSLINNPRIIFADEPTGNLDSKSEKEIMQ
ILHKLNEQGITVIVVTHEEEIGQQAKRLIRLRDGVIQSDERLQALPAAPTTALEKRQEQP
AKWPVREMIEHLHQGFQTLAANKVRSGLSMLGILIGVAAVVGMLALGTGARQSIEKQLSS
LGSNLLVLRAGNVRVGGVMQESGVRIRISLDDVSTIKNQISGIKDVSPSSSGRGQITYLN
KNWNTQVMGVAPAYEQMRASTPIFGRFFSEEENQRRTLVAVIGTTVARELFGDKSPIGEM
IKINKVNFRVIGVLPEKGAAGPQDQDDRILVPVVTAMYRLFGKNYVDSVDIEVRDAADIP
DVQDSLQELMNKRHRVPVSSQGDAFNVFNMADIQQALNSTNQTMSMLLASIAAISLVVGG
IGIMNIMLVSVTERTKEIGLRKAIGARRRDILLQFLAESIVVSVCGGLLGIALGVGFSLL
ISKVLGWSTVVSAGSVILSFGFSALIGIVFGSYPASKASKLHPIEALRYE
>F2BCL1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHVLKNVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAT
SGSYQIDGIETSKMNPDELAGLRRERFGFIFQRYNLLGSLTARDNVALPAVYMGAAHKER
SERAEKLLHDLGLQSKENNKPNELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEDGHTVIMVTHDPGIAANANRVIEIRDGEIISDTVKNPDIPPSSVERVKE
NASWSFYYDQFMEAFKMSVQAITAHKMRSLLTMLGIIIGIASVVSVVALGNGSQQKILED
INSMGTNTVSIFPGRGFGDRRSGRIKTLTIADAQAIAKQGYVASVTPQTSSSGTLTYRNT
DLTAMLYGVGDQYFDVRGLKLASGRLFDEDDIKQDAQVAVVDDNVKTKLFGDGVDPLGKT
ILFKKRPLTVIGVLQKEENNFGSSDSLMVWSPYTTVMHQITGETYASSITVKIKDDVSSQ
VAEKSLTELLKARHGTEDFFMNNSDSIKQMVEKTTGTMTLLISSIAVISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRSNILQQFLIEAVLICLIGGLIGVGISLAIGVLFNQFVT
DFPMTFSTLSIVGAVVCSTAIGVAFGFMPANRASKLNPIDALAQD
>AAR37060|FEATURES|ARDB_deepARG|glycopeptide|vanD|antibiotic target alteration|1
MYKLKIAVLFGGCSEEHDVSVKSAMEVAANINKEKYQPFYIGITKSGAWKLCDKPCRDWE
NYAGYPAVISPDRRTHGLLIQKDGGYESQPVDVVLPMIHGKFGEDGTIQGLLELSGIPYV
GCDIQSSVTCMDKSLAYMVVKNAGIEVPGFRVLQKGDSLKAETLSYPVFVKPARSGSSFG
VNKVCRAEELQAAVTEAGKYDCKILVEEAVSGSEVGCAILGNENALMAGEVDQIELRHGF
FKIHQEAQPEKGSENAVIRVPAVLPDEVRERIQKTAMKIYRILGCRGLARIDLFLREDGC
IVLNEVNTMPGFTSYSRYPRMMTAAGFTLTEILDRLIELSLRR
>YP_001345920|FEATURES|ARDB_deepARG|multidrug|mexA|antibiotic efflux|1
MGHGAGWITGHRAKTFQVFSREASGRLQTPMNVSILPAFFEPVQRLHAASAAFAHEDNAM
QRTPAMRVLVPALLVAISALSGCGKSEAPPPAQTPEVGIVTLEAQTVTLNTELPGRTNAF
RIAEVRPQVNGIILKRLFKEGSDVKAGQQLYQIDPATYEADYQSAQANLASTQEQAQRFK
LLVADQAVSKQQYADANAAYLQSKAAVEQARINLRYTKVLSPISGRIGRSAVTEGALVTN
GQANAMATVQQLDPIYVDVTQPSTALLRLRRELASGQLERAGDNAAKVSLKLEDGSQYPL
EGRLEFSEVSVDEGTGSVTIRAVFPNPNNELLPGMFVHAQLQEGVKQKAILAPQQGVTRD
LKGQATALVVNAQNKVELRVIKADRVIGDKWLVTEGLNAGDKIITEGLQFVQPGVEVKTV
PAKNVASAQKADAAPAKTDSKG
>V5CPL1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKPPRHEGTGSGRLSLIHILLGMIPAVVIGLVFHDAIKTLFNPK
NVAYALVVGGVLLIAAELLKPKVPRAQGVDDMTYRQAFLIGCFQCLALWPGFSRSGATIS
GGMLVGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTTGDIPMFAVGFVTAFIVALI
AIKTFLELIKHISFIPFAIYRFIVAAAVYVVFF
>M5RVL4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIQLHGLRKDYRVGDHDLPVLKGITLNIEAGEYVALMGSSGSGKTTLMNLLGSLDHPTDG
DYHLAGIDVSSLTPLELAAFRSQHIGFVFQNFNLLPRATALDNVMLPTIYASDGRARREC
IEDATKLLESVGLGGRLDHMPNQLSGGERQRIAIARALMNRPKLLLADEPTGNLDTVTEQ
EILALFRQLNQEHGITLVVVTHDAEVAHEADRVVRMKDGLVSEDVRQRASTVDRSRLANS
RSEPLREPASAWSLPATWNAVIVAVLALRRNALRTVLTMLGVIIGVASVISTMELSAGAS
TAIEETVASMGASMLTISPGKASSTSGRQRPIQIIPDDVVAVAEQCSAVKVAAPLVYSQV
QLVRQNRRWSPNLALGTTSQYLAARNWDQLELGTPFTQEQVLDAAKVCILGKTVAHELFD
SEYPIGEEIRVNGVPLRVVGVLTEKGGDVIGNDQDDIIIGPWTTFKLRVNSSTGATAQFS
TFADQMPPMQLASTRRSTQREEIHQIYVEAESPDHVELARQQITQLLSRRHNVEPAGAYR
INDITEVSKVVGQVVGGVSALGLVIAGVSLMVGGVGIMNIMLVSVTERTREIGLRMAVGA
NRSAILRQFLIEATVLCVVGGFLGIFAGHMWSMLVGRVIGWPTAMSIWAPIVAVTVAASV
GIVFGYYPARTASRLNPIDALRYE
>Q2FC66|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
>F2I5A2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKVFIMGIVEGITEWLPISSTGHLILVEEFISMDFRPEFWNIFVYVIQLGAILAVV
WIYFDRLNPFSSQKSAEEKKQTWETWFKVVVGCIPAGVIGLLFNDFAEKHFQNWVVVSAA
LIIYGIAFIVVENRNKTRPVTVHSTQDLSYKKAFQIGLFQALSVIPGTSRSGSSILGATI
LGTSRPTAADFSFFMSIPIMFGMTFLKLTKGFLDGFRFSTEEGFLLILGMVIAYIVSILT
IRFLLRYVQKNDFKAFGWYRIALGIIVIIFFAIFQ
>A0A0X8SFI1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLELSGISRSYQSGDQTVAVLKNVSLSIEAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLDSDALARLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAVALLQRLGLSERVSYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILKQLREQGHTVIIVTHDPAVAQQAERIIEIRDGEIIADSRPDGQSNPNAKPLEM
VTPAPSWQQTIGRFREALVMAWRAMAASKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPTFRQALKYDDLAALREQPYVSALSPSIASSMRLRL
GNVDVAANVNGVSEQFFRVYGMTFTEGVGIDQLQVQSQSQTVVIDANTQRRLFPNQKEVV
GRVILVGNMPATVVGVAKEKQSMFGSSKTLNVWVPYSTMANRLMGNAYFDSITVRIRDGY
NSQEAEQQLTRLLTLLHGKKDVFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLLVQL
VLPGWQISFPPAALLSAFVCSTAIGVVFGYLPARSAARLNPIDALARE
>A0A0P9T2D1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADMIHHYLFNAITVATALV
LGGVIMLWAERREHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>ZP_03823621|FEATURES|ARDB_deepARG|multidrug|AdeA|antibiotic efflux|1
MQKHLLLPLVLSIGLVLHGCNSEVEQPEAPPAKVSVINVQPQSVNFSENLPARVQAFRTA
EIRPQVGGIIEKVLFTQGSEVKAGQALYKINSETFQADVNSNRASLNKAEAEVTRLKVQL
ERYEQLLPSNAISKQEVSNVQAEYRQALADVAQMKALLTRQNLNLQYATVRAPISGRIGQ
SFVTEGALVSQGDANTMATIQQIDKVYVDVKQSIGDFERLQAALQSGELSANDQKTVRIF
NSHGQPYNVTARMLFEDINVDPETGDVTIRIEVNNPERKLLPGMYVRVNIDRASVPQALL
IPAQAIQRNISGEPQVYVINTKGTAEIRPIELGQQYEQYYLVNKGLKTGEKVVVEGIDRI
QPDQKLEMTAWKIPATQGAQ
>E9YKZ7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLHVWLPYSTMSGLVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>YP_001096379|FEATURES|ARDB_deepARG|aminoglycoside|APH(3'')-Ib|antibiotic inactivation|1
MAFIIHAEDIQHSAGNRRWHLRKKPLKMRDRPEHNRCKSIATRFFSQVEPPPRFIRKLKE
PPLNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWL
KGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVD
QCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDM
VVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAF
AVLFNVLGIEAPDRERLAFYLRLDPLTWG
>J3A3D9|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MRLSSKYEMIRRILSDFKQPEYRYAQIMDAIFKQNIGEYGRMTILPKFLRDELTRILGPN
VCSIVPVKEFTSKQVSKVLFAIAGDERVEAVRLTYERGWKSYCISTQCGCGFGCRFCATG
TIGLKRNLTADEITDQLLHFRLNGHALDSVSFMGMGEALANPHIFDAMTILTDPHLFGLG
HRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLNELDR
HIRHTGRKVYIAYILLRGVNDSTAHAEAVAELLKGRGPGEHLYHVNLIPFNSTEVTPDSY
RQSDPNRIKAFVRILKSKGISITVRTQFGSDINAACGQLYRSK
>R6QZU9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIIEILKVIVLGIVEGITEWLPISSTGHLIIVNEFLKLKASDAFVEMFNVVIQLGAILA
VIVLYFKRLWPIDKKKDSKGLEWNKDKLILWAKILVACVPAGIIGILFDDKIDEIFYNPY
VVSVTLIIYGVAFILIEIRNRNKEFKITDVKAMTFKTALIIGLFQVLALIPGTSRSGATI
VGAMLIGTSRTAAAEFTFFLAIPVMAGASLVKILKFVSDGTGFTQNELYMLIIGMLVAYL
VSMLVIKFLMSYIRKHDFKPFGVYRIILGIAVILYFTLS
>X6GK40|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWKMLLDLPHDRLTRHFAIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
IGGVVLLAVDRMNLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAVGFVAAFVTALIVVRFLLDY
VSRKGYALFGWWRLVVGGVGLVALMIWG
>A0A0Q5PX61|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDGILFCKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTNAQAKTFDVVIQFGAILAIV
WEYRRKIGSIVAGLPTQPSARRFTLNVIIATIPAIVLGLLLEKHIKAVLFAPVPVSVALI
VGGLVILWAEARNRDSVVPPRVTSVDDLSYSDALKVGLAQCFALIPGTSRSGSTIIGGML
FGLERKVATEFSFFLAIPIIFGATIYELARDWKSLTVDSLGLFLVGLVAAFISAFICIRW
LLRYVATHDFTAFAWYRIGFGLLILIVGYSGGLSWAE
>BAG17078|FEATURES|ARDB_deepARG|aminoglycoside|APH(3'')-Ia|antibiotic inactivation|1
MSDHPGPGAVTPELFGVGGDWLAVTAGESGASVFRAADATRYAKCVPAADAAGLEAERDR
IAWLSGQGVPGPRVLDWYAGDAGACLVTRAVPGVPADRVGADDLRTAWGAVADAVRRLHE
VPVASCPFRRGLDSVVDAARDVVARGAVHPEFLPVEQRLAPPAELLARLTGELARRRDQE
AADTVVCHGDLCLPNIVLHPETLEVSGFIDLGRLGAADRHADLALLLANARETWVDEERA
RFADAAFAERYGIAPDPERLRFYLHLDPLTWG
>A0A0K6MIS5|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLV
DYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMSD
RFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTEWMKGNATGDKLIRA
GVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIAEATKV
IVKALR
>A0A0B5QLP1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLDILFIIKAIIIAIVEGLTEFIPVSSTGHMILASSIINFKGDFVKMYEVVIQLGAILA
VVVLYWKKIKDSVIEFFRYIFTKGKEGKTGFNFGINVIVGCIPMLIIGLLFYKKIKSLFN
PEAVVIGFIVGGILLIIIENMFRKSNKHATKSLDSITPMQALKVGVFQVLSVWPGMSRSA
STIMGGWIAGLSTPIAAEFSFFLAIPAMIGASAKDLMEFDYSGMNLTSWISLVVGFIVAF
VVSVVVMDKFVSYLKKRPMRVFAVYRIGAGIVFGILMFFGFLNFTL
>M9G4S4|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAMMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A060KTQ9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>S1J3Q3|FEATURES|UNIPROT_deepARG|beta_lactam|A1WS_00156|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWIRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NSSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0R1STJ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKAIILGIVEGITEFLPISSTGHLILVNEFIKMSQSTQFTDMFNVVIQLGAIMAVV
VLYFHKLNPLSPSKTHVEQHDTWILWFKVIVAVLPSVVIGLLFNDWMDAHLMNWAVVAAM
LLLYGILFIVIENRNANRQPRFTDLGRLSYRTAFIIGMFQLLSLVPGTSRSGATILGGIL
IGTSRYVATEFSFFLAIPTMFGASLLKVYKYFSNGGAFTGLQTAILLTGMFVSFVVAYFA
IRFLLNYIQHNNFKVFGWYRIVLSIIVIIYFGFMAR
>P44927|FEATURES|UNIPROT_deepARG|multidrug|emrB|antibiotic efflux|1
MGNSAKKFPPIQGGALILLTLALSLATFMQVLDSTIANVAIPTIAGDLGASFSQGTWVIT
SFGVANAISIPITGWLAKRFGEVRLFLVSTFLFVVSSWLCGIADSLEALIIFRVIQGAVA
GPVIPLSQSLLLNNYPPEKRGMALAFWSMTIVVAPIFGPILGGWISDNIHWGWIFFINVP
IGLSVVLISWKILGSRESEIVHQPIDKVGLVLLVLGVGCLQLMLDQGREQDWFNSNEIII
LAVVAVVCLIALVIWELTDDNPVVDISLFHSRNFSVGCLCTSLAFLIYLGSVVLIPLLLQ
QVFHYTATWAGLAASPVGLFPILLSPIIGRFGYKIDMRILVTISFIVYAITFYWRAVTFE
PSMTFVDVALPQLVQGLAVSCFFMPLTTITLSGLPAHKMASASSLFNFLRTLAGSVGTSL
TTFMWYNREAVHHTQLTEHINPYNPISQSFYHQMNQFGLSDTQTSAYLAQQITSQGFIIG
ANEIFWLSAMGFLGLLIVIWFAKPPFGTQH
>M6D8N1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFSEENFGMEFDDLFDIFIQSGAIL
SVLFLYREKFGSQIVSSFRYVTKQNSDPQGFYFLLQIAIGAFPILAAGFVAKKFLDTIKA
RSDLLDILASAWIFGGVLILIAEWFFHKKQNGSERKPVGFQDAILIGIFQCVALIPGVSR
SAATIITARFLGKDTKSSAEFSFFLAVPVLLAAGIYKLLKYRSILNGDTIPVLAFGFSVS
FLLCTLVIRWFLRYLQKHSFGSFGVYRILLGVGVLVFTKFIR
>D5ERC2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIRLYRFLFFWLLATAASSAAPSAPAQVDQASPDGPAKTISYTDALILGLVEGITEYLP
VSSTGHLILTNAALKLDEPTPLMKADGQPLEIEADDGSTRPFTLADAAYAYAIIIQFGAI
LAVVIVFWERVSSILMGVLGKDPNGLKLLKNLIIAFLPAVVLGLLLDDFIEATLAGPLPV
VAALIAGGLLMLAVERWHKKKHPGESVSHETAHCPDLHELSIAQCLTVGFLQCVAMWPGT
SRSMMTIVGGYIIGLSPVRAAEFSFLLGLITLSAASAYKALQVGPYIVETISLGPILLGI
VVATLSAMLAVKWLVGFLNKHGLGLFAWYRIALAFLVLFLIA
>A0A0R2AGR4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVELFKAFLFGIVEGITEWLPISSTGHMILLDEFVKLDVSKDFYSMFEVVIQLGAIMAVV
VIYWHRIWPFRLAKANGIGAPQGLWRFIDKETFIMWVKIFIACLPAGIIGVKFNDTFEKL
FYNPVCVALALIIFGVAFIWIETIHKGSRPKINSIAELSYYTVLMIGFFQLIAAVFPGTS
RSGATILGALLLGVSRTVAAEFTFFLAIPVMFGAAVFKLAKFGLVFSSMEMWIMVVGLIT
AFVSSIVVIKFLMQYIKKHDFKIFGWYRIILGILVLAYFWLLK
>A0A068N7C4|FEATURES|UNIPROT_deepARG|beta_lactam|BcrFT9_01992|antibiotic inactivation|1
MFSDDFYPYTQPYNPNSECSDLRKCPPSDVQLRFLFLPVYFVFLVRCVFLKSVELFFKLA
RLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLVDY
SPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMSDRF
ETELNEAIPGDIRDTSTAKAVATNLKDLTVGNALPHQKRNILTDWMKGNATGDKLIRAGV
PTDWVVADKSGAGSYGTRNDVAIVWPPNRSPIIIAILSSKDEKEATYDNQLIAEAAEVVV
NAFK
>CAQ86952|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MIELFYHSLSVIEKSEMNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFG
VLLALYALMQVIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLS
GITGATGAVAASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIA
ALLNIVAFLVVMFWFRETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIG
QIPATVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIA
DSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNA
TGVIGPLLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>S9SPG8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKVQGLNHLCFSVSDLERSIAFYEHILEAKLVVKGRKLAYFDLHGLWIALNEEQDVPRDE
IHPTYTHIAFTVSEHDIDEIKTKLVQYGVQILPGRERDERDKRSIYFTDPDGHRFEFHSG
QLADRLDYYKETMPHMTFLE
>YP_001175677|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVSITAVYPGADAKTVQDT
VTQVIEQNMNGIDKLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTNGTMTQEDISDYVGANMKDAISRTSGVGDVQLFGS
QYAMRIWMDPNKLNNFQLTPVDVIAAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSADEFSKILLKVNQDGSQVRLRDVAKVELGGENYDVIAKFNGQPASGLGIKLATGANAL
DTATAIRAELKKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILSIFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGENKKGFFGWFNRMFDKSTNHYTDSIGGILRSTGR
YLLLYIIIVVGMAFLFVRLPSSFLPDEDQGVFLTMAQLPAGASQERTQKVLDEVTDYYLT
KEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERSGDENKVEAITGRAMGTFSQIKD
AMVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGEIAKHPDLLVGVRPNG
MEDTPQYKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYIMSEAQYR
MLPNDINNWFVRGSDGQMVPFSAFSTSHWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MNLMEELASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLEAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMITATVLAIF
FVPVFFVVVRRRFSRKNEDVEHSHSVDHH
>P24619|FEATURES|UNIPROT_deepARG|aminoglycoside|grm|antibiotic target alteration|1
MTTSTGDDRIDQLQQAITKSRRYQTVAPATVRRLARAALVASRGDVPDAVKRTKRGLHEI
YGAFLPPSAPNYTALLRHLDSAVEAGDDEAVVRWDRRAMSVHMSTRERVPHLDEFYREIF
RHVPRPNTLRDLACGLNPLAVPWMGLSDETVYVASDIDARLMDFVGAALTRLGVAHRTSV
VDLLEARLDEPADVTLLLKTLPCLETQQRGSGWEVIDIVNSPIIVVTFPTKSLGQRSKGM
FQNYSQSFESQASERSCRIQRLEIGNELIYVIHK
>A0A076FC00|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIELKNIKKSFAIGGVQSEVLKGINLTIDKGEFVAIIGQSGSGKSTLMNILGCLDTPTSG
TYLLENQDISKFDRDGLSALRLKKFGFIFQRYNLLSSNDSKSNVALPGVYAGVSKAKRLE
IAKELLDKLGLKEKCDAYPNHLSGGQQQRVSIARALMNGGEILLCDEPTGALDSASGVMV
MEILRDLHKDGHTIIVVTHDKEIAAWANRVIEIKDGNIINDTKKSAQIYEYKEPKNTKKS
KFNSIKDRFFESFAMSVGAIKAHKLRSFLTMLGIIIGIASVICVVALAKGSQEKILADIN
NMGTNTISLYPGKGFGDRNSNKVKSLTIDDSNFLEQLDFVDYSTPRMNTSGLLTYANKSL
DASLRGGSQNSLSISNVKISSGRDFVAEDIYLSKSNIIIDQFVKKEFFKDVDPIGKVILF
NRQPFTIIGVANREDTSFSGDSLTVFAPYTTTMNKLTGDRNIRSIAVKLKDGVNAQVAEQ
SIIEVMQVRRGAKDFFTRNTDTIMQTVQSTMNTMSLLISGIALISLMVGGIGVMNIMLVS
VFERTKEIGIRMAIGAKSNDIMLQFLIEAILLCAIGGVVGVGLAYAIGYLVNLAGAGFTM
IFSTASIVIAIGVSSLIGIIFGYIPARNASRLNPIDALLRE
>YP_001780068|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MLLILKAIIIGIVEGITEFLPVSSTGHMIIAGSLIGFDGTVYRKAYTDMFSVVIQLGAIL
AVVVLYWDKIMSTLKNFFPSDRVPVKKCGLKFWINIVIASIPAAIIGIPFNDKIEEKLFY
PLPVTIALIVGAIWMIYAENRYRNNSKVISIDDVNAKQAIIIGVFQCLALWPGMSRSAST
IIGAWIVGLSTVAAAEFSFFLAIPAMIGASGMSLIKHNVFSTCSSIELIALAAGFIVSFI
VALVVIDKFIAFLKKKPMKVFAIYRIVLGIVLIILIYTNIITWH
>YP_002394666|FEATURES|ARDB_deepARG|quinolone|QnrS|antibiotic target protection|1
MDTNNSTYHQHSFAQQDLSELTFTACTFIRCDFRRSNLRDATFINCKFIEQGDIEGCHFD
IADLRDASFQNCQLAMANFSNANCYGIELRECDLKGANFTRANFANQVSNRMYFCSAYIT
GCNLSYANLEQACLEKCELFENRWIGTYLGGASLKESDLSRGVFSEDVWGQFSMQGANLC
HAELEGLDPRKVDTTGIKIVAWQQEQLLETMGIVVMPD
>A0A0A2ZE78|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQHIIEIKNLNKFFGEGENRVHILKNIHLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
SSGSYQIAGKETAKLSADQLSELRQQRFGFIFQRYNLLSTLSAQENVALPAVYTGMAKAQ
RLQRAAQLLEKLGLGNKIDNKPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSG
ETVMQILQQLHQEGHTIILVTHDKHIAQFANRIIEIKDGEIIQDQRQSLQITARKMTQTT
TNRGWQFYRDQFFEALNMSINAIIAHKLRSLLTMLGIIIGITSVVCVVALGNGSQQKVLQ
NINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQPYIESVTPNSSVSGTLTYRN
NAFTAQVRGVSEQYFNVKGIQTVAGQLFSGEQVKQNQSVAVIDQNTQKRIFQDRNPLGQI
IMINKKPLKVIGIVDIQNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTA
AAEKNVTALLLSRHGKKDFFILNTDTIKQTIESTTNTMKFLISSIALISLIVGGIGVMNI
MLVSVTERTKEIGVRMAIGAKQQNILQQFLIEAVLVCLVGGIIGIILSGLIGFLFNRFMS
EFTMLFSTFSIVVAVLCSTLIGIIFGYVPAKNAAKLNPITALSQE
>F8I1B5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDFIKSIIIGIVEGLTEFLPVSSTGHIIIAESLMKIPGGTVWTKAFMNVFDYVIQLGAI
MAVIQLYFHKLNPFSPKKNGIEKQQTWQLWFKVIVACLPAAVIGLLLNDFMDAHFMTPTV
VASALIFYGILFIFMEKHNEREDVQPWLTDVNKMSYKLAFTIGLIQVLSIVPGTSRSGAT
ILGAVFLGVSRVAAAEFSFFLSIPVMVGVSILKLGSFFHKGGTFTGMQGIVLAIGFIVSW
IVAWYAIKFMMNYIKQNDFKAFGWYRIVIGIVVIILGAFGLLHM
>C4FI26|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTTLEAVILGVVEGLTEFLPISSTGHLILVSNLLGIQQTEQHKAFEVSIQLGSILAVVFL
YFKKFLDTNLMKRILIAFIPTGILGFVLYKIIKSLFNPYIVVFMLVFGGLLLILIELYHK
NKSYDINSIYEVPYQKAFLIGVFQALAMIPGTSRSGATIVGGLLLGLNRKTAAEFSFMLA
VPTMFMATFYDVYKNHSNFNLSDWENLIVGFIVAFISALFAIKWLLKFISNHSFIPFGIY
RIILGILYYFIVLR
>A0A094TG06|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSTFDKIKKVSVVIPVYNEEESLPQLLERTIKSCKQLEQEYELILVDDGSSDNSAKMLEE
AATIEENHVIAIILNRNYGQHSAIMAGFNQADGDLVITLDADLQNPPEEIPRLVTTAEEG
YDVVGTRRRNRQDSWFRKTASKMINSMITKATGRSMGDYGCMLRAYRRHIVEAMLQCHER
STFIPILANTFARRTIEIDVAHAEREYGDSKYSFLKLINLMYDLLTCLTTAPLRLLSIVG
SVIAVSGFVLALLLIVLRIIFGAMWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYN
DVRARPRYFIQKVVGVNKPNEDQEKD
>A0A0W0PEC1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLNAGYDIAAVFTHADDPAEKTFFGSVAQLCARHDIPVHA
PEDPNHPLWVERIGILAPDFIFSFYYRQLLGEPLLACAKKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPVVAQQRVSISATDTALTLHGKLREAASSLLCEALP
LLAQGQLSGTPQDESKATYFGRRTPADGLIDWSLPAARLYDLIRAVTQPYPGAFCPVGDN
KLIVWSARIEPRNNHQAPGTVISHDPLRIACGEDSLVISAGQRGDNGLYLSGAQLAREFG
LVEGSQLLDTQKRRPARRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGCDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRGGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSIDNARQLIDWAPGIELSETIGKTLDFFLREAMAEKA
DQC
>A0A0L7T235|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MNEQEINKVSVVIPVFNEQECLPELIRRTCAACALLPMDYEILLVDDGSSDDSAEIMAAA
AEQPGSHIVAVLLNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVSVAAEGY
DVVGTVRQNRQDSWFRKRASRLINHLIQRTTGKAMGDYGCMLRAYRRHIIEAMLHCHERS
TFIPILANTFARRAIEIPVKHAEREFGDSKYSFMKLINLMYDLITCLTTTPLRMLSVFGS
VIALFGFAISLLLILLRLFFGPQWAAEGVFMLFAILFIFIGAQFVGMGLLGEYIGRIYND
VRARPRYFIQRVVKHSSSSSAQDNQ
>U6A458|FEATURES|UNIPROT_deepARG|beta_lactam|blaFONA-2|antibiotic inactivation|1
MAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYSDNTA
MNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDPRDTSSPLAMAKSLQNLT
LGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWIVGD
>A0A0R1FFM4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKAVILGIVEGITEFLPISSTGHIVLVNEFIQLHESKAFIDMFNVVIQLGAILAVV
VFYFHKLNPLSGRKSQLERSQTWTLWWKVLLAVIPSVIVGLPLNDWMDAHLMNWAVVSAT
LIIYGILFIVIENHNKGLTPKFADLNTLPYKTALFIGVFQLLSLIPGTSRSGATILGAII
IGTSRYVATEFSFFMAIPTMLGASLLKIYKFYDHGNSLVGLQSVVLLVGVVVSFIVAYLS
IRFLLSYIKKNDFKAFGWYRIVLGILVIGYFVFFG
>A0A0G0JLC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQYIDAIIFGIIEGLTEFLPISSTGHLMLTAQVLGGQTEFLKTFEIVIQLGAILSVVVLY
WRSFLVDFAVLKRVIVAFIPTGILGLIFYKIVKTYLMSSMTTVLWALAIGGAVIIAFELI
NKGDGGTSEIAKISYKKAALIGVFQSIAMIPGVSRSAATIIGGLSLGLSRKAIVEFSFLL
AVPTMLAASSMDLYKNATAFSTSQIGFLAIGFTVSFLVAILAIKFFLKFIQKHSFTWFGV
YRIIIAAIGFWLLF
>NP_706721|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISFC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETAMRIGEKLSLKELGRDYKLVLKNGRFVAGALGFVSLPLLAWIAQS
PIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVA
AAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLIFT
VGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>T6GRL8|FEATURES|UNIPROT_deepARG|beta_lactam|G736_04738|antibiotic inactivation|1
MLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGAIGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>A0A0M4UHT8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIFLKNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDTPSSGTYVF
DEYEVTKLNNDEKARLRREKIGFIFQRYNLLSLLSAKENVSLPAVYAGKKLQERSQNAKK
LLNDLELAHKLDSKPNELSGGQQQRVSIARALMNGGELILADEPTGALDSKSGIMVLEIL
QKLNAQGHAIVLVTHDPKIAAQAKRVIEIKDGEILSDTKKEKAQEKLTLKTMSKEKKTLT
LLKNQAFECFKIAYSSILAHKLRSILTMLGIIIGIASVVCVVALGLGSQAKVLESIARLG
TNTIEIRPGRGFGDLRSGKTRLNFSDLETLRSLEYLEAVDAHSNTSGVATYTNISLSARA
EGVGVNNFAIEGLRIDAGRILNNDDVKNSTNVAVLDFNAKKNLFPDEKSENILGRVVLFN
SQPFKIIGVLQKDTDKPIEDNVVRLYIPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
AIIRILEIKRGQKDFFTFNSDTFKQAITANKRTTTILTACVAVIALIVGGIGVMNIMLVS
VSERTREIGIRMAIGARREDIMMQFLIEAVMICTIGAILGVILSIFVIFAFNTLSTDFPM
ILNAYSVLLGLLSSMFIGVVFGFFPARNAANLNPISALSKE
>V2T650|FEATURES|UNIPROT_deepARG|beta_lactam|F987_03249|antibiotic inactivation|1
MNQPKAFSMTLKKLSLLAGLLSCSSALWAGNLTEQQVKSIVDQQFKPLLAQYKIPGMAVA
VTLNGQHYFVNYGLASKQNQQAVSNNTLFELGSVSKTFNATLTGYAQAQGQLSLSDHPAK
YFPELKHTAVNRATILNLGAYNAGGFPLQFPDEVVQQQDMIKYFQTWQAKTKVGAARQYS
NPSIGLMGYVTALAMKKPYSELIEKTLLPQLGMTQSFIRVPEQHMSQYAWGYKADQAMRV
SPGMFDAEAYGLKSSSADMLKFLDAQINPQQFKQPLRKAIENTHVGYFKVGAMTQGLGWE
QYAYPISLETLLQGNSSKMALESHAITPIKQPKLAPPETFFNKTGATNGFGAYVAFIPQQ
KIGIVMLANTNFPNEERIKASYRVMQQLVQNNSAQ
>YP_002030218|FEATURES|ARDB_deepARG|multidrug|smeC|antibiotic efflux|0
MKPMLLRALAAATMTTVLGGCVSMAPHYQRPEAPVPAQIGNAATGEAEPVLTMPAWREVF
LEPRLQQVIALALQNNRDLRVAVLQVQKERAQYRIQRAALLPSVDASGSVTRSRVSDANS
ETGATQITESDAVQVGISSWELDLFGRIRSLNNEALQNWLASAENQRAARTSLVAEVATA
WLALAADEQSLAFTRQTLDSQQQTLQRTEARHAQGLASGLDLSQVQTSVEAARAALAKLQ
TQQARDRDALQLLVGAPLDAALLPGAQALDGTVALAPLSANLPSSVLLQRPDVLSAEHAL
QAANADIGAARAAFFPTLTLTANYGHSSTALSTLFSAGTRGWSFAPSITAPIFHAGALKA
SLDASKIGKDIGIAQYEKAIQQAFSEVADALATRDHLIAQMEAQRALVAASQRSYTLADA
RYRTGLDGYLQALDAQRSLYAAQQDLIALQQQEAGNRVTLFKVLGGGADAQ
>A0A0L1M8L5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQGINHMCFSVSNLEQSIIFYQKVLGAELLVKGKSTAYFSLNGLWLALNEEKNIPRSDI
QYSYTHLAFSISIENFDEARELLKQHNVTILSGRKRDERDKKSIYFTDPDGYKFEFHTGT
LQERLAYYQEEKPHMTFYSPEE
>I6YPN9|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKCESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRVPLILVTYFTQPQPKAESRRDVLAS
>A0A067A8P2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHQKTNLKPGILAALTLSLVTGQSLADTSLASTVNAAVRPLMQQQAIPGMAVAISVDGQQ
HYFNYGVASTQSGQAVNADTLFEIGSVSKTFTATLAGFAEASAKLSLGDPASKHWPALKG
TAFDGITLLNLGTYSAGGLPLQFPDEVKGEADLPGYYGHWKADYAPGTHRLYSNPSLGLF
GYLTAKSLGTPFAELMEKQLLPQLGLQHSYLQVPAAQMGNYAQGYNKQDQPVRVGPGPLD
GEAYGLKVTAVDLLHYLDLNMQPHSLSKPLQRAIATTQTGYYQVGEMTQGLGWEQYAYPV
SLEQLQAGNAPSMVLQAQPVTWLKPARPLPANTLLNKTGSTDGFGAYVAFVPSKRIAIVL
LANKNYPIAERVKVAHRILTALAK
>NP_521874|FEATURES|ARDB_deepARG|multidrug|MexC|antibiotic efflux|1
MKIERLRRHGGVHVLLAAMLAGCGPSEPQSAPPAAEVATTTVAPAHLELTEDLPGRVAAV
RVAEIRPQVSGIVQRRLFEQGTEVRAGQPLFQINPAPFRADADTAAAALRRAEAALARAR
VQTTRLQPLVEADAVSRQAYDDAVSQRDQAAADVEQARATLARRQLDLKFATVEAPIPGR
IDQALVTEGALVSSGDSNPMARIQQIDQVYVDVRRPASSLEALRQTLATQKTGAGDGLPV
AVLRSNGEPYEAKGHILFSGINVDAGTGDVLLRVLVNNPQRQLLPGMFVRARVPHARYTD
ALTVPQQAVVRVGGQPQVWTLDANSHARLKPVELGELADRRYRIRAGLSAGQKIVVEGME
RLSDGAAVAAHDWKSPEPVPAGPAR
>Q689F1|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLALHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>B1SBL2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFFELLKAIFLGVVEGITEWLPVSSTGHLILVQEFIKLNQDKAFLDMFNIVIQLGAILA
VIVIYFKRLNPFQPGKTAREVQLTWQLWLKVVIACIPSILIAVPFDDWFEAHFNYMIPIA
IALIVYGIAFIWIEKRNANIEPEVTDLAHMPYLTAFWIGCFQVLSIIPGTSRSGATILGA
IIVGTSRSVAADFTFFLAIPTMFGYSGLKAVKFFLDGNVLNFSQFLILMVASVTAFLVSL
YVIRFLTDYVKKHDFTIFGKYRIVLGTILILYSIAKFIF
>ZP_03064983|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MTNLKSDTRGLHMNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTE
PLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIAPATYQATYDSA
KGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETAR
INLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQ
ELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLL
PGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWL
VTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>A1A9U9|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQISN
>A0A080UE39|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MDFHQIDIDRWNRKPYFEHYIKEGKCSYSVTANLNVTALLNGLRKKNMKLYPAFIYMISR
VVNSHIEFRTAFNDKGQLGYWEQMVPTYTIFHKEDKTFSAMWTEYSSDFSLFYKNYLQDI
DRYGDKKGLWVKENVPAHTFSISALPWVSFTGFQLNLYNGEYLLPIITLGKYFSDGETVC
LPISLQVHHAVCDGYHVSMFINELQKLADSFEEWL
>A0A0W4HGN1|FEATURES|UNIPROT_deepARG|aminoglycoside|IN69_18810|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAESAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>CAR56415|FEATURES|ARDB_deepARG|multidrug|OpcM|antibiotic efflux|0
MLEDRKMDNMHNTNGLMRFAKVAAASTLLATLLAACAVGPDYQRPDAAAPAAFKEAPTLA
AGEQAGTWKTAEPSDGEHRGEWWKVFGDPVLDSLETQALAANQNLKAAAARVEEARAATR
SARSQWFPQVGAGFGPTREGLSSASQFQPQGTGPTNATLWRAQGTVSYEADLFGRVGRNV
EASRADQAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYRRTVELREQALKLVQRRF
NEGDISELDVSRAKNELASAQADAVGVARRRAASEHALAILLGKAPADFAFKETPIVPVA
VKIPPGLPSALLERRPDVSAAERAMAAANARIGLAKSAYFPKLDITGSFGYEASTLGNLF
LWSSRTFLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQVANYRQQVLVAFREVEDNL
ADLRLLDDQIRAQEAAVNASRRAATLSRTQYQEGEVAYLDVIDSERSVLQSQLQANQLTG
AQAVSTVNLIRALGGGWGNAPAPTAVGDAASGKADVAAR
>A0A120HUS0|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFALPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKIL
ESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGM
TVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDE
RDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGA
GERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A0H4IS11|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-163|antibiotic inactivation|1
MVKKSLSQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0D0I3H3|FEATURES|UNIPROT_deepARG|beta_lactam|ST44_11125|antibiotic inactivation|1
MGKNRKKQIVVLCIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVYNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>A0A0Q4ENB0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACKQLAYEYEIILVDDGSRDNSAQLLEDA
AAEDGSNVVAVILNRNYGQHAAIMAGFEQCRGEVIITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGMLFAFALVFLRLVFGAEWAGSGMFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAEPAPVVVVDGLATSHSPTSPSDQVSS
>YP_001373621|FEATURES|ARDB_deepARG|bacitracin|BcrA|antibiotic efflux|1
MYVKDHRKWVFTIHTIIKTTNLTKVYGKQKSVDHLNINVNKGEIYGFIGRNGAGKTTTIR
MLLGLIKPTNGKIEIFGEDFTKNQKDILRRIGSIVEVPGFYENLTAKENLLINAKIIGVH
KKNAIEEALEIVGLQHETKKLVGKYSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGI
KEMRKLIKTLAQERNITIFISSHILSEVEQLVDHMGIIHKGKLLEETSLDALRKMNRKYL
EFQVNNDNKAALLLEKQFHIFDYEVHDEGNIRVYSHFGQQGQINKMFVQNDIEVLKIIMS
EDRLEDYFTKLVGGGTIG
>A0A034T263|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MDMTMSDFKTIQFVSVVIPVYNEQESLPELLSRTIAACDAMGKQYEIVLVDDGSSDRSAE
ILREAAQRPGSRVVAVLLNRNYGQHSAIMAGFSHIKGDLVITLDADLQNPPEEIPRLVET
ADQGYDVVGTIRQNRQDSWFRKRASRMINGLIQRTTGKSMSDYGCMLRAYRSSIIKAMLH
CHERSTFIPILANSFARRTIEIPVKHAEREHGESKYGLMKLINLMYDLVTCLTTTPLRAL
SIFGSVIALLGFAFAVLLILMRLTLGPQWAAEGVFTLFAVLFIFIGAQFVGMGLLGEYIG
RIYNDVRARPRYFIQNVVRANPPDEEQEK
>H3NK34|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQAVDLLELLKIFILSVVQGITEWLPISSTGHLILVEEFIQLNLDPAFIEMFRTVVQFGS
ILAVVVLYFNKLNPFNPAKSPQDRKETWIIWFKVVVASIPAAVLGLLINDYMEMYFNTPT
VVASALIIYGFAFLWIEDRKTGRHAKHTSQVTQISYPTAFKTGLFQALSLIPGTSRSGST
ILGGLLLGMDRTVATEFSFFMSMPIMLGASLVKLKDFGFSFTTAELVYLLFGMLVAFIVS
LIVIQSLLKFIKTNNFKPFGYYRIILGAIVILYTLFK
>Q0GA83|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLERYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVPAYGVKSTLPDMLSFIHANLNPQEYPADIQRAINETHQGFYQANTMYQALGW
EEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENI
GLVTLTNKRIPNEERIKAAYAVLNAIKK
>CAF18336|FEATURES|ARDB_deepARG|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGVVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>A0A0R2FIG4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MANIIKAIVLGIIEGITEWLPISSTGHLVLAGSVLNMAESKDYMDMFNYVIQLGAILAVC
VLYFHKLNPFSPRKSKLQQKQTWSLWGKVIIAVIPSVIIGLPLNDWMDTHLMNNYVVASM
LILYGILFIIVENHNDKLSPRYTDLNTLPIKITFIIGCFQALSIVPGTSRSGATILGAII
IGCSRYVATEFSFFMAIPTMFGVSILKIGGYFLKGKTFTGDQLSILIIGMVVSFVVSIIA
IKFLMKYIQNHDFKVFGWYRIILGILVLAMMFF
>A0A140CWH6|FEATURES|UNIPROT_deepARG|beta_lactam|blaVEB|antibiotic inactivation|1
MKIVKRILLVLLSLFFTIAYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHYPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWDYYLNK
>A0A0F9ZXY7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILKVILLAVEQGITELLPISSSAHLILSSQILNIKMDTYLLSVLHLGTTMALLIYFAP
ILFKDIFKKSSINFYLKILISTLPAALIGFFFESTIENSLRGNEVIAISLVFWGIIMILV
ERNKKVDEQDLREVTWKQSLLMGIGQTIALIPGSSRSGTSAIIGVLAGLNKYTAIQYSFL
LGLPLLVAAPIYTIIKDAPERTLNISDLIGIVVAFIFTFLSLALLKRFSKDRWLTFFGIY
RIILGIVVLLTILF
>A0A0V9HC16|FEATURES|UNIPROT_deepARG|aminoglycoside|APT96_01115|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFELMITKAINAKPISALFLTDQELLAIYKEALNLLNSVA
IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDFDAELWGDHKTYLSLWNELTETRVEER
LVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLKH
LKNDRPDKRNYFLKLDELN
>A0A127T3C7|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-129|antibiotic inactivation|1
MEGDLIHVSHQGAMKTIAAYLVLVFFSSTALSESISENVAWNKEFTTESVHGVFVLCKNS
TNSCTTNNAARASTAYIPASTFKIPNALIGLETGAIKNERQVFKWDGKPRAMKQWERDLT
LRGAIQVSAVPVFQQIARDVGEIRMQKYLNLFSYGNANIGGGIDKFWLEGQLRISAVNQV
KFLESLYLNNLPASKANQLIVKEAIVTEATPEYIVHSKTGYSGVGTESNPGVAWWVGWVE
KGTEVYFFAFNMDIDNESKLPSRKSIPAKIMAGEGIIIGG
>A0A060KZ03|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLCAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>C2WPJ9|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0023_30080|antibiotic inactivation|1
MTLIGCSNSNTQSESPKQTNQINQVKQVNTGNHAFAKLEKEYNAKLGIYALDTSTNQTVA
YHADDRFAFASTSKSLAVGALLRQNSIEALDERITYTREDLSNYNPITEKHVDTGMTLKE
LADASVRYSDSTAHNLILKKLGGPSAFEKILREIGDTVTNSERFEPELNEVNPGKTHDTS
TPEAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTGDKLIRAGVPKGWEVADKTGAGSYG
TRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLIADATKVVLDTLKVTNK
>F6EUC7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASTWAMFNVIIQLGAILAVVV
LYWRTFWAVGMGLLRREPTSWRFLRNLLVAFIPAAVIGLALHNYIEELLGAPKVVAWALI
AGGIAILGIERMVKENRFHGIADIPFVRVVGIGFIQCLAMIPGVSRSGATIMGALMLGVE
RRTAAEFSFFLAIPTMLGATVLELLKNGDKLTSATVGWDSIALGFIVSFIVAVLVIKWFV
GLVSRHGFTPFAWYRIVAGITALAWLSLR
>A0A075TZ25|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFELLKSMIIGIVEGITEFLPISSTGHIIITQTFLKIPGGDLWTSSFAHMYEYVIQLGA
IMAVIQLYFHKLNPFSPTKSTVERKQTWTLWFKVAVGVLPAVVIGFLLNDYMQDNIWIVA
AMLILYGILFIVIENYLKNKQPVVTDINQLTYQLALWIGFFQVLAIIPGTSRSGATILGA
LLLGASRLVAAEFSFFMSIPVMFGVTILKVGSYLKDGGTFTSSQAWVLAVGFIVSWIVAY
VAIKFLLDYIKNNDFKIFGYYRIALGLFVILLGAIGILH
>A0A0X8F9N8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLELLKIILIGLIEGITEWLPISSTGHMILVEEFVQLQVRPEFWDIFIVVIQLGAILAVI
WIYFNRLNPFSPQKTKEEKRETWETWFKVAVGCIPAAILGLLIDDWMEAHLMNWLVVALA
LIIYGIAFILVENYNKTRTSQVNSMSELSYRRAFTIGLFQCLSLVPGTSRSGSSILGATI
MGTSRPVAADFSFFMSIPIMFGASFLKLVKGFLEGFRFTGLELGYLAVGMVVAFLVSVIT
IKLLLRYIQSNDFKPFGWYRIALGLVVIIYFAWIR
>B7LVU5|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTFNFGELAEKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPYPVKDVRVLSRITTEAFNQRRKTIRNSLGNLFSVEVLTG
MGIDPAMRAENISVAQYCQMANYLAENAPLQES
>A0A0Q6X9Y9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLWVKAAIMGIVEGLTEFLPISSTGHLILTGSLLDFTGDTIKVFEIAIQTGAMIAVV
WEYRARLISTFAGIRSEPVAQRFALNVVIAFIPAGIFGFLFNKAIKAHLFHPVPVAVAFI
VGGLVILWVERRHHRLYGERDLEGTHHARVETVDDMTPLDALKVGLLQCLALIPGTSRSG
ATIIGSLVLGFSRKAATEFSFFLGIPTLTAAGAYSVWKSRDLLHWGDLPIFLIGTAFAFI
SALICIRWLIRYVSSHDFTVFAWYRIVFGVIVLATAYTGTVNWAA
>A0A089NLV6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIIKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSMDFLGKYTANTFKVVIQLGS
ILAVVVIFRNRFIDLLGLKRFSRKELTAVPEGQPAVETAGRLKLAQVIVGLIPAGVLGFL
FEDYIDEHLFSTATVLIGLVVGAILMICADLFAPKKIKAESVDQITYRQALSVGLIQCLS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLISLLKNWQYFTLDALPFF
IAGFISAFLFALLSMRFFLKLINRIKLMPFAIYRIILAAVVYLVWF
>A0A0M0KXL0|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEWQQQVPPVQGLNHLLFSVSHLDQSVAFYQDVFGAKLLVKGRTTAYFDLKGIWLALNVE
TDIPRQEIHQSYTHLAFTIKEADFDETLHMLQMRGVHILPGRERDQKDKKSIYFTDHDGH
KFEFHTGSLQDRMNYYQKEKTHMTFY
>A0A0S3PVD0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDLIKAAFLGVIEGFTEFLPVSSTGHLLLIGHFLGFEDADFGKTFVVLIQLGAILAILS
IYFGRLWKIAMALPYDVFARRFVIGVLIAFLPAALIGYLARGFIKGTLFNPWVVCVSLIV
GGFILLWVDRQEIAQRFNDAMRYPLPMYLGIGIAQCLAMIPGVSRSGSTIVAAMLMGSDK
RSAAEFSFFLAIPTMVGAFALDLLKSYDQLSSNNILIIAVGFVTSFVAGWFVVRSLLDYV
SQHGFAVFAWWRIIVGAIGLIGLALLG
>A0A0W0MUY0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQALLELKGISRSFIAGEKAFMALKDVNLTINAGEMVAITGASGSGKSTLMNILGCLDY
ATDGSYTISGRETRDLGDQELAELRRDHFGFIFQRYHLLPHLSAMHNVEMPAIYAGVPEG
QRHSRAKELLARLGLATHLANRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDTAS
GKEVMNILLELHAAGHTVIIVTHDPKVAANAERIIEMRDGEVLSDRVNERVGVELAAPDA
TATKAKPGRRLVASLGLFKEAFVMAWVALISHRMRTLLTMLGIVIGITSVVSIVAIGEGA
KRYVLSDIQAIGSNTIDIYPGTDFGDSHASAIETLVLADVTALSQLHYIDSATPNAGRNL
LLRFGNIDVDATVNGVSASSFQVRGIKLAEGITFSQDDDTRQAQVVVIDHNTRNRLFGPN
VDALGQIILVGNLPCTVIGVAADNKNIFNTSKALNVWVPYETAAGRLLGLRYLDSITVRI
KDGQPSKVVEDNVVKLMEQRHGTKDFFTYNLDSIMQTVQKTSQSLALLLSLIALISLVVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGISLSFGIGF
VFSLLIKEWQMVFSLESIITAFVCSSLIGIIFGFVPARNAARLDPIEALARD
>J8JVH4|FEATURES|UNIPROT_deepARG|beta_lactam|IIM_01725|antibiotic inactivation|1
MIVSKKFFPISHYKKMLPVVLLSCATLIGCSNSNTQSESPKQTKQEHISNQSFVKLEKKY
DAKLGIYALDTGLNQTVTYRSDERFAYASTHKALAVGALLQKKSIKDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKKNTTGDNLIRA
GVPGEWKVADKTGSGPYGTRNDIAIIWPPNKKPIVLAILSNHAKEDAKYDDKLIADATKI
VLDSLKVTNKS
>NP_460137|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRDRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFILCALF
NAWLLPAWKLSTVRTPVREGMRRVMSDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
SPAAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMLPIGMVGNLQQL
FTLICAFYIGSVIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDMG
KALAQPELPWMMLGIIGFITFLALGWQFSHKRTPRRMLEPGA
>ZP_04657259|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>Q3MSL6|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAKEHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>A0A023DF97|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVEIIKAIILGMVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYAANTFKVVIQLGS
ILAVVVVFKDRFIDLLGLRGRHRDGQPRLKLMQVIVGLIPAGVLGVLFDDYIDEHLFSTA
TVLIGLVLGALLMIAADWFAKKNTPKAQTVDQITYKQAIIVGLVQCLSLWPGFSRSGSTI
SGGVLAGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTAADIPFFIAGFISAFLFAL
LAIRFFLHLINRVRLVPFAVYRIVLALVIYVLYF
>CAA36829|FEATURES|ARDB_deepARG|beta_lactam|mecC|antibiotic target replacement|1
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEV
EMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKED
GMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTHMRLGIVPKNVSK
KDYKAIAKELSISEDYINNKWIKIGYKMIPSFHFKTVKKMDEYLSDFAKKFHLTTNETES
RNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT
IVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFE
KGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNINAPHLLKDTKNKVWKKNIISKENINLLNDGMQQVVNKTHKEDIYRSYANLIGKSGT
AELKMKQGESGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENG
NKKYDIDE
>A0A0B3XUC2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFADEKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGEVPHEGKTAGRLKLTHILLAMIPAVVLGLIFHDVIKSLFYPQN
VMYALVIGGFLLLAAEWFKPKQPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSWHFLSLADVPMFAVGFVTAFIVALIA
IKTFLKIIKRISFVPFAIYRFIVAGVVYMVFM
>A0A0C3I6J4|FEATURES|UNIPROT_deepARG|aminoglycoside|RO22_05705|antibiotic inactivation|1
MIPYEAQQAQSIAEDVLGESIVGIYLFGSAVADGLQRNSDVDVLVAVSDSPSCKQREALV
AQLMKVSGTIGNAQATRPVELTVITISDVVPWRFPPRAELIYGEWLRDEFEAGHIPKPAC
DPDLAIVLKKVIDNSLPLYGINAAEVFEPVPMADVQRAIRDSLPTLLAETAGDERNVLLT
LSRMWLTVATGDIASKDVAAEWAKEQLAKEDAALLDYAKQGYLGKVVDQWQGKQGEFQAL
ICSMRQSIETCLATPH
>A0A0C1HVG6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIVEILKSIIFGIVEGITEWLPISSTGHLILVQEFLKYKDQNAAFMEMFNVVIQLGAIL
AVVVIYFDKLNPFKPGKTAREVQKTWQLWAKVVIAAAPAAIIGLPLDDWFDAHFYNFISV
ACMLIIYGVAFILLEKRNKTVEPAITNLDRLPYKTALYIGLFQVLSLFPGTSRSGATIVG
GLLNGTSRSVVTEFTFFLGIPVMFGASGWKILKFIIKGNTLGFGQFFLLLVAMGVAFGVS
LYVIRFLTDYVKKHDFTIFGKYRIGLGVLLIVYGIFKAIF
>D4FLF5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEITNVNHICFSVSDLNTSIQFYKDILHGDLLVSDRTTAYLTIGHTWIALNQEKNIPRNE
ISHSYTHVAFSIDEEDFQQWIQWLKENQVNILKGRPRDIKDKKSIYFTDLDGHKIELHTG
TLKDRMEYYKCEKTHMQFYDEF
>F0PKQ5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVKGRKLAYFNICGVWIALNEEIHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYREDKPHMTFY
>A0A0T6UVA1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQQRRALALLTLGSLLLTPCTYARGEAPLTATVDGAIQPMLKEYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVNEQTLFEIGSVSKTLTATLGAYAAVKGGVELDDKVSQHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLTANSLGQPFEQLMSQTLQPKLGLHHTYIQVPESAIANYAYGYSKEDKPVRVTPGVLAA
EAYGIKTGSADLLRFAEANMGYQGDAAVKSAIALTHTGFYSVGEMTQGLGWESYAYPVTE
QTLLAGNSPAVSLKANPITRFAAPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>A0A140PV79|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFRNSFLIIIQLGAILSV
VVYFWKDISPFVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLDNVFVVAIT
LITYGVIFIGIEVVYKLKNIKPKVKRFAGLKYRTAFLIGLFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEMEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIVVIILLLY
>BAE71359|FEATURES|ARDB_deepARG|beta_lactam|CARB-3|antibiotic inactivation|1
MLWSSNDVTQQGSRPKTKLAILWSLMLLYKMCDNQNYGVTYMKFLLAFSLLIPSVVFASS
SKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQRFPLTSTFKTIACAKLLYDA
EQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFATMTTSDNTAANIILSAVGG
PKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKAIASTLNKFLFGSALSEMNQ
KKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLA
QTQASMAERNDAIVKIGHSIFDVYTSQSR
>R7ZAQ1|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIQNINHFLFSVSNLGNSIAFYKNVFDAKLLVKGSNTAYFDLNGLWLALNVEKDIPRNE
IHQSYTHIAFSILEEDFDKMYEKLMHYNVNILEGRQRDVRDEKSIYFTDPDGHKFEFHTG
TLQDRLQYYKKEKVHMEFFD
>NP_455648|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIILLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGG
FIPNANALIATQVPRHKSGWALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVL
FICFLLTFFFIRENFLPVSKKEMLHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>YP_002238610|FEATURES|ARDB_deepARG|beta_lactam|LEN-22|antibiotic inactivation|1
MRYVRLCVISLLANLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSPRSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>A0A0S6V9K0|FEATURES|UNIPROT_deepARG|beta_lactam|SLIQ_07845|antibiotic inactivation|1
MTKINRLAAALFAALILPTGHAAEKADIDAIIQPLMQKYAVPGMAIAVSVDGKQQFYHYG
VASKQTSKPITNQTLFEIGSLSKTFTATLAAYAQNEGKMSFADPASRYLPTLRGSAFDQV
TLLNLATHTSGLPLFVPDDVTNDAQLMAYYRQWQPPHAVGSYRVYSNLGIGMLGMITAKS
LNQPFTQAMEKTLLPALGMDHTFIKVPAEEMENYAQGYNKKDQPVRVTPGPLDAEAYGIK
SNAQDLIRYLDANMQVVKVGEPWRKALASTHTGYYRTGVFTQDLMWESYPYPEKLATLTE
GNNAGMIMNGAPATAITPPQQDQGAAWYNKTGSTGGFSTYAVFIPSQKIAVVMLANKWFP
NDDRVAATYQIVQALDKR
>BAG80214|FEATURES|ARDB_deepARG|tetracycline|tetC|antibiotic efflux|1
MKSNNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCA
PVLGALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYI
ADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFL
MQESHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDR
FRWSATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAADALGYVLLAFATRG
WMAFPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTSIIGPLIFTAIYA
ASASTWNGLAWIVGAALYLVCLPALRRGAWSRATST
>A0A0S4M503|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSIELIFKACLLGIVQGITEFLPISSSAHVVLLSGILGDFGKHTKSMLIFLQGVSILAVM
RLYWQFLRKTLTINTVTSRSLLKSIAFGALPFMIVGFISHKFIFLYLFSPSIVSAFLILG
GVVLIFVNYFFHRNYFCKINSVDFIEPKHGFMVGLGQILAIFPGVSRSGATIVGGLLCGM
TRPVAVQFSFLLAIPLLFSVSIFQLLSVVGVLTFDEWLIMGVASVVTVGVSCAVVGRLFD
FLSYGRNSFFLIGIYRVCLGLGLFYWSAR
>A0A158FCC5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGIVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRAKIGAVVTGLPARTEARRFTLNLIIATIPAVVLGLMFEKNIKAVLFSPVPVSVALI
IGGIVILWAEARQRERGVAPRVTSVDDLSYADAFKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATLYEMAKYWRTLTVDDISLFAIGLVAAFVSAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>G9WT43|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIVEFLKVIVFSLVEGFTEWLPISSTGHLILLQNIIPLAGTKEFFSTFEVLIQLGAVMA
VVQEFFFRLWPFGKRKKSGGIYLKEEKVILIGKVLLACLPAAVFGLLLDDFLDQYLYNGF
VVSLMLILYGVFFIVLEQRNASRKFAFNRVEDLPWTLCLEIGLFQCLALIPGTSRSGATI
IGAMLLSVGRVAATEFSFFLSVPVMAGASLLKLIKHGGHFSGMEWFTLLLSMVLAYLVSL
YCIRFLLRYIRSHDFKIFGYYRIIFGGIMLMWFLVSRFLL
>A0A127T444|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-2|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVGAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>A0A0M2P3T6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQSINHVTYSVSDIKQSIVFYKDILKANILVESDKTAYFALGGLWLALNEEKDIPRNEI
QYSYTHIAFTIDENTFDEWYQWLKDNNVNILEGRNRDIRDKKSIYFTDPDGHKLELHTGT
LQDRLDYYKEEKPHMKFYI
>A0A088XVS4|FEATURES|UNIPROT_deepARG|beta_lactam|DM82_6293|antibiotic inactivation|1
MLKSTQFVIRMWLALSCCIASAAHTAHAARGVEPADIERTVDAVAWPLQDKYGIPGLAIA
VTVDGRHYFYNYGVASKATRQPVTDRTLFEIGSLSKTFTATLAAYAQEGGELSFADSVSR
YLPALQGSSFDRISLLNMGTQTSGLPLFVPDRIANTAELLDYLKSWRPEHTPGTHRVYSN
LGIGTLGVIAAASMNERFETLIEKNLFPEFRMTHSYIDVPAEQSGDYAQGYTKQDTPIRL
KAGMLASEAYGVRSCTSDLIKFIDANMGLVPLSDKWARALDATHVGYYDAGGMIQSLIWE
QYPYPVSLDKLLAGNDLIGKDVVAKPFNPPLPPKRDAWINKTGSTNGFSTYAAFVPSKKV
GVVILANKSYPLSERVTAGYKIVDSIIRAERSGHPSLPQDQQ
>A0A0M0W6H8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MIVKIREYELPHADSGPYGITLGKDGALWFTQHKTNQIGRMTVGGKVKHFNVPTINAGAL
SITSTTQGDIWFAENKANKIGKLTITGEIMEYVLPNPDSAPFGITEGHNGDIWFTEMNGN
RIGRILPSGEIIEYDLPRPGSYPSFIVAGSDNALWFTLNQSNQIGRITLEGDVTTYNLPT
EKAGPVGITNGPDGALWFVEINGNKIGRITISGVISEYPIPTPNARPHAIVTGPDDALWF
TEWGSNQIGRITVNGKITEYPIPTKKAEPHGIVVGSDKALWFAEECNKLGRLSFGQKS
>A0A060NV66|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLLKAAVMGLVQGITEFLPISSTGHLILTSALLGLYGEKVRLFEVVIQVGALLAIV
SVYLERLLDTAKGLPRGDAVAWRFTSNLVIGCLPAVILGVLFFDFITGVLFNPLVVAFSF
ISGGLVILWVEARQARQPPQRIQEVDAVGWRDSLTVGLIQCLALVPGVSRSGATIVGAMA
FGFSRRAATEFSFFLSIPMLVGAAGYDLYKNADLLTRADLPFFAVGMVVTWLSAWACVRW
LLRYVAQHTFVPFAWYRIGFGLLVLLTAYMGWVDWTR
>YP_002095804|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GSGDYAMRVWLDPQKVAQRGLSAEDVVQSIREQNVQVAAGVIGASPSLPGTPLQLSVNAR
GRLQTEDEFGDIVVKTTPDGGVTHLRDIARIELDASEYGLRSLLDNKPAVAMAINQSPGA
NSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIEGGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVR
GVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFSERHGKALSAGAIAGALN
QKYSAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAP
GFSSGQAQAAVERIAHETLPRGVRFEWTDLTYQQILAGDSAMYVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGADSEMRHAMGRRGVLRDAR
RDAVRADADAGVLRCAADARGRQDPRRRQGFDGVRRAGARCLRTRK
>A0A0F2L2S3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMIDQYLDATLMGLVEGLTEFLPVSSTGHLIMLDELLGFQGPPGKVFEVVIQLGAILAIC
VVYFQRLWHVATGLKDDPGARRFVMAVLIAFLPAMVLGAGLHGVIKTLLFNPTVVSIALI
LGGVAILVVERLVPTARYHRIENFPAPLALKIGFCQCLALVPGVSRSGASILGALLMGVD
RRAAAEFSFFLAVPTMAGATAYDLYKNWSVMSLDSGLLILVGFVTAFIAAALVVRTLVDF
VGRYGFAPFGWYRIAIGTGMLAFLYL
>ZP_04090195|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVKGRKLAYFNICGVWIALNEEIHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQERLNYYREDKPHMTFY
>W1HC62|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MSRVSQARSLGKYFLLVDNMLVVLGFFVVFPLISIRFVDQMGWAALMVGIALGLRQLVQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAGGFAAMAVAHEPWVLWFSCILSGLGGTLFDPPR
AALVVKLVRPHQRGRFFSILMMQDSAGAVIGALLGSWLLQYDFRLVCSAGAALFIACAAF
NAWYLPAWKLSTVKTPIREGLGRVLRDKRFVTYVLTLTGYYMLAVQVMLMLPIMVNDIAG
SPAAVKWMYAIEATISLTLLYPIARWSEKRFRLEHRLMAGLLVMTLAMLPIGMTSSLQQL
FTLICLFYIGSIIAEPARETLGASLADARARGSYMGFSRLGLAFGGALGYAGGGWLFDAG
KPSASPNCRG
>A0A0T9XTV9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAELGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGAXXXXXXLPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQ
TLGLVAGARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAIS
RFLLHPRFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENL
RIIRYCVKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVI
WAYGEKEGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQK
RCFTDIRDGIEALFRIIVNEGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHF
PPFAGFQVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVD
VAERAS
>A0A0H3YEU2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-2|antibiotic inactivation|1
MTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQI
LYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTMT
LAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPR
DTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGSG
EYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>ZP_02834606|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFILCALF
NAWLLPAWKLSTVRTPVREGMRRVMSDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
SPAAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMLPIGMVGNLQQL
FTLICAFYIGSVIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDMG
KAFAQPELPWMMLGIIGFITFLALGWQFSHKRTPRRMLEPGA
>A0A068HNP8|FEATURES|UNIPROT_deepARG|beta_lactam|KONIH1_31700|antibiotic inactivation|1
MAGRHAADHPPKKFHNAEWRNFLGFPLTPPVTEKHLTDGMTVRELCSAAITMSDNTAANL
LLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGE
LLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSR
IVVIYTTGSQATMDERNRQIAEIGASLIKHW
>C4KT19|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALALGIVEGLTEFLPVSSTGHLIVAGSFLRFHPEQAKTFDVVIQFGAILAVC
WEYRRRIIDVVTGLPAQREARRFTMNVVIATVPAVALALLFEKTIKSVLFAPVPVAVALV
VGGAAILWVEGRQRERSEPARVQSIGALTPFDALKVGLAQCCALIPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPVIFGATLYETAKDWRAFNVDSVGLFAIGLVAAFVSAFACVRW
LLRYVASHDFTAFAWYRIAFGLFVLLVGYSGWIEWT
>ZP_04268622|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MEKMKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVH
TELGYFSGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAH
ADRIGGMKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQSVTNLKFGNMKVETFYPGKG
HTEDNIVVWLPQYQILAGGCLVKSASSKDLGNVADAYVNEWSTSIENVLKRYGNINLVVP
GHGEVGDRGLLLHTLDLLK
>A0A098F6S2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNMWEIFVAVILGLVEGLTEFAPVSSTGHMIIVDDLWLNSKELFGSEVANAFKVVIQLGS
ILAVVVLFWGRFMDLLGLRKLKGTSAVNGQKLNLLQIIVGLLPAGVLGLLFEDYIDDHLF
TMKTVIVGLFLGAFLMIAADKFRPKLTAETVDQITYKQAFGVGLIQCLSLWPGFSRSGST
ISGGVLLGMSYRAASDFTFIMAVPIMAGASLLKIVKYWDSFTPEVLPFFIAGFISAFIFA
LFCIRFFLILINKVKLTPFAIYRIVLAVVLLFIIW
>U5W082|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNIREITVAGAQAGPYGITAGPDGALWLTFTHAGRIARLTTGGEVTTFDLGAPDSQPMVI
TSGPDGALWFTRNRDDRIGRITTGGDLTDFALPTPGSGPYAITTGPDGALWFTEMNTDRI
GRLTPEGDLREFEVPAEKAFVSVITSGPDDALWFTLNQADAVGRITTDGQVTLHQLPTQG
AAPVGITATADALWFVEIGAGQVGRITPAGRIDEFALPDTAARPHAITPDATGGCWLTEW
GANRVAHITATGEITEHELPTPKSEPHGLVLGPDGNLWVALETGGVAVLECAQ
>A0A0C2QMF5|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MRLTSKYETIRRMLSDFKQPEYRYAQIMDAIFKQNVGEYGRMTILPKFLRDELTRMLGPN
VCSIVPVKELTSKQVSKVLFAIAGDERVEAVRLTYERGWKSYCISTQCGCGFGCRFCATG
TIGLKRNLTADEITDQLLHFRLNGHALDSVSFMGMGEALANPHIFDAMTILTDPHLFGLG
HRRITISTIGLLPGIDRLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLKALDR
HILHTGRKVYIAYILLRGVNDSTAHAEEVAELLRGRGPGEHLYHVNLIPFNSTDVTPDSY
RQSDPDRIKAFVRILKSKGISVTVRTQFGSDINAACGQLYRSE
>A9WW52|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVFFNLLEAAFLGLIEGLTEFIPVSSTGHLLLIGHFLGFESTGKTFEVLIQLGAILAILS
VYSAKLARIATDFPRDARTRRFVLGVLVAFLPAAVIGALAHGFIKGVLFETPMLVCIMLI
VGGFILLWVDQLNLRPRYHNVMDYPLPICLAIGFIQCLAMIPGVSRSGSTIVGSLLLGAD
KRSAAEFSFFLAMPTMAGAFAYDLFKSRNILSFNDGALIVVGFIMAFISGVFVVRHLLDY
VSRHGFALFGWWRLIVGSAGMAALIIWG
>A0A060VJS6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTANTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKPPAHEGHGSGRLSLIHILLGMIPAVVMGLIFHDTIKSLFNPV
NVMYALIVGGVLLIAAEVLKPKQPRAVGIDDMTYRQAFVIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDVYKSIGFLNMGDVPMFAVGFVMAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>J8X2C4|FEATURES|UNIPROT_deepARG|beta_lactam|IEO_02954|antibiotic inactivation|1
MKNTLLKLGVCVSLLGTTQFVSTISSVQAERTVEQKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHSDR
IGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQRITNLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNILAGGCLVKSAEAKNLGNVADAYVNEWSTSIENVLKRYGNINAVVPGHG
DVGDRGLLLHTLDLLK
>A0A094RJH3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MIDDIKNVSIVIPVYNEEESLPVLLERTLAACRQIGKPWEIILVDDGSSDRSADLLTEAA
SDPEKHIIAVLLNRNYGQHSAIMAGFQQAVGDVVITLDADLQNPPEEIPRLVEYAAQGYD
VVGTVRANRQDSLFRKLASKTINMMIRRSTGKSMVDYGCMLRAYRRHIVSAMLRCHERST
FIPILANTFARKTIEIDVLHAEREFGTSKYSFLKLINLMYDLLTCLTTTPLRILSLIGSV
VALSGFLLALLLIGLRLFFGAEWAAEGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYTDV
RARPRYFVQKTVSAATPLTTSLRDEEE
>YP_002041176|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIADFRRALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQPGQAP
>X2L7W0|FEATURES|UNIPROT_deepARG|beta_lactam|act-2|antibiotic inactivation|1
LSTSCSVLAIPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYEGQPHYFTFGKADVAAN
KPVTPQTLFELGSISKTFTGVLGGDAIVRGEISLGDPVTKYWPELTGKQWQGIRMLDLAT
YTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSYE
QAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMA
SWVMVNMKPDSLQDNSLRKGLTLAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVEGSDNKV
ALAPLPAREVKPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANK
>E2ZHE0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALIEFDEVCKYYQMGDTTVKAADHITMKIEKGEFVAIVGQSGSGKSTCMNIIGCLDVP
THGTYRLNGKDVGRMSRNELASVRNEMLGFIFQQYNLLPRLNLMENVEVPLVYAGIGRAE
RHARAKEVLEQVGLGDKLRNRPNQLSGGQQQRVSIARALVRNPAVILADEPTGALDSHTG
REVLGMLQQMHDEGHTVVLITHDNSIAVQADRIIRLEDGRVVYDGDAHAPEAVVQPTLLP
DEEEKA
>A0A0Q0D922|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAV
VWEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATAL
VIGGVIMLWAERREHTVRTETVDDMSWSDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGL
SRKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRGLLK
FIATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A0D0QXW4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDTYSLLVAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQLGSILAV
VAVFWRRLFGLIGIHFGQKPEPGHATLSLIHVILGMMPAIVVGLAIHSWIKANLFGPQTV
MYALVAGGILLIIAEKFRPAVRSETLDDISYKQAFGIGLFQCLALWPGFSRSGATISGGM
LMGISRHAAAEFSFIMAVPMMMAASTLDLYKSRDFLSMADFPMFTVGFITAFVVAMIAIK
SFLALIRRLDFIPFAIYRFIVAFAVYLLFVA
>A7XM85|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAKKK
>A0A127SAS2|FEATURES|UNIPROT_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MFTLIDFENWERKEHYLHFYNDVRCSYSTCVNIDISNLNGQRLYPAMLWLLTQTINEMPE
FRTALTEKGLGYFSEMHPAYTIFNQGQKTFSGIWTAYKSNYTAFLSSYEADVAKYSSSEK
YDPKPERPVNSFDVSMIPWFSFTAFNLQVFGDGSYLLPIFTMGKAFDAGTKKMLPLAIQV
HHAVCDGYHIGRFIELLQEKINDFDSSFNSTSYEISATAKERMYEMTDKAPWVFSDMSGN
CSNTISLCEATKEDAPFIASVYNQAILAGNCTCDTKTVTSEMREKWICQHAADGYPVYLC
LENGMPVGYGYLTAYRQTV
>A1A9B7|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAVEKVNATGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>J7XFW6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNQIGRINATGEINSFPIPTANAGAM
SIISDQTGDLWFTEYNSSKIGKMSMNGLFEEYVLPTTNAAPFGITEGPDGAIWFTEMNNG
RIGRITKSGEITEFELPNSKSFPSFITLGSDGALWFTQNQNNRIGRITTKGEVKEYPIPT
PNSGPVGIASGPDGAIWFVQIIGNKIGRITFEGEIKEFVIPTPNARPHAIIPGKNRDLWF
TEWGGNQISRITVEGVITEYTIPTNNAEPHGITFCPDGDLWFAEECNQIGRLKIIA
>I6ZRE8|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-38|antibiotic inactivation|1
RMMFAAAAXIPXXXGSAPLYXQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDE
RFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSA
AALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPR
AMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAARIRAGLPTSWTVGDKTGSGDYGTTN
DIAVIWPQGRAPLVLVTYFTQPQQNAESRRD
>G8EX99|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
CGLAGALVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVKENSMVYFGAKGVTVVGAT
WTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSD
WAEIVAFTRKGLPDYPDLPLVLPNVVHEGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDQQ
VLYGNCILKEKLGNLSFADVKAYPQTIERLKAMKLPIKTVVGGHDSPLHGPELIDHYEA
>A0A0A8FFI8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADLHSLLVAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFEGDTAKTFEVIIQLGSILAV
VVVFWRRMFGLIGIHFGQPPQHEGRGKGHLTLAHIILAMIPAVVLGLVLHDAIKSLFNPV
TVTYALVAGGVLLLLAEWRKPNKPTAEGLDDISYLQAFLIGCFQCLALWPGFSRSGATIS
GGMLVGVNRYAASEFSFILAVPIMLGASGLDLYKSWHFLSLSDLPMFVTGFVTAFVVAMI
AIKTFLQLIKRVSFVPFAIYRFIVAAVVWLVLM
>E6V2S9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTEPLLKLRGIGRSFPSGDEEVQVLKDVDLDIGNGEMLAIVGASGSGKSTLMNILGCLDR
PSSGTYTVSGQDVGTLDSDALAQLRREHFGFIFQRYHLMQHLTATGNVEVPAVYAGTEGA
AREARARQLLARLGLEDRTEHRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSKS
GQEVIGILRELHAQGHTIIIVTHDMQVASCTERIIEIADGVIVGDRPNVPTVAAPAQASG
ADASTPPAMTRPNLGIARFSTGWARFAEAFRMAWRSMMAHRMRTALTMLGIVIGITSVVS
IVAIGEGAKRFVLSDIRAIGTNTLDVYPGRDFGDDKAASIRTLTPPDLQAIAAQPYVHSV
TPTTMRGLRLRYRSADINGNVNGVSDAFFRVRDIQMASGTAFTAEDVRHQSQVVVIDQNT
RRKLFPDGTEPVGKVILVGNLPCTVIGVSQEKKSMFGENKSLNIWLPYSTGASRLFGQQH
FDGITVRIRDDQPTKAAEDSIVRLLTLRHGTKDFFTFNMDSIVKTAERTSQSLTLLLSLI
AVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDVLQQFLTEAVLVCLVGGFIGV
VLSYGISFLFSLFVTQWQMIFSMGAVVSAFLCASLIGVLFGYLPARNAARLDPIEALARE
>A0A0K6KEQ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP_4|antibiotic target alteration|0
MTLWELFVAAILGIVEGLTEYAPVSSTGHMIIVDDIWLKSSNLMSAEAANSFKVVIQLGS
ILAVVIVFKDRILNLLGLKKNITSDQKQGHKLSIAQIAVGLVPAAVLGFLFEDYIDEYLF
SVKTVAFGLIAGAVLMLFADWVNKRKAATDTLDRISYKQAIGVGLFQCLALWPGFSRSGS
TISGGVILGLNHRAAADFTFIMAMPIMMGASFLSLVKHWDSLSSDLMPFFIVGFICAFVV
ALFVVRFFLKLINKIKLVPFAIYRIILGVILLLIMM
>A0A0C5K322|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTSASAPLLRLCGISRTFGEGVGAVTVLRNVDLEIRRGEMVAIMGPSGSGKSTLMNVLGC
LDRATEGRYEIDGRDVASLSDDALAKLRREYFGFIFQRYHLMGHLTAQANVEVPAVYAGV
TRSNRASRSAALLERLGLGKHRLHRPSQMSGGQQQRVSIARALMNGGDIILADEPTGALD
SRSGREVMHILRELHTRGHTIILVTHDPGVAAWAQRVIEIADGRVKGDRINETPRAVEAP
ADDGRRDGDNGGDGGDDGIEGDSPSSSDSSSRASEPSPSSQRPWLTRWITGWPTFSESLA
MAWHALASHRLRTGLTMLGIIIGITSVVSLSAIGEGTKRRVLDDIGNIAPNTITVLRGKD
FNDDKATEIRTLLPRDAALLAAQPYTDSVTPQIGPRTARMRFGRIDTDAQVHGEGADFMR
ANGLKLARGRSFDASEVARQAQVALLGENTLRKLMPNGGDPIGKIVLAGSLPLRVIGVVR
DRSSMFVSRTLNVYVPWTTVASRLAGQQHLESITVRILDGHPPAAAEAGIVRVLTRAHGQ
KDFFTFNMDTIVKSISRTSQMLTLLLSFVALISLVVGGIGVMNIMLVSVTERTREIGIRR
AIGARRQDILRQFLIEAVLVCLMGGAIGVALSYAIGWLVSTLIPQVAVVFSVNTFAAAVA
CACAIGMLSGWLPARSAARLDPVDALARE
>A2TJ36|FEATURES|UNIPROT_deepARG|beta_lactam|blaPSE|antibiotic inactivation|1
MCDNQNYGVTYMKFLWAFSHLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVYDTQN
GEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVG
QAITLDDACFATMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKL
GDLRDTTTPKAIASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADR
SGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>A0A0M2LXQ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLTAILLGIVEGVTEFLPVSSTGHLVLATELLGYDPQRWAVFNIAIQPGAILAIVVL
YWRTFMAVLSGLMKGEKHSIAFVRNLLIAFIPAVALGLAFNDQIEALLENAVVVAWALII
GGVAILIVERLAKTRDVGGISGVSVSQSVKIGLVQCMAMIPGVSRSGATIMGAMAFGIDR
RTAAEFSFFLALPTLTGATVLQMYKHRDAITANDLQLIGVGALVSFVVALVVVKAFMAVV
TKHGFAPFAWYRIVAGSVALLVLAAK
>T2G781|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
METFFTALVLGIVEGLTEFLPVSSTGHLILTGHLLGYTGPRADTFEVIIQLGAILAVAVM
YRDRFIGLFSPQPGQAFGGVRGMWLLFLTCLPAVVLGLLTHGLIKEHLFGPRTVALALGV
GALAILLVEAQPRRTRYRSLDDLTPMLALGVGLFQCLALWPGFSRAAATIMGAMLLGADR
KTAAQYSFIAAVPIMFAATGYDLLKSWSFLDAGWFQFLAVGFAVSFVAAWVAVKGFIRLL
GSMTLRPFAWYRLALAPVVLLFWPS
>A0A0U1YUC8|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-181|antibiotic inactivation|1
LVASIIGMPAVAKEWQESKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATQQIAFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A060KTF6|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRLDVLASAAKIVTHGL
>A0A085VNF1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLINFGGERAMAFNIIIQLGAILAVV
WEFRRKIIDVVVGLPKQRQAQRFTVNLLIAFLPAVVLGVLFADWIHEYLFNPITVATALV
VGGIIMLWAERREHTVHAESVDDMTWVDALKVGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYHHLFQPADFPVFAIGFVTSFVFAMIAVRGLLRF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWTSVSG
>W4E4V5|FEATURES|UNIPROT_deepARG|beta_lactam|C175_21593|antibiotic inactivation|1
MKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDSLNEVITYTKEDLV
DYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNEIGGPKGYEKALRHMGDRITMSD
RFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKTLTEWMKGNATGDKLIRA
GVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATKV
IVKALR
>A0A0N9U809|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDASRWAIFNIAIQPGAILAIVVL
YRKLFWDMFTGFFRRDPVAIAFVRNLLLAFFPAVILGLAFGDYIELLLENAVVVAWALII
GGFAILLVERFAKTKDVGGVANVTTRQSILVGLVQCIAMIPGVSRSGATILGAMSFGVDR
KTAAEFSFFLALPTLSGATALQLFRHRDAITSNDLGLIGLGAFVSFVVAWVVIKAFLAVV
TRYGFAPFAWYRIIVGAAALVWLTMR
>L8AKV2|FEATURES|UNIPROT_deepARG|aminoglycoside|ant|antibiotic inactivation|1
MSNLINGKIPNQAIQTLKIVKDLFGSSIVGVYLFGSAVNGGLRINSDVDVLVVVNHSLPQ
LTRKKLTERLMTISGKIGNTDSVRPLEITVINRSEVVPWQYPPKREFIYGEWLRGEFENG
QIQEPSYDPDLAIVLAQARKNSISLFGPDSSSILVSVPLTDIRRAIKDSLPELIEGIKGD
ERNVILTLARMWQTVTTGEITSKDVAAEWAIPLLPKEHVTLLDIARKGYRGECDDKWEGL
YSKVKALVKYMKNSIETSLN
>A0A024M674|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSKALKVQLDGGPYALAAGSDGAMWVTLVHGGAVARVSVTGDVRTYPVGEGSRPSIIAAG
PDGALWFTRAGDDRIGRITTAGELTSFELPSGSAPFGIATGPDGALWFTMMSSGEIGRID
TDGEITTAATVGGMPSMITRGPDDALWFTLNESGAVGRLAVDGTLKLRELPTAAAGPVGI
AATHDDAVWFTEIRADKIGRIPVDDAIQELDLPGKPHAVVADPTDGVWVSLWGSDQIARI
SGDGDVVTIDLPSGSEPHGLAIGPDGACWVALECGFVLKMPT
>A0A140DM78|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLTHTWITVPQNEQKDYAWGYREGKPVHSSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPALKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>A0A089HP43|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTSRLLHFNEQSDLMKTFEIVIQLGAILAIAL
VYRRRILDLLGIGRKRDRGGVMPRSRLNLIHVLLGIIPALAVAFFARDFIKSHFSASTVL
WALVAGGILMIIAEWVNKRKIRVTAEEMDDISYGQALAIGLYQIISVLWPGFSRSGSTIS
GGMLTGVSYKASADFSFLIAIPIMCVASGYELLDSYKEITGDMIGIFAIGFLVSFVVAYI
VVVLFMRLIQKIRLTHFAIYRFVLAACFWLFVMR
>A0A127SFY7|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMACWVRSNMNPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>A0A076LSQ8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGVQSLIDAGYEIAAIVTHQDAPGENLFFGSVARLAAQHNIPVFAPD
DVNHPLWVERLRALQPQVIFSFYYRHLLSDAILTLAPQGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMEKRADAGNIIAQRRIAIAEEDTALTLHHKLCQCARALLAEALPQI
RSGSYAEFPQDESAATYVGRRTPADGRLEWSKPARELYNLVRAVTEPWPGAFSYAGNRQF
TVWQARVRSDLPAARPGTVLSASPLAIACGEGALEIVAGQPQDGLYMQGSQLAESLGLVE
GAILNSSLNFGVRRATRVLILGVNGFIGNHLTERLLAEDNYEVYGLDIGSDAISRFIDHP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRDC
VKYKKRIIFPSTSEVYGMCSDPQFDEDSSNLIVGPINKQRWIYSVSKQLLDRIIWAYGAK
DELRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDI
KEGVEALFRIIENKDNLCDGQIINIGNPDNEASIRELAEQLLVCFEQHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAQRLLGWQPVIPMESTIEDTLDFFLQTFDGTEQE
>A0A0I9WGX1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANFIKAIILGIVEGITEWLPISSTGHLILVDNILKMQISKEFTSMFNVVIQLGAIMA
VVYLYFNKLNPFDQQKSKLEQKQTWDLWLKVVVACFPSAVIGLLFDDWLDAHLYKPFPVA
LMLIIYGIGFIWVENRNRNIKPKCTDLNRFTYKAAIMIGVFQVLALIPGTSRSGATILGG
ILIGASRYVAAEFSFFLGIPTMFGASALKIFKFIKNGNLFDLQSTFILLTGMIVSFIVSV
LVIKFLMDYIKKHDFSVFGWYRIILGSIIILTMIF
>A0A0G1RET7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNWGQGVILAVVEGVTEFLPVSSTGHMILVGQLLGVAQTGFVKSFEIAIQLGAIGAIVAL
YWRKLLQQSRVATRVAMAFLPTGIIGVLAYKLVKQYLLGNAWVTVGALFLGGVVLLIWEG
DRLKKQKSNSKFEIQNLSYGRCVLIGLGQAVAMIPGVSRALATILSGEIAGLGRKEAVEF
SFLLAVPTMMAATGWDLVKSGGSFGRGEWEMLGLGFGAAFAAARVTVKWLVSYVKNNNLA
GFGWYRIGLAVGWWLLFA
>A0A0G1ESK1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTVFHGLILGLIEGLSEFLPISSTAHLILAGEWLRLPSSEFFKTFTISIQLGAILAVVVL
YWKKIWHSWELFGKIGAAFLPTALIGLIFYKIVKNYLLDNNYVIAGSLFVGGLVLIIFEK
YYSRKQTAEILSAEEENNEKEKEDKGRGLEMNVSYKQAAGIGFFQALAIIPGVSRSAATI
IGGLALGIGRKNIVEFSFLLAIPTMIAATGLDLYKSRATLGLLVGQDLTVWAIGFVMSFI
TAIISIRFFLNFIQKHNFTFFGWYRMALALIVMIWLRF
>A0A031J240|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSQPLLELKGITRSFMAGEREFIALKGIDLTIQAGEMIAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPQT
QRHSRARELLERLGLASHTTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVCDGEIISDKANTRSGLDAPAEAP
IEPRRSGARRLVASLGLFKEAFNMAWVALVSHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVDALNQLYYVDSATPVVGRSL
LLRYGNIDLDAQVNGVSDRYFKVKGLKLEAGIAFSESDARRQAQVVVIDHNTRHRLFGPN
VDPLGQVILVGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGLIGISLSYALGF
LFSLFVKEWEMVFSVGSIVTAFACSTLIGIVFGFVPARNAARLDPIEALARD
>J2QDX1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWLIAIVLGLVEGLTEFIPVSSTGHLLLTKIALGLTDPTWDTFIVLIQLGAVLAVVAL
YFQRLWAVVVGLPTKPEARRFALSVIIGCIPAFVAGLALHGVIKHFFENPFLPQVICVSL
IVGGVILLVVDKKAPPAREHDGMALSLKTALLIGLFQCLSLVPGVSRSGSTIVGSMLLGV
ERKAAAEFSFFMAIPIMVGAFALDLLKSYDQIDASHAGTIAIGFVVSFLSGLVVVKTMIG
FIGKRGFTPFAWWRIVVGVIGLGLIYIPR
>A0A0Q8AIC5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHHYLFNPITVAAALV
VGGVIMLWAEKRQHEVHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IASHSYAAFAWYRIAFGLLILATWQFGWVDWTAAQP
>A0A0K0I3N5|FEATURES|UNIPROT_deepARG|chloramphenicol|B4107_1104|antibiotic inactivation|1
MFKQIDENYPRKEHFHHYMKVTRCSYSLVIDLDITKLHSILKEQKLKVYPVQIYLLARAV
QKIPEFRMDLVNDELGHWDLLHPSYTILNKETKTFSSIWTPYDENFARFYKSCVADIEAY
SESNKLFPKPHMPENMFNISSLPWIDFTSFNLNVSTDETYLLPIFTLGKFKLEEEKIILP
VAIQVHHAVCDGYHAGQYVEYLRWLIEHCEEWLNDSLYT
>A0A0R2ZS29|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADLINFGGERFEAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQRNAQRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALV
VGGVIMLWAERRQHAVHAESVDEITWKDALKVGMAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAALYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKGLLKF
IANHSYAAFAWYRIAFGLVILATWQFGWIDWTAVKP
>A0A0M3F3F6|FEATURES|UNIPROT_deepARG|beta_lactam|OA46_09945|antibiotic inactivation|1
MKKIALCSLLVLLSGPSLAATTSATNIADVVTPVIAALMKEEAIPGMAVAVIYQGKPYYF
TWGLADVAGNKEVDRQTLFELGSVSKTFTGVLGGEAVARGEVALDDPASRYWSALSGKQW
EGITLLHLATYTAGGLPLQVPDDVTDRTSLANFYQQWQPQWAPGTKRLYANSSIGLFGAL
AVTPSRLSFEKALGDRVLKPLQLNHTWLQVPPSEEQHYAWGYRDGKPVHVSAGMLDAEAY
GVKTTIVDMAAWLQANMQPAEIKVQSLKQGMTLAQSRYWQAGAMYQGLGWEMLDWPVSER
TLEEGSANTYALSPQSVEKITPPTPPVSAFWVHKTGATGGFGSYIAFIPEKEIGIVMLAN
KNYPNPVRIRAAYRILDALQ
>A0A0W0AQT1|FEATURES|UNIPROT_deepARG|aminoglycoside|VO68_05910|antibiotic inactivation|1
MTETGWRIVPLDEARLAQWATLRQQLWPHHGIAAHLQEGGELLTNAGLNAFLALDEQSQA
VGFADAALRHDYVNGCESSPVVYLEGVYVQPASRRRGLARALIAQVAQWGRELGCRELAS
DAAIDNLASQRMHERLGFAETERVVFFKKALG
>A0A0V8E5V9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIATLPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMNIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLSFEQFGVLLVACIVAF
GVSMVAIKFLTDYVKKHDFTFFGKYRIVLGIILLIYAMFKAFLG
>Q9K2Y1|FEATURES|UNIPROT_deepARG|multidrug|tolC|antibiotic efflux|0
MKKLLPLFVSAALGTLSSAVWAENLAEIYNQAKENDPQLLSVAAQRDAAFEAVTSSRSAL
LPQINLTAGYNINRSDQAPRESDLLSAGINFSQELYQRSSWVSLDTAEKKARQADSQYAA
TQQGLILRVAKAYFEVLRAQDNLEFVRAEKAAVGRQLEQTKQRFEVGLSAITDVHDAQAQ
FDGVLADEVLAENSLTNSYEALREITGQEYSKLAVLDTKRFAASRTTESSEALIEKAQQQ
NLSLLAARISQDVARDNISLASSGHLPSLTLDGGYNYGNNSNDNAKNTSGEEYNDFKIGV
NLKVPLYTGGNTTSLTKQAEFAYVAASQDLEAAYRSVVKDVRAYNNNINASIGALRAYEQ
AVISAKSALEATEAGFDVGTRTIVDVLDATRRLYDANKNLSNARYDYILSVLQLRQAIGT
LSEQDVMDVNAGLKVAKK
>A0A0J8FXE6|FEATURES|UNIPROT_deepARG|beta_lactam|ACR52_25270|antibiotic inactivation|1
MNILSAISLACITSQVFANQSDLTLTNFKGPLYIVEDKEYVQENSMVYIGEQHITVIGAT
WTPATAEKLEQEIRKVSPLPIKEVINTNYHTDRAGGNAYWRELGASIVSTQLTYDLEKSQ
WRSIVDFTRQGMEHYPVLEQSLPDQVYPGDFALQNGHVRALYLGASHTEDGIFVYFPEER
VLYGNCILKEKLGNMTFANRSEYPKTLKKLQGLISSGELPVETIIAGHNSPIQSVELIDH
YLNLLEHGEQ
>Q9AM99|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-12|antibiotic inactivation|1
PRFMSIQRRNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPRDARDTTTPASM
AATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIV
ALLGPNNKAERIVVLYIGX
>M4QA53|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLG
RRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFL
HNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWME
G
>A0A0T8WS84|FEATURES|UNIPROT_deepARG|beta_lactam|ERS232495_02549|antibiotic inactivation|1
MKERVEKIKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKN
VWVHTELGYFSGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVII
THAHADRIGGMKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQSVTNLKFGNMKVETFY
PGKGHTEDNIVVWLPQYQILAGGCLVKSASSKDLGNVADAYVNEWSTSIENVLKRYGNIN
LVVPGHGEVGDRGLLLHTLDLLK
>A0A0U1A5U2|FEATURES|UNIPROT_deepARG|chloramphenicol|cat3|antibiotic inactivation|1
MPAEHALLVVMATFEPLDLQQWPRREWFEHYLDRCPTYYSMTVDLDITNLRAAVDASGRK
TYPTQIWALATVVNRHPEFRMALDDQGNPGVWDVVDPAFTVFNPDRETFAGISARYTPDF
DAFHTEAAELLNEYRNASTFFPQGASRPRNVFDISSIPWTRFTGFTLTIAPGWEHLAPIF
TIGKFYEQEGRTMMPLALQIHHAAADGYHSARLVEGLREIIANPDWVRD
>A0A127SEB3|FEATURES|UNIPROT_deepARG|beta_lactam|TLA-3|antibiotic inactivation|1
MKKHLVVIVFCALFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAILGIEDNFKLNVNE
KHHYPMQSTYKFHLALAVLHKLDKENISVDKKLFVKKSDLLPDTWSPLRDKYPNGNLELS
FSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYT
IWTTPDATVQLLKKFYKNEILSKNSYDFLLNTMIETTTGPKRLKGLLPDGTVVAHKTGSS
DTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYLIKGG
K
>D4JZH9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLEIIKAILMGIVEGITEWLPISSTGHMILLEQVVKFNASEEFMSMFRVVIQLGAILAV
VVLFWGRLWPFGLRHGRVISKPGVWQLWFKVVAATLPVLVISPLDDWMEAHFYNYITVAA
MLILYGVLFLVVESRRTAPRVTHLEQITYRDALIIGVWQMLAIIPGTSRSGATIVGGLLL
GLSRACVAEFTFYLAIPVMAGASLLKVLKFAVSGVAITGTEVAVLAVGCVVAFVVSLAAI
RFLMDYVKRHNFTFFGIYRIALGLVVLAVAVVSAMV
>AAC64522|FEATURES|ARDB_deepARG|multidrug|amrB|antibiotic efflux|1
MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSASYPGASAKVVEEA
VTAIIEREMNGAPGLLYTKATSQHRQASLTLTFRQGVNADLAAVEVQNRLKIVESRLPES
VRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAE
YAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLV
TPEQFGEIPLRIRADGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVA
TAKHPRHPRRVSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNF
RATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAE
EGLSPHDATVKPMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSA
FLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLV
YTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPV
AYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAM
NSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPKI
RLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADGAKRLGIDDIG
RLHVRNEQGEMVPLATFAKAAWTLGPPQLTRYNGYPSFNLEGQAAPGYSSGEAMQAMEQL
MQGLPEGIAHEWSGQSFEERLSGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPL
GVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAA
RLRLRPIVMTSLAFGFGVVPLALSSGAGSGAQVAIGTGVLGGIVTATVLAVFLVPLFFLV
VGRLFRLRKAPRTGNSPQIPTEQA
>H1AFJ4|FEATURES|UNIPROT_deepARG|beta_lactam|AmpC|antibiotic inactivation|1
HRHSLLALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAAN
KPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLAT
YTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYE
QAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMA
NWGHGKHGAGERC
>A0A0J0Y708|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNYFEALILAIIEGLTEFLPVSSTGHMIIGSSFMGIASDPFVKLFTVAIQLGAILSVVVL
YFKRFFKTINFYIKLLVAFVPAAVFGLLLSKKIDELLESPLAVGVSLLVGGIILLFVDKW
FNQPTIDEEENVSYLTALKIGLFQCIAMIPGVSRSGATIVGGMSQKLSRKVAAEFSFFLA
VPTMFAATAKKLYDFYKEGNTITHEQVNLLVVGNVVAFVVALLAIKSFIGFLNKHGFKAF
GWYRIAAGLIIIILLASGHNLQII
>J8ATP3|FEATURES|UNIPROT_deepARG|beta_lactam|IEE_04287|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQANQTNQIKQKNTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSEQVEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DNLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>AAT48136|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMENID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMVSYIKRARSMRDIRNEKGTAKPDPAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVEPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRLPSAIILQRASR
>A0A0L7DEB7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGEKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGVGTGRLSLIHILLGMVPAVVVGLVLHDQIKTLFNPIN
VMYALVVGGVLLLAAEYLKPKQPKAVGVDDITYRQALMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSIGFLTMEDFPMFAVGFVTAFIVALIA
IKAFLQLIKRISFVSFAIYRFIVAAAVYMVFM
>Q9KHL7|FEATURES|ARDB_deepARG|glycopeptide|vantg|antibiotic target alteration|0
MTKNESYSGIDYFRFIAALLIVAIHTSPLFSFSETGNFIFTRIVAPVAVPFFFMTSGFFL
ISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYH
LWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLI
FQLTDYTRNGIFFAPIFFVLGGYISDSPNRYRKKNYIRIYSLFCLMFGKTLTLQHFDIQK
HDSMYVLLLPSVWCLFNLLLHFRGKRRTGLRTISLDQLYHSSVYDCCNTIVCAELLHLQS
LLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNT
LQKAMSPKCELMAVVKAEAYGHGMYEVTTYFEPIGVFYLAVATIDEGIRLRKYGIFSEIL
ILGYTSPSRAKELCKFELTQTLIDYRYLLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDK
ILAAFFLKHIKVAGIFTHLCAADSLEEKEVAFTNKPIGSFYKVLDWPKSSGLNIPKVNIQ
TSYGLWNIQSWNVIYQSGVALYGVLRSTNDKTKLETDLRACSFLKAKVVLIRKIKQGGSV
GYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTD
IPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMEHRLNIIRRA
>U5URI7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLLELIKGLILGIVEGLTEFAPVSSTGHMILVDNMWLKSTEFLGEQSAFTFKVVIQLGS
VFAAAWVFRERFFELLHIGKHKPEQHATAGRRSKPQRLNLLHVLVGMIPAGILGFLFDDV
IEKYLFSVPTVMIGLFLGAIYMIIADKYSEKVTNPQTVDQINYFQAFVIGISQAIAMWPG
FSRSGSTISTGVLMKMNHKAASDFTFIMSVPIMLAASGLSLLKHYEYIHLAHIPFYLLGF
LAAFIVGLIAIKTFLHLINKVKLVPFAIYRIILVVIIAILYFGFGIGKGI
>A0A0Q0EA43|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MGCGGGLSMNQKVDIEALHETSINSDQPLLRLQQVSRSFMAGDREFQVLKHIDLAIHTGE
LVAIIGASGSGKSTLMNILGCLDHASAGSYQVNGQETRELDDDALAALRRDHFGFIFQRY
HLLPHLDAVRNVEIPAIYAGTAQAKRHERAQALLTRLGLGGHLQHRPSQMSGGQQQRVSI
ARALMNGGQVILADEPTGALDTASGKEVMRTLLELHAAGHTVILVTHDPKVAANAERIIE
VSDGEIISDRRTAQATQPVPEAQPAKQPGLAPRRLIASLGLFREAFNMAWIALISHRMRT
LLTMLGIIIGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGANFGDSRAKSIETLL
PTDVAALNQLYYIDSATPVVGRSMLVRYRNVDVDAQLNGVSSRYFQVRNIQLAAGITFSD
QDARRQAQVVVLDHNTAQRLFGPGVNPLGQVILVGKLPCTVIGVTSDHKNLFIAGNTLNL
WMPYETAAGRVLGQRHLDSISVRVKDGMPSKAVEEQIKALMLQRHGTKDFFTNNLDSVMQ
TVQKTSRSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQF
LVEAVMVCLMGGVIGIGLSYAIGYLFTLFVQQWEMVFSLASVVTAFACSTLIGVLFGFVP
ARNAARLDPIEALARD
>A0A0U4HIC9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTALLELSDIRRSYLSGDQTIDVLKNVSLRINAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGTYRVAGQDVATLDGDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAAALLQRLGLGERITYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILKQLREQGHTVIIVTHDPAVAQQAERIIEIRDGEIIADSRPQAQGNPQAKMLDM
AAPAPSWQQVAGRFREALVMAWRAMAANKMRTALTMLGIIIGIASVVSILVIGDAAKQMI
LADIKSIGTNTVDIYPGKDFGDDDPSFRQALKYGDLSALREQPYVSALSPNISSSMRLRF
GNIDVAANVAGVGEQFFRVYGMTLSQGVGIDALQVQSQAQVVVIDANTQRRLFPHKKNVV
GEVILIGNMPATVVGVAKEKQSMFGSSKALSVWVPYSTMANRLMGNDYFDSITVRIREGY
NSQEAEQQLTRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGIALSFAIGLLVQL
VMPGWQISFPPVALLSAFLCSTGIGVVFGYLPARSAARLNPIDALARE
>A0A0T6UNG5|FEATURES|UNIPROT_deepARG|beta_lactam|AO724_16170|antibiotic inactivation|1
MSRLLLSSLLAAGLLTALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGFLVDEEHPALPFKPGYDDWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKLGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAQLKKL
>A0A0E9BTF2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDDKEIEKVSVVIPVYNEQESLPALIQRTNDACKSLNLDYEILLVDDGSQDASAVMIAD
AASLPDSHIVAVLLNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAAAQEG
YDVVGTVRQNRQDSWFRRQASRTINQMIQRVTGKSMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRTIELPVTHAEREHGSSKYSFMRLINLMYDLVTCLTTTPLRMLSVLG
SLIALTGFAFSVVLILLRLCFGAAWAGDGVFVLFAVLFIFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVINPQKDRSVQETE
>A7UXY8|FEATURES|UNIPROT_deepARG|chloramphenicol|BACUNI_00159|antibiotic inactivation|1
MLKCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHIFARLMNAHPEFRMAMKDGELVIWDS
VHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSA
NPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNE
LQQYCDEWQGGA
>ABK51578|FEATURES|ARDB_deepARG|chloramphenicol|cmlA5|antibiotic efflux|1
MLLLYGSAAKSFVQGDGFVRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPN
ALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSA
EVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALV
DMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCY
AAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVL
RMGMGCLIAGAVLLAITEIWASQSVLGFIAPMWLVGIGVATAVSVSPNGALRGFDHVAGT
VTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGE
HDVVALQSAESTSNPNR
>ZP_02698483|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MQRIIQFFSQRATTLFFPMALILYDFAAYLTTDLIQPGIINVVRDFNADVSLAPASVSLY
LAGGMALQWLLGPLSDRIGRRPVLIAGALIFTLACAATLLTTSMTQFLVARFVQGTSICF
IATVGYVTVQEAFGQTKAIKLMAIITSIVLVAPVIGPLSGAALMHFVHWKVLFGIIAVMG
LLALCGLLLAMPETVQRGAVPFSAVPFSAVSVLRDFRNVFRNPIFLTGAATLSLSYIPMM
SWVAVSPVILIDAGGMSTSQFAWAQVPVFGAVIVANMIVVRLVKDPTRPRFIWRAVPIQL
SGLATLLLGNLLLPHVWLWSVLGTSLYAFGIGMIFPTLFRFTLFSNNLPKGTVSASLNMV
ILTVMAVSVEVGRWLWFHGGRLPFHLLAAVAGVIVVFTLATLLQRVRQHEAAELAAEK
>A0A009G3V4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESKQFEHKTDDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTSDNMVNIGVGFVAAFIAALLVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSA
>M7REN6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRCEHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAEEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERMREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALVRE
>A0A0D6BI99|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWSAAQALILGIVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILEVVIGLPNQPKAQRFTVNLLIAFLPAVVLGGIFADLIHAYLFNPITVATALV
IGGVIMLWAERRQHRVHAESVDEITWKDALKVGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDFPVFAIGFVTAFIFAMIAVKGLLKF
IASHSYAAFAWYRIAFGLLILATWQFGWVDWTAVKS
>YP_001764893|FEATURES|ARDB_deepARG|multidrug|AmrA|antibiotic efflux|1
MNNKRTQWRRMRLAPFALAALLAVAGCGKGDKDAAPETAKQATVVTVRPTAVPMSVELPG
RLDAYRQAEVRARVAGIVTARTYEEGQEVKQGAVLFRIDPAPLKAARDAAQGALAKAQAA
ALAATDKRRRYDDLVRDRAVSERDHTEAVAADTQAKAEVASAKAELARAQLQLDYATVTA
PIAGRARRALVTEGALVGQDQATPLTTVEQLDPIYVNFSQPAADVDALRRAVKSGRATGI
AQHDVAVTLLRADGTAYPLKGKLLFSDLAVDPTTDTVAMRALFPNPERELLPGAYVRIAL
DTAVDQRAILVPRDALLRTADRTSVRVVGANGKVKDVEVTADQMSGRDWRITRGLAGGER
VIVDDAAQFAPDTAVKPVEKAPPSKAAPVAAASQAAARQT
>YP_002201843|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmV|antibiotic target alteration|1
MARPSRVSRALSQNFLTDRAAAARLARLAVPRPKNPLLLEVGAGKGALTELLAPRCRTLL
AYEIDERLVPVLAARFSGTPQVRVIGGDFLAARPPRTAFSVAGNVPFSRTAAIVDWCLRA
PALTDATLLTQVEYARKRTGDYGSWTLLTVLNWPRYEWRLAGLVGRRSFRPVPRVDAGIL
RIERRGVPLLPPGALPGWRHLVELGFSGVGGSLHASLCRAHPRRRVDAGFRAARLDRDVL
VGEVAPERWLRLHEVLAP
>A0A090ZCZ9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MDIKGINHFCFSVADLERSIAFYEQVFDAKMVVKGRKLAYFDLHGLWIALNQEDIPRDKE
NRTYTHIAFTIEETDFDAVLDKLRQLSVEVLPGRERDVRDKKSIYFFDPDGHLFEFHTGT
LADRLDYYRAEKSHMTFY
>T3D9A2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLDIIFILKSVMIAIVEGLTEFIPVSSTGHMILVGSLIDFKGQFAEMFEVVIQLGAILA
VVVLYWKKIKDSVIEFFKFIFTGGKKGKTGFKFGMNVIIACIPFAIVGVLFYDNIKALFN
LQSVIIGFIVGGILLLVVETLFRKKKHSTDNIDKITPIQALKVGVLQVLSAWPGMSRSAS
TIMGGWIAGLNSPIAAEFSFFLAVPAMVASSGKDLFEFDYSIMTPTLWIALIVGFIVAFI
VSIVVMEKFVDFLKKKSMRVFAIYRILMGILLAILAFTNIISV
>YP_691296|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGASPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLAAGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVIYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMRL
SVFVAMSLTPALCATILKATPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPDQVTGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>G6C0S5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNALILVIILAVVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFTNSFLIIIQLGAILSV
VVYFWKNLTPFVGTKEKFVLRFRLWLKIIVGVLPAMVIGLFLDDIIDKYFMNNVTVIAIT
LIVYGIIFIAIEVIYKIKHVKSRVRKFRELKYRTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEREWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIIVLTLLR
>Q104Y8|FEATURES|UNIPROT_deepARG|beta_lactam|bla(ampc-EC12)|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0B2YWX8|FEATURES|UNIPROT_deepARG|aminoglycoside|QQ44_03550|antibiotic inactivation|1
MTEWLPVTRGESGAGVFRSADGSRYRKVVGPAAVADLAGERDRMSWAHDHGLSVPEVIDW
GATGDGGAFLVSSAVGGVGADRLTEAALRSVWPAVVDAVRTLHAIAVEDCPYRRDLDDML
ARARSVVAADAVNPEFLRDEDRDVPPGELLARVEREAGLRRRQEAADRVVCHGDLCLPNI
LIDPDRLTVEGFVDLGRLGLADRHADLALLSANTADTFPGFAEGAAAGLAAGYPAAIDDE
RLRFYLALDPLTWG
>E2PCR1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFMIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIGFHSNHKVFEITIQLGAVLAVVF
EYRQRFSNVLHGLGKDRKANRFVLNLAIAFIPAAVMGLLFGKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIADVDALRPIDALMIGVAQVFALVPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFIAAFVSGLVAVKALLK
FVSKKNYIPFAYYRIVFGIVIIILWLSGWISWE
>G9Y480|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF0454_01344|antibiotic inactivation|1
MLIGVQDPKYIRLKGHLFMRKKMQNTLKLLSVITCLAATAQGAMAANIDESKIKDTVDGL
IQPLMQKNNIPGMSVAVTIRGRNYIYNYGLAAKQPQQPVTEDTLFEVGSLSKTFAATLAS
YAQVSGKLSLEQSVSHYVPELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLK
AWKPADAAGTHRVYSNIGTGLLGMIAAKSLGVSYEDAIEKTLLPLLGMSHTYLKVPADQM
ENYAWGYNKKDEPVHVNMEILGNEAYGIKTTSSDLLHYVQANMGQLKLDGNAKIQHALTA
THTGYFKSGEITQDLMWEQLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKT
GSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVTVAYKILSSLEGNK
>CAC08522|FEATURES|ARDB_deepARG|sulfonamide|sul1|antibiotic target replacement|1
MLRSRVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPV
SPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIA
EADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGM
GFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELH
AIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>A0A0U1YUY3|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAIAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVVPVYQEFARQI
GGARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATQQIAFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>R8EAJ8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQSINHICFSVANLEKAIDFYQTILQAKLLVKGRKLAYFDLNGLWIALNVEESIPRNEI
QCSYTHIAFTVTNNEFDSLKEILIQNHVNILPGRERDDRDKRSIYFTDPDGHKFEFHTGT
LQDRLQYYKEDKNHMTFY
>ACJ41453|FEATURES|ARDB_deepARG|multidrug|AdeC|antibiotic efflux|0
MSKSAIVSRGLILSTLSVTLVACVNMQAPQPAITSHIPQNFSQNHSGKTIAEKSYKEFIS
DPKLVQVIEISLNNNRDLRTATLNIERVQQQYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPNHAIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGISKV
>NP_863283|FEATURES|ARDB_deepARG|beta_lactam|PC1|antibiotic inactivation|1
MKKLIFLIVMALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>F0H4M5|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9303_0778|antibiotic inactivation|1
MSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTV
KVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPV
ISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADH
NKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVI
AHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVY
SLLMQTSVKS
>A0A0M1QZA4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKKSLSCALLLSVACSAFAAPMSEKQLANVVERNVTPLMKAQAIPGMAVAVIYQGQPHYF
TFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQW
QGIRLLDLATYTAGGLPLQVPDAVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSL
AVKPSGMRFEEAMTERVFKPLKLNHTWINIPHAEEPHYAWGYREGKAVHVSPGLLDAEAY
GVKSNVKDMASWVMANMAPETIQQPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAK
TVVNGSDNKVALAPLPAAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLAN
KSYPNPLRVETAYRILDTLQ
>D3NQR0|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MMIDQYLDATLLGLIEGLTEFLPVSSTGHLIMLDELLGFEGPPGKVFEVVIQLGAILAIC
VVYFQRLWHVATGLKDDPGARRFVMAVVIAFLPAMVLGAGLHGIIKAVLFNPTVVSIALI
VGGIAILLVERMVPVPRYHRIENFPAPLALKIGFCQCLALVPGVSRSGASILGALLMGVD
RKTAAEFSFFLAVPTMAGATVYDLYKNWSGMSFDSGLLILVGFVTAFIAAALVVKTLVDF
VGRYGFTPFGWYRIAVGTGMLAFLYL
>A0A0W0B3K5|FEATURES|UNIPROT_deepARG|aminoglycoside|VO70_16065|antibiotic inactivation|1
MTETGWRIVPLDEARLAQWATLRQQLWPHHGIAAHLQEGGELLTNASLNAFLALDEQDQA
VGFADAALRHDYVNGCESSPVVYLEGVYVQPASRRRGLARALIAQVAQWGRKLGCRELAS
DAAIDNLASQRMHERLGFAETERVIFFKKALG
>A0A155VZU4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEAAPIKKVSVVIPVFNEQESLPELIRRTSATCEKLGKDYEILLIDDGSSDRSAQLMMD
ASQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEG
FDVVGTVRQNRQDSVFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAATGFTLSVLLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTQSTEENRA
>J8AI21|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDIIISIILGIVEGLTEFAPVSSTGHLILVGHLLGFEGTPRVTTFEVVIQLGSILAVVS
VFWNRLLNIVGIGKTVHNTGPVKSHLNLLHVCIGILPFMIGGLLFHDFIKTVLFSPKTVV
VGLITGGILMIAADLLRKNRSATLDLDSVTYKQALYMGLFQCFALIPGFSRMGATLSGGL
LVGMNHKTASEFSFIMAVPIMFAASCKDLFDNWQYLTVHDLPLFVIGFLTAFIVALISIK
FFLSLISKIKLIPFAIYRFLLAIVFWIFIL
>A0A0X8EWS7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSLKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPKENNFYGSVAQLCARKGIPVHA
PEDANHPLWIERIRKLNADYIFSFYYRNLLGEELLASVSQGAFNLHGSLLPRYRGRAPAN
WVLVKGETETGVTLHRMVKRADAGDILAQQRISIERTDTALTLHGKLRETAAQLLAEALP
LLPQGKLKETPQDESKATYFGRRTPADGLLQWARPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWGAEVVAGNQGHAPGQVISCDPLRIACGQDSLVVTAGQRNENGLYLSGPQLARELG
LVEGSRLRGSESGRKARRTRVLILGVNGFIGNHLSERLLQDDQYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLKFTLFRPFNWMGPRLDRLDSARVGSSRAITQLILHLVEGTPIRLVDGGEQKRCFT
DVADGIEALARIIDNKGGKCDGQIINIGNPENEASIRELGEELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGTGYQDVSHRKPSVENARRLIDWTPTTELSETIGKTLDFFLREAMVEIA
EKR
>A0A0M4FLF5|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-459|antibiotic inactivation|1
MTVRLSSCALGAALSLSALAGAPAQAAVLCTVVADAADGRIVYQQGTQQACAARYTPAST
FKLPIALMGADAGILTGPHAPVWNYQPDYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFHYGNEDVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKVVNRQLP
VKAAAYDLAENLFEVGEAGGWRLHGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVF
ARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK
>A0A0F0FCY2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHQKTNLKPGILAAFTLCLVAGQSLAQTPLESTVSAAVRPLMQQQAIPGMAVAISVDGQQ
HYFNYGVASKQSGQPVNADTLFEIGSVSKTFTATLAGFAQASGKLSLGDTASKHWPALKG
TAFDGITLLNLGTYSAGGLPLQFPDAVKGEADLAGYYGHWKADYAPGTQRLYSNPSLGLF
GYLTAKSLGTPFAQLMEQQLLPQLGLQHSYLQVPGAQMGNYAQGYNKQDQAVRVGPGPLD
GEAYGLKVTAVDLLHYLDLNMQPHSLSKPLQRAIATTQAGYYQVGAMTQGLGWEQYAYPV
SLEQLQAGNAPSMVLEPQPVSWLKPARPLPADTFLNKTGSTDGFGAYVAFVPSKRIAIVL
LANKNYPIAERVKVAHQILTALAK
>ACC64523|FEATURES|ARDB_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MNFNKIDLDNWKRKEIFNHYLNQQTTFSITTEIDISVLYRNIKQEGYKFYRAFIFLVTRV
INSNTAFRTGYNSDGELGYWDKLEPLYTIFDGVSKTFSGIWTPVKNDFKEFYDLYLSDVE
KYNGSGKLFPKTPIPENAFSLSIIPWTSFTGFNLNINNNSNYLLPIITAGKFINKGNSIY
LPLSLQVHHSVCDGYHAGLFMNSIQELSDRPNDWLL
>J8DRI7|FEATURES|UNIPROT_deepARG|beta_lactam|IGC_02121|antibiotic inactivation|1
MKKNTLLKLGVCVSLLGTTQFVSTISSVKAEQKLEQKVIKNETGTISLSQLNKNVWVHTE
LGYFNGEAVPSSGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLPQYKILAGGCLVKSADSKGLGNVADAYVNEWSTSIGNVLNRYGNMKLVVPGH
GEVGDRGLLLHTLDLLK
>A0A024CHR9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVEVAALHETTIDTGSPILHLQGVSRSFMAGDREFLALKHIDLAIHAGELVAIIGAS
GSGKSTLMNILGCLDHASGGSYKVNGQETRDLDDEELAALRRDHFGFIFQRYHLLPHLDA
VRNVEIPAVYAGKSQAQRHQRASELLTRLGLSGHLSHRPSQMSGGQQQRVSIARALMNGG
QVILADEPTGALDTASGKEVMNILLELHGLGHTVILVTHDPKVAAHAERIIEVSDGEIIS
DQRTVHKAQAAPEPEPQLQHEGAARRLGVSLGLFREAFNMAWIALISHRMRTLLTMLGII
IGITSVVSISAIGEGAKRYVLKDIQAIGSNTIDIYAGSNFGDSRAKSIETLLPSDVAALN
RMYYIDSATPVVGRSMLVRYRNIDVDAQLNGVSNRYFQVRNIQLAAGITFNEQDARRQAQ
VVVLDHNTAQRLFGPGVNPLGKVILIGNLPCTVIGVTSDHKNLFIAGNTLNIWMPYETAA
GRVLGQRHLDSISVRVKDGMPSKQVEEEIKALMLQRHGTKDFFTNNLDSVMQTVQKTSRS
LTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVC
LIGGVIGIALSYGIGYLFTLFVKQWEMVFSPASIVTAFACSTLIGVLFGFVPARNAARLD
PIEALARD
>A0A149PLF8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKFRALSLLATAIFSFGAMSGAALAADSDTAKIRQTVDQTIKPLMALHGIAGMAVGVVVD
GRPYVFDYGVASKATKQPVTRDTLFELGSISKTFTATLASYAQIEGDLSLNDPVSRHLPS
LDGTEFGKVTLLNLGTHTPGGLPLQVPDEVHDNAQLMQYFKAWRPTQPPGTIRTYANPGI
GTLGLITAKSMKQDFDALMQTHLFPALGLKHSYIDVPASKQRDYAQGYAKDDAPIRMKGG
VLSSEAYGVRSTAADMTRFLQINMNMVRIDPAFQRAVDATHTGYFQAGPMTQDLIWEQYP
YPVALQPLIDGNAPSMIMNATPVTRIDPPQAPRDDVWINKTGSTNGFGAYIAFVPKARVG
IVMLANRNIPNEERVKAAYAIITSLVEGQ
>A0A0A0R052|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA|antibiotic inactivation|1
MAKTKLNIMREVVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLV
TVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEW
QRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTL
WNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYL
GQEEDRLASRADQLEEFVHYVKGEITKVVGK
>W0I2E0|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MADMHEWVIAFILGVVEGLTEFLPVSSTGHMILVGSLLGFTDDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGQVPHEGIGSGRLRLGHILLGMIPAVVLGLVFHEQIKAIFAPQY
VMYALVVGGLLLLAGEWLKPKQPRAAGIDDLTYLQAFLIGCFQCLALWPGFSRSGATISG
GLLVGVSRYAASEFSFILAVPMMLGATVLDLYKSLPFLAWQDFPMFAIGFVTAFVVALLA
IKFFLQIIKRISFVPFAIYRFILAAVVYWVLVG
>YP_002099037|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MALSFDHFGVGPRMDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTF
DVVIQFGAILAVCWEYRQRIVSVVAGLPSRPDAQRFALNVVIATIPAIALGLLFEKKIKA
VLFSPVPVAFALVVGGAIILWAEARQRERGVAPRVQSIDALTPLDALKVGIAQCFALIPG
MSRSGSTIIGGMLFGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSLGLFVVGL
VSAFVSAFVCVRWLLRYVATHDFTVFAWYRILFGLFVLLVGYSGWLNWA
>A0A0F7A4N4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
IGGVIMLWAERREHTVRTETVDDMSWSDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>YP_002410375|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETA
AVELSLTTGVAQLYYSMQASYQMLDLLEQTRNVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLDTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
AAPVVEKK
>A0A0P7L0N9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLFKALILGIIEGLTEFLPISSTGHLIVFGNLMDFKSNGKVFEIAIQLGAVLAVIF
EYRIRFKHVVNYVGKDRAVNRFVVNLIIAFIPAAVVGFLFSKQIKAVLFNPISVATMLVL
GGFFILWVEKRAKSHQPKVTSVDDMSPKDALIVGLAQICALVPGTSRSGSTIMGGMLWGL
DRKVATEFSFFLAVPVMIMATTYDILKNYKLFSLQDIGLIVVGFVAAFVAGLLAVKALLK
FVSAKNYIPFAYYRIIFGGLILLTWQMGWVQWTLD
>S4NTF3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MACLSHKLNRLEVGMMLDIIKAIILGIVEGITEFLPISSTGHLILVNEFIKMSQTTQFTD
MFNVVIQLGAIMAVVVLYFHKLNPLSPRKTHVEQHETWVLWFKVIVAVLPSVVIGLLFND
WMDAHLMNWQVVSAMLLLYGILFIVIENRNANRQPQFTDLSRLSYSTAFIIGMFQLLSLI
PGTSRSGATILGGIIIGTSRYVATEFSFFLAIPTMFGASLLKVYKYFSNGGAFTGLQTTI
LLTGMLVSFIVAYFAIRFLLNYIQHNNFKVFGWYRIILSIIVIGYFGFLAH
>YP_001886771|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGLDFLFIFKAIIVAIVEGLTEFVPVSSTGHMILASDLINFQGEFVKMFEVVIQLGAILA
VVVLYWKKIKDSVIEFFAYIFTGGKKGEVGFRFGINVLIGSIPAGVIGILFYSKIKTLFK
PQAVVVGFIVGGILLLVIENIFRKKRHSVKSIDRITPMQSIKVGLFQVLSMWPGMSRSAS
TIMGGWIAGLSTPIAAEFSFFLAIPAMVGSSAKDLFEFDFALMNLTTWVALIVGFIVAFI
VSLVVMEGFVAYLKKKPMRVFAIYRIIAGIVFAILMYMGIVTLHL
>U1ZCE2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEIKGINHLLFSVSHLDTLIDFYQKVFDAKLLVKGRTTAYFDMNGIWLALNEEPDIPRND
IKLSYTHIAFTIEDHEFEEVSAKLKRLHVNILPGRERDERDRKSIYFTDPDGHKFEFHTG
TLQDRLRYYKQEKTHMHFYDETAF
>A0A0K5GD65|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVTSVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRSLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>NP_764009|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MFLLELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSTNFLGSQSAFTFKVVIQLGS
VFAAAWVFRERFLEILHIGQHKPEPSTSGDRRSKPRRLNLIHVLVGMVPAGILGFLFDDL
IEKYLFSVPTVLIGLFIGAIYMIIADKYSKTVQHPQTVDQINYFQAFVIGISQAIAMWPG
FSRSGSTISTGVLMKLNHKAASDFTFIMSVPIMLAASGLSLLKHYEYIHLAHIPFYILGF
LAAFIVGLIAIKTFLHLINKVKLVPFAIYRIVLVIFIAILYFGFGIGKGI
>H7E611|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYKIAAIFTHADNPAENTFFGSVSRLAAGLGIPVYAPD
NVNHPVWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVATVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPSAASGKRRIRVLILGVNGFIGNHLTERLLNEENYDVYGMDIDSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIEELATLLLDSFDKHPLRGHFPPFAGF
QIVESRSYYGKGYQDVAHRKPNIDNARRCLDWEPSIAMRDTVEETLDFFLRSVDITERAS
>A0A0M3E7B2|FEATURES|UNIPROT_deepARG|chloramphenicol|AAY51_12970|antibiotic inactivation|1
MQKINPTYTVVDLSHWARKEHFEAFQTFAQCTFSQTVQLDITTLLKDINTVGWKIYPAII
FLLAKIVNRHSEFRMSVKDNDLIIWDDIHPCYTIFNDKTETFSSLWSHYDGNIHHFLKNY
SDDVARYKNSISYLPKEESLENVFFVSANPWVSFTGFNINIANFQNFFAPMFTTGKYYQQ
GERVLLPFAVQVHHAVCDGFHVARLINELQTMCDDLLRYCEPDS
>F0JMH2|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWAMATMGIAVLMLSLFILKE
TRPAAPAASDKPRENRESLLNRFFLSRVVITTLSVSVILTFVNTSPVLMMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAISLFGITL
ICAGFSIGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVTPGRPVAAHEEIHHHA
>E6WCM5|FEATURES|UNIPROT_deepARG|beta_lactam|Pat9b_1950|antibiotic inactivation|1
MRLLTKLTLLLAWASGSALAQAPDIASITRPLMQQYQVPGMAVAVLYRGKTTFYNYGVAS
KTTQQPVTEQTLFEIGSLSKTFTATLASYAVQQHKMRFSDSASQWLPELKGSAFDHVSLL
NLATHTSGMPLFVPDAVTNTAQLMAWYQQWQPPAVPGTQRVYSNLGIGMLGMIAAKSLHQ
PFRQAMEQQLLPAMGMHHSWITVPSARMQDYAQGYNKQDQPVRVTPGPLDAEAYGLKSSS
ADLIRWLAIQINAVKIDPNWRQAIAATHNGQYHTEAFTQAMMWEYYPLPVTESALVAGNS
GQRIMQGMAAQAITPPQPAPQQAWYNKTGSTNGFSTYAVFIPSQQVAVIMLANKWFPNDD
RVVAVHKIIQAIQGKE
>BAC67138|FEATURES|ARDB_deepARG|tetracycline|tetB|antibiotic efflux|1
MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWL
VFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLNNATGVIGPLLFAVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>A0A024KHB7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNADQGLFVPLILGIIEGLTEFLPVSSTGHLLLVEHFLGFDSPGRVFEVLIQLGAILAIV
VIYFWRLVGIARDVFLRKPYALRFALCVILACLPAAVAGVLLHDFIKNVIYESPIVICVM
LIVGGVILLFVDQLKLKPRYTEIYTYPPLMCFYIGLFQMLALVPGVSRSGATIVGSLLLG
TDKRSAAEFSFFVALPLMVGAFGYDLYKNRELIGPELGLNIAIGFAAAFIVGTLVVKYLL
NFVSRHGFSFFAYWRIFVGAVGLWGLLLFK
>R8KIJ0|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEKSIIFYEKVLEGELLVKGRKLAYFHICGVWVALNEETHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCKSIYFVDPDGHKFEFHSGT
LQDRLNYYREDKPHMTFY
>A0A133MQR4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANIIKAVILGIIEGITEWLPISSTGHLILADEFIKLDASSQFMSMFNVVIQLGAILA
VVVLYFHKLNPFSPSKSTIEKKDTWTLWFKVIVACIPAIIIGLPLDDWLEANFHKFLPVA
IVLIVYGIAFIIVEKRNKNKTPRWTSLNDFTYQAALLVGLFQVLALVPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASGLKIVKYLAEGNSFKMEETVVLLVGTFVSFVVSI
LAIKFLLSYLKKNDFTAFGWYRIILGIILIGYWFIAM
>A0A0S1UVC4|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MPPPTPAPIDLDTWPRRQHFDHYRRRVPCTYAMTVEVDVTAFAAALRRSPRKSYLAQVWA
LATVVNRHEEFRMCLTASGDPAVWPVVHPAFTVFNPERETFACVWAPYDPDFGTFHDTAA
PLLAEHSRATDFFPQGNPPPNAFDVSSLPWASFTGFTLDIRDGWDHLAPIFTLGRYTERD
ARLLLPLSVQIHHAAADGFHTARLTDELQTLLADPAWL
>E3DK50|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDIGCTGLRALAEAGYQIAAVFTHADNAAENHFFSSVARTATQLGVPVYAPE
DVNHPLWIDRIRSMAPDVIFSFHYRHMLNDAIINSASRGAFNLHASLLPKYRGRAPLNWV
LVNGEQETGVTLHRMVKQADAGAIIAQKKVPIADRDDALTLHHKVCAAAGELLAITLPDM
QSGNDVGHPQDESLASYVGRRTPEDGRIDWRLPAQQIHNLVRAVTDPWPGAFSYVGSGKF
IVWQSKVRHDCPANRPGTILSVAPLVVACSAGALEIVTGQSDSGIYMQGSQLAQTLGLVA
GALLHNQPAAVLQRRTRVLILGVNGFIGNHLTERLLVDENFDVFGLDIGSDAISRFIGHE
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDATFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGGQKRCFTDI
HDGIEALFRIIENRQHNCDGQIINIGNPENEASIKQLAEQLLASFERHPLRNRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLNWQPEVALDKTIDDTLDFFLQSVEPGDAG
>A0A103K0K9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFTMTRFAATLLVAACATTAAGRAAATVQDDIRDTVTRHVAPLMKQYAIPGMAIGIVAD
GKPYVFDYGVMSKQTGKPVTGGTLFEIGSVSKTLTATLASDAQEGGELSLADPVAKYLPE
LQGKPFGVVTLLQLGTHTPGGTPLQVPDSIRDDAGLIRYLDAWRPEYAPGTHRKYSNVAI
GMLGWLTAKAMHKDFAALMEQRLFPALGMTHTYINVPDARMADYAQGYTKDGRPVRMTQG
MLWQPAYGVRTTAADLLRFVQANMGMIQTAPRLQRAIDRTHAGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNAPKMLYDAVPASAIKPPLAPNPDTWINKTGSTGGFSTYVAFVPSKRIA
IVMLANGSVPIEDRVKAAYGILGSLGAGR
>A0A099S1S9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMLEILKAILFGIIEGITEWLPVSSTGHMILLDEFVKLNVSAVFKEMFLVVIQLGAILA
VVVTYWKKIMPFSLNSKEFIKKDVFVMWMKIIVACIPAAVVGLLWDDKIEALFYNYKTVA
IMLILFGVLFIIVENNNKGKETKINAISEITFKAAFIIGMFQLIAAVFPGTSRSGSTILG
GILINMSRTIAAEFTFFMAIPVMFGASLLKLVKFGLAFNQMELLILTTGMVTAFIVSVIV
IKFLMQYIKKHDFKVFGWYRIVLGIIVLLYFLIR
>A0A0A2E0J7|FEATURES|UNIPROT_deepARG|beta_lactam|HQ37_03235|antibiotic inactivation|1
MKKSRRKRLVILCIALVCIIVLVFLLFSKSTSNNSTNPPLTDVLTDSISRIVSACPGEIG
VAIIINNTDTVKVNDKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVKIDRNRLDSKTW
SPMMKDYSELVMSLTVRDLLRYTIAQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHDRAYFNYTSPLGAAMLMNRLFTESIVSGEKQSFIKNTLKECVTGTDRIV
APLLDKERVSIAHKTGSGYVNENGILAAHNDVAYICLPNNVCYTLAIFVKDFKGNESQAS
QYVAHISEVVYSLLIQNSAIP
>A0A0Q6KXS8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWLTLLKALILGMVEGLTEFAPVSSTGHLIVVDDLMIKSQEILGKYPANTFKVVVQLGS
ILAVVIVFRDRFIEMLGLRRKKEKTHTLKLSHIIVGLLPAMVLGLLFDDFIDEHLFSLKT
VLIGLAAGSILMIAADMFRPKVPVIETVDQLTYKKAILVGLMQCIALWPGFSRSGSTISA
GVLFGLSYSAASDFTFIMAVPIMAGASGISLLKNWMYMTPEFAPFLITGFISAFIFAYLS
IRFFLTVISRIKLIPFAIYRLVLVAVIVIFFM
>A2THF2|FEATURES|UNIPROT_deepARG|beta_lactam|GES-5|antibiotic inactivation|1
MRFIHALLLAGIAHSEYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>F0J2P5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MPGAVPGAVIELRGVSRTYRSGDVEVQALREVDLVIGPGEFVAIMGSSGSGKSTLMAILG
CLDRPSRGEYRFESVDVARLEEPELARVRSARIGFVFQSFNLLARTSALDNVALPLFYAS
DGPVKGGSRTARALRALGQMGLAGREGNTPSQLSGGQQQRVAIARALINAPRLLLADEPT
GNLDTRTSHEIMETLAALNRERGTTILVVTHEPDIAAYADRVLTMRDGRIVGDERREKAR
GEAAPPAAVAEAAPDAAPNETPDAAPARRRAGIAWAFGAMIVGAAVQALARNRLRSALTM
LGVFIGVAALITMVAVGQGANQAIRKQIESLGTNLLVVLPGATTAGGARAGFGSASTITV
DDARAILREDPAVSRIGYLIRAAGQVRYASQNWTTAIAGVSIDYPAMTNWRVAEGRPIGA
QDERNGALVGLIGQTVRQQLFAPGEDPVGATILVKGTPIRVIGVLAGKGQTAFGTDQDDI
VMLPFSTAEQRVLGTATPSRQDAPLNWAYPAWPNPYGLQLRLTGYVNQLFAQAVSPDAVA
EAMEQISGTLSVRHRIQPNGLKDFSVRNLSQIAAAAQGSSRIMSLLLAIVASISLLVGGI
GIMNILLVSVTERTREIGLRMAIGARRLHVLLQFLAESVFLSVTGGLGGIVLGVALSGGI
TLFAGWPAPVSLLAVAGGFLFSVAVGVAFGFYPARKAARLDPIEALRYE
>X6CUS2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTFVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWKMLLELPHDRLTRHFVIGILIAFLPAAVIGALAHDFIKTVLFESPRLICIMLI
IGGVVLLAVDRMNLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAIGFVAAFVTALIVVRFLLDY
VSRNGYSLFGWWRLVVGGVGLVALMIWG
>A0A0R0LK73|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSSLLLIKAALLGTVEGLTEFLPVSSTGHLILAGSLLHFNDEKGKVFEIVIQFAAILAVC
WEYRRKISQVITELPSQKSAQRFVANLLLAFLPAAVLGLLFAKKIKASLFAPLPVALAFI
IGAFFILWIESRQNKTIIHRVDDMDWRTALKIGFCQSLALIPGTSRSGATIMGALFFGLS
RQAATEFSFFLAIPTLFAATLYEVVKYHHLFHREDITLFAVGSLFSFIFAFVTVRALLRF
VSGHRFTSFAIYRILFGVLILITAYQGWVDWSNG
>YP_001797193|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDLILLLKAVILGVVEGLTEFLPISSTGHLILVGDLLDFNDDRGKAFEVIIQFGAILAVC
WEFREKLIKVTSSFASSPNARRFVLNLFIASIPAMGLGFLFGKHIKAVLFSPIPVASAFI
VGTLIIFWAERRQQNLVDVSSYIKSVDDLRPLDALKVGLAQCAALIPGTSRSGATIIGGM
LFGLPRAVATEFSFFLAIPVIGGATAYELLKLWKAPVAFSGEFTLAIVVGFIAAFISAFV
CVRWLIHYVAHHNFIPFAWYRIAFGILVLFTSYTGLIAWSH
>R5CDI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLFETVIIAIVEGLTEFLPVSSTGHMIIAQSLLGVESTPFVKAFTVIIQFGAILSVICL
YWKRFFYPNAESQGKSYWRSMFDFYARLVVGVLPAVVLGLAFNDFIESNLGNVQLVAWML
IVGGIFMLFCDRIFNKGSEDTKLTYKRAFMIGLIQCISMIPGVSRSMSTIVGGMSQRLTR
KAAAEFSFFLAVPTMLGATCLEMFKMITHGDGSILAQGNNLEMLIIGSVVAFIVAILAIK
FFINYVTKYGFAAFGWYRIIVGLVIIICALCGVELKMVD
>ZP_03612802|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MFLLELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSTKFLGEQSAFTFKVVIQLGS
VFAAAWVFRDRFLEILHIGHHKPENEGSVQRRSQPKRLNLLHVLVGMIPAGILGFLFDDL
IEKYLFSVPTVMIGLFIGAIYMILADKYSEKVQHPQTVDQINYFQAFVIGISQAIAMWPG
FSRSGSTISTGVFMKLNHKAASDFTFIMSVPIMLAASGLSLLKHYEYIHLAHVPFYLLGF
LAAFIVGLIAIKTFLHLINKVKLIPFAIYRIVLVVIIAILYFGFGIGKGI
>A3NNE3|FEATURES|UNIPROT_deepARG|beta_lactam|oxa|antibiotic inactivation|1
MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLVQNGDCGRRASPASTFKIAIS
LMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQR
FAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQISPLEQLEFLGKMLNRKLPVSPTAV
DMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDWARGSGWFVGWIVRGKQTLVFARLT
QDERKQPVSAGIRTREAFLRDLPRLLAAR
>P0A2S4|FEATURES|UNIPROT_deepARG|multidrug|marA|antibiotic efflux|0
MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRS
RKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNMHGESRYML
PLNHGNY
>A0A127SHI8|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQTLEGKIAGFLKGKKATVGVAVLTDKDETIL
HNNEVHYPLLSVFKFHVALAVLDKMNREKIPLKHIVHVKASQLQPNTYSPLRQKHSGQDL
DISLGELLQYSISLSDNNACDILIEYAGGIGHIHQYIRKLGINDFNLSETEDSMHRNPPK
AYYNWSTPSEMVRLLKMADEKDLFAPVYRDFLWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGVVIMPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDVRG
QGDITTT
>A0A0P8X1S3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIESLLSSGFEIAAVFTHADDPKENAFYGSVAQLCARHGIAVHA
PEDANHPLWIERIAKLDPDYIFSFYYRNLLSETLLATARKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIVAQQKVAIERSDTALSLHGKLRVAASDLLRDTLP
ALLQGKASETPQDESKATVFGRRTPADGKLVWAKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAKGNEGLAPGRVISVDPLRIACAEDSLIINAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDPNFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRANFPPFA
GFRDIESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKR
>A0A0H2M8S2|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MKSSANRRTFLLAASALPLASACTAWSAKGPRDTAFSSAEAQLAALERSVGGRLGLVAFD
TATGARVQHRATERFPMCSTFKMMASAAILARSTREPGLLERRVSYGRSDILSNSPITEK
HLGQGMTVSALCAATIQYSDNAAANLLMKILGGPSAVTAFARSIGDPVFRLDRWETELNS
AIPGDPRDTTSPEAMAASLQRLVLGDGLGAAQRSQLEAWLLGNTTGATRIRAGVPADWKV
GDKTGAGSYGTVNDIAVLWPPAGAPLVMAVYLTFPTPDAAGRNDVIASAARIAADALRG
>A0A0M2PNV4|FEATURES|UNIPROT_deepARG|chloramphenicol|WQ54_10930|antibiotic inactivation|1
MKFNMINRNNWYRKEYFEHFLQQQTTFSITNEINITILMKNLKRKNYKLYPAFIFMVTKI
VNSHIEFRISFDSEGNLGYWTEICPSYTIFDKKKHTFSAIWSPNVDHFSEFHSQYNKDVE
KYNGTGSLFPKTPIPENNIPISMIPWSSFTAFNLNINNGGDFLLPIITGGKYFQVNGELI
LPVSLQIHHAVCDGFHASVFMNDLQKLAYESTDWI
>CAL30184.1|FEATURES|CARD_deepARG|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTHRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>A0A0H2Y255|FEATURES|UNIPROT_deepARG|beta_lactam|Bcen_5713|antibiotic inactivation|1
MRFNATRVAATLFVAACATATAGSAAAVTQDDLHDTVTRHIAPLMKQYAIPGMAIGIVAD
GKPQVFDYGVMSKQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPVARYLPE
LQGKPFGVVTLLQLGTHTPGGTPLQVPDSIRDDAGLIRYLDAWRPEYAPGTHRKYSNVAI
GMLGWLTAKAMHEDFATLMEQRLFPALGMTHTTIDVPAARMTDYAQGYTKDGKPVRMSQG
MLWQPAYGVRTTAADLLRFVQANLGMIQTAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLAGNAPKMLFDAVPASAIQPPLAPNPATWINKTGSTGGFSTYVAFVPAKRIG
IVMLANGNVPIEDRVKVAYRILGSLGDGR
>A0A0K1A2M9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFFELIKAIILGIVEGLTEFAPVSSTGHMILVDDMWLKSTEFLGSQSAFTFKVVIQLGS
IFAAAWVFRHKYFEMLHIGKYAPERQEGRRSKPRRLKLSHIIVGMIPAGILGFLFDDLIE
KYLFSVPTVLIGLFLGAIYMILADKYSRNVRNPKTVDEINYFQAFVIGLSQAIAMWPGFS
RSGSTISTGVLMKLDHKSASDFTFMMAVPIMLAASGLSIVKHYNYIQFAHIPFYILGFLA
AFIFGFISIKLFLKLIQNVKLLPFAIYRIVLVVVIAVVYYGIL
>R4WX70|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGIVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRAKIGSIVTGLPSRPDARRFTLNVIIATIPAIVLGLMFEKSIKSVLFSPVPVSVALI
IGGIVILWAEARQRDRAVPPRVTSVDDLSYSDAFKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATLYEMAKYWRTLTVDDISLFAIGLVAAFVSAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>A0A150BY18|FEATURES|UNIPROT_deepARG|beta_lactam|AT269_23675|antibiotic inactivation|1
MKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTVLTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLNRYGNMNLVVPGH
GEVGDRGLLLHTLDLLK
>J8FTU3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLRGINHLCFSVSDLEKSIIFYEKVLEGELLVKGRKLAYFNICGVWIALNEEAHIPRNEI
HQSYTHIAFSVEQEDFERLLQRLEEKEVHILQGRERDVRDCESIYFLDPDGHKFEFHSGT
LQDRLNYYREEKPHMTFY
>A0A076V4Y8|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
CETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLG
GPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQ
RAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLILVT
>A0A157QAB4|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIRRYLRHALTAALSCSALTALPASARMLCTLVADASDGRILVQQGTQGDCTSRYTPASS
FKLPIALMGFDAGILQDAHTPTWSYESTYPDWGGEEWRKPADPERWIKYSIVWYSQQVAR
RLGQKRFQQYATAFQYGNEDVSGDAGKHNGLDGAWIVSSLRVSPMEQIGFLRKLVNRRLP
VRPEVYGMVEPLFEIDPSREGWHVYGKTGTGSPGDNGRYDREHAYGWFVGWARKDGRQVV
FARLIQDEKATAPAAGLRARDQMLSQWAGMMAASARP
>ABI20753|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-14|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TQAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>R5RBL9|FEATURES|UNIPROT_deepARG|aminoglycoside|BN682_00261|antibiotic inactivation|1
MIIKQALPGEENDVAALALKMWPEHEADELRRLFAALLKAPDAAVFVARDGGVAVGFAQT
QLRRDYVEGTSESPVGYLEGIYVEEKFRGRGIARSLLAECENWSRNRGCSEFASDCGLDN
VDSLKFHLGCGFGEAGRIICFTKKI
>ZP_01996651|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
EIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTWIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>I3VNW0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-24|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIADGL
>A0A0G8F3I9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKQEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMIGATGLDLLKSWTYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A0U1HQ02|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MKHSPLRRSLLLAGITLPLVNFALPAWAATLPTSLDKQLAELEQQSQGLLGITVINTGNG
RKIQYRGTQRFPFCSTFKFILAAAVLNKSASQPKLLDKHLHYHERDLLSYAPITRKNLAH
GMSVSQLCAATVQYSDNTAANLLIQELGGVESVNQFARSIGDQTFRLDRLEPELNSALPN
DPRDTTTPSAMAASMNALVLGDALPAAQREQLAVWLKGNTTGGETIRAGAPAEWIVGDKT
GTGDYGTTNDIAVLWPTKAAPIVLVIYFTQREKDAKPRRDVLAAATKILLSHLP
>NP_250708.1|FEATURES|CARD_deepARG|multidrug|amrB|antibiotic efflux|1
MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSASYPGASAKVVEEA
VTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNADLAAVEVQNRLKIVESRLPES
VRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAE
YAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLV
TPEQFGEIPLRIRADGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVA
TAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQN
FRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMA
EEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFS
AFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWML
VYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEP
VAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYA
MNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQ
IRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADGAKRLGIDDI
GRLHVRNEQGEMVPLATFAKAAWTLGPPQLTRYNGYPSFNLEGQAAPGYSSGEAMQAMEQ
LMQGLPEGIAHEWSGQSFEERLSGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVP
LGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEA
ARLRLRPIVMTSLAFGFGVVPLALSSGAGSGAQVAIGTGVLGGIVTATVLAVFLVPLFFL
VVGRLFRLRKAPRTGNSPQIPTEQA
>D4CUD8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNALILVIILALVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFTNSFLIIIQLGAILSV
VVYFWKDLTPFVGTKEKFVLRFRLWLKIIVGVLPAMVIGLFLDDIIDKYFMNNVSIIAIT
LIVYGIIFIAIEVIYKIKNIKSRVKKFTELKYSTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLLKNGLVFTQVEWAYLALGSAISFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIIVLVLLR
>A0A0J6L3C8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPVSSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPTQPSARRFTVNLIIAVLPAVVLGVIFADMIHEYLFNPITVASALV
IGGVIMLWAERRTHVIRAETVDDMTWKDAVKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPDDLPVFAIGFVTAFIFAMIAVRALLKF
ISNHSYAAFAWYRIAFGMLILATWKFGWIDWSAAG
>S1P580|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANFIKAVILGIVEGITEWLPISSTGHLILVDHLIKMQVSKEFTTMFNVVIQLGAIMA
VVYLYFNKLNPFDASKSPLQRKQTWDLWFKVIVACFPSAVIGLLFDDWLDAHFYKPFPVA
LMLIIYGIGFIWVENRNRHLKPKCTDLNRFTYRAAVMIGIFQILALMPGTSRSGATILGG
ILIGASRYVAAEFSFFLGIPTMFGASGLKLLKFLKEGNVFDFQLTVILLTGMIVSFVVSV
LVIKFLMDYIKKHDFSVFGWYRIILGVIIILTMIF
>M4Q6K1|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
LCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAA
NLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLT
GELLTLASRQQLIDWMEGIKLQDH
>A0A089N844|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHNTFIAIIQGIVEGLTEFLPVSSTGHLILSGQLLGFTGDKADTFEIIIQLGAILAVAII
YWRRILGLLGLKTVETGEAVQSGQPKLNLLHVILACLPAMVLGLALHSVIKTYLFSPYTV
LAGLVLGGGFMLLGQKKQTAVQAATIDQLSYKQAVSIGLFQCLSLWPGFSRSGATIAGGL
LSGASYSAATNFSFLIAIPMMIAASGFELLKSIHTLNASDAGFFLTGFIVAFVVAFLAVI
TFLKLLERLKLAPFAYYRFVLAAVFLVYLLSQ
>A0A080ES22|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAMMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGVTLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>Q7NUJ3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSGAGLELDGVWRRFPSGEDEVAVLKNVTLSIAPGEMVAIVGASGSGKSTLMNILGCLDQ
PSVGRYRVAGQDAGCLDGDQLAALRRGHFGFIFQRYHLLPHLSALDNVAMPAVYAGMALH
QRRERARALLARLGLAGKEHHRPGQLSGGQQQRVSIARALMNGGRIILADEPTGALDSHS
GEEVMRILKELNAAGHTVIIVTHDPAIAAQTERVIEIRDGEILRDSGAPAREAASQATEA
QPDGGPLLRERLAEAFKMAMLAMSANRLRTALTMLGIVIGIASVVSVIAIGEGSRDYVLK
GIREMGTQTITVFRGKDWGDDKADGVRTFLPGDVAALEGEGYVDSVTPETAQAQRIRYRN
VDVNASVIGVGRDFFRVQGMKLAEGQSFSRDDIHFQRQVVVLDKNSRRKLFGDGEAVGRV
ILVGMVPATVIGVVAQRDRGFGGNSLQMWMPYSTAASRLFGQQHFDRFVIRVKDGQPTKL
AEKAIGALLTQRHGGKDFFTYNMDEILKTVESSSRALSLLLALVAVISLVVGGIGVMNIM
LVSVTERTREIGIRMAVGARQGDVLQQFLTEAVLVCLVGGAIGVALSYGVSFVFSLFVTE
WKMSLSPPVIALAVACSSLIGVLFGFLPARNAAKLNPIDALARE
>AAA26083|FEATURES|ARDB_deepARG|trimethoprim|dfrB1|antibiotic target replacement|1
MERSSNEVSNPVAGNFVFPSNATFGMGDRVRKKSGAAWQGQIVGWYCTNLTPEGYAVESE
AHPGSVQIYPVAALERIN
>A3PNJ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDSTTLVALVLGLLEGLTEFIPVSSTGHLLLAGHFLGFESAGRSFEVVIQLGAVLAVLT
VYAAKLVSVIRAAPHDPRAFRFLVAVLVAFLPAVVIGVLAHGFIKAVLFETPILIATMLI
LGGIVLLFVDRMAPEPRYDDAMDLPLNVALKIGFIQCLAMVPGVSRSGATIVGGLMLGAG
KRAAAEFSFFLSMPTMAGAFAFDLFKNRDVLDASALGEIAVGFVAAFVAAVLVVRWLLGY
VSRHGYALFGWWRIAVGSVALAALLAGY
>A0A0E1CLX4|FEATURES|UNIPROT_deepARG|beta_lactam|KPNJ1_05814|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRGTELNEAIPNDERDTTMP
AAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSR
GIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A0P9I4G6|FEATURES|UNIPROT_deepARG|polymyxin|ALO51_04846|antibiotic target alteration|0
MERIGKLAPDFIFSFYYRQLLGEPLLACASKGALNLHGSLLPRYRGRAPANWVLVNGESE
TGVTLHQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLPLLALGQLSG
TPQDESLATCFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCPVGENKLIVWAASA
EAGNNGEAPGTVISHDPLRIACGEGSLVINAGQRGDNGLYLSGAQLAREFGLVEGSQLLD
TEKRRLARRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLRTKPNFHFIE
GDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTR
>T5NRH6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>CAA75611|FEATURES|ARDB_deepARG|beta_lactam|CMY-31|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDCIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGRLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSSGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>T0C6S8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEIGSINHLLFSVSNLERSIEFYQKVFGAKLLVRGRKLAYFDLNGLWLALNVEEDIPRNE
IHQSYTHIAFSLKPEEFDEAVETLKALGVNILAGRIRDERDKQSVYFTDPDGHKFEFHTG
TLKDRLDYYRETKTHMQFFD
>F7XX72|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MHVHEWLIAFIMGLVEGLTEFLPISSTGHMILVGSLLGVTDEKTKTLELIIQLGAILAVL
VVFWRQLCSLIGTNFSPLSPQIIIGHERLSLGHILLGMIPAGVLGLVLYNHIKAIFLPQY
VIYALVVGGWLLLAGEWLKPKQPQTIDINDLTYLQAFFIGCCQCLALWPGFSRSGATING
GIIIGVSRYVAWEFSFILAVPIMLGATVIDIYKSIPCIIWHDFTMFAIGFATAFLVALLA
IKFFLHIIRNISFLPFVIYRFLLAAIVTWLI
>A0A0A0Q8L2|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-12|antibiotic inactivation|1
MMKKSLCCALLLSTSCAALAAPLSETQLAKVVERTVTPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGA
LAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKSEEQHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVAANMAPDGVQDASLKQGMVLAQSRYWRTGSMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>X7R747|FEATURES|UNIPROT_deepARG|beta_lactam|AJ90_05610|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILDHYKES
>YP_002394084|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTMQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAITQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLVSEINKLQHTIAEGQCWQSDWRIS
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMVADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVVLERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>P23212|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|msrA|antibiotic target protection|1
MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESG
TVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNY
SPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRV
FKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIA
PDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPII
AQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMA
YYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSL
AVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELT
GQSIHDIT
>A0A0A7HFD6|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
EDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIH
YSQNDLVEYSPVTEKHLTDGMTVRESCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMG
DHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKV
AGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQ
IAE
>YP_001452184|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MLMPLSIDMYLPALPVISAQFGVPAGSAQMTLSTYILGFAVGQLIYGPMADSLGRKPVIL
GGTLVFAAAAVACALAQTIDQLIIMRFFHGLAAAAASVVINALMRDIYPKEEFSRMMSFV
MLVTTIAPLMAPIIGGWVLVWLSWHYIFWILAVAAILASVMIFLLINETLPVERRQPFHI
RTTIGNFASLFRHKRVLSYMLASGFSFAGMFSFLSAGPFVYIEINHVSPQHFGYYFALNI
VFLFVMTIINSRFVRRVGALNMFRTGLWIQFVMAAWMVFSALFGVGFWALVVGVAAFVGC
VSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGALLSLATFTSAWPMIWSIAFC
ATCSILFYLYASRPKKR
>J3I9Z1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTTTQVSILGLVEGLTEFLPISSTGHQIIAADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILEITTGLPTQRNAQRFTLNLLIGFLPAVVLGVMFADKIHEYLFNPITVAVALV
IGGIIMLWAEQREHVVVIEHVDEMRWTDALKVGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQSADLPVFALGFVAAFLFAMIAVRGLLKF
IANHSYAVFAWYRIAFGLLILATWFLGWIDWNHLSEGA
>NP_671620|FEATURES|ARDB_deepARG|rifampin|rif|antibiotic inactivation|0
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMPHYISLSGVMTNDGPDNQAIASFEIRD
QYITALNHLVLSLELPEVKGIGRFGYVPYVGYKCINNVSISSCNGVIWEIEGEELYNNCI
NNTIALKHSGYSSELNDISIGLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITV
TVTFNPVSDIVIRDSSFDFETFNKEFVYVPELSFIGYMVKNVQIKPSFIEKPRRVIGQIN
QPTATVTEVHAATSLSVYTKPYYGNTDNKFISYPGYSQDEKDYIDAYVSRLLDDLVIVSD
GPPTGYPESAEIVEVPEDGIVSIQDADVYVKIDNVPDNMSVYLHTNLLMFGTRKNSFIYN
ISKKFSAITGTYSDATKRTVFAHISHTINIIDTSIPVSLWTSQRNVYNGDNRSAESKAKD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
FTPKIFFRPTTITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQG
VSITKIMGDNN
>K7TAV6|FEATURES|UNIPROT_deepARG|beta_lactam|B932_2238|antibiotic inactivation|1
MALSVAVIASRIFPAKADSFSEQAREVLRPVMKKYDIPGLVVGITRNGKHEFYVAGVASR
ADNRAVTPDTLFELGSISKIFNVTLAALAEERGKLSLNDTVAHYVCVDACSIGNRLTLMD
LATHQSGGLPLQVPGSITDVDGLVAWLKNWHPSEPGARSYSNISIGMLGYITGKAMDSDY
KHVVQDVLIPMFRLQHTWIDIPKSEMGQYAWGYERKTNTPIRMSPGVLADEAYGIKSNAR
DMLKVLDVEMGQGAASEELRKAVKKTHEGQYKTAFFTQDMIWEQYSWPTHLHTMIRGNGS
DFIMKPQSEKKLSPPLPPQKNVLLNKTGSTNGFGGYIAILPGKNIGVVVLANKNYPNEAR
VKAVYSLIEGLHSKQ
>YP_002090521|FEATURES|ARDB_deepARG|multidrug|oprJ|antibiotic efflux|0
MRKPAFGVSALLIALTLGACSMAPTYERPAAPVADSWSGAAAQRQGAAIDTLDWKSFIVD
AELRRLVDVALDNNRSLRQTLLDIEAARAQYRIQRADRVPGLNAAATGNRQRQPADLSAG
NRSEVASSYQVGLALPEYELDLFGRVKSLTDAALQQYLASEEAARAARIALVAEVSQAYL
SYDGALRRLALTRQTLVSREYSFALIDQRRAAGAATALDYQEALGLVEQARAEQERNLRQ
KQQAFNALVLLLGSDDAAQAIPRSPGRRPKLLQDIAPGTPSELIERRPDILAAEHRLRAR
NADIGAARAAFFPRISLTGSFGTSSAEMSGLFDGGSRSWSFLPTLTLPIFDGGRNRANLS
LAEARKDSAVAAYEGTIQTAFREVADALAASDTLRREEKALRALANSSNEALKLAKARYE
SGVDNHLRYLDAQRSSFLNEIAFIDGSTQRQIALVDLFRALGGGWDEGRSLVVHRGGRS
>A0A0P1D1N8|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MIFTKIIRGFIRVEPPPRFIRKLKEPPLNRTNIFFGESHSDWLPVRGGESGDFVFRRGDG
HAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADL
SGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKS
TPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADR
YADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG
>M5ISA2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKNLIELKNLSKKFKLGDNVFDALKDVNLTIKKGEFIAIIGQSGSGKSTLMNILGCLDNP
SGGQYLLEERDISKFEGDELARLRREKFGFIFQRYNLLSTLTTLQNVALPSVYAGVSKKD
REKKAGELLEGLGLGEKLQNLPSKLSGGQQQRVSIARALINGGEIILADEPTGALDSKSG
LMVMDILTNLHKDGHTIIIVTHDPNIAAYANRVIEIKDGKILSDTVKSEEIFASEKPAVK
QKNIFSFYKDQFIESFKMSINAILSHKLRSVLTMLGIIIGITSVICVVALGQGSQEQILS
DIRGIGTNTIDIYNGKGFGDRSERIKALTISDATLLSKQDYLDSVTPNASTSATLTYRNK
SASATVRGGSEDSLDVMGYKMESGREFTADDVRDSASVAIIDQATKNEFFKNADPVGETL
LINRRPFKIIGVLQKQEKGFDDGSTLKVYTTYTAIINKLTGDKHIASITAKVKDNINAQI
AEQSITEILTAKHGKKDFKTRNSDSIKVTIEEATKTMTLLISCIAFISLLVGGIGVMNIM
LVSVTERTKEIGIRMAIGARQGNILEQFLIEAVLLCLIGGLIGVGSAFSIGYLTENFAPD
IKMIFSQTSIVVALVVSSAIGVIFGYMPARSASKLNPIDALSRE
>A0A156EUW0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLNLTVCQAQSNPTDYACLMGPDTPLTRYYGRLLMMKKSLCCALLLGLSCSALAAPVSEK
QLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHYYTFGKADIAANKPVTPQTLFELGSIS
KTFIGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVT
DNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDH
TWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADA
SLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVAEVNPPAP
PVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILEALQ
>A0A0U1YWI2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMGKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANADYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>YP_001453247|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARQLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGCVSVLIMFVLWNAGYIIRSMHNID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVIGFLGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFIAMASYVKRARSMRDIRNERGFSKPDTAVMKRLVQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLGVGVCMAVITAIFTVTLREPIALLYNDNPEVVTLAAQLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYILALTDLVVDRMGPAG
FWMGFIIGLTSAAIMMMLRMRYLQRQSSAIILQRAAR
>A0A127SSZ0|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRTQQMSELENRIDSLLNGKKATAGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMAQLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAQTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDNADIIARISRMVY
DAMR
>D4S8A4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELVKVAVLGIVEGVTEWLPVSSTGHMILVDEFIRLDVSTAFMDMFLVVIQLGAILAVVV
LNVGKLNPFLTSKSRQERRETFDLWGKVIVACLPAAVIGLAFNKYMEEHFMNAPVVAAML
ILYGILFIIVERWNKRRVPRVESLAQLDYRTAFIIGIFQVLSLVPGTSRSGATILGGIIF
GASRYVATEFTFFLAIPVMFGASFLKLVKFGWNYSRTELVILGVGMATAFIVSILSIRFL
LRYIKRNDFTVFGWYRIALGIVVFAYLFIIGDPTKG
>CAG34264|FEATURES|ARDB_deepARG|multidrug|smeD|antibiotic efflux|1
MLLSRIRPFALSLAIAATVAACGGQPQAPEQGPGDVTVVTLKSETVGLTRELPGRTNAFL
VAEVRPQVNGIVAKRLFTEGGMVKAGEPLYQIEDASYRAQANSARAQLARAEATANAARL
SAKRITELAKVDAVSQQDLENAVAAQKQAEADVGAAKASLDAANVTLGYARITAPISGRI
GKSSVTQGALVSAGQANALATVQQLDPIYVDLTQSSAELLQLRRELAAGRLQDNQTLPVS
ILMEDGSTFEHKGTLEFSEVSVDPTTGSFGLRVKVDNPDGLLMPGMYVRAVIGGGVRSDA
VLVPMQGIGRDPKGDTTAMVVGKDNKVEVRPVKVSRTVGDKWLVEDGLKAGDKVIVEGLQ
KIGPGMPVKATEKGDVPAKPAAAAQPAAPAGDAK
>C4IHX2|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MGLDFLFILKAIIIAIVEGLTEFIPVSSTGHMILASSIIGFNDPKVFVDMFEVVIQLGAI
LAVVVLYWKKIKDSVIEFFTYIFTKGKKGKTGFQFGINVLIGCIPMGVIGIVFYRQIKML
FNPKIVVAGLIVGGILLIIIENKFRKNRKYSTKNIDSITPLQSLKVGVFQVFAVWPGMSR
SASTIMGGWVAGLSTPIAAEFSFFLAVPAMIGSTAKDLFEFDFSMMNMTLWITLIVGFIV
AFIVSLVVMEKFVAYLKKRPMRVFAVYRVGIGIIFAILMMLGMNLNM
>E5AZW2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLEKSESEPNLLNQRV
>L0IW73|FEATURES|UNIPROT_deepARG|beta_lactam|Mycsm_02498|antibiotic inactivation|1
MTGVSRRRALIGGLTFATAAAFATKPAAADPAAPTPRIQNRIAALERRYDAYVGLFAVDV
DDGRAISHRGQEAFAMCSTFKGYASARVLQMVEQGQLTLDQRVFVDPAATVANSPRTAPR
AGGDMTLDELCQAALRVSDNTAGNLLLQTIGGPPAITAFARSIGDPSTRLDRWETELNSA
IAGDPRDTSTPEALGGGYRNLLTGDALAPPQRQQLEDWMRANETSSMRSGLPPQWTTADK
TGSGAYGSTNDVGIAYGPDGQRVLLALMTRSQVNDPKAQNQRALIGELTALLVPELSS
>G3ESU5|FEATURES|UNIPROT_deepARG|beta_lactam|pdc-26|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKAYDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLNVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>CAA70425|FEATURES|ARDB_deepARG|beta_lactam|mecA|antibiotic target replacement|1
MKKLIIAIVIVIIAVGSGVFFYASKDKKINETIDAIEDKNVKQVFKNSTYQSKNDNGEVE
MTDRPIKIYDSLGVKDINIKDRDIKKVSKNKKQVTAKYELQTNYGKINRDVKLNFIKEDK
DWKLDWNQNAIIPGMKKNQSINIEPLKSERGKILDRNNVELATTGTTHEVGIVPNNVSTS
DYKAIAEKLDLSESYIKQQTEQDWVKDDTFVPLKTVQDMNQDLKNFVEKYHLTSQETESR
QYPLEEATTHLLGYVGPINSEELKQKAFKGYKKDAIVGKKGIEKLYDKDLQNKDGYRVTI
IDDNNKVIDTLIEKKKIDGKDIKLTIDARVQKSIYNNMKDDYGSGTAIHPQTGELLALVS
TPSYDVYPFMNGMSDEDYKKLTEDDKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDGK
TSYKINGKGWQKDKSWGDYNVTRYEVVNADIDLKQAIESSDNIFFARVALELGSKKFEEG
MKRLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENKG
NVNAPHVLKDTKNKVWKKNIISQENIKLLTDGMQQVVNKTHREDIYRSYANLVGKSGTAE
LKMKQGETGQQIGWFISYDKDNPNIMMAINVKDVQDKGMASYNAKISGKVYDDLYDNGKK
TYRIDK
>A0A0Z8L251|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
MTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAI
ALIVYGIAFIWIENRNSGVEPQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAI
ILGPSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWILLVASVTAYLVSLV
VIRFLTDFVKKHDFTVFGYYRIILGAILLVYAFITFLF
>Q5YWV1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPEILEVVDVDGGPYGVTVDETGTLWFTLAARGAVGRLVDGTVETVALEPADGSPTVIMA
EGDGAWFTEFRGNRIGRVEANGALSFLTAESPYGLCRAGDGGLWYTELSAGGVVHRAPDG
TTTRHAVEGMPSMIAEAADGTVFVTLNQGNAVARITPDGQVRTTALPTAGAGPVGLATAA
DGAWFVELLAGQLGHVDRDGTVTEHPLPDRDARPHAVVVAPDGTVWFTEWAAARLGRRTA
DGEITELALPGAEPHGLAVAPDGTLWVAMESGALVHVRP
>J2L4S5|FEATURES|UNIPROT_deepARG|beta_lactam|PMI17_02969|antibiotic inactivation|1
MKLISRTLLASLLASVSAISMAAQPEVEASVSQIIKPLMQQQAIPGMAVAVIVKGQPYFF
TWGLADTQHLLPVTADTLFELGSVSKTFTGVLGGVAVTKGEIKLSDAANIYWPALNAPQW
RPITLLQLATYTAGGLPLQVPDAVTDEDKLVNFYQQWQPQWQPGATRQYANSSIGLFGLL
AVKPSGLSFEQAMQQRVLTPLKLDHTFINVPQKEQKRYAWGYRDGKPVRVSPGMLDAEAY
GVKSSIKDMARWMQANMDPQQVEDKTLQQALELAQTRFYRTAALYQGLGWEMLDWPGQAA
MTEKGADNKVALGAQPVLDARPHPRVNASWVHKTGATGGFGAYVAFIPEKQLGIVMLANK
NYPNTERVKAAMQILTALQ
>P24618|FEATURES|UNIPROT_deepARG|aminoglycoside|grm|antibiotic target alteration|1
MTTSAPEDRIDQVEQAITKSRRYQTVAPATVRRLARAALVAARGDVPDAVKRTKRGLHEI
YGAFLPPSPPNYAALLRQLDSAVDAGDDEAVRAALRRAMSVHVSTRERLPHLAEFYQEIF
RHVPQPNTLRDLACGLNPLAAPWMGLSDQTVYVASDIDARLIGFVDAALTRLGVAHRTSV
VDLLEDRLDEPTDVTLLLKTLPCLETQRRGSGWEVIDIVNSPIIVVTFPTKSLGQRSKGM
FQNYSQSFESQARERSCRIQRLEIGNELIYVIQK
>A0A0D7XTP4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLWEMFTAAVLGIVEGLTEYAPVSSTGHMIIADDIWLKSGSLMNPEAANSFKVVIQLGS
ILAVAIVFKDRILHLLGLKKNVTRDQQKGYRLTIAQIAVGLVPAAVLGFLFEDFIDRYLF
SVRTVAYGLIAGAVLMLIADWINKRKETIDTVDRITYKQAFCVGLFQCLALWPGFSRSGS
TIAGGVIVGLNHRAAADFTFIMAIPIMAGASLLKLVKYWGSLSYDMIPFFLVGFICAFVV
ALLVVKFFLRLINRIKLVPFAIYRVILGIILIMLVR
>A0A095ALV1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDLIKAIIIGIIEGLTEFLPVSSTGHIILAESLMRIPGGTVWTKAFSSVFDYSIQLGAI
FAVIQLYFNKLNPFSSKKTDHEKFQTWRLWIRVIVGVIPAMIFGFALNDFMDAHLMNYKV
VAATLIIYGIAFIVIENRQKSIVPVITNVNQITFKLALYIGLFQVLSIVPGTSRSGATIL
GAIILGASRFVAAEFSFFLSIPVMFGVTFLKMGSFFLKGGSFTGMQSLVMLIGFIVSWIV
AWFAIKFMMDYIKNNDFKAFGYYRIIVGAIFLILGLVGIVK
>A0A0W0L9I0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSIKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPREKTFFGSVAQMCARHGITVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLP
LLAAEGQLPATPQDESRATYFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCPVGE
NKLIVWAANAEAGNNAEAPGTVISHDPLRIACGEGSLVITAGQRGDSGLYLSGAQLAREF
GLVAGSQLLDKAQRRSIRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVVDGIEALARIIENRDERCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGKGYQDVSHRTPSIDNAKKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>C1DUY6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSNLQAFILGVVEGLTEFLPISSTGHLILVSTLMGIDQTDTQKAFEVSIQLGSILAVVFL
YFGKFKDINLLKKLIVAFIPTGILGFLLYKVIKSFFNPYIVVFMLVLGGVILILIEYYHK
NKDYPVKSLEDVSYKKAFFIGLFQSLSMVPGTSRSGATIIGGLILGLNRKTAAEFSFLLA
VPTMFMATFYDIYKNHSHFNTSDWSNLAIGFITAFIFAILAIKLLLKFISNHNFIPFGVY
RIILGIVYYLVVLR
>S3N8V5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLLFIQAAVMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVVAIQVGAIAAV
IYEYWGKLWGAATGLVTGEKKGRHLGISLILASIPIMLVGLTFGQTVKGLLFNDISVAIG
LIVGGLIIWWVEKNPRQIHAEEVDNITIKEAIYIGLIQVLALIPGTSRSGATIIGAMMLG
VSRKAATEFSFFLGIPVIVGAGLLDLYQSYHVFTTEQDWMVLAFGTLVSFVSALVLIRVL
VAYVAKRDFMVFAWYRIVSGLIILLFALTGWKLW
>I1V577|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VMAAAAVLKQSETQKDLLSQRVEIKSSDSINYNPIAEKHVNGTMTLGELSAAALQYSDNT
AMNKLIAHLGGPGKVTAFARAIGDDTFRLDRTEPTLNTAIPGDPRDTTTPLAMAQALRNL
TLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVV
>ABD49191.1|FEATURES|ARDB_deepARG|trimethoprim|dfrA14|antibiotic target replacement|1
MRTLKVSLMAAKAKNGVIGCGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNR
KYAVVTRSGWTSNDDNVVVFQSIEEAMDRLAEFTGHVIVSGGGEIYRETLPMASTLHLST
IDIEPEGDVFFPSIPNTFEVVFEQHFTSNINYCYQIWKKG
>A0A0T9SLA5|FEATURES|UNIPROT_deepARG|polymyxin|pmrF_1|antibiotic target alteration|0
MSQNEKIKKVSVVIPVYNEQESLPALIERTSAACKLLTQPYEIILVDDGSSDSSADILTA
AANEPDSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGGEQTENNQEIEK
>A9VQI2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLDFEGERAKTFEIVIQLGAILAITIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEAKKAEATAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIAIPVMAGATGLDLLKSWKYLSVDDIPMFAVGFITSFLVAMLAVVTFLKLL
EKIGLKPFAYYRILLAIVFTLFVLL
>A0A127SHJ6|FEATURES|UNIPROT_deepARG|beta_lactam|OXY-2-7|antibiotic inactivation|1
MLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQILYRGDERFAI
CSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQ
YSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERDTSTPLAMAE
SLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAGDYGTTNDIAV
IWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>A0A0H4KPT7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDLLKALILGIVEGLTEFAPVSSTGHMIIVDDLLLKSKEILTEPVANTFKVVIQLGSIL
AVVIVFKDRFIDLLGLNRKKHYATENRLKLGQVIVGLLPAAVLGLLFEDFIDEHLFSINT
VIYSLVAGAILMIIADIVSRNKPQINTIDKITYKQALGVGLFQCIALWPGFSRSGATISG
GVLLGMSHRAAADFTFIMAVPVMAGASFLSLLKNWQYFSMDVLPFFIIGFISAFVFALVS
IRFFLKLINRIKLLPFAIYRIIIAIIIYIVFL
>A0A126QHI2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|PM0996|antibiotic efflux|1
MNQPLIELKNIVRRYGHGDTETTVLKSINLKIYAGEMVAIVGASGSGKSTLMNILGVLDQ
ADDGEYLFRGRQISTLSSDELADLRCYHFGFVFQRYHLLPHLTAVENVEIPAIYSAMEKE
KRIERAQKLLCRLGLENQLKHKPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQS
SQEVLSVLKTLNHQGHTVILITHDMQIASHADRIITMKDGEIIADSGVTQNLMKSSVQEV
TPQLSSMHYLATLRRYHAAFLMAMHMMFAHKIRTLLTMLGIIIGIAAVVCVIALGEGAKN
KVLAEFSALGNNTIDIYPGKNWGDPDAIKIQTLNQVDLALLRQQPYLKGATPQISVDLPL
RFLNRTVNASVYGVSDAFFQLRKHRLLSGRWFNAHDMATHQAVSVIDKKSQQVIFGTESA
VGKTVFIGQIPILIVGVVETPPQNIEGQRATIWLPYNTVVSRLYNQSYFQQITVQVKEHI
APELAEKAIIDLLTIQHGRKDFFTFSSRKFLQSLQRTTQTLTMMISSIAFISLVVGGIGV
MNIMLVSVIERTREIGIRVAVGAKEKDILHQFLIESASVSLLGGMLGVLLSLLLGGLFSA
FTDSIKMQFTFSSFLIAFVCSSMIGMIFGYFPARNAARLKPVVALSQE
>A0A0F5B741|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLEAGYEIAAIFTHADNPAENAFFGSVSRLAAGLGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEDILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSLPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPSATSGKRRIRVLILGVNGFIGNHLTERLLNEENYDVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QIVESRSYYGKGYQDVAHRKPNIDNARRCLDWEPSIAMLDTVEETLDFFLRSVDIAERAS
>V3CCZ9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTTQPASLPHSISLQDIDMFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTMGKAYE
ILLVDDGSSDNSALMMTDAAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDAD
LQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCM
LRAYRRHIVDAMLHCHERSTFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMY
DLITCLTTTPLRLLSVFGSIIAVAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIG
AQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQEHKASQEEIHP
>A0A0G3CVM9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGNFHDLVVAFILGVVEGLTEFLPVSSTGHMIIVGELLGFSGDRASTFEVVIQLGSILAV
VVVFWRRLFGLIGIHFGEVPHEGRGKGRLTLGHIILGMLPAVVVGFALHDMIKANLFGAK
TVMYALIAGGLLLIAAELLKPKKPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFILAVPMMLGATILVMYKSIGLLVWDDLPMFTVGFFTAFVVALL
AIKTFLNLIKRFSFIPFAIYRFFVAGVIYLVFF
>A0A090DJ46|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTSHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFSKLWQMLIKLPSDPQTRHFVIGILIAFLPAAVIGALAHDFIKTFLFESPRLICIMLI
IGGAVLLAVDRMNLKPVHHDVERFPTSLYLKIGLFQCLSLIPGTSRSGSTIVGALLMGVD
KRAAAEFSFFLAMPTMVGAFAFDLFKNRNVLTSADLPIIAVGFVAAFVTALFVVRFLLDY
VSRNGYALFGWWRLVVGGLGLLALMVWG
>ABB77558|FEATURES|ARDB_deepARG|trimethoprim|dfrA14|antibiotic target replacement|1
MKVSLMAAKAKNGVIGCGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNRKYA
VVTRSGWTSNDDNVVVFQSIEEAMDRLAEFTGHVIVSGGGEIYRETLPMASTLHLSTIDI
EPEGDVFFPSIPNTFEVVFEQHFTSNINYCYQIWKKG
>Q1QRR2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFSDAIRAVILGIVEGVTEFLPVSSTGHLLLAERFFDLGSGNFWNTFTVLIQLGAILAIV
VIYFEKLWRIALGMFSNDADRRFVIGVLAAFLPAVVVGLIAGKYIKELLFNPWVVCFSLI
VGGAVLMWVDQLDHKPHEHDATAFPLPMYIWIGIAQCLAMIPGVSRSGATIVSAMLLGAD
KRAAAEFSFFLAIPTMIGAFAYDFYKNRADMTTDHLGIVAIGFVVSFVTAIVVVKAFLSY
VTRNGFTFFAWWRVIVGTLGLIALALGR
>A0A0J6FYT5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGIIEGLTEFLPISSTGHLLIAERWLGHRSDFFNIVIQAGAILATTLVFRQ
RLWDLATGLGDRANRDYAFKLGAAFLVTAVVGLVVRKAGWQLPDSVEPVAWALVIGGVWM
LVAEYFAARLPERETVTWTVAIAVGLAQVVAGVFPGTSRSAATIFLAMLLGLSKRSAAAE
FAFLVGIPTMFAASAYSFLELYKDGGLGSENWGDVALAFVASMVTGFVVVKWLLGYIKSH
RFTAFAVYRIVLGTALLLWLPAA
>B8ZI16|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGPAESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKN
>YP_997055|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDVVLLVKAAIMGVVEGLTEFLPISSTGHLILAGALLGFDDAKAQVFDVAIQTGAILAVI
LVYWAKIRATLHALPSERQAQRLAFNLAIGFFPAVLLGLLFGKAIKAHLFTPVVVASTFI
IGGLVILWAERRAPAATRIHTLDAMTAPDALKVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRQAATDFSFFLAIPTLIGAGVYSLYQERALLTVADLPMFLTGLVFSFLSAWLCVRWLLR
YIASHSFVPFAYYRIGFGLMVLVTASTGWVPWVD
>C3FCE9|FEATURES|UNIPROT_deepARG|beta_lactam|bthur0007_60310|antibiotic inactivation|1
MLPYKKIVPVLFLSCATLIGCSNSNTQSEPPKQAKQENTVNHSFAKLEKEFDAKLGIYAL
DTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIENLNQRILYTREDLVNYNPITEKY
VDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLIEIGDTVTNPERFEPELNEV
HPGETHDTSTPKALATSLQAFALGDVLSTEKRNLLIDWMKRNTTGDNLIRAGVPGGWKVA
DKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKIVLDTLKTPN
KQ
>C5R7Y5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAIILGIVEGITEFLPISSTGHLILANEFIQMKQSTQFTDMFNVVIQLGAIFAVV
VIYFHKLNPFSPKKNSLEKHDTWILWLKVLVAIVPSVVLGLLFNDWMDAHLMNWQVVAAM
LLIYGILFIVIENRNDRLTPRFTNLSNLPYQTAFIIGMFQLLSLVPGTSRSGATILGAIL
IGTSRFVATEFSFFLAIPTMFGASLLKIVKYFSHGGAFTGTQTMVLLTGTVVSFVVAYLS
IRFLLNYIKNNDFKAFGWYRIILSVLVIAYFGFFAK
>W1SB21|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDAATWAMFNVVIQLGAILAVVV
LYWRTFWAVGMGLLRGEAVSWRFLRNLVVAFIPAAVIGLALHDYIEILLGEPQVVAWALI
VGGIAILAIERMVKQDLFHGIADIPLVRVIAIGFIQCLAMVPGVSRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGATTLELLKKGDQITSATVGWDSIALGLLVSFIVALLVIKWFV
GLVSKHGFAPFAWYRIVAGVSALIWLAMR
>E5G517|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDPPGGTELNEALPGDARDTTTP
ASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGAR
GIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>A0A0S1Z215|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY|antibiotic inactivation|1
MMKKSLYCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>A0A067LXT9|FEATURES|UNIPROT_deepARG|chloramphenicol|W824_05930|antibiotic inactivation|1
MANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA
>A0A0K3YB97|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLATGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPAAVLHNMVRAVADPWPGAFSYAGNQKF
TVWSSRVHPHTSAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENVGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>G3K0V2|FEATURES|UNIPROT_deepARG|beta_lactam|blaP1|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGNGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>F0BGW2|FEATURES|UNIPROT_deepARG|aminoglycoside|XVE_3490|antibiotic inactivation|1
MSTQAGWRVRAAVGADAQALLALRLALWPDADDGLAELQAALAQADASHLLAVDDADAAL
GFAEVSVRHDYVNGTESTPVGFLEGWYVSPAWRGRGLGRALVAAAVAWTREQGCAELASD
ARLDDSGAQAAHAACGFEPTERVVYYRLQLA
>D8EKD7|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9345_01600|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>V9QY78|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACKQLAYEYEIILVDDGSRDKSAQLLENA
AEEDGSNVVAVILNRNYGQHAAIMAGFEQCRGDVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVNHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
CLAGLGGLFAFALIILRLAFGAQWAGDGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGLASSHTTTTSPSDQVSS
>Q84GI6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYY
FTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQ
WQGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKLLYANASIGLFGA
LAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQLDAEA
YGVKSSIEDMAHWVLANMNSEAVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLNWPVPA
EVVINGSDNKVALAATPVTAVNPPAPSVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKSYPNPER
>R5D2R0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELIEILKVVVLGIVEGVTEWLPISSTGHMLLVDEFIHMNVSESFKDMFFVVIQLGAILA
VVMLFWDKMWPFQTKDKSKPVIRKDVFSMWFKVVVACIPGAIVTLLFDDYIEAHLHTPTV
IALALVVYGVAFIVIENWNIKRTPKVLALEDISYKTAFIIGLFQVLSIIPGTSRSGSTII
GALTIGVSRVAAAEFTFFLAVPVMIGLSFIKILKFGFSFTSVELMTLAIGCVVAFLVSVL
VIKFLMSYIKKRDFKIFGWYRIVLGVILLLYFM
>Q2FC60|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVSYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIEFNYYSPKSKKDTSTPAAFGK
>Q9KJD3|FEATURES|UNIPROT_deepARG|beta_lactam|acc-3a|antibiotic inactivation|1
MRKKMQNTLKMLSVITCLAVTAQGAMASEMDQAKIKDTVDSLIQPLMQKNNIPGMSVAVT
LNGKDYIYNYGLASKQPQQPVTDNTLFEVGSLSKTFAATLASYAQVSGKLSLDKSISHYV
PELRGSSFDHISVLNAGTHTTGLALFMPEEVKNTDQLMAYLKAWKPADPAGTHRVYSNIG
TGLLGMIAAQSMGMTYEDAIEKTLLPKLGMTHTYLNVPADQAENYAWGYNKKNEPIHVNM
EVLGNEAYGIRTNASDLIRYVQANMGQLKLDGNSTLQKALTDTHIGYFKSGKITQDLMWE
QLPYPVSLPDLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVMLANKNYSIDQRVT
>A0A150K1Y6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHLWNLFVAAILGLVEGLTEFAPVSSTGHMIIVDDLILKSNHLYGTEAANVFKVVIQLGS
IMAMVVVFWDRFLNLLGLKKNITREQMYGERLKLTHVITGLVPAAVLGFLFEDYIDAHLF
SVNTVLVALVAGAVLMIVADLTRPRRPKTETVDQITYRQAFVVGLFQCLALWPGFSRSGS
TISGGVLLGMSHRAAADFTFIMAVPIMFGASFLSLVKHWGAVTPETIPFFITGFISAFIF
ALIAIKFFLALINKVKLVPFAVYRILLAIILLLLIWNR
>CAL44994|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|lnuA|antibiotic inactivation|1
MKNNNVTEKELFYILDLFEHMKVTYWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVI
QKLEDIGYKIEVDWMPSRMELKHEEYGYLDIHPINLNDDGSITQANPEGGNYVFQNDWFS
ETNYKGRKIPCISKEAQLLFHSGYDLTEKDHFDIKNLKSIT
>F9PQ02|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWLLDIIKVIILGIVEGITEWLPVSSTGHMILVDEFLKLNQSAEFKEMFLVVIQLGAILA
VVIMFFNKLNPFSKRKTKEQQKDTINMWLKVIVGVIPAGVLGVLFDKTLEKYFYNFPTVA
FTLVLYGILFIVVENNPKFKKQNIKRFEDLSYTLAFYVGCFQVLSLIPGTSRSGATIIGA
LILGLSRSLAAEFSFFMSIPVMFGASLLKLRKFGFAFSFFQFFILILGMLVAFVVSVMAI
KMLMRYIKKHDFKVFGYYRIVLGVILILYYILH
>U6A4I8|FEATURES|UNIPROT_deepARG|beta_lactam|blaFONA-5|antibiotic inactivation|1
MAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYSDNTA
MNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDKRDTTSPQAMAKSLQNLT
LGKALAEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
>CAB61229|FEATURES|ARDB_deepARG|glycopeptide|vanRA|antibiotic target alteration|0
MSNKILVVDDEHDIADLVELYLKNENYTVFKYYTAKEALDCIDKTELDLAILDIMLPGAS
GLSICQKIRDKYTYPIIMLTAKDSEIDKITGLTIGADDYITKPFRPLELIARVKAQLRRY
KKYSGVTEQNENIIVHSGLVININTHECFLNEKPLSLTPTEFSILRILCENKGNVVSSEQ
IFHEIWGEEYFNKSNNTITVHIRHLREKMNATIDNPKYIKTVWGVGYKIEK
>YP_001848841|FEATURES|ARDB_deepARG|aminoglycoside|Aac2Ic|antibiotic inactivation|1
MHTEVHTARLVHTADLDSETRQGIRQMVTAAFAGDFTDHDWEHALGGMHALIWHRGAIIA
HGAVVQRRLIYRGSALRCGYVEGVAVREDWRGQGLATAVLDATEQVIRGAYELGALSSSA
GARRLYTSRGWLPWHGPTSVLSPTGPTPTPDDDGTVFVLPVDASLDTSAELMCDWRAGDV
W
>A0A0Q4KF55|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSELLTVILLGIVEGITEFLPVSSTGHLILATRLLGYDAGRWEVFNVVIQLGAILAIVVL
YWRTFWAVGMGLIRREPKSWLFLRNLVVAFIPAAVIGLALHHYIEALLGNAEVVAIALVV
GGFAILAVERFAPRSDISGVADIPLRTVVGIGMLQCLAMIPGVSRSGATILGALALGVER
RTAAEFSFFLAIPTMLGASGLELMKNHAALTSGEGVGLLSIAIGALVSFVVALLVVKWFV
GIVTKHGFVPFAWYRIAAGSAALVWLLSK
>A0A0K2F866|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIQGWNHICFSVSDLEKSIHFYQNILDGKLLVKGRKLAYLDCLGMWLALNVEEDIPRNE
IHQSYTHIAFSVAEADFESMLNKLRTFNVTILPGRERNEQDKRSVYFTDPDGHKFEFHTG
QLQDRLNYYRNDKKHMTFYD
>F9F087|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILTLLKALLMGIVEGLTEFLPISSTGHLIVLGDLLNFHSNGKVFEIAIQLGAVLAVIF
EYRQRFTSVLSGLGKDRTANRFVLNLAIAFVPAALMGFLFRKQIKLYLFNPKTVAIMLVL
GGLFILWVERRQSKVKPKVKSVDEMRPIDALVVGCAQVCALVPGTSRSGSTIMGGMLWGI
ERKAATEFSFFLAVPMMIAATGYDVFKHYELFTLQDIGLIAVGFIAAFLAGFLAIKSLLK
FVSSKNYVPFAYYRIVFGGLILLTSHMGWVKWTA
>A0A034T1M2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHTLLNAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFEGDKAKTFEVIIQLGSILAVV
VMFWRRLFGLIGIHFGRPVAREGRGQGQLTLGHIVLAMIPAVVLGLLFHDFIKSLFTPLT
VAYALVVGGLLLLAAEWLKPAQAWAVGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGASALELYKSLPYLSLGDLPMFSVGFVTAFVVALIA
IKTFLNVIKRISFVPFAIYRFIVAAAVYLVFC
>A0A029NTT5|FEATURES|UNIPROT_deepARG|beta_lactam|AB26_5212|antibiotic inactivation|1
MHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWM
EADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMD
ERNRQIAEIGASLIKHW
>Q2KDF4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYINAAILGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWREPENRDYAAKLIVAFLITAILGLVVKKLGFELPETATPIAWALIIGGIWMI
FAEWAAARRPPHKQITWLVAILVGIAQIVAGVFPGTSRSGATIFVALLAGTGNRAAATEF
AFLVGIPTMYAASGYELLKTFKDGGAAGEDWTALAIAFVVSTIVAFIAVKWLLAYIRSNR
FTLFAIYRIILGVLLLGMTATGMIA
>A0A0N0L6T2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKTLAGVASPKMLAMGLALFATGPCFALDNIETVVNDAVRPVMQAQAVPGIAVAVTVNGK
PHYFNYGVALKESGNAVTENTLFEIGSVSKTFTATLAAYAQASGKISLSDKASHILPELR
GSAFDTISVLQLGTYSAGGLPLQFPSESDAPEKMLGYFKQWKPTYPAGSHRLYSNPSIGL
FGYLAAHRMGASFDDVMTKTLLPKLGLKHTYLKVPQDQMGLYANGYNKQDQPVRVTPGAL
DSEAYGVKTSAADLIRFVEANMKPEGLEKPLQQAIATTHTGYYTVGDMTQGLGWELYSYP
ITLDKLLAGNSTPMAMEAHTVQWLNPPRAQPENVLINKTGSTGGFGAYIAYVPSKDIGIV
ILANKNYPIPDRVKIAHTILNALAHPE
>ZP_04543635|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|1
MTKKKLPVRFTGQHFTIDKVLIKDAIKQANITQQDTVLDIGAGKGFITVHLLKNVNKVVA
IENDLVLYKHLCKRFNNAQNVQVVGCDFRKFTVPLLPFKVVSNIPYGITSDIFRILMFDN
VELFLGGSIVLQSEPAKKLVSSKVYNPYTVFYHTFYDLEFLYEISPGSFLPPPTVKSALL
KIKRKQSSIDFELKVKYLAFISCLLQKPDLSVRTALKSIFRKSQVRSISEKFGINLNAQI
VCLSPSQWKNCFLEMLEVVPEKFHPS
>A0A0D7XHH4|FEATURES|UNIPROT_deepARG|chloramphenicol|UZ38_30635|antibiotic inactivation|1
TWYRKSYFDHYMKEAKCSFSITTNVNVTNLLAVLKKKKIKLYPVFIYIVSRAIHSRPEFR
TTFNDKGQLGYWEQMHPCYTIFHQDDQTFSALWTEYSNDFSRFYRQYLQDAERFGDKKGL
WAKPDIPPNAFSVSSIPWVRFTNFNLNLDNSEHLLPIITNGKYFSEGGETFLPVSLQVHH
AVCDGYHAGAFMNELERLAADCEEWLM
>A0A094M3J9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSRIGIEEFPVPGEGPYAIAHGPDDALWYTLVRSGHIGRLVPGGSPENWPLAPDSGPTVI
AVGPDGALWFTEYQAHRIGRITTAGVISEFSLPTPECGPYGLAAGPDGALWFTEIAADRI
GRITVSGEVTEFALPGTGTFPSAIVAGPDGALWFTMNQADAIGRITTGGEITVHRLPTQA
AGPVGIAAGPDGALWFTEITAGQIGRITVHGEVTEFPLPDRSARPHAITRGDDASWFTEW
GGNRVGSITPDGVIETHDLPTPGSEPHGLAFGPDRALWTALELGALARIDNEGEVR
>G9R0X3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIELIKVIILGIVEGITEWLPISSTGHMILVDEFIKLNVSADFLEMFLVVIQLGAILA
VVVLYWKKLIPFDYKNRWRIKKDTFSMWFKIIFACLPAAVVGLLFDDQLNELFYNPLTVA
IALIVFGVLFIFIENYNKGKETKINSLSEITYNTALIIGIFQLIAAVFPGTSRSGATIVG
ALLIGVSRTVAAEFTFFLAIPVMFGASLLKLVKFGFAFTTAELLLLVIGMLVAFVVSMLT
IKFLMSYIKKHDFKAFGWYRIILGIIVLIYFMVF
>BAG76102|FEATURES|ARDB_deepARG|multidrug|EmrE|antibiotic efflux|0
MNPYIYLGGAILAEVIGTTLMKFSEGFTRLWPSVGTIICYCASFWLLAQTLAYIPTGIAY
AIWSGVGIVLISLLSWGFFGQRLDLPAIIGMMLICAGVLVINLLSRSTPH
>A0A0U3BI35|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
QYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMA
QTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNHIA
>A0A0R2CJ60|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDIIKAIIIGIVEGLTEFLPISSTGHIDLVQSLIHMGQSQQFKDMFNYVIQLGAIMAVV
ILYFNKLNPLAPSKSHSEKRSTWLLWAKVIVAVLPSVIIGFPLNDWMDEHLQTPPVIATT
LILYGILFIVIERWNAKRTPVINTLADVSFQLALCIGLFQALSIVPGTSRSGATILGAII
LGTSRYVATEFSFFLAIPTMFGVSILKLGKFFAQGNAFTGEQFAVLAVGFIVSWIVAWLT
IKWLLRFVQGHDFQGFGWYRIALGIVVVLVMVL
>A0A0M8KD47|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILQTIIIAIVEGLTEFLPVSSTGHMIIAEAVCGVEPTPFVKAFTVIIQFGAILAVVVL
YHHRFFENWKFYKTLLIAFLPAAVVGLLLGKKIDLLLENVPVIATMLIAGGVFMLFADKL
FSHVSRNQEITTKRALIIGFCQCLAMIPGVSRSMATTVGGMAQKLSRRHAAEFSFFLAVP
TMFAATAYKLFGLLREPVEREVLSANLTILLIGNLVAFVVAFFAMGLFINILTKYGFKPF
GYYRIIVGGTILILLAMGYDLQII
>A0A0J9DV81|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTTLHIIILACVQGLAELLPVSSSAHVILAEKWLGLDPTSPDMTLMLVMLHTGTMFAVIV
YFWRSWRQTYFSSTKALWNNGVQLAVATAATGIVGLTLLYVIKHVFMGGADSFEVEHLFG
NTKLMAVSLAVAGVLIIVSSRYANTTATGDLTGWRALWIGAVQGLCLPFRGLSRSGATIS
SGMLVGVQRRRAEEFSFALAVVLTPAVIVKEGYRFYKAYAGTADSMLHMLAPSLLGMVFS
FIAGLVALRWLSRWLEQGRWYLFGCYCLVASVVVWMFGG
>A6CVT6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSNNNAKQSLANMPLVELTNICKYYASGEMEVRALDGVDLTINQGEFLSILGPSGSGKST
LMNMLGCLDKPSDGDYLLAGQNVASLTANALATIRNQKIGFVFQSFNLLEYATALDNVAL
PLVYGGIKAKERRQRAARLLEQVGLGDRLDHKPNQLSGGQKQRVAIARALVNDPQIILAD
EPTGALDSKSGAEIEALFNQLHEEGRTLIIVTHDNALAERTKRIITIKDGKVISDRAPT
>A0A0A2DVI1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSRIEAFILAIIEGITEFLPVSSTGHMVVAQGLMGMESTAYVRAFTVMIQLGAILSVVVL
YRERFFQISPKNKAQTSSAWLASVGHFYLKLLVGIIPAAVLGFLFNDWVDKMLGSIMVVI
ANLFIGGVAMLFIDRISFRKSGDEVSYKQAFLVGLWQCIAIFLPGISRSMATIVGGLFSG
LTKKSAAEFSFFLAVPTMFGATLLQAYKLHKEFGMQVFVDNADTLIIGNVVSFIVAMLAI
KFFVSYISRKGFAAFGVYRILFASVVGVLVYWGITFMI
>A0A059KIT2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLKAAVMGIVEGLTEFLPISSTGHLILAGQLLGMNAHMSEATVKVFDIAIQTGAIFAVI
LVYWQRLSRTVTHLGSSRDARRFALNVLIGFLPAVVLGLLIGKMVKAHLFTPIIVASAFI
VGGLIILWAERRPASAVRVHSVDDMTALDALKVGLVQCVAMIPGTSRSGSTIIGGMLMGL
SRQTATDFSFFLGIPTLIGAGAYSLLKEREHLSMADAPMFIVGLVFSFLSAWLCVRWLLK
YVATHDFVPFAWYRIGFGLLILVTSYTGVVNWTE
>A0A0B5KE67|FEATURES|UNIPROT_deepARG|beta_lactam|RK21_02363|antibiotic inactivation|1
MPLSRLAALAAAITLTLGYSAAQADDQLQAKVDQIIRPLMQEQGITGMAVAIYARNHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLDAPAKRYHPALAGAP
IGDASVLELGAYSADCLPLQFPDAVQTPQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMSEGLLIQMGLRNTYLQVPASAQGLYAQGYDSADKPVRVGPGPYADE
AYGIKTSASDLLRYVRLHMQPEGLPPALAQATAITQRGYFQVGAMTQGLGWERYPYPVTL
ATLIDGNGPQLIREPQATTRLQPALPPLPAAWYNKTGSTNGFGAYAAFVPAEQLAVVLLA
NRNYPNEARVRAAFDILSGL
>D1B4M2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIFQSVIMGIVEGFTEFLPVSSTGHMIIVGDWLGLKQDNFIKAYEIIIQFAAILAVVLN
YKEKFSPKKINLWMKLAVAFVPLGAVGFLFAKQVKAMFSVEIVALMFIIGGIIFLAVEKF
YKPKEHFVDDVEKVSYKQALWIGIAQIFALIPGTSRAGSTIIGAMLVGLTRKASAEFSFL
LAFPVMCATTGYDILKHHNELLMEGNFTALAVGFVVSFIVAYATIKLFLKFLERFTFVSF
GIYRILFGIALLLYV
>X5D266|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTEGKTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRXDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>P00809|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITYTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITM
SNRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLI
RAGIPTDWVVGDKSGAGSYGTRNDIAVVWPPNSAPIIVLISSKDEKEAIYNDQLIAEATK
VIVKGS
>BAC67136|FEATURES|ARDB_deepARG|tetracycline|tetB|antibiotic efflux|1
MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHLGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWL
VFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLNNATGIIGPLLFAVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>A0A126PIU4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTLGKAYEILLVDDGSSDDSALMLTE
AAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLVTCLTTTPLRLLSVFG
SVIALAGFTLSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKASQEENHP
>A0A0K2N1K3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTALLELRDIRRSYPSGETEVEVLKGVTLTINAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGSYKVAGVDVATLGDDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAIYAGTGRAA
REARARELLARLGLEARVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSRSG
EEVIATLKQLRDRGHTVIIVTHDPDVAAQAERIIEIRDGEIISNPPPAGKRGVARLPAQP
HDAPALGQFINSFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVL
EDIRSIGTNTIDVYPGKDFGDDDPQYQQALQYDDLQALQRQPWVSSATPAVSQNLRLRYG
NVDVAASANGVSGQYFNVYGMTFSEGNTFNDEQLRGRAQVVVIDSNARRQLFPNKAKVVG
EVVLVGNMPATVIGVAEEKQSMFGSSKILRVWMPYSTMSGRIMGQSWLNSITVRVKEGYD
SGEAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARKSDVLQQFLIEAVLVCLVGGALGIGLSLLIAFALQLI
LPGWEIGFSPVALLTAFLCSSATGVLFGWLPARNAARLNPVDALARE
>A0A0T9MNA3|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFILGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGAVPHEGKTDGHLTLGHILLAMIPAVILGLAFHDVIKALFDPKS
VMYALVAGGVLLLAAEWFKPKNPKAVGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMIGASGLDLYKSLHFLTLGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFIVAAVVYWVFM
>A0A0A1RVM8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSNIRRSYPSGEGQVEVLKDVSLRIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDSQVAAQAERVIEIRDGEIVRNPPPQKPAAGRDIDEPT
VTTASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLVAIQKQPWVSSVTPAVSKNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRRQLFPSKAKVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKEGF
DSAQAEQQLTRLLSLRHGKKDFFTWNMDGILKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTATGILFGWLPARNAARLDPVDALARE
>D6NSM9|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFRKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSSSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0H3YFL2|FEATURES|UNIPROT_deepARG|aminoglycoside|APH(3')-VIa|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFELMITKAINAKPISALFLTDQELLAIYKEALNLLNSVA
IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDFDTELWGDHKTYLSLWNELNETRVEER
LVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLKH
LKNDRPDKRNYFLKLDELN
>P52067|FEATURES|UNIPROT_deepARG|fosmidomycin|fsr|antibiotic efflux|0
MAMSEQPQPVAGAAASTTKARTSFGILGAISLSHLLNDMIQSLILAIYPLLQSEFSLTFM
QIGMITLTFQLASSLLQPVVGYWTDKYPMPWSLPIGMCFTLSGLVLLALAGSFGAVLLAA
ALVGTGSSVFHPESSRVARMASGGRHGLAQSIFQVGGNFGSSLGPLLAAVIIAPYGKGNV
AWFVLAALLAIVVLAQISRWYSAQHRMNKGKPKATIINPLPRNKVVLAVSILLILIFSKY
FYMASISSYYTFYLMQKFGLSIQNAQLHLFAFLFAVAAGTVIGGPVGDKIGRKYVIWGSI
LGVAPFTLILPYASLHWTGVLTVIIGFILASAFSAILVYAQELLPGRIGMVSGLFFGFAF
GMGGLGAAVLGLIADHTSIELVYKICAFLPLLGMLTIFLPDNRHKD
>A0A0R1X084|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLTLNMIKTIILGIVEGFTEWLPISSTGHLVLVGNVLKLDESKAFIDMFNYVVQFGAIMA
VIILYFHKLNPFSPQKDQLAQKQTWTLWFKVILAVMPSVVIGFPLNDWMDEHLMQNWIVA
SMLILYGILFIIIENRSRNHEAKYADLNNLPWLTAFWIGCFQALSIIPGTSRSGATILGA
IILGTSRYVGAEFSFFMAIPTMVGVSILKIGKFFYQGNHFTGDQSLILLVGMVVSFIVSV
ISIKFLMDYIQKHDFKVFGWYRIILGLLVLGTMLLA
>A0A0U4J0J6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLELSDIRRSYQSGDQTLEVLKSVSLRIEAGEMVAIIGASGSGKSTLMNILGCLDKP
NSGIYRVAGQDVATLNGDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGMNNSA
RHARAAALLQRLGLGERIAYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
KEVMTILKQLCEQGHTVIIVTHDPAVAQQAERIIEIHDGEIIGDSRPQGQGKAQAKSLEL
ATPAPSWQQMADRFREALSMAWWAMAANKMRTLLTMLGIVIGIASVISILVIGDAVQQQV
LAEIKSIGTNTIDVYPGKDFGDDDPTLRQALKYDDLSALDAQPYISALSPMTRSSMRLRF
GNIDVAANVAGVSEQFFRVYGMELSQGAAIDVRQVESQTQTVVIDTNTQRRLFPQQKNVL
GEVILIGNMPATVVGVAKEKQTMFGSSKMLSVWVPYTTMANRLMGNDYFDSITVRIRDGY
NSQEAEQQLTRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLILVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGILGIALSFTIGLLVQL
AMPGWQINFPPVALLSAFLCSTGIGVVFGYLPARSAARLDPIDALARE
>ZP_04543532|FEATURES|ARDB_deepARG|beta_lactam|BL2e_cfxa|antibiotic inactivation|1
MKKSRRKRLVILCIALVCIIVLVFLLFSKSTSNNSTNPPLTDVLTDSISRIVSACPGEIG
VAIIINNTDTVKVNDKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVKIDRNRLDSKTW
SPMMKDYSELVISLTVRDLLRYTIAQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHDRAYFNYTSPLGAAMLMNRLFTESIVSGEKQSFIKNTLKECVTGTDRIV
APLLDKERVSIAHKTGSGDVNENGILAAHNDVAYICLPNNVCYTLAIFVKDFKGNESQAS
QYVAHISEVVYSLLIQNSAIP
>U7UW92|FEATURES|UNIPROT_deepARG|chloramphenicol|HMPREF0202_02929|antibiotic inactivation|1
MFFKKIDIENWKRKEYYEYFSKDIPCTVSLTTKIDITNIKELNLKIYPALIFALTKTVNE
FEEFRINKNSNGVLGVYETLYPCYTYLKDGNDLFTNLWSDCISSYSEFYNSYVLDIAKFG
DSIKMIGKENPPENSFPVSMIPWNTFDGFNLNLKNGYDYYFPIFTFGKFYLENNKYLIPL
AIQVHHAVCDGFHLCRFIDKLQEIINDKKTFLN
>H0K1V7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTTPAITDHWVAGERGSGTGPYGVTVGPDGAVWFTMARSGCVGRWVPGEEPTLHSLAPDC
QPTVIVTGPDGALWFTETQGHRIGRLTTDGELTEFATPTGESGPYGLTVGPDGAMWFTEL
NTDRIGRITSTGEITEYPLTRAGAFPSAIATGADDALWFTMNQANAVGRLAMDGTVTVYD
LPTEAAGPVGLTAGDDGALWFVEIMAGQLGRITTTGEITEYPLPDRNAKPHAITAGGDGR
CWFTEWGSGRVGSITSEGVIDVYDLPVPASEPHGIAVGPDGVVWAALEVGALARIDTRRR
DG
>A0A0A1AEM9|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLVCSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVTIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A0G4D2Y5|FEATURES|UNIPROT_deepARG|beta_lactam|KNN_03447|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARLGVYAIDTGTNQTISYRSNERFAFTSTYKALAAGVLLQQNSIDSLNEVITYTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAT
KVIVKALR
>X2L3W6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
PGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTL
FELGSVSKTFTGVLGAVSVAKKEMTLNDPAAKYQPELALPQWKGITLLDLATYTAGGLPL
QVPDEVKSRADLLHFYQQWQPSWKPGDMRLYANSSIGLFGALTANAVGMPYEQLLTERIL
APLGLSHTFITVPESAENQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEINME
PSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVT
DNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAI
>S3CAC0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNSIGLYRRRVCSSIFSDNEHFRLIARFYIVDWLYLLQATVLGIVEGLTEFLPISSTGHL
IIASDLVGFAETPGADEFVVAIQSGAILAVCWYYRERIWAVLRGLTSSPKEQRLAVNTVV
AFLPAAVIGVFAAGYIKHYLFNPTAVAVALIVGGFIILWVENRIVRLRIPPRVAAMDDMS
WKDALLVGCMQCLAMIPGTSRSGSTIIGGMVLGLSRRAATEFSFFLAIPTIFGATVYDLW
KARDDLALDNLPGLALGTAVSFVSALLVVHWLLRFVAAHDFKGFGWYRIGFGILILAASG
FGWIEWRSI
>A0A0Q8GC15|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWLIAIVLGLVEGLTEFIPVSSTGHLLLTKIALGLTDPAWDTFIVLIQLGAVLAVVAL
YFQRLWAVVVGLPTRPEARRFALSVIIGCIPAFVAGLALHGVIKHFFENPFLPQVICVSL
IIGGVILLIVDKKAPPARELDGMALSLKTALFIGLFQCLSLLPGVSRSGSTIVGSMLLGV
ERKAAAEFSFFMAIPIMVGAFVLDLYKSYDQIDASHAGAIAVGFVVSFLSGLVVVKYMID
FVGKRGFTPFAWWRIVVGVIGLGLIYIPR
>A0A076GRZ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANIIKAVILGIIEGITEWLPISSTGHLILADEFIKLDASSQFMSMFNVVIQLGAILA
VVVLYFHKLNPFSPSKSTIEKKDTWTLWFKVIVACIPAIIIGLPLDDWLEANFHKFLPVA
IVLIVYGIAFIIVEKRNKNKTPRWTSLNDFTYQAALLVGLFQVLALVPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASGLKIVKYLAEGNSFKMEETVVLLVGTFVSFVVSV
LAIKFLLSYLKKNDFTAFGWYRIILGIILIGYWFIAM
>A0A085A521|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQKMLNAALAFTALTLTTAAFAAGNTLTPAQISKTVDKTIAPLLKAQAIPGMAVAVIYQG
QPYYFTYGKADIKHGSPVTQETLFELGSVSKTFAGVLGGDAISRGEISLSDPATKYWPEL
TGSQWKGITLLHLATYTAGGLPLQVPDEAKDSASLLNFYQHWQPKWAPGTRRLYANSSIG
LFAALAVKPSGMSYEQALTERVFQPLNLTHTWVNVPPREEKNYAWGYRDGQPVRLTPGML
MAEAAGLKSSVVDIAAWLQVNMDPQRIGNRTLREAVSLAQSRYWRIGSMYQGLGWEMLNW
PVKADTVINGSDNSVALAPLPAVAIDPPAPRVAASWVHKTGSTNGFGAYVAFIPEKQLGI
VMLANKAYPNTERVKAGYAILNALQ
>A0A0A0YVJ5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLEPTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFAKGEIIKSVGK
>R8S1W6|FEATURES|UNIPROT_deepARG|beta_lactam|IGM_02948|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRITM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRNILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAT
EVIVKALR
>ACH85847|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACA
PVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYI
ADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFL
LPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDR
FHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRG
WMAFPIMVLLATGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYA
ASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQRADR
>A7JYJ3|FEATURES|UNIPROT_deepARG|beta_lactam|VEx25_A1013|antibiotic inactivation|1
MKLNNALVAILSLTSFVTFAKTELTVSSQLKSVVDECAKGLMNEYDIPGLAVAVTIDGKR
YFYNYGLADESKGSLVTNDTIFELGSISKTFAATLTGYAQEKGKLDMGDKVKDYIPELEN
SALGNTKLVHVATYTAGGLPLQFPSEVTNDAEMMQYYKTWQPEYEAGTKRKYSNPSIGLF
GYIGALSMKSDYTEMMETVILPELGMTNTFVDVPKDKLNNYAFGYSSEGKPVRVNPGILD
AQAYGIKSTSLDMLQYIEANMGQAQLNTDIENALERTHTKYFDTDTFTQAVGWEGYDYPV
SLSQLLKGNSSDVILNAKPVQASVSGTLGRDVWYNKTGSTGGFGAYIAYVPSEKIGIVIL
ANKNYPNAERVEAAYNIISSVVK
>A0A091A3N2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTESYALFVAFVLGIVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQMGSILAV
VAVFWRRLFGLIGIHFGQKPAQDHATLSLVHIILGMLPAVLIGLAIHSWIKANLFGPETV
MYALVAGGILLIIAEKFRPAVRSETLDDISYQQAFGIGLFQCLALWPGFSRSGATISGGM
LMGISRQAAAEFSFILAVPMMVAASGLDLYKSRDLLSMADFPMFAVGFVTAFVVAMIAIK
TFLALIRRLDFIPFAIYRFVVAFAVYLVFVA
>CAI92122|FEATURES|ARDB_deepARG|trimethoprim|dfrA22|antibiotic target replacement|1
MNPELVRIYLVAAMGANRVIGNGPDIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPL
PNRRTVVLSRQASYSAAGCAVVSTLSQAIAIAAEHGKELYVAGGAEVYALALPRADGVFL
YEVHQTFEGDAFFPVLDEAEFEVVSAETVQATITYTHSVYARRNG
>ZP_04278944|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQETYKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPVEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALR
>U2LBA4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILQAIVLAIVEGLTEFLPVSSTGHMIIAEGIMGVKSTSFVRAFTVMIQFGAILSVLVL
YRKRFFCFPVAPRALGQGKGKEFMSRFDLYWKLLIALVPAVILGFLFEDWVDRMLGSVWV
VAVVLFLGGIFMLFVDKLFASSDRGEITYPKAFVIGLFQCLAIFLPGLSRSMATIVGGQQ
QKLSRKAAAEFSFFLAVPTMLGATLLKAYKLYKEGGIEIFREHMTVLLVGNIVAFIVALA
AIKFFIGFLTRYGFKAFGYYRILVGGLLIVLMLSGVSLAV
>YP_001573343|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGQLTLIHILLGMIPAMVLGLVFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLSAADIPMFAVGFVTAFVVALI
AIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>D2AF33|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCALLITASYSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLPPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAACQILNALQ
>A0A0D0RVR3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKRNLQTLLVSALFLGSGSCMAAVDIRQVVDSNVKALMQQQAIPGLSVAVVNQGKVQYFN
YGVAAKDTQAPVTEDTLFEIGSVSKTFTATLGGYAQATGKLKLSDMASQHLPALAGSAFD
RISLLQLATYTSGGLPLQFPDAADRAASMLSYFQHWKPTYAPGEQRLYSNPSIGLFGYLA
AQSLGQPFNVAMEKTLLPKLGLTNTYVRVRADKAGQYAQGYDKQQNPVRVSPGALDSEAY
GIKTSSQDLARYVIANMHPQTLEQPLQQAIAATHAGYYRVNEMTQGLGWERYPYPITLQA
LIDGNSTPMAMEPHKVNWLSPAQAQPANVLYNKTGSTGGFGAYVAYVPSKDMGVVILANR
NYPNAERVKVAHAILSALDK
>A0A0Q8MR25|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWIAAVILGLVEGLTEFIPVSSTGHLLLTKKLLGLPSGFWDTFSVMIQLGAILAVVVI
YFQRLWGVFVRLPSDPKARWFAASVVLSVIPSMAAAFFAHDFIKRVLFESAELICVMLIL
GGIILLFADRFAPAPKEDDAMQLSWKRTLGIGFCQCLAMVPGVSRSGATIVGGMYLGIDR
RAAAEFSFFMAIPTMVGAFVLDFWENKDVLTGDNLGIIALGFVVSFVSGVVVVRTMLDFI
NRYGLAPYGWWRIAVGVIGLGVLALA
>ZP_03583211|FEATURES|ARDB_deepARG|multidrug|OpcM|antibiotic efflux|0
MLEDNKMDNMHNTNGLMRIAKVAAASTLLATLLAACAVGPDYKRPDVTTPAAFKEAPTLA
PGEQAGTWKPAEPADGAHRGEWWKVFGDPVLDALEEQALAANQNLKAAAARVEEARAATR
TARSQWFPQVGVGFGPTREGLSSASQFQPQGTGPTNATLWRAQGTVSYEADLFGRVSRNV
EASRADQAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYRRTVELREEALKLVQRRF
NEGDISELDVSRAKNELASAQADAVGVARRRAASEHALAILLGKAPADFAFKETPLVPVA
VKIPPGLPSALLERRPDVAAAERAMAAANARIGLAKSAYFPKLDITGSFGYEASTLGNLF
LWSSRTFLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQVANYRQQVLVAFREVEDNL
ADLRLLDDQIRAQNAAVNASRRAATLSRTQYQEGEVAYLDVIDSERSVLQSQLQANQLTG
AQAVSTVNLIRALGGGWGEAPTAVGGAAAKAEIAGR
>ZP_03835677|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAIAITAMYPGADAETVQNT
VTQVIEQNMNGIDHLMYMSSNGDSTGTATITLTFESGTDPDIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKASSSFLMVVGVINTNGTMNQDDISDYVAANMKDTISRTSGVGDVQLFGS
QYAMRIWMDPNKLNNFQLTPVDIINALKTQNAQVAAGQLGGTPPVKGQQLNASIVAQTRL
TNTEEFGKILLKVNQDGSQVRLRDVAKIELGGESYDVVAKFNGQPASGLGIKLATGANAL
DTANAIRAELKKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLAEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAIFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFDKSTHHYTDSVGGILRSTGR
YLALYLIIVVGMAYLFVRLPSSFLPDEDQGVFLTMAQLPAGATQERTQKVLDEVTNYYLT
KEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERPGEENKVEAITGRAMGAFSQIKD
AMVFAFNLPAIVELGTATGFDFQLIDQAGLGHEKLTQARNQLFGEVAKHPDLLVGVRPNG
LEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPEDIGNWYVRGGDGQMVPFSAFSTSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MAMMEQLASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDIEHSHSVDHH
>L0GLJ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWVAIQALILGVVEGITEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVI
WEYRRKIIDVVVGLPKERQAQKFTTNLLIAFLPAVVLGVAFADLIHEYLFNPITVATALV
IGGIVMLWAERRDHAIRAETVDDMTWTLALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDFAVFAIGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRIGFGLLILATWQLGLIDWTSVQA
>V8MNH2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAGLGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGNIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNEGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLNWEPSIAMRDTVEETLDFFLRSVDVAERAS
>NP_756937|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTMQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIASLFLIYKWSYGEPLIRLIIAGPILMSCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEAVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAITQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHSITEGQCWQSDWRIS
ESEAMTARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMVADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLH
IRIGLHAAFNACEEMCQRVVLERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGVATALSHSPQITLEETSASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>A0A142I9J7|FEATURES|UNIPROT_deepARG|beta_lactam|blaPDC|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGEDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0R2IDB8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDILKAILLGIIEGITEWLPISSTGHMILVDEFLKLNVSAEFMKMFLVVIQLGAILAVV
VLYFHKLNPFSPKKTKQENQDTFSLWFKVIVAVLPAAVLGFLFDDYLDEKFYNFQTVAAT
LIIYGVLFIVIETWNKDRKPSITNFNELSYKMALFIGFFQVLALIPGTSRSGATILGAIL
LGTSRFVATEFSFFLSIPVMFGASLLKLVKFGFVFTGMEYAILFTGMITAFIVSIIAIKF
LLGYIKNNDFKAFGYYRIILGIILLGYLFFIK
>CAC35725|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLSIMKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFQSGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTNGTMTQEDISDYVGANMKDAISRTSGVGDVQLFGS
QYAMRIWMDPTKLNNFQLTPVDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSADEFSKILLKVNQDGSQVRLRDVAKVELGGENYDIIAKFNGQPASGLGIKLATGANAL
DTANAIRAELAKMEPYFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILAVFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIQKGGHGEHKGFFGWFNRMFDKSTHHYTDSVGNILRSTGRY
LVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFLSMAQLPAGASQERTQKVLDEMTDYYLTK
EKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERPGSENKVEAITGRAMARFSQIKDA
MVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGMVAQHPDLLVGVRPNGL
EDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRM
LPEDIGNWYVRGSDGQMVPFSAFSTSHWEYGSPRLERYNGLPSMEILGQAAPGRSTGEAM
AMMEQLASKLPSGVGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLI
EATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATVLAIFF
VPVFFVVVRRRFTKKTEDIEHNHPVEHH
>A0A127SVW8|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSSFEAVYRNW
STPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNADIIARISRMVYDAMRRQGG
YW
>E8T261|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLDAVILGVVEGVTEFLPISSTGHMILASYLLGIKQSAFTKTFEIAIQLGAILAVVFI
YREKLSKSLELWKKLIAAFIPTGILGLLLHHYVEELFSPLVVSVMLIVWGVIFIVVELLY
KEREHQIDRPEEISYAKAIGIGLFQSLAMIPGTSRSGATIIGGLLLGMNRVAATEFSFLL
AIPTMLAATGFELVKNASSLSGGHFVLLGVGFVVAMVSAFAAVKWLLNFIKSHTFIPFGI
YRIIVGLIFLLILL
>CAR51973|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVIAIFIMLGGLFAIRALPVAQYPDIAPPVVSIYATYPGASAQVVEES
VTALIEREMNGAPGLLYTSATSSAGAASLYLTFKQGVNADLAAVEVQNRLKTVDARLPEP
VRRDGIQVEKAADNIQLVVSLTSDDGRMTDVQLGEYASANVVQALRRVEGVGKVQFWGAE
YAMRIWPDPVKMAGHGLTASDIASAVRAHNARVTIGDIGRSAVPASAPIAATVFADAPLK
TPADFGAIALRARPDGSALFLRDVARVEFGGNDYNYPSYVNGKVATGMGIKLAPGSNAVS
TEKRVRATMDELSAYFPPGVKYQIPYETSSFVRVSMNKVVTTLIEAGVLVFLVMFLFMQN
LRATLIPTLVVPVALAGTFGVMYAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEGLGPYDATVKAMRQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFALSLAVSIGFS
AFLALSLTPALCATLLKPVSGDHHEKGGFFGWFNRFVARATQRYATRVGTMLKKPVRWLV
VYGALTAAAALMLTQLPTAFLPDEDQGNFMVMVIRPQGTPLAETMQSVREVESAIRRDEP
TAYTYALGGFNLYGEGPNGGMIFVTLKNWKERKAERDHVQSIVARINERFAGTPNTTVFA
MNSPALPDLGSSSGFDFRLQNRGGLDYATFSAAREQLLAVGGKDRALTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMDEINTTLAVMFGSDYIGDFMHGTQVRRVMVQADGLHRLDPDDV
KKLRVRNARGEMVPLAAFTTLHWTLGPPQLTRYNGYPSFTINGSAAAGHSSGEAMSAIER
IAAKLPAGIGYAWSGQSFEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVLGVTLRMMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLVDAALEA
ARLRLRPIVMTSLAFGVGVLPLAFASGAASGAQMAIGTGVLGGVITATVLAVFLVPLFFV
IVGRLFDVGPRRRGGAQPTTMEGSQP
>X2KPW1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
LLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAA
KKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGIRMLDLA
TYTAGGLPLQVPDEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLFGALAVKPSGMSF
EQAMTKRVFKPLKLDHTWINVPKEEEAYYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDM
ASWVKANMNPAALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEAKTVVEGSDNK
VALAPLPVAEVPPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLANKS
>ACI72002|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYVSADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPYEANLAKSEASLAALDKQIMLTQRSVDAQQFGADSVN
ATVEKARAAAKQATDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ
>S7T9A0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDSDIGNLSASEKTAPLKMNKYLWTLILGGMCLWGLATVFPGGGFLIEHPGEGNGFQWY
HAVVLGIVEGVTEYLPVSSTGHLLLVQHFMGLTATKTGKAAADAYAVIIQIGAILAVLSL
YRRRSGRIALGLIGRDPEGLRLAVMLVISFIPAAVVGLCLGDRIKAHLFGPWPIAIGWLV
GGIVILMMPNLQNRSKQISIENIQWRQALAIGLFQVFALWPGISRSLATIIGGIVAGMGL
VAAVEFSFLLGLITLGAATVYEMAGYGLLVVAEYGVTLPLVGIICSFAAAWVSVKWLVAY
LHQRGLALFGYYRILLAAVTGILLFCGIL
>C7NCD5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFADIIKVFILSLVEGLTEFIPVSSTGHMIIVDQFLQLSQNEEFANAFKIIIQLGAILSV
VVYYWKRIFPFAKGLSQSQRMDIIQMWIKIVIAVLPAVVLGLLFDDIIDKVLFNSVVVAV
MLVIYGVILIWLESREKKEGGITSITQMSVKTAIGVGLFQCLAMIPGTSRSAATIIGGVL
LGLNRVLATEFSFFLAIPTMLGATLLKLVKLGTALSGYEWFLIALGFVLSFVFAYAVIKV
FMNYIKKHDFKIFGYYRIVLGIVVLVLYFMGAIK
>CAA26199|FEATURES|ARDB_deepARG|aminoglycoside|aadA|antibiotic inactivation|1
MVTAQWRFSWLLVMTCFFGVQSMPRASKQQARYAVGRCLMLWSSNDVTQQGSRPKTKLNI
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>R6PDK9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAYFFDILKTILFGIVEGITEWLPISSTGHLLILQSMVGEIISHDFMEMFDVVIQLGAIL
AVVVIYFNKLNPFSSKKTAIEKQNTINLWIKVIVACLPAAVIGLLLDDWLDAHLFKTSVV
AVTLILYGIAFIVVEERHRGKKFKYKDLNTLPLSVAIGIGMFQVLALVPGTSRSGATILG
GMILGASRYVSAEFTFFLAIPVMFGASLLKLVKFGLAFSFGEFFALILGMVVSFVVSILA
IKFLMNYIKKHNFKVFGIYRIILGIVILVFFAIFGK
>L3P6R2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPTI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0X3VQY1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRRTPLSPISLTIEEFAVADRDSGPYAVTTGPDGALWFTLVHSGRIGRLVPGGVPTGFPL
DPSSGPTIIVPGPDGALWFTEYRAHRIGRISVDGSVDEFALPTPACGPFGIAPGPDGALW
FTETAADRIGRITPAGDITEFPLPVSGAFPSAITAGGDGGMWFTLNQANAIGRIGMDGKI
SVHPLPTEAAAPVGITAGRDGDLWFVEIAAGQVGRITAEGEITEFPLPDRSARPHAITVD
GNGTPWFTEWGANRVGRITPQGAIDVYDLPTPGSEPHGIALGPDGALWTALEIGTLARVS
PRQAPDRNNNQEV
>A0A0M3QFA7|FEATURES|UNIPROT_deepARG|beta_lactam|mrdA|antibiotic target replacement|1
MGLSSPTDIPGLRNRFLVCSLAAIAIFLLLVLRLWYLQVISADRYLTLSEKNRIRYISIA
AARGPIYDRNGELLVDNRPAFGVSVLRQEVEEIDPLLTQIGGLLDVDVEKLRARWDAGQR
FPRYRPLPLADDVSRDALDRVQENSVDLPGMLIEVRPLRSYPYKEMAAHLLGYLGEITEQ
ELQEEAFAGYRPGEFVGKSGLEKFLDPYLQGTEGERRVEVDVRGRELRLLKTQEPIPGNK
VFLTLRRDLQLAAEKALEGEAGAVVALDVRTGEVLAMVSTPAFDPAAFARGITGQEWVKI
LKNPRHPLTNKAIKGQYPPASTFKIVTALAALKGGVISPSTTVDCQGSLTLGNQEFRCWK
KEGHGPTNLKKALKESCDVYFYMVSLDLGIDRLSAMAQDLGMGKPLGFLLDGEKGGLIPT
RQWKRERFRVPWYDGETVIASIGQGYVLATPLQLAVMTAAIANGGTVLRPHVLKKIEDLD
GKILRETTPEVIGTALAAEKDFREVRRGLEAAVNEPGGTGQASRLQGVRVAGKTGTAQVV
RLKDKDDINPDREIPYRFRDHALFVAYAPAETPEIAVAVVVEHGSHGGSAAGPVARVLFE
TYFGIDDSAGKSVPVPENGSAAFSEQREE
>J8ALF8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MVKGINHLCFSVSNLEKSITFYEKVLEGELLVKGRKLAYFNICGVWVALNEETHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYREDKPHMTFY
>A0A150YGJ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIELLKALLLGFVEGMTEFAPVSSTGHMIIVDDMWLKTQEFLGSSSANTFKIVIQLGS
ILAVVVVMWKRILSLVGLYKIEGQTSTQRFHLGHVIAGIIPAGIFGVLFEDMIDEHLFRM
ETVIIGLIIGAILMIIADKFGPKKPAITSLDQISYGKALKIGLVQCLSLWPGFSRSGATI
SGGVLLGLDHKTAADFTFIMAVPIMAGASGLSLIKHWEDINPDHFMFYAVGFISAFVFAL
LSIKFFLKLISRVKLTPFAIYRIALAALLLVVLYL
>J2PTD0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEAVVCSFTGRLLHMILDFIHRSVEFLGLWEAFVAIVLGLVEGLTEFAPVSSTGHMIIV
DDFLFQTKEMFSPEVANTFKIVIQLGSILAVVVLMWDRFMSLLGLNRLAGKREVQAGPRL
NLATVIVGLIPAGILGVLFDDYIDEYLFSTKTVVIGLVLGALLMLAADWFRPRRAKIESV
DQITYKQAFLVGLIQCFSLWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASF
LSLLKRWDAITMDSIPFFVVGFISAFVFALLSIRFFLKLINRIKLTPFAIYRLVLAAVIY
FVFM
>A0A0D6JEP4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSTWQVVLLGLIEGLTEFIPVSSTGHILLVGHFIGFDSPGKTFEVLIQLGAILAILSVYF
ARILQILYDLPRDRKTQRFVLGILIAFLPAAVIGASAHSIIKGVLFESPMLICVMLIIGG
IILLYVDRLDLEPRYHDVMDFPPSLALKIGLFQCLAMVPGVSRSGATIVGALLMGTDKRS
AAEFSFFLAMPTMAGAFAYDLYKNWSVIDTADVTSIAIGFVTAFISAVFVVRYLLAFVSR
HGYALFGWWRLIVGGLGLGALLVLG
>U5I8Q1|FEATURES|UNIPROT_deepARG|beta_lactam|BL2a_1|antibiotic inactivation|1
MKKNILLKLGVCVSLLGTTQFVSTISSIQAERTVEQKIIKNETGTISISQLNKNVWVHTE
VGYFNGEAVPSNGLVLTASKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKMLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLTRYRNINAVVPGH
GEVGDRGLLLHTLDLLK
>A0A0F5Q2X4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNADQGLFVPLILGILEGLTEFLPVSSTGHLLLAGHFFGLTQPTTFIVLIQLGAILAVIT
VYFAKLGMLIRDALTGKAYAWQFALSVILACFPAVIAGVLLRDFIQGDLWESASLICWTL
LIGGVILLIVDRLPLKPKYDDIYQLPWHVALIIGLFQMLSLVPGVSRSGSTVVGGMLFGA
SKRAAAEFTFFIALPIMIGAFGYDLYKSRDLIDASIALNVAIGFAAAFVVGALVVRYLLG
FVSKYGFAPFAYWRIAVGIAGLVAIYAFGQ
>G8A3S3|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
ESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRILYSQNDLVEYSPVTEKHLTDGM
TVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDE
RDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGA
GERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A023YU38|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|ybjZ|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPTIEKVNVAGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>R5MG71|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLQTVIIAIVEGLTEFLPVSSTGHMIIAQGLLGVESTPFVKAFTVIIQFGAILSVICL
YWRRFFYPEAVLSGTSYWKAMYDFYARLVVGVLPAVVLGLAFNDFIESNLGNVTLVAVML
IIGGVFMLFCDKLFGNGSENTKLTYRRAFIIGLIQCISMIPGVSRSMSTIVGGMSQKLTR
KAAAEFSFFLAVPTMFGATCLETYKLISHGGGSLLSAGNNLEMLIVGSVVAFIVAILAIK
FFINYVTKYGFAAFGWYRIIVGIIILICMLCGVDMKMAD
>A0A116L681|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
MTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAI
ALIVYGIAFIWIENRNSGVEPQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAI
ILGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWILLVASVTAYLVSLV
VIRFLTDFVKKHDFKVFGYYRIILGAILLVYAFITFLF
>ZP_04097561|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVEEMKNTLLKLGVCVSLLGITPFVSTISSVQAERKVEHKVIKNETGTISISQLNKN
VWVHTELGYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKNSVTDVII
THAHADRIGGIKTLKERGIKTHSTTLTAELAKKNGYEEPLGDLQAITKLKFGYMKVETFY
PGKGHTEDNIVVWLPQYNMLVGGCLVKSASAKDLGNVTDAYVNEWSTSIENVLKRYENIN
FVVPGHGEVGDKGLLLHTLDLLK
>F8J8N6|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
METWQVILLGLIEGLTEYLPVSSTAHLLLTERLLGVTSTGRTFEVLIQLGAILALLTVYS
AKLWRLAVDFPSDPRTRRFVFAILLAFLPAVFIGVAAHNIIKDVLFESPLIICVSLVIGG
IILLVVDRMRYQPQYVDVMDIPPLKALIIGFVQCLAMIPGVSRSGSTIVGGMLLGADKRT
AAEFSFFLAMPTMTGAFAYDLYKNWSILTPDDVSHIVLGFIAAFITGAIVVRYMLDFISR
RGLSFFGWWRILVGGLGLGALMVLH
>A0A0K2DRT4|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-109|antibiotic inactivation|1
AMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAA
LQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAM
AQTLRNLTLGEALGDSQRAQLVTRMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDI
>A0A010SJP6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLNAGFEIAAVFTHADDPKENTFYGSVAQLCARKGIPVHA
PEDVNHPLWIERIAKLNPDYLFSFYYRNLLGEQLLATARKGAFNLHGSLLPTYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIIAQQRVAIERADTALTLHGKLREAASNLLRDTLP
LLAQGKITETAQDESKATVYGRRTAADGKLVWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVVKGNEGLAPGRVISVDPLRIACGEDSLVVTSGQRNENGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDKYDVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIVDNENDSCNGQVINIGNPDNEASIRQLGEELLRQFEAHPLRANFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKR
>A0A0W0BDL8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MELIYADARIDCASHGVGVTYIHHETHQMEKATTRSLLVLSTLLLSPLSHAKEAEALTAV
VDGAIQPLLKEHRVPGMAVAVLKEGKAHYFNYGVADRESGARVSEQTLFEIGSVSKTLTA
TLGAYAAVKGGFQLEDKASQHAPWLKGSAFDGITMAELATYSAGGLPLQFPDEVDSTDKM
RAYYRQWTPAYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQV
PESAMANYAYGYSKEDKPVRVNPGVLAAEAYGIKTGSADLLKFVEANMGYQGDAVVKSAI
ALTHTGFYSVGEMTQGLGWESYAYPVTEQTLLAGNSSAVIYNANPVKSVAKSQEMGGARL
YNKTGSTGGFGAYVAFVPAKGIGIVMLANRNYPNEARVKAAHAILSQLAE
>A0A0W0A956|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLAIILPALLMGIVEGLTEFLPISSTGHLILLSDLIGFQGPPGKTFEIVIQLGAILAVI
VVYWRDLIAMATGFWTPRSRERYAVVNLLLAFIPAMVLGALLHKTITEVLFNPYVVCFAL
IIGGIALIIIERNRPKPSIHSIAEIGPLSALLIGFGQVLAMIPGTSRSGATIIFALLFGV
ERKAAAEFSFLLAIPTMLAATVYSLYKARAELAVGDISEIAIGFFAAFVVALLVVRWVLR
HISRMGFQPFGWYRIALGLVMLALLSLR
>A0A0D0KRR0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSWLAFQALILGIVEGLTEFLPISSTGHLIVVGDLLSFNGERATAFKIIIQLGAILAVM
WEFRQRITSVVTGLGSDPMARRFTVNVLVAFIPAVILGLLFADIIEHWLFNPITVSAALI
VGGVVMIWAEKRQHRIVAESVDDMDWKLALKVGCAQCLALIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVAATVYSLYKYREILQWSDLPMFAIGFVTTFIVAMLTVRALLVF
IANHSYAVFAWYRIAFGLVILATWQFAWIDWSTAEG
>N9VLD8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKQMTLRHTGLVLLTSLCGGALAAEGDALKRAVDGAVRPLMKEHRIPGMAVAVLADGRMN
FFNYGVTSLADPRPVTKGTLFELGSVSKTFTGLLGAYLVAEGRFAYDDPVSRHMPALAGS
AFDRITMVQAATYSAGGLPLQFPDAVQDEAGMLAYFRDWKPGHPAGSVRQYSNPSIGLFG
NVAARSAGAPFATLMEQTLLPRLGLSDTYLTVPAAAMGRYAFGHSAEDQTVRVSPGMFDA
EAYGIKSSSADLLRYLEAFGRAPADPALGKAMVDVQQPRYRVGPMQQGLGWEVYSYPVSR
QDLLAGNAREVSFGVQPAGPMTPIEGPRLINKTGSTGGFGAYLLAVPERGIGIVLLANRN
YPIPARVDTAYTILEVVQGKQP
>YP_002100652|FEATURES|ARDB_deepARG|multidrug|OpcM|antibiotic efflux|0
MLADALAASRSPLNTSVPDAPTPAAFKEAPTLRARASRPARGKRAEPADDAHRGEWWKVF
GDPVLDSLEEQALAANQNLKAAAARVEEARAATRTARSQWFPQVGVGFGPTREGLSSASQ
FQPQGTGPTNATLWRAQGTVSYEADLFGRVSRNVEASRADQAQSEALFRSVQLALQADVA
QNYFELRQLDADQDLYRRTVELREQALKLVQRRFNEGDISELDVSRAKNELASAQADAVG
VARRRAASEHALAILLGKAPAEFAFKETPIVPVTVKIPPGLPSALLERRPDVSAAERAMA
AANARIGLAKSAYFPKLDITGSFGYEASTLGNLFLWSSRTFLLGPFAGTALTLPLFDGGR
RAAGVQQARAQYDEQVANYRQQVLVAFREVEDNLANLRLLDDQIRAQNAAVNASRRAATL
SRTQYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVATVNLIRALGGGWGDTPTAVGG
AASGKENVAAR
>A0A157Z5W6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRAKIGSVVTGLPVRADARRFTLNVIVATIPAVVLGLLLEKHIKAVLFSPVPVSVALI
VGGIVILWAESRQRERGAITRVHSVDDLSLADAFKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATLYEMAKYWRTLTVNDLGLFAIGLVAAFVSAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>J9SPF2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA364|antibiotic inactivation|1
MPLRLPLRALGAALSLFALAGAPASAAVLCTVVADAADGRIVFQQGTQAACAERYTPAST
FKLPIALMGADAGILQGAHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFQYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLP
LKPAAYDLAETLFDAGEAGGWRLYGKTGTGSPGSNGVYTPDNAYGWFVGWARKDGRQLVF
ARLLQDEKATRPNAGLRARDELLREWPAMADAPRQ
>W0HV77|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTIPMKIDKVSIVIPVYNEQESLPELMRRTVAACEQLDAAYEILLVDDGSSDDSAAVLTA
AAEAPGSHIVAVLLNRNYGQHSAIMAGFSHVSGDLIVTLDADLQNPPEEIPRLVEVAAQG
YDVVGTVRQNRQDSWFRKRASRMINALIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARKTIEIPVMHSEREFGDSKYSLMKLVNLMYDLITCLTTTPLRMLSVIG
SIIALLGFAFSLLLITLRLFLGAHWAAEGVFMLFAVLFIFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQRVVSQNPLSSQQETQ
>A0A0P1D1D2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTVQAAFSWKQQMDIVLLFKALILGIVEGLTEFLPISSTGHLIVLGDLMNFNSNGKVFEI
AIQLGAILAIVVEYRQRFANVITGIGRNDQANRFVLNLAIAFIPAAVVGLLFRKHIKEYL
FNSITVAIALIVGGLLILWIEKRTQHRPPKVKNVDDMSGKDALMVGLAQCLALIPGTSRS
GSTIMGGMLWGIERKAATEFSFFLAVPMMVAATGYDIYKSWQEFTWGDVGLIAVGFVAAF
VSGLFAVKALLKFVSTKNYVPFAYYRIVFGAFILITSQIGWITWSQM
>I2ECD2|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFRKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSSSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLDAI
>A0A086EPR9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFDDEKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGDVPHEGKTAGRLKLTHILLAMIPAVVLGLIFHDFIKSLFYPQN
VMYALVSGGFLLLAAEWFKPKQPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSWHFLSLADVPMFAVGFVTAFIVALIA
IKTFLKIIKRISFVPFAIYRFIVAGVVYMVFM
>V5W4S6|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-15|antibiotic inactivation|1
TMFLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPG
DPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKT
GSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAK
>A0A095UDB2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MQNSYLVNKVSIVIPVYNEQDSLPLLISRTTAACELLNRPYEILLVDDGSSDDSAQMIID
AAEQPGSSVVAVLLNRNYGQHSAIMAGFSYVTGDLIVTLDADLQNPPEEITRLVTTAEQG
YDVVGTVRQNRQDSPFRKIASKMINRLIQSTTGKAMGDYGCMLRGYRRSIIEAMLHCQER
STFIPILANTFARHTTEIPVLHAEREHGTSKYSFMRLINLMYDLVTCLTTTPLRMLSVIG
ALIACAGFLFAFLLLVLRLIYGAYWGAEGVFSLFAILFIFIGAQFIGMGLLGEYIGRIYS
DVRARPRYFVQRVVNHTTASTTEEETK
>CAE55180|FEATURES|ARDB_deepARG|beta_lactam|CMY-53|antibiotic inactivation|1
MMKKSLCCVLLLTASFSTLAASKTEQQITDIVNRTITPLMKEQAIPGMAVAIIYQGKSYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLNDPVTRYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDEVTDKAALLHFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMGYEEAMINRILQPLKLKHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSIMDMARWVQVNMDASHVQEKTLQQGIELAQSRYWRIGEMYQGLGWEMLNWPVKA
DIVINGSDSKIALAALPAVEVNPPAPVVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLA
NKSYPNPARVDAAWRILEKLQ
>A0A0W0KQ11|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSRALLELKGVTRRFVAGEKDFIALNDINLTINAGELVAITGASGSGKSTLMNVLGCLDH
ANSGSYKVDGRETGTLTDDELAELRRDHFGFIFQRYHLLPHLAAIQNVEMPAIYAGTGKS
MRVERAQKLLERLGLSGHLEHRPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSVS
GKEVMNILLELNSAGHTVILVTHDEKVAAHAERIIEMRDGEIIADRVNTDRPIVNEKTTE
RLPSKPRQGNRLMANIGLFQEAFVMAWVALISHRMRTLLTMLGIIIGITSVVSIVAIGEG
AKRYVLKDIQAIGSNTIEVFPGSDFGDTKSMDIQTLALSDVTALSSEYYIDSATPNIGRN
LLVRYRNIDVSATVSGVSPSYFQVRGTKMGLGVGFNKDDARRQAQVVVIDHNTRIRLFGP
KVDPLGQVILVGNLPCTVIGVTENKKNIFDTSKNLNIWMPYETASGRLLGQTYLDGITVR
VKDGQPSKVVEDNVNKLLQKRHGTKDFFTYNLDSVMQTVQKTSQSLALLLSLIAVISLAV
GGIGVMNIMLVSVTERTREIGIRMAVGARQADIRQQFLVEAVMVCLIGGVIGIGLSFVIG
YVFSLLVKEWQMVFSVSSIVTAFICSTLIGIVFGFVPARNAAQLDPIEALARD
>U5NMI1|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-4|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDVSTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLENSTRLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>A5FVA1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MPGAVPGAVIELRGVSRTYRSGDVEVQALREVDLVIGPGEFVAIMGSSGSGKSTLMAILG
CLDRPSRGEYRFESVDVARLEEPELARVRSARIGFVFQSFNLLARTSALDNVALPLFYAS
DGPVKGGSRTARALRALGQMGLAGREGNTPSQLSGGQQQRVAIARALINAPRLLLADEPT
GNLDTRTSHEIMETLAALNRERGTTILVVTHEPDIAAYADRVLTMRDGRIVGDERREKAR
GEAAPAVAEAAPDAAPNETPDAAPARRRAGIAWAFGAMIVGAAVQALARNRLRSALTMLG
VFIGVAALITMVAVGQGANQAIRKQIESLGTNLLVVLPGATTAGGARAGFGSASTITVDD
ARAILREDPAVSRIGYLIRAAGQVRYASQNWTTAIAGVSIDYPAMTNWRVAEGRPIGAQD
ERNGALVGLIGQTVRQQLFAPGEDPVGATILVKGTPIRVIGVLAGKGQTAFGTDQDDIVM
LPFSTAEQRVLGTATPSRQDAPLNWAYPAWPNPYGLQLRLTGYVNQLFAQAVSPDAVAEA
MEQISGTLSVRHRIQPNGLKDFSVRNLSQIAAAAQGSSRIMSLLLAIVASISLLVGGIGI
MNILLVSVTERTREIGLRMAIGARRLHVLLQFLAESVFLSVTGGLGGIVLGVALSGGITL
FAGWPAPVSLLAVAGGFLFSVAVGVAFGFYPARKAARLDPIEALRYE
>A0A0U1YUM7|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLGGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A0M1IXD0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDIIFILKAIIIAVVEGLTEFIPVSSTGHMILVGSAINFNGEFAKMFEVIIQLGAILA
VVVLYWKKIKENIVEFFKFIFTKGKEGKTGFKFGANVIVGSIPIGITGVLFYHKIKALFR
PEAVIIGFIVGGLLLLIIENMFRKREHAVQNIDSITFAQALKVGLLQILSVWPGMSRSAS
TIMGGWIAGISTPIAAEFSFFLAIPAMIGTSLKDLFEFDYSIMEPTLWSALILGFIVAFI
VSIIVMNKFVSYLKKKPMKIFAIYRVLAGLLLAVLVFTKIIVLTA
>S0NJ05|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFENIIKAIILGIIEGITEWLPISSTGHLILADEFIKLNASEAFMTMFNVVIQLGAILA
VVVLYFNKLNPFSPSKTTEENRETWSLWFKVIVAIIPSVILGLPLDDWLEENFHSFLPVA
IMLIVYGIAFIIVEKRNKTKTPKVTNLTQITYQFALLIGMFQVLALIPGTSRSGATILGG
ILIGASRFVSAEFSFFLGIPTMFGASLLKIVKFITSGNSFDMNGIVTLLVGTVVSFIVSI
IAIKFLMNYIKKNDFTAFGWYRIVLGIILIGYWAFMM
>R6ZKC7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIELLKSAFLGLVEGITEWLPISSTGHMILVDEFISLNVTKEFWSMFQVVIQLGAILA
VCVYFFHQLNPFSPSKGAEGRRATWTLWGKIIVACIPAAVIGILFDDFMEEHFYNAPVVA
AALIVYGVAFIVIERWRAHKLEVRVAAEGVRPGSRPAGAHFARPAEDAEPTEGGDFGSIT
RLEDLPWSTALGIGVFQVLSLIPGTSRSGSTIIGGLLLGTTRSVAAEFTFFLAIPVMFGA
SALRLGKYVFLDGGTFGMNEISIMVVGCVVAFLVSLVAIKWLMGFVRRHTFTAFGIYRIV
LGALVLAYFFIIGPMFGLV
>A0A0G4D0X4|FEATURES|UNIPROT_deepARG|beta_lactam|KNN_02707|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTNQTKQETTGNDSFAKLE
KEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLYTRE
DLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVT
NPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTGDNL
IRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEA
TKIALGVLKAKNK
>L0EW02|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSGYSIINALILGIIEGVTEFIPVSSSAHLLLIGHFLGFKSPGNSFSILIQLGAISSLLF
VYFHKLLKIVIAFPSQEYARHFVACIFVASLPAAVIGFLSYHFIKFVLFEQPILICMTLI
IGGIILLVVDRIDFKPRYTNSMNYPLLVAFKIGIFQCLSIFPGVSRSGSTIVGALIMGVD
KRSATEFSFFLSMPIVFGACILDFYKNRSVIMHDSGLLIVIGFFSAFLSGLLVVRSFLNF
VSKKGYTVFALWRIIFGVISLIALSI
>A0A0E1NTL1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLELEGIRRSYQSGEEIVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGIYRVAGQNVDELDDDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKHE
RRERANMLLTRLGLGDRVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERVIEIKDGRIMADSGSKNEPVVAAAELMS
LTPAAPSWQQLVGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDIYPGKDFGDDDPSTRQALVHDDMAALKAQSYVSAVSPSIGGSMRLR
FGNIDVAASVLGVSDEYFRVFGMAMEQGAPITREQVERQAQTVVIDLNTQRRLFPHMKDV
VGQVILVGNMPATVVGVVAEKKSMFGSNKALRVWVPYSTMANRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTLRHGKKDIFTYNMDSLLQTAEKTTQTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAVLVCLIGGALGISLSFAIGLIVE
MFLPNWRIAFPPMALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>AAY60807|FEATURES|ARDB_deepARG|beta_lactam|mecC|antibiotic target replacement|1
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEV
EMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKED
GMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSK
KDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLRDFAKKFHLTTNETES
RNYPLGKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT
IVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFE
KGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENG
NKKYDIDE
>C0VLX1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKPNDFSRTLKKLLMAAGLLSFSSILWAKNLTEQQVKAVIDQQFKPLLTQYKVPGMAVA
VTLNGKHYFVNYGLASKQSQQAVSNKTLFELGSVSKVFNATLAGYAQAQGQLSFSDHPAQ
YFPELKNTAVNQATLLNLGTYNAGGFPLQFPDHVVKQQDMIRYFQEWQSKTKIGAARQYS
NPSIGLMGYVTALAMKKPYVELIEQTLFPQLGMTQSFINVPKPYMSQYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAQINVQQLQQPIRKAIEHTHVGYFELGAMTQGLGWE
QYAYPVKLETLLEGNSSKMALESHAITPIKQPKIASPATYFNKTGATNGFGAYAAFIPQQ
KIGMVMLANTNFPNEARITATYQAMQQILKQNAAQ
>ZP_04294082|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFEDDRAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSTIKEVLFGPGPVVISLVVG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSSADITLFATGFITAFVVALLAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFIM
>YP_077525|FEATURES|ARDB_deepARG|beta_lactam|BL2a_III2|antibiotic inactivation|1
MKLWFSTLKLKKVAAVLLFSCVALAGCGSNHSNASHSAEKDEKTEMKDDFAKLEEQFDAK
LGIFALDTGTNRTVTYRPDERFAFASTIKALTVGVLLQQKSIEDLNQRITYTRDDLVNYN
PITEKHVDTGMTLKELADASLRYSDNTAQNLILKQIGGPESLKKELRKIGDEVTNPERFE
PELNEVNPGETQDTSTARALATSLQAFALEDKLPSEKRELLIDWMKRNTTGDALIRAGVP
EGWEVADKTGAGSYGTRNDIAIIWPPKGDPVVLAVLSSRDKKDAKYDDKLIAEATKVVVK
ALNMESK
>A0A0W7XI38|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKVKGINHLLFSVSDLEASIDFYTKIFDATLLAKGRTTAYFDLNGLWLALNVEKDIPRQD
IHESYTHIAFSIDEEDINYMYNKLKNLNVNLLQGRPRDEKDRQSIYFTDPDGHKFEFHTG
TLKNRLEYYKQEKTHIEFFDK
>A0A0U1YUV6|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFVRQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>ZP_03031860|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSALFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTASFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>ZP_02345654|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNETSASLQLTQTLFDMSKWRGLTLQEKAAGIQDVTY
QTDQQTLILNTANAYFKVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEELRQVTGNYYPELASLNVEHFKTDKPKAVNALLKEAEN
RNLSLLQARLSQDLAREQIRQAQDGHLPTLNLTASTGISDTSYSGSKTNSAQYDDSNMGQ
NKIGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASISSI
NAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARYTYLINQLNIK
YALGTLNEQDLLALNSTLGKPIPTSPESVAPETPEQGAAADGYNAHSAAPAVQPTAARAN
SNNGNPFRH
>A0SKI3|FEATURES|UNIPROT_deepARG|aminoglycoside|Ant3Ia|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLV
SRADQLEEFVHYVKGEITKVVGK
>A0A013RU75|FEATURES|UNIPROT_deepARG|beta_lactam|J658_0368|antibiotic inactivation|1
MQFKKISCLLLPPLFIFSTSIYAGNTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFDDTPGKYWKEL
RNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKEWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLENTIFPELGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINTNLNPQKYPADIQRAINETHQGFYQVGTMSQALGWEEFSY
PAPLQTLLGSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>U2GA87|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MISLKNITKSFKLGDNEIEILHGINLEIKKGEFIAIIGQSGSGKSTLMNILGCLDSPSGG
QYLLDGKDISKFDSDSLAKLRRDKFGFIFQRYNLLSTMNALENVALPSIYAGANKSEREK
RANELLGSLGLSEKAKNLPNKLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGLRV
MEILVDLYKKGHTIIIVTHDPKIAEYASRVIEIKDGNIVSDNVKNSKIYEASKQTQPEKS
KFTYYKDQLIESFKMSVNAMLAHKLRSLLTMLGIIIGITAVISVVALGKGSQEQILAGIR
KIGTNTIDIMPGKGFGDMLSGKVKTLSISDANMLAKQSFLDSVTPNTSTSGVLTYENISL
SASLKGGGVGSFDVNGLKLEEGRIYDDDEVLNSASVALIDQNTKNSIFKNDDPIGKIILF
NKKPLRIIGVLQKDDFKMGDSSTLKIYAPYTTVLNKVTGDKFISSVTAKVNEGVNAQIAE
KTLTELLEIKHGKKDFFTRNSDSIKQTIEETISTMRLLISSIAVVSLVVGGIGVMNIMLV
SVTERTKEIGIKMAIGARQSNILQQFLIEAVLLCLIGGAIGIVLSYAIGYIFNNFLNGFS
MIFSNGSIVLALVTSMAIGIIFGYMPAKNASKLNPIDALSRE
>AAL14439|FEATURES|ARDB_deepARG|multidrug|adeA|antibiotic efflux|1
MQKHLLLPLFLSIGLILQGCDSKEVAQAEPPPAKVSVLSIQPQSVNFSENLPARVHAFRT
AEIRPQVGGIIEKVLFKQGSEVRAGQALYKINSETFEADVNSNRASLNKAEAEVARLKVQ
LERYEQLLPSNAISKQEVSNAQAQYRQALADVAQMKALLARQNLNLQYATVRAPISGRIG
QSFVTEGALVGQGDTNTMATIQQIDKVYVDVKQSVSEYERLQAALQSGELSANSDKTVRI
TNSHGQPYNVTAKMLFEDINVDPETGDVTFRIEVNNTERKLLPGMYVRVNIDRASIPQAL
LVPAQAIQRNISGEPQVYVINAQGTAEIRPIEIGQQYEQFYIANKGLKVGDRVVVEGIER
IKPNQKLALAAWKAPAVANHASSVETKTSIAEGAQP
>U3QX51|FEATURES|UNIPROT_deepARG|beta_lactam|N234_27645|antibiotic inactivation|1
MKKILTASIAVLATTLCEASAHAADSSAQSQIGRTVNATIRPVMQANNVPGMAVAVTVGG
KHYFYSYGVASKSGGKKVTENTIFEIGSISKTFTATLASYAQVRGSLSLSDKASKYLPAL
AGSSFDAISLLDLGTYAAGGLPLQFPEAVTDQAKMVAYFKDWRPSYAPGTHRRYSNPSIG
LFGYLAAQSMGQPFDDLMEKTLFPGLGLKHTYIRVPQARMADYATGYTKDDKPTRVSPGV
LDSEAYGVKTTAADMIRFVEANMNGAGLDDTLQRAIAGTHTGYFKVGDMMQGLGWEMYDY
PTRVDSLLAGSSTQVVFAANKVNRLDPPRTAKADVLVNKTGSTNGFGAYVVFVPAQRIGI
VMLANKNFPVAARIKAAYQILTALDGKLAAAEAR
>A0A0P8BA58|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRRIVAANVALIMTGTFWLGQSAWALDTTESTQIKPLVDDTITALIEEHRIPGMAVAISV
NGQSHYFNYGVANQETDQPVTDETLFELGSVSKIFTATLAAYADASGALSLSDPVSQHLP
ALEGSAFDEITLRELGTYTAGELPLQFPDDVQSEAAMIDYYRQWQPESAPGSHRLYSNPS
LGLLGYITAQRLDQPFETLMAETLFTPLGIENSYYQVPDAQQTHYAYGYDKQDDPIRVNP
GMLDAQAYGLKSTAADVLTFVEANMDGAELDAPLRQAMDTTRRGYATVGELHQGLGWESY
AYPVALDTLVAGNSLDMILEPNPVENLDPPLPSRQAALYNKTGSTNGFGGYVAFVPDEQL
GIVMLANRNYPNQARIKAAHQLLSTLADAH
>I3VVR5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILLIKAFILGIVEGLTEFLPVSSTGHLIIVGDLLNFKGAYATMFEVVIQLGAILAIVYY
YREKIWNSLKNLAPNKWGFRLWLKIVIAFIPSAILGLLLNDFIDKHLFSPFTVSIALVIG
AIMMIIVENAFSNYKIDDMDKVTPGKSFLIGVAQCMSLFPGMSRSASTIMGGMMVGLSVK
AAAEFSFFLAIPTMLGATVVSLHKGIATMTTIEWEALAVGFIMSFIVALIVVDKFLSYLK
SHPLRPFAYYRLIVGIIMIGLVLTNIVK
>A0A059HVB7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIFLKNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDTPSSGTYVF
DEYEVTKLNNYEKARLRREKIGFIFQRYNLLSLLSAKENVSLPAVYAGKNLQERSQNAKK
LLNDLELAHKLDSKPNELSGGQQQRVSIARALINGGELILADEPTGALDSKSGIMVLEIL
QKLNEQGHTIVLVTHDPKIAAQAKRVIEIKDGEILSDTKKEKAQEKLILKTMPKEKKTLT
LLKNQAFECFKIAYSSILAHKLRSILTMLGIIIGIASVVCVVALGLGSQAKVLESIARLG
TNTIEIRPGKGFGDLRSGKTRLNFSDLETLRSLEYLEAVDAHSNTSGVATYTNISLSARA
EGVGINNFAIEGLRIDAGRILNNDDVKNSTNVAVLDFNAKKNLFPDEKSENILGRVVLFN
SQPFKIIGVLQKDTDKPIEDNVVRLYIPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
AIIRILEIKRGQKDFFTFNSDTFKQAITANKRTTTILTACVAVIALIVGGIGVMNIMLVS
VSERTREIGIRMAIGARREDIMIQFLIEAVMICTIGAILGVILSIFVIFAFNTLSTDFPM
ILNAYSVLLGLLSSMFIGVVFGFFPARNAANLNPISALSKE
>W6CYJ0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
NYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLD
RTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQA
GLPASWVVGDKTGSGGYGTTNHIA
>J8LCH4|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEI
HQSYTHIAFSVEQEDFKCLIKRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>A0A060KQE2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVAWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0B4XF27|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSQISSRTYAVCAGACFSLFGTFLACSAEADVVEGRIRPVVDRTIKGLMTENGVAGMAVG
ISVDGRRFIFNYGLADKEKATPVTADTLFEIGSVSKTFTATLGAYAEAKGALALSDAASE
HMRELAGSAFDHITVLELGTYTAGGLPLQFPDEVINNSTLTRYFRGWRPGYEPGTYRVYS
NPSIGLFGTLAAASLRKPFPELMEGTLFPALGLTNSYIRVPEAEMGDYAFGYNKKNNPVR
VSPGALDAQAYGVKTTAADLLRFVEANIDTSGLESSLQKAIGATQTGYYRTGDTFQSLGW
ELYAWPATLDTLLAGNSSDMAMKPHAVTPLVPPQKPAEDVFFNKTGSTGGFGAYAAFVPT
RRIGIVLLANRNYPIPERIKAAYSILGMLEAVSQDERHR
>CAJ77026|FEATURES|ARDB_deepARG|aminoglycoside|APH(6)-Id|antibiotic inactivation|1
MGLMFMPPVFPAHWHVSQPVLIADTFSSLVWKVFLPDGTPAIVKGLKPIEDIADELRGAD
YLVWRSGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEE
PLPSALLPIRERFAALFQRARDDQNAGRQTDYVHAAIIADQMMSNASELRGLHGDLHHEN
IMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPR
RLLDQAYAYGCLSAAWNADGEEEQRDLAIAAAIKHVRQTSY
>AAT70090|FEATURES|ARDB_deepARG|glycopeptide|vanA|antibiotic target alteration|1
MNRVKVAILFGGCSEEHDVSVKSAREIAANIDNEKYEPLYIGITKFGVWKMCEKPCAEWE
NSNCYSAVLSPDKKMHGLLVKKNHEYEIHHVDVAFSVLHGKSGEDGSIQGLFELSGIPYV
GCDIQSSAICMDKSLTYTIAKNAGIATPDFWVINKDDKPAIDAFTYPVFVKPARSGSSYG
VKKVNGADELDAAIESARQYDSKILIEQAVLGCEVGCAVLGNSSELIVGEVDQIRLQHGI
FRIHQEAEPEKGSENAVITIPADLSVEVRGRIQETAKKIYKALGCRGLSRVDMFLQDNGS
IVLNEVNTLPGFTSYSRYPRMMVAAGITLPELIDRLIVLALKG
>W0RK63|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSFLEALILGIVEGITEFLPISSTAHLVLASTLLGIADDPFAKSFEIIIQLGAILSVVVL
YWRKLLDVELLKKTIVAFIPTGILGLTVYKIVKGYLLGNVYVVLGALLVGGLVLIAFERF
RPSDEREVDFGEITYKRALLIGLFQSIAMIPGVSRSAATIVGGSAIGVSKRTIVEFSFIL
AIPTMAAATGLELLKGYKDLLGHFDVLAVGFVVSFVTALLAIKSFLGYIKRHSFAAFGWY
RIVLAVAYFLVFLR
>R6AFI5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLEILKAILFGIVEGITEWLPISSTGHMILLDQVVKLNVSADFYKMFQVVIQLGAIMAV
VILFWNKLWPFYMKKTKSGKKAAWKDGALAMWIKIIIACIPAAIVGLIFDDKIDELFYHP
IPVAIALIVVGIVFIVVENAKKGSRPAIRSIGEITYKAAIIIGLFQLIAAVFPGTSRSGA
TIIGALIIGVSRSVAAEFTFFLAVPVMFGASLLKIAKYAAVGMAMTGTEWVVLIVGCLVA
FFVSVFVIKFLMGYIKKHDFKVFGVYRIILGIAVIALSFVLF
>AAF71278|FEATURES|ARDB_deepARG|glycopeptide|vanSG|antibiotic target alteration|0
MDSDYTQLQTKILIRTAVVLFGAFALISASLSLLSGHFSRAVVGILEIFYKDYEKALVVY
TYVFRDNKEWFVMIAAFVVSNCITMYLKGFTKYFNEINRGINALKEESSEDVVLSSELAA
TEKTINTIKHTLEQQKTAALVAEQRKNDLVVYLAHDLKTPLTSVIGYLTLLRDEKQISDE
LREKYICISLEKAERLENLINEFFEITRFNLSNIILEYSVVNLTRMLEQLVFEFNPMLAE
KKLNCVLKTMPNKMIRCDANKMQRVFDNLLRNAVNYSFENTEISITVTQNENMVHIKFVN
HGNTIPKEKLERIFEQFYRLDTSRSTGNGGAGLGLAIAREIVMLHGGTITARSEDERIEF
EVTILSS
>A0A0J6GY81|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MESHSIMPKKNQRKLASYSAFALLLGVSHSFADERIEAIVKATIEPVMQQQQIPGVAVAI
TVNGKAHYFNYGVASKENGKAVTENTLFEIGSVSKTFTATLAAYAQATGKLTLSDNASQV
LPTLRGSAFDRISLLQLGTYTAGGLPLQFPSDADHQDKMLGYFKQWKPTYTAGTHRQYSN
PSIGLFGYLAAQSMGAPFDELMEKTLLPKLGLKHSYLKVPQDQMGLYAWGYNKDNKPVRV
EPGALDSEAYGVKTSASDLLRYVEANMNPTSLEKPLQQAIAITHTGYYTVGEMTQGLGWE
FYNYPVTLDTLLVGNSSQMAMEAHAVQPLNPPQPPHDNVLINKTGSTGGFGAYVACIPTK
DIGIVILANKNYPNPERIKIAHKILSALTE
>I0IED0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTWYEALILGIVEGLTEYLPVSSTGHLILTQWLLGLNADPQTEAAVNSFNIIVQAGAIAA
VLGLYRQRVGQMIRGLLGRDEEGRRLALMLIAAFMPAAVLGVLLADPIERHLFAPWPVIA
ALAAGGLLMLGVARWRRGADEADGKEVEQIDLRMALLIGFAQCLAMWPGTSRSMMTIVAA
FLVGLRPRAAAEFSFLLGLVTLGAATVYKSAQGGTQMVEQLGAFPILVGLVGATVSAALA
VKWFVRFLTRNGLAPFGWYRLALSAVLAGLILSGVMEGF
>G4C1H4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAELGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQRF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDIAERAS
>A0A143GF31|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLELKGIVRSFMAGDREFIALKGIDLTIHAGEMVAITGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRTLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPET
ARHSRAGELLARLGLSGHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIIEVRDGEIVSDRANESVGLDLPTEAP
IEPKRSGARKLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFPGKSFGDSRASAIETLLPSDVEALNQLYYVDSATPVVGRNL
LLRYGNIDLDAQVNGVSDRYFQVKGLKLEAGITFSESDARRQAQVVVIDHNTRHRLFGPG
VDPLGQVILVGSLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEENVTKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGMIGISLSFAIGY
LFSLFVKEWEMVFSLGSVVTAFACSTLIGIVFGFVPARNAARLDPIEALARD
>R9V686|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAV
VWAFRGKILDVVSGLTSQPKARRFTGNLLLAFLPAVVLGVLFADLIHEYLFNPVTVATAL
VVGGIIMLWAERREHRVQVDHVDDMRWSDALKIGFVQCLAMIPGTSRSGSTIIGGLLFGL
SRKAATEFSFFLAMPTMVGAAVYSGYKYRDLFRPSDLPVFAIGFVTSFIFAMIAVRALLK
FIANHSYAAFAWYRIIFGLLILATWQFGWVDWSTAHG
>P37323|FEATURES|ARDB_deepARG|beta_lactam|SHV-5|antibiotic inactivation|1
SPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVD
AGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGP
AGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQL
QLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRD
TPASMAERNQQIAGIGAALIEHWQR
>A0A133LAZ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILDLLKVFILSIVEGVTEFLPVSSTGHLILVNEFVKLEPEKFANAFNVIIQLGAILSVV
VLFFSKLNPWNLEKTQKYFPKNYANLNGQSKIYYRLTHPHKETIELWKRVIIGVIPAGIL
GFLLDDIIDAYLFNPMVVALMLFVWGIGIILLEKKNKNENRQRIDNLSLISYKTAFFIGC
FQVLAMIPGTSRSAATIIGAMILGLSRSASAEFSFFLAIPTMLGATLLKVVKNVSGFSGY
EWILIIIGMILSFIVAYIVIKKFISYVQKNDFIIFGKYRIVLAVIVFLYFLIIK
>Q704Z0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLHFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYDQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>J3TFQ5|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTTHMKINKVSIVIPVYNEQESLPELIRRTEAACKKLSVAYEILLIDDGSSDDSAAMLTA
AAEALDSHIVALLLNRNYGQHSAIMAGFSHVTGDLVVTLDADLQNPPEEITRLVEVAAQG
YDVVGTVRQNRQDSWFRRRASSMINSLIQRTTGKAISDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARKTIEIPVMHAEREFGDSKYSLMKLVNLMYNLITCLTTMPLRMLSVIG
SIIALLGFACSLILIMLRLFFGSHWAAEGVFMLFAVLFIFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFIQRVVSQNRLSSQQERQ
>ZP_04001477|FEATURES|ARDB_deepARG|multidrug|mdtE|antibiotic efflux|1
MLTACDDKSAENAAAMTPEVGVVTLSPGSVNVLSELPGRTVPYEVAEIRPQVGGIIIKRN
FIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARITFNRQASLLKTNYVSR
QDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVSGKSSVTVGALVTANQA
DSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPVQLNLENGKRYGQTGTL
KFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQNVLLVPQEGVTHNAQGK
ATALILDKDDVVQLREIEASKAIGDQWVVTSGLQAGDRVIVSGLQRIRPGIKARAISSSQ
ENASTESKQ
>A0A127SX82|FEATURES|UNIPROT_deepARG|chloramphenicol|catS|antibiotic inactivation|1
MTVKLDITQIKKKRMKLYPAMLYYLATIVNRHSEFRTAINQAGELGIYDEMIPSYTIFHE
DTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDVPENVFNVSMIPWSTFDGF
NLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQVHHAVCDGFHICRFVNELQELINS
>A0A0V8D837|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMDIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLSFEQFGVLLVACIVAF
GVSMVAIKFLTDYVKKHDFTFFGKYRIVLGIILLIYAMFKAFLG
>A0A132GFH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRGKILEVVFGLTSQPKARRFTGNLLLAFMPAVVLGVLFADLIHEYLFNPITVATALV
VGGVIMLWAERRDHSVQVDHVDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYAAFAWYRIVFGLLILATWQFGWVDWSTAHG
>A0A0E9EI06|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MWLLDIIKVIILGIVEGITEWLPVSSTGHMILVDEFLKLNQSAEFKEMFLVVIQLGAILA
VVIMYFNKLNPFSKKKTKEQQKNTINMWLKVVVGVIPAGVLGVLFDKVLEKYFYNFPTVA
FTLVLYGILFIIVENNPNFKKQNVRRFEDLSYSLAFYVGCFQVLSLIPGTSRSGATILGA
LILGLSRSLAAEFSFFMSIPVMFGASLLKLRKFGFAFSFFQFFILLLGMFIAFVVSIMAI
KMLMKYIKKHDFKVFGYYRIVLGVILILYYFLIK
>A0A0A1FB89|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSANLNAGVAPGRQPDLVIDVRNLTRTYQLGSQEVHALRGVSLAIERGEFVAIMGASGSG
KSTLMNLIGCLDQTSGGTYLLEGVDIAALDEQALAKIRSRRIGFVFQSFNLLPRTTAAEN
VALPLFYSGLLADGAHRVRETLALLGLGERLDNRPNQLSGGQQQRVALARALINQPAILL
ADEPTGNLDSTTANEIMNTLRDLNREQGLTVILVTHEQEMADFADRIITLRDGLVLSDIR
KNDAPTLVKGTTQPLPTEAASSGLSLAELFSFLSMAFIAAFSAIGRNKLRSALTMLGIFI
GVCALIIMLAVGEGARAAVQEQLKSLGTDLLIVLPGSSRGGGVRGGSGSASSLKVADGAA
ILEEDPAVAVISYVNRQSAQVENGDENWSTSVQGVTPSYLAIRNWGLSAGRLISETDERE
GRTVCILGQTVVDNLFGEGQNPIGATVIVKNVPMEVIGVLAVKGHSASGQDQDDVALIPF
RTSQVRVLGVAQPSVAMTQGGTVYPAPPNPFNIQAKLQGFVQTMYIQARGADQVKAALEQ
VTQTLERRHRIKPDQSDDFSVRDLTEIAEVADENSRVMELLLAAIASISLLVGGIGIMNI
LLVSVTERTREIGIRMAIGARRFHVLLQFLIEATLLSLIGGGAGVLAGIVASKVIAHVAG
WPTLLHTSIIIGAFCFSAGIGMFFGFYPARKASLLNPIDALRYE
>A0A017HFG7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTGETILLPLLLGLLEGLTEFIPVSSTGHLLLGGHFLGFESAGKTFEVVIQLGAVLALLT
IYFGRLWGVLRAAPRDPQARRFVAAVLIAFLPAAVIGVMAHDIIKTVLFETPMLIAVMLV
LGGIVLLFVDRMAPTPRHGDAMRLPVPTALTIGFFQVLAMVPGVSRSGATIVGGLLMGVD
KRAAAEFSFFLSMPTMAGAVAYDLFQNRAVLDLSAIHEIAIGFAMAFVAGAVVVKWLLGY
VSRHGYALFGWWRIVIGGIALAGLFLAG
>A0A0E8XG89|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MSLNEPIKKVSIVIPVYNEQESLPALIDRTTAACKLLTQAYEIILVDDGSSDNSTELLTA
AANDPDSHIIAVLLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRLVHVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGNSKYSLMRLINLMYDLITCLTTTPLRLLSLVG
SAIALLGFTFSVLLVALRLIFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGAEQTENNQDVEK
>A0A127SF18|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETIL
HNNEVHYPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLRQKHSGQDL
DISLGELLQYSISLSDNNACDILIEYAGGIGHIHQYIKKLGINDFNLSETEDSMHRNPQK
AYSNWSTPSEMVRLLKMADEKDLFAPVYRDFFWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGVVIMPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDEVK
>A0A066Y026|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSDIPAVQEVAVADRDAGPYGITTGPDGALWLTFVHGGRIGRLTPDGELTEYPLDSPSCR
PAVITPGPDGALWFTRLGDHRIGRVTVDGETESFRPPTPDCGPYGITAGPDGALWFTQMN
TDRIGRVTPEGAFTEFALPVTGAYPSALTTGPDGALWFTLNQADAIGRITVEGTVVLHPL
PTPGAAPVGITSDGTDLWFVEIAAGRLGRISPAGRVEEFPLPDPASRPHALTTTGPGDCW
FTLWAADRVAHRAPDGTLTEHALPSPASEPHGITVGPDGALWVALEAGAVARVAP
>Q84GI7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYY
FTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQ
WQGISLLHLATYTAGGLPLKVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGA
LAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQLDAEA
YGVKSSIEDMAHWVLANMNSEAVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLNWPVPA
EVVINGSDNKVALAATPVTAVNPPAPSVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKSYPNPERVKAAYHILEALQ
>J8NYS5|FEATURES|UNIPROT_deepARG|beta_lactam|IKO_02723|antibiotic inactivation|1
MKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKMLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNLKFGNIKVETFYPGKGHT
EDNIVVGLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSISIENVLNRYGNMNLVVPGH
GEVGDRGLLLHTLDLLK
>ZP_02831928|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVEALARE
>F5T4S0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIVEFLKVIVFSLVEGFTEWLPISSTGHLILLQNIIPLAGTKEFFSTFEVLIQLGAVMA
VVQEFFFRLWPFGKRKKSGGIYLKEEKVILIGKVLLACLPAAVFGLLLDDFLDQYLYNGF
VVSLMLILYGVFFITLEQRNASRKFAFNRVEDLPWTLCLEIGLFQCLALIPGTSRSGATI
IGAMLLSVGRVAATEFSFFLSVPVMAGASLLKLIKHGGHFSGMEWFTLLLSMVLAYLVSL
YCIRFLLRYIRSHDFKIFGYYRIIFGGIMLMWFLVSRFLL
>Q6A4I3|FEATURES|UNIPROT_deepARG|aminoglycoside|aphA-3|antibiotic inactivation|1
MRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDM
MLWLEGKLPVPKVLHFEQHDGWNNLLMSEAGGVLCSEEYETEQNPEKIIELYAECIKLFH
SIDISDCPFTNNIDSRLAELDYLLNSNLADVYCENWEEDTPFKDPRELYDFLKMNKPEEE
LVFSHGDLGDSNIFVKDGKISGFIDLGRSGKADKWYDIAFCVRSIREDIGEEQYVELFFD
LLGIKPDWEKIKYYILLDELV
>A0A0E2LGZ0|FEATURES|UNIPROT_deepARG|beta_lactam|M001_11900|antibiotic inactivation|1
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLNQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAQLKKQ
>ABQ42698|FEATURES|ARDB_deepARG|beta_lactam|ACC-1|antibiotic inactivation|1
MRKKMQNTLKLLSVITCLAATVQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVT
VNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYV
PELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIG
TGLLGMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNM
EILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWE
QLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVMLANKNYSIDQRVTVAYKILSSLEGNK
>W6EIL9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLQSILILHVGIFVDIFQSIIMGIVEGFTEFLPVSSTGHMIIVGDWLGVKQDSMVKAYEV
IIQFAAILAVVLNYKEKFSPKKIDLWMKLAVAFVPLGLVGFIFAKQVKAMFSVEIVALMF
IIGGIVFLVVEKFYTPKEHFIDDVEKVSYTQALWIGIAQVFALIPGTSRAGASIIGAMLV
GLTRKASAEFSFLLAFPVMCATTAYDLVKHRSELFTDTNFAVLAVGFVVSFLVAYATIKL
FLKFLETFTFVSFGIYRILFGVALLAFY
>ZP_03002705|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEAPLAALDKQIMLTQRSVDAQQFGADSVN
ATVEKARAAAKQATDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ
>YP_002444825|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFEDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSTIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSSADITLFVTGFVTAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>A0A0S8G6B8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIELKDVHKTYSLGGTEVRALRGVTLTIEAGEYVAIMGPSGSGKSTLMNVLGLLDVPDRG
SYRLFGREVSKLGEDELAVLRREAIGFVFQQFHLLPRLSAAENAALPLLYSQHRLDAARG
AELLGDVGLGERAGHRPNELSGGQQQRVAIARALVNRPRIILADEPTGNLDSASQKEILA
ILRKLNEAGITVIIVTHEEDVSREARRQIRMRDGKIVSDERTSSSRPPTAGRAASLETVV
PRGFGLREVAEHFRQGLKVLTTNKVRTALSALGILIGVAAVVSMLAIGEGAKRDIETRLA
SLGSNLLVLRKGPARVGGVTMETGAARITVDDAEALRERIPAIKEVAPNVSSRVQVSYGS
RNWNTSVVGAVPPYARMRAAEPDVGRFLTYDENRKRARVVLLGRTVVRELFQGEDPIGAT
VKINRQSFQVIGILPEKGATAWRDQDDLIVMPLTTAMYRVLGKDYVDYVDIEVRSAAEIE
PTQQAVQNLMVSRHRIPSSEQRDAFQIRNMAEIQATLTETSRTMSMLLAVIAAISLLVGG
IGIMNIMLVSVTERTREIGLRKAVGARRRDVLAQFLVETVVVSVTGGLAGILLGWTITVV
LTTFAGWTASVSASAALLAFTFSVGIGVMFGIYPARKAAGLNPIEALRFE
>B6XH69|FEATURES|UNIPROT_deepARG|beta_lactam|PROVALCAL_02707|antibiotic inactivation|1
MDICMKNLFRHGRLLVAVSLALTSLSSAALTQSDVDSIIKPLMKQQQIPGMSVAISVDGK
HFIYHYGIQSKQTKVPVTDNTLYEIGSLSKTFTATLASYAQGQGKLDFSQPVSHYLPELK
NTVFDKVTVMNLATHTSGLSLFVPNTVTNSAELIQYYQQWSPEKPIGEYRSYSNLGVGLL
GIVTAKQLGTTFSQATDNMMLPALGMKHTYLQVPQHQQQNYAQGYNKQHQPVRVTPEILD
NEAYGLKSTAKDLIRFLDINMQVVDVKKSWQEAVEDTHTGVYMTDSFVQDLMWESYPWPV
SLAQLQQGNRDDMALKPQKVEAIQPPLPPESAAFYNKTGSTNGFAAYAAFIPDEKIGIVL
LSNQWYPIPERINAAYQLIEKVKH
>M1R657|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIVHAIILGIVEGALEFLPVSAAGHLTLVGKLLGINTENPAFKIYEIFMQIGAVIAVII
LYSKRLIVDKEIWLKIIAGFVPTGAIGFLFYKPIKHYLLGNPLITASMVFIGGVIIIIVE
SLSKKPKITSLKDVTIKDAIAVGFIQSLALIPGVSRSGATIIGAMLIGFERKTAADFSFL
IAIPTILSAGLYSLLKDHSQIRHQDILPMGISFITALVFAIVSVKTFLNFISFNNLKIFG
YYRIITGLAYLAYLLR
>A1ZFF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIVQNLILAIIEGITEFLPVSSTGHMIIASSVMGINENTFVKTYEVSIQFGAILSVVVL
YWRRFFQSLDFYFKLFVAFLPAAVIGLLLNDYIDMLLESVIVVAVMLVLGGILLIFVDRW
FTYDPEKDHDIELKYPTALKIGFFQCIAMIPGTSRSAATIIGAMTQKLNRKQAAEFSFFL
AVPTMLAAAGYKLLKTYKESPAAITENIEALVIGNVVAFVVALLAIKFFISFLTKYGFKV
FGYYRIVVGLAILIMWAMGVKLQV
>Q6QIU6|FEATURES|UNIPROT_deepARG|beta_lactam|blaampC|antibiotic inactivation|1
MNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGVAS
KQTGKPITEETLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGVSLL
NLATHTSGLPLFVPDDVTNDAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSLDQ
PFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAKSYGIKSNA
RDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIEGNN
AGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFPNDD
RVEAAYHIVQA
>C2Z3Z3|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0029_8350|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQATQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>D0CC38|FEATURES|UNIPROT_deepARG|beta_lactam|F911_01258|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0S3N6K1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGVERKR
RLARAQELLQRLGLEERVDYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPATENMNVVAGTESI
VKMSSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQRQPWVASATPAVSQNLRLRY
SNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNSRRQLFPHKANVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRIMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFALQL
FLPGWEIGFSPLALLLAFLCSTVTGVLFGWLPARNAARLDPVEALARE
>A0A099HZ41|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIFKAIILGIVQGITEWLPVSSTGHLILVEQFVKFDLSQVFVSTFMVVIQLGSILAVL
TLYFKKLNPLDSSKTEKEKKDTINLWIKVIIAVIPSGILGVLFDDAIDSLFFNPTTVSIT
LIVYGVIMILIENRNKKPKVNDFSQLTYKLALGIGLFQCLALIPGTSRSGSTIIGAALLG
TSRYVAAEFSFFLAIPTMFGASALKLVKTGAAFSGFEWLVLGAGFVTAFIVSVFAIKFLM
DYIKKHDFKVFGYYRIVLGIIVFAYFTFLI
>A0A140DCN8|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
MKLLKILSLVCLSISIGACAEHSMSRAKTSTFPQVNNSIIDQNVQALFNEISADAVFVTY
DGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKEWDKD
FTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQ
EVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENSLYAKSGWGMAVDPQVGWYVGFVEK
ADGQVVAFALNMQMKAGDDSALRKQLSLDVLDKLGVFHYL
>ZP_04217288|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLIHGINHLCFSVSDLEESIQFYETILEGKLLVKGRKLAYFDVCGVWIALNEEVDIARNE
IHQSYTHLAFSVQQEDFQQLLKRLEENKVHILQGRERDVRDCQSIYFIDPDGHKFEFHSG
TLQDRLKYYKEAKPHMKFY
>R5ER43|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSKVLLNLKDIKKSFGQGESKVEILHGINLTINKGELVAIIGPSGSGKSTLMNIIGCLDT
PTEGSYQVDGHDTFNMLPDELASLRRDFFGFIFQRYHLLGHLNAMENVQVPAIYSGTGKE
KRESRSVKLLEILGLGNKTENKPSQLSGGQQQRVSIARALMNGGQIILADEPTGALDSKS
GAEVMDILTELNKEGHTVILVTHDPRIAAHAHRVITIKDGAIESDTVNDNISDHQNKDDV
SLAVHFSDKVVNSYRAYFDRFKEAYTMAIRAMISNRMRTLLTMLGIIIGIMSVVTVVALA
RGASDQIISNISSMGTNTITIMPGQKMGDMRSGRVRTLSVKDLKALKGQPFVDSASPTVQ
NSGMVQRYNVDATATVIGVSGEYFRVYGMEIEKGRMFSEDEASLSPQVGVIDYNTKNTFF
KNEDPIGKRLFVQGKPITVIGLLVDKEVAFRHSDNLYIYVPYSTMMNRIVKQNYISSIIV
RTADGFSPAVAEASITSLLKSRHGRKDFFMMSSDTIMKSINQATGTFTLLISAIAVISLV
VGGIGVMNIMLVSVTERTREIGIRMAVGARRSDIMTQFLIESVTVCLIGGMLGVVFSMVT
GYVLSIFVPNIPLSFSLASIVIAVLTSSIIGVLFGYMPARSAARLNPIDALARE
>A0A0L1LVG6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPKKNQRKLASYSAFALLLGVGHSFADDRIEAIVKAAIEPVMQQQQIPGVAVAITVNGKP
HYFNYGVASKENGKAVTEDTLFEIGSVSKTFTATLAAYAQATGKLALSDNASQVLPALRG
SAFDSISVLQLGTYTPGGLPLQFPSDADHQDKMLGYFKQWKPTYAAGTHRQYSNPSIGLF
GYLAAHSMGARFDDLMVKTLLPKLGLKHSYLKVPQDQMGLYAQGYNKDDKPVRVEPGALD
SEAYGMKTSASDLLRYVEANMNPTSLEKPLQQAIATTHTGYYTVGEMTQGLGWEFYNYPV
TLDTLLVGNSSQMAMEAHAVQPLNPPQSPRDNVLINKTGSTGGFGAYVAYIPAKDIGIVI
LANKNYPNPERIKIAHKILSALTE
>A0A150L0X3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTPEAANTFKVVIQLGSILAVAIVFKDRILNLLGMKKNITSDQTKGHKLSIAQIAVGLVP
ATILGFLFEDYIDQYLFSVKTVAFGLIAGAVLMLAADFMNKRKETTETVDRITYKQAIGA
GLFQCLALWPGFSRSGSTIAGGVMLGLNHRAAADFTFIMAIPIMMGASTLTLVKNWDSLN
ADLLPFFSVGFISAFIVALFVVRFFLRLINKIKLVPFAIYRIILGIVLLMIFF
>A0A086BXU0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWWTAFQAFILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAKAFNIIIQLAAILAVV
WEFRGKIFQVVRDLPSQHQAQRFTVNLLIAFFPAVILGVLFADLIHEWLFNPITVALALV
VGGVIMLWAERRQHVIRAEHVDDMTWKDALKIGCAQCLAMIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFRPEDLPVFAVGFVTSFVFAMVAVRALLKF
IGNHSYAAFAWYRIAFGLLILATWQFHLIDWSTAGDL
>A0A0D0SFW9|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MDFWTAIQALILGIVEGLTEFLPISSTGHQIIVADLINFGGERFEAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQPKARRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALV
VGGVIMLWAERRQHAVRAEAVDDITWKDALKVGLAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKALLKF
IASHSYAAFAWYRIAFGLVILATWQFGWIDWTAVKP
>C0Q070|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTTACESLGKAWEILLIDDGSSDSSAELMVK
ASQEADSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAISGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTPFTEESHQ
>R4WAW6|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-12|antibiotic inactivation|1
MSRLLLSGLLGAGLLFSLPASAATGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGFLVDEEHPALPFKPGYDDWLPAWRETTTPRRWETYSVVWFSQQITEWLGMDRFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
DNILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAKLKTL
>D8JEP8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAIIQGFAELLPVSSSAHVILAEKLMGYDPSAPDMTFLLVMLHTGTMFAVIV
YFWKSWRKTYFSSWESFKKQAFYIILATLITGVLGLALQSLIKHVFFGGASSFEIEHLFS
NSKLMAAALISAGVLIILSSRLDRGQQGEISLRSASIIGAVQALCLPFRGFSRSGATIST
GLFLGVSRQKAEEFSFALAVVLTPAVILKELYRLVHAQGLQTVTHGQVFHSMVPSLLGMC
FSFGAGLLALKWLSSWLEHGRWHLFGLYCIGFAVVVLCVN
>A0A127SZ19|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMACWVRSNMNPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSDNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>W6VJQ1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKTVVFAYHDIGCAGIEALLNSGYDIAAVFTHADDPKENAFYASVAQLCANKGIPVHA
PEDANHPLWIERIAKLDPEYIFSFYYRNLLSEPLLALAKKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADTGAIVAQQRVAIDRSDTGLTLHAKLRTAASDLLRDTLP
NMLQGKITETPQDESKATVFGRRTPADGKLVWAKPAEELFNLVRAVTRPYPGAFCAVGEH
KLIVWSAEVVKGNEGQAPGRVISVDPLRIACGQDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIDRLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDSSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIANAKRLLNWEPTVEMRETIGNTLDFFLREAMLEIA
DKK
>CAG34266|FEATURES|ARDB_deepARG|multidrug|smeF|antibiotic efflux|0
MARRYHRDPQGVAMKFSSLAVSLAGVLALAGCSTLAPKNTAVAPAIPAQWPAEAAQGQVA
DVAAVGWRDFFIDARLQQLIEQSLQNNRDLRVAVLNVERARGQYRVQRADRVPGVAVTGQ
MQRQGTDAGVTEQFTAGVGVAEFELDLFGRVRNLSEAALQQYFAVAANRRNAQLSLVAET
ATAWLTYGADAQRLKIADATLKTYEDSLRLAEARHERGGSSALELTQTRTLVETARTDAA
RLRGQLAQDRNALALLAGGQLDPALLPDGIEPQLLALAPPPAGLPSDVLLQRPDIMAAEH
QLLAANANIGAARAAFFPSISLTGSIGSGSSELSSLFDSGTRVWSFLPKITLPIFQGGKL
RANLAVANADRDIALAQYEKSIQVGFRETADALALNVSLDEQVSSQQRLLEAAEQANRLS
QARYDAGLDSFVTLLDARRTAYNAQQTQLQAQLAQQANRITLYKVLGGGWHERS
>D4P8T0|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MNFNNKTKYGKIQEFLRSNNEPDYRIKQITNAIFKQRISRFEDMKVLPKLLREDLINNFG
ETVLNIKLLAEQNSEQVTKVLFEVSKNERVETVNMKYKAGWESFCISSQCGCNFGCKFCA
TGDIGLKKNLTVDEITDQVLYFHLLGHQIDSISFMGMGEALANRQVFDALDSFTDPNLFA
LSPRRLSISTIGIIPSIKKITQEYPQVNLTFSLHSPYSEERSKLMPINDRYPIDEVMNIL
DEHIRLTSRKVYIAYIMLPGVNDSLEHANEVVSLLKSRYKSGKLYHVNLIRYNPTISAPE
MYGEANEGHVEAFYKVLKSAGIHVTIRSQFGIDIDAACGQLYGNYQNSQ
>A0A085H3A4|FEATURES|UNIPROT_deepARG|beta_lactam|GLAD_03960|antibiotic inactivation|1
MKKSLLCALLVCLSGSALATTSQEAQVAQVVNPTITALMKAQAIPGMAVAVIYQGKPYYF
TWGQADVAANRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIALSDPASKYWTALSGKQW
EGITLLHLATYTAGGLPLQVPDNVTDAASLEKYYQSWQPEWAPGTKRQYANASIGLFGAL
AVKPSRMDFEQALTRRVLKPLNLNHTWVTVPASEQANYAWGYRDGKAVHVSPGMLDAEAY
GVKASIVDMAGWLQANIQPDKIQNASLKKGVALAQSRYWQVGEMYQGLGWEMLNWPVTSR
ALEQGADNQYALAARGARDINPAQPPVKASWVHKTGATGGFGSYIAFIPEKNIGIVILAN
KNYPNPERVKAAYQILDALQ
>A7Y405|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIPVNRGP
LDAAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFS
YPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVM
LTNKRIPNEERIKAAYAVLNAIKK
>YP_001438873|FEATURES|ARDB_deepARG|multidrug|AcrA|antibiotic efflux|1
MNKNRGFTPLAVVLMLSGSFALTGCDGEQAQQQAPQAPEVGVVTLKSEPLQITTELPGRT
LAYRVAEVRPQVSGIILKRNFEEGSEIKAGVSLYQIDPAPYQASYESAKGDLAKAQASAN
IAQVTLSRYQKLLGTQYISKQDYDNAQAEAQQANAAVVAAKAAVETARINLAYTKVTSPI
SGRIGKSNVTEGALVQNGQTTALAVVQQLDPIYVDVTQSSNDFLRLKQELASGQLKQENG
KAKVTLSTADGLKYPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
VNPNAILVPQQGVTRTPRGDATVMVVGEGDKVEVRPVQVGQAMGDKWVVTDGVKAGDRVI
ITGLQKVRPGAQVKAQEVTDNQQQQKQSGAAGQTQSQQPQS
>M7NGU6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLIEAIILGIIEGLTEFLPVSSTGHMILASYLMQMQETALLKTFEVVIQLGAILAIVWL
YAKRFLTSFTIYLKLVVAFLPTGIIGLLAYKTIKAYLFSPGVVAVSLILGGAVLVLLNRR
IETTASKYPDVGDISFKRAFLIGVAQCFSMIPGVSRAAATIIGGVYYGLDKKQAAEFSFL
LAVPTMFAASGYDLLKADIAYTSETLTILGVGLLMAFLTAWVVVKVFVKYIHLISFKHFG
YYRIVIGIIFLILIFTGVLDDAQLLPVGSGLAP
>CAD03195|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQ
LFYGPLSDRVGRRPVILVGMSIFMVATLIAMTTHSLTVLIAASAMQGMGTGVGGVMARTL
PRDLYEGTQLRHANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMA
RWMPETRPAGAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFSALMWQSVICCLLAGLMMWIPGWFGVMNVW
TLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQT
GQGSLGLLMTLMGLLILACWLPLASRISHQGQTV
>A0A0Q5EEW2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAWVAVQALILGIVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLGAILAVV
WEFRSKIFEVVLGLPRQRQAQRFTGNLLLAFLPAVVLGVLLADWIHHYLFNPITVAVALV
VGGIIMLWAERREHVIKVQEVDDMTWKDALKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPDDFSVFAVGFVVSFIFAMIAVRGLLKF
IASHSYALFAWYRIAFGLLILATWLFGWVDWSTAQG
>N9CXW5|FEATURES|UNIPROT_deepARG|beta_lactam|F938_04047|antibiotic inactivation|1
MALLKKTKTIFYVLISSMGLTTYVNANQQITTAKVENAMTQAFQPLMQKYAVPGMAIGVL
YQGKSYEKYYGVQSLADKKSVNKNTLFELGSVSKLFTATAGSYAQSVSKLSLQDHPGKYL
PALKNSEINQVTLLQLATYTTGNLPLQFPDQIETDAQTLKYFQDWKVNQPVGQFRQYSNP
SIGLFGEATAKAMNMPFSTLLERVIFPQLQLQHSYVNVPKAQQAQYAFGYDQNNRPIRVN
PGPFDAQAYGVKSNLPDLLQFLKLNLNPDQAKASIRPAIEGTHIGYFKMGGMTQALGWET
FDYPVSLETLLESNSDRVVMQSNPVEKTLVKSGARVFHKTGSTNGFGTYLIYIPAEKFGL
VMLMNKRIANAERIQAAYEVLNTLKQTSHP
>D3V277|FEATURES|UNIPROT_deepARG|beta_lactam|XBJ1_2301|antibiotic inactivation|1
MLLSSLRLTRISATIFPLLGALITFPIHATTQQNQITNQLSALEKNANGRLGVVLIDTAD
HSTITYRAHERFPLCSTSKMMAVSALLKKSETNEGLLNQRIHYQQSDIVEYSPITEKHLK
DGMTLAKLSAATIQYSDNTAMNLLIDQLGGTHDVTRFARSIGDNEFRLDRKEPELNMVTP
DDERDTTTPQAMADSLYKLALGNTLAATQRAQLVEWLKGNTTGGASIRAGVPDNWIVGDK
TGRCDYGSTNDIAVIWPDKNKAPLILVTYFTQPNDKDAEAHPDVLAAAARIMTQER
>E4L8I1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYQYFCAVIIGIVEGMTEYLPVSSTGHMIIVSSMLNFTGDLAKFFEVFIQLGAILSVLVV
YKEKFIFMLDTHHWFRKKGPSCFNIIISMIPACVMGLLFHGMIKKYLFGPETVIIGLIIG
GIFMIYGEKKGKRKNVSVKNVEDINTKQAFKIGLFQCLSLWPGFSRSGSTIAGGLLLGVS
RKAAADFSFIMAVPLMFLATLYDLLKNIKYLHFSDIGVLLTGFIVSFIVAYLSIVWFLKF
LNKYNLTGFALYRFLVAIVAFLFVI
>A0A0R2CNC3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAAILGIVEGITEFLPISSTGHLVLVDEFIQLQQSKQFIDMFNVVIQLGAIMAVV
VIYFHKLNPWSPQKTNLEKKQTWTLWKKVILAVIPSVIVGLPLNDWMDAHLMNWQVVAGA
LIIYGILFIIIENHNRNNRPRFADLNNLPYSIALAIGLCQVLSLVPGTSRSGSTILGAIT
IGTSRYVATEFSFFLAIPTMFGASLLKLFKYFVHGGSLAGLPGIVLLVGVVVSFVVAYIS
IRFLLNYIKKNDFKVFGWYRIILGIIVIGYFSLVH
>D6CJG0|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKTAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>A0A060VAT3|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDIHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTANTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKPPAHEGKGSGRLSLIHILLGMIPAVVMGLIFHDTIKSLFNPV
NVMYALIVGGVLLIAAEVLKPKQPRAVGIDDMTYRQAFVIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDVYKSIGFLNMGDVPMFAVGFVMAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>S0F2P5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA27|antibiotic inactivation|1
MTIEISNRLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAG
HLEEFIRFVKGEIIKSVGK
>A0A0E2PIP0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSYLADVVLGVIEGITEFLPISSTGHLLLAEAWLGARSDTYNIAIQAGAILAVTLIYWRR
ITGLFLGLGQSENRDYLIKLAVAFGITAVLGLVVKKLGFALPETVMPIAWALVLGGIWMI
VAEWLAGKKPDCATITLRVAIAVGVAQIIAGVFPGTSRSGATIFVAMLMGTTNRAAATEF
AFLVGIPTMYAATGYELLKTLRGGGPAEDWTALGIGFAVSTVTAFVAVKWLLTYIQSHRF
TFFAIYRIVFGGVLLALGAAGVLV
>AAK08976|FEATURES|ARDB_deepARG|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MVKKSLRQFALLAATVFPLLAGSVSLQAQTLSVEQKLAALEQRSGGRLGVALIDTADGSQ
ILYRGDERFAMCSTSKVMAAAAVLKQSESQHDLLNQRIEIKKGDLTNYNPIAEKHVGGSM
SLSELSAAALQYSDNVAMNKLIAQLGGPQGVTAFARKIGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDAQRAQLVTWMKGNTTGTASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLVLVTYFTQPQPEAESRRDVLASAAKIVTEGL
>A0A0A6YEL3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYHDMGCAGINALLKAGFTISAIYTHADTASENHFFGSVARIAAENSIPVYAPD
EVNHPLWIDRIKSAEPDVIFSFYYRNLLCDDILNCAKQGAFNLHGSLLPKYRGRAPLNWA
LVNGETETGVTLHRMVKKADAGEIIAQQRIAIAEEDNALTLHRKLVDCASELLESTLPAM
KQGNIVGKPQNEAEATVVGRRTPEDGRINWSLPAKQINNLVRAVTDPWPGAFAFAGTTKF
VVWKAKVLTTAHNARPGTVLSADPFVVACGEGALEIQTGQTPNSVYMNGVQLAQHLGMVN
GALLYSQAVAAVKRRTRVLILGVNGFIGNHLTERLLQDDNFEVFGLDIGSDAISRFVGHP
RFQFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIVRDC
VKYGKRIIFPSTSEVYGMCTDSNFDEDHSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLFDGGRQKRCFTDI
SDGVEALFRIIENKNNNCDGQIINIGNPDNEASIKELAERLLESFERHPLRASFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLGWTPEVQMNTTIDNTLDFFLRTVELQDDKA
>A0A127SIC2|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLITGSCSTFAAPQQINDILHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLIDPATKYWPELTAKQWNGI
TLLHLAPYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKAGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0W0SII2|FEATURES|UNIPROT_deepARG|beta_lactam|Lcin_2538|antibiotic inactivation|1
MKKISILLGMTLLFCTSTWAQKTCFLARENQTVLKHEGNDCDQRYAPQSTFKIVLSLMGF
DAGILKDAFHPEWPYKKEYELYLNVWKYPQNPHTWMRDSCVWYSQVLTQQLGMKRFKEYV
DAFHYGNEDVSGDKGQNNGLTHAWLSSSLAISPTEQMQFLQKMVTRKLPVSQRAFDMTKD
IMYIQELAGGWKLYGKTGTGEQLTKDKNQKLSLRQGWFVGWIEKDNRKVTFVNHITDCNE
SFAGLKARNEALIQLFHLINELEK
>A0A0E4AGK0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRLNATRFAATLLAAVCALLAAGRAAAFTEDGIRDVVGRHVAPLMKRYGIPGMAIGIVAD
GKPYVFDYGVMSTQTGKPVAGDTLFEIGSVSKTLTATLAADAEEGGELSLSDPAGKYWPA
LQHTPFGGVTLLELGTHTPGGMPLQVPDDIRDDAALMRYLAAWRPAYAPGSRRTYSNVAI
GMLGRLTANAMNRDFTSLMEQRLFPALGMMHTYIDVPAARIGDYAQGYTENGKPIRMAGG
MLWQPAYGVRTTAADLLRFVQANMGLVDTAPRLRRALERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNAPKMLFDAMPATAIDPPLAPRDDVWINKTGSTNGFSTYVAFVPAKRLA
IVMLANRSFPIEDRVKTAYAILSSLGGER
>Q5HKJ6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEITNVNHICFSVSDLNTSIQFYKDILHGDLLVSGRTTAYLTIGHTWIALNQEKNIPRNE
ISHSYTHVAFSIDEEDFQQWIQWLKENQVNILKGRPRDIKDKKSIYFTDLDGHKIELHTG
TLKDRMEYYKCEKTHMQFYDEF
>G5CK59|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-163|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEXQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREF
CSAAISINL
>A0A127SST5|FEATURES|UNIPROT_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MFKLIEKDTWKRKPYFDHYFNQIRCTYSITVNIDISKVITFKNKHHTKLYPLLIYALTKA
VNNHEEFRTAINDKGELGVWDTLLPCYTVFHKENETFSNLWTEWNDNLMAFLSSYERDIE
MFGANYDIDAKPGIPANTFPISSLPWATFTGFNLNIFADGSYLLPIFTYGKYFQQDDKYL
IPLSIQVHHAVCDGFHVSRLINEIQQICNNITADI
>V4QAU3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFIELLKAIFFGIVEGITEWLPISSTGHLILVQEFVKMNQDKAFMDMFNIVIQLGAIIA
VMVIYFERLNPFQPGKTAREVQLTWQLWLKVVIACVPSAIFGLLLDDWMEAHFYNFVVVA
LMLILYGFAFIWIEKRNEHQEAQVKDLAKMTYKTAFLIGCFQVLSIVPGTSRSGATILGA
IFLGTSRIVAADFTFFLAIPTMFGYSGLKALKFFLDGNHLAFSQLLILIVASLTAFVVSL
YAIRFLTDYVKKHDFTLFGKYRIVLGSILILYFLVSLFV
>A0A0J6HHV1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTTTQVSILGLVEGLTEFLPISSTGHQIIAADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILEITTGLPTQRNAQRFTLNLLIGFLPAVVLGVMFADKIHEYLFNPITVAVALV
IGGVIMLWAEQREHVVVIDHVDEMRWTDALKVGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQSADLPVFALGFVAAFLFAMIAVRGLLKF
IANHSYAVFAWYRIAFGLLILATWFLGWIDWNHLSEGA
>YP_001401994|FEATURES|ARDB_deepARG|polymyxin|RosB|antibiotic efflux|0
MHHSTPLITTIVGGLVLAFLFGTLAHRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPEL
AEIGVILLMFGVGLHFSLKDLLAVKSIAIPGAIAQIAVATLLGMGLSHFLGWDLITGLVF
GLCLSTASTVVLLRALEERQLIDSQRGQIAIGWLIVEDLAMVLTLVLLPAFAGVMGNETT
NLNQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAY
GAVELFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILVN
EPLAVIASLAIIIFGKSAIAFALVRLFGHSKRTALTISVSLAQIGEFAFILAGLGISLDL
LSGHGRNLVLASAILSIMLNPLLFTLLDRYLAKTETMEDLILEEAVEEEKQIPVDLCNHV
LLVGYGRVGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVFGNAANADVMALGRLD
CARWLLLTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISDRGANQVVMGEREIA
NSMLNMLKIETLTEEDKMPVCPI
>A0A0R0MI26|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDITLLIKAALMGIVEGLTEFLPISSTGHLILAGALLGFDDEKAKVFDIAIQTGAILAVI
LVYWQKLRATVVALPTSRQAQQFTLNVLIAFVPAVVLGLLFGKAIKANLFTAEVVATTFI
IGGFVILWAERRQARAETAPRILDVDQMGWKDAVKVGLVQCLAMIPGTSRSGATIIGGML
LGLSRKAATDFSFYLAIPTLIGAGAYSLVKERALLSLADLPMFGVGLLFSFISAWLCVRW
LLRFISTHSFVGFAWYRIVFGIVVLATAWSGAVKWSA
>A0A096AIY6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLQTIIISIVEGLTEFLPVSSTGHMIITRHLLGVQGSPFVNAFTYIIQFGAILSVVCL
YWKRFFQIDHTPVPADETCTFKKIIHPIRFYWLLFIGVLPAVIIGLAAKKSGLLDWLLDS
VWVVAIMLVVGGIFMLYCDKLFNKGKEENQVTEKRAFSIGLFQCLSVIPGTSRSMATIVG
GMANGLTRKRAAEFSFFLAVPTMAGATLLDLLDLLKGDSTWASAHNLIMLAVGCVVSFIV
ALLAMKWFVSFLAKYGFKWFGWYRIIVGVIIIIMLLCDIPLNMVD
>A0A0Q8FXG9|FEATURES|UNIPROT_deepARG|aminoglycoside|ASD85_11650|antibiotic inactivation|1
MSRQFVIETAGETSLDDWSLLRHRLWSDASPAEHRAELQDFSDNEVGFIAHDPAGAAIGF
AEASLRQDYVNGCDTSPVAFLEGVYVEEAFRKQGVAAALIAEVTRWAISRGVSELASDAD
ISNVDSHRMHAALGFEETQRVVYFRKSLPLGS
>A0A0M8RKV1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPSRPEVTLQEYVVAGPETGPYALTAGPDGALWCTLVHQGRVARVTTAGDVTTYPLRTAT
GGPTMIATGTDGALWCTEFKEHRVTRLVPGRAADGGAQVESFTLPTADAAPLGIAAGPDG
AVWFTESAADRIGRITPDGTVTEYPLPVRGAFASVIATGPDGALWFTANQANAIGRITPD
GDTVLHDLPTPGAGPVGLTAGPDGALWFVEIAAGRVGRITTDGTVEEFPLPDPACRPHAI
AAGPDGALWFTEWGAGRIGRITTSGRVDGYDLPDPASEPHGIALGPDGALWAALETGSVV
RIAVAAEGA
>AAS87172|FEATURES|ARDB_deepARG|chloramphenicol|catI|antibiotic inactivation|1
MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFI
HILARLMNAHPELRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIY
SQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA
>A7GH77|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKQTKTKYGKMKQIVSNLKLPDYRYEQLTKAIFHQRIDNFDDMHILPKVLRMSLVNEFGK
NVSSVIPVFSQDSKQAQKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCGFGCRFCAT
GSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGL
SQRRITISTIGIIPGIQSLTQKFPQVNLAFSLHSPFESQRSDLMPINKRFPLNQVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHAEAVVGLLKNRGSWEHLYHIDLIPYNSTDKTTFK
FQSSNAIKQFCSTLKKAGISATVRTQFGSEISAACGQLCYENEL
>A0A0V8EN49|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGVIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMNIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLSFEQFGVLLVACIVAF
GVSMVAIKFLTDYVKKHDFTFFGKYRIVLGIILLIYAMFRAFLG
>CAD57182|FEATURES|ARDB_deepARG|trimethoprim|dfrA16|antibiotic target replacement|1
MAAKSKNGIIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
NFSTNDEGVMVFSSIQDALINLEEITDHVIVSGGGEIYKSLISKVDTLHISTVDIERDGD
IVFPEIPDTFKLVFEQDFESNINYCYQIWQKS
>A0A0J6HW22|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSLKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPKENNFYGSVAQLCARKGIPVHA
PEDANHPLWIERIRKLNADYIFSFYYRNLLGEELLASVSKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGDILAQQRISIERSDTALSLHAKLRETAAQLLADALP
LLPQGKLTETPQDESKATYFGRRTPADGLLQWNRPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWGAEVVAGNQGHAPGQVISCEPLRIACGQDSLVITAGQRNDNGLYLSGPQLARELG
LVEGSRLRGSESGRPARRTRVLILGVNGFIGNHLSERLLQDDRYEVYGLDIGSDAIDRLR
SHPNFHFVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GTKGLKFTLFRPFNWMGPRLDRLDSARVGSSRAITQLILHLVEGTPIRLVDGGEQKRCFT
DVADGIEALARIIDNKGGKCDGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGTGYQDVSHRKPSVENARRLIDWTPTTELSETIGKTLDFFLREAMVEIA
EKR
>A0A0Q8MX84|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHEDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFIPAVVLGLLLSDFIDGLLENPITVAVSLLIGGLILLKVDEW
FNNPNTTETSQEITYLQAVKIGLFQCIAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFFL
AVPTMLGATVKKCYDYYKAGFELSHDQVNILIIGNIVAFIVALLAIKTFIGFLTKNGFKV
FGYYRILAGIILLLIHFFIHPLTII
>I6F5Y8|FEATURES|UNIPROT_deepARG|beta_lactam|SF123566_7517|antibiotic inactivation|1
MFKTTLCALLITASYSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLPPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIP
>A0A0M7GMG0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTENTLYLIKAFVLGIIEGLTEFIPVSSTGHLILVGDWINFESSQGKVFEVVIQLGSILA
VMWVFRARLLTLIRGTLTGVPTEVAFTRNLIIAFLPAAVVGAIFIKSIKSIFYHPAVVVV
TLVLGGLIMLYVERKTHHTPGDMPGAADDTASDERATARTLEQISWKQALGVGVAQCLAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDMYKNFGVLTQHDLSGIA
VGFIAAFLSAMVVVRAVLRFVANHTYRVFAWYRIIFGGVVAAWIFTR
>NP_465227|FEATURES|ARDB_deepARG|fosfomycin|FosX|antibiotic inactivation|1
MISGLSHITLIVKDLNKTTTFLREIFNAEEIYSSGDQTFSLSKEKFFLIAGLWICIMEGD
SLQEQTYNHIAFRIQSEEVDEYIERIKSLGVEIKPERPRVEGEGRSIYFYDFDNHLFELH
AGTLEERLKRYHE
>B8ZI25|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHXKLTDLEKRSRGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQEGKN
>A0A073JSD7|FEATURES|UNIPROT_deepARG|beta_lactam|BAMA_18520|antibiotic inactivation|1
MNKKRVYQILAPISLVLMVVGCSDEKKQVVQHSKTEHTGGANQTSENIMEKETVIEKFEQ
LEKEYDARLGVYAIDTGTKETIEFRENERFAYTSTFKALAGAVLLKQNPISALEEIRTFT
DEDIVTYSPITEDFVNKGMSLGEIAKAAIQYSDNTAGNLLFEELGGPDGFEKALRESGDT
ITMADRIEPDLNEAIPGDSRDTSTPKALATTLEVFGISEYLPADKQEIFTNWLKGNTTGD
SLIQAGVPEGWEVGDKSGAGSYGTRNDIAIVWPPNREPIVIAVMSSRKEENASFNDELIA
KATKVITQAFSNNK
>L2VXV1|FEATURES|UNIPROT_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDNDTSINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSELNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKIMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLLLCFFVTLFCIKEKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQIATGSIAP
ILTLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRFPQVSN
>A0A0H2ZEU7|FEATURES|UNIPROT_deepARG|aminoglycoside|aph|antibiotic inactivation|1
MHDAATSMPQAPSTWADYLAGYRWRGQGEGCSAATVHRLEAERRPTLFVKQEVLSAHAEL
PAEIARLRWLHGAGIDCPQVLNETQSDGRQWLLMSAVPGDTLSALAQRGELEPERLVRLV
AAALRRLHDLDPAACPFDHRLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLLD
RRPAVEDLVVAHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIEAELGAAW
AEAFLVEYGGDIDGERLAYFRLLDEFF
>A0A127SNV0|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MFFEKIDINSWTRHEYFEHYFTNIPCTYSMTVKLDITQIKKKRMKLYPAMLYYLATIVNR
HSEFRTAINQAGELGIYDEMIPSYTVFHKDTETFSNLWTEYMPNIEEFSRAYENDIQRYG
SNHGMTGKPDVPENVFTVSMIPWSTFDSFNLNLQKGYSYLIPIFTLGKYYEEDGRIVLPL
AVQVHHAVCDGFHICRFVNELQELINS
>R6BD36|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQFIEILKTIVLGIIQGITEWLPISSTGHMILADTFLQLNQPKDFMDMFFVVIQLGSILA
VVVLYFNKLNPFAPSKSRAERYSTFQLWAKVLVAVLPVGVIGLLVDDWVTEHFYTPVVIA
IALIFYGILFILLERRNRTAKPRIRSFEQLSWRTALCIGFLQLLAIIPGTSRSGSTILGA
MLLSCSRFVATEFSFFMAVPVMFGASGYKILKFVLKTGLASITGFQWGLLLLGSVVSFVV
SLFAIKFLMNYIRKHDFTAFGWYRIVLGAIVLLYFGIFA
>A0A0A0QAV6|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-10|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLLEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>J3B763|FEATURES|UNIPROT_deepARG|beta_lactam|PMI33_05337|antibiotic inactivation|1
MHNSTFGKVLSCSAFGLLLNAGYCVAGNQTDAQIEAAVNAAVAPVMQQQNIPGMAVAITV
NGKQHYFNYGAASKETGTPVTESTLFEIGSVSKTFTATLAAYAQASGKLSLSDKASHVLP
ALRGSAFDHVSVLQLGTYTAGGLPLQFPDNADAADKMLGYFKQWKPAYTAGSHRLYSNPS
LGLFGYLAANSMGQPFDELMEKTVLPKLGLQHTYLKVPQDQMALYAQGYTKEDKPVRVEP
GALDSEAYGVKTSASDLLRYVEANIKPSGLEAPMQQAIATTHAGYYTVGDMTQGLGWEFY
HYPITLDKLLAGNSSPMAMEAHKVQWLNPPQAQPDNVLINKTGSTGGFGAYVAYVPSKDI
GIVILANKNYPNPERVKIAHAVLSTLTQ
>A0A0H3WME5|FEATURES|UNIPROT_deepARG|beta_lactam|TEM|antibiotic inactivation|1
HPLVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWLLA
>W1TXU4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYEYFAALIIGIVEGLTEYIPVSSTGHMIIVGDMIGFSGTKESVFEVFIQLGAILSVLLI
YRDKFKMMLRRENWFKKRGTSCYNLICAMLPAMAIGYLTHHFIKTYLFGWQTVVIGLILG
GILMLFAERVNIRTRTDDVDAITTKQAVLIGVFQILSLWPGFSRSGSTISGGLLLGISRK
AAADFSFIMAAPLMFVACTYDLLKIWRYLHWSDFGIFALGFVTAAVVAYASVLWFLKFLN
NSSLASFAYYRFALAVATCLYFWL
>A0A127SUM6|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
PLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLREL
MQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSSFEAVYRNWST
PSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSDRN
ADGMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDNADIIAR
>L1LY94|FEATURES|UNIPROT_deepARG|beta_lactam|CSV86_16915|antibiotic inactivation|1
MTLRLSLFALGALFYIPAQAATLCTVVADADDGRILFQQGAQQDCAARYTPASTFKLPIA
LMGADAGVLKGPHEPVWQYESGYPDWGGDAWRQPTDPQRWITYSVVWYSQLIARSLGQER
FQHYTSAFGYGNEDVSGEPGKNNGTDGAWIISSLRISPVEQLAFLRKVVNRQLPIKAEAY
DLAENLFEVSEADGWRLYGKTGTGSPGNNGVYTPANAYGWFVGWARREGRQLVFASLVQD
ATATKPNAGLRARDDLIRNWHAMVGGPR
>A0A0H4IQL2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-127|antibiotic inactivation|1
MMKKSLCCALLLTAPLSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAIAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYRPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVNPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>U4R251|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLLFVLKSIVLGIVEGVTEFLPISSTGHLIIFENIMGFKSASPNYVEMYTYVIQLGAI
LAVVLLYWKKIKETIINFFPQKVGYEKSGFKFWFMIFIACLPGAAVKLLLDKPVEKYLMT
PVTVAIVLILGGLWMIYAEKRFRNNNLGKQKLSVTPKQALIIGAFQCLAIIPGMSRSAST
IIGGWVAGLSTVVGAEFSFFLAIPVMFGYSLLEIIKIGGLTSLPAAELISLVVGFVVAFL
VSVAVISQFISYLKRKPLKSFAIYRMIFAVIVLIAGFMGFF
>A0A127SF42|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-2|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEQQRLVKELMI
>A0A060KZY9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>A0A0Q8R0Y9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MEVRESFLRGLKVRSAVDGAIRPLMAEHGMPGMAVAVTLDGKPYYFNYGIASRETNAPVS
ENTLFEIGSVSKAMTATLATWAQAQGKLSLDAHPSRYLPQLKGSEIDKATLLHLGTYTAG
GLKLQFPDDVREGREMAFFRAWKADAAPGAKRRYSNPSIGLLGHAAAAALRKDFATAMVS
EIFPRFGMNNTYEDVPEHAMANYAWGYKGDLQVRVNPGPFDAEAYGVKTSSADLLRFVQA
NIDPGRLEPSMRRAVAATHVPYFEAGPLVQGLGWEQYPYPVSLERLQSGSAPSMTRELVA
AKRLDARGAAGGATLFHKTGSTGGFGAYAVFVPKKKIGIVMLANSTYPNEDRIKAAYTIL
QQLAP
>I6YPK7|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMVVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>ABO60988|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRFTLLAFALAVALPAVHASAAEAPLPQLRAYTVDASRLQPMAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLRLILLSHAHADHAGTVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAAGSKASAEALTCNAYADAAEKKFDAQLARETAGTR
>R6TMH6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIFDIIKSVIFGIVEGITEWLPISSTGHMILLNEILPLRIGKNPDDFYSMFEVVIQLGA
ILAVVVLFWSQIWPFGRKNNKAPLAKTGIGAWVKTDIFVLWFHILVSTIPAAIIGVLFDD
VFERLFYNFQTVAIMLILFGIAFIVIETRHNGKSAKINSLVDISYTTALMIGFFQLIAAV
FPGTSRSGATIVGALLIGVSRTVAAEYTFFLAIPVMFGASLLKLVKFGFHFTGEEAVILI
IGMVVAFVVSLIVIKFLMGYIKKHNFIVFGWYRIMLGAIVLLCGIAGLL
>A0A142FD21|FEATURES|UNIPROT_deepARG|beta_lactam|BAMY6639_17555|antibiotic inactivation|1
MKNKAGIQVGLCIGLLCLSFTGFNPLFGSAHAEEKSIEDAKMTSCITNQKFVQLEKKFDA
RLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLVTY
SPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKADRF
ETDLNSAIPGDRRDTSTAKALATDLKTFALGNTLTADKRTILTDWMRGNATGDELIRAGA
PAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDANYNNALIAEAAKVAL
NALK
>A0A101AVG1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSLVRQIGGGPYALAAGADGAMWVTLVHDGAIARVGADGAVDRFPVAEGSRPSLITSGPD
GALWFTRNGDDRIGRITTAGELTEFALGEGSAPFGICVGADGALWFTEMGVGGIGRITVD
GEVSGEASARGTPSMITRGPDDALWFTLNAGSAIGRLHPADGLTIRELPTRGAGPVGITA
THDDAIWFTEILADKLGRIPLDGALQEIDMPGKPHAVVADPSGGVWVSLWGADQLARIGF
DGEVETFDLPRGSEPHGLAIGPDGALWAALESGFVVRVPD
>A0A150PA09|FEATURES|UNIPROT_deepARG|bacitracin|BE04_17150|antibiotic target alteration|0
MFWFDAVLLGVLEGLTEFLPVSSTGHLILLGAWLGHESEAAKTLDIVIQLGAVLAVVVYF
RERLAVTVRGIFRRDPDSLRLALALAFAFFPAALVGLLFHKAIKAHLFGPGPVAVALIAG
GFLMIGVESARRRRPDQGAPRVEDVTLQRALAIGVAQCFSLWPGASRSMATIVGGQLSGL
STAAAAEFSFLLAIPTLGAATVFDLAKNGRALLDAPGGAAALAVGLAVSFAVALLVIAVF
LRYLKRY
>A0A0B3T011|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKPYLTLCAALAATAAIGWMAFSARSYAAEPAAAAPADPRQAEIKSLVDNTITPLMARQ
NVPGMAVGIVFDGHTYVFDYGVADKATRKPVTPDTLFEIGSVSKTFTATLAAYAQTTGAL
SLDDKTSRFVPELAGTPFGDVKLMNLGTHTTGGMPLQVPDDIHNTDQIVQYFKAWKPAQP
TGTVRTYSNVSIGALGWITARAMHGDFSTLVTEHVFKPLDLKHTFIRVPEDQQANYAWGY
GKDGKPIRVNPGVFEQEAYGVKTTASDLLQFVQANLGGPVRDESLRKAIQATHTGYFFDK
PMTQDLIWEQYPYPVGVDALLEGNANHMAYEPTPARELSPPMAPTSVVWINKTGSTNGFG
TYVAFVPSKQMGIVLLANKNYPMDERIRAAHHILTTLDGGTRATAASRE
>ZP_02357856|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MRTSRSRIAAATLAVVVIAGLGAFGAIRVNASAPDKSAVPLPEVDVANVLSKTITDWQSY
SGRLEAVEKVDVRPLVSGTIVSVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLAAAQ
ARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREAFANLKAADAALETARINLGYTRI
TAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYIGGAKDGRK
VPVELGLANESGYSRQGVIDSVDNRLDTSSGTIRVRARFDNQDGALVPGLYARVKVGGSA
PHPALLIDDAAVNTDQDKKFVFVVDQQGRVSYREVQLGSQHGNQRVIVGGLSAGDRIVVN
GTQRVRPGEQVKPHLVPMTGGDDAAAATPVAGGVQRPQTTQGNARA
>A0A095T798|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAIVFAYHDMGCVGIEALIDAGYQITAIYTHLDNPGENHFFGSVAHLAAEHNIEVFSPE
NVNHPLWIERIKQSSPDIIFSFYYRDLICDEILSIPTQGAFNLHGSLLPRYRGRAPLNWV
LVNGETETGVTLHKMVHRADAGDIAAQYKVTIDPTDDALRLHKKLTLTAQELLTAQLPLI
KKGQLQLTPQDESKATYVGRRTPEDGRLDWNRSATELHNLVRAVSEPWPGAFSFSGTIRF
IVWKSRVRQDMPSAVPGKVLATAPLVIATAEGALEVVTGQTENSVYMQGSELAKTLGLVE
GAVLSSQPVTRDKKRTRVLILGVNGFIGNHLTERLLQDDNYEVYGMDIGSDAVSRFLAND
RFHFVEGDITIHSEWIDYHIKKCDVVLPLVAIATPVEYTRNPLRVFELDFEENLKIIRGC
VKHKKRIIFPSTSEVYGMCTDKTFDEDNSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EHLRFTLFRPFNWMGPRLDNLNSARIGSSRAITQLILNLVEGSPIKLIDGGAQKRCFTDI
SDGIEALFRIIENKNGQCDSQIINIGNPENEASIRELAEMLYCCFERHPLRHHFPPFAGY
REVESSSYYGKGYQDVEHRKPDIRNAHRLLGWTPQTEMETTVEQTLDFFLRTVIPSDKTP
>B9CVR1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIEKLNKYFGEGENRAHILKDIDLTIEQGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGICRIGGKETQQMTSDELSDLRQRKFGFIFQRYNLLSALNANENVALPAIYAGMDSASR
KERANQLLDKLGLSDKTENRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLGILQDLHKEGHTIVMVTHDPNIAATASRIIEVKDGRIIRDERQMPYADEQKLSKPPH
KAPRFLDQLSESFKMAMSAIFAHKLRALLTMLGIVIGITSVISVVALGRGSQEQILSNIN
SLGTNTMTIMNGTGFGDRRANLTKNLTISDATMLAKQTYVDSTTPSSNLSATLIYGNTNV
TGTVNGVGEQYLSVKGMKMVSGRFFTADEVTQAAQVVVIDANTKKDLKLTEPVEGKIILV
DKKPLKIIGLAEESNNMNQTSLKLWTPYTTLMQRISGEKSIDSLTVKVKDDIESQTAEKS
ITELLTAKHGKKDFFIMNADTIKQTITSTTNTMTLLISSIALISLVVGGIGVMNIMLVSV
TERTKEIGVRMAIGAKQSNILQQFLIEAILICLLGGVIGILLAMSIIFAFNAFGSDFKMV
LAPESVVLAVLCSTLIGVVFGYMPAKNASKLNPITALAQE
>A0A0D1B8G3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFIELLKAIFFGVIEGVTEWLPISSTGHLILVQEFIRLHQDKAFMEMFNIVIQLGAIIA
VIVIYFERLNPFQPGKSPQQIRLTWQLWLKVAIACIPSIIIAVPLDDWFDVHFNHMLPIA
IALIVYGVAFLWIEKRHQTLEPRVVKLSRMSYKTAFFIGCFQVLSIIPGTSRSGATILGA
IILGASRTVAADFTFFLAIPTMFGYSGLKALKFFIDGNHLTLSQLLVLLVASLTAFAVSL
YVIKLLTDYVKKHDFTVFGRYRIVLGSLLIVYSVFKSLF
>A8S7Z8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALIEFDEVCKYYQMGDTTVKAADHITMKIEKGEFVAIVGQSGSGKSTCMNIIGCLDVP
TYGTYRLNGRDVGKMNRNELAAVRNEMLGFIFQQYNLLPRLNLMENVEVPLVYAGISRAE
RHIRAREVLEQVGLGDKLKNRPNQLSGGQQQRVSIARALVRNPPVILADEPTGALDSHTG
REVLGLLQQLHKQGHTVVLITHDNSIAVQADRIIRLEDGQVVYDGDSHAPEAMVQPTLLP
ETPEKEEQA
>A0A127SFC4|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-10|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>A0A060DGQ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIDQYLDAALLGLIEGLTEFLPVSSTGHLIIFDTLLGFEGPPGKVFEVVIQLGAILAIC
TVYFARLWNVVTGLKDDPGARHFAMAVILAFLPAMVLGAALHGVIKAVLFNPTVVSVALI
LGGVGILMAERLVPVARYHQIERFPAPLALKIGLCQCLALVPGVSRSGATIIGSLLMGVD
RRTAAEFSFFLAIPTMAGATVYDLYKNWSLMNVDSALLIGVGFVTAFVAAALVVKVLVDF
VGRYGFAPFAWYRIAIGTGMLAFLYL
>R5J720|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIFKAIFLGIVQGITEWLPVSSTGHMILVDQFLHLAGSKKFVDTFLVVIQFGSILAVL
ILYFEKLNPFSKNKGPKARKATWDLWTKVVIAVIPSGLIGVLFEKKIDEVFFNPTVVALA
LIVYGIIMIWLESRHKRPNITKFSQVSYKTALMIGMFQVLALVPGTSRSGSTIIGATLLG
TSRFVAAEFSFFLAIPTMLGASLLKLLKAGFAFTGFEWFIMLVGSVTAFVVSVIVIKMFM
SYIKKHSFKSFGIYRICLGILVFVYFAFAG
>A0A0K2IRH8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGFGQRENREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGIWM
LLVEAYTARLPNRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLELAKEGNLASENWTDVGVAFVAAAITGFVVVKWLMGYIKSH
RFTAFAIYRIALGAALLLWLPSGS
>A0A0T9QKT1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKKSIINTLVFTAFAATPLYISAQTTVSTQNNNSARTILTPKQVARIVNDAITPLVEKQD
IPGMAVAVFYDGKPQFFNYGVADKKTGRPVTENTLFELGSVSKTFTGIAGEYAAQTGIMN
LNDPVTKYAPELTGNQWKDVKMLHLATYTAGGLPLQLPDSVIDKTTLWQFYQQWQPQWAP
GVMRNYSNASIGLFGALAVKRSQLTFENYMTQHVFHPLKLDHTFITVPEAMQSNYAWGYK
DGQPVRVTLGMLGEEAYGVKSSSHDMVKFLQANMNPNSLPAGNDELKKAITASQSRYFQA
GEMFQGLGWEMYNWPINPQHVVADSGNDIALKPRKVEALVPPLNAMPASWVHKTGATNGF
GAYIVFIPEENIGIVMLANKNYPNPVRVQAAYNILQALR
>A0A031LXI0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIELKKINKFVGPDNNQQHILKDVSLSIEQGEFISIIGQSGSGKSTLMNLLGCLDQAS
SGQFLFRGQDISLLSNDELSSLRLKSFGFVFQRYNLLNALSALENVALPAIYSNLNAENR
ADRALQLLAQLGLADKSDNKPNEMSGGQQQRVSIARALMNGGEVILADEPTGALDSESGE
MVLQILEDLHRQGHTIILVTHDKSIAERADRVIEIKDGRILSDTQRKSLGQVSPSKVFHA
DMKFSFVSQVYEAMKMSLHSIFANRLRSFLTMLGIIIGICSVTIVIAIGNGAKEKFLNDW
GGLKTATLEIYPGGTALAASASRLNMDDLNALNEMKEITHVSPHVSLSGNMIYQNRNIDV
SATGADGFYLKIRNMKVQYGRFFTQSDVEQRSQIVVIDKQAAEKLFGQQKLALGKTVLFN
KRSYEVVGIAEPQYSSGSSQIWMPYNVLMSQISSSDNVNLLTAVLHQNTDSVKAEKKVRQ
LLIARHGVEDFDIYNSDESMKSFEKYLGTMTFFISAVAFISLVVGGVGVMNIMLVSVTER
IKEIGLRIAVGARQSDVQAQFLIESAVLCLIGGVIGVAIALIASFIFNAISSDYKMVFSW
SVAIIALLFSTLVGLIFGYMPAKRAANLKPIEALAHE
>G3ESU1|FEATURES|UNIPROT_deepARG|beta_lactam|pdc-22|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLLATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>Q6DMQ4|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA7|antibiotic inactivation|1
MSEKVPAEISVQLSQALNVIGRHLESTLLAVHLYGSALDGGLKPYSDIDLLVAVAAPLND
AVRQALLVDLLEVSASPGQNKALRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAG
IFEPATTDSDLAILLTKAKQHSIVLAGSAAKDLFSSVPESDLFKALADTLKLWNSPPDWA
GDERNVVLTLSRIWYTAATGKIAPKDVAATWAMARLPAQHQPILLNAKRAYLGQEEDYLP
ARADQVAALIKFVKYEAVKLLGASQ
>A0A0Q6D417|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYLDAIILGFVEGLTEFIPVSSTGHILLLGELIGFHSTAGTFEVLIQLGAVLAVLSVYAA
KIYELIVTLPKSPASRRFVAGVLVAFLPAAVIGAIAHDFIKTVLFESPMTICVALLVGGI
ALLFIDRMPIERKYTSLADYTLPLCFKIGLFQCLAMIPGTSRSGATIAGALLLGTDKRSA
AEFSFFLAMPTMAGAFAYDLYKNRDVLSTDDISLIAIGFVVSFVTALFVVRYLLDFVSKH
GFAPFAWWRIAVGSIGIVTLLLR
>W6RBJ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDHVNSIILGIIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWRDPRNRTYAAKLIVAFLITAILGLVVKKLGFQLPETATPIAWALIIGGVWMM
FAEWAAARRPPHKEITWLVAILVGIAQVVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASAFELLKTFKDGGAANEDWTGLGIAFVVSTVVAFIAVKWLLSYIRSNR
FTVFAIYRIILGVILLGMAASGMIA
>A0A0A2XGU4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSELLIAFILGCVEGLTEFLPVSSTGHMIIAGHFLGFEGQKAATFEVIIQLGSILAVIFV
YWCKMFGLIGIHFGEKVDRNKAHLNLIHIILGMIPAVVLGLLFHSTIKSWFNIHNVIGAL
VAGGILLILAEKFRPQPAYAEELDQITYRQAFAIGLFQCLALFPGFSRSGATISGGLLMG
VGKKAAAEYSFILAVPMMIGATALDLYKSLPFLSWDDLPLFVVGFVTAFVVAMIAIRTFL
HLIGKISFVSFAIYRFILAILLAWIVLA
>J9RPK4|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-193|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDELGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRCIQYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAATYF
>B6IBA3|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMENID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMVSYIKRARSMRDIRNEKGTAKPDPAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVKPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRLPSVIILQRASR
>A0A0U1LGP6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLNLTVCQAQSNLTDYACLTGPDIPLTRYYGRLLMMKKSLCCALLLGLSCSALAAPVSEK
QLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAANKPVTPQTLFELGSIS
KTFTGVLGGDAIARGEISLDDPVTRYWPELTGKQWQGIRMLDLATYTAGGLPLQVPDEVT
DDASLLRFYQHWQPQWKPGTTRLYANASIGLFGALAVKPSGMRYEQAMTERVFKPLALHH
TWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADA
SLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVAEVNPPAP
PVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILEALQ
>C2NAQ9|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0002_56900|antibiotic inactivation|1
MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESNKQTNQTNQVKQENKGNHAFA
KLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITY
TRKDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREMGD
TVTNSERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLSILSNHDKEDAEYDDTLI
ADATKIVLETLKVTNK
>A0A0P7M9Y4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTNKTNMARLTVLGACVALLGAGPCLAQAQTDQQIQSTVDAAIKPILQTQGVPGMAVAVT
VNGKPHYFNYGVASKESVQAVTENTLFEIGSVSKTFTATLGAYAIATGKLSLSDKASQVL
PDLRGSAFDNVSVLQLGTYTAGGLPLQFPDEADHADKMLGYFKQWKPVYAAGTHRQYSNP
SIGLFGYLAAHNLGVPFDEAMTNTLLPKLGLTHTFLRVPPDQMSVYAQGYDKNDKPVRVD
PGALDSEAYGVKTSTADMIRYVQANLKPASLEKPLQQAIATTHTGYYTVGDMTQGLGWER
YSYPISLDKLLGGNSTPMAMEAHKVQWLTPPQPEPESVLINKTGSTGGFGAYVAFVPAKD
IGIVILANKNYPIPERIKAAHQILSALAK
>B7C865|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEENMIEILKSILYGIVEGITEWLPVSSTGHMILLEEIMPMNVSSSFWSMFLVVIQLGAI
LAVVLLYCNKIFPFRKNNKGKYVPVKSIWILWSKILVATIPAAVIGLLLDDWIDAHLYNG
FVVAIMLILVGVAFIYVENRNKNMRPSVDTLAALSYKDALIIGLFQVVAAVLPGTSRSGS
TIIGGLMIGVSRAVAAEFTFFLAIPVMFGASLLKLVKFGFSFSLLEFFILAFGMIVAFVV
SIFVIRFLMSYIKKHDFKVFGWYRIALGIIVLVFFMVRAIF
>A0A127T6Q7|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNRPITQNTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTRYWPELTGKQ
W
>YP_002411785|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIITCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMAAGLSLYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLLLMVIFLKDKQMGNSHEG
>ABC38311|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEES
VTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKTVEARLPEP
VRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAE
YAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLT
TPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVA
TEKRVRATMDELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQN
FRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFS
AFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTQRVGRVLKRPLRWLV
VYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSP
SAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRAQDQVQAIIAGINAHFAGTPNTMVFA
INMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLADGRKDPVLTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGQHRLDPGDV
TKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIER
IASALPAGIGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQGMSLADAALEA
ARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFV
CVGRVVDIVPRRRGGARAALEIK
>H8XRX7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAILLAIIEGITEFLPVSSTGHMIIASSFFGIAQDDFTKLFTIVIQLGTILSVVVL
YFKRFFQSFDFYFKLFVGFIPAVIFGLLFSDAIDQLLENPITVAVSLIIGGVLLLKVDDW
FGNSEETKISYLTAFKIGLFQCLAMIPGVSRSGASIVGGMTQKLSRTTAAEFSFFLAIPT
MLGATVKKSYDYYKAGFELTQEQVNLLIIGNIVGFIVALIAIKSFIGYLQKHGFKIFGYY
RIIAGIAILLIHFFIQKLTII
>J9V7B1|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-142|antibiotic inactivation|1
RQSGGRLGGALINTADNSQILYRADERFAECSTSKVMAAAAVLKKSESEPNLLNQRVEIK
KSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDE
TFRLDRTEPTLNTAIPGDPRDTTSPRAMAQ
>C8C152|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMACWVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIVNGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>A0ESG5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLCCALLLSTSCAALAAPLSETQLAKVVERTVTPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGA
LAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKAEEQHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVVANMAPDGVQDASLKQGMVLAQSRYWRTGSMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVSPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>U2CYP5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSANLMFLLKTVIIAIVEGITEFLPISSTGHMIIVGHFINFTGEYATFFEVVIQLGAILA
IVVLYWKKISESLRPNNLFVPGRPGFRLWLNMIIAFIPAAVIGLVFKKKIDKYLFNTLTV
AVAMIVGGTLLIFIENSFRKNRHATRDLENVSPIQALKIGIFQCLSLWPGMSRSASTIMG
GWISGLSTPAAAEFSFFLAIPTMIAASGLDIIKDRPHMTSIELIALILGFVVSFLVALLV
VEKFINFLKKRPMRVFAIYRILVGVILLVLAALKIITITK
>L0MM14|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAAAEPIIALNNISRYFSSGPETVAVLKNISLTINAGEMVAIVGASGSGKSTLMNIIGCL
DNPTSGEMRIKSVSTQSASGEQLAQLRSQYIGFIFQRYHLMPYLNAAENVAIPALYTAMP
AGERQTRAEYLLQRLGLPHRMAYKPAQLSGGQQQRVSVARALMNGAEIILADEPTGALDR
SSGQELMEILHSLHQSGHTIIIVTHDRDVARQAQRIIEISDGEIIADRLNDSATQSAKPQ
TLPAATATGRAPLWQGVREAVRMAWRSLLGHRVRAFLSMLGIIIGISSVVSAIAVGEGAR
QSILDKISQLGTSTMEIRPGLGWDKPRPDFERSLTIDDVEMLAKQPYIDAISPQVNKYIS
IIRGGKQVMTSLSGVSEDYFHVQGVTLLSGNALTRHDLDEREPVVIIDAELAKTLFPDGE
QPLGAIVQIGGTPFRVSGVAMKKGALMGGRLNAWVPYTSLQERLAGDAPLESISLRVVDG
YALAQAQKDVELQLEMFHGRRDFFTQTNDQMTQTIQQASDSMQLLITAIAGISLLVGGVG
VMNIMLVSVTERTHEIGIRLSVGARPLDIMRQFLIEAMVICTLGGMVGIAGAMLAGIMFS
WFTDEFTMLFTWPPIALACSFSALIGLGFGFFPARNAARLHPTEALARE
>AAQ92181|FEATURES|ARDB_deepARG|multidrug|MexB|antibiotic efflux|1
MSRFFIDRPIFAWVIALVIMLVGALSILKLPINQYPSIAPPAIAIQVTYPGASAQTVQDT
VVQVIEQQLNGIDNLRYVSSESNSDGSMTITATFEQGTNSDTAQVQVQNKLNLATPLLPQ
EVQQQGIRVTKSVKNFLLVIGVVSRDGSMTKDDLSNYIVSNMQDPISRTAGVGDFQVFGS
QYAMRVWLDPAKLNNFSLTPVDVKAAIAAQNIQVSSGQLGGLPAAPGQQLNATIIGKTRL
QTAEQFNKILLKVNKDGSQVRLSDVADVGLGGENYSINAQFNGAPASGLAVKLANGANAL
DTAKALRNTINTLKPFFPQGMEVVFPYDTTPVVTESIKGVVETLVEAIVLVFLVMFLFLQ
NFRATVITTMTVPVVLLGTFGILAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
SEEGLSPKEATKKSMGQIQGALVGIALVLSAVLLPMAFFSGSTGVIYKQFSITIVSAMAL
SVLVALIFTPALCATMLKAIPKGEHGTPKRGFFGWFNRSFDRGVKSYERGVGNMLAHKAP
YLLAYLIIVVGMIWLFTRIPTAFLPEEDQGVLFAQVQTPAGSSAQRTQVVIDEMRSYLLD
KESSAVASVFTVNGFNFAGRGQSSGLAFIMLKPWDQRDAENSVFKLAARAQQHFFTFRDA
MVFAFAPPAVLELGNATGFDVFLQDRAGIGHEKLMEARNQFLGMAAQSKVLYQVRPNGLN
DEPQYQLEIDDEKASALGITLSDINSTLSIALGSSYVNDFIDRGRVKKVYVQGQPGSRMS
PEDIKKWYVRNSAGTMVPFSAFAKGQWIYGAPKLSRYNGVEAMEILGAPAPGYSTGEAMA
EVEALAKKLPAGVGISWTGLSYEERLSGSQAPALYALSLLMVFLCLAALYESWSIPIAVM
LVVPLGIIGALLATSLRGLSNDVYFQVGLLTTIGLAAKNAILIVEFAKELHEQGRSLRDA
AIEACRMRLRPIIMTSLAFVLGVVPLAISTGAGSGSQHAIGTGVIGGMITATVLAIFWVP
LFFVTVSSIGQRKTADQDDAIEPSKEAG
>B0BL16|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEAPNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVVGK
>I3E3W8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MQIGGINHLTFSVSDLEKSIHFYQNVFGAKLLVKGRNLAYFALNGIWLALNVQRDIPRKE
IQHSYTHIAFSIQEEDIDYVVQKLKEFGVNILPGRDRDGRDKRSVYFTDPDGHKFEFHTG
SLDDRLSYYRSEKHHMQFFD
>A0A0N0G4T7|FEATURES|UNIPROT_deepARG|beta_lactam|AC499_5646|antibiotic inactivation|1
MPRNKTLLCAALVLNASLACAQEPAPDLDAVVQQAAQQVMQENNIAGMSIAITRNGTQQF
YNYGVASKANRQPVSSDTLFELGSISKTFTATLATWAQANGQLSLTDSIDTYLPQLNDTR
LGKIPVFHLGTHTAGGFPLQVPDKVQNTRQLMDYFKAWQPDYLPGTHRTYANPSVGLLGI
VAARSMKLPYEKALQQRLFPALNLSNTYVNVPDEKQKLYAQGYNKLDEPVRVNPGPLASE
AYGVKSSARDMIRFVEAHLGPGQYDAPLQHALSDTRISYFKVGGMTQDLIWEQYPMPVGL
GQLLEGNASAMLNTLKTEVIEPPQAAQSAVWVNKTGSTNGFGGYVAFIPEKQLGIVILAN
KNYPNEERIRLAYRILGESGCCSKP
>YP_985461|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDTLLLLKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQRIRATLVALPTERQARRFALNVLIGFLPAVLLGLLLGKAIKAHLFTPVVVASTFI
LGGFVILWAERRQQAAVRIHAVDDMTPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDYSFFLAIPTLIGAGVYSLYKERALLSAADIPLFAVGLVFSFISAWLCVRWLLR
YISLHSFVPFAWYRIAFGLVVLATAWSGLVTWAE
>A0A127SLS2|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
ALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKK
QPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLAT
YTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFE
QAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVKSTIEDMA
CWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKI
ALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVA
AAWQILNALQ
>F3FF77|FEATURES|UNIPROT_deepARG|polymyxin|PSYJA_07768|antibiotic target alteration|0
NLHGSLLPRYRGRAPANWVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISATDTALTL
HGKLRDAAADLLCETLPLLAAQGQLPATPQDESRATYFGRRTPADGLIDWSLPGTQLYNL
IRAVTQPYPGAFCPVGDNKLIIWAASVDTSSNGEAPGTVISHEPLRIACGDGSLVITAGQ
RGDNGLYLSGAQLAREFGLVAGSQLLDKAKRRSVRRTRVLILGVNGFIGNHLSERLLQDD
RYEIYGMDIGSDAIERLRAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYT
RNPLRVFELDFEENLKIVRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQ
RWIYSVSKQLLDRVIWAYGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLV
EGTPIRLVDGGAQKRCFTDVVDGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEE
LLHQFEAHPLRGHFPPFAGFREVESQSFYGKGYQDVSHRTPSIDNAKKLIGWTPGIELSE
TIGKTLDFFLREAMAEKADQC
>A0A0D0S6Q6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIIKAIIIGIVEGITEWLPISSTGHMILVEEFIKLDVSKEFNEMFLVVIQLGAILAVC
VIFFDRLFPFTKRKSPEQKQETFNLWGKVIVGCIPAGILGVLFNDWFDEHFYNTFTVATT
LIIYGIIFIVLENINKNKSFEVRRISNLSYMQAFIVGCFQCLALVPGTSRSGATILGAMI
LGISRPVAAEFSFFLAAPVMFGASGLKVVKFIKTGVSISGLEIAVLAIGSVVAFMISMIA
INFLMDYVRKHSFALFGYYRIILGILILGYFLVF
>B1IL14|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKQTKTKYGKMKQMVSNLKLPDYRYEQLTKAIFHQRIDNFDDIHILPKALRMSLVNEFGK
NVSSVIPVFSQDSKQAQKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCGFGCRFCAT
GSAGFKRNLTADEITDQLLYFYFNNHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGL
SQRRITISTIGIIPGIQRLTKKFPQVNLAFSLHSPFESRRSDLMPINKRFPLNEVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHAEAVVGLLKNRGSWEHLYHIDLIPYNSTDKTTFK
FQSSSAIKQFCSTLKKAGISATVRTQFGSEISAACGQLCYENEL
>CAE46566|FEATURES|ARDB_deepARG|beta_lactam|VIM-4|antibiotic inactivation|1
MRVGLTQALCRTHPYGVLMLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVG
EVRLYQIADGVWSHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQ
IGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSG
DAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAVHELSRTSAGNVADADLAEWPTS
VERIQKHYPEAEVVIPGHGLPGGLDLLQHTANVVKAHKNRSVAE
>A0A0J6D8Z3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESNKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNP
INVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATI
SGGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFVTAFVVAL
IAIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>N8WAW5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILTGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIIGGFIILWAERRPHQIVTQEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMAVLGVGIIVAFVSALVVIRALI
RYVSKHDFTAFAYYRIIFGLFILATWWTGWVHW
>A0A0S1UWX2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MGDEKDGPYGIASGADGALWLTFAGSGRIARLAPGGGLRTYALDAPGCRPTVITPGPDGA
LWFTRHGDHRIGRVTVDGDSTSFPLPTPDSGPFGITAGPDGALWFTETRTDRVGRITVAG
EVTEFGLPGTAPGALPSAITAGPDGALWFTLNQADAIGRVTVDGEVTTYPLPTSGAAPVG
ITSDGTALWFVEIGAGRIGRISVDGVIEEFPLPDPAARPHAVVAPAPGECWFTEWGANRV
GRLTGDGEITEYDLPTPASEPHGITSGPDGALWAALETGGVARIVP
>ZP_02681785|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIADFRHALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQ
>A0A0R5RQ02|FEATURES|UNIPROT_deepARG|beta_lactam|ROB-1|antibiotic inactivation|1
MLNKLKIGTLLLLTLTACLPNFVHSVTSNPQPASAPVQQSATQATFQQTSANLEQQYQAR
IGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYS
PETQKYVGKGMTIAQLCEAAVRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHTNRLE
PDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATP
TSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFH
TLQLN
>R7BQ22|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIDLLIEALKAALIGVVEGITEWLPISSTGHMILVDEFVQLQVSPEFLALFLVVIQIGS
IMAVIVSFRHKLNPFSRTKTHDEQRGTWRLWGMVVIGVIPAAVFGLLLDDWASSHLFNAY
TVSAMLILYGVIFIILEQRNRRRERKYLETLEPPRGKHAAPLSEEDQKAGMFKINDVSEI
DWKMAIKIGFFQVLAIVPGTSRSGATIIGGMLCGCSRTAAAEFTFFLAIPVMFGWGMVKI
VKFILGGLVMTQTEIVVLVVGIVCAFVMGVIAIKFLMGYIKKNDFTAFGVYRIIIGLVVL
VYFGVKAFL
>H3RK89|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDDKKIEKVSVVIPVYNEQESLPALIQRTDDACKSLNLDYEILLVDDGSQDASATMIAD
AASLPGSHIVAVLLNRNYGQHSAIMAGFSNVSGDLIITLDADLQNPPEEIPRLVAAAQEG
YDVVGTVRQNRQDSWFRRQASRTINQMIQRVTGKSMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRTIELPVTHAEREHGSSKYSFMRLINLMYDLVTCLTTTPLRMLSVLG
SLIAIAGFAFSVILILLRLFLGAAWAGDGVFMLFAVLFIFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVIFPQKDRSVQETE
>A0A0P9XQI1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGDRAAAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKEQQAQRFTINLLIAFMPAVILGVIFADLIHHYLFNPITVATALV
IGGVIMLWAERREHVVHAETVDDMKWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDVAVFAIGFITSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWAAAKA
>B2CD53|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
PEGRFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRE
LCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTT
MPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVQDHYALVP
>E2D103|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEVFIRFVKGEIIKSVGK
>YP_403947|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLHREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIDKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNIRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMLGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTSANDIPMDVGAGASYVLYHLFFRYPCKVLPAVGGALGITLSLLIAFTL
QLFLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDVLARE
>A8T2U3|FEATURES|UNIPROT_deepARG|beta_lactam|AND4_10224|antibiotic inactivation|1
MKKRLLLLVLLTCSGATYAAKLNEAISAIEEHISGRIGVSVWDTQTDERWDYRGDERFPM
MSTFKTLACATMLSNMDNETLDKNATAKVEKHNMVVWSPVMDRMAGQTIRIEHACEAAML
MSDNTAANIVLRSIDGPQGVTKFLRSIGDKITRLDRFEPTLNEANPGDKQDTTTPNAMVN
TLNTLLESDALSYESRIQLKIWMQDNKVSDSLIRSVLPKGWSIADRSGAGGFGSRGITAM
VWKENHRPIYISIYITETDLSLQARDQVIAQISQLILDGYTSI
>M6C6Z7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDNTLNAFLRGIIEAATEFLPVSSTGHLFLFSYFFPFENLNIDHEAFEDLFDIFIQTGAI
LSVVVLYFKVLWIHTKTAVQFVTKTSDDKSGFQFYRNLIVGILPIIVLGFVFKNILDQIK
MRPDLLLILGLSWFVGGLVMVFVELKHYDESDGRVIGIKESVFIGLFQCFALIPGVSRSA
ATIITARTLGVSKKDSAEFSFFLAIPVLTLAGLYKLYKHRAILNSETIGLLLFGSIVSFV
ICYFIIRLFMAFIRRRSFLSFGIYRILLGILVILYFVRG
>G7TKL4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
RLWTLATGLGERDNRDYVLKVSVAFLVTAVVGLIVRKAGWQLPETLQPVAWALLIGGVWM
LVAEHVAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSRRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGTENWADVAVAFVAATITGFVVVKWLLSYIKKH
RFTVFAVYRIVLGAALLLWMPAAAG
>A0A108E577|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNAIRIAATLFVAACAAATAGRAAAATQEEIHDTVTRHVAPLMKRFAIPGMAIGVVAD
GKPYVFDYGVMSTQTRAPVTADTLFEIGSVSKTLTATLAADAQEGGELSLTDRAGKYLPA
LQGKPFGAVTLLNLGTHTPGGMPLQVPDSIRDDADLMRYLHAWRPAYAPGTRRTYSNVAI
GMLGILTAKAMHEDFTVLMEQRLFPALGMTHTYIDVPAARQADYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLVETSPQLQRALERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLAGNAPPMLYDATPATQLEPPLAPRPDTWINKTGSTNGFSTYVAFVPAKRIA
IVMLANRSFPIEDRVKTAYRIVESLHGKL
>A0A0Q4YB54|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAMSIVKAVVLAVVEGATEFIPVSSTGHQLLVGHFIGFQSPNNTFEVLIQLGAILAILA
VYFRRLLGIAVAFPSDPNARRFVLGILLAFLPAAIIGGLFSKYIKFYLFNPWIVCATLVA
GGLVLLVLDETDLEVKKRDVFDFTLPMDFRIGLFQCIAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAIPTMAGAFAKDLLDNYKNLSQDDAGLIVIGFVVAFLSAFVVVRTVLDYV
SSHGFRLFAWWRIIVGSLGFAGLILFG
>A0A0A2YM25|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSELLIAFILGCVEGLTEFLPVSSTGHMIIAAHFLGFEGQKAATFEVIIQLGSILAVIFV
YWRKMFGLIGIHFGEKVDQNKAHLNLIHIILGMIPAVVLGLLFHSTIKSWFNIHNVIGAL
VAGGILLILAEKFRPQPAYAEELDQITYRQAFAIGLFQCLALFPGFSRSGATISGGLLMG
VGKKAAAEYSFILAVPMMIGATALDLYKSLPFLSWDDLPLFAVGFVTAFIVAMIAIRTFL
HLIGKISFVSFAIYRFILAILLAWIVLA
>C3XCX7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLFLLKALIMGIVEGVTEFLPISSTGHLILAGSLLDFTGEKIKVFEIAIQSGAMLSVC
WVYHEKIISVTKGFFTNARDRRFVTNLIIAFLPAAILGVSFNKIIKSCLFAPVPVAAAFI
IGGLIIIVVERKNERNPVSKIESVDEMSMMDAFKVGCAQAFALIPGTSRSGATIIGGMIC
GLSRKVATEFSFFLAIPTLFGATVYSVYKERALLSAADLPWFSVGAIAAFISAFICVRWL
LRYISSHNFIPFAWYRIAFGLFILVSAYYGWVNWVD
>R6QD19|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLEILKAILMGVVEGITEWLPISSTGHMILVEQIIKFNASEEFLSMFRVVIQLGAILAV
VVLFWHKLWPFGLQHGRVVSKPQVWQLWFKVVAATLPVLVISPLDDWMEARFYNYITVAA
MLILYGVLFILVENRRTTPHVTRLEQITYREAFLVGVWQMLAIIPGTSRSGATIVGGLLL
GLSRACVAEFTFFLAIPVMAGASLLKVVKFVLSGAAMTGTEVAVLVVGCVVAFVVSLAAI
RFLMDYVKRHNFKFFGLYRIVLGAIVLAVAAITAIA
>NP_348076|FEATURES|ARDB_deepARG|tetracycline|tetPB|antibiotic target protection|1
MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGSVDSGNTQTDSMELERKRGITIKSS
TISFNWNDVKINIIDTPGHVDFISEVERSLSVLDGAIIVISGVEGIQSQTRILFNTLKEL
NIPTIIFVNKLDRIGADFNKVFEEIKKNISNRVVRLQEAYDMGSKDVYIRNLSDICPINN
DAVDVISDLDEVFLERYISGVEPNKEEVQEKLSLYAREGSLYPVFCGAAAIGLGIGDLLD
GICSYLPFAGDECEGNLSGVVFKIERTSTNEKKVYVRLFGGRVSVRDRIQVPSKEIVEKV
KKINSLENGRIIETQSIEAGDIGILYGLTDFQVGDVIGVSNNKIKNISIAKPTLKTTISA
IDKEENQELFKALTLLAEEDPLLELEMNDIDEEIYVNLFGEVQMEILSSILDGLYGIKVE
FSNIQTIYKEKPKGVGMSIMRMQEDLNPFWATVALKIEPKGRGEGLRYISNVSVGSLPKS
FQNAIEEAVVKTSKQGLFGWEVTDAKVTLTCGEFFSPASTPSDFRNVTPMVFMEALYRAQ
TVLLEPLYEFELRIPQDVLSKAIWDLETMRAIFDSPIVIGDEFSIRGLIPVENSKEYKMK
IASYTKGKGMFTTKFYGYKEVSAKFAKARPKTTYDPLNKKEYLLYKLNAIRD
>R6ET56|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIIKAIIYGIVEGITEWLPISSTGHLILVERLIPFQQTSEGFFDMFDVVIQLGAILAV
VVLFWNKIWPFYLKKNKQPKKGGIVKSAKDPAVGNVALSMDAFWMWVKIVVACIPAVVYG
LLFDDAVGEAFQKEIGSSGVTIQVIVVAVMLVVVGVLFIVIENWNKDRVPTTTKLSQLTY
RDALIIGLCQLVAAALPGTSRSGATILGAIMIGISRTVAAEFTFFLAIPVMFGASLLKVL
KFGFAFTGMELACLLVGTVVSFIVSLFVLRFLMGYIKKHDFKVFGWYRIVLGIIVLLYFL
VFA
>A0A059UYQ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAIAFNIIIQLAAILAVV
WEFRGKILDVVFGLTSQPTARRFTGNLLLAFLPAVVLGVLFADLIHHYLFNPITVAAALV
VGGVIMLWAERRTHRVAVDHVDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYATFAWYRIAFGLLILATWQFGWIDWSTAQG
>C7LUH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTSYLNAIILGIVEGLTEFLPVSSTGHLIIAGHLLDFTGPKAETFSIVIQLGAILAVVAL
YWPTFWGLVRPTKRPFSGMRGLILLFLTSLPAAMLGLFAHSAIKEHLFSPVTVAFALAAG
ALAILMVERMPAKNRVTSLDEITPALALGIGCFQCLSLWPGFSRSAATIMGGMILGAGRR
TAAEYSFVAAVPIMFAATGYDMLKSWRLFSPDDFLILGVGFAVSFVSAWLAVKGFIALLG
RLTLRPFAWYRLALAPVVLWIFW
>A0A0P9HUW1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLWDAFVALILGLVEGMTEFVPVSSTGHMIIVDDFLFQTKRMFSPEAAVAFKIVIQLGSI
LAVVVLMWDRFMDLLGLRKSQGQTASGPRLNLWQVLVGLLPAGILYLLLDDYIDTYLFST
ETVVIGLVAGAVLMLAAEWLRPRKLKTETVDQMTYKQAVAVGLFQCLSMWPGFSRSGSTI
SGGVLMGMSHRAAADFTFIMAVPVMAGVSFFSLLKHWEYFTPDVISFCAVGMISAFVFAL
LSIRFFLKLIQRIKLVPFAIYRLALAALIYFVFL
>C6G241|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREVVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQANLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0G9KYK7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFDSILLGIIEGFTEFLPISSTGHLIVLSEILGLEQNNVNKAFEIIIQFAAIMALVFV
YPSKFTFSHIELWKKIVVAFLPIGIVGFLFSSQIKNLFSIEIIAWMFIIGGVVFLIIEKF
YDENKTHTLDVENVSYKQAIFIGVMQIFALIPGTSRAGASIIGAMMAGLNRKTSAEFSFL
LAVPVMCATTGYDLVKHHEELLLVGANLLNLAIGFVVSFIVALIVIKLFLKFLERFTFVA
FGIYRIIFGILILLIF
>W0FF77|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-15|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGHTHGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>V5UDN7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MAFSARSFAAEPDDATTRTNPRQEEIRSLVDKTIRPLMARQDIPGMAVGILFDGHTYVFE
YGVADKAANKPVTADTLFEIGSVSKTFTATLAAYAQADGALSLTDKASRFAPEFAGTPFG
DVKLVNLGTHTSGGMPLQLPDNVRTTDQIADYLKAWKPAKPTGTVRTYSNVSIGALGWLT
ARAMQGDFATLMAEHVFKPLDLRHTFIRVPEAEQANYAWGYKDGKPVRVTPALLEPEAYG
VKTTAADLLRFVNANLGQPVPDRKLRHAIYATRTGYYFDAPMTQDLVWEQYPYPVTLDAL
LEGNSSHMALNPTPVRELSPPMAPTPVAWVNKTGSTNGFGAYVAFVPSKQMGIVLLANRN
YAMDERIRAAHHILTTLDGARP
>M1M5L7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFSNFYYFVQTCFLGIIEGITEFIPVSSTAHLIFLGKIIGFDSEESRVFEVFIQAGAMFS
LLVFFREKIKDLVLGLIRLDSKQLLFFRNLLVSIIPTVLIGFCFISRIKDIFNYEIIISI
SLIIGGFIILIVENNYYSNNHRESSIYKISLKQALFIGLLQCLAMIPGVSRSGATIVAGI
VIGLDRRNATEFSFMMAIPTIIGAAMYDIYSNMGLLSSKLCIGMSIGFIASFISAMCVVH
IVIEFVANHSYKIFGWYRIIIGLLMLLMIMQ
>A0A0R2N5C6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFVKLNEPTAFINMFMVVIQFGAILAV
ILIYFHKLNPFSPRKNHVEKSQTWSIWFKVIVAILPSVIIGLPLNDWMDKHLTSWQVISA
TLLIYGILFIVVENWLKNKRPKTADLESLSYKTAFQIGLFQVLSLVPGTSRSGATILGGM
TVGTSRFVATEFSFFLAIPTMFGASLLKIFKYFKHGNTFTGDQTIILLVGTLVSFIVAYA
SIKFLLDYIKRNDFKAFGWYRIILAIIVIAYFGSKAIMG
>A0A127SCW7|FEATURES|UNIPROT_deepARG|beta_lactam|TLA-3|antibiotic inactivation|1
MKKHLVVIVFCALFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAILGIEDNFKLNVNE
KHHYPMQSTYKFHLALAALDKLVKENISVDKKLFVKKSDLLPDTWSPLRDKYPNGNLELS
FSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYT
NWTTPDATVQLLKKFYKNEILSKNSYDFLLNTMIETTTGPKRLKGLLPDGTVVAHKTGSS
DTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYLIKGG
K
>A0A0A8HI92|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIEYYYALILGIIEGLTEFLPVSSTGHMILGAELLRLQINDFWRSFFIIIQLGSILAVI
FIFKDRLVQKIDIWLKLFVGFLPAGGVGFIMYKFLKELFNGYTVATMLIIGGIIFIIIEL
KHRKKDYAIHSLDEVSYKQAFLIGLTQALAIIPGTSRSGASIIGGLLLGLDRKIASEFSF
LLAIPTMIAATSYSIYKEPEILSNMNNFIPLSIGFITAFITAFIVIKIFLKLISKINFIP
FGTYRIILGLIFLWLFANGILDTSKTSI
>S9SMD8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYLIEILKSIFFGIVEGITEWLPISSTGHLILVEEFVQHKDQNEAFMSMFNVVIQLGAIL
AVMVIYFNKLNPFKPGKNKAEVRRTWQLWSKVLVATLPLLLVFKLDDWFDTHFHNMVSVA
IMLIIYGVAFIYLEKRNKAQAIEPTVTELEKLPYKTALYIGLFQVLALFPGTSRSGATIV
GGLLNGTSRSVVTEFTFYLGIPVMFGASALKIFKFIKAGQLLSFGQLFLLLVAMGVAFAV
SMVAIRFLTGYVKKHDFTLFGKYRIVLGSVLLLYSFVRLFV
>A0A0G1KJT7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSFIHVVILGLVEGITEFLPISSTAHLIITSRLLNIPQTEFQKFFEVFIQSGAILAVVFL
YIQYIIKNPKVIKNIIISFIPTAVVGFLLHKVIKNYFFDSLRLIEVTMFSVGVLFIVFEL
LVKNKKINLKKSINQLSVRHAIAVGIVQSLAVVPGVSRAGAVMLGMMGMGYKREESATYS
FLLAMPTIFAASAFDLYQSKQLLFSNLSNIWFLVFGFLISFVFAYISIKWLINYLKKNTL
SGFGIYRVLISLVLLFIK
>A0A0A0WN21|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENAIMFYERVLEGELLVKGRKLAYFNICGVWIALNEEAHIPRKEI
HQSYTHLAFSVEQEDFERLLQRLEENKVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>A0A0D0ETN3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLMFLKTIILGMVEGLTEFAPVSSTGHMIIVDDLWLQSKEFLGGQYVANTFKVVIQLG
SILAVVVVMKDRFLDLLGLKKRSFKIGQKSTGHLRLTHIIVGILPAGILGVLFEDIIDEV
LFGYQYVVYALIAGAILMIFADKFRAKRPAAETVDQITYKQALLIGLFQCLSLWPGFSRS
GATISGGVLMGLSHRAAADFTFIMAVPIMAGASLISLVKNWQYFSIDALPFFIAGFISAF
IFALISIRFFLKLINRIKLVPFAIYRIILAVLLLLLVK
>A0A073J4Q4|FEATURES|UNIPROT_deepARG|beta_lactam|SUH3_15695|antibiotic inactivation|1
MQTRNSTLSRTVAGIVLGVSMAAASFAQTPVGELEQTVDRIEARLGGRIGIALVDTGSDF
TWANRPDEQFLMNSTVKVPLCGAVLARVDAGTLSLTDELPVTEGDIVTYAPVTEQHVGQS
MNMAALCLAAIDMSDNTAANLLIEHLGGPQAITQFFRSTGDIESRLDRFEPELNTFTPGD
PRDTTTPVASADTVRNLLLGDVLSENSRKQLADWMRHGGVTGKLLRAGAPADWQIYDKSG
SGSHTRNLVAMVIPDGRAPWIVSIFISDIDADFETRNAALQDISRAIRAVIGQ
>A0A0E3MLH3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACEQLAYEYEIILVDDGSRDDSAQLLGDA
AAAEGSHVVAVILNRNYGQHAAIMAGFEQCRGDVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGVLFAFALIIMRLAFGADWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGLVSSHTSTSPSDQVQS
>A0A127T607|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTPM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A0D6SXL4|FEATURES|UNIPROT_deepARG|beta_lactam|SZ39_2035|antibiotic inactivation|1
MLVSKKFFHIAHYKKMLPVVLLSCXXLIGCSNSNIQXEPPKQTKQENTGNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNKS
>ZP_04679156|FEATURES|ARDB_deepARG|multidrug|MepA|antibiotic efflux|0
MKDEQLYFFEKAPIFKAMMHFSLPMMIGTLLSVIYGILNVYFIGFLDDSHMISAISLTLP
IFAALMGFGNLFGVGGGTYISRLLGAKDYSKSKYVSSFSIYGGLLFGIIIALITIPFTDQ
IAQILGAHGETIHFTSEYLRIMFLSAPFVILFFILEQFARAVGAPFVSMAGMLASVVLNM
ILDPILIFGFDLNVVGAALGTAISNLAAAIFFIIYFVKKIDSLSLNIKFAKPKKDMMAEI
FKIGIPAFLMVVLMGVTGLVLNLFLAHYGNYAIASYGIQFRLVQFPELIIMGLSEGVVPL
IAYNFVANQSRMKDTIKAVIISIFAIFAVSMVIVFIFGHQIIQLFSTDPHIVNLATFMLQ
VTMTSLLLNGIGFLFTGMLQATGQGRGATIMAILQGTIIIPVLFVMNSLFGLTGVVWSLL
IAETLCALAAMLIVYLLRNKLTVDKEALLEE
>A0A060KT62|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRKFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
HDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAAIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0F0XVH7|FEATURES|UNIPROT_deepARG|chloramphenicol|SS33_18555|antibiotic inactivation|1
MEKIIPEYTAVDLSRWARKEHFEVFQGFAQSTFNQTVLVDITVLLSHIKNVGWKFYPTII
FLVAKVVNRHPEFRMAMKDNELVIWNEIHPNYTVFHNETETFSSLWSHYDGDIQHFQKTY
SEDMARYGDKLAYWPKEESRENIFFISGIPWVSFTSFSVSVANMKNFFAPMFTLGKYYEQ
EGRVLLPLAVQVHHSVCDGFHVARFFNELQEVCDALPQQTGQQE
>A0A060KZ21|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPSLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>K0CZS9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIQLDGVSRRYKTEGFEVTALDKVSLSIDKGEFVAIMGQSGSGKSTLMNILGCLDTPS
EGEYRIHGQSVSSLNPDQLSALRLKTFGFVFQRYQLLSSLNATENVALPAIYSGTPGEER
TQKAQQLLDKLGLASRKEHKPGELSGGQQQRVSVARALINGAEVILADEPTGALDSASGE
QLLALLRELHAEGVTIILITHDSAVAEHADRQIHLLDGKIVTDTKSAPRSQGESVEKNAA
SEQHAHAQERKSEPAIKPFPSISLFSALSMAFTALRMNWFRTLLTLLGIIIGVAAVVTMM
AIGEGGKQQVLERIETIGTNLISIRPGGRNMRSSGDIASLTLADATALKSVPGVAYVAPE
RSARATIRYSENDFSGRITGTTPDYFHAKDWEMAQGVFFSDEDVTTYAPVVVIGDTVAET
LFEDKYRAVGEYILMQNAFYQVVGVLNSKGASAGGNDMDDEVLIPVTTGRLKVFGRDYLS
SITIKAESTEVATQVKDDVLALLVERHGQEDVMVRTTESLVEAVTETQDTLTWLLASVAA
ISLFVGGIGVMNIMLVNVSERKREIGLRIATGAKPRDILRQFNIEAWVVCILGGIFGILL
GYFVVLIVASFSVPVAYTLMPPVLAFVTSLAVGLIFGYAPAQKASKLNPIDALAEE
>A0A089V4T7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADLHSLLVAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFEGDTAKTFEVIIQLGSILAV
VVVFWRRMFGLIGIHFGQPPQHEGRGKGHLTLAHIVLAMIPAVVLGLVLHDFIKSLFNPV
TVTYALVVGGVLLLLAEWFKPKKAKAEGLDDISYLQAFLIGCFQCLALWPGFSRSGATIS
GGMLVGVNRYAASEFSFILAVPIMLGASGLDLYKSWHFLSLSDLPMFATGFLTAFVVAMI
AIKTFLQLIKRISFVPFAIYRFIVAAVVWLVLM
>ZP_04276394|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVDNMKKNTLLKVGLCVSLLGTTQFVSTISSVQASQKVEQTVIKNETGTISISQLNK
NVWVHTELGYFNGEAVPSNGLVLNTAKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVV
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKNSGYEEPLGDLQTITSLKFGNTKVETF
YPGKGHTEDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNI
NSVVPGHGEVGDKGLLLHTLDLLK
>J8KRY8|FEATURES|UNIPROT_deepARG|beta_lactam|IK9_05831|antibiotic inactivation|1
MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESTKQTNQTNQVKQENIGNHAFA
KLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITY
TREDLSNYNPITEMHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRKMGD
TVTNSERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
NKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLSILSNHDKEDAEYDDTLI
ADATKIVLETLKVTNK
>A0A157T8S3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC_1|antibiotic inactivation|1
MEKYFMMKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYH
GKPYYFTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQ
LTGQQWQGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASI
GLFGALAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQ
LDAEAYGVKSSIEDMAHWVLANMNSEAVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLN
WPVPAEVVINGSDNKVALAATPVTAVNPPAPSVKASWVHKTGSTGGFGSYVAFIPQQDLG
IVMLANKSYPNPERVKAAYHILEALQ
>Q8VTS8|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFGFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>A0A0G3KF61|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MQQCLACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQ
GDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA
>J8KRD3|FEATURES|UNIPROT_deepARG|beta_lactam|IKO_01971|antibiotic inactivation|1
MLVSKKFFHIAHYKKMLPVVLLSCATLIGCSNSNIQSEPPKQTKQENTGNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASLRFSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIADATKI
VLDNLKVTNK
>A0A0E3K2Y8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLVLILKAVVIGIVEGLTEFLPVSSTGHMIIIGNLINFKAPAYPKAYVDMFEVVIQLGA
ILAVVVLYWDKIKETLLNFLPSERVSAKESGLRFWIIILIACIPAIIIGFPLKDKIEDKL
FYPIPVAVALVLGAVWMIYAENKYRNNNRHITISNINARQALIIGAFQCLALWPGMSRSA
STIIGAWIAGLSTVVGAEFSFFLAIPMMVGASGLSLIKHNVFSTCNLEQIIALIVGFIVS
FLVALVVIDKFIKFLKKRPMRVFAVYRIFIGLIILGLALTHKL
>C4K3Z9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|HDEF_0539|antibiotic efflux|1
MRGNSHVRFLREWALAACLPNQSVRRSYQSGEESLDVLKNISLKIYSGELVAIIGASGWG
KSTLMNILGYLDQATSGTYYIAGQNVVDLNNDDLAILRREYFGFIFQRYHLLPHLSAAHN
VEIPAIYAGSPKNERKKRAVTLLTRLGLGERINYRPNQLYQLSGGQQQRVSIARALMNGG
QIILADEPTGALDSHSSVEVMNILKQLQQKGHTVIVVTHNPEVANQADRTIEIKDGEIIS
DSGYQPTQELKKAPEPSSPSVEQASCQQWVGRLHEALLMAWRAMLSNKMRTALTMLGIII
GIASVVSILVVGDAAQQKVLANIRAIGTNTISIYPGRDYGDDDPSNRQALIYEDIAALQA
QSYISAISPIISGNIRLRSGNIDVASTILGVGGQYFKAYGIKIQNGERILERQVRDQSQV
VVIDKNTQRRLFPRTKDVIGKEILVGNIPMTVVGIAKEKQSMYGNNNALRIWIPYSTMTN
LFTGRSYFDAITVRIKEGYNNNEAEQQLIRLLTLRHGKKDIYTFNVNTVLKTAEKTTRTM
QLFLSLVAAISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARSSDVLQQFLIEAVLVCL
VGGTIGILLSFCIGFAVEFFLPTWSLTFSSIALFIAFFCSTMIGIVFGYLPARHASRLNP
IDALAPE
>A0A0A1FAN2|FEATURES|UNIPROT_deepARG|beta_lactam|LT85_1566|antibiotic inactivation|1
MRQKNMNIIKLLSVSMCFLAASSYAADKVDPSSVRGIVDAAIQPLIEKNNVPGIAVAVTV
DGKNYFYNYGVASKETQHPITSETLFEIGSLSKTFTATLATYAQLNGNLSLSDSPAKYFP
YLRDSKFGKVSLINLGTHTPGGFPVQVPDEIGNTDQLLDYLKLWKPAYAAGTQRSYSNVS
IGMLGMITAKSMHVSFDDAIEKKLFPELGMKHSYINVPTDRLKDYAQGYTKKDAPIRMNK
GILGSEAYGIKSSTIDMIRFIDANMQTIKLDQKLQKAITDTHTGYYKSGEITQDLIWEQY
AYPVELNDCWQVMPTRWLPRVIRQPD
>A0A127SN46|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSPLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>A0A0P9J0I5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVDIEALHETSINSDQPLLRLQQVSRSFMAGDREFQVLKHIDLAIHTGELVAIIGAS
GSGKSTLMNILGCLDHASAGSYQVNGQETRELDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNVEIPAIYAGTAQTTRHERAQALLTRLGLGGHLQHRPSQMSGGQQQRVSIARALMNGG
QVILADEPTGALDTASGKEVMRTLLELHAAGHTVILVTHDPKVAANAERIIEVSDGEIIS
DRRTAQTTQPAPEAQPATPPGPAPRRLLASLGLFREAFNMAWIALISHRMRTLLTMLGII
IGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGANFGDSRAKSIETLLPSDVAALN
QLYYIDSATPVVGRSMLVRYRNVDVDAQLNGVSSRYFQVRNIQLAAGITFSDQDARRQAQ
VVVLDHNTAQRLFGPGVNPLGQVILVGKLPSTVIGVTSDHKNLFIAGNTLNLWMPYETAA
GRVLGQRHLDSISVRVKDGMPSKAVEEQIKALMLQRHGTKDFFTNNLDSVMQTVQKTSRS
LTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVC
LMGGVIGIGLSYAIGYLFTLFVQQWEMVFSLASVVTAFACSTLIGVLFGFVPARNAARLD
PIEALARD
>A0A086YC10|FEATURES|UNIPROT_deepARG|aminoglycoside|CN97_05115|antibiotic inactivation|1
MNLNFILLDGLHSNWLPARGGESGNTVFRRADEQAYAKIAPTALRKELAEERDRLIWLCS
RGVACPEVISWREEQEGACLVMTAIPGVPAADLSGSDLLEAWPSMVDQLNAVHSLSAEEC
PFERRLSEMFARAVDVVSRNAVNPDFLPDEDKLTPQPELLARIERELAVRLEQESRELTV
CHGDPCMPNFMVSTKSLQCTGLIDVGRLGKADLYADLTLMISNAEEIWASSDEAKCAFDI
LFARLGIDAPDRERLAFYLRLDPLTWG
>G9XC70|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKVVILSLVEGITEFIPVSSTGHLILVNEFIKLKPESFANMFSIIIQLGAILSVIL
IYFNKLNPFSHKKSASKKRETIEIWKRVIIGVLPAAVLGLKFDDFIDEKLMNPYVVMTTL
FVWGIVIIFIEARHKKAKIKSISDMSYKTALLIGLAQCIALVPGTSRSAATIIGAMLLGC
SRTVSAEFSFFLAIPTMFGATSLKIVKVILRGTPMSMWQVFLILLGTVLSFIFALIVIRK
FMKYVKEHNFIAFGLYRVVLSVVMAIYFLIIAK
>A0A0K2B8A3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MYRQAINTLRIAAALSLLAGCSSYASPSADRPEIQGMVDAAVRPLMEKYVIPGMAVAVSV
DGKNYFYNYGVASKSDGQPVSNTTLFEIGSLSKTLTATLASYAQVNGQLSLSDSVSRHLP
YLKGGSFDNISLMNLGTHTAGDFPLQLPDEVSNEQQLMDYYKNWKPTHAAGTFRNYSNPG
IGLLGVVTAKSMGVPFADAMEKTLFPQLGMTHSYVRVPAGQMKNYAQGYNKAGAPVRVNP
GMLADEAYGVKTNTHDLIRFIDANMGLVKLDPKLQQAVTDTHTGYFKAGEITQDLIWEQY
PDTAPLSRLLAGNANQMVYQGVTAVKLAPPLPPQADVLLNKTGSTGGFGAYALYAPARKI
GIVILANRNYPNDERVTAAYRILTGLGARDAARR
>A0A0Q7TCK4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIIEGLTEFLPVSSTGHMILTAHLLGLSEDNESVKTFEVVVQLGAVLAVVVLYWNKFID
MFRFTGGKRSYSRRLNLGHIFLAMVPAVVIGLVFRDWIKAHLFGPETVLYSLVIGGVLMI
VAERWSHRSERITTHDVDDISYKQAFVVGLFQILALWPGFSRSGSTISGGLFAGISRVAA
AEFTFLVSVPIMIGATGYDLYKSIDHLNGSDFPIFAIGFIAAFIVAMLAIKTFLSILKRL
SLTVFAVYRFVLAAVFFIILM
>I2WPI6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
DVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLTSFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>L7H842|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPRFIPSVTALALFIGASHCLAAADLRAVVDASVKPLMQQQAIPGLVVGVLQDGKAQYFS
YGVADKQSGQSVSENTLFEVGSVSKTFTATLAGYAVATGKLTLDQPASHYLPALKGGRFD
HISVLNLGTYTAGGLPLQFPQEADASQRMIGYFQQWQPAFAPGTQRLYSNPSLGLFGYLA
AQSLGQPFDQLMEKTLLPRLGLKHTFLKIPLNKMSLYAQGYDSKGKPVRVGAGAMDSEAY
GIKTSAADLLHYVDVNMNPAGQAKLVQQAIALTHTGYYTVNGMTQGLGWEMYPYPIALDA
LIDGNSTQMAVEPHKVEWLTPARAPHADTLVNKTGSTNGFGAYVAYVPSKRLGVVILANR
NYPNSERVKVAHGILKALAP
>G8GMB3|FEATURES|UNIPROT_deepARG|beta_lactam|IMP|antibiotic inactivation|1
TAAESLPDLKIERLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNTEAYLIDTPFTAKDTEK
LVTWFVGRGYKIKGSISSHFHSDNTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSF
GGVSYWLVKNKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKPYGLGNLGDANLEAWPK
SAKLLMSKYGKAKL
>CAS11536|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRHRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGVSQ
LFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMARTL
PRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFSMA
RWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVLGL
SSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMNVW
TLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLPQT
GQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>A0A0U1YUG7|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATGQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A0K2FGP8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIIEGLTEFLPVSSTGHMILTADLLGLNTENDTVKTFEVIVQLGAVLAVVVLYWRRFLS
LFDFRRKISSQPRLNLLHIILAMIPAGLIGVLFRDVIKQYLFGPETVLYSLVIGGLLMIA
AEKFHPPIRSHTLDEITYKQAFTIGLFQVLALWPGFSRSGSTMSGGLFARVSHTAAAEFT
FLVSVPVMLGASGIDMIKSMDHLSMSDFPVFAAGFITAFIVGMLAIKTFLGLLKRLSLTT
FAIYRFVLAAVFFFIIL
>YP_302113|FEATURES|ARDB_deepARG|multidrug|Bmr|antibiotic efflux|1
MNKQFIILYFNIFLVFLGIGLVVPVLPVYLKDLGLKGSDLGILVAVFALAQMIISPFGGT
LADKLGKKLIICIGLGLFAISEFLFAASHTFSLLIVSRILGGFSAGMVMPGVTGMIADIS
VGRDKAKNFGYMSAIINSGFILGPGMGGFLAEFSHRLPFYVAGFSGCVALILSIALIKNP
KNSTQDGFTQYQPELLSKINWKVFLTPIILTLVLAFGLSAFETLFPLYTADKAHYSPLDI
SFAITGGGIAGAIFQVFFFDKFMKHFKELTFITYALLYSAIILLALTFVHSYWSIMIISF
IVFIGFDMIRPAITNYFSNIAGNRQGFAGGLNSTFTSMGNFIGPLVAGTLYDINFEFPLY
MSVLVMVLGMFVIFIEKMIRSRFSNI
>A0A0M2SJ28|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTFLDLLKALILGMVEGLTEFAPVSSTGHMIIVDDMWLQSQQFLGKYAANTFKVVIQLGS
ILAVVIIFKERFIEMLGMKKMTEAEKENRLKLTQVLVGLIPAGVLGVLFEDYIDEHLFSL
STVLIGLVVGAVFMILADIFGKKQPSIQTVDQITYKKAFAVGLIQCLSLWPGFSRSGSTI
SGGVLLGMSHKAAADFTFIMAVPIMAGASFLSLVKNWQYFTMDALPFFIAGFIAAFVFAL
VSIRFFLKLINRIKLIPFAIYRILLAGAIYILYF
>A0A0D5M8Y1|FEATURES|UNIPROT_deepARG|beta_lactam|KO116_04145|antibiotic inactivation|1
MGKMLAANSGLIMTGSLVIGSFAWASDATENADIEALVNDTIAPLMAEHRIPGMTVAVSI
GGQQHYFNYGEADQEAGTPVTDETLFELGSISKIFTAALTGYAQSSGALSLSDPASQYLP
ALEGSAFDEITLLELGTYTAGELPLQFPDAVQNEEQMLDYYRQWQPESPPGSHRLYSNPS
IGLMGYLTAQRLGKPFEMLMEKALFAPLGLEHSYFQVPEAQQAHYAYGYSKEDKPIRVNP
GMLDAQAYGLKSTAADVLTFVEAHMGLAELDESLSQALAATRTGYFGVGNMTQGLGWESY
AYPVALDQLLAGNSLEMILQPTPANRLAPPLAPRQEALYNKTGSTNGFGGYVAFVPSEQI
GIVMLANRNYPNQARIEAAHHLLTALTDAP
>W0SJB3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFHPLLQALLLGLVEGFTEFLPVSSTGHLILAGDLLHFNDEKGKLFEIVIQSGAILAVC
WEYRERIVKVFGTLGHDADSQRLVRNIAVAFMPLAILGLLFGKAIKATLFNPVAVATAFI
VGAFIILWAERREHVIRVERVEDLNLMDAVKLGLAQACALIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAIPTLLAATAYQLYKERHLLSMDDLGMWVVGFVASFVSAFLCVRWLLRF
ISSHDFTIFAWYRIAFGIVVLASWQMGIVNWSAA
>A0A0H5BJW6|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MNFNIIKLENWDRKEYFEHYFNQQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEV
VNKNKVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLL
EYKDKEEMFPKKPIPENAIPISMIPWIDFSSFNLNIGNNGSFLLPIITIGKFYSENNKIY
IPVALQLHHAVCDGYHASLFMNEFQDIIHRVDDWI
>U2KVN8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIQTLIISIVEGLTEFLPVSSTGHMIITQNLLGVPQGDPFVHAFTFIIQFGAILSVVC
LYWKHFFQMRTMEEFLSKMKFYGLLIVGVIPAVVIGLLAKKSGLLDKLLDSVEVVAVTLV
IGGVFMLFCDRIFNQGKEENKVDWKRAFKIGCFQCLSVIPGMSRSMSTIVGGMQQKLTRK
RAAEFSFFLAVPTMAGATLLDLLDMFKEGTTWATPDNIKMLILGCVVAFVMAIFAMKWFV
SFLTKYGFKAFGWYRIIVGTVILILLFTGHSLVMVD
>A0A128EJ98|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_3|antibiotic efflux|1
MIKLESINKKFRLGENIIHVLKDINLEIKKGEFIAIIGQSGSGKSTLMNIIGCLDTPTSG
IYKIDDKDVSRLGSDELANLRSKKFGFVFQRYNLIASMSAASNVSLPAVYAGVDAEVRHD
KAIELLDGLELKDKSENLPNKLSGGQQQRVSIARALINGGEIILADEPTGALDSKSGLMV
MDILSKLYEKGHTVIIVTHDINVANYANRIIEIKDGEILSDNVKSDKTYKLEKVDIKKKN
PILAYKDQLVESFKMSVSAIFSHKLRSLLTMLGIIIGIASVICVVALGQGSQEKILSSIR
AIGTNTINIYPGKNFGDMRSGAIKTLTVADSQVLASQPYLDYSTPNVSTSGTLTYANLSS
RGNLQGGGVNSLAVNGIKIASGRSFTDNDIKESSSVVIIDENTKNTFFQDTQPLGKVILF
NSKPLSIIGVTLKDDNAFGSSDTLRIYAPYTTVMNKISGSRDINSITVKIKDNINAQMAE
ASLSEILIQRHGTKDFFTRNSDTIKQTVESTTGTMRILISSIAFISLIVGGIGVMNIMLV
SVTERTKEIGVRMAIGAKESNILQQFLIEAILLCVIGGVIGVSVAYGLGVVFNIISTDFA
MIFSPTPAIIALVASSAIGIIFGYLPARNASKLNPIDALSQE
>A0A0L0LKC0|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTALDAIILGLLEGAAEFLPISSTGHLILASDLLAIPDSAFLTSFIIAIQFGAIAAVLIT
YWKSFLNIEVLKRLFVAFLPTAVIGFTLYPLIKDVLLKSELTVVIALFVGGILLIIFELL
HKEPVQPTETDSFATIPYRKAFLVGLFQSIAVIPGVSRSAATIMGGLLLGIRRTAIVEFS
FLLAVPTMGAATSYDLLKNYESFVDADIGVLAIGMVTAFITALLVLRLFLSFIKRYTFIP
FGVYRIVLAGVFFFLVLY
>A0A0F5X7P5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILLELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSTQFLGSESAFTFKIVIQLGS
VFAGAWVFRERYFEMLHIGKYRSEPIDGIGQKPKRLNLLHIIVGMIPAGILGLMFDDVIE
KYLFSVPTVMIGLFIGAIYMIIADIYSKKVTNPQTVDQINYFQAFVIGLSQAIAMWPGFS
RSGSTISTGVLMKMNHKSASDFTFIMAVPVMLAASGLSLVKNFEYIHLNHIGFYFLGFIT
AFIVGLIAIKTFLFLISKIKLIPFAIYRIILVIIIAILYFGFGIGQGISGQ
>A0A0D6T542|FEATURES|UNIPROT_deepARG|beta_lactam|SZ39_1136|antibiotic inactivation|1
MKKNTLLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTVLTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSISVENVLKRYGNTNLVVPGH
GEVGDRGLLLHTLDLLK
>A0A0K1ED20|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSWIDALLLGILEGLTEFLPVSSTGHLILLGSWLGHEDEAAKTLEVVIQLGAVMAVVVYY
RNRLLDLGRGVLARDPASLRFVMALGIAFMPAAGLGYLLHKKIKALLFGPMPVAVALIVG
GVVMIAMERLQRKRGQEGLTRLQDVTPKRALIIGIAQAFALWPGASRSMSSILGGQLVGL
STAAAAEFSFLLAIPTLGAATVFDLVKNGQTLLDAPGGMLNLGVGLVVSFIVALLVISGF
LRYLKRFGLTPFGWYRIALGVLVLALASR
>ZP_01063069|FEATURES|ARDB_deepARG|quinolone|QnrS|antibiotic target protection|1
MDTNNSTYHQHSFAQQDLSELTFTACTFIRCDFRRSNLRDATFINCKFIEQGDIEGCHFD
IADLRDASFQNCQLAMANFSNANCYGIELRECDLKGANFTRANFANQVSNRMYFCSAYIT
GCNLSYANLEQACLEKCELFENRWIGTYLGGASLKESDLSRGVFSEDVWGQFSMQGANLC
HAELEGLDPRKVDTTGIKIVAWQQDQLLETMGIVVMPD
>L0MNB4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGGKPVAHEGHTPGHLKLTHILLAMAPAVVLGLLFHDVIKSLFEP
KNVMYALVIGGVLLLTAEWLKPKKPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATI
SGGMLVGVSRYAASEFSFILAVPMMIGASGLDLYKSLHFLTLADLPMFAVGFVTAFLVAL
VAIKTFLTLIKRISFVPFAIYRFIVAAAVYVVFM
>ZP_02656843|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNETSASLQLTQTLFDMSKWRGLTLQEKAAGIQDVTY
QTDQQTLILNTANAYFKVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEELRQVTGNYYPELASLNVEHFKTDKPKAVNALLKEAEN
RNLSLLQARLSQDLAREQIRQAQDGHLPTLNLTASTGISDTSYSGSKTNSTQYDDSNMGQ
NKIGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASISSI
NAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARYTYLINQLNIK
YALGTLNEQDLLALNSTLGKPIPTSPESVAPETPEQDAAADGYNAHSAAPAVQPTAARAN
SNNGNPFRH
>A0A0R1H4Q0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDILRAIFLGIIEGITEFLPISSTGHLYLADYFIKLSQSKAFIDMFMVVIQFGAILSVI
LIYFNKLNPFSPSKRPAEKRQTWTLWLKVIVATIPSIIIGLPLNDFMEEHLTSWPVIATT
LIIYGILFIVLENRNKHARFAITDLNKLTYQTALLIGLFQVLALVPGTSRSGATILGAML
IGASRFVSTEFSFFLAIPTMFGASLLKLAKFFIKGNEFTGMQLPILLVGMVVSFIVAYLA
IKFLLSYVKTHDFKPFGWYRIILGILVILIGFVF
>A0A0T9SN89|FEATURES|UNIPROT_deepARG|aminoglycoside|ERS008727_00138|antibiotic inactivation|1
MEIKKLSSTNINLWIALREQLWPHHPENKTDGENIILSDELASFIAIDDDGLGIGFADAS
IRNDYVNGCIHSPVAFLEGIFIVPSSRRGGVAKQLVDAVQAWGLEKGCQELASDTALDNV
LSQQVHEALGFKETERVVYYRKA
>A0A109FSL6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNVLHVFLGVFPAVVVGLLLHDVIKAYLFQPYTVVIGLVA
GAFLMIFAEAKKAEVTAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIALPVMVGATGLDLLKSWKYLSADDIPMFAIGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAIVFTLFVLL
>A0A0H3W0Y8|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
AIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFAYASTSKAI
NSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKYSDNTANNK
IINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANG
KLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKNQSE
PIILVIFTNKDNKSDKPNDK
>A0A0K8MWB8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAIIIGIVEGLTEFLPVSSTGHIDLVSQFVQISQGKAFENMFEYVIQFGAIMAVV
ILYFSKLNPFSAKKTVRERQDTWVLWFKVIIACLPSIIIGLPLNDFMDEHLHKPAVVATA
LIVYGILFIVIENIYKNKAPKISSLANIGYSTAFYIGLFQALSIVPGTSRSGATILGAII
LGASRYVATEFSFFLAIPTMVGVTILKVGSYLLKGNTFTGEQWAVLATGTLVSFIVAVIA
IKWLLKFVQTHDFKAFGWYRIVVGLIVFAVMFM
>R8EIA2|FEATURES|UNIPROT_deepARG|beta_lactam|IIU_02022|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSITSLEAFTGGELQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITM
SDRFETELNEAIPGDIRDTSTAKAIAMNLKAFTVGNALPAEKRKILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIVILSSKDEKEATYDNQLIAEAT
KVIVKALR
>S6A6R2|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-108|antibiotic inactivation|1
MEKYFMMKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYH
GKPYYFTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQ
LTGQQWQGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASI
GLFGALAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQ
LDAEAYGVKSSIEDMAHWVLANMNSEAVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLN
WPVPAEVVINGSDKVALAATPVTAVNPPAPSVKASWVHKTGSTGGFGSYVAFIPQQDLGI
VMLANKSYPNPERVKAAYHILEALQ
>Q57M56|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTTACESLSKAWEILLIDDGSSDSSAELMVK
ASQEADSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTPFTEESHQ
>A8MFV5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIIELLKVIFLGIVEGITEWLPISSTGHMILVEEFIQLNASAAFKEMFFVVVQLGAIMA
VVLLYFNKLNPFALSKTKREKRETMRIWYKVVVGIIPAGVMGLLFDDWLNEHLYNYWTVA
AMLIVYGVLFIIIENRNKHRYAKINSFSELSYSTAFLIGLFQVLSLIPGTSRSGATIIGA
IILGTSRYIAAEYSFFMSIPIMFGASAVKLLKFGFNFTSIEIITLVTGMVVAFVVSIIAI
RLLMAYIKNNDFKAFGWYRIFLGVVVIGYFLITNGKVLS
>ZP_04612440|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGKVPHEGKTSGHLTLGHILLAMIPAVGLGLVFHDAIKSLFNPQS
VMYALVAGGLLLLAAEWFKPKNPKSIGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMLGASALDLYKSLHFLTLGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFVVAAAVYWVFM
>YP_002110288|FEATURES|ARDB_deepARG|multidrug|AmrA|antibiotic efflux|1
MKYEWARTRRLSAALAVAAFVAAGCGKHESEHDAAAPREASVVTVKKTSVPLSVELPGRL
DAYRQAEVRAWGAGIVTARTYEEGQEVKRGAVLFRIDPAPFKAARDAAAGALEKARAAHL
AALDKRRRYDELVRDRAVSERDHTEALADERQAKAAVASARAQLQLDYATVTAPIDGRAR
RALVTEGALVGQDQATPLTTVEQLDPIYVNFSQPAADVESLRRAVKSGRAAGIAQQDVEV
TLVRPDGSTYARKGKLLFADLAVDPSTDTVAMRALFPNPERELLPGAYVRIALDRAVARD
AILVPRDALLRTADSATVKVVGQNGKIRDVTVEAAQMKGRDWIVTRGLAGGERVVVVDAA
QFEAGTTVKALERGAAAQPASGAAAASAPGRRST
>A0A0F0G2D3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIIEGLTEFLPVSSTGHMILTADLLGLNTENDTVKTFEVIVQLGAVMAVVVLYWRRFLS
LFDFRRKISSQPRLNLLHIILAMIPAGVIGVLFRDVIKQYLFGPETVLYSLVIGGLLMIA
AEKFHPPIRSHTLDEITYKQAFTIGVFQVLALWPGFSRSGSTMSGGLFARVSHTAAAEFT
FLVSVPVMLGASGIDMIKSMDHLSMSDFPVFAAGFITAFIVGMLAIKTFLGLLKRLSLTT
FAIYRFVLAAVFFFIIL
>K9C685|FEATURES|UNIPROT_deepARG|beta_lactam|ACINWC487_2691|antibiotic inactivation|1
MRFKKISYLLLPSLFIFNTSIYAGNSSKDQEIKQLVDQNFKPLLEKYNVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFDDTPGKYWKEL
KNTPIDQVNLLQLAIYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQCAINETHQGRYQVNSMYQALGWEEFAY
PATLQTLLDSNSEQIVMKPNKVTAISKEQRWIRKFEQHL
>D4IWH7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAILFGIVEGITEWLPISSTGHMILLDEIVKLDVSEEFYSMFQVVIQLGAILAVV
LIFWNKIWPFGKKDNKAPLSQSGIGAWIKTDIFVLWFHILVSCVPAAIVGVLWDDLFEEL
FYNPTCVALALIVFGVAFIVVETMHTGKNSKINSVADITYTTAFLIGMFQLIAAIFPGTS
RSGATIVGALIIGVARTVAAEYTFYLAIPVMLGASLLKIAKFGLSFTAMEAVILLVGMVV
AFVVSMFVIKFLMDYIKKHDFKVFGWYRIVLGIIVLICGFVGLI
>Q4ZSZ2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPREKTFFGSVAQLCARHGIAVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLP
LLAAQGQLPATPQDESRATYFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCPVGD
NKLIVWAASVDTSSNGEAPGTVISHEPLRIACGEGSLVITAGQRGDNGLYLSGEQLAREF
GLVAGSQMLDKAKRRSVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVVDGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGKGYQDVSHRTPSIDNAKKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>E0URD0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLFDSVILGIIEGFTEFLPISSTGHLIVASQFLGIDQTSVTKAYEVIIQFAAILAVVFN
YKEKFTLKHISLWTKVFLAFLPIGIVGFIFSHQIKALFSINIVATMFIIGGIIFLLVEKF
YIPKEKKLTKDVEDVTLKQSLWIGIAQVFALIPGTSRAGATIIGALLVGLDRKASAEFSF
LLAFPVMGAVSGYDLLKHYHEFSSANIEALAVGFFVAFIVAYLTIKLFLKFLEKFTFVAF
GVYRILFGVILLTLFN
>R6NS27|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEFLKSFLFGIVEGITEWLPISSTGHLILLNQFVKLNVSEEFYSMFEVVIQLGAILAVV
ILFWNQIFPFGAPEGSHTVRRRQAKHAHRKKKSGNGILSYVKMDIIILWLKVLVACIPAI
VIGMPFNDLFEKWFYNYPCVAIALIVFGIAFIIVENNHKGKPAKINSMDELTYKTAFLIG
LFQLIAAIFPGTSRSGATIVGALILGVSRTVAAEFTFVLAIPVMFGASLLKLVKFGLNFT
GTEAIILLIGMVTAFVSSIIVIQFLMGYIKKHDFKVFGYYRIVLGILVILYALFLA
>K1IXU2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MNHNDIKRVSVIIPVYNEEASLPELLQRVTDTCEQLSQDYEVILIDDGSRDRSAAIISEA
AAREGSKLVAVLLNRNYGQHAAIMAGFETAKGDLVITLDADLQNPPEEIPRLVATAMEGY
DVVGTIRRNRQDSWFRKTASRFINKSVQKATGVQMSDYGCMLRAYRRHIIDAMLCCQERS
TFIPILANSFARRTTELEVGHAERAHGESKYGLMHLINLMYDLVTCMTTAPLRLLSIVGS
VVAGIGFIFSILLLLLRLLLGADWAADGVFTLFAILFTFVGVQLIGMGLLGEYIGRMYTD
VRARPRYFIHQIVRSTPDASQQETQS
>YP_001921729|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGLDFLFIFKAIIVAIVEGLTEFVPVSSTGHMILASDLINFQGEFVKMFEVVIQLGAILA
VVVLYWKKIKDSVIEFFTYIFTGGKKGEVGFRFGINVLIGSIPAGVIGILFYSKIKTLFK
PQAVVVGFIVGGILLLVIENIFRKKRHSVKSIDRITPMQSIKVGLFQVLSMWPGMSRSAS
TIMGGWVAGLSTPIAAEFSFFLAIPAMIGSSAKDLFEFDFALMNTTNWVALIVGFIVAFI
VSLIVMEGFVAYLKKKPMRVFAIYRVVAGIVFAILMYKGIVTPHL
>ZP_04102233|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEASYDNQLI
AEATEVIVKALK
>A0A0D6SUQ3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQSINHICFSVANLEKAIEFYQNILQAKILVKGRKLAYFDLNGLWIALNVEESIPRNEI
QYSYTHIAFTVTNNEFDSLKEILIQNHVNILPGRERDDRDKRSIYFTDPDGHKFEFHTGT
LQDRLQYYKEDKKHMTFY
>J7TR21|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENAIMFYERVLEGELLVKGRKLAYFNICGVWIALNEEAHIPRKEI
HQSYTHLAFSVEQEDFERLLQRLEENKVHILQGRERDVRDYESIYFVDPDGHKFEFHSGT
LQNRLNYYREEKPHMTFY
>A0A0X3R3K7|FEATURES|UNIPROT_deepARG|aminoglycoside|AR275_08620|antibiotic inactivation|1
MEAPDPFADGMPLPWAWQETLADARIERQSIGVSRADVARVQRPGQADAFVKSEVIDAFS
ELGDEIARLRWLQEQGQPVPTVIATAEEAGRRWLLMSALPGRDLASSPELAPQQLVELLA
DALRGLHALPLAACPFDQRLHLRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELCST
RPDHEDLVVSHGDACLPNLMVVEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VAPLFQRYGMVADERRLAFYRLLDEFF
>A0A0J7EMG5|FEATURES|UNIPROT_deepARG|beta_lactam|TU65_19470|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQATQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGLTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>I9NKF0|FEATURES|UNIPROT_deepARG|aminoglycoside|Rleg9DRAFT_6255|antibiotic inactivation|1
MEPSIEVATTKDVEPWAQLRLALWPHHSLDDHRAELGRAFLSENAEAVAYIARNAANDAV
GFAEATLRHDYVNGCSSSPVLFLEGIYVRPVDRRKGIAGLLCNAVADWGKSLGCVEFGSD
APLENSASHALHAALGFEETQRVVFFRKPL
>B8ZI09|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWXKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQ
>A8A0L0|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMENID
PALAEKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMVSYIKRARSMRDIRNEKGTAKPDPAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVEPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRMPSAIILQRASR
>CAL13705|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGKVPHEGKTNGHLTLGHILLAMIPAVGLGLAFHDVIKSLFNPQS
VMYALVAGGLLLLAAEWFKPKNPKATGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMLGASGLDLYKSLHFLSWGDLPMFAVGFITAFVVALIA
IKTFLSLIKRISFVPFAIYRFIVAAAVYWVFM
>A0A0T9ML50|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_5|antibiotic efflux|1
MTVLLELNGIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAVLDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNE
RRERANMLLTRLGLGDRVGYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERVIEIKDGRIMADSGSKTVQAVAASEAIS
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVYDDMAALKAQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVFGMKLEQGTAITHEQVERQSQVAVIDRNTQRRLFPHMKDV
VGQVILVGNMPATVVGVVEEKQSMFGSSKALRIWVPYSTMASRLMGRAYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLVVE
MFLPNWQIAFPPVALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>CAR58198|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDRFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
KLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTMNFGELSAQLGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCQVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPYPVKDIRVLSRITTEAFNQRRKTIRNSLGNLFSVETLTE
MGIDPAMRAENISVAQYCQMANYLSENAPLKES
>A0A0B6AP17|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQGINHMCFSVSNLEQSIIFYQKVLGAELLVKGKSTAYFSLNGLWLALNEEKNIPRSDI
QYSYTHLAFSISIKNFDEARELLKQHNVTILPGRNRDERDRKSIYFTDLDGHKFEFHTGT
LQDRLAYYQEDKPHMTFYSPEE
>YP_002400589|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDSLIQRTLSGSHPLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETV
AVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLDTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
AAPIVEKK
>A0A0L8P889|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPSRPEVTLQEYVVAGPEAGPYALTAGPDGALWCTLVHQGRVARVTTAGDVTTYPLRTAT
GGPTMIATGTDGALWCTEFKEHRVTRLVPGRAADGGAQVESFTLPTADAAPLGIAAGPDG
AVWFTESAADRIGRITPDGTVTEYPLPVRGAFASVIATGPDGALWFTANQANAIGRITPD
GDTVLHDLPTPGAGPVGLTAGPDGALWFVEIAAGQIGRITTDGTVEEFPLPDPACRPHAI
AAGPDGALWFTEWGAGRIGRITTSGRVDGYDLPDPASEPHGIALGPDGALWAALETGSVV
RIAVTAEGAQPGR
>CAQ76847|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHMNVTDNDDMEQWDAVIM
GDDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>A0A034TZS0|FEATURES|UNIPROT_deepARG|beta_lactam|JCM18905_3838|antibiotic inactivation|1
MKLNNALVAILSLTSFVTFAKTELTVSSQLKSVVDECAKGLMNEYDIPGVAVAVTIDGKR
YFYNYGFADESTGSLVTNDTIFELGSISKTFAATLTGYAQEKGKLNMDDKVKDYIPELEN
SVLGNTKLVHVATYTAGGLPLQFPSEVTNDAEMMQYYKTWKPEYEAGTKRKYSNPSIGLF
GYIGASMKSDYTEMMETVILPELGMTNTFVDVPKDQLNNYAFGYSSEGKPVRVNPGILDA
QAYGIKSTSLDMLQYIEANMGQAQLNTDIENALERTHTKYFDTDTFTQALGWEGYDYPPV
SLSQLLKGNSSDVILNAKPVQASESGTLGRDVWYNKTGSTGGFGAYIAYVPSEKIGIVIL
ANKNYPNAERVEAAYNIISSVVK
>ABS34716|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MLLILKAIIIGIVEGITEFLPVSSTGHMIIAGSLIGFDGTVYRKAYTDMFSVVIQLGAIL
AVVVLYWDKIISTLKNFFPSDRVPVKKCGLKFWINIVIASIPAAVIGIPFNDKIEEKLFY
PLPVTIALIVGAIWMIYAENRYRNNSKVISIDDVNAKQAIIIGVFQCLALWPGMSRSAST
IIGAWIVGLSTVAAAEFSFFLAIPAMIGASGMSLIKHNVFSTCSSIELIALAAGFIVSFV
VALVVIDKFIAFLKKKPMKVFAIYRIVLGIVLIILIYTNIITWH
>A0A070SVY0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQQIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQQTLFELGSVSKTFTGVLGGDAIAREEITLSDPVTKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNTD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAAAWQILNALQ
>A0A150RC96|FEATURES|UNIPROT_deepARG|bacitracin|BE17_17935|antibiotic target alteration|0
MFWFDAVLLGVLEGLTEFLPVSSTGHLILLGAWLGHESEAAKTLDIVIQLGAVLAVVVYF
RERLAVTVRGILRRDPDSLRLALALAIGFLPAALVGLLFHKAIKAYLFGPGPVAVALIAG
GFLMIGVESARRRRPDQGAPRVEDVTLQRALAIGFAQCFALWPGASRSMTTIVGGQLSGL
STAAAAEFSFLLAIPTLGAATVFDLAKNGRALLDAPGGATALAVGLAVSFAVALLVIAVF
LRYLKRYGLAPF
>C2WY75|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YYKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKTEATAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFILL
>ZP_04232797|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSTIKKVLFGPGPVVVSLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSTADIPLFATGFITAFVVAMFAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFFIM
>A0A127SAQ9|FEATURES|UNIPROT_deepARG|aminoglycoside|APH(3'')-Ib|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGVPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>A0A0A8UFM4|FEATURES|UNIPROT_deepARG|polymyxin|yfbF|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNELESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRTIEIPVHHSEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0U1YUD0|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQGFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A120A1C6|FEATURES|UNIPROT_deepARG|beta_lactam|per1|antibiotic inactivation|1
MKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETILHNNEVH
YPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLRQKHSGQDLDISLGE
LLQYSISLSDNNACDILIEYTGGIGHIHQYIRKLGINDFNLSETEDSMHRNPQKAYANWS
TPSEMVRLLKMADEKDLFAPVYRDFLWKTMTETATGSNKLKGLLPSNTVVGHKTGSSDRN
LKGVKMADNDAGIVIMPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDEMK
>ZP_03836622|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYVSEARQLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRDRIAHQIRQGFWLAGSVSVLIMVVLWNAGYIIRSMHNID
PALAEKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPAMVMGFLGLLVNIPVNYVFIY
GHLGMPELGGVGCGVATAAVYWVMFAAMLSYVKRARSMRDIRNERGFQKPDSAVMMRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLEAQTAARTGLGVGVCMAVVTAIFTVTFREHIALLYNKNPEVVALAAQLMLL
AAVYQISDSIQVIGSGVLRGYKDTRSIFFITFTAYWVLGLPSGYILALTDLVVDRMGPAG
FWMGFIIGLTSAAVLMMLRMRYLQRQPSAVILQRAAR
>A0A0G0CA67|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNFFDSIILGIIEGITEFLPISSTAHLILTADLLGLSQSEFLKSFEIIIQFGAILAVVVL
YWKLFLKWEVLKKLIVAFIPTGILGLIFYKIIKTYFLESTSLILWTLFLGGIFLIIFEKW
HKEKENASEDIANISYKHCFYIGLFQSIAMIPGISRSATTILGGLLIGLRRKTIVEFSFL
LAVPTMLVASGFDLLNNIEKFSLSESHLLAVGFITSFGMAILGIKFFLAYIQKRTFIAFG
IYRIIIVILFLVK
>K0WEZ3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRSVSIVIPVYNEQESLPELLRRTEAACRQLHHDFEIVLVDDGSRDESANMLEEA
AGRENSPFVAVILNRNYGQHAAIMAGFEQCKGDVVITIDADLQNPPEEIPRLVAEAEKGY
DVVGTVRGNRQDSALRRYPSKLINLAVQRSTGVAMSDYGCMLRAYRRNIIDAMLACRERS
TFIPILANSFARHTTEIVVAHAEREHGDSKYSPMRLINLMFDLVTCMTTTPLRLLSIVGF
AMAGLGVLFAVALIILRLAFGAGWAGGGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRSQPADPAPAVTVDGLSSTATSSTSDQVLS
>C0M550|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
APVSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLF
ELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQ
VPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEQAMAERVFK
PLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAP
ETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAE
VNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYHILEAL
Q
>L0FG90|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAIAFNIIIQLAAILAVV
WEFRGKILEVVFGLTSQPTARRFTGNLLLAFLPAVVLGVLFADLIHHYLFNPITVATALV
VGGVIMLWAERRTHRVAVDHVDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYATFAWYRIAFGLLILATWQFGWIDWSTAQG
>N9LD89|FEATURES|UNIPROT_deepARG|beta_lactam|F904_01163|antibiotic inactivation|1
MNQPKAFSMTLKKLFVLTGLLSCSSALWAGNLTEQQVQTIVDQQFKPLLAQYKIPGMAVA
VTLNGQHYFVNYGLASKQNQQAVSNSTLFELGSVSKTFNATLAGYAQTQGQLSLSDHPAK
YFPELKNTAVNRATLLNLGTYSAGGFPLQFPDEVVQQQDMIKYFQAWQPKTTIGAARQYS
NPSIGLMGYVTALAMKKPYNELIEKTLLPQLGMTQSFIRVPEQHMPQYAWVYKADQAMRV
SPGMFDAEAYGLKSSSADMLKFLDAQINPQQFKQPLRQAIESTHVGYFKVGAMTQGLGWE
QYVYPVSLETLLQGNSSKMALESHAITAIKQPKLATPATYFNKTGSSNGFGAYAAFIPKQ
KIGIVMLANTNFPNEERIKASYRVMQQLVQSNSAQ
>CAG34256|FEATURES|ARDB_deepARG|multidrug|smeD|antibiotic efflux|1
MLLSRIRPFALSLAIAAAVAACGGQPQAPEQGPGDVTVVTLKSETVGLTRELPGRTNAFL
VAEVRPQVNGIVAKRLFTEGGMVKAGEPLYQIEDASYRAQANSARAQLARAEATANAARL
SAKRITELAKVDAVSQQDLENAVAAQKQAEADVGAARASLDAANVTLGYARITAPISGRI
GKSSVTQGALVSAGQANVLATVQQLDPIYVDLTQSSAELLQLRRELAAGRLQDNQTLPVS
ILMEDGSTFEHKGTLEFSEVSVDPATGSFGLRVKVDNPDGLLMPGTYVRAVIGGGVRSDA
VLVPMQGIARDPKGDTTAMVVGKDNKVEVRPVKVSRTVGDKWLVEDGLKAGDKVIVEGLQ
KIGPGMPVKATEKGAAPAKPAAAAQPAAPAGDAK
>A0A061CS64|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MAFQALILGIVEGLTEFLPISSTGHLIVVGDLLGFNGQTATAFKIIIQLGAILAVIWEFR
AKVLGVVVGLPNEPKAQRFTFNLLLAFIPAVIFGLAFADLIEHWLFNPITVAMALIIGGI
IMLWAEKRDHTIQAETVDDMDWKLALKVGFAQCLALIPGTSRSGATIIGGLVFGLSRKAA
TEFSFFLAMPTMVAATVYSLFKYRDILQMSDLPIFAIGFVSTFIVAMITVRALLKFITNH
SYAVFAWYRIAFGLVILATWQLHLIDWSTAQP
>T0SE09|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAVILGIVEGITEFLPISSTGHLVLVDEFIKLNEPKKFIDMFNVVIQLGAIMAVV
VLYFHKLNPWSPKKSRLERSQTWTLWKKVIIAVIPSVIIGLPLNDWMDAHLMNWLVVSIA
LIVYGVLFIVIENHNQNLRPRFDSLNTLPYKMAILIGCFQILSLIPGTSRSGATILGAIL
IGTSRYVAAEFSFFLAIPTMFGASLLKLYKFFAHGGTLAGNQGLILAVGVIVSFVVAYAS
IRFLLNYIKTKDFKAFGWYRIILGVIMIAYFALLAH
>A0A085F935|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLAVKAIIMGLVEGFTEFLPISSTGHLILMGSLLDFTGPKSVVFKIVIQAGAMLAVV
WEYRDRIARVLKGLGADPVQQRFARNVVIAFFPAAIAGVLFSSTITELLFHPVPVAIALV
IGGVLILYVERRNRLRPTAARVETVEDMSALDALKVGLAQSFALIPGTSRSGSTIIGGML
FGLSRKAATEFSFFLAMPTMLGATVYSVYKERALLSAADLPLFGLGFFSAFLAAFLCVRW
LLRYISSHDFTIFAWYRIVFGILVLVTAHFGLVTWAE
>A0A096DN48|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLMGFVGGKAKVFEIAIQTGAIFAVM
LVYWQKIRDTLVELPSSRQAQKFALNVIIGFLPAVVLALLFGKYVQEHLFTPVIVATTFI
LGGFVILWAENRPAAATRVQSVDDMTALDALKVGLVQCFALVPGTSRSGSTIIGGMLMGL
SRKAATDFSFFLAMPTLIGAGVYSLYKERALLSMADVPLFAVGLIFSFISAWLCVRWLLR
FISTNSFVPFAWYRIVFGIIVLVTAYTGIVDWHH
>I1V567|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNV
AMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNL
TLGKALGDSQQAQLVTWMKGNTTGAASIQAGLPASWVV
>D4GER5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYHDMGCAGINALLKAGFTISAIYTHADTASENHFFWLSGANRGENSIPVYAPD
EVNHPLWIDRIKSAEPDVIFSFYYRNLLSDQILNSAKQGAFNLHGSLLPKYRGRAPLNWA
LVNGETETGVTLHRMVKKADAGDIIAQQRVAIADEDNALTLHRKLVDCASALLESALPAM
KQGNIVGTPQNEADATVVGRRTPEDGRINWALPASQINNLVRAVTDPWPGAFAFAGTTKF
VVWKAKVLSTPHNVRPGTVLSAEPFVVACGEGALEIQTGQTANSVYMNGVQLAQHLGMVN
GALLYSQAVAAVKRRTRVLILGVNGFIGNHLTERLLQDDNFEVFGLDIGSDAISRFVGHP
RFQFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIVRDC
VKYGKRIIFPSTSEVYGMCTDANFDEDHSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLFDGGRQKRCFTDI
SDGVEALFKIIENKNNNCDGQIINIGNPDNEASIKELAERLLESFERHPLRASFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLGWTPTVEMNTTIDNTLDFFLRTVELQDDKE
>C4SSA3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLELNGIRRSYQSGEEIVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAALDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGVGKNE
RRERANMLLTRLGLGDRVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVASQAERIIEIKDGRIMADSGSKTVATAAASEAIS
LTPPAPSWQQLTGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVHDDMTALRAQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVYGMKLEQGTSITSEQVERQSQVVVIDRNTQRRLFPHLKEV
VGEVILIGNMPATIVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLIVE
MFLPNWQIAFPPMALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A0V9H6E8|FEATURES|UNIPROT_deepARG|chloramphenicol|APT96_04865|antibiotic inactivation|1
MGTKNMGYTVVDLSQWERKEHFEAFQSFAQCTFSQTVQLDITSLLKNVKKNGDKFYPTFI
YIISQLVNKHAEFRMAMKDGELVIWDSVNPGYTIFHEQTETFSSLWSYHHKDINQFLKTY
SEDIAQYGNDLAYFPKEFIENMFFVSANPWVSFTSFNLNVANINNFFAPVFTIGKYYTQG
DKILMPLAIQVHHAVCDGFHVGRLLNELQQYCYEGWQ
>A0A0V9JBS6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFVTAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>U2XFP2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAVILGIVEGITEFLPISSTGHLVLVDEFIKMQQSTQFTDMFNVVIQLGAIMAVV
VLYFHKLNPLSPRKDTTEKRNTWVLWSKVLLAVIPSVIVGLPLNDWMDEHLMNWAVVSAT
LIIYGVLFIVIENHNKRLTPRFTNLQTLPYTTALFIGCFQLLSLIPGTSRSGATILGAIL
IGTSRYVATEFSFFMAIPTMFGASLLKLVKFFAHGGSLAGLQGAVLAVGVIVSFVVAYLS
IRFLLDYIKKNDFKAFGWYRIVLGVLVIGYFTLIH
>A0A0E1ZPV7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIFLKNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDTPSSGTYVF
DEYEVTKLNNDEKARLRREKIGFIFQRYNLLSLLSAKENVSLPAVYAGKNLQERSQNAKK
LLNDLELAHKLDSKPNELSGGQQQRVSIARALINGGELILADEPTGALDSKSGIMVLEIL
QKLNEQGHTIVLVTHDPKIAAQAKRVIEIKDGEILSDTKKEKAQEKLILKTMPKEKKTLT
LLKNQAFECFKIAYSSILAHKLRSILTMLGIIIGIASVVCVVALGLGSQAKVLESIARLG
TNTIEIRPGKGFGDLRSGKTRLNFSDLETLRSLEYLEAVDAHSNTSGVATYTNISLSARA
EGVGVNNFAIEGLRIDAGRILNNDDVKNSTNVAVLDFNAKKNLFPDEKSENILGRVVLFN
SQPFKIIGVLQKDTDKPIEDNVVRLYIPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
AIIRILEIKRGQKDFFTFNSDTFKQAITANKRTTTILTACVAVIALIVGGIGVMNIMLVS
VSERTREIGIRMAIGARREDIMMQFLIEAVMICTIGAILGVILSIFVIFAFNTLSTDFPM
ILNAYSVLLGLLSSMFIGVVFGFFPARNAANLNPISALSKE
>J2XMD6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WQFRRKIFDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVATALV
VGGVVMLWAERRQHEVHAESVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFITAFIFAMIAVRALLIF
IASHSYATFAWYRIAFGLVILATWQFGWVDWTAVKP
>U2T4R7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAIAFNIIIQLAAILAVV
WEFRGKILEVVFGLTSQPTARRFTGNLLLAFLPAVVLGVLFADLIHHYLFNPITVAAALV
VGGVIMLWAERREHRVEVDHVDEMRWSHALKIGFIQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYATFAWYRIAFGLLILATWQFGWIDWSTAQG
>A0A0N8SIH8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIKFVSIVIPVYNEQQSLPELLRRTEAACEQLNHRFEIVLVDDGSRDDSTDILQRA
AGRADSPFVAVILNRNYGQHAAIMAGFEQCQGDVVITLDADLQNPPEEIPRLVKLAEQGY
DVVGTVRSNRQDSAWRRWPSKLINLAVQRSTGVAMNDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEVLVDHAEREHGDSKYSPMRLINLMFDLITCMTTTPLRLLSIIGF
SMALLGVSFAALLIVLRLIFGASWAGDGMFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVVRSSSRVATDSVDSPVTPYMNKVAP
>YP_002847275|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIESIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
KLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTMNFGELAQTMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPAPKVDSAVVRLVPHTTMPYPVKDVRVLSRITTEAFNQRRKTVRNSLGNLFSVEVLTE
LGIDPAMRAENISVAQYCRMANYLSENAPSKES
>CAJ85716|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-Ib|antibiotic inactivation|1
MPESMAAHVMGYKWARDKVGQSGCAVYRLHSKSGGSDLFLKHGKDAFADDVTDEMVRLRW
LAGHISVPSVVSFVRTPNQAWLLTTAIHGKTAYQVLKSDFGARLVVVDALAAFMRRLHAI
PVSECSVQQWTTHAGLPERGSIEAGVVDVDDFDKEREGWTAEQVWEAMHRLLPLAPDPVV
THGDFSLDNLLIVEGKVVGCIDVGRAGIADRYQDLAVLWNCLEEFEPSLQERLVAQYGIA
DPDRRKLQFHLLLDELF
>A0A0J7HAJ3|FEATURES|UNIPROT_deepARG|beta_lactam|TU65_24875|antibiotic inactivation|1
MILKNKRMLKIGICIGILGISLTSLETFTGGALQVEAKEKTGQVKHKKHATYKEFSQLEK
KFDARLGVYAIDTGTHQTIAYRPNERFAFASTYKALAAGVLLQQNSTNKLNEVITYTKDD
LVEYSPVTEKHVDTGMTLGEIAEAAVRTSDNTAGNILFNKIGGPKGYEKALRQMGDRITM
ADRFETELNEAIPGDIRDTSTAKAIATNLKALTVGNALPAHKRNILTEWMKGNATGDKLI
RAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAA
EVIVKALK
>A0A0U5B2K6|FEATURES|UNIPROT_deepARG|beta_lactam|blaPER-9|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEF
SVPVQQLLLYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELK
KLSALSPN
>F1DI16|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
VMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLAVLSASALRYSVNV
AMNKLISHVGGPASLTAFARQLGDETFRLDRTEPTLNTAIPGD
>A0A149RI55|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRAKIGSVVTGLPVRADARRFTLNVIIATIPAVVLGLLFEKTIKSVLFSPVPVSVALI
VGGIVILWAESRQRERAAAPRVLSVDDLSYADALKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATLYEMAKYWRTLTVNDFGLFAIGLVAAFVSAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>H5WAW3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIDVIKGLPNDPRQQRFAVNVIVATIPAITLALIFGKTIKAHLFNPIVVASAFI
IGGLVILLVEWRERRRGQTHDPRGNALLEAAKAGAPRIETLDDLRLSDAIKVGLAQCFAL
IPGTSRSGATIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKERALLSADDLSIFG
IGFVAAFISAFFCVRWLLRFIASHDFRGFAWYRIVFGIIVLVTAYTHFIAWQA
>A0A038GWS0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRAKIGSVVTGLPVRADARRFTLNVIIATIPAIVLGLLFEKGIKSVLFSPVPVSVALI
VGGIVILWAESRQRERAVAPRVHSVDDLSYADAFKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATLYEMAKYWRTLTVDDFGLFAIGLVAAFVSAFVCIRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>M6FU90|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSSTGHLFLFSSFFPFSGESFGIEFDDLFDIFIQSGAILSVLFLYREKFESQIFSSFQYL
TKRNSNPEGFYFLVRIVIGAFPILVLGFLAKKFLDTIKTRSDLLDILAGAWIFGGVLILV
AEWLFRKRQGAEEKKPVGFRDAILIGIFQCVALIPGISRSAATIVTARFLGKDAKSSAEF
SFFLAVPVLFAAGIYKLVKHRSILNETTIPVLTFGFLISFLLCALVIRLFLRYLQKHSFG
VFGIYRILLGVGVLVFTKFIR
>AAL05857|FEATURES|ARDB_deepARG|beta_lactam|ACT-7|antibiotic inactivation|1
MMRKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>M2Q1U1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIKILISILFGIVEGITEWLPISSTGHMILLNKFISLETVTSAKFYSMYEVVIQLGAILA
VVVIFWDKIWPFQKSDETQKGIKKYVKMPIIDLWLKIILACLPAAVIGLAFDELFEKWFY
NYWCVAIALIVFGIAFIIVENKNEDHKPRVKSLKQLNGKTALEIGFFQLIAAIFPGTSRS
GSTIVGSLMLGVSRTTAAEFTFFLAIPVMFGASLLKIVKFGFAFSMSEIVVLLTGMLVAF
LTSLMIIRFLMDYIKKHDFKIFGYYRIALGVIVLLYGIFLG
>A0A0L0LEC5|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTHLVAIILGFVEGATEFLPISSSGHLIIARHLMGVNDLGGLTFDAVLQLATTLAIVFYF
WKDIWYLVQTFFNLVRKNPVMEKDRVLFYSILIGTIPAIIAGLFLENYMDTVFRNINLVA
LTLILGSVLFWFAQKISKKNSDLSIGKGIMIGFFQCLALIPGVSRSGATISGGLIAGLTQ
EESVRFSFLLSIPILLGAGLKKVFEVRHELFTSDFGSSLLLGSVVAFVTGLMAINFLIRY
LKNNNLDIFIYYRIGLAIAIFLLF
>Q0HRE5|FEATURES|UNIPROT_deepARG|beta_lactam|Shewmr7_3328|antibiotic inactivation|1
MRALALSAVLMVTTMIGMPAVAKEWQENKSWNAHFSEHKTQGVVVLWNENKQQGFTNDLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNLDSFWLDGGIRISATQQIAFLRKLYHNK
LHVSERSQRIVKQAMLTEANADYIIRAKTGYSVRIEPKIGWWVGWVELDDNVWFFATNMD
MPSAEGLGLRQSITKAVLKQEKIIP
>A0A084CET5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNMNVELSAPLAVANGNGEPLLRLQGVSRSFLAGDREFLALKGIDLQIHSGELVAIIGAS
GSGKSTLMNILGCLDNASSGSYQVGGQETRTLGDDALAALRRDHFGFIFQRYHLLPHLDA
LHNVEIPAVYAGTPQAQRHARARELLTRLGLVGHLGHRPSQLSGGQQQRVSICRALMNGG
QVILADEPTGALDTASGKEVMNILLELHAAGHTVILVTHDPKVAAHAERIIEVSDGQIVS
DRRTGTVAVPTPAAEPPRAAEPARRLVASLGMFREAFKMAWIALISHRMRTLLTMLGIVI
GITSVVSISAIGEGAKGYVLKDIQAIGSNTIDIYSGSNFGDSRAKTIETLVPADVTALNA
LYYVDSATPVIGQSTLVRYRNLDVDVQLNGVSEHYFQVRNIPLAAGIVFSADDARRQAQV
VVIDHNTRKRLFGPHVDPLGQVILVGNLPCTVIGVTAENKNLFVASNQLNIWVPYETAAG
RVLGQRHLDSISVRIKDGVPSKRVEEEVTKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSL
TLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCL
FGGVVGIGLSYGIGYLFELFVKQWEMVFSPASIVMAFACSTLIGVLFGFVPARNAARLDP
IEALARD
>A0A060KQ83|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKESDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A077NGT8|FEATURES|UNIPROT_deepARG|polymyxin|pbgP|antibiotic target alteration|0
MTFEKIKKVSVVIPVYNEEESLPQLLERTIAACQQLEQKYELILVDDGSRDSSADILTQA
AETPENHVIAILLNRNYGQHSAIMAGFHQADGDLVITLDADLQNPPEEIPRLVKTAEEGY
DVVGTRRANRQDSWFRKTASKIINAMITKATGRSMGDYGCMLRAYRRHIVHAMLQCHERS
TFIPILANTFARRTTEIDVTHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLSVVGS
IIAVTGFLLAVLLIALRLIFGSIWAAEGVFTLFAILFMFIGAQFVAMGLLGEYVGRIYND
VRARPRYFIQKVVGVRKINDNQEKS
>A0A080NJ07|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVV
LVYWQKIRSTVVDLPTSRQAQRLTLNVIIGFLPAVVLALIFGKFIKAHLFTPTVVATTFI
LGGFVILWAERRPASAMRVQTVDEMTPLDALKVGLVQCLAMIPGTSRSGATIIGGMLMGL
SRKAATDFSFFLAIPTLIGAGVYSLYKERALLSVADIPMFAVGLVFSFISAWLCVRWLLR
YISTNSFVPFAWYRIAFGIIVLVTAFTGVVSWSEA
>A0A060V7U2|FEATURES|UNIPROT_deepARG|polymyxin|yfbF|antibiotic target alteration|0
MLTYPPVKKVSVVIPVYNEQDSLPELLRRTETACAALGRQYEILLIDDGSSDDSARMLTE
AAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFG
SVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQPETASKEEDRS
>A0A0F0XMI2|FEATURES|UNIPROT_deepARG|beta_lactam|SS33_21635|antibiotic inactivation|1
MKTKSLCCALMLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKATHVSPGMLDAEA
YGVKTNVQDMASWVKANMNPDALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>A0A0G3QHV2|FEATURES|UNIPROT_deepARG|beta_lactam|AB182_22595|antibiotic inactivation|1
MSMSRFRLPLLSLLAAFCLPAFAHPATQESVKQAEDQLNARVGYAELDLTNGQMRGSYRP
QERFPMMSTFKVLLCGAVLARVDAGQEQLARRIQYRQQDLVEYSPVTEKHLTDGMTMAEL
CSAAITMSDNTAGNLLLSAIGGPSELTAFLRKTGDRVTRLDRWETALNEALPGDERDTTT
PEAMAQTLRQLLTGKILTPASQQQLMAWMEADKVGGPLIRSVIPTGWFIADKTGAGGRGS
RGIVAALGPDGKPTRIVVIYLTGTKATMDERNKKIADIGDSLIKHW
>A1AHP3|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSALFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIALLMLSLFILKE
TRPAAPTTSDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>D2TUE2|FEATURES|UNIPROT_deepARG|beta_lactam|ROD_12321|antibiotic inactivation|1
MFKNRFRRTVLIAATMMPFVVGSASLWAQAQPDAQQVQQKLAALEKQSGGRLGVALINTA
DNSQLLYRGDERFAMCSTSKVMVAAAVLKQSETRPAILQQKIPIKKADLTNWNPVTEKYV
GKEMTLAELSAATLQYSDNTAMNKLIAHLGGPGKVTAFARSTGDTTFRLDRQEPELNTAI
PGDERDTSSPRAMADSLRNLTLGDALADTQRAQLVAWLKGNTTGGQSIRAGVPAHWVVGD
KTGAGEYGTTNDIAIIWPENRPPLILVTYFTQRQQDAKWRKDVLAAAAKIVTEGR
>CAG34043|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-Vb|antibiotic inactivation|1
MESTLRRTYPHHTWHLVNEGDSGAFVYRLTGHGPELYAKIAPRTPENSAFHLDGEADRLD
WLARHGISVPRVVERGADDTTAWLVTEAVPGAAASEEWPEDERAAVVDAIAEMARTLHEL
PVSECPFDRRLDVTVGEARHNVREGLVDLDDLQEERAGWTGDQLLAELDRTRPEKEDLVV
CHGDLCPNNVLLDPETHRITGLIDVGRLGVADRHADLALAARELAIDEDPWFGPAYAERF
LERYGAHHVDQEKMAFYQLLDEFF
>A0A0P9NP36|FEATURES|UNIPROT_deepARG|beta_lactam|ALO88_04947|antibiotic inactivation|1
MQRNGTLLCTGLLLVSSVAFAEDNSAALDTLVQTEARKVMQENNITGLSIAITHHGKQQF
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGRLSLTQSIDSYMPQLRDTR
LGKIPVFHLGTHTAGGFPIQVPEKVQNTRQLMDYFKAWQPEYLPGTHRTYANPSIGLLGV
IAARSMNMPFQEAMQQRLFPALGLNSTYVNVPDDKQALYAQGYNTLDEPVRVNPGVLADE
AYGVKSSSRDLIRFVEANIGLGQYDAPLQRALSDTRIGYFKVGGMTQDLAWEQYPTPIHL
DVLLAGNASAMLNTQKADAIEPPLAAQPTAWVNKTGSTNGFGGYVAFIAQKQLGIVILAN
KNYPNEERVKLAYRILQHAEPLN
>A0A0T9Q3R2|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MKHSPLRRSLLLAGITVPLLNFALPSWAVGAKLSLDNQLAELEKSSNGRLGLALINTGKG
TKIHYRGGQRFPFCSTFKLMLVAAVLGHSQSQPNLLSKHITYHESDLLAYAPITRKHLAQ
GMTVAELCAATIQYSDNTAANLLIKQLGGLEMVNQFARSIGDQTFRLDRWEPELNTALPN
DPRDTTPPAAMAASVNKLVLGDALAAPQREQLALWLKGNTTGAATIRAGAPTDWVIGDKT
GSGDYGTTNDVAVLWQAKGAPLVLVVYFTQLKKAAEPRRDVLAAATKIVLAHLS
>A0A075K8Y9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSENLIAVIIGIVEGVTEYLPVSSTGHMILVGSMLGFEGEKASVFEVFIQLGAILSVIFL
YREKFARILRPQKVSMFGGGLSMQHILAGIVPVMGIAYLLHKPIKTYLFSPYTVIVGLIL
GAILMLVAEKVAKRPVTTDVDKMTLKQAFFVGLFQVLALWPGFSRSGSTISGGLLLGMSR
AAAAEFSFIIAVPLMAVACLYDLLKVWDKLNIADLQMFAIGFVVAFVVAYLSIVWFISFL
NKSTLASFAYYRFVLAAASYYYFFGRI
>P0C0R6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAGLGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGVLPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLSAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNEGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVASRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>A0A154U3X0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNVNRFFGSGENRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAT
SGSYQIDGIETSQMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMDSKER
AERAEKLLGDLGLQNKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEDGHTVIMVTHDPGIAANANRVIEIRDGQIISDTSKNPDIPPSKVERIKE
KASWSFYYDQFMEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSQQKILED
INSMGTNTISIFPGRGFGDRRSGRIKTLTINDAKAISQQSYVASATPQTNSSGTLTYRNT
DLTASLYGVGEQYFDVRGLKLEEGRLFDDDDVKTDAQVVVIDQNTKTKLFGEGVNPLGKT
ILFKKRPLTVIGIMKKDDNSFGNSDSLMLWSPYTTVMHQITGESYTNSIVVKIKDDANTQ
VAEKSLTELLKARHGTEDFFMNNSDSIKEMVESTTGTMTLLISSIAVISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLSGVLLSASISLVFNYFVT
NFPMSISMTSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALAQD
>R5JYA1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEILKAIIYGIVEGITEWLPISSTGHLILVENFLPFKGVSENFFDMFDVVIQLGAIMAVV
VLFWSQIWPFAFTRKARNGETGFASVFKKDIWSMWFKILVSCVPAAVIGILFDDLFNRLF
YNPVCVSIALIVFGVAFIIIERWNKGRSSKVNALSEIGYNTAILIGIFQVIAAVFPGTSR
SGATIVGALLIGVSRKVAAEYTFFLAIPVMFGASLLKIVKFGFAFSSLELVVLAVGTIVS
FLVSMVVLKFLMAYIKKHDFQVFGWYRIVLGAIVLICGIAGVINV
>A0A0U1YUF1|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVALWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSRMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>D2J7V8|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSPHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKGLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>A0A0C2A587|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKTVVFAYHDIGCAGIQALLDSGYDIAAVFTHADDPKENTFYASVAQLCANKGIAVHA
PEDANHPLWIERIAKLDPDYIFSFYYRNLLSEPLLALAKKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQRVAIERSDTALSLHGKLRITASDLLRDALP
AMLHGKLRETPQDESQATVFGRRTPADGKLVWAQPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWSADVVKGNEGQAPGRVISVDPLRIACGEDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSLLRGAESGRGPRRTRVLILGVNGFIGNHLSERLLRDERYEVYGLDIGSDAIDRLR
SHPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKHFDEDRSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIANAKRLLDWTPTVEMRETIGNTLDFFLREAMAEIE
SKR
>A0A0J1K7Y9|FEATURES|UNIPROT_deepARG|beta_lactam|SK32_02805|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMKEQAIPGMAVAVIYQGKPYY
FTWGKADIANNRPITQNTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTRYWPELTGKQ
WQNISLLHLATYTAGGLPLQIPDEVTNKTALLRFYQNWQPQWAPGAKRLYANSSIGLFGV
LAVKPSGMSYEGAMIRRVLQPLKLTHTWITVPQNEQRDYAWGYRDGKPVHVSPGQLDAEA
YGVKSSIMDMARWVQANMDASHVQEKTLQQGIGLAQSRYWRIGEMYQGLGWEMLNWPVKA
DTIINGSDSKIALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLA
NKSYPNPARVDAAWRILEKLQ
>A0A0U1YUF4|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERGQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A0I9QQ15|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
RSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>A0A0A3YPZ6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYHDMGCAGITALLNAGFEISAIFTHADSANENHFFGSVARLAAEQGIAVYAPE
DANHPLWVDRIKSMAPDYIFSFYYRNLLNDSILSSARLGAFNLHGSLLPKYRGRAPLNWA
LVNGETETGVTLHRMVKRADAGDIVAQQRVVIEEQDNALTLHRKLTACATQLLEQALPAM
KRGEIAAIPQDHSQATVVGRRTPEDGRIKWEQSAQSINNLVRAVTDPWPGAFAFAGTVKF
VVWKGRVHADAPKAKPGTVISVEPFLIACGEGALEVVTGQSENGVYMNGSQLAQSLGMVP
GALLYSQPVAAVKRRTRVLILGVNGFIGNHLTERLLQDDNFEVYGLDIGSDAISRFLDQP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDKHFDEDHSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGAQKRCFTDI
RDGIEALFRIIENKNNNCDGQIVNIGNPENEASIKELAERLLASFERHPLRNQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIKNARRLLDWTPTIEMDTTIDNTLDFFLRTVELQDKP
>L8K7C6|FEATURES|UNIPROT_deepARG|beta_lactam|D505_09853|antibiotic inactivation|1
MKNIMRALILVFGFMSFFMFGQENPDVKIDKLKDNLYVYTTYNTFNGTKYAANAVYLVTD
KGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTK
MTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCI
IKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINEY
QQKQKASN
>YP_002386378|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQGLLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>A0A022SW47|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFYGENVEFDDLFDIFIQSGAILSV
LFLYREKFKSQIVSSFRYILKQNSDSEGFHFLIQICIGAFPILIAGFIAKKFLDTIKARP
DLLEILSGAWIFGGVLILVAEWYFHQRPEEKKPIGFKDSILIGIFQCMALIPGMSRSAAT
IITARFLGKDTKSSAEFSFFLAVPVLLAAGIYKLIKYRSILNGNTIPVLMFGFLVSFLLC
TLVIRWFLRYIQKHSFSVFGVYRILLGVGVLVLTKLI
>R8R0S8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDTIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAVL
YHKRLVSLCSIKPLLQKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKPEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTMSGGLLAKVNY
NAASEFSFLIALPVMVGATGLDLLKSWEHLSIDDIPMFAVGFITSFVVAMLAVVTFLKLL
SKIGLKPFAYYRILLAIVFTIFVLL
>G5LNQ4|FEATURES|UNIPROT_deepARG|aminoglycoside|LTSEALA_2290|antibiotic inactivation|1
MPSHHARPLIRSALMDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASF
IAMADGVAIGFADASIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTN
KGCREMASDTTPENTISQKVHQALGFEETERVIFYRKRC
>A0A127SBC5|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MMQFTKIDINNWTRKEYFDHYFGNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTIIN
RHEEFRTALDKNGQVGVFSEMLPCYTVFHKETETFSSIWTEFTADYTEFLQNYQKDIDAF
GERMGMSAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEEGGKYYIP
LSIQVHHAVCDGFHVCRFLDELQDLLNK
>A0A0U1YUE5|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATQQIAFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWAELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>J8GHZ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YYKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKTEATANSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLARVNY
KTASEFSFLIALPVMIGATGLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFILL
>W6VQX0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTFIQVLILGAVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRPKIFDIVKGLPTQRNAQRFTLNLLIAFLPAVILGVLFADKIHQYLFNPITVAMALV
VGGIVMLWAEQRSHVVSVDHVDDMRWSDALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQASDLPVFALGFVIAFIFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLLILATWVFGWVNWTEAAAG
>CAA61967|FEATURES|ARDB_deepARG|fosfomycin|FosB3|antibiotic inactivation|1
MIKGINHITYSVSNIAKSIEFYRDILGADILVESETSAYFNLGGIWLALNEEKNIPRSEI
KYSYTHIAFTISDNDFEDWYNWLKENEVNILEGRDRDIRDKKSIYFTDLDGHKLELHTGS
LEDRLSYYKEAKPHMNFYI
>J2Y9L4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRGKILEVVFGLASQPKARRFTGNLLLAFMPAVVLGVLFADLIHHYLFNPITVAAALV
VGGVIMLWAERRSHRVEVDHVDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYAAFAWYRIVFGLLILATWQFGWVDWATANG
>M1MA90|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLDILFIIKAIIMGIVEGITEFIPVSSTGHLILTGSIINFRGDFADMFEVVIQLGAILA
VVVLYWEKIRDSVVDFFQYIFTKGKEGEVGFRFGINVIVGTIPAVIFGGILHDKIKKILF
GPEPVVIAFLVGGILLIIIENKFRKNKHAIRDIDKITPMQSLKIGLFQCLAMWPGMSRSA
STIMGGWVAGLSTSIAAEYSFFLAIPAMVGSSGLDLIKFDYSQMNLTNALALAIGFIVSF
IVALIVMRRFINYLKKRPMRVFAVYRIGAGIVFGILIFLKVISV
>C9A026|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANFIKAILFGIIEGITEWLPISSTGHLILADEFIGLKVSPEFMAMFNVVIQLGAILA
VVYLYFHKLNPFSPTKNALEKRDTWTLWSKVIIAVLPSVIIGLPLDDWLDAHFYNFLSVS
IVLIIYGIGFIVVEKRNKNKEPKCTDLNKFTYKAALIVGMFQVLALIPGTSRSGATILGG
IMIGASRFVATEFSFFLGIPTMFGASIWKIYKFLKVGNAFDLQGTVILLTGTIVSFIVSV
LAIRFLMNYIKRNDFTFFGWYRIVLGAVLIVYWLVSL
>A0A0D1N8M4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELTGIHRRYLSGGEPVDVLKGVTLSINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGSYKVAGVDVATLNSDELAKLRREHFGFIFQRYHLLSHLTAAQNVEIPAIYAGVARKA
RQQRARELLDRLGLAARVDYSPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMATLKQLRDRGHTVIIVTHDPAIAAQAERVIEIRDGEIISNPPARSGRAAANVERTP
ADGGWQQLTSGFREAFSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLE
DIRSIGTNTIDIYPGTDFGDDDPQYQQALKYDDLVAIQKQPWVRSATPALSSNLRVRYGN
KDVAASANGVSEQYFNVYGMTFSEGNTFNQAQHQGRAQVVVIDENTRRQLFPDKRNVVGE
VILVGNMPATIIGVAQEKQSMFGSSKILRVWLPYSTMSGRVMGQSWLNSITVRVKDGYNS
QEAEQQLTRLMSLRHGKKDFFTWNMDGFLQTAERTTRTLQLFLTLVAVISLLVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGIGLSLLIAFTLQLFL
PGWQIGFSGLALLTAFVCSTATGILFGWLPARNAARLNPVDALARE
>ZP_02414083|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIAAAAFAVVFIAGLGTFGAIRVNAGAPEKSAAPLPEVDVATVLSKTITDW
QSYSGRLEAVEKVDVRPLVSGTIVSVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
GAQARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREASANLKAAEAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYIGGAKD
GRKVPVELGLANESGYSRQGVIDSVDNRLDTSSGTIRVRARFDNADGALVPGLYARVKVG
GSAPHPALLIDDAAINTDQDKKFVFVVDQQGRVSYREVQLGAQHGNQRVIVGGLAASERI
VVNGTQRVRPGEQVKPHLVPMTGGDDAAAATPVAGGVQRPRTAQGNARA
>A0A0M1I685|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGNLEAFKALFLGFIEGLTEFLPISSTGHLILFGHLIDFHSDSGRAFEVVIQLGAILAVC
WLYRKKIIDLVKGFFSGDAEARHFTFSVLIAFFPAVIIGVLAVDFIKSVLFSPMVVAVAL
IVGGLIIFWVESRDFKPSTTEATRITFKQAIIVGFVQCIAMIPGTSRSGATIIGGMLSGL
SRKAATEFSFFLAMPTMLGAATYDLMRNASILTSDNMLNIGLGFVAAFISALFVVRALVR
FVEKHTLRVFAWYRIALGAIIMLVMF
>A0A0K2P0K2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGDTEVEVLKGVSLTIHAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGSYKVAGVDVATLSGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAIYAGTGRAA
RQARARELLARLGLEARVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVIATLKQLRDRGHTVIIVTHDPNVAAQAERVIEIRDGEIISNPPPVAAREGARLNTQP
HDAPALGQFINSFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVL
EDIRSIGTNTIDVYPGKDFGDDDPQYQQALQYDDLQAIQRQPWVSSATPAVSQNLRLRYG
NVDVAASANGVSGQYFNVYGMTFSEGNTFNDEQLRGRAQVVVIDSNARRQLFPNKASVVG
EVVLVGNMPATVIGVAEEKQSMFGSSKILRVWMPYSTMSGRIMGQSWLNSVTVRVKEGYD
SGEAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGIGLSLLIAFALQLI
LPGWEIGFSPVALLTAFLCSSATGVLFGWLPARSAARLNPVDALARE
>Q0B2H6|FEATURES|UNIPROT_deepARG|beta_lactam|Bamb_6103|antibiotic inactivation|1
MRFNAIRIAATLFVAACAAVTAGRAAAATPDEIHDTVTRNVAPLMKQFAIPGMAIGIVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLASDAQEGGELSLSDPAAKYLPA
MQGKPFGGVTLLELGTHTPGGMPLQVPDSIRDDADLMRYLDAWRPAYAPGTRRTYSNVAI
GMLGQLTAKAMNRDFAALMEQRLFPALGMTHTYINVPAARRGDYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLVETAPRMQRALERTHTGYFRAGPFTQDLIWEQYP
YPVALPTLLEGNGPAMLHDATPATELKPPLAPRPDTWINKTGSTNGFSTYVAFVPAKRIA
IVMLANRSFPIEDRVKAAYRIVESLNGKP
>I0TEV1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLIQTIIISIVEGLTEFLPVSSTGHMIITQHLLGVSQGSPFVHAFTFIIQFGAILSVVC
LYWKRFFHIDRTPVPADVENPFLRFIHPLRFYWLLFVGVLPAVVIGLAAKKSGLLDWLLD
SIWAVAIMLVVGGIFMLFCDKVFNKGREENKVNEKRAFNIGLWQCLSVIPGTSRSMATIV
GGMANGLTRKRAAEYSFFLAVPTMAGATLLDLLDILKEDATWVNTHDLLMLAVGCVVSFV
VALLAMKWFVSFLTKYGFKVFGWYRIIIGIIIIVMLLSGISLNMVD
>W0U1C3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQALLELKGISRSFVAGEKAFMALKDVSLTINAGEMVAITGASGSGKSTLMNILGCLDY
ATDGSYTISGRETRDLADQELAELRRDHFGFIFQRYHLLPHLSAMHNVEMPAIYAGVSEG
ERHSRAKELLARLGLANHLVNRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTAS
GKEVMNILLELHAAGHTVIIVTHDAKVAANAERIIEMRDGEVLSDRVNERAGVEVAPPAS
TTIKAKPGRRLVASLGLFKEAFVMAWVALISHRMRTLLTMLGIVIGITSVVSIVAIGEGA
KRYVLSDIQAIGSNTIDIYPGNDFGDSHASAIETLVLSDVTALSELHYIDSATPNAGRNL
LLRFGNIDVDATVNGVSASSFQVRGIKIAEGITFSQDDDTRQAQVVVIDHNTRNRLFGPN
VEALGQIILVGNLPCTVIGVAADNKNIFNTSKALNVWVPYETAAGRLLGQRYLDSITVRI
KDGQPSKVVEDNVVKLMEQRHGTKDFFTYNLDSIMQTVQKTSQSLALLLSLIALISLVVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGISLSFGIGF
VFSLLIKEWQMVFSLESIVTAFVCSSLIGIIFGFVPARNAARLDPIEALARD
>N8QUY6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFELVKGFFSGDSEARHFAFSVLIAFFPAVVIGIFAVDFIKSVLFSPLVVAIAL
IVGGLIIFWVESKNFDHKTTEATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAATFDLIRNADVLTQDNMLNIGVGFVAAFISALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>L0M3G6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGVQALLDAGYEIAAIFTHPDNAQENHFFGSVARLAAEHGITVYAPD
DVNHPLWIDRIRAMAPDVIFSFYYRNLLSDAILSLAPKGGFNLHGSLLPKYRGRAPLNWV
LVNGEQETGVTLHRMVKRADAGDIVAQQKVAIAESDSALSLHRKLCAASQTLLHDALLQI
YENRTHERKQDESQATYVGRRTPEDGRLEWEKTANELHNLVRAVSDPWPGAFSFVGQHKF
IVWKSRVHPQPVTARAGTVLSVAPLMIACGEGALEIQTGQTEKGVYMQGAQLAQSLGLVT
GALLSSKPVVALKRRTRVLILGVNGFIGNHLTERLLKDDRYEIYGLDIGSDAIGRFMDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRDC
VKYNKRIVFPSTSEVYGMCTDKDFDEDNSNLVVGPINRQRWIYSVSKQLLDRVIWAYGEK
SGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGSQKRCFTDI
SDGIEALYRIIENEDNRCDGQIINIGNPDNEASIKELAEMLLDCFERHPLRQHFPPFAGF
RDVESSDYYGKGYQDVEHRKPSIRNARRCLNWQPGIAMQQTVEETLDFFLRTVELGGDEP
S
>A0A0B7J251|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILLFKALLLGLVEGATEFLPISSTGHLIIVGDLIDFLDKEKRDVFEIVIQLGSILSV
VWLYQARFKTIARTIASDKQSQQFVLQLLIAFLPLAILGLLFHHQIKAVLFNPISVAIAL
IAGGLIILYIEKLSLKARISKIESMTMLDALKIGLAQALALIPGVSRAGATILGGMSFGL
SRQVATEFSFFLAVPVMFAASGYDLLKNRHLLTLDDAGLFAIGFIAAFLSALVAIKTFIR
YIAAHDFRVFAWYRIALGLIVLLYFK
>A0A132PIK8|FEATURES|UNIPROT_deepARG|beta_lactam|AFM11_22160|antibiotic inactivation|1
MTGLSRRNVLIGSLAAVAAVGVSSRTAYAVPVDDQIGELERRHNAVIGIYAVNLDSNRIV
SHRADDMFAMCSTFKAYAAGRVLQMVGRDQLSLDNRVFVDPDAIVMNSPVTEPRAGSEMT
LGELCAAALQRSDNTAGNLLLKTIDGPAGITAFARSIGDERTRLDRWEVELNSAIPGDPR
DTSTPAALAIGYRALLVGDALSPPQRRQLEDWMRANQTSSMRAGLPAGWTTADKTGSGDY
GSTNDVGVAYGPAGQRLLLAMMTRSQTDDPKAANLRPLIGELTASVLPSLL
>A0A0T9QQB9|FEATURES|UNIPROT_deepARG|polymyxin|pmrF_1|antibiotic target alteration|0
MLIGWLMHSQRLWGHTVSQNEAIKKVSIVIPVYNEQESLPALIERTSAACQHLTQPYEII
LVDDGSSDSSGDILTAAANEPDSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQ
NPPEEIPRLVTVAEEGYDVVGTVRSNRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLR
AYRRHIVEAMLHCHERSTFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDL
ITCLTTTPLRLLSLVGSVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQ
FVGMGLLGEYIGRIYNDVRARPRYFIQKVVGGEQTENNQEVEK
>A0A0F3LXD7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYHDMGCAGITALLNAGFEISAIFTHADSANENHFFGSVARLAAEQGITVYAPE
DANHPLWVDRIKSMAPDYIFSFYYRNLLNDSILSSARLGAFNLHGSLLPKYRGRAPLNWA
LVNGETETGVTLHRMVKRADAGDIVAQQRVVIEEQDNALTLHRKLTTSASQLLEQALPAM
KRGEIVAIPQDHTQATVVGRRTPEDGRILWEQSAQSINNLVRAVTDPWPGAFAFAGTVKF
VVWKGRVHADAPKAKPGTVISVEPFLIACGEGALEVVTGQSENGVYMNGSQLAQSLGMVP
GALLYSQPVAAVKRRTRVLILGVNGFIGNHLTERLLQDDNFEVYGLDIGSDAISRFLEQP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDKHFDEDHSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGAQKRCFTDI
RDGIEALFRIIENKNNNCDGQIVNIGNPENEASIKELAERLLASFERHPLRNQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIKNARRLLDWTPTIEMDTTIDNTLDFFLRTVELQDKP
>B9L7I2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIFDSIILGIVEGITEFLPISSTAHMIIVSTLLGLKQSVQNVAFEVIIQLGATLAIVLI
YLEKINFKEINLWKKVLIAFMPLAVIGFLLRHQIKALFTIQTVAWMFIIGGIVFFIVEKI
YSEEKVKIRDVEKVSLREALIIGFFQVFALIPGTSRSGATIVGGMLSGLSRKTAADFSFL
LAIPTMFAASGYELLKNIDSFTNQNMTVLAVGFVVSFIASYIAVKLFLKYVQKYTLNAFG
VYRIIFGIILLYLINQGIITS
>K9AZR3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MQGINHITFSVSDLKRSIYFYNHILKAKLIVEGHSSAYLDLAGIWLALNEEKDIPRDEIK
YSYTHIAFSIEENAFEEWYEWLVENEVNILEGRTRDERDKKSIYFTDPDGHKLELHTGTL
DDRIKYYKEAKPHMRFY
>A0A0P7CMR2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRGKIFEVVFGLASQPKARRFTGNLLLAFMPAVVLGVLFADLIHEYLFNPITVAAALV
VGGVIMLWAERREHRVQVDHVDDMRWTHALKIGFIQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYAAFAWYRIVFGVLILATWQFGWVDWSTAHG
>V5RTQ2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MNIFSAILLGLIEGVTEFLPISSTGHMILVSDILKLPNTDFLKSFEIAIQVGAIFAIIVM
YTPRFLKNIRVYQLLLFAFLPATIIGFLFYDFIKTYLFNPAIVSATLITGGVFLVYFDRK
IKNHSEKIEKLEEISSKDAFIIGLSQTLAMIPGVSRAAATITGGVLRGLSKKQAMEFSFL
LAVPTMLAATGYDLIKTSSNYSTYEFGLLGMGSIVSFVSAWIAVRLFIKIIDKHGLAFFG
YYRIILGVVYLLYFQ
>ABX79421|FEATURES|ARDB_deepARG|glycopeptide|VanXYC|antibiotic target alteration|1
MNPYLQLVSKEFPLEKNQEPPHLVLAAFSEDDVYLQPEAAKQWKRLVKALKLENEICLLD
GYRTEKQQRYLWEYSLKENGLAYTKQFVALPGCSEHQLGLAIDVGLKGSQDDLICPRFRD
SAAADLFTQEMMNYGFILRYPADKQEITGIGYEPWHFRYVGLPHSQIIASQQWTLEEYHQ
YLEQTARQFA
>ACI85881|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFMTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>AAD51061|FEATURES|ARDB_deepARG|glycopeptide|VanXD|antibiotic target alteration|1
MKKNFAFLDEMIPGIRWDAKYATWDNFTGKPVDGYMVNRVMGTKELGVALRKAHKMAEKL
GYGLLLWDGYRPQCAVDCFLNWASQPEDNLTKKRYYPNIKRNEMITKGYVASQSSHSRGS
TVDLTIFHLNSGMLVPMGGDFDFMDERSHHAASGLSEEESKNRQCLRYIMESSGFEAYRY
EWWHYVLADEPYPDTYFDFCIA
>P9WJX8|FEATURES|UNIPROT_deepARG|tetracycline|MT1297|antibiotic efflux|0
MRNSNRGPAFLILFATLMAAAGDGVSIVAFPWLVLQREGSAGQASIVASATMLPLLFATL
VAGTAVDYFGRRRVSMVADALSGAAVAGVPLVAWGYGGDAVNVLVLAVLAALAAAFGPAG
MTARDSMLPEAAARAGWSLDRINGAYEAILNLAFIVGPAIGGLMIATVGGITTMWITATA
FGLSILAIAALQLEGAGKPHHTSRPQGLVSGIAEGLRFVWNLRVLRTLGMIDLTVTALYL
PMESVLFPKYFTDHQQPVQLGWALMAIAGGGLVGALGYAVLAIRVPRRVTMSTAVLTLGL
ASMVIAFLPPLPVIMVLCAVVGLVYGPIQPIYNYVIQTRAAQHLRGRVVGVMTSLAYAAG
PLGLLLAGPLTDAAGLHATFLALALPIVCTGLVAIRLPALRELDLAPQADIDRPVGSAQ
>ZP_04187115|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MEKMKNNTLLKLGVCVSLLGTTQFVSTISSVQAEQKLEKKVIKNESGTISISQLNKHVWV
HTELGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHA
HADRIGGIKTLKERGIKAHSTALTAELAKKSGYEEPLGDLQSITNLKFGNMKVETFYPGK
GHTEDNIVVWLPQYNILAGGCLVKSASAKDLGNVADAYVNEWSTSIENVLKRYGNINSVV
PGHGGVGERDLLLHTLDLLK
>A0A059I2I0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDNLHALILGIIEGLTEFLPISSTGHMILGTTILGIDINEFWKSFLIIIQLGSILAVLFV
FWRKLFKGLDIWFKLAVGFFPTGLIGFVLYKYLKELFNGYVVVVMLILGGIVFIVIELAH
KNKEYKTNSLEKVSFLQAFCIGIIQSLAMIPGTSRSGASIIGGLLLGLNRKTAAEFSFLL
AIPTMIVATAYSIYKEPELLSNANALIPLSIGFVTAFVVAVFVIKFFLKFISKFDFIPFG
IYRIVLGILFFYLYYSGILNSGSEFKL
>A0A119LN97|FEATURES|UNIPROT_deepARG|beta_lactam|WJ87_19210|antibiotic inactivation|1
MTYSSQRRTLLLAAATAPLALTLSACASPLANASSVGAATSLAELERAAGGRLGVHALDT
ATGRRVQHRADERFPFCSTFKAILIAAVLAESVARPALFTQRVTYRQADLLEWSPVTEKH
VDTGMTVSELCEATAQYSDNAAANLLMKLLGGPAAVTAFARSIGDDTFRLDRWEPELNTA
LPGDARDTTTPAAMVASLRALALGDALPAPQRAQFAQWLRGNKTGDKRIRAGVPTGWQVG
DKTGTGDYGTTNDIGVLWPPARGPIVLTVYYTQARADAKRKDDVIAAATRIAIAALG
>A0A085GFM6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|GEAM_1419|antibiotic efflux|1
MADSTALIELKGIYRHFISGSKSVEVLKNISLSIHSGEMVAIVGASGSGKSTLMNIIGCL
DKPTQGEMRIMSVPTDTASSAELAQLRSQFIGFIFQRYHLIPYLTAQENVSIPALYTAMP
AAEREVRAQHLLTRLGLAGRMLYRPAQLSGGQQQRVSIARALMNGANIILADEPTGALDS
TSGQELMAILHGLHQAGHTLIIVTHDRTIARQCQRIIEISDGEIVADNQNPEWEKSTISA
ALPLAVATGRSPAWRDVKESIRMAWRSLLGHRGRAFLSMLGIIIGISSVVSSMAVGEGAR
LSIISQINQLGSSTLDILPGIGWEQTRPEFQRALKISDVELLQRQPYVDSLSPVVVKQTT
AIRASKQVWASLNGVSEGYFDVLGATFSAGRRFNQQDVSHGEPVIVIDSNVKATLFPYNQ
NPLGQIIQLAGVPFRVIGVADKPGPKYSGAYLEAWTPYTALLQRMSGDKPLDSITLRVAQ
GYDMNNVQRKVEKQLEVEHGQRDFFIMTNDEMSKAIKSASDSMTLLITAIAGISLLVGGV
GVMNIMLVSVTERTHEIGIRLSVGARPSDIMRQFLIEAMVICSLGGAIGIIGSGIAGLIF
AQITDAFTMVFTWPPVVMACAFSALIGLGFGFAPARNAARLHPTEALARE
>K9MQ30|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MVFVAKPPPRFIRKLKEPPLNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAP
ASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKA
WPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLA
RVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMI
ANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG
>Q83ZX5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0H0SY32|FEATURES|UNIPROT_deepARG|beta_lactam|AA982_22440|antibiotic inactivation|1
MTGLSRRNVLIGSLVAAAAVGTGVGGAAPAFAAPIDDQLAELERRDNVLIGLYASNLDSG
RRITHRADQMFAMCSTFKGYAAARVLQMAERGEISLDNRVFVDADALVPNSPVTETRAGA
EMTLAELCQAALQRSDNTAANLLLKTIGGPAAVTAFARSVGDERTRLDRWEVELNSAIPG
DPRDTSTPAALAVGYRAILAGDALSPSQRGLLEDWMRANQTSSMRAGLPEGWTTADKTGS
GDYGSTNDAGIAFGPDGQRLLLVMMTRSQAHDPKAENLRPLIGELTALVLPSLL
>YP_002896634|FEATURES|ARDB_deepARG|multidrug|OprA|antibiotic efflux|0
MKAMIKPRARRRGARAARRPNGPRAWPLAVAAALVAGCTLAPRYERPAAPVPAHYWSTAA
GAPREAGPAAAGGPRAMPDARRGDAGRDARDARLDDWRAYFTDPALRALIDAALANNRDL
RIATLRIQEARGLYGVARADRLPSIDGSLGYERTRLYDPVLRESATSSLYRASVGVSAFE
IDLFGRVKSLSDAALAEYFATAEAQRAVRISLIAEVASAYVTERALVDQLGLAERTLAAR
DAAYALTQRRYAAGTSTAIELRTAEMLVASARASKAALEREHTQAASALKLLAGDFMTAL
PADAPALDALAVARVSPGLSSDLLEQRPDIRQAEQRLVAANANIGAARAAFFPRIALTTD
VGSVSDAFSGLFSAGSSVWTFAPRLTLPIFAGGRNRANLDVADARKHIAVAEYEKTIQTA
FREVADALAARDQIDAQLAAQQAVYGADAERLRLAQRRYDSGVASYLELLDAQRSTFESG
QELIRLKQLRLTNAITLYRALGGGWSRAGCGGDECA
>A0A0G3FFI8|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-1|antibiotic inactivation|1
PETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDA
GQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPK
ELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQ
LIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGS
QATWDER
>YP_001348103|FEATURES|ARDB_deepARG|multidrug|oprN|antibiotic efflux|0
MIHAQSIRSGLAPTLGLFSLLALSACTVGPDYRTPDTAAAKIDATASEPYDRSRFESLWW
KQFDDPTLNQLVEQSLTGNRDLRVAFARLRAARALRDDVANDRFPVVTSRASADIGKGQQ
PGVTEDRVNSERYDLGLDTAWELDLFGRIRRQLESSDALSEAAEADLQQLQVSLIAELVD
AYGQLRGAQLREKIALSNLENQKESRQLTEQLRDAGVGAELDVLRADARLAATAASVPQL
QAQAERSRHRIATLLGQRPEELTVDLSPRDLPAISKALPIGDPGELLRRRPDIRAAERRL
ASSTAEVGVATADLFPRVSLSGFLGFTAGRGSQIGSNAARAWSVGPSISWAAFDLGSVRA
RLRGARADADAALASYEQQVLLALEESANAFSDYGKRQERLVSLVRQSEASRAAAQQAAI
RYREGTTDFLVLLDAEREQLSAEDAQAQAEVELYRGIVAIYRSLGGGWQPSA
>U1S3W9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEMKNINRYFGAGENRVHILKDISLNIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAT
SGSYKIDEKETIELTADQLSDLRSQKFGFIFQRYNLLSSLTAAENVALPAIYAGMPHNQR
LERAKQLLKKLGLSDKWQNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQSGE
NVLEILRQLHQEGYTIIMVTHDKHIAASANRMIEIKDGEIISDTQAQPVKSAVKNSGVFK
GRFGFSKDQLMEAFRMSVSAIVAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILENI
RGIGTNTITIFNGTGFGDRRAEQMQNLTVSDANTLRQQTYVQSVTPNSASSGTLIYANKA
FSTTSLKGVSEESFDVEGLKLKQGRLLSAQDVAENAQVALIDESAKKAIFPNENPLGKVV
IFNKRPLRIIGVVSDRQMGGASSSLNLYAPYTTVMNRISGSKKIGSITVKVAEDVNTTAA
EKGITELLTLRHGKKDFFIMNSDTIKQTIESTTGTMKLLISSIAFISLIVGGIGVMNIML
VSVTERTKEIGVRMAIGARQSNILQQFLIEAVLICLIGGVTGILLSGAIGVLFNTFMTDF
TMAFSGGSIIAAVAFSSLIGVVFGYTPAKRAAQLDPITALAHE
>A0A061YU99|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
KLWTLATGLGQRDNRDYVLKIGVAFLVTAVVGLIVRKAGWQLPETVQPVAWALLIGGLWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASAIFLAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGSENWADVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAVYRIVLGAALLLWLPALA
>YP_002388977|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPASFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPDQVTGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>V9SHK8|FEATURES|UNIPROT_deepARG|beta_lactam|pSA268_007|antibiotic inactivation|1
MKKLIFLIAISLVLSACNSNSPHAKKLNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQIPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>A0A0V2DG86|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLVAAQAERIIEIHDGKIVHNPPAQEKKREQGVAAAT
VNTASGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQVLKYDDLVAIQKQSWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFSEGNTFNAVQQRDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKQSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
NSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A024IRB6|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLVSIALALPTSAKARRFVLAVALAFLPAAVIGALAHDFIKTVLFETPMLICVVLI
IGGVILLAVDRMPLKPKYTDIMDYPPSLAFKIGLFQCLAMIPGTSRSGATIVGSLLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDGALIAVGFIAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIVIGSLGLIALLIFG
>A0A0N9LX21|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-12|antibiotic inactivation|1
MPRMLLSSLLAAGLFCALPASAASGCMLFADGTGKPVSTQGDCAAQLTPASTFKIPLALM
GYDSGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSSWMQFSVIWYSQRLTEWLGEARFQH
YVDSFDYGNRDLEGNPGKHDGLTQAWLSASLAISPQEQARFLGKMVSGKLPVSAQTLRHT
ANLMRQPDIDGWQIHGKTGMGYPKLLDGSLDREQQIGWFVGWASKQDKTLIFVHTVIQTP
GKQFASLRAREEVFAALPARLKTL
>A0A127SAW1|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-12|antibiotic inactivation|1
MLLSGLLAAGLFCALPASAASGCMLFADGTGKPVSTQGDCAAQLTPASTFKIPLALMGYD
SGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSSWMQFSVIWYSQRLTEWLGEARFQHYVD
SFDYGNRDLEGNPGKHDGLTQAWLSASLAISPQEQARFLGKMVSGKLPVSAQTLRHTANL
MRQPDIDGWQIHGKTGMGYPKLLDGSLDREQQIGWFVGWASKQDKTLIFVHTVIQKPGKQ
FASLRAREEVFAALPARLKTL
>C7IVG9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLIKAFIMGIVEGLTEFLPISSTGHLIIVGSFINFTGKFATMFEIVIQLGAILAVVYY
YKGKIFASLKNLKPGDWGFNLWFKIFIAFIPAAVIGLFTHKYIEEHLFSPFTVAIALIVG
AIMMIVIEDTFGKRYKIDNMDKVDTKKSLLIGIAQVMSLFPGMSRSASTIMGGMLAGLSV
KAAAEFSFFLAIPTMFAATTLSLLKGFSAMSLLEWQALAVGFITSFLTALFVVDKFLSYL
TRHSLKPFAYYRLAVGVLMILLVAEKIVK
>R5W6M8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEGDLSLFQTIVIAIVEGLTEFLPVSSTGHMIITQHILGVESTDFVKAFTFIIQFGAILS
VVCLYWKNFFHLNHTPMPENCTPVKRFLHKYDFYWKLLVAFIPAAVLGLLFSDMIDAMLE
SVTVVAVMLIAGGIFMLFCDKIFGNGSEKTVLTEKRAFFIGLFQCISMIPGVSRSMATIV
GGMAQKLTRKKAAEFSFFLAVPTMFAATVYKMAKLFMDGGAEIISTNLTTLIVGNVVAFI
VALLAIKFFISFVTKYGFVAFGWYRIIVGSIILIMSFLGYNLELA
>A1YJK6|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA21|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A086MZZ5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTEFRKVSASVRELTVSGPDAGSYALAEGPDGALWFTLVHQGAVARRDPGGGGVTVHPVG
AGPTIVAAGPDGAVWFTEYRAHRIGRIAPDGSYSSFAPPTPEGGPFGIVAGPDGAMWFTL
SAADRIGRVTMGGEMTEYPAPGAFPSAITAGPDGALWTTLNQHNAIGRIGTDGTGTVHAL
PTGGAAPVGIAAGPDGALWFTEIGAGRIGRITVDGEITEYPLPDPACRPHAVTAGPDGAM
WFTEWGGGRVGRITVDGRVTSYALSRPDSEPHGIAPHDGALWCALETGSLARIEVPV
>A0A0S3JHI2|FEATURES|UNIPROT_deepARG|beta_lactam|AO703_07405|antibiotic inactivation|1
MWSTRPVAPLVMAAALLMASNTAMAEKTQNLDELVNSTITPLMKQQDIPGMAVAVIVDGK
THIYHYGLADVKNQRPVTDDTLFELGSVSKTFTGIAGGYAVQSGILRLNDPVARYAPQLT
SPQWRKITMLQLATYTAGGLPLQVPDDVDNTDALWLYYQHWRPQWTPGTQRQYSNASIGL
FGALAVKNSGLSFDAFMKQHVFTPLQLNHTWINVPAEAEKDYAWGYRNGQPVRVSPGMLD
AEAYGVKTTVKDMAAFMQANIDPEALAAKEAGLAKAIAIAQTGYYKIGDMYQGLGWEMYP
WPADAEKVITASGNDLALKARPAKRLSPSRPVTAATWLHKTGSTNGFGAYIVFIPEKKVG
IVMLANKNYPNPARVSAAWQILQKLP
>A0A0S3BXC1|FEATURES|UNIPROT_deepARG|beta_lactam|ATN06_12140|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDSNTQSESLKQTKQTNQIKQETTGNDSFA
KLEKKFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEMYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKTLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKKNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIALDTLKTTNK
>A0A0N0XGS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MDVVLLLKSLIMGVVEGVTEFLPISSTGHLILAGDLINFWPDQKEKRDVYEIFIQLGAIL
AVVWEYRAKLAQTFAGATRPGRDRNLLLAVIVAFIPAAILGKLLSETIKAHLFKPVPVAL
AFIIGGLLILWAEKRQHRVRIQDVDNITWKDGLKVGFAQCLALIPGTSRSGATIIGGLFL
GLSRKAATEFSFFLGIPTLTAASVYSMWKLRHVLDMADFGVFAVGFVAAAISAFIAVRAL
LRFIATHTFIAFAWYRIAFGIIVLLTAYTGVVHWAE
>YP_001175678|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGLTPLAIVLMLSGGLALTGCDEKQAQQGAQQAPEVGVVTLKTEPLQITTELPGRT
SAYRVAEVRPQVNGIILKRNFTEGGDVKAGESLYQIDPATYQAAYESAKGDLAKAEAAAR
ISQVTLNRYKKLLGTQYISQQDYDTAQADSQQANAAVVAAKATVETARINLAYTKVTSPI
SGRIGKSSVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLQKELASGALKQENG
KAKVQLVTNDGNKFAQEGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
INPTALLVPQQGVTRTPRGDASALVVGADDKVEMRQITATQAIGDKWLVTQGLKDGDRVI
ITGLQKVRPGAQVKAQEVKSDEKQQAAAGGESEQTKS
>A0A061SVJ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSSTTLVAAFLGLVEGLTEFIPVSSTGHLLLAGHFLGFESAGKTFEVVIQLGAVLAILT
LYAGRLWSVFSTAPHDAQSRRFILSVLIAFLPAVFIGVLAHDFIKTVLFETPMLIAIMLI
LGGFILLVVDRIAPEPVHDDAMRFPISMALAVGFIQCLAMIPGVSRSGATIVGALMMGSS
KRAAAEFSFFLSMPTMAGAFAYDLYKNRDVLDASAMGEIAVGFAMAFVSAVLVVRWLLGY
VSKHGYALFGWWRIIVGTAAVAGLLTLG
>A0A0J7GMR6|FEATURES|UNIPROT_deepARG|beta_lactam|TU58_23735|antibiotic inactivation|1
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGITALKERGIKAHSTALTAELAKKNGYEEPLGDLQTVTNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNINAVVPGH
GEVGNKGLLLHTLDLLK
>K4ZGC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFYVIVAVVLGIVEGLTEFIPVSSTGHMILTTKLMGIEEQASWLKTFEIVIQLGATLAMM
VVYWDRIMGMLGLRKRTVQQGNVVCQRLNLLHVAIGIAPALGVAYLAKDHIKQLFDSTST
VLLALVVGGAFMWFAEWYGSRREPSAKTMDDISYKQAFSIGLFQILSVLWPGFSRSGSTM
SGGMMSGVSYRASADFSFLIAIPIMCAASGYELLDNYKMFTLDILAFLCSVFSIFCGSLC
NCCCLPQAYSAD
>F3MDY6|FEATURES|UNIPROT_deepARG|chloramphenicol|HMPREF9412_0771|antibiotic inactivation|1
MNFHTIDIERWNRLPYFEHYTNVNQCTYSMTVDTDITLLLQALKIRGYKLYPAFIYMVTR
VVNERVEFKTSYSPEGQLGYWDSMTPSYTFFHKDDHTFSSLWTEFANDFDRFHDLYEQDM
ERYRDVKGIFVKENPPPNTFPISMIPWARFSGFNLNIATNKEYLLPIITGGKYAEQGGRM
LLPVSLQVHHAVCDGYHASMFFQALQKMADSCEDWLK
>A0A127SQ00|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
ALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKK
QPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLAT
YTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFE
QAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMA
RWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKI
ALAARPVKAITPPTPAVCASWVHKTGA
>A0A0T9MAQ1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLKKSVINTLVFTAIATSPFYTSAQTILTEQQVAAIVNNTLKPLLEQQNIPGMAVAVFYD
GKPQFFNYGVADIKADIPVTENTLFELGSVSKTFTGIAGEYAMQTGIMNLNDPVTEYAPE
LTGSQWQDVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPQWAPGVMRNYSNASI
GLFGALAVKRSQLTFEDYMKKYVFQPLKLTHTFITVPESMQSSYAWGYKDGQPVRVTLGM
LGEEAYGVKTTTKDMVRYMQANMDPDSLPAENDKLKKAIIAAQSRYFQAGEMFQGLGWEM
YNWPIDPQRVIADSGNDIALKPRKVEELLPPHSATRASWVHKTGATNGFGAYIVFIPEEN
IGIVMLANKNYPNPVRVQAAYNILQALR
>C2MKR8|FEATURES|UNIPROT_deepARG|chloramphenicol|bcere0001_21780|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCTFSMTVNVDITMLLEEVYQKGIKFYPVFIYLVSKV
VNNHKEFRTSFNDEGALGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEKDMR
CYASVHGLFTKENIPPNVFPISSIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEENKIM
LPVSLQVHHSVCDGYHASRFIEDLQELSNSCNEWLK
>Q58G67|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGVAS
KQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFKDPASRYLPELRGSAFDGVSLL
NLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSLDQ
PFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIKSNA
RDLIRYLDANLQQVKVAQPWREALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLVEGNN
AGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFPNDD
R
>A0A139D818|FEATURES|UNIPROT_deepARG|aminoglycoside|mprF|antibiotic target alteration|0
MKGQNQNFIDKYFNLKNSFLYFGLFLFISVVSLYYINKIYSEGSNLDVFLRFPVKIIISI
FLLLFFYFIFDGLRLYFVLKTLKADISFWNIYKLVFINIFISNITPLATGGGFAQVYFLQ
KKGVPLGKSSAAVLIRTLLSAMMLFLSVPFILFRNQAMLNLLPGNYMYIYLAIFLSLYFL
VFYLLIFKLRLIMKYIYKLFYFLKKRHLLSKKRFRKIILYIFKHLELFSEDLAFFIQGKK
IFVFLSLIFTIIFLLAEFSFTFLILKGLGYSISFYQILTMQILVVFIMYFAPTPGAAGIA
EGGYSLLFARFVAKKDLFPLLFYWRFFSKYIGIFIGIFVFFYLIIRGGIKDEE
>K5YNN3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWIAVQALILGVVEGLTEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVV
WEYRRKIIGVVVGLPKEREAQRFTLNLLIAFMPAVVLGVLFADLIHHYLFNPITVATALV
IGGIVMLWAENRDHRIEAETVDDMRWTHALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDFPVFAIGFVTSFLFAMLAVRALLKF
IGNHSYAAFAWYRIVFGIIILATWQFGLIDWSTAVG
>A0A127T3S6|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
QKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGE
IKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAW
APGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWG
YREGKAVHVSPGALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQT
GDMYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGF
GSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>A0A0P9YNP6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVEVADLHEAPIAAQQPLLQLENVSRSFMAGDREVTVLKQINLSIHAGELVAIIGAS
GSGKSTLMNILGCLDNASSGTYRVAGQQTRDLDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNTEIPAVYAGTSQAGRHQRAQELLTRLGLGGHLEHRPSQMSGGQQQRVSIARALMNGG
EVILADEPTGALDTTSGKEVMRILLELHAMGHTVILVTHDPKVAANAERVIEVSDGEIIS
DKRTSPRVQPVAEPKPALQPAATTRRRMIASFGLFREAFNMAWIALISHRMRTLLTMLGI
IIGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGSNFGDSRAKSIETLLPSDVTAL
NQMYYIDSATPVVGRSMLVRYRNIDVDAQLNGVSSRYFQVRNIQLAAGITFDDQDARRQA
QVVVLDHNTAQRLFGPGVDPLGKVILIGKLPCTVIGVTSDHKNLFIAGNTLNIWMPYETA
AGRVLGQRHLDSISVRVKDGMPSKVVEEEIKALMLQRHGTKDFFTNNLDSVMQTVQKTSR
SLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMV
CLIGGVIGIGLSYGIGYLFTLFVKQWEMVFSMASVVTAFACSTLIGVLFGFVPARNAARL
DPIEALARD
>A0A081MH11|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPEDSIVSALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFQSPGNTFAVLIQLGAIMAILX
VYFRRLLDIAVNLPNSARARHFVLTVLIAFLPAALIGALAHGFIKTILFETPVLICIVLI
LGGIVLLIVDRMAFQPRYTDVMDYPLSLAFKIGLFQCLAMVPGTSRSGATIVGSLLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRXLISFDDGAVIVVGFIAAFLTALIVVRSLLDF
ISSRGYALFAWWRIFIGTAGLLGLLLF
>D4YEG5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDTLKVILLGIVQGITEWLPISSTGHMILLEEFITLNARREFWDIFLVVIQLGAILAVV
WINFNQLNPFAPSKSKAEKEETWMTWFKVVVGCLPAAIAGLILDSWIEANLMNWFVVAVM
LIVYGIWFIWIENRNTNRQAKINSMAEMTYMDAFKIGLFQVLALVPGTSRSGSTILGATI
VGTSRPLAANFSFFMSIPIMFGASALKLVKAFLSGFVFTGTEIWLLLVGMVVAYVISVLT
IKLFLKYIKANDFKVFGWYRIVLGIVVILYFLLFKS
>A0A0K1DN66|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQWNGTLVCTGLLLVSSVAFAEDNAAALDTLVQTEARKVMQENNIAGLSIAITRHGKQQF
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGQLSLTQSIDTYLPQLRDTR
LGKIPVFHLGTHTAGGFPIQVPENVQNTRQLMDYFKAWQPDYLPGTHRTYANPSIGLLGV
IAARSMNMPFQEAMQRRLFPALGLNSTYVSVPDEKQALYAQGYNKLDEPVRVSPGILAAE
AYGVKSSSRDLIRFVEANIGLGQHDAPLQRALSDTRVGYFKVGGMTQDLAWEQYPTPIRL
DMLLAGNASAMLNTQKAEAIEPPLAEQPTAWVNKTGSTNGFGGYVAFFIAERQIGIVILA
NKNYPNEERVKLAYRILQHAAPFN
>J7K749|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKVAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRRLVNRQLP
VKAAAYELAENLFEVGQADGWRLFGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP
>A0A0H3MX55|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MLLELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
MTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAI
ALIVYGIAFIWIENRNRGIEPQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAI
ILGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWILLVASVTAYLVSLV
VIRFLTDFVKKHDFTVFGYYRIILGAILLVYAFITFLF
>A0A062Y416|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSALSAPQQLNEIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGI
TLLHLATYPAGGLPLQVPDDVKSSSDLLRFYQNWQPEWAPGTQRLYANASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKHYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>YP_001668663|FEATURES|ARDB_deepARG|multidrug|MexD|antibiotic efflux|1
MSKFFIKRPNFAWVVALFISLAGLLVIPTLPVAQYPNVAPPQITITATYPGASAKVLVDS
VTSIIEESLNGAKNLLYFESTNNSNGMAEVVVTFEPGTDPELAQVDVQNRLKKAEARMPQ
AVITQGIQVEQTSAGFLLIYALSYKEGAGQADTTALGDYAARNINNELRRVPGVGKLQFF
SSEAAMRVWVDPQKLVGYGLSIDDVSNAIRGQNVQVPAGSFGSAPGSSQQELTATLAVQG
TLDDPQAFGRVVLRANPDGSLVRLADVARLEVGMESYNFSSRLNGKPAVAGAVQLAPGAN
ALKTADLVKERLAELSAFFPEGVEYSVPYDTSRFVDVAIEKVIHTLLEAMVLVFLVMFLF
LQNIRYTLIPSIVVPVCLLGTLMVMKLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVER
IMAEEGLSPVDATIKAMGQVSGAIIGITLVLSAVFMPLAFMSGSVGVIYQQFSLSLAVSI
LFSGFLALTFTPALCATMLKPVAPGHHEKRGFFGAFNRGFARLTERYSVMNNALVRRAGR
YMLLYAGILAMLGYFYLRLPESFVPVEDQGYAIVDVQLPPGASRVRTDATGQALEQFLMS
REALASAFLVSGFSFSGMGENAALAFPTYKDWSVRSAEQSVDAETQAINAQFASHGDGTI
MAVNPPPIDGLGNAGGFALRLLDRGGLGREALLAARDKILGEANGNPVILYAMMEGLAEA
PQLRVDIDREKARALGVPFETINSTLATAFGSAVINDFTNAGRQQRVVVQAEQGERMTPE
SVLRLYAPNVDGQQVPFSSFVTTRWEEGPVQIVRYNGYPSIRISGDATPGYSTGQAMAEM
ERLVSELPPGIGYAWTGLSYQEKVSSGQASSLFALAILVVFLLLVALYESWAIPLTVMLI
VPIGALGAVLAVMVTGMPNDVYFKVGLITIIGLAAKNAILIVEFAKELWEKGYSLRDAAI
EAARLRFRPIVMTSMAFILGVVPLAIASGAGAASQRAIGTGVIGGMLSATLLGVLFVPIC
FVWVLSLLKRKPAPQAQPAEVLE
>N9ESN3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFELVKALFLGLIEGLTEFLPISSTGHLILFGHLIDFHSDSGRVFEVVIQLGAILAVC
WLYRQKIIELVRGFFSGDVHARRFTINVLVAFIPAVVIGVLAVDFIKQVLFSPLVVAFAL
IIGGLIIFAVEARKFEPKTIEATDITLKQAILVGFAQCVAMIPGTSRSGATIIGGMLSGL
SRKAATEFSFFLAMPTMLGAATYDLIRNADVLTSDNLMNISVGFVAAFIAAILVVKALVK
FVEKHTLRVFAWYRVVLGIILLIVFL
>R4S350|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-11|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVDGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>A0A0K9YPD6|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKLTSKYNTIRRILSDLKQPEYRYAQIMDAIFKQNISEYGRMKILPKFLREELTRILGPD
VCSIVPVKEVSSKQVSKVLFAIEGDERVEAVRLTYERGWKSYCISTQCGCGFKCKFCATG
TIGLKRNLTADEITDQLLYFRLNGHALDSISFMGMGEALANPHIFDAMTILTDPYLFGLG
HRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLVELDR
HIRQTGRKVYIAYILLRGVNDSAEHAQAVAELLRGRGPGEHLYHVNLIPYNSTDVTPESF
HQSDKDRVQKFVSILKSKGIKVTVRTQFGTDIDAACGQLYGHNK
>ZP_02889084|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIATAAIVTLAVVGLGTFGAMRVSANAPEKAAAPLPEVDVATVVPQTVTDW
QSYSGRLEAVEKVDVRPQVSGTIVAVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
GAQARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREASANLKAAEAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYINGARN
GRKVPVELGLANETGYSRSGEIDSVDNRLDTSSGTIRVRARFDNADGALVPGLYARVKVG
GSAPHQALLVDDAAINTDQDKKFVFVVDQQGRVSYREVQQGMQHGNRRVIVSGLSAGDRV
VVNGTQRVRPGEQVKPHMVPMTGGDAPSAPLASTAKPAAPAKADS
>ZP_03034063|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTY
QTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNTLLKEAEK
RNLSLLQARLSQDLAREQIRQAQDGHLPALDLTASTGISDTSYSGSKTRGAAGTQYDDSN
MGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQL
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSA
RTTTSNGHNPFRN
>A0A127SUG7|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRTQQMSELENRIDSLLNGKEATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMAQLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAQTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDNADIIARISRMVY
DAMR
>AAZ98840|FEATURES|ARDB_deepARG|glycopeptide|VanXD|antibiotic target alteration|1
MMKQNFIFLDEVLPGIRWDAKYATWDNFTGKPVDGYEVNRIVGTKELGAALRKAQKLAMK
QGYGLLLWDGYRPQRAVDCFLHWASLPENNLTKNRYYPNIKRNEMVTKGYVASQSSHSRG
GAVDLTIFYLDTGMLVPMGGDFDFMDERSHHAASGLTEEESRNRECLRHIMGRSGFEAYC
NEWWHYVLADEPYPNTYFNFCIA
>ABX00596|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|LmrA|antibiotic efflux|1
MSVFARATSLFSRAARTRAADEAARSRSRWVTLVFLAVLQLLIAVDVTVVNIALPAIRDS
FHVDTRQLTWVVTGYTVVGGGLLMVGGRIADLFGRRRTLLFGAFLFGASSLAAGLAPNLE
LLVLARFGQGAGEALSLPAAMSLIALLFPETAARSKALSVWASVASVGLVLGFLLSGVIT
QLFSWRWIFLINIPLVSLVLVAVLLLVKKDETTARNPVDLPGALLFTAAPLLLIFGVIEL
GEDEPRLPLAVGSLLAAAVCAAAFVAVERRTAHPLVPLTFFGNRVRLVANGATVLLSAAL
STSFFLLTMHLQEERDLSPIEAGLSFLPLALSLILASLLVPRLIERIGTTGAAVLGMALA
ALGIGCFALLPSDNSLLTSVFPGMILLACGMATGLVALQNAALHAVTEADAGVASGVQRC
ADQLGGASGIAVYVSIGFSPHLGGDWDPFTVAYSLAGIGLIAAVLAVLALSPDRRLAAPR
EQED
>ZP_03027991|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIITCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQQAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIIIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>R9C4H4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDKLWELIVAFILGIVEGLTEFAPVSSTGHMILVDDLWLKSGEIFSPEVANTFKVVIQLG
SILAVVIIFKDRFLNILGLKKTINGEKVTGHKLSLVQILIGLIPAGVLGLLFDDYIDEHL
FNFETVAYALIVGAILMILADYTQKKKKPTTTSLDQITNKQAFFIGLFQCIALWPGFSRS
GSTISGGVLMGLSHRVAADFTFIMAVPIMAGASFISLLNNWEYITSAALPFFIVGFISAF
IFALISIRFFLKLIDRIKLTPFAIYRIIIAIIIMVVFF
>A0A0T5XRG9|FEATURES|UNIPROT_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPTDAPINWKRNLTVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIIMLLMGVAQNVWQFLILRALLGLLGG
FIPNANALIATQIPRQKSGWALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVL
FLCFLVTLICIRENFTPVAKKEMLHARDVLASLKNPKLVLSLFVTTMIIQVATGSIAPIL
TLYVRDLAGNVSNIAFISGLIASVPGVAALLSAPRLGKLGDRIGPEKILICALIVSVLLL
IPMAMVQSPWQLGVLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDLGNVT
GPLVGAGISASFGFRAVFIVTAGVVLFNAVYSWLSLSRALRPGRIRQHRDG
>D7B661|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTHRLQQRSVREYPVAAQGSGPYGITAGTDGSLWVTLVHHGRIARMTPDGSTTVYPLDST
ACAPSLITTGPDHALWFTRTKDDRIGRITADGKADSFALPTPGAQPFGITAGPDGALWFT
EMNADRIGRITTDGEVTEFPLPTRGGFPSFIASGPDGALYFTLNQADAVGRVTVGGDVTL
HPLPTGQAGPVGITAGPDGALWFVEIAAGQIGRLTTDGRIREFPLPRRDSRPHAITADPE
GGCWFTEWGANRVGHITAGGDIDLFDLPAPSREPHGVAVTADGTVWVALETGGIASLAP
>N6V6I0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAEQIIIALVLGLVEGLTEFIPVSSTGHLILLGHFLGFKEAATFDVLIQLGAILAILLVY
FNRLVQIAKALPVSVKARHFVLAVLFSFLPAAVIGALAHDFIKTVLFDSPKVVCISLILG
GIVLLVVDRIKFKPKYNSAYEFSWPMAIKIGFFQCLAMIPGTSRSGSTIVGALLLGADKR
SAAEFSFFLAMPTMAGAFALDLWKSRHDLSTDQGLLIVIGFVTAFISALFVVRALLDFVS
RRGYAPFAWWRIAVGTVGLIGLYFG
>A0A0U4C382|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTYWHALLLAIVEGITEFLPVSSTGHMIIASALLGIPTTAFTKLYLVVIQFGAILSVLAV
YWKRFFQSVDFYLKLLVAFLPIVVVGLLLKKHIDALLESVTTVAVMLLVGGIVLLFIDRW
FPQEEPNEGGHPVTTPNWREAFTIGLFQCIAVVPGVSRSAATIIGGLTQKLTRRAAAEFA
FFLAMPTMAAAAAKDLYDYYKVTKAQGLDLAHTFTAVEVKQLILGNVVAFVVALLAIRLF
VGFVTKYGFRAFGIYRIIVGGLLLIMLGLGINLQLV
>A0A0Q0W930|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHEDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFIPAVVLGLLLSDFIDGLLENPVTVAVSLLIGGLILLKVDEW
FNKPNAAETSQEITYLQAFKIGLFQCLAMIPGVSRSGGSIVGGMSQKLTRTTAAEFSFFL
AVPTMLGATAKKCYDYYKAGFELSHDQINLLVIGNVVAFIVALLAIKTFIGFLTKNGFKV
FGYYRIIAGIVLLLIHFFIHPLTII
>A0A0B0HXC9|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MEWMEYIKAVILGIVEGLTEFAPVSSTGHMIIVDDMWLKTQQFLSQPAANTFKVVIQLGS
ILAVVVLFWSRFMDLLGLRRRKPAEGSGEQAQGRLKLTQVIVGLIPAGILGVLFEDYIDE
HLFSTRTVLIGLVVGALLMIAADLWRPKRPKAETVDQITYGQAFSVGLIQCLSLWPGFSR
SGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASGISLLKNWEYFTADMLPFFAAGFISS
FIVALIAIRFFLKLINRIKLVPFAVYRIVLAGIIFLML
>A0A0I9QPZ6|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-21|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQMDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNSAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>Q0T5W7|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSASAVIGALLGSWLLQYDFRLVCATGPVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>ABY43546|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MMILKNKRMLKIGLCVGILGLSLTSLEVFTGGALQVEAKEKTGPVKHKNHATYKEFSQLE
KKFDARLGVYAIDTGTNRTIAYRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITYTKD
DLVEYSPITEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVT
IADRFEPELNEATPGDIRDTSTAKAIATNLKAFTVGNALPADKRKVLTEWMKGNATGDKL
IRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEAAYDNQLIAEA
TEVIVKALK
>AAS61063|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVIAIIIMLAGALAIMKLPVAQYPTIAPPAITIAANYPGADATTVQNT
VTQVIEQNMNGIDNLLYMSSSSDSSGNVQLTLTFNSGTDPDIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVAGFISEDGTMQQEDIADYVGSNIKDPISRTPGVGDVQLFGS
QYAMRIWMDPHKLNNYKLTPVDVINAIKIQNNQVAAGQLGGTPPVPGQELNSSIIAQTRL
TNAEEFSQILLKVNTDGSQVRLKDVAIVKLGAESYNIIARYNGKPAAGIGIKLATGANAL
NTSAAVKAELAKLQPFFPSGLTVVYPYDTTPFVKISINEVVKTLIEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILSAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
QEEGLPPKEATKKSMEQIQGALVGIALVLSAVFVPMAFFGGATGAIYRQFSITIVSAMVL
SVLVALILTPALCATMLKPIKKGDHGPKTGFFGWFNNMFEKSTHHYTDSVANILRSTGRY
LVIYLAIVIGMAVLFMRLPSSFLPEEDQGVFLTMVQLPAGATQERTQKVLNHVTDYYLDK
EKNVVNSVFTVNGFGFSGQGQNTGLAFVSLKNWDERKGEQNKVPAIVSRASAAFSKIKDG
MVFAFNLPAIVELGTATGFDFQLIDQGNLGHQQLTDARNQLLGMAAQHPDMLVGVRPNGL
EDTPQFKVEVDQEKAQALGVAISDINTTLGSAMGGSYVNDFIDRGRVKKVYVQADAPFRM
LPDDIDKWYVRNNMGQMVSFATFSTAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAM
DLMQELAAKLPSGVGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAATLRGLENDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLV
ESTLESVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFF
VPLFFVVVRRRFSRKTDDIEHSHPVNTPVK
>A0A0E3VZF8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLLLELQSVKRSYQSGEESLDVLKNISLKIYSGELVAIIGASGSGKSTLMNILGCLDQA
SSGTYYIAGQNVADLNNDDLAILRREYFGFIFQRYHLLPHLSAAHNVEISAIYAGSPKNE
RQKRAVTLLTRLGLGERINYRPNQLSGGQQQRVSIARALMNGGQIILADEPTGALDSHSS
VEVMNILRQLQQKGHTVIVVTHNPEVANQADRTIEIKDGEIISDSGYQPTQELKKIPEPS
SPSVEQASCQQWVSRLHEALLMAWRAMVSNKMRTALTMLGIIIGIASVVSILVVGDAAQQ
KVLANIRAIGTNTISIYPGRDYGDDDPSNRQALIYEDIAALQAQSYVSAISPIISGNIRL
RSGNIDVASTILGVGGQYFKAYGIKIQNGERILERQVRDQSQVVVIDKNTQRRLFPRTKD
VIGKEILVGNIPMTVVGIAKEKQSMYGNNNALRIWIPYSTMTNLFTGRSYFDAITVRIKE
GYNNNEAEQQLIRLLTLRHGKKDIYTFNVNTVLKTAEKTTRTMQLFLSLVAAISLVVGGI
GVMNIMLVSVTERTREIGIRMAVGARSSDVLQQFLIEAVLVCLVGGTIGILLSFCIGFAV
EFFLPTWSLTFSSIALFIAFCCSTMIGIVFGYLPARHAARLNPIDALAAE
>A0A0A0IU03|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESLLFIIKVIIIGIVEGITEFLPVSSTGHMIIIEDLIKFKEGVEPISLYTKQYKDAFTM
IIQLGAILAIVVLYWDKIKKSFENFSPSHPKSGFKFWLNIAVAAVPAGVIGLKYHSKINE
KLFNPESVTAALIVGAVWMIFAEKRYRGKFKTRDIDSVTIKQAFIIGCFQCLALWPGMSR
SASTIIGAWIVGVSTVAAAEFSFFLALPVMFGVTLKSLKDINVFDLSSMHIIGLTVGFIV
SFVVALIVVDKFINFLKKKPMRVFAIYRILLGIILIVLFLFNVIQL
>J8X555|FEATURES|UNIPROT_deepARG|beta_lactam|IEO_02650|antibiotic inactivation|1
MIVLNKFFNMLHYKKIVPVVFLSCATLIGCSDSNTQSESPKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDAHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDVKYDDKLI
AEATKIVLDALKAKNK
>A0A0K9TF27|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPTTSDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMLTSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A0E4H8K9|FEATURES|UNIPROT_deepARG|bacitracin|uppP2|antibiotic target alteration|0
MHDYIIAIIQGIVEGITEFLPVSSTGHLILSGELLGFTGEKADTFEIIIQLGAILAVAVI
YWRRILGLLGLVKVDSENGNTNAKQKLNLIHVILACLPAMVLGLVLHSFIKTYLFSPYTV
LAGLVLGGLFMLLGQYKRTAIQAENIDQLSYKQAITIGLFQCLSLWPGFSRSGATIAGGL
LAGAGYKAATNFSFLIAIPMMVAASGYELLKSYHTLTASDAGFFITGFIVAFVVALLAVI
TFLKLLERLKLAPFAYYRFVLAAVFLIYLISK
>K7QCV2|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
VKENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYW
KSIGAKVVATRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRA
FYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTV
IGGHDSPLHGPE
>A0A0T6YU34|FEATURES|UNIPROT_deepARG|aminoglycoside|N183_18725|antibiotic inactivation|1
MRVLLMDGETIGRWVEMRLALWPDTPEAEHRAEVESSLAEPDRYASFLCEDEAGVAAGFA
EASIRRDYVNGCETSPVAFLEGIYVLPRYRRRGVARALITAVERWATSQGCQELASDTAT
DNLRSQSLHMALGFEETERVVYFRKELSPAVADN
>YP_001178158|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MKKLLPILIGLSLTGFSAMSQAENLLQVYQQARLGNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYGNGFRDSNGVNSNTTGASLQLTQTLFDMSKWRSLSLQEKSAGIQDVTY
QTDQQTLILNTATAYFNVLSAIDSLSYTEAQKQAIYRQLDQTTQRFNVGLVAITDVQNAR
SQYDTVLANEVTARNNLDNALESLRQVTGNYYPELASLNVDNFKTDKPQAVNALLKEAEN
RNLALLQARLSQDLAREQIRQAQDGHLPTLSLTASSAVTDTSYSGSKTGGANASQFDDSN
VGQNKVGLSFSMPLYQGGMVNSQVKQAQYNFVGASEQLESAHRNVVQTVRSSFNNVNASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLFNAKQQLSSARYNYLINQL
NIKSALGTLNEQDLQMLNSTLGKPVSTTPENVAPENPQQDASADGYNANDSAPAAQPAAA
RTTTNNAAGNPFRN
>A0A0E2NXC2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSHTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVLGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
VGGVVLLVVDRMKLQPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAIGFVAAFVTALIVVRFLLDY
VSRNGYSLFGWWRLVVGAVGLVALFIWG
>U2ZE81|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDWLIALLLGIVEGLTEFIPVSSTGHLLLLGHFLGFESTGKTFEVVIQLGALLAIVTVY
LRRLFELATRWPHDRQARHFLIGLLVAFLPAMVIGVFMYDTIKNVFFETPVIICVSLILG
GFVLLWLDRRPMTPVHLDAAKYPMRMYLIIGVAQCLAMVPGVSRSGATIAGALLLGADKR
SAAEFSFFLALPTMGAAVAYDLFQNRAVLDFSDFGLIAVGFIAATITAFLTVKAVLAFVT
RHGFAVFAWWRIVVGTVGLAGLWLTGAL
>A0A0K4J0D3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGHEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHHCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A109WEL2|FEATURES|UNIPROT_deepARG|beta_lactam|AUL54_04575|antibiotic inactivation|1
MKNKARIQVGICIGLLCLSFTGFSPLFGSTHAEAKSIEDTKMTSCTTNKKFVQLEKKFDA
RLGVYAIDTGSNKTITYRPNEQFAYASTYKVLAAAAVLKTSSNEKLNDIIRYTKDDLVTY
SPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHLTKADRF
ETDLNSAIPGDRRDTSTAKALATDLKTFALGNTLTADKRTILTDWMRGNATGDELIRAGA
PAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSKRFTEDANYHNALISEAAKAAL
DGLK
>N9LRP1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILAGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASVPIVIIGLSFGDVVKAYLFNAVTVAIA
LIVGGGVILWAERRPHQIVSQEVEDLTFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
ISRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMAILAVGIIVAFVSALIVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>A0A0B5IJP8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFTYPPVKKVSVVIPVYNEQESLPELIRRTDTACATLGREYEILLVDDGSSDDSALMLTA
AAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVEKADEG
YDVVGTVRQNRQDTFFRKAASKTINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVFG
SVIALLGFTFSILLIVLRLVLGPQWAAEGVFVLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQPETASQEEDRS
>A0A0N1AKP3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEDQSIISALVLGLIEGLTEFVPVSSTAHVLLAGHFLGFESPGNTFAVLIQLGAILAILS
VYFAKLLKIALSLPTSAESRRFVGAVLLGFLPAAVIGFIAHDFIKTVLFETPMLICVVLI
LGGFVLLWIDRLPLKPRYHDVTEYPLSLALKIGFCQCVAMIPGTSRSGATIVGALLLGAD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRNALTVDDTLIIAIGFVAAFISALFVVRGLLNF
VSKRGYAPFAWWRIAVGTAGIIGLLMFG
>A0A061BM56|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAIILGIIEGVTEFLPISSTGHLYLADYIIKLDQPTSFINMFMVVIQLGAILSVI
VIYFNKLNPFAPSKSKREKGQTWQIWFKVIAAVLPSIIIGLPLNDWLEENMTSWQVISAT
LIIYGILFIVLENYYAKRQPSLTDLNKMSNKTALLIGCFQVLSMIPGTSRSGATILGAML
IGSSRYVATEFSFFLAIPTMFGASLLKLVKFFKAGHVFVGNQLAILLVGMVVSFIVAYLS
IKFLLKYVQTHDFKPFGWYRIVLGIIVTICGLVFA
>A0A137RSF1|FEATURES|UNIPROT_deepARG|beta_lactam|AYK81_28945|antibiotic inactivation|1
MIVLNKFFNMLPYKKIVPVLFLSCATLIGCSNSNTQSEPPKQAKQENTVNHSFAKLEKEF
DAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRILYTREDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDTHDTSTPKALATSLQAFALGDILSAEKRNLLIDWMKRNTTGDKLIRA
GVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLHALKATNK
>F0RJA1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLYALVYGVVEGITEFLPISSTGHLIVTGHLMGVPWSKEVKDTFEVVIQGGAILAVLV
YYWKDFVAQARALGQGGAAAQGTKTLWLGVLVACLPAAILGLAFSDIIKQYLFRPSVVAW
ALIVGGAIIWWLEDRRTQPTVHAIENIGVKRSLLIGAVQCLAMLWPGFSRSASSILGGML
TGLDRPTATKFSFYLGIPTLGGAALIDLVRSLDQLAEIGLGTVALGAVTSFAVAYLATGW
LLRFVATNDFKPFAVYRIVVGALILALVYSGNLTNAV
>A7K2A8|FEATURES|UNIPROT_deepARG|beta_lactam|VEx25_A0387|antibiotic inactivation|1
WDTQTDERWDYRGDERFPLMSTFKTLACATMLSDMDSGKLSKNATAKIDERSIVVWSPVM
DKLAGQSTRVEHACEAAMLMSDNTAANLVLNEIGGPKAVTMFLRSIGDKATRLDRLEPRL
NEATPGDNRDTTTPNAMVNTLRTLIEGETLSYESRVQLKIWMQDNKVSDSLMRSVLPTGW
SIADRSGAGGHGSRGINAIIWKENHRPVYISIYVTETELSLQARDQLIAQISQLILQKYK
DN
>A0A0A0DUJ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLFMKSALMGIVEGLTEFLPISSTGHLILADSLLDFARSTGADKAKVFEIAIQTGAI
FAVILVYLQRVKDTVTGLFSDPKAQRFALNVFVGFLPAVVMGLAVGKAIKAHFFTATVVA
TTFILGGVIILIAERFAAQRPQQRVQTVDDMSLMDAFKVGVIQCLALIPGTSRSGATIIG
GMLMGLSRKAATDFSFFLGIPTLIGAGVYSLYKERALLSVNDLPLFSVGLVFAFVSAWLC
VRWLIRYVSSHNFVPFAWYRIAFGIFILVSANMGWMTWAE
>ZP_04204110|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVDNMKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNK
NVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTVTNLKFGNMKVETF
YPGKGHTEDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNI
NAVVPGHGEVGNKGLLLHTLDLLK
>A0A100HUJ0|FEATURES|UNIPROT_deepARG|beta_lactam|SAMD00023378_3062|antibiotic inactivation|1
MFPRWSKTFALALTACAFVMGASQAHAELVVRDDLKRVFDEAGVAGTFVLMDISGDRTYV
VDPARAARRIHPASTFKIPNSLIAFDTGAVRDDHEVIPYGGKPQPFKQWEKDMALPEAIR
VSNVPIYQEVARRIGPARMQAYVDAFDYGNRQIGSVIDQFWLRGPLEISAFEEARFTSRL
ALKQLPVKPRTWDLVHRMLLIEKQGDAALYAKTGVATEYQPEIGWWVGWVEREGKVYAFA
LNIDMPLEADMAKRIPLGKRLMQALEVWPTP
>AAB47941|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVSTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMENID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMVSYIKRARSMRDIRNEKGTAKPDPAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVEPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRLPSAIILQRASR
>L8XJD7|FEATURES|UNIPROT_deepARG|beta_lactam|B878_10312|antibiotic inactivation|1
MKKLFLLLGLLACSNATYAAKLNEDISAIEEHISGRIGVSVWDTQTDEHWDYRGDERFPM
MSTFKTLACATMLRDMDDEKLDKNATAKVEERNMVVWSPVMDRMAGQTTRIEHACEAAML
MSDNTAANIVLRSIGGPRGVTTFLRSIGDKATRLDRFEPRLNEANPGDKRDTTTPNAMVN
TLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAM
IWKENHKPVYISIYITETDLSLQARDQVIAQVSQLILDEYNTI
>A0A0M4T6X9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILLIQAVIMGIVEGITEFLPISSTGYLILSADIMSFWTKEKVDLFVVVVQFGAILAV
IYDYWGRLWHALTGLVTGEADGLKNPRQLGLSLIVATIPVMILGFTFADEIKLYLFNPVT
VAIMLIIGGLLIFYVENRPKTIIAEEAEDVSLKTALMIGLIQCFALIPGTSRSGATIVGA
LWLGVSRKASAEFSFFLGIPVIVGAALLDLVKHHGVMTTSEDWLVLGIGTVVSFIVALLC
IRLLVAWVSRRDFKIFAWLRIITGILVLIAAWGFGYQMAG
>I1V573|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VMAAAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTMTFGELSAAALQYSDNT
AMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDPRDTTTPLAMAQALRNL
TLGNALGGTQRAQLVMWLKGNATGAASIQAGLPTSWVV
>L7RT24|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGIIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDKPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEETIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYIVFIPKENIGLVML
TNKRIPNEERIKAAYAVLSAIKK
>G7SN81|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MLLELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
MTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAI
ALIVYGIAFIWIENRNSGVEPQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAI
ILGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWILLVASVTAYLVSLV
VIRFLTDFVKKHDFTVFGCYRIILGAILLVYAFITFLF
>YP_002009764|FEATURES|ARDB_deepARG|multidrug|OprA|antibiotic efflux|0
MKAMMKPRARRRCARAARRPNGPRAWPLAVAAALVAGCTLAPRYERPAAPVPAHYWSTAA
GAPREAGPAAAGGPRAMPDARRGDAGRDARDARLDDWRAYFTDPALRALIDAALANNRDL
RIATLRIQEARGLYGVARADRLPSIDGSLGYERTRLYDPVLRESATSSLYRASVGVSAFE
IDLFGRVKSLSDAALAEYFATAEAQRAARISLIAEVASAYVTERALVDQLGLAERTLAAR
DAAYALTQRRYAAGTSTAIELRTAEMLVASARASKAALEREHTQAASALKLLAGDFMTAL
PADAPALDALAVARVSPGLSSDLLEQRPDIRQAEQRLVAANANIGAARAAFFPRIALTTD
VGSVSDAFSGLFSAGSSVWTFAPRLTLPIFAGGRNRANLDVADARKHIAVAEYEKTIQTA
FREVADALAARDQIDAQLAAQQAVYGADAERLRLAQRRYDSGVASYLELLDAQRSTFESG
QELIRLKQLRLTNAITLYRALGGGWSRAGCGGDECA
>A0A0A7TU30|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLDEKPLQKISVVIPVYNEEESLPELVRRTSAACSTLGLNFEILLVDDGSSDRSAQMIAD
AADMPGSHVVGVLLNRNYGQHSAIMAGFAHVSGDLIITLDADLQNPPEEIPALVKAAQQG
YDVVGTVRQNRQDSWFRKRASRAINQLIQRVTGKAMGDYGCMLRAYRRHIVDAMLNCHER
STFIPILANTFARRTIELPVAHAEREFGDSKYSVMKLINLMYDLVTCLTTTPLRLLSIAG
SLIALAGFAFSIVLVILRLFFGAGWAGDGLFMLFAVLFIFVGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVIHPQQETPQVQEIKP
>I6ZI91|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNLQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>ZP_04228847|FEATURES|ARDB_deepARG|beta_lactam|BL2a_1|antibiotic inactivation|1
MEKMKKNTLLKLGVCVSLLGITQFISTISSVKAEQKLEQKVIKNETGTISISQLNKNVWV
HTELGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHA
HADRIGGITTLKERGIKAHSTALTAELAKKSGYEEPLGDLQTITSLKFGNTKVETFYPGK
GHTEDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSVSIGNVLKRYKNMNSVV
PGHGDVGDKGLLLHTLDLLK
>A0A0E3K2L7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIFILKAVIIAIVEGVTEFIPVSSTGHMILVGWAIGFKGEFTKMFEVVIQLGAIMSVV
VLYWKKIKESIVEFFEFIFTKGREGKTGFKFGINIIVSSIPMGIAGVLFYSKIKSKFIPE
AVIIGFVVGGLLLLIIENKFRNRKYKIESIDKITPKQAFKVGLFQLICIWPGMSRSASTI
MGGWIAGLSTPVAAEFSFFMAIPAMIGSTGKDLFEFDYSIMTPTLWISLILGFVVAFIVA
LIVMRKFIDFLKKKPMRVFAIYRIIAGSLLGILVLTKIITLTA
>A0A0J8IQD9|FEATURES|UNIPROT_deepARG|aminoglycoside|ACR52_17315|antibiotic inactivation|1
MLMIKRCTLLDHAGWLALRIALWPDSAFGSEDETQTLLSAPERNLVLTFHDADGQAVGFA
EASVREDYVNGTSTSPVAFLEGLYVAPASRGQGVARQLVAAVEQWAVDVGCVELASDALL
ENHSSHAMHQALGFAETERVVYFLKPLAASDK
>ZP_02901868|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHADNPGEKAFYASVARLAAETGIPVYAPD
NVNHPLWVERIAQMSPDVIFSFYYRHLISDDILQLAPVGAFNLHGSLLPKYRGRAPLNWV
LVNGENETGVTLHRMVKKADAGAIIAQQRVVISPDDIAITLHHKLCHTARLLLEQTLPAI
KHGHFQEIAQRENEATCFGRRTPDDSFLDWHKPADVLHNMVRAVADPWPGAFSYAGNQKF
TVWSSRVHPDTSTAQPGSVISVAPLRVACGHGALEIITGQAGDGITMQGSQLAQTLGLVE
GSRLNNQPLCAAQRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALFRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLGWEPKIDMQETIDETLDFFLRTVDLTDKSS
>A0A0N0JZE2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDQDLLTVIILGIVEGVTEFLPVSSTGHLILASALLGYDPERWKVFNIVIQLGAILAIVV
LYWRTLLTVLMGLARRQPESLRFTRNVLLAFIPAVAIGLAFHDQVEALLGRGDVVAWALI
VGGVAILLVERFAGSARVKGVAALPVGTAVGVGLIQCLAMIPGVSRSGATILGALSLGVE
RRTAAEFSFFLAIPTMLGATSLELYKNRDLMSQGELGLIAVGFGVAFVVALVVVKAFVTL
IGRYGFAPFAWYRIVAGVAALVWLNAG
>G8EXA5|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
KCGLAGALMLMASFWGGSVRAAGISLTQVSGPVYVVEDNYYVKENSMVYFGAKGVTVVGA
TWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKS
DWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDE
QVLYGNCILKEKLGNLSFADMKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYKA
>A0A132SCF9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MAVAVTVDGRQHFFDFGVASKQTQAPVTRDTLFEIGSVSKTFTATLAGYAAAQGTLDLND
HPSRFLPALAGAPIDDARLINLGTYTAGGLPLQFPESVTDDEQMIAYFQQFRPTAAPGER
RQYSNPSIGLFGHLAARALHGEFTDLLQSQIMPGLGLARSFVNVPDSAMDSYAWGYDKTN
EPVRVNPGVFDAEAYGVKSTTVDMIRFVERNIDPGGLEPPLREAVQGTQVGYYEVGPMVQ
GLGWEQYPYPVSLDQLLAGNSAEMAMSPQAALPLAAQSVGRTAFFNKTGSTDGFGAYAAF
VPERRIGIVMLANKNFPIAARVTAAHAVLSALAP
>A0A0B4ZPH3|FEATURES|UNIPROT_deepARG|beta_lactam|BL2d_oxa9|antibiotic inactivation|1
MHLLSAQRSNEGYLDEKKILLLHMLVFVSATLPISSVASDEVETLKCTIIADAITGNTLY
ETGECARRVSPCSSFKLPLAIMGFDSGILQSPKSPTWELKPEYNPSPRDRTYKQVYPALW
QSDSVVWFSQQLTSRLGVDRFTEYVKKFEYGNQDVSGDSGKHNGLTQSWLMSSLTISPKE
QIQFLLRFVAHKLPVSEAAYDMAYATIPQYQAAEGWAVHGKSGSGWLRDNNGKINESRPQ
GWFVGWAEKTDGKLFSPDWK
>M5PIH6|FEATURES|UNIPROT_deepARG|beta_lactam|BSONL12_02412|antibiotic inactivation|1
MKSLHKMSRLFQLKKIAPVLLLSCAALAGCSGGEAHSAQPEQKHQETALNDAFAKLEDQF
DARLGVYALDTGTNQTIAYRADERFAYASTHKALAVGALLQQKSITDLNQRITYTRDDLV
NYNPITEKHVDTGMTLKELCDASIRYSDNTAGNLILKQIGGPDGFKKSLRKIGDKVTNPE
RFEPELNEVKPGETHDTSTPKALATSLKAFTIGDALPKEKRMMLIDWLKRNTTGDALIRA
GVPKGWEVGDKTGAGSYGTRNDIAVIWPPKGDPIVLAILSSRDQKDAEYDDKLIAQAAKE
VIDALQNKDK
>B8H6C3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWLIALILGLIEGLTEFIPVSSTGHLLLLGHFLGFHSPGNTFQVLIQLGAILAITGVY
FGRLWGLLTTLPTEPGSRRFVIGILLAFLPAVFVGVAAHDFIKTVLYETPALVCSTLIIG
GFILLALDRMKLEPRYTDVAEYPLKTAFIIGLFQCLALVPGVSRSGATIAGALLLKCDKR
SAAEFSFFLAMPTMAGAFAYDLYKNIDKLSTNDLGLIGIGFLAALVSGVFVVKTVLDFIT
RHGFAPFAYWRIAVGVVGLALLYIPR
>A0A0Q7ZWU4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFLTLLKVLVLGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRPRIFDIVKGLPTQRNAQRFTLNLLIGFLPAVVLGVLFADKIHEYLFNPITVAVALV
VGGIVMLWAEQRDHVVQVEHVDDMRWSDALKVGFAQCLAMVPGTSRSGSTIIGGLLFGLS
RKAATEYSFFLAMPTMVGAAVYSGYKYRDLFQNSDLPVFALGFVTAFFFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLLILATWIFGWVNWTAAAAVG
>A0A105TG93|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSLKAVVFAYHDIGCTGIEALLNAGYDIAAVFTHADDPKENNFYASVAQLCARKGIPVHA
PEDANHPLWIERIRKLNAQYIFSFYYRHLLGEELLASVSHGAFNLHGSLLPRYRGRAPAN
WVLVNGETQTGVTLHRMVKRADAGDILAQQRVSIERSDTALSLHAKLRDSAAKLLAEALP
LLPEGKLKETPQDESKATYFGRRTAADGLLQWSRPAEELFNLVRAVTQPYPGAFCAVGEH
QLIVWASEVMPGNNGMAPGHVISCDPLRIACGKDSLIINAGQRNADGLYLSGPQLARELG
LVDGSRLRGSESGRPARRTRVLILGVNGFIGNHLSERLLQDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGFKFTLFRPFNWMGPRLDRLDSARVGSSRAITQLILHLVEGTPIRLVDGGEQKRCFT
DVADGIEALARIIENRDGKCDGQIINIGNPENEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGTGYQDVSHRKPSIENARRLIDWTPTIELSETIGKTLDFFLREAMVEIA
EKR
>A0A0J6L5K4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLLGFEDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKKVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASALDLFKSWDVLSAADIPLFATGFITAFVVAMLAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFLM
>YP_215504|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDPISRTSGVGDVQLFGS
QYAMRIWMNPTELTKYQLTPVDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTDEFGKILLKVNQDGSQVRLRDVAKIELGGENYDVIAKFNGQPASGLGIKLATGANAL
DTATAIRAELKKMEPFFPPGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
TEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPVAKGDHGEGKKGFFGWFNRLFDKSTHHYTDSVGNILRSTGR
YLLLYLIIVVGMAYLFVRLPSSFLPDEDQGVFLTMVQLPAGATQERTQKVLDEVTDYHLN
KEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEKNKVEAITQRATAAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLFGEVAKYPDLLVGVRPNG
LEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDINDWYVRGSDGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MAMMEELASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
VEATLEAVRMRLRPILMTSLAFMLGVMPLVISSGAGSGAQNAVGTGVLGGMVTATVLAIF
FVPVFFVVVRRRFSRKSEDIEHSHSTEHR
>A0A0T9UDW7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLITTLVLTAIAATPLYSSAQTKLTEQQVAAIVNDTLKPLIEKQDIPGMAVAVFYD
GKPQFFNYGVADIKAGTPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTDYAPE
LTGSQWKAVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPEWAPGEMRNYSNASI
GLFGALAVKRSQLTFEEYMKKSVFQPLKLNHTFITVPESMLPNYAWGYKDGQPMRVTLGM
LGEEAYGVKSTTKDMVSFMQANMNPESLPVENDKLKKALIAAQSRYFQAGEIFQGLGWEM
YNWPIDPQRVIADSGNDVALKPRKAKELLPPPPAVRASWVHKTGATNGFGAYIVFIPEQN
IGIVMLANKNYPNPVRVQAAYNILQALR
>A0A103FBI3|FEATURES|UNIPROT_deepARG|aminoglycoside|WS71_14620|antibiotic inactivation|1
MTHPASLFTIRAAAASDALAWRQLRRALWPHADDAEHARDVAQQLDAPYRHACFIAWTPD
GAPLGFAEVAVRRDYVNGCDTSPVLFLEGIFVDPAARRRGVARALCSAAAVWGATCGCAE
FASDAPLGNAASHALHRALGFDETERVVFFRKTLAR
>V0SV59|FEATURES|UNIPROT_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLILSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYTSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN
>A0A0E2MCV2|FEATURES|UNIPROT_deepARG|chloramphenicol|L360_02059|antibiotic inactivation|1
MTKITPEYTVVDLSRWARKEHFEVFQGFAQSTFNQTVQLDITVLLKHIKEVGWKFYPAII
SLISHVVNRHPEFRMAMKDNELVIWNEVHPSYTLFHKETETFSSLWSHFDGNIHHFQNVY
AEDVSRYGDNLAYWPKEESRENIFFISDIPWVSFSSFNVNVANMRNFFAPMFTFGKYYNQ
DEKVLLPFAVQVHHSVCDGFHVARMINELQELCDNLPHHSEAPNV
>B6G804|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLSPRLRSNVWEVHVDIIELLKSAFLGLVEGITEWLPISSTGHMILVDEFIKLNVTEEF
WNMFLVVIQLGAILAVCVLFIRDLLPFGFGKTRQECRDTWSLWGKIIVGCLPAAIIGIPL
DDFMEEHLYNAWVVAAALIVYGIAFIVIERWRANKLAARVAEEAAANARPGGAHFAAPAV
AVEPTQGGDFGAITSLEDLSYKTALGIGCFQVLSLIPGTSRSGSTIIGGLLLGTTRSVAA
KFTFFLAIPVMFGASFLKLVKFFLKGGVFDASGLAILGVGCAVAFVVSLVAIKWLMGFVR
RHDFTAFGIYRIVLGIAVLGYFALLG
>V6FGM1|FEATURES|UNIPROT_deepARG|beta_lactam|EC990741_4783|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NVSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0R2HZD0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKAVLLGIVEGITEWLPISSTGHMILVDEFIKLNTSAAFKEMFFVVIQLGAILAVV
VLYFHKLNPFSPKKTKEEKSDTFSLWFKVIVAVLPAAVIGLKFDDMLEAKFYNFQTVAFT
LIIYGILFIVIENWNKDRKPAITTFNQLTYKTALLIGVFQVLALIPGTSRSGATIIGAII
LGTSRYIAAEFSFFLSIPVMFGASLLKLVKFGFHFTGMEYAILFTGMIVAFVVSIIAIKF
LMSYIKQNDFKAFGYYRIILGVILIGYMVLFK
>A0A086MLN4|FEATURES|UNIPROT_deepARG|aminoglycoside|JH26_07980|antibiotic inactivation|1
MRGEPCPVADNLEPRVEPCMLQTLEEWVALRHALWPEGPMEDHRSEAQAMLWDQKEAIAF
LVRLPDGTPAGFAEAALRHDYVNGCATSPVAFLEGIYVQPEHRGRGLARLLCRAVERWAR
SLGCSEFASDVFLDNTASQSMHKALGFEETERVVYYRKPLSRS
>R9B4S4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILAGQLLDFWSIEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGGLKGQEQGRRLSINLIIASIPIVIVGLTFGDVIKAYLFNAITVAIA
LIVGGFIILWAERRPHSIQTQEVDDLTYKQATLIGLIQCLALFPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRADLHSNDMAVLAVGIIVAFISALIVIRALI
RYVSKHDFTAFAYYRIGFGLFILATWWTGWVTW
>B8I004|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLLFVLKSIVLGIVEGVTEFLPISSTGHLIIFENIMGFKSASPNYVKMYTYVIQLGAI
MAVVLLYWKKIKETVINFFPGKVGYEKSGFKFWFMIFIACIPGAAVKLLLDAPVEKYLMT
PVSVAIVLILGGLWMIYAEKKFRNNNLGKQKLSVTPKQALIIGAFQCLAIIPGMSRSAST
IIGGWVAGLSTVVAAEFSFFLAIPVMFGYSLLEIIRIGGLTSLPAAELISLVVGFIVAFI
VAVAVISQFISYLKRKPLKSFAIYRMIFAVIVLIAGFMGFF
>A0A0Q9YCB2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIKGINHLLFSVSDLEKSVNFYQKVFGAKLLVKGRSTAYFDLNGIWIALNVEKDIPRDG
INLSYTHIAFSIKEDEYDKIYKKLQGLNVKILPGRQRDEREKKSIYFTDPDGHKFEFHTG
TLQDRLKYYKQEKSYMEFFD
>A0A0Z8HYI7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
MTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAI
ALIVYGIAFIWIENRNSGVEPQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAI
ILGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWILLVASVTAYLVSLV
VIRFLTDFVKKHDFTVFGYYRIILGAILLAYAFITFLF
>Q470Y4|FEATURES|UNIPROT_deepARG|beta_lactam|Reut_A1684|antibiotic inactivation|1
MLASRQTVRMPGWHSPSLPMLPSRTRRTLLLAAAAAPFASACASSARSTTPDAESRLATL
ERSAGGRLGVFARHTGDSRQVRHRAEERFPFCSTFKVILAGAVLQRSAGAPGLLDEHVRY
TRQDLVAYSPITEKHVADGMTIAQLCAAAIQYSDNGAANLLMHRLGGPAAVTGFARSIGD
QTFRLDRWETELNTAIPGDPRDTSTPAAMAASLQALALDGALPPVQRNQLQAWLRGNTTG
AARIQAGMPAGWQIGDKTGSGDYGTTNDIAVLWPLAGAPIVVAIYFTQAAPDAKWSNETI
ASAARIALSALG
>A0A098URI9|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-3|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A0B5ECS4|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
GLGLAAGNRVDYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRR
IHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHN
MGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEAD
>A0A0N0L0Y1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MAEALLQLSGITRSFTAGDREFLALKNIDLTIHAGEMVAIIGASGSGKSTLMNILGCLDY
ATAGSYKINGRETRDLDSEAQAELRRDYFGFIFQRYHLLPHLSAMHNVEIPAIYAGTPEP
QRHARARELLARLGLERHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTTS
GKEVMHILQELHAAGHTVILVTHDPKVAANAERIIEVSDGEILSDRRNVPDSDASANDDR
LAPHATAARRLVASLGLFKEAFKMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIYSGTSFGDSRSAAIETLVPADVAALNQLYYVDSATPVVGRNL
LLRYRNIDVDAQVNGVSDLYFQVRGIKMAAGIHFSESDARRQAQVVVIDHKTRQRLFGEQ
VDPLGQVILIGNLPCTVIGVAAENKNLFAASKSLNVWVPYETAAGRLLGQRYLDSISVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLVVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGAIGISLSYAIGH
LFSLFIKEWEMVFSMASVMTAVFCSTLIGVVFGFVPARNASRLDPIEALARD
>A0A0B2YQA1|FEATURES|UNIPROT_deepARG|beta_lactam|QQ44_10325|antibiotic inactivation|1
MTGLSRRNVLIGSLVAVAAVGAGVGNAAPAFAAPIDDQIAELERRDNALIGLYATNLDSG
RTITHRPDEMFAMCSTFKGYAAARVLQMVGRKQISLDNRVFVDPDAIVEYSPVTEPRAGG
EMTLGELCRAALQQSDNTAGNLLLKTIDGPPGITAFARSIGDQRTRLDRWETELNSAIPG
DPRDTSTPAALAGGYREILAGDALSPPQRRQLQDWMRANETSSVRAGLPEGWTTADKTGS
GDFGSTNDVGIAYGPDGQQLLLAVMTRSQADDPKADNLRPLIGELAALILPSLL
>NP_471146|FEATURES|ARDB_deepARG|fosfomycin|FosX|antibiotic inactivation|1
MISGLSHITLIVKDLNKTTTFLEEIFDAEEIYSSGDDTFSLSKEKFFLIAGLWICIMEGE
SLQERTYNHIAFQIQAEEMDEYIERIKSLGMEIKPERSRVKGEGRSVYFYDYDNHLFELH
AGTLEERLKRYHK
>A0A0I9PTB6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGSVEVLKGITLSINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDIAQLNGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGSERRA
RLARAHDLLVRLGLGDRSDYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
EEVMAILHQLKAQGHTVIIVTHDPQVAAQAERIIEIRDGEIVRNPPGSRQGGGLRARQQP
EPSAWRQFTSGFREALVMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLA
DIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQPWVRSATPAVSKSLRLRANN
IDVAASAEGVGPQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNTRRQLFPNKAKVVGE
VILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVHEGYDS
ETAEKQLLRLLELRHGKKDVFTWNMDSILKTAERTTHTLQLFLTLVAVIALVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLMIAFILQLFL
PGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>J6IDJ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIALEALKALLIGVVEGLTEWLPVSSTGHMILVDEFVKLDVTPEFLALFLVVIQIGAIMA
VIILYFSKLNPFARTKTPDERRSTWRLWGMVVIGCVPAAVVGILLDDWVNTHFYHAYVVA
AMLIAYGVIFIALERRNARRFAAYARGVESGAVKGDVPRLADGSLDPDGLFAVRTVDDID
WRTALKIGCFQVLAIIPGTSRSGATIIGGMLTGCSRTAAAEFTFFLAIPIMFGWGLVKIV
KYIAHAGLAMDSTEIAVLVVGIVTAFLVSVVSIKFLMGYIKRNDFAPFGVYRIVVGVIVL
GYFLAKGLAA
>A0A0C2BKL3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDGILALKALIMGIVEGLTEFLPISSTGHLILAGSLLNFTGEKIKVFEIAIQAGAMLAVC
WEYRTRIANVLAGLFSDAKAQKFAINLAIAFLPAAVLGFLLNKKIKAVLFAPIPVAAAFI
VGGLIILWVERRNGNAKTAARIYSVDEMTALDAFKVGCAQAFALIPGTSRSGATIIGGML
FGLSRQAATEFSFFLAIPTLFAATFYSLYKERALLSAADFPLFGVGTIAAFVSAFFCVRW
LLRYISSHDFTAFAWYRIVFGVIILATAYSGMVAWVD
>A3MZZ2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIEKLNKYFGSGENTAHVLKDINLTIEQGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGVCKIDGKETLNMTSDELSDLRQRKFGFIFQRYNLLPALTANENVALPAIYAGMDNTSR
KARANQLLEKLGLADKTGNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLEILKDLHKEGHTIIMVTHDANIAANASRIIEIKDGYIIRDERQQPYSEDLKLTKREY
KKPRFFDQLIESFKMAINAITAHKLRALLTMLGIVIGITSVISVVALGQGSQQQILSNIN
SLGTNTMTIMNGTGFGDRRANLTKNLTISDAMMLNKQQFVDSTTPSSNLNGTVIYGNTNV
TASINGVGEQFVNVKGLKMISGRFFDADEVKLSSQVVVIDGNTKKDLGLTDPVEGKVILV
DKKPLTVIGMAQESNNLNQTSLKMWMPYTTLMQRISGEKFIDSLTVKVKDNVESQTAEKS
INELLTAKHGKKDFFVMNSDTIKQTITSTTNTMKLLISSIAMISLIVGGIGVMNIMLVSV
TERTKEIGVRMAIGAKQNNILQQFLIEAILICLLGGIIGILFAMAIIFSFNTLGTNFKMI
LSPASVVLAVFCSTLIGVVFGYMPAKNASKLNPITALAQE
>AAM48121|FEATURES|ARDB_deepARG|beta_lactam|CfxA2|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNGFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>A0A0F0KHP3|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MRRSPAFSLCCLLAGFALAGCVGSPPPAAESAPASPTARATATDLDELVADELAGLEREY
DATVGVMAVDTGTGESVAYGENRRFGFASTIKAFAAAVFLQSASGAARDESVRWTAEEAA
AAGHAPVTSQHVEDGLTYAQLAEAAVRVSDNAALNLILDRIGGPAALDDALAELGDATTE
VVNDEPGLNTIESDSTEDTTTAAAFTASLARLLDGSTLSPADTALLVDWMSDNRTGDALI
RAGAPAGWTVADKSGGAGPIRNDIAVVTRPGHDPIIITVLTSRNEPHADFDDTLVASAAS
ITLHALDHSNS
>A0A0Q7JWD8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MDRMATIKLGLSTAILATLASSAFAEGGERAQIAAAVDKAIRPIMREHKVPGMAVAVTVE
GRHYFLNYGVASKETNAPVTENTLFELGSISKAFAATLASYAQVTGKLSFDDHPRKYIPA
FAGTPIDKATLLHLATYTAGGLPLQFPDAVKSDADMVGYFSTWKPEAKPGKTRRYSNPSI
GLFGHTAALAMGGSFSAVLESEIFPKLGLKHSYVRVPDSQMGSYAWGYGKADKPIRVTAG
TFDAEAYGVKSSAADMIRFVETNIQPELLDGAIRKAVEGTHVGYFDSGKMVQGLGWEQYP
YPVSLERLLDGNSRDMALKSNPVKALDPPKRPDGSTLYNKTGSTNGFGGYVAFVPEKKIG
IVLLANRNYPNPERIKAAHAILKSLEAAAK
>A0A0U1YWT4|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVALWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLIAAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>YP_790742|FEATURES|ARDB_deepARG|multidrug|oprN|antibiotic efflux|0
MIHAQSIRSGLAPALGLFSLLALSACTVGPDYRTPDTAAAKIDATASKPYDRSRFESLWW
KQFDDPTLNQLVEQSLSGNRDLRVAFARLRAARALRDDVANDRFPVVTSRASADIGKGQQ
PGVTEDRVNSERYDLGLDSAWELDLFGRIRRQLESSDALSEAAEADLQQLQVSLIAELVD
AYGQLRGAQLREKIALSNLENQKESRQLTEQLRDAGVGAELDVLRADARLAATAASVPQL
QAEAERARHRIATLLGQRPEELTVDLSPRDLPAITKALPIGDPGELLRRRPDIRAAERRL
AASTADVGVATADLFPRVSLSGFLGFTAGRGSQIGSSAARAWSVGPSISWAAFDLGSVRA
RLRGAKADADAALASYEQQVLLALEESANAFSDYGKRQERLVSLVRQSEASRAAAQQAAI
RYREGTTDFLVLLDAEREQLSAEDAQAQAEVELYRGIVAIYRSLGGGWQPSA
>H8FR50|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTAYFDALILGLIEGLTEFLPISSTAHLLLIGDFLGFEGPPGKTFEIVIQLGSILAICVV
YWGKLWSVASSLDQPGSRAFVRNILIAFLPACIAGAFLYKYIRQLLDTPIVAAIALIVGG
FVILAIEKMVHTPRVHTVEDISPKRALAIGACQVLAMVPGVSRAGATIMGSLLLGVDRRT
ATEFSFFLAIPTMIGASAYSIYKNWSALSFDNAALIAVGFVAAFLAALLVVRSLVVFVGR
HGFAPFAWYRIAFGGTMLVLLLMR
>A0A0W7UZH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFFELLKAIFLGVVEGITEWLPVSSTGHLILVQEFIKLNQDKAFLDMFNIVIQLGAILA
VIVIYFKRLNPFQPGKTAREVQLTWQLWLKVVIACIPSILIAVPFDDWFEAHFNYMIPIA
IALIVYGIAFIWIEKRNANIEPEVTDLARMPYLTAFWIGCFQVLSIVPGTSRSGATILGA
IIVGTSRSVAADFTFFLAIPTMFGYSGLKAVKFFLDGNVLNFSQFLILMVASVTAFLVSL
YVIRFLTDYVKKHDFTIFGKYRIVLGTILILYSIAKNIF
>K9BAK6|FEATURES|UNIPROT_deepARG|aminoglycoside|ACINWC323_2837|antibiotic inactivation|1
MKIMPVTEPFLADWLQLRRLLWPDHEDAHLLEMRQLLEQTQTLQLLSYNDQQQAIAMLEA
SIRYEYVNGTQSSPVAFLEGIYVLPEYRRSGVASALVQQVEHWSKQFACTEFASDAALDN
TISHAMHRALGFQETERVVYFKKNIS
>A0A0W0UC94|FEATURES|UNIPROT_deepARG|beta_lactam|Lgra_3373|antibiotic inactivation|1
MKKISVFSSMVLLFCTTTWAQKNCFLARENQTVLKHEGKDCNQRYAPQSTFKIALSLMGF
DAGILKDAFHPEWPYKKEYELYLNVWRYPQNPHTWMRDSCVWYSQVLTQQLGMKRFKEYV
NSFHYGNEDVSGDKGQNNGLTHAWLSSSLAISPIEQMQFLQKMVTRKLPVSQRAFNRTKE
ILYIQELAGGWKLYGKTGTGEQLTKDKNQKLPLRQGWFVGWIEKDNRKVAFVNHITGCKE
SFAGLKARNDALIKLFYLINELEK
>A0A0K0QEE3|FEATURES|UNIPROT_deepARG|beta_lactam|AC241_15790|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSESPKQTKQTNQIKQETTGNDSFV
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKTTNK
>R8KK70|FEATURES|UNIPROT_deepARG|chloramphenicol|ICS_03273|antibiotic inactivation|1
MRFHIIDRENWNREQYFEHYLKLKCTFSMTVNVDITMLLEELHQKGIKFYPVFIYLISKV
VNNHKEFRTCFNDEGVLGYWEEMTPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMR
CYANVHGLFTKENIPPNVFPISSIPWTSFTGFNLNINNDADFLLPIITCGKYFNEENKVM
LPVSLQVHHSVCDGYHASRFIEDLQELSNSCNLK
>B2CD67|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
QGLKHMLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITM
SDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATT
LRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWYFAD
>A0A064D688|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEALPITKVSVVIPVYNEQESLPELFRRTTAACESLGKDYEILLIDDGSSDHSARLLID
ASEAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKTASKMINHLIQRTTGKAMGDYGCMLRAYRQHIIDAMLHCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAVTGFTLSILLVILRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIRPESPHSTKENQ
>BAC12781|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLFSVSNLEQSIDFYQQVFDAKLLVKGRSTAYFDLNGIWLALNEEKHIPRNEINESYTHT
AFSIDESELESAIQHLKALNVNILEGRERAEQDKQSIYFTDPDGHKFEFHTGTLQERLKY
YRDQKKHMTFY
>F4LVX9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLLFKAAVMGIVEGITEFLPISSTGHMIIVGDFIDFKGNSFHTMFEIVIQLGAILAVVY
YYRYKIIDSIKHIRPGEKGFELWFKIFIAFLPAAVIGLLINDVIEKYLFSSFTVAIALVV
GGFLMILAENYFGRSGLNDMDKTDLGQAFIIGIGQCLALIPGMSRSASTIMGGMAAGLSV
KAAAEFSFFLAIPTMVAATGFSLFKGYSGTSPLELQALVVGFVVSFIVALLAVDRFLSYL
KQHSLKPFAYYRIVVGIIMILLITTGIL
>A0A0U4UUJ9|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
MRVLALSTVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>I4KUW7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKYQPKYLVSALLLVSGGCMAATDMRQVVDSNIKPLMQQQGIPGLAVAVVNQGKVQYFNY
GVAAKDTQAAVTQNTLFEIGSVSKTFTATLGGYAQAIGKLKLSDTASQYLPSLAGSAFDR
ISLLQLATYTPGGLPLQFPDAADSASTMLGYFQHWKPTYAAGEQRLYSNPSIGLFGYLTA
QSLGQPFNVAMEKTLLPKLGLTNTYVNVRTDKASQYAQGYDKQQKPVRVSPGALDSEAYG
LKTTSQDLARYVIANMHPQTLEQPVQQAIAATHAGYYTVNGMTQGLGWERYPYPITLQAL
IDGNSTPMAMEPHKVTWLNPAQAQPANVLYNKTGSTGGFGAYVAYVPSKDMGVVILANKN
YPNAERVKVAHAILSAMDQ
>Q62ZD8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MQIRMTEYQVPDPESGPYGITVCANGRIWFTEQKGNRIGMLTESGDITEYTIPTESAGAS
IITSGIDGELWFTEYKAGKIGKITPQGKITEYALPPGAAPFGIAAGCDDAMWYTDMAGHQ
IGRLSSSGEITEYKLPKPGAFPSFITRGADGALWFTQNQSGSIGRITADGDISEYPLPQE
QSGPVGITAGPDGALWFTEINANQIGRITVSGKISEYQLPTAHARPHAIAAGGDGALWFT
EWGAGQIGRITVDGDITEYPIPTADSEPHGIAAGSAHSIWFAEECGRIGKISIQN
>Q0T2M8|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERDIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEIFQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQMLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFLPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSCYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A127SF43|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-10|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKISYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>F4FWG9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMLDIIKAIILGIVEGITEFLPISSTGHLILVNEFIKMSQTTQFTDMFNVVIQLGAIMAV
VVLYFHKLNPLSPKKTHVEQHQTWVLWFKVIVAVLPSVVIGLLFNDWMDAHLMNWQVVSA
MLLIYGVLFILIENRNANRQPLFSDLNTLSNRTAFIIGMFQLLSLVPGTSRSGATILGGI
LIGTSRYVATEFSFFLAIPTMFGASLLKVYKYFSHGGAFTGMQTAVLLTGMLVSFVVAYF
AIRFLLNYIQHNNFKIFGWYRIILSLIVIGYFGFLAH
>A0A023Z4Y1|FEATURES|UNIPROT_deepARG|multidrug|mdtl|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGVGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLTVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>YP_001694417|FEATURES|ARDB_deepARG|quinolone|PmrA|antibiotic efflux|1
MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISA
ALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNA
TALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAI
LTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVR
DLGQTENLLFVSGLIVSSMGFSSIMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANA
SSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGS
AVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI
>A0A0E3U330|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDLYLLVISFILGMVEGLTEFLPISSSLHMNFVGELLGFSDDKVGIVLNVVIQLGAVLS
IVFVFWKSFFVVFIKRVCFGNFGFFSGSFLSCGHIILGVLPTVVLGLIFYENVKNVFKIQ
YMIYFLILGGVLLLIAEWFTREFYVLDHISNIDDLSYLQAFVIGCFQCLSLCPGFSRSGV
TISGGLMVGLNRYVASTFSFVLAVPMIFSATVLVLYKNFYFITWEYFPVLVIGFLSSFFT
SLFTVKFFMEIIRCVSFVPFAVYRFIVAIVLCLFY
>A0A0G3WAC1|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MIVWKTDVYMGIKVTILIYGGKNSMVFIELLKVIFLGIVEGITEWVPISSTGHMILVEEF
IQLNASEAFKEMFFVVIQLGAIMAVVLLYFQKLNPFLAKKSIRQKKDTMKIWYKVIVGVI
PAAVTGLLFDDWLNEHFYNYQTVAIMLIVYGVLFIVIENRNKNKVTKINSFNELSYLTAF
YIGIFQVLALIPGTSRSGATIIGAILLGTSRHIAAEYSFFLSIPVMFGASALKLIKFGFN
FTGFEIVSLLTGMMVAFVVSIIAIRFLLSYIKNNDFKPFGWYRIILGFILIAYFTFR
>I0VYE8|FEATURES|UNIPROT_deepARG|beta_lactam|ECW26_04230|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTTGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIVNGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>CAC08444|FEATURES|ARDB_deepARG|beta_lactam|ACT-32|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTSYPN
PARVEAAYHILEALQ
>A0A009H9I3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNTQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNGIKK
>BAH17153|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTFFELVKALILGIVEGLTEFAPVSSTGHQILVDDMWLQTKYVLNSQESANTFKIVIQLG
SIFAAAWIFRHRFLEVLHIEKTKTEGPRLNLLHIFIGLIPAGIMGLLFDDFIDKHLFSVP
TVLIGLALGALLMIAADLFNKKVTHTTTVDEMTYKQALIIGVAQCLALWPGFSRSGSTIS
AGVLLKMNHKAASDFTFIMAVPIMFAASAKSLASNIQYIHSDQILFYIVGFIAAFIFGVL
SIRLFLSLINRVKLMPFAIYRLILVAVIAVLYFGFGIGKGI
>ZP_02902384|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKYQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFDKSTHHYTDSVGGILRSTGR
YLALYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTDYYLT
KEKKNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGDENKVEAITMRATRAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLGEAAKHPDLLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPEDIGDWYVRAANGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MALMEELASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDLEHNHTVNHH
>YP_002706077|FEATURES|ARDB_deepARG|multidrug|smeE|antibiotic efflux|1
MARFFIDRPIFAWVIAIIIMLAGGLALFKLPVSMYPNVAPPAVEISATYPGASAKVVEDS
VTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQ
EVQRQGINVAKSSSGFLNVIAFVSENGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGG
KYAMRIWLDPNKLHTYGLSVAEVTAAVKAQNAQVAIGQLGGAPSVKGQQLNATINAQSRL
QTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANAL
DTAAGVDAALQDMKSFFPAGLKAEIPYDTTPFVRVSIKGVVQTLIEAIVLVFVVMYLFLQ
NFRATLIPTIAVPVVLLGTFGVLAMLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIM
SEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMAL
SVLVAIVLTPALCATMLKPLKKGEHHVAHKGWSGRFFNGFNHGFDRTSESYQRGVRGIIH
RPWRFMGIVAALFVLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESITALEN
HFLQNEKDAVESVFSVQGFSFAGMGQNAGMAFVKLKDWSERDADNGVMPITGRAMAALGQ
IKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAGSKKLANVRP
NGQEDTPQFRIDIDAAKATSLGLSIDQINGTLAAAWGSSYIDDFVDRGRVKRVFVQADQP
FRMVPEDFDLWSVKNDKGEMVPFSAFATKHWDYGSPRLERYNGVSAMEIQGEPAPGVASG
DAMAEIEQLAKQLPAGFGIEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAAMYESWSVP
TAVLLAAPLGILGAVLANTFKGLERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGAS
LIESIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGV
FFVPLFFVVVQRVFKRKSAT
>A0A091A6T2|FEATURES|UNIPROT_deepARG|aminoglycoside|JM66_13945|antibiotic inactivation|1
MQIVPLSQARLAQWAALRQLLWPHHDASAHLQDGIAMLANARQSAFLALDEHGQAVGFAD
AALRLDYVNGCESSPVVYLEGIYVQPQQRRQGVARALISHVECWGIEHGCHELASDTAIE
NLASQQMHQQLGFSETERVVFFKKALG
>E0N6P9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIGFHSNHKVFEIAIQLGAVLAVVF
EYRQRFSNVLHGLGKDRKANRFVLNLAIAFIPAAVMGLLFGKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIADVDALRPIDALMIGVAQVFALVPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFVAAFVSGLVAVKALLK
FVSKKNYIPFAYYRIVFGIAIIILWLSGWISWE
>K9ADU3|FEATURES|UNIPROT_deepARG|beta_lactam|C273_11191|antibiotic inactivation|1
MGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMFNN
KNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKP
NDKLISETAKSVMKEF
>A0A127SV09|FEATURES|UNIPROT_deepARG|chloramphenicol|catS|antibiotic inactivation|1
MTVKLDITQIKKKRMKLYPAMLYYLATIVNRHSEFRTAINQEGELGIYDEMIPSYTIFHE
DTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDVPENVFNVSMIPWSTFDGF
NLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQVHHAVCDGFHICRFVNELQKLINS
>A0A154W9V3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNASTPLLKLSGVYRRYGEGEAAVTVLKDVDLEIGRGEFVAIVGQSGSGKSTLMNIIGCL
DRPTEGRYEVAGQDVADLSTDALAGLRRQTFGFIFQRYHLVPGITALGNAELPAVYAGLS
GAQRRGRAEKLLGRLGLSDRLTHRPSELSGGQQQRVAIARAVIGRPKLLLADEPTGALDS
ESGREVMGILHEMHREGRTIVIVTHAPEIAEQAERVIQIKDGVIVSDERTRPALTGQGPG
APAPADGMALAKVIGESFAMAMRALAHNRLRTLLTMLGIVIGVASVVAMLAIGTGARQNI
MTRIEAMGTDLLLVKRGQLGVRASGREVISFVAPDIEAIAKLPGVEAVVPETTQTVLIRY
GNRDGQVSALGTGRDYPAVRAWNAERGVFFTRDHERRYAQVVVIGASIAKSLFAQENPVG
KYLLVDSAPFQIIGVMEAKGITTGGGMYDRDEMIWLPYSTAGTRLFGRQHFSDITVKVAP
GYQLAEVEQRLHELLLRRHGKEDFHIRNMGEIIDTVNATQDTFQTLLGAIGIISLLVGGI
GVMNIMLVSVTERIGEIGVRMAVGARPLDVMLQFLTESVIVCFIGGMLGVALGIGASYAL
TALGSGWNAVVTLEPILLAFGCAFLTGLVFGLAPARKAARLDPVAALTRE
>A0A0D1MM07|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDMHSLVIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGETAKTFEVVIQLGSILAV
VVMFWRRLFSLIGIHFGHPPHEGLGRGRLSLIHILLGMVPAVVLGLAFHDLIKSLFNPIN
VMYALVVGGVLLIVAELCKPKEPRAPGLDDMTYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFLLAVPMMMGATALDLYKSFHFLTAADIPMFAVGFVTAFLVALVA
IKTFLQIIKRISFIPFAIYRFIVAAAVYVVFM
>A0A0Q7XLZ5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MGPCLYWCPSRTNPENALSTKSIVLACLSLLPLTAGAVDAAAVRVAVDRAIQPLMAQHDV
PGIAVAVTVDGQALFFNYGEASKQEHKPVTENTLFELGSVSKTVTATLACYAQGLGKLSL
ADHPGQYVPQLKGSAIDRASVLELGTYTPGGLPQQFPHDVETEAQTIAYFRTWRPDAAPG
TLRRYSNPSLGLFGHVTARALGVGFADAVEGRLFPALGLKHSHIRVPAGAMGDYAWGYDK
TNRPVRVGPGPFDAETYGVKASAADMIRFVQLNIDASSLSEPMRRAIDCTHTGYFRIGDT
VQGLGWEQYRAPVSLAALQAGNSTKMSAEPNPAVRLEPAQVPPPGTLFNKTGATRGFGAY
VLFVPQRRVGIVMLANKNYPNSARVEAAHSILEHLVP
>YP_002748724|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDDRAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSAADLPLFATGFITAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>A0A0R2V8E5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLYLLWAAFVLGVIEGATEFLPVSSTGHLIIAADVLNFSNSSSDVFEIFIQLGAIMAVI
TEYRKKLIQTISDIPHDPAAQKFAASIAIAFIPAAILGFFFHSAIKLYLFNPVTVAIALI
VGGIAMIVIEKSMPVLSVAKQSDVSFKQAFLIGIAQCLALIPGVSRSASTIMGGVLSGLD
RKSATEFSFFLAIPIIIAASFYDLIKNFHLLDKHDFLIFFIGSLTAYISALFIIKLFIRY
VAHNNFIGFGWYRIIVGIITLFYFY
>A0A034SY69|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGVQSLIDAGYEIAAIVTHQDAPGENLFFGSVARLAAQHNIPVFAPD
DVNHPLWVERLRALQPQVIFSFYYRHLLSDAILTLAPQGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMEKRADAGNIIAQRRIAIAEEDTALMLHHKLCQCARALLAEALPQI
RSGSYAEFPQDESAATYVGRRTPADGRLEWSKPARELYNLVRAVTEPWPGAFSYAGNRQF
TVWQARVRSDLPAARPGTVLSASPLAIACGEGALEIVAGQPQDGLYMQGSQLAESLGLVE
GAILNSSLNFGVRRATRVLILGVNGFIGNHLTERLLAEDNYEVYGLDIGSDAISRFIDHP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRDC
VKYKKRIIFPSTSEVYGMCSDPQFDEDSSNLIVGPINKQRWIYSVSKQLLDRIIWAYGAK
DELRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDI
KEGVEALFRIIENKDNLCDGQIINIGNPDNEASIRELAEQLLVCFEQHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAQRLLGWQPVIPMESTIEDTLDFFLQTFDGTEQE
>A0A0M3R6L4|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV-11|antibiotic inactivation|1
SEKTPCRRHTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETE
LNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAG
WFIADKTGAGERGARGIVALLGPKKKAKRIVVIYLR
>D4C2D7|FEATURES|UNIPROT_deepARG|beta_lactam|PROVRETT_08647|antibiotic inactivation|1
MKTLFRQGRIFVALSLALTTLSANAFTQKDVDDIIKPLMEQKQIPGMSVAISVEGKHYIY
HYGVQSKQSLVPVSDETLFEIGSLSKTFTATLAAYAQDQGKLDFSQKVSHYLPELKGSAF
DQVTVMNLATHTSGLSLFVPDSITNSAELIRYYQHWKPTKAIGQYRSYSNLGVGLLGIVT
AKQLKMPFEQAMEKLMLPALGLKHTYIHVPKNQHKNYAQGYNKHDQPIRVAPQILDAESY
GLKSNAKDLIRFLDINMQTKKVAKPWQEAVENTHTGFYMTDSFMQDMMWESYSWPVSLAQ
LQQGNRNEMALQPQKVEAITPVMPPETQAFYNKTGSTNGFATYAAFIPENQVGIIILSNK
WYPIPDRITAAYQLIEKAKH
>I1CXP7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTEVVITEHPVVADTGGAGPYGLTGGPDGALWFTLARSGRIGRMIPGEEPTFHSLDPECQ
PTVIVAGPDGALWFTEYRGHRIGRITTGGELTEFAPPTTESGPYGLTVGPDALWFTELGA
DRIGRITTDGEITEYPLPWPGAFPSVVDTGADGALWVTLNGANAIGRMTLDGAVTRYELP
TEAAAPVGLTVGHDGALWFVEIAAGQIGRITTDGEITEYPLPDRAAKPHAITAGGDGRHW
FTEWGTGRVGAITSDGTVEVYALSERHSEPHGIAVGPDGAVWVALESGALARIDVES
>J2DNX5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASVWAMFNVMIQLGAILAVVV
LYWRTFWAVAMGLLRLDPVSIRFVRNLLVAFIPAVVIGLALHDYIDTLLGSPRVVACALV
VGGVAILVIERLIKDQRFHGIADIPLVRVIGIGFIQCLAMVPGVSRSGATIMGALALGVE
RRTAAEFSFFLAIPTMLGASTLELLKKGDQLTSAQVGWDSIALGFIVSFIVALLVIRWFV
GLVSRHGFAPFALYRIIAGIGALIWLTLR
>M4Q8X9|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
CSPRNAGEVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRI
DAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGG
PKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASR
QQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKP
>J8M8M2|FEATURES|UNIPROT_deepARG|beta_lactam|IK9_01490|antibiotic inactivation|1
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLNTTKGLVLVDSSWDNKLTKELMEMVEKKFQKRITDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKNSGYEEPLGDLQIITSLKFGNTKVETFYPGKGHT
EDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNINSVVPGH
GEVGDKGLLLHTLDLLK
>AAD51058|FEATURES|ARDB_deepARG|glycopeptide|VanYD|antibiotic target alteration|0
MMEYQNNNGNYDKRNRRKAKKRKLLFYRAACVILCLLIVSVIFGVVHFLGESKDPGILSK
ENTKTDKNYSWLTDDQKEAVPSVSEPAISDQANKISVNITAANAIVMNKDTNEVLYQKKS
TAQIAPASTAKMIMALTALDYCSPEDEMKVGAEIEMIQSDSSTAWLMKGDTLTVRQLLIA
LMLPSGNDAAYTLAVNTGKKIAGDKSLTHQQAIEVFMDKVNEKAVDLGATNSKFIAPDGY
DAEGQYTTAYDLAIIAKACLDNPIISEIVASYSSYEKWPNGREVTYSNSNELLDPNSPYY
RPEVIGLKTGTSSLGGACIVSAAVIDGETYICVVMGSTKESRFQDSVDILDKIKAQ
>B8ED72|FEATURES|UNIPROT_deepARG|beta_lactam|Sbal223_0838|antibiotic inactivation|1
MRSFAISTVLVMSSLLASSIIAAPTFASTAAKTEWQETRSWDAIFTQHQVEPQQAKQQQA
KPQKNKSQQASGVVVLWNENKQQGYTNNLKRANQGFLPASTFKIPNSLIALELGVVKDEH
QVFKWDGKSRDIATWNRDHNLITGMKYSVVPVYQEFARQIGEARMSKMIASFDYGNEDIS
GNLDSFWLDGGIRISATEQIDFLRRLYHNKVHASERSQRIVKQAMLTEANGDYIIRAKTG
YAVRAEPSIGWWVGWVELDDNVWFFAMNMDIPDAAGLPLRQAITKEVLKLEHVIP
>A0A0H3I3Z0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MIDDIKNVSVVIPVYNEEESLPVLIERTLAACRKIGKPWEIILVDDGSSDRSAELLTEAA
SDPDSHIIAVLLNRNYGQHSAIMAGFQQAVGDVVITLDADLQNPPEEIPRLVEYASQGYD
VVGTVRANRQDSLFRKLASKTINMMIRRSTGKSMVDYGCMLRAYRRHIVSAMLRCHERST
FIPILANTFARKTIEIDVLHAEREFGTSKYSFLKLINLMYDLLTCLTTTPLRILSLIGSV
VALSGFLLALLLIGLRLFLGAEWAAEGVFTLFAVLFMFIGAQFIGMGLLGEYIGRIYTDV
RARPRYFVQKTVSAATPLTTSLRDEEE
>A0A0P9M5E0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPGEKTFFGSVAQMCARHGIAVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVAISDTDTALTLHGKLRDAAADLLCETLP
LLAAQGQLPGTPQDESRATYFGRRTPADGLIDWSLPASQLYNLIRAVTQPYPGAFCPVGD
NKLIVWAASVDTSSNGEAPGTVISHEPLRIACGEGSLVITAGQRGDNGLYLSGAQLAREF
GLVAGSQLLDKAKRRSVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYQIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGKGYQDVSHRKPSIDNARKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>A4WAM3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDIGCAGINALVAAGYDITAIYTHPDAPSENHFFGSVARTAAEHGIPVYAPN
DVNHPLWIDRIKSAQPDVIFSFYYRNLLCDEILNSATVGAFNLHGSLLPHYRGRAPLNWV
LVKGETETGVTLHKMVSRADAGAIVAQHRVAIAPEETALTLHHKLTQASSDLLKDILPVI
KTGHFPEVEQDHSQASIFGRRTAQDGCIDWHATAQEISNLVRAVTDPWPGAFGYVGGSKF
IVWKARALEGLQAAKAGTVLSVSPLVIATGGGALEIMTGQTENGVYMQGSQLAQTLGLVA
GAIISSQPVSAIKRRTRVLILGVNGFIGNHLTERLLQDDNFEVYGLDIGSDAISRFIGNS
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYQKRIIFPSTSEVYGMCSDKVFDEDHSNLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGRQKRCFTDI
SDGIEALFRIIENKNSNCDGQIINIGNPDNEASIKELAEMLLASFEKHPLRNHFPPFAGF
REVESSTYYGKGYQDVEHRKPSIRNAHRLISWTPTVEMEKTIDETLDFFLKTVELTEPQA
>R7B4C4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSFVEILKVIVLGIVEGFTEWLPISSTGHMILVDEIIHLDVSEAYREVFMVVIQLGAILA
VMVLYFNKLNPFSPHKSMAQKRGTIRLWIKIIIACIPAAVIGLPLDHFMDKLMNGYVVAA
MLILYGVLFIVLENRNVHRHFPIERVTQISFQTAALIGCFQVLAMIPGTSRSGATILGAM
LIGCSRPAAAEFSFFLGIPVMFGASFLKIVKFFIQGGGFSFAEFIYLVLGMVVAFGVSVY
SIKFLMGYVRKHDFKFFGYYRIVLGIVVLSYFGISALVG
>A0A128C8S3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTSGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>YP_698526|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGIDFLFILKALIIAIVEGLTEFVPVSSTGHMILVGDLIHFNTQSGGFPEMYEVVIQLGA
ILAVVVLYWRKISSSVVEFLSYIFSFIGLKASGDKRKYEKRLAESKTGFRFGINVIIGTI
PAAILGLLFHDEIKEYLFSTKTVAIGFIVGGILLIVIENNFRKRAKRSKIVKDIDKMTYG
QSLLVGCFQCLSLWPGMSRSASTIMGGWISGLSTTVATEFTFFLAIPAMVGASGLDLFKF
DYSQMNATNLISLILGFIVAFIVSLVVIDKFINYLKKKPMRIFAIYRVFAGIVLAILIFT
KVIS
>A0A076PVR2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-161|antibiotic inactivation|1
LLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVT
AFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVT
WLKGNTTGAASIRAGLPTSWTVGDKTGSGGYGTTNDIAVIWPQGRAPLILVT
>A0A154TLQ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILILFKALILGIIEGLTEFLPISSTGHLIVFGDLMNFQSNGKVFEIAIQLGAVLAVVF
EYRQRFTHIIKGLGKERTANRFVLNLFIAFIPAAVVGLLFSKQIKLHLFNPITVATMLVL
GGFFILWVEKRQATVKPKVNHVDDMRPIDAFVVGCAQICALIPGTSRSGSTIMGGMLWGL
ERKTATEFSFFLAVPMMIAATGYDILKNYKLFTLQDVGQIAIGFIAAFIAGLLAVKALLK
FVSSKNYVPFAYYRIVFGGLILLTWMLGWVSWSE
>G5D8W8|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV-142|antibiotic inactivation|1
TAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLL
QWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALAWPRKTKAS
>A0A0T9REF0|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFALGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGATPHEGKTNGHLTLGHILLAMLPAVGLGLVFHNAIKALFNPHS
VMYALVAGGLLLLAAEWFKPKNPKAVGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMMGASGLDLYKSLHFLSLGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFVVAAAVYWVFM
>N9GTT2|FEATURES|UNIPROT_deepARG|beta_lactam|F927_00938|antibiotic inactivation|1
MTKPNDFSRTFKKLLMVAGLISFSSALWAENLTEQQVKAVIDQQFKPLLTQYKVPGMAVA
VTLNGKHYFVNYGLASKQSQQAVSNKTLFELGSVSKVFNATLAGYAQAQGQLSFSDHPAQ
YFPELKNTAVNRATILNLGTYNAGGFPLQFPDDVVKQQDMIRYFQEWQSKTKIGAARQYS
NPSIGLMGYVTALAMKKPYVELIEQTLFPQLGMTQSFINVPEPHIPQYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAQINVQQLQQPIRKAIENTHVGYFKVGAMTQGLGWE
QYAYPVKLETLLEGNSSKMALESHVITPIKQPKIVSPATYFNKTGATNGFGAYVAFIPQQ
KIGMVMLANTNFPNEARITATYQAMQQILKQNAAQ
>H1Q2M9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLIQTIIISIVEGLTEALPISSTGHMIITQHLLGVPQNDMFVHSFTFIIQFAAILSVVL
LYWKRFFRLNTSPAPEGSNALQILLHKFRFYWLLVVGVIPAVIIGFAAKKSGLLDWLLDS
VWVVAVMLVVGGVFMLFCDKLFNSKDNEKNEVDEHRAFKIGLFQCLSVIPGVSRSMATIV
GGMASGLSRKRSAEFSFFLAVPTMAGATLLDVLDLLKGDATWATGHNVFLLLVGCAVSFV
VALFAMKWFVAFLTKYGFKAFGWYRIIVGGIILIMLLSGASLNMIG
>G5MKX7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTTACESLGKAWEILLIDDGSSDSSAELMVK
ASQEADSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVLG
SVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTPFTEESHQ
>YP_002226662|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYTSEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLVMIVLWNAGYIIRSMHNID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFLGLLVNIPVNYIFIY
GHFGMPELGGIGCGVATAAVYWVMFIAMLSYIKHARSMRDIRNEKGFGKPDSIVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLGVGICMAVVTAIFTVTLRKHIALLYNDNPEVVALAAQLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYILALTDLVVDRMGPAG
FWMGFIIGLTSAAVLMMLRMRYLQRQPSAIILQRAAR
>Q92EE1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|1
MQQEATGGQKIRPIPIIASFLMAGFIGLFSETALNMALSDLIQVFDISSATVQWLTTGYL
LTLGILVPISGLLLQWFTTRGLFFTAVSFSIAGTLIAALSPTFAMLMIGRVVQAVGTALL
LPLMFNTILLIFPEHKRGSAMGMIGLVIMFAPAVGPTISGLILENLTWNWIFWISLPFLI
IALLFGMKFMQNVSVVTKPKIDILSIILSTLGFGGVVFAFSSAGENGWGSATVLVSIIVG
GIALGLFVWRQLTMEKPLMDLKVFKYPMFTLGLILVFISFMMILSTMILLPLYLQNSLAL
AAFSAGLVLLPGGVLNGLMSPFTGRLFDAYGPRALVIPGFIVAVIALFFLTRIEVGTSAL
TIIVLHSVLMIGISMVMMPAQTNGLNQLPPKLYPDGTAIMNTLQQVSGAIGTAVAITIMS
AGQKAYMETAQGVGPEQMIASLTAGIQNAFVFGLIMACIGLLCSLFIRKAK
>YP_002196817|FEATURES|ARDB_deepARG|tetracenomycin|tcmA|antibiotic efflux|1
MTSQTTVEKAPRDPQDSAPAPVKGLRGHPWLTLFSVAIGVMMVALDGTIVAIANPAIQKD
LGASLADVQWITNGYLLALAVALITAGKLGDRFGHRQTFIIGIAGFAAASAAIGLSDSIV
LVIAFRVLQGLFGALLMPAALGLLRATFPAEKLNMAIGIWGMVIGASTAGGPILGGVLVE
HVSWQSVFFINVPVGILAVVLGLVILKDHRAENAPKSFDILGILLLSGAMFSLIWPLIKA
GEWGWGSAGTLGWLAGSVVLFGLFAFWESKVDEPLVPLAMFRSVPLSAGVVLMVLMAFAF
MGGLFFVTFFLQGVQEMSPVDSGLRLLPLTGMMIVSSPLAGALITKFGPRLPLVGGMVCT
AAAMFGMTTLSEGTGTFAMSLWFALLGLGLAPVMVGATEVIVGNAPMELSGVAGGLQQAA
MQVGGALGTAVLGAVMSAKVSAEFADNWKAAGIPAPPDPRLEQAAEFGTVPGELAQAPGM
TPELVTTIGDVIHDTFMSGMGLAFTVAGIVAVVAALVAVLTKRGENAEAGAGAAHI
>A0A0F4U2E7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIESLLSSGFEIAAVFTHADDPKENAFYGSVAQLCARHGIAVHA
PEDANHPLWIERIAKLDPDYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIVAQQKVAIERNDTALSLHGKLRTAASDLLRDTLP
ALLQGKASETPQDESKATVFGRRTPADGKLVWAKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEIAKGNEGLAPGRVISVDPLRIACGQDSLIINAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDNNFDEDNSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRANFPPFA
GFRDIESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKR
>E1W5K3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEIKDLNRYFGEGENRIHILKNVSLNIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAT
NGSYKINGKETIELSKDQLSDLRSQKFGFIFQRYNLLSSLTAAENVALPAIYAGISQEKR
LSRAKQLLEKLGLGDKWQNKPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQSGQ
NVMEILRQLHAEGHTIIMVTHDREIAASANRVIEIKDGEIIGDTQKEAVKSAVENPTKSK
PHFGFSKDQFVEAFRMSVSAIIAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILENI
KGIGTSTMTIFNGTGFGDRRAEQMQNLTINDAIALNQQSYVQSVTPNSSSSGTLIYGNQT
FSSTSLKGVGEQYFDVDGLKLKSGNLFSAQDVADNNQVALIDESAKKSIFPDENPIGKIV
MFNKRPLRIIGVVSDKQMGGASSSLNLYAPYTTVMNRISGSKKIGSITVKVDDSVNTTVA
EKGITELLTMRHGKKDFFIMNSDTIKQTIESTTGTMKLLISSIAFISLIVGGIGVMNIML
VSVTERTKEIGVRMAIGARQFNILQQFLIEAVLICLIGGVTGILLSGLIGLLFNVFMTDF
TMAFSTGSIVAAVVFSTLIGVIFGYMPAKRAAQLDPITALARE
>ZP_04173668|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFEDDRAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSTIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSSADITLFATGFITAFVVALLAIVSFLKLLA
RVKLTPFAYYRFVLAAVFYFFIM
>A0A0N8NXE1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLDFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHGVIKTYLFQPYTVVIGLVA
GAILMLFAEVKKKEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSVNDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>S6J898|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MGEKTRITLAALGTCAALLGTGQCLAAAPDAPQLKALVDATIKPLMQAQDIPGMAVAISI
DGQAHYFNYGVASRESRQAVSNSTLFEIGSLSKTFTATLGAYAQATGKLTLSDAASQYLP
ALRGSALEHISLLQLATYSAGGLPLQFPDDVKSAEQTLDYYNTWKPAYPPGSQRLYSNPS
IGLFGYLAARSLGQPFETLMSNTLLPKLGLKHSYLQVPQDQQHLYAQGYTQANQPIRVGA
GPLDAEAYGMKTNSADLLSFVQSNLQPDPLEPALQQAIALTHSGYYRVADMTQGLGWEMY
AYPISEQKLVDGNSSAMALQPHAVHWLNPVQAPQAQMLLNKTGSTNGFGAYAAFVPGQHI
GIVMLANKNYPNAERVKAARTLLQALQTKP
>A0A0H4J4C1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-128|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQERAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKTELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASLVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>D7PII7|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-2|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLKKSDLVNYNPITEKHLD
TGMTVGELAAAALQYSDNTAMNKLIEQLGGPRKVTEYARTLGDKTFRLDRTEPTLNTAIP
GDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDK
TGSGDYGTTNDIAVIWPDNKAPLILITYFTQPQKDAKS
>E3WD95|FEATURES|UNIPROT_deepARG|bacitracin|bcrD|antibiotic target alteration|0
MALDFIEILKVIFLGIVEGITEWLPISSTGHMLLVDEFITLNMSEAFKEMFFVVIQLGAI
LAVVVMFWNKMFPFQFKNKSQSIIKKDTFSLWFKVAVACVPSAIMGILFDDYLDAHLHTP
VVIAIMLILYGVLFIVIENRNKKRTATTSTLADISYKTALMIGVFQVLSLIPGTSRSGAT
IIGALLIGVSRVAAAEFTFFLAVPTMLGASAFKLLKFGFDFTSAELLTLVIGMAVAFAVS
VFVIKFLMSYIKKHDFKVFGWYRIVLGILVLLITAI
>D9IAH7|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY-5|antibiotic inactivation|1
MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKHSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKADLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKIIGYLGGPEKVTAFAQSIGDVTFRLDRMEPALNSAIPGDER
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>A0A0R5RPH9|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>T0JMZ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIFTFEGSLVTIFDSVILGIIEGFTEFLPISSTGHLIVASEFLGINQTDTTKAYQVIIQ
FAAILAVVFNYKDKFTIKKIDLWAKIFLAFIPIGGVGFIFSSEIKTLFSVEVVAVMFIVG
GVIFLVVEKFFIPTEKILIDDVEQVTLKQSLIIGFAQVFALIPGTSRAGATIIGALLVGL
SRKASAEFSFLLAFPVMCAVTAYDLLKHYHEFSNDNLVALAVGFIVSFIVAYLTIKLFLV
FLERFTFVAFGIYRIIFGALLLILL
>G8LGX8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGITLRVEAGEMVAIVGASGSGKSTLMNILGCLDRP
TSGTYRVAGMDVSTLDGDALAKLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGVERKK
RLERAQMLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIRDGELVSNPPARHARAAAPKEVLS
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKTNVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
AQAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A023Z033|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLVAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVTRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEVAQRENEATCFGRRTPDDSFLEWYKPASVLHNMVRAVADPWPGAFSYAGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSISNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>CAA24909|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MKPNIPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALVQFACA
PVLGALSDRFGRRPILLVSLAGATVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYI
ADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFL
LPESHKGERRPLRREALNPLSFVRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDR
FHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRG
WMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYA
ASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQRADR
>F2BDZ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDILKAALFGIVEGITEWLPVSSTGHMVLLDEFVRLDVSPEFWKMFLVVIQLGAIAAVA
VLYFDKLWPFARGLRLKPEAVPLWGKILLACVPAAVVGLSLDNWIDRHFYNPFTVAVMLI
SFGAAFIVVENRNKHHRPKTADLAGISYMQALWVGLFQVIAAVLPGTSRSGATILGGIAV
GLSREVAAEFTFFLAVPVMFGASLLKIAKHGPAFSGHELAVLACGMAVSFIVSVLTIKFL
MAYIKRHDFKIFGWYRIVLGALVLLYFAVLK
>AAM48124|FEATURES|ARDB_deepARG|beta_lactam|CfxA3|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTFKECKTGVDRIA
APLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>A0A074LJ66|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDILIAILLGIVEGLTEFLPVSSTGHLILVGSLFDFEGDVATTFKIVIQLGAVLAVLIL
YWKRYMDILKGLVTLNFREKNKLNAVHMILAMIPALIVYLLLKDFIKDVLFSPATVLIGL
VIGGVLMIIAARAKRNVTAEDTDDISYKQAFGIGLFQCLALWPGFSRSGSTISGGMLLGT
SQKAAADFTFIISVPVMLGATALDLWDSREYLTSDAMLLFGIGFIAAFVVAMIAVVTFLN
LIKRLKLEWFAVYRFVIAALFFFFLLK
>A0A0H1ACS5|FEATURES|UNIPROT_deepARG|beta_lactam|WQ59_27450|antibiotic inactivation|1
MHPSTSRPSRRTLLTATAGAALAAATLVRGTAHASSGSRGRGHGSASDAERRLAGLERAS
GARLGVYAYDTGSGRTVAYRADELFPMCSVFKTLSSAAVLRDLDRNGEFLSRRIFYTQDD
VEQAGGAPETGKAENLANGMTVEELCEVSITASDNCAANLMLRELGGPAAVTRFARSLGD
RVTRLDRWEPELNSAEPGRVTDTTSPRAITRTYGRLVLGDALNPRDRRLLTSWLLANTTS
GDRFRAGLPDDWTLGDKTGAGRYGTNNDAGVTWPPGRPPIVLTVLTAKTEQDATRDDGLV
ADAARVLAETLG
>ZP_03837521|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQNSSIAIVFILGLLAMLMPLSIDMYLPALPVISEQFGVPAGSAQMTLSTYILGFAV
GQLLYGPMADSIGRKPVILGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLLAPIVGGWVLVWLSWHYIFWILAVAAILASVM
IFTLIKETLPVERRQPFRLRTTLGNFASLFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVSPQHFGYYFALNIVFLFVMTIINSRFVRRVGALNMFRAGLWIQFVMAGWMVFSA
LFGVGFWALVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATSSILFYLYASRAKKR
>CAA67865|FEATURES|ARDB_deepARG|multidrug|oprN|antibiotic efflux|0
MIHAQSIRSGLASALGLFSLLALSACTVGPDYRTPDTAAAKIDATASKPYDRSRFESLWW
KQFDDPTLNQLVEQSLSGNRDLRVAFARLRAARALRDDVANDRFPVVTSRASADIGKGQQ
PGVTEDRVNSERYDLGLDSAWELDLFGRIRRQLESSDALSEAAEADLQQLQVSLIAELVD
AYGQLRGAQLREKIALSNLENQKESRQLTEQLRDAGVGAELDVLRADARLAATAASVPQL
QAEAERARHRIATLLGQRPEELTVDLSPRDLPAITKALPIGDPGELLRRRPNIRAAERRV
AASTADVGVATADLFPAGQPQRLPRLHRRAGSQIGSSAARAWSVGPSISWAAFDLGSVRA
RLRGAKADADAALASYEQQVLLALEESANAFSDYGKRQERLVSLVRQSEASRAAAQQAAI
RYREGTTDFLVLLDAEREQLSAEDAQAQAEVELYRGIVAIYRSLGGGWQPSA
>E7S6Y5|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MLIIELLKALFLGVVEGVTEWLPVSSTGHLILVQEFMKLNQSKSFVEMFNIVIQLGAIMA
VIVIYFKRLNPFQPGKSAREIRLTWQLWLKVVIACIPSILIALPFDNWFEAHFNFMIPIA
IALIFYGFVFIWVEKRNAHLKPQVTELASMSYKTAFLIGCFQVLSIVPGTSRSGATILGA
IIIGTSRSVAADFTFFLAIPTMFGYSGLKAVKYFLDGNVLSLDQSLILLVASLTAFVVSL
YVIRFLTDYVKRHDFTIFGKYRIVLGSLLILYWLVVHLF
>A0A0P9YCJ1|FEATURES|UNIPROT_deepARG|beta_lactam|ALO84_04992|antibiotic inactivation|1
MQRNGTLLCTGLLLVSSVAFAEDNSAALDTLVQTEARKVMQENNITGLSIAITRHGKQQF
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGRLSLTQSIDTYMPPLRDTR
LGKIPVFHLGTHTAGGFPIQVPEKVQNTRQLMDYFKAWQPEYLPGTHRTYANPSIGLLGV
IAARSMNMPFQEAMQQRLFPALGLNSTYVNVPDDKQALYAQGYNTLDEPVRVNPGVLAAE
AYGVKSSSRDLIRFVEANIGLGQYDAPLQRALSDTRIGYFKVGGMTQDLAWEQYPTPIHL
DVLLAGNASAMLNTQKADAIEPPLAAQPTAWVNKTGSTNGFGGYVAFIAQKQLGIVILAN
KNYPNEERVKLAYRILQHAEPLN
>A0A0F4BN81|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDTAGENNFFGSVARIAAERGIPVYAPD
DVNHPLWVDRIRALAPDVIFSFYYRNLLSDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVHRADAGAIVAQQKVAIDADETALQLHQKLNATAQTLLRDALPAI
LNGTFNETAQDESKASCFGRRAPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLVVSCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGSDAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMELTIDETLDFFLRTVELSEQAS
>A0A089Q2X0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLPTLAIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGQTAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPEHEGVGTGRLSLIHILLGMIPAVVLGLVLHDAIKSLFNPV
NVMYALVVGGVLLIAAECLKPKVPSAVGVDDITYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTMGDLPMFAVGFVTAFIVALI
AIKTFLHLIKRISFIPFAIYRFVVAAVVFFIFT
>A0A0P9TKY0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MATIFYTTTSNSEPAASLHGGMMDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLID
FGGERAMAFNIIIQLGAILAVVWEFRRKILDVVVGLPKHQEAQRFTLNLLIAFMPAVVLG
VIFADTIHHYLFNAITVATALVVGGVIMLWAERRVHTVRTETVDDMTWRDALKIGLVQCL
AMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAV
FAIGFITSFVFAMIAVRALLKFIATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A109LWJ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDASAMNDFLTAIFLGIVEGLTEFIPVSSTGHLILATEISGADPNEWAMFNVVIQLGAIL
AVVYQYWGTFWSAGMGVLKGEREGLMFARNILLGFLPSAVIGFALYESFEAMLGNPGIVP
WALIAGGIAIIVIERVAQPRDEGRGVAELPLKKVLGVGFAQCLAMVPGVSRSGATIMGAL
AMGINRKTAAEFSFFLAVPTMIGASTLEVVTKYDEMMRGTTRVGWDEIAVGFVVSFIVAL
VVIRAFVAFVSRSGFTPFAWYRIVAGTAALIWLSIA
>M1ZWC0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDIMFILKAIIIAVVEGLTEFIPVSSTGHMILVGSAINFNGDFAKMFEVVIQLGAILA
VIVRYWEKIKESIVEFFKFIFTKGKEGKTGFKFGVNVIVGSIPIGITGLLFYHKIKSLFR
PEAVIIGFIVGGILLLIIENMFRKKEHAVQDIDSITFAQALKVGLLQILSVWPGMSRSAS
TIMGGWIAGISTPIAAEFSFFLAIPAMIGTSLKDLFEFDYSIMTPTLWSALILGFVVAFI
VSIIVMNKFVSYLKKKPMKVFAIYRVLAGLLLAVLVFTKIIVLTV
>A0A0E1C7P0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTMSLALSPHCASCQDVDMLTYPPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYE
ILLIDDGSSDDSARMLTEAAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDAD
LQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCM
LRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMY
DLVTCLTTTPLRLLSIFGSVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIG
AQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASKEEDRS
>L5N5L0|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIGPVNHYLFSVADLDRSITFYREVFQAKLLVKGRTTAYLDLNGMWLALNEEKDIPREE
IHQSYTHIAFTIAEEEVESAYEELLELGVPILSGRPRDTRDGSSIYFTDPDGHKFELHTG
TLEKRLAYYKAAMPHMKFYT
>YP_001569056|FEATURES|ARDB_deepARG|beta_lactam|PC1|antibiotic inactivation|1
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALNTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>T5HPY8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIWDIIVAIILGIVEGLTEYAPVSSTGHMIIVDDVWLKSKELLTPEAANTFKVVIQLGS
ILAVAIVFKDRILNLLGMKKNITEEQKSGNRLSIAQIAVGLVPAAVLGFLFEDYIDQYLF
SVRTVAVGLIAGAVLMLAADWINRRKDTTDSVDRMTYKQALGMGLFQCLALWPGFSRSGS
TISGGVILGLSHRAAADFTFIMAIPIMMGASLLSLIKNWAYLSADLLPFFIAGFISAFIV
ALFVVRFFLRLINKIKLVPFAIYRIVLGLLLFILFL
>A0A0Q0BFH7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGLQALLDAGYEIAAVYTHADDPDENTFFGSVARLCARHGITVHA
PEDPNHPLWVERVAKLAPDFIFSFYYRQLLGEPLLACAKKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHQMVKRADAGPVFAQQRVPISATDTALTLHGKLREAATDLLSETLP
LLAQDRLSGTPQDESRATCFGKRTPADGLIDWSLPAARLYDLIRAVTQPYPGAFCTVGDN
KLIIWAADLELRNDGEAPGTVISHDPLRIACGEGSLAILAGQRGDAGLYLSGAQLAREFG
LVEGSQLLDTQKRRPVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
IQPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDESFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGKGYQDVSHRKPSIANARQLIGWTPGIELSTTIGKTLDFFLREAMIEKA
DQR
>A0A0Q9DAK2|FEATURES|UNIPROT_deepARG|aminoglycoside|ASE60_09885|antibiotic inactivation|1
MRVLLMDGETIGRWVEMRLALWPDTPEAEHRAEVESSLAETDRYASFLCEDEAGVAAGFA
EASIRRDYVNGCETSPVAFLEGIYVLPGYRRRGVARALITAVERWATSQGCQELASDTAT
DNLRSQSLHMALGFEETERVVYFRKELSPAVADN
>A0A158A173|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSEPLIELSKVTLHYHAGDESVLILDDISLTINAGEFVAIVGASGSGKTTLLNIIGCLAR
PSTGAYKLDGESVLDADRETLARLRREYFGFIFQRYNLLPQLSATENVEVPAVYAGGPSF
RRRCRAQELLTSLGLGNRVEHRPNQLSGGQQQRVSIARALMNGGKVLLGDEPTGALDSKS
AREVMETFNSLHRQGHTVILVTHDERVAEHAHRIIKIEDGIIVDDRPTSKEEFRRTRVSP
SVGSDCADLTTVEGKAGLTANTAICERERLLSFIACLRTSVEIALRSLADNRLRTALTMI
GIVIGVAAVVSIVALSAGAKERTLDMIRSLGTNTITFWPSVDSDDAKQSLKRSLTLSDLR
LLSTQSEVDSATAEIEQEVLLQHGGAHGRGSLDGVNKDYFKVRGLRFLAGTGFDDDVGKN
SQVAVISEHARQRLFGPHGAAIGQIISLNKVPARVVGVIEDKPDMFSDPNALNVWMPLSA
ATTRIMGRQLPNRLIVRVRDGLRADDAEARLSSALVKRHGRKDFTTLNANSFATLLHKTE
HIMTILMIVVAITTLGVAGIGVMNMMLVSINERTREIGIRMAVGARQSDILQQFLTEALF
LCVTGGLIGLILSLGISAFVSHVADEWKMLHSPITAVTAFISSTLVGVVFGLMPARRAAG
LDPIDALAHE
>YP_002396141|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTFNFGELAAKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPHPVKDVRVLSRITTEAFNQRRKTIRNSLGNLFSAEVLTG
MGIDPAMRAENISVAQYCQMANYLAENAPLQES
>A0A0A0Q9K1|FEATURES|UNIPROT_deepARG|beta_lactam|MIR-10|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTFTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEVALDDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>A0A0U1NXW0|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MANKLQGNDLESLFICAYFFGTDNSIGAFFAFIFNLRDRQLLSIYSYKTSESYGRMRKMQ
LIQSNKYRRIKEFLREHNYPNFRMKQILNAIFKERINKFNEINVLPKSLREILVKEFGES
ILNVVPLKEQHSEQVTKVLFEISGNEKIETVNMKYKAGWESFCISSQCGCNFGCKFCATG
DIGLKRNLTSDEITDQILHFYLQGHSIDSISFMGMGEALANVQVFDALDVLTDPTLFGLS
PRRLSISTIGIIPSIKKMTLTYPQVNLTFSLHSPFNEQRSKLMPINDRYPLLDVMDTLDE
HIRITSRKVYIAYIMLPGVNDSIEHAKEVVSLLKGRYKEGRLYHVNLIRYNPTVSSPLRF
GEVDEGYVVNFYKKLKSSGINVTIRSQFGIDIDAACGQLYGNYQKSNKQ
>D2JC69|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIVIALVLSACNSNSSHTQELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQHLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>A0A085GC02|FEATURES|UNIPROT_deepARG|chloramphenicol|GBAG_2532|antibiotic inactivation|1
MEKTTLEYTPVDLSRWARKEHFEVFQSFAQSTINQTVLIDITELLKHIREAGWKFYPTII
FLLSKIVNSHAEFRMAIKNNELVIWNEIHPSYTIFHNETETFSSLWSHYDGNIHHFQDIY
SEDVARYGNNLSYWPKGESRENIFFVSAIPWVSFTSFNINVANMQNFFAPMFTLGKYYKQ
DGKVLLPLAVQVHHSVCDGFHVARLINELQEMSDGIKHLSEEPNA
>A0A0S8IJT9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNILHACVLGLIEGLTEFLPISSTGHLILAVRSLGIAQTEFVKSFEIAIQSGAILAVAVM
YWGTLLKSWEIGKRILVAFVPTAVIGVIFYKFIKSFMFNNVLVVLWALFVGGIMLIAFER
FHREKESDTQDLAAITYPKALAIGLFQTIAVIPGVSRSAATILGGLALGLKRRTIVEFSF
LLALPTLISATAWDMFKCAPSFKESDFLLLSTGFIISGVVSFLSMRFLLTFVKKHSFIVF
GIYRIVLAIIFWLGMK
>AAC27753|FEATURES|ARDB_deepARG|multidrug|AmrA|antibiotic efflux|1
MKYEWARTRRLSAALAVAAFVAAGCGKHESEHDAAAPREASVVTVKKTSVPLSVELPGRL
DAYRQAEVRARVAGIVTARTYEEGQEVKRGAVLFRIDPAPFKAARDAAAGALEKAQAAHL
AALDKRRRYDELVRDRAVSERDHTEALADERQAKAAVASARAELARAQLQLDYATVTAPI
DGRARRALVTEGALVGQDQATPLTTVEQLDPIYVNFSQPAADVESLRRAVKSGRAAGIAQ
QDVEVTLVRPDGSTYARKGKLLFADLAVDPSTDTVAMRALFPNPERELLPGAYVRIALDR
AVARDAILVPRDALLRTADSATVKVVGQNGKIRDVTVEAAQMKGRDWIVTRGLAGGERVV
VVDAAQFEAGTTVKALERGAAAQPASGAAAASAPGRRST
>A0A085GCF2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGVNALVAAGYDITAIYTHPDSPAENHFFGSVARTAAEHGIPVYAPD
DVNHPLWVDRIKSAQPDVIFSFYYRNLLNDEILNSASVGAFNLHGSLLPAYRGRAPLNWA
LVNGETETGVTLHRMVKRADAGAIVAQHPVAIAATDTALTLHHKLTEAASDLLDDMLPVI
KTGHFPQVEQDHSKATVFGRRTPQDGCINWQSTAREINNLVRAVTDPWPGAFGYVGGSKF
IVWKSRVLEGLQAAKAGTVLSINPLVIATGGGALEIVTGQTENGVYMQGSQLAQSLGLVA
GALLCSKPVSAIKRRTRVLILGVNGFIGNHLTERLLQDDNFEVYGLDIGSDAISRFLGNE
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYQKRIIFPSTSEVYGMCSDKMFDEDNSNLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGRQKRCFTDI
SDGIEALFRIIENKDNNCDGQIINIGNPDNEASIKELAEMLLVSFEKHPLRNHFPPFAGF
REVESSTYYGKGYQDVEHRKPSIRNAHRLLNWTPTVEMEKTVDETLDFFLKTVELTEPQA
>A0A0P8WM15|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
METIMLIIKSIILGIVEGITEFLPVSSTGHLVIFQNLIGFKGTNDYYVEMYTYVIQLGAI
LAVIILYHRKILDTLVNFFPKKVGYEKSGFKFWFMIFIACIPGGVIGILLDDLADMYLFT
PVSVAITLFLGGIWMVYAENKFRTSSSKSANLNVTAKQALIIGLFQCLAIIPGMSRSAST
IIGGWVAGLSTVAAAEFSFFLAIPVMSGMSLLKIIKIGGLSILTPNEIISLCVGFVVSFI
VALVVIDRFISYLKKKPMKIFAVYRMIFAVIVLAAGFLGIFH
>A0A089YTQ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAMQALILGIVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLGAILAVV
WEFRRKILEVVTGLPTQRNAQRFTINLLIGFLPAVVLGVIFADKIHEYLFNPITVAVALV
IGGFIMLWAEKREHAVRVHHVDDMHWTDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKFHHLFQPADFPVFALGFVVSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLVILATWQFGWIDWSSAQG
>D0JB33|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNYIQSILLGIIEGITEFFPISSTGHMILAASIMGILEKKITNLFLVSVQLGAVLSVVFL
YRNKFFFQKWDFYLKIFVSSFPVGILGFFFQKTNFLLGNPLTVALSLFIGGLVILKTENF
YEKNSSNKKNSITYLKAFIIGLFQCMALIPGVSRSASTIVACLLQNISRRKSIEFSFFLS
VPVIGIATCKKLFDYYFQLNSFTFQEIELLFLGNLAAFITGIIAVKFFMKYLKKNNFKFF
GYYRIILGIFFLVIHYLMKPLGKF
>B5UYF1|FEATURES|UNIPROT_deepARG|beta_lactam|BCAH1134_C0540|antibiotic inactivation|1
MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESNKQTNQTNQVKQENKGNHAFA
KLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREMGD
TVTNSERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLSILSNHDKEDAEYDDTLI
ADATKIVLETLKVTNK
>A0A0D1GG05|FEATURES|UNIPROT_deepARG|beta_lactam|H334_07645|antibiotic inactivation|1
MVRVFTRYSLLNIAKVRIKTKRTKNTRMKKLFLLVGLMVCSTVSYASKLNEDISLIEKQT
SGRIGVSVWDTQTDERWDYRGDERFPLMSTFKTLACATMLSDMDSGKLNKNATARIDERN
IVVWSPVMDKLAGQSTRIEHACEAAMLMSDNTAANLVLNEIGGPKAVTLFLRSIGDKATR
LDRLEPRLNEAKPGDKRDTTTPNAMVNTLHTLMEDNALSYESRTQLKIWMQDNKVSDSLM
RSVLPKGWSIADRSGAGNYGSRGISAMIWKDNYKPVYISIYVTDTDLSLQARDQLIAHIR
VD
>F1W3D8|FEATURES|UNIPROT_deepARG|beta_lactam|IMCC9480_1114|antibiotic inactivation|1
MPVSDAMYRKSPSHAPADSVFCLCDVTGQRGNAAADAPPAVLKSHIDRAITPLMQQYGIP
GMAVAVTINHRHYFFNYGIASRQTRQPVTGDTLFEIGSISKTLTATLAAYAEDQGHLALS
DSASKYYPSLRGSAFDKIRLLDLGPHPSGGLPLQVPDGIATTDQLMTYFRNWQPDHAAGT
HRTYSNPGIGLLGMIAAKSMNMSFANALQKWLFPLLGMTHSYLDVPAAHLPDYAQGYTKQ
DAPIRVSPGMLDAEAYGVKSTSADMLRFLDANLQTGVTDTALQRALARTHTGYFKAGDLT
QDLIWEQYAYPVALETLLSGNTNAMAYESVSATAIEPPLPPQAASWINKTGSTNGFAAYV
AFVPAANIGIVMLANKSYPVAARVEVGYRVMEGLAGARFTE
>A0A023XTB4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILGIIEGVTEFLPVSSTGHLLLAERFFHLGEGAFWDSFTVLIQLGAILAIVVLYFKKLW
DVAIGMFTGDAYARRFVIGVLVAFLPAVIVGLVAGKYIKTLLFNPWVVCFSLIVGGAILL
WVDRLNLKPREHDATRFPLLMYLYIGIAQCIAMIPGVSRSGASIVAAMFLGADKRAAAEF
SFFLAIPTMIGAFAYDFYKNRSEMTMDHMGVVAIGFVVSFITAIIVVKTFLSYVTRHGFV
LFAWWRVIVGTLGLIALALGH
>A0A127SBF9|FEATURES|UNIPROT_deepARG|beta_lactam|TLA-3|antibiotic inactivation|1
MKKHLVVIVFCALFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAILGIEDNFKLNVNE
KHHYPMQSTYKFHLALAVLDKLDKENISVDKKLFVKKSDLLPDTWSPLRDKYPNGNLELS
FSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYT
NWTTPDATVQLLKKFYKNEILSKNSYDFLLNTMIETTTGPKRLKGLFAGWNCCCS
>D8JRI7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHSWEALLLGLIEGLTEFLPVSSTAHLLLTEELLGVKSTGRTFEVLIQLGAILALLTVYS
GRLWHLVSALPSDARSRRFVLAVLIAFLPAAVIGAAAHSFIKNYLFESPLIICIALVLGG
IVLLFIDRLPLKPRYHDVMDLPLLSALGIGFCQCLAMIPGVSRSGSSIVGAMLLGADKRT
AAEFSFFLAMPTMTGAFAYDLYKNWSILTPDDVGMIAIGFVAAFVAGVVVVRYALDFIAR
RGLSFFGWWRLLVGGVGLGALAVLH
>I0BMZ8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MQARIQEYLLTEQDTAPYGITAGPDGALWFTEQKGNRIGRITLDGEMRFHPVPTPESGLS
CITAGEDGALWFTAYKAGRIGRITVEGVITEFALPGDGSAPFGITPGPDGALWVTLTAAG
RIGRVSLTGEITEHALPQAGCFPSFIACGPDGALWFTENQGNAIGRITTDGEVREYPLPR
EKSGPVGLACGPDGALWFTELLGNRIGRISTSGELREYELPAENARPHAITPGLDGDLWF
TEWGSGRIGRITAGGEITEYSIPTEGAEPHGIALGSDGAVWFAEECGRIGRLIPEGPGVP
QA
>X0Q7L1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLFVQAVIMGIVEGITEFLPISSTGYLILSADVMGFWTKEKVDLFVVVVQLGAILAV
IYDYWGRLWQALMGLLTGKSEGMTNPRQLGLSLIVSTILVMIVGFTFADEIKAYLFNPIV
VAIMLIIGGLLIFYVEKRPKTVIAEEAEDVSIKLALMIGLFQCLALIPGTSRSGATIIGA
LWLGVSRKASAEFSFFLGIPVIVGAALLDLLKHGDVLTNSEDWLVLGIGTIVSFVVALLC
IRLLVAWVSRRDFTIFAWLRIITGVIVLVAAWGFGYQMAG
>J8HGU9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRELAYFNICGVWIALNEETHIPRNEI
HQSYTHIAFSVEQEDFKCLIKRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGA
LQDRLNYYRDEKPHMTFY
>X8H384|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVDKLIGGEYLSPTFRNSFLIIIQLGAILSV
VVYFWKDISPFVKTKKEFVLRLRLWLKIIVGVLPAMVIGLLLDDIIDKYFLDNVLIIAIT
LIVYGIIFIGIEIVYKLKNIKPKVKRFSGLKYRTVFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEIEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIVVVILLLH
>A0A085V5T3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVIIGLPKQREAQRFTLNLFIAFLPAVVLGVIFADLIHEYLFNPITVATALV
IGGVIMLWAERREHVIRAYSVDEMTWVDALKVGMAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSAYKYRDLFRPDDFPVFAIGFITSFVFAMIAVRGLLKF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWTSVKG
>A0A088NP96|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWSALQAVILGVVEGLTEFLPISSTGHQIIVADLINFGGDRAMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPTQAPARRFTTNLLIAFIPAVILGVLFADLIHEYLFNPITVAAALV
VGGVIMLWAERRQHRVEVDHVDEMRWSHALKIGLVQCLAMIPGTSRSGSTIIGSLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDLPVFAIGFVVSFIFAMIAVRGLLKF
IANHSYAVFAWYRIAFGLLILATWEFGWVDWSTAHG
>A0A081Y5U1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKTLVFAYHDIGCAGIEALLAAGYQIDAVFTHADDARENRFFGSVAQLCAQRGIPVHA
PEDVNHPLWIARIRELQPQFIFSFYYRHLLGEELLACARRGAFNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHRMVKRPDAGAIIAQQRVAIDAEDTALSLHGKLREAAGELLERLLP
AMLEGDFVEREQDESQASYFGRRTPADGQLDWRRPAGALHNLVRAVTQPYPGAFAPVGER
KLIVWQSKVVPGNQGRPAGAVLSVEPLRIACGEDSLEIVAGQQGDAGLFLAGAQLAREMG
LVTGSRLHAVGKPRRKTRVLILGVNGFIGNHLSERLLRDGNYEVYGLDIGSDAVERLKSN
PDFHFVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLVRY
CVKYGKRVIFPSTSEVYGMCSDASFDENSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQ
KGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDV
DDGIEALARIVDNDGGRCDGQIVNIGNPDNEASIRELGEELLRQFEAHPLRAHFPPFAGF
REVESRSFYGDGYQDVAHRKPSIDNARRLLDWEPKVHMRETIAKTLDFFLREAIAEQQQA
GKLRVAS
>D1LFI8|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
QLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAEVSAAALQYSDNTAMNKLIAQLGGPGGV
TAFAREIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLV
TWLKGNTTGAASIRAGLPTSWS
>W8HGS0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRIQEFAVSDETSGPYAITTGPDHALWVTLVHAGRIARLTVDGEVATYPLDTAECGPTII
TPGPDAALWFTRFRDHRIGRMTSDGAIDSFPTPTSDSGPFGIVAGPDDALWFTETNADRI
GRITTDGQIAEFPLPTDGGFPSAITLGPDDALWFTLNQANAIGRIDVDGNVAVHSLPTPA
AGPVGITRGTDDALWFVEIGAGQIGRISVQGRIDEFALPDRSARPHAIVADPDGGCWFTE
WGANRIGHIGPGGDITEYDLPTPSSEPHGIAVGPDGAVWAALEIGLVACLRPVSTC
>A0A0B1R8D3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNYFDVSILAVIQGLAELLPVSSSAHVIMTEKLLGLDPSSPEMTLLLVMLHTGTMFAVIV
YFWQNWRDTYFSSTHAFKKNVLLIILATCVTGAVGLTLMKLIKYFFAANADTFEIESLFS
NSKIIASGLAAAGLLIIVSSRLKEKERGELSPLSAAGIGFVQGLCLPFRGFSRSGATIST
GLSLGVARKRAEEFSFALAVVLTPAVIVKEGLRAFSAGSPNHVAVSSGILLPSLVGMVLS
FVAGLLALRWLSRWLEHDRWHLFGGYCLCAAVLIGWLG
>Q8L1B1|FEATURES|UNIPROT_deepARG|mupirocin|ileS2|antibiotic target alteration|0
MSTEGSGPVRFPAMEDAVLERWEKEKTFEQSISAREGKPVYVFYDGPPFATGLPHYGHIL
TSYIKDVIPRYQTMLGKQVPRRWGWDCHGLPVEFEVEKAMGFKSKRDILEFGVEQFNDEC
RELVLKYADDWRGFVNRMGRWVDFDGAYKTMDNDYMESVLWGFKTLHDKGHVYEGGKIVP
YCVRCQTVLSNFEARLDDAFRPRRDMSAYVKFRQQDRPDTFFLAWTTTPWTLPANVALAV
AADENYVCIEHGEERLWLAEGCLGGLFDEPVILERCTGAELAGLRYLPVVGEVIDASAHR
VVTADFVQMGDGSGIVHIAPAFGEDDALLGQQYELPAPNPVRDDGTFSDAVAQYAGQNIF
EATPRILADLKSSGLLFKQEQIEHNYPHCWRCDNPLIYRAVESWFIRASALREQLVENNS
QVNWVPEHVKEGRFGDWIRNARDWAVSRNRFWGAPIPVWRCDQCGTVEVMGSIAQIEARS
GRKVEDLHVPHIDEHRFACQCCEGTMSRVTGVFDCWFESGAMPFASRHYPFENKQEFEQT
FPADFIVEYLAQTRGWFYTMMVISTGCFEQNPFKNAMCHGVILAKDGRKMSKRLKNYPNP
MDLMQTHGSDALRVALLASPVCKGEDIKFSEESVRDVVRRYHLLFWNCLQFYKTFTEIDQ
FSPSGDLGQPLDNVLDHYLLHELAALESDIKMWMESLDFSKIYSRIEVFINVLSTWYLRL
NKARIWRDGLDDDKRQCYEVLHYALSNFARLLAPFMPFLAEAVYTELGYADSVHLQDWPS
IDRQYLSYELADEMSSLRNLIASVRNVRETNGVSQKFPLRSIRVAGIEQAVLERYAQFLE
EELNVKQVQWAADADEWAQPVVVLIFSLLGKRLGPAMKAVTTAVKAGEYVIDEQGGLVAA
GQTIQPHEFERRLTVRDTLNNVGIVENMVVWLDLDIDASLKREGAVRELNRRLQDLRKKA
KLGYTEKVDIAVLGGAYVDEILVHHEDWLKSQLLVQSLLRSDLEAPLAVDEVELPEGDPV
RIQLRRSVLA
>D1LUJ5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEPDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>D3Y4X8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLTARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A0Z8G0P8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
MTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAI
ALIVYGIAFIWIENRNSGVEPQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAI
ILGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWILLVASVTAYLVSLV
VIRFLTDFVKKHDFTVFGYYRIILGVILLVYAFITFLF
>A0A060L053|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIRAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A157RNF3|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDGTLYLIKAFILGVLEGLTEFIPVSSTGHLILFGDLIHFESSSGKVFEVVIQLGSILA
VMWIFRARLWQLVSGTLRGERQEVAFTRNLIIAFLPAAVVGAIFISAIKRLFYAPEVVAV
TLVLGGLIMLWVERRTHHTPGDQPGAADDTASDERATAHTLEQITWKQALAVGVAQCLAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLAAAVYDMYRNMSLLTSHDLSGIA
VGFVAAFLSALLIVRAVLRFVANHTYRIFAWYRIALGIVVAVVLMV
>A0A0N0WZ45|FEATURES|UNIPROT_deepARG|beta_lactam|AC503_3575|antibiotic inactivation|1
MQRNGTLLCTGLLLVSSVAFAEDNSAALDTLVQTEARKVMQENNITGLSIAITRHGKQQF
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGRLSLTQSIDTYMPPLRDTR
LGKIPVFHLGTHTAGGFPIQVPEKVQNTRQLMDYFKAWQPEYLPGTHRTYANPSIGLLGV
IAARSMNMPFQEAMQQRLFPALGLNSTYVNVPDDKQTLYAQGYNTLDEPVRVNPGILAAE
AYGVKSSSRDLIRFVEANIGLGQYDAPLQRALSDTRIGYFKVGGMTQDLAWEQYPTPIHL
DVLLAGNASAMLNTQKADAIEPPLAAQPTAWVNKTGSTNGFGGYVAFIAQKQLGIVILAN
KNYPNEERVKLAYRILQHAEPLN
>A0A119A5M6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQPQARRFTVNLIIAVLPAVVLGVIFADTIHEYLFNPITVATALV
IGGVIMLWAERRQHVIHAETVDDMTWKDAVKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVRALLKF
ISSHSYAAFAWYRIVFGLLILATWQFGWIDWSAASA
>A0A0J6V9U7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSTWRPFGRLALVAGILFSQLSRFSVRTKLNAALACLLASIVAAGCSGAVQEVRDVDPVG
SVVDPTIRRLMAEHAIPGMAVAVIVDGKPHFFDYGVASKSEGAPVDDDTLFEVGSLSKTF
TATLAGYAQARGTLSLSDPASTHWSALHGTAFDRISMLQLGTYSAGGLPLQFPAEADTPE
SMLGYFRHWDPSYPPGSRRLYSNPSLGLFGYLAARSLGGSFADLLQNTLLPQLGLDNTYL
QIPSNEMAHYAQGYTKTGAPTRVTPGALDAETYGIKTTTHDLVQFVTAAMQPEGRDDPWR
RAIETTQTGYYRVNGMTQGLGWEIYPQPVTETALIAGNSDAMASQPPPIEWLDTPSPPDP
SALFNKTGSTNGFGSYVAYIPQKRLAVILLANKNYSNSARVDAAYRILDSVGHVAE
>A0A023P926|FEATURES|UNIPROT_deepARG|beta_lactam|CY96_16185|antibiotic inactivation|1
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTVTNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNINVVVPGH
GEVGNKGLLLHTLDLLK
>B1Y0S1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIKAAVMGIVEGFTEFLPISSTGHLILTGSLLGFTDAKSKVFDIAIQTGAIFAVILVYW
QRIASTARGLGSDARARRFALNVLIGFLPAAVAGLLLGKAIKSHLFTPEIVAAAFIVGGM
IILWVERRPDTRIRVATIDDMNHADALKVGLIQCVAMIPGTSRSGATIIGGMMLGLSRQA
ATDFSFFLGIPTLIGAGAYSLWKERALLSAQDLPMFGVGLLFSFISALLCIRWLLRYVAT
HNFVPFAWYRIAFGIVVLATSYSGLIVWSE
>A0A109CMX6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEDQSIVSALLLGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILA
VYIQKLLGIALSLPSNPKSRHFVLAVLVAFLPAAIIGALAHDFIKAVLFETPMLICVMLI
LGGVILLWVDRMTFKPRYTDVMDYPLSLALKIGLFQCLAMIPGTSRSGATIVGSLLMGTD
KRSAAEFSFFLAMPTMLGAFVLDLYKNRNALSMDDGLLIGVGFLAAFISALVVVRGLLDF
VSRRGYAPFAWWRIAVGVAGLTGLLVWG
>AFG73660.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib9|antibiotic inactivation|1
MTEHDLSMLHEWLNRPHIVEWWGGEDERPTLDEVYEHYLPRVLAQESVTPYIAMLGNEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQSLANPTKLNKGLGTKLVRALADLLFSDASVT
KIQTDPAPGNHRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>NP_274611.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MNTQAHAPHTDSNTLMLGRYAERAYLEYAMSVVKGRALPEVSDGQKPVQRRILFAMRDMG
LTAGAKPVKSARVVGEILGKYHPHGDSSAYEAMVRMAQDFTLRYPLIDGIGNFGSRDGDG
AAAMRYTEARLTPIAELLLSEINQGTVDFVPNYDGAFDEPLHLPARLPMVLLNGASGIAV
GMATEIPPHNLNEVTQAAIALLKKPTLETADLMQYIPAPDFAGGGQIITPADELRRIYET
GKGSVRVRARYEIEKLARGQWRVIVTELPPNANSAKILAEIEEQTNPKPKAGKKQLNQDQ
LNTKKLMLDLIDRVRDESDGEHPVRLVFEPKSSRIDTDTFINTLMAQTSLEGNVSMNLVM
MGLDNRPAQKNLKTILQEWLDFRTVTVTRRLKFRLNQVEKRLHILEGRLKVFLHIDEVIK
VIRESDDPKADLMAAFGLTEIQAEDILEIRLRQLARLEGFKLEKELNELREEQGRLNILL
SDENEKRKLIVKEMQADMKQYGDARRTLVEEAGRAVLTQTTADEPITLILSEKGWIRSRA
GHNLDLSQTAFKEGDCLKQTLEGRTVLPVVILDSSGRTYTLDAAEIPGGRGDGVPVSSLI
ELQNGAKPVAMLTGLPEQHYLLSSSSGYGFITKLGDMVGRVKAGKVVMTADSGETVLPPV
AVYASSFINPDCKIIAATSQNRALAFPIGELKIMAKGKGLQIIGLNAGESMTHTAVSSEL
EILIESEGRRGAAHKDRIPISLLEAKRGKKGRLLPISGSLKQLSSPK
>AAC45607.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYKYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLL
FNGRKQLPIF
>NP_274686.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MAKNNQYSESSITVLKGLEPVKERPGMYTRTDSPTHICQEVIDNASDEALGGFATAIDVQ
IHEDGSLSVHDNGRGIPVGLHPEEGVSVVELVFTRLHAGGKFNKKDGGSAYAFSGGLHGV
GVSVTNALSTRLEVTVKREGKIHRIVFAGGDVVEPLAQVGKCAVKDSGTEVRVWPDGKYF
ESPNYSIPELERLLRAKAVLLPGVRVSLTRPVKGEDEAHTQTWHYPDGLKSYLTDLIADA
QEAVPLFSCENYISDEHNGDFSIGEGAAFALTWLEEGSCANESYVNLIPTPLGGTHEAGL
KQAVFNAVNNFINLHNLLPRGVKVQSDDVFGKTAFVLSARVLDPQFQGQTKDKLTNRDAL
KLVATVSGDPLELWLNQNVDFGKKIAELAIRQAQARMRSVKKIEKKKGSGVAVLPGKLTD
CESEDIRENELFLVEGDSAGGSAKLARDKATQAILPLRGKVLNSFEVHPDQLFGNAEIHD
ISVAIGVDPHGINDHPDLSGLRYGKIAILSDADVDGSHIQVLLLTLFYRHFPKLVADGHI
YVAQPPLFRVDVNAQGKSKPARKFYALDQNELDSILERLQKEGVKETAYSISRFKGLGEM
NPDQLKDTTMHPDTRRLLQVQIPEGADDETRDIFVKLMGKGEAAARRAWMEREGDTAELD
I
>AAO79891.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSEEIKENIQDVNLTSEMKESFIDYAMSVIVARALPDVRDGLKPVHRRILYGMNELGVTP
DKPHKKSARIVGDVMGKYHPHGDSAIYESMVRMAQPFSYRAMLVDGHGNFGSVDGDGAAA
MRYTEARMSKIALEMLRDINKNTVDFQGNYDDSEQEPVVLPARFPNLLVNGTTGIAVGMA
TNIPPHNLSEVIDATSLLMDNPDVTTNELMEVLPGPDFPTGGLVMGKSGIRRAYETGKGS
ITVRAKVELTEMPNGKERILVTELPYMVNKAKLIERISELHRDKRIEGITDLRDESSREG
MRIVIDVRRDVSASVVLNNLYKMTALQTSFGFNMLAIEKGVPKILSLKRILENYVEHQKE
VITRRTIFDKNKAEARAHILEGLRIALDHIDEIIAIIRGSQSDDEAKATLIERFEFSDRQ
AQAILDMRLRRLTGLERDKIENEYQELLKFIADLEDILARPERVIEIIKTELNDVRTKFG
DARRTELLVGEVLSLEDEDLIEEEEVVITLTNNGYIKRMANSEFRAQRRGGRGVQGMGVH
DDDFVKNLVSCSTHDTLLFFTNTGKVYRAKGYEIPEYGRTAKGIPVINLLGIDSAEKIQA
IISVEGKAEAGKYLFFTTLKGTVKRTAVTAFSNIRSNGLIAISLKEDDELVNVVTTNGNQ
KMIIGTHAGYSVTFDENTVRDMGRTASGVRGIRLRENDYVVGAAILDENKEVLVITENGY
GKRTKASEYPVKGRGGKGIKTANITEKNGPLAGLTTVNGDEDILLITNKGVIIRFNVDSV
SQTGRATLGVRLMRMEDGAKVVTMAVVEPEEVEEEIVEVVETTENETTSETEE
>AER57902.1|FEATURES|megares|aminoglycoside|AAC(6')-IIa|antibiotic inactivation|1
MSASTPPITLRLMTERDLPMLHDWLNRPHIVEWWGGDEERPTLDEVLEHYLPRAMAEESV
TPYIAMLGEEPIGYAQSYVALGSGGGWWEDETDPGVRGIDQSLADPTQLNKGLGTRLVRA
LVELLFSDPTVTKIQTDPTPNNHRAIRCYEKAGFVREKIITTPDGPAVYMVQTRQAFERK
RGVA
>NP_253651.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSESLDLSLEGVERRSLAEFTEQAYLNYSMYVIMDRALPHIGDGLKPVQRRIVYAMSELG
LDADSKHKKSARTVGDVLGKFHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPK
SFAAMRYTEARLSRYSEVLLSELGQGTVDWVPNFDGTLDEPAVLPARLPNLLLNGTTGIA
VGMATDVPPHNLREVASACVRLLDQPGATVAELCEHVPGPDFPTEAEIITPRADLQKVYE
TGRGSVRMRAVYRVEDGDIVIHALPHQVSGSKVLEQIAGQMQAKKLPMVADLRDESDHEN
PTRIVIIPRSNRVDVEELMTHLFATTDLETSYRVNLNIIGLDGKPQVKDLRQLLSEWLQF
RIGTVRRRLQFRLDKVERRLHLLDGLLIAFLNLDEVIHIIRTEDQPKAVLMERFELSEVQ
ADYILDTRLRQLARLEEMKIRGEQEELLKEQKRLQTLLGSEAKLKKLVREELIKDAETYG
DDRRSPIVARAEARALSETELMPTEPVTVVLSEKGWVRCAKGHDIDAAGLSYKAGDGFKA
AAPGRSNQYAVFIDSTGRSYSLPAHSLPSARGQGEPLSGRLTPPPGASFECVLLPDDDAL
FVIASDAGYGFVVKGEDLQAKNKAGKALLSLPNGSAVVAPRPVRDVEQDWLAAVTTEGRL
LLFKVSDLPQLGKGKGNKIIGIPGERVASREEYLTDLAVLPAGATLVLQAGKRTLSLKGD
DLEHYKGERGRRGNKLPRGFQRVDSLLVDIPPQD
>CBW28949.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|1
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKHYGGAARAFDQIDNAPEEKARG
ITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALQALN
GVAEWEEKILELANHLDTYIPEPERAIDQPFLLPIEDVFSISGRGTVVTGRVERGIIRTG
DEVEIVGIKDTAKTTVTGVEMFRKLLDEGRAGENIGALLRGTKREEIERGQVLAKPGSIT
PHTDFESEVYVLSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMT
VSLIHPIAMDQGLRFAIREGGRTVGAGVVAKIIK
>ACR56004.1|FEATURES|megares|nitroimidazole|nimA|antibiotic inactivation|1
FREMRRKRQLLPTEESITILEKMTNGTLALHGDNGYPYAVPVSYVYADGKIYFHSAVKGH
KVDAILRNNKVSFCVVEQDDVKPAEFTTYFRSVIAFGKARILADEGEKQLAFRLLADKYS
HGEVGMEAEIAKGFNHLLMVEIMVEHMTGKEA
>CAP02766.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MTQYTAQSLEVLSGLDPVRRRPGMYTDTSRPNHLAQEVIDNAVDEALAGHADKICVTVYK
DGSLSVEDNGRGMPVDIHPEYGQSGIEIILTKLHAGGKFSTDNYQFSGGLHGVGISVVNA
LSTRVEVEVQRQGNLYQMAFEQGEPVAPLAVLEGKAPKRATGTTVRFWPEAKYFDSPKFA
LKALKHNLKAKAVLAAGLKITYIDQINDEKIEWQFENGLVDYLMDELQDREILPNPAFVS
SGQADRAACEFAICWNVEGGEQVQESYVNLIPTAQGGTHVNGLRSGVTEALREFCELRNL
LPRNLKLSAEDVWDGVNYILSLKFQEPQFSGQTKERLSSREAANIVLNIAKDAFALWLNQ
HAEIAMQLAEMVISKAGRRLKAAKKVERKKIVSGPALPGKLADCVGQTREESELFIVEGD
SAGGSAKQARDKNFQAIMPIRGKILNTWEVSSDEVLASQEVHDIAIAIGVDPGSDDLSEL
RYGKICILADADSDGLHIATLLCALFVKHFPALVEEGHLYVAMPPLFRIDIGKDVHYALD
DEELETILKNVKGNKNPQITRFKGLGEMNAIQLRETTMDPNTRRLVQLDLDDAHLTAGLL
DKLLAKKRAADRKQWLEQKGNLADITV
>WP_000733281.1|FEATURES|megares|beta_lactam|blaZ|antibiotic inactivation|1
LKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>AAO81397.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MEKRQEVQELTLEEVMGDRFGRYSKYIIQERALPDIRDGLKPVQRRILFSMNKDGNTFDK
GFRKSAKSVGNIMGNYHPHGDSSIYEAMVRLSQDWKLREVLIEMHGNNGSMDGDPPAAMR
YTEARLSQLSGELLKDIDKNTVDFVWNFDDTEKEPTVLPAKYPNLLVNGSTGISAGYATE
IPTHNLAEIIDGTVYLIDHPNASLEKLMEYIPGPDFPTGGILQGKAEIKKAYETGRGKVI
LRAKTKIEPLKGGKQQIVISEIPYEVNKATLVKKMDEIRLNKKVDGIAEVRDESDRTGLQ
IVVELKKDVNAEGILNYLFKNTELQINYNFNMVAIDNMTPQQVGLKRILESYITHRKSVI
INRCQFELDKARKREHIVAGLIKALSILDKVIATIRGSKDKKDAKKNLVSDYAFTEEQAE
AIVTLQLYRLTNTDITDLQEEAKTLEQQIAELLNILNNEKELFSVMKKELREVKKQYGNP
RLTQIEEEIQEIKIETAVLVAQEDVVVTVTHEGYIKRSSIRSYTASKPEEIGMKEGDFLL
YAGEVNTLDHLLLVTNKGNMIYRPVHELPDLRWKEIGEHISQTILNLAIDESIIAVYPYK
ELSPTKTFVFITKAGMIKQTKMADFEPWRTYKSRPTSCMKLKSDQDEITNVYLTNDQDLL
DVFLVSNRGFGLRYPLYEVPVVGSKAAGVKSMNLKEDDYVVNGLLVHSEGDTPIVIVTQR
GGVKRMLAQELTQLGRAKRGLMVLRELKKNPHRVVFMSESTDLDLLVTTQKGTQEVIQSK
NYPISERTSNGSFVIDEQKDGQVMEVHEMHSAVIEEEQTN
>CAC29169.1|FEATURES|megares|aminoglycoside|sat-4|antibiotic inactivation|0
MKAGHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDEEDEEADCL
EYIDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINISIEW
AKHKNLHGLMLETQDNNLIACKFYHNCGFKIGSVDTMLYANFENNFEKAVFWYLRF
>CBW29606.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MTDSIQSSITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFSMDREGNTA
NKKYVKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDAPAA
MRYTEVRMQKITQALLTDLDKETVNFSPNYDGELMIPDVLPTRIPALLANGSSGIAVGMA
TNIPPHNLNEVLNGCLAYIDNNEITIDELMQHIPGPDFPTAALINGRKGIEEAYRTGRGK
VYVRARATVETNEKGREQIIVSELPYQVNKAKLVEKIAELIREKKIEGISNITDLSNKEG
IRIEIDIKRDAVGEVVLNHLYSLTQMQVTFGINMVALDHGQPRLFNLKEIIEAFVLHRRE
VVTRRSIFELRKARERTHILEGLAVARSNIDEMIAIIRNSKNREEAATAISSRSWTLHSD
IINLLDASARPDELEENLGIQGEQYYLSPAQVNAILELRLHRLTGIAFEEVIKEYEELLV
KIADLLHILSSAERLMEVIREELEEVKAQFGDDRLTEITAASGDIDLEDLIAQEDVVVTL
SHEGYVKYQPLTDYEAQRRGGKGKSATKMKEEDFIEKLLVANTHDTILCFSSRGRLYWLK
VYQLPQASRGARGRPIVNILPLQENERITAILPVSAYEEDKFVVMATAGGIVKKIALTEF
SRPRSNGIIALNLRDEDELIGVDITNGSNEIMLFSSQGRVVRFAENAVRAMGRLATGVRG
IKLALTNDISDDESAVEIEDISDDNAEASLDLNIDKVVSLVVPKGEGAILTATQNGYGKR
TQLSEYPTKSRNTKGVISIKVSERNGKVVAATQVEETDQIMLITDAGTLVRTRVSEVSIV
GRNTQGVRLIRTADDEHVVSLERVCDADEEDSLEESSSEE
>ACH58981.1|FEATURES|megares|multidrug|hlyD|antibiotic efflux|0
MNEAATPTAPADVPATGNRRRILLTITFVLLLLAAGWTVLEVLVLSKREKTDDAYVTGNQ
IRVSSQIAGIVVEVFARNTSRVEPGQKLLRLDDADARQALERAAANLAQTVRQVRQQTAQ
SVQFDAQIAGRELELQQAEEDLRQREPLLAEQAVAGEEVRHARNAVALARTALRQSQQQS
AAARALVDHVSLEQNPSVLAAVAAYKDAWLHTQRSIIVAPAGGYIAQRSVQLGQRIAPGE
PLMSIIALQDVWLEANFKEKQLRNLRIGQPAEIETDVYGGDVVFHGRIIGLSAGTGAAFS
LLPPQNASGNWIKITQRVPVKIALDPRELAAHPLRIGLSTTTTIDTHDRDGAVLAVDPVS
DVHESTLSYVHDPVTAEQEALKIIRANSGGN
>AAA26443.1|FEATURES|megares|aminoglycoside|APH(3'')-Ib|antibiotic inactivation|1
MGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPLHDLLARVE
RELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANA
EENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG
>BAH73495.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSDLIQIEEELKKSYLEYSLSVIIGRAIPDVRDGLKPVHRRILYAMHDLSNTYNRPYKKS
ARVVGDVIGKYHPHGDQSVYDALVRMAQDFSMRDAIVDGQGNFGSIDGDAAAAMRYTEVR
MSRLAGEFLADIEKETVDFRPNYDNSLEEPAVLPTKVPNLLLNGSSGIAVGMATNIPPHN
LGELCDGLLHLLDTPSCPVTDIIGLVKGPDFPTGAAIYGGKGLTEAYTTGRGTIKIRGRA
EVEERKKDYVSVVIREIPYALNKSSLVEKIAALINDGRIEGVSDLRDESDRKGIRIVLDL
KKGVIPDIVINALYKYTPLETSFGINMLVVADNRPALLNIKQVLEHFLTHRRDVILRRTR
FDLRKSEERAHILEGLRIALDNIDEVVSIIRASKNAVEARERLMERFGLSERQAQAILDM
RLQRLTNLERQKLIDEYNELIKLIEYLRSILENDEVLRGVIRDEIKEIQDRYATPRKTEI
LEDLEGINILDLIPDEDVVITLSRRGYIKRTKIDNYQQQKRGGKGIAGVATAGDDFVQSF
CATTNHQQLLLFTNLGRMFMLPVHQIPEGQRTAKGAHIANLLPMDKEEFVATALSIREFS
EERYFLFVTRKGMVKRTCTDLYKNCRSTGIIAVGLKENDELLTVKEIDDETEVLLATQQG
LSNRFHISGVRPTGRGAAGVKGIALKGNDRVAAGVVITSVSRSEVLTVSANGYGKRTSIE
HYPIRNRGGSGVINMRVTPKTGQVIGAVMVGDDDELLLLTSANKIIRLSVSGISSVGRAT
QGVMLVRMDENDTVMGFDLVDPSDLDRCAPSGE
>BAJ45007.1|FEATURES|megares|beta_lactam|ampH|antibiotic inactivation|1
MALVVIDGNQRVFRSYGETRPGNNVRPQLDSVVRIASLTKLMTSEMLVKLLDQGTVKLND
PLSKYAPPGARVPTYNGTPITLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWKYLST
AKLKAAPGSQAAYSNLAFDLLADALANASGKPYTQLFEEQITRPLGMKDTTYTPSPDQCR
RLMVAERGASPCNNTLAAIGSGGVYSTPGDMMRWMQQYLSSDFYQRSNQADRMQTLIYQR
AQFTKVIGMDVPGKADALGLGWVYMAPKEGRPGIIQKTGGGGGFITYMAMIPQKNIGAFV
VVTRSPLTRFKNMSDGINDLVTELSGNKPLVIPAS
>WP_001289561.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MYSSGNTHDKNFRKSAKTVGDVIGQYHPHGDSSVYEAMVRLSQDWKLRHVLIEMHGNNGS
IDNDPPAAMRYTEAKLSLLAEELLRDINKETVSFIPNYDDTTLEPMVLPSRFPNLLVNGS
TGISAGYATDIPPHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKK
AYESGKGRIIVRSKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEV
RDETDRTGLRIAIELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIID
SYLNHQIEVVANRTKFELDNAEKRMHIVEGLIKALSILDKVIELIRSSKNKCDAKENLIE
VYEFTEEQAEAIVMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEEL
NEIKKKFKSERLSLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSFNASGVED
IGLKDGDSLLKHQEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDE
VVINVFNEKDFNTDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDDLISVMRF
EKDQLITVITNKGMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMAT
QRGSLKRISFKILQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHG
LINDIHKSEQYTNGSFIVDTDDFGEVIDMYIS
>ADA79632.1|FEATURES|megares|glycopeptide|brp|antibiotic inactivation|0
MLQSIPALPVGDIKKSIGFYCDKLGFTLVHHEDGFAVLMCNEVRIHLWEASDEGWRSRSN
DSPVCTGAESFIAGTASCRIEVEGIDELYQHIKPLGILHPNTSLKDQWWDERDFAVIDPD
NNLISFFQQIKS
>AAS09879.1|FEATURES|megares|beta_lactam|shv5|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKNGASKRGARG
IVALLGPNNKAERIVVIYLRDTPANMAERNQQIAGIGAALIEHWQR
>WP_001557340.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MNKQNNYSDDSIQVLEGLEAVRKRPGMYIGSTDKRGLHHLVYEIVDNSVDEVLNGYGNEI
DVTINKDGSISIEDNGRGMPTGIHKSGKPTVEVIFTVLHAGGKFGQGGYKTSGGLHGVGA
SVVNALSEWLEVEIHRDGSIYHQSFKNGGSPSSGLVKKGKTKKTGTKVTFKPDDTIFKAS
TSFNFDVLSERLQESAFLLKNLKITLNDLRSGKERQEHYHYEEGIKEFVSYVNEGKEVLH
DVATFSGEANGIEVDVAFQYNDQYSESILSFVNNVRTKDGGTHEVGFKTAMTRVFNDYAR
RINELKTKDKNLDGNDIREGLTAVVSVRIPEELLQFEGQTKSKLGTSEARSAVDSVVADK
LPFYLEEKGQLSKSLVKKAIKAQQAREAARKAREDARSGKKNKRKDTLLSGKLTPAQSKN
TEKNELYLVEGDSAGGSAKLGRDRKFQAILPLRGKVINTEKARLEDIFKNEEINTIIHTI
GAGVGTDFKIEDSNYNRVIIMTDADTDGAHIQVLLLTFFFKYMKPLVQAGRVFIALPPLY
KLEKGKGKTKRVEYAWTDEELNKLQKELGKGFTLQRYKGLGEMNPEQLWETTMNPETRTL
IRVQVEDEVRSSKRVTTLMGDKVQPRREWIEKHVEFGMQEDQSILDNSEVQVLENDQFDE
EEI
>BAE78115.1|FEATURES|megares|polymyxin|pmrA|antibiotic target alteration|0
MKILIVEDDTLLLQGLILAAQTEGYACDSVTTARMAEQSLEAGHYSLVVLDLGLPDEDGL
HFLARIRQKKYTLPVLILTARDTLTDKIAGLDVGADDYLVKPFALEELHARIRALLRRHN
NQGESELIVGNLTLNMGRRQVWMGGEELILTPKEYALLSRLMLKAGSPVHREILYNDIYN
WDNEPSTNTLEVHIHNLRDKVGKARIRTVRGFGYMLVANEEN
>AFJ11387.1|FEATURES|megares|chloramphenicol|cat|antibiotic inactivation|1
MTNFFESPFKGIPLDQQVTHPNIVVGRHSYYSGYYHGHGFDDCARYVLPDADADRLIIGA
FCSIGSGAAFIMAGNQGHRHEWVSTFPFFYANESWQQAQAADGYLPAGDTVIGNDVWIGS
EAIIMPGVRVGDGAIIGTRALVTRDVEPYAIVGGNPARVLRKRFDEDRIALLLEMRWWDW
PDAAIEATMPLMTSGDIEGLHAAWQRQTRR
>ACD35502.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MTNPAPLGRRERKKAATRKAISDVATAMFLERGFDEVSIREVADAADVSPTTVFAHFPQK
EALVFDEDDEQRDRLVAAVRERPSGSTINRAIHDFYASELRANVDEHGDEITRTFMRFLN
ETPALRDYAAKMWLRHEDALSDAIADELGLDTPTPEIRVYSRFILQMQLLVNENDDPFGT
LEAGFVILENGWAPVEAGLSGSAS
>AEE68735.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|1
MAKGKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLSNKFGGEARGYDQIDAAPEEKARG
ITINTSHVEYETETRHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI
LLSRQVGVPYIIVFLNKADMVDDAELLELVEMEVRELLSKYDFPGDDTPIVKGSAKLALE
GDKGELGEQAILSLAQALDTYIPTPERAVDGAFLMPVEDVFSISGRGTVVTGRIERGVVK
VGEEIEIVGIKPTVKTTCTGVEMFRKLLDQGQAGDNVGILLRGTKREDVERGQVLAKPGS
INPHTDFTAEVYILSKEEGGRHTPFFNGYRPQFYFRTTDVTGTIDLPADKEMVLPGDNVS
MTVKLLAPIAMEEGLRFAIREGGRTVGAGVVAKIIK
>ATB17820.1|FEATURES|megares|beta_lactam|DHA-1|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>WP_012683793.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAEETARFPKVDISHEMRESFISYAMSVIVSRALPDVRDGLKPVHRRILYAMHDMGLTPD
KPFRKSANVVGEVMANYHPHGDSSIYEAMVRMAQDFNMRYMLVEGQGNFGSVDGDPAAAM
RYTESRFSKLALELLRDIDKETVDFIPNYDGRKEEPVVLPSRFPNLLLNGASGIAVGMAT
NIPPHNLTEVVDGVIAMIDNPDITIQDLMKIIKGPDFPTAGEILGYSGIRRAYETGRGSI
IMRAKTQIEEDGKGKPRIIVTEIPYQVNKARLVEKIAELVREKKIEGITDLRDESDRKGM
RIVMELRRDVIPKVVLNNLFKHTQMQSTFGVNMLALVDSRPRVLNLRDMLYYYLEHQRVI
IRRRTEYDLKQAEARAHILEGLRIALDHIDEIISLIRSSQTTEEARTGLMENYSLSYEQA
QAILDMRLQRLTGLEREKIENEYQELMVKIAELRAILADEAKIYAIIRDELGEIKEKFGD
ERRTEITFDENHIEDADLIPEEDVVITLTHDGYIKRLPVSTYRSQKRGGRGVQGLGTKDD
DFVEHLYITNSHDYIMFFTSKGKVYRLKGFEIPDLSRTAKGTPIINLIQIEKGERVSAVI
PVKEFDQEHYLFFATKKGIIKKTTLESYENIRKGGLIAVNLREDDELIGVRLTDGQQQII
MGTHKGMSVRFNEGDVRTMGRNATGVKGITLDDDDDVIDMDVIKPNAEVLIVTANGYGKR
TPVDEYRIQSRGGKGIKTHNVTDRSGPVVGLKVVEPEEDLMIITTSGIIIRTEMKGISVM
GRYTQGVKLIRLSENEQVGSVAKCPPTEEEDMTDEDAEEGIEDLQDGETVEATEPIEPTE
PTEE
>CAF05909.1|FEATURES|megares|aminoglycoside|ant3-dprime|antibiotic inactivation|1
QFLRPPSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPW
RYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPE
QDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQ
YQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>AAK91785.1|FEATURES|megares|macrolide-lincosamide-streptogramin|vatE|antibiotic inactivation|1
MTIPDANAIYPNSAIIEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
KLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGN
DVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALEN
LAWWNKDIEWITANVPKLMQTTPTLELINSLMEK
>ADZ05811.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVCYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>WP_000819096.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDSSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMESLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELETILADEEVLLQLVRDELTEIRDRF
GDDRRTEIQLGGFEDLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDAEDETNEDEQSTSTVSEDGTEQQREAV
VNDETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSSDEDEE
>ABB62283.1|FEATURES|megares|multidrug|asmA|antibiotic efflux|0
MRRFLTTLMILLVVLVAGLSALVLLVNPNDFRDYMVKQVAARSGYQLQLDGPLRWHVWPQ
LSILSGRMSLTAQGASQPLVRADNMRLDVALLPLLSHQLSVKQVMLKGAVIQLTPQTEAV
RSEDAPVAPRDNTLPDLSDDRGWSFDISSLKVADSVLVFQHEDDEQVTIRNIRLQMEQDP
QHRGSFEFSGWVNRDQRDLTISLNGTVDASDYPHDLTAAIEQINWQLQGADLPKQGIQGQ
GSFQAQWQELHKRLSFNQISLTANDSTLSGQAQVTLTEKPEWQLRLQFPQLNLDNLIPLN
ETANGENGAAQQGQSQSTLPRPVISSRIDEPAYQGLQGFTADILLQASNVRWRGMNFTDV
ATQMTNKSGLLEITQLQGKLNGGQVSLPGTLDATSINPRINFQPRLENVEIGTILKAFNY
PISLTGKMSLAGDFSGADIDADAFRHNWQGQAHVEMTDTRMEGMNFQQMIQQAVERNGGD
VKAAENFDNVTRLERFTTDLTLKAGVVTLNDMQGQSPVLALTGEGMLNLAAQTCDTQFDL
RVVGGWNGESKLIDFLKETPVPLRVYGNWQQLNYSLQVDQLLRKHLQDEAKRRLNDWAER
NKDSRNGKDVKKLLEKM
>CAA25643.1|FEATURES|megares|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
MPSWSGLDDEPFDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPL
PLPPHSPASPVARVHELDGQVLLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLV
RVDYLENDHCCERFALADRWLKEKSLQKEGPVGHAFARLIRSRDIVATALGQLGRDPLIF
LHPPEGGMRRMRCRSPVDWLSS
>AAA22595.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmD|antibiotic target alteration|1
MKKKNHKYRGKKLNRGEYPNFSGQHLMHNKKLIEEIVDRANISIDDTVLELGAGKGALTT
MLSQKAGKVLAVENDSKFVAILTRKTAQHPNTKIIHQDIMKIHLPKEKFVVVSNIPYAIT
TPIMKMLLNNPASGFQKGIIVMEKGAAKRFTSKFIKNSYVLAWRMWFDIGIVREISKEHF
SPPPKVDSAMVRITRKKDAPLSHKHYIAFLGLAEYALKEPQAPFCVALRGIFTPRQMKHL
RKSLKINNEKTVGTLTENQWAVIFNTMTQYVMHHKWPRANKRKPGEI
>AJG01378.1|FEATURES|megares|beta_lactam|OXA-208|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASRSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAG33663.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib10|antibiotic inactivation|1
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>AEY63633.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADE
IRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCR
LVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLS
PAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNG
ADYVRTHAPGDLRSAITISETLAKFRSRDARDRGLDHA
>EDS78884.1|FEATURES|megares|tetracycline|tet44|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAV
TSFNWNDYKINIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMN
IPTIIFINKIDQDGINLNNIYQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVIS
RNDKLLKKYIAGEKLTIQELTYEEYRCVKKGSLFPIYHGSARNNIGTQQLIEAISNLFCS
EMNENGSELCGRVFKIEYTDHKQRLVYLRLYSGTLHLRDTIILPEKKKVKLTEIYIPSNG
EMIQTKIVCSGDIFIIPNNTLRLNDIIGNEKILPCNVWNDNTAPILRTRIEPIKIEEREK
LLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHINIRIEDPTVIY
LEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREG
INYGLEQGLYGWKVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYL
SFILFTPQEYFSRAYNDAQKHCAIIETSQSKNDEVIFTGHIPARCINEYRNTLTLYTNGQ
AVFLTELKDYQIATCEPVIQSRRPNNRIDKVRHMFNKKEN
>NP_253438.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MSNPQYPTRLPCGSRVLDLARPHVMGILNVTPDSFSDGGRYDRLDDALRHAERMVLEGAT
LIDVGGESTRPGARSVSPTEELERVAPVVERIARELDVVISVDTSTPAVMRETARLGAGL
INDVRSLQRDGALDAAVDSGLAVCLMHMRGEPQTMQDAPAYQDVVAEVGAFLQERVDACV
AAGIDRERLLLDPGFGFAKTLEHNLVLFRHLQALHGLGLPLLVGVSRKSMIGKVLGREVD
ERLYGSLALAALALAKGARIIRVHDVAATVDVMRMISAVEMAD
>AEI54991.1|FEATURES|megares|chloramphenicol|cmlA5|antibiotic efflux|1
MDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAY
VVASMGLALTSSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLA
MVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLP
VKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFM
GRVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWASQSVLGFIAPMWLVGIGVATAVSVSP
NGALRGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLS
CVSRVKGSRGQGEHDVVALQSAESTSNPNR
>ABF71542.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIERIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFNRALTNRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>AAO82932.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MIDLKKNYQIMGIVNTTPDSFSDGGSYTTVDVAYQHALHLLEAGADILDIGGQSTRPGYE
EVSPQVEADRVLPLIKKIRETSLAPISVDTYYPEVAEAAIQAGATMINDIKGLDTPGMAE
VLAQYPEVQVVIMHSRKRQSLSLKEELHQFYTEKIEQCQKYGLSLEKICFDPGIGFHKTV
AENLQLLKDPNAFRYQDYPLLYGVSRKRTIGALTNEPEPANRDFGSAAASLYAAQQGVEI
LRVHNVQGLKQTFDVWRALSEKE
>ABR79724.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MGRLVSELRNPMVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQYGL
EAAFRSVFPIQSYSGNSELQYVSYRLGEPVFDVKECQIRGVTYSAPLRVKLRLVIYEREA
PEGTVKDIKEQEVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGK
VLYNARIIPYRGSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVV
FEIRDNKLQMELIPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKDDIKHIEVPV
EYIAGKVAAKDYIDEATGELICPANMELSLDLLAKLSQSGHKRIETLFTNDLDHGPYISE
TVRVDPTNDRLSALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSL
LRDEIEGSGILSKDDIIEVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLV
RVERAVKERLSLGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRR
ISALGPGGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLET
PYRKVTDGVVTDEIHYLSAIEEGNYVIAQANSNLDENGHFVEDLVTCRSKGESSLFSRDQ
VDYMDVSTQQVVSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVA
VDSGVTAVAKRGGTVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCINQMP
CVSLGEPIERGDVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFT
TIHIQELACVSRDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTP
KGETQLTPEEKLLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIE
EMQLKQAKKDLSEELQILEAGLFSRIYAVLVSGGVEAEKLDKLPRDRWLELGLTDEEKQN
QLEQLAEQYDELKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRRIQPGDKMAGR
HGNKGVISKINPIEDMPHDANGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGDKIN
AMLKQQQEVAKLREFIQRAYDLGADVRQKVDLNTFSDEEVLRLAENLRKGMPIATPVFDG
AKEAEIKELLQLGDLPTSGQITLFDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTG
SYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIV
DGNHQMEPGMPESFNVLLKEIRSLGINIELEDE
>WP_001819727.1|FEATURES|megares|peptide|rpoB|antibiotic target alteration|0
MKIGLASPEKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWECSCGKYKRVR
YKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLLLDMSPRALEEVI
YFASYVVVDPGPTGLEKKTLLSEAEFRDYYDKYPGQFVAKMGAEGIKDLLEEIDLDEELK
LLRDELESATGQRLTRAIKRLEVVESFRNSGNKPSWMILDVLPIIPPEIRPMVQLDGGRF
ATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGRRGRPVTGPG
NRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKEMALELFKPF
VMKELVQREIATNIKNAKSKIERMDDEVWDVLEEVIREHPVLLNRAPTLHRLGIQAFEPT
LVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQNILNPKDGKPVV
TPSQDMVLGNYYLTLERKDAVNTGAIFNNTNEVLKAYANGFVHLHTRIGVHASSFNNPTF
TEEQNKKILATSVGKIIFNEIIPDSFAYINEPTQENLERKTPNRYFIDPTTLGEGGLKEY
FENEELIEPFNKKFLGNIIAEVFNRFSITDTSMMLDRMKDLGFKFSSKAGITVGVADIVV
LPDKQQILDEHEKLVDRITKQFNRGLITEEERYNAVVEIWTDAKDQIQGELMQSLDKTNP
IFMMSDSGARGNASNFTQLAGMRGLMAAPSGKIIELPITSSFREGLTVLEYFISTHGARK
GLADTALKTADSGYLTRRLVDVAQDVIVREEDCGTDRGLLVSDIKEGTEMIEPFIERIEG
RYSKETIRHPETDEVIIRPDELITPEIAKKITDAGIEQMYIRSAFTCNARHGVCEKCYGK
NLATGEKVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGSDITQGLPRIQEIFEARNP
KGQAVITEIEGVVEDIKLAKDRQQEIVVKGANETRSYLASGTSRIIVEIGQPVQRGEVLT
EGSIEPKNYLSVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLRKVRIIEAGD
TKLLPGSLVDIHNFTDANREAFKHRKRPATAKPVLLGITKASLETESFLSAASFQETTRV
LTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYEKTAKPVAEVESQTEVTE
>AAQ76282.1|FEATURES|megares|beta_lactam|OXA-50|antibiotic inactivation|1
MRPLLLSALLLLSGHTQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLREAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTHFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>ACQ61253.1|FEATURES|megares|beta_lactam|gyrA|antibiotic target alteration|0
MSDLAKEITPVNIEDELRSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEVRMSKIAHELLADLDKETVDYVPNYDGTEQIPAVLPTKIPNLLINGASGIAVGMAT
NIPPHNLGEVIDGCLAYIDNEAITIDELMDYIPGPDFPTAALISGRKGIIDAYKTGRGKV
YMRSKAEIETDKNGKETIIVSEIPYQVNKARLIEKIAELVKEKKVEGISALRDESDKDGM
RIVIECKRDAVGEVVLNNLYANTQLQTTFGINMVALDNGQPKLFNLKEMLKCFVDHRREV
VTRRTIFELRKARERAHILEGLALALANIDEIIELIRRAATPAEAKEGLIARGWDLGNVA
AMLERAGTDAARPEWLEPQYGIRDGKYFLTEQQAQAILDLRLHKLTGLEHEKILDEYKQL
LEEIAALMHILASTERLMEVIREELEAIRAGFSDARRTEITAATHDIDMEELIAREDVVV
TLSHEGYVKYQLLSDYEAQRRGGKGKSATKMKEEDYIERLLVANTHDNILLFSTRGKTYR
MKVYQLPLASRTARGKPIVNLLPLEENERITAILPVTEFSEDKFIFMATGDGTVKKTSLD
QFANVRANGLIALNLRDEDSLIGVDITDGESEIMLFSKFGKVVRFKESEETAVVDENGQP
VLDENGQPEIKFKGVRPMGRTAAGVRGMKLADGDQVVSLIVPKTEGDVLTVTENGYGKRT
SLSEYPTKGRGTQGVVSIKVSERNGSVVGAVQVAEGDEFMMITNAGTLVRTRVAEVSQVG
RNTQGVTLIRTSEGESVVGLQRIDEIEESELPEGEEALVENDAPVAQDDDGEQE
>ABR79111.1|FEATURES|megares|tetracycline|tufab|antibiotic target alteration|1
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGSARAFDQIDNAPEEKARG
ITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALE
GDAEWEAKIIELAGHLDTYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVG
EEVEIVGIKETAKTTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIN
PHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMV
VTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG
>NP_253288.1|FEATURES|megares|multidrug|mexD|antibiotic efflux|1
MSEFFIKRPNFAWVVALFISLAGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDS
VTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQ
AVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFF
SSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKG
TLDDPQEFGQVVLRANEDGSLVRLADVARLELGKESYNISSRLNGTPTVGGAIQLSPGAN
AIQTATLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLF
LQNVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVER
IMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSI
LFSGFLALTFTPALCATLLKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGR
FMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKS
REAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSAAAEIAALNEHFALPDDGTV
MAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEA
PQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPE
SVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEM
ERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLI
VPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAI
EAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPIC
FVWLLSLLRSKPAPIEQAASAGE
>AAR37057.1|FEATURES|megares|glycopeptide|vanSD|antibiotic target alteration|0
MACSILIIAAVYLFVLKDNFANVVVAILDSFIYHDRDEAVAVYLRTFKAYEIWLFLIAVM
GVFFMIFRRYLDSISKYFKEINRGIDTLVHEDTNDIALPPELASTERKINSIRHTLTKRK
TDAELAEQRKNDLVMYLAHDLKTPLSSVIGYLNLLRDENQISEELREKYLSISLDKAERL
EELINEFFEITRFNLSNITLVYSKINLTMMLEQLGHEFKPMLAGKNLKCEFDVQPDMMLS
CDANKLQRVFDNVLRNAVSYCYENTTIQVNARQAEDYVLIQVINEGDTIPGERLERIFEQ
FYRLDVSQSSSTGGAGLGLAIAREIVELHHGQITARSENGITSFEVTLPTVGKS
>ABD84038.1|FEATURES|megares|beta_lactam|blaA|antibiotic inactivation|1
MINTGNGTKILYRGARRFPFCSTFKFMLAAAVLGQSQSQPNLLNKHINYHESDLLSYAPI
TRKNLAHGMTVSELCAATIQYSDNTAANLLLKELGGLAAVNQFARSIGDQMFRLDRWEPD
LNTALPNDPRDTTTPAAMAASINKLVLGDALHPAQRSQLTAWLKGNTTGDATIRAGAPTD
WIVGDKTGSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDANPVPDVLALCQPKYFGRK
F
>NP_312865.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKV
YIRARAEVEVDAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDG
MRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRRE
VVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRHAPTPAEAKTALVANPWQLGNV
AAMLERAGDDAARPEWLEPEFGVRDGLYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLDQIAELLRILGSADRLMEVIREELELVREQFGDKRRTEITANSADINLEDLITQEDVV
VTLSHQGYVKYQPLSEYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDHILCFSSRGRVY
SMKVYQLPEATRGARGRPIVNLLPLEQDERITAILPVTEFEEGVKVFMATANGTVKKTVL
TEFNRLRTAGKVAIKLVEGDELIGVDLTSGEDEVMLFSAEGKVVRFKESSVRAMGCNTTG
VRGIRLGEGDKVVSLIVPRGDGAILTATQNGYGKRTAVAEYPTKSRATKGVISIKVTERN
GLVVGAVQVDDCDQIMMITDAGTLVRTRVSEISIVGRNTQGVILIRTAEDENVVGLQRVA
EPVDEEDLDTIDGSAAEGDDEIAPEVDVDDEPEEE
>WP_000167922.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MTKTKIMGILNVTPDSFSDGGKFNNVESAINRVKAMIDEGADIIDVGGVSMRPGHEMVSL
EEEMNRVLPVVEAIVGFDVKISVDTFRSEVAEACLKLGVDMINDQWAGLYDHRMFQIVAK
YDAEIILMHNGNGNRDEPVVEEMLTSLLAQAHQAKIAGIPSNKIWLDPGIGFAKTRNEEA
EVMARLDELVATEYPVLLATSRKRFTKKMMGYDTTPVERDEVTAATTAYGIMKGVRAVRV
HNVELNAKLAKGIDFLKENENARHNLS
>AAG42227.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNIRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>AFP97030.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVR
ALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFER
TRSDA
>WP_012117653.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MHADGNTFDKNFRKAAKTVGNVIGNYHPHGDSSVYEAMVRMSQDWKVRNVLIEMHGNNGS
IDGDPPAAMRYTEARLSSIASELLRDIDKNTVEFVPNFDDTSKEPVVLPAMFPNLLVNGS
TGISAGYATDIPPHHLGEVIDAVIKRIESPDCTVDDLMQVIKGPDFPTGGIIQGVDGIRK
AYETGKGKIIIRGKAEVESVRGGREQIVITEIPFEVNKANLVKKMDEYRIDKKVEGISEV
RDETDRTGLRVVVELKKEADAKGILNFLYKNTDLQTTYNFNMVAIHNRRPMLMSLTAILD
AYISHQKEVVTNRSVFELQKAKERHHIVEGLMKALSVLDEVIAVIRASSDKKDAKQNVMS
KFTFTEPQAEAIVSLQLYRLTNTDITALKEEAEELSKKIQELEAILSHDKKLLKVITSSL
KKLKKTYADSRRSVIEEKIEEIKINLEVMVASEDVYVTVTKDGYVKRTSQRSFAASNGQD
FGMKDTDRLIHQFEMNTTDVLLLFTNKGSYVYCPVHQLPDIRWKDMGQHVTNIITIDRDE
TIVKAIPVKEFDPSSYLLFMTKNGMVKRTEMTHYKAQRYSKALVALNLKGDDELIDVHVT
DGGSQLFIATRLGYGLWFGEDEVNVVGARAAGVKGINVKDGDTVVSGQILHETDSLVLVT
QRGAIKRMNLSEFEKTSRAKRGVIMLRELKKNPHRAVGVFACALADMIAAETEKGERIEI
AVKSLRANDRYSNGSFFTDEDETGPVTDVWRIPASDV
>CAA57832.1|FEATURES|megares|chloramphenicol|catB8|antibiotic inactivation|1
MKNYFDSPFKGELLSEQVKNPNIKVGRYSYYSGYYHGHSFDECARYLHPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRHDWASSFPFFYMQEEPAFSSALDAFQRAGDTAIGNDVWIG
SEAMIMPGIKIGDGAVIGSRSLVTKDVVPYAIIGGSPAKQIKKRFSDEEISLLMEMEWWN
WPLDKIKTAMPLLCSSNIFGLHKYWREFVV
>AAB05245.1|FEATURES|megares|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRKRIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>BAD02332.1|FEATURES|megares|trimethoprim|dfrA17|antibiotic target replacement|1
MGVLPNRKYAVVSKNGISSSNENVLVFPSIENALKELSKVTDHVYVSGGGQIYNSLIEKA
DIIHLSTVHVEVEGDIKFPIMPENFNLVFEQFFMSNINYTYQIWKKG
>AAN41426.1|FEATURES|megares|aminoglycoside|ant3-dprime|antibiotic inactivation|1
MGEFFPAQVFEQLSHARAVIERHLAATLDTIHLFGSAIDGGLKPDSDIDLLVTVSAAPND
SLRQALMLDLLKVSSPPGDGGTWRPLELTVVARSEVVPWRYPARRELQFGEWLRHDILSG
TFEPAVLDHDLAILLTKARQHSLALLGPSAATSFEPVPKEHFSKALFDTIAQWNAESDWK
GDERNVVLALARIWYSASTGLIAPKDVAAAWVSERLPAEHRPLICKARAAYLGSEDDDLA
MRVEETAAFVRYAKATIERILR
>AAC74603.2|FEATURES|megares|multidrug|marR|antibiotic efflux|0
MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVEL
KKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLH
QELTKNLTADEVATLEYLLKKVLP
>WP_011765121.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MPNFVCGRFELDLTQPRIMAIINVTDDSFSGDGLRGNLDGALNKAERALAEGADILDLGA
ESTRPGSDPVPEQQEIDRLVPLIEALQGCGVPLSVDTLKPSVMRAALAAGADLINDVNGF
RAEGAVEAVAAGTAGLCVMHMQGEPRTMQQAPQYANVVDEVGAFLVRRTEVLLRAGVRRE
RVLLDPGFGFGKSTEHNLALVRGLGALRDLGYPLLVGLSRKSLLGAITGKPVEARGPASV
AAALMAVQYGAAIVRVHDVAPTRDALAVWQAMS
>CBA33631.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MTQSYNADAIEVLTGLEPVRRRPGMYTDTSRPNHLGQEVIDNSVDEALAGHARRVDVILH
ADQSLEVIDDGRGMPVDIHPEEGVPAVELILCRLHAGGKFSNKNYQFSGGLHGVGISVVN
ALSKRVEVNVKRDGQIYNIAFENGEKVKELSVVGTCPKRQTGTSVHFWPDEKFFDSPRFS
VSRLTHLLKAKAVLCPGVEINFKDQVNNTEQRWCYLDGLNDYLCEAVNGLITLPEKPFIG
NFSGETEAVDWALLWLPEGGELLTESYVNLIPTMQGGTHVNGLRQGLLDAMREFCEYRNI
LPRGVKLSAEDIWERCAYVLSVKMQDPQFAGQTKERLSSRQCAAFVSGVVKDAFSLWLNQ
NVQAAEQLAELAIASAQRRLRAAKKVVRKKLTSGPALPGKLADCTAQDLNRTELFLVEGD
SAGGSAKQARDREYQAIMPLKGKILNTWEVSSDEVLASQEVHDISVAIGIDPDSDDLSQL
RYGKVCILADADSDGLHIATLLCALFVKHFRSLVKGGHVYVAMPPLYRIDLGKEVYYALD
EEEKAGVLEQLKRKKGKPNVQRFKGLGEMNPMQLRETTLDPNTRRLVQLTISDDDDARTL
AVMDMLLAKKRSEDRRNWLQEKGDMADIEV
>AAY52012.1|FEATURES|megares|glycopeptide|vanHF|antibiotic target alteration|1
MKNIGITIYGCEQDEADVFKELSPRFGVIPAITSSAVSETNVMLAPGNQCISVGHKSEIS
ESILLALKESGVKYISTRSIGYNHIDMKAAESMGIAVGNVAYSPDSVADYTLMLMLMAVR
NAKSIVRSVEKHDFKLDSVRGKVLRDMTVGVLGTGHIGKRVIERLRGFGCHVLAYGHNKE
AAANYVSLNELLQKSDILTIHVPLSADTYHMIGREQIKAMKQGAFLINTARGGLIDTDVL
VKALENGKLGGAALDVLEGEEGLFYFDCTQKPIDNQFLLKLQRMPNVIITPHTAYYTEQA
LRDTVENTIKNCLEFERRETLV
>AAY43211.1|FEATURES|megares|aminoglycoside|ANT(2'')-Ia|antibiotic inactivation|1
MDTTQVTLIHKILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAI
VEMLGGRVMEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIARRPV
RCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA
>ABB63696.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQYGLEAAFRSVFPIQ
SYSGNSELQYVSYRLGEPVFDVQECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ
EVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR
GSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVIFEIRDNKLQME
LVPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKDDVKLIEVPVEYIAGKVVAKD
YIDESTGELICAANMELSLELLAKLSQSGHKRIETLFTNDLDHGPYISETLRVDPTNDRL
SALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSLLREEIEGSGIL
SKDDIIDVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS
LGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTR
ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRKVTDGVVT
DEIHYLSAIEEGNYVIAQANSNLDEEGHFVEDLVTCRSKGESSLFSRDQVDYMDVSTQQV
VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVTAVAKR
GGVVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCINQMPCVSLGEPVERG
DVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVS
RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEK
LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEEMQLKQAKKDL
SEELQILEAGLFSRIRAVLVAGGVEAEKLDKLPRDRWLELGLTDEEKQNQLEQLAEQYDE
LKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRRIQPGDKMAGRHGNKGVISKIN
PIEDMPYDENGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAK
LREFIQRAYDLGADVRQKVDLSTFSDEEVMRLAENLRKGMPIATPVFDGAKEAEIKELLK
LGDLPTSGQIRLYDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG
GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMP
ESFNVLLKEIRSLGINIELEDE
>ABB63349.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MLRGFFLSIHTRDNIMKLFAQGTSLDLSHPHVMGILNVTPDSFSDGGTHNSLIDAVKHAN
LMINAGATIIDVGGESTRPGAAEVSVEEELQRVIPVVEAIAQRFEVWISVDTSKPEVIRE
SAKVGAHIINDIRSLSEPGALEAAAETGLPVCLMHMQGNPKTMQEAPKYDDVFAEVNRYF
IEQIARCEQAGIAKEKLLLDPGFGFGKNLSHNYSLLARLAEFHHFNLPLLVGMSRKSMIG
QLLNVGPSERLSGSLACAVIAAMQGAHIIGVHDVKETVEAMRVVEATLSAKENKRYE
>ABR76392.1|FEATURES|megares|multidrug|ompF|reduced permeability to antibiotic|0
MMKRNILAVVIPALLVAGAANAAEIYNKNGNKLDFYGKMVGEHVWTTNGDTSSDDTTYAR
IGLKGETQINDQLIGYGQWEYNMDASNVEGSQTTKTRLAFAGLKAGEYGSFDYGRNYGAI
YDVEAATDMLVEWGGDGWNYTDNYMTGRTNGVATYRNSDFFGLVDGLSFALQYQGKNDHD
RAIRKQNGDGFSTAATYAFDNGIALSAGYSSSNRSVDQKADGNGDKAEAWATSAKYDANN
IYAAVMYSQTYNMTPEEDNHFAGKTQNFEAVVQYQFDFGLRPSIGYVQTKGQGPAVACWL
LRRRCGSG
>AAM27272.1|FEATURES|megares|chloramphenicol|catB8|antibiotic inactivation|1
MKNYFNSPFKGELLSEQVKNPNIRVGRYSYYSGYYHGHSFDECARYLFPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRHDWASSFPFFYMQEEPAFSSALDAFQRAGDTVIGNDVWIG
SEAMIMPGIKIGDGAVIGSRSLVTKDVEPYALIGGNPAKQIKKRFSDEEISLLMEMEWWN
WPLDKIKTTMPLLCSSNIFGLHKYWREFAV
>AAK48071.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MGVLNVTDDSFSDGGCYLDLDDAVKHGLAMAAAGAGIVDVGGESSRPGATRVDPAVETSR
VIPVVKELAAQGITVSIDTMRADVARAALQNGAQMVNDVSGGRADPAMGPLLAEADVPWV
LMHWRAVSADTPHVPVRYGNVVAEVRADLLASVADAVAAGVDPARLVLDPGLGFAKTAQH
NWAILHALPELVATGIPVLVGASRKRFLGALLAGPDGVMRPTDGRDTATAVISALAALHG
AWGVRVHDVRASVDAIKVVEAWMGAERIERDG
>WP_012683975.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAGKVIQSGRHRQRRTYSRINEVLGLPNLIEIQQKSYQWFLDEGLREMFQDISPIQDFTG
NLVLEFIDYSLGEPKYDVDESKERDVTYAAPLRVKVRLLNKETGEVKEQEVFMGDFPLMT
ETGTFIINGAERVIVSQLVRSPSVYYNTKVDKNGKQTFTATVIPNRGAWLELETDAKDVI
YVRIDRTRKIPVTVLLRALGFGSDIEILNLLGEDEYIKNTLEKDNTDSTEKALIEIYERL
RPGEPPTVENAKSLLISRFFDPKRYDLASVGRYKMNKKLHLKNRLYNQRLAETLIDTTTG
EIFAEAGQMIDRRVLERIVPALEGSIGFIDVRTHGGVLEDEAIHLQSINIFSPIEDGKII
KVIGNGNVDKSFKHITPADIVSAINYFMNLLHSVGSTDDIDHLGNRRLRSVGELLQNQFR
IGLSRMERVVRERMSIQDQNQITPQALINIRPVIASLKEFFGSSQLSQFMDQTNPLAELT
HKRRLSALGPGGLTRERAGFEVRDVHHSHYGRMCPIETPEGPNIGLINSLSSFARINDYG
FIETPRRKVDPETGFVLTDISYLTADEEDVFNVAQANQPLDEDGRFVNDMVICRRKGEIL
SVPRDKVDFMDVSPKQVVSVATALIPFLENDDANRALMGSNMQRQAVPLLIPQAPFVGTG
MEHKAAQDSGVAIVAKHPGQVERVTAREIWIRRYQEIDGRKVAGDLDKYKMHKFIRSNQG
TCINQRPIVSTGDWIEKGDIVGDGPSTEKGELALGRNVIVAFMTWEGYNYEDAILLSEKL
VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVGEDALKNLDERGIIRVGAEIQDGDI
LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGGSGIIVDVKVFTRENGDEL
PPGVNQLVRVYIAQKRKISVGDKMAGRHGNKGVIARIMAEEDMPFLPDGSPVEIVLNPLG
VPSRMNIGQVLETHLGMAAKLLGIHVATPVFDGARQAEVFETLAEAGLDRDGKTILFDGR
TGEPFDRRVTVGCVYMLKLAHLVDDKIHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEVW
ALEAYGAAYTLQEILTVKSDDVVGRVKTYEAIVKGENVPEPGVPESFKVLIKELQSLGMD
VKILSGDEQEIEMREMEDEDEGNGEKLNLVLEGGSLNEE
>AAQ76280.1|FEATURES|megares|beta_lactam|OXA-50|antibiotic inactivation|1
MRPLLFSALLLLSGHAQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVKSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>AEE66364.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MDSFAKETLPVSLEEEMRRSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMHELNNDWN
RAYKKSARIVGDVIGKYHPHGDQSVYDTIVRMAQDFSMRYMLVDGQGNFGSIDGDNAAAM
RYTEIRLAKIAHELLADIDQETVDFGPNYDGSEQEPLLLPSRLPNLLVNGSSGIAVGMAT
NIPPHNLQEVVDGCLYCLRNPECSIDELIELIPAPDFPTGGVIYGITGVREGYRTGRGRV
IMRAKTHFEDMEKGNRQAIVVDAIPYQVNKKTLQERIAELVNDKKIEGISDIRDESDKDG
MRLVIELKRGEVPEVVLNNLYKNTQLQDTFGMNLVALVDGQPRLLNLKQLIEYFLQHRRE
VVTRRTVFQLRKARERGHVLEGLAVALANIDDFIAIIKAAPTPPVARQELMARSWDSSLV
REMLARVDGDAAGGVAAFRPDDLAPEYGLQGDGNYRLSETQAQEILNMRLQRLTGLEQDK
IIGEYKDVMATIADLLDILARPDRITTIISEELQAIKAEFSTSAKDTRRAEIEVNATELD
TEDLITPMDMVVTLSHGGYIKSQPLSEYRSQKRGGRGKQATAMKENDWVDQLFIANTHDY
LLCFSNRGRVYWLKVWEVPQGTRNSRGKPIVNMFPLADGEKVTVVLPVKEFSEDHYVFMA
TSRGTVKKTPLSDFSNPRKAGIIAVDLDDGDYLIGADLTDGKHDVMLFSDAGKAVRFDEN
DVRPMGRNARGVRGMMLEEGQTVIALLVAGDETQSVLTATENGYGKRTPITEYTRHGRGT
KGMIAIQTSSRNGRVVGAVLVMPSDEIMLITTGGVLVRTRVAEIREMGRATQGVTLISVD
DGSSLSGVRRVVESDADADDEDGGEEGGEEGGDQGGDDTGAQGKDSEPTEPTE
>CAC81945.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRVRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>CCM44120.1|FEATURES|megares|beta_lactam|blaZ|antibiotic inactivation|1
MLALILSACNTKHSTNNDIEKLEKKYGANIGMYALNTQNSEALSFNENKRFAYASTLKAI
SSAMLLEQTPYNKLDKKIHINKDDIVPYSPVLEKYIGKEITIKKLIEATMLFSDNTANNK
IIDELGGYEHVKNRLTDLGDTTTHPSRKEPDLNFYSPKDKRDTTTPMAYGKSLNKLIVDG
NLSKANKDLLLDLMLKNKSGDTLIKDGAPSNFKVMDKSGQALTYGSRNDVALVYPDGQDK
PIILVIFTNKDKKDGKPNDKIVSEVAEIVLKNMSK
>AEE66654.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MATPRYTEASIRVLKGLEPVRQRPGMYTRTENPLHIVQEVIDNAADEALAGYGKQIQVTL
HGDGSISVEDDGRGIPVGLHPEENAPVVELVFTRLHAGGKFDKQGGGAYAFSGGLHGVGV
SVTNALATRLEVVVWRDGAVHRLVFAGGDVIEALAPYPEGGRKKSGTRVRVWPDAKYFDS
PAIPMAELTHLLRSKAVLLPGVKVSLVNEKTGDTRTWQYQEGLRGYLAEALAGAELMIPF
FEGQQYAGADHDSFAEGEGAQWVVAWAEDGNVVRESYVNLIPTPAGGTHESGLREGLFGA
VKGFAELHSLLPKGVKLLPEDVFTRASFVLSAKVLDPQFQGQIKERLNSRDAVRLVGCFA
KSALDLWLHSNVEYGKKLAELAIRQAQARQRSAQKVEKRKSSGVAVLPGKLTDCESSDAS
RTEVFLVEGDSAGGSAKMGRDKEFQAILPLRGKVLNSWEVDRDRLFANNEIHDISVAIGV
DPHGPGDEPDLSGLRYGRICILSDADVDGSHIQVLLLTLFYRHFPKLIEAGNVFVARPPL
FRVDVPAQGKRPARKIYCLDAGELEAAQDKLRKEGVRESAWSVSRFKGLGEMNPEQLWET
TMNPDTRRLLPVGYGDLTPGDTTRMFDMLMGKGESSQRRAWIEEKGNLAELDI
>AGS61245.1|FEATURES|megares|quinolone|rpoB|antibiotic target alteration|0
MVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPDGQNGLEAAFRSVFPIQ
SYSGNAELQYVSYRLGEPVFDVKECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ
EVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR
GSWLDFEFDPKDNLFVRIDRRRKLPATIILRAMNYSTEDILNLFFEKTTFEISNNKLMMT
LVPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKEQIERIEVPVEYIAGKVVARD
YIDEATGELICAANMEISLDVLARLSQAGHKTIETLFTNDLDHGAYISETIRVDPTNDRL
SALVEIYRMMRPGEPPTREAAENLFENLFFSEDRYDLSAVGRMKFNRSLGREEVEGSGIL
SQEDIIEVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS
LGDLDALMPQDMINAKPISAAVKEFFGSSQLSKFMDQNNPLSEITHKRRISALGPGGLTR
ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRVVENNAVT
DEIHYLSAIEEGNFIIAQANSVLDDDGHFVEELVTCRHKGESSLFSRDQVQYMDVSTQQV
VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRGDKPLVGTGMERAVAVDSGVTAVAKR
GGTVQYVDASRIVIKVNEDETYAGEAGIDIYSLTKYTRSNQNTCINQTPCVSLGEPVERG
DVLADGPSTDLGELALGQNMRVAFMPWNGYNYEDSILVSERVVQEDRFTTIHIQELACVS
RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVKGGDILVGKVTPKGETQLTPEEK
LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEESQLREVKKDL
TEELRIFEAGLFARIRGVLIAGGIEADKLDKLPRERWLELGLADEEKQNQLEQLAEQYDE
LKAEFAKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRQIQPGDKMAGRHGNKGVISKIN
PIEDMPYDENGNPVDLVLNPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAK
LREFIQKAYDLGMAPRQKVDLDTFSDEEVLRLAENLKKGMPTATPVFDGAEEMEIKEMLK
LADLPTSGQITLFDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG
GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMP
ESFNVLLKEIRSLGINIELEDE
>ACJ63263.1|FEATURES|megares|beta_lactam|OXA|antibiotic inactivation|0
MKEKVVVDKAISLYTESFGDPAHEPIILIMGAMSSAVWWPDEFCSQLAKMGRYVIRYDHR
DTGKSTSYEPGQAPYSVEELADDVVRVIDGYGLEAAHLVGMSLGGFLSQLVALKYPKRVK
SLTLIASERLADADPDMPAFDPAIIEYHQRAESLDWSDRDAVVAYQVGAWRINSGTAHAF
DAEKIQNIAELNFDRTPNILTTFNHTTLGGGERWLGRLNEIAVPTLIIHGTEDPVLPYVH
GLALKDAIRGSKMLTLEGTGHELHHEDWPRIIQAIKGQTS
>NP_358351.1|FEATURES|megares|aminoglycoside|parC|antibiotic target alteration|0
MYLMSNIQNMSLEDIMGERFGRYSKYIIQDRALPDIRDGLKPVQRRILYSMNKDSNTFDK
SYRKSAKSVGNIMGNFHPHGDSSIYDAMVRMSQNWKNREILVEMHGNNGSMDGDPPAAMR
YTEARLSEIAGYLLQDIEKKTVPFAWNFDDTEKEPTVLPAAFPNLLVNGSTGISAGYATD
IPPHNLAEVIDAAVYMIDHPTAKIDKLMEFLPGPDFPTGAIIQGRDEIKKAYETGKGRVV
VRSKTEIEKLKGGKEQIVITEIPYEINKANLVKKIDDVRVNNKVAGIAEVRDESDRDGLR
IAIELKKDANTELVLNYLFKYTDLQINYNFNMVAIDNFTPRQVGIVPILSSYIAHRREVI
LARSRFDKEKAEKRLRIVEGLIRVISILDEVIALIRASENKADAKENLKVSYDFTEEQAE
AIVTLQLYRLTNTDVVVLQEEEAELREKIAMLAAIIGDERTMYNLMKKELREVKKNFATP
RLSSLEDTAKAIEIDTASLIAEEDTYVSVTKAGYIKRTSPRSFAASTLEEIGKRDDDRLI
FVQSAKTTQHLLMFTSLGNVIYRPIHELADIRWKDIGEHLSQTITNFETNEAILYVEVLD
QFDDATTYFAATRLGQIKRVERKEFTPWRTYRSKSVKYAKLKDDTDQIVAVAPIKLDDVV
LVSQNGYALRFNIEEVPVVGAKAAGVKAMNLKEDDVLQSGFICNTSSFYLLTQRGSLKRV
SIEEILATSRAKRGLQVLRELKNKPHRVFLAGAVAEQGFVGDFFSTEVDVNDQTLLVQSN
KGTIYESRLQDLNLSERTSNGSFISDTISDEEVFDAYLQEVVTEDK
>CAD57667.1|FEATURES|megares|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSILAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>ADY20942.1|FEATURES|megares|macrolide-lincosamide-streptogramin|mph|antibiotic inactivation|1
MTTLKVKQLANKKGLNILEDSIEINESGVDFQVAHVTEQNGDKWILRIPRRPESMRHALR
EKEALEIMKKHAAFQVPNWSIFSEELIAYKQLNGFPAATIDIEQQRYVWNFNEKNVPIEY
YISLGKVLANVHSLPQQKFNNIGVEILIANELRTSMQQRMNRVKEQYHINQNLWDRWQAW
LAEDSFWPSHVGVKHGDIHPGHILIDKKNNVTGLIDWTEVGIGDVSIDFTSHYLLFGKDG
LTKLIHSYDNAGGKTWSRMDEHIIELLTTSSITVAEYAQVSGLKDMHEAAIHMLATEC
>CAC42502.1|FEATURES|megares|tetracycline|tetA|antibiotic efflux|1
MPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAA
VDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGM
VAGPVLGGLMGGFSPHGPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFR
WARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQA
MITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAIL
SRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPA
LRRGLWSGAGQRADR
>ABB02504.1|FEATURES|megares|tetracycline|tet39|antibiotic efflux|1
IGRIFAGITGANMAVATAYVSDITPAHERAKRFGLLGAVFGIGFIAGPVIGGVLGEWNLH
APFFAAAFMNGINLIMTAVLLKESKHSNKMTEKVQEQSILKKLSYLITQPNMAPLLGIFL
IITLVSQVPATLWVIYGQDRYGWSIFIAGVSLASYGICHSIAQAFAIAPMVKRFGEKNTL
LCGIACDAIGLLLLSIAVEEWVPFALLPLFALGGVAVPALQAMMS
>ABQ57180.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MKKIPNMNEVTEKKPLTEFTEKAYLDYSMYVILDRALPSIADGLKPVQRRIVYAMSELGL
KATAKYKKSARTVGDVLGKFHPHGDSACYEAMVLMAQPFSYRYPFVDGQGNWGSPDDPKS
FAAMRYTEARLSLYADVLLGELLQGTVDWVDNFDGTLQEPALLPARLPNILLNGATGIAV
GMASDILPHNLTEVANACIHLLDNPQADIKTICEYIKGPDFPTEAEIISPSETIRAMYES
GNGSIKMRAIYAQEKQNIVITALPYQVSGARVMEQIALQMQQKKLPMVEDLRDESDHEHP
TRLVIIPRSNRVDIESLMSHLFATTDLERSYRVNFNMIGLDGKPRVKGLLAILTEWLEFR
LTTVKRRLQFRLEKVLERIHILEGLLIAYLNIDEVIAIIREHEQPKQGLISRFNLTERQA
EAILEMKLRHLAKLEEIKLRGELDELSDERDTLQKTLASHSLLKELVKEEITKDRDEFGD
PRRSPIITREDSQALKEEDILPNEPITVVLSKNGWVRAAKGHDVDGKELSYKAGDEFKAQ
TLARTNQQVLFFDGEGKVYSLPGHALPSARGQGEPLTGKLNPAEGVLFEAIVGGEPEQKV
LLATDSGYGFIAKIEDLYVKNRNGKACIKLSENSHILPPRLIPNREQLFVACATNVGRLL
IFSLEELPELSRGKGNKLISIPVAKAVSREEYIVDMQVLTTNDSLTVHAGKRHFTLKGED
LTHYKGERGRRGNRLPRGLQNVSQLHVTQSE
>EHT14135.1|FEATURES|megares|fosfomycin|FosA5|antibiotic inactivation|1
MLSGLNHLTLAVSSLAPSVAFYHQLLGMTLHARWDGGAYLSCGDLWLCLSLDPQRRVTPP
EESDYTHYAFSVAEADFAGFSARLETAGVAVWKVNRSEGASYYFLDPDGHKLELHVGSLA
LRLAACREQPYKGMVFYDE
>AGS61873.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MKLIARGRELNLSSPQVMGILNVTPDSFSDGGTHNSLNDAINHAAKLIAEGASIIDIGGE
STRPGASDVSVDEELHRVIPVVEAIQQRFDVWISVDTSKAQVITESAQAGASIINDIRSL
TEPGALQAAAKTGLPVCIMHMQGLPKTMQHSPQYKNVMIEVDAFLAENIQRCIDAGIEKN
QIILDPGFGFGKNLAHNYQLLAHLSDFHHFGLPILAGMSRKSMVGQLLNVPPQERVAGSV
ACAVIAAMQGAQIIRVHDVKETVDAMKVVQATLSAKENNE
>CBA27171.1|FEATURES|megares|quinolone|rpoB|antibiotic target replacement|0
MDRVGRLVSELRNPMVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQ
YGLEAAFRSVFPIQSYSGNSELQYVSYRLGEPVFDVKECQIRGVTYSAPLRVKLRLVIYE
REAPEGTVKDIKEQEVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHS
SGKVLYNARIIPYRGSWLDFEFDPKDNLFVRIDRRRKLPATIILRALDYTTEQILDLFFE
KVVFEIRDNKLQMELIPERLRGETASFDIEANGKIYVEKGRRITARHIRQLEKDEIKLIE
VPVEYIAGKVAAKDYVDASTGELICPANMELSLDLLAKLSQSGHKRIETLFTNDLDHGPY
MSETVRVDPTTDRLSALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFN
RSLLRDEIEGSGILSKADIIDVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRV
GLVRVERAVKERLSLGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITH
KRRISALGPGGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGF
LETPYRKVTDGVVTDEIHYLSAIEEGNYVIAQANTNLTEEGRFADDLVTCRSKGESSLFS
ADQVDYMDVSTQQVVSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMER
AVAVDSGVTAVAKRGGTVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCIN
QMPCVSLNEPVERGDVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQED
RFTTIHIQELACVSRDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGK
VTPKGETQLTPEEKLLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRAL
EIEEMQLKQAKKDLSEELQILEAGLFSRIRAVLIAGGVEAEKLDKLPRDRWLELGLTDEE
KQNQLEQLAEQYDELKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRQIQPGDKM
AGRHGNKGVISKINPIEDMPYDENGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGD
KINAMLKRQEEVAKLREFIQKAYDLGQDVRQKVDLNTFSDEEVLRLAENLRKGMPLATPV
FDGAKEAEIKELLQLGDLPTSGQITLFDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHAR
STGSYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYK
NIVDGNHQMEPGMPESFNVLLKEIRSLGINIELEDE
>ACK43805.1|FEATURES|megares|chloramphenicol|catB8|antibiotic inactivation|1
MKNYFNSPFKGELLSEQVKNPNIRVGRYSYYSGYYHGHSFDECARYLLPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRHDWASSFPFFYMQEEPAFSRALDAFQRAGDTVIGNDVWIG
SEAMIMPGIKIGDGAVIGSRSLVTKDVEPYAIIGGNPAKHIKKRFSDEEISLLMEMEWWN
WPLDKIKTAMPLLCSSNIFGLHKYWREFAV
>AFK80332.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MGYSPVFGKRIKEAVTITKRLTRQQSRQVTREQILRSAAALFAGQGVSGTSVEQIVESAG
YTRGAFYGNFEGKHELVLALLEQRTQHELEEIQAMSREAATFEEMLDHLRSWHRRRDENL
ASWLALRTELWLYGLRDPELLPLLADRERRSRDAIAQSLEQGFAARGVTTPAPVELLALI
VHALDDGLSIQRVLFPSDSGTDSVVDVVELLMKSWTALARSTAPAPAAEPAAEPPTEKLE
KNP
>WP_000167944.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MTKTKIMGILNVTPDSFSDGGKFNNVETAINRVKAMIDEGADIIDVGGVSTRPGHEMVTL
EEELNRVLPVVEAIVGFDVKISVDTFRSEVAEACLKLGVDMINDQWAGLYDHRMFQIVAK
YDAEIILMHNGNGNRDEPVVEEMLTSLLAQAHQAKIAGIPSNKIWLDPGIGFAKTRNEEA
EVMARLDELVATEYPVLLATSRKRFTKEMMGYDTTPVERDEVTAATTAYGIMKGVRAVRV
HNVELNAKLAKGIDFLKENENARHNLS
>AEX26000.1|FEATURES|megares|aminoglycoside|aadB|antibiotic inactivation|1
MDTTQVALILQFLAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAI
VEMLGGRVTEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIAGRPV
RCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA
>WP_011766471.1|FEATURES|megares|multidrug|ompR|antibiotic efflux|0
MTNQPDHILIVDDDRDIRSLLADYLEKQGLRCTTAADGREMKAALERHRVDLIVLDLMLP
GEDGLTLCRNLRAGGSHANTPILMLTARGEDMDRIIGLEMGADDYLPKPFVPRELYARVR
AILRRARALPPNLDTQPQAQARELRFAQWRLDTVNRHLIDAQGTVVPLSGAEYRMLGVFL
AHPQRVLSRDQLMELTQGREADVFDRSIDLMVSRLRQRLGDNAREPAIIKTVRNEGYVLS
AEVVAGDGSLSQ
>WP_011246831.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MAKSERYLDLPLEEVIGDRFSRYSKYIIQERALPDARDGLKPVQRRILYAMYNEGNTADK
PYRKAAKTVGNVIGNYHPHGDSSVYEAMVRMSQEWKVREQLIDMHGNNGSVDGDPPAAMR
YTEARLSAISAELMRDLDKGTVDYIPNFDDSIEEPVVLPAMFPNLLVNGSTGISAGYATD
IPPHHLPEIIDGITLLMQKPHTSLDELLEIIKGPDFPTGGIVQGSNGIRQAYETGKGKIV
VRGRTAIEETRGGRKQIVITEIPYEVVKASLVKKMDEIRFDKKVDGIAEVRDDTDRTGMR
IVVELKKEADPEAILHYLFKNTDLQVTYHFNMVAIHNKTPKLMGLLDLMQAYIDHQKQVF
TRRSQFELKKAVDRAHIVEGLMKAVSILDEVIAVIRASKDKKDAKANLQSQFGFTEPQAE
AIVTLQLYRLTNTDITTLQKEAEELEKQIAELKAILASEKKLISVIKKELNQIKKTFASP
RRTEIRAEIEEIKINMDMLIASEDVRVTITKAGYVKRTSLRSYSASSQDGPGMKEGDRLL
LSQEANTTDVVLLFTKRGSYLYVPVHSLPDIRWKDDGQHVANLVAIDADDEIIAAQIIRE
FAETKYLLFMTRAGMAKRSTLNLYQAQRYSKPLMALKLKEGDEVVRVLLTDGQQELFVAT
AFGYGLWFSEEDVSLVGQRAAGVKGINLKEGDYCIGAEAFGLEDSVEFLVATHRGAVKKM
AITEFEKSSRAKRGVLMLRELKNNPHRLVGLKRVRSQDETFAIETAKGDMIAISPRDYRR
ADRYSNGSYAFDQHESGDALTLVRVIQ
>ACO83795.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MVHPVQVGKRTRMSFSRLKEVGQMPNLIEVQLDSYDWFLKEGLQEVFDDINPIQDYTGNL
NLEFVGYKLDLDSIKYSVEECKERDSTYAAPLKVKVRLLNKETGEIKEQEVFMGDFPLMT
EQGTFIINGAERVIVSQLVRSPGVYYDMTVDKTGSKLFSATVIPNRGAWLEYETDSNNII
YVRIDKTRKLPITILARALGYGTDAEIIEFFGEDERLKATIEKDNTKTREEALLEIYKRL
RPGEPPTVDSAESLIESLFFDAKRYDLSRVGRYKFNKKLAIHLRITNQIADQDIVNPQTG
EILVQKGEKIDKDKAIEIQNCGINEVYIKIDDKSFKVIGNHFVDIHSLVPFDISDLNIKE
YVFYPVLKEILDNYADEESIKEEIRKNIYRLIPKHIIREDIYATINYELGLSYDIGYKDD
IDHLGNRRLRSVGELLQNQFRIGLSRMERVVKERMTIQDQEVITPQALINIRPVAASIKE
FFGSSQLSQFMDQTNPLSELTHKRRLSALGPGGLSRERAGFEVRDVHHSHYGRMCPIETP
EGPNIGLINSLATFAKVNEYGFIETPYRRIDPKNKRATNDIVYMTADEEDLYVIARSDEP
IDENGYFIDDKVTVRAKEEVLVVPVSEVEYMDISPRQLVSVATAMIPFLENDDASRALMG
SNMQRQAVPLLKPQAPIVGTGIEYKAATDSGVLPKAKNAGTVVYVSADEIRVRRDSDGGI
DKYKLLKFKRSNQGTCINQRPIVSKGEVVAKETLLADGPSTDLGEIALGKNILMGFITWE
GYNYEDAMLISEQLVKEDVFTSIHIEEYEAEARDTKLGPEEITRDIPNVGEEALKDIDER
GIIRIGAEVRSGDILVGKVTPKGETELTAEERLLRAIFGEKAREVRDTSLRVPHGEAGII
VDVKIFTRENGDELPPGVNKLVRCYIAQKRKISVGDKMAGRHGNKGVISRVLPEEDMPFL
PDGRPLQICLNPLGVPSRMNIGQVLEVHLGLAASKLGWHIATPVFDGAIESDIVDCLRKA
GYSEDGKTVLYDGRTGEPFDNRVTVGYMYILKLAHLVDDKIHARSTGPYSLVTQQPLGGK
AQFGGQRFGEMEVWALEAYGAAHTLQEILTVKSDDVVGRVKTYEAIVKGENIPEPGVPES
FKVLIKELQALCLDVKVLNDDNQEIKLKESVDEDADELEVNIEGTENQPEEKEEKEKEDS
DEYDDLREEDVEPDLEELSLDDLDLDDFGDEH
>AEM66521.1|FEATURES|megares|multidrug|floR|antibiotic efflux|1
MTDKQKQRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSL
YMVMLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGAS
AMLVATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGVLIGEFLGWQAIFITLAI
LAMLALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTYFVFFSTAPR
VLIGQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGI
GELYGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIV
GTLAVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>CAD57197.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHSNARPVSPAD
EIRRIGPLLDALSDQMHRVSINSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>WP_000349358.1|FEATURES|NCBI|bleomycin|bleomycin|antibiotic inactivation|0
DHATPNLPSRDFDATVAFYERLGFRLRFRDTGWMILERGGLVLEFLRHPELDPLTSWFSC
CLRLDDLAGFYAHCEAAGITEATKGYPRLHAPQAQEWGGTMAALIDLDGTLLRLIAN
>AGV79345.1|FEATURES|NCBI|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MIDLDVEIYQHLNEQIKINKLCYLSSGDDSDTFLCNEQYVVKVPKRDSVRFAQKREFELY
RFLENCNLSYQTPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKEL
HSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENISSNAV
IFNYIPCLVHNDFSANNLIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGR
KVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKGVSELLQTQAEMFIF
>WP_033639326.1|FEATURES|NCBI|aminoglycoside|ERS381432_03028|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRHDYVNGCESSPVAFLEGIYTAERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_046687856.1|FEATURES|NCBI|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCLREEHRAEMREILASPHHTAFMARGLDGAFVGFAEI
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKMLG
>WP_048325528.1|FEATURES|NCBI|aminoglycoside|JL05_07470|antibiotic inactivation|1
MIVICDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVECARRQGWATRLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_004937175.1|FEATURES|NCBI|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMHEILASPHHTAFMARGLDGVFVGFAEV
ALRHDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_049189080.1|FEATURES|NCBI|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGVFVGFAEV
ALRHDYVNGCESSPVAFLEGIYTVERARRQGWATRLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_033636082.1|FEATURES|NCBI|aminoglycoside|ERS381446_03540|antibiotic inactivation|1
MIVICDHDNLDAWLALRSALWPSSSPEAHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>CAA02068.1|FEATURES|NCBI|multidrug|ble|antibiotic inactivation|0
MVKFTGAIPVLTAVDVPADVAFWVGTLGFEEDFADEGFAGIHRGDVQLFISRTEHQLVAD
NTSAWVEVLGLDELHAKWSRVLSTDYADTSGPAMTEVTSSPSGREFAVRDPAGNCVHFAA
EH
>YP_001096451.1|FEATURES|NCBI|multidrug|tetC|antibiotic efflux|0
MFLRLSRPHHHDTINILTVCYFKSIMENKNHQQENFKSTYQSLVNSARILFVEKGYQAVS
IDEISGKALVTKGAFYHHFKNKKQLLSACYKQQLIMIDAYITTKTDLTNGWSALESIFEH
YLDYIIDNNKNLIPIQEVMPIIGWNELEKISLEYITGKVNAIVSKLIQENQLKAYDDDVL
KNLLNGWFMHIAIHAKNLKELADKKGQFIAIYRGFLLSLKDK
>WP_058477694.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MSKKTIQEKQLIELLNVHYGLDIHTTQLVLGGADMNAFGYKADSESNSYFVKIKYGFHDE
INLSIIRLLHDSGIKEIIFPIHTLETKLFQQLDHFKLIVYPFIHAANGFTQNLTEKQWKE
LGKVLRQIHETSVPASIQQQLRKETYSGKWREIVRSFYSKIKSDSSDDKITADFKSFFNQ
NIASIHQLVDSAEELSKKIQLDLDKYVLCHSDIHAGNVLVVDEESIYIIDWDEPMLAPKE
RDLMFIGGGVGNVWNKPHEIHYFYEGYGKTNVDKTILSYYRHERIVEDIAVYGQDLLTSA
QSDQSRLESLKHFKSMFEPNDVIEIAFATP
>WP_061692069.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLRNNITDQHLIALLKVYYGIDIHTVQLIVGGADMNAFGYKADSESNSYFVKLKYGHHDE
INLSIIRLLHDSGIKEIIFPIYTRDTKLFQQIDHFKIIVYPFINAPNGFTQNLTEKQWHQ
LGKVLRQIHETSVPTAIQQRLRKETYSPKWREMVRSFYNKIGFDDSDDQITTDFKTFFNQ
KIDSIHRLVDSSEELSKKIQLDLDKYVLCHSDVHAGNVLVVNEESIFIIDWDEPMLAPKE
RDLMFIGGGIGNVWNKPHEIDYFYEGYGKTNVDKIILSYYRHERIVEDIAVYGQDLLSRD
QNNESRLESFKHFKSMFDPNDVVEIAFSSD
>WP_027221672.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLRNNIPDQQLIELLKVYYGIDIHAVQLIVGGADMNASGYKADSESNSYFVKLKYGHHDE
INLSIISLLHNSGVKEIVFPVHTLEAKLFQQVDHFKMIVYPFIDAPDGFTKNLTEKQWKQ
LGKVLRQIHETTVPTSIQQRLRKETYSPKWREMVRSFYSQIGLDESDDQITTDFKSFFNQ
KIDSIHRLVDSSDDLSKKIQPDLDKYVLCHSDVHAGNVLVVNEESIYIIDWDEPMLAPKE
RDLMFIGGGIGNVWNKPHEIDYFYEGYGKTNVDKIILSYYRHERIVEDIAIYGQDLLSRV
QNDESRLESFKHFKSMFDPNDVIEIAFSSD
>WP_027267093.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLRNNIPDQHLIELLKVYYGIDIHTVQLIVGGADMNAFGYKADSESNSYFVKLKYGHHDE
INLSIIRLLHDSGVKEIVFPINTLEANLFQQVDHVKIIVYPFIDAPNGFTKNLTEKQWKQ
LGKILRQLHGTSVPTSIQQRLRKETYSSKWREMVRSFYSQIRFDESDDQITTDFKSFFNQ
NIDSIHQLVNSSEELSKKIQPDFEKYVLCHSDIHAGNVLVVDEESIYIIDWDEPMFAPKE
RDLMFIGGGIGNVWNKHHEIDYFYEGYGTTNVDKIILSYYRHERIVEDIAVYGQDLLSRD
QNDESRLESLKHFKSMFDPNNVVEIALSSD
>NZ_CP023410.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|lnu|antibiotic inactivation|1
MIGINDACEILSWAYNNNIEIWLDGGWGVDALLGKETRQHNDIDLFVEEKNYNKFIEIIK
NKGFNEIVVEYTSEVHTIWSDNKLRIIDLHMFKDNCDGTICYEGEVFQKNIFDGVGKIGN
IMVSCINAKNQVLFHLGYEFGESDIHDVKLLCKEFNIPIPKEYENF
>AAS76334.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
MKNWLFLAIAIFGEVVATSALKSSHGFTKLVPSVVVVAGYGLAFYFLSLALKSIPVGIAY
AVWAGLGIVLVAAIAWIFHGQKLDLWAFVGMGLIVSGVAVLNLLSKVSAH
>WP_031943933.1|FEATURES|NCBI|kasugamycin|AAC(2')-IIb|antibiotic inactivation|1
HWLKTDYRTLFRLCPDGRIERENDPDCSPGPRFWLAGCSEGNVFGVRADVPDDIALKLEE
LASVEPPFTPPAIPKHLERYLSLLGSDGPVTHDLGLIYELPHAQQYPSKARLIGSGSEEG
ESLMQTWAEDRVPEALFELGFREVADFWTPWCAAVVDGEVASIAFAARLADAGAELGLVT
AKAFRGQGFAAAATAGWSRLSALRSRTLFYSTDRDNISSQRVAARLGLRLRGASLRIS
>WP_006898231.1|FEATURES|NCBI|aminoglycoside|LTSEINV_2403|antibiotic inactivation|1
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERDIFYRKRC
>WP_045900228.1|FEATURES|NCBI|aminoglycoside|SG9_1532|antibiotic inactivation|1
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADYLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHLALGFEETERVIFYRKRC
>WP_001748408.1|FEATURES|NCBI|aminoglycoside|SEET0819_14790|antibiotic inactivation|1
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQTEHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKFHQALGFEETERVIFYRKRC
>WP_047622667.1|FEATURES|NCBI|aminoglycoside|aac|antibiotic inactivation|1
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGLAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHLALGFEETKRVIFYRKRC
>WP_023212386.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Iy|antibiotic inactivation|1
MDIRQMNRTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFVAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGKNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_000354866.1|FEATURES|NCBI|aminoglycoside|aac6|antibiotic inactivation|1
MDIRQMNRTHLDHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFVAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGLAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_004308783.1.|FEATURES|NCBI|macrolide-lincosamide-streptogramin|linAn|antibiotic inactivation|1
MTKKEHTTITELFQVLDLLESLDMQFWLDGGWGVDVLYGQQTRLHRDIDIDFDANYTDQL
LDLLQERGYQIETNWLPTRVELYSKELGYIDIHPFVLNADGTSKQADLDGGWYEFQPDYF
GTAVFEGRSIPCISAKGQQVFHSGYDLREKDIHDLSIIKQCITTMSLTIR
>WP_063853729.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mef|antibiotic efflux|1
MNHWKSTLAVIGIGQLISILTSTIVGFSIIFWISNEFKSPTALSLAILAGFLPQFVLGLF
AGVYVDRWNRKKTMFYSDLFIAFCTLCLFIVITKGYKDLSFFYLLTACRSIGSTFHAPAL
QASIPLLVPKHHLVRVSGLYHSIQSFSEVIAPVVGASLVVWLPIQYILLIDVIGAVAACL
TLLCVQIPSLQKTKVLPDFKKELTEWLHTLRRTMGILPLFVCFTLVTFVLMPVFTLFPFM
TLLHFNGNILQMGVVEMGWGSGALLGGLVLACKALKSKQTLVMHTAYVILGLYLISASYL
PSSAFIGFVCLTFTGGIAYSIYHALFIAIIQQNLASDMLGRTFSLIFSLSTFPSMLGIVA
SGYWVEAWGITSVFMISGWVIFLIGVGANFISSIKQLDNYA
>WP_030945209.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|carA|antibiotic target protection|1
MSTAQLALHDITKRYQDHAVLDRVGFTIRPGEKVGVIGDNGSGKSTLVKLIAGREQPDNG
TLTVVAPGGVGYLAQTLELPPESTVQDAVDLALADLRELEAGMRRTEAQLAERPYEVGQA
GQQDAGLAALLENYAALVDQYQARGGYEADSRVEIALHGLGLPGLERDRRLGTLSGGERS
RLALAATLAAEPELLLLDEPTNDLDDGAVGWLEEHLRGHRGTVVAVTHDRLFLDRLTTTI
LEVDSGRVARYGNGYAGYLAAKAAERERRLLEYERWRAELDRSRDLIASNVARLDNIPRK
LPLAVFGAGGFRTRGRGHGAMVRIRNAKERVARLTENPVAPPPEPLAFTAEITTEAAAQP
QETVAELTDVGVGDRLTVDSLRLVPGERLLITGPNGAGKTTLLRILAGELAPDSGTVRVS
GRVGHLRQDQVPWPEGLTVLQAFGDGRVGDLDEHTEALLSLGLFSPDDLRRRVEDLSYGQ
RRRIELARLVTEPVDLLLLDEPTNHLSPALVEELEEALTDYQGAVAVVTHDRRMRSRFSG
SHLTLRDGRVAEFSGG
>WP_031875417.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|0
MANKQVEISMAEWDVMNIIWDKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
YKSENIYFYSSNIKEDDIKMKTAKTFLNKMYGGDMKSLVLNFAKNEELNNKEIEELRDIL
NDISKK
>WP_001284656.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|0
MANKQVEISMAEWDVMNIIWGKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
YKSENIYFYSSNIKEDDIKMKTAKTFLNKLYGGDMKSLVLNFAKNEELNNKEIEELRDIL
NDISKK
>CNC13957.1|FEATURES|NCBI|glycopeptide|VanI|antibiotic target alteration|1
MDRLKIAIIFGGCSEEHPVSVKSAGEVAKNLDLDKYEPFYIGITKNGVWQLCRYPEANWE
NGICPSVILSPDRSLQGLLVLEQGQYKTIPLDLVFPVLHGKFGEDGAVQGLLELSGIPYV
GCDIPSSALCMDKSLAYIVAGNAGIATPKFRTVTAKEAIDAERLAYPVYVKPARSGSSFG
VTKVCRQEELLSAVAIASQYDSKVLIEEAVIGTEVGCAIFGNDLDLMAGEVDQIRLSHGF
FRIHQENEPEKGSENSTLIVPADISPQARSRVQETAKAIYRALGCKGLARVDMFLKEDGE
VILNEVNTLPGMTSYSRFPRMMAAAGLPFAEVIDRLVSLALQ
>ABX79430.1|FEATURES|NCBI|glycopeptide|vanC|antibiotic target alteration|1
KKIAIIFGGNSPEYTVSLASATSAIEALQSSPYDYDLSLIGIAPDAMDWYLYTGELENIR
QDTWLLDTKHKQKIQPLFEGNGFWLSEEQQTLVPDVLFPIMHGKYGEDGSIQGLFELMKL
PYVGCGVAGSALCMNKWLLHQAAAAIGVQSAPTILLTNQANQQEQIEAFIQTHGFPVFFK
PNEAGSSKGITKVTCVEEIASALKEAFTYCSAVLLQKNIAGVEIGCGILGNDSLTVGACD
AISLVDGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYRSLGLKGLARIDFFVT
DQGELYLNEINTMPGFTSHSRYPAMMAAVGLSYQELLQKLLVLAKEE
>ABX79422.1|FEATURES|NCBI|glycopeptide|vanC|antibiotic target alteration|1
KKIAIIFGGNSSEYTVSLASATSAIEALQSSPYDYDLSLIGIAPDAMDWYLYTGELENIR
QDTWLLDTKHTQKIQPLFEENGFWLSEAQQTLVPDVLFPIMHGKYGEDGSIQGLFELMKL
PYVGCGVAASALCMNKWLLHQAAAAIGVQSAPTILLTNQDNQQQQIEAFIQTHGFPVFFK
PNEAGSSKGITKVTCVEEIAPALKEAFAYCSAVLLQKNIAGVEIGCGILGNDSLTVGACD
AISLVEGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYHSLGLKGLARIDFFVT
DQGELYLNEINTMPGFTSHSRYPAMMAAIGLSYQELLQKLLVLAKEE
>WP_046930149.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELHGDKVVLRPVTDGDTEILERVVREPEVAAWWSPPDDYEGMLAVVFEGEVIGAVQFDEE
TDPEFRHAGIDIFLTARRHGKGLGADTVRTLARWLVQERGHHRLTIDPAAANTAAIRCYS
KVGFKPVGIMRAYGRDHRTGAWQDGLLMDLLADELS
>WP_053638058.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
RLHGNQVVLRAVTESDIGTLDRIVREPEVAAWWSPPEDYGGMLAVVFEGEVVGAVQFHEE
TDPEFRHAGIDIFLTARQHGKGLGTDTVRTLARWLVEERGHHRLTIDPAAANTAAIRCYA
GVGFKPVGIMRAYARDHRTGTWQDGLLMDLLAAELT
>WP_030403494.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
RLHGNQVVLRAVTGSDIGTLDRIVREPEVAAWWSPPEDYGGMLAVVFEGEVVGAVQFHEE
TDPEFRHAGIDIFLTARQHGKGLGTDTVRTLARWLVEERGHHRLTIDPAAANTAAIRCYA
GVGFKPVGIMRAYARDHRTGTWQDGLLMDLLAAELT
>WP_029391459.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib-SK|antibiotic inactivation|1
ELHGEKVVLRPVEDSETETLDRIVREPEVAAWWSPPNGYENTFAVFLDDEIIGAVQFTEE
SDPEYRHAGIDVFLTARRTGAGLGTDTVRTLARWLLDDRGHHRLTIDPAAENAPAIASYR
KVGFQPVGVLRRYWRDHQTGEWRDGLLMDLLADELT
>WP_018893623.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGERVLLRSTTPADTAALDRIVREPEVALWWPPPEGYARMLAVVVDGEVIGAIQFSEE
TDPEFRHAGIDLFLSARWHGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANTYAVRSYR
KVGFAPVGIMRAYWRDHRTGEWEDGLLMDLLAAELT
>WP_017000318.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphC|antibiotic inactivation|1
MTQHNEIIKCAEKYQLHIQPQTISVNESGLDFQVAFGEDEQGVEWVLRLPRRPDVYKRTK
SEKQTVDFLQNNVSFEVPKWKVHEKDLIAYPKLTGKPAATIDPQIQNYVWEIEHKPVPEN
FVNTLAETLVDLHNIPEENITAHHINIKTIQEIRNDFQRRMNKVKETYGVADELWNRWQQ
WLENDELWPQHATMIHGDLHPGHIMVDNEANVTGLIDWTEATHSDPSMDFMGHHRVFGDE
GLEQLITSYDKAGGETWPRMKEHILELNAVFPMFIAEFAMESGEAAYEKMALKELGMEE
>WP_031921728.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|0
MDNKTYEISSAEREVMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>WP_000417520.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>WP_000417518.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGFLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>KGF31920.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLSGGLLLGRLGGFEKHVLLITSSFFLMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>ACG58974.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGDRVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMDYFNGTPVHISITEISFASGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNYWFLLSGVLIIGIAIACPMITEVRKLDLK
>AAQ62547.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSLASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAASSVLTIVALYMELPVWMVMIVLFIRSIGTAFHN
PALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPALAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNPVQSLEPNFIREMREGIVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFAERIGVNDWFLLSGVLIIGIAIACPMITEVRKLDLK
>CDG57849.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAVAGAVLAIVALFTELSVWMVMVVLFIRSIGTAFHS
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIISPAAAALLYSVWKLNAIIAIDVLGAVI
ASITVAIVSIPKLGDQVQSLKPNFLREMKEGIVALRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEIAFASGMLVGGLLLGRLRNFEKRVLLITGSFFIMGASLA
VSGLLPPSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSFAMP
IGLILSGFYADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK
>ABE02098.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPVWIVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGDQVQSLEPNFIREMKEGIVVMRQNKGLFALLLLGTLYTFVYMPINA
LYPLISMEYFNGTPMHISITEIAFASGMLAGGLILGRLGSYEKRVPLITGSFFMMGASLA
IAGLLPPSGFIIFVVCCAIMGLSVPFYSGVQTALFQQKIKPEYLGRVFSFTGSIMSLAMP
LGLILSGFFADRIGINHWFLISGILIIGIAIVCPMMTEVRKLDLK
>WP_000163435.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|0
MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_063854491.1|FEATURES|NCBI|nitroimidazole|nimC|antibiotic inactivation|1
MFRAMRPKRHELPTDESVGILKRMTNGTLALHGDGDYPYAVPVSYVYSDGRIYFHTATQG
HKVDALMRNDKVSFCVVEQDDVKSAEFTTYFRSVIPFGRARILTDETENGAALQLLADKY
SSGMPGLEAVIAKGFRHLLMVEIDIEHLTGKES
>WP_025091335.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MRKSTTLLIGFLAGSAVIPASGALAAGTINDDELRRIVDETVRPLMAGQKIPGMGVAISI
DGKSHFFGYGVASKESGQKVDKDTIFEIGSISKTFTATLGGYGLATGAFSPSDPATRWAP
ELAGSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFRKWKPDYPAGAQRRYSNPS
IGLFGYLAARSMGQPFDVLMEQKLLPAFGLKNTFVHVPESRMKDYAYGYAKADKPTRVAS
GTRDAEAYGIKTTAPDLLRFVELNIDSASLAPDFQKAVAATHTGYYRVGANNQGLGWEIY
TYPVTLKTLLAGNSSDMTLKSHKIEKFDPPHAPSADMFINKTGSTKGFGAYAAFVPAKKT
GIVLLANRNYPNDERIKAAYRILQAIDKSE
>ACN22662.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLAIAIVGEVIATFALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLRGQKLDAWGFVGMGLIVSGVVVLN
>WP_053276349.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAYYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>AAO15536.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVPKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>CAE81271.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
MKNWLFLATAIIFEVIATSALKSSEGFTRLVPSFIVVAGYAAAFYFLSLTLKSIPVGIAY
AVWSGLGIVLVTAIAWVLHGQKLDMWGFVGVGFIISGVAVLNLLSKASVH
>AGX26873.1|FEATURES|NCBI|multidrug|ykkD|antibiotic efflux|0
MGWIYLILAGVFEVGWPVGLKMAQTPETRWSGIGVAVAFMTVSGFLLWLAQRQIPIGTAY
AVWTGIGAAGTFFVGVLYYGDPTSFFRYMGVALIIAGVITLKLAH
>WP_004202660.1|FEATURES|NCBI|beta_lactam|bla|antibiotic inactivation|1
MNHSPLRRSLLVAAISTPLIGACAPLRGQAKNVAAAERQLRELESTFDGRLGFVALDTAT
GARIAHRGDERFPFCSTSKMMLCAAVLARSAGEPALLQRRIAYAKGDLIRYSPITEQHVG
AGMSVAELCAATLQYSDNTAANLLIALLGGPQTVTAYARSIGDATFRLDRREPELNTALP
GDERDTTTPAAMAASVHRLLVGDALGAAQRAQLNAWMLGNKTGDARIRAGVPADWRVADK
TGTGDYGTANDIGVAYPPNRAPIVFIVYTTMRNPNAQARDDVIASATRIAARAFA
>WP_025123646.1|FEATURES|NCBI|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MVKNTLRQTTLMVAAVMPLLFGSASVWAQPANAKNTIQQQLADLEKSSGGRLGVALIDTA
DNSQILYRADERFAMCSTSKVMAVSALLKQSETDKNLLDRRMAIKQSDLVNYNPIAEKHL
DTGMTLGEFSAATIQYSDNTAMNKILEHLGGPAKVTTFARSIGDKTFRLDRTEPTLNTAI
PGDERDTTSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPAKWIVGD
KTGSGDYGTTNDIAVIWPSNNAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGF
>WP_007698054.1|FEATURES|NCBI|fosfomycin|FosA4|antibiotic inactivation|1
LSGLNHLTLAVRDVARSLAFYRTLPGLRLHARWDGGAYLSCGDLWLCLSLDDNAGQPARD
YTHYAFTVSEADFPQVVDTLTAAGVKIWKTNRSEGDSWYFLDPDGHQLELHVGSLATRLA
ACRTRPYRGMTFFD
>ACL98099.1|FEATURES|NCBI|streptothricin|sat-1|antibiotic inactivation|0
MKISVIPEQVAETLDAENHFIVREVFDVHLSDQGFELSTRSVRPFRKDYISDDDSDEDSA
CYGAFIDQELVGKIELNSTWNDLASIEHIVVSHTHRGKGVAHSLIEFAKKWALSRQLLGI
RLETQTNNVPACNLYAKCGFSLGGIDLFTYKTRPQVSNETAMYWYWFSGAQDDA
>BAD10981.1|FEATURES|NCBI|streptothricin|sat-1|antibiotic inactivation|0
MKISVIPEQVAETLDAENHFIVREVFDVHLSDKGFELSTRSVSPYQNDYISDDDSDEDSA
CYGAFIDQELVGKIELNSTWNDLASIEHIVVSHTHRGKGVAHSLIEFAKKWALSRQLLGI
RLETQTNNVPACNLYAKCGFTLGGIDLFTYKTRPQVSNETAMYWYWFSGAQDDA
>WP_007782418.1|FEATURES|NCBI|glycopeptide|SCO3595|antibiotic target alteration|1
MDKLKIAIIFGGCSEEHPISVKSAQEVAKNLDLEKYEPFYIGITKNGVWKLCPRPEANWE
KGSCRSVMLSPDRSVHGLLVLEQGQYKTIPLDMVFPVLHGKLGEDGAMQGLLELSGIPYA
GCDVQSSALCMDKSLAYIVAGKAGIATPNFRTVTAKGTIDADGLTYPVFVKPARSGSSFG
VSKVCRKEELLSAVAIARQYDSKVLIEEAVAGSEVGCAILGNDPDLMAGEVDQISLSYGF
FRIHQENEPEKGSENSTFIVPADISAEARLQVQETAKAVYRALGCRGLARVDMFLKEDGK
VILNEVNTLPGMTSYSRYPRMVAAAGLSFAEVIDRIVALTL
>WP_015943583.1|FEATURES|NCBI|glycopeptide|SCO3595|antibiotic target alteration|1
MSKLKIAIIFGGCSEEHPVSVKSAGEVAKNLDLEKYEPFYIGITKDGVWQLCHYPEANWE
KGSCRPAILSPDRSVQGLLVLEQGQYQRIPLDLVFPVLHGKFGEDGAIQGLLELSGIPYV
GCDIPSSALCMDKSLAYIVAGKAGIATPKFRTVTAKETIDAERLAYPVYVKPARSGSSFG
VTKVCRQEELLSAVEIARQYDSKVLIEEAVVGSEVGCAIFGNDLDLMAGEVDQICLSHGF
FRIHQENEPEKGSENSTLIVPADISPEARSRVQETAKAIYRALGCRGLARVDMFLKEDGT
VILNEVNTLPGMTSYSRFPRMMAAAGLPFAEVIDRLVSLAF
>WP_003126779.1|FEATURES|NCBI|glycopeptide|vanXYC|antibiotic target alteration|1
TLQLINKNHPLKKNQEPPHLVLAPFSDHDVYLQPEVAKQWERLVRATGLEKDIRLVDGYR
TEKEQRRLWEYSLKENGLAYTKQFVALPGCSEHQIGLAIDVGLKKQEDDDLICPHFRDSA
AADLFMQQMMNYGFILRYPEDKQEITGISYEPWHFRYVGLPHSQVITAQKWTLEEYHDYL
>CPR17499.1|FEATURES|NCBI|multidrug|emrB|antibiotic efflux|1
RKPLKGASLAWMTVALSLATFMQVLDSTIANVAIPTIAGNLGASNSQGTWVITSFGVANA
ISIPITGWLAKRFGEVRLFLLSTALFAFTSWMCGISSSLEMLIFARVLQGIVAGPLIPLS
QSLLLNNYPPARRSIALALWSMTVVVAPICGPILGGWISDNYHWGWIFFINVPLGVAVVV
ITLQTLRGRETKTEIKPIDTVGLALLIVGIGSLQMMLDRGKELDWFNSNEIIILTVIAVI
TLTFLIVWELTDDHPVVDLSLFKSRNFTIGCLCLSLAYMFYFGAIVLLPQLLQEVYGYTA
TWAGLASAPVGLMPVVLSPIIGRFAPRLDMRQLVTFSFIMYAVCFYWRAYTFEPGMDFGA
SAWPQFVQGFAVACFFMPLTTITLSGLPPERMAAASSLSNFTRTLAGSIGTSITTTLWAQ
RESLHHAHLTESITPYNPQAQEAYQQLQQTLGMSQSQASSYIASEITAQGLIISANEIFW
AAAAVFLMLLVLVWFARPPFTS
>WP_034610906.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
LNAQQALTDAPPMSLFESWNTPIEPFKIFNHVYYVGTENLSSVLFDTGDGLVLIDSGIDQ
SAVQIKANIEKLGFKITDVKYLLNSHARLDQAGGFAKLKQWSGAQLVASAANAEMLENGG
VTDFALGKQLPFPSVAVDIIIKDGQQLKLGRQIFTAHATPGHLPGATSWTTDIRYHFKNY
KVIYADSLFTGGYYLLNNNNYPNLVSDIRHTFKTLDAIHADIFLANKADRFHMKQKLAKL
NAGDKKAFIDQTGLQNYVAKGRIEFEQQLQ
>WP_048233629.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFKDPASHYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LGQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAKSYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVQLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIIQALEKR
>WP_004621313.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MPANWTKPTRPYRVVGNIYYVGTEGISSWLIVSSEGHVLLDAGPNAEVGKQIERNITALG
FQLTDVKVLINTHAHYDHAGGFAQLKADIPTAKLWISRGDAPAIEQGHHIGDNENGPTPM
PPVKVDKTFGDGAKLKLGETALIAHLTPGHTIGCTSWTTAVIERGRPLNVTFPCSLSVAG
NVLVGNKTHRNIVADYRQSFVKLRAIPTDVMLPAHEEQGDLLAKRRKQLRGDPNAFVDPT
ELGRFVDASEAAFNQELARQQAA
>WP_041538501.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGHVILDGGPNAETGKQIERNIASLG
FQLADVKFLINTHAHYDHAGGLAQLKADIPAAKLWISRGDEPAIEQGHHIGDNENGPTPM
PAVKVDRAFGDGQKLKLGETSLVAHLTPGHTIGCTTWTTAVIEKGRPLNVTFPCSLSVAG
NMLVGNKGHKTIVADYRASFATMRAIPTDVVLPSHEEQGDLLAKRQKQLRGDPNAFVDPT
EMGRFVDGYEAAFNKGLARQQGV
>AKI29916|FEATURES|NCBI|beta_lactam|blaOXA-451|antibiotic inactivation|1
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIVLDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKK
>AKI29914|FEATURES|NCBI|beta_lactam|blaOXA-450|antibiotic inactivation|1
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRTMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKK
>ENU64030|FEATURES|NCBI|beta_lactam|blaOXA-282|antibiotic inactivation|1
MKILILLPLLSCLGLTACSLPVSSLLSQSTSTQSTQAIAQLFDQAQSAGVLVIQRGQQIQ
VYGNDLSRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGEA
MQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVS
ALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIV
AFSLNMQMQNGIDPAIRLEILQQALAELGLYPKAEG
>ENX16434|FEATURES|NCBI|beta_lactam|blaOXA-284|antibiotic inactivation|1
MKTLIFLPLLNCLSLTACTLPVSSSPSHITSTQSTQAIAQLFDQAQSSGVLVIQRGQQIQ
VYGNDLSRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFSAWEKDMTLGEA
MQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKITPKQEVEFVS
ALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIV
AFSLNMQMQNGIDPAIRLEILQQALAELGLYPKAEG
>ADC79563.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALVMAQTALAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKAEAAFDAQLKKQRGG
>WP_036471842.1|FEATURES|NCBI|beta_lactam|MUS-1|antibiotic inactivation|1
MRKILSAITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSCNSMYVLTDEGV
ILIDTPWDKDQYEPLVDYIRTNHNKEIKWVITTHFHEDRSGGLGYFNSIGAQTYTYALTN
KILKERNEPQAQHSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKS
AEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMTGHIENTERILSAYNQQ
HSTKND
>WP_041894747.1|FEATURES|NCBI|beta_lactam|MUS-1|antibiotic inactivation|1
MRKILSSIAMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSCNSMYVLTDEGV
ILIDTPWDKDQYEPLVEYIRTNHNKEIKWVITTHFHEDRSGGLGYFNSTGAQTYTYALTN
KILKERNEPQAQHSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFLKEEVLFGGCLIKS
AEATTLGNISDSDVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMTGHIENTERILSEYNQQ
HSTKND
>WP_034707448.1|FEATURES|NCBI|beta_lactam|TLA-2|antibiotic inactivation|1
MKKIGLFFLLISSLAVAQKSALEQKINSITEGKKATVGISVLGFENNFKYSKNGDQKLPM
LSVFKFHIAAAALDLVDKGKLSLDQKVFVSKTDLKEKTWSPFREKYPAGNIEVTLNEVID
YTVALSDNNLCDLLLKLIGGTKKVQQFMDSKGVKDFQIRYNEQEMHEKNWKSLYENYTTP
NSAAQVLKKFYDGKLLSKKSTDYLMKIMTGTKTGTNKIIEQLPKNTPTAHKTGSSGKNDN
GLTIAENDIGIITLPNGKHYAIAVFVSNSTEADAVNCKMVSDISKAVWDDFNK
>WP_019542800.1|FEATURES|NCBI|beta_lactam||antibiotic inactivation|1
MKKFCFLFLIICGLMVFCLQDCQARQKLNLADLENKYNAVIGVYAVDMENGKKICYKPDT
RFSYCSTLKVFTAAELLRQKNTSDLNEIRKFSAEDILSYAPITKDHVADGMTLAEICSAS
LRWSDNTAANLILQEIGGVENFKVALKNIGDKTTKPARNEPELNLFNPKDNRDTSTPRQM
VKNLQVYIFGDILSDDKKKLLIDWMSDNSITDTLIKAETPQGWKVIDKSGSGDYGARNDI
AVIYPPNRKPIVMAIMSRRTEKNAKSDDAMIAEAAKRIFDNLVF
>WP_048787200.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDITRDEILNTFNSRDTTIRSNVE
KLMNVQLTKEQAQKILTTIQMYVKPFEHPSKKQVTNLFKKVKKLKTPLISDEVLQTSTYI
GWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKGFCSICNKESRVALFMRKTRTGNDGQ
YTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ
>WP_041079788.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDVTRDEILSTFNSRDTTIRSNVE
KLMNVQLTKEQAQKILTTIQMYVKPFEHPSNKQVTNLFKKVKKLKTPLISDEVLQTSTYI
GWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKGFCSICNKESRVALFMRKTRTGNDGQ
YTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ
>WP_002484106.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDVTRDEILSTFNSRDNTIRSNVE
KLMNVQLTKEQAQKILTTIQMYVKPFEHPSNKQVTNLFKKVKKLKTPLISDEVLQTSTYI
GWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKGFCSICNKESRVALFMRKTRTGNDGQ
YTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ
>WP_011094382.1|FEATURES|NCBI|beta_lactam|BJP-1|antibiotic inactivation|1
ATAHTLPSQGTETKGAETNSPAITSLTGCGPSSAINQFFNQFGSSGKMPAELGRWLNDAK
AQAVEPYQVFDNVYYVGICWVSAWLIKTSEGPVLIDTLYGEFTDQLMDNIKKIGVEPSDI
KMVLLTHGHFDHVGGVSKLKSLTNARFVMSEEGWKEAQADAKKTLGKPSAWAMPDPATTD
ILVKDGDALTVGDTTFHAYITPGHTWGTTSYVLDVKERNNTYHAITIGGLGLNAIDGPQQ
VEAYIRSIDRIKVMVEDSKHPITVHLTAHPFSNGQIEMQNQLKVHQPDQPHPMVDAKGLL
KQLATLRAGAIERLAVEQAR
>WP_048689629.1|FEATURES|NCBI|tetracycline|tetA(46)|antibiotic efflux|1
MIRAIWEYIRERKWRYVKIAMVLILYDYTLLIPTQVIQRLVDHLSQQTLTQSNFVWDMVL
LVGSAILNYLTAFYWQLRLFQSSIHFKSTLQEQAFRKLVAMRRPFFEKFRSGDLLTRFTT
DVDGMADMAGYGMMIILYGGGLFTFIILAMFFLSWQLTLICFIPMIFLVVSTYFLSKKQE
DYIEQNREAVAQLNDEVLESIEGIRVMRAYSRREQQVKQFQTKTASLAKTGDKIASIQYS
FGPLALLFIGVSTVLLLVFGGQSLASGQLSLGKLLALQLYLVFLVEPMWMLSDFILVYQT
GQMSFKKLKEVIDETDDLEPDGPHYLTQIDSVEFKDYSFRYPGAERKSLSGIYWTVQKGQ
TVGIVGRTGSGKTTLIRQFLRQYPVGEGGFLINQQPVVAYNRRSIEDKIGYVSQEHILFS
KSIRDNIALGKNGASDEDIVEAVAQAAFADDLERMSQGMDTMIGEKGVSVSGGQKQRISL
ARAFLRDADLLLLDDSLSAVDAKTEQAIIDTIQKERKDKTTIIVSHRLSAVHQADWIIVL
DQGQIVEEGRACDLLAQEGWYYEQYQRQQKQEGE
>CQD12588.1|FEATURES|NCBI|aminoglycoside|GLE_1155|antibiotic inactivation|1
MTTTNEIRVAEVADAGVVAKLLRDFNTEFDTPVPEGLEERFAQIIAHDDAFVLLAGDIGF
AYVTLRPSPYYDGPVAMLDELYVAPAHRNRGVGTALLQRVFEEIRKHSAGELQINVDEVD
TDARRFYERHGLTNIEQGSRMLLYIREL
>CAA37050.1|FEATURES|NCBI|bacitracin|uppP2|antibiotic inactivation|0
MAKLTSAVPVLTARDVAGAVEFWTDRLGFSRDFVEDDFAGVVRDDVTLFISAVQDQVVPD
NTLAWVWVRGLDELYAEWSEVVSTNFRDASGPAMTEIGEQPWGREFALRDPAGNCVHFVA
EEQD
>AAA98399|FEATURES|NCBI|fosfomycin|fosA|antibiotic inactivation|1
MLQSLNHLTLAVSDLQKSVTFWHELLGLTLHARWNTGAYLTCGDLWVCLSYDEARQYVPP
QESDYTHYAFTVAEEDFEPLSQRLEQAGVTIWKQNKSEGASFYFLDPDGHKLELHVGSLA
ARLAACREKPYAGMVF
>ALQ43092.1|FEATURES|NCBI|beta_lactam|OXA-85|antibiotic inactivation|1
MKKFILVMLLFMFSIISFGNENQFMKEIFERKGLNGTFVVYDLKNDKIDYYNLDRANERF
YPASSFKIFNTLIGLENGIVKNVDEMFYYYDGSKVFLDSWAKDSNLRYAIKVSQVPAYKK
LARELGKERMQEGLNKLNYGNKEIGSEIDKFWLEGPLKISAMEQVKLLNLLSQSKLPFKL
ENQEQVKDITILEKKDDFILHGKTGWATDNIVVPIGWFVGWIETSDNIYSFAINLDISDS
KFLPKREEVVREYFKNINVIK
>WP_041628446.1|FEATURES|NCBI|multidrug|msbA|antibiotic efflux|0
MKTYSWFVPPVPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGSGIAAFV
PVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLS
SGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAVCAMVAMWSVSPWISL
AIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVATR
FHAETAKAKRLMLTHLRVEVWLGFARFCVAWLCNLGIVGLSAWMTLRGEITPGQLTSVAL
LVQPALTMAGLAFGDLASGWGRAVASGQRIEQLHHAGDDTAGPELTDTPVPGAGLWILEP
EERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILR
RLGGINEAGELPNAPLGETGLNLSGGQRQRVALARALAADPDVLILDDPTTGLDSVTQAD
VVEAVAALRADKTTVVITGNAAWQHAGTALEVA
>WP_034998978.1|FEATURES|NCBI|multidrug|msbA|antibiotic efflux|0
MKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSFLIGSGIAAFA
PVVVGMIVDGLVGEEKFNAWWLFGVLVGIFIIQFAGEATGDGLAAASVRRVTHNAQQHLS
SGVLRRGAGAMSPGTVLNTIDADANTIGRYRELLSFPLMAIGYAAGAIVAMWTVSPWVSL
AIPVSALVIALFAAWTAGPVTRVSLKRRAAEADVASLATDTSQGLRTVKGLGAGGTVAHR
FHTETAKAKRLMLTHLRVEVWLGFARLCVAWLCNLGIVGLAAWMTLRGEITPGQLTSVAL
LVPPALNMAGFAFGDLASGWGRAVASGQRIQQLHHAGDDTAGPEPTDTPVPGAGLWILEP
AERSYATAVAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDAVKQALAAAHCQDILR
RLGGIGENGELPDAPLGEAGLNLSGGQRQRVALARALAADPEVLILDDPTTGLDSVTQAD
VVEAVAVLRADKTTVVITGNSAWQHAGTALEVA
>KGT10052.1|FEATURES|NCBI|beta_lactam|TLA-3|antibiotic inactivation|1
MKRISIIFLFLSLFVFSQNSKPELLEKINTITKDKKATVAVSVLGIENDFQFSNANGNLK
MPMLSVFKFHIALAVLNQVDKGNLTLDQKILIKKSDLLENTWSPLREKYPDGNVELPLSE
IITYTVAQSDNNGCDILLRLIGGTKTVQKLMDVNGVKNFQIKYNEEEMHKNDVKTLYANY
TTTASMVKTLKAFYKGMFLSKRSTIFLMDIMTKTNTGMSKLPGLLPKVRMARKTGSSGKM
KNGLTIAENDSGIVTLANGKHYAIAVFVKDSMESEEVNCGIIAQVSKIVWDALNKKNKP
>ZP_09907955.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
PTLLPPAPRYLVPQSALTSVRNPKEIEEETGGRMGIALVDREGALILGFNRDDRFAMCST
FKAPLAAAVLIGAQGGKFGLEGEIPFTKDDILDYAPVVKKNKKRGRMSMAELAAAAVEVS
DNSAANLLLPMLGGPEGLTSFIRAHGDKITRLDRIEPDLNENIAGDPRDTTSPAAMAGLM
GRLLFRDMAAADADRLRGWLNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSP
AGEEYILAIYLDRPTVDDKKAEAAIAEAAHSALEFVSKAQKSGLN
>ZP_10541948.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
PTQLPPAPRYLVPQSALTSVRNPKEIEEETGGRMGIALVDRDGALILGFNRDDRFAMCST
FKAPLAAAVLIGAEGGKFGLDGEIPFTKDDILDYAPVVKKNRKRGRMSMAELAQAAVEVS
DNSAANLLLPMLGGPEGLTAFMRAHGDKITRLDRNEPALNENIEGDGRDTTSPAAMAGLM
SRLLFRDMQAADADRLRGWLNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKAP
SGEEYILAIYLDRPTVDQKAAEAAIAEAAHSALEFVSKAKKSGLD
>WP_003015518.1|FEATURES|NCBI|beta_lactam|blaA|antibiotic inactivation|1
MRLLVTTLSLIPSIILAAPQLDDSFKNLENKYDGKIGIYTLNTDDKTNIKYNESYHFPIC
SVFKFLLVGAILDYDMHNQGFLDKKIPINQDDIGKLGYAPITAKNVGKTLTISQLNYAAI
LSDSPASNILVRELGGLQNLNKFIKKLGDNDTIITADEPEINYTQPHSNINKITPKAITK
DIYKLAFGNILDKKHKDIFIKYLQDNNTGANRIAFGMPKDWIIGDKTGTCGQYAATNDVA
IIWPKNQQPIALGILYTNPNDKNAPSNEEIIQQAAKLIANDLTNTYK
>WP_003034156.1|FEATURES|NCBI|beta_lactam|blaA|antibiotic inactivation|1
MRILVTTLSLIPTIILAGPLLNDSFKSLENKYDGKIGIYTLNTDDKTNIKYNESYHFPIC
SVFKFLLVGAILDYDMHNQGFLDKKIPITQDDIGKLGYAPITAKNVGKTLTISQLNYAAI
LSDNPAANILVRELGGLQSLDKFIKKLGDNDTIITADEPEVNYTQPHSNINKTTPKAITK
DIYKLAFGNILDKKHKDIFIKYLQDNNTGTNRIAFSMPKDWIIGDKTGTCGQYAATNDVA
IIWPKNQQPIALGILYTNPNDKNAPSNEEIIQQAAKLIANNLTNTYK
>WP_002415370.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIDIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
PNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>WP_009040233.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|EreB|antibiotic inactivation|1
MKNIKPLTFPFNSENNTSIKQSLFRFREYFDSSTIVGLGENAHFIKEFFTFRHQVIEFLV
TECDFDTLAFEFGFSEGLEVDKWIKSQIPFDDLDKLLSHFYYPNEFKDTLLWLRRYNQDN
NNQITFLGVDIPKNGGSYFPNFRIVSDYLQRLSIVSSDVLQKILNLAEKFDFYSTSQLAL
NLSLFDEAEHNELKALLLKVYIRLITLQPKLESLEFQSIVHQVKGLIYMNYNADAMESFI
TERGIEGDMGAKDQYMAESIDWFLKNSLGKKIILVAHNAHIQKTPVDFDGFISCYPMGQR
LSMTFGEKYKAFAITNLRGETAALYPDNDYQFGFRVDKFPLDFPESDSVEFIMQEFGGKE
CCLLMNRSTELKNCNKIRFDSMCLKTEIEEAFDGIFLIEKSTVSEVVD
>WP_032865068.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSKKLKCLALFTAVFFAIPMTACQSFSQQKQQFSTQKNEQQQISSLFQSAQTSGVLMIYD
GKKIQSYGNDLDRAEQRYIPASTFKMLNALIGIQHHKTTPDEVFKWDGKKRAFSSWEKDL
TLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPIEE
VRFAYALAKQKLPFDQPTQQQVKAMLLVDQIQGTKIYAKSGWGMDVSPQVGWWTGWIEQP
NGKITAFSLNMQMSQPEHADARKVIVYQALQELGLLAH
>ENX18112.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSKKLKCLALLTPCILILQLTACQSVSQQKQQLSTQTNEQQQISSLFQSAQTKGVLVIYD
GKKIQSYGNDLNRAEQRYIPASTFKILNALIGIQYHKTTPNEVFKWDGKKRTFSSWEKDL
SLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLQITPVEE
VRFVYALAKQKLPFDQSTQQQVKGMLLADERQGTKIYAKSGWGMDVSPQVGWWTGWIEQP
NGKTIAFSLNMQMSQPEHANARKVIVYQALQELGLLAN
>WP_032879257.1|FEATURES|NCBI|beta_lactam|F889_02977|antibiotic inactivation|1
MSKKLKCLALLTPLILILPLTACQSPSQKKQQVVSLQNEQQRVANLFQQAQTTGVLVIYD
GKQIQTYGNATRRADQRFIPASTFKILNALIGIQHHKTTPNEVFKWDGQKRAFSSWEKDL
SLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKHIGTQVDNFWLVGPLKITPVEE
VRFVYALAKQKLPFDQSTQQQVKDMLLVDEHQGTKIYAKSGWGMDVTPQVGWWTGWIEQP
NGKIIAFSLNMQMSQPAHADARKVIVYQALQELGLLAN
>WP_000175803|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|1
MTLSIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
AQRATLMQELLALSSPPGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDMVLLITQILETSIPLKGERAERLFTPAPAAQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAATLRAAQREYLGLEQQDWH
ILLPAVVRFVDFAKAHIPTQFT
>WP_052970651.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|1
MTLPIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
TQRATLMQELLALSSPPGASAEKRALEVTVVLYSQLVPWCFPPAREMQFGEWLREDICQG
IYEPAQQDWDILLLITQILETSIPLKGERAERLFTPAPVAQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAATLRAAQREYLGLEQQDWH
ILLPAVVRFVDFAKAHIPTQFT
>WP_023214503.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|1
MTLSIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
TQRAMLMQELLALSSPPGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDMVLLITQILETSIPLKGERAERLFTPAPAAQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGKFTSKDAAADWLLPQLPEEYAATLRAAQREYLGLEQKDWH
ILLPAVVRFVDFAKTHIPTQFT
>WP_000171874|FEATURES|NCBI|aminoglycoside|AADA2|antibiotic inactivation|1
MTLFKPPSIQRQTDAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTIGQPLTE
VQRATLMQELLALSSPSGASAETRALEVTVVLYSQLAPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAEQLFTPVPTAQLLKALRYPLDLWQSAADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAATLRAAQREYLGLEKKDWH
ILLPTVVRFVDFAKAHIPTQFT
>WP_000175809|FEATURES|NCBI|aminoglycoside|aadA9|antibiotic inactivation|1
MTLSIPPSIQRQTDAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTIDQPLTE
AQRATLMQELLALSSPSGASAETRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPVPAAQLLKALRDPLDLWQSAADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPVDYAATLHAAQREYLGLEKKDWH
ILLPAVVRFVDFAKAHIPTQFT
>WP_023247969.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|1
MILSIPPSIQCQTDAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
VQRATLMRELLALSSPSGLSAEKRALEVTVVLYSQLVPWRFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILEASIPLKGEHAERLFTPAPAAQLVKALRYPLDLWQSAADVQ
GDEYHIVLTLARIWYTLSTGRFTSKNAAADWLLPQLPEDYAATLRAAQREYLGLEKKDWR
ILLPAVVRFVDFAKAHIPTQFT
>ADZ53064.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|1
MTLSIPPSIQCQTEAACRLITPVTGDTLGAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
AQRATLMQELLALSSPPAASADKRALEVTVVLYTQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDMVLLITQILVTSIPLMGERAERLFTPAAAAQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTARFTSKDAAADWLLPQLPEDYAATLRAGQREYLGLEQQDWH
ILLPAVVRFVEFAKAHIPTQFT
>WP_060874262.1|FEATURES|NCBI|beta_lactam|TUS-1|antibiotic inactivation|1
MYKFLSSILLLASTTFVFAQSKPLKVEKLQDNIYVYITYQMYNGVEYSSNALYIVTDEGA
ILIDTPWDKEQNDPLVEHIRKQHNKEVKWVITTHFHEDRSGGLDYFRKAGAETYTYALTN
EILKNRNEPQAEFTFGKEKHFTFGKEEIVVYFLGEGHSKDNTVVWFPKEKVLYGGCLIKS
AEATDIGYIGDGNTDAWPATIKAVKSKFKQAKTVIPGHDNWNQSGHIENTERILSAYNAQ
KVKNNK
>WP_002988050.1|FEATURES|NCBI|beta_lactam|TUS-1|antibiotic inactivation|1
MYHYFSSLFVLIFSTLVYPQSDKLKIEPLNDHMYVYTTYQVFQGVEYSSNALYVVTDEGV
ILIDTPWDKDQYAPLVEHIRREHNKEIKWVITTHFHEDRSGGLDYFNKAGAETYTYALTN
EILKQRNEPQATFTFGSTKQFNLGKEKIEVYFLGEGHSKDNTVVWFPEEAILYGGCLIKS
AEATTIGNIVDGNVEAWPTTIKAVKRKFKKAKVIIPGHDAWNQSGHLENTARILSAYQAQ
KLKNNK
>WP_041852221.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDDIARHAGYSKWHLQRLFLHYKGESLGRYIRERKLS
LAARDLLNTNDKVYDICLKYGFDSQQTFTRIFTRTFNQPPGAWRKENH
>WP_028018442.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLL
LAARDLRESDERVYEICLRYGYDSQQTFTRIFTRTFNQPPGAYRKENH
>WP_045136121.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIEEIARKAGYSKWHLQRLFMQYKGESLGRNIRERKLL
MAARDLRESDERVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENH
>WP_039031578.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVDWIDDNLHQPLRIEDIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLR
LAARDLRESDEKVYDICLRYGFDSQQTFTRVFTRTFNQPPGAYRKDNH
>WP_017025661.1|FEATURES|NCBI|quinolone|QnrC|antibiotic target protection|1
MNYSYKTYDQIDFSGQDLSSHQFTHCKFFGCNFNRVNLRDAKFADCTFIEPNDFEGCNFI
YADLRDTSFMNCMLSMSNFQGANCFGLELRECDLKGANFQGANFVNHVSNKMYFCSAYIT
GCNLSYANFDKQCLEKCDLFENRWVGASLHGASFKESDLSRGSFSDDFWEQCRIQGCDLT
HSELNGLEPRKVDLTGVKICSWQQEQLLEQLGVIVIPDKVF
>WP_004293868.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGCVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKANLSQDVLFMQNVVDGSVYPVCSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAITSFI
LPPASVSNRLSSYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIN
QGREINVDEVGANDIAIVEDMDDFRIGNYLGAEPCLIQGLSHQHPALKSSVRPDRPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKGGYSDNIRMNEKDKLLFMFQKSM
>CAM98048.2|FEATURES|NCBI|aminoglycoside|aadA24|antibiotic inactivation|1
AEISTQLLEVLSVIERHLEPTLLAVHLYGSAVNGGLKPYSDIDLLVTVTVRLNETTRRAL
LNDLLEVSTFPGESEALRAIEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAT
IDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLKLWNSQPDWAGDERNV
VLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVLLEARQAYLGQEEDRLALHADQL
EEFVHYVKGESTKVVG
>CAA31362.1|FEATURES|NCBI|aminoglycoside|aadA1|antibiotic inactivation|1
AEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRAL
INDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAT
IDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNV
VLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQL
EEFVHYVKGEITKVVG
>AAB60002.1|FEATURES|NCBI|aminoglycoside|aadA2|antibiotic inactivation|1
IEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRAL
LNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAM
IDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNV
VLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHL
EEFIRFVKGEIIKSVG
>ABL95942.1|FEATURES|NCBI|aminoglycoside|aadA21|antibiotic inactivation|1
IEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRAL
LNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAT
IDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNV
VLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQL
EEFVHYVKGEITKVVG
>WP_053505284.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIRTPHARLWPVLTADGEPAMLKIAGETEEQNSHRLLRWWDGDG
AARLLAQEGPAILIERASGQSLRQRSIDGADDACTTILCQVLQRLHRPRSAPPADLVCLR
RWFADLLQPRAALPPLLEQCRSLAEGVLQEEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASAA
LSAVWFRDDGDPADIDEAVARMALEALAER
>WP_014037144.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETPHARLWPVLTAAGTPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHAGPAILIERAGGDSLRQRSIEGDDEACTTILCQVLQRLHRPRSAPPAELVCLR
RWFVDLLEPRAALPPLLEQCRSLAEGLLQDEREIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASMA
LSAVWFRDDGDPADVDEAVARMALEALAEG
>WP_065184884.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETAHARLWPVLTAAGTPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHAGPAILIERAGGDSLRQRSIEGDDEACTTILCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAEGLLQEEREVRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASAG
LSAVWFRDDGDPADVDEAVARMALEALAES
>WP_049460784.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETAHARLWPVLTAAGTPAMLKISSEAEEQNSHRLLRWWDGDG
AARLLAHAGPAILIERAGGDSLRQRSIEGDDEACTTILCQVLQRLHRPRSAPPAELVWLR
TWFADLLQPRAALQPLLEQCRSLAEGLLQEEREVRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASMA
LSAVWFRDDGDPAEVDEAVARMALEALAES
>WP_005416478.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETPHARLWPVLTAAGEPAMLKISSEAEEQNSHRLLCWWDGDG
AARLLAHAGPAILIERAGGDSLRQRSIEGDDEACTTILCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAEGLLQEEREVRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAYDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASMA
LSAVWFRDDGDPADVDEAVARMALEALAES
>WP_053496675.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETPHARLWPVLTAAGTPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHAGPAILIERAGGDSLRQRSIEGDDEACTTILCQVLQRLHRPRSAPPAELACLR
TWFADLLQPRAALPPLLEQCRSLAEVLLMEEREVRPLHGDLHHDNVLDFGRRGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASMA
LSAVWFRDDGDPADVDEAVARMALEALAEA
>CRX67081.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETPHARLWPVLTAAGEPAMLKISSEAEEQNSHRLLRWWDGDG
AARLLAHAGPAILIERAGGDSLRQRSIEGDDEACTTILCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAEGLLRDEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARLEQVTALAGLERTRLLRWIAASAG
LSAVWFRDDGDPAEVDEAVARMALEALAAG
>WP_061478689.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAMETPHARLWPVLTAAGEPAMLKISSEAEEQNSHRLLRWWDGDG
AARLLAHAGPAILIERAGGDSLRQRSIEGDDEACTTILCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAEALLMEEREVRPLHGDLHHDNVLDFGRRGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARLEQVTALASLERTRLLRWIAASAG
LSAVWFRDDGDPADVDEAVARMALEALAAG
>WP_032961884.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTADGEPAMLKVSSETEEQNGHRLLRWWDGDG
AARLLAHEGPAILIERAGGDSLRQRSIEGDDDACTTILCQVLRQLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAERVLREEHEIRPLHGDLHHDNVLDFGTRGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERARLLRWIAASTA
LSAVWFRDDGDPADVDETVARMALEALAEA
>WP_053511873.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGASIKTPHALLWPVLTAAGEPAMLKVSSETEEQNSHRLLRWWDGDG
AARLLAHDGPAILIERARGDSLRQRSIDGNDDACTTILCQVLQQLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSMAEELLQDEQEIRPLHGDLHHDNVLDFGPRGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARLEQVSTLAGLERARLLRWIAASVG
LSAVWFRDDGDLADVDGAVARMALEALAAG
>WP_025879128.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPSIRTPHARLWPVLTASGEAAMLKVSTETEEQNGHRLLRWWNGDG
AARLLAHEGPAILIERAHGDSLRQRSIKGEDDACTMILCQVLQQLHRPRSAPPEDLVCLR
RWFADLLQPRAPLPPLLEQCRSLAMALLEDEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFHARVEQVCRLADLERTRLLRWIAASAG
LSAVWFRDDGDPADIDEAVAVMALQALAEA
>WP_025784473.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KNIPSISESEWEIMNVLWDKAPQTANDIILSLQESTDWKPKTIRTLLDRLVQKDVVGVNK
DLRIYTFYPLYTQEKCQRAETESFIKRIYGGTLKSMLVQFIQEDTLSEDDINELRFILNK
K
>WP_040387795.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KKVPNISEAEWEVMNVLWDRAPQTANEVIHSLQERTEWKPKTVRTLLDRLVQKKVVGVNR
NQKVYTFFPLYSQKECQHAEAQSFLKRIYGGTLKSMLIQFIQEDSLTEEDIKELRSILNE
K
>EQM73317.1|FEATURES|NCBI|tetracycline|tet42|antibiotic efflux|1
MLIVLTMLTVIGMTVVLPVLPFVVLQYVSHESDLAIWVGVLEAVNGLCAFLVAPFLGRLS
DRFGRRPVIIVAAFGAAFSMALFGIGGAIWVLVLARMIQGLTAGDLPALFAYLADITPPE
QRAKRFGLLGALTGIGTMVGPGIGGLLAAVSIQLPVFLTSAVALTIAILSIFLLPESLKP
GNRISAIRLRDVQPFAVFKEAFGRKELRGLMIGFGLLALPFGFFVNNFSVLALDSIQWGP
TQIGLLTAAVGIIDILIQGVLLGILLPRIGERGVIISGIVAQMVGLAALAIVASIFAQPW
VFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQSLNAAMGTAAPLIAGALYA
LVSHAAPYWLGVALMIVAVIVVSRAHIANTAKRPVTDGVGAPPVEAVETVG
>WP_025154280.1|FEATURES|NCBI|tetracycline|tetD|antibiotic efflux|1
MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPL
LGRWSDKLGRRPVLLLSLAGAAFDYTLLALSGVLWMLYLGRIISGITGATGAVAASVVAD
STAVSERTAWFGRLGAAFGAGLIAGPAVGGLAGDISPHLPFVIAAMLNACTFLMVFFLFK
PAVQADEKPAEQKAESAGIRFITLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWD
SAAVGFSLAGLGAMHALFQAVVAGALATRLSEKTIIFAGFIADATAFLLMSAITSGWMAY
PVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQQ
SADGTVWLIGTALYGLLLAICLLIRKPAQVAVTC
>BAA78835.1|FEATURES|NCBI|tetracycline|tet(B)|antibiotic efflux|1
MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWL
VFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETS
>WP_000804063.1|FEATURES|NCBI|tetracycline|tet(A)|antibiotic efflux|1
KPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAP
VLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIA
DITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLL
PESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRF
HWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGW
MAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAA
SITTWNGWAWIAGAALYLLCLPALRRGLWRNSSN
>WP_046334921.1|FEATURES|NCBI|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISVLNQNTAPHSATDFIKKSLFFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS
>WP_060555694.1|FEATURES|NCBI|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISALNQETAPHSATGFIKKSLFFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGILHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS
>WP_049196983.1|FEATURES|NCBI|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISVLNQDTAPHSATGFIKKSLCFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFTS
>WP_032490787.1|FEATURES|NCBI|tetracycline|tetH|antibiotic efflux|1
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLALYATMQVIFAPI
LGRLSDKYGRKPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAVCASAMSD
VTPAKNRTRYFGFLGGVFGVGLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFR
ETQKREALVANRTPENQTASNTVTVFFKKSLYFWLATYFIIQLIGQIPATIWVLFTQYRF
DWNTTSIGMSLAVLGVLHIFFQAIVAGKLAQKWGEKTTIMISMSIDMMGCLLLAWIGHVW
VILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLVSLTNITGIIGPLLFAFIYSY
SVAYWDGLLWLMGAILYAMLLITAYFHQRKTT
>WP_015382135.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFFTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHST
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>WP_021406957.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLKNLPRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>WP_050883549.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESRAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIKQLLKLPAECFHPKPKVNSALKKLPRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKYAKVNDLSTVTYEQVLSIFNSYLL
FNGRK
>WP_052255513.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
MNQKNPKDTQNFITSKKNVKEILNHTNFNKQDKVIELGSGKGHFTKELVKMSQSLTAIEI
DKNLWRTTQKAVESFENVKVIHTDILKFAFPQNTNYKIFGNIPFNISTEIVKKITFESQA
KYSYLIVEKGFSKRLKNLQRALGLLLMVEMDIKILTKVPRMYFHPKPSVDSVLIILERHE
PLILKKDYKKYQSFVYRWTNKEYYALFTKNQFRQALKHANVTDPNKVSKEQFISIFNSYK
LFQ
>WP_049094497.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRGLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRHYVAP
QESDYTHYAFSIAAEDFEPFSYKLKQAGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLA
SRLAKCREKPYSGMRFGPGK
>WP_049152503.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQSGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLA
SRLTKCREKPCSGMRFGSGK
>WP_064760099.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQAGVPVWKDNKSEGQSFYFLDPDGHKLELHVGDLA
SRLAQCREKPYSGMRFGPGE
>WP_000941935.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWVCLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSCKLKQAGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLA
SRLTQCREKPYSGMRFGPGK
>WP_023460056.1|FEATURES|NCBI|aminoglycoside|AEAC466_20400|antibiotic inactivation|1
EREKACAAPQIPIVMSAQVNGYGWARDTIGESGAAVYRLDGKGRAPDFFLKHGKDAVADD
VTDEMVRLGWLSGFMPVSTVVQFVRTPNEAWLLMAAIQGKTAYQILAADPDARAAVVDAL
AAFLRRLHAIPVNQCPFNSDHAFRLARARARIDAGLVETDDFDEEREGWTAEQVWEALQA
LLPFTPDPVVTHGDFSLDNLLIVDGEVIGCIDLGRVGIADRYQDLAILWNCLGEFDPSLQ
DRLFQQYGIPDPDPGKLQFHLILDELF
>WP_026792830.1|FEATURES|NCBI|aminoglycoside|APH(3')-Ib|antibiotic inactivation|1
DREDAEAAPPVPLSMSAEVEGYAWVRDTIGESGGAVYRLRDKAGAPDLFLKHGWDAVADA
ITEEMVRLRWLAAYVPVPAVVQFVRTANEAWLLMTAIPGKTAYQILSSSVAARPAVVDAL
SAFLRRLHAIPTSACPFSSDHAHRLAIARWRIDAGLVDADDFDEERQGWTVEQVWNGLQE
LLPLEAEPVVTHGDFSLDNLLIHNGAVVGCIDVGRAGIADRYQDLAILWNCLHEFGPSLQ
GRLFQQYGATDPDRRKLQFHLMLDELF
>KTK23273.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ia|antibiotic inactivation|1
NYQIVNIAECSNYQLEAANILTEAFNDLGNNSWPDMTSATKEVKECIESPNLCFGLLINN
SLVGWIGLRPMYKETWELHPLVIRPDYQNKGIGKILLKELENRAREQGIIGIALGTDDEY
YRTSLSLITITEDNIFDSIKNIKNINKHPYEFYQKNGYYIVGIIPNANGKNKPDIWMWKS
L
>WP_034799972.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MKTRTEITTDLRQLGVRTGDLVMVHASLKAVGAVKGGPTAIVGALLDAIGSSGTLMGYAS
WDRSPYEETLNGVRMADEARRTWPPFDPATARTYPGFGLLNQFLVEAPGARRSAHPDASM
VAVGPLSETLIEPHRLGQALGNGSPIQRFVELRGKVLLLGAPLNSVTALHYAEAIADIPG
KRRVTYEMPLLGPNGETVWETAEDFDTNGILDRFAVAGQADAVETIANAYVATSRHRSGT
VGDAFCHLFDARDIVSFGVAYLESRFGK
>WP_062803490.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MRSQTTITCELRSLGVNAGDLVMVHASLKAIGPIEGGAVGLVAALRDAVGTEGTLLGYAS
WDRSPYDETLHGAKMDDQQRRNWPPFDPATAGTYRGFGLLNHYLATSPGALRSGHPDASM
VALGPRARFLIEPHRLGEAFGNGSPIERFVNEGGKVLLLGAGLDALTVLHYAEAIAEIPG
KRRVTYEMPLQGADGQTVWEAVEDFDSNGILDCFAIEGQPDGVETIARAYVPLGRHTQGQ
VGCAHCYLFDARDIVAFGVSYLEQRYFA
>WP_001243406.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RNENEMMSLFENIAMNDDRIRLSVLEGSRTNKNIPKDDFQDYDISFFVSDIESYKKDDYW
LEIFGDLIFMQKPEDMELFPAELGNWFSYIMYFNDGIKIDLTLIPLNEIDQYLSDADGLV
EILIDKDKHINEKIVPNDKKYWIKKPSEREFDDCCNEFWCVSAYIAKGFYRKELFYALDH
FNQILRPELLRMMSWEVGIREGFNFSVGKNHKFIGNYLPEEELEKLIKTFSQSGYKESWG
SFKLCCDMFRAYSKKVASLLDFNYPDYDEKMTDFIQHNYT
>WP_065107267.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSKKEIMELGMNFAINCEKIRIFTLEGSLTNSNIPEDEFQDYDFSYFVTDMDFFKKSDDW
LDYFGQRIILQKPEAMELFPPELGNWFSYLMIFEDGSKIDLTLIPLNEFEDYFKESDGLV
EVLLDKDQLIKKTIIPSDAKYHIQRPSMQSFDDCCNEFWMTSTYVAKGLARKEILFANDI
MNSAFRPNLLTMLRWKIGIETNFSLSIGKSDKFLKKYVSNETWDTLLSTYNMSTYQAVWD
ALNFSFELFRESSLYVSKTLGYPYPEYDKKVTNYIERIQR
>WP_010270625.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMDLLLGFARGDERIRLVTLEGSRTNPNIPPDSFQDYDISYFVTDMASFKKDDAW
LEPFGRRLMMQKPEAMELFEPELGNWFSYLMLFEDGSKVDLTLIPIEETEFYFTRNDGLV
KVLLDKDRLIPHEVVATDSQYWIRKPTAGEFDDCCNEFWMVSTYVVKGLARQEILFAIDH
LNEIARPNLLRMMAWQIGFTHGYTFSLGKNYKFLQRYLPQNDWNTLLSTYAVNSCEAVWE
SLFTCYQLFRSCSRTLAQNLGYPYPHYDEAITRYTDFIYK
>WP_026326919.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMELLIDCAKKDERIRVVTLEGSRTNPNIPKDRFQDFDISYFVTDMDSFKENDRW
LDIFGRRAMLQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPLNEIDEYFASSDGLV
EVLLDKDRRVQHEVVANDRNYWIIEPTARQFDDCCNEFWMASTYVVKGLARKEILFAIDL
LHEVVRPNLLRMMAWHIGWERGYTFSLGKNYKFIDRYLPPESWEALLSTYSGNSYDHMWK
SLFTCHALFRQYSKAVAANLGYRYPDYDDAISRYTDTVYR
>WP_026682661.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMNLLISFAKNDNRIRLVTLEGSRTNKSIPKDSFQDYDISYFVTDMDSFKEDDEW
LDVFGKRLIMQKPEDMELFPPELGGWFSYLMLFKDRNRIDLKLIPIDEVEDYFFNNDGLV
KVLLDKDSLVENDIIPSDRKYWIKKPTVREFDDCCNEFWWVSTYVVKGLARKEILFAIDH
LNEIARPNLLRMMSWQVGLEKGYSFSVGKNYKFIDSYLPQEDWETLLTTYSEGSYSNMWQ
SLFTCYDLFRKYSKSLAEDLGYKYPDYDESISKYTQNIYK
>WP_021255911.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RKEREMMDMFIEFAKQDDRIRLATLEGSRTNKNITPDTYQDYDISYFVTNLDSFKANDQW
LDAFGARLMMLKPENMELFPPGLGNWFSYLILFEDGNKLDLTLIPLNEVEAYFTDNDGLV
EVLLDKDTLIPNKVVPNDSQYWIKKPSARKYDDCCNEFWMVSTYVVKGLGRKEILFAIDH
LHEVARPNLLRMMAWHIGAERGYTFSVGKNYKFIDRYLPPEDWETLLATYAESTYPSMWQ
SLFACCELFRKYSKAVAEHHGYMYPDYDQVITTYMRGIYD
>WP_044428795.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQVMMDIFLDFALNDERIRLVTLEGSRTNRNILPDNFQDYDISYFVTDMESFKENDRW
LEFFGTRIMMQKPEDMELFPPELGNWFSYIILLEDGNKLDLTLIPISEVEDYFAKNDGLV
EVLLDKDNFIKNKVIPNDRQYWIKKPSAREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNEIVRPNLLRMMAWHIASQQGYTFSLGKNYKFIKRYLSNKEWEELMSTYSMNGYQEMWK
SLFTCYELFRKYSKVVSESLRYKYPDYDKGITKYTESIYN
>WP_042234623.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMNILVDFARNDDRIRLATLEGSRTNKNIPPDTYQDYDISYFVTDMDSFKENDQW
LETFGKRVMLQKPEDMELFPSELGNWFSYLILFGDGNKVDLTLIPINEAEDYFTNSDGLV
EVLLDKDTLIKNEVIADDRQYWIKKPTAREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNEIARPNLLRMMAWQIGSEQGYTFSVGKNYKFINRYLPNEDWESLLSTYSENGYPEMWQ
SLLTCYELFRKCSKAVAESLDYTYPDYDETITAYTERIYT
>ANH58931.1|FEATURES|NCBI|beta_lactam|blaCTX-M-185|antibiotic inactivation|1
MMRKSVSRAILMTTACVSLLLASVPLYAQANDIQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKDLLSQRVEIKSSDLINYNPIAEKHVNGTM
TLGELSAAALQYSDNTAMNKLIAHLGGPGKVTAFARVIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLRNLTLGNALGDTQRAQLVTWLKGNTTGAASIQAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLVLVTYFTQPKPKAESRRDVLAAAARIVTDGY
>WP_064475214|FEATURES|NCBI|beta_lactam|TU65_24875|antibiotic inactivation|1
ILKNKRMLKIGICIGILGISLTSLETFTGGALQVEAKEKTGQVKHKKHATYKEFSQLEKK
FDARLGVYAIDTGTHQTIAYRPNERFAFASIYKALAAGVLLQQNSTNKLNEVITYTKDDL
VEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRITMA
DRFETELNEAIPGDIRDTSTAKAIATNLKALTVGNALPVHKRNILTEWMKGNATGDKLIR
AGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAE
VIVKALR
>WP_063857824.1|FEATURES|NCBI|beta_lactam|blaB-15|antibiotic inactivation|1
KKMKWALVLALGLTGLNAFGQETPEVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVTSK
GVVVIDSPWGEEKFKNFTDEIYKRHGKKVIMNIATHSHDDRAGGLEYFKSLGVKTYSTKM
TDSILAKDNKPRAQYTFDNNKSFKVGKDEFQVYYPGKGHTADNVVVWFPKDKVLVGGCII
KSGDSKDLGFLGEAYVNDWTQSVHNIQKKFPNVQYVVAGHDDWKDQTAIQHTLDLISEYQ
QKQKASN
>WP_059154943.1|FEATURES|NCBI|beta_lactam|blaB1|antibiotic inactivation|1
KGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTDK
GVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTKM
TDSILAKENKPRAKYTFDNNKSFKVGNTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIV
KSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEYQ
QKQKASN
>AMP54231.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MTLLKHKKITIIGAGPVGLTMARLLQQNRVDVTVYERDKDRDARIFGGTLDLHRDSGQEA
MKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQN
DTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFN
IQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTR
VDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESII
NETEMFSSDFSFQKLMNL
>AGG19392.1|FEATURES|NCBI|glycopeptide|vanWB|antibiotic target alteration|1
MDRKRLTQRFPFLLPMRRAQRKMCFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
TGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFSFWWLVRHADKDTPYKDGLTVTNGKLT
TMSGGGMCQMSNLLFWMFLHTPLTIIQRRGHEVKEFPEPNSDEIKEVDATISEGWIDLKV
RNDTDCTYQIWVTLDDEKIIGQVSADKEPQALYKITNGSIQYVRESGGIYEYAQVKRMQV
ALGTGEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>ANW86194.1|FEATURES|NCBI|glycopeptide|vanWB|antibiotic target alteration|1
MNRKRLTQRFPFLLPMRQAQRKICFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
TGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFSFWWLVRHADKDTPYKDGLTVTNGKLT
TMSGGGMCQMSNLLFWMFLHTPLTIIQRRGHEVKEFPEPNSDEIKGVDATISEGWIDLKV
RNDTDCTYQIWVTLDDEKIIGQVFADKQPQALYKIANGSIQYVRESGGIYEYAQVKRMQV
ALGTGEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>AAY43149.1|FEATURES|NCBI|aminoglycoside|aadA1k|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRA
LINDLLETSASPGESEILRAVVVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
TIDIDLAILLTKAREHSVALVGPAVEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERN
VVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRVDQ
LEEFVHYVKGEITKVVGK
>CAP69683.1|FEATURES|NCBI|aminoglycoside|aadA1ae|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLCGSAVDGGLKPHSDIDLLVTVTVRLDETTRRA
LINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
TIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGAERN
VVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQ
LEEFVHYVKGEITKVVGK
>WP_034732386.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
MKSWLFLTISILGEVVATSALKSSEGFTKLVPSFIVIVGYGIAFYFLSLVLKSIPVGVAY
AVWSGLGVVLVTAVAWGLYGQKIDAWGFVGISLIVCGVLVLNLLSKASVH
>WP_058818681.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KSWIFLAVAIVGEVIATSALKSSEGFTRLIPSAIVVVGYAVTFYCLSLALKTIPVGIAYA
VWAGLGIVLVAGIAWAMHGQTLDAWAVVGIALIVCGVAVLNLLSNVSAH
>ACN22665.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
MKGWLFLAIAIVGEVIATFALKSSEGFTKLAPSAAVIIGYGIAFYFLSLVLKSIPVGVAY
AVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIVSGVVVLNLLSKASAH
>ACN22676.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KNWLFLATAIIFEVIATSALKSSEGFTRLVPSFIVVAGYAAASCFLSLTLKSIPVGIAYA
VWSGLGIVLVTAIAWVLHGQKLDMWGFVGVGFIISGVAVLNLLSKASVH
>WP_048269931.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KIWLFLATSIISEVIATSALKSSEGFTRLVPSFIVVAGYAAAFYFLSLTLKSIPVGIAYA
VWSGLGIVLVTAIAWVLHGQKLDMWGFVGVGFIISGVAVLNLLSKASVH
>WP_015059047.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KNWLFLAIAIFGEVVATSALKSSHGFTKLVPSVVVVAGYGLAFYFLSLAIKSIPVGIAYA
VWAGLGIVLVAAIAWIFHGQKLDLWAFVGMGLIVSGVAVLNLLSKVSAH
>WP_032010424.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSATVSRGLVISTLSIALVACVNMQAPQPAITSHIPHNFSQNASGKTIAEQSYKEFIS
NPKLAQVIEITLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVMGSAARQVDPSINPN
NPASTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNVTQAWLNYA
FAQANLNLAEQTLKTQLDSYHLNKKRFEVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQHLLPDHPIQNITFEKTFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPTIDLPIFDWGTRKANIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATDATYKLSMARYRTGV
DSYFSVLDAQRSAYAAQQGLLALEQMKFNNQIEIYKALGGGISKS
>WP_017392737.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSATVSRGLVISTLSIALVACVNMQAPQPAITSHIPHNFSQNASGKTIAEQSYKEFIS
DSKLAQVIEITLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVMGSAARQVDPSINPN
NPASTFQVGSGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNVTQAWLNYA
FAQANLNLAEQTLKTQLDSYHLNKKRFEVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHSIQNITFEKTFAAGLPSDLLNYRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPTIDLPIFDWGTRKANIKIAE
TDQKIALAKYEKAIQSAFHEVNDALAMHAHIGERLGAQRRLVSATDATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMKLNNQIEIYKALGGGISKS
>WP_049836683.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKAAIVSRGLVVSALSVAMVACVNMQAPQPTAISHIPQNFAQNSSGTTIAEKSYKEFIS
DTKLLQVIEIGLNNNRDLRTATLNIERVQQQYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQIGLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFEVGIDSEVPLKQAQISVETARNDVATYKTQILQ
AKNLLDLLAGSPVPQNLLPSDSIKNITLEKNFAAGLPSDLLNHRPDLKAAEYSLRAAGAN
IGAAKARMFPTISLTGSTGYASAELKDLFKSGNFAWSIGPSVDLPIFDWGTRKAGIKIAE
IDQKVALSEYEKSIQTAFKEVNDALATHAHIEERLDAQRRLVSATSATYKLSMARYKAGV
DSYFTVLDAQRSAYAAQQGLLALEQVKLNNQIEIYKVLGGGLSKE
>CAW30932.1|FEATURES|NCBI|rifampin|arr-3|antibiotic inactivation|1
VRGPFYHGTKAHLSIGDLITTGHLSHFEDGRALKHVYFSALMEPAIWGAELAMSLSRLDG
RGYIYIVEPTGPFEDDPNLTNKRFPGNPTKSYRTCDPLRIVGSVEDWQGHPADVLQQMLE
SLEDLERRGLAIIED
>WP_037035924.1|FEATURES|NCBI|beta_lactam|CARB-10|antibiotic inactivation|1
KRVSFALVVACGVPAVGAAGELLDTVNRLENEVGGRIGVVLQHTGSDWAIESRADERFPM
ASTFKALLCGAVLARVDRGEERLGEVVAYSKAELVSYSPVTKKHVAEGMRVGELCEATVT
MSDNTAANLLLKRVDGPKGLTRFLRGLGDRVTRLDRREPEMNEAKPGDARDTTSPRAVVQ
TLDRLLFEEVLQPSSRAQLQQWMVDDKVADALIRKHLPSDWRIADKSGAGHNGSRGIIAA
IWPETGEPYLAAVYMTGSDANFKKRNAVIAEIGKAIIEEIQQR
>WP_031944967.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
KKKMLFIGSILLTSLSTSAAPLKLPDDWTQNTQPFQITENIYYVGTHGLAAYLLASGHQA
LLIDTGLPENTEQIEQNIKQLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQQ
DVKALEIGKPIGENTFQTIPFTPVKVDKVIHDGEVVKLGKFKLKATLTPGHTPGCTTWST
EVKSNGKNLNVVFPCSLSVAGNVLQNNHQYPNIVADYRKSFERLKNMKADIVLTSHPEVA
DILGNKARKDAGQTNAFIQPEKLSSIVKDAEMAFEKSLVSSHP
>WP_043592266.1|FEATURES|NCBI|beta_lactam|VK98_00160|antibiotic inactivation|1
MFKHLILFASLAAPLTQAVAADPLAVAADKLAKLERDFGGSIGVYAIDTGSGATVANRPN
ERFPMCSSFKGFLAAGVLAQSQDKPGLLDKRIRYSKAALPNWSPITTKHQASGMTVAELN
AASVQYSDNGAANLLLKEINGPAALTAFMRSIGDASFRLDRREPELNSAIPGDPRDTSTP
KAVAESAQKLALGKALPEPQRQQLADWLKGNTTGNARIRAAVPAGWEVGDKTGTCGVYGT
ANDFAVIWPPKRAPIVLAVYTKHAKKEAKHSDEVIAAAARAALEAFNVKK
>CAJ77832.1|FEATURES|NCBI|aminoglycoside|ANT(3'')-IIa|antibiotic inactivation|1
MSDFIQLEYLQEKLQQLLAESLFAIYLYGSAVDGGLGPESDLDVLVVVTQPLTSALREQL
AQELLKISQPVGELQRPLEVTILLKDEIQSGNYPLSYEMQFGEWLREELKEGGTLSSQKD
PDISILLRKARFHHAVLFGPALDQWAPEISDQELWQAMSDTYPEIVAHWDEDADERNQIL
ALCRIYFSLVMKDIASKGNAARWVMPQLPPEQKFVLQRLIQEYRGEIGKQNWQEEHYALQ
PIVNFLSSKIEEQFEQKR
>CZU17723.1|FEATURES|NCBI|quinolone|QnrB3|antibiotic target protection|1
MALIFEGERIGRTRFTGEKIENAIFRNCDFSGTDLTNTEFIGCQFYDRESQQGGKFSRAQ
LKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCSAYITKSN
LSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSE
LGELDVRGIDLQGVKLDSYQIAQLMERLGIVVLG
>WP_034703427.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
KAREEKLKQIISWAEGNPDLRAVLLTSSLVNPYAPVDDFSDLDIELVFENMNEYENDKKW
IDLFGKPISMIEENETYFDGKHAMKMVLYTDHVKVDFKLYHKLEFLKEIAEETLPEDWDV
GYKVLVDKDDLTKNMKPPTYQSIMIRKPTEQGFQQLMNDFWWDTTYVAKCLKRGDLFYAK
FMSENVIRTDYLVPLIEWYIAANSDWKDITANKHGRLFKKYLSAELWIKAEATFAGSSIE
DNWNALYAAADLVHELGTALAKKLNFRYPQKLEDDIRNYLDEVKS
>WP_034693616.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
KVREEKLEQIIHWAENNPDIRAVLLTSSLVNPYAPVDDFSDLDVELVFENRASYESGNKW
IRLFGEPISMIEEDDSVFDGKHAMKMVLYKDHVKVDFKLYQVAEFIEEIKEENLPEDWDV
GYKVLIDKDKLTENLKPPTYQSIMIQKPSEKEFQQLMNDFWWDTTYVAKCLKRGDIFYAK
FMSENILRTDYFVPLIEWHIAGNHGWNNITTNKHGRLFKKYLSADLWNKVEKTFSGSDIE
ENWNALFAYADVVHELGTSLAEKLHFIYPEKLEEDIRNYLKEVQT
>WP_050022107.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
ITREEKLQQIIQWCENNPDIRAALLTSSLVNPHAPVDDFSDLDIELVFQNRSVYEADHTW
LDLFGEPISMIEEDDTVFDGKHAMKMVLYKDHVKVDFKLYQVADFLKDIDLEVLPDDWDL
GYRVLIDKDNLTENIKAPTYQSIMIQKPDEQKFRQLINDFWWDTTYVAKCLKRGDIFYAK
FMSENILRTDYLVPLIEWYIANLHSWHNITTNKHGRLFKKYLPANIWKDIESTFSGSDIE
ENWIALFAFADLVHNLATDLALKLGFVYPEQLENDIRNYLSEVRA
>AAL02176.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|EmtA|antibiotic target alteration|0
TLYFASVLSGLEYVLSNEINNKVSDSEIIQINRGKVFFTTAESFTCLSSLRSADHLFQVI
DQFQIGPHKKHLSQVSERISQLDLEFIDHKDLFWVNASRKGKQTYSRFELAKKAMEGINK
RYPDWNIGTSQNHQIEFRLDIEHHNVIFSLRLTDATFRFRNQTRRFSRASLLPSVAHAMV
WLSDPESKDVFVDFCCGSGTILSERATYPANQIIGGDISEAVTKIAKSNLDDSKVQVNVW
DARKLPFSTGCVDKIVTNLPFGRQISPDEDLELFNHHIMIEVCRVLKPNGRAVILSESVN
QLFWEAKRLGLFCLESYPLSLKGVNPTLFVFEKQDG
>WP_077718888.1|FEATURES|NCBI|bacitracin|uppP|antibiotic target alteration|0
TLYFASVLPGLEDVLSDEINHKLIDSEVIQINRGKVFFTAAESFTCFNSLRSADNLFQVL
DQFQIGPHKKHLSQVRERISQLDLGFMGRKDAFWVNASRKGKQTYSRFEVAKEAIEGIHK
RYPDWKIGTSRNHQIEFRIDVEHHHVIFSLRLTKATFRFRNQRRRFSPASLRPPVAHAMV
WLSEPASTDVFVDPCCGSGTILSERGAYPADEIVGGDISDEITKIAKSNLDGLEVVVHVW
DARKLPFSDGCVDKVVTNLPFGRQISPDGDLQLFNHQMMHEIWRVLKPNGRAVILSDSAN
QLFWEAERLDLYCLKSYLLSLKGLNPTLFVFEKQGR
>WP_032063602.1|FEATURES|NCBI|fosfomycin|FosA4|antibiotic inactivation|1
MKLSGLNHLTISIENVDRSFSFYKDVLGFTPRAKWNKGAYLSLGELWLCLSLDVVSITSD
YTHYCFSISEEHIDEFRQKIKLLNIREWKNNQSEGESIYFLDPDGHKLEVHVGNLLSRLE
SCKKNPYEGMVFFDE
>WP_079863305.1|FEATURES|NCBI|beta_lactam|ADC-2|antibiotic inactivation|1
MFFNQKYFFQASFITMVIGFGMNLNASEVSQNEKNIEKVVTQSFKPLIDEYGVAGMAIGV
IYNGKSYEKYYGVRSKDTNESVNSQTLFELGSLSKTFTAISGTYANNQGKISFNDHPSKY
VPALKNSEIDKVNLLELLTYTSGNLPLQFPDNIKTDKQILEYFKNWKVKNPPGTYREYSN
PSIGLFGYLTAKSMNVPFSSLLEKTVFPQLNLKHTYVNVPEAQKTNYAFGYDENNKPIRV
NPGPLSDEAYGVKSTLPDMLKFVNSNLNVDTNSPAMKKAILDTHKGYFKVSDSGMTQALG
WEMFSYPTTSEILQASNSKQILLGSNPVVKELSQPKSKVFHKTGSTNGFGAYVLFIPEEG
FGLVMLMNKKIPNVDRIKASYNVFETLKDN
>WP_065804663.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNRARN
SEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLD
SEIAQMKGDKLVVFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYQFAPDDQTRVPMQ
VWMSPGFTKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>SHE15091.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
IGPNPNEKYPIPGNRNLQFIKNTITKPNIIVGDYSYYDALDGELFEDQVLYHYEVIGTKL
IIGKFCSIAPEVRFLMDGGNHRMDGSTFPFNIFGHGWEKHTPSLNQLSIKGDTVVGNDVW
IGRRATIMPGVRIGDGSIVSAEAVVVKDVEPYTVVGGNPAREIKQRFSQEVIQEFLEIKW
WDFDIELINQYIGAIVSGDIETLKKIKQ
>WP_090666825.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
LGPNPREKYPIPGNKNVQFINNTITKSNIIVGDYSYYDALHGESFEDQVLYHYEVLGTKL
VIGKFCSIAPETRFIMGGGNHRMDGSTYPFNIFGNGWEAYTPTLEQLPLKGDTVVGNDVW
IGRRATIMPGVRIGDGAIIGAESVVVKDVKPYTIVGGNPAKEIRKRYSPEIIEELLEIRW
WDNDIEIINQNIEAIVSGDIESLRKMRS
>WP_003725293.1|FEATURES|NCBI|multidrug|EmrE|antibiotic efflux|0
MNPYVLLIGAILFEVFGSSMMKASNGFKKLVPTVGLVIGMGSAFYLLSKALEHIPLGTAY
AIWSGGGTALTAIVGILVWKEKFNLKILLGLLIIIAGVVVLKLSH
>WP_083090492.1|FEATURES|NCBI|qa_compound|Qac|antibiotic efflux|0
MKEYVALGIAIIGEIFGTSMLKLSEGFTNIYPTIGVAIGFFIAFYTLSLSLKTLPLSLAY
AIWSGVGTALTALIGVLVWNEPFNILTFIGLVMIVGGVIILNQRSADTKTSTSH
>AFN94071.1|FEATURES|NCBI|qa_compound|emrE|antibiotic efflux|0
MKGYVALGIAIIGEIFGTSMLKLSEGFTNIYPTIGVAIGFFIAFYTLSLSLKTLPLSLAY
AIWSGVGTALTALIGVLAWNEPFNILTFIGLVMIVGGVIILNQRSADTKTSTSH
>AAM52493.1|FEATURES|resfam|aminoglycoside|AAC(6')-Ib9|antibiotic inactivation|1
MKNTIHSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLP
SVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKG
LGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQ
TRQAFERTRSDA
>NP_253684.1|FEATURES|resfam|multidrug|MsbA|antibiotic efflux|1
MSDSPQNPGPSSLKIYFRLLGYVKPYIGMFLLSIVGFLIFASTQPMLAGILKYFVDGLSN
PDAALFPNVQWPWLRDLHLVYAVPLLIILIAAWQGLGSFLGNFFLAKVSLGLVHDLRVAL
FNKLLVLPNRYFDTHSSGHLISRITFNVTMVTGAATDAIKVVIREGLTVVFLFLYLLWMN
WKLTLVMLAILPVIAVMVTTASRKFRKQSKKIQVAMGDVTHVASETIQGYRVVRSFGGEA
YEEKRFLDASQSNTDKQLRMTKTGAVYTPMLQLVIYVAMAILMFLVLWLRGDASAGDLVA
YITAAGLLPKPIRQLSEVSSTVQRGVAGAESIFEQLDEAAEEDQGTVEKERVSGRLEVRN
LSFRYPGTDKQVLDDISFIAEPGQMIALVGRSGSGKSTLANLVPRFYQHNDGKILLDGVE
VEDYRLRNLRRHIALVTQQVTLFNDSVANNIAYGDLAGAPREEIERAAKAANAKEFIDNL
PQGFDTEVGENGVLLSGGQRQRLAIARALLKDAPLLILDEATSALDTESERHIQAALDEV
MKGRTTLVIAHRLSTIEKADLILVMDQGQIVERGSHAELLAQNGHYARLHAMGLDEQAPA
PVG
>WP_001209508.1|FEATURES|resfam|aminoglycoside|aadA|antibiotic inactivation|1
MRASLVAKTKLNIMREVVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSD
IDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKREL
QFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALN
ETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEA
RQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>resfam_RmtF-4|FEATURES|resfam|aminoglycoside|RmtF-4|antibiotic target alteration|1
MDERAQAALDALLSAKNLRDVCPETVRRVFMELLPRYRKPKDAEKAARTHLHQITGALEL
LPRYRKPKDAEKAARTHLHQITGAFMTADAQKKARALLARWNEGDESALAAALSLHASTR
ERLPGADEWMRRVSPFLGADARVLDLACGLNPILLGSMGVTNALGMDIHLGCVRLVNETA
RARGWHTRARACDLLSEIPAEEADAALLMKLLPVLEAQKTGRAAELLASLRAPRLVVTFP
TRTLGGRGVGMEKHYADWFERILPDTLSVRDRFTVSDELVYLVERT
>YP_001838371.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MVMWFVKTKAIQISFLGIYFLLGVFVSGCQRQIVSESPNQVTFPGSITKLSENSSPQHLE
WIKIKETVWIHKSFGNFLGKTYESNGLVVLSSRGVVVIDTPWTESQTEELFEGIKTKFQK
EILFLIVTHAHDDRMAGVTQFQNRNIPVYSTSLTSKLAKEKGLGKTNPILDLQTRVSAGN
VSVEIFFPGHGHSPDNIVVWLPNTHILFGGCLVKAIDATDLGNVKDANLLEWENAVKRVL
SRYPDAEVVVPGHGNWGKLDLLRHTIRLLVSTNH
>YP_005567024.1|FEATURES|NCBI|beta_lactam|ICS_02171|antibiotic inactivation|1
MKNTLLKLGVCVSLLGTTQFVSTISSVQAERTVEQKVIKNETGTISISQLNKNVWIHTEL
GYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQTVTKLKFGNMKVETFYPEKGHTE
DNIVVWLPQYQILAGGCLVKSASSKDLGNVADAYVNEWSTSIENVLKRYGNINLVVPGHG
EVGDRGLLLHTLDLLK
>WP_006095170.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MKMKKKLILKVGLCASILGISQFASSIFPVQAAEKVEQIKNKDQEKDVSISQLYPKVWMH
TSIGVVNGTRIPANGLILETSKGLVLIDTPWNDDLTDQLLQILKKQFPTKEVTGAIVTHA
HDDRIGGIKTLTKKGVKVHSTALTADLAEKQGFDKPLGDLKKRDNMRFGDINVETFYPGK
GHTQDNITVWLPKYKILFGGCLIKSLDTQEIVQTPGSYVSNWSKAIKKVEKKYSDINIIV
PGHGDPGDSRLFTHTLNLLKNNEN
>YP_003919855.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MRRFTLFIAGLFLLGLFTAGMKPAHAAEGSELKGVTLTQLAPHVWMHTSTGMADGRPVPA
NGLLLDTSKGIVLIDTPWNDSLTEQLMTQINQQFPGKRMTDAIVTHAHDDRIGGLNTLYK
YGVKVHSTKLTADFARKQGYARPLGDLKNVAKLQFGDMEMETFYPGKGHTEDNITVWLPQ
DKLLFGGCLIKSLETKEIVPTPGFYPDQWPRAVQKVMKRYQDISIVVPGHGSPGDGRLLP
HTISLLKENK
>WP_004156189.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MTKLTTTCFVLALSLLSYACYAQKIKVKKLEKNVYVHISYKKMGNTNVPSNGLIVKTNKG
VWIIDTAWDDDQTKQIIGWVKKNLKKPIQQVIITHAHDDRAGGIQAFLDEKIPVTSTQLT
AKRTVKSGLPSPQPVLKKSQVIDCGNNNLEIFSPGWGHAPDNIVVYLTKQKVLFGGCFIK
STDTRKLGNTKDAHLKLWKKGLLKVQSKFKEVETVVPGHQDWGDGRLITHTMDLLDVSLH
R
>ABO21420.1|FEATURES|NCBI|beta_lactam|BD94_2866|antibiotic inactivation|1
MLKKIKISLILALGLTSLQAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
DKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYST
KMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVLVWFPKEKVLVGGC
IIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINE
YQQKQKASN
>YP_209357.1|FEATURES|NCBI|chloramphenicol|cmlA1|antibiotic efflux|1
MSSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLM
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWALQSVLGFIAPMWLVGIGVATAVSVAPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAESTSNPNR
>YP_130954.1|FEATURES|NCBI|chloramphenicol|catB10|antibiotic inactivation|0
MANIIFLHGTSSSGKSTLSQVIQKQSETPFWHFASDQFVEAGMLPKRVNDGGDFDWSKNR
PLFFDAFHGCIKAVADAGNNIILDHIIESKEWFHYLQELLSNHDVFFVGIHCPIEVLRER
EINRGDGSIGNRYLGESEYHLKHVHTYSAYDYEIDTSSQPTEHSAEMVLSAWEQRGQSAF
FSVLEK
>ACZ65151.1|FEATURES|NCBI|beta_lactam|IND-14|antibiotic inactivation|1
MKKRIQFFMVSMMLSPLFSAQVKDFVIEPPIKKNLHIYKTFGVFGGKEYSANSVYLVTQK
GVVLFDVPWEKVQYQSLMDTIQKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATAK
TNEFLKKDGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSKAATDLGYIKEANVEQWPKTINKLKSKYSKASLVIPGHDEWKGGGHVEHTLELLNKK
>YP_001475146.1|FEATURES|NCBI|beta_lactam|BL3_shw|antibiotic inactivation|1
MSIYLDFVAAAFSFAIPYLRAGAVVLLLGASFSSVAEIHHPEAAWSSDAIKIKQVSPALY
LVKSYKEIKLYQDKPAMTFDSNSFIYVDKHNAYLIDTPWSESDMPDLMSWLKIQKLLLKG
TIVTHYHQDRAGGLGYLDKHGFATYASDMTNQLLVKDKQPMSNHSFSGDKFELLKGQIET
YYPGSGHSMDNLVVWLPKENILIGGCLLKSNETNNLGWTGDADLANWYHSASKVKADFPQ
AKFIFPGHGDGAEGQSILEHTMALTKGVASLK
>WP_003013519.1|FEATURES|NCBI|beta_lactam|CGB-1|antibiotic inactivation|1
TYATAATNAILKADHKPEATHLIELDKTIHIGGKQFVIKYFGEGHTADNVVIWFPKEKIL
DGGCLIKSSEAKNLGYVGEANVKEWPKTISKIQQT
>WP_008681849.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MLALIVCCWSPAKTAAQEIGESARVAEDLDVVRLSGRVYMHVSRYEMPPFGLVPANGLIL
VDKGEAFLFDTPWTESQTEVLLDWIENVLHARVTACVPNHWHKDAMGGLPAVRRRGIPTY
AYDGTIAIARQKGLRPPEHGFASERTLKLHGLEVRNVYLGGGHSTDGIFVWIPAENLLFP
GCMAKDAKTVNLGNTEDADVRAWPGTMEKALAAFPDACIVVPGHGQPGGPELLRHTRDLA
LRAGGSR
>1A7T_A|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
AQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVINNHQAALLDTPINDAQT
EMLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQRKGVQSYANQMTIDLAKEKGLPVPE
HGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGGCMLKDNQTTSIGNISDA
DVTAWPKTLDKVKAKFPSARYVVPGHGNYGGTELIEHTKQIVNQYIESTSKP
>YP_002262687.1|FEATURES|NCBI|beta_lactam|GIM-1|antibiotic inactivation|1
MKFMFKLTLALLSSVIGFNAAAEPVVKPLQFEEITNNVFLVKSYREFKNLQSPKKPILVD
ANSLVYVDGKDAYLIDTPWNASNMPQLMTWIENRGLTLKKTVFSHFHEDQTGGLEYLQEH
HFETYASALTNKFLKGDNKKATNHQFSGDNFVLLENKIEVFYPGGGHTKDNAVVWLPKEK
VLLGGCLMRANEVNTIGWTGDADMKAWAGSAQKVLTKYPQANFVVPGHGNVGEGTSIISH
TVDITGKI
>ACU65238.1|FEATURES|NCBI|beta_lactam|IMP-6|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILYGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPGHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>4ZNB_A|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
AQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVINNHQAALLDTPINDAQT
ETLVNWVADSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYANQMTIDLAKEKGLPVPE
HGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGGSMLKDNQATSIGNISDA
DVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVNQYIESTSKP
>YP_004318456.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MKHCFFYGLAFLLLSCKLSAQTDKSYVSDDFTIKKVKDNVYEHTSYLLTDDFGKVPCNGM
IVYDGGEAIVFDTPTNDSIADILIDWVKDSLDCTIVAVIPTHFHDDCLGGLAAFHKNRIP
SYASNKTIAFAKAKNLIMPQHGFHKKLELKVGERKIIAEFNGEGHTKDNIIGYFPNRRVM
FGGCLIKEMNASKGYLGDSNVESWSETVMKIKQKYPEAELIIPGHGKSGGQELLDYTINL
FKQ
>ACY78406.1|FEATURES|NCBI|beta_lactam|VIM-2|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVGSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>YP_564153.1|FEATURES|NCBI|beta_lactam|IMP-41|antibiotic inactivation|1
MRFILCLLLMVSSLTYAAQGPSKLKIVQLSDIVYQHTSLSDGDAYGVMAANGLIVIVGKQ
AYLIDTPWTEADTNTLIQWVTVKGLTIGGVIVTHFHQDSSGGLAVLNKLKINTYATTLTN
QLLKANNREPASNEITSETFDLVPGVIQAYYPGAGHTQDNLVVWLAKSNLLFGGCLVQSF
NNRKLLNIEDASIKDWPKSLQNVMVKYPNIDMVIPGHGQIGDVSLLELTQQLARKAL
>ACT52235.1|FEATURES|NCBI|beta_lactam|IMP-7|antibiotic inactivation|1
TSFEEVNGWGVVPKHGLVVLVNTDAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFH
SDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFSGASYWLVKKKIEIFYPGPGH
TPDNVVVWLPEHRVLFGGCFVKPYGLGNLGDANLEAWPKSAKLLVSKYGKAKLVPSHSEV
G
>ABB99430.1|FEATURES|NCBI|beta_lactam|IMP-4|antibiotic inactivation|1
DECVYVHTSFEEVNGWGVVPKHGLVVLVDAEAYLIDTPFTAKDTEKLVTWFVERGYKIKG
SISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFGGVNYWLVKNKIEV
FYPGPGHTPDNLVVWLPERKILFGGCFIKPYGLGNLGDANLEAWPKSAKLLISKYGKANW
V
>CAQ87575.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTEMLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQRKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQTTSIGNISDADVTAWP
>ABX00642.1|FEATURES|NCBI|beta_lactam|IMP-9|antibiotic inactivation|1
SAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVIPKHGLVVLVNTDAYLIDTPFTAKDTE
NLVNWFVERGYRIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKYS
FSGVSYWLVKKKIEVFYPGPGHAPDNVVVWLPENRVLFGGCFVKPYGLGNLGDANLEAWP
>YP_458405.1|FEATURES|NCBI|beta_lactam|NDM-6|antibiotic inactivation|1
MIARVLALAAALALPACVPGEIRSSVAEQEADRDIIRFGEVSFSQLAEGVWMHTTYLDLM
GFGPIPSNGLLVVNGDNTILVDTAWTDEQTEQIVAWASMVLAKPVRAAVVTHAHQDKMGG
MAALHGANIATWAHPLSNELAPEEGLVPARNAITFDANGWATGEAAQSLAPLRLYYPGGA
HTRDNITVGLPELGIAFGGCMIKAGDASNLGNLADADTAAYAQSVRNFAAAFPDARTIAM
SHSPPEGRKAIERTLDLAEEL
>ACT52233.1|FEATURES|NCBI|beta_lactam|VIM-11|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVYSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGSEIPTHSLEGLSS
>1X8H_A|FEATURES|NCBI|beta_lactam|cphA7|antibiotic inactivation|1
AGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKP
VLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPL
VLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFVYFPDEQVLYGGCILKEKLGNLSFADV
KAYPQTLERLKAMKLPIKTVIGGHDSPLHGPELIDHYEALIKAAPQSS
>ABO60999.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTTLALTATLAFDVTAADAPLPQLQAYTVDASWLQPMAPLQIADRTWQIGTEDLTA
LLVQTADGAVLLDGGMPQMAGHLLDNMKARGVAAQDLRLILLSHAHADHAGPVAELKRRT
GASVAANAESAVLLARGGSNDLHFGDSITFPPASADRIIMDGEEVTVGGIAFTAHFMPGH
TPGSTAWTWTDTRDGQPARIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVRGLPCDL
LLTPHPGASNWNYAAGAEAGANALTCKAYADAAEKKFDAQLAKETATAR
>2QIN_A|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
AEVPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTALLVQTPDGAVLLDGGMPQMA
SHLLDNMKARGVTPRDLRLILLSHAHACHAGPVAELKRRTGAKVAANAESAVLLARGGSD
DLHFGDGITYPPANADRIVMDGEVITVGGIVFTAHFMAGHTPGSTAWTWTDTRNGKPVRI
AYADSLSAPGYQLQGNPRYPHLIEDYRRSFATVRALPCDVLLTPHPGASNWDYAAGARAG
AKALTCKAYADAAEQKFDGQLAKETAGAR
>BAF47405.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
AAEPPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTALLVQTPQGAVLLDGGMPQM
ADHLLRNMKARGVAPQDLRLILLSHAHADHAGPVAALKRSTGAQIVANAESAVLLARGGS
HDLHFGDGITYPPANADRIIMDGEVVTVGGIDFTAHFMPGHTPGSTAWTWTDTRDGTPVR
IAYADSLSAPGCQLRDNPRYPRLIEDYKRSFATVRALPCDELLTPHPGASNWNYSAGAKA
GAKALTCKAYADEAEKKFDAQLAKETAGAR
>CAB94704.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EAPLPQLRAYTVDASWLQPMAPLQVADHTWQIGTEDLTALLVQTAEGAVLLDGAMPQMAG
HLLDNMKLRGVAPQDLRLILLSHAHADHAGPVAELKRRTGAHVAANAETAVLLARGGSND
LHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPGHTPGSTAWTWTDTRDGKPVRIA
YADSLSA
>ADC79557.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALLLAQPAMAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKAEA
>CAB94700.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EVPLPQLRAYTVDASWLQPMAPVQIADHTWQIGTEDLTALLVQTPDGAVLLDGGMPQMAS
HLLDNMKARGVTPRDLRLILLSHAHADHAGPVAELKRRTGAKVAANAESAVLLARGGSDD
LHFGDGITYPPPNADRIIMDGEVITVGGIVFTAHFMAGHTQGSTAWTWTDTRIGKPVRIA
YAGSLSA
>WP_006832294.1|FEATURES|NCBI|beta_lactam|AIM-1|antibiotic inactivation|1
MSARTLLLASLSLAATACANATAQPASDPVVAPPASEAAPTPRERVAAFLETCEEWDEWD
KPAPPFHILGNTWYVGTCGISAILVTSPQGHVLIDSGTERGAEIVLANIEAAGFAPRDVR
YLLPSHEHFDHVGGFAKIREATGADVVASSIAAEVLRSGVVNEGDPQAAVLDPMAPVEVA
RVVNDGEVVMLGDLEFTAHATPGHTPGALSWSWTACSNPGEPPICRRIAYVDSLSPVSAD
GYRFSDHPAYVGAFRTSIDRVRALPCDELFTPHPSASGMIGNMRTGKIASCTDYAAALTR
KLDERLAKEAAQ
>YP_002116679.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPMKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDIRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>YP_152702.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYVLFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPMKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLSSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPPVTTDKIIHNQESISLGGVTVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQPQ
>WP_001082978.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFLVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFIIQLTAQQPQ
>WP_001522169.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFLVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGISVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTHAFFDSNGLQQYVERSRQRFITQLTAQQP
>WP_005019677.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MKIRNTFLFIFGLATVSTGNILAEPLKLPAEWTQSIEPFRIAGSIYYVGTRGLGSYLLVS
GSKAILIDTGLTENAALIEQNILKLGLNLSDVKIILVSHAHWDHVGALAQIQKNTGAKVF
AMDKEVTALTTGKPKGDNILQSFSYTPVKVDHILRDKEVIKMGKIHLKATLTPGHTPGCT
TWSTSLKEHGKTLNVVFPCSLSVAGNVLSNNQTYPGIVQDYQLSFHRLSKMPADIVLTSH
PEAADLMNRKAKSEAGQLDAFTDRKLLEKIIKDAEFSFNQSLDNQKK
>WP_006271975.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MKPLFFSFAALGLILASPTLADGDPSWSAPHEPYHIVDNVWYVGTAGIGVYLITTDEGHF
LIDGATKDGAAIVEDNIKTLGFDIKDVKYIVETHAHYDHVGGLARLKADSGAELVASVAD
RTALEAGQHEGDNIYGASTFPAVKVDRIVGEGGTITLADSTLMARLTPGHTKGATTWTLT
ALDNGQPRRVVFASSVSVAGNVLVDNATYPHIVRDYRIAFDRLETISADIFLSSHPTFAS
LEDKYQKQKTIKYPEDKAQPFVDSTEFPKYVAQARADFETELARQENAKK
>WP_006871733.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MSLVEFFRIKMKKVSLFLSLAITLFCNLCFAYPVGNPFPPFRVAGNLYYVGTDDLASYLI
VTPKGNILINSDLEVNVPMIKKSIEALGFKFSDTKILLISHAHLDHAAGSQLIKQETKAK
YMVMAEDVPVIESGGKSDFHYANDTSMYFPATTVDRTLHDGDTVKLGGTVLTAHLTAGHT
KGCITWTMQVMEHGKPYQVVMVGSLGVNPGYKLINNTTYPNIAKDYEHAIKVLKSLHCDI
FLGAHAMYFDLGKKYALLNRSVINPFVDPEGYKKHVAQKEHEFYTELKKQESALSLKSA
>WP_006275253.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MVKSISLCAAVLLAGCTATAPQGLSPLADDRQVLNAEAAPLADMAAEAHWNDPFAPFKVV
GNIYYVGTTGVSAWLITTPRGHFLLDGALPQTPPQIIANIQALGFDIRDVKYLLNSHAHF
DHAGGLAALQRAAGATMVASAADRAVLESGRVGYGPTADISVPPVRVDRLVGQGDTLSLG
GVTLTAHLTPGHTPGCTSWSMDVRGDDGELHHVFFHCSTTTGGQSLVPESYPGMIASYRA
TFAYIRNVKADIFLANHANFFNLADKRARQIAGDSDAFVSSTALADFNAQSERDFDAELA
RQQAAASQ
>YP_497017.1|FEATURES|NCBI|beta_lactam|AIM-1|antibiotic inactivation|1
MSIVLASLAAGAATLAAPATPADPQAARDLVRRCEGKESFSDPAPPARIFGNVWYVGTCN
VTVLLVTGPAGHILVDAATEEAVPSILDNIRAAGFEPKDVRWIVSSHEHFDHVGGLAALA
RATGARVAATRAAAKVIRSGKVSPADPQAQEIHGSRPARVDRLIDTGDVVRAGPLALTAF
ATPGHTEGSTSWHWKSCDGADCRTVTYVDSVTALPLGTYRFADHPERVAMFRNTFAQVEA
LECGILLTPHPSASAMFERMSAERRLDEPGACKALAAGARDRLEKALAQ
>WP_007164418.1|FEATURES|NCBI|beta_lactam|AIM-1|antibiotic inactivation|1
MALANSTQALAEGPVTEAERKQAEIARFSQECEKWDDWDKPAHPYRIHANTYYVGTCGIA
AILITSDDGHILIDSGTEAGAQVVLDNIESLGFALEDVEILLHSHEHFDHVGGHALVAER
TGARVGASPLAKPVLETGQVADNDPQHAIHPAMAPVAVGFTLESGRSVSLGKLRIYPFTT
AGHTPGARSYFWRSCEDRDCKAIVFADSMSPVSSDDYRFSEHPDYVSEYRAGIERVAGMS
WRCDILLTPHPSHSKMIERAAAGRLDNGMSCEAFAAGKTEDLNARLEREAGANQ
>WP_008504272.1|FEATURES|NCBI|beta_lactam|LRA-12|antibiotic inactivation|1
MKRILTLLIFLCVNCCTLAQNVSEPSSKMHPEWSKPYPPFQIAGNLYYVGTYDLACYLIV
TPKGNILINTGLASSGQLIKTSIESLGFKLTDTRILLTTQAHFDHMGAMAELKRLTGAKM
MVDEGDAAVVADGGLSDYDLQGKVCVFKPVKVDRILHNGDSIMLGGMKLTTLHHPGHTKG
SCSYLFDVQDNDRKYSVLIANMPTIVTDKKFADVLAYPNIANDYAYTLNAMKHITFDIWL
ASHASQFNLTDKHQPGTAYNPGAFMDKKYYYDKIDDLRKEYDSKVNSK
>AAM93471.1|FEATURES|NCBI|beta_lactam|AN672_11615|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKHSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASLVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>BAD16740.1|FEATURES|NCBI|beta_lactam|BCh11DRAFT_01667|antibiotic inactivation|1
MKGWLLGVSLTLLGGGSVALAQDDASDRQTREVLDPIVASLMEAQQIPGMAIALVRPEGT
TISHYGAADRETGTPVDDDTLFEIGSLSKTLTATLASLAEVEGKLDFDAPVSRYLPELEG
SAFDDISGLNLGTHTGGGLPLFVPDEVTDRASLMAWYREWQPTEPIGESRTYSNLGIGLL
GLETAASLDGEFVPTMRAKVLAPLGMQDTWYDVPEARMADYAMGEDKDGQPTRVSPGVLD
DEAYGIKTTAADLAKLVRANLHLADVDAELQQAIDATRQGHYRVGDMTQALIWEQYSLPV
APETLRAGNGYDMILEPNAAEALEPPQSPRDDVWVNKTGSTNGFGGYIVMLPGKHTGLVM
LANKNYPNDARVEAAYRILSGLGAIDVP
>Q48743.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MKRLLAFCLLFFAALGQAKVPPPARSAADAEIQRAVAAFMQQYQVPGVAVGITVDGAERY
YNYGVSSRKTQAKVGANTLFEVGSVSKTFTATLASYAQVNQQLSLADHPGKYLPEMKGHD
FDKVTLLNLGTHTAGGFPMQVPTQVKTDQQLTAYFQSWHPQYPAGTKRTYANPGIGMLGV
IAAKSMRMPFQKAMTGVLLPKLGLTNTYLTVPPAKMAFYAQGYDDKGQPVRMSPGALWEP
TYGIKTTARDLLRFVEINLDQVKVEPKLKRAIDGTHVGYYRLGEMTQGLVWEQLPYPASE
TSLQANSSQKVIFESNAVAALTPPRPPQANVLINKTGSTRGFGAYVAFNPARKIGIVLLM
NRSVPMDGRIKLAHTILDTAGGMAK
>WP_002459970.1|FEATURES|NCBI|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQKIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQKTLFELGSVSKTFTGVLGGDAIAREEITLSDPVTKYWPELTAKQW
NRITLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAAAWQILNALQ
>YP_691594.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLPPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAACQILNALQ
>NP_311274.1|FEATURES|resfam|multidrug|emrK|antibiotic efflux|0
MEQINSNKKHSNRRKYFSLLVIVLFIAFSGAYAYWSMELEDMISTDDAYVTGNADPISAQ
VSGSVTVVNHKDTNYVRQGDILVSLDKTDATIALNKAKNNLANIVRQTNKLYLQDKQYSA
EVASARIQYQQSLEDYNRRVPLAKQGVISKETLEHTKDTLISSKAALNAAIQAYKANKAL
VMNTPLNRQPQVVEAADATKEAWLALKRTDIKSPVTGYIAQRSVQVGETVSPGQSLMAVV
PARQMWVNANFKETQLTDVRIGQSVNIISDLYGENVVFHGRVTGINMGTGNAFSLLPAQN
ATGNWIKIVQRVPVEVSLDPKELMEHPLRIGLSMTATIDTKNEDIAEMPELASTVTSMPA
YTSKALVIDTSPIEKEISNIISHNGQL
>CAC20134.1|FEATURES|resfam|tetracycline|tetC|antibiotic efflux|1
NNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCAPVL
GALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYIADI
TDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFLMQE
SHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDRFRW
SATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAADALGYVLLAFATRGWMA
FPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTSITGPLIVTAIYAASA
STWNGLAWIVGAALYLVCL
>YP_001266290.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|1
MAFTDPFIRRPVLASVVSLLILLLGFQAWNKLQIRQYPQMENALITVTTAYPGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNFSIISIYARVGADSDRLFTELLAKANEVRNKLP
QDSEDPVLSKEAADASALMYVSFYSKEMSNPQITDYLSRVIQPKLATLPGMAEAEILGNQ
VFAMRLWLDPVKLAGFGLSATDVTNAVRRYNFLSAAGEVKGEYVVTSVNASTELKSAEAF
AALPLKTSGDSRVLLGDVARVEMGAENYDTVSSFDGTPSVYIGIKATPAANPLDVIKEVR
RIMPELESQLPSALKVSIAYDATRFIQASIDEVIKTLGEAVLIVIVVVFLFLGALRSVLI
PVVTIPLSMIGVLFFMQMMGYSLNLLTLLAMVLAIGLVVDDAIVVVENIHRHMEEGKSPF
DAALEGAREIAMPVVSMTITLAAVYAPIGFLTGLTGALFKEFALTLAGAVVISGIVALTL
SPMMCALLLRREQNPSGLAHRLDQLFERLKGRYQRVLHATLDSRPVVLVFAVIILCLIPV
LLKFTQNELAPNEDQGVIFMMSSSPQPANLDYLNAYTDQFTPLFKAFPEYYSSFQINGFN
GVQTGIGGFLLKPWNERERTQMELLPLVQAKLEEISGLQIFGFNLPSLPGTGEGLPFQFV
INTAGDYPALLDVAQRIKTRAQASGKFAFLDIDLAFDKPEVVVDIDRAKAAQMGVSMDTL
GGTLATLLGEAEINRFTLEGRSYKVIAQVERPYRDNPGWLNNYYVKNEQGQLLPLSTLIT
LTDRARPRQLNQFQQLNAAIIQGVPMVSLGEALKTVQDIAREEAPEGFAFDYAGVARQYV
QEGSALWVTFGLALAIIFLVLAAQFESFRDPLVILVTVPLSICGALLPLFLGVSSMNIYT
QVGLVTLIGLISKHGILIVEFANQLRDERGLSVREAIEEAAAIRLRPVLMTTAAMVFGMV
PLILATGAGAVSRFDIGMVIATGMSIGTLFTLFVLPCVYTLLAHKASAKAPAIA
>YP_350221.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|1
MAFTDPFIRRPVLATVVSLLIVLLGFQAWSKLPLRQYPQMENALITVTTAYPGANAETIQ
GYITQPMQQSLASAEGIDYMTSVSRQNFSVISIYARIGSNSDRLFTELLAKANEVKNKLP
QDAEDPVLSKEAADASALMYISFFSKELNNPQITDYLSRVIQPKLATLPGMAEAEILGNQ
VFAMRLWIDPVKLAGFGLSASDVTNAVRQYNFLSAAGEVKGEYVVTSINANTELKSAEAF
GKIPLKVSGDSRVLLSDVARVEMGAENYNSISSFGGTPSVYIGIKATPGANPLDVIKEVR
KIMPELEAQLPPNLKSEIAYDATLFIQASIDEVVKTLFEAVLIVIVVVFLFLGALRSVVI
PVVTIPLSMIGVMFFMQMMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKTPL
EAALEGAREIAMPVVSMTITLAAVYAPIGFLTGLTGALFKEFALTLAGAVVISGVVALTL
SPMMCAMLLRHDENPTGLAHRLDRIFDSLKRRYQRMLHGTLNTRPVVLVFAVIVLCLIPV
LLKFTKSELAPDEDQGIIFMMANAPQPTNLDYLNTYTDEFIKIFKEFPEYYSSFQINGYN
GVQSGIGGFLLKPWNERSRTQMEILPEVQGKLEGIPGLQIFGFNLPSLPGTGEGLPFEFV
INTANDYELLLQVADRIKKRAMESGKFAFVDLDLAFDKPEVVVDIDRAKAAQMGVSMQDL
GGTLATLLGEAEINRFTIEGRSYKVIAQVERAYRDNPDWLNNYYVKNTQGELLPLSTLIT
VTDRARPRQLNQFQQLNAAKLSGFPLVSMGEAIDSVLQIAREEAPAGFAFDYGGASRQFV
QEGSALWVTFALALAIIFLVLAAQFESFRDPLVILVTVPLSICGALIPLFLGWSSMNIYT
QVGLVTLIGLISKHGILIVEFANQLRKDKGLTPREAVEEAAAIRLRPVLMTTAAMVFGMV
PLIVATGAGAVSRFDIGTVIATGMSIGTLFTLFVLPCVYTVLAKPDPRE
>YP_002874485.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|1
MKFTDVFIRRPVLAMVVSLLIVLLGFQAYSKLPLRQYPSMENALITVTTAYPGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNFSVISIYARIGANSDRLFTELLAKANEVKNKLP
QDAEDPVLSKEAADASALMYISFSSGQLSNPQITDYLSRVIQPKLATLPGMAEAEILGNQ
VFAMRIWLDPVKLAGFGLSASDITDAVRRYNFLSAAGEVKGEFVVTSINANTDLKSADAF
GAITVKTAGDSRVLLRDVARVEMGAENYNAISSFGGTPSVYIGIKATPSANPLDVIKEVR
KIMPELESQLPPTLKAEIAYDATLFIQASINEVVKTLFEAVLIVIVVVFLFLGALRSVVI
PVITIPLSMIGVLFFMQLMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEDGKTPL
DAALEGAREIALPVVSMTVTLAAVYAPIGFLEGLTGALFKEFALTLAGAVIISGIVALTL
SPMMCALLLRHDENPSGLAHRLDRIFDSLKRRYQSMLHGTLNTRPVVIVFALIVLCLIPV
FLKFTQSQLAPDEDQGIIFMMASAPQPTNLDYLNTYTDEFIKIFKEFPEYYSSFQINGFN
GVQSGIGGFLLKPWNERDRTQMQILPEVQKRLEQIPGLQVFGFNLPSLPGTGEGLPFGFV
INTANDYESLLDVANRVKKRAMASGKFAFVDIDLAFDKPEVVVDIDRAKAAQMGVSMQDL
GGTLATLLAEAEINRFTLDGRSYKVIAQVERAYRDNPDWLNNYYVKNAQGELLPLSTLIT
LTDRARPRQLNQFQQLNSALISGFPIVSMGEAIDTVRQIALEETPPGYAFDYSGASRQFI
QEGTALWVTFGLALAIIFLVLAAQFESFRDPLVILVTVPLSICGALIPLFLGWSSMNIYT
QVGLVTLIGLISKHGILIVEFANQLRKDKGLTPRQAVEEAAAIRLRPVLMTTAAMVFGMV
PLIFATGAGAVSRFDIGMVIATGMSIGTLFTLFVLPCVYTLLAKPDKA
>WP_041643050.1|FEATURES|resfam|multidrug|amrB|antibiotic efflux|1
MSVLARLVEFSLTQRLLVLVLTALLVGAGAMALRSLPIDAFPDVSTTQVKIIVKAPGMTP
EEVEARITVPIEQELLGIPAQRMLRAVSKYGITDITVDFDDGTDIYWARQQVSERLDAAM
SGLPAQASGGLAPITTPLGEMFMFTIEGPLSLEEKRTLLDRVIRPQLRTIRGVADVNSLG
GHVRSYEVVPNPQLLAARGLGLNLLREAIERNNRNDGAGRLGDGEETLIVRAEGAVNEPA
DLAAVVVATRDGVPVRLGDVAEVRIGSLTRYGAVTRDGAGETVQGLVLGLRGANAQAVIA
GVKARLAELAPSLPPGVSIVPFYDRSALVDRAVGTVSKALFEAIALVVVLLLAFLGNLRA
ALVVALTLPLAALGTFILMRYTGVSANLMSLGGLAIAIGMLVDAAVVVVENVETQLAADG
VQARLPLLHVVYRAVREVALPVASGIAIIIIVFVPLLTLQGLEGKLFVPVALSIVYALAS
SLVLALTVIPVLASLLLKRGEAHTPWLVRRLDAAYAPALDWALANARTVIAVALLSLALA
AAGYAFVGKTFMPTMDEGDLIMQLEKLPSIGLEQTIAVDSRVQRTILEQVPEVKSVVARS
GSDELGLDPMGLNQTDSFLVLKPVAEWRQPDKAWLTDELRRVVAEFPGIDVTFTQPIDMR
VSEMLTGVRGDIAIKVFGTDLAALGRAAGEIEALLAAMDGAEDVFTAKNEGVQYLRVEID
HLAAGRLGLSVDDVQSALRSLVEGEQAGAVIEAGRRVPILIRADEGVRASASRFADLRLA
LPGGGAVPLSAVARLERVAGPVKVDRENGSRYVTVQSNVRGRDLVGFVEEAQARVAATVK
LPAGYRLEWSGQFENQQRAAARLAVVVPVALLLIFLLLFSTFGSVRQAALVLANVPFALV
GGVFALLLAGEYLSVPASVGFIALLGIAVLNGVVMVTYFNQLIEQGMPLARVVVEGARRR
LRPVLMTASIAAFGLVPLLFATGPGSEIQRPLAIVVIGGLISSTLLTLLLLPILFRRFGM
DRAPALSAPEALLP
>WP_011766065.1|FEATURES|resfam|multidrug|MuxB|antibiotic efflux|1
MNPSRLYILRPVATSLLMLAILLAGLIGYRLLPVAALPEVEYPTIQVSTLYPGASPEVVA
SSITAPLERQLGQIAGLKQMSSTSSGGASVITLQFALGLSMDVSQQEVLAAINAASALLP
GDLPMPPVFSKVNPADAPIVTLAISSDTLSLPQVADLVDTRLAQKISRIAGVGLVSIGGG
QRPAVRIQVNPQALAAQGLNLEDIRTAIGEANVNIAKGSFDGPLRASTLDANDQLRSADE
YRRLIIAWKNGAPIRLGDIAELVDGAENTRLAAWADTRPAVILNIQRQPGANVIDTVDRI
KALLPTLQASLPATVDLRLLSDRTTTIRASVRDVGHELLLAIALVVMVIFIFLRNLPATF
IPSVAVPLSLVGTFAVMYLAGFSINNLTLMALTIATGFVVDDAIVMIENIVRHLEEGESP
LEAALKGAQQIGFTIISLTFSLIAVLIPLLFMGDVVGRLFREFAITLAVAILISAVVSLT
LTPMMCARLLHHAPEENHGAFFRLTGAFIDRCIARYAVALRWVLARQGLTLAVAGATLGL
TVLLYLIVPKGFFPSQDTGLIQGITDAPQNVSFAAMAQRQQAAVSAILADPAVDSVSSVV
GVDGVNATLNSGRLLIALKPLGERDAGAAAVIQRLQARLKAVPDIAVYMQAVQDLTIESR
AARTQYQFSLEGANAEQLGEWVHLLRDRLAREPALADVATDWLDQGRQAYVDIDRDSAGR
LGITPADIDAALYNAFGQRQISTIFTQTNLYRVVLEVKPEFQRGLAALDSLYLVSANGAQ
VPLSAVARISERPTLLAINHIGQFPAATFSFNLAPGAALSNAVEDIRAAFAELDPPASLS
LHFQGAAQAFQASLTSTVWLIVAAIVTMYIVLGVLYESYIHPVTILSTLPSAGVGALLAL
LLAGSDLGIIGIVGIILLIGIVKKNAIMMIDFALEAERDHGKSPDEAIFEACLLRFRPIL
MTTLAALLGALPLMLSTGVGAELRQPLGITMVGGLIVSQVLTLFTTPVIYLAFDRLGRRA
RHRLGGLGAQAGEG
>WP_011763980.1|FEATURES|resfam|multidrug|acrB|antibiotic efflux|1
MARFFIDRPIFAWVVAIVIMLAGALSILSLPVSQYPAIAPPQIAINATYPGATAKAVEDS
VTQVIEQKMTGLDNLLYMNSTSDSYGRVTVTLTFNAGTNPDIAQVQVQNKLQTALPLLPQ
AVQQQGVQVAKSTRNFLMVLGFVSRDGSQSANDLSDFLASTVQDPLSRVTGVGEVQVFGS
QYAMRVWLDPAKLNNYKLMPSDVRSALEAQNTQVSAGQLGGTPALPGQGFTASITAQSRL
QTAEQFENILLKSSAQGGEVRLRDVARVEVGAQDYGFTARYNGKPAAGIGIKLAAGSNAL
DTAKAVRKAIDGMSRYFPAGVEVVTPYDTTPFVRLSIEEVVKTLVEAIVLVFLVMFLFLQ
NLRATLIPTIAVPVVLLGTFGLMAAFGFSINTLTMFGVVLAIGLLVDDAIVVVENVERIM
TEEGLSPREATRKSMGQITGALIGIGLVLSAVFVPMAFFGGSTGVIYRQFSITIVSAMAL
SVLVAIVFTPALCATMLKPVEKGHDHSEGGWFSGFFRWFNRMFARNTTRYESAVGGILRR
SGRFLLIYALIVGVLAFLFLRMPTSFLPEEDQGVMFTQVMLPAGATQERTIEVLKKVENH
FLEGEKDYAKSIFTVAGFSFAGSGQNMAIGFVHLRDWDERKGPAGNVKAVAGRAMAAFSQ
IREAMVFAFVPPAVLELGTSNGFDVQLQDRSGLGHDALIAARNQFLGMAAQDKRLVAVRP
NGQEDMQEYVLDIDHAKAGALGVSVSDINATLSTAWGGVYVNDFLDRGRIKKVYLQSQAE
GRMRPEDLTKWYVRNKAGEMVPLSAFASGHWAFGSPRLERYNGQSSVEVLGQGAPGVSSG
DAMAAVEEIIAKLPPGIGYEWTGTSYEERRSGSQAPALYALSLIVVFLCLAALYESWSVP
FAVMLVVPLGVLGAIVAATGRGLSNDVYFQVGLLATIGLSAKNAILIVEFAKEQMEKEGK
ALIDATLEAVRMRLRPILMTSLAFGLGVLPLAVATGAGSGSQNAIGTGVLGGTIFATVLG
IFFIPLFYVAIKRIFKDKPAADAAPLAVQEAR
>WP_000592303.1|FEATURES|resfam|multidrug|mdtb|antibiotic efflux|1
MIKKLLQFSLGNKFAIFLMVVLVVLGGVYASAKLKLELLPNVQNPVISVTTTMPGATPQS
TQDEISSKIDNQVRSLAYVKNVKTQSIQNASIVTVEYENNTDMDKAEEQLKKEIDKIKFK
DEVGQPELRRNSMDAFPVLAYSFSNKENDLKKVTKVLNEQLIPKLQTVDGVQNAQLNGQT
NREITLKFKQNELEKYGLTADDVENYLKTATRTTPLGLFQFGDKDKSIVVDGQYQSVDAF
KNINIPLTLAGGQGQSQSQSDNKQNSAMSDVNQASPQQNSKASAPNNISGMPTAKLGDLA
DITVGDVRTSISKTNGKDAVNLQITKAQDANTVQVAKDVQRKIDTFVDENKDFNVTKTMD
TAKPVEKSLYTMVEKASLGTIVAIIVILLFLRNIRTTAISIISIPLSLLMALIALKLSDV
SLNILTLGALTVAIGRVIDDSIVVVENIYRRLTDSEEQLKGENLIISATTEVFKPIMSST
LVTIIVFLPLVFVSGSVGEMFRPFALAIAFSLLASLLVSITLVPALAATLFKKGVKRRNK
QHQEGLGVVSTTYKKVLHWSLNHKWIVIILSTLILVATIVFGGPRLGTSFISAGDDKFLA
ITYTPKPGETEQAVLNHAKDVEKYLKQKKHVKTIQYSVGGSSPVDPTGSTNSMAIMVEYD
NDTPNFDVEADKVIKHADGFKHPGEWKNQDLGTGAGNKSVEVTVKGPSMDAIKSTVKDIE
QKMKQVKGLANVKSDLSQTYDQYEIKVDQNKAAENGISASQLAMHLNENLPEKTVTTVKE
NGKTVDVKVKQNKQTDWSEDKLNNITLKKPTGGTIKLGDIATLVKTTTPSKLTQEQGDYA
TTVSAKVTNKDVGGTTRQVMSKINNLDKPNNVKVNIGGASDDINNAMTQLAFAMLAAIII
VYLILVITFKGGLAPFTILFSLPFTVIGVIIALLITGETISVPSLIGMLMLIGIVVTNAI
VLIDRVINNEQQGMEMKEALIEAGGTRIRPILMTAIATIGALVPLLFGQDSSILISKGLA
ATVIGGLISSTLLTLVVVPVIYEILFTLKKRFTKR
>WP_011764518.1|FEATURES|resfam|multidrug|mexN|antibiotic efflux|1
MNVSAWSIRNPIPAGMLFVLLSFAGLLSFAGMKVQNFPDIDLPTVTVTASLPGATPSQLE
NDVARKIENAIATLQGLKHIYTKVQDGSVVITVEFRLEKPVQEAVDDVRSAVARVKADLP
GDLRDPIVNKVDLAGQPVLAFTIRSARMDDEALSWFVDDTVSRRLLAVRGVGAVTRVGGV
TRELRVTLDPLRLQALGATAAAISHQLRQVQTESAGGRADLGGGEQPVRTLATVASAAEL
ADLELALSDGRSIRLSQVASITDTFAEPRSAALLNGQPVVGFEVARSRGESEVEVGAAVQ
GALDELRAAHPDIEITEAFNFVAPVQEEYDGSLQLLYEGALLAVLVVWLFLRDWRATFVS
AVALPLSVIPAFIGMYLLGFSVNVITLLALSLVVGILVDDAIVEVENIVRHLRMGKTPYE
AAMEAADEIGLAVIATTFTLIAVFLPTAFMSGVAGKFFKQFGWTAALAVFASLVVARVLT
PMMAAYILKPVVGTHREPRWLAWYERWAERCLRHRALTMLAAAAFFIGSLMLVPLLPTGF
IPPDDNSQTQVYLELPPGATLATTRAVAEEARLALTRVDHVVSVYTTIGAGSAGGDPFAP
KGEGEVRKATLTVQLSPRGERPRKQDIENRIRAALEPLPGVRSKVGLGGSGEKYVLVLTG
EDPRALQATALAVERDLRTIPGLGSVASTASLIRPEIAVRPDFARAADLGVTSSAIGETL
RVATLGDYDMSLAKLNLSQRQVPILVRLDESARQDLALLERLAVPGAEGPVMLRQVATLE
VAGGPAVIDRYDRSRNINFEIELSGLPLGDVTAAVAELPSVKNLPPGIRVVPVGDAEVMG
ELFASFGLAMLTGVLCIYIVLVLLFKDLLHPVTILMALPLSLGGAFVGLLIAQKSFSMPS
LIGLIMLMGIATKNSILLVEYAIVARRDHGMSRSEALLDACRKRARPIVMTTIAMGAGMM
PIAIGAGAADTSFRSPMAIAVIGGLITSTVLSLLVVPVVFTYVDSFKNRFLALFGRG
>WP_011766296.1|FEATURES|resfam|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVLILLGGLLAMFQLPISEYPEVVPPSVVVRAQYPGANPKVIA
ETVASPLEESINGVEDMLYMQSQANSDGNLALTVHFRLGMDPDKAQQLVQNRVSQALPRL
PEDVQRLGVTTVKSSPTLTLVVHLISPDDRYDATYLRNYAVLNVKDRLARIQGVGEVSIW
GAGNYAMRVWLDPNKVAQRGLTASDVVRAIREQNVQVAAGVIGASPTLPDVPLQFSVNAQ
GRLKTEVEFRDIVLKTAADGGVTRLGDVARVELDAAEYGLRSLLDNKPAIGMGIMQAPGA
NALAVSAAVRDAMAELKQDFPSSVDYRIEYDPTQFVRASIKAVIVTLLEAVALVVLVVIL
FLQTWRASIIPLLAVPVSIVGTFGLMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIAAGLSPRDATYRAMQEVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALAALLLKPHHDHNPDWLTRAMNRVFGGFFARFNHAFGRASENYGRGV
TGVIGRKSKVMAVYAVLLALTAGVSYVVPGGFVPAQDKQYLISFAQLPNGASLDRTESVI
RRMSQIALEQPGVQSAIAFPGLSINGFTNSSSAGIVFVTLKPFDERRAPELSAGAITAAL
HGKYAAIKDSFIAVFPPPPVMGLGTLGGFKLQIEDRGALGYAELDAAAKAFIAAAQKAPE
LGPSFTSYQINVPQLDVDLDRVKAKQLGVSVTDVFDTMQIYLGSLYVNDFNRFGRVYQVR
AQADAPFRARPEDIGQLKTRNAAGEMVPLSSMVRVHNSFGPEMVVRYNGYTAADINGGPA
PGYSSDQAEAAAERIAAETLPPGIKFEWTDLTYQKILAGNAGVWIFPLSVLLVFLVLAAQ
YESLTLPLAVIMIVPMSILAALTGVWLTAGDNNLFTQIGLMVLVGLSAKNAILIVEFARE
LELQGSTPKEAAIEASRLRLRPILMTSIAFIMGVVPLVLSSGAGSEMRHAMGVAVFFGML
GVTLFGLFLTPVFYVLLRSLGRGSKLHTASPHAAPIPAPHLVS
>resfam_SHV-6|FEATURES|resfam|beta_lactam|SHV-6|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARATTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-19|FEATURES|resfam|beta_lactam|SHV-19|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEAFPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-23|FEATURES|resfam|beta_lactam|SHV-23|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEFCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAGTLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-91|FEATURES|resfam|beta_lactam|SHV-91|antibiotic inactivation|1
MRYIRLCIISLLATLSLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-112|FEATURES|resfam|beta_lactam|SHV-112|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPDNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-116|FEATURES|resfam|beta_lactam|SHV-116|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWHADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-117|FEATURES|resfam|beta_lactam|SHV-117|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYLQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-121|FEATURES|resfam|beta_lactam|SHV-121|antibiotic inactivation|1
MRYARLCIISLLATLPLVVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITVSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-123|FEATURES|resfam|beta_lactam|SHV-123|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGGNIKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-130|FEATURES|resfam|beta_lactam|SHV-130|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAP20890.1|FEATURES|resfam|beta_lactam|SHVL-13|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLHKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHVL-58|FEATURES|resfam|beta_lactam|SHVL-58|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIAEKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHW
>resfam_SHVL-68|FEATURES|resfam|beta_lactam|SHVL-68|antibiotic inactivation|1
QPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAG
DEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAG
LTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQL
LQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLSPNNKAERIVVIYLRDTP
ASMAERNQQIAGIGAALI
>AAV91760.1|FEATURES|resfam|beta_lactam|SHVL-71|antibiotic inactivation|1
LEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAMLARVDAGDE
QLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLT
AFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQ
WMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPAS
MAERNQQI
>ABN09740.1|FEATURES|resfam|beta_lactam|TEML-47|antibiotic inactivation|1
MSIQHFRVALIPAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTF
KVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
TAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRK
LLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPD
GKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABQ14389.1|FEATURES|resfam|beta_lactam|TEML-49|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYAPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14401.1|FEATURES|resfam|beta_lactam|TEML-55|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLATIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14422.1|FEATURES|resfam|beta_lactam|TEML-56|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGVTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14385.1|FEATURES|resfam|beta_lactam|TEML-60|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYPQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14413.1|FEATURES|resfam|beta_lactam|TEML-61|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSHIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14384.1|FEATURES|resfam|beta_lactam|TEML-65|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHSMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14426.1|FEATURES|resfam|beta_lactam|TEML-71|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAERGA
>ABQ14425.1|FEATURES|resfam|beta_lactam|TEML-73|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTALLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14397.1|FEATURES|resfam|beta_lactam|TEML-74|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVRDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGPRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14415.1|FEATURES|resfam|beta_lactam|TEML-75|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILKSFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYPQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14427.1|FEATURES|resfam|beta_lactam|TEML-81|antibiotic inactivation|1
ALIPFFAAFYLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14408.1|FEATURES|resfam|beta_lactam|TEML-87|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDMVEYSPVTEKHLTDGMTVRGLCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAEPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14421.1|FEATURES|resfam|beta_lactam|TEML-88|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMVS
TFKVLLRGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14377.1|FEATURES|resfam|beta_lactam|TEML-96|antibiotic inactivation|1
ALIPFSAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPIDERDTTMPVAMATTL
RKPLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14439.1|FEATURES|resfam|beta_lactam|TEML-98|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRTHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAADLLLATIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDRMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>AAA80669.1|FEATURES|resfam|beta_lactam|TEML-101|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTSGNYG
>ABQ14429.1|FEATURES|resfam|beta_lactam|TEML-102|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLRGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVIIYTTGSQATMDERNRQIA
>resfam_TEM-27|FEATURES|resfam|beta_lactam|TEM-27|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-44|FEATURES|resfam|beta_lactam|TEM-44|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
SGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-61|FEATURES|resfam|beta_lactam|TEM-61|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-73|FEATURES|resfam|beta_lactam|TEM-73|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
CGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-66|FEATURES|resfam|beta_lactam|TEM-66|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLDRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAR02602.1|FEATURES|resfam|beta_lactam|TEML-117|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDVGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABJ97318.1|FEATURES|resfam|beta_lactam|TEML-125|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAISMSDNTAANLLLTTIGGPKELTAFFHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAB68655.1|FEATURES|resfam|beta_lactam|TEML-129|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERHTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABF81660.1|FEATURES|resfam|beta_lactam|TEML-130|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRDDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_012477537.1|FEATURES|resfam|beta_lactam|TEML-132|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVLSHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAA99042.1|FEATURES|resfam|beta_lactam|TEML-134|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
LYAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEML-141|FEATURES|resfam|beta_lactam|TEML-141|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILEGFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAD31807.1|FEATURES|resfam|beta_lactam|TEML-146|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRILYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMPTTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAF09467.1|FEATURES|resfam|beta_lactam|TEML-153|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHFDLLVFVKDCEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLFRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAA56743.1|FEATURES|resfam|beta_lactam|TEML-160|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PTAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>1CK3_A|FEATURES|resfam|beta_lactam|TEM-116_with_artificial_N276D_mutation_(N-23)_[_V84I_A184V_N276D]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRID
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERDRQIAEIGASLIKHW
>1FQG_A|FEATURES|resfam|beta_lactam|TEM-1_with_artificial_E166N_mutation_(N-23)_[_E166N]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWNPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>WP_000010517.1|FEATURES|resfam|multidrug|smeF|antibiotic efflux|0
MSFSMTKLSVALLLTSSLVGCAAVVKTPYQAPAVQVPGSFQYDKAKAKTASVEQYSDHWW
TLFGDAQLNQLVTNVLERNSDLAVAGITLKQARLQADLTANKQGLRTSSSVSTGHSFDLN
SGDDSAKGLSMSAGVSYELDLFGKLARQTEASKWEALATEQDLQATGQSLIATTAKLYWQ
LGYLNERYATAQQSLATSQKLYQLVQTQYKAGAVSGLDLTQAEQSVQSQKASLSQIEQQL
VETRTAIAVLLHEPVQQLNIQEPQRLPRTALPAIGAGLPADILSRRPDLQAAELRLRKAL
ATKDATKASYYPSISLTSSLGSSSTSLTELLRNPALTLGASLSLPFLQYNDMKKDIAISN
LDYEKAIIQYRQTLYQAFADVENALSSRTELDKQVAIQERNVELAEKTERLTEVRYRYGA
VALKTLLDAQQTTRTARLSLVETKQSQYNAYVTLMQALGGSPVKELPQ
>WP_000680574.1|FEATURES|resfam|multidrug|smeR|antibiotic efflux|0
MKHIMLVEDEVELAHLVRDYLEAAGFEVSMFHDGQDAYTNFQQRKPNLMILDLMVPRMDG
LTICRKVREQSDLPIIMVTARTEEIDRVLGLNMGADDYVCKPFSPKELVARVQAVLRRLE
RKAEPEQNDSFRIDKAQQRIWYQQKSLSLTPTEFRLLELFLEHVGQVYSRAQLLDHINPD
SFDVADRVIDSHIKNLRRKITEVAETGNRHEWIQAVYGVGYRFEYPEE
>NP_310914.1|FEATURES|resfam|multidrug|baeR|antibiotic efflux|0
MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLSYVRQTPPDLILL
DLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVAR
VKTILRRCKPQRELQQQDAESPLIIDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVF
SREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIV
>WP_072498116.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|1
MGGFFGLLNETLLVTALPSIMKDFEISYTQVQWLTTAFLLTNGIVIPLSALVIQRYTTRQ
VFLVGISIFFLGTLLGGLSPHFATLLVARIIQALGAGIMMPLMMTTILDVFQPHERGKYM
GIFGLVIGLAPAIGPTLSGYLVEYFNWRSLFHVVAPIAAVTFLIGFKTIKNVGTTIKVPI
DFISVIFSVLGFGGLLYGTSSISEKGFDNPIVLVSMIGGVVLVALFVLRQYRLSTPLLNF
AVFKNKQFTVGIIIMGVTMVSMIGSETILPIFVQNLLHRSALDSGLTLLPGAIVMAFMSM
TSGALYEKFGPRNLALVGMAIVVITTAYFVVMDEQTSTIMLATVYAIRMVGIALGLIPVM
THTMNQLKPEMNAHGSSMTNTVQQIAGSIGTAALITILSHASKNFSPTMSDYNGMNKIDM
MNQIKVDTMLHGYHAGFLFALLITVVSFFCSFMLQGKKKEVDSRQ
>WP_001140995.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|1
MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLV
NGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMP
LMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTATGLIIDQASWRVPFIIILGIAILA
FVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMV
IIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSA
LLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYL
IVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFG
AKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF
>AAK47485.1|FEATURES|resfam|qa_compound|Qac|antibiotic efflux|0
MIYLYLLCAIFAEVVATSLLKSTEGFTRLWPTVGCLVGYGIAFALLALSISHGMQTDVAY
ALWSAIGTAAIVLVAVLFLGSPISVMKVVGVGLIVVGVVTLNLAGAH
>WP_011764346.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKREAFSPSASSTGAGTPLIELAGITRSFRNGEIETRVLHGIDLTIYPGEFVAIVGASGS
GKSTLMNILGCLDRPSSGTYRFMGEDVAGFDRDELARLRREAFGFVFQSYNLLGGASARE
NVEVPAVYSGMPPAERHARAEQLLASLGLGERSHHRPSQLSGGQQQRVSIARALMNGGRI
ILADEPTGALDSRSGEEVMKLLRQLSAEGHTIILITHAREVAEMAQRIIEIRDGHIVADP
GPSKPQGPEPDFAPHVDRTSSMSDLVEATRTALRALRANLFRSALTLLGIVIGVASVIAM
LAIGDGAKAKVVDQISAMGTNLLTVRPGAPNQRGRETTATLVIEDVRAIAELPNVLASVP
EQSASVTLRADNTDQRTTANATSWNYGVARNWPVASGTFFSAEDEARYATVAVLGQTTAG
ALFPGVDPIGQYVLVNNIPFQVIGVMSPKGATPWGQDQDDIVFVPFTTGSLRVTGQRYLR
NVTVAVEDVSRIDATQNEVSQLLLARHGVEDFQIRNMASVIDTVSATQNTLTILLGTVAA
ISLLVGGIGVMNIMLVSVTERTREIGIRMATGARMKNILQQFLIEALVVSALGGLIGVAV
GLGTAAVIALFDTPIKYSLLPVVLAFGCAFATGLVFGYLPARKAARLDPVVALASE
>WP_011764568.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAQIELSGIERVFTLGDSQVHALRDVSLEIEAGEYVAVMGPSGSGKSTLLNLLGLLDRPD
AGHYRLEGRDVTTLSADEQAQVRRNRIGFVFQSFHLVPRLTAAENIALPLMLAGLAPAER
QARVGRALKDFGLETRADHRPDELSGGQRQRVAIARATIMQPAMLLADEPTGNLDRHTGQ
EVTELLEALNAAGTTLIVVTHDPAMGNRARRRLMMEDGMLRQDLRDGTPAPTGTP
>YP_001708126.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTKQALLEVSNLVREFPAGESTIQILKGIDLTIYEGELVAIVGQSGSGKSTLMNILGCLD
RPTSGSYKVNGQETGKLEPDQLAQLRREYFGFIFQRYHLLGDLSAEGNVEVPAVYAGVTP
ADRKQRATALLTELGLGTKTQNRPSQLSGGQQQRVSIARALMNGGDVILADEPTGALDSH
SGVEVMRILRELNAAGHTIILVTHDMQVAKNATRIIEISDGEIISDRPNVPDQSLEEVKS
DPDAAPALQNKQKKGKSISAWRSTLDRLSEAFQMALLSMNAHRMRTFLTMLGIIIGIASV
VTVVALGNGSQQQILSNISSLGTNTITVFQGRGFGDNSKTANFKTLVPADADALMTQPYV
SAVSPMVSTSKTMRSQQNEANATINGVSNDYFDVKGLVFKDGQTFDQRSVRDRSQDVVID
TNTQKQFFSDGTNPIGQVVLLGSVPARIIGIVEPQTSGMGSDDTLNVYMPYTTVMSRMLG
QAHVRNIVVRINDKYSTSAAENAIVNLLTQRHGAQDIFTMNSDSIRQTIEKTTSTMTLLV
SAIAVISLVVGGIGVMNIMLVSVTERTQEIGVRMAVGARQSDILQQFLIEAILVCLIGGV
LGVLLSLGLGQLINKFAGGNFAVAYSTTSIVAAFVCSTLIGVVFGFLPAKNAAKLDPVAA
LSRE
>WP_001549960.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|0
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISSFT
>WP_000351003.1|FEATURES|resfam|multidrug|golS|antibiotic efflux|0
MDIGEVSKKAKVTTATLRFYEEKGLIKSIGRQGLRRQYGKQVIDQLALIALGRAAGFSLN
EVATMFRQDGKPDLDRQKLKDKAEQLEQMAKRLHFISQGLEHAAVCPAENHMECPTFQKF
LKAAIAGEYQPTKL
>WP_000004112.1|FEATURES|resfam|multidrug|golS|antibiotic efflux|0
MLTVGEVAKRSGVAVSTLHFYESKGLIKSIRTNGNQRRFTLVVLRYIAIIKIAQKVGIPL
DEIKQALSKYPMGSKLTAQQWKELSLDWRKNLDERIQKLTRLRDEMDWCIGCGCLSLEQC
PLRNPNDVLGQEGAGPRILERP
>CAG25751.1|FEATURES|resfam|glycopeptide|vanSO|antibiotic target alteration|0
MDRAAGMSVRLKLTLSYACFLVLAGVLLLASVWLFLLRDVPDVLAKPPPGGVLERSVLVR
NFLPAAGSVLFFLLLFGLLGGWILAGRMLAPLTRITDAARMAANGSLSHRIRLEGTEDEF
RELADAFDAMLARLEAHVAAQRRFAANASHELRTPLAITQALLEVARNDPAKDPLLVFDR
LHAVNARAIDLTEALLVLSRADQRAFTREPVDLSLLVEEAIETLLPIAEKRRVVIIASGH
ISRVVGSATLLLQ
>AAV68179.1|FEATURES|resfam|glycopeptide|vanSE|antibiotic target alteration|0
MKNNLTVQITKKYFYTMIIITTILVILPLVAKMFLSLRVWQGTEFFYPILYILNRSLGVW
LIVTPLFIWLIVTYMFFRKMISYLEEMIVATKSLIETPNEKIVLRVELAEFENEINHIRI
DSLENKKMAEEAGKKRDDLLTYLAHDLRTPLTSIIGYISLLQNEQTYLELDSTKRKNYID
IISDKANRLEHLLNDFFEIAKTGKSREEVYKEEVDLSLMLSQISSEFLPLLDEKKLEWDF
KIEPNVFVQLNINKFERVLDNLIRNAISFAQ
>AAA26657.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|MsrA|antibiotic target protection|1
MLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRD
VSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLI
LDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT
>AAA26034.1|FEATURES|NCBI|tetracycline|tetK|antibiotic efflux|1
MFSLYKKFKGLFYSVLFWLCILSFFSVLNEMVLNVSLPDIANHFNTTPGITNWVNTAYML
TFSIGTAVYGKLSDYINIKKLLIIGISLSCLGSLIAFIGHNHFFILIFGRLVQGVGSAAF
PSLIMVVVARNITRKKQGKAFGFIGSIVALGEGLGPSIGGIIAHYIHWSYLLILPMITIV
TIPFLIKVMVPGKSTKNTLDIVGIVLMSISIICFMLFTTNYNWTFLILFTIFFVIFIKHI
SRVSNPFINPKLGKNIPFMLGLFSGWANIFYSSWFYINGALYDENYLSCKCSDNR
>AAS76623.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(39)|antibiotic target alteration|1
MSSKNQGRHEHGQNFLCDRRVVADIVKIVSHTTGSIVEIGAGDGALTVPMQRLGRPLTAI
EIDRRRAERLARRTTAHVVTADFLRYRLPPTEHVVVGNLPFHLTTAILRRLLHSPAWTDA
VLLMQWEVARRRAAVGGATMMTAQWWPWFEFGLARKVSADAFRPRPSVDAGLLTITRRRE
PLIDGADRRRYQALVHAVFTGRGRGVAQIVGPRVPRHWLRHNGITPSALPRDLTAAQWAA
LFEVTSEAKRC
>ABD98019.1|FEATURES|NCBI|tetracycline|tetS|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYSSGRIKELGSVDSGTTKTDTMFLERQRGITIQTAI
TSFQRENVKVNIVDTPGHMDFLADVYRSLSVLDGAILLISAKDGVQSQTRILFHALRKMN
IPIIFFINKIDQNGINLPDVYQDIKDKLSDDIIIKQTVNLNLKPYVIDYTEPEQWETVIV
GNDYLLEKYTIGKTLNIAELEKEENERIQSCSLYPVYHGSAKNNIGIKQLIEVITSKLFS
PTQLNSDKLCGNVFKVEYSDDGQRLVYVRLYSGTLHLRDSVNISEKEKIKVTEMYTSING
ELRQIDKAEPGEIIILKNELLKLNNVLGDKKRLPHREILENPLPMLQTTIEPCKSVQREK
LLDALFEISDSDPLLQYYVDTVTHEIVLSFLGEVQMEVTCTLIQEKYHIEIETRKPTVIY
MERPLKKSEFTIDIEVPPNPFWASIGLSVTPLPLGSGIQYESLVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWKLTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQAFRKSGTELLEPYL
SFEIYVPQEYLSRAYNDASKYCANILNTKLKGNEVILIGEIPARCIQEYRNSLTFFTNGR
SVCLTELKGYQVTNIKSAFQPRRPNNRIDKVRHMFNKINLH
>ACR40098.1|FEATURES|NCBI|chloramphenicol|nimI|antibiotic inactivation|0
MFREMRRKRQQLSDAESVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKG
HKVDAIRGCDKASFCVIEQDEVHGEEYTTYFRSVIAFGRIRILEDETERMAAARLLGDRY
HPHHEEALGRELAKSFSHMLVICLDIEHMTGK
>CBL13258.1|FEATURES|NCBI|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
EIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>ADK91600.1|FEATURES|NCBI|tetracycline|tetM|antibiotic target protection|1
MEEIKLKIINIGILAHVDAGKTTLTESLLYSSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKIGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVIT
NKFYSSTHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMY
TSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKP
EQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKE
PTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPDRCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>ADN51953.1|FEATURES|NCBI|tetracycline|tetL|antibiotic efflux|1
MNTSYSQSNLRHNQILIWLCVLSFFSVLNEMVLNVSLPDIANDFNKSPASTSWVNTAFML
TFSIGTALYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFPILILARFIQGAGAAAF
PALVMVVVARYIPKENRGKAFGLIGSIVAMGEGIGPAIGGMIAHFIHWSYLLLIPMMTII
TVPFLIKLLKKEVRIKGHFDIVGIILMSVGIVFFMLFTTSYNISFLIISILSFLIFVKHI
RKVTEPFVEPALGKNISFIIGVLCGGLIFGTVAGFIYMVPYMMKDVHQLSTAAIGSVIIF
PGTMSVIIFGYIGGLLVDRKGPLYVLTIGVTFLSVSFLIAAFFLEVTPWLLTIILVFVFG
GLSFTKTVISTIVSSSLKQKEAGAGMSLLNFTSFLSEGIGIAIVGGLLSVRLLNQKLLPM
DLDQSTYLYSNMLFLFTGVVVTSWLITLNVYKRRQIQFKS
>AFJ38137.1|FEATURES|NCBI|fosfomycin|fosX|antibiotic inactivation|1
MKGISHITFIVRDLNRMAALLCEGLGAREVYDSSNQNFSLSREKFFVLGSTWLAAMEGEP
PAERSYQHVAFAVSETDLPAYQARLEALGVEIRPPRSRVDGEGLSLYFYDFDNHLFELHS
GTLEQRLVRYQAGR
>WP_005260134.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSKKLKLLALCATVISAATLVGCQNIQSQAQPLVLKKQTQDQIATAFENIQTTGVLVTYD
GKNFQKYGNDLSRADQRYIPASTFKMLNALIGIQHHKTSPNEVFKWDGQKRAFRSWEKDL
TLAEGMQASAVPVYQELARRIGLELMASEVKRVGYGNQNIGAQVDNFWLVGPLEITPVEE
VKFAYALAKQQLPFDPSTQQQVRDMLLIENVQGTRIYAKSGWGMDVNPQVGWWTGWIEQT
NGQITAFSLNMEMKKAEHADARKAIVYQALQQLGLLPQ
>AGV79342.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MEIVQDKIRIRTLTNDDFPLMLKWLTDDRVLEFYGGRDKKYTLESLKEHYTEKWEDEVFR
VIIEYDNVPIGYGQVYKMYDELYSDYHYPKTNEIVYGMDQFIGEPEYWSKGIGSKYTKMI
FEFLKKERNANAVILDPHKNNPRAIRSYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYD
DNVTNVKAMKYLIEHYFEDFKVESIKVIGSGYDSVAYLVNGEYIFKTKFSANKKKGYEKE
KAIYDFLNQRLNTNIKIPNVKYSYFSDNISILGYKEIKGTFLTPEIYFALSKEKQELLKQ
DIAMFLRQMHDLDYSEISLYTIDNKQNVLEEYQLLKDTIYDSLTDIEKQYVEDFMQRLHS
TTIFDGKKCLCHNDFSCNHLLLDDENRLCGVIDFGDSGIIDEYCDFIYLLEDSEEEIGVS
FGEDILRLYGNIDISKAKEYQDVVEQYYPIETIVYGIKNNRPDFIEKGRKEIYIRTRKDE
KLRK
>WP_028086456.1|FEATURES|NCBI|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCIPSNG
EIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTWIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>AJC94664.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MKKIFLLFGLFCSFALANENLKDLFKDYNESGVFIAYDGKNYYSNDFKKANKRILPASTF
KIFNALIALNEGVVKDTNEIFYHYKGEKVFLPSWKNNANLALAMQRSQLPAYKELARKIG
LEKMQKNLNKLNYGNQKISKIDEFWIDDSLQISLKEQATLLFKLANLTLDYPKHIQEEVI
NIIKLKENDHYELFAKTGWGLRQYGQIVGFIKSKKSDKIYAFALNMNISDFNKLYLREEI
VQLYLDQL
>AKI29912.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNDFKRAKEPFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
KIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKDIKNIKIREELL
EKYIYSLN
>AKQ05899.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MPHTKKILVIGASIAGPALCYWLNHYGFQPTLVEKNQSTRKGGYAIDLRGIAVDVAKQMG
IYDSVCAMRTSLQCVRYVDAAGNLLFEEHGEKGGFRQGDEVEIVRGDLVDILMKTITDIP
CFYDHAIESLTQHDDHVTVQFKNGKTENYDLVIAADGLHSATRRMVFSKDDYHLRNLGCY
ISVFSIPNYLQLDHCETLLEAKQKLVSITSDKDSTKAFAGFMFRSSNSPNYIRDEASQKD
FLRENFTNHGWESNKLLSLMNDANDFYFDAIMQVKMKDWTKGRIALVGDAGYTPSPLSGQ
GTSLALVGAYILAGELKTATDHVAAFARYNELLKPYVEANQAFGVWVSESFLADEPLSAE
QAEERNNIVLGIMKKATHAIELPEY
>ALA99187.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MKKIISRWRRGVFGLRVALAVVSPMVFAVPAHATEAAGGAAGTKAAAVHMKERADWGKFF
DAEGVKGTIVVLDGRTQTYQAFDTARAERRMSPASTYKIFNSLLALESGALDNEREIIPW
DGKPRRGKYWNAAMDLRTAFRVSCLPCYQVVSHKIARQFAQSKLNEAGYGNHTIGRAADA
YWVDDSLQISAREQVDFLQRLARGTLPFSARSQDIVRQISIVEANPDYVLHGKTGWFVDK
KPDIGWWVGWIERDGNITSVALNIDLKDDADAPKRARIVRAVLSSLQLI
>ALA99189.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MKRILSRWRRAAVVLRLASAVVAHGLLPSPAHALELSRASAAAAPSVAAPVHVTERADWG
KFFAAENVKGTVVVLDGKTQTYQAYDSARAERRMSPASTYKIFNSLLALESGALDNERET
IPWDGKPRRIKAWNAELNLRDAFRVSCYPCYQVVSHKIPRAYAQAKLDAVGYGNRTIGRV
NDTYWVDDSLQISAREQVDFLQRLARGTLPFSARSQDIVRQISIVEANADYVLHGKTGWF
VEKKPDIGWWVGWLERDGNLTMIALNIDMNGDADGPKRARIVREVLKNLKLI
>ALA99190.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MKKTFSRWRRGALVLRILGALASPVVFATPGHAAEPVRPPSVHITERADWGKYFADEGVK
GTVVVLDGRTQTYQAYDAARAERRLSPASTYKIFNSLLALESGAIDNEREVIPWDGKPRS
MKAWNAALNLRDAFRVSCLPCYQILSHKIPRQYAQAKLNEVGYGNRTIGHAADTYWVDDS
LQISAREQVDFLQRLAKGTLPFSARSQDIVRNISIVEANADYVLHGKTGWFTDKKPDIGW
WVGWLERDGNLTMIALNIDIQSDADGPKRVRIVRSVLKDLKLI
>AMM74643.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AOE23833.1|FEATURES|NCBI|quinolone|QnrB19|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYRASLLMERLGIAVIG
>AON96413.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSEATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>APM84488.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTYSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>AQK48217.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDHTAFI
R
>AQM75611.1|FEATURES|NCBI|multidrug|cfr|antibiotic target alteration|1
MSKYKKMKQLIADMRLPEYRYKQLLDAVFLQGIMRFEDMKLLPKTLREKLVEQFGETVVE
IKAIHHEKSMQTDKVLFELSDGNRVETVGLFYKEGWNSFCISSQSGCGFGCKFCATGTLG
LRRNLTVDEITDQILYFMQQGCSINSISFMGMGEPFANPQVFEALHDLTAPELFGLSKRR
ITISTIGIVPGIQKLTREYPQVNLAYSLHAPTDRLRETLMPITKTYPLGQVLDTLDQHIR
QTNRKVFLAYIMLKDVNDSDRHAEQLTKLLFKHKKYLPLYHLDLIPYNQTTVTETMVPSS
HTRIKAFCRIIHNAGISINIRTQFGSDINAACGQLAGAYRDDQKQGERTMSARDVKSFGE
EVCEYGFYNQGAMRSTNSS
>ARB18025.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MFREMRRKRQLLPTEESITILEKMTNGTLALHGDNGYPYAVPVSYVYADGKIYFHSAVKG
HKVDAILRNNKVSFCVVEQDDVKPAEFTTYFRSVIAFGKARILADEGEKQLAFRLLADKY
SHGEVGMEAEIAKGFNHLLMVEIMVEHMTGKEA
>ASK49940.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MVQHTSVWYRCSVSPFVLVASVSVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLVRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDTRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNTICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFITQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>WP_094315354.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNRARN
SEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLD
SEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYQFAPDDQTRVPMQ
VWMSPGFIKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>ATP60693.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFVLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNRARN
SEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLD
SEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGELGLYLHGTPYQFAPDDQTRVPMQ
VWMSPGFIKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>CAH16951.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MGVLNVTSDSFYDGGKYLSVDRACDQALKLIACGADLIDIGGESTKPGAPPVPLDVELSR
VLPVIKQLRALADVCISIDTNKPEVMEAAIDAGANVINDVYALRRDGALNVAAQLDVPVC
LMHMKGEPRTMQENPSYPEGIMKELQHFFEERIDKCQKAGLNKNKLILDPGFGFGKRIKD
NLKLIYHLNELRSFGLPILLGVSRKSTIGAVLNNEVEQRLIGSITLGIYAALKGTAIIRT
HDVDETNQALTMINAIYQAAKEIS
